PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	von Moltke, J; Trinidad, NJ; Moayeri, M; Kintzer, AF; Wang, SB; van Rooijen, N; Brown, CR; Krantz, BA; Leppla, SH; Gronert, K; Vance, RE				von Moltke, Jakob; Trinidad, Norver J.; Moayeri, Mahtab; Kintzer, Alexander F.; Wang, Samantha B.; van Rooijen, Nico; Brown, Charles R.; Krantz, Bryan A.; Leppla, Stephen H.; Gronert, Karsten; Vance, Russell E.			Rapid induction of inflammatory lipid mediators by the inflammasome in vivo	NATURE			English	Article							CASPASE-1 ACTIVATION; IMMUNE RECOGNITION; MICE DEFICIENT; PYROPTOSIS; MECHANISM; INFECTION; INJURY; SUSCEPTIBILITY; SUBSTRATE; FLAGELLIN	Detection of microbial products by host inflammasomes is an important mechanism of innate immune surveillance. Inflammasomes activate the caspase-1 (CASP1) protease, which processes the cytokines interleukin (IL)-1 beta and IL-18, and initiates a lytic host cell death called pyroptosis(1). To identify novel CASP1 functions in vivo, we devised a strategy for cytosolic delivery of bacterial flagellin, a specific ligand for the NAIP5 (NLR family, apoptosis inhibitory protein 5)/NLRC4 (NLR family, CARD-domain-containing 4) inflammasome(2-4). Here we show that systemic inflammasome activation by flagellin leads to a loss of vascular fluid into the intestine and peritoneal cavity, resulting in rapid (less than 30 min) death in mice. This unexpected response depends on the inflammasome components NAIP5, NLRC4 and CASP1, but is independent of the production of IL-1 beta or IL-18. Instead, inflammasome activation results, within minutes, in an 'eicosanoid storm'-a pathological release of signalling lipids, including prostaglandins and leukotrienes, that rapidly initiate inflammation and vascular fluid loss. Mice deficient in cyclooxygenase-1, a critical enzyme in prostaglandin biosynthesis, are resistant to these rapid pathological effects of systemic inflammasome activation by either flagellin or anthrax lethal toxin. Inflammasome-dependent biosynthesis of eicosanoids is mediated by the activation of cytosolic phospholipase A(2) in resident peritoneal macrophages, which are specifically primed for the production of eicosanoids by high expression of eicosanoid biosynthetic enzymes. Our results therefore identify eicosanoids as a previously unrecognized cell-type-specific signalling output of the inflammasome with marked physiological consequences in vivo.	[von Moltke, Jakob; Trinidad, Norver J.; Vance, Russell E.] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, Berkeley, CA 94720 USA; [Kintzer, Alexander F.; Krantz, Bryan A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Wang, Samantha B.; Gronert, Karsten] Univ Calif Berkeley, Vis Sci Program, Berkeley, CA 94720 USA; [Moayeri, Mahtab; Leppla, Stephen H.] NIAID, Parasit Dis Lab, Microbial Pathogenesis Sect, NIH, Bethesda, MD 20892 USA; [van Rooijen, Nico] Vrije Univ Amsterdam, Fac Med, Dept Mol Cell Biol, NL-1081 BT Amsterdam, Netherlands; [Brown, Charles R.] Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Vrije Universiteit Amsterdam; University of Missouri System; University of Missouri Columbia	Vance, RE (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, 229 Stanley Hall, Berkeley, CA 94720 USA.	kgronert@berkeley.edu; rvance@berkeley.edu	Van Rooijen, Nico/Z-1578-2019	Moayeri, Mahtab/0000-0002-4448-8883; Kintzer, Alexander/0000-0001-9630-7258; Brown, Charles/0000-0002-1914-9601; Krantz, Bryan/0000-0002-4911-5824	Burroughs Wellcome Fund; Cancer Research Institute; National Institutes of Health (NIH) [AI075039, AI080749, AI063302, EY016136, EY022208]; Cancer Research Coordinating Committee of the University of California; NATIONAL EYE INSTITUTE [R01EY016136, R01EY022208] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001032, P01AI063302, R01AI075039, R01AI080749] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); Cancer Research Institute; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Coordinating Committee of the University of California(University of California System); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Mariathasan and V. Dixit for Nlrc4<SUP>-/-</SUP> mice; I. Bergin and S. Griffey for pathology reports; D. Crown for help with survival experiments; L. Lopez for support in our animal facility; D. Bautista and R. Nichols for help with calcium imaging; and M. Fontana and members of the Barton and Vance laboratories for discussions. Work in R.E.V.'s laboratory is supported by Investigator Awards from the Burroughs Wellcome Fund and the Cancer Research Institute and by National Institutes of Health (NIH) grants AI075039, AI080749 and AI063302. K.G.'s laboratory is supported by NIH grants EY016136 and EY022208. J.v.M. is supported by a grant from the Cancer Research Coordinating Committee of the University of California.	Agard NJ, 2010, MOL CELL PROTEOMICS, V9, P880, DOI 10.1074/mcp.M900528-MCP200; Amer A, 2006, J BIOL CHEM, V281, P35217, DOI 10.1074/jbc.M604933200; Annacker O, 2005, J EXP MED, V202, P1051, DOI 10.1084/jem.20040662; Bergsbaken T, 2011, J IMMUNOL, V187, P2748, DOI 10.4049/jimmunol.1100477; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Case CL, 2009, INFECT IMMUN, V77, P1981, DOI 10.1128/IAI.01382-08; Fink SL, 2006, CELL MICROBIOL, V8, P1812, DOI 10.1111/j.1462-5822.2006.00751.x; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gijon MA, 2000, ADV ENZYME REGUL, V40, P255, DOI 10.1016/S0065-2571(99)00031-X; Glomski IJ, 2003, INFECT IMMUN, V71, P6754, DOI 10.1128/IAI.71.12.6754-6765.2003; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Hassan IR, 2009, J IMMUNOL, V182, P3223, DOI 10.4049/jimmunol.0802064; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Krantz BA, 2005, SCIENCE, V309, P777, DOI 10.1126/science.1113380; Lamkanfi M, 2010, J IMMUNOL, V185, P4385, DOI 10.4049/jimmunol.1000803; Lamkanfi M, 2008, MOL CELL PROTEOMICS, V7, P2350, DOI 10.1074/mcp.M800132-MCP200; Leedom AJ, 2010, AM J PATHOL, V176, P74, DOI 10.2353/ajpath.2010.090678; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Liclican EL, 2010, INVEST OPHTH VIS SCI, V51, P6311, DOI 10.1167/iovs.10-5455; Lightfield KL, 2008, NAT IMMUNOL, V9, P1171, DOI 10.1038/ni.1646; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Monroe KM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000665; RIVIERE PJM, 1991, J PHARMACOL EXP THER, V256, P547; ROBERT A, 1976, PROSTAG OTH LIPID M, V11, P809, DOI 10.1016/0090-6980(76)90189-1; SAMUELSSON B, 1983, BIOSCIENCE REP, V3, P791, DOI 10.1007/BF01133779; Sapieha P, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001571; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Serhan C. N., 2011, FUNDAMENTALS INFLAMM, P153; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Shao W, 2007, J BIOL CHEM, V282, P36321, DOI 10.1074/jbc.M708182200; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Terra JK, 2010, J IMMUNOL, V184, P17, DOI 10.4049/jimmunol.0903114; Tobin DM, 2010, CELL, V140, P717, DOI 10.1016/j.cell.2010.02.013; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	39	313	316	2	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2012	490	7418					107	U126		10.1038/nature11351	http://dx.doi.org/10.1038/nature11351			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015LG	22902502	Green Submitted, Green Accepted			2022-12-28	WOS:000309446800042
J	Elliott, MJ; De Coppi, P; Speggiorin, S; Roebuck, D; Butler, CR; Samuel, E; Crowley, C; McLaren, C; Fierens, A; Vondrys, D; Cochrane, L; Jephson, C; Janes, S; Beaumont, NJ; Cogan, T; Bader, A; Seifalian, AM; Hsuan, JJ; Lowdell, MW; Birchall, MA				Elliott, Martin J.; De Coppi, Paolo; Speggiorin, Simone; Roebuck, Derek; Butler, Colin R.; Samuel, Edward; Crowley, Claire; McLaren, Clare; Fierens, Anja; Vondrys, David; Cochrane, Lesley; Jephson, Christopher; Janes, Samuel; Beaumont, Nicholas J.; Cogan, Tristan; Bader, Augustinus; Seifalian, Alexander M.; Hsuan, J. Justin; Lowdell, Mark W.; Birchall, Martin A.			Stem-cell-based, tissue engineered tracheal replacement in a child: a 2-year follow-up study	LANCET			English	Article							COLONY-STIMULATING FACTOR; BONE-MARROW; MYOCARDIAL-INFARCTION; AIRWAY STENTS; TRANSPLANTATION; MOBILIZATION; STENOSIS; ERYTHROPOIETIN; MANAGEMENT; HEART	Background Stem-cell-based, tissue engineered transplants might off er new therapeutic options for patients, including children, with failing organs. The reported replacement of an adult airway using stem cells on a biological scaffold with good results at 6 months supports this view. We describe the case of a child who received a stem-cell-based tracheal replacement and report findings after 2 years of follow-up. Methods A 12-year-old boy was born with long-segment congenital tracheal stenosis and pulmonary sling. His airway had been maintained by metal stents, but, after failure, a cadaveric donor tracheal scaffold was decellularised. After a short course of granulocyte colony stimulating factor, bone marrow mesenchymal stem cells were retrieved preoperatively and seeded onto the scaffold, with patches of autologous epithelium. Topical human recombinant erythropoietin was applied to encourage angiogenesis, and transforming growth factor beta to support chondrogenesis. Intravenous human recombinant erythropoietin was continued postoperatively. Outcomes were survival, morbidity, endoscopic appearance, cytology and proteomics of brushings, and peripheral blood counts. Findings The graft revascularised within 1 week after surgery. A strong neutrophil response was noted locally for the first 8 weeks after surgery, which generated luminal DNA neutrophil extracellular traps. Cytological evidence of restoration of the epithelium was not evident until 1 year. The graft did not have biomechanical strength focally until 18 months, but the patient has not needed any medical intervention since then. 18 months after surgery, he had a normal chest CT scan and ventilation-perfusion scan and had grown 11 cm in height since the operation. At 2 years follow-up, he had a functional airway and had returned to school. Interpretation Follow-up of the first paediatric, stem-cell-based, tissue-engineered transplant shows potential for this technology but also highlights the need for further research.	[Birchall, Martin A.] UCL, Ear Inst, Royal Natl Throat Nose & Ear Hosp, London WC1X 8EE, England; [Elliott, Martin J.; Speggiorin, Simone; Fierens, Anja; Vondrys, David] Hosp Children, Dept Cardiothorac Surg, London, England; [De Coppi, Paolo] Hosp Children, Dept Surg, London, England; [Roebuck, Derek; McLaren, Clare] Hosp Children, Dept Radiol, London, England; [Butler, Colin R.; Janes, Samuel] UCL, Ctr Resp Res, London, England; [Crowley, Claire; Seifalian, Alexander M.] UCL, Ctr Nanotechnol & Regenerat Med, London, England; [Beaumont, Nicholas J.; Hsuan, J. Justin] UCL, Ctr Mol Cell Biol, London, England; [Samuel, Edward; Lowdell, Mark W.] Royal Free Hosp, Dept Haematol, Paul OGorman Lab Cellular Therapeut, London NW3 2QG, England; [Cogan, Tristan] Univ Bristol, Sch Vet Sci, Bristol BS18 7DU, Avon, England; [Bader, Augustinus] Univ Leipzig, Dept Cell Tech & Appl Stem Cell Biol, Leipzig, Germany	University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of Bristol; Leipzig University	Birchall, MA (corresponding author), UCL, Ear Inst, Royal Natl Throat Nose & Ear Hosp, 330332 Grays Inn Rd, London WC1X 8EE, England.	m.birchall@ucl.ac.uk	Elliott, Martin J/E-9229-2010; Hsuan, Justin/C-8825-2009; Seifalian, Alexander M/I-6028-2013; Roebuck, Derek/ABB-8690-2021	Elliott, Martin J/0000-0002-3913-9099; Hsuan, Justin/0000-0001-6083-7564; Seifalian, Alexander M/0000-0002-1180-3322; Butler, Colin/0000-0003-4192-0519; seifalian, Alexander/0000-0002-8334-9376; De Coppi, Paolo/0000-0002-1659-0207; Roebuck, Derek/0000-0003-1734-2536; Janes, Sam/0000-0002-6634-5939	Great Ormond Street Hospital NHS Trust; Royal Free Hampstead NHS Trust; University College Hospital NHS Foundation Trust; Region of Tuscany; University College Hospital NHS Foundation Trust (London); University College Hospital NHS Foundation Trust (England); Region of Tuscany (Italy) [GRT 1210/08]; UK Department of Health's National Institute for Health Research; National Health Service National Commissioning Mechanisms; Wellcome Trust; Medical Research Council Translational Stem Cell Research Committee [G1001539]; Great Ormond Street Hospital Charity; Medical Research Council [G1001539] Funding Source: researchfish; MRC [G1001539, G108/596] Funding Source: UKRI	Great Ormond Street Hospital NHS Trust; Royal Free Hampstead NHS Trust; University College Hospital NHS Foundation Trust; Region of Tuscany(Regione Toscana); University College Hospital NHS Foundation Trust (London); University College Hospital NHS Foundation Trust (England); Region of Tuscany (Italy); UK Department of Health's National Institute for Health Research; National Health Service National Commissioning Mechanisms; Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council Translational Stem Cell Research Committee(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Great Ormond Street Hospital Charity; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Great Ormond Street Hospital NHS Trust, The Royal Free Hampstead NHS Trust, University College Hospital NHS Foundation Trust, and Region of Tuscany.; This work was supported by Great Ormond Street Hospital NHS Trust, The Royal Free Hampstead NHS Trust, and University College Hospital NHS Foundation Trust (all London, England), and by a grant (pd 239- 28/04/2009, delib. GRT 1210/08) from the Region of Tuscany (Italy) entitled "Clinical laboratory for complex thoracic respiratory and vascular diseases and alternatives to pulmonary transplantation". Both Great Ormond Street Hospital and University College Hospital receive translational research funding from the UK Department of Health's National Institute for Health Research Biomedical Research Centres scheme (MJE, PDC, SJ, and MAB). MJE is Director of the Service for Severe Tracheal Disease in Children, funded by the National Health Service National Commissioning Mechanisms. SJ is a recipient of a Wellcome Trust Senior Fellowship in Clinical Science. Some laboratory work was supported by a Medical Research Council Translational Stem Cell Research Committee grant to MB (G1001539) and a Great Ormond Street Hospital Charity grant to PDC. We thank Caroline Doyle, whose superb administrative skills were essential to the co-ordination of this procedure. We also thank the anaesthetic, technical, paramedical, and nursing staff in operating theatres, intensive care units, and wards at Great Ormond Street Hospital for Children National Health Service Trust, as well as the senior management of the Trust who approved the internal funding. We thank staff at the Royal Victoria Hospital NHS Trust in Belfast who saved the child's life at first presentation and cared for him on several occasions over the past 11 years. All the staff of the Paul O'Gorman Laboratories for Cell Therapy at the Royal Free Hospital Hampstead NHS Trust contributed to cell, cytokine, and graft preparation, as did many members of the Nanotechnology and Surgical Sciences Laboratories at the same institution. We thank our patient's parents, who were an essential and supportive part of the team and decision-making processes. We also thank the Tuscany Transplant Authority, the Thoracic Surgeons, General and Medical Directors of the University Hospital Careggi in Florence (Italy), staff at the UK's Medicines and Healthcare Products Regulatory Agency (MHRA), especially Ian Rees, who gave timely and free advice on regulatory aspects of this case. The Chairman and members of the Clinical Ethics Committee at Great Ormond Street Hospital constructively considered all aspects to the case and helped with design of the parent's information sheet. We finally pay particular tribute to the courageous and inspiring young man himself.	[Anonymous], 2009 ANN REP US ORG; Antoshina Elena, 1997, In Vitro Cellular and Developmental Biology Animal, V33, P212; Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Bader A, 2011, REJUV RES, V14, P57, DOI 10.1089/rej.2010.1050; Baiguera S, 2010, BIOMATERIALS, V31, P8931, DOI 10.1016/j.biomaterials.2010.08.005; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brouard N, 2010, STEM CELL RES, V5, P65, DOI 10.1016/j.scr.2010.04.002; Delaere P, 2010, NEW ENGL J MED, V362, P138, DOI 10.1056/NEJMoa0810653; Elliott M, 2003, INT J PEDIATR OTORHI, V67, pS183, DOI 10.1016/j.ijporl.2003.08.023; Engelmann MG, 2006, J AM COLL CARDIOL, V48, P1712, DOI 10.1016/j.jacc.2006.07.044; Jacobs JP, 1999, ANN THORAC SURG, V68, P1043, DOI 10.1016/S0003-4975(99)00878-4; Jacobs JP, 2000, EUR J CARDIO-THORAC, V18, P505, DOI 10.1016/S1010-7940(00)00534-0; Jeong JO, 2011, CIRC RES, V108, P1340, DOI 10.1161/CIRCRESAHA.110.239848; Jungebluth P, 2011, J GERONTOL B-PSYCHOL, V6736, P61715; Kassis I, 2006, BONE MARROW TRANSPL, V37, P967, DOI 10.1038/sj.bmt.1705358; Kocyildirim E, 2004, J THORAC CARDIOV SUR, V128, P876, DOI 10.1016/j.jtcvs.2004.07.008; Lange P, 2011, OTOLARYNG HEAD NECK, V145, P544, DOI 10.1177/0194599811419083; Lischke R, 2011, EUR J CARDIO-THORAC, V40, P619, DOI 10.1016/j.ejcts.2010.12.047; Logters T, 2009, MED MICROBIOL IMMUN, V198, P211, DOI 10.1007/s00430-009-0121-x; Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6; Moretti M, 2005, TISSUE ENG, V11, P1421, DOI 10.1089/ten.2005.11.1421; Novotny L, 2012, J THORAC CARDIOV SUR, V143, P437, DOI 10.1016/j.jtcvs.2011.08.002; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345; Rezaeian F, 2008, ANN SURG, V248, P919, DOI 10.1097/SLA.0b013e31818f678e; Ripa RS, 2007, CIRCULATION, V116, pI24, DOI 10.1161/CIRCULATIONAHA.106.678649; Rizzo JD, 2010, BLOOD, V116, P4045, DOI 10.1182/blood-2010-08-300541; Siddiq S, 2009, COCHRANE DB SYST REV, V1; Tatsumi K, 2008, CIRC J, V72, P1351, DOI 10.1253/circj.72.1351; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; Vondrys D, 2011, ANN THORAC SURG, V92, P1870, DOI 10.1016/j.athoracsur.2011.07.042; Wurtz A, 2010, J THORAC CARDIOV SUR, V140, P387, DOI 10.1016/j.jtcvs.2010.01.043	32	321	341	4	145	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 15	2012	380	9846					994	1000		10.1016/S0140-6736(12)60737-5	http://dx.doi.org/10.1016/S0140-6736(12)60737-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	005JF	22841419	Green Accepted			2022-12-28	WOS:000308746000029
J	Coulthard, G; Erb, W; Aggarwal, VK				Coulthard, Graeme; Erb, William; Aggarwal, Varinder K.			Stereocontrolled organocatalytic synthesis of prostaglandin PGF(2 alpha) in seven steps	NATURE			English	Article							PROSTACYCLIN; ANALOGS; ROUTE	Prostaglandins are hormone-like chemical messengers that regulate a broad range of physiological activities, including blood circulation, digestion and reproduction(1,2). Their biological activities and their complex molecular architectures have made prostaglandins popular targets for synthetic organic chemists for over 40 years(3,4). Prostaglandin analogues are widely used as pharmaceuticals and some, such as latanoprost, which is used to treat glaucoma(5,6), have become billion-dollar drugs. Previously reported syntheses of these compounds are quite lengthy, and every chemical step costs time and energy, generates waste and is accompanied by material losses. Using a new bond disconnection, here we report a concise synthesis of the most complex prostaglandin, PGF(2 alpha), with high levels of control of relative and absolute stereochemistry, and fewer steps. The key step is an aldol cascade reaction of succinaldehyde using proline organocatalysis to create a bicyclic enal in one step and an enantiomeric excess of 98%. This intermediate bicyclic enal is fully primed with the appropriate functionality for attachment of the remaining groups(7). Access to this bicyclic enal will not only render existing prostaglandin-based drugs more affordable, but will also facilitate the rapid exploration of related chemical structures around the ubiquitous five-membered ring motif, such as potentially therapeutic prostaglandin analogues.	[Coulthard, Graeme; Erb, William; Aggarwal, Varinder K.] Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England	University of Bristol	Aggarwal, VK (corresponding author), Univ Bristol, Sch Chem, Cantocks Close, Bristol BS8 1TS, Avon, England.	v.aggarwal@bristol.ac.uk	Aggarwal, Varinder/AAG-8504-2019	Erb, William/0000-0002-2906-2091; Aggarwal, Varinder/0000-0003-0344-6430	EPSRC; European Research Council [246785]; Royal Society; EPSRC [EP/E052185/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/E052185/1, EP/D501725/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Research Council(European Research Council (ERC)European Commission); Royal Society(Royal Society of London); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank EPSRC and the European Research Council (FP7/2007-2013, ERC grant no. 246785) for financial support. V. K. A. thanks the Royal Society for a Wolfson Research Merit Award and EPSRC for a Senior Research Fellowship.	[Anonymous], 2011, PFIZER REPORTS 4 QUA; Bahmanyar S, 2003, J AM CHEM SOC, V125, P2475, DOI 10.1021/ja028812d; Bindra J. S., 1981, TOTAL SYNTHESIS NATU, V4, P353; Bindra J. S., 1977, PROSTAGLANDIN SYNTHE; COLLINS PW, 1993, CHEM REV, V93, P1533, DOI 10.1021/cr00020a007; Corey E.J., 1995, LOGIC CHEM SYNTHESIS; COREY EJ, 1978, J AM CHEM SOC, V100, P8031, DOI 10.1021/ja00493a055; COREY EJ, 1969, J AM CHEM SOC, V91, P5675, DOI 10.1021/ja01048a062; COREY EJ, 1971, TETRAHEDRON LETT, P4753; COREY EJ, 1974, TETRAHEDRON LETT, P2439; DANISHEFSKY SJ, 1989, J AM CHEM SOC, V111, P3456, DOI 10.1021/ja00191a067; Das S, 2007, CHEM REV, V107, P3286, DOI 10.1021/cr068365a; EULER U. S. v., 1934, ARCH EXP PATH U PHARMAKOL, V175, P78; Flower RJ, 2006, BRIT J PHARMACOL, V147, pS182, DOI 10.1038/sj.bjp.0706506; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gourlay BS, 2006, TETRAHEDRON LETT, V47, P799, DOI 10.1016/j.tetlet.2005.11.104; HOWARD CC, 1980, J CHEM SOC PERK T 1, P852, DOI 10.1039/p19800000852; LIPSHUTZ BH, 1985, J ORGANOMET CHEM, V285, P437, DOI 10.1016/0022-328X(85)87388-5; List B, 2000, J AM CHEM SOC, V122, P2395, DOI 10.1021/ja994280y; Mukherjee S, 2007, CHEM REV, V107, P5471, DOI 10.1021/cr0684016; Nair S. K., 2010, MODERN DRUG SYNTHESI, P329; Northrup AB, 2002, J AM CHEM SOC, V124, P6798, DOI 10.1021/ja0262378; RESUL B, 1993, J MED CHEM, V36, P243, DOI 10.1021/jm00054a008; Rey MDA, 1999, J ORG CHEM, V64, P3196; Sheddan NA, 2006, ORG LETT, V8, P3101, DOI 10.1021/ol061141u; Stix G, 2006, SCI AM, V294, P60, DOI 10.1038/scientificamerican0506-60; STORK G, 1986, J AM CHEM SOC, V108, P6384, DOI 10.1021/ja00280a043; SUZUKI M, 1988, J AM CHEM SOC, V110, P4718, DOI 10.1021/ja00222a033; Ungrin MD, 2001, MOL PHARMACOL, V59, P1446, DOI 10.1124/mol.59.6.1446; WOODWARD RB, 1973, J AM CHEM SOC, V95, P6853, DOI 10.1021/ja00801a066	30	101	104	2	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2012	489	7415					278	281		10.1038/nature11411	http://dx.doi.org/10.1038/nature11411			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003UC	22895192				2022-12-28	WOS:000308635900038
J	Emanuel, E; Tanden, N; Altman, S; Armstrong, S; Berwick, D; de Brantes, F; Calsyn, M; Chernew, M; Colmers, J; Cutler, D; Daschle, T; Egerman, P; Kocher, B; Milstein, A; Lee, EO; Podesta, JD; Reinhardt, U; Rosenthal, M; Sharfstein, J; Shortell, S; Stern, A; Orszag, PR; Spiro, T				Emanuel, Ezekiel; Tanden, Neera; Altman, Stuart; Armstrong, Scott; Berwick, Donald; de Brantes, Francois; Calsyn, Maura; Chernew, Michael; Colmers, John; Cutler, David; Daschle, Tom; Egerman, Paul; Kocher, Bob; Milstein, Arnold; Lee, Emily Oshima; Podesta, John D.; Reinhardt, Uwe; Rosenthal, Meredith; Sharfstein, Joshua; Shortell, Stephen; Stern, Andrew; Orszag, Peter R.; Spiro, Topher			A Systemic Approach to Containing Health Care Spending	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PROVIDERS; PAYMENT		[Emanuel, Ezekiel; Tanden, Neera; Berwick, Donald; Calsyn, Maura; Cutler, David; Daschle, Tom; Lee, Emily Oshima; Podesta, John D.; Stern, Andrew; Spiro, Topher] Ctr Amer Progress, Washington, DC USA; [Daschle, Tom] DLA Piper, Washington, DC USA; [Kocher, Bob] Brookings Inst, Washington, DC 20036 USA; [Emanuel, Ezekiel] Univ Penn, Philadelphia, PA 19104 USA; [Altman, Stuart] Brandeis Univ, Waltham, MA USA; [Armstrong, Scott] Grp Hlth Cooperat Puget Sound, Seattle, WA USA; [de Brantes, Francois] Hlth Care Incent Improvement Inst, Newton, CT USA; [Berwick, Donald; Chernew, Michael] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Rosenthal, Meredith] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Cutler, David] Harvard Univ, Cambridge, MA 02138 USA; [Colmers, John] Johns Hopkins Med, Baltimore, MD USA; [Kocher, Bob] Venrock, Palo Alto, CA USA; [Milstein, Arnold] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Shortell, Stephen] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Reinhardt, Uwe] Princeton Univ, Princeton, NJ 08544 USA; [Sharfstein, Joshua] Maryland Dept Hlth & Mental Hyg, New York, NY USA; [Stern, Andrew] Columbia Univ, New York, NY USA; [Orszag, Peter R.] Citigrp & Council Foreign Relat, New York, NY USA	Brookings Institution; University of Pennsylvania; Brandeis University; Group Health Cooperative; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Johns Hopkins University; Johns Hopkins Medicine; Stanford University; University of California System; University of California Berkeley; Princeton University; Columbia University	Emanuel, E (corresponding author), Ctr Amer Progress, Washington, DC USA.		Callahan, Charles D/L-1641-2013	Cutler, David/0000-0002-4949-8917; Rosenthal, Meredith/0000-0003-3410-0184				Berenson RA, 2012, HEALTH AFFAIR, V31, P973, DOI 10.1377/hlthaff.2011.0920; Cassel CK, 2012, JAMA-J AM MED ASSOC, V307, P1801, DOI 10.1001/jama.2012.476; Centers for Medicare & Medicaid Services, 2012, COMP BIDD UPD ON YEA; Commonwealth of Massachusetts, 2011, REC SPEC COMM PROV P; Commonwealth of Massachusetts Office of Attorney General Martha Coakley, 2011, EX HLTH CAR COST TRE, P33; Congressional Budget Office, 2012, 2012 LONG TERM BUDG; Cutler DM, 2012, NEW ENGL J MED, V366, P1075, DOI 10.1056/NEJMp1113361; Emanuel EJ, 2012, NY TIMES        0829; Emanuel EJ, 2008, JAMA-J AM MED ASSOC, V299, P2789, DOI 10.1001/jama.299.23.2789; Farrell D, 2008, ACCOUNTING COST US H; Government Accountability Office, 2011, HLTH CAR PRIC TRANSP; Government Accountability Office, 2012, LACK PRIC TRANSP MAY; Institute of Medicine, 2010, I MED WORKSH SER SUM; Jena AB, 2011, NEW ENGL J MED, V365, P629, DOI 10.1056/NEJMsa1012370; Mechanic RE, 2011, NEW ENGL J MED, V365, P777, DOI 10.1056/NEJMp1105963; Medicare Payment Advisory Commission, 2009, C IMPR INC MED PROGR; Mitchell JM, 2012, HEALTH AFFAIR, V31, P741, DOI 10.1377/hlthaff.2011.1372; Office of Management and Budget, 2011, LIV OUR MEANS INV FU, P40; Pittman P, 2012, NURS RES PRACT, V2012, DOI 10.1155/2012/671974; Reinhardt UE, 2011, HEALTH AFFAIR, V30, P2125, DOI 10.1377/hlthaff.2011.0813; Sinaiko AD, 2010, AM J MANAG CARE, V16, P123; Sisko AM, 2010, HEALTH AFFAIR, V29, P1933, DOI 10.1377/hlthaff.2010.0788; US Healthcare, 2010, EFF IND NAT PROGR RE, P7	23	136	136	0	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 6	2012	367	10					949	954		10.1056/NEJMsb1205901	http://dx.doi.org/10.1056/NEJMsb1205901			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	999VO	22852883				2022-12-28	WOS:000308343300015
J	Gabriel, SE; Normand, SLT				Gabriel, Sherine E.; Normand, Sharon-Lise T.			Getting the Methods Right - The Foundation of Patient-Centered Outcomes Research	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gabriel, Sherine E.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Gabriel, Sherine E.] Mayo Clin, Dept Med, Rochester, MN USA; [Normand, Sharon-Lise T.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Normand, Sharon-Lise T.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Mayo Clinic; Mayo Clinic; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Gabriel, SE (corresponding author), Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA.			Normand, Sharon-Lise/0000-0001-7027-4769				Anderson G, 2010, CHRONIC CARE MAKING; Le Fanu J., 2011, RISE FALL MODERN MED; Ogden C.L., 2012, PREVALENCE OBESITY U, P1; Patient-Centered Outcomes Research Institute, 2012, PREL DRAFT METH REP	4	167	169	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 30	2012	367	9					787	790		10.1056/NEJMp1207437	http://dx.doi.org/10.1056/NEJMp1207437			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	996EN	22830434				2022-12-28	WOS:000308067400014
J	Clark, PU				Clark, Peter U.			Ice Sheets in Transition	SCIENCE			English	Editorial Material							PLEISTOCENE CLIMATE; TEMPERATURES; PROXY		Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA	Oregon State University	Clark, PU (corresponding author), Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA.	clarkp@onid.orst.edu						Barker S, 2005, QUATERNARY SCI REV, V24, P821, DOI 10.1016/j.quascirev.2004.07.016; Bintanja R, 2005, NATURE, V437, P125, DOI 10.1038/nature03975; Clark PU, 2006, QUATERNARY SCI REV, V25, P3150, DOI 10.1016/j.quascirev.2006.07.008; Elderfield H, 2012, SCIENCE, V337, P704, DOI 10.1126/science.1221294; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; IMBRIE J, 1993, PALEOCEANOGRAPHY, V8, P699, DOI 10.1029/93PA02751; Lisiecki LE, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001164; Nurnberg D, 1996, GEOCHIM COSMOCHIM AC, V60, P803, DOI 10.1016/0016-7037(95)00446-7; PISIAS NG, 1981, EARTH PLANET SC LETT, V52, P450, DOI 10.1016/0012-821X(81)90197-7; Sosdian S, 2010, SCIENCE, V328, DOI 10.1126/science.1186768; Sosdian S, 2009, SCIENCE, V325, P306, DOI 10.1126/science.1169938; Yu J., 2010, SCIENCE, V328, p1480c	12	3	4	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2012	337	6095					656	658		10.1126/science.1226335	http://dx.doi.org/10.1126/science.1226335			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986PE	22879493				2022-12-28	WOS:000307354500030
J	Meng, L; Ampuero, JP; Stock, J; Duputel, Z; Luo, Y; Tsai, VC				Meng, L.; Ampuero, J. -P.; Stock, J.; Duputel, Z.; Luo, Y.; Tsai, V. C.			Earthquake in a Maze: Compressional Rupture Branching During the 2012 M-w 8.6 Sumatra Earthquake	SCIENCE			English	Article							INDIA-AUSTRALIA PLATE; STRESS; DEFORMATION; DISPLACEMENT; SEISMICITY; ANDAMAN; BASIN; SLIP	Seismological observations of the 2012 moment magnitude 8.6 Sumatra earthquake reveal unprecedented complexity of dynamic rupture. The surprisingly large magnitude results from the combination of deep extent, high stress drop, and rupture of multiple faults. Back-projection source imaging indicates that the rupture occurred on distinct planes in an orthogonal conjugate fault system, with relatively slow rupture speed. The east-southeast-west-northwest ruptures add a new dimension to the seismotectonics of the Wharton Basin, which was previously thought to be controlled by north-south strike-slip faulting. The rupture turned twice into the compressive quadrant, against the preferred branching direction predicted by dynamic Coulomb stress calculations. Orthogonal faulting and compressional branching indicate that rupture was controlled by a pressure-insensitive strength of the deep oceanic lithosphere.	[Meng, L.; Ampuero, J. -P.; Stock, J.; Duputel, Z.; Luo, Y.; Tsai, V. C.] CALTECH, Div Geol & Planetary Sci, Seismol Lab, Pasadena, CA 91125 USA	California Institute of Technology	Meng, L (corresponding author), CALTECH, Div Geol & Planetary Sci, Seismol Lab, Pasadena, CA 91125 USA.	lsmeng@gps.caltech.edu	Stock, Joann Miriam/AAN-1526-2021; Duputel, Zacharie/C-2906-2016; Tsai, Victor C/J-8405-2012; Ampuero, Jean Paul/N-3348-2013	Stock, Joann Miriam/0000-0003-4816-7865; Duputel, Zacharie/0000-0002-8809-451X; Tsai, Victor C/0000-0003-1809-6672; Ampuero, Jean Paul/0000-0002-4827-7987	NSF [EAR-1015704, EAR-0106924]; Gordon and Betty Moore Foundation; Southern California Earthquake Center (SCEC); USGS [02HQAG0008]; Division Of Earth Sciences [1015704] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Southern California Earthquake Center (SCEC); USGS(United States Geological Survey); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was supported by NSF grant EAR-1015704, by the Gordon and Betty Moore Foundation, and by the Southern California Earthquake Center (SCEC), which is funded by NSF Cooperative Agreement EAR-0106924 and USGS Cooperative Agreement 02HQAG0008. The Japanese Hi-net (www.hinet.bosai.go.jp) and the European ORFEUS (www.orfeus-eu.org) data centers were used to access the broadband seismograms. The magnetic anomalies are from the EMAG2 database available at the National Geophysical Data Center (www.ngdc.noaa.gov). The satellite gravity anomaly data are from the UCSD TOPEX v. 18.1 database. The multibeam bathymetry from the KNOX06RR cruise is available at Marine Geoscience Data System (www.marine-geo.org). We thank R.-C. Lien and B. Ma for providing the Roger Revelle (RR1201) multibeam data from the DYNAMO cruise. We thank H. Kanamori for valuable discussions about this event. This paper is Caltech Tectonics Observatory contribution 215, Caltech Seismo Lab contribution 10078, and SCEC contribution 1656.	Abercrombie RE, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB000674; Allmann BP, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005821; Antolik M, 2000, J GEOPHYS RES-SOL EA, V105, P23825, DOI 10.1029/2000JB900246; Chlieh M, 2007, B SEISMOL SOC AM, V97, pS152, DOI 10.1785/0120050631; Choy GL, 2002, GEOPHYS J INT, V150, P506, DOI 10.1046/j.1365-246X.2002.01720.x; CLOETINGH S, 1986, TECTONOPHYSICS, V132, P49, DOI 10.1016/0040-1951(86)90024-7; Cocco M, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2000JB000138; Delescluse M, 2007, GEOPHYS J INT, V168, P818, DOI 10.1111/j.1365-246X.2006.03181.x; Delescluse M, 2008, EARTH PLANET SC LETT, V276, P140, DOI 10.1016/j.epsl.2008.09.017; DeMets C, 2010, GEOPHYS J INT, V181, P1, DOI 10.1111/j.1365-246X.2009.04491.x; Deplus C, 1998, GEOLOGY, V26, P131, DOI 10.1130/0091-7613(1998)026<0131:DEOADI>2.3.CO;2; Engdahl ER, 2007, B SEISMOL SOC AM, V97, pS43, DOI 10.1785/0120050614; Escartin J, 2001, GEOLOGY, V29, P1023, DOI 10.1130/0091-7613(2001)029<1023:SOSSPI>2.0.CO;2; Horikawa H, 2001, B SEISMOL SOC AM, V91, P112, DOI 10.1785/0119990131; Jung H, 2004, NATURE, V428, P545, DOI 10.1038/nature02412; Kelemen PB, 2007, NATURE, V446, P787, DOI 10.1038/nature05717; Klingelhoefer F, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006569; Lay T, 2011, EARTH PLANETS SPACE, V63, P713, DOI 10.5047/eps.2011.05.006; McGuire JJ, 2012, SCIENCE, V336, P1118, DOI 10.1126/science.1223983; Meng LS, 2012, EARTH PLANETS SPACE, V64, P1101, DOI 10.5047/eps.2012.05.010; Meng LS, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048118; Oth A, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044572; Poliakov ANB, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000572; Robinson DP, 2001, SCIENCE, V292, P1145, DOI 10.1126/science.1059395; Rollins JC, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB007117; Sager WW, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044347; Tanioka Y, 1996, GEOPHYS RES LETT, V23, P861, DOI 10.1029/96GL00736; WELLS DL, 1994, B SEISMOL SOC AM, V84, P974; Wesnousky SG, 2006, NATURE, V444, P358, DOI 10.1038/nature05275; WIENS DA, 1983, J GEOPHYS RES, V88, P6455, DOI 10.1029/JB088iB08p06455	30	196	202	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2012	337	6095					724	726		10.1126/science.1224030	http://dx.doi.org/10.1126/science.1224030			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986PE	22821986				2022-12-28	WOS:000307354500052
J	Mappes, J; Lindstrom, L				Mappes, Johanna; Lindstrom, Leena			How Did the Cuckoo Get Its Polymorphic Plumage?	SCIENCE			English	Editorial Material							BATESIAN MIMICRY; DISTASTEFULNESS; PARASITE; DEFENSE; MODEL		[Mappes, Johanna; Lindstrom, Leena] Univ Jyvaskyla, Ctr Excellence Biol Interact Res, Dept Biol & Environm Sci, Jyvaskyla 40014, Finland	University of Jyvaskyla	Mappes, J (corresponding author), Univ Jyvaskyla, Ctr Excellence Biol Interact Res, Dept Biol & Environm Sci, POB 35, Jyvaskyla 40014, Finland.	johanna.mappes@jyu.fi	Mappes, Johanna/AAZ-3627-2021; Lindstrom, Leena/B-2326-2012	Lindstrom, Leena/0000-0002-6452-4538; Mappes, Johanna/0000-0002-1117-5629				AVERY ML, 1994, ANIM BEHAV, V48, P1371, DOI 10.1006/anbe.1994.1373; Bates H.W., 1862, T LINN SOC LOND, V23, P495; CLARKE B, 1962, SYST ASS PUBL, V4, P47; Davies NB, 2009, SCIENCE, V324, P1318, DOI 10.1126/science.1172227; GOODALE MA, 1977, ANIM BEHAV, V25, P660, DOI 10.1016/0003-3472(77)90117-8; Honza M, 2006, J ORNITHOL, V147, P629, DOI 10.1007/s10336-006-0088-y; Lindstrom L, 1997, P ROY SOC B-BIOL SCI, V264, P149, DOI 10.1098/rspb.1997.0022; Lindstrom L, 2004, EVOLUTION, V58, P1294, DOI 10.1554/03-271; Mappes J, 1997, EVOLUTION, V51, P2050, DOI 10.1111/j.1558-5646.1997.tb05129.x; Nijhout HF, 2003, EVOL DEV, V5, P579, DOI 10.1046/j.1525-142X.2003.03063.x; PAYNE RB, 1967, AM NAT, V101, P363, DOI 10.1086/282504; Seppanen JT, 2007, ECOLOGY, V88, P1622, DOI 10.1890/06-1757.1; Thorogood R, 2012, SCIENCE, V337, P578, DOI 10.1126/science.1220759; Voipio P., 1953, Ornis Fennica, V30, P97; Welbergen JA, 2011, BEHAV ECOL, V22, P574, DOI 10.1093/beheco/arr008	15	7	7	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2012	337	6094					532	533		10.1126/science.1225997	http://dx.doi.org/10.1126/science.1225997			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982PU	22859476				2022-12-28	WOS:000307058700028
J	Wheeler, TM; Leger, AJ; Pandey, SK; MacLeod, AR; Nakamori, M; Cheng, SH; Wentworth, BM; Bennett, CF; Thornton, CA				Wheeler, Thurman M.; Leger, Andrew J.; Pandey, Sanjay K.; MacLeod, A. Robert; Nakamori, Masayuki; Cheng, Seng H.; Wentworth, Bruce M.; Bennett, C. Frank; Thornton, Charles A.			Targeting nuclear RNA for in vivo correction of myotonic dystrophy	NATURE			English	Article							MODIFIED ANTISENSE OLIGONUCLEOTIDE; TRINUCLEOTIDE REPEAT; PHOSPHOROTHIOATE OLIGONUCLEOTIDES; GENE-EXPRESSION; MESSENGER-RNA; MOUSE MODELS; CTG REPEAT; TOXIC RNA; 3' END; PROTEIN	Antisense oligonucleotides (ASOs) hold promise for gene-specific knockdown in diseases that involve RNA or protein gain-of-function effects. In the hereditary degenerative disease myotonic dystrophy type 1 (DM1), transcripts from the mutant allele contain an expanded CUG repeat(1-3) and are retained in the nucleus(4,5). The mutant RNA exerts a toxic gain-of-function effect(6), making it an appropriate target for therapeutic ASOs. However, despite improvements in ASO chemistry and design, systemic use of ASOs is limited because uptake in many tissues, including skeletal and cardiac muscle, is not sufficient to silence target messenger RNAs7,8. Here we show that nuclear-retained transcripts containing expanded CUG (CUG(exp)) repeats are unusually sensitive to antisense silencing. In a transgenic mouse model of DM1, systemic administration of ASOs caused a rapid knockdown of CUG(exp) RNA in skeletal muscle, correcting the physiological, histopathologic and transcriptomic features of the disease. The effect was sustained for up to 1 year after treatment was discontinued. Systemically administered ASOs were also effective for muscle knockdown of Malat(1), a long non-coding RNA (lncRNA) that is retained in the nucleus(9). These results provide a general strategy to correct RNA gain-of-function effects and to modulate the expression of expanded repeats, lncRNAs and other transcripts with prolonged nuclear residence.	[Wheeler, Thurman M.; Nakamori, Masayuki; Thornton, Charles A.] Univ Rochester, Dept Neurol, Rochester, NY 14642 USA; [Wheeler, Thurman M.; Nakamori, Masayuki; Thornton, Charles A.] Univ Rochester, Ctr Neural Dev & Dis, Rochester, NY 14642 USA; [Leger, Andrew J.; Cheng, Seng H.; Wentworth, Bruce M.] Genzyme Corp, Framingham, MA 01701 USA; [Pandey, Sanjay K.; MacLeod, A. Robert; Bennett, C. Frank] Isis Pharmaceut, Carlsbad, CA 92010 USA	University of Rochester; University of Rochester; Sanofi-Aventis; Genzyme Corporation; Isis Pharmaceuticals Inc	Thornton, CA (corresponding author), Univ Rochester, Dept Neurol, 601 Elmwood Ave, Rochester, NY 14642 USA.	charles_thornton@urmc.rochester.edu	Cheng, Seng H/AAC-6564-2022; Nakamori, Masayuki/ABE-2169-2020	Nakamori, Masayuki/0000-0003-4714-3044	US National Institutes of Health (NIH) [AR049077, U54NS48843, AR/NS48143, K08NS064293, U01NS072323]; Saunders Family Neuromuscular Research Fund; Run America; Muscular Dystrophy Association; Uehara Memorial Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR048143, R01AR049077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS064293, U01NS072323, U54NS048843] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Saunders Family Neuromuscular Research Fund; Run America; Muscular Dystrophy Association(Muscular Dystrophy Association); Uehara Memorial Foundation(Uehara Memorial Foundation); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was carried out at the Wellstone Muscular Dystrophy Cooperative Research Center and Center for RNA Biology at the University of Rochester, with support from the US National Institutes of Health (NIH) (grants AR049077, U54NS48843, AR/NS48143, K08NS064293 and U01NS072323), the Saunders Family Neuromuscular Research Fund, Run America and a fellowship (to M.N.) from the Muscular Dystrophy Association and Uehara Memorial Foundation. The authors thank G. Gourdon for providing DM328XL mice, M. Sabripour for assistance with principal components analysis and L. Richardson and S. Leistman for technical assistance.	Alter J, 2006, NAT MED, V12, P175, DOI 10.1038/nm1345; Bennett CF, 2010, ANNU REV PHARMACOL, V50, P259, DOI 10.1146/annurev.pharmtox.010909.105654; Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P675, DOI 10.1016/j.nmd.2004.06.008; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; Cheruvallath ZS, 2003, NUCLEOS NUCLEOT NUCL, V22, P461, DOI 10.1081/NCN-120022050; Davis BM, 1997, P NATL ACAD SCI USA, V94, P7388, DOI 10.1073/pnas.94.14.7388; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Du HQ, 2010, NAT STRUCT MOL BIOL, V17, P187, DOI 10.1038/nsmb.1720; Geary RS, 1999, ANAL BIOCHEM, V274, P241, DOI 10.1006/abio.1999.4290; Geary RS, 2003, DRUG METAB DISPOS, V31, P1419, DOI 10.1124/dmd.31.11.1419; Gomes-Pereira M, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030052; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; Hasselblatt P, 2005, NUCLEIC ACIDS RES, V33, P114, DOI 10.1093/nar/gki155; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Koller E, 2011, NUCLEIC ACIDS RES, V39, P4795, DOI 10.1093/nar/gkr089; Lee JE, 2012, P NATL ACAD SCI USA, V109, P4221, DOI 10.1073/pnas.1117019109; Leeds JM, 1996, ANAL BIOCHEM, V235, P36, DOI 10.1006/abio.1996.0088; Li LB, 2010, TRENDS NEUROSCI, V33, P292, DOI 10.1016/j.tins.2010.03.004; Lin XY, 2006, HUM MOL GENET, V15, P2087, DOI 10.1093/hmg/ddl132; Lorenz P, 2000, NUCLEIC ACIDS RES, V28, P582, DOI 10.1093/nar/28.2.582; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Mankodi A, 2002, MOL CELL, V10, P35, DOI 10.1016/S1097-2765(02)00563-4; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Mulders SAM, 2009, P NATL ACAD SCI USA, V106, P13915, DOI 10.1073/pnas.0905780106; Nakamori M, 2011, MOL THER, V19, P2222, DOI 10.1038/mt.2011.191; Napierala M, 1997, J BIOL CHEM, V272, P31079, DOI 10.1074/jbc.272.49.31079; Osborne RJ, 2009, HUM MOL GENET, V18, P1471, DOI 10.1093/hmg/ddp058; PONTIUS BW, 1992, J BIOL CHEM, V267, P13815; Prasanth KV, 2005, CELL, V123, P249, DOI 10.1016/j.cell.2005.08.033; Raychaudhuri S, 2000, Pac Symp Biocomput, P455; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Seznec H, 2000, HUM MOL GENET, V9, P1185, DOI 10.1093/hmg/9.8.1185; Seznec H, 2001, HUM MOL GENET, V10, P2717, DOI 10.1093/hmg/10.23.2717; Suzuki Y, 2010, MOL CELL BIOL, V30, P5123, DOI 10.1128/MCB.00619-10; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Vickers TA, 2003, J BIOL CHEM, V278, P7108, DOI 10.1074/jbc.M210326200; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Wheeler TM, 2007, J CLIN INVEST, V117, P3952, DOI 10.1172/JCI33355; Wheeler TM, 2009, SCIENCE, V325, P336, DOI 10.1126/science.1173110; Wilusz JE, 2008, CELL, V135, P919, DOI 10.1016/j.cell.2008.10.012; Wu HJ, 2004, J BIOL CHEM, V279, P17181, DOI 10.1074/jbc.M311683200	43	347	359	0	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 2	2012	488	7409					111	+		10.1038/nature11362	http://dx.doi.org/10.1038/nature11362			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ZE	22859208	Green Accepted			2022-12-28	WOS:000307010700043
J	Kasting, JF; Catling, DC; Zahnle, K				Kasting, James F.; Catling, David C.; Zahnle, Kevin			Atmospheric oxygenation and volcanism	NATURE			English	Letter							BLACK SMOKERS; PRESSURE		[Kasting, James F.] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Catling, David C.] Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; [Catling, David C.] Univ Washington, Astrobiol Program, Seattle, WA 98195 USA; [Zahnle, Kevin] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Kasting, JF (corresponding author), Penn State Univ, Dept Geosci, 443 Deike, University Pk, PA 16802 USA.	kasting@essc.psu.edu	Kasting, James/AAF-6851-2020	Catling, David/0000-0001-5646-120X	Division Of Earth Sciences [0921580] Funding Source: National Science Foundation	Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		Gaillard F, 2011, NATURE, V478, P229, DOI 10.1038/nature10460; Hayes JM, 2006, PHILOS T R SOC B, V361, P931, DOI 10.1098/rstb.2006.1840; Holland HD, 2002, GEOCHIM COSMOCHIM AC, V66, P3811, DOI 10.1016/S0016-7037(02)00950-X; Kasting James F., 1998, P35; Kump LR, 2007, NATURE, V448, P1033, DOI 10.1038/nature06058; Kump LR, 2005, EARTH PLANET SC LETT, V235, P654, DOI 10.1016/j.epsl.2005.04.040	6	13	13	1	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2012	487	7408					E1	E1		10.1038/nature11274	http://dx.doi.org/10.1038/nature11274			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979KD	22837006	Bronze			2022-12-28	WOS:000306815300001
J	Quirk, T				Quirk, Trevor			Writers should not fear jargon	NATURE			English	Editorial Material												tsquirk@bu.edu							0	1	1	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2012	487	7408					407	407		10.1038/487407a	http://dx.doi.org/10.1038/487407a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	979KD	22836963	Bronze			2022-12-28	WOS:000306815300006
J	Yumoto, N; Kim, N; Burden, SJ				Yumoto, Norihiro; Kim, Natalie; Burden, Steven J.			Lrp4 is a retrograde signal for presynaptic differentiation at neuromuscular synapses	NATURE			English	Article							IN-VIVO; ORGANIZING MOLECULES; NEURAL DEVELOPMENT; SKELETAL-MUSCLE; RECEPTOR; JUNCTION; AGRIN; MUSK; FORM; NEUROTRANSMITTER	Motor axons receive retrograde signals from skeletal muscle that are essential for the differentiation and stabilization of motor nerve terminals(1). Identification of these retrograde signals has proved elusive, but their production by muscle depends on the receptor tyrosine kinase, MuSK (muscle, skeletal receptor tyrosine-protein kinase), and Lrp4 (low-density lipoprotein receptor (LDLR)-related protein 4), an LDLR family member that forms a complex with MuSK, binds neural agrin and stimulates MuSK kinase activity(2-5). Here we show that Lrp4 also functions as a direct muscle-derived retrograde signal for early steps in presynaptic differentiation. We demonstrate that Lrp4 is necessary, independent of MuSK activation, for presynaptic differentiation in vivo, and we show that Lrp4 binds to motor axons and induces clustering of synaptic-vesicle and active-zone proteins. Thus, Lrp4 acts bidirectionally and coordinates synapse formation by binding agrin, activating MuSK and stimulating postsynaptic differentiation, and functioning in turn as a muscle-derived retrograde signal that is necessary and sufficient for presynaptic differentiation.	[Yumoto, Norihiro; Kim, Natalie; Burden, Steven J.] NYU, Sch Med, Mol Neurobiol Program,Skirball Inst Biomol Med, Helen L & Martin S Kimmel Ctr Biol & Med, New York, NY 10012 USA	New York University	Burden, SJ (corresponding author), NYU, Sch Med, Mol Neurobiol Program,Skirball Inst Biomol Med, Helen L & Martin S Kimmel Ctr Biol & Med, 540 1st Ave, New York, NY 10012 USA.	burden@saturn.med.nyu.edu		Burden, Steven/0000-0002-3550-6891	New York University Cancer Institute Center Support Grant (National Institutes of Health (NIH)/National Cancer Institute (NCI)) [5 P30CA16087-31]; National Institutes of Health [NS36193]; Skirball Institute; New York State Stem Cell Science (NYSTEM); NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036193, R37NS036193] Funding Source: NIH RePORTER	New York University Cancer Institute Center Support Grant (National Institutes of Health (NIH)/National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skirball Institute; New York State Stem Cell Science (NYSTEM); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank L. Landmesser and K. Hata for helping us to establish a motor-neuron and muscle co-culture system, W. Zhang for constructs encoding Fc- and AP-tagged forms of Lrp4, T. Jessell and J. Dasen for HB9::GFP mice, J. Sanes for agrin-mutant mice, K. Anderson and L. Niswander for Lrp4-mutant mice, and D. Littman and R. Lehmann for comments on the manuscript. We are grateful to P. Lopez and M. J. Sunshine and personnel in the transgenic mouse core for their assistance. The flow cytometry and transgenic mouse cores are supported by a New York University Cancer Institute Center Support Grant (National Institutes of Health (NIH)/National Cancer Institute (NCI) 5 P30CA16087-31). This work was supported with funds from the National Institutes of Health (NS36193 to S. J. B.), the Skirball Institute and postdoctoral training support to N.Y. from New York State Stem Cell Science (NYSTEM).	Arber S, 2002, CURR OPIN NEUROBIOL, V12, P100, DOI 10.1016/S0959-4388(02)00296-9; Bao JX, 2003, J CELL BIOL, V161, P1133, DOI 10.1083/jcb.200212085; Burden SJ, 2011, CELL, V144, P826, DOI 10.1016/j.cell.2011.02.037; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Drescher U, 1997, CURR BIOL, V7, pR799, DOI 10.1016/S0960-9822(06)00409-X; Engel AG, 2003, NAT REV NEUROSCI, V4, P339, DOI 10.1038/nrn1101; Flanagan-Steet H, 2005, DEVELOPMENT, V132, P4471, DOI 10.1242/dev.02044; Fox MA, 2007, CELL, V129, P179, DOI 10.1016/j.cell.2007.02.035; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; Gomez AM, 2011, DEV DYNAM, V240, P2626, DOI 10.1002/dvdy.22772; Hata K, 2007, J NEUROSCI, V27, P14481, DOI 10.1523/JNEUROSCI.3847-07.2007; Higuchi O, 2011, ANN NEUROL, V69, P418, DOI 10.1002/ana.22312; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; Kim N, 2008, NAT NEUROSCI, V11, P19, DOI 10.1038/nn2026; Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; Lin WC, 2005, NEURON, V46, P569, DOI 10.1016/j.neuron.2005.04.002; Misgeld T, 2005, P NATL ACAD SCI USA, V102, P11088, DOI 10.1073/pnas.0504806102; Panzer JA, 2006, J NEUROSCI, V26, P934, DOI 10.1523/JNEUROSCI.3656-05.2006; Pun S, 2006, NAT NEUROSCI, V9, P408, DOI 10.1038/nn1653; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Umemori H, 2004, CELL, V118, P257, DOI 10.1016/j.cell.2004.06.025; Umemori H, 2008, J BIOL CHEM, V283, P34053, DOI 10.1074/jbc.M805729200; Valdez G, 2010, P NATL ACAD SCI USA, V107, P14863, DOI 10.1073/pnas.1002220107; Weatherbee SD, 2006, DEVELOPMENT, V133, P4993, DOI 10.1242/dev.02696; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; Yang X, 2000, SCIENCE, V287, P131, DOI 10.1126/science.287.5450.131; Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006; Zhang W, 2011, J BIOL CHEM	29	136	146	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2012	489	7416					438	U130		10.1038/nature11348	http://dx.doi.org/10.1038/nature11348			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AK	22854782	Green Accepted			2022-12-28	WOS:000308860900047
J	Jost, TS; Rosenbaum, S				Jost, Timothy Stoltzfus; Rosenbaum, Sara			The Supreme Court and the Future of Medicaid	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Jost, Timothy Stoltzfus] Washington & Lee Univ, Sch Law, Lexington, VA 24450 USA; [Rosenbaum, Sara] George Washington Univ, Dept Hlth Policy, Sch Publ Hlth & Hlth Serv, Washington, DC USA	Washington & Lee University; George Washington University	Jost, TS (corresponding author), Washington & Lee Univ, Sch Law, Lexington, VA 24450 USA.							[Anonymous], 2012, PREFECT POLICE F PEC; Buettgens M, 2011, STATES WOULD SPEND L	2	14	14	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2012	367	11					983	985		10.1056/NEJMp1208219	http://dx.doi.org/10.1056/NEJMp1208219			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	003ZE	22830436				2022-12-28	WOS:000308649100002
J	Keleman, K; Vrontou, E; Kruttner, S; Yu, JY; Kurtovic-Kozaric, A; Dickson, BJ				Keleman, Krystyna; Vrontou, Eleftheria; Kruettner, Sebastian; Yu, Jai Y.; Kurtovic-Kozaric, Amina; Dickson, Barry J.			Dopamine neurons modulate pheromone responses in Drosophila courtship learning	NATURE			English	Article							SEX-PEPTIDE; EXPRESSION; BEHAVIOR; MEMORY; FEMALES	Learning through trial-and-error interactions allows animals to adapt innate behavioural 'rules of thumb' to the local environment, improving their prospects for survival and reproduction. Naive Drosophila melanogaster males, for example, court both virgin and mated females, but learn through experience to selectively suppress futile courtship towards females that have already mated(1). Here we show that courtship learning reflects an enhanced response to the male pheromone cis-vaccenyl acetate (cVA), which is deposited on females during mating and thus distinguishes mated females from virgins. Dissociation experiments suggest a simple learning rule in which unsuccessful courtship enhances sensitivity to cVA. The learning experience can be mimicked by artificial activation of dopaminergic neurons, and we identify a specific class of dopaminergic neuron that is critical for courtship learning. These neurons provide input to the mushroom body (MB) gamma lobe, and the DopR1 dopamine receptor is required in MB gamma neurons for both natural and artificial courtship learning. Our work thus reveals critical behavioural, cellular and molecular components of the learning rule by which Drosophila adjusts its innate mating strategy according to experience.	[Keleman, Krystyna; Vrontou, Eleftheria; Kruettner, Sebastian; Yu, Jai Y.; Kurtovic-Kozaric, Amina; Dickson, Barry J.] Res Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Keleman, K (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	keleman@imp.ac.at; dickson@imp.ac.at	Dickson, Barry/AAE-7632-2019	Dickson, Barry/0000-0003-0715-892X; Yu, Jai/0000-0003-0628-2531; Kozaric, Amina/0000-0002-6063-7260	European Research Council; Austrian Science Fund; European Molecular Biology Organization; Boehringer Ingelheim GmbH	European Research Council(European Research Council (ERC)European Commission); Austrian Science Fund(Austrian Science Fund (FWF)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Boehringer Ingelheim GmbH(Boehringer Ingelheim)	We thank E. Leitner for performing the gas chromatography-mass spectrometry analysis; P. Garrity, U. Heberlein, M. Heisenberg, E. Kubli, S. Waddell, the Drosophila Genetic Resource Centre, the Bloomington Stock Center and the VDRC for fly stocks; K. Jandrasits and Z. Portik-Dobos for technical assistance; M. Zimmer for critical comments on the manuscript. Basic research at the Institute of Molecular Pathology is funded in part by Boehringer Ingelheim GmbH. This work was additionally supported by grants from the European Research Council (B.J.D.) and the Austrian Science Fund (K. K.). E. V. was supported by a European Molecular Biology Organization long-term postdoctoral fellowship.	Aso Y, 2010, CURR BIOL, V20, P1445, DOI 10.1016/j.cub.2010.06.048; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BUTTERWORTH FM, 1969, SCIENCE, V163, P1356, DOI 10.1126/science.163.3873.1356; CHEN PS, 1988, CELL, V54, P291, DOI 10.1016/0092-8674(88)90192-4; Claridge-Chang A, 2009, CELL, V139, P405, DOI 10.1016/j.cell.2009.08.034; Dickson BJ, 2008, SCIENCE, V322, P904, DOI 10.1126/science.1159276; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Everaerts C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009607; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Ha TS, 2006, J NEUROSCI, V26, P8727, DOI 10.1523/JNEUROSCI.0876-06.2006; Hadjieconomou D, 2011, NAT METHODS, V8, P260, DOI 10.1038/NMETH.1567; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; JALLON JM, 1981, CR ACAD SCI III-VIE, V292, P1147; Kamyshev NG, 1999, LEARN MEMORY, V6, P1; Keleman K, 2007, NAT NEUROSCI, V10, P1587, DOI 10.1038/nn1996; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Krashes MJ, 2007, NEURON, V53, P103, DOI 10.1016/j.neuron.2006.11.021; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Liu HF, 2003, P NATL ACAD SCI USA, V100, P9929, DOI 10.1073/pnas.1631700100; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Nakayama S, 1997, MOL GEN GENET, V254, P449, DOI 10.1007/s004380050438; Neckameyer WS, 1998, LEARN MEMORY, V5, P157; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Root CM, 2007, P NATL ACAD SCI USA, V104, P11826, DOI 10.1073/pnas.0704523104; Saudan P, 2002, EUR J BIOCHEM, V269, P989, DOI 10.1046/j.0014-2956.2001.02733.x; SIEGEL RW, 1979, P NATL ACAD SCI USA, V76, P3430, DOI 10.1073/pnas.76.7.3430; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; TOMPKINS L, 1984, BEHAV GENET, V14, P411, DOI 10.1007/BF01065443; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; Waddell S, 2010, TRENDS NEUROSCI, V33, P457, DOI 10.1016/j.tins.2010.07.001; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Yu JY, 2010, CURR BIOL, V20, P1602, DOI 10.1016/j.cub.2010.08.025; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672	35	138	141	1	69	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 6	2012	489	7414					145	U210		10.1038/nature11345	http://dx.doi.org/10.1038/nature11345			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999WW	22902500				2022-12-28	WOS:000308347000052
J	Koo, BK; Spit, M; Jordens, I; Low, TY; Stange, DE; van de Wetering, M; van Es, JH; Mohammed, S; Heck, AJR; Maurice, MM; Clevers, H				Koo, Bon-Kyoung; Spit, Maureen; Jordens, Ingrid; Low, Teck Y.; Stange, Daniel E.; van de Wetering, Marc; van Es, Johan H.; Mohammed, Shabaz; Heck, Albert J. R.; Maurice, Madelon M.; Clevers, Hans			Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors	NATURE			English	Article							SMALL-INTESTINE; NEGATIVE REGULATOR; BETA-CATENIN; IN-VITRO; LGR5; CANCER; COLON; UBIQUITYLATION; TRANSCRIPTION; INHIBITION	LGR5(+) stem cells reside at crypt bottoms, intermingled with Paneth cells that provide Wnt, Notch and epidermal growth factor signals(1). Here we find that the related RNF43 and ZNRF3 transmembrane E3 ubiquitin ligases are uniquely expressed in LGR5(+) stem cells. Simultaneous deletion of the two genes encoding these proteins in the intestinal epithelium of mice induces rapidly growing adenomas containing high numbers of Paneth and LGR5(+) stem cells. In vitro, growth of organoids derived from these adenomas is arrested when Wnt secretion is inhibited, indicating a dependence of the adenoma stem cells on Wnt produced by adenoma Paneth cells. In the HEK293T human cancer cell line, expression of RNF43 blocks Wnt responses and targets surface-expressed frizzled receptors to lysosomes. In the RNF43-mutant colorectal cancer cell line HCT116, reconstitution of RNF43 expression removes its response to exogenous Wnt. We conclude that RNF43 and ZNRF3 reduce Wnt signals by selectively ubiquitinating frizzled receptors, thereby targeting these Wnt receptors for degradation.	[Spit, Maureen; Jordens, Ingrid; Maurice, Madelon M.] Univ Med Ctr Utrecht, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands; [Koo, Bon-Kyoung; Stange, Daniel E.; van de Wetering, Marc; van Es, Johan H.; Clevers, Hans] KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Koo, Bon-Kyoung; Stange, Daniel E.; van de Wetering, Marc; van Es, Johan H.; Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Low, Teck Y.; Mohammed, Shabaz; Heck, Albert J. R.] Univ Utrecht, Biomol Mass Spectrometry & Prote Grp, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; [Low, Teck Y.; Mohammed, Shabaz; Heck, Albert J. R.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CH Utrecht, Netherlands; [Low, Teck Y.; Mohammed, Shabaz; Heck, Albert J. R.] Netherlands Prote Ctr, NL-3584 CH Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University	Maurice, MM (corresponding author), Univ Med Ctr Utrecht, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands.	M.M.Maurice@umcutrecht.nl; h.clevers@hubrecht.eu	Stange, Daniel E/O-1837-2015; Heck, Albert/D-7098-2011; Galmes-Spit, Maureen/T-6013-2019; Mohammed, Shabaz/D-1042-2010; Mohammed, Shabaz/AAY-6313-2020; Low, Teck Yew/J-4403-2014; Low, Teck Yew/Q-5946-2019; van+Es, Johan/ABD-5411-2021; Koo, Bon-Kyoung/V-5219-2017	Stange, Daniel E/0000-0003-4246-2230; Heck, Albert/0000-0002-2405-4404; Mohammed, Shabaz/0000-0003-2640-9560; Mohammed, Shabaz/0000-0003-2640-9560; Low, Teck Yew/0000-0001-7878-7534; Low, Teck Yew/0000-0001-7878-7534; Koo, Bon-Kyoung/0000-0002-4134-8033; Jordens, Ingrid/0000-0001-7865-2816; Maurice, Madelon/0000-0001-6885-5361; Spit, Maureen/0000-0002-8593-0447	European Research Council [EU/232814-StemCeLLMark]; National Research Foundation of Korea [NRF-2011-357-C00093]; Centre van Biomedical Genetics; European Research Council, ERC-StG [242958]; KNAW/3V-fund;  [EU/Health-F4-2007-200720];  [Ti Pharma/T3-106]	European Research Council(European Research Council (ERC)European Commission); National Research Foundation of Korea(National Research Foundation of Korea); Centre van Biomedical Genetics; European Research Council, ERC-StG(European Research Council (ERC)); KNAW/3V-fund; ; 	We thank A. A. Rolf, I. Kuper, M. van den Born, C. Kroon-Veenboer, H. Begthel, J. Korving and S. van den Brink for technical assistance, L. Lum for providing IWP1 and S. Bartfeld for the schematic drawing. This work was funded in part by grants from the European Research Council, EU/232814-StemCeLLMark and the National Research Foundation of Korea, NRF-2011-357-C00093 (B.-K.K.); EU/Health-F4-2007-200720 (M.v.d.W.); The Centre van Biomedical Genetics (D. E. S.); Ti Pharma/T3-106 (J.H.v.E.); the European Research Council, ERC-StG no. 242958 (M. M. M.) and the KNAW/3V-fund.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Berndt JD, 2011, J CELL BIOL, V194, P737, DOI 10.1083/jcb.201107021; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; CHENG H, 1974, AM J ANAT, V141, P461, DOI 10.1002/aja.1001410403; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Haglund K, 2012, J CELL SCI, V125, P265, DOI 10.1242/jcs.091280; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020; Ivanov I, 2007, ONCOGENE, V26, P2873, DOI 10.1038/sj.onc.1210098; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kazanskaya O, 2008, DEVELOPMENT, V135, P3655, DOI 10.1242/dev.027284; Koo BK, 2012, NAT METHODS, V9, P81, DOI [10.1038/NMETH.1802, 10.1038/nmeth.1802]; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Liu GZ, 2003, MOL CELL BIOL, V23, P5825, DOI 10.1128/MCB.23.16.5825-5835.2003; March HN, 2011, NAT GENET, V43, P1202, DOI 10.1038/ng.990; Mukai A, 2010, EMBO J, V29, P2114, DOI 10.1038/emboj.2010.100; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Ong CK, 2012, NAT GENET, V44, P690, DOI 10.1038/ng.2273; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Shimomura Y, 2010, NATURE, V464, P1043, DOI 10.1038/nature08875; Tauriello DVF, 2010, MOL CELL, V37, P607, DOI 10.1016/j.molcel.2010.01.035; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; Wu J, 2011, P NATL ACAD SCI USA, V108, P21188, DOI 10.1073/pnas.1118046108; Yagyu R, 2004, INT J ONCOL, V25, P1343; Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695	31	581	606	11	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2012	488	7413					665	+		10.1038/nature11308	http://dx.doi.org/10.1038/nature11308			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996NC	22895187				2022-12-28	WOS:000308095100058
J	Giovino, GA; Mirza, SA; Samet, JM; Gupta, PC; Jarvis, MJ; Bhala, N; Peto, R; Zatonski, W; Hsia, J; Morton, J; Palipudi, KM; Asma, S				Giovino, Gary A.; Mirza, Sara A.; Samet, Jonathan M.; Gupta, Prakash C.; Jarvis, Martin J.; Bhala, Neeraj; Peto, Richard; Zatonski, Witold; Hsia, Jason; Morton, Jeremy; Palipudi, Krishna M.; Asma, Samira		GATS Collaborative Grp	Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys	LANCET			English	Article								Background Despite the high global burden of diseases caused by tobacco, valid and comparable prevalence data for patterns of adult tobacco use and factors influencing use are absent for many low-income and middle-income countries. We assess these patterns through analysis of data from the Global Adult Tobacco Survey (GATS). Methods Between Oct 1, 2008, and March 15, 2010, GATS used nationally representative household surveys with comparable methods to obtain relevant information from individuals aged 15 years or older in 14 low-income and middle-income countries (Bangladesh, Brazil, China, Egypt, India, Mexico, Philippines, Poland, Russia, Thailand, Turkey, Ukraine, Uruguay, and Vietnam). We compared weighted point estimates and 95% CIs of tobacco use between these 14 countries and with data from the 2008 UK General Lifestyle Survey and the 2006-07 US Tobacco Use Supplement to the Current Population Survey. All these surveys had cross-sectional study designs. Findings In countries participating in GATS, 48.6% (95% CI 47.6-49.6) of men and 11.3% (10.7-12.0) of women were tobacco users. 40.7% of men (ranging from 21.6% in Brazil to 60.2% in Russia) and 5.0% of women (0.5% in Egypt to 24.4% in Poland) in GATS countries smoked a tobacco product. Manufactured cigarettes were favoured by most smokers (82%) overall, but smokeless tobacco and bidis were commonly used in India and Bangladesh. For individuals who had ever smoked daily, women aged 55-64 years at the time of the survey began smoking at an older age than did equivalently aged men in most GATS countries. However, those individuals who had ever smoked daily and were aged 25-34-years when surveyed started to do so at much the same age in both sexes. Quit ratios were very low (<20% overall) in China, India, Russia, Egypt, and Bangladesh. Interpretation The first wave of GATS showed high rates of smoking in men, early initiation of smoking in women, and low quit ratios, reinforcing the view that efforts to prevent initiation and promote cessation of tobacco use are needed to reduce associated morbidity and mortality.	[Giovino, Gary A.] SUNY Buffalo, Sch Publ Hlth & Hlth Profess, Dept Community Hlth & Hlth Behav, Buffalo, NY 14214 USA; [Mirza, Sara A.; Hsia, Jason; Morton, Jeremy; Palipudi, Krishna M.; Asma, Samira] CDCP, Global Tobacco Control Branch, Off Smoking & Hlth, Atlanta, GA USA; [Samet, Jonathan M.] Univ So Calif, Inst Global Hlth, Keck Sch Med, Dept Prevent Med, Los Angeles, CA USA; [Gupta, Prakash C.] Healis Sekhsaria Inst Publ Hlth, Cbd Belapur Navi Mumbai, India; [Jarvis, Martin J.] UCL, Dept Epidemiol & Publ Hlth, London, England; [Bhala, Neeraj] Univ Oxford, Epidemiol Studies Unit, Oxford, England; [Bhala, Neeraj] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Zatonski, Witold] Inst Oncol, Warsaw, Poland; [Zatonski, Witold] Maria Sklodowska Curie Mem Canc Ctr, Dept Canc Epidemiol & Prevent, Warsaw, Poland; [Zatonski, Witold] Inst Rural Hlth, European Hlth Inequal Observ, Lublin, Poland	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Centers for Disease Control & Prevention - USA; University of Southern California; University of London; University College London; University of Oxford; University of Oxford; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Institute of Rural Health in Lublin, Poland	Giovino, GA (corresponding author), SUNY Buffalo, Sch Publ Hlth & Hlth Profess, Dept Community Hlth & Hlth Behav, 310 Kimball Tower, Buffalo, NY 14214 USA.	ggiovino@buffalo.edu	Jarvis, Martin J/B-1034-2008; Malta, Deborah C/H-7880-2012; Malta, Deborah Carvalho/GNM-8218-2022; Andreeva, Tatiana I/G-6306-2010; Zaman, M Mostafa/H-5155-2019	Jarvis, Martin J/0000-0001-9238-8038; Malta, Deborah C/0000-0002-8214-5734; Malta, Deborah Carvalho/0000-0002-8214-5734; Andreeva, Tatiana I/0000-0001-5663-6225; England, Sarah/0000-0002-0953-8136; Bhala, Neeraj/0000-0003-2502-1177; Zaman, M Mostafa/0000-0002-1736-1342; Hoang Van, Minh/0000-0002-4749-5536; Jha, Prabhat/0000-0001-7067-8341; Reynales - Shigematsu, Luz Myriam/0000-0002-5350-0928; Kim Bao, Giang/0000-0003-2290-0205	Bloomberg Philanthropies' Initiative to Reduce Tobacco Use; Bill and Melinda Gates Foundation; Brazilian Government; Indian Government; CDC Foundation; British Government; US Government (National Cancer Institute); US Government (CDC); MRC [MC_U137686857, G0701732] Funding Source: UKRI; Cancer Research UK [14135] Funding Source: researchfish; Medical Research Council [MC_U137686857, G0701732] Funding Source: researchfish	Bloomberg Philanthropies' Initiative to Reduce Tobacco Use; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Brazilian Government; Indian Government; CDC Foundation(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); British Government; US Government (National Cancer Institute); US Government (CDC); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Bloomberg Philanthropies' Initiative to Reduce Tobacco Use, Bill and Melinda Gates Foundation, Brazilian and Indian Governments.; The views expressed in this Article are solely those of the authors and do not necessarily represent the official position of the US Centers for Disease Control and Prevention (CDC) or the Global Adult Tobacco Survey partner organisations. Technical assistance was provided by the US CDC, Regional Offices of WHO, Johns Hopkins Bloomberg School of Public Health, University of North Carolina at Chapel Hill, and RTI International. Programme support was provided by the CDC Foundation. The General Lifestyle Survey was funded by the British Government. The Tobacco Use Supplement to the Current Population Survey was sponsored by the US Government (National Cancer Institute and CDC). GAG, JMS, PCG, and WZ were supported by the CDC Foundation. RP, NB, and MJJ received no outside funding for their work on this project. SAM, JH, KMP, and SA are employees of the US Government (CDC). JM is a contractor to CDC. We are particularly grateful to Glenda Blutcher-Nelson (contractor to CDC) for programming and analyses of GATS datasets, Angela Trosclair (CDC) for programming and analysis of the US Tobacco Use Supplement to the Current Population Survey datasets, Jessica Kulak (University at Buffalo, NY, USA) for assistance with editing and the creation of tables and figures, Jane Zanca (CDC, National Center for Chronic Disease Prevention and Health Promotion) for editorial comments, and Edward Rainey (contractor to CDC) for assistance with the creation of some figures. We thank the thousands of fieldworkers for their contributions and the survey respondents for their co-operation, without whom this work would not have been realised, and the members of the GATS Collaborative Group for all of their expertise and contributions.	Ahmad OB, GPE DISCUSSION PAPER, V31; Akl EA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-244; Alwan A, 2010, LANCET, V376, P1861, DOI 10.1016/S0140-6736(10)61853-3; Ashley DL, 2009, HDB EXPT PHARM, V192; Asma S., 2009, TOBACCO OXFORD TXB P, DOI [10.1093/med/9780199218707.003.0075, DOI 10.1093/MED/9780199218707.003.0075]; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Boffetta P, 2008, LANCET ONCOL, V9, P667, DOI 10.1016/S1470-2045(08)70173-6; Carter LP, 2009, CANCER EPIDEM BIOMAR, V18, P3241, DOI 10.1158/1055-9965.EPI-09-0948; Centers for Disease Control and Prevention, GLOB TOB SURV SYST; Choudhury S., 2010, Morbidity and Mortality Weekly Report, V59, P613; Cummings KM, 2002, TOB CONTROL, V11, pI1, DOI 10.1136/tc.11.suppl_1.i1; Eriksen M, 2012, TOBACCO ATLAS; Giovino Gary A, 2009, Prev Med, V48, pS4, DOI 10.1016/j.ypmed.2008.08.007; Global Adult Tobacco Survey Collaborative Group, GLOB AD TOB SURV GAT; Global Tobacco Surveillance System (GTSS), TOB QUEST SURV SUBST; Gupta P. C., 2008, BIDI SMOKING PUBLIC; Haenszel W, 1956, US PUBLIC HLTH SERVI, V463; Haenszel W, 1956, TOBACCO SMOKING PATT, V45; Harper S, 2012, CANCER CAUSE CONTROL, V23, P11, DOI 10.1007/s10552-012-9901-5; IARC, 1985, IARC MON EV CARC RIS, V37; IARC, 2008, IARC HDB CANC PREV T, V12; International Tobacco Control Policy Evaluation Project, SURV PROJ PROT; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jha P, 2008, NEW ENGL J MED, V358, P1137, DOI 10.1056/NEJMsa0707719; Jung-Choi KH, 2011, TOB CONTROL, DOI 10.1136/tobaccocontrol-2011-050012; Kalsbeek WD, GLOBAL ADULT TOBACCO; Ministry of Health and Family Welfare (Department of Health and Family Welfare) Notification, 2011, AM IND CIG OTH TOB P; National Cancer Institute, 2008, TOB CONTR MON US DEP, V19; Office for National Statistics, GEN LIF SURV TECHN A; Roberts B, 2012, AM J PUBLIC HEALTH, V102, P1320, DOI 10.2105/AJPH.2011.300547; U.S. Department of Health and Human Services, 1989, RED HLTH CONS SMOK 2, P89; [US Department of Commerce Census Bureau National Cancer Institute and Centers for Disease Control and Prevention], 2008, TOB US CURR POP SU S; Warren CW, 2009, GLOBAL TOBACCO SURVE; WHO Regional Office for South-East Asia, 2009, GLOB AD TOB SURV GAT; World Health Organization, 2012, COMPR GLOB MON FRAM; World Health Organization, GLOB HLTH RISKS MORT; World Health Organization, 2019, WHO REPORT GLOBAL TO; World Health Organization, 2005, WHO FRAM CONV TOB CO; Youlden DR, 2008, J THORAC ONCOL, V3, P819, DOI 10.1097/JTO.0b013e31818020eb	39	476	506	3	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 18	2012	380	9842					668	679		10.1016/S0140-6736(12)61085-X	http://dx.doi.org/10.1016/S0140-6736(12)61085-X			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	991SE	22901888				2022-12-28	WOS:000307721000032
J	Koplan, JP; Mackay, J				Koplan, Jeffrey P.; Mackay, Judith			Curtailing tobacco use: first we need to know the numbers	LANCET			English	Editorial Material									[Koplan, Jeffrey P.] Emory Univ, Emory Global Hlth Inst, Atlanta, GA 30322 USA; [Mackay, Judith] Hong Kong Off, World Lung Fdn, Hong Kong, Hong Kong, Peoples R China	Emory University	Koplan, JP (corresponding author), Emory Univ, Emory Global Hlth Inst, Atlanta, GA 30322 USA.	jkoplan@emory.edu						Carden C., 2009, KNOWLEDGE POLICY MAK; Eriksen M, 2012, TOBACCO ATLAS; Giovino GA, 2012, LANCET, V380, P668, DOI 10.1016/S0140-6736(12)61085-X; Koplan JP, 2010, LANCET, V375, P1330, DOI 10.1016/S0140-6736(10)60398-4; Lavis JN, 2010, CAN MED ASSOC J, V182, pE350, DOI 10.1503/cmaj.081164; Oliver TR, 2006, ANNU REV PUBL HEALTH, V27, P195, DOI 10.1146/annurev.publhealth.25.101802.123126; Ross H, 2012, TOB CONTROL, V21, P465, DOI 10.1136/tc.2011.043380; WHO, WHO MPOWER	8	3	3	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 18	2012	380	9842					629	630		10.1016/S0140-6736(12)61307-5	http://dx.doi.org/10.1016/S0140-6736(12)61307-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	991SE	22901873				2022-12-28	WOS:000307721000008
J	Lalmohamed, A; de Vries, F; Bazelier, MT; Cooper, A; van Staa, TP; Cooper, C; Harvey, NC				Lalmohamed, Arief; de Vries, Frank; Bazelier, Marloes T.; Cooper, Alun; van Staa, Tjeerd-Pieter; Cooper, Cyrus; Harvey, Nicholas C.			Risk of fracture after bariatric surgery in the United Kingdom: population based, retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BONE-MINERAL DENSITY; VERTICAL-BANDED GASTROPLASTY; GASTRIC BYPASS-SURGERY; MORBIDLY OBESE WOMEN; PARATHYROID-HORMONE; SECONDARY HYPERPARATHYROIDISM; SURGICAL-TREATMENT; HIP/FEMUR FRACTURE; CALCIUM-METABOLISM; WEIGHT-LOSS	Objectives To estimate fracture risk in patients receiving bariatric surgery versus matched controls. Design Population based, retrospective cohort study. Setting Use of records from the United Kingdom General Practice Research Database, now known as the Clinical Practice Research Datalink (from January 1987 to December 2010). Participants Patients with a body mass index of at least 30, with a record of bariatric surgery (n=2079), and matched controls without a record (n=10 442). Each bariatric surgery patient was matched to up to six controls by age, sex, practice, year, and body mass index. Patients were followed from the date of bariatric surgery for the occurrence of any fracture. We used time dependent Cox regression to calculate relative rates of fracture, adjusted for disease and previous drug treatment, and time-interaction terms to evaluate fracture timing patterns. Main outcome measure Relative rates of any, osteoporotic, and non-osteoporotic fractures. Results Mean follow-up time was 2.2 years. Overall, there was no significantly increased risk of fracture in patients who underwent bariatric surgery, compared with controls (8.8 v 8.2 per 1000 person years; adjusted relative risk 0.89, 95% confidence interval 0.60 to 1.33). Bariatric surgery also did not affect risk of osteoporotic and non-osteoporotic fractures. However, we saw a trend towards an increased fracture risk after three to five years following surgery, as well as in patients who had a greater decrease in body mass index after surgery, but this was not significant. Conclusion Bariatric surgery does not have a significant effect on the risk of fracture. For the first few years after surgery, these results are reassuring for patients undergoing such operations, but do not exclude a more protracted adverse influence on skeletal health in the longer term.	[de Vries, Frank; van Staa, Tjeerd-Pieter; Cooper, Cyrus; Harvey, Nicholas C.] Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton Gen Hosp, Southampton SO16 6YD, Hants, England; [Lalmohamed, Arief; de Vries, Frank; Bazelier, Marloes T.; van Staa, Tjeerd-Pieter] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands; [de Vries, Frank] Maastricht Univ, Med Ctr, Dept Clin Pharm & Toxicol, Maastricht, Netherlands; [Cooper, Alun] Bridge Med Ctr, Crawley, England; [van Staa, Tjeerd-Pieter] Medicines & Healthcare Prod Regulatory Agcy, London, England; [Cooper, Cyrus] Univ Oxford, Inst Musculoskeletal Sci, Oxford, England	University of Southampton; Utrecht University; Maastricht University; The Medicines & Healthcare Products Regulatory Agency; University of Oxford	Cooper, C (corresponding author), Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton Gen Hosp, Southampton SO16 6YD, Hants, England.	cc@mrc.soton.ac.uk	de Vries, Frank/E-4934-2011	de Vries, Frank/0000-0003-3837-8319; Cooper, Cyrus/0000-0003-3510-0709; van Staa, Tjeerd/0000-0001-9363-742X; Harvey, Nicholas/0000-0002-8194-2512	International Osteoporosis Foundation; SERVIER; Netherlands Organisation for Health Research; Development, Dutch Health Care Insurance Board; Royal Dutch Pharmacists Association; Top Institute Pharma; EU Innovative Medicines Initiative; EU; Dutch Medicines Evaluation Board; Dutch Ministry of Health and industry (including GlaxoSmithKline, Pfizer)	International Osteoporosis Foundation; SERVIER(Servier); Netherlands Organisation for Health Research(Netherlands Organization for Health Research and Development); Development, Dutch Health Care Insurance Board; Royal Dutch Pharmacists Association; Top Institute Pharma; EU Innovative Medicines Initiative; EU(European Commission); Dutch Medicines Evaluation Board; Dutch Ministry of Health and industry (including GlaxoSmithKline, Pfizer)	This study was funded by a research grant from the International Osteoporosis Foundation and SERVIER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: support from the International Osteoporosis Foundation and SERVIER for the submitted work; AL, FV, MB, and TS are employed by the Division of Pharmacoepidemiology and Clinical Pharmacology at Utrecht Institute for Pharmaceutical Sciences, which has received unrestricted research funding from the Netherlands Organisation for Health Research and Development, Dutch Health Care Insurance Board, Royal Dutch Pharmacists Association, private-publicly funded Top Institute Pharma (www.tipharma.nl, which includes cofunding from universities, government, and industry), EU Innovative Medicines Initiative, EU 7th Framework Program, Dutch Medicines Evaluation Board, Dutch Ministry of Health and industry (including GlaxoSmithKline, Pfizer); no financial relationships with any organisations that might have an interest in the submitted work in the previous 3 years; no other relationships or activities that could appear to have influenced the submitted work.	Adachi Y, 2000, CALCIFIED TISSUE INT, V66, P119, DOI 10.1007/s002230010025; Bano G, 1999, INT J OBESITY, V23, P361, DOI 10.1038/sj.ijo.0800827; Bjorntorp P, 1997, LANCET, V350, P423, DOI 10.1016/S0140-6736(97)04503-0; Chapin BL, 1996, ARCH SURG-CHICAGO, V131, P1048; Coates PS, 2004, J CLIN ENDOCR METAB, V89, P1061, DOI 10.1210/jc.2003-031756; Cundy T, 1996, BRIT J SURG, V83, P1468, DOI 10.1002/bjs.1800831046; De Laet C, 2005, OSTEOPOROSIS INT, V16, P1330, DOI 10.1007/s00198-005-1863-y; de Vries F, 2007, J INTERN MED, V261, P170, DOI 10.1111/j.1365-2796.2006.01754.x; DiGiorgi M, 2008, OBES SURG, V18, P1144, DOI 10.1007/s11695-007-9408-4; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; FRAX, 2001, FRAX WHO FRACTURE RI; Giusti V, 2005, INT J OBESITY, V29, P1429, DOI 10.1038/sj.ijo.0803040; Gomez JM, 2009, OBES SURG, V19, P345, DOI 10.1007/s11695-008-9529-4; Goode LR, 2004, OBES RES, V12, P40, DOI 10.1038/oby.2004.7; Guney E, 2003, OBES SURG, V13, P383, DOI 10.1381/096089203765887705; Hamoui N, 2003, ARCH SURG-CHICAGO, V138, P891, DOI 10.1001/archsurg.138.8.891; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Johnson JM, 2005, J GASTROINTEST SURG, V9, P1106, DOI 10.1016/j.gassur.2005.07.012; Khan NF, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X483562; Kolanowski J, 1997, BRIT MED BULL, V53, P433, DOI 10.1093/oxfordjournals.bmb.a011621; Lalmohamed A, 2012, OSTEOPOROSIS INT, V23, P861, DOI 10.1007/s00198-011-1852-2; Lalmohamed A, 2012, ARCH INTERN MED, V172, P1229, DOI 10.1001/archinternmed.2012.2713; Leff DR, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3402; Lewis JD, 2004, PHARMACOEPIDEM DR S, V13, P437, DOI 10.1002/pds.902; Madsen OR, 1997, EUR J APPL PHYSIOL O, V75, P554, DOI 10.1007/s004210050204; Marceau P, 2002, J GASTROINTEST SURG, V6, P690, DOI 10.1016/S1091-255X(01)00086-5; MARTIN LF, 1995, SOUTH MED J, V88, P895, DOI 10.1097/00007611-199509000-00001; Meier CA, 2002, J CLIN ENDOCR METAB, V87, P1184, DOI 10.1210/jc.87.3.1184; Nakamura K, 2009, ENDO C; Newbury L, 2003, OBES SURG, V13, P893, DOI 10.1381/096089203322618722; Olmos JM, 2008, OBES SURG, V18, P197, DOI 10.1007/s11695-007-9307-8; Pouwels S, 2011, OSTEOPOROSIS INT, V22, P903, DOI 10.1007/s00198-010-1337-8; Pouwels S, 2009, OSTEOPOROSIS INT, V20, P1499, DOI 10.1007/s00198-008-0826-5; Pouwels S, 2009, STROKE, V40, P3281, DOI 10.1161/STROKEAHA.109.554055; Pugnale N, 2003, INT J OBESITY, V27, P110, DOI 10.1038/sj.ijo.0802177; Recker R, 2000, J BONE MINER RES, V15, P1965, DOI 10.1359/jbmr.2000.15.10.1965; Reid IR, 2002, BONE, V31, P547, DOI 10.1016/S8756-3282(02)00864-5; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Slater GH, 2004, J GASTROINTEST SURG, V8, P48, DOI 10.1016/j.gassur.2003.09.020; Stunkard AJ, 1996, AM J MED, V100, P230, DOI 10.1016/S0002-9343(97)89464-8; Valderas JP, 2009, OBES SURG, V19, P1132, DOI 10.1007/s11695-009-9890-y; Van Loan MD, 1998, AM J CLIN NUTR, V67, P734, DOI 10.1093/ajcn/67.4.734; Van Staa TP, 2000, PHARMACOEPIDEM DR S, V9, P359, DOI 10.1002/1099-1557(200009/10)9:5<359::AID-PDS507>3.0.CO;2-E; Viegas M, 2010, ARQ BRAS ENDOCRINOL, V54, P158, DOI 10.1590/S0004-27302010000200011; Vilarrasa N, 2009, OBES SURG, V19, P860, DOI 10.1007/s11695-009-9843-5; von Mach MA, 2004, METABOLISM, V53, P918, DOI 10.1016/j.metabol.2004.01.015	46	119	122	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 7	2012	345								e5085	10.1136/bmj.e5085	http://dx.doi.org/10.1136/bmj.e5085			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988NA	22867649	hybrid, Green Published, Green Submitted, Green Accepted			2022-12-28	WOS:000307496500003
J	Khalil, AS; Lu, TK; Bashor, CJ; Ramirez, CL; Pyenson, NC; Joung, JK; Collins, JJ				Khalil, Ahmad S.; Lu, Timothy K.; Bashor, Caleb J.; Ramirez, Cherie L.; Pyenson, Nora C.; Joung, J. Keith; Collins, James J.			A Synthetic Biology Framework for Programming Eukaryotic Transcription Functions	CELL			English	Article							ZINC-FINGER NUCLEASES; STRUCTURE-BASED DESIGN; GENE NETWORKS; SYNERGISTIC ACTIVATION; PROTEIN; CELLS; COMPLEX; GAL4; CONSTRUCTION; DIMERIZATION	Eukaryotic transcription factors (TFs) perform complex and combinatorial functions within transcriptional networks. Here, we present a synthetic framework for systematically constructing eukaryotic transcription functions using artificial zinc fingers, modular DNA-binding domains found within many eukaryotic TFs. Utilizing this platform, we construct a library of orthogonal synthetic transcription factors (sTFs) and use these to wire synthetic transcriptional circuits in yeast. We engineer complex functions, such as tunable output strength and transcriptional cooperativity, by rationally adjusting a decomposed set of key component properties, e. g., DNA specificity, affinity, promoter design, protein-protein interactions. We show that subtle perturbations to these properties can transform an individual sTF between distinct roles (activator, cooperative factor, inhibitory factor) within a transcriptional complex, thus drastically altering the signal processing behavior of multi-input systems. This platform provides new genetic components for synthetic biology and enables bottom-up approaches to understanding the design principles of eukaryotic transcriptional complexes and networks.	[Lu, Timothy K.] MIT, Dept Elect Engn & Comp Sci, Synthet Biol Grp, Cambridge, MA 02139 USA; [Khalil, Ahmad S.; Bashor, Caleb J.; Pyenson, Nora C.; Collins, James J.] Boston Univ, Dept Biomed Engn, Howard Hughes Med Inst, Boston, MA 02215 USA; [Khalil, Ahmad S.; Bashor, Caleb J.; Pyenson, Nora C.; Collins, James J.] Boston Univ, Ctr BioDynam, Boston, MA 02215 USA; [Ramirez, Cherie L.; Joung, J. Keith] Massachusetts Gen Hosp, Mol Pathol Unit, Ctr Canc Res, Charlestown, MA 02129 USA; [Ramirez, Cherie L.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Charlestown, MA 02129 USA; [Ramirez, Cherie L.] Harvard Univ, Sch Med, Div Med Sci, Biol & Biomed Sci Program, Boston, MA 02115 USA; [Joung, J. Keith] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Collins, James J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Boston University; Howard Hughes Medical Institute; Boston University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University	Lu, TK (corresponding author), MIT, Dept Elect Engn & Comp Sci, Synthet Biol Grp, Cambridge, MA 02139 USA.	timlu@mit.edu	Lu, Timothy/G-4267-2012	Ramirez, Cherie/0000-0002-0397-6872; Lu, Timothy/0000-0002-3918-8923	Howard Hughes Medical Institute; NIH [DP1 OD003644, DP1 OD006862]; Office of Naval Research Multidisciplinary University Research Initiative (MURI); National Science Foundation [CCF-1124247]; Defense Advanced Research Projects Agency [DARPA-BAA-11-23]; National Science Foundation Graduate Research Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP1GM105378] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006862, DP2OD008435, DP1OD003644] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Naval Research Multidisciplinary University Research Initiative (MURI)(MURI); National Science Foundation(National Science Foundation (NSF)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Collins Lab for helpful discussions, Carl O. Pabo for helpful suggestions on reducing nonspecific affinity of zinc fingers, and Katie M. Flynn for help with artwork. This work was supported by the Howard Hughes Medical Institute (J.J.C.), NIH Director's Pioneer Awards DP1 OD003644 (J.J.C.) and DP1 OD006862 (J.K.J.), an Office of Naval Research Multidisciplinary University Research Initiative (MURI) grant (T. K. L.), the National Science Foundation CCF-1124247 (T. K. L.), a Defense Advanced Research Projects Agency grant (DARPA-BAA-11-23), and a National Science Foundation Graduate Research Fellowship (C.L.R.).	Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Bashor CJ, 2010, ANNU REV BIOPHYS, V39, P515, DOI 10.1146/annurev.biophys.050708.133652; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Beerli RR, 2002, NAT BIOTECHNOL, V20, P135, DOI 10.1038/nbt0202-135; Blancafort P, 2005, P NATL ACAD SCI USA, V102, P11716, DOI 10.1073/pnas.0501162102; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Bryant GO, 2003, MOL CELL, V11, P1301, DOI 10.1016/S1097-2765(03)00144-8; Cormack BP, 1997, MICROBIOL-UK, V143, P303, DOI 10.1099/00221287-143-2-303; Craven SE, 1998, CELL, V93, P495, DOI 10.1016/S0092-8674(00)81179-4; Ellis T, 2009, NAT BIOTECHNOL, V27, P465, DOI 10.1038/nbt.1536; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Elowitz M, 2010, NATURE, V468, P889, DOI 10.1038/468889a; Elrod-Erickson M, 1998, STRUCTURE, V6, P451, DOI 10.1016/S0969-2126(98)00047-1; ElrodErickson M, 1996, STRUCTURE, V4, P1171, DOI 10.1016/S0969-2126(96)00125-6; FISCHER JA, 1988, NATURE, V332, P853, DOI 10.1038/332853a0; Foley JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004348; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Guet CC, 2002, SCIENCE, V296, P1466, DOI 10.1126/science.1067407; Hahn S, 2011, GENETICS, V189, P705, DOI 10.1534/genetics.111.127019; Harris BZ, 2001, J CELL SCI, V114, P3219; Harris BZ, 2001, BIOCHEMISTRY-US, V40, P5921, DOI 10.1021/bi010142l; JOUNG JK, 1993, P NATL ACAD SCI USA, V90, P3083, DOI 10.1073/pnas.90.7.3083; JOUNG JK, 1994, SCIENCE, V265, P1863, DOI 10.1126/science.8091212; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Kramer BP, 2004, BIOTECHNOL BIOENG, V87, P478, DOI 10.1002/bit.20142; Lu TK, 2009, NAT BIOTECHNOL, V27, P1139, DOI 10.1038/nbt.1591; MA J, 1988, CELL, V55, P443, DOI 10.1016/0092-8674(88)90030-X; MA J, 1988, NATURE, V334, P631, DOI 10.1038/334631a0; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Maeder ML, 2009, NAT PROTOC, V4, P1471, DOI 10.1038/nprot.2009.98; Maxon ME, 2001, P NATL ACAD SCI USA, V98, P1495, DOI 10.1073/pnas.98.4.1495; Mukherji S, 2009, NAT REV GENET, V10, P859, DOI 10.1038/nrg2697; Murphy KF, 2007, P NATL ACAD SCI USA, V104, P12726, DOI 10.1073/pnas.0608451104; Nandagopal N, 2011, SCIENCE, V333, P1244, DOI 10.1126/science.1207084; Nissim L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.99; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Pomerantz JL, 1998, BIOCHEMISTRY-US, V37, P965, DOI 10.1021/bi972464o; PTASHNE M, 1986, NATURE, V322, P697, DOI 10.1038/322697a0; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; PTASHNE M, 2002, GENES SIGNALS; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; RubinBejerano I, 1996, MOL CELL BIOL, V16, P2518; Sander JD, 2011, NAT METHODS, V8, P67, DOI 10.1038/NMETH.1542; Sebastiano V, 2011, STEM CELLS, V29, P1717, DOI 10.1002/stem.718; Smolke CD, 2011, CELL, V144, P855, DOI 10.1016/j.cell.2011.02.020; Townsend JA, 2009, NATURE, V459, P442, DOI 10.1038/nature07845; Wang BS, 1999, P NATL ACAD SCI USA, V96, P9568, DOI 10.1073/pnas.96.17.9568; Wang BS, 2001, NAT STRUCT BIOL, V8, P589, DOI 10.1038/89617; Weber W, 2009, CHEM BIOL, V16, P287, DOI 10.1016/j.chembiol.2009.02.005; WEBSTER N, 1988, CELL, V52, P169, DOI 10.1016/0092-8674(88)90505-3; Wolfe SA, 2000, STRUCT FOLD DES, V8, P739, DOI 10.1016/S0969-2126(00)00161-1; Wright DA, 2006, NAT PROTOC, V1, P1637, DOI 10.1038/nprot.2006.259; Xie Z, 2011, SCIENCE, V333, P1307, DOI 10.1126/science.1205527; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023	60	222	248	5	120	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 3	2012	150	3					647	658		10.1016/j.cell.2012.05.045	http://dx.doi.org/10.1016/j.cell.2012.05.045			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	985WO	22863014	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000307301400021
J	Noel, JF; Wellinger, RJ				Noel, Jean-Francois; Wellinger, Raymund J.			Exposing Secrets of Telomere-Telomerase Encounters	CELL			English	Editorial Material							TPP1		[Noel, Jean-Francois; Wellinger, Raymund J.] Univ Sherbrooke, Dept Microbiol & Infectiol, Fac Med & Hlth Sci, Sherbrooke, PQ J1E 4K8, Canada	University of Sherbrooke	Wellinger, RJ (corresponding author), Univ Sherbrooke, Dept Microbiol & Infectiol, Fac Med & Hlth Sci, Sherbrooke, PQ J1E 4K8, Canada.	raymund.wellinger@usherbrooke.ca	Wellinger, Raymund/K-3207-2019	Wellinger, Raymund/0000-0001-6670-2759				Abreu E, 2010, MOL CELL BIOL, V30, P2971, DOI 10.1128/MCB.00240-10; Armbruster BN, 2004, MOL CELL BIOL, V24, P3552, DOI 10.1128/MCB.24.8.3552-3561.2004; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Gallardo F, 2011, MOL CELL, V44, P819, DOI 10.1016/j.molcel.2011.09.020; GREIDER CW, 1987, CELL, V51, P887, DOI 10.1016/0092-8674(87)90576-9; Londono-Vallejo JA, 2012, TRENDS BIOCH SCI; Stern JL, 2012, MOL CELL BIOL, V32, P2384, DOI 10.1128/MCB.00379-12; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Zaug AJ, 2010, GENE DEV, V24, P613, DOI 10.1101/gad.1881810	9	11	11	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 3	2012	150	3					453	454		10.1016/j.cell.2012.07.015	http://dx.doi.org/10.1016/j.cell.2012.07.015			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	985WO	22863000	Bronze			2022-12-28	WOS:000307301400005
J	Peng, ZQ; Freunberger, SA; Chen, YH; Bruce, PG				Peng, Zhangquan; Freunberger, Stefan A.; Chen, Yuhui; Bruce, Peter G.			A Reversible and Higher-Rate Li-O-2 Battery	SCIENCE			English	Article							LITHIUM-OXYGEN BATTERY; LI-AIR BATTERIES; CARBONATE ELECTROLYTES; ELECTROCHEMISTRY; SOLVENTS; LIQUID; ETHER; O-2	The rechargeable nonaqueous lithium-air (Li-O-2) battery is receiving a great deal of interest because, theoretically, its specific energy far exceeds the best that can be achieved with lithium-ion cells. Operation of the rechargeable Li-O-2 battery depends critically on repeated and highly reversible formation/decomposition of lithium peroxide (Li2O2) at the cathode upon cycling. Here, we show that this process is possible with the use of a dimethyl sulfoxide electrolyte and a porous gold electrode (95% capacity retention from cycles 1 to 100), whereas previously only partial Li2O2 formation/decomposition and limited cycling could occur. Furthermore, we present data indicating that the kinetics of Li2O2 oxidation on charge is approximately 10 times faster than on carbon electrodes.	[Peng, Zhangquan; Freunberger, Stefan A.; Chen, Yuhui; Bruce, Peter G.] Univ St Andrews, Sch Chem, St Andrews KY16 9ST, Fife, Scotland	University of St Andrews	Bruce, PG (corresponding author), Univ St Andrews, Sch Chem, St Andrews KY16 9ST, Fife, Scotland.	p.g.bruce@st-andrews.ac.uk	Chen, Yuhui/ABD-7887-2021; Peng, Zhangquan/G-4044-2012; Bruce, Peter/AAB-2011-2019; Chen, Yuhui/ABD-7407-2021; Freunberger, Stefan/F-5221-2012	Chen, Yuhui/0000-0002-3498-0057; Peng, Zhangquan/0000-0002-4338-314X; Bruce, Peter/0000-0001-6748-3084; Chen, Yuhui/0000-0002-3498-0057; Freunberger, Stefan/0000-0003-2902-5319	UK Engineering and Physical Sciences Research Council; Supergen Programme and Alistore; EPSRC [EP/H019596/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H019596/1] Funding Source: researchfish	UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Supergen Programme and Alistore; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	P.G.B. is indebted to the UK Engineering and Physical Sciences Research Council, including the Supergen Programme and Alistore for financial support.	Abraham KM, 1996, J ELECTROCHEM SOC, V143, P1, DOI 10.1149/1.1836378; Allen CJ, 2011, J PHYS CHEM LETT, V2, P2420, DOI 10.1021/jz201070t; AURBACH D, 1991, J ELECTROANAL CHEM, V297, P225, DOI 10.1016/0022-0728(91)85370-5; Bruce PG, 2012, NAT MATER, V11, P19, DOI [10.1038/nmat3191, 10.1038/NMAT3191]; Bryantsev VS, 2010, J PHYS CHEM A, V114, P8165, DOI 10.1021/jp1047584; Christensen J, 2012, J ELECTROCHEM SOC, V159, pR1, DOI 10.1149/2.086202jes; Debart A, 2008, ANGEW CHEM INT EDIT, V47, P4521, DOI 10.1002/anie.200705648; Freunberger SA, 2011, ANGEW CHEM INT EDIT, V50, P8609, DOI 10.1002/anie.201102357; Freunberger SA, 2011, J AM CHEM SOC, V133, P8040, DOI 10.1021/ja2021747; Girishkumar G, 2010, J PHYS CHEM LETT, V1, P2193, DOI 10.1021/jz1005384; Hassoun J, 2011, ANGEW CHEM INT EDIT, V50, P2999, DOI 10.1002/anie.201006264; Hummelshoj JS, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3298994; Jung HG, 2012, NAT CHEM, V4, P579, DOI [10.1038/nchem.1376, 10.1038/NCHEM.1376]; Laoire CO, 2010, J PHYS CHEM C, V114, P9178, DOI 10.1021/jp102019y; Lu YC, 2011, J AM CHEM SOC, V133, P19048, DOI 10.1021/ja208608s; Lu YC, 2011, ENERG ENVIRON SCI, V4, P2999, DOI 10.1039/c1ee01500a; McCloskey BD, 2012, J PHYS CHEM LETT, V3, P997, DOI 10.1021/jz300243r; McCloskey BD, 2011, J PHYS CHEM LETT, V2, P1161, DOI 10.1021/jz200352v; McCloskey BD, 2011, J AM CHEM SOC, V133, P18038, DOI 10.1021/ja207229n; Mizuno F, 2010, ELECTROCHEMISTRY, V78, P403, DOI 10.5796/electrochemistry.78.403; Mo YF, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.205446; Ogasawara T, 2006, J AM CHEM SOC, V128, P1390, DOI 10.1021/ja056811q; Peng ZQ, 2011, ANGEW CHEM INT EDIT, V50, P6351, DOI 10.1002/anie.201100879; Read J, 2002, J ELECTROCHEM SOC, V149, pA1190, DOI 10.1149/1.1498256; Scrosati B, 2011, ENERG ENVIRON SCI, V4, P3287, DOI 10.1039/c1ee01388b; Veith GM, 2011, J PHYS CHEM C, V115, P14325, DOI 10.1021/jp2043015; Visco S. J., 2007, US Pat., Patent No. 7282295; Wang H, 2012, ELECTROCHIM ACTA, V64, P29, DOI 10.1016/j.electacta.2011.12.080; Wang YG, 2010, J POWER SOURCES, V195, P358, DOI 10.1016/j.jpowsour.2009.06.109; Xu W, 2011, J POWER SOURCES, V196, P3894, DOI 10.1016/j.jpowsour.2010.12.065; Yang XH, 2009, ELECTROCHEM COMMUN, V11, P1127, DOI 10.1016/j.elecom.2009.03.029; Zhang JG, 2011, HANDBOOK OF BATTERY MATERIALS, 2ND EDITION, P759	32	1519	1580	60	2322	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2012	337	6094					563	566		10.1126/science.1223985	http://dx.doi.org/10.1126/science.1223985			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982PU	22821984				2022-12-28	WOS:000307058700040
J	Pochan, DJ				Pochan, Darrin J.			Approaching Asymmetry and Versatility in Polymer Assembly	SCIENCE			English	Editorial Material							MICELLES		Univ Delaware, Newark, DE 19716 USA	University of Delaware	Pochan, DJ (corresponding author), Univ Delaware, Newark, DE 19716 USA.	pochan@udel.edu						Bates FS, 2012, SCIENCE, V336, P434, DOI 10.1126/science.1215368; Bishop KJM, 2009, SMALL, V5, P1600, DOI 10.1002/smll.200900358; Christian DA, 2009, NAT MATER, V8, P843, DOI [10.1038/NMAT2512, 10.1038/nmat2512]; Cui HG, 2007, SCIENCE, V317, P647, DOI 10.1126/science.1141768; Dupont J, 2010, SOFT MATTER, V6, P3654, DOI 10.1039/c0sm00044b; Groschel AH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1707; Grzelczak M, 2010, ACS NANO, V4, P3591, DOI 10.1021/nn100869j; LoPresti C, 2011, ACS NANO, V5, P1775, DOI 10.1021/nn102455z; Moughton AO, 2012, MACROMOLECULES, V45, P2, DOI 10.1021/ma201865s; Pochan DJ, 2011, SOFT MATTER, V7, P2500, DOI 10.1039/c0sm00960a; Rupar PA, 2012, SCIENCE, V337, P559, DOI 10.1126/science.1221206; Wang JY, 2012, J AM CHEM SOC, V134, P5801, DOI 10.1021/ja2066187	12	9	9	1	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2012	337	6094					530	531		10.1126/science.1225524	http://dx.doi.org/10.1126/science.1225524			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982PU	22859474				2022-12-28	WOS:000307058700026
J	Rhee, DK; Clark, RP; Blair, RJ; Katz, JT; Loscalzo, J				Rhee, David K.; Clark, Roger P.; Blair, Ralph J.; Katz, Joel T.; Loscalzo, Joseph			Breathtaking Journey	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HANTAVIRUS CARDIOPULMONARY SYNDROME; GENETIC IDENTIFICATION; PULMONARY SYNDROME; NORTH-AMERICA; TRANSMISSION; DIAGNOSIS; SURVIVAL; OUTBREAK; VIRUS	A 48-year-old man came to the emergency department in early August with a 3-day history of influenza-like symptoms and profound dyspnea on exertion, which had started 3 days after his return to Boston from a vacation in California. On his return flight, subjective fevers, headache, myalgias, and nausea developed, and the patient had one episode of vomiting. Over the next 2 days, a nonproductive cough and profound exertional dyspnea developed. The patient said that he did not have a rash, neck stiffness, visual changes, diarrhea, dysuria, or joint pain.	[Rhee, David K.; Blair, Ralph J.; Katz, Joel T.; Loscalzo, Joseph] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Rhee, David K.; Blair, Ralph J.; Katz, Joel T.; Loscalzo, Joseph] Harvard Univ, Sch Med, Boston, MA USA; [Clark, Roger P.] Faulkner Hosp, Div Infect Dis, Boston, MA USA; [Clark, Roger P.] Tufts Univ, Sch Med, Boston, MA 02111 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Tufts University	Katz, JT (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.	jkatz@partners.org	Loscalzo, Joseph/ABD-8980-2021					[Anonymous], REP CAS HPS US; CHILDS JE, 1994, J INFECT DIS, V169, P1271, DOI 10.1093/infdis/169.6.1271; DUCHIN JS, 1994, NEW ENGL J MED, V330, P949, DOI 10.1056/NEJM199404073301401; Hardestam J, 2007, APPL ENVIRON MICROB, V73, P2547, DOI 10.1128/AEM.02869-06; Kallio ER, 2006, J GEN VIROL, V87, P2127, DOI 10.1099/vir.0.81643-0; Koster F, 2001, AM J CLIN PATHOL, V116, P665; Mertz GJ, 2004, CLIN INFECT DIS, V39, P1307, DOI 10.1086/425007; Mertz GJ, 2006, CURR OPIN INFECT DIS, V19, P437, DOI 10.1097/01.qco.0000244048.38758.1f; Monroe MC, 1999, EMERG INFECT DIS, V5, P75, DOI 10.3201/eid0501.990109; NICHOL ST, 1993, SCIENCE, V262, P914, DOI 10.1126/science.8235615; Outbreak of acute illness - southwestern United States, 1993, MMWR MORB MORTAL WKL, V42, P421; SMADEL JE, 1953, AM J PUBLIC HEALTH, V43, P1327; Torres-Perez F, 2010, EMERG INFECT DIS, V16, P308, DOI 10.3201/eid1602.090735; Wells RM, 1997, EMERG INFECT DIS, V3, P171, DOI 10.3201/eid0302.970210; Wernly JA, 2011, EUR J CARDIO-THORAC, V40, P1334, DOI 10.1016/j.ejcts.2011.01.089; Young JC, 2000, AM J TROP MED HYG, V62, P714, DOI 10.4269/ajtmh.2000.62.714	16	3	3	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 2	2012	367	5					452	457		10.1056/NEJMcps1103955	http://dx.doi.org/10.1056/NEJMcps1103955			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	981VZ	22853017				2022-12-28	WOS:000307001900012
J	Vyas, MV; Garg, AX; Iansavichus, AV; Costella, J; Donner, A; Laugsand, LE; Janszky, I; Mrkobrada, M; Parraga, G; Hackam, DG				Vyas, Manav V.; Garg, Amit X.; Iansavichus, Arthur V.; Costella, John; Donner, Allan; Laugsand, Lars E.; Janszky, Imre; Mrkobrada, Marko; Parraga, Grace; Hackam, Daniel G.			Shift work and vascular events: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ISCHEMIC-HEART-DISEASE; ACUTE MYOCARDIAL-INFARCTION; CARDIOVASCULAR RISK-FACTORS; METABOLIC SYNDROME; SOCIAL-CLASS; MORTALITY; HEALTH; ENVIRONMENT; MEN; EXPOSURE	Objective To synthesise the association of shift work with major vascular events as reported in the literature. Data sources Systematic searches of major bibliographic databases, contact with experts in the field, and review of reference lists of primary articles, review papers, and guidelines. Study selection Observational studies that reported risk ratios for vascular morbidity, vascular mortality, or all cause mortality in relation to shift work were included; control groups could be non-shift ("day") workers or the general population. Data extraction Study quality was assessed with the Downs and Black scale for observational studies. The three primary outcomes were myocardial infarction, ischaemic stroke, and any coronary event. Heterogeneity was measured with the I-2 statistic and computed random effects models. Results 34 studies in 2 011 935 people were identified. Shift work was associated with myocardial infarction (risk ratio 1.23, 95% confidence interval 1.15 to 1.31; I-2 = 0) and ischaemic stroke (1.05, 1.01 to 1.09; I-2 = 0). Coronary events were also increased (risk ratio 1.24, 1.10 to 1.39), albeit with significant heterogeneity across studies (I-2 = 85%). Pooled risk ratios were significant for both unadjusted analyses and analyses adjusted for risk factors. All shift work schedules with the exception of evening shifts were associated with a statistically higher risk of coronary events. Shift work was not associated with increased rates of mortality (whether vascular cause specific or overall). Presence or absence of adjustment for smoking and socioeconomic status was not a source of heterogeneity in the primary studies. 6598 myocardial infarctions, 17 359 coronary events, and 1854 ischaemic strokes occurred. On the basis of the Canadian prevalence of shift work of 32.8%, the population attributable risks related to shift work were 7.0% for myocardial infarction, 7.3% for all coronary events, and 1.6% for ischaemic stroke. Conclusions Shift work is associated with vascular events, which may have implications for public policy and occupational medicine.	[Vyas, Manav V.; Garg, Amit X.; Donner, Allan; Hackam, Daniel G.] Western Univ, Dept Epidemiol & Biostat, London, ON, Canada; [Garg, Amit X.; Mrkobrada, Marko; Hackam, Daniel G.] Western Univ, Dept Med, London, ON, Canada; [Garg, Amit X.; Mrkobrada, Marko; Hackam, Daniel G.] St Josephs Hlth Ctr, Lawson Res Inst, Kidney Clin Res Unit, London, ON, Canada; [Costella, John] Western Univ, Allan & Betty Taylor Lib, Res & Instruct Serv, Trondheim, Norway; [Donner, Allan; Mrkobrada, Marko; Hackam, Daniel G.] Western Univ, Robarts Res Inst, Clin Trials Unit, Trondheim, Norway; [Laugsand, Lars E.; Janszky, Imre] Norwegian Univ Sci & Technol, Dept Publ Hlth, N-7034 Trondheim, Norway; [Janszky, Imre] Karolinska Inst, Dept Publ Hlth, Stockholm, Sweden	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Norwegian University of Science & Technology (NTNU); Karolinska Institutet	Hackam, DG (corresponding author), SPARC, Room 100K-2,Siebens Drake Res Bldg,1400 Western R, London, ON N6G 2V2, Canada.	dhackam@uwo.ca	Costella, John/L-9241-2013; Garg, Amit X/G-3295-2011; Hackam, Dan G/A-1143-2009; Parraga, Grace/K-6465-2013; Mrkobrada, Marko/G-3336-2011	Costella, John/0000-0001-6542-6000; 	Canadian Institutes for Health Research (CIHR)	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	MVV was supported by a Canadian Institutes for Health Research (CIHR) strategic training program fellowship in vascular disease. AXG was supported by a CIHR clinician scientist award. DGH and GP were supported by CIHR new investigator awards.	Akerstedt T, 2004, CHRONOBIOL INT, V21, P1055, DOI 10.1081/CBI-200038520; ALFREDSSON L, 1985, INT J EPIDEMIOL, V14, P378, DOI 10.1093/ije/14.3.378; Allesoe K, 2010, OCCUP ENVIRON MED, V67, P318, DOI 10.1136/oem.2008.043091; Babisch WF, 2005, EPIDEMIOLOGY, V16, P33, DOI 10.1097/01.ede.0000147104.84424.24; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Biggi N, 2008, CHRONOBIOL INT, V25, P443, DOI 10.1080/07420520802114193; Boggild H, 1999, SCAND J WORK ENV HEA, V25, P85, DOI 10.5271/sjweh.410; Boggild H, 1999, OCCUP ENVIRON MED, V56, P640, DOI 10.1136/oem.56.9.640; Brown DL, 2009, AM J EPIDEMIOL, V169, P1370, DOI 10.1093/aje/kwp056; Cappuccio FP, 2009, QJM-INT J MED, V102, P271, DOI 10.1093/qjmed/hcp004; Chang MH, 2001, J CLIN EPIDEMIOL, V54, P634, DOI 10.1016/S0895-4356(00)00343-7; Copertaro A, 2008, EUR J CARDIOV PREV R, V15, P224, DOI 10.1097/HJR.0b013e3282f364c0; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Ellingsen T, 2007, J R SOC PROMO HEALTH, V127, P265, DOI 10.1177/1466424007083702; FALGER PRJ, 1992, J PSYCHOSOM RES, V36, P777, DOI 10.1016/0022-3999(92)90136-P; Frost P, 2009, SCAND J WORK ENV HEA, V35, P163, DOI 10.5271/sjweh.1319; Fujino Y, 2006, AM J EPIDEMIOL, V164, P128, DOI 10.1093/aje/kwj185; Fukuoka Y, 2005, INT J CARDIOL, V100, P29, DOI 10.1016/j.ijcard.2004.04.003; Garde AH, 2009, INT ARCH OCC ENV HEA, V82, P1219, DOI 10.1007/s00420-009-0419-4; General Social Survey, 2010, CYCL 24 TIM STRESS W; HALE HB, 1971, AEROSPACE MED, V42, P156; Hansen J, 2012, OCCUP ENV MED; Haupt CM, 2008, ATHEROSCLEROSIS, V201, P205, DOI 10.1016/j.atherosclerosis.2007.12.059; Hermansson J, 2007, SCAND J WORK ENV HEA, V33, P435, DOI 10.5271/sjweh.1165; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hublin C, 2010, EUR J EPIDEMIOL, V25, P315, DOI 10.1007/s10654-010-9439-3; Karlson B, 2009, J OCCUP HEALTH PSYCH, V14, P97, DOI 10.1037/a0014116; Karlsson B, 2005, SCAND J WORK ENV HEA, V31, P30, DOI 10.5271/sjweh.845; KAWACHI I, 1995, CIRCULATION, V92, P3178, DOI 10.1161/01.CIR.92.11.3178; Knutsson A, 1999, OCCUP ENVIRON MED, V56, P46, DOI 10.1136/oem.56.1.46; Knutsson A, 2004, CHRONOBIOL INT, V21, P1037, DOI 10.1081/CBI-200038525; Knutsson A., 1986, Lancet, Vii, P89; Knutsson A, 1998, SCAND J SOC MED, V26, P183, DOI 10.1177/14034948980260030801; KOLLER M, 1983, INT ARCH OCC ENV HEA, V53, P59, DOI 10.1007/BF00406178; Laugsand LE, 2011, CIRCULATION, V124, P2073, DOI 10.1161/CIRCULATIONAHA.111.025858; Lieu SJ, 2012, J HYPERTENS, V30, P61, DOI 10.1097/HJH.0b013e32834e1ea3; Lin YC, 2009, WORLD J GASTROENTERO, V15, P5654, DOI 10.3748/wjg.15.5654; Liu Y, 2002, OCCUP ENVIRON MED, V59, P447, DOI 10.1136/oem.59.7.447; Lo SH, 2010, CHRONOBIOL INT, V27, P1454, DOI 10.3109/07420528.2010.498067; McNamee R, 1996, OCCUP ENVIRON MED, V53, P367, DOI 10.1136/oem.53.6.367; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; MOLLER L, 1991, SCAND J SOC MED, V19, P116, DOI 10.1177/140349489101900207; Nabe-Nielsen K, 2008, SCAND J WORK ENV HEA, V34, P206, DOI 10.5271/sjweh.1230; Netterstrom B, 1999, OCCUP ENVIRON MED, V56, P339, DOI 10.1136/oem.56.5.339; Pan A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001141; Peter R, 1999, SCAND J WORK ENV HEA, V25, P376, DOI 10.5271/sjweh.448; Puttonen S, 2010, SCAND J WORK ENV HEA, V36, P96, DOI 10.5271/sjweh.2894; RAFNSSON V, 1990, BRIT J IND MED, V47, P721; Ruidavets JB, 1998, ARCH MAL COEUR VAISS, V91, P957; Steenland K, 1996, AM J IND MED, V29, P278, DOI 10.1002/(SICI)1097-0274(199603)29:3&lt;278::AID-AJIM8&gt;3.0.CO;2-M; Suwazono Y, 2008, OBESITY, V16, P1887, DOI 10.1038/oby.2008.298; Szosland D, 2010, INT J OCCUP MED ENV, V23, P287, DOI 10.2478/v10001-010-0032-5; Tarumi Kimio, 1997, Journal of UOEH, V19, P193; TAYLOR PJ, 1972, BRIT J IND MED, V29, P201; TAYLOR PJ, 1972, BRIT J IND MED, V29, P208; Tuchsen F, 2006, OCCUP ENVIRON MED, V63, P451, DOI 10.1136/oem.2006.026716; TUCHSEN F, 1993, INT J EPIDEMIOL, V22, P215, DOI 10.1093/ije/22.2.215; Uetani M, 2011, ANN EPIDEMIOL, V21, P327, DOI 10.1016/j.annepidem.2011.01.001; VERTIN PG, 1978, J OCCUP ENVIRON MED, V20, P346; Viitasalo K, 2008, SCAND J WORK ENV HEA, V34, P198, DOI 10.5271/sjweh.1228; Virkkunen H, 2006, OCCUP ENVIRON MED, V63, P378, DOI 10.1136/oem.2005.022558; Virtanen SV, 2002, INT J EPIDEMIOL, V31, P614, DOI 10.1093/ije/31.3.614; Wang XS, 2011, OCCUP MED-OXFORD, V61, P78, DOI 10.1093/occmed/kqr001; Williams C, 2008, WORK LIFE BALANCE SH, V9; Yadegarfar G, 2008, OCCUP ENVIRON MED, V65, P158, DOI 10.1136/oem.2006.030627	66	481	487	1	72	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 26	2012	345								e4800	10.1136/bmj.e4800	http://dx.doi.org/10.1136/bmj.e4800			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	981UY	22835925	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000306997700001
J	Berryman, JW				Berryman, Jack W.			Motion and rest: Galen on exercise and health	LANCET			English	Editorial Material									Univ Washington, Sch Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Berryman, JW (corresponding author), Univ Washington, Sch Med, Seattle, WA 98195 USA.	berryman@u.washington.edu						Berryman JW, 2010, CURR SPORT MED REP, V9, P195, DOI 10.1249/JSR.0b013e3181e7d86d; BERRYMAN JW, 1992, SPORT EXERCISE SCI E, P1; Galen, 1951, GALEN TRANSLATION GA; RATHER L J, 1968, Clio Medica, V3, P337; Singer Peter N., 1997, GALEN SELECTED WORKS	5	15	15	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 21	2012	380	9838					210	211		10.1016/S0140-6736(12)61205-7	http://dx.doi.org/10.1016/S0140-6736(12)61205-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	976TV	22826836				2022-12-28	WOS:000306609200017
J	Schmelcher, P				Schmelcher, Peter			Molecule Formation in Ultrahigh Magnetic Fields	SCIENCE			English	Editorial Material							RANGE RYDBERG MOLECULES; HYDROGEN MOLECULE; GROUND-STATE		Univ Hamburg, Zentrum Opt Quantentechnol, D-22761 Hamburg, Germany	University of Hamburg	Schmelcher, P (corresponding author), Univ Hamburg, Zentrum Opt Quantentechnol, D-22761 Hamburg, Germany.	pschmelc@physnet.uni-hamburg.de	Schmelcher, Peter/D-9592-2014	Schmelcher, Peter/0000-0002-2637-0937				Bendkowsky V, 2009, NATURE, V458, P1005, DOI 10.1038/nature07945; Detmer T, 1998, PHYS REV A, V57, P1767, DOI 10.1103/PhysRevA.57.1767; FRIEDRICH H, 1989, PHYS REP, V183, P37, DOI 10.1016/0370-1573(89)90121-X; Gallagher T. F., 1994, RYDBERG ATOMS; Greene CH, 2000, PHYS REV LETT, V85, P2458, DOI 10.1103/PhysRevLett.85.2458; Kravchenko YP, 1997, PHYS REV A, V56, pR2510, DOI 10.1103/PhysRevA.56.R2510; Lange KK, 2012, SCIENCE, V337, P327, DOI 10.1126/science.1219703; Ruder H., 1994, ATOMS STRONG MAGNETI; SCHMELCHER P, 1988, PHYS REV A, V37, P672, DOI 10.1103/PhysRevA.37.672; Schmelcher P, 1998, ATOMS MOL STRONG EXT; Tellgren EI, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2996525	11	17	17	2	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2012	337	6092					302	303		10.1126/science.1224869	http://dx.doi.org/10.1126/science.1224869			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975WQ	22822137				2022-12-28	WOS:000306542600037
J	Moyer, VA				Moyer, Virginia A.		US Preventive Serv Task Force	Screening for Coronary Heart Disease With Electrocardiography: US Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article							ASYMPTOMATIC ADULTS; RISK	Description: Update of the 2004 U.S. Preventive Services Task Force (USPSTF) recommendation statement on screening for coronary heart disease (CHD). Methods: The USPSTF reviewed new evidence on the benefits of screening with electrocardiography (ECG) in asymptomatic adults to reduce the risk for CHD events versus not screening, the effect of identifying high-risk persons on treatment to reduce risk, the accuracy of stratifying individuals into risk categories, and the harms of screening. Recommendations: The USPSTF recommends against screening with resting or exercise ECG for the prediction of CHD events in asymptomatic adults at low risk for CHD events (D recommendation). The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening with resting or exercise ECG for the prediction of CHD events in asymptomatic adults at intermediate or high risk for CHD events (I statement).	[Moyer, Virginia A.; US Preventive Serv Task Force] US Prevent Serv Task Force, Rockville, MD USA		Moyer, VA (corresponding author), US Prevent Serv Task Force, Rockville, MD USA.							American Academy of Family Physicians, 2012, REC CLIN PREV SERV C; Calonge N, 2009, ANN INTERN MED, V151, P474, DOI 10.7326/0003-4819-151-7-200910060-00008; Chou R, 2011, AHRQ PUBLICATION; Chou R, 2011, ANN INTERN MED, V155, P375, DOI 10.7326/0003-4819-155-6-201109200-00006; Greenland P, 2010, CIRCULATION, V122, P2748, DOI 10.1161/CIR.0b013e3182051bab; HOPKIRK JAC, 1984, J AM COLL CARDIOL, V3, P821, DOI 10.1016/S0735-1097(84)80259-4; Lloyd-Jones DM, 1999, LANCET, V353, P89, DOI 10.1016/S0140-6736(98)10279-9; Matheny M, 2011, 1105155EF1 AHRQ AG H; Myers J, 2009, CIRCULATION, V119, P3144, DOI 10.1161/CIRCULATIONAHA.109.192520; NOTO TJ, 1991, CATHETER CARDIO DIAG, V24, P75, DOI 10.1002/ccd.1810240202; Pignone M., 2003, SYSTEMATIC EVIDENCE; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Xu Jiaquan, 2010, Natl Vital Stat Rep, V58, P1	13	59	62	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 2	2012	157	7					512	U108		10.7326/0003-4819-157-7-201210020-00514	http://dx.doi.org/10.7326/0003-4819-157-7-201210020-00514			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	016MQ	22847227				2022-12-28	WOS:000309523200006
J	Migliori, GB; Sotgiu, G				Migliori, Giovanni Battista; Sotgiu, Giovanni			Treatment of tuberculosis: have we turned the corner?	LANCET			English	Editorial Material							DRUG-RESISTANT TUBERCULOSIS; PULMONARY TUBERCULOSIS; UPDATE		[Migliori, Giovanni Battista] Fdn S Maugeri, Care & Res Inst, Collaborating Ctr TB & Lung Dis, WHO, I-21049 Tradate, Italy; [Sotgiu, Giovanni] Univ Sassari, Dept Biomed Sci, Epidemiol & Med Stat Unit, I-07100 Sassari, Italy	Istituti Clinici Scientifici Maugeri IRCCS; World Health Organization; University of Sassari	Migliori, GB (corresponding author), Fdn S Maugeri, Care & Res Inst, Collaborating Ctr TB & Lung Dis, WHO, I-21049 Tradate, Italy.		Migliori, Giovanni Battista/AAB-8589-2020; Sotgiu, Giovanni/N-1032-2017	Migliori, Giovanni Battista/0000-0002-2597-574X; Sotgiu, Giovanni/0000-0002-1600-4474				Abu-Raddad LJ, 2009, P NATL ACAD SCI USA, V106, P13980, DOI 10.1073/pnas.0901720106; Baciewicz AM, 2008, AM J MED SCI, V335, P126, DOI 10.1097/MAJ.0b013e31814a586a; Chen Jiezhong, 2006, Ann Clin Microbiol Antimicrob, V5, P3, DOI 10.1186/1476-0711-5-3; Diacon AH, 2012, J GERONTOL B; Diacon AH, 2009, NEW ENGL J MED, V360, P2397, DOI 10.1056/NEJMoa0808427; Donald P R, 2003, Expert Rev Anti Infect Ther, V1, P141, DOI 10.1586/14787210.1.1.141; Falzon D, 2011, EUR RESPIR J, V38, P516, DOI 10.1183/09031936.00073611; Gler MT, 2012, NEW ENGL J MED, V366, P2151, DOI 10.1056/NEJMoa1112433; JINDANI A, 1980, AM REV RESPIR DIS, V121, P939; Lange C, 2012, EUR RESPIR MONOGR, P1; Migliori GB, 2012, CLIN INFECT DIS, V54, P1379, DOI 10.1093/cid/cis128; Pontali E, 2012, EUR RESPIR MONOGR, P194, DOI 10.1183/1025448x.10023711; Raviglione MC, 2011, EUR RESPIR J, V37, P978, DOI 10.1183/09031936.00003111; Raviglione M, 2012, LANCET, V379, P1902, DOI 10.1016/S0140-6736(12)60727-2; Skrahina A, 2012, EUR RESPIR J, V39, P1425, DOI 10.1183/09031936.00145411	15	17	17	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 15	2012	380	9846					955	957		10.1016/S0140-6736(12)61183-0	http://dx.doi.org/10.1016/S0140-6736(12)61183-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	005JF	22828484				2022-12-28	WOS:000308746000009
J	Sommers, BD; Baicker, K; Epstein, AM				Sommers, Benjamin D.; Baicker, Katherine; Epstein, Arnold M.			Mortality and Access to Care among Adults after State Medicaid Expansions	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEALTH-INSURANCE; IMPACT; ELIGIBILITY; COVERAGE; US	Background Several states have expanded Medicaid eligibility for adults in the past decade, and the Affordable Care Act allows states to expand Medicaid dramatically in 2014. Yet the effect of such changes on adults' health remains unclear. We examined whether Medicaid expansions were associated with changes in mortality and other health-related measures. Methods We compared three states that substantially expanded adult Medicaid eligibility since 2000 (New York, Maine, and Arizona) with neighboring states without expansions. The sample consisted of adults between the ages of 20 and 64 years who were observed 5 years before and after the expansions, from 1997 through 2007. The primary outcome was all-cause county-level mortality among 68,012 year- and county-specific observations in the Compressed Mortality File of the Centers for Disease Control and Prevention. Secondary outcomes were rates of insurance coverage, delayed care because of costs, and self-reported health among 169,124 persons in the Current Population Survey and 192,148 persons in the Behavioral Risk Factor Surveillance System. Results Medicaid expansions were associated with a significant reduction in adjusted all-cause mortality (by 19.6 deaths per 100,000 adults, for a relative reduction of 6.1%; P = 0.001). Mortality reductions were greatest among older adults, nonwhites, and residents of poorer counties. Expansions increased Medicaid coverage (by 2.2 percentage points, for a relative increase of 24.7%; P = 0.01), decreased rates of uninsurance (by 3.2 percentage points, for a relative reduction of 14.7%; P<0.001), decreased rates of delayed care because of costs (by 2.9 percentage points, for a relative reduction of 21.3%; P = 0.002), and increased rates of self-reported health status of "excellent" or "very good" (by 2.2 percentage points, for a relative increase of 3.4%; P = 0.04). Conclusions State Medicaid expansions to cover low-income adults were significantly associated with reduced mortality as well as improved coverage, access to care, and self-reported health.	[Sommers, Benjamin D.; Baicker, Katherine; Epstein, Arnold M.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Sommers, BD (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave,Rm 406, Boston, MA 02115 USA.	bsommers@hsph.harvard.edu						Afendulis CC, 2011, HEALTH SERV RES, V46, P1022, DOI 10.1111/j.1475-6773.2011.01244.x; Allen H, 2010, HEALTH AFFAIR, V29, P1498, DOI 10.1377/hlthaff.2010.0191; [Anonymous], 2009, MAINECARE CHILDL AD; [Anonymous], 2010, MED PROGR GLANC; [Anonymous], 2009, NEW YORK PARTN PLAN; [Anonymous], AR RES FIL ARF 2009; [Anonymous], 2011, NAT DIAB STAT 2011; [Anonymous], 2010, 10 LEAD CAUS DEATH A; [Anonymous], 2004, AR HLTH INS FLEX ACC; Arias Elizabeth, 2010, Natl Vital Stat Rep, V58, P1; Artiga S, 2005, COVERAGE GAINS RECEN; Atherly A, 2012, HEALTH SERV RES, V47, P939, DOI 10.1111/j.1475-6773.2011.01376.x; Baicker K, 2011, NEW ENGL J MED, V365, P683, DOI 10.1056/NEJMp1108222; Bendavid E, 2009, ANN INTERN MED, V150, P688, DOI 10.7326/0003-4819-150-10-200905190-00117; Bertrand M, 2004, Q J ECON, V119, P249, DOI 10.1162/003355304772839588; Besley T, 2004, Q J ECON, V119, P91, DOI 10.1162/003355304772839533; Cooper AL, 2012, NEW ENGL J MED, V366, P150, DOI 10.1056/NEJMsa1104273; Cotet AM, 2012, HLTH EC; Currie J, 1996, J POLIT ECON, V104, P1263, DOI 10.1086/262059; Currie J, 1996, Q J ECON, V111, P431, DOI 10.2307/2946684; Cutler DM, 1996, Q J ECON, V111, P391, DOI 10.2307/2946683; Doyle JJ, 2005, REV ECON STAT, V87, P256, DOI 10.1162/0034653053970348; Epstein AM, 1998, HEALTH CARE FINANC R, V19, P85; Feinberg Emily, 2002, Matern Child Health J, V6, P5, DOI 10.1023/A:1014308031534; Finkelstein A., 2011, OREGON HLTH INSURANC; Frakt A, 2011, NEW ENGL J MED, V364, DOI 10.1056/NEJMp1103168; Gaglia MA, 2011, AM J CARDIOL, V107, P675, DOI 10.1016/j.amjcard.2010.10.041; Gottlieb S, 2011, WALL STREET J; Gray BH, 2006, INQUIRY-J HEALTH CAR, V43, P211, DOI 10.5034/inquiryjrnl_43.3.211; Howell EM, 2001, MED CARE RES REV, V58, P3, DOI 10.1177/107755870105800101; Institute of Medicine, 2002, CAR COV TOO LITTL TO; Kronick R, 2009, HEALTH SERV RES, V44, P1211, DOI 10.1111/j.1475-6773.2009.00973.x; Kwok J, 2010, CANCER-AM CANCER SOC, V116, P476, DOI 10.1002/cncr.24774; Levy H., 2004, HLTH POLICY UNINSURE, P179; Lien DS, 2005, J HUM RESOUR, V40, P373; Long SK, 2005, HEALTH SERV RES, V40, P39, DOI 10.1111/j.1475-6773.2005.00341.x; MACKINNON JG, 1985, J ECONOMETRICS, V29, P305, DOI 10.1016/0304-4076(85)90158-7; McWilliams JM, 2009, ANN INTERN MED, V150, P505, DOI 10.7326/0003-4819-150-8-200904210-00005; Miilunpalo S, 1997, J CLIN EPIDEMIOL, V50, P517, DOI 10.1016/S0895-4356(97)00045-0; Natoli C, 2011, WHO WILL ENROLL MED; Pauly MV, 2007, HEALTH AFFAIR, V26, P1304, DOI 10.1377/hlthaff.26.5.1304; RUBIN DB, 1991, STAT MED, V10, P585, DOI 10.1002/sim.4780100410; Ryan P, 2012, PATH PROSPERITY FISC; Smith V, 2012, MIDYEAR STATE MEDICA; Wilper AP, 2009, AM J PUBLIC HEALTH, V99, P2289, DOI 10.2105/AJPH.2008.157685	45	378	379	2	66	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2012	367	11					1025	1034		10.1056/NEJMsa1202099	http://dx.doi.org/10.1056/NEJMsa1202099			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	003ZE	22830435	Green Published			2022-12-28	WOS:000308649100009
J	Dawson, MA; Kouzarides, T; Huntly, BJP				Dawson, Mark A.; Kouzarides, Tony; Huntly, Brian J. P.			Targeting Epigenetic Readers in Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							BROMODOMAIN PROTEIN BRD4; FRAGMENT-BASED DISCOVERY; ACUTE MYELOID-LEUKEMIA; HISTONE H3; TRANSCRIPTIONAL REGULATION; CHROMATIN MODIFICATIONS; MOLECULAR-MECHANISM; MULTIPLE-MYELOMA; DRUG-SENSITIVITY; BET BROMODOMAINS		[Dawson, Mark A.; Huntly, Brian J. P.] Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Dawson, Mark A.; Huntly, Brian J. P.] Univ Cambridge, Cambridge Univ Hosp Natl Hlth Serv Fdn Trust, Cambridge CB2 0XY, England; [Dawson, Mark A.; Kouzarides, Tony] Univ Cambridge, Gurdon Inst, Cambridge CB2 0XY, England; [Dawson, Mark A.; Kouzarides, Tony] Univ Cambridge, Dept Pathol, Cambridge CB2 0XY, England; [Huntly, Brian J. P.] Univ Cambridge, Wellcome Trust & Med Res Council, Cambridge Stem Cell Inst, Cambridge CB2 0XY, England	University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge	Huntly, BJP (corresponding author), Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Cambridge CB2 0XY, England.	bjph2@cam.ac.uk	huntly, brian JP/E-6725-2014; Dawson, Mark A/B-9317-2017	huntly, brian JP/0000-0003-0312-161X; Dawson, Mark A/0000-0002-5464-5029; Kouzarides, Tony/0000-0002-8918-4162	Medical Research Council [G0800784B] Funding Source: researchfish; MRC [G0800784] Funding Source: UKRI; Medical Research Council [G0800784] Funding Source: Medline; Wellcome Trust [092096, 079249] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Allis CD, 2007, EPIGENETICS; Bamborough P, 2012, J MED CHEM, V55, P587, DOI 10.1021/jm201283q; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Berger SL, 2009, GENE DEV, V23, P781, DOI 10.1101/gad.1787609; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chen JJ, 2010, NAT REV CANCER, V10, P23, DOI 10.1038/nrc2765; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; Chiang Cheng-Ming, 2009, F1000 Biol Rep, V1, P98, DOI 10.3410/B1-98; Chung CW, 2012, J MED CHEM, V55, P576, DOI 10.1021/jm201320w; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Foss FM, 2011, BLOOD, V117, P6756, DOI 10.1182/blood-2010-05-231548; French CA, 2010, J CLIN PATHOL, V63, P492, DOI 10.1136/jcp.2007.052902; Garcia-Manero G, 2011, J CLIN ONCOL, V29, P516, DOI 10.1200/JCO.2010.31.0854; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Houzelstein D, 2002, MOL CELL BIOL, V22, P3794, DOI 10.1128/MCB.22.11.3794-3802.2002; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jiang YW, 1998, P NATL ACAD SCI USA, V95, P8538, DOI 10.1073/pnas.95.15.8538; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Lin CQ, 2010, MOL CELL, V37, P429, DOI 10.1016/j.molcel.2010.01.026; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Milne TA, 2010, MOL CELL, V38, P853, DOI 10.1016/j.molcel.2010.05.011; Mohan M, 2010, NAT REV CANCER, V10, P720, DOI 10.1038/nrc2915; Mueller D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000249; Muntean AG, 2010, CANCER CELL, V17, P609, DOI 10.1016/j.ccr.2010.04.012; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Rando OJ, 2009, ANNU REV BIOCHEM, V78, P245, DOI 10.1146/annurev.biochem.78.071107.134639; Rowley JD, 2008, BLOOD, V112, P2183, DOI 10.1182/blood-2008-04-097931; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Segal E, 2009, TRENDS GENET, V25, P335, DOI 10.1016/j.tig.2009.06.002; Shang EY, 2009, DEV DYNAM, V238, P908, DOI 10.1002/dvdy.21911; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shou YP, 2000, P NATL ACAD SCI USA, V97, P228, DOI 10.1073/pnas.97.1.228; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tan MJ, 2011, CELL, V146, P1015, DOI 10.1016/j.cell.2011.08.008; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Tefferi A, 2009, NEW ENGL J MED, V361, P1872, DOI 10.1056/NEJMra0902908; Wouters BJ, 2009, BLOOD, V113, P291, DOI 10.1182/blood-2008-04-153239; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Yokoyama A, 2010, CANCER CELL, V17, P198, DOI 10.1016/j.ccr.2009.12.040; Zhao R, 2011, NAT CELL BIOL, V13, P1295, DOI 10.1038/ncb2341; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	60	293	299	5	75	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 16	2012	367	7					647	657		10.1056/NEJMra1112635	http://dx.doi.org/10.1056/NEJMra1112635			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988NB	22894577				2022-12-28	WOS:000307496600008
J	Shigemura, J; Tanigawa, T; Saito, I; Nomura, S				Shigemura, Jun; Tanigawa, Takeshi; Saito, Isao; Nomura, Soichiro			Psychological Distress in Workers at the Fukushima Nuclear Power Plants	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Shigemura, Jun; Nomura, Soichiro] Natl Def Med Coll, Dept Psychiat, Saitama, Japan; [Tanigawa, Takeshi; Saito, Isao] Ehime Univ, Grad Sch Med, Dept Publ Hlth, Matsuyama, Ehime 790, Japan	National Defense Medical College - Japan; Ehime University	Shigemura, J (corresponding author), Natl Def Med Coll, Dept Psychiat, Saitama, Japan.	tt9178tt9178@gmail.com	Ley, Sarah/Y-9216-2019; Shigemura, Jun/ACX-4803-2022	Shigemura, Jun/0000-0002-7907-5034				Asukai N, 2002, J NERV MENT DIS, V190, P175, DOI 10.1097/00005053-200203000-00006; Bromet EJ, 2011, CLIN ONCOL-UK, V23, P297, DOI 10.1016/j.clon.2011.01.501; FONTANA A, 1994, J NERV MENT DIS, V182, P677, DOI 10.1097/00005053-199412000-00001; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; Sakurai K, 2011, PSYCHIAT CLIN NEUROS, V65, P434, DOI 10.1111/j.1440-1819.2011.02236.x; Shigemura J, 2011, JAPAN J TRAUMA STRES, V9, P141	6	65	67	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2012	308	7					667	669		10.1001/jama.2012.9699	http://dx.doi.org/10.1001/jama.2012.9699			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988NC	22893158	Bronze			2022-12-28	WOS:000307496700016
J	Ioannidis, JPA				Ioannidis, John P. A.			The Importance of Potential Studies That Have Not Existed and Registration of Observational Data Sets	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEART-DISEASE; RISK; DEPRESSION; CAFFEINE; COFFEE		[Ioannidis, John P. A.] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Dept Med, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Stat, Sch Humanities & Sci, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Ioannidis, JPA (corresponding author), Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Dept Med, Med Sch Off Bldg,1265 Welch Rd,Room X306, Stanford, CA 94305 USA.	jioannid@stanford.edu	Ioannidis, John P. A./G-9836-2011					Boutron I, 2010, JAMA-J AM MED ASSOC, V303, P2058, DOI 10.1001/jama.2010.651; Dickersin K, 2012, JAMA-J AM MED ASSOC, V307, P1861, DOI 10.1001/jama.2012.4230; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Fortier I, 2010, INT J EPIDEMIOL, V39, P1383, DOI 10.1093/ije/dyq139; Ioannidis JPA, 2012, CIRC RES, V110, P658, DOI 10.1161/RES.0b013e31824da8ad; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Lucas M, 2011, ARCH INTERN MED, V171, P1571, DOI 10.1001/archinternmed.2011.393; Ruusunen A, 2010, PUBLIC HEALTH NUTR, V13, P1215, DOI 10.1017/S1368980010000509	8	50	50	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2012	308	6					575	576		10.1001/jama.2012.8144	http://dx.doi.org/10.1001/jama.2012.8144			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	984YA	22871867				2022-12-28	WOS:000307228400022
J	Witten, E				Witten, Edward			Quantum Mechanics of Black Holes	SCIENCE			English	Editorial Material							ENTROPY	The popular conception of black holes reflects the behavior of the massive black holes found by astronomers and described by classical general relativity. These objects swallow up whatever comes near and emit nothing. Physicists who have tried to understand the behavior of black holes from a quantum mechanical point of view, however, have arrived at quite a different picture. The difference is analogous to the difference between thermodynamics and statistical mechanics. The thermodynamic description is a good approximation for a macroscopic system, but statistical mechanics describes what one will see if one looks more closely.	Inst Adv Study, Sch Nat Sci, Princeton, NJ 08540 USA	Institute for Advanced Study - USA	Witten, E (corresponding author), Inst Adv Study, Sch Nat Sci, Olden Lane, Princeton, NJ 08540 USA.	witten@ias.edu						BEKENSTEIN JD, 1973, PHYS REV D, V7, P2333, DOI 10.1103/PhysRevD.7.2333; DUFF MJ, 1995, PHYS REP, V259, P213, DOI 10.1016/0370-1573(95)00002-X; Gubser SS, 1996, PHYS REV D, V54, P3915, DOI 10.1103/PhysRevD.54.3915; HAWKING SW, 1974, NATURE, V248, P30, DOI 10.1038/248030a0; Kovtun PK, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.111601; Maldacena J., 1999, International Journal of Theoretical Physics, V38, P1113, DOI 10.1023/A:1026654312961; Sachdev S, 2012, ANNU REV CONDEN MA P, V3, P9, DOI 10.1146/annurev-conmatphys-020911-125141; Thorne K.S., 1986, BLACK HOLES MEMBRANE	9	5	5	0	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2012	337	6094					538	540		10.1126/science.1221693	http://dx.doi.org/10.1126/science.1221693			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982PU	22859480				2022-12-28	WOS:000307058700032
J	Wortmann, UG; Paytan, A				Wortmann, Ulrich G.; Paytan, Adina			Rapid Variability of Seawater Chemistry Over the Past 130 Million Years	SCIENCE			English	Article							SULFUR; CARBON; FLUCTUATIONS; EVAPORITES; DEPOSITION; EVOLUTION; CYCLES; OCEAN	Fluid inclusion data suggest that the composition of major elements in seawater changes slowly over geological time scales. This view contrasts with high-resolution isotope data that imply more rapid fluctuations of seawater chemistry. We used a non-steady-state box model of the global sulfur cycle to show that the global delta S-34 record can be explained by variable marine sulfate concentrations triggered by basin-scale evaporite precipitation and dissolution. The record is characterized by long phases of stasis, punctuated by short intervals of rapid change. Sulfate concentrations affect several important biological processes, including carbonate mineralogy, microbially mediated organic matter remineralization, sedimentary phosphorous regeneration, nitrogen fixation, and sulfate aerosol formation. These changes are likely to affect ocean productivity, the global carbon cycle, and climate.	[Wortmann, Ulrich G.] Univ Toronto, Dept Geol, Geobiol Isotope Lab, Toronto, ON M5S 3B1, Canada; [Paytan, Adina] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA	University of Toronto; University of California System; University of California Santa Cruz	Wortmann, UG (corresponding author), Univ Toronto, Dept Geol, Geobiol Isotope Lab, Toronto, ON M5S 3B1, Canada.	uli.wortmann@utoronto.ca; apaytan@ucsc.edu		Wortmann, Ulrich/0000-0001-7854-9173	Natural Sciences and Engineering Research Council of Canada; NSF CAREER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD))	We thank B. Brunner, M. Kastner, and T. Lowenstein for discussions and their comments on an early draft of this manuscript. We also thank the three anonymous reviewers for their thoughtful comments, which helped clarify and improve the manuscript. This research was support by a Natural Sciences and Engineering Research Council of Canada Discovery Grant to U. G. W. and a NSF CAREER award to A. P. Model Data and Code are available as supplementary materials on Science Online.	Adams DD, 2010, NAT GEOSCI, V3, P201, DOI 10.1038/NGEO743; ALLISON PA, 1988, PALAEONTOLOGY, V31, P1079; BERNER RA, 1983, GEOCHIM COSMOCHIM AC, V47, P855, DOI 10.1016/0016-7037(83)90151-5; Bots P, 2011, GEOLOGY, V39, P331, DOI 10.1130/G31619.1; BURKE K, 1988, MAR GEOL, V83, P309, DOI 10.1016/0025-3227(88)90064-3; Cardenas AL, 2010, NAT GEOSCI, V3, P430, DOI 10.1038/NGEO869; Clementz M, 2011, GEOLOGY, V39, P15, DOI 10.1130/G31585.1; DeBond N, 2012, ISOT ENVIRON HEALT S, V48, P180, DOI 10.1080/10256016.2012.659732; Einsele G., 1992, SEDIMENTARY BASINS E; GUSTAVSON TC, 1982, EARTH SURF PROC LAND, V7, P545, DOI 10.1002/esp.3290070604; Hay WW, 2006, PALAEOGEOGR PALAEOCL, V240, P3, DOI 10.1016/j.palaeo.2006.03.044; Horita J, 2002, GEOCHIM COSMOCHIM AC, V66, P3733, DOI 10.1016/S0016-7037(01)00884-5; Kiel S, 2009, TERRA NOVA, V21, P279, DOI 10.1111/j.1365-3121.2009.00882.x; Kurtz AC, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000908; Lowenstein TK, 2003, GEOLOGY, V31, P857, DOI 10.1130/G19728R.1; Lowenstein TK, 2001, SCIENCE, V294, P1086, DOI 10.1126/science.1064280; Marino R., 2003, DEV HYDROBIOL, V171, P277; Najman Y, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2010JB007673; Nichols G., 2009, SEDIMENTARY PROCESSE, P242; Paytan A, 2004, SCIENCE, V304, P1663, DOI 10.1126/science.1095258; RAYMO ME, 1988, GEOLOGY, V16, P649, DOI 10.1130/0091-7613(1988)016<0649:IOLCMB>2.3.CO;2; Ribas VW, 2010, CHEM PHYS LETT, V492, P19, DOI 10.1016/j.cplett.2010.04.036; SOUTHAM JR, 1981, SEA, V7, P1617; WILKINSON BH, 1979, GEOLOGY, V7, P524, DOI 10.1130/0091-7613(1979)7<524:BPATEO>2.0.CO;2; Wortmann UG, 2007, NATURE, V446, P654, DOI 10.1038/nature05693; Zharkov M. A., 1981, HIST PALEOZOIC SALT; [No title captured]	27	80	81	3	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2012	337	6092					334	336		10.1126/science.1220656	http://dx.doi.org/10.1126/science.1220656			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975WQ	22822148				2022-12-28	WOS:000306542600049
J	Qu, Y; Misaghi, S; Izrael-Tomasevic, A; Newton, K; Gilmour, LL; Lamkanfi, M; Louie, S; Kayagaki, N; Liu, JF; Komuves, L; Cupp, JE; Arnott, D; Monack, D; Dixit, VM				Qu, Yan; Misaghi, Shahram; Izrael-Tomasevic, Anita; Newton, Kim; Gilmour, Laurie L.; Lamkanfi, Mohamed; Louie, Salina; Kayagaki, Nobuhiko; Liu, Jinfeng; Koemueves, Laszlo; Cupp, James E.; Arnott, David; Monack, Denise; Dixit, Vishva M.			Phosphorylation of NLRC4 is critical for inflammasome activation	NATURE			English	Article							INNATE IMMUNE RECOGNITION; III SECRETION APPARATUS; PROTEIN-KINASE-C; FRANCISELLA-TULARENSIS; AIM2 INFLAMMASOME; HOST-DEFENSE; IPAF; CASPASE-1; FLAGELLIN; SALMONELLA	NLRC4 is a cytosolic member of the NOD-like receptor family that is expressed in innate immune cells. It senses indirectly bacterial flagellin and type III secretion systems, and responds by assembling an inflammasome complex that promotes caspase-1 activation and pyroptosis(1-6). Here we use knock-in mice expressing NLRC4 with a carboxy-terminal 3xFlag tag to identify phosphorylation of NLRC4 on a single, evolutionarily conserved residue, Ser 533, following infection of macrophages with Salmonella enterica serovar Typhimurium (also known as Salmonella typhimurium). Western blotting with a NLRC4 phospho-Ser 533 antibody confirmed that this post-translational modification occurs only in the presence of stimuli known to engage NLRC4 and not the related protein NLRP3 or AIM2. Nlrc4(-/-) macrophages reconstituted with NLRC4 mutant S533A, unlike those reconstituted with wild-type NLRC4, did not activate caspase-1 and pyroptosis in response to S. typhimurium, indicating that S533 phosphorylation is critical for NLRC4 inflammasome function. Conversely, phosphomimetic NLRC4 S533D caused rapid macrophage pyroptosis without infection. Biochemical purification of the NLRC4-phosphorylating activity and a screen of kinase inhibitors identified PRKCD (PKC delta) as a candidate NLRC4 kinase. Recombinant PKC delta phosphorylated NLRC4 S533 in vitro, immunodepletion of PKC delta from macrophage lysates blocked NLRC4 S533 phosphorylation in vitro, and Prkcd(-/-) macrophages exhibited greatly attenuated caspase-1 activation and IL-1 beta secretion specifically in response to S. typhimurium. Phosphorylation-defective NLRC4 S533A failed to recruit procaspase-1 and did not assemble inflammasome specks(7) during S. typhimurium infection, so phosphorylation of NLRC4 S533 probably drives conformational changes necessary for NLRC4 inflammasome activity and host innate immunity.	[Qu, Yan; Newton, Kim; Kayagaki, Nobuhiko; Dixit, Vishva M.] Genentech Inc, Dept Physiol Chem, San Francisco, CA 94080 USA; [Misaghi, Shahram; Louie, Salina] Genentech Inc, Dept Early Stage Cell Culture, San Francisco, CA 94080 USA; [Izrael-Tomasevic, Anita; Arnott, David] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Gilmour, Laurie L.; Cupp, James E.] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [Lamkanfi, Mohamed] VIB, Dept Med Prot Res, B-9000 Ghent, Belgium; [Lamkanfi, Mohamed] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium; [Liu, Jinfeng] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Koemueves, Laszlo] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Monack, Denise] Stanford Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Flanders Institute for Biotechnology (VIB); Ghent University; Roche Holding; Genentech; Roche Holding; Genentech; Stanford University	Dixit, VM (corresponding author), Genentech Inc, Dept Physiol Chem, 1 DNA Way, San Francisco, CA 94080 USA.	dixit@gene.com	dixit, vishva m/A-4496-2012	dixit, vishva m/0000-0001-6983-0326; Liu, Jinfeng/0000-0002-0343-8222; Monack, Denise/0000-0003-3804-2209				Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Amer A, 2006, J BIOL CHEM, V281, P35217, DOI 10.1074/jbc.M604933200; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Castellana NE, 2011, PROTEOMICS, V11, P395, DOI 10.1002/pmic.201000487; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Hersh D, 1999, P NATL ACAD SCI USA, V96, P2396, DOI 10.1073/pnas.96.5.2396; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; MIZUNO K, 1993, FEBS LETT, V330, P114, DOI 10.1016/0014-5793(93)80254-R; Poyet JL, 2001, J BIOL CHEM, V276, P28309, DOI 10.1074/jbc.C100250200; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Soltoff SP, 2007, TRENDS PHARMACOL SCI, V28, P453, DOI 10.1016/j.tips.2007.07.003; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Vendel AC, 2009, J IMMUNOL, V182, P1509, DOI 10.4049/jimmunol.182.3.1509; Wang GG, 2006, NAT METHODS, V3, P287, DOI 10.1038/NMETH865; WOLF M, 1988, BIOCHEM BIOPH RES CO, V154, P1273, DOI 10.1016/0006-291X(88)90277-X; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	22	210	223	0	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2012	490	7421					539	+		10.1038/nature11429	http://dx.doi.org/10.1038/nature11429			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NK	22885697				2022-12-28	WOS:000310196200042
J	Driessens, G; Beck, B; Caauwe, A; Simons, BD; Blanpain, C				Driessens, Gregory; Beck, Benjamin; Caauwe, Amelie; Simons, Benjamin D.; Blanpain, Cedric			Defining the mode of tumour growth by clonal analysis	NATURE			English	Article							CANCER STEM-CELLS; MOUSE SKIN; ADULT TISSUES; EVOLUTION; EPIDERMIS; REPLACEMENT; UNITS; FATE; BETA	Recent studies using the isolation of a subpopulation of tumour cells followed by their transplantation into immunodeficient mice provide evidence that certain tumours(1,2), including squamous skin tumours(3-5), contain cells with high clonogenic potential that have been referred to as cancer stem cells (CSCs). Until now, CSC properties have only been investigated by transplantation assays, and their existence in unperturbed tumour growth is unproven. Here we make use of clonal analysis of squamous skin tumours using genetic lineage tracing to unravel the mode of tumour growth in vivo in its native environment. To this end, we used a genetic labelling strategy that allows individual tumour cells to be marked and traced over time at different stages of tumour progression. Surprisingly, we found that the majority of labelled tumour cells in benign papilloma have only limited proliferative potential, whereas a fraction has the capacity to persist long term, giving rise to progeny that occupy a significant part of the tumour. As well as confirming the presence of two distinct proliferative cell compartments within the papilloma, mirroring the composition, hierarchy and fate behaviour of normal tissue, quantitative analysis of clonal fate data indicates that the more persistent population has stem-cell-like characteristics and cycles twice per day, whereas the second represents a slower cycling transient population that gives rise to terminally differentiated tumour cells. Such behaviour is shown to be consistent with double-labelling experiments and detailed clonal fate characteristics. By contrast, measurements of clone size and proliferative potential in invasive squamous cell carcinoma show a different pattern of behaviour, consistent with geometric expansion of a single CSC population with limited potential for terminal differentiation. This study presents the first experimental evidence for the existence of CSCs during unperturbed solid tumour growth.	[Simons, Benjamin D.] Univ Cambridge, Cavendish Lab, Dept Phys, Cambridge CB3 0HE, England; [Driessens, Gregory; Beck, Benjamin; Caauwe, Amelie; Blanpain, Cedric] Univ Libre Brussels, IRIBHM, B-1070 Brussels, Belgium; [Simons, Benjamin D.] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Blanpain, Cedric] WELBIO, B-1070 Brussels, Belgium	University of Cambridge; Universite Libre de Bruxelles; University of Cambridge; WELBIO	Simons, BD (corresponding author), Univ Cambridge, Cavendish Lab, Dept Phys, JJ Thomson Ave, Cambridge CB3 0HE, England.	bds10@cam.ac.uk; Cedric.Blanpain@ulb.ac.be	Blanpain, Cedric/ABD-8392-2021; Simons, Benjamin/AAY-8920-2020	Simons, Benjamin/0000-0002-3875-7071; Beck, Benjamin/0000-0001-8162-7566	Brussels Region; FNRS; program d'excellence CIBLES of the Wallonia Region; Fondation Contre le Cancer; ULB foundation; fond Gaston Ithier; European Research Council (ERC); EMBO; Engineering and Physical Sciences Research Council [EP/F032773/1] Funding Source: researchfish; EPSRC [EP/F032773/1] Funding Source: UKRI	Brussels Region; FNRS(Fonds de la Recherche Scientifique - FNRS); program d'excellence CIBLES of the Wallonia Region; Fondation Contre le Cancer; ULB foundation; fond Gaston Ithier; European Research Council (ERC)(European Research Council (ERC)); EMBO(European Molecular Biology Organization (EMBO)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	C.B. is investigator of WELBIO and chercheur qualifie of the FRS/FNRS. B.B. is charge de recherche of the FRS/FNRS and G.D. is supported by the Brussels Region. This work was supported by the FNRS, the program d'excellence CIBLES of the Wallonia Region, a research grant from the Fondation Contre le Cancer, the ULB foundation and the fond Gaston Ithier, a starting grant of the European Research Council (ERC), and the EMBO Young Investigator Program. We thank F. Bollet-Quivogne and J.-M. Vanderwinden for their help with confocal imaging.	Abel EL, 2009, NAT PROTOC, V4, P1350, DOI 10.1038/nprot.2009.120; Beck B, 2011, NATURE, V478, P399, DOI 10.1038/nature10525; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Doupe DP, 2010, DEV CELL, V18, P317, DOI 10.1016/j.devcel.2009.12.016; Ghazizadeh S, 2001, EMBO J, V20, P1215, DOI 10.1093/emboj/20.6.1215; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Kemp CJ, 2005, SEMIN CANCER BIOL, V15, P460, DOI 10.1016/j.semcancer.2005.06.003; Klein AM, 2011, DEVELOPMENT, V138, P3103, DOI 10.1242/dev.060103; Klein CA, 2009, NAT REV CANCER, V9, P302, DOI 10.1038/nrc2627; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; Mackenzie IC, 1997, J INVEST DERMATOL, V109, P377, DOI 10.1111/1523-1747.ep12336255; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Nguyen LV, 2012, NAT REV CANCER, V12, P133, DOI 10.1038/nrc3184; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Owens DM, 2003, NAT REV CANCER, V3, P444, DOI 10.1038/nrc1096; Perez-Losada J, 2003, NAT REV CANCER, V3, P434, DOI 10.1038/nrc1095; Potten C S, 1981, Int Rev Cytol, V69, P271; Rocheteau P, 2012, CELL, V148, P112, DOI 10.1016/j.cell.2011.11.049; Schober M, 2011, P NATL ACAD SCI USA, V108, P10544, DOI 10.1073/pnas.1107807108; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Van Keymeulen A, 2009, J CELL BIOL, V187, P91, DOI 10.1083/jcb.200907080; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551	26	522	547	2	148	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2012	488	7412					527	+		10.1038/nature11344	http://dx.doi.org/10.1038/nature11344			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992FS	22854777	Green Accepted			2022-12-28	WOS:000307761600040
J	Peach, G; Griffin, M; Jones, KG; Thompson, MM; Hinchliffe, RJ				Peach, G.; Griffin, M.; Jones, K. G.; Thompson, M. M.; Hinchliffe, R. J.			Diagnosis and management of peripheral arterial disease	BMJ-BRITISH MEDICAL JOURNAL			English	Review							INTERMITTENT CLAUDICATION; PREVALENCE; RISK; GRAFTS		[Peach, G.; Griffin, M.; Jones, K. G.; Thompson, M. M.; Hinchliffe, R. J.] St Georges Healthcare NHS Trust, St Georges Vasc Inst, London SW17 0QT, England	St Georges University London	Hinchliffe, RJ (corresponding author), St Georges Healthcare NHS Trust, St Georges Vasc Inst, London SW17 0QT, England.	rhinchli@sgul.ac.uk						Adam DJ, 2005, LANCET, V366, P925; BECKER GJ, 1989, RADIOLOGY, V170, P921, DOI 10.1148/radiology.170.3.2521745; Belch JJF, 2003, ARCH INTERN MED, V163, P884, DOI 10.1001/archinte.163.8.884; Belch JJF, 2010, J VASC SURG; Bertel V, 1997, EUR J VASC ENDOVASC, V14, P91; CRIQUI MH, 1992, NEW ENGL J MED, V326, P381, DOI 10.1056/NEJM199202063260605; Department of Health, 2011, NHS OUTC FRAM 2012 1; deVries SO, 1997, J VASC SURG, V26, P558, DOI 10.1016/S0741-5214(97)70053-3; Diabet Control Complications Trial DCCT Res Grp, 1995, AM J CARDIOL, V75, P894; DORMANDY J, 1994, BRIT J SURG, V81, P33, DOI 10.1002/bjs.1800810110; FOWKES FGR, 1991, INT J EPIDEMIOL, V20, P384, DOI 10.1093/ije/20.2.384; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Hart W, 1995, BR J MED EC, V8, P211; HIATT WR, 1995, CIRCULATION, V91, P1472, DOI 10.1161/01.CIR.91.5.1472; Jeffcoate W, 2006, PRACT DIABETES INT, V23, P28; JONASON T, 1985, ACTA MED SCAND, V218, P27; KANNEL WB, 1970, CIRCULATION, V41, P875, DOI 10.1161/01.CIR.41.5.875; LUNDGREN F, 1989, ANN SURG, V209, P346, DOI 10.1097/00000658-198903000-00016; McDaniel M D, 1989, Ann Vasc Surg, V3, P273, DOI 10.1016/S0890-5096(07)60040-5; MONETA GL, 1992, J VASC SURG, V15, P275, DOI 10.1016/0741-5214(92)90249-8; Murabito JM, 1997, CIRCULATION, V96, P44; Muradin GSR, 2001, RADIOLOGY, V221, P137, DOI 10.1148/radiol.2211010039; National Institute for Health and Clinical Excellence, 2011, CG119 NAT I HLTH CLI; National Institute for Health and Clinical Excellence, 2012, CG147 NAT I HLTH CLI; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; Novo S., 2004, Current Drug Targets - Cardiovascular & Haematological Disorders, V4, P219, DOI 10.2174/1568006043335989; RADACK K, 1991, ARCH INTERN MED, V151, P1769, DOI 10.1001/archinte.151.9.1769; Selvin E, 2004, CIRCULATION, V110, P738, DOI 10.1161/01.CIR.0000137913.26087.F0; Selvin E, 2004, ANN INTERN MED, V141, P421, DOI 10.7326/0003-4819-141-6-200409210-00007; Sobel M, 2008, CHEST, V133, p815S, DOI 10.1378/chest.08-0686; Stewart K, 2011, HEART, V97, P585, DOI 10.1136/hrt.2010.219717; Watson L, 2008, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858; Willigendael EM, 2005, J VASC SURG, V42, P67, DOI 10.1016/j.jvs.2005.03.024; Yusuf S, 2000, NEW ENGL J MED, V342, P145	34	72	77	0	34	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 14	2012	345								e5208	10.1136/bmj.e5208	http://dx.doi.org/10.1136/bmj.e5208			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992CD	22893640				2022-12-28	WOS:000307752000004
J	Laurent, S; Schlaich, M; Esler, M				Laurent, Stephane; Schlaich, Markus; Esler, Murray			New drugs, procedures, and devices for hypertension	LANCET			English	Article							RENAL SYMPATHETIC DENERVATION; ENDOTHELIN-RECEPTOR ANTAGONIST; RANDOMIZED CONTROLLED-TRIAL; AMBULATORY BLOOD-PRESSURE; CAROTID-SINUS STIMULATOR; OBSTRUCTIVE SLEEP-APNEA; DEEP BRAIN-STIMULATION; RESISTANT HYPERTENSION; DOUBLE-BLIND; VASOPEPTIDASE INHIBITORS	Successful treatment of hypertension is difficult despite the availability of several classes of antihypertensive drug, and the value of strategies to combat the effect of adverse lifestyle behaviours on blood pressure. In this paper, we discuss two promising therapeutic alternatives for patients with resistant hypertension: novel drugs, including new pharmacological classes (such as vasopeptidase inhibitors and aldosterone synthase inhibitors) and new molecules from present pharmacological classes with additional properties in blood-pressure or metabolism pathways; and new procedures and devices, including stimulation of arterial baroreceptors and catheter-based renal denervation. Although several pharmacological targets have been discovered with promising preclinical results, the clinical development of novel antihypertensive drugs has been more difficult and less productive than expected. The effectiveness and safety of new devices and procedures should be carefully assessed in patients with resistant hypertension, thus leading to a new era of outcome trials and evidence-based guidelines.	[Laurent, Stephane] Hop Europeen Georges Pompidou, AP HP, Dept Pharmacol, Paris, France; [Laurent, Stephane] Univ Paris 05, F-75015 Paris, France; [Laurent, Stephane] INSERM, PARCC U970, Paris, France; [Schlaich, Markus; Esler, Murray] Baker IDI Heart & Diabet Inst, Neurovasc Hypertens & Kidney Dis & Human Neurotra, Melbourne, Vic, Australia	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Baker Heart and Diabetes Institute	Laurent, S (corresponding author), Univ Paris 05, Hop Europeen Georges Pompidou, Dept Pharmacol, F-75015 Paris, France.	stephane.laurent@egp.aphp.fr	Laurent, Stephane/J-8624-2015	Schlaich, Markus/0000-0002-1765-0195	NHMRC of Australia; Medtronic; AstraZeneca; Boehringer Ingelheim; Chiesi; Daiichi-Sankyo; Menarini; Negma; Novartis; Recordati; Servier; Esaote-Pie Medical; Omron; Atcor; Daiichi-Esaote-Pie Medical; Sankyo; Abbott; Kona Medical; Cardiosonic	NHMRC of Australia(National Health and Medical Research Council (NHMRC) of Australia); Medtronic(Medtronic); AstraZeneca(AstraZeneca); Boehringer Ingelheim(Boehringer Ingelheim); Chiesi(Chiesi Pharmaceuticals Inc); Daiichi-Sankyo(Daiichi Sankyo Company Limited); Menarini(Menarini Group); Negma; Novartis(Novartis); Recordati; Servier(Servier); Esaote-Pie Medical; Omron; Atcor; Daiichi-Esaote-Pie Medical; Sankyo; Abbott(Abbott Laboratories); Kona Medical; Cardiosonic	SL has received fees for consultancy and speaking, and honoraria from the drug companies AstraZeneca, Boehringer Ingelheim, Chiesi, Daiichi-Sankyo, Menarini, Negma, Novartis, Recordati, and Servier, and manufacturers Esaote-Pie Medical and Omron; and research funding from AstraZeneca, Atcor, Daiichi-Esaote-Pie Medical, Sankyo, Novartis, and Servier. MS has received fees for consultancy and speaking, and honoraria from Abbott, AstraZeneca, Boehringer Ingelheim, Medtronic, Novartis, and Servier; research funding from Abbott and Medtronic. ME received relevant consultancies, and honoraria or speaker's fees from Abbott, AstraZeneca, Boehringer Ingelheim, Kona Medical, Medtronic, Cardiosonic and Novartis; and research funding from Medtronic and Servier.; SL thanks Institut National de la Sante et de la Recherche Medicale (INSERM), Assistance-Publique Hoitaux de Paris, Universite Paris Descartes. MS and ME are supported by research fellowships from the NHMRC of Australia and are both prinicipal investigators in clinical trials of renal denervation sponsored by Medtronic.	Adam A, 2002, LANCET, V359, P2088, DOI 10.1016/S0140-6736(02)08914-6; Altena MR, 2009, BLOOD PRESSURE, V18, P273, DOI 10.1080/08037050903272925; Amar L, 2010, HYPERTENSION, V56, P831, DOI 10.1161/HYPERTENSIONAHA.110.157271; Atherton DS, 2012, CLIN ANAT, V25, P628, DOI 10.1002/ca.21280; Azizi M, 2006, CLIN PHARMACOL THER, V79, P49, DOI 10.1016/j.clpt.2005.09.011; Bakris GL, 2010, HYPERTENSION, V56, P824, DOI 10.1161/HYPERTENSIONAHA.110.156976; Bisognano JD, 2011, J AM COLL CARDIOL, V58, P765, DOI 10.1016/j.jacc.2011.06.008; Bodineau L, 2008, HYPERTENSION, V51, P1318, DOI 10.1161/HYPERTENSIONAHA.107.098772; Bradley TD, 2009, LANCET, V373, P82, DOI 10.1016/S0140-6736(08)61622-0; Breschi MC, 2006, J MED CHEM, V49, P2628, DOI 10.1021/jm0600186; Broderick KE, 2007, EXP BIOL MED, V232, P1432, DOI 10.3181/0703-RM-70; Calhoun DA, 2011, CIRCULATION, V124, P1945, DOI 10.1161/CIRCULATIONAHA.111.029892; Calhoun DA, 2010, CARDIOL CLIN, V28, P517, DOI [10.1016/j.ccl.2010.04.001, 10.1016/j.ccl.2009.10.001]; Campbell DJ, 2003, HYPERTENSION, V41, P383, DOI 10.1161/01.HYP.0000054215.71691.16; CAMPESE VM, 1995, HYPERTENSION, V25, P878, DOI 10.1161/01.HYP.25.4.878; Carter HH, 2011, HYPERTENSION, V57, pE24, DOI 10.1161/HYPERTENSIONAHA.111.170183; Casimiro-Garcia A, 2011, J MED CHEM, V54, P4219, DOI 10.1021/jm200409s; CLOZEL M, 1993, NATURE, V365, P759, DOI 10.1038/365759a0; CONVERSE RL, 1992, NEW ENGL J MED, V327, P1912, DOI 10.1056/NEJM199212313272704; Corti R, 2001, CIRCULATION, V104, P1856, DOI 10.1161/hc4001.097191; Dampney RAL, 2003, PROG NEUROBIOL, V71, P359, DOI 10.1016/j.pneurobio.2003.11.001; Daull P, 2007, J CARDIOVASC PHARM, V50, P247, DOI 10.1097/FJC.0b013e31813c6ca5; de Souza F, 2010, HYPERTENSION, V55, P147, DOI 10.1161/HYPERTENSIONAHA.109.140988; DiBona GF, 2010, AM J PHYSIOL-REG I, V298, pR245, DOI 10.1152/ajpregu.00647.2009; DiBona GF, 1997, PHYSIOL REV, V77, P75, DOI 10.1152/physrev.1997.77.1.75; Dive V, 2009, CURR PHARM DESIGN, V15, P3606, DOI 10.2174/138161209789271889; Elliot William J, 2004, J Clin Hypertens (Greenwich), V6, P553, DOI 10.1111/j.1524-6175.2004.03553.x; ERNST CB, 1972, ARCH SURG-CHICAGO, V104, P496; ESLER M, 1988, HYPERTENSION, V11, P3, DOI 10.1161/01.HYP.11.1.3; Esler M, 2010, J APPL PHYSIOL, V109, P1996, DOI 10.1152/japplphysiol.00182.2010; Esler MD, 2010, LANCET, V376, P1903, DOI 10.1016/S0140-6736(10)62039-9; Fryer RM, 2008, BRIT J PHARMACOL, V153, P947, DOI 10.1038/sj.bjp.0707641; Funke-Kaiser H, 2010, HYPERTENS RES, V33, P98, DOI 10.1038/hr.2009.206; Green AL, 2007, J CLIN NEUROSCI, V14, P592, DOI 10.1016/j.jocn.2006.04.015; Grossmann C, 2009, MOL CELL ENDOCRINOL, V308, P53, DOI 10.1016/j.mce.2009.02.005; Gu J, 2010, J CLIN PHARMACOL, V50, P401, DOI 10.1177/0091270009343932; Hering D, 2012, J AM SOC NEPHROL, V23, P1250, DOI 10.1681/ASN.2011111062; Heusser K, 2010, HYPERTENSION, V55, P619, DOI 10.1161/HYPERTENSIONAHA.109.140665; Illig KA, 2006, J VASC SURG, V44, P1213, DOI 10.1016/j.jvs.2006.08.024; Jamerson K, 2008, NEW ENGL J MED, V359, P2417, DOI 10.1056/NEJMoa0806182; Kalk P, 2011, HYPERTENSION, V57, P755, DOI 10.1161/HYPERTENSIONAHA.110.163972; Kaplan NM, 2005, J HYPERTENS, V23, P1441, DOI 10.1097/01.hjh.0000174968.72212.ac; Kass DA, 2001, CIRCULATION, V104, P1464, DOI 10.1161/hc3801.097806; KOSOGLOU T, 1990, CIRCULATION, V82, P554; Kostis OB, 2004, AM J HYPERTENS, V17, P103, DOI 10.1016/j.amjhyper.2003.09.014; Kowala MC, 2004, J PHARMACOL EXP THER, V309, P275, DOI 10.1124/jpet.103.055855; Krum H, 1998, NEW ENGL J MED, V338, P784, DOI 10.1056/NEJM199803193381202; Krum H, 2009, LANCET, V373, P1275, DOI 10.1016/S0140-6736(09)60566-3; Kumbhani DJ, 2011, AM HEART J, V161, P622, DOI 10.1016/j.ahj.2010.12.006; Kurtz TW, 2009, HYPERTENS RES, V32, P826, DOI 10.1038/hr.2009.135; Laurent S, 2000, HYPERTENSION, V35, P1148, DOI 10.1161/01.HYP.35.5.1148; LEVIN ER, 1995, NEW ENGL J MED, V333, P356, DOI 10.1056/NEJM199508103330607; Li YQ, 2007, EUR J PHARMACOL, V577, P100, DOI 10.1016/j.ejphar.2007.08.008; Lohmeier TE, 2012, HYPERTENSION, V59, P331, DOI 10.1161/HYPERTENSIONAHA.111.185074; Lozano L, 2010, J HYPERTENS, V28, P2161, DOI 10.1097/HJH.0b013e32833b9c63; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; MICHEL JB, 1987, P NATL ACAD SCI USA, V84, P4346, DOI 10.1073/pnas.84.12.4346; Ruilope LM, 2010, LANCET, V375, P1255, DOI 10.1016/S0140-6736(09)61966-8; Murca TM, 2012, EXP PHYSIOL, V97, P699, DOI 10.1113/expphysiol.2011.063461; NARAGHI R, 1994, LANCET, V344, P1466, DOI 10.1016/S0140-6736(94)90289-5; Nilsson PM, 2009, HYPERTENSION, V54, P3, DOI 10.1161/HYPERTENSIONAHA.109.129114; OPARIL S, 1987, CAN J PHYSIOL PHARM, V65, P1548, DOI 10.1139/y87-244; PEET MM, 1947, NEW ENGL J MED, V236, P270, DOI 10.1056/NEJM194702202360802; Pepperell JCT, 2002, LANCET, V359, P204, DOI 10.1016/S0140-6736(02)07445-7; Rippy MK, 2011, CLIN RES CARDIOL, V100, P1095, DOI 10.1007/s00392-011-0346-8; Sadowski J, 2011, HYPERTENSION, V57, P911, DOI 10.1161/HYPERTENSIONAHA.110.163014; Sanchez LA, 2010, ANN VASC SURG, V24, P178, DOI 10.1016/j.avsg.2009.10.003; SANKARI B, 1992, J UROLOGY, V148, P206, DOI 10.1016/S0022-5347(17)36554-0; Sasaki S, 2011, J CLIN HYPERTENS, V13, P818, DOI 10.1111/j.1751-7176.2011.00522.x; Schlaich MP, 2009, NEW ENGL J MED, V361, P932, DOI 10.1056/NEJMc0904179; SCHWARTZ SI, 1967, AM J SURG, V114, P5, DOI 10.1016/0002-9610(67)90034-7; Sharma SK, 2011, NEW ENGL J MED, V365, P2277, DOI 10.1056/NEJMoa1103944; Simms AE, 2009, J PHYSIOL-LONDON, V587, P597, DOI 10.1113/jphysiol.2008.165902; Tabrizchi R, 2008, CURR OPIN INVEST DR, V9, P301; Tissot AC, 2008, LANCET, V371, P821, DOI 10.1016/S0140-6736(08)60381-5; Unger T, 2011, EUR HEART J, V32, P2739, DOI 10.1093/eurheartj/ehr253; Weber MA, 2001, LANCET, V358, P1525, DOI 10.1016/S0140-6736(01)06584-9; Weber MA, 2009, LANCET, V374, P1423, DOI 10.1016/S0140-6736(09)61500-2; Weber MA, 2009, AM J MED, V122, P16, DOI 10.1016/j.amjmed.2009.03.004; Wheatley K, 2009, NEW ENGL J MED, V361, P1953, DOI 10.1056/NEJMoa0905368	80	110	118	0	41	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 11	2012	380	9841					591	600		10.1016/S0140-6736(12)60825-3	http://dx.doi.org/10.1016/S0140-6736(12)60825-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988SQ	22883508				2022-12-28	WOS:000307511400032
J	Swann, O; Powls, A				Swann, Olivia; Powls, Andrew			Green Teeth in Neonatal Sepsis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Swann, Olivia; Powls, Andrew] Princess Royal Matern Hosp, Glasgow, Lanark, Scotland		Swann, O (corresponding author), Princess Royal Matern Hosp, Glasgow, Lanark, Scotland.	livvyswann@doctors.org.uk							0	1	1	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 9	2012	367	6					E8	E8		10.1056/NEJMicm1110461	http://dx.doi.org/10.1056/NEJMicm1110461			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	986AE	22873557				2022-12-28	WOS:000307310800010
J	Kukulski, W; Schorb, M; Kaksonen, M; Briggs, JAG				Kukulski, Wanda; Schorb, Martin; Kaksonen, Marko; Briggs, John A. G.			Plasma Membrane Reshaping during Endocytosis Is Revealed by Time-Resolved Electron Tomography	CELL			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; ACTIN CYTOSKELETON; FISSION YEAST; BUDDING YEAST; BAR DOMAINS; IN-VIVO; VESICLE; MICROSCOPY; CURVATURE; MECHANISM	Endocytosis, like many dynamic cellular processes, requires precise temporal and spatial orchestration of complex protein machinery to mediate membrane budding. To understand how this machinery works, we directly correlated fluorescence microscopy of key protein pairs with electron tomography. We systematically located 211 endocytic intermediates, assigned each to a specific time window in endocytosis, and reconstructed their ultrastructure in 3D. The resulting virtual ultrastructural movie defines the protein-mediated membrane shape changes during endocytosis in budding yeast. It reveals that clathrin is recruited to flat membranes and does not initiate curvature. Instead, membrane invagination begins upon actin network assembly followed by amphiphysin binding to parallel membrane segments, which promotes elongation of the invagination into a tubule. Scission occurs on average 9 s after initial bending when invaginations are similar to 100 nm deep, releasing nonspherical vesicles with 6,400 nm(2) mean surface area. Direct correlation of protein dynamics with ultrastructure provides a quantitative 4D resource.	[Kukulski, Wanda; Schorb, Martin; Kaksonen, Marko; Briggs, John A. G.] European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany; [Kukulski, Wanda; Kaksonen, Marko; Briggs, John A. G.] European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL)	Kaksonen, M (corresponding author), European Mol Biol Lab, Struct & Computat Biol Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	kaksonen@embl.de; briggs@embl.de	Kukulski, Wanda/H-1766-2013; Briggs, John/J-3096-2012	Kaksonen, Marko/0000-0003-3645-7689; Briggs, John/0000-0003-3990-6910; Schorb, Martin/0000-0003-4910-1868	EMBL interdisciplinary postdoctoral fellowship; Swiss National Science Foundation	EMBL interdisciplinary postdoctoral fellowship; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was technically supported by Frank Thommen and by the EMBL EM core facility. We thank Jan Ellenberg and Francois Nedelec for critical reading of the manuscript and Wolfgang Huber for statistical advice. W. K. acknowledges an EMBL interdisciplinary postdoctoral fellowship and a fellowship for advanced researchers from the Swiss National Science Foundation.	ANDERSON RGW, 1977, CELL, V10, P351, DOI 10.1016/0092-8674(77)90022-8; Boettner DR, 2012, NAT CELL BIOL, V14, P2, DOI 10.1038/ncb2403; Boettner DR, 2009, CURR BIOL, V19, P1979, DOI 10.1016/j.cub.2009.10.062; Boukellal H, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.061906; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Campelo F, 2010, FEBS LETT, V584, P1830, DOI 10.1016/j.febslet.2009.10.023; Carroll SY, 2012, MOL BIOL CELL, V23, P657, DOI 10.1091/mbc.E11-02-0108; Collins A, 2011, CURR BIOL, V21, P1167, DOI 10.1016/j.cub.2011.05.048; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Cureton DK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001127; den Otter WK, 2011, TRAFFIC, V12, P1407, DOI 10.1111/j.1600-0854.2011.01241.x; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Galletta BJ, 2010, CURR OPIN BIOTECH, V21, P604, DOI 10.1016/j.copbio.2010.06.006; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Henne WM, 2010, SCIENCE, V328, P1281, DOI 10.1126/science.1188462; HEUSER J, 1980, J CELL BIOL, V84, P560, DOI 10.1083/jcb.84.3.560; HEUSER J, 1989, J CELL BIOL, V108, P401, DOI 10.1083/jcb.108.2.401; Hinrichsen L, 2006, P NATL ACAD SCI USA, V103, P8715, DOI 10.1073/pnas.0600312103; Hoffmann A, 2010, TRAFFIC, V11, P1129, DOI 10.1111/j.1600-0854.2010.01084.x; Idrissi FZ, 2008, J CELL BIOL, V180, P1219, DOI 10.1083/jcb.200708060; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Karpova TS, 1998, J CELL BIOL, V142, P1501, DOI 10.1083/jcb.142.6.1501; Kirchhausen T, 2009, TRENDS CELL BIOL, V19, P596, DOI 10.1016/j.tcb.2009.09.002; Kishimoto T, 2011, P NATL ACAD SCI USA, V108, pE979, DOI 10.1073/pnas.1113413108; Kukulski W, 2011, J CELL BIOL, V192, P111, DOI 10.1083/jcb.201009037; Liu J, 2006, P NATL ACAD SCI USA, V103, P10277, DOI 10.1073/pnas.0601045103; Liu J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000204; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; MULHOLLAND J, 1994, J CELL BIOL, V125, P381, DOI 10.1083/jcb.125.2.381; Newpher TM, 2005, DEV CELL, V9, P87, DOI 10.1016/j.devcel.2005.04.014; Nixon SJ, 2009, TRAFFIC, V10, P131, DOI 10.1111/j.1600-0854.2008.00859.x; Perrais D, 2005, DEV CELL, V9, P581, DOI 10.1016/j.devcel.2005.10.002; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pruggnaller S, 2008, J STRUCT BIOL, V164, P161, DOI 10.1016/j.jsb.2008.05.003; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Qualmann B, 2011, EMBO J, V30, P3501, DOI 10.1038/emboj.2011.266; Reider A, 2009, EMBO J, V28, P3103, DOI 10.1038/emboj.2009.248; ROTH TF, 1964, J CELL BIOL, V20, P313, DOI 10.1083/jcb.20.2.313; Sirotkin V, 2010, MOL BIOL CELL, V21, P2894, DOI 10.1091/mbc.E10-02-0157; Stimpson HEM, 2009, MOL BIOL CELL, V20, P4640, DOI 10.1091/mbc.E09-05-0429; Takagi T, 2003, J ELECTRON MICROSC, V52, P161, DOI 10.1093/jmicro/52.2.161; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Toshima JY, 2006, P NATL ACAD SCI USA, V103, P5793, DOI 10.1073/pnas.0601042103; Traub LM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000192; Upadhyaya A, 2003, CURR BIOL, V13, pR734, DOI 10.1016/j.cub.2003.08.051; Wu XF, 2003, MOL BIOL CELL, V14, P516, DOI 10.1091/mbc.E02-06-0353; Wu XF, 2001, J CELL BIOL, V155, P291, DOI 10.1083/jcb.200104085; Yarar D, 2005, MOL BIOL CELL, V16, P964, DOI 10.1091/mbc.e04-09-0774; Youn JY, 2010, MOL BIOL CELL, V21, P3054, DOI 10.1091/mbc.E10-03-0181	51	229	231	3	65	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 3	2012	150	3					508	520		10.1016/j.cell.2012.05.046	http://dx.doi.org/10.1016/j.cell.2012.05.046			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	985WO	22863005	Bronze			2022-12-28	WOS:000307301400011
J	Song, ZR; Cutler, DM; Chernew, ME				Song, Zirui; Cutler, David M.; Chernew, Michael E.			Potential Consequences of Reforming Medicare Into a Competitive Bidding System	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Song, Zirui; Chernew, Michael E.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Song, Zirui] Harvard Univ, Sch Med, Francis Weld Peabody Soc, Boston, MA 02115 USA; [Song, Zirui; Cutler, David M.; Chernew, Michael E.] Harvard Univ, Natl Bur Econ Res, Cambridge, MA 02138 USA; [Cutler, David M.] Harvard Univ, Dept Econ, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; National Bureau of Economic Research; Harvard University	Song, ZR (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	zirui_song@hms.harvard.edu		Cutler, David/0000-0002-4949-8917	NATIONAL INSTITUTE ON AGING [T32AG000186, P01AG032952, F30AG039175] Funding Source: NIH RePORTER; NIA NIH HHS [P01 AG032952, F30 AG039175, T32 AG000186] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aaron HJ, 2012, NEW ENGL J MED, V366, P877, DOI 10.1056/NEJMp1200448; Abaluck J, 2011, AM ECON REV, V101, P1180, DOI 10.1257/aer.101.4.1180; Antos JR, 2012, NEW ENGL J MED, V366, P879, DOI 10.1056/NEJMp1200446; Centers for Medicare & Medicaid Services, PLAN PAYM DAT; Department of Health and Human Services Centers for Medicare & Medicaid Services, 2011, MED SHAR SAV PROGR A; Ericson KMM, 2011, MARKET DESIGN FIRMS; Feldman R, COMPETITIVE BIDDING; House Budget Committee, FISC YEAR 2013 BUDG	8	8	8	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2012	308	5					459	460		10.1001/jama.2012.7909	http://dx.doi.org/10.1001/jama.2012.7909			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	981DQ	22851110	Green Accepted, Green Published			2022-12-28	WOS:000306947400021
J	Melenotte, C; Million, M; Hartung, O; Botelho-Nevers, E; Claudel, M; Craighero, F; Brouqui, P; Raoult, D				Melenotte, Clea; Million, Matthieu; Hartung, Olivier; Botelho-Nevers, Elisabeth; Claudel, Matthieu; Craighero, Fabien; Brouqui, Philippe; Raoult, Didier			Query rectal bleeding	LANCET			English	Editorial Material									[Raoult, Didier] Univ Mediterranee, Fac Med, URMITE CNRS UMR IRD 198 6236, Unite Rech Malad Infect & Trop Emergentes,IFR 48, F-13385 Marseille 5, France; [Hartung, Olivier; Claudel, Matthieu] Hop Nord Marseille, Serv Chirurg Vasc, Marseille, France; [Craighero, Fabien] Hop Nord Marseille, Serv Imagerie Med, Marseille, France; [Melenotte, Clea; Million, Matthieu; Botelho-Nevers, Elisabeth; Brouqui, Philippe] Hop Nord Marseille, Serv Malad Infect & Trop, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Raoult, D (corresponding author), Univ Mediterranee, Fac Med, URMITE CNRS UMR IRD 198 6236, Unite Rech Malad Infect & Trop Emergentes,IFR 48, 27 Blvd Jean Moulin, F-13385 Marseille 5, France.	didier.raoult@gmail.com	Million, Matthieu/F-7693-2011; Botelho-Nevers, Elisabeth/H-2063-2019; RAOULT, Didier/A-8434-2008; Brouqui, Philippe/P-5771-2016; MELENOTTE, Clea/AAG-7011-2020	Million, Matthieu/0000-0002-5556-6947; Botelho-Nevers, Elisabeth/0000-0003-2773-7750; RAOULT, Didier/0000-0002-0633-5974; 				Kloppenburg Geoffrey Tl, 2011, J Med Case Rep, V5, P565, DOI 10.1186/1752-1947-5-565; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; Merhej V, 2012, COMP IMMUNOL MICROB, V35, P45, DOI 10.1016/j.cimid.2011.09.010; Wegdam-Blans MCA, 2011, EUR J VASC ENDOVASC, V42, P384, DOI 10.1016/j.ejvs.2011.04.013; Wever PC, 2010, NED TIJDSCHR GENEES, V154, pA2122	5	9	9	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 28	2012	380	9839					446	446		10.1016/S0140-6736(12)60470-X	http://dx.doi.org/10.1016/S0140-6736(12)60470-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	979TN	22841338				2022-12-28	WOS:000306842800042
J	White, TD				White, Tim D.			Phillip V. Tobias (1925-2012) RETROSPECTIVE	SCIENCE			English	Biographical-Item									Univ Calif Berkeley, Human Evolut Res Ctr, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	White, TD (corresponding author), Univ Calif Berkeley, Human Evolut Res Ctr, Berkeley, CA 94720 USA.	timwhite@berkeley.edu						TOBIAS PV, PUBLICATION LIST	1	2	2	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2012	337	6093					423	423		10.1126/science.1225988	http://dx.doi.org/10.1126/science.1225988			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979FS	22837516				2022-12-28	WOS:000306802300030
J	Groen, RS; Samai, M; Stewart, KA; Cassidy, LD; Kamara, TB; Yambasu, SE; Kingham, TP; Kushner, AL				Groen, Reinou S.; Samai, Mohamed; Stewart, Kerry-Ann; Cassidy, Laura D.; Kamara, Thaim B.; Yambasu, Sahr E.; Kingham, T. Peter; Kushner, Adam L.			Untreated surgical conditions in Sierra Leone: a cluster randomised, cross-sectional, countrywide survey	LANCET			English	Article							PUBLIC-HEALTH; SURGERY; EXPERIENCE; DISEASES	Background Surgical care is increasingly recognised as an important part of global health yet data for the burden of surgical disease are scarce. The Surgeons OverSeas Assessment of Surgical Need (SOSAS) was developed to measure the prevalence of surgical conditions and surgically treatable deaths in low-income and middle-income countries. We administered this survey countrywide in Sierra Leone, which ranks 180 of the 187 nations on the UN Development Index. Methods The study was done between Jan 9 and Feb 3, 2012. 75 of 9671 enumeration areas, the smallest administrative units in Sierra Leone, were randomly selected for the study clusters, with a probability proportional to the population size. In each cluster 25 households were randomly selected to take part in the survey. Data were collected via handheld tablets by trained local medical and nursing students. A household representative was interviewed to establish the number of household members (defined as those who ate from the same pot and slept in the same structure the night before the interview), identify deaths in the household during the previous year, and establish whether any of the deceased household members had a condition needing surgery in the week before death. Two randomly selected household members underwent a head-to-toe verbal examination and need for surgical care was recorded on the basis of the response to whether they had a condition that they believed needed surgical assessment or care. Findings Of the 1875 targeted households, data were analysed for 1843 (98%). 896 of 3645 (25%; 95% CI 22.9-26.2) respondents reported a surgical condition needing attention and 179 of 709 (25%; 95% CI 22.5-27.9) deaths of household members in the previous year might have been averted by timely surgical care. Interpretation Our results show a large unmet need for surgical consultations in Sierra Leone and provide a baseline against which future surgical programmes can be measured. Additional surveys in other low-income and middle-income countries are needed to document and confirm what seems to be a neglected component of global health.	[Groen, Reinou S.; Kingham, T. Peter; Kushner, Adam L.] Surg OverSeas, New York, NY 10003 USA; [Groen, Reinou S.] Johns Hopkins Univ Hosp, Dept Gynecol & Obstet, Baltimore, MD 21287 USA; [Groen, Reinou S.] Royal Trop Inst, Dept Int Hlth, NL-1105 AZ Amsterdam, Netherlands; [Samai, Mohamed; Kamara, Thaim B.] Coll Med & Allied Hlth Sci, Freetown, Sierra Leone; [Stewart, Kerry-Ann] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA; [Cassidy, Laura D.] Med Coll Wisconsin, Inst Hlth & Soc, Milwaukee, WI 53226 USA; [Cassidy, Laura D.] Med Coll Wisconsin, Div Epidemiol, Milwaukee, WI 53226 USA; [Kamara, Thaim B.] Connaught Hosp, Dept Surg, Freetown, Sierra Leone; [Kamara, Thaim B.] Univ Sierra Leone, Freetown, Sierra Leone; [Yambasu, Sahr E.] Stat Sierra Leone, Freetown, Sierra Leone; [Kingham, T. Peter] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Kushner, Adam L.] Columbia Univ, Dept Surg, New York, NY USA	Johns Hopkins University; Johns Hopkins Medicine; Stanford University; Medical College of Wisconsin; Medical College of Wisconsin; Connaught Hospital; Memorial Sloan Kettering Cancer Center; Columbia University	Groen, RS (corresponding author), Surg OverSeas, New York, NY 10003 USA.	rsgroen@hotmail.com	MITCHELL, KERRY-ANN/AAD-4847-2019	MITCHELL, KERRY-ANN/0000-0002-2996-4837; Groen, Reinou/0000-0002-1372-6068; Kingham, T Peter/0000-0002-3359-3186; Kushner, Adam/0000-0002-7797-4837	Surgeons OverSeas, Thompson Family Foundation	Surgeons OverSeas, Thompson Family Foundation	Surgeons OverSeas, Thompson Family Foundation.	Bae JY, 2011, B WORLD HEALTH ORGAN, V89, P395, DOI 10.2471/BLT.11.088229; BENNETT S, 1991, World Health Statistics Quarterly, V44, P98; Bickler S, 2010, WORLD J SURG, V34, P374, DOI 10.1007/s00268-009-0261-6; Debas HT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1245; Dikshit R, 2012, LANCET, V379, P1807, DOI 10.1016/S0140-6736(12)60358-4; Grimes CE, 2011, WORLD J SURG, V35, P941, DOI 10.1007/s00268-011-1010-1; Groen RS, 2012, WORLD J SURG, V36, P1970, DOI 10.1007/s00268-012-1591-3; Groen RS, 2012, WORLD J SURG, V36, P771, DOI 10.1007/s00268-012-1448-9; Hang HM, 2009, PUBLIC HEALTH, V123, P58, DOI 10.1016/j.puhe.2008.07.018; HENDERSON RH, 1982, B WORLD HEALTH ORGAN, V60, P253; Kingham TP, 2009, ARCH SURG-CHICAGO, V144, P122, DOI 10.1001/archsurg.2008.540; Kushner AL, 2012, LANCET, V379, P1488, DOI 10.1016/S0140-6736(12)60631-X; Kushner AL, 2011, LANCET, V378, P567, DOI 10.1016/S0140-6736(11)61287-7; Kushner AL, 2010, J SURG EDUC, V67, P270, DOI 10.1016/j.jsurg.2010.05.004; Mbuba CK, 2008, EPILEPSIA, V49, P1491, DOI 10.1111/j.1528-1167.2008.01693.x; Mock C, 1999, INT J EPIDEMIOL, V28, P750, DOI 10.1093/ije/28.4.750; Mock CN, 1997, J TRAUMA, V42, P504, DOI 10.1097/00005373-199703000-00019; MoH& S, 2009, NAT HLTH SECT STRAT; Nordberg E, 2000, E AFR MED J, V77, pS1; Ozgediz D, 2008, PLOS MED, V5, P850, DOI 10.1371/journal.pmed.0050121; Schwarz NG, 2009, VACCINE, V27, P5371, DOI 10.1016/j.vaccine.2009.06.100; Statistics Sierra Leone and ICF Macro, 2009, SIERR LEON DEM HLTH; Tollefson TT, 2012, JAMA-J AM MED ASSOC, V307, P667, DOI 10.1001/jama.2012.158; United Nations Development Program, INT HUM DEV IND; van den Boogaard J, 2012, QUAL HEALTH RES, V22, P835, DOI 10.1177/1049732312438968; Vos T, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000149; Walker IA, 2010, B WORLD HEALTH ORGAN, V88, P897, DOI 10.2471/BLT.10.076703; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8; WHO, COUNTR FOC SIERR LEO; WHO, GLOB HLTH OBS SIERR	30	175	175	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 22	2012	380	9847					1082	1087		10.1016/S0140-6736(12)61081-2	http://dx.doi.org/10.1016/S0140-6736(12)61081-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007VL	22898076				2022-12-28	WOS:000308916400029
J	Lefebvre, JL; Kostadinov, D; Chen, WSV; Maniatis, T; Sanes, JR				Lefebvre, Julie L.; Kostadinov, Dimitar; Chen, Weisheng V.; Maniatis, Tom; Sanes, Joshua R.			Protocadherins mediate dendritic self-avoidance in the mammalian nervous system	NATURE			English	Article							RETINAL GANGLION-CELLS; BAX-DEFICIENT MICE; MOUSE RETINA; GAMMA-PROTOCADHERINS; TRANSGENIC MICE; PURKINJE-CELLS; AMACRINE CELLS; REQUIRE DSCAM; AXON GUIDANCE; EXPRESSION	Dendritic arborizations of many neurons are patterned by a process called self-avoidance, in which branches arising from a single neuron repel each other(1-7). By minimizing gaps and overlaps within the arborization, self-avoidance facilitates complete coverage of a neuron's territory by its neurites(1-3). Remarkably, some neurons that display self-avoidance interact freely with other neurons of the same subtype, implying that they discriminate self from non-self. Here we demonstrate roles for the clustered protocadherins (Pcdhs) in dendritic self-avoidance and self/non-self discrimination. The Pcdh locus encodes 58 related cadherin-like transmembrane proteins, at least some of which exhibit isoform-specific homophilic adhesion in heterologous cells and are expressed stochastically and combinatorially in single neurons(7-11). Deletion of all 22 Pcdh genes in the mouse gamma-subcluster (Pcdhg genes) disrupts self-avoidance of dendrites in retinal starburst amacrine cells (SACs) and cerebellar Purkinje cells. Further genetic analysis of SACs showed that Pcdhg proteins act cell-autonomously during development, and that replacement of the 22 Pcdhg proteins with a single isoform restores self-avoidance. Moreover, expression of the same single isoform in all SACs decreases interactions among dendrites of neighbouring SACs (heteroneuronal interactions). These results suggest that homophilic Pcdhg interactions between sibling neurites (isoneuronal interactions) generate a repulsive signal that leads to self-avoidance. In this model, heteroneuronal interactions are normally permitted because dendrites seldom encounter a matched set of Pcdhg proteins unless they emanate from the same soma. In many respects, our results mirror those reported for Dscam1 (Down syndrome cell adhesion molecule) in Drosophila: this complex gene encodes thousands of recognition molecules that exhibit stochastic expression and isoform-specific interactions, and mediate both self-avoidance and self/non-self discrimination(4-7,12-15). Thus, although insect Dscam and vertebrate Pcdh proteins share no sequence homology, they seem to underlie similar strategies for endowing neurons with distinct molecular identities and patterning their arborizations.	[Lefebvre, Julie L.; Kostadinov, Dimitar; Sanes, Joshua R.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Lefebvre, Julie L.; Kostadinov, Dimitar; Sanes, Joshua R.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Chen, Weisheng V.; Maniatis, Tom] Columbia Univ, Med Ctr, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Harvard University; Harvard University; Columbia University	Sanes, JR (corresponding author), Harvard Univ, Ctr Brain Sci, 52 Oxford St, Cambridge, MA 02138 USA.	sanesj@mcb.harvard.edu		Lefebvre, Julie/0000-0002-3110-860X; Kostadinov, Dimitar/0000-0001-7548-2209	NIH [R01NS029169, R01EY022073, R01NS043915]; NARSAD; NATIONAL EYE INSTITUTE [R01EY022073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS078893, R01NS029169, R01NS043915] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD(NARSAD); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of our laboratory for providing advice and reagents, including D. Cai and K. Cohen (rAAV), I.-J. Kim (fstl4-line 1 mice) and M. Yamagata for modified Rosa-CAG targeting vector. We also thank B. Stevens (Children's Hospital) for advice on culture methods. This work was supported by grants from NIH to J.R.S. (R01NS029169 and R01EY022073) and T.M. (R01NS043915) and NARSAD Young Investigator Award to J.L.L.	Chen W. V., NEURON IN PRESS; Chen YC, 2008, J NEUROSCI METH, V171, P239, DOI 10.1016/j.jneumeth.2008.03.013; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Fuerst PG, 2008, NATURE, V451, P470, DOI 10.1038/nature06514; Fuerst PG, 2009, NEURON, V64, P484, DOI 10.1016/j.neuron.2009.09.027; Furuta Y, 2000, GENESIS, V26, P130, DOI 10.1002/(SICI)1526-968X(200002)26:2<130::AID-GENE9>3.0.CO;2-I; Grueber WB, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001750; Hattori D, 2009, NATURE, V461, P644, DOI 10.1038/nature08431; Hong YK, 2011, J COMP NEUROL, V519, P1691, DOI 10.1002/cne.22595; Hughes ME, 2007, NEURON, V54, P417, DOI 10.1016/j.neuron.2007.04.013; Jelinek HF, 1998, J NEUROSCI METH, V81, P9, DOI 10.1016/S0165-0270(98)00021-1; Kaneko M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020108; Kaneko R, 2006, J BIOL CHEM, V281, P30551, DOI 10.1074/jbc.M605677200; Kay JN, 2011, NAT NEUROSCI, V14, P965, DOI 10.1038/nn.2859; Kay JN, 2011, J NEUROSCI, V31, P7753, DOI 10.1523/JNEUROSCI.0907-11.2011; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; KRAMER AP, 1983, J NEUROSCI, V3, P2474; Kuchibhotla KV, 2008, NEURON, V59, P214, DOI 10.1016/j.neuron.2008.06.008; Lee S, 2006, NEURON, V51, P787, DOI 10.1016/j.neuron.2006.08.007; Lefebvre JL, 2008, DEVELOPMENT, V135, P4141, DOI 10.1242/dev.027912; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; MONTAGUE PR, 1991, J NEUROSCI, V11, P1440; MONTAGUE PR, 1989, P NATL ACAD SCI USA, V86, P7223, DOI 10.1073/pnas.86.18.7223; Neves G, 2004, NAT GENET, V36, P240, DOI 10.1038/ng1299; Prasad T, 2008, DEVELOPMENT, V135, P4153, DOI 10.1242/dev.026807; RODIECK RW, 1991, VISUAL NEUROSCI, V6, P95, DOI 10.1017/S095252380001049X; Rossi J, 2011, CELL METAB, V13, P195, DOI 10.1016/j.cmet.2011.01.010; Rowan S, 2004, DEV BIOL, V271, P388, DOI 10.1016/j.ydbio.2004.03.039; Sanes JR, 2010, NEURON, V66, P15, DOI 10.1016/j.neuron.2010.01.018; Schreiner D, 2010, P NATL ACAD SCI USA, V107, P14893, DOI 10.1073/pnas.1004526107; Smith TG, 1996, J NEUROSCI METH, V69, P123, DOI 10.1016/S0165-0270(96)00080-5; Soba P, 2007, NEURON, V54, P403, DOI 10.1016/j.neuron.2007.03.029; Srinivas S, 1999, DEV GENET, V24, P241; Stacy RC, 2003, J COMP NEUROL, V456, P154, DOI 10.1002/cne.10509; Wang J, 2004, NEURON, V43, P663, DOI 10.1016/j.neuron.2004.06.033; Wang XZ, 2002, NEURON, V36, P843, DOI 10.1016/S0896-6273(02)01090-5; WASSLE H, 1981, NATURE, V292, P344, DOI 10.1038/292344a0; Weiner JA, 2005, P NATL ACAD SCI USA, V102, P8, DOI 10.1073/pnas.0407931101; White FA, 1998, J NEUROSCI, V18, P1428; Whitney IE, 2008, J COMP NEUROL, V508, P1, DOI 10.1002/cne.21630; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469; Yamagata M, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00018; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020; Zhang XM, 2004, GENESIS, V40, P45, DOI 10.1002/gene.20062; Zipursky SL, 2010, CELL, V143, P343, DOI 10.1016/j.cell.2010.10.009	50	280	286	2	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2012	488	7412					517	+		10.1038/nature11305	http://dx.doi.org/10.1038/nature11305			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992FS	22842903	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000307761600038
J	Watts, GF; Ooi, EM				Watts, Gerald F.; Ooi, Esther M.			Balancing the cardiometabolic benefits and risks of statins	LANCET			English	Editorial Material							SCOTLAND CORONARY PREVENTION; DIABETES-MELLITUS; THERAPY; METAANALYSIS; CHOLESTEROL; DISEASE; TRIALS; WEST		[Watts, Gerald F.; Ooi, Esther M.] Univ Western Australia, Sch Med & Pharmacol, Royal Perth Hosp, Cardiometabol Res Ctr & Clin Serv, Perth, WA 6001, Australia	Royal Perth Hospital; University of Western Australia	Watts, GF (corresponding author), Univ Western Australia, Sch Med & Pharmacol, Royal Perth Hosp, Cardiometabol Res Ctr & Clin Serv, Perth, WA 6001, Australia.	gerald.watts@uwa.edu.au	Ooi, Esther MM/B-3257-2011	Ooi, Esther MM/0000-0002-2097-633X; Watts, Gerald/0000-0003-2276-1524				Bruckert E, 2005, CARDIOVASC DRUG THER, V19, P403, DOI 10.1007/s10557-005-5686-z; Culver AL, 2012, ARCH INTERN MED, V172, P144, DOI 10.1001/archinternmed.2011.625; Elliott WJ, 2007, LANCET, V369, P201, DOI 10.1016/S0140-6736(07)60108-1; Freeman DJ, 2001, CIRCULATION, V103, P357; Freeman DJ, 2002, DIABETES, V51, P1596, DOI 10.2337/diabetes.51.5.1596; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Koh KK, 2011, ATHEROSCLEROSIS, V215, P1, DOI 10.1016/j.atherosclerosis.2010.10.036; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; NICE, 2010, NICE CLIN GUID 67 LI; Preiss D, 2011, JAMA-J AM MED ASSOC, V305, P2556, DOI 10.1001/jama.2011.860; Rajpathak SN, 2009, DIABETES CARE, V32, P1924, DOI 10.2337/dc09-0738; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Ridker PM, 2012, LANCET, V380, P565, DOI 10.1016/S0140-6736(12)61190-8; Sampson UK, 2011, CURR OPIN CARDIOL, V26, P342, DOI 10.1097/HCO.0b013e3283470359; Sattar N, 2008, LANCET, V371, P1927, DOI 10.1016/S0140-6736(08)60602-9; US Food and Drug Administration, FDA DRUG SAF COMM IM; 2001, JAMA, V285, P2486	17	10	10	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 11	2012	380	9841					541	543		10.1016/S0140-6736(12)61301-4	http://dx.doi.org/10.1016/S0140-6736(12)61301-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988SQ	22883491				2022-12-28	WOS:000307511400005
J	Lavik, E; Ustin, J				Lavik, Erin; Ustin, Jeffrey			Leveraging Shear Stress to Bust Clots with Nanoparticles	SCIENCE			English	Editorial Material							PA		[Lavik, Erin; Ustin, Jeffrey] Case Western Reserve Univ, Cleveland, OH 44106 USA	Case Western Reserve University	Lavik, E (corresponding author), Case Western Reserve Univ, Cleveland, OH 44106 USA.	erin.lavik@case.edu		Lavik, Erin/0000-0002-0644-744X				Balucani Clotilde, 2010, Curr Cardiol Rep, V12, P34, DOI 10.1007/s11886-009-0082-0; Chung TW, 2008, BIOMATERIALS, V29, P228, DOI 10.1016/j.biomaterials.2007.09.027; COLLEN D, 1984, ARTERIOSCLEROSIS, V4, P579, DOI 10.1161/01.ATV.4.6.579; Grotta J, 2007, SURG NEUROL, V68, pS12, DOI 10.1016/j.surneu.2007.07.079; Holme MN, 2012, NAT NANOTECHNOL, V7, P536, DOI [10.1038/nnano.2012.84, 10.1038/NNANO.2012.84]; Kibos Ambrose, 2011, Acute Card Care, V13, P136, DOI 10.3109/17482941.2011.606477; Korin N, 2012, SCIENCE, V337, P738, DOI 10.1126/science.1217815; Mukherjee D, 2011, WORLD NEUROSURG, V76, pS85, DOI 10.1016/j.wneu.2011.07.023; Roger VL, 2012, CIRCULATION, V125, P188, DOI 10.1161/CIR.0b013e3182456d46; Silverstein MD, 1998, ARCH INTERN MED, V158, P585, DOI 10.1001/archinte.158.6.585; Wang SS, 2009, J BIOMED MATER RES A, V91A, P753, DOI 10.1002/jbm.a.32234; Wardlaw JM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000213.pub2	12	11	11	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2012	337	6095					658	659		10.1126/science.1227097	http://dx.doi.org/10.1126/science.1227097			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986PE	22879494				2022-12-28	WOS:000307354500031
J	Gleeson, T; Wada, Y; Bierkens, MFP; van Beek, LPH				Gleeson, Tom; Wada, Yoshihide; Bierkens, Marc F. P.; van Beek, Ludovicus P. H.			Water balance of global aquifers revealed by groundwater footprint	NATURE			English	Article							HUMAN APPROPRIATION; RESOURCES	Groundwater is a life-sustaining resource that supplies water to billions of people, plays a central part in irrigated agriculture and influences the health of many ecosystems(1,2). Most assessments of global water resources have focused on surface water(3-6), but unsustainable depletion of groundwater has recently been documented on both regional(7,8) and global scales(9-11). It remains unclear how the rate of global groundwater depletion compares to the rate of natural renewal and the supply needed to support ecosystems. Here we define the groundwater footprint (the area required to sustain groundwater use and groundwater-dependent ecosystem services) and show that humans are overexploiting groundwater in many large aquifers that are critical to agriculture, especially in Asia and North America. We estimate that the size of the global groundwater footprint is currently about 3.5 times the actual area of aquifers and that about 1.7 billion people live in areas where groundwater resources and/or groundwater-dependent ecosystems are under threat. That said, 80 per cent of aquifers have a groundwater footprint that is less than their area, meaning that the net global value is driven by a few heavily overexploited aquifers. The groundwater footprint is the first tool suitable for consistently evaluating the use, renewal and ecosystem requirements of groundwater at an aquifer scale. It can be combined with the water footprint and virtual water calculations(12-14), and be used to assess the potential for increasing agricultural yields with renewable groundwaterref(15). The method could be modified to evaluate other resources with renewal rates that are slow and spatially heterogeneous, such as fisheries, forestry or soil.	[Gleeson, Tom] McGill Univ, Dept Civil Engn, Montreal, PQ H3A 0C3, Canada; [Wada, Yoshihide; Bierkens, Marc F. P.; van Beek, Ludovicus P. H.] Univ Utrecht, Fac Geosci, Dept Phys Geog, NL-3508 TC Utrecht, Netherlands; [Bierkens, Marc F. P.] Deltares, NL-3508 AL Utrecht, Netherlands	McGill University; Utrecht University; Deltares	Gleeson, T (corresponding author), McGill Univ, Dept Civil Engn, Montreal, PQ H3A 0C3, Canada.	tom.gleeson@mcgill.ca	Wada, Yoshihide/F-3595-2012; Van Beek, Rens/B-4904-2014; Bierkens, Marc F.P./AAE-8176-2019; Gleeson, Tom/F-2552-2011	Wada, Yoshihide/0000-0003-4770-2539; Van Beek, Rens/0000-0002-4758-108X; Gleeson, Tom/0000-0001-9493-7707; Bierkens, Marc F.P./0000-0002-7411-6562	Natural Sciences and Engineering Research Council of Canada; Canadian Institute for Advanced Research junior fellowship; Utrecht University Focus Areas Theme 'Earth and sustainability'	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institute for Advanced Research junior fellowship(Canadian Institute for Advanced Research (CIFAR)); Utrecht University Focus Areas Theme 'Earth and sustainability'	S. Siebert, M. Jellinek, M. Lathuilliere, A. Henderson and W. Rees read or discussed earlier versions of the manuscript, which markedly improved it. T. G. was supported by the Natural Sciences and Engineering Research Council of Canada and a Canadian Institute for Advanced Research junior fellowship. Y.W. was supported by Utrecht University Focus Areas Theme 'Earth and sustainability'.	Alcamo J, 2003, HYDROLOG SCI J, V48, P339, DOI 10.1623/hysj.48.3.339.45278; Allan JA, 1998, GROUND WATER, V36, P545, DOI 10.1111/j.1745-6584.1998.tb02825.x; CIESIN, 2011, GRIDD POP WORLD VER; Doll P, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/3/035006; Famiglietti JS, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046442; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Foster S, 2004, HYDROGEOL J, V12, P81, DOI 10.1007/s10040-003-0300-6; Giordano M, 2009, ANNU REV ENV RESOUR, V34, P153, DOI 10.1146/annurev.environ.030308.100251; Gleeson T, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL045565; Hoekstra AY, 2009, ECOL ECON, V68, P1963, DOI 10.1016/j.ecolecon.2008.06.021; Hoekstra A.Y., 2011, WATER FOOTPRINT ASSE, DOI DOI 10.1080/0969160X.2011.593864; Hoekstra AY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032688; Hoekstra AY, 2012, P NATL ACAD SCI USA, V109, P3232, DOI 10.1073/pnas.1109936109; Hoekstra AY, 2009, P NATL ACAD SCI USA, V106, pE114, DOI 10.1073/pnas.0909948106; Konikow LF, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048604; Oki T, 2006, SCIENCE, V313, P1068, DOI 10.1126/science.1128845; Poff NL, 2010, FRESHWATER BIOL, V55, P147, DOI 10.1111/j.1365-2427.2009.02204.x; Postel SL, 1996, SCIENCE, V271, P785, DOI 10.1126/science.271.5250.785; Rees, 1996, ECOLOGICAL FOOTPRINT; Rodell M, 2009, NATURE, V460, P999, DOI 10.1038/nature08238; Smakhtin V, 2004, WATER INT, V29, P307, DOI 10.1080/02508060408691785; Smakhtin VU, 2001, J HYDROL, V240, P147, DOI 10.1016/S0022-1694(00)00340-1; Sophocleous M, 2010, HYDROGEOL J, V18, P559, DOI 10.1007/s10040-009-0540-1; van Beek LPH, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR009791; Vorosmarty CJ, 2000, SCIENCE, V289, P284, DOI 10.1126/science.289.5477.284; Wada Y, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR010562; Wada Y, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR009792; Wada Y, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044571; [No title captured], DOI DOI 10.5194/hess-14-1863-2010	29	741	754	31	694	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2012	488	7410					197	200		10.1038/nature11295	http://dx.doi.org/10.1038/nature11295			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985LE	22874965				2022-12-28	WOS:000307267000030
J	Inzucchi, SE				Inzucchi, Silvio E.			Diagnosis of Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; HEMOGLOBIN A(1C); A1C; RISK; CLASSIFICATION; DEFINITION; MANAGEMENT; MELLITUS; GLYCEMIA; CRITERIA	A 42-year-old asymptomatic man with hypertension presents for his annual physical examination. His medications include atenolol combined with chlorthalidone (at doses of 50 mg and 25 mg, respectively, per day). Both parents had type 2 diabetes mellitus later in life. He does not smoke cigarettes. His body-mass index (BMI, the weight in kilograms divided by the square of the height in meters) is 32.3, and his blood pressure is 130/80 mm Hg. Would you screen the patient for diabetes, and if so, how?	Yale Univ, Endocrinol Sect, Sch Med, New Haven, CT 06520 USA	Yale University	Inzucchi, SE (corresponding author), Yale Univ, Endocrinol Sect, Sch Med, 333 Cedar St,FMP-106, New Haven, CT 06520 USA.	silvio.inzucchi@yale.edu	Inzucchi, Silvio/ABF-4121-2021		Merck; Takeda Pharmaceuticals; Amylin Pharmaceuticals; Daiichi Sankyo; Boehringer Ingelheim; Medtronic; Purdue Pharma; Eisai; Novartis; Novo Nordisk; Eli Lilly; Abbott	Merck(Merck & Company); Takeda Pharmaceuticals(Takeda Pharmaceutical Company Ltd); Amylin Pharmaceuticals(Bristol-Myers Squibb); Daiichi Sankyo(Daiichi Sankyo Company Limited); Boehringer Ingelheim(Boehringer Ingelheim); Medtronic(Medtronic); Purdue Pharma; Eisai(Eisai Co Ltd); Novartis(Novartis); Novo Nordisk(Novo Nordisk); Eli Lilly(Eli Lilly); Abbott(Abbott Laboratories)	Dr. Inzucchi reports receiving consulting fees from Merck, Takeda Pharmaceuticals, Amylin Pharmaceuticals, Daiichi Sankyo, Boehringer Ingelheim, Medtronic, Purdue Pharma, Eisai, and Novartis; lecture fees from Novo Nordisk; payment for providing expert testimony on behalf of Eli Lilly regarding product litigation; and grant support to his institution from Takeda Pharmaceuticals, Merck, Amylin Pharmaceuticals, Eli Lilly, Medtronic, Boehringer Ingelheim, Abbott, and Novo Nordisk. No other potential conflict of interest relevant to this article was reported.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Amer Coll Endocrinologists Board T, 2010, ENDOCR PRACT, V16, P155; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc10-S062, 10.2337/dc13-S067, 10.2337/dc12-s064, 10.2337/dc11-S062]; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc35-S011, 10.2337/dc12-s004]; Bloomgarden ZT, 2010, ENDOCR PRACT, V16, P5, DOI 10.4158/EP.16.1.5; Calonge N, 2008, ANN INTERN MED, V148, P846, DOI 10.7326/0003-4819-148-11-200806030-00007; Carson AP, 2010, DIABETES CARE, V33, P95, DOI 10.2337/dc09-1227; Centers for Disease Control and Prevention, 2011 NAT DIAB FACT S; Coban E, 2004, ACTA HAEMATOL-BASEL, V112, P126, DOI 10.1159/000079722; Cohen RM, 2010, J CLIN ENDOCR METAB, V95, P5203, DOI 10.1210/jc.2010-2352; Davidson MB, 2011, DIABETES CARE, V34, P524, DOI 10.2337/dc10-1689; DeFronzo RA, 2001, DIABETES CARE S2, V34, pS202; [Department of Veterans Affairs Department of Defense], 2010, MAN DIAB MELL PRIM C; Diabetes Prevention Program Research Group, 2002, NEW ENGL J MED, V346, P393, DOI [10.1056/NEJMoa012512, DOI 10.1056/NEJMOA012512]; Fajans SS, 2011, METABOLISM, V60, P86, DOI 10.1016/j.metabol.2010.06.017; Freedman BI, 2010, AM J NEPHROL, V31, P375, DOI 10.1159/000287561; Gavin JR, 1997, DIABETES CARE, V20, P1183; Genuth S, 2003, DIABETES CARE, V26, P3160; Hanas R, 2010, DIABETES CARE, V33, P1903, DOI 10.2337/dc10-0953; HARRIS M, 1979, DIABETES, V28, P1039; Heianza Y, 2011, LANCET, V378, P147, DOI 10.1016/S0140-6736(11)60472-8; Herman WH, 2011, MED CLIN N AM, V95, P373, DOI 10.1016/j.mcna.2010.11.010; Hu YM, 2010, ACTA DIABETOL, V47, P231, DOI 10.1007/s00592-009-0143-2; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Ismail-Beigi F, 2012, NEW ENGL J MED, V366, P1319, DOI 10.1056/NEJMcp1013127; James C, 2011, DIABETES CARE, V34, P387, DOI 10.2337/dc10-1314; Jorgensen ME, 2010, J CLIN ENDOCR METAB, V95, pE333, DOI 10.1210/jc.2010-0710; Kelly TN, 2009, ANN INTERN MED, V151, P394, DOI 10.7326/0003-4819-151-6-200909150-00137; Khera PK, 2008, DIABETES, V57, P2445, DOI 10.2337/db07-1820; Kolberg JA, 2009, DIABETES CARE, V32, P1207, DOI 10.2337/dc08-1935; Lipska KJ, 2010, J CLIN ENDOCR METAB, V95, P5289, DOI 10.1210/jc.2010-1171; Mann DM, 2010, DIABETES CARE, V33, P2190, DOI 10.2337/dc10-0752; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Olson DE, 2010, DIABETES CARE, V33, P2184, DOI 10.2337/dc10-0433; Sacks DB, 2011, CLIN CHEM, V57, P150, DOI 10.1373/clinchem.2010.158071; Sacks DB, 2011, DIABETES CARE, V34, P518, DOI 10.2337/dc10-1546; Sacks DB, 2003, CLIN CHEM, V49, P1245, DOI 10.1373/49.8.1245; Salomaa V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010100; Selvin E, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-5-201103010-00004; Selvin E, 2011, DIABETES CARE, V34, P84, DOI 10.2337/dc10-1235; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Taylor EN, 2006, DIABETES CARE, V29, P1065, DOI 10.2337/dc05-2366; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Unwin N, 2002, DIABETIC MED, V19, P708, DOI 10.1046/j.1464-5491.2002.00835.x; World Health Organization, US GLYC HAEM HBA1C D; Zhang XP, 2010, DIABETES CARE, V33, P1665, DOI 10.2337/dc09-1939; Ziemer DC, 2010, ANN INTERN MED, V152, P770, DOI 10.7326/0003-4819-152-12-201006150-00004	51	140	169	0	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 9	2012	367	6					542	550		10.1056/NEJMcp1103643	http://dx.doi.org/10.1056/NEJMcp1103643			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	986AE	22873534				2022-12-28	WOS:000307310800008
J	Hawkes, N				Hawkes, Nigel			A jab in the dark	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						Hawkes N, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5108	1	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 8	2012	345								e5313	10.1136/bmj.e5313	http://dx.doi.org/10.1136/bmj.e5313			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988ND	22875956				2022-12-28	WOS:000307496800004
J	Batniji, R				Batniji, Rajaie			The art of medicine Searching for dignity	LANCET			English	Editorial Material									[Batniji, Rajaie] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Batniji, Rajaie] Stanford Univ, Ctr Democracy Dev & Rule Law, Stanford, CA 94305 USA	Stanford University; Stanford University	Batniji, R (corresponding author), Stanford Univ, Dept Med, Stanford, CA 94305 USA.	Batniji@stanford.edu							0	8	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 4	2012	380	9840					466	467		10.1016/S0140-6736(12)61280-X	http://dx.doi.org/10.1016/S0140-6736(12)61280-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	983GY	22870512				2022-12-28	WOS:000307109000014
J	Volonteri, M				Volonteri, M.			The Formation and Evolution of Massive Black Holes	SCIENCE			English	Review							ACTIVE GALACTIC NUCLEI; ACCRETION FLOWS; GROWTH; REDSHIFT; GALAXIES; FEEDBACK; STARS; SIGMA; QUASAR	The past 10 years have witnessed a change of perspective in the way astrophysicists think about massive black holes (MBHs), which are now considered to have a major role in the evolution of galaxies. This appreciation was driven by the realization that black holes of millions of solar masses and above reside in the center of most galaxies, including the Milky Way. MBHs also powered active galactic nuclei known to exist just a few hundred million years after the Big Bang. Here, I summarize the current ideas on the evolution of MBHs through cosmic history, from their formation about 13 billion years ago to their growth within their host galaxies.	[Volonteri, M.] Inst Astrophys, F-75014 Paris, France; [Volonteri, M.] Univ Michigan, Dept Astron, Ann Arbor, MI 48109 USA	UDICE-French Research Universities; Sorbonne Universite; University of Michigan System; University of Michigan	Volonteri, M (corresponding author), Inst Astrophys, F-75014 Paris, France.	martav@iap.fr			NASA [ATP NNX10AC84G]; Smithsonian Astrophysical Observatory [TM1-12007X]; NSF [AST 1107675]; Marie Curie Career Integration grant; Direct For Mathematical & Physical Scien [1107675] Funding Source: National Science Foundation	NASA(National Aeronautics & Space Administration (NASA)); Smithsonian Astrophysical Observatory(Smithsonian InstitutionHarvard-Smithsonian Center for Astrophysics); NSF(National Science Foundation (NSF)); Marie Curie Career Integration grant; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	I acknowledge funding support from NASA (through award ATP NNX10AC84G), Smithsonian Astrophysical Observatory (award TM1-12007X), NSF (award AST 1107675), and from a Marie Curie Career Integration grant. I thank B. Devecchi, M. Colpi, S. Callegari, and M. Begelman for inspriation in the creation of the illustrations shown in Figs. 1 and 3.	Ball WH, 2011, MON NOT R ASTRON SOC, V414, P2751, DOI 10.1111/j.1365-2966.2011.18591.x; Begelman MC, 2006, MON NOT R ASTRON SOC, V370, P289, DOI 10.1111/j.1365-2966.2006.10467.x; Begelman MC, 2010, MON NOT R ASTRON SOC, V402, P673, DOI 10.1111/j.1365-2966.2009.15916.x; Bellovary JM, 2010, ASTROPHYS J LETT, V721, pL148, DOI 10.1088/2041-8205/721/2/L148; Bournaud F, 2011, ASTROPHYS J LETT, V741, DOI 10.1088/2041-8205/741/2/L33; Bromm V, 2004, ANNU REV ASTRON ASTR, V42, P79, DOI 10.1146/annurev.astro.42.053102.134034; Centrella J, 2010, ANNU REV NUCL PART S, V60, P75, DOI 10.1146/annurev.nucl.010909.083246; Ciotti L, 2007, ASTROPHYS J, V665, P1038, DOI 10.1086/519833; Cisternas M, 2011, ASTROPHYS J, V726, DOI 10.1088/0004-637X/726/2/57; Colpi M, 2007, AIP CONF PROC, V924, P705, DOI 10.1063/1.2774931; Devecchi B, 2009, ASTROPHYS J, V694, P302, DOI 10.1088/0004-637X/694/1/302; Di Matteo T, 2012, ASTROPHYS J LETT, V745, DOI 10.1088/2041-8205/745/2/L29; Fender R, 2012, SCIENCE, V337, P540, DOI 10.1126/science.1221790; Greene JE, 2010, ASTROPHYS J, V721, P26, DOI 10.1088/0004-637X/721/1/26; Gultekin K, 2009, ASTROPHYS J, V698, P198, DOI 10.1088/0004-637X/698/1/198; Haiman Z., 2012, 1 GALAXIES THEORETIC; Hopkins PF, 2010, MON NOT R ASTRON SOC, V407, P1529, DOI 10.1111/j.1365-2966.2010.17064.x; Hosokawa T, 2011, SCIENCE, V334, P1250, DOI 10.1126/science.1207433; Johnson JL, 2012, ASTROPHYS J, V750, DOI 10.1088/0004-637X/750/1/66; King A, 2003, ASTROPHYS J, V596, pL27, DOI 10.1086/379143; Kormendy J, 2011, NATURE, V469, P377, DOI 10.1038/nature09695; Lodato G, 2006, MON NOT R ASTRON SOC, V371, P1813, DOI 10.1111/j.1365-2966.2006.10801.x; Madau P, 2001, ASTROPHYS J, V551, pL27, DOI 10.1086/319848; Maiolino R., 2012, MON NOT R ASTRON SOC; McConnell NJ, 2011, NATURE, V480, P215, DOI 10.1038/nature10636; Merloni A, 2004, MON NOT R ASTRON SOC, V353, P1035, DOI 10.1111/j.1365-2966.2004.08147.x; Merloni A, 2004, MON NOT R ASTRON SOC, V354, pL37, DOI 10.1111/j.1365-2966.2004.08382.x; Merloni A, 2010, ASTROPHYS J, V708, P137, DOI 10.1088/0004-637X/708/1/137; Mortlock DJ, 2011, NATURE, V474, P616, DOI 10.1038/nature10159; Murray N, 2005, ASTROPHYS J, V618, P569, DOI 10.1086/426067; Ohsuga K, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/1/2; Omukai K, 2008, ASTROPHYS J, V686, P801, DOI 10.1086/591636; Ostriker JP, 2010, ASTROPHYS J, V722, P642, DOI 10.1088/0004-637X/722/1/642; Paczynski B., 1982, MITTEILUNGEN ASTRONO, V57, P44; Park K, 2012, ASTROPHYS J, V747, DOI 10.1088/0004-637X/747/1/9; Peterson BM, 2005, ASTROPHYS J, V632, P799, DOI 10.1086/444494; Proga D, 2008, ASTROPHYS J, V676, P101, DOI 10.1086/527535; Rees M. J., 1978, STRUCTURE PROPERTIES, P237; Shiokawa H, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/2/187; Silk J, 1998, ASTRON ASTROPHYS, V331, pL1; Springel V, 2005, MON NOT R ASTRON SOC, V361, P776, DOI 10.1111/j.1365-2966.2005.09238.x; van Velzen S, 2011, ASTROPHYS J, V741, DOI 10.1088/0004-637X/741/2/73; Volonteri M, 2005, ASTROPHYS J, V633, P624, DOI 10.1086/466521; Volonteri M, 2011, MON NOT R ASTRON SOC, V417, P2085, DOI 10.1111/j.1365-2966.2011.19391.x; Volonteri M, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/2/50; Volonteri M, 2010, ASTRON ASTROPHYS REV, V18, P279, DOI 10.1007/s00159-010-0029-x; Volonteri M, 2009, MON NOT R ASTRON SOC, V400, P1911, DOI 10.1111/j.1365-2966.2009.15577.x; Wang R, 2010, ASTROPHYS J, V714, P699, DOI 10.1088/0004-637X/714/1/699; Willott CJ, 2010, ASTRON J, V140, P546, DOI 10.1088/0004-6256/140/2/546	51	185	187	3	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 3	2012	337	6094					544	547		10.1126/science.1220843	http://dx.doi.org/10.1126/science.1220843			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982PU	22859482	Green Submitted			2022-12-28	WOS:000307058700034
J	Yu, HB; Remer, LA; Chin, M; Bian, HS; Tan, Q; Yuan, TL; Zhang, Y				Yu, Hongbin; Remer, Lorraine A.; Chin, Mian; Bian, Huisheng; Tan, Qian; Yuan, Tianle; Zhang, Yan			Aerosols from Overseas Rival Domestic Emissions over North America	SCIENCE			English	Article							DUST; TRANSPORT; POLLUTION; AERONET; CALIPSO	Many types of aerosols have lifetimes long enough for their transcontinental transport, making them potentially important contributors to air quality and climate change in remote locations. We estimate that the mass of aerosols arriving at North American shores from overseas is comparable with the total mass of particulates emitted domestically. Curbing domestic emissions of particulates and precursor gases, therefore, is not sufficient to mitigate aerosol impacts in North America. The imported contribution is dominated by dust leaving Asia, not by combustion-generated particles. Thus, even a reduction of industrial emissions of the emerging economies of Asia could be overwhelmed by an increase of dust emissions due to changes in meteorological conditions and potential desertification.	[Yu, Hongbin] Univ Maryland, Earth Syst Sci Interdisciplinary Ctr, College Pk, MD 20740 USA; [Yu, Hongbin; Chin, Mian; Bian, Huisheng; Tan, Qian; Yuan, Tianle; Zhang, Yan] NASA, Earth Sci Directorate, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Remer, Lorraine A.; Bian, Huisheng; Yuan, Tianle] Univ Maryland Baltimore Cty, Joint Ctr Earth Syst Technol, Baltimore, MD 21228 USA; [Tan, Qian; Zhang, Yan] Univ Space Res Assoc, Goddard Earth Sci Technol & Res Ctr, Columbia, MD 21044 USA	University System of Maryland; University of Maryland College Park; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University System of Maryland; University of Maryland Baltimore County; Universities Space Research Association (USRA)	Yu, HB (corresponding author), Univ Maryland, Earth Syst Sci Interdisciplinary Ctr, College Pk, MD 20740 USA.	hongbin.yu@nasa.gov	Chin, Mian/J-8354-2012; Zhang, Yan/C-4792-2012; Yuan, Tianle/D-3323-2011; Yu, Hongbin/C-6485-2008	Yuan, Tianle/0000-0002-2187-3017; Yu, Hongbin/0000-0003-4706-1575; ZHANG, Yan/0000-0002-6954-5178	NASA [NNXAH66G, NNX11AJ91G]; GMI [NNX10AK61G]	NASA(National Aeronautics & Space Administration (NASA)); GMI	We acknowledge the NASA support of this work via NNXAH66G (The Science of Terra and Aqua Program) and NNX11AJ91G (Atmospheric Composition Modeling and Analysis Program) (H.Y.), both managed by R. Eckman. The NASA Modeling, Analysis, and Prediction program managed by D. Considine is acknowledged for supporting the model development of GOCART (M. C.) and GMI (H. B., under NNX10AK61G). We are grateful to J. Zhang for providing his reprocessed MODIS data, Z. Liu for providing insights in the lidar characterization of Asian dust, and X. Pan for acquiring CALIOP data. The MODIS data were obtained from the NASA Level 1 and Atmosphere Archive and Distribution System. The CALIOP data were obtained from the NASA Langley Research Center Atmospheric Science Data Center.	Bian H, 2009, ATMOS CHEM PHYS, V9, P2375, DOI 10.5194/acp-9-2375-2009; Biscaye PE, 2000, SCIENCE, V290, P2258, DOI 10.1126/science.290.5500.2258; Chin M, 2007, ATMOS CHEM PHYS, V7, P5501, DOI 10.5194/acp-7-5501-2007; Chin M, 2009, ANN GEOPHYS-GERMANY, V27, P3439, DOI 10.5194/angeo-27-3439-2009; Dentener F., 2010, AIR POLLUTION STUDIE, V17; Eck TF, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005274; Hadley OL, 2010, ATMOS CHEM PHYS, V10, P7505, DOI 10.5194/acp-10-7505-2010; Heald CL, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006847; Husar RB, 2001, J GEOPHYS RES-ATMOS, V106, P18317, DOI 10.1029/2000JD900788; Kalashnikova OV, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD010083; KAUFMAN YJ, 2005, J GEOPHYS RES, V110, DOI DOI 10.1029/2003JD004436; Liu J, 2008, ATMOS CHEM PHYS, V8, P3721, DOI 10.5194/acp-8-3721-2008; Liu ZY, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008878; Maring H, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002536; Prospero JM, 2005, AEROBIOLOGIA, V21, P1, DOI 10.1007/s10453-004-5872-7; Ramanathan V, 2008, NAT GEOSCI, V1, P221, DOI 10.1038/ngeo156; Remer LA, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009661; Sassen K, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014051; Stith JL, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010924; Su L, 2011, ATMOS CHEM PHYS, V11, P3263, DOI 10.5194/acp-11-3263-2011; Warneke C, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036194; Winker DM, 2010, B AM METEOROL SOC, V91, P1211, DOI 10.1175/2010BAMS3009.1; Yu H., 2009, ATMOSPHERIC AEROSOL; Yu HB, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000754; Yu HB, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009349; Yu HB, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010648; Zhu P, 2007, J GEOPHYS RES-SPACE, V112, DOI 10.1029/2006JA011991	27	172	177	1	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 3	2012	337	6094					566	569		10.1126/science.1217576	http://dx.doi.org/10.1126/science.1217576			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982PU	22859485				2022-12-28	WOS:000307058700041
J	Bulgarelli, D; Rott, M; Schlaeppi, K; van Themaat, EVL; Ahmadinejad, N; Assenza, F; Rauf, P; Huettel, B; Reinhardt, R; Schmelzer, E; Peplies, J; Gloeckner, FO; Amann, R; Eickhorst, T; Schulze-Lefert, P				Bulgarelli, Davide; Rott, Matthias; Schlaeppi, Klaus; van Themaat, Emiel Ver Loren; Ahmadinejad, Nahal; Assenza, Federica; Rauf, Philipp; Huettel, Bruno; Reinhardt, Richard; Schmelzer, Elmon; Peplies, Joerg; Gloeckner, Frank Oliver; Amann, Rudolf; Eickhorst, Thilo; Schulze-Lefert, Paul			Revealing structure and assembly cues for Arabidopsis root-inhabiting bacterial microbiota	NATURE			English	Article							CATALYZED REPORTER DEPOSITION; IN-SITU HYBRIDIZATION; DIVERSITY; ENDOPHYTES; PATTERNS	The plant root defines the interface between amulticellular eukaryote and soil, one of the richest microbial ecosystems on Earth(1). Notably, soil bacteria are able to multiply inside roots as benign endophytes and modulate plant growth and development(2), with implications ranging from enhanced crop productivity(3) to phytoremediation(4). Endophytic colonization represents an apparent paradox of plant innate immunity because plant cells can detect an array of microbeassociated molecular patterns (also known as MAMPs) to initiate immune responses to terminate microbial multiplication(5). Several studies attempted to describe the structure of bacterial root endophytes(6); however, different sampling protocols and low-resolution profiling methods make it difficult to infer general principles. Here we describemethodology to characterize and compare soil-and rootinhabiting bacterial communities, which reveals not only a function formetabolically active plant cells but also for inert cell-wall features in the selection of soil bacteria for host colonization. We showthat the roots ofArabidopsis thaliana, grown in different natural soils under controlled environmental conditions, are preferentially colonized by Proteobacteria, Bacteroidetes and Actinobacteria, and each bacterial phylum is represented by a dominating class or family. Soil type defines the composition of root-inhabiting bacterial communities and host genotype determines their ribotype profiles to a limited extent. The identification of soil-type-specific members within the root-inhabiting assemblies supports our conclusion that these represent soil-derived root endophytes. Surprisingly, plant cell-wall features of other tested plant species seem to provide a sufficient cue for the assembly of approximately 40% of the Arabidopsis bacterial root-inhabitingmicrobiota, with a bias for Betaproteobacteria. Thus, this root sub-community may not beArabidopsis-specific but saprophytic bacteria that would naturally be found on any plant root or plant debris in the tested soils. By contrast, colonization of Arabidopsis roots by members of the Actinobacteria depends on other cues from metabolically active host cells.	[Bulgarelli, Davide; Rott, Matthias; Schlaeppi, Klaus; van Themaat, Emiel Ver Loren; Ahmadinejad, Nahal; Assenza, Federica; Rauf, Philipp; Schulze-Lefert, Paul] Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, D-50829 Cologne, Germany; [Huettel, Bruno; Reinhardt, Richard] Max Planck Inst Plant Breeding Res, Max Planck Genome Ctr, D-50829 Cologne, Germany; [Peplies, Joerg; Gloeckner, Frank Oliver] Ribocon GmbH, D-28359 Bremen, Germany; [Gloeckner, Frank Oliver; Amann, Rudolf] Max Planck Inst Marine Microbiol, Dept Mol Ecol, D-28359 Bremen, Germany; [Eickhorst, Thilo] Univ Bremen, Fac Biol & Chem, D-28359 Bremen, Germany	Max Planck Society; Max Planck Society; Max Planck Society; University of Bremen	Schulze-Lefert, P (corresponding author), Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, D-50829 Cologne, Germany.	schlef@mpipz.mpg.de	Amann, Rudolf I/C-6534-2014; Schlaeppi, Klaus/HCI-8011-2022; Eickhorst, Thilo/M-1200-2014; Schlaeppi, Klaus/ABE-6731-2020; Schulze-Lefert, Paul/B-6707-2011	Amann, Rudolf I/0000-0002-0846-7372; Schlaeppi, Klaus/0000-0003-3620-0875; Schlaeppi, Klaus/0000-0003-3620-0875; Reinhardt, Richard/0000-0001-9376-2132; Bulgarelli, Davide/0000-0002-2020-6642; Brocke-Ahmadinejad, Nahal/0000-0002-7335-6564	Max Planck Society [M.IF. A. ZUCH8048]; Swiss National Science Foundation [PBFRP3-133544]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank R. Franzen and S. Schumacher for technical assistance, S. Wulfert for providing Arabidopsis liquid cultures, H. Schmidt for sharing the CARD-FISH protocol and performing the cell counts. We thank S. Klages and K. Stuber for support with bioinformatic pipelines. We are grateful to R. Panstruga and P. Bakker for comments on the manuscript. Golm soil was shipped by J. Schwachtje and J. van Dongen. This work was supported by funds from the Max Planck Society to P. S.-L. (M.IF. A. ZUCH8048). K. S. is supported by the Swiss National Science Foundation (PBFRP3-133544).	Basilio A, 2003, J APPL MICROBIOL, V95, P814, DOI 10.1046/j.1365-2672.2003.02049.x; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; BuchholzCleven BEE, 1997, SYST APPL MICROBIOL, V20, P301, DOI 10.1016/S0723-2020(97)80077-X; Chelius MK, 2001, MICROB ECOL, V41, P252, DOI 10.1007/s002480000087; Eickhorst T, 2008, SOIL BIOL BIOCHEM, V40, P1883, DOI 10.1016/j.soilbio.2008.03.024; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Gans J, 2005, SCIENCE, V309, P1387, DOI 10.1126/science.1112665; Hardoim PR, 2008, TRENDS MICROBIOL, V16, P463, DOI 10.1016/j.tim.2008.07.008; Hardoim PR, 2011, FEMS MICROBIOL ECOL, V77, P154, DOI 10.1111/j.1574-6941.2011.01092.x; Inceoglu O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023321; Kunin V, 2010, OPEN J, V1, P1; Mei Chuansheng, 2010, Recent Pat Biotechnol, V4, P81, DOI 10.2174/187220810790069523; Pernthaler A, 2002, APPL ENVIRON MICROB, V68, P3094, DOI 10.1128/AEM.68.6.3094-3101.2002; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Reinhold-Hurek B, 2011, CURR OPIN PLANT BIOL, V14, P435, DOI 10.1016/j.pbi.2011.04.004; Rosenblueth M, 2006, MOL PLANT MICROBE IN, V19, P827, DOI 10.1094/MPMI-19-0827; Timmusk S, 2005, APPL ENVIRON MICROB, V71, P7292, DOI 10.1128/AEM.71.11.7292-7300.2005; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Weyens N, 2009, CURR OPIN BIOTECH, V20, P248, DOI 10.1016/j.copbio.2009.02.012	21	1292	1377	76	1192	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 2	2012	488	7409					91	95		10.1038/nature11336	http://dx.doi.org/10.1038/nature11336			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ZE	22859207				2022-12-28	WOS:000307010700039
J	Van Brabandt, H; Neyt, M; Hulstaert, F				Van Brabandt, Hans; Neyt, Mattias; Hulstaert, Frank			Transcatheter aortic valve implantation (TAVI): risky and costly	BRITISH MEDICAL JOURNAL			English	Editorial Material							ELDERLY-PATIENTS; REPLACEMENT; STENOSIS; SURGERY		[Van Brabandt, Hans; Neyt, Mattias; Hulstaert, Frank] KCE, Belgian Hlth Care Knowledge Ctr, Adm Ctr Kruidtuin, B-1000 Brussels, Belgium; [Van Brabandt, Hans] CEBAM, Belgian Ctr Evidence Based Med, Louvain, Belgium; [Van Brabandt, Hans] Branch Dutch Cochrane Ctr, Louvain, Belgium		Neyt, M (corresponding author), KCE, Belgian Hlth Care Knowledge Ctr, Adm Ctr Kruidtuin, Kruidtuinlaan 55, B-1000 Brussels, Belgium.	mattias.neyt@kce.fgov.be		Hulstaert, Frank/0000-0003-2879-9910				[Anonymous], 2012, HEARTWIRE        MAY; [Anonymous], 2006, BUSINESSWEEK; Blackman D, 2011, OUTCOME TAVI VALVE A; [British Cardiovascular Intervention Society Society of Cardiothoracic Surgeons], TRANSC AORT VALV IMP; Cortez M, 2011, BLOOMBERG NEWS  0404; FDA, 2011, SAPIEN THV BRIEF DOC, P301; FDA, EDW SAPIEN TRANSC HE; FDA, 2011, FDA EX SUMM EDW SAPI; Guard M, 2011, EUROPCR C PAR 17 20; Hirschler B, 2012, EU MED HEAD URGES TO; Hulstaert F, 2011, 158CD20111027331 KCE; Iung B, 2005, EUR HEART J, V26, P2714, DOI 10.1093/eurheartj/ehi471; Kodali SK, 2012, NEW ENGL J MED, V366, P1686, DOI 10.1056/NEJMoa1200384; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Makkar RR, 2012, NEW ENGL J MED, V366, P1696, DOI 10.1056/NEJMoa1202277; Nainggolan L, 2011, GERMANY TOPS TAVI TA; National Institute for Health and Care Excellence (NICE), 2012, TRANSC AORT VALV IMP; Neyt M, 2011, KCE REPORTS C; Neyt M, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001032; Nielsen HH, 2012, EUROINTERVENTION; O'Riordan M, 2011, HEARTWIRE       1110; Ray S, 2008, CONS M 16 DEC 2008; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Stewart BF, 1997, J AM COLL CARDIOL, V29, P630, DOI 10.1016/S0735-1097(96)00563-3; Varadarajan P, 2006, EUR J CARDIO-THORAC, V30, P722, DOI 10.1016/j.ejcts.2006.07.028; Wood S, 2012, HEARTWIRE       0614	26	42	42	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUL 31	2012	345								e4710	10.1136/bmj.e4710	http://dx.doi.org/10.1136/bmj.e4710			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	985XB	22849955				2022-12-28	WOS:000307302700001
J	Archin, NM; Liberty, AL; Kashuba, AD; Choudhary, SK; Kuruc, JD; Crooks, AM; Parker, DC; Anderson, EM; Kearney, MF; Strain, MC; Richman, DD; Hudgens, MG; Bosch, RJ; Coffin, JM; Eron, JJ; Hazuda, DJ; Margolis, DM				Archin, N. M.; Liberty, A. L.; Kashuba, A. D.; Choudhary, S. K.; Kuruc, J. D.; Crooks, A. M.; Parker, D. C.; Anderson, E. M.; Kearney, M. F.; Strain, M. C.; Richman, D. D.; Hudgens, M. G.; Bosch, R. J.; Coffin, J. M.; Eron, J. J.; Hazuda, D. J.; Margolis, D. M.			Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy	NATURE			English	Article							HISTONE DEACETYLASE INHIBITORS; SUBEROYLANILIDE HYDROXAMIC ACID; VALPROIC ACID; IN-VIVO; TYPE-1; EXPRESSION; INFECTION; CELLS; PCR; ACTIVATION	Despite antiretroviral therapy, proviral latency of human immunodeficiency virus type 1 (HIV-1) remains a principal obstacle to curing the infection(1). Inducing the expression of latent genomes within resting CD4(+) T cells is the primary strategy to clear this reservoir(2,3). Although histone deacetylase inhibitors such as suberoylanilide hydroxamic acid (also known as vorinostat, VOR) can disrupt HIV-1 latency in vitro(4-6), the utility of this approach has never been directly proven in a translational clinical study of HIV-infected patients. Here we isolated the circulating resting CD4(+) T cells of patients in whom viraemia was fully suppressed by antiretroviral therapy, and directly studied the effect of VOR on this latent reservoir. In each of eight patients, a single dose of VOR increased both biomarkers of cellular acetylation, and simultaneously induced an increase in HIV RNA expression in resting CD4(+) cells (mean increase, 4.8-fold). This demonstrates that a molecular mechanism known to enforce HIV latency can be therapeutically targeted in humans, provides proof-of-concept for histone deacetylase inhibitors as a therapeutic class, and defines a precise approach to test novel strategies to attack and eradicate latent HIV infection directly.	[Archin, N. M.; Liberty, A. L.; Kashuba, A. D.; Choudhary, S. K.; Kuruc, J. D.; Crooks, A. M.; Parker, D. C.; Hudgens, M. G.; Eron, J. J.; Margolis, D. M.] Univ N Carolina, Chapel Hill, NC 27599 USA; [Anderson, E. M.; Kearney, M. F.; Coffin, J. M.] NCI, HIV Drug Resistance Program, NIH, Frederick, MD 21702 USA; [Strain, M. C.; Richman, D. D.] VA San Diego Healthcare Syst, San Diego, CA 92093 USA; [Strain, M. C.; Richman, D. D.] Univ Calif San Diego, San Diego, CA 92093 USA; [Bosch, R. J.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Hazuda, D. J.] Merck Res Labs, White Horse Junction, PA USA	University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; Harvard University; Harvard T.H. Chan School of Public Health; Merck & Company	Margolis, DM (corresponding author), Univ N Carolina, Chapel Hill, NC 27599 USA.	dmargo@med.unc.edu	Kearney, Mary/AAU-8132-2020; Margolis, David M./Y-2468-2019	Margolis, David M./0000-0001-5714-0002; Kearney, Mary/0000-0003-3839-6576; Parker, Daniel/0000-0001-8512-1044	National Institutes of Health [AI084553, AI095052, AI096113, RR024383, AI50410]; Merck Co; James B. Pendleton Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410, U01AI095052, U19AI096113, R34AI084553] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck Co(Merck & Company); James B. Pendleton Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health grants AI084553, AI095052 and AI096113, and by a grant from Merck & Co to D. M. M., National Institutes of Health grants RR024383 to the UNC TRaCS Institute, AI50410 to the UNC Center for AIDS Research, and an equipment grant from the James B. Pendleton Charitable Trust. Merck & Co provided VOR. The ClinicalTrials.gov identifier is NCT01319383. We thank N. P. Dahl, R. Sackmann, M. Cheema, A. Wiegand and N. White for technical support, Y. Park and the staff the UNC Blood Bank, R. J. Bedimo and C. M. van der Horst for study oversight, and J. Scepanski and A. Sugarbaker for patient follow-up and study coordination. We thank M. S. Cohen, J. V. Garcia-Martinez, W. C. Greene, J. Karn and R. F. Siliciano for discussions. Finally, we are grateful for the contributions of the patients who have participated in these studies.	Archin NM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009390; Archin NM, 2009, AIDS, V23, P1799, DOI 10.1097/QAD.0b013e32832ec1dc; Archin NM, 2009, AIDS RES HUM RETROV, V25, P207, DOI 10.1089/aid.2008.0191; Archin NM, 2008, AIDS, V22, P1131, DOI 10.1097/QAD.0b013e3282fd6df4; Blankson JN, 2002, ANNU REV MED, V53, P557, DOI 10.1146/annurev.med.53.082901.104024; Contreras X, 2009, J BIOL CHEM, V284, P6782, DOI 10.1074/jbc.M807898200; Du LH, 2005, RAPID COMMUN MASS SP, V19, P1779, DOI 10.1002/rcm.1984; Edelstein LC, 2009, AIDS RES HUM RETROV, V25, P883, DOI 10.1089/aid.2008.0294; Gui CY, 2004, P NATL ACAD SCI USA, V101, P1241, DOI 10.1073/pnas.0307708100; Hermankova M, 2003, J VIROL, V77, P7383, DOI 10.1128/JVI.77.13.7383-7392.2003; Israel-Ballard K, 2005, J CLIN VIROL, V34, P253, DOI 10.1016/j.jcv.2005.02.013; Keedy KS, 2009, J VIROL, V83, P4749, DOI 10.1128/JVI.02585-08; Lee JH, 2010, P NATL ACAD SCI USA, V107, P14639, DOI 10.1073/pnas.1008522107; Lee JH, 2011, P NATL ACAD SCI USA, V108, P19629, DOI 10.1073/pnas.1117544108; Lehrman G, 2005, LANCET, V366, P549, DOI 10.1016/S0140-6736(05)67098-5; Margolis DM, 2011, CURR OPIN HIV AIDS, V6, P25, DOI 10.1097/COH.0b013e328341242d; May R. C., 2012, U N CAROLINA CHAPEL; Palmer S, 2003, J CLIN MICROBIOL, V41, P4531, DOI 10.1128/JCM.41.10.4531-4536.2003; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Robinson LH, 2002, J VIROL METHODS, V104, P147, DOI 10.1016/S0166-0934(02)00059-9; Rubin EH, 2006, CLIN CANCER RES, V12, P7039, DOI 10.1158/1078-0432.CCR-06-1802; Sagot-Lerolle N, 2008, AIDS, V22, P1125, DOI 10.1097/QAD.0b013e3282fd6ddc; Siliciano JD, 2007, J INFECT DIS, V195, P833, DOI 10.1086/511823; Tonelli R, 2006, LEUKEMIA, V20, P1307, DOI 10.1038/sj.leu.2404221; VanLint C, 1996, EMBO J, V15, P1112, DOI 10.1002/j.1460-2075.1996.tb00449.x	25	840	879	2	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2012	487	7408					482	U1650		10.1038/nature11286	http://dx.doi.org/10.1038/nature11286			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979KD	22837004	Green Accepted, Green Submitted			2022-12-28	WOS:000306815300038
J	Hoffmann, U; Truong, QA; Schoenfeld, DA; Chou, ET; Woodard, PK; Nagurney, JT; Pope, JH; Hauser, TH; White, CS; Weiner, SG; Kalanjian, S; Mullins, ME; Mikati, I; Peacock, WF; Zakroysky, P; Hayden, D; Goehler, A; Lee, H; Gazelle, GS; Wiviott, SD; Fleg, JL; Udelson, JE				Hoffmann, Udo; Truong, Quynh A.; Schoenfeld, David A.; Chou, Eric T.; Woodard, Pamela K.; Nagurney, John T.; Pope, J. Hector; Hauser, Thomas H.; White, Charles S.; Weiner, Scott G.; Kalanjian, Shant; Mullins, Michael E.; Mikati, Issam; Peacock, W. Frank; Zakroysky, Pearl; Hayden, Douglas; Goehler, Alexander; Lee, Hang; Gazelle, G. Scott; Wiviott, Stephen D.; Fleg, Jerome L.; Udelson, James E.		Romicat-II Investigators	Coronary CT Angiography versus Standard Evaluation in Acute Chest Pain	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COMPUTED TOMOGRAPHIC ANGIOGRAPHY; EMERGENCY-DEPARTMENT PATIENTS; DIAGNOSTIC PERFORMANCE; ARTERY-DISEASE; ASSISTED TOMOGRAPHY; TRIAL; ASSOCIATION; MULTICENTER; RADIATION; OUTCOMES	BACKGROUND It is unclear whether an evaluation incorporating coronary computed tomographic angiography (CCTA) is more effective than standard evaluation in the emergency department in patients with symptoms suggestive of acute coronary syndromes. METHODS In this multicenter trial, we randomly assigned patients 40 to 74 years of age with symptoms suggestive of acute coronary syndromes but without ischemic electrocardiographic changes or an initial positive troponin test to early CCTA or to standard evaluation in the emergency department on weekdays during daylight hours between April 2010 and January 2012. The primary end point was length of stay in the hospital. Secondary end points included rates of discharge from the emergency department, major adverse cardiovascular events at 28 days, and cumulative costs. Safety end points were undetected acute coronary syndromes. RESULTS The rate of acute coronary syndromes among 1000 patients with a mean (+/- SD) age of 54 +/- 8 years (47% women) was 8%. After early CCTA, as compared with standard evaluation, the mean length of stay in the hospital was reduced by 7.6 hours (P<0.001) and more patients were discharged directly from the emergency department (47% vs. 12%, P<0.001). There were no undetected acute coronary syndromes and no significant differences in major adverse cardiovascular events at 28 days. After CCTA, there was more downstream testing and higher radiation exposure. The cumulative mean cost of care was similar in the CCTA group and the standard-evaluation group ($4,289 and $4,060, respectively; P = 0.65). CONCLUSIONS In patients in the emergency department with symptoms suggestive of acute coronary syndromes, incorporating CCTA into a triage strategy improved the efficiency of clinical decision making, as compared with a standard evaluation in the emergency department, but it resulted in an increase in downstream testing and radiation exposure with no decrease in the overall costs of care. (Funded by the National Heart, Lung, and Blood Institute; ROMICAT-II ClinicalTrials.gov number, NCT01084239.)	[Hoffmann, Udo; Truong, Quynh A.; Zakroysky, Pearl; Goehler, Alexander] Massachusetts Gen Hosp, Cardiac MR PET CT Program, Boston, MA 02114 USA; [Hoffmann, Udo; Zakroysky, Pearl; Goehler, Alexander; Gazelle, G. Scott] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Hoffmann, Udo; Truong, Quynh A.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Nagurney, John T.] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Schoenfeld, David A.; Hayden, Douglas; Lee, Hang] Massachusetts Gen Hosp, Ctr Biostat, Boston, MA 02114 USA; [Goehler, Alexander; Gazelle, G. Scott] Massachusetts Gen Hosp, Inst Technol Assessment, Boston, MA 02114 USA; [Hoffmann, Udo; Truong, Quynh A.; Schoenfeld, David A.; Hauser, Thomas H.; Goehler, Alexander; Lee, Hang; Gazelle, G. Scott; Wiviott, Stephen D.] Harvard Univ, Sch Med, Boston, MA USA; [Pope, J. Hector] Baystate Med Ctr, Dept Emergency Med, Springfield, MA USA; [Hauser, Thomas H.] Beth Israel Deaconess Med Ctr, Cardiovasc Inst, Boston, MA 02215 USA; [Wiviott, Stephen D.] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; [Udelson, James E.] Tufts Med Ctr, CardioVasc Ctr, Boston, MA USA; [Udelson, James E.] Tufts Med Ctr, Div Cardiol, Boston, MA USA; [Weiner, Scott G.] Tufts Med Ctr, Dept Emergency Med, Boston, MA USA; [Mullins, Michael E.] Washington Univ, Sch Med, Div Emergency Med, St Louis, MO USA; [Woodard, Pamela K.] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO USA; [Chou, Eric T.; Kalanjian, Shant] Kaiser Permanente Fontana Med Ctr, Fontana, CA USA; [White, Charles S.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Fleg, Jerome L.] NHLBI, Div Cardiovasc Sci, Bethesda, MD 20892 USA; [Mikati, Issam] Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, Dept Emergency Med,Dept Med, Chicago, IL 60611 USA; [Peacock, W. Frank] Baylor Coll Med, Dept Emergency Med, Houston, TX 77030 USA; [Wiviott, Stephen D.] Thrombolysis Myocardial Infarct TIMI Study Grp, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Baystate Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital; Tufts Medical Center; Tufts Medical Center; Tufts Medical Center; Washington University (WUSTL); Washington University (WUSTL); Kaiser Permanente; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Northwestern University; Feinberg School of Medicine; Baylor College of Medicine; Harvard University; Brigham & Women's Hospital	Hoffmann, U (corresponding author), Massachusetts Gen Hosp, Cardiac MR PET CT Program, 165 Cambridge St,Suite 400, Boston, MA 02114 USA.	uhoffmann@partners.org	Woodard, Pamela/AAC-3892-2020; Wiviott, Stephen/HIK-2534-2022; Mullins, Michael E./H-7831-2019	Mullins, Michael E./0000-0001-8605-0217; Weiner, Scott/0000-0002-4672-5184	National Heart, Lung, and Blood Institute [U01HL092040, U01HL092022]; National Institutes of Health [UL1RR025758, K23HL098370, L30HL093896]; GE Healthcare; Astellas; Harvard Clinical Research Institute; American College of Radiology Imaging Network; Bracco Diagnostics; Genentech; Siemens Healthcare; Alere (Biosite); Brahms Diagnostica (Fischer); Nanosphere; St. Jude Medical; Qi Imaging; Arena Pharmaceuticals; AstraZeneca; Bayer; Bristol-Myers Squibb; Ortho-McNeil; Daiichi Sankyo; Eli Lilly; Merck; Schering-Plough; Novartis; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL098370, U01HL092040, U01HL092022, K24HL113128] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GE Healthcare(General ElectricGE Healthcare); Astellas(Astellas Pharmaceuticals); Harvard Clinical Research Institute; American College of Radiology Imaging Network(General Electric); Bracco Diagnostics; Genentech(Roche HoldingGenentech); Siemens Healthcare(Siemens AG); Alere (Biosite); Brahms Diagnostica (Fischer); Nanosphere; St. Jude Medical(St. Jude Medical); Qi Imaging; Arena Pharmaceuticals; AstraZeneca(AstraZeneca); Bayer(Bayer AG); Bristol-Myers Squibb(Bristol-Myers Squibb); Ortho-McNeil; Daiichi Sankyo(Daiichi Sankyo Company Limited); Eli Lilly(Eli Lilly); Merck(Merck & Company); Schering-Plough(Merck & CompanySchering Plough Corporation); Novartis(Novartis); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants from the National Heart, Lung, and Blood Institute (U01HL092040 and U01HL092022) and the National Institutes of Health (UL1RR025758, K23HL098370, and L30HL093896, to Dr. Truong).; Dr. Gazelle reports receiving consulting fees from GE Healthcare; Dr. Hauser, receiving consulting fees from Astellas and the Harvard Clinical Research Institute; Dr. Hoffmann, receiving grant support from the American College of Radiology Imaging Network, Bracco Diagnostics, Genentech, and Siemens Healthcare on behalf of his institution; Dr. Nagurney, receiving grant support from Alere (Biosite), Brahms Diagnostica (Fischer), and Nanosphere on behalf of his institution; Dr. Truong, receiving grant support from St. Jude Medical and Qi Imaging on behalf of her institution and travel support from Medconvent and the Society of Cardiac Computed Tomography; Dr. Wiviott, receiving consulting fees from Arena Pharmaceuticals, AstraZeneca, Bayer, Bristol-Myers Squibb, and Ortho-McNeil, grant support from AstraZeneca, Daiichi Sankyo, Eli Lilly, and Merck and Schering-Plough on behalf of his institution, and lecture fees from AstraZeneca, Daiichi Sankyo, Eli Lilly, Novartis, and Schering-Plough; and Dr. Udelson, being on the scientific advisory board of Lantheus Medical Imaging. No other potential conflict of interest relevant to this article was reported.	Abbara Suhny, 2009, J Cardiovasc Comput Tomogr, V3, P190, DOI 10.1016/j.jcct.2009.03.004; Achenbach S, 2010, EUR HEART J, V31, P340, DOI 10.1093/eurheartj/ehp470; Budoff MJ, 2008, J AM COLL CARDIOL, V52, P1724, DOI 10.1016/j.jacc.2008.07.031; Gerber TC, 2009, CIRCULATION, V119, P1056, DOI 10.1161/CIRCULATIONAHA.108.191650; Goldstein JA, 2011, J AM COLL CARDIOL, V58, P1414, DOI 10.1016/j.jacc.2011.03.068; Hoffmann U, 2012, AM HEART J, V163, P330, DOI 10.1016/j.ahj.2012.01.028; Hoffmann U, 2009, J AM COLL CARDIOL, V53, P1642, DOI 10.1016/j.jacc.2009.01.052; Hollander JE, 2009, ACAD EMERG MED, V16, P693, DOI 10.1111/j.1553-2712.2009.00459.x; Litt HI, 2012, NEW ENGL J MED, V366, P1393, DOI 10.1056/NEJMoa1201163; Marano R, 2009, EUR RADIOL, V19, P1114, DOI 10.1007/s00330-008-1239-8; Meijboom WB, 2008, J AM COLL CARDIOL, V52, P2135, DOI 10.1016/j.jacc.2008.08.058; Miller JM, 2008, NEW ENGL J MED, V359, P2324, DOI 10.1056/NEJMoa0806576; Roe MT, 2000, CIRCULATION, V102, P1101, DOI 10.1161/01.CIR.102.10.1101; Rubinshtein R, 2007, CIRCULATION, V115, P1762, DOI 10.1161/CIRCULATIONAHA.106.618389; Schlett CL, 2011, JACC-CARDIOVASC IMAG, V4, P481, DOI 10.1016/j.jcmg.2010.12.008; Shreibati JB, 2011, JAMA-J AM MED ASSOC, V306, P2128, DOI 10.1001/jama.2011.1652; Than M, 2011, LANCET, V377, P1077, DOI 10.1016/S0140-6736(11)60310-3; von Ballmoos MW, 2011, ANN INTERN MED, V154, P413, DOI 10.7326/0003-4819-154-6-201103150-00007	18	560	573	2	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 26	2012	367	4					299	308		10.1056/NEJMoa1201161	http://dx.doi.org/10.1056/NEJMoa1201161			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	978KD	22830462	Green Accepted			2022-12-28	WOS:000306738300004
J	Tan, M; Yamey, G				Tan, Megan; Yamey, Gavin			Paying the poor	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Tan, Megan; Yamey, Gavin] Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Tan, M (corresponding author), Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA.	megan.e.tan@gmail.com						Economist, 2010, ECONOMIST        062; International Policy Centre for Inclusive Growth, 2009, IMP NOT EN IM CCT SU; Lagarde M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008137	3	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 23	2012	345								e4929	10.1136/bmj.e4929	http://dx.doi.org/10.1136/bmj.e4929			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	981UP	22826578				2022-12-28	WOS:000306996800009
J	Hubbell, JA; Chilkoti, A				Hubbell, Jeffrey A.; Chilkoti, Ashutosh			Nanomaterials for Drug Delivery	SCIENCE			English	Editorial Material							IN-VIVO; NANOPARTICLES; TUMOR; TRANSPORT; PEPTIDES		[Hubbell, Jeffrey A.] Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, CH-1015 Lausanne, Switzerland; [Hubbell, Jeffrey A.] Ecole Polytech Fed Lausanne, Sch Engn, CH-1015 Lausanne, Switzerland; [Hubbell, Jeffrey A.] Ecole Polytech Fed Lausanne, Sch Basic Sci, Inst Chem Sci & Engn, CH-1015 Lausanne, Switzerland; [Chilkoti, Ashutosh] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA; [Chilkoti, Ashutosh] Duke Univ, Ctr Biol Inspired Mat & Mat Syst, Durham, NC 27708 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Duke University; Duke University	Hubbell, JA (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, CH-1015 Lausanne, Switzerland.	jeffrey.hubbell@epfl.ch	Hubbell, Jeffrey A/A-9266-2008	Hubbell, Jeffrey A/0000-0003-0276-5456				Baish JW, 2011, P NATL ACAD SCI USA, V108, P1799, DOI 10.1073/pnas.1018154108; Christian DA, 2009, MOL PHARMACEUT, V6, P1343, DOI 10.1021/mp900022m; Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956; Douglas SM, 2012, SCIENCE, V335, P831, DOI 10.1126/science.1214081; Gao WP, 2010, P NATL ACAD SCI USA, V107, P16432, DOI 10.1073/pnas.1006044107; Hatakeyama S, 2011, P NATL ACAD SCI USA, V108, P19587, DOI 10.1073/pnas.1105057108; Hirosue S, 2010, VACCINE, V28, P7897, DOI 10.1016/j.vaccine.2010.09.077; MacKay JA, 2009, NAT MATER, V8, P993, DOI [10.1038/NMAT2569, 10.1038/nmat2569]; Moon JJ, 2011, NAT MATER, V10, P243, DOI 10.1038/NMAT2960; Murakami M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001385; Nembrini C, 2011, P NATL ACAD SCI USA, V108, pE989, DOI 10.1073/pnas.1104264108; Peters D, 2009, P NATL ACAD SCI USA, V106, P9815, DOI 10.1073/pnas.0903369106; Petros RA, 2010, NAT REV DRUG DISCOV, V9, P615, DOI 10.1038/nrd2591; Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI [10.1038/nbt1332, 10.1038/nbtl332]; Schellenberger V, 2009, NAT BIOTECHNOL, V27, P1186, DOI 10.1038/nbt.1588; von Maltzahn G, 2011, NAT MATER, V10, P545, DOI [10.1038/nmat3049, 10.1038/NMAT3049]; Yoo JW, 2011, NAT REV DRUG DISCOV, V10, P521, DOI 10.1038/nrd3499	17	409	421	4	312	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2012	337	6092					303	305		10.1126/science.1219657	http://dx.doi.org/10.1126/science.1219657			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975WQ	22822138				2022-12-28	WOS:000306542600038
J	Maron, BJ; Maron, MS				Maron, Barry J.; Maron, Martin S.			Hypertrophic cardiomyopathy	LANCET			English	Article							LEFT-VENTRICULAR HYPERTROPHY; CARDIOVASCULAR MAGNETIC-RESONANCE; ALCOHOL SEPTAL ABLATION; IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS; GENOTYPE CLINICALLY USEFUL; OUTFLOW TRACT OBSTRUCTION; SYSTOLIC ANTERIOR MOTION; SUDDEN CARDIAC DEATH; MYOSIN HEAVY-CHAIN; LONG-TERM SURVIVAL	Hypertrophic cardiomyopathy is a common inherited cardiovascular disease present in one in 500 of the general population. It is caused by more than 1400 mutations in 11 or more genes encoding proteins of the cardiac sarcomere. Although hypertrophic cardiomyopathy is the most frequent cause of sudden death in young people (including trained athletes), and can lead to functional disability from heart failure and stroke, the majority of affected individuals probably remain undiagnosed and many do not experience greatly reduced life expectancy or substantial symptoms. Clinical diagnosis is based on otherwise unexplained left-ventricular hypertrophy identified by echocardiography or cardiovascular MRI. While presenting with a heterogeneous clinical profile and complex pathophysiology, effective treatment strategies are available, including implantable defibrillators to prevent sudden death, drugs and surgical myectomy (or, alternatively, alcohol septal ablation) for relief of outflow obstruction and symptoms of heart failure, and pharmacological strategies (and possibly radiofrequency ablation) to control atrial fibrillation and prevent embolic stroke. A subgroup of patients with genetic mutations but without left-ventricular hypertrophy has emerged, with unresolved natural history. Now, after more than 50 years, hypertrophic cardiomyopathy has been transformed from a rare and largely untreatable disorder to a common genetic disease with management strategies that permit realistic aspirations for restored quality of life and advanced longevity.	[Maron, Barry J.; Maron, Martin S.] Minneapolis Heart Inst Fdn, Hypertroph Cardiomyopathy Ctr, Minneapolis, MN USA; [Maron, Barry J.; Maron, Martin S.] Tufts Med Ctr, Boston, MA 02111 USA	Minneapolis Heart Institute Foundation; Tufts Medical Center	Maron, MS (corresponding author), Tufts Med Ctr, Boston, MA 02111 USA.	mmaron@tuftsmedicalcenter.org			Medtronic; Genzyme	Medtronic(Medtronic); Genzyme(Sanofi-AventisGenzyme Corporation)	BJM has consulted for GeneDx and received grants from Medtronic and Genzyme. MSM has consulted for PGx Health and received grants from Genzyme.	Ackerman MJ, 2002, J AM COLL CARDIOL, V39, P2042, DOI 10.1016/S0735-1097(02)01900-9; Adabag AS, 2008, J AM COLL CARDIOL, V51, P1369, DOI 10.1016/j.jacc.2007.11.071; Adabag AS, 2006, AM J CARDIOL, V98, P1507, DOI 10.1016/j.amjcard.2006.07.029; Agarwal S, 2010, J AM COLL CARDIOL, V55, P823, DOI 10.1016/j.jacc.2009.09.047; Alcalai R, 2008, J CARDIOVASC ELECTR, V19, P104, DOI 10.1111/j.1540-8167.2007.00965.x; Arad M, 2005, CIRCULATION, V112, P2805, DOI 10.1161/CIRCULATIONAHA.105.547448; Autore C, 2005, J AM COLL CARDIOL, V45, P1076, DOI 10.1016/j.jacc.2004.12.067; Ball W, 2011, J AM COLL CARDIOL, V58, P2313, DOI 10.1016/j.jacc.2011.08.040; Basso C, 2000, HUM PATHOL, V31, P988, DOI 10.1053/hupa.2000.16659; Basso C, 2009, EUR HEART J, V30, P1627, DOI 10.1093/eurheartj/ehp121; Berul CI, 2008, J AM COLL CARDIOL, V51, P1685, DOI 10.1016/j.jacc.2008.01.033; Bos JM, 2009, J AM COLL CARDIOL, V54, P201, DOI 10.1016/j.jacc.2009.02.075; BRAUNWALD E, 1964, CIRCULATION, V30, P3; Cecchi F, 2003, NEW ENGL J MED, V349, P1027, DOI 10.1056/NEJMoa025050; Chan RH, 2012, J AM COLL CARDIOL, V59, pE1570, DOI 10.1016/S0735-1097(12)61571-X; Christiaans I, 2009, HEART RHYTHM, V6, P1366, DOI 10.1016/j.hrthm.2009.04.029; Corrado D, 1998, NEW ENGL J MED, V339, P364, DOI 10.1056/NEJM199808063390602; Corrado D, 2006, JAMA-J AM MED ASSOC, V296, P1593, DOI 10.1001/jama.296.13.1593; Cuoco FA, 2008, J AM COLL CARDIOL, V52, P1718, DOI 10.1016/j.jacc.2008.07.061; Decker JA, 2009, J AM COLL CARDIOL, V54, P250, DOI 10.1016/j.jacc.2009.03.051; Di Donna P, 2010, EUROPACE, V12, P347, DOI 10.1093/europace/euq013; Dukkipati SR, 2011, CIRC-ARRHYTHMIA ELEC, V4, P185, DOI 10.1161/CIRCEP.110.957290; Elliott PM, 2006, EUR HEART J, V27, P1933, DOI 10.1093/eurheartj/ehl041; Elliott PM, 2001, LANCET, V357, P420, DOI 10.1016/S0140-6736(00)04005-8; Elliott PM, 2000, J AM COLL CARDIOL, V36, P2212, DOI 10.1016/S0735-1097(00)01003-2; Fang MC, 2008, J AM COLL CARDIOL, V51, P810, DOI 10.1016/j.jacc.2007.09.065; Firoozi S, 2002, EUR HEART J, V23, P1617, DOI 10.1053/euhj.2002.3285; Germans T, 2006, J AM COLL CARDIOL, V48, P2518, DOI 10.1016/j.jacc.2006.08.036; Gersh BJ, 2011, J AM COLL CARDIOL, V58, pE212, DOI 10.1016/j.jacc.2011.06.011; Geske JB, 2007, CIRCULATION, V116, P2702, DOI 10.1161/CIRCULATIONAHA.107.698985; Gettes LS, 2008, JAC, V51, P2085, DOI DOI 10.1016/J.JACC.2008.02.033; Gruner C, 2011, CIRC-CARDIOVASC GENE, V4, P288, DOI 10.1161/CIRCGENETICS.110.958835; Harris KM, 2006, CIRCULATION, V114, P216, DOI 10.1161/CIRCULATIONAHA.105.583500; Hauser RG, 2005, CIRCULATION, V112, P2040, DOI 10.1161/CIRCULATIONAHA.105.580381; Ho CY, 2010, CIRCULATION, V122, P2430, DOI 10.1161/CIRCULATIONAHA.110.978924; Ho CY, 2010, NEW ENGL J MED, V363, P552, DOI 10.1056/NEJMoa1002659; Ho CY, 2002, CIRCULATION, V105, P2992, DOI 10.1161/01.CIR.0000019070.70491.6D; Kelly M, 2009, CIRC-CARDIOVASC GENE, V2, P182, DOI 10.1161/CIRCGENETICS.108.836478; Kitaoka H, 2003, AM J CARDIOL, V92, P1183, DOI 10.1016/j.amjcard.2003.07.027; KLUES HG, 1991, CIRCULATION, V84, P1188, DOI 10.1161/01.CIR.84.3.1188; KLUES HG, 1995, J AM COLL CARDIOL, V26, P1699, DOI 10.1016/0735-1097(95)00390-8; KLUES HG, 1992, CIRCULATION, V85, P1651, DOI 10.1161/01.CIR.85.5.1651; Kubo T, 2007, J AM COLL CARDIOL, V49, P2419, DOI 10.1016/j.jacc.2007.02.061; Kubo T, 2009, CIRC J, V73, P1599, DOI 10.1253/circj.CJ-09-0140; Landstrom AP, 2010, CIRCULATION, V122, P2441, DOI 10.1161/CIRCULATIONAHA.110.954446; Maron BJ, 2008, J CARDIOVASC ELECTR, V19, P1118, DOI 10.1111/j.1540-8167.2008.01147.x; Maron BJ, 2008, AM J CARDIOL, V101, P544, DOI 10.1016/j.amjcard.2007.09.101; Maron BJ, 2007, CIRCULATION, V116, P196, DOI 10.1161/CIRCULATIONAHA.107.691378; Maron BJ, 2007, JAMA-J AM MED ASSOC, V298, P405, DOI 10.1001/jama.298.4.405; Maron BJ, 2006, CIRCULATION, V114, P1633, DOI 10.1161/CIRCULATIONAHA.106.613562; Maron BJ, 2012, J AM COLL CARDIOL, V60, P705, DOI 10.1016/j.jacc.2012.02.068; Maron BJ, 2012, AM J CARDIOL, V109, P1341, DOI 10.1016/j.amjcard.2011.12.027; Maron BJ, 2012, HEART RHYTHM, V9, P57, DOI 10.1016/j.hrthm.2011.08.009; Maron BJ, 2011, AM J CARDIOL, V108, P1783, DOI 10.1016/j.amjcard.2011.07.048; Maron BJ, 2009, J AM COLL CARDIOL, V54, P191, DOI 10.1016/j.jacc.2008.11.069; Maron BJ, 2011, EUR HEART J, V32, P1055, DOI 10.1093/eurheartj/ehr006; Maron BJ, 2011, AM J CARDIOL, V107, P604, DOI 10.1016/j.amjcard.2010.10.022; Maron BJ, 2009, CIRC-CARDIOVASC GENE, V2, P81, DOI 10.1161/CIRCGENETICS.108.788703; Maron BJ, 2010, CIRCULATION, V121, P445, DOI 10.1161/CIRCULATIONAHA.109.878579; Maron BJ, 2009, J AM COLL CARDIOL, V54, P2339, DOI 10.1016/j.jacc.2009.07.050; Maron BJ, 2009, HEART RHYTHM, V6, P993, DOI 10.1016/j.hrthm.2009.03.014; Maron BJ, 2009, HEART RHYTHM, V6, P599, DOI 10.1016/j.hrthm.2009.02.007; Maron BJ, 2009, JAMA-J AM MED ASSOC, V301, P1253, DOI 10.1001/jama.2009.371; Maron BJ, 2009, CIRCULATION, V119, P1085, DOI 10.1161/CIRCULATIONAHA.108.804617; Maron Barry J., 2003, Journal of the American College of Cardiology, V42, P1687, DOI 10.1016/S0735-1097(03)00941-0; MARON BJ, 1983, CIRCULATION, V68, P282, DOI 10.1161/01.CIR.68.2.282; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; Maron BJ, 2000, CIRCULATION, V102, P858; Maron BJ, 2005, J AM COLL CARDIOL, V45, P1340, DOI 10.1016/j.jacc.2005.02.011; Maron BJ, 2004, J AM COLL CARDIOL, V44, P2125, DOI 10.1016/j.jacc.2004.08.052; Maron BJ, 1999, JAMA-J AM MED ASSOC, V281, P650, DOI 10.1001/jama.281.7.650; Maron BJ, 2004, CIRCULATION, V109, P984, DOI 10.1161/01.CIR.0000117098.75727.D8; Maron BJ, 2004, AM J MED, V116, P63, DOI 10.1016/j.amjmed.2003.10.012; Maron BJ, 2003, J AM COLL CARDIOL, V42, P882, DOI 10.1016/S0735-1097(03)00855-6; Maron BJ, 2003, J AM COLL CARDIOL, V41, P974, DOI 10.1016/S0735-1097(02)02976-5; Maron BJ, 1999, CIRCULATION, V99, P2927, DOI 10.1161/01.CIR.99.22.2927; Maron BJ, 2000, NEW ENGL J MED, V342, P365, DOI 10.1056/NEJM200002103420601; Maron BJ, 2002, J AM COLL CARDIOL, V39, P301, DOI 10.1016/S0735-1097(01)01727-2; MARON BJ, 1995, CIRCULATION, V92, P785, DOI 10.1161/01.CIR.92.4.785; Maron BJ, 2001, ANN NONINVAS ELECTRO, V6, P277, DOI 10.1111/j.1542-474X.2001.tb00118.x; Maron BJ, 2001, J AM COLL CARDIOL, V38, P315, DOI 10.1016/S0735-1097(01)01386-9; MARON BJ, 1979, CIRCULATION, V59, P689, DOI 10.1161/01.CIR.59.4.689; MARON BJ, 1986, NEW ENGL J MED, V315, P610, DOI 10.1056/NEJM198609043151003; MARON BJ, 1986, J AM COLL CARDIOL, V8, P545, DOI 10.1016/S0735-1097(86)80181-4; MARON BJ, 1987, J AM COLL CARDIOL, V10, P733, DOI 10.1016/S0735-1097(87)80264-4; Maron BJ, CIRCULATION IN PRESS; Maron MS, 2008, CIRCULATION, V118, P1541, DOI 10.1161/CIRCULATIONAHA.108.781401; Maron MS, 2007, AM J CARDIOL, V100, P1293, DOI 10.1016/j.amjcard.2007.05.061; Maron MS, 2012, CIRC-CARDIOVASC IMAG, V5, P441, DOI 10.1161/CIRCIMAGING.112.972760; Maron MS, 2011, CIRCULATION, V124, P40, DOI 10.1161/CIRCULATIONAHA.110.985812; Maron MS, 2010, CIRC-HEART FAIL, V3, P574, DOI 10.1161/CIRCHEARTFAILURE.109.922872; Maron MS, 2010, AM J CARDIOL, V105, P1842, DOI 10.1016/j.amjcard.2010.01.367; Maron MS, 2009, J AM COLL CARDIOL, V54, P866, DOI 10.1016/j.jacc.2009.04.072; Maron MS, 2009, J AM COLL CARDIOL, V54, P220, DOI 10.1016/j.jacc.2009.05.006; Maron MS, 2006, CIRCULATION, V114, P2232, DOI 10.1161/CIRCULATIONAHA.106.644682; Maron MS, 2005, AM J CARDIOL, V95, P1329, DOI 10.1016/j.amjcard.2005.01.077; Maron MS, 2003, NEW ENGL J MED, V348, P295, DOI 10.1056/NEJMoa021332; Maron MS, 2011, CIRCULATION S, V124, P14156; MCKENNA WJ, 1984, ARCH DIS CHILD, V59, P971, DOI 10.1136/adc.59.10.971; McLeod CJ, 2009, J AM COLL CARDIOL, V54, P229, DOI 10.1016/j.jacc.2009.02.071; Melacini P, 2007, HEART, V93, P708, DOI 10.1136/hrt.2006.099416; Melacini P, 2010, EUR HEART J, V31, P2111, DOI 10.1093/eurheartj/ehq136; Monserrat L, 2003, J AM COLL CARDIOL, V42, P873, DOI 10.1016/S0735-1097(03)00827-1; Moon JCC, 2004, HEART, V90, P645, DOI 10.1136/hrt.2003.014969; Morita H, 2008, NEW ENGL J MED, V358, P1899, DOI 10.1056/NEJMoa075463; MORROW AG, 1961, ANN SURG, V154, P181, DOI 10.1097/00000658-196108000-00003; Nagueh SF, 2001, J AM COLL CARDIOL, V38, P1701, DOI 10.1016/S0735-1097(01)01614-X; Nagueh SF, 2011, J AM COLL CARDIOL, V58, P2322, DOI 10.1016/j.jacc.2011.06.073; Niimura H, 1998, NEW ENGL J MED, V338, P1248, DOI 10.1056/NEJM199804303381802; Nishimura RA, 2010, CIRC-CARDIOVASC INTE, V3, P91, DOI 10.1161/CIRCINTERVENTIONS.110.952085; Nistri S, 2012, AM J CARDIOL, V110, P715, DOI 10.1016/j.amjcard.2012.04.051; Noseworthy PA, 2009, AM J CARDIOL, V104, P128, DOI 10.1016/j.amjcard.2009.02.056; Olivotto I, 2006, J AM COLL CARDIOL, V47, P1043, DOI 10.1016/j.jacc.2005.10.050; Olivotto I, 2005, J AM COLL CARDIOL, V46, P480, DOI 10.1016/j.jacc.2005.04.043; Olivotto I, 2001, CIRCULATION, V104, P2517, DOI 10.1161/hc4601.097997; Olivotto I, 2008, J AM COLL CARDIOL, V52, P559, DOI 10.1016/j.jacc.2008.04.047; Olivotto I, 2010, AM J CARDIOL, V106, P261, DOI 10.1016/j.amjcard.2010.03.020; Olivotto L, 2007, J AM COLL CARDIOL, V50, P831, DOI 10.1016/j.jacc.2007.05.018; Ommen SR, 2005, J AM COLL CARDIOL, V46, P470, DOI 10.1016/j.jacc.2005.02.090; Paz R, 1996, NEW ENGL J MED, V335, P938, DOI 10.1056/NEJM199609263351305; Pelliccia A, 2005, EUR HEART J, V26, P1422, DOI 10.1093/eurheartj/ehi325; Richard P, 2003, CIRCULATION, V107, P2227, DOI 10.1161/01.CIR.0000066323.15244.54; Rickers C, 2005, CIRCULATION, V112, P855, DOI 10.1161/CIRCULATIONAHA.104.507723; Rowin EJ, 2012, AM J CARDIOL, V110, P1027, DOI 10.1016/j.amjcard.2012.05.035; Rowin EJ, 2012, JACC-CARDIOVASC IMAG, V5, P119, DOI 10.1016/j.jcmg.2011.08.020; Seidman CE, 2011, CIRC RES, V108, P743, DOI 10.1161/CIRCRESAHA.110.223834; SHAH PM, 1981, AM J CARDIOL, V48, P258, DOI 10.1016/0002-9149(81)90605-6; Sherrid MV, 2005, J AM COLL CARDIOL, V45, P1251, DOI 10.1016/j.jacc.2005.01.012; Shirani J, 2000, J AM COLL CARDIOL, V35, P36, DOI 10.1016/S0735-1097(99)00492-1; Sorajja P, 2003, CIRCULATION, V108, P2342, DOI 10.1161/01.CIR.0000097110.55312.BF; Sorajja P, 2008, CIRCULATION, V118, P131, DOI 10.1161/CIRCULATIONAHA.107.738740; Spirito P, 1999, CIRCULATION, V99, P2132, DOI 10.1161/01.CIR.99.16.2132; Spirito P, 2000, NEW ENGL J MED, V342, P1778, DOI 10.1056/NEJM200006153422403; Spirito P, 1997, NEW ENGL J MED, V336, P775, DOI 10.1056/NEJM199703133361107; Spirito P, 2009, CIRCULATION, V119, P1703, DOI 10.1161/CIRCULATIONAHA.108.798314; ten Cate FJ, 2010, CIRC-HEART FAIL, V3, P362, DOI 10.1161/CIRCHEARTFAILURE.109.862359; Topilsky Y, 2011, CIRC-HEART FAIL, V4, P266, DOI 10.1161/CIRCHEARTFAILURE.110.959288; Valeti US, 2007, J AM COLL CARDIOL, V49, P350, DOI 10.1016/j.jacc.2006.08.055; Van Driest SL, 2002, CIRCULATION, V106, P3085, DOI 10.1161/01.CIR.0000042675.59901.14; Watkins H, 2000, NEW ENGL J MED, V342, P422, DOI 10.1056/NEJM200002103420609; WATKINS H, 1992, NEW ENGL J MED, V326, P1108, DOI 10.1056/NEJM199204233261703; Weidemann F, 2009, CIRCULATION, V119, P524, DOI 10.1161/CIRCULATIONAHA.108.794529; WIGLE ED, 1995, CIRCULATION, V92, P1680, DOI 10.1161/01.CIR.92.7.1680; Woo A, 2005, CIRCULATION, V111, P2033, DOI 10.1161/01.CIR.0000162460.36735.71	144	655	713	11	144	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 19	2013	381	9862					242	255		10.1016/S0140-6736(12)60397-3	http://dx.doi.org/10.1016/S0140-6736(12)60397-3			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	075LL	22874472				2022-12-28	WOS:000313887600036
J	Cresswell, JA; Campbell, OMR; De Silva, MJ; Filippi, V				Cresswell, Jenny A.; Campbell, Oona M. R.; De Silva, Mary J.; Filippi, Veronique			Effect of maternal obesity on neonatal death in sub-Saharan Africa: multivariable analysis of 27 national datasets	LANCET			English	Article							BODY-MASS INDEX; UTERINE CONTRACTILITY; NUTRITION TRANSITION; DEVELOPING-COUNTRIES; PREPREGNANCY WEIGHT; PREGNANCY OUTCOMES; RISK; WOMEN; STILLBIRTHS; UNDERWEIGHT	Background Rates of obesity are increasing worldwide, including in sub-Saharan Africa. Neonates born to obese mothers in low-income settings are at increased risk of complications including admission to neonatal intensive care, macrosomia, low Apgar scores, and perinatal death. We investigated whether maternal obesity is a risk factor for neonatal death in sub-Saharan Africa and the effect on the detailed timing of death within the neonatal period. Methods Cross-sectional Demographic and Health Surveys from 27 sub-Saharan countries (2003-09) were pooled. We used multivariable logistic regression to assess the risk of neonatal death (in women's most recent singleton livebirth in the 5 years preceding the survey) by maternal body-mass index (BMI) category (measured during the survey). Timing of death was investigated with a discrete-time survival model. Findings 15 518 of 81 126 eligible women were overweight (4266 were obese), 52 006 had an optimum BMI, and 13 602 were underweight. Maternal obesity was associated with an increased odds of neonatal death after adjustment for confounding factors (adjusted odds ratio 1.46, 95% CI 1.11-1.91). Maternal obesity was a significant risk factor for neonatal deaths occurring during the first 2 days of life (1.62, 1.11-2.37). We noted no statistically significant relation later in the neonatal period (days 2-6 1.36, 0.84-2.21; days 7-27 1.19, 0.65-2.18), possibly because of low statistical power. Interpretation Maternal obesity in sub-Saharan Africa is associated with increased risk of early neonatal death. Potential mechanisms include prematurity, intrapartum events, or infections. Strategies to prevent and reduce obesity need to be considered; obese women should be advised to deliver in a health-care facility that can provide emergency obstetric and neonatal care.	[Cresswell, Jenny A.; Campbell, Oona M. R.; De Silva, Mary J.; Filippi, Veronique] Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Cresswell, JA (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England.	jenny.cresswell@lshtm.ac.uk		Campbell, Oona/0000-0002-9311-0115; Cresswell, Jenny/0000-0002-9553-1132	Economic and Social Research Council [PTA-031-2006-00109]	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	Economic and Social Research Council.; JC was funded by a PhD studentship from the Economic and Social Research Council (PTA-031-2006-00109). We thank Emma Slaymaker for her support and advice during data analysis, and the reviewers who provided us with many helpful suggestions.	[Anonymous], 2006, DHS METHODOLOGICAL R; Bhattacharya S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-168; Cedergren MI, 2009, EUR J OBSTET GYN R B, V145, P163, DOI 10.1016/j.ejogrb.2009.05.022; Cedergren MI, 2004, OBSTET GYNECOL, V103, P219, DOI 10.1097/01.AOG.0000107291.46159.00; Chen MH, 2010, J MATERN-FETAL NEO M, V23, P89, DOI 10.3109/14767050903168440; Cnattingius S, 1998, NEW ENGL J MED, V338, P147, DOI 10.1056/NEJM199801153380302; Ehrenberg HM, 2004, AM J OBSTET GYNECOL, V191, P964, DOI 10.1016/j.ajog.2004.05.052; Hill K, 2006, DEMOGR RES, V14, P429, DOI 10.4054/DemRes.2006.14.18; Idemyor V, 2010, J NATL MED ASSOC, V102, P650, DOI 10.1016/S0027-9684(15)30643-X; Kalk P, 2009, EUR J MED RES, V14, P216; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Kristensen J, 2005, BJOG-INT J OBSTET GY, V112, P403, DOI 10.1111/j.1471-0528.2005.00437.x; Law DCG, 2007, HUM REPROD, V22, P414, DOI 10.1093/humrep/de1400; Lawn J, 2005, B WORLD HEALTH ORGAN, V83, P409; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, 2010, SEMIN PERINATOL, V34, P371, DOI 10.1053/j.semperi.2010.09.011; Lawn JE, 2009, INT J GYNECOL OBSTET, V107, pS5, DOI 10.1016/j.ijgo.2009.07.016; Levitt NS, 2008, HEART, V94, P1376, DOI 10.1136/hrt.2008.147306; Mbanya JCN, 2010, LANCET, V375, P2254, DOI 10.1016/S0140-6736(10)60550-8; Mendez MA, 2005, AM J CLIN NUTR, V81, P714; Nohr EA, 2007, OBSTET GYNECOL, V110, P1083, DOI 10.1097/01.AOG.0000286760.46679.f8; Popkin BM, 2004, NUTR REV, V62, pS140, DOI 10.1111/j.1753-4887.2004.tb00084.x; POPKIN BM, 1994, NUTR REV, V52, P285, DOI 10.1111/j.1753-4887.1994.tb01460.x; Prentice AM, 2006, INT J EPIDEMIOL, V35, P93, DOI 10.1093/ije/dyi272; Pullum TW, 2008, DHS METHODOLOGICAL R; Sebire NJ, 2001, BRIT J OBSTET GYNAEC, V108, P61, DOI 10.1111/j.1471-0528.2001.00021.x; The NHS Information Centre, 2010, LIF STAT STAT OB PHY; Verdiales M, 2009, J PERINAT MED, V37, P651, DOI 10.1515/JPM.2009.110; Zhang J, 2007, BJOG-INT J OBSTET GY, V114, P343, DOI 10.1111/j.1471-0528.2006.01233.x	29	61	62	0	25	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 13	2012	380	9850					1325	1330		10.1016/S0140-6736(12)60869-1	http://dx.doi.org/10.1016/S0140-6736(12)60869-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	022BZ	22884609				2022-12-28	WOS:000309931400031
J	Richman, DD				Richman, Douglas D.			Antiretroviral drug resistance in resource-limited settings	LANCET			English	Editorial Material							NAIVE INDIVIDUALS; THERAPY		[Richman, Douglas D.] VA San Diego Healthcare Syst, La Jolla, CA 92093 USA; [Richman, Douglas D.] Univ Calif San Diego, Ctr AIDS Res, La Jolla, CA 92093 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego	Richman, DD (corresponding author), VA San Diego Healthcare Syst, La Jolla, CA 92093 USA.	drichman@ucsd.edu						Bennett DE, 2012, CLIN INFECT DIS, V54, pS280, DOI 10.1093/cid/cis207; Foster GM, 2012, ANTIVIR THER S, V17, P23; Gill VS, 2010, CLIN INFECT DIS, V50, P98, DOI 10.1086/648729; Gupta RK, 2009, LANCET INFECT DIS, V9, P409, DOI 10.1016/S1473-3099(09)70136-7; Gupta RK, 2012, LANCET; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Little SJ, 2008, J VIROL, V82, P5510, DOI 10.1128/JVI.02579-07; Losina E, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000173; Oyugi JH, 2007, AIDS, V21, P965, DOI 10.1097/QAD.0b013e32802e6bfa; Pasquet A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013414; UNAIDS, UNAIDS REP GLOB AIDS; von Wyl V, 2012, CLIN INFECT DIS, V54, P131, DOI 10.1093/cid/cir728	12	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 6	2012	380	9849					1210	1211		10.1016/S0140-6736(12)61188-X	http://dx.doi.org/10.1016/S0140-6736(12)61188-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	020NG	22828483				2022-12-28	WOS:000309817500007
J	Boyd, M; Mohapi, L				Boyd, Mark; Mohapi, Lerato			STRETCHing delivery of HIV health services	LANCET			English	Editorial Material							ANTIRETROVIRAL THERAPY; CARE		[Boyd, Mark] Univ New S Wales, Kirby Inst, Sydney, NSW 2052, Australia; [Boyd, Mark] St Vincents Hosp, Sydney, NSW 2010, Australia; [Mohapi, Lerato] Univ Witwatersrand, Chris Hani Baragwanath Hosp, Perinatal HIV Res Unit, Johannesburg, South Africa	University of New South Wales Sydney; Kirby Institute; St Vincents Hospital Sydney; University of Witwatersrand	Boyd, M (corresponding author), Univ New S Wales, Kirby Inst, Sydney, NSW 2052, Australia.	mboyd@kirby.unsw.edu.au		Boyd, Mark/0000-0002-6848-3307				Cain LE, 2011, ANN INTERN MED, V154, P509, DOI 10.7326/0003-4819-154-8-201104190-00001; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Emery S, 2008, J INFECT DIS, V197, P1133, DOI 10.1086/586713; Fairall L, 2012, LANCET; Fairall LR, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-21; Fox MP, 2010, AIDS, V24, P2041, DOI 10.1097/QAD.0b013e32833c703e; Funk MJ, 2011, ARCH INTERN MED, V171, P1560, DOI 10.1001/archinternmed.2011.401; Jaffar S, 2009, LANCET, V374, P2080, DOI 10.1016/S0140-6736(09)61674-3; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Sanne I, 2010, LANCET, V376, P33, DOI 10.1016/S0140-6736(10)60894-X; Severe P, 2010, NEW ENGL J MED, V363, P257, DOI 10.1056/NEJMoa0910370; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; The Global Fund to Fight AIDS, WHO WE AR; The United States President's Emergency Plan for AIDS Relief, PEPFAR; UNITAID, CHAIRS STAT CAN WE C; WHO, 2010, ANT THER HIV INF AD	16	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 8	2012	380	9845					865	867		10.1016/S0140-6736(12)60952-0	http://dx.doi.org/10.1016/S0140-6736(12)60952-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	002QL	22901954				2022-12-28	WOS:000308547300007
J	Antos, JR; Pauly, MV; Wilensky, GR				Antos, Joseph R.; Pauly, Mark V.; Wilensky, Gail R.			Bending the Cost Curve through Market-Based Incentives	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Antos, Joseph R.] Amer Enterprise Inst Publ Policy Res, Washington, DC 20036 USA; [Pauly, Mark V.] Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA; [Wilensky, Gail R.] Project Hope, Millwood, VA USA	American Enterprise Institute for Public Policy Research; University of Pennsylvania	Antos, JR (corresponding author), Amer Enterprise Inst Publ Policy Res, Washington, DC 20036 USA.							Congressional Budget Office, 2011, RED DEF SPEND REV OP; Congressional Budget Office, 2012, UPD EST INS COV PROV; House Budget Committee, 2012, PATH PROSP BLUEPR AM; Joint Committee on Taxation, 2012, EST FED TAX EXP FISC; Keehan SP, 2012, HEALTH AFFAIR, V31, P1600, DOI 10.1377/hlthaff.2012.0404	5	24	24	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 6	2012	367	10					954	958		10.1056/NEJMsb1207996	http://dx.doi.org/10.1056/NEJMsb1207996			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	999VO	22852881	Bronze			2022-12-28	WOS:000308343300016
J	Reis, RC; Miller, JM; Reynolds, MT; Gultekin, K; Maitra, D; King, AL; Strohmayer, TE				Reis, R. C.; Miller, J. M.; Reynolds, M. T.; Gueltekin, K.; Maitra, D.; King, A. L.; Strohmayer, T. E.			A 200-Second Quasi-Periodicity After the Tidal Disruption of a Star by a Dormant Black Hole	SCIENCE			English	Article							ACTIVE GALACTIC NUCLEI; X-RAY; FUNDAMENTAL PLANE; ACCRETION FLOWS; OSCILLATION; DISCOVERY; OUTBURST; MASS; FREQUENCIES	Supermassive black holes (SMBHs; mass is greater than or approximately 10(5) times that of the Sun) are known to exist at the center of most galaxies with sufficient stellar mass. In the local universe, it is possible to infer their properties from the surrounding stars or gas. However, at high redshifts we require active, continuous accretion to infer the presence of the SMBHs, which often comes in the form of long-term accretion in active galactic nuclei. SMBHs can also capture and tidally disrupt stars orbiting nearby, resulting in bright flares from otherwise quiescent black holes. Here, we report on a similar to 200-second x-ray quasi-periodicity around a previously dormant SMBH located in the center of a galaxy at redshift z = 0.3534. This result may open the possibility of probing general relativity beyond our local universe.	[Reis, R. C.; Miller, J. M.; Reynolds, M. T.; Gueltekin, K.; Maitra, D.; King, A. L.] Univ Michigan, Dept Astron, Ann Arbor, MI 48109 USA; [Strohmayer, T. E.] NASA, Astrophys Sci Div, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA	University of Michigan System; University of Michigan; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Reis, RC (corresponding author), Univ Michigan, Dept Astron, Ann Arbor, MI 48109 USA.	rdosreis@umich.edu		Gultekin, Kayhan/0000-0002-1146-0198; reis, rubens/0000-0002-6618-2412; Miller, Jon/0000-0003-2869-7682	Michigan Society of Fellows; NASA [PF1-120087]; ESA; United States (NASA); Suzaku satellite; Japan (Japan Aerospace Exploration Agency)	Michigan Society of Fellows; NASA(National Aeronautics & Space Administration (NASA)); ESA(European Space Agency); United States (NASA)(National Aeronautics & Space Administration (NASA)); Suzaku satellite; Japan (Japan Aerospace Exploration Agency)	R.C.R. thanks the Michigan Society of Fellows and NASA for support through the Einstein Fellowship Program, grant PF1-120087. R. C. R. also thanks C. Reynolds and R. Mushotzky for comments on our early work. We all thank N. Schartel and the XMM-Newton staff for executing monitoring observations of Swift J164449.3+573451. This work is based on observations made with XMM-Newton, a European Space Agency (ESA) science mission with instruments and contributions directly funded by ESA member states and the United States (NASA), and the Suzaku satellite, a collaborative mission between the space agencies of Japan (Japan Aerospace Exploration Agency) and the USA (NASA). This work also made use of data supplied by the UK Swift Science Data Centre at the University of Leicester.	Bloom JS, 2011, SCIENCE, V333, P203, DOI 10.1126/science.1207150; Burrows DN, 2011, NATURE, V476, P421, DOI 10.1038/nature10374; Cenko SB, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/1/77; Cui W, 1998, ASTROPHYS J, V492, pL53, DOI 10.1086/311092; Falcke H, 2004, ASTRON ASTROPHYS, V414, P895, DOI 10.1051/0004-6361:20031683; Gezari S, 2008, ASTROPHYS J, V676, P944, DOI 10.1086/529008; Gezari S, 2006, ASTROPHYS J, V653, pL25, DOI 10.1086/509918; Greiner J, 2000, ASTRON ASTROPHYS, V362, pL25; Gultekin K, 2009, ASTROPHYS J, V706, P404, DOI 10.1088/0004-637X/706/1/404; HILLS JG, 1975, NATURE, V254, P295, DOI 10.1038/254295a0; Komossa S, 1999, ASTRON ASTROPHYS, V349, pL45; Levan AJ, 2011, SCIENCE, V333, P199, DOI 10.1126/science.1207143; LEWIN WHG, 1988, SPACE SCI REV, V46, P273, DOI 10.1007/BF00212242; McHardy IM, 2006, NATURE, V444, P730, DOI 10.1038/nature05389; McKinney JC, 2012, MON NOT R ASTRON SOC, V423, P3083, DOI 10.1111/j.1365-2966.2012.21074.x; Merloni A, 2003, MON NOT R ASTRON SOC, V345, P1057, DOI 10.1046/j.1365-2966.2003.07017.x; Middleton M, 2010, MON NOT R ASTRON SOC, V403, P9, DOI 10.1111/j.1365-2966.2009.15969.x; Miller JM, 2011, ASTROPHYS J LETT, V738, DOI 10.1088/2041-8205/738/1/L13; Nowak MA, 1997, ASTROPHYS J, V477, pL91, DOI 10.1086/310534; Psaltis D, 1999, ASTROPHYS J, V520, P262, DOI 10.1086/307436; REES MJ, 1988, NATURE, V333, P523, DOI 10.1038/333523a0; Schnittman JD, 2006, ASTROPHYS J, V651, P1031, DOI 10.1086/507421; Strohmayer TE, 2003, ASTROPHYS J, V586, pL61, DOI 10.1086/374732; Strohmayer TE, 2007, ASTROPHYS J, V660, P580, DOI 10.1086/512723; Strubbe LE, 2009, MON NOT R ASTRON SOC, V400, P2070, DOI 10.1111/j.1365-2966.2009.15599.x; van der Klis M., 2006, COMPACT STELLAR XRAY, P39; van Velzen S, 2011, ASTROPHYS J, V741, DOI 10.1088/0004-637X/741/2/73; VANDERKLIS M, 1989, NATO ADV SCI I C-MAT, V262, P27; Zauderer BA, 2011, NATURE, V476, P425, DOI 10.1038/nature10366	34	68	68	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2012	337	6097					949	951		10.1126/science.1223940	http://dx.doi.org/10.1126/science.1223940			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992VI	22859817	Green Submitted			2022-12-28	WOS:000307807600040
J	Fernandez, IE; Eickelberg, O				Fernandez, Isis E.; Eickelberg, Oliver			New cellular and molecular mechanisms of lung injury and fibrosis in idiopathic pulmonary fibrosis	LANCET			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; COLLAGEN-PRODUCING CELLS; PROSTAGLANDIN E-2; GASTROESOPHAGEAL-REFLUX; INTERSTITIAL PNEUMONIA; FIBROBLASTIC FOCI; SONIC HEDGEHOG; STEM-CELLS; ACTIVATION; RECEPTOR	Idiopathic pulmonary fibrosis is a serious and progressive chronic lung disease that is characterised by altered cellular composition and homoeostasis in the peripheral lung, leading to excessive accumulation of extracellular matrix and, ultimately, loss of lung function. It is the interstitial pneumonia with the worst prognosis-mortality 3-5 years after diagnosis is 50%. During the past decade, researchers have described several novel cellular and molecular mechanisms and signalling pathways implicated in the pathogenesis of idiopathic pulmonary fibrosis, resulting in the identification of new therapeutic targets. These advances will hopefully result in increased survival rates and improved quality of life for patients with this disorder in future.	[Eickelberg, Oliver] Univ Munich, Univ Hosp, Comprehens Pneumol Ctr, D-81377 Munich, Germany; [Fernandez, Isis E.; Eickelberg, Oliver] Helmholtz Ctr Munich, German Ctr Lung Res, D-81377 Munich, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Eickelberg, O (corresponding author), Univ Munich, Univ Hosp, Comprehens Pneumol Ctr, D-81377 Munich, Germany.	oliver.eickelberg@helmholtz-muenchen.de	Eickelberg, Oliver/A-5461-2013	Eickelberg, Oliver/0000-0001-7170-0360	Roche; Bayer; InterMune; Helmholtz Association	Roche(Roche Holding); Bayer(Bayer AG); InterMune; Helmholtz Association(Helmholtz Association)	Both authors have sponsored grants for fibrosis research from Roche. OE has received speaker's fees from Roche, Bayer, and InterMune.; We thank the Helmholtz Association for funding.	Amara N, 2010, THORAX, V65, P733, DOI 10.1136/thx.2009.113456; American Thoracic Society, 2002, Am J Respir Crit Care Med, V165, P277; Aoyagi-Ikeda K, 2011, AM J RESP CELL MOL, V45, P136, DOI 10.1165/rcmb.2010-0140OC; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Barry-Hamilton V, 2010, NAT MED, V16, P1009, DOI 10.1038/nm.2208; Bondi CD, 2010, J AM SOC NEPHROL, V21, P93, DOI 10.1681/ASN.2009020146; Bozyk PD, 2011, AM J RESP CELL MOL, V45, P445, DOI 10.1165/rcmb.2011-0025RT; Chapman HA, 2011, J CLIN INVEST, V121, P2855, DOI 10.1172/JCI57673; Chen ZH, 2010, P NATL ACAD SCI USA, V107, P18880, DOI 10.1073/pnas.1005574107; Chen ZH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003316; Cool CD, 2006, AM J RESP CRIT CARE, V174, P654, DOI 10.1164/rccm.200602-205OC; Coward William R, 2010, Ther Adv Respir Dis, V4, P367, DOI 10.1177/1753465810379801; Crosby LM, 2010, AM J PHYSIOL-LUNG C, V298, pL715, DOI 10.1152/ajplung.00361.2009; Dackor RT, 2011, AM J PHYSIOL-LUNG C, V301, pL645, DOI 10.1152/ajplung.00176.2011; Ding H, 2012, J AM SOC NEPHROL, V23, P801, DOI 10.1681/ASN.2011060614; Ebrahimkhani MR, 2011, NAT MED, V17, P1668, DOI 10.1038/nm.2490; Eickelberg O, 2010, AM J RESP CRIT CARE, V181, P883, DOI 10.1164/rccm.201001-0124UP; Enomoto N, 2006, CHEST, V130, P22, DOI 10.1378/chest.130.1.22; Fabian SL, 2012, AM J PATHOL, V180, P1441, DOI 10.1016/j.ajpath.2011.12.039; Fabre A, 2008, EUR RESPIR J, V32, P426, DOI 10.1183/09031936.00126907; Faner R, 2012, AM J RESP CRIT CARE, V186, P306, DOI 10.1164/rccm.201202-0282PP; Fang XJ, 2000, BIOCHEM J, V352, P135, DOI 10.1042/0264-6021:3520135; Fitch PM, 2011, INT J EXP PATHOL, V92, P8, DOI 10.1111/j.1365-2613.2010.00743.x; Flaherty KR, 2003, AM J RESP CRIT CARE, V167, P1410, DOI 10.1164/rccm.200204-373OC; Funke M, 2012, AM J RESP CELL MOL, V46, P355, DOI 10.1165/rcmb.2010-0155OC; Gardner A, 2012, AM J PATHOL, V180, P2293, DOI 10.1016/j.ajpath.2012.02.022; Ghosh M, 2011, AM J RESP CELL MOL, V45, P459, DOI 10.1165/rcmb.2010-0314OC; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Haspel JA, 2011, AM J RESP CRIT CARE, V184, P1237, DOI 10.1164/rccm.201106-0966CI; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Hinz Boris, 2009, Curr Rheumatol Rep, V11, P120; Huang XW, 2012, AM J RESP CELL MOL, V47, P340, DOI 10.1165/rcmb.2012-0050OC; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Jayachandran A, 2009, THORAX, V64, P1053, DOI 10.1136/thx.2009.121798; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Jiang X, 2010, FEBS J, V277, P2015, DOI 10.1111/j.1742-4658.2010.07632.x; Jin Y, 2012, AUTOPHAGY, V8, P426, DOI 10.4161/auto.19258; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Konigshoff M, 2011, EMBO MOL MED, V3, P575, DOI 10.1002/emmm.201100166; Konigshoff M, 2010, THORAX, V65, P949, DOI 10.1136/thx.2009.134353; Konigshoff M, 2010, AM J RESP CELL MOL, V42, P21, DOI 10.1165/rcmb.2008-0485TR; Konigshoff M, 2009, J CLIN INVEST, V119, P772, DOI 10.1172/JCI33950; Lasithiotaki I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027800; Latronico MVG, 2009, NAT REV CARDIOL, V6, P418, DOI 10.1038/nrcardio.2009.56; Lee JS, 2011, AM J RESP CRIT CARE, V184, P1390, DOI 10.1164/rccm.201101-0138OC; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Li YJ, 2011, J EXP MED, V208, P1459, DOI 10.1084/jem.20102510; Lin SL, 2008, AM J PATHOL, V173, P1617, DOI 10.2353/ajpath.2008.080433; Liu QH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032009; Liu TJ, 2009, AM J PATHOL, V174, P1745, DOI 10.2353/ajpath.2009.080618; Liu TJ, 2004, AM J PATHOL, V164, P1315, DOI 10.1016/S0002-9440(10)63218-X; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Lorenzen JM, 2011, NAT REV NEPHROL, V7, P286, DOI 10.1038/nrneph.2011.26; Maher TM, 2010, AM J RESP CRIT CARE, V182, P73, DOI 10.1164/rccm.200905-0674OC; Martin Thomas R, 2005, Proc Am Thorac Soc, V2, P214, DOI 10.1513/pats.200504-031AC; Milara J, 2012, THORAX, V67, P147, DOI 10.1136/thoraxjnl-2011-200026; Misumi Shigeki, 2006, Proc Am Thorac Soc, V3, P307, DOI 10.1513/pats.200602-018TK; Moeller A, 2008, INT J BIOCHEM CELL B, V40, P362, DOI 10.1016/j.biocel.2007.08.011; Moore BB, 2008, AM J PHYSIOL-LUNG C, V294, pL152, DOI 10.1152/ajplung.00313.2007; Mubarak KK, 2012, EUR RESPIR J, V39, P133, DOI 10.1183/09031936.00141010; Nasreen N, 2009, AM J PHYSIOL-LUNG C, V297, pL115, DOI 10.1152/ajplung.90587.2008; Oh CK, 2012, PULM MED, V2012, DOI 10.1155/2012/808260; Olsen KC, 2011, AM J RESP CRIT CARE, V184, P699, DOI 10.1164/rccm.201101-0013OC; Pandit KV, 2010, AM J RESP CRIT CARE, V182, P220, DOI 10.1164/rccm.200911-1698OC; Patel AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041394; Patel P, 2010, MATRIX BIOL, V29, P97, DOI 10.1016/j.matbio.2009.10.004; Pozharskaya V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007559; Que JW, 2008, P NATL ACAD SCI USA, V105, P16626, DOI 10.1073/pnas.0808649105; Raghu G, 2006, EUR RESPIR J, V27, P136, DOI 10.1183/09031936.06.00037005; Raghu G, 2012, NEW ENGL J MED, V366, P1968, DOI 10.1056/NEJMoa1113354; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Rajkumar VS, 2006, AM J PATHOL, V169, P2254, DOI 10.2353/ajpath.2006.060196; Rock JR, 2011, P NATL ACAD SCI USA, V108, pE1475, DOI 10.1073/pnas.1117988108; Rock JR, 2011, CELL STEM CELL, V8, P639, DOI 10.1016/j.stem.2011.04.003; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Rodriguez HM, 2010, J BIOL CHEM, V285, P20964, DOI 10.1074/jbc.M109.094136; Ryter SW, 2012, ANNU REV PHYSIOL, V74, P377, DOI 10.1146/annurev-physiol-020911-153348; Selman M, 2008, PLOS MED, V5, P373, DOI 10.1371/journal.pmed.0050062; Strieter RM, 2009, CHEST, V136, P1364, DOI 10.1378/chest.09-0510; Sundberg C, 1996, LAB INVEST, V74, P452; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Tanjore H, 2009, AM J RESP CRIT CARE, V180, P657, DOI 10.1164/rccm.200903-0322OC; Taskar Varsha S, 2006, Proc Am Thorac Soc, V3, P293, DOI 10.1513/pats.200512-131TK; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Venkatesan N, 2011, AM J PHYSIOL-LUNG C, V300, pL191, DOI 10.1152/ajplung.00214.2010; Visscher Daniel W, 2006, Proc Am Thorac Soc, V3, P322, DOI 10.1513/pats.200602-019TK; Walker NM, 2012, AM J RESP CRIT CARE, V185, P77, DOI 10.1164/rccm.201105-0834OC; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Yang HZ, 2012, AM J PATHOL, V180, P275, DOI 10.1016/j.ajpath.2011.09.019; Yang SZ, 2012, AM J PATHOL, V180, P484, DOI 10.1016/j.ajpath.2011.10.005; Zhang Y, 2008, NAT GENET, V40, P862, DOI 10.1038/ng.157	95	293	310	17	115	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 18	2012	380	9842					680	688		10.1016/S0140-6736(12)61144-1	http://dx.doi.org/10.1016/S0140-6736(12)61144-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	991SE	22901889				2022-12-28	WOS:000307721000033
J	Kruidenier, L; Chung, CW; Cheng, ZJ; Liddle, J; Che, KH; Joberty, G; Bantscheff, M; Bountra, C; Bridges, A; Diallo, H; Eberhard, D; Hutchinson, S; Jones, E; Katso, R; Leveridge, M; Mander, PK; Mosley, J; Ramirez-Molina, C; Rowland, P; Schofield, CJ; Sheppard, RJ; Smith, JE; Swales, C; Tanner, R; Thomas, P; Tumber, A; Drewes, G; Oppermann, U; Patel, DJ; Lee, K; Wilson, DM				Kruidenier, Laurens; Chung, Chun-wa; Cheng, Zhongjun; Liddle, John; Che, KaHing; Joberty, Gerard; Bantscheff, Marcus; Bountra, Chas; Bridges, Angela; Diallo, Hawa; Eberhard, Dirk; Hutchinson, Sue; Jones, Emma; Katso, Roy; Leveridge, Melanie; Mander, Palwinder K.; Mosley, Julie; Ramirez-Molina, Cesar; Rowland, Paul; Schofield, Christopher J.; Sheppard, Robert J.; Smith, Julia E.; Swales, Catherine; Tanner, Robert; Thomas, Pamela; Tumber, Anthony; Drewes, Gerard; Oppermann, Udo; Patel, Dinshaw J.; Lee, Kevin; Wilson, David M.			A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response	NATURE			English	Article							HISTONE LYSINE DEMETHYLASES; SUBSTRATE-SPECIFICITY; STRUCTURAL INSIGHTS; GENE-EXPRESSION; JMJD3; METHYLATION; DISEASE; FAMILY; UTX	The jumonji (JMJ) family of histone demethylases are Fe2+ - and a-ketoglutarate-dependent oxygenases that are essential components of regulatory transcriptional chromatin complexes(1-4). These enzymes demethylate lysine residues in histones in a methylation-state and sequence-specific context(5). Considerable effort has been devoted to gaining a mechanistic understanding of the roles of histone lysine demethylases in eukaryotic transcription, genome integrity and epigenetic inheritance(2,4,6), as well as in development, physiology and disease(3,7). However, because of the absence of any selective inhibitors, the relevance of the demethylase activity of JMJ enzymes in regulating cellular responses remains poorly understood. Here we present a structure-guided small-molecule and chemoproteomics approach to elucidating the functional role of the H3K27me3-specific demethylase subfamily (KDM6 subfamily members JMJD3 and UTX)(8). The liganded structures of human and mouse JMJD3 provide novel insight into the specificity determinants for cofactor, substrate and inhibitor recognition by the KDM6 subfamily of demethylases. We exploited these structural features to generate the first small-molecule catalytic site inhibitor that is selective for the H3K27me3-specific JMJ subfamily. We demonstrate that this inhibitor binds in a novel manner and reduces lipopolysaccharide-induced proinflammatory cytokine production by human primary macrophages, a process that depends on both JMJD3 and UTX. Our results resolve the ambiguity associated with the catalytic function of H3K27-specific JMJs in regulating disease-relevant inflammatory responses and provide encouragement for designing small-molecule inhibitors to allow selective pharmacological intervention across the JMJ family.	[Kruidenier, Laurens; Liddle, John; Diallo, Hawa; Mander, Palwinder K.; Ramirez-Molina, Cesar; Sheppard, Robert J.; Smith, Julia E.; Lee, Kevin; Wilson, David M.] GlaxoSmithKline R&D, Med Res Ctr, Immunoinflammat Therapy Area, Epinova DPU, Stevenage SG1 2NY, Herts, England; [Chung, Chun-wa; Bridges, Angela; Hutchinson, Sue; Jones, Emma; Katso, Roy; Leveridge, Melanie; Mosley, Julie; Rowland, Paul; Tanner, Robert; Thomas, Pamela] GlaxoSmithKline R&D, Med Res Ctr, Platform Technol & Sci, Stevenage SG1 2NY, Herts, England; [Cheng, Zhongjun; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Che, KaHing; Bountra, Chas; Schofield, Christopher J.; Tumber, Anthony; Oppermann, Udo] Univ Oxford, Struct Genom Consortium, Headington OX3 7DQ, England; [Che, KaHing; Swales, Catherine; Oppermann, Udo] Univ Oxford, NIHR Biomed Res Unit, Botnar Res Ctr, Oxford OX3 7LD, England; [Joberty, Gerard; Bantscheff, Marcus; Eberhard, Dirk; Drewes, Gerard] Cellzome AG, D-69117 Heidelberg, Germany	GlaxoSmithKline; GlaxoSmithKline; Memorial Sloan Kettering Cancer Center; University of Oxford; University of Oxford; GlaxoSmithKline; Cellzome GmbH	Wilson, DM (corresponding author), GlaxoSmithKline R&D, Med Res Ctr, Immunoinflammat Therapy Area, Epinova DPU, Gunnels Wood Rd, Stevenage SG1 2NY, Herts, England.	david.m.wilson@gsk.com	Bantscheff, Marcus/AAQ-2903-2021	Bantscheff, Marcus/0000-0002-8343-8977; Drewes, Gerard/0000-0003-0575-6766; Sheppard, Robert/0000-0002-5876-5589; Schofield, Christopher/0000-0002-0290-6565	Starr Foundation; Abby Rockefeller Mauze Trust; Maloris Foundation; Canadian Institutes for Health Research; Canada Foundation for Innovation; Genome Canada; GlaxoSmithKline; Lilly Canada; Novartis Research Foundation; Pfizer; Takeda; Ontario Ministry of Economic Development and Innovation; Wellcome Trust; National Institute for Health and Research (NIHR) Biomedical Research Unit, Oxford; Versus Arthritis [18358] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Starr Foundation; Abby Rockefeller Mauze Trust; Maloris Foundation; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Genome Canada(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Lilly Canada(Eli Lilly); Novartis Research Foundation; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); Ontario Ministry of Economic Development and Innovation; Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health and Research (NIHR) Biomedical Research Unit, Oxford(National Institute for Health Research (NIHR)); Versus Arthritis(Versus Arthritis); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the following colleagues for their help and advice in preparing the manuscript: A. Argyrou, S. Atkinson, M. Barker, M. Campbell, L. Gordon, R. Gregory, R. Grimley, P. Humphreys, P. Jeffrey, A. Kucik, B. Leavens, C. Lewis, V. Ludbrook, R. Prinjha, S. Ratcliffe, C. Sharp, D. Thomas, D. Tough and M. Woodrow. Help was also provided by N. Burgess-Brown, S. Ng, J. Dunford, A. Kawamura, N. Rose and M. Daniel. D. J. P. was supported by funds from the Starr Foundation, the Abby Rockefeller Mauze Trust and the Maloris Foundation. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canada Foundation for Innovation, Genome Canada, GlaxoSmithKline, Lilly Canada, the Novartis Research Foundation, Pfizer, Takeda, the Ontario Ministry of Economic Development and Innovation, and the Wellcome Trust. This study was supported by the National Institute for Health and Research (NIHR) Biomedical Research Unit, Oxford. Thanks also to M. Boesche and the Cellzome biochemistry and mass spectrometry teams for assistance with the chemoproteomics experiments. Finally, we acknowledge additional contributions from members of Platform Technology Sciences and the Epinova DPU and the JMJD3 programme team for supporting this research.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Bantscheff M, 2011, NAT BIOTECHNOL, V29, P255, DOI 10.1038/nbt.1759; Couture JF, 2007, NAT STRUCT MOL BIOL, V14, P689, DOI 10.1038/nsmb1273; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; De Santa F, 2009, EMBO J, V28, P3341, DOI 10.1038/emboj.2009.271; Gamo FJ, 2010, NATURE, V465, P305, DOI 10.1038/nature09107; Gehani SS, 2010, MOL CELL, V39, P886, DOI 10.1016/j.molcel.2010.08.020; Horton JR, 2010, NAT STRUCT MOL BIOL, V17, P38, DOI 10.1038/nsmb.1753; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Loenarz C, 2011, TRENDS BIOCHEM SCI, V36, P7, DOI 10.1016/j.tibs.2010.07.002; Mackeen MM, 2010, J PROTEOME RES, V9, P4082, DOI 10.1021/pr100269b; Miller SA, 2010, MOL CELL, V40, P594, DOI 10.1016/j.molcel.2010.10.028; Mosammaparast N, 2010, ANNU REV BIOCHEM, V79, P155, DOI 10.1146/annurev.biochem.78.070907.103946; Ng SS, 2007, NATURE, V448, P87, DOI 10.1038/nature05971; Pedersen MT, 2010, TRENDS CELL BIOL, V20, P662, DOI 10.1016/j.tcb.2010.08.011; Sakurai M, 2010, MOL BIOSYST, V6, P357, DOI 10.1039/b912993f; Sengoku T, 2011, GENE DEV, V25, P2266, DOI 10.1101/gad.172296.111; Shi Y, 2007, NAT REV GENET, V8, P829, DOI 10.1038/nrg2218; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Trojer P, 2006, CELL, V125, P213, DOI 10.1016/j.cell.2006.04.003; Yang Y, 2010, CELL RES, V20, P886, DOI 10.1038/cr.2010.86; Yu M, 2006, BIOCHEMISTRY-US, V45, P14788, DOI 10.1021/bi061621t	25	631	653	4	109	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2012	488	7411					404	408		10.1038/nature11262	http://dx.doi.org/10.1038/nature11262			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OS	22842901	Green Accepted			2022-12-28	WOS:000307501000047
J	Lee, SH; Kwan, AC; Zhang, SY; Phoumthipphavong, V; Flannery, JG; Masmanidis, SC; Taniguchi, H; Huang, ZJ; Zhang, F; Boyden, ES; Deisseroth, K; Dan, Y				Lee, Seung-Hee; Kwan, Alex C.; Zhang, Siyu; Phoumthipphavong, Victoria; Flannery, John G.; Masmanidis, Sotiris C.; Taniguchi, Hiroki; Huang, Z. Josh; Zhang, Feng; Boyden, Edward S.; Deisseroth, Karl; Dan, Yang			Activation of specific interneurons improves V1 feature selectivity and visual perception	NATURE			English	Article							ORIENTATION SELECTIVITY; CORTICAL-NEURONS; ELECTRODE ARRAYS; CORTEX; INHIBITION; RESPONSES; INNERVATION; POPULATIONS; PERFORMANCE; MODULATION	Inhibitory interneurons are essential components of the neural circuits underlying various brain functions. In the neocortex, a large diversity of GABA (gamma-aminobutyric acid) interneurons has been identified on the basis of their morphology, molecular markers, biophysical properties and innervation pattern(1-3). However, how the activity of each subtype of interneurons contributes to sensory processing remains unclear. Here we show that optogenetic activation of parvalbumin-positive (PV+) interneurons in the mouse primary visual cortex (V1) sharpens neuronal feature selectivity and improves perceptual discrimination. Using multichannel recording with silicon probes(4,5) and channelrhodopsin-2 (ChR2)-mediated optical activation(6), we found that increased spiking of PV+ interneurons markedly sharpened orientation tuning and enhanced direction selectivity of nearby neurons. These effects were caused by the activation of inhibitory neurons rather than a decreased spiking of excitatory neurons, as archaerhodopsin-3 (Arch)-mediated optical silencing(7) of calcium/calmodulindependent protein kinase II alpha (CAMKII alpha)-positive excitatory neurons caused no significant change in V1 stimulus selectivity. Moreover, the improved selectivity specifically required PV+ neuron activation, as activating somatostatin or vasointestinal peptide interneurons had no significant effect. Notably, PV+ neuron activation in awake mice caused a significant improvement in their orientation discrimination, mirroring the sharpened V1 orientation tuning. Together, these results provide the first demonstration that visual coding and perception can be improved by increased spiking of a specific subtype of cortical inhibitory interneurons.	[Lee, Seung-Hee; Kwan, Alex C.; Zhang, Siyu; Phoumthipphavong, Victoria; Flannery, John G.; Dan, Yang] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Lee, Seung-Hee; Dan, Yang] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Masmanidis, Sotiris C.] CALTECH, Kavli Nanosci Inst, Broad Fellows Program Brain Circuitry, Pasadena, CA 91125 USA; [Taniguchi, Hiroki; Huang, Z. Josh] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Zhang, Feng; Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Dept Bioengn, Stanford, CA 94305 USA; [Boyden, Edward S.] MIT, Media Lab, Cambridge, MA 02139 USA; [Boyden, Edward S.] MIT, McGovern Inst, Cambridge, MA 02139 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; California Institute of Technology; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Stanford University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Dan, Y (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	ydan@berkeley.edu	Lee, Seung-Hee/J-5971-2013; Macrae, Rhiannon/AAX-1536-2020	Flannery, John/0000-0002-0720-8897; Dan, Yang/0000-0002-3818-877X; Huang, Z. Josh/0000-0003-0592-028X; Kwan, Alex/0000-0003-2169-1667; Zhang, Siyu/0000-0003-1745-2532; Zhang, Siyu/0000-0001-7298-1475	National Institutes of Health [R01 EY018861, PN2 EY018241]; National Science Foundation [22250400-42533]; NATIONAL EYE INSTITUTE [PN2EY018241, R01EY018861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067199] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Goard, L. Pinto, M. Xu and M. Viesel for help with experimental setup, A. Kaluszka for help with data analysis and H. Alitto and M. Poo for discussion and comments on the manuscript. This work was supported by National Institutes of Health grants R01 EY018861 and PN2 EY018241 and National Science Foundation grant 22250400-42533.	Andermann ML, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00003; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Ayaz A, 2009, J NEUROPHYSIOL, V101, P958, DOI 10.1152/jn.90547.2008; Blanche TJ, 2005, J NEUROPHYSIOL, V93, P2987, DOI 10.1152/jn.01023.2004; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Chen Y, 2008, NAT NEUROSCI, V11, P974, DOI 10.1038/nn.2147; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; David C, 2007, EUR J NEUROSCI, V25, P2329, DOI 10.1111/j.1460-9568.2007.05496.x; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Di Cristo G, 2004, NAT NEUROSCI, V7, P1184, DOI 10.1038/nn1334; Du JG, 2009, J NEUROPHYSIOL, V101, P1671, DOI 10.1152/jn.90992.2008; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; Green DM, 1966, SIGNAL DETECTION THE; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Hazan L, 2006, J NEUROSCI METH, V155, P207, DOI 10.1016/j.jneumeth.2006.01.017; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Kang KJ, 2004, J NEUROSCI, V24, P3726, DOI 10.1523/JNEUROSCI.4272-03.2004; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Ma WP, 2010, J NEUROSCI, V30, P14371, DOI 10.1523/JNEUROSCI.3248-10.2010; Maheshri N, 2006, NAT BIOTECHNOL, V24, P198, DOI 10.1038/nbt1182; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Mehaffey WH, 2005, J NEUROSCI, V25, P9968, DOI 10.1523/JNEUROSCI.2682-05.2005; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; NELSON S, 1994, SCIENCE, V265, P774, DOI 10.1126/science.8047882; O'Connor DH, 2010, J NEUROSCI, V30, P1947, DOI 10.1523/JNEUROSCI.3762-09.2010; Runyan CA, 2010, NEURON, V67, P847, DOI 10.1016/j.neuron.2010.08.006; Schmitzer-Torbert N, 2005, NEUROSCIENCE, V131, P1, DOI 10.1016/j.neuroscience.2004.09.066; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P287, DOI 10.1113/jphysiol.1975.sp011055; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Toledo-Rodriguez M, 2004, CEREB CORTEX, V14, P1310, DOI 10.1093/cercor/bhh092; Troyer TW, 1998, J NEUROSCI, V18, P5908; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Xu XM, 2010, J COMP NEUROL, V518, P389, DOI 10.1002/cne.22229; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226	36	386	387	7	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2012	488	7411					379	+		10.1038/nature11312	http://dx.doi.org/10.1038/nature11312			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OS	22878719	Green Accepted, Green Submitted			2022-12-28	WOS:000307501000042
J	Tsubokura, M; Gilmour, S; Takahashi, K; Oikawa, T; Kanazawa, Y				Tsubokura, Masaharu; Gilmour, Stuart; Takahashi, Kyohei; Oikawa, Tomoyoshi; Kanazawa, Yukio			Internal Radiation Exposure After the Fukushima Nuclear Power Plant Disaster	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							CHERNOBYL		[Tsubokura, Masaharu] Univ Tokyo, Inst Med Sci, Div Social Commun Syst Adv Clin Res, Tokyo, Japan; [Gilmour, Stuart] Univ Tokyo, Dept Global Hlth Policy, Tokyo, Japan; [Takahashi, Kyohei] Hara Machi Cent Obstet & Gynecol Clin, Minamisoma, Fukushima, Japan; [Oikawa, Tomoyoshi; Kanazawa, Yukio] Minamisoma Municipal Gen Hosp, Dept Internal Med, Minamisoma, Fukushima, Japan	University of Tokyo; University of Tokyo	Tsubokura, M (corresponding author), Univ Tokyo, Inst Med Sci, Div Social Commun Syst Adv Clin Res, Tokyo, Japan.	tsubokura-tky@umin.ac.jp	Ley, Sarah/Y-9216-2019; Tsubokura, Masaharu/D-7300-2017; Tsubokura, Masaharu/AAV-4364-2021	Tsubokura, Masaharu/0000-0001-8027-202X; Tsubokura, Masaharu/0000-0001-8027-202X				Brumfiel G, 2011, NATURE, V471, P273, DOI 10.1038/471273a; Hoshi M, 2000, HEALTH PHYS, V79, P182, DOI 10.1097/00004032-200008000-00011; National Council on Radiation Protection and Measurement, 2008, HDB NAT COUNC RAD PR; Ruhm W, 1999, HEALTH PHYS, V77, P373, DOI 10.1097/00004032-199910000-00004; Takatsuji T, 2000, HEALTH PHYS, V78, P86, DOI 10.1097/00004032-200001000-00014	5	98	99	1	31	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2012	308	7					669	670		10.1001/jama.2012.9839	http://dx.doi.org/10.1001/jama.2012.9839			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988NC	22893159	Bronze			2022-12-28	WOS:000307496700017
J	Tomioka, K; Yoshimura, M; Fukui, T				Tomioka, Katsuhiro; Yoshimura, Masatoshi; Fukui, Takashi			A III-V nanowire channel on silicon for high-performance vertical transistors	NATURE			English	Article							FIELD-EFFECT TRANSISTORS; GROWTH	Silicon transistors are expected to have new gate architectures, channel materials and switching mechanisms in ten years' time(1-4). The trend in transistor scaling has already led to a change in gate structure from two dimensions to three, used in fin field-effect transistors, to avoid problems inherent in miniaturization such as high off-state leakage current and the short-channel effect. At present, planar and fin architectures using III-V materials, specifically InGaAs, are being explored as alternative fast channels on silicon(5-9) because of their high electron mobility and high-quality interface with gate dielectrics(10). The idea of surrounding-gate transistors(11), in which the gate is wrapped around a nanowire channel to provide the best possible electrostatic gate control, using InGaAs channels on silicon, however, has been less well investigated(12,13) because of difficulties in integrating free-standing InGaAs nanostructures on silicon. Here we report the position-controlled growth of vertical InGaAs nanowires on silicon without any buffering technique and demonstrate surrounding-gate transistors using InGaAs nanowires and InGaAs/InP/InAlAs/InGaAs core-multishell nanowires as channels. Surrounding-gate transistors using core-multishell nanowire channels with a six-sided, high-electron-mobility transistor structure greatly enhance the on-state current and transconductance while keeping good gate controllability. These devices provide a route to making vertically oriented transistors for the next generation of field-effect transistors and may be useful as building blocks for wireless networks on silicon platforms.	[Tomioka, Katsuhiro; Yoshimura, Masatoshi; Fukui, Takashi] Hokkaido Univ, Grad Sch Informat Sci & Technol, Sapporo, Hokkaido 0608628, Japan; [Tomioka, Katsuhiro; Yoshimura, Masatoshi; Fukui, Takashi] Hokkaido Univ, RCIQE, Sapporo, Hokkaido 0608628, Japan; [Tomioka, Katsuhiro] Japan Sci & Technol Agcy PRESTO, Kawaguchi, Saitama 3320012, Japan	Hokkaido University; Hokkaido University	Tomioka, K (corresponding author), Hokkaido Univ, Grad Sch Informat Sci & Technol, Kita 13 Nishi 8, Sapporo, Hokkaido 0608628, Japan.	tomioka@rciqe.hokudai.ac.jp	Tomioka, Katsuhiro/N-9611-2015; Tomioka, Katsuhiro/A-2815-2014; Fukui, Takashi/A-5261-2012	Tomioka, Katsuhiro/0000-0003-3482-2371; Tomioka, Katsuhiro/0000-0003-3482-2371; 	MEXT; Japan Science and Technology Agency - PRESTO programme	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency - PRESTO programme	We thank J. Motohisa, S. Hara, K. Hiruma, T. Hashizume and T. Waho for discussions. We especially thank Y. Hori for instructing us on the current-voltage measurement. This work was financially supported by a Grant-in-Aid for Scientific Research from MEXT and the Japan Science and Technology Agency - PRESTO programme.	Cho MK, 2010, ICCAD-IEEE ACM INT, P694, DOI 10.1109/ICCAD.2010.5654255; del Alamo JA, 2011, NATURE, V479, P317, DOI 10.1038/nature10677; Ferain I, 2011, NATURE, V479, P310, DOI 10.1038/nature10676; Furukawa Y, 2002, JPN J APPL PHYS 1, V41, P528, DOI 10.1143/JJAP.41.528; Galindo PL, 2007, ULTRAMICROSCOPY, V107, P1186, DOI 10.1016/j.ultramic.2007.01.019; Ghalamestani SG, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/1/015302; Gu J. J., 2011, IEDM, DOI DOI 10.1109/IEDM.2011.6131662; Ionescu AM, 2011, NATURE, V479, P329, DOI 10.1038/nature10679; Ishii H, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.121101; Kim S, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.014201; MIMURA T, 1980, JPN J APPL PHYS, V19, pL225, DOI 10.1143/JJAP.19.L225; Noborisaka J, 2007, JPN J APPL PHYS 1, V46, P7562, DOI 10.1143/JJAP.46.7562; Radosavljevic M, 2010, INT EL DEVICES MEET; Radosavljevic M., 2009, IEDM, P13, DOI [DOI 10.1109/IEDM.2009.5424361, 10.1109/IEDM.2009.5424361]; Radosavljevic M., 2011, IEDM, P765; Rehnstedt C, 2008, IEEE T ELECTRON DEV, V55, P3037, DOI 10.1109/TED.2008.2005179; Seabaugh AC, 2010, P IEEE, V98, P2095, DOI 10.1109/JPROC.2010.2070470; TAKAGI S, 1994, IEEE T ELECTRON DEV, V41, P2357, DOI 10.1109/16.337449; TAKATO H, 1991, IEEE T ELECTRON DEV, V38, P573, DOI 10.1109/16.75168; TAN IH, 1990, J APPL PHYS, V68, P4071, DOI 10.1063/1.346245; Tanaka T, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.025003; Tomioka K., 2011, IEDM, P773; Tomioka K, 2008, NANO LETT, V8, P3475, DOI 10.1021/nl802398j; Tomioka K, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/14/145302; Wernersson LE, 2010, P IEEE, V98, P2047, DOI 10.1109/JPROC.2010.2065211; Wieder HH, 2003, J VAC SCI TECHNOL B, V21, P1915, DOI 10.1116/1.1588646; Wu YQ, 2009, IEEE ELECTR DEVICE L, V30, P700, DOI 10.1109/LED.2009.2022346; Xuan Y, 2007, IEEE ELECTR DEVICE L, V28, P935, DOI 10.1109/LED.2007.906436	28	580	599	19	435	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 9	2012	488	7410					189	+		10.1038/nature11293	http://dx.doi.org/10.1038/nature11293			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985LE	22854778				2022-12-28	WOS:000307267000028
J	Mantha, S; Karp, R; Raghavan, V; Terrin, N; Bauer, KA; Zwicker, JI				Mantha, S.; Karp, R.; Raghavan, V.; Terrin, N.; Bauer, K. A.; Zwicker, J. I.			Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							3RD-GENERATION ORAL-CONTRACEPTIVES; DEPOT-MEDROXYPROGESTERONE ACETATE; TISSUE FACTOR; PROTEIN-C; THROMBOSIS; LEVONORGESTREL; EXPRESSION	Objectives To evaluate the risk of venous thromboembolic events associated with the use of progestin-only contraception and whether that risk differs with the mode of drug delivery (oral, intrauterine, or depot injection). Design Systematic review and meta-analysis of randomised controlled trials and observational studies. Data sources Pubmed, Embase, Cochrane Library, and reference lists of relevant reviews. Study selection Randomised controlled trials and case-control, cohort, and cross sectional studies with venous thromboembolic outcome for progestin-only contraception reported relative to a non-hormone comparator group. Data extraction Data were extracted by two independent investigators, and consensus for inclusion was reached after assessment by additional investigators. Results Among the 2022 unique references identified by all searches, eight observational studies fulfilled inclusion criteria. A total of 147 women across all studies were diagnosed with a venous thromboembolic event while taking progestin-only contraception, and the summary measure for the adjusted relative risk of a venous thromboembolic episode for users versus non-users of a progestin-only contraceptive was, based on the random effects model, 1.03 (95% CI 0.76 to 1.39). Subgroup analysis confirmed there was no association between venous thromboembolic risk and progestin-only pills (relative risk 0.90 (0.57 to 1.45)) or a progestin intrauterine device (0.61 (0.24 to 1.53)). The relative risk of a venous thromboembolic event for users of an injectable progestin versus non-users was 2.67 (1.29 to 5.53). Conclusions Published data assessing the risk of venous thromboembolism in women prescribed progestin-only contraception are limited. In this meta-analysis of eight observational studies, the use of progestin-only contraception was not associated with an increased risk of venous thromboembolism compared with non-users of hormonal contraception. The potential association between injectable progestins and thrombosis requires further study.	[Karp, R.; Bauer, K. A.; Zwicker, J. I.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Thrombosis & Hemostasis, Boston, MA 02215 USA; [Karp, R.; Bauer, K. A.; Zwicker, J. I.] Harvard Univ, Div Hematol Oncol, Boston, MA 02215 USA; [Mantha, S.] Lahey Clin Fdn, Div Hematol Oncol, Burlington, MA USA; [Raghavan, V.] Harvard Univ, Sch Med, Mt Auburn Hosp, Cambridge, MA 02138 USA; [Terrin, N.] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA USA; [Bauer, K. A.] Harvard Univ, VA Boston Healthcare Syst, Sch Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Lahey Hospital & Medical Center; Harvard University; Mount Auburn Hospital; Tufts Medical Center; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Boston Healthcare System	Zwicker, JI (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Thrombosis & Hemostasis, 330 Brookline Ave, Boston, MA 02215 USA.	jzwicker@bidmc.harvard.edu		Zwicker, Jeffrey/0000-0001-5810-6893	National Center for Research Resources; National Center for Advancing Translational Sciences, National Institutes of Health [UL1 RR025752]; US National Institute of Health; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025752] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was funded by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health (grant No UL1 RR025752). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: support from US National Institute of Health for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.	Barsoum MK, 2010, THROMB RES, V126, P373, DOI 10.1016/j.thromres.2010.08.010; Bergendal A, 2009, ACTA OBSTET GYN SCAN, V88, P261, DOI 10.1080/00016340902730375; Bogdanov VY, 2003, NAT MED, V9, P458, DOI 10.1038/nm841; Conard J, 2004, CONTRACEPTION, V70, P437, DOI 10.1016/j.contraception.2004.07.009; d'Arcangues C, 1999, CONTRACEPTION, V59, P31; Department of Reproductive Health World Health Organization, 2009, MED EL CRIT CONTR US; Freudenberger T, 2009, BRIT J PHARMACOL, V158, P1951, DOI 10.1111/j.1476-5381.2009.00470.x; GERSTMAN BB, 1991, AM J EPIDEMIOL, V133, P32, DOI 10.1093/oxfordjournals.aje.a115799; Heinemann L A, 1999, Eur J Contracept Reprod Health Care, V4, P67, DOI 10.3109/13625189909064007; Helmerhorst FM, 1997, THROMB HAEMOSTASIS, V78, P327; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; JICK H, 1995, LANCET, V346, P1589, DOI 10.1016/S0140-6736(95)91928-7; Kato S, 2005, J CLIN ENDOCR METAB, V90, P1181, DOI 10.1210/jc.2004-0857; Kemmeren JM, 2001, BRIT MED J, V323, P131, DOI 10.1136/bmj.323.7305.131; Kemmeren JM, 2004, BLOOD, V103, P927, DOI 10.1182/blood-2003-04-1285; Lidegaard O, 2009, BMJ-BRIT MED J, V339, P1; Lidegaard O, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6423; Lockwood CJ, 2009, J CLIN ENDOCR METAB, V94, P2164, DOI 10.1210/jc.2009-0065; Meirik O, 2001, OBSTET GYNECOL, V97, P539, DOI 10.1016/S0029-7844(00)01220-5; Nanda K, 2008, FERTIL STERIL, V90, P965, DOI 10.1016/j.fertnstert.2007.07.1348; NILSSON CG, 1986, FERTIL STERIL, V45, P805; Pagano M., 2000, PRINCIPLES BIOSTATIS, V2nd edition; POULTER NR, 1995, LANCET, V346, P1575; Rosing J, 1999, LANCET, V354, P2036, DOI 10.1016/S0140-6736(99)06092-4; Rott H, 2012, HAMOSTASEOLOGIE, V32, P15, DOI 10.5482/ha-1177; Shirk RA, 2005, J STEROID BIOCHEM, V94, P361, DOI 10.1016/j.jsbmb.2004.12.026; STANCZYK FZ, 1983, CONTRACEPTION, V28, P241, DOI 10.1016/0010-7824(83)90065-3; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tchaikovski SN, 2007, THROMB HAEMOSTASIS, V98, P1350, DOI 10.1160/TH07-07-0439; Vaillant-Roussel Helene, 2011, Contraception, V84, pe23, DOI 10.1016/j.contraception.2011.06.008; Van Vliet HAAM, 2008, J THROMB HAEMOST, V6, P346, DOI 10.1111/j.1538-7836.2007.02863.x; Vasilakis C, 1999, LANCET, V354, P1610, DOI 10.1016/S0140-6736(99)04394-9; Verani Jennifer R., 2010, Morbidity and Mortality Weekly Report, V59, P1; VESSEY M, 1986, BRIT MED J, V292, P526, DOI 10.1136/bmj.292.6519.526; Vlieg AV, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2921; Vlieg AVH, 2010, ARTERIOSCL THROM VAS, V30, P2297, DOI 10.1161/ATVBAHA.110.211482	37	117	123	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 7	2012	345								e4944	10.1136/bmj.e4944	http://dx.doi.org/10.1136/bmj.e4944			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988NA	22872710	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000307496500002
J	Moyer, VA				Moyer, Virginia A.		US Preventive Serv Task Force	Prevention of Falls in Community-Dwelling Older Adults: US Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; VITAMIN-D SUPPLEMENTATION; MULTIFACTORIAL INTERVENTION; FUNCTIONAL MOBILITY; PEOPLE; RISK; CALCIUM; WOMEN; POPULATION; REDUCE	Description: Update of the 1996 U. S. Preventive Services Task Force (USPSTF) recommendation statement on counseling to prevent household and recreational injuries, including falls. Methods: The USPSTF reviewed new evidence on the effectiveness and harms of primary care-relevant interventions to prevent falls in community-dwelling older adults. The interventions were grouped into 5 main categories: multifactorial clinical assessment (with or without direct intervention), clinical management (with or without screening), clinical education or behavioral counseling, home hazard modification, and exercise or physical therapy. Recommendations: The USPSTF recommends exercise or physical therapy and vitamin D supplementation to prevent falls in community-dwelling adults aged 65 years or older who are at increased risk for falls. (Grade B recommendation) The USPSTF does not recommend automatically performing an in-depth multifactorial risk assessment in conjunction with comprehensive management of identified risks to prevent falls in community-dwelling adults aged 65 years or older because the likelihood of benefit is small. In determining whether this service is appropriate in individual cases, patients and clinicians should consider the balance of benefits and harms on the basis of the circumstances of prior falls, comorbid medical conditions, and patient values. (Grade C recommendation)	[Moyer, Virginia A.; US Preventive Serv Task Force] US Prevent Serv Task Force, Rockville, MD USA		Moyer, VA (corresponding author), US Prevent Serv Task Force, Rockville, MD USA.				U.S. Congress mandates that the Agency for Healthcare Research and Quality	U.S. Congress mandates that the Agency for Healthcare Research and Quality	The USPSTF is an independent, voluntary body. The U.S. Congress mandates that the Agency for Healthcare Research and Quality support the operations of the USPSTF.	American Geriatrics Society British Geriatrics Society, 2010, 2010 AGS BGS CLIN PR; Birks YF, 2004, OSTEOPOROSIS INT, V15, P701, DOI 10.1007/s00198-004-1599-0; Bischoff-Ferrari HA, 2006, ARCH INTERN MED, V166, P424; Bohannon Richard W, 2006, J Geriatr Phys Ther, V29, P64; Close J, 1999, LANCET, V353, P93, DOI 10.1016/S0140-6736(98)06119-4; Cumming RG, 2007, J AM GERIATR SOC, V55, P175, DOI 10.1111/j.1532-5415.2007.01046.x; Davison J, 2005, AGE AGEING, V34, P162, DOI 10.1093/ageing/afi053; Dhesi JK, 2004, AGE AGEING, V33, P589, DOI 10.1093/ageing/afh209; Dukas L, 2004, J AM GERIATR SOC, V52, P230, DOI 10.1111/j.1532-5415.2004.52060.x; [Food and Nutrition Board Institute of Medicine Standing Committee on the Scientific Evaluation of Dietary Reference Intakes], 1997, DIET REF INT CALC PH, DOI 10.17226/5776; Ganz DA, 2007, JAMA-J AM MED ASSOC, V297, P77, DOI 10.1001/jama.297.1.77; Gillespie Lesley D, 2012, Cochrane Database Syst Rev, pCD007146, DOI 10.1002/14651858.CD007146.pub3; Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218; Logan PA, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2102; Lord SR, 2005, J AM GERIATR SOC, V53, P1296, DOI 10.1111/j.1532-5415.2005.53425.x; MATHIAS S, 1986, ARCH PHYS MED REHAB, V67, P387; Michael Y., 2010, AHRQ PUBLICATION; Michael YL, 2010, ANN INTERN MED, V153, P815, DOI 10.7326/0003-4819-153-12-201012210-00008; National Institute on Aging, 2009, AGEPAGE FALLS FRACT; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Sanders KM, 2010, JAMA-J AM MED ASSOC, V303, P1815, DOI 10.1001/jama.2010.594; Scott V, 2007, AGE AGEING, V36, P130, DOI 10.1093/ageing/afl165; Spice CL, 2009, AGE AGEING, V38, P33, DOI 10.1093/ageing/afn192; Stevens J. A., 2008, PREVENTING FALLS WHA; TINETTI ME, 1994, NEW ENGL J MED, V331, P821, DOI 10.1056/NEJM199409293311301; U.S. Department of Health and Human Services, 2008, 2008 PHYS ACT GUID A; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18; Vind AB, 2009, J AM GERIATR SOC, V57, P971, DOI 10.1111/j.1532-5415.2009.02270.x; WAGNER EH, 1994, AM J PUBLIC HEALTH, V84, P1800, DOI 10.2105/AJPH.84.11.1800	29	217	222	0	34	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 7	2012	157	3					197	+		10.7326/0003-4819-157-3-201208070-00462	http://dx.doi.org/10.7326/0003-4819-157-3-201208070-00462			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	992PB	22868837				2022-12-28	WOS:000307789900006
J	Sol, D; Maspons, J; Vall-Llosera, M; Bartomeus, I; Garcia-Pena, GE; Pinol, J; Freckleton, RP				Sol, Daniel; Maspons, Joan; Vall-Llosera, Miquel; Bartomeus, Ignasi; Garcia-Pena, Gabriel E.; Pinol, Josep; Freckleton, Robert P.			Unraveling the Life History of Successful Invaders	SCIENCE			English	Article							EVOLUTION; BIRDS; ESTABLISHMENT; CONSEQUENCES; TRAITS	Despite considerable current interest in biological invasions, the common life-history characteristics of successful invaders remain elusive. The widely held hypothesis that successful invaders have high reproductive rates has received little empirical support; however, alternative possibilities are seldom considered. Combining a global comparative analysis of avian introductions (>2700 events) with demographic models and phylogenetic comparative methods, we show that although rapid population growth may be advantageous during invasions under certain circumstances, more generally successful invaders are characterized by life-history strategies in which they give priority to future rather than current reproduction. High future breeding expectations reduce the costs of reproductive failure under uncertain conditions and increase opportunities to explore the environment and respond to novel ecological pressures.	[Sol, Daniel; Maspons, Joan; Vall-Llosera, Miquel; Bartomeus, Ignasi; Garcia-Pena, Gabriel E.; Pinol, Josep] Ctr Ecol Res & Forestry Applicat CREAF, Cerdanyola Del Valles 08193, Spain; [Sol, Daniel] CSIC, Ctr Adv Studies Blanes CEAB, Cerdanyola Del Valles 08193, Spain; [Bartomeus, Ignasi] Rutgers State Univ, New Brunswick, NJ 08901 USA; [Pinol, Josep] Autonomous Univ Barcelona UAB, Cerdanyola Del Valles 08193, Spain; [Freckleton, Robert P.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); Rutgers State University New Brunswick; Autonomous University of Barcelona; University of Sheffield	Sol, D (corresponding author), Ctr Ecol Res & Forestry Applicat CREAF, Cerdanyola Del Valles 08193, Spain.	d.sol@creaf.uab.cat	Peña, Gabriel Ernesto García/CAA-2684-2022; Sol, Daniel/A-5238-2008; Peña, Gabriel Ernesto García/AAG-5250-2019; Maspons, Joan/D-3814-2014; Freckleton, Rob P/B-6455-2013; Vall-llosera, Miquel/AAM-8895-2020; Pinol, Josep/K-3577-2014	Peña, Gabriel Ernesto García/0000-0002-3515-6908; Sol, Daniel/0000-0001-6346-6949; Peña, Gabriel Ernesto García/0000-0002-3515-6908; Maspons, Joan/0000-0003-2286-8727; Vall-llosera, Miquel/0000-0003-2644-2643; Pinol, Josep/0000-0002-4067-3301; Freckleton, Robert/0000-0002-8338-864X; Bartomeus, Ignasi/0000-0001-7893-4389	Spanish government [CGL2010-1838, 'MONTES' CSD2008-00040, BES-2011-043668]; Mexican government [CONACyT-121695]; Royal Society of London	Spanish government(Spanish GovernmentEuropean Commission); Mexican government; Royal Society of London(Royal Society of London)	This research was supported by funds from the Spanish government (CGL2010-1838, 'MONTES' CSD2008-00040, BES-2011-043668), from the Mexican government (CONACyT-121695) and the Royal Society of London. We thank T. Price, V. Bokony, E. Marks, S. Vignieri, and referees for help with revising the manuscript; A. Liker and K. Davis for facilitating data; L. Lefebvre, T. Szekely, and T. Blackburn for discussions; and the R-team for the R free software.	Blackburn TM, 2009, GLOBAL CHANGE BIOL, V15, P2852, DOI 10.1111/j.1365-2486.2008.01841.x; Blackburn TM, 2009, OXFORD AVIAN BIOL, P1; Bokony V, 2009, AM NAT, V173, P589, DOI 10.1086/597610; Brown JH, 2006, P NATL ACAD SCI USA, V103, P17595, DOI 10.1073/pnas.0608522103; COLE LC, 1954, Q REV BIOL, V29, P103, DOI 10.1086/400074; Cubaynes S, 2011, BIOL LETTERS, V7, P303, DOI 10.1098/rsbl.2010.0778; Forcada J, 2008, GLOBAL CHANGE BIOL, V14, P2473, DOI 10.1111/j.1365-2486.2008.01678.x; Grevstad FS, 1999, ECOL APPL, V9, P1439, DOI 10.1890/1051-0761(1999)009[1439:FITCOP]2.0.CO;2; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Lewontin R. C., 1965, P77; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Morris WF, 2008, ECOLOGY, V89, P19, DOI 10.1890/07-0774.1; PIELOU E C, 1969, P286; Pimm S.L., 1991, BALANCE NATURE; Ricklefs RE, 2002, TRENDS ECOL EVOL, V17, P462, DOI 10.1016/S0169-5347(02)02578-8; Saether BE, 2004, AM NAT, V164, P793, DOI 10.1086/425371; Saether BE, 2000, ECOLOGY, V81, P642, DOI 10.2307/177366; Sol D, 2005, P NATL ACAD SCI USA, V102, P5460, DOI 10.1073/pnas.0408145102; Sol Daniel, 2007, V193, P127; Sol D, 2009, BIOL LETTERS, V5, P130, DOI 10.1098/rsbl.2008.0621; Stearns S.C., 1992, pi; Stearns SC, 2000, NATURWISSENSCHAFTEN, V87, P476, DOI 10.1007/s001140050763; Williams G. C., 1966, P307; Yeh PJ, 2004, AM NAT, V164, P531, DOI 10.1086/423825	25	182	186	1	168	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 3	2012	337	6094					580	583		10.1126/science.1221523	http://dx.doi.org/10.1126/science.1221523			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982PU	22859488				2022-12-28	WOS:000307058700045
J	Kaelin, WG				Kaelin, William G., Jr.			Use and Abuse of RNAi to Study Mammalian Gene Function	SCIENCE			English	Editorial Material							HUMAN-CELLS; SCREENS; INTERFERENCE; EXPRESSION		Dana Farber Canc Inst, Dept Adult Oncol, Off M457, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute	Kaelin, WG (corresponding author), Dana Farber Canc Inst, Dept Adult Oncol, Off M457, 450 Brookline Ave, Boston, MA 02215 USA.	william_kaelin@dfci.harvard.edu			NATIONAL CANCER INSTITUTE [R01CA076120, R01CA068490] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R01 CA076120, R01 CA068490] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Barrows NJ, 2010, J BIOMOL SCREEN, V15, P735, DOI 10.1177/1087057110374994; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Goff SP, 2008, CELL, V135, P417, DOI 10.1016/j.cell.2008.10.007; Khan IF, 2011, NAT PROTOC, V6, P482, DOI 10.1038/nprot.2011.301; Kittler R, 2005, P NATL ACAD SCI USA, V102, P2396, DOI 10.1073/pnas.0409861102; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599	15	117	122	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2012	337	6093					421	422		10.1126/science.1225787	http://dx.doi.org/10.1126/science.1225787			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979FS	22837515	Green Accepted			2022-12-28	WOS:000306802300029
J	Pulendran, B; Artis, D				Pulendran, Bali; Artis, David			New Paradigms in Type 2 Immunity	SCIENCE			English	Review							T-HELPER-CELL; THYMIC STROMAL LYMPHOPOIETIN; ANTIGEN-PRESENTING CELLS; DUST MITE ALLERGEN; RESPONSES IN-VIVO; DENDRITIC CELLS; EPITHELIAL-CELLS; INNATE IMMUNITY; IL-4 PRODUCTION; LYMPHOID-CELLS	Nearly half of the world's population harbors helminth infections or suffers from allergic disorders. A common feature of this population is the so-called "type 2 immune response," which confers protection against helminths, but also promotes pathologic responses associated with allergic inflammation. However, the mechanisms that initiate and control type 2 responses remain enigmatic. Recent advances have revealed a role for the innate immune system in orchestrating type 2 responses against a bewildering array of stimuli, from nanometer-sized allergens to 20-meter-long helminth parasites. Here, we review these advances and suggest that the human immune system has evolved multiple mechanisms of sensing such stimuli, from recognition of molecular patterns via innate immune receptors to detecting metabolic changes and tissue damage caused by these stimuli.	[Pulendran, Bali] Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Dept Pathol, Atlanta, GA 30329 USA; [Artis, David] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Artis, David] Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA	Emory University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Pulendran, B (corresponding author), Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Dept Pathol, 954 Gatewood Rd, Atlanta, GA 30329 USA.	bpulend@emory.edu; dartis@mail.med.upenn.edu	Pulendran, Bali/AAW-9550-2021	Artis, David/0000-0002-1753-4100; Pulendran, Bali/0000-0001-6517-4333	NIH [U19AI090023, HHSN266200700006C, U54AI057157, R37AI48638, R37DK057665, U19AI057266, N01 AI50025, AI061570, AI087990, AI074878, AI083480, AI095466, AI095608]; Bill and Melinda Gates Foundation; Burroughs Wellcome Fund in Pathogenesis of Infectious Disease Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI048638, U19AI057266, U01AI095608, R21AI083480, R01AI061570, N01AI050025, R21AI087990, R01AI074878, R01AI095466, U19AI090023, U54AI057157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK057665] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Burroughs Wellcome Fund in Pathogenesis of Infectious Disease Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Research in the Pulendran lab is supported by the NIH (grants U19AI090023, HHSN266200700006C, U54AI057157, R37AI48638, R37DK057665, U19AI057266, and N01 AI50025 to B.P.) and the Bill and Melinda Gates Foundation. Research in the Artis lab is supported by the NIH (grants AI061570, AI087990, AI074878, AI083480, AI095466, and AI095608 to D.A.) and the Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Disease Award (D.A.). We sincerely apologize to our colleagues that, owing to limitations of space, we were unable to cite many relevant references.	Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Allen JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002003; Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Barrett NA, 2011, J EXP MED, V208, P593, DOI 10.1084/jem.20100793; Bergman MP, 2004, J EXP MED, V200, P979, DOI 10.1084/jem.20041061; Braun MC, 1999, J EXP MED, V189, P541, DOI 10.1084/jem.189.3.541; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Briot A, 2009, J EXP MED, V206, P1135, DOI 10.1084/jem.20082242; Chapman MD, 2007, J ALLERGY CLIN IMMUN, V119, P414, DOI 10.1016/j.jaci.2006.11.001; Chen F, 2012, NAT MED, V18, P260, DOI 10.1038/nm.2628; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Everts B, 2009, J EXP MED, V206, P1673, DOI 10.1084/jem.20082460; Fritz JH, 2007, IMMUNITY, V26, P445, DOI 10.1016/j.immuni.2007.03.009; Godefroy E, 2011, CANCER CELL, V19, P333, DOI 10.1016/j.ccr.2011.01.037; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Kaiser F, 2009, J EXP MED, V206, P1863, DOI 10.1084/jem.20091059; Karasuyama H, 2011, ANNU REV IMMUNOL, V29, P45, DOI 10.1146/annurev-immunol-031210-101257; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kelso A, 1999, INT IMMUNOL, V11, P617, DOI 10.1093/intimm/11.4.617; Khodoun MV, 2004, J EXP MED, V200, P857, DOI 10.1084/jem.20040598; Klechevsky E, 2008, IMMUNITY, V29, P497, DOI 10.1016/j.immuni.2008.07.013; Kool M, 2011, IMMUNITY, V34, P527, DOI 10.1016/j.immuni.2011.03.015; Kouzaki H, 2009, J IMMUNOL, V183, P1427, DOI 10.4049/jimmunol.0900904; Lambrecht BN, 2012, ANNU REV IMMUNOL, V30, P243, DOI 10.1146/annurev-immunol-020711-075021; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; Marichal T, 2011, NAT MED, V17, P996, DOI 10.1038/nm.2403; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Ohnmacht C, 2010, IMMUNITY, V33, P364, DOI 10.1016/j.immuni.2010.08.011; Palm NW, 2012, NATURE, V484, P465, DOI 10.1038/nature11047; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Pawankar R, 2012, CURR OPIN ALLERGY CL, V12, P39, DOI 10.1097/ACI.0b013e32834ec13b; Pedroza-Gonzalez A, 2011, J EXP MED, V208, P479, DOI 10.1084/jem.20102131; Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740; Phythian-Adams AT, 2010, J EXP MED, V207, P2089, DOI 10.1084/jem.20100734; Poulsen LK, 2009, CLIN EXP ALLERGY, V39, P623, DOI 10.1111/j.1365-2222.2009.03245.x; Pulendran B, 2001, J IMMUNOL, V167, P5067, DOI 10.4049/jimmunol.167.9.5067; Pulendran B, 2010, NAT IMMUNOL, V11, P647, DOI 10.1038/ni.1894; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Ramachandran R, 2012, NAT REV DRUG DISCOV, V11, P69, DOI 10.1038/nrd3615; Rissoan MC, 1999, SCIENCE, V283, P1183, DOI 10.1126/science.283.5405.1183; Ronald PC, 2010, SCIENCE, V330, P1061, DOI 10.1126/science.1189468; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Schmidt M, 2010, NAT IMMUNOL, V11, P814, DOI 10.1038/ni.1919; Shreffler WG, 2006, J IMMUNOL, V177, P3677, DOI 10.4049/jimmunol.177.6.3677; Siracusa MC, 2011, NATURE, V477, P229, DOI 10.1038/nature10329; Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Steinfelder S, 2009, J EXP MED, V206, P1681, DOI 10.1084/jem.20082462; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Sullivan BM, 2011, NAT IMMUNOL, V12, P527, DOI 10.1038/ni.2036; Tang H, 2010, NAT IMMUNOL, V11, P608, DOI 10.1038/ni.1883; Traidl-Hoffmann C, 2005, J EXP MED, V201, P627, DOI 10.1084/jem.20041065; Traidl-Hoffmann C, 2009, J ALLERGY CLIN IMMUN, V123, P558, DOI 10.1016/j.jaci.2008.12.003; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; van Rijt LS, 2005, J EXP MED, V201, P981, DOI 10.1084/jem.20042311; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Voehringer D, 2011, CURR OPIN IMMUNOL, V23, P789, DOI 10.1016/j.coi.2011.09.005; Wang YH, 2010, J EXP MED, V207, P2479, DOI 10.1084/jem.20101376; Wenink MH, 2009, J IMMUNOL, V183, P6960, DOI 10.4049/jimmunol.0900713; Whelan M, 2000, J IMMUNOL, V164, P6453, DOI 10.4049/jimmunol.164.12.6453; Yang D, 2012, J EXP MED, V209, P157, DOI 10.1084/jem.20101354; Yoshimoto T, 2009, NAT IMMUNOL, V10, P706, DOI 10.1038/ni.1737; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	72	300	312	0	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 27	2012	337	6093					431	435		10.1126/science.1221064	http://dx.doi.org/10.1126/science.1221064			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979FS	22837519	Green Accepted			2022-12-28	WOS:000306802300033
J	Halevy, I; Peters, SE; Fischer, WW				Halevy, Itay; Peters, Shanan E.; Fischer, Woodward W.			Sulfate Burial Constraints on the Phanerozoic Sulfur Cycle	SCIENCE			English	Article							MESSINIAN SALINITY CRISIS; ATMOSPHERIC OXYGEN; SEDIMENTARY SULFUR; MARINE EVAPORITES; NORTH-AMERICA; EVOLUTION; SEAWATER; MIOCENE; HISTORY; CARBON	The sulfur cycle influences the respiration of sedimentary organic matter, the oxidation state of the atmosphere and oceans, and the composition of seawater. However, the factors governing the major sulfur fluxes between seawater and sedimentary reservoirs remain incompletely understood. Using macrostratigraphic data, we quantified sulfate evaporite burial fluxes through Phanerozoic time. Approximately half of the modern riverine sulfate flux comes from weathering of recently deposited evaporites. Rates of sulfate burial are unsteady and linked to changes in the area of marine environments suitable for evaporite formation and preservation. By contrast, rates of pyrite burial and weathering are higher, less variable, and largely balanced, highlighting a greater role of the sulfur cycle in regulating atmospheric oxygen.	[Halevy, Itay] Weizmann Inst Sci, Environm Sci & Energy Res, IL-76100 Rehovot, Israel; [Halevy, Itay; Fischer, Woodward W.] CALTECH, Pasadena, CA 91125 USA; [Peters, Shanan E.] Univ Wisconsin, Madison, WI 53706 USA	Weizmann Institute of Science; California Institute of Technology; University of Wisconsin System; University of Wisconsin Madison	Halevy, I (corresponding author), Weizmann Inst Sci, Environm Sci & Energy Res, IL-76100 Rehovot, Israel.	itay.halevy@weizmann.ac.il	HALEVY, ITAY/K-1364-2012; Halevy, Itay/W-9850-2019; Peters, Shanan E/A-5620-2013	HALEVY, ITAY/0000-0002-7325-8139; Halevy, Itay/0000-0002-7325-8139; Peters, Shanan E/0000-0002-3346-4317	Texaco Postdoctoral Fellowship in Geological and Planetary Sciences at the California Institute of Technology; Sir Charles Clore Prize for Outstanding Appointment in the Experimental Sciences at the Weizmann Institute of Science; NSF [EAR-0819931]; Agouron Institute; David and Lucile Packard Foundation Fellowship for Science and Engineering	Texaco Postdoctoral Fellowship in Geological and Planetary Sciences at the California Institute of Technology; Sir Charles Clore Prize for Outstanding Appointment in the Experimental Sciences at the Weizmann Institute of Science; NSF(National Science Foundation (NSF)); Agouron Institute(Pfizer); David and Lucile Packard Foundation Fellowship for Science and Engineering(The David & Lucile Packard Foundation)	We thank D. Canfield and J. Adkins for helpful discussion, and C. Scotese for help with the paleogeographic reconstructions. I. H. acknowledges support from a Texaco Postdoctoral Fellowship in Geological and Planetary Sciences at the California Institute of Technology and a Sir Charles Clore Prize for Outstanding Appointment in the Experimental Sciences at the Weizmann Institute of Science. S. E. P. was funded by NSF grant EAR-0819931. W. W. F. acknowledges support from the Agouron Institute and a David and Lucile Packard Foundation Fellowship for Science and Engineering. The binned macrostratigraphic data are available as a supplementary table on Science Online.	[Anonymous], 2001, ATLAS EARTH HIST; Berner RA, 2004, AM J SCI, V304, P438, DOI 10.2475/ajs.304.5.438; BERNER RA, 1984, GEOCHIM COSMOCHIM AC, V48, P605, DOI 10.1016/0016-7037(84)90089-9; BERNER RA, 1987, AM J SCI, V287, P177, DOI 10.2475/ajs.287.3.177; Canfield DE, 1999, AM J SCI, V299, P697, DOI 10.2475/ajs.299.7-9.697; Canfield DE, 2005, ANNU REV EARTH PL SC, V33, P1, DOI 10.1146/annurev.earth.33.092203.122711; Canfield DE, 2004, AM J SCI, V304, P839, DOI 10.2475/ajs.304.10.839; Edmond JM, 1997, TECTONIC UPLIFT CLIM, P329, DOI [DOI 10.1007/978-1-4615-5935-1_14, 10.1007/978-1-4615-5935-1_14]; GARRELS RM, 1984, AM J SCI, V284, P989, DOI 10.2475/ajs.284.9.989; Gill BC, 2011, NATURE, V469, P80, DOI 10.1038/nature09700; Haq BU, 2005, GEOARABIA, V10, P127; Horita J, 2002, GEOCHIM COSMOCHIM AC, V66, P3733, DOI 10.1016/S0016-7037(01)00884-5; JORGENSEN BB, 1982, NATURE, V296, P643, DOI 10.1038/296643a0; Kampschulte A, 2004, CHEM GEOL, V204, P255, DOI 10.1016/j.chemgeo.2003.11.013; Krijgsman W, 1999, NATURE, V400, P652, DOI 10.1038/23231; KUMP LR, 1986, AM J SCI, V286, P337, DOI 10.2475/ajs.286.5.337; Lowenstein TK, 2001, SCIENCE, V294, P1086, DOI 10.1126/science.1064280; Morel F. M. M., 1993, PRINCIPLES APPL AQUA; Peryt TM, 2006, SEDIMENT GEOL, V188, P379, DOI 10.1016/j.sedgeo.2006.03.014; Peters SE, 2010, PALEOBIOLOGY, V36, P61, DOI 10.1666/0094-8373-36.1.61; Peters SE, 2006, J GEOL, V114, P391, DOI 10.1086/504176; Rahimpour-Bonab H, 2007, GEOL J, V42, P37, DOI 10.1002/gj.1069; Raiswell R, 2011, ELEMENTS, V7, P101, DOI 10.2113/gselements.7.2.101; Ronov A.B., 1982, INT GEOL REV, V24, P1313, DOI [10.1080/00206818209451075, DOI 10.1080/00206818209451075]; Rouchy JM, 2006, SEDIMENT GEOL, V188, P35, DOI 10.1016/j.sedgeo.2006.02.005; ROUCHY JM, 1995, SEDIMENT GEOL, V94, P277, DOI 10.1016/0037-0738(94)00095-C; Rowley DB, 2002, GEOL SOC AM BULL, V114, P927, DOI 10.1130/0016-7606(2002)114<0927:ROPCAD>2.0.CO;2; Sadler P. M., 1999, GEORESEARCH FORUM, V5, P15; Strauss H, 1997, PALAEOGEOGR PALAEOCL, V132, P97, DOI 10.1016/S0031-0182(97)00067-9; Warren JK, 2010, EARTH-SCI REV, V98, P217, DOI 10.1016/j.earscirev.2009.11.004; Wu NP, 2010, GEOCHIM COSMOCHIM AC, V74, P2053, DOI 10.1016/j.gca.2009.12.012; Zharkov M. A., 1981, HIST PALEOZOIC SALT	32	94	94	3	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2012	337	6092					331	334		10.1126/science.1220224	http://dx.doi.org/10.1126/science.1220224			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975WQ	22822147				2022-12-28	WOS:000306542600048
J	Zutic, I; Lee, J				Zutic, Igor; Lee, Jeongsu			Spin Twists in a Transistor	SCIENCE			English	Editorial Material							SEMICONDUCTORS; FERROMAGNETISM; SPINTRONICS		[Zutic, Igor; Lee, Jeongsu] SUNY Buffalo, Dept Phys, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Zutic, I (corresponding author), SUNY Buffalo, Dept Phys, Buffalo, NY 14260 USA.	zigor@buffalo.edu; jl376@buffalo.edu	Zutic, Igor/S-4933-2018					Betthausen C, 2012, SCIENCE, V337, P324, DOI 10.1126/science.1221350; DATTA S, 1990, APPL PHYS LETT, V56, P665, DOI 10.1063/1.102730; Dery H, 2012, IEEE T ELECTRON DEV, V59, P259, DOI 10.1109/TED.2011.2173498; Dery H, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3624923; Fabian J, 2007, ACTA PHYS SLOVACA, V57, P565, DOI 10.2478/v10155-010-0086-8; FURDYNA JK, 1988, J APPL PHYS, V64, pR29, DOI 10.1063/1.341700; Horowitz P., 2015, ART ELECT; Jungwirth T, 2006, REV MOD PHYS, V78, P809, DOI 10.1103/RevModPhys.78.809; Koo HC, 2009, SCIENCE, V325, P1515, DOI 10.1126/science.1173667; Li L, 2011, NAT PHYS, V7, P762, DOI 10.1038/nphys2080; Ohno H, 2000, NATURE, V408, P944, DOI 10.1038/35050040; Rangaraju N, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.117202; Sugahara S, 2005, IEE P-CIRC DEV SYST, V152, P355, DOI 10.1049/ip-cds:20045196; Wunderlich J, 2010, SCIENCE, V330, P1801, DOI 10.1126/science.1195816; Yamada Y, 2011, SCIENCE, V332, P1065, DOI 10.1126/science.1202152; Zutic I, 2004, REV MOD PHYS, V76, P323, DOI 10.1103/RevModPhys.76.323	16	5	5	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2012	337	6092					307	308		10.1126/science.1225219	http://dx.doi.org/10.1126/science.1225219			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975WQ	22822141				2022-12-28	WOS:000306542600041
J	Balter, V; Braga, J; Telouk, P; Thackeray, JF				Balter, Vincent; Braga, Jose; Telouk, Philippe; Thackeray, J. Francis			Evidence for dietary change but not landscape use in South African early hominins	NATURE			English	Article							ABLATION ICP-MS; PLASMA-MASS SPECTROMETRY; TRACE-ELEMENTS; TOOTH ENAMEL; AUSTRALOPITHECUS; ISOTOPES; TEETH; DISTRIBUTIONS; OPPORTUNITIES; DIAGENESIS	The dichotomy between early Homo and Paranthropus is justified partly on morphology(1,2). In terms of diet, it has been suggested that early Homo was a generalist but that Paranthropus was a specialist(3). However, this model is challenged and the issue of the resources used by Australopithecus, the presumed common ancestor, is still unclear. Laser ablation profiles of strontium/calcium, barium/calcium and strontium isotope ratios in tooth enamel are a means to decipher intra-individual diet and habitat changes. Here we show that the home range area was of similar size for species of the three hominin genera but that the dietary breadth was much higher in Australopithecus africanus than in Paranthropus robustus and early Homo. We also confirm that P. robustus relied more on plant-based foodstuffs than early Homo. A South African scenario is emerging in which the broad ecological niche of Australopithecus became split, and was then occupied by Paranthropus and early Homo, both consuming a lower diversity of foods than Australopithecus.	[Balter, Vincent; Telouk, Philippe] Ecole Normale Super Lyon, CNRS, UMR 5276, Lab Geol Lyon, F-69342 Lyon 07, France; [Braga, Jose] Univ Toulouse Paul Sabatier, CNRS, UMR 5288, Comp Assisted Palaeoanthropol Team, F-31000 Toulouse, France; [Thackeray, J. Francis] Univ Witwatersrand, Inst Human Evolut, ZA-2050 Johannesburg, South Africa	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Witwatersrand	Balter, V (corresponding author), Ecole Normale Super Lyon, CNRS, UMR 5276, Lab Geol Lyon, 15 Parvis Rene Descartes,BP 7000, F-69342 Lyon 07, France.	Vincent.Balter@ens-lyon.fr	Balter, Vincent/C-8415-2012; TELOUK, Philippe/AAY-6708-2021; Braga, Jose/A-4025-2010	Balter, Vincent/0000-0002-9236-4834; Braga, Jose/0000-0002-8483-076X; Thackeray, Francis/0000-0001-6884-382X	South African National Research Foundation; French Ministry of Foreign Affairs; French Embassy in South Africa through the Cultural and Cooperation Services; French Institut National des Sciences de l'Univers	South African National Research Foundation(National Research Foundation - South Africa); French Ministry of Foreign Affairs; French Embassy in South Africa through the Cultural and Cooperation Services; French Institut National des Sciences de l'Univers	The authors thank F. Albarede, J. Blichert-Toft, B. Bourdon and G. Escarguel for helpful comments on the manuscript. This work was supported by the South African National Research Foundation, the French Ministry of Foreign Affairs, the French Embassy in South Africa through the Cultural and Cooperation Services, and the French Institut National des Sciences de l'Univers through the programs ECLIPSE II and PALEO2. The authors are grateful to S. Potze and the Ditsong National Museum of Natural History (formerly Transvaal Museum, Northern Flagship Institution), and the South African Heritage Resources Agency for facilitating access to the fossil samples.	Balter V, 2004, OECOLOGIA, V139, P83, DOI 10.1007/s00442-003-1476-0; Balter V, 2008, GEOCHIM COSMOCHIM AC, V72, P3980, DOI 10.1016/j.gca.2008.05.048; Balter V, 2008, EARTH PLANET SC LETT, V267, P236, DOI 10.1016/j.epsl.2007.11.039; Berger LR, 2010, SCIENCE, V328, P195, DOI 10.1126/science.1184944; Copeland SR, 2011, NATURE, V474, P76, DOI 10.1038/nature10149; Dolphin AE, 2005, AM J PHYS ANTHROPOL, V128, P878, DOI 10.1002/ajpa.20213; Grun R, 2008, GEOCHIM COSMOCHIM AC, V72, P5278, DOI 10.1016/j.gca.2008.08.007; Hinners TA, 1998, J ANAL ATOM SPECTROM, V13, P963, DOI 10.1039/a803373k; Hinz EA, 2010, GEOCHIM COSMOCHIM AC, V74, P3213, DOI 10.1016/j.gca.2010.03.011; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Humphrey LT, 2008, P NATL ACAD SCI USA, V105, P6834, DOI 10.1073/pnas.0711513105; Jackson SE, 2003, J ANAL ATOM SPECTROM, V18, P205, DOI 10.1039/b209620j; Kang D, 2004, ANAL BIOANAL CHEM, V378, P1608, DOI 10.1007/s00216-004-2504-6; Kay R.F., 1988, P427; Kohn MJ, 1999, GEOCHIM COSMOCHIM AC, V63, P2737, DOI 10.1016/S0016-7037(99)00208-2; Laden G, 2005, J HUM EVOL, V49, P482, DOI 10.1016/j.jhevol.2005.05.007; MCHENRY HM, 1984, AM J PHYS ANTHROPOL, V64, P297, DOI 10.1002/ajpa.1330640312; Prohaska T, 2002, J ANAL ATOM SPECTROM, V17, P887, DOI 10.1039/b203314c; Schweissing MM, 2003, J ARCHAEOL SCI, V30, P1373, DOI 10.1016/S0305-4403(03)00025-6; Scott RS, 2005, NATURE, V436, P693, DOI 10.1038/nature03822; Sponheimer M, 1999, SCIENCE, V283, P368, DOI 10.1126/science.283.5400.368; Sponheimer M, 2006, GEOCHIM COSMOCHIM AC, V70, P1644, DOI 10.1016/j.gca.2005.12.022; Telouk P, 2003, GEOSTANDARD NEWSLETT, V27, P5, DOI 10.1111/j.1751-908X.2003.tb00708.x; WOLPOFF MH, 1973, AM J PHYS ANTHROPOL, V39, P375, DOI 10.1002/ajpa.1330390306; Wood B, 2004, J HUM EVOL, V46, P119, DOI 10.1016/j.jhevol.2003.11.004; Wood B, 2010, P NATL ACAD SCI USA, V107, P8902, DOI 10.1073/pnas.1001649107	26	67	68	4	156	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2012	489	7417					558	560		10.1038/nature11349	http://dx.doi.org/10.1038/nature11349			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	046RG	22878716				2022-12-28	WOS:000311781500002
J	Doupe, DP; Alcolea, MP; Roshan, A; Zhang, G; Klein, AM; Simons, BD; Jones, PH				Doupe, David P.; Alcolea, Maria P.; Roshan, Amit; Zhang, Gen; Klein, Allon M.; Simons, Benjamin D.; Jones, Philip H.			A Single Progenitor Population Switches Behavior to Maintain and Repair Esophageal Epithelium	SCIENCE			English	Article							STEM-CELLS; IDENTIFICATION; EPIDERMIS; MOUSE; DIFFERENTIATION; PROLIFERATION; ARCHITECTURE; FUSION; ADULT	Diseases of the esophageal epithelium (EE), such as reflux esophagitis and cancer, are rising in incidence. Despite this, the cellular behaviors underlying EE homeostasis and repair remain controversial. Here, we show that in mice, EE is maintained by a single population of cells that divide stochastically to generate proliferating and differentiating daughters with equal probability. In response to challenge with all-trans retinoic acid (atRA), the balance of daughter cell fate is unaltered, but the rate of cell division increases. However, after wounding, cells reversibly switch to producing an excess of proliferating daughters until the wound has closed. Such fate-switching enables a single progenitor population to both maintain and repair tissue without the need for a "reserve" slow-cycling stem cell pool.	[Doupe, David P.; Alcolea, Maria P.; Roshan, Amit; Jones, Philip H.] Hutchison MRC Res Ctr, Med Res Council MRC, Canc Cell Unit, Cambridge CB2 0XZ, England; [Zhang, Gen; Klein, Allon M.; Simons, Benjamin D.] Univ Cambridge, Cavendish Lab, Dept Phys, Cambridge CB3 0HE, England; [Klein, Allon M.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Doupe, David P.; Simons, Benjamin D.] Univ Cambridge, Wellcome Trust, Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; Harvard University; Harvard Medical School; Cancer Research UK; University of Cambridge; Wellcome Trust Sanger Institute	Jones, PH (corresponding author), Hutchison MRC Res Ctr, Med Res Council MRC, Canc Cell Unit, Cambridge CB2 0XZ, England.	phj20@cam.ac.uk	Simons, Benjamin/AAY-8920-2020; Doupe, David/M-7914-2017; Jones, Philip/D-2464-2009; Roshan, Amit/AAV-5512-2020	Simons, Benjamin/0000-0002-3875-7071; Doupe, David/0000-0002-9748-9388; Jones, Philip/0000-0002-5904-795X; Roshan, Amit/0000-0002-2034-2759; Alcolea, Maria P./0000-0002-8396-6454	MRC; EPSRC (Engineering and Physical Sciences Research Council); NC3Rs (National Centre for the Replacement, Refinement and Reduction of Animals in Research); Wellcome Trust; Sidney Sussex College, Cambridge; European Union Marie Curie Fellowship [PIEF-LIF-2007-220016]; Royal College of Surgeons of England; Cambridge Cancer Centre; EPSRC [EP/F032773/1] Funding Source: UKRI; MRC [MC_U105370181, G0800784] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/F032773/1] Funding Source: researchfish; Medical Research Council [G0800784, G0800784B, G0601740, MC_U105370181] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EPSRC (Engineering and Physical Sciences Research Council)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NC3Rs (National Centre for the Replacement, Refinement and Reduction of Animals in Research)(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); Wellcome Trust(Wellcome Trust); Sidney Sussex College, Cambridge; European Union Marie Curie Fellowship(European Commission); Royal College of Surgeons of England; Cambridge Cancer Centre; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank E. Choolun and the staff at ARES and CBS Cambridge for technical assistance; D. Winton and D. Adams (Cambridge) for mice; and M. Gonzalez (London) for the Geminin antibody. We acknowledge the support of the MRC, EPSRC (Engineering and Physical Sciences Research Council), the NC3Rs (National Centre for the Replacement, Refinement and Reduction of Animals in Research), the Wellcome Trust, Sidney Sussex College, Cambridge (D. P. D.), European Union Marie Curie Fellowship PIEF-LIF-2007-220016 (M. P. A.), the Royal College of Surgeons of England (A. R.), and Cambridge Cancer Centre (A. R.). This work uses methods included in the patent WO2009010725 (A2), a method of detecting altered behavior in a population of cells; inventors were P.H.J., B. D. S., and A.M.K.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; Chapellier B, 2002, EMBO J, V21, P3402, DOI 10.1093/emboj/cdf331; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Collins CA, 2008, DEV BIOL, V324, P55, DOI 10.1016/j.ydbio.2008.08.034; Croagh D, 2008, STEM CELL REV, V4, P261, DOI 10.1007/s12015-008-9031-3; Croagh D, 2007, STEM CELLS, V25, P313, DOI 10.1634/stemcells.2006-0421; Dent J, 2005, GUT, V54, P710, DOI 10.1136/gut.2004.051821; Doupe DP, 2010, DEV CELL, V18, P317, DOI 10.1016/j.devcel.2009.12.016; Goetsch E, 1910, AM J ANAT, V10, P1, DOI 10.1002/aja.1000100102; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Jacinto A, 2001, NAT CELL BIOL, V3, pE117, DOI 10.1038/35074643; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kalabis J, 2008, J CLIN INVEST, V118, P3860, DOI 10.1172/JCI35012; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Klein AM, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.021910; Klein AM, 2011, DEVELOPMENT, V138, P3103, DOI 10.1242/dev.060103; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; MARQUESPEREIRA JP, 1965, AM J ANAT, V117, P73, DOI 10.1002/aja.1001170106; Martin P, 2003, CURR BIOL, V13, P1122, DOI 10.1016/S0960-9822(03)00396-8; MESSIER B, 1960, AM J ANAT, V106, P247, DOI 10.1002/aja.1001060305; POTTEN CS, 1975, J CELL SCI, V17, P413; Seery JP, 2000, CURR BIOL, V10, P1447, DOI 10.1016/S0960-9822(00)00803-4; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436	28	205	211	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2012	337	6098					1091	1093		10.1126/science.1218835	http://dx.doi.org/10.1126/science.1218835			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22821983	Green Accepted			2022-12-28	WOS:000308125800046
J	Naik, S; Bouladoux, N; Wilhelm, C; Molloy, MJ; Salcedo, R; Kastenmuller, W; Deming, C; Quinones, M; Koo, L; Conlan, S; Spencer, S; Hall, JA; Dzutsev, A; Kong, H; Campbell, DJ; Trinchieri, G; Segre, JA; Belkaid, Y				Naik, Shruti; Bouladoux, Nicolas; Wilhelm, Christoph; Molloy, Michael J.; Salcedo, Rosalba; Kastenmuller, Wolfgang; Deming, Clayton; Quinones, Mariam; Koo, Lily; Conlan, Sean; Spencer, Sean; Hall, Jason A.; Dzutsev, Amiran; Kong, Heidi; Campbell, Daniel J.; Trinchieri, Giorgio; Segre, Julia A.; Belkaid, Yasmine			Compartmentalized Control of Skin Immunity by Resident Commensals	SCIENCE			English	Article							REGULATORY T-CELLS; HUMAN MICROBIOME; DENDRITIC CELLS; INNATE IMMUNITY; SYSTEM; RECOGNITION; DIVERSITY; INTESTINE; INFECTION; RESPONSES	Intestinal commensal bacteria induce protective and regulatory responses that maintain host-microbial mutualism. However, the contribution of tissue-resident commensals to immunity and inflammation at other barrier sites has not been addressed. We found that in mice, the skin microbiota have an autonomous role in controlling the local inflammatory milieu and tuning resident T lymphocyte function. Protective immunity to a cutaneous pathogen was found to be critically dependent on the skin microbiota but not the gut microbiota. Furthermore, skin commensals tuned the function of local T cells in a manner dependent on signaling downstream of the interleukin-1 receptor. These findings underscore the importance of the microbiota as a distinctive feature of tissue compartmentalization, and provide insight into mechanisms of immune system regulation by resident commensal niches in health and disease.	[Naik, Shruti; Bouladoux, Nicolas; Wilhelm, Christoph; Molloy, Michael J.; Spencer, Sean; Belkaid, Yasmine] NIAID, Mucosal Immun Sect, Parasit Dis Lab, Bethesda, MD 20892 USA; [Naik, Shruti; Spencer, Sean] Univ Penn, Immunol Grad Grp, Philadelphia, PA 19104 USA; [Salcedo, Rosalba; Dzutsev, Amiran; Trinchieri, Giorgio] NCI, Canc & Inflammat Program, Ctr Canc Res, Frederick, MD 21702 USA; [Salcedo, Rosalba; Dzutsev, Amiran] NCI, SAIC Frederick Inc, Frederick, MD 21701 USA; [Kastenmuller, Wolfgang] NIAID, Lymphocyte Biol Sect, Immunol Lab, Bethesda, MD 20892 USA; [Deming, Clayton; Conlan, Sean; Segre, Julia A.] NHGRI, Genet & Mol Biol Branch, Bethesda, MD 20892 USA; [Quinones, Mariam] NIAID, Bioinformat & Computat Biosci Branch, Bethesda, MD 20892 USA; [Koo, Lily] NIAID, Res Technol Branch, Bethesda, MD 20892 USA; [Hall, Jason A.] NYU, Sch Med, Skirball Inst Biomol Med, Kimmel Ctr Biol & Med,Mol Pathogenesis Program, New York, NY 10016 USA; [Kong, Heidi] NCI, Dermatol Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Campbell, Daniel J.] Benaroya Res Inst, Seattle, WA 98101 USA; [Campbell, Daniel J.] Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); New York University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Benaroya Research Institute; University of Washington; University of Washington Seattle	Belkaid, Y (corresponding author), NIAID, Mucosal Immun Sect, Parasit Dis Lab, Bethesda, MD 20892 USA.	ybelkaid@niaid.nih.gov	Trinchieri, Giorgio/F-9369-2015; Conlan, Sean/B-4401-2008; Wilhelm, Christoph/ABE-7176-2020; Kong, Heidi H/L-4856-2018	Trinchieri, Giorgio/0000-0001-5892-7464; Conlan, Sean/0000-0001-6848-3465; Wilhelm, Christoph/0000-0002-9839-0291; Kong, Heidi H/0000-0003-4424-064X; Spencer, Sean/0000-0002-7328-5399; Quinones, Mariam/0000-0002-8520-5114; Belkaid, Yasmine/0000-0001-9962-3571; Bouladoux, Nicolas/0000-0003-1593-671X	Division of Intramural Research of the National Institute of Allergy and Infectious Diseases (NIAID); National Human Genome Research Institute, the National Cancer Institute, NIH [F30 DK094708]; Human Frontier Science Program; NATIONAL CANCER INSTITUTE [ZIABC011153, ZIABC010938] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001115, R01AI085130, ZICAI001051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK094708] Funding Source: NIH RePORTER	Division of Intramural Research of the National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Human Genome Research Institute, the National Cancer Institute, NIH; Human Frontier Science Program(Human Frontier Science Program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by the Division of Intramural Research of the National Institute of Allergy and Infectious Diseases (NIAID) and by the National Human Genome Research Institute, the National Cancer Institute, NIH grant F30 DK094708 (S. S.), and the Human Frontier Science Program (C. W.). We thank the NIAID gnotobiotic facility staff, in particular C. Acevedo and D. Trageser-Cesler; K. Holmes and the NIAID sorting facility; K. Beacht, B. Kelsall, T. Tamachi, C. Brown, J. Benchley, A. MacDonald, L. Mijares, K. Shenderov, and A. Sher; and Yakult Central Institute for Microbiological Research for sharing SFB via a material transfer agreement. DNA sequence data are available via GenBank (accession no. SRS345653). The data reported in this paper are tabulated in the main paper and in the supplementary materials.	Belkaid Y, 2000, J IMMUNOL, V165, P969, DOI 10.4049/jimmunol.165.2.969; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Cebra JJ, 1999, AM J CLIN NUTR, V69, p1046S, DOI 10.1093/ajcn/69.5.1046s; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; de Oliveira M R, 1999, Rev Inst Med Trop Sao Paulo, V41, P87, DOI 10.1590/S0036-46651999000200005; Gallo RL, 2011, J INVEST DERMATOL, V131, P1974, DOI 10.1038/jid.2011.182; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Guilliams M, 2010, BLOOD, V115, P1958, DOI 10.1182/blood-2009-09-245274; Guo LY, 2009, P NATL ACAD SCI USA, V106, P13463, DOI 10.1073/pnas.0906988106; Hall JA, 2008, IMMUNITY, V29, P637, DOI 10.1016/j.immuni.2008.08.009; Hill DA, 2010, MUCOSAL IMMUNOL, V3, P148, DOI 10.1038/mi.2009.132; Hu W, 2011, IMMUNITY, V35, P1010, DOI 10.1016/j.immuni.2011.10.013; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kong HDH, 2012, GENOME RES, V22, P850, DOI 10.1101/gr.131029.111; Lai YP, 2009, NAT MED, V15, P1377, DOI 10.1038/nm.2062; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Miller LS, 2006, IMMUNITY, V24, P79, DOI 10.1016/j.immuni.2005.11.011; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Shaw MH, 2012, J EXP MED, V209, P251, DOI 10.1084/jem.20111703; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Sumaria N, 2011, J EXP MED, V208, P505, DOI 10.1084/jem.20101824; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; UMESAKI Y, 1995, MICROBIOL IMMUNOL, V39, P555, DOI 10.1111/j.1348-0421.1995.tb02242.x; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wilson NS, 2008, IMMUNOL CELL BIOL, V86, P200, DOI 10.1038/sj.icb.7100125; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001	33	558	579	6	162	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2012	337	6098					1115	1119		10.1126/science.1225152	http://dx.doi.org/10.1126/science.1225152			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22837383	Green Accepted			2022-12-28	WOS:000308125800053
J	Farese, P				Farese, Philip			How to build a low-energy future	NATURE			English	Editorial Material									[Farese, Philip] Advantix Syst, Sunrise, FL USA		Farese, P (corresponding author), Advantix Syst, Sunrise, FL USA.	philip.farese@advantixsystems.com						[Anonymous], 2009, REAL PROSPECTS ENERG; Belzer D., 2012, PROJECTED IMPACTS BU; Farese P., TOOL PRIORI IN PRESS; Holliday C, 2010, CATALYZING AM INGENU; Jenkins J., 2011, ENERGY EMERGENCE REB; Meyers S., 2012, ENERGY EC IMPACTS US; Natl. Res. Counc, 2001, EN RES DOE WAS IT WO; Sanchez M., 2008, 2008 STATUS REPORT S; Sorrell S, 2009, ENERG POLICY, V37, P1356, DOI 10.1016/j.enpol.2008.11.026; US Energy Information Administration, 2012, ANN EN OUTL 2012	10	17	18	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2012	488	7411					275	277		10.1038/488275a	http://dx.doi.org/10.1038/488275a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	988OS	22895318	Bronze			2022-12-28	WOS:000307501000014
J	Reck, BK; Graedel, TE				Reck, Barbara K.; Graedel, T. E.			Challenges in Metal Recycling	SCIENCE			English	Review							ELECTRONIC EQUIPMENT; THERMODYNAMIC ANALYSIS; E-WASTE; CYCLE; DESIGN; ELEMENTS; PRODUCT; INDIUM; MODEL	Metals are infinitely recyclable in principle, but in practice, recycling is often inefficient or essentially nonexistent because of limits imposed by social behavior, product design, recycling technologies, and the thermodynamics of separation. We review these topics, distinguishing among common, specialty, and precious metals. The most beneficial actions that could improve recycling rates are increased collection rates of discarded products, improved design for recycling, and the enhanced deployment of modern recycling methodology. As a global society, we are currently far away from a closed-loop material system. Much improvement is possible, but limitations of many kinds-not all of them technological-will preclude complete closure of the materials cycle.	[Reck, Barbara K.; Graedel, T. E.] Yale Univ, Sch Forestry & Environm Studies, Ctr Ind Ecol, New Haven, CT 06511 USA	Yale University	Reck, BK (corresponding author), Yale Univ, Sch Forestry & Environm Studies, Ctr Ind Ecol, New Haven, CT 06511 USA.	barbara.reck@yale.edu	Reck, Barbara K/A-7096-2013	Reck, Barbara K/0000-0002-1594-4245; Graedel, Thomas E/0000-0002-4007-3189				Ayres RU, 1997, RESOUR CONSERV RECY, V21, P145, DOI 10.1016/S0921-3449(97)00033-5; Bigum M, 2012, J HAZARD MATER, V207, P8, DOI 10.1016/j.jhazmat.2011.10.001; Chancerel P, 2009, J IND ECOL, V13, P791, DOI 10.1111/j.1530-9290.2009.00171.x; Chancerel P, 2009, WASTE MANAGE, V29, P2336, DOI 10.1016/j.wasman.2009.04.003; Chapman P.F., 1983, METAL RESOURCES ENER, DOI 10.1016/C2013-0-04151-5; Chi XW, 2011, WASTE MANAGE, V31, P731, DOI 10.1016/j.wasman.2010.11.006; Dahmus JB, 2007, ENVIRON SCI TECHNOL, V41, P7543, DOI 10.1021/es062254b; Du XY, 2011, SCI REP-UK, V1, DOI 10.1038/srep00145; Eckelman MJ, 2008, ENVIRON SCI TECHNOL, V42, P8564, DOI 10.1021/es800117h; Eckelman MJ, 2008, ECOL ECON, V67, P265, DOI 10.1016/j.ecolecon.2008.05.020; Eckelman MJ, 2012, J IND ECOL, V16, P334, DOI 10.1111/j.1530-9290.2011.00425.x; Eckelman MJ, 2010, RESOUR CONSERV RECY, V54, P256, DOI 10.1016/j.resconrec.2009.08.008; European Commission, 2010, CRIT RAW MAT EU REP; Fuse M, 2011, ECOL ECON, V70, P788, DOI 10.1016/j.ecolecon.2010.11.017; Gaustad G, 2010, J IND ECOL, V14, P286, DOI 10.1111/j.1530-9290.2010.00229.x; Graedel TE, 2012, MRS BULL, V37, P325, DOI 10.1557/mrs.2012.34; Graedel TE, 2011, J IND ECOL, V15, P355, DOI 10.1111/j.1530-9290.2011.00342.x; Graedel T.E, 2011, RATES METALS STATUS; Gutowski T. G., 2011, THERMODYNAMICS DESTR, P113; Hageluken C, 2012, PLATIN MET REV, V56, P29, DOI 10.1595/147106712X611733; Hageluken C, 2010, GOLD BULL, V43, P209, DOI 10.1007/BF03214988; Hageluken C., 2005, MAT FLOWS PGMS GERMA; Heber J, 2011, NAT MATER, V10, P162, DOI 10.1038/nmat2973; Hiraki T, 2011, SCI TECHNOL ADV MAT, V12, DOI 10.1088/1468-6996/12/3/035003; Honda, 2012, HOND REUS RAR EARTH; International Lead and Zinc Study Group, 2012, END US LEAD; Izard CF, 2010, RESOUR CONSERV RECY, V54, P1436, DOI 10.1016/j.resconrec.2010.06.008; Johansson JG, 2010, J IND ECOL, V14, P258, DOI 10.1111/j.1530-9290.2009.00191.x; Johnson J, 2008, ENERG POLICY, V36, P181, DOI 10.1016/j.enpol.2007.08.028; Kahhat R, 2009, ENVIRON SCI TECHNOL, V43, P6010, DOI 10.1021/es8035835; Krohns S, 2011, NAT MATER, V10, P899, DOI 10.1038/nmat3180; Mao JS, 2008, RESOUR CONSERV RECY, V52, P1050, DOI 10.1016/j.resconrec.2008.04.005; Matsuno Y, 2007, INT J LIFE CYCLE ASS, V12, P34, DOI 10.1065/lca2006.05.246.2; Minami T, 2008, THIN SOLID FILMS, V516, P5822, DOI 10.1016/j.tsf.2007.10.063; Nakajima K, 2007, MATER TRANS, V48, P2365, DOI 10.2320/matertrans.MAW200702; Nakajima K, 2011, ENVIRON SCI TECHNOL, V45, P4929, DOI 10.1021/es104231n; Nakajima K, 2010, ENVIRON SCI TECHNOL, V44, P5594, DOI 10.1021/es9038769; Oguchi M, 2012, WASTE MANAGE, V32, P96, DOI 10.1016/j.wasman.2011.09.012; Oguchi M, 2011, WASTE MANAGE, V31, P2150, DOI 10.1016/j.wasman.2011.05.009; Oswald I, 2011, GAIA, V20, P41, DOI 10.14512/gaia.20.1.9; Plachy J., 2003, FLOW STUDIES RECYCLI, pZ1; Rankin WJ, 2011, MINERALS, METALS AND SUSTAINABILITY: MEETING FUTURE MATERIAL NEEDS, P1; Reck B. K., 2012, J IND ECOL, V16; Renter M, 2008, JOM-US, V60, P39, DOI 10.1007/s11837-008-0106-z; Rochat D., 2007, R 07 C DAV SWITZ 3 5; Rombach G, 2006, ECO EFFICIEN IND SCI, V19, P295; Rydh CJ, 2002, RESOUR CONSERV RECY, V34, P289, DOI 10.1016/S0921-3449(01)00114-8; Sagar AD., 1997, J CLEAN PROD, V5, P39, DOI [DOI 10.1016/S0959-6526(97)00006-1., 10.1016/S0959-6526(97)00006-1]; Sepulveda A, 2010, ENVIRON IMPACT ASSES, V30, P28, DOI 10.1016/j.eiar.2009.04.001; Streicher-Porte M, 2005, ENVIRON IMPACT ASSES, V25, P472, DOI 10.1016/j.eiar.2005.04.004; Tabuchi H., 2010, NY TIMES        0330; van Schaik A, 2007, MINER ENG, V20, P875, DOI 10.1016/j.mineng.2007.03.016; van Schaik A, 2010, MINER ENG, V23, P192, DOI 10.1016/j.mineng.2009.09.004; Walser T., 2012, NAT NANOTECHNOL, DOI [10.1038/NNANO.2012.1064, DOI 10.1038/NNANO.2012.1064]; Wernick IK, 1998, ANNU REV ENERG ENV, V23, P465, DOI 10.1146/annurev.energy.23.1.465; Williams E, 2008, ENVIRON SCI TECHNOL, V42, P6446, DOI 10.1021/es702255z; Worrell E., 2004, ENCY ENERGY, V5, P245	57	424	440	33	405	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2012	337	6095					690	695		10.1126/science.1217501	http://dx.doi.org/10.1126/science.1217501			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	986PE	22879508				2022-12-28	WOS:000307354500043
J	von Messling, V; Cattaneo, R				von Messling, Veronika; Cattaneo, Roberto			A Henipavirus Vaccine in Sight	SCIENCE			English	Editorial Material							NIPAH VIRUS; REACTIVITY; PROTECTS; MEASLES; HENDRA		[von Messling, Veronika] Duke NUS Grad Med Sch Singapore, Emerging Infect Dis Program, Singapore 169857, Singapore; [Cattaneo, Roberto] Mayo Clin, Dept Mol Med, Coll Med, Rochester, MN 55905 USA	National University of Singapore; Mayo Clinic	von Messling, V (corresponding author), Duke NUS Grad Med Sch Singapore, Emerging Infect Dis Program, Singapore 169857, Singapore.	veronika.vonmessling@duke-nus.edu.sg; cattaneo.roberto@mayo.edu						Balzer M, 2011, AUST VET J, V89, pN2; Bossart KN, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004241; Callaway T. R., 2004, Animal Health Research Reviews, V5, P35, DOI 10.1079/AHR200462; Chua KB, 1999, LANCET, V354, P1257, DOI 10.1016/S0140-6736(99)04299-3; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Drexler JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1796; FULGINITI VA, 1967, J AMER MED ASSOC, V202, P1075, DOI 10.1001/jama.202.12.1075; KAPIKIAN AZ, 1969, AM J EPIDEMIOL, V89, P405, DOI 10.1093/oxfordjournals.aje.a120954; Luby SP, 2009, CLIN INFECT DIS, V49, P1743, DOI 10.1086/647951; Marsh GA, 2012, CURR OPIN VIROL, V2, P242, DOI 10.1016/j.coviro.2012.03.006; McEachern JA, 2008, VACCINE, V26, P3842, DOI 10.1016/j.vaccine.2008.05.016; Pallister J, 2011, VACCINE, V29, P5623, DOI 10.1016/j.vaccine.2011.06.015; Playford EG, 2010, EMERG INFECT DIS, V16, P219, DOI 10.3201/eid1602.090552; West R, 1999, BIODRUGS, V12, P423, DOI 10.2165/00063030-199912060-00002	14	2	2	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2012	337	6095					651	652		10.1126/science.1227810	http://dx.doi.org/10.1126/science.1227810			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986PE	22879489				2022-12-28	WOS:000307354500026
J	Fleischmann, R; Kremer, J; Cush, J; Schulze-Koops, H; Connell, CA; Bradley, JD; Gruben, D; Wallenstein, GV; Zwillich, SH; Kanik, KS				Fleischmann, Roy; Kremer, Joel; Cush, John; Schulze-Koops, Hendrik; Connell, Carol A.; Bradley, John D.; Gruben, David; Wallenstein, Gene V.; Zwillich, Samuel H.; Kanik, Keith S.		ORAL Solo Investigators	Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MODIFYING ANTIRHEUMATIC DRUGS; QUALITY-OF-LIFE; JAK INHIBITOR; INADEQUATE RESPONSE; REVISED CRITERIA; CP-690,550; VALIDATION; CLASSIFICATION; METHOTREXATE; IMPROVEMENT	BACKGROUND Tofacitinib (CP-690,550) is a novel oral Janus kinase inhibitor that is being investigated as a targeted immunomodulator and disease-modifying therapy for rheumatoid arthritis. METHODS In this phase 3, double-blind, placebo-controlled, parallel-group, 6-month study, 611 patients were randomly assigned, in a 4:4:1:1 ratio, to 5 mg of tofacitinib twice daily, 10 mg of tofacitinib twice daily, placebo for 3 months followed by 5 mg of tofacitinib twice daily, or placebo for 3 months followed by 10 mg of tofacitinib twice daily. The primary end points, assessed at month 3, were the percentage of patients with at least a 20% improvement in the American College of Rheumatology scale (ACR 20), the change from baseline in Health Assessment Questionnaire-Disability Index (HAQ-DI) scores (which range from 0 to 3, with higher scores indicating greater disability), and the percentage of patients with a Disease Activity Score for 28-joint counts based on the erythrocyte sedimentation rate (DAS28-4[ESR]) of less than 2.6 (with scores ranging from 0 to 9.4 and higher scores indicating more disease activity). RESULTS At month 3, a higher percentage of patients in the tofacitinib groups than in the placebo groups met the criteria for an ACR 20 response (59.8% in the 5-mg tofacitinib group and 65.7% in the 10-mg tofacitinib group vs. 26.7% in the combined placebo groups, P<0.001 for both comparisons). The reductions from baseline in HAQ-DI scores were greater in the 5-mg and 10-mg tofacitinib groups than in the placebo groups (-0.50 and -0.57 points, respectively, vs. -0.19 points; P<0.001). The percentage of patients with a DAS28-4(ESR) of less than 2.6 was not significantly higher with tofacitinib than with placebo (5.6% and 8.7% in the 5-mg and 10-mg tofacitinib groups, respectively, and 4.4% with placebo; P = 0.62 and P = 0.10 for the two comparisons). Serious infections developed in six patients who were receiving tofacitinib. Common adverse events were headache and upper respiratory tract infection. Tofacitinib treatment was associated with elevations in low-density lipoprotein cholesterol levels and reductions in neutrophil counts. CONCLUSIONS In patients with active rheumatoid arthritis, tofacitinib monotherapy was associated with reductions in signs and symptoms of rheumatoid arthritis and improvement in physical function. (Funded by Pfizer; ORAL Solo ClinicalTrials.gov number, NCT00814307.)	[Fleischmann, Roy] Metroplex Clin Res Ctr, Dallas, TX 75231 USA; [Cush, John] Baylor Res Inst, Dallas, TX USA; [Kremer, Joel] Albany Med Coll, Ctr Rheumatol, Albany, NY 12208 USA; Univ Munich, Div Rheumatol, Med Klin, Munich, Germany; [Schulze-Koops, Hendrik] Univ Munich, Poliklinik 4, Munich, Germany; [Connell, Carol A.; Bradley, John D.; Gruben, David; Wallenstein, Gene V.; Zwillich, Samuel H.; Kanik, Keith S.] Pfizer, Groton, CT USA	Metroplex Clinical Research Center; Baylor Scott & White Health; Baylor University Medical Center; Albany Medical College; University of Munich; University of Munich; Pfizer	Fleischmann, R (corresponding author), Metroplex Clin Res Ctr, 8144 Walnut Hill Lane, Dallas, TX 75231 USA.	rfleischmann@arthdocs.com		Pacheco-Tena, Cesar/0000-0002-0793-8988	Amgen; Abbott; Bristol-Myers Squibb; GlaxoSmithKline; Janssen Biotech; Lexicon; Lilly; Pfizer; Roche; Sanofi-Aventis; UCB; Astellas; AstraZeneca; Biogen Idec; Dynavax; Merck; Novartis; Genentech; Human Genome Sciences; Celgene; GlaxoSmithKline-Human Genome Sciences; Merck-Essex; Mundipharma; Nycomed; Actelion; Gilead; Roche-Chugai; CSL Behring; Biotest	Amgen(Amgen); Abbott(Abbott Laboratories); Bristol-Myers Squibb(Bristol-Myers Squibb); GlaxoSmithKline(GlaxoSmithKline); Janssen Biotech(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lexicon; Lilly(Eli Lilly); Pfizer(Pfizer); Roche(Roche Holding); Sanofi-Aventis(Sanofi-Aventis); UCB(UCB Pharma SA); Astellas(Astellas Pharmaceuticals); AstraZeneca(AstraZeneca); Biogen Idec(Biogen); Dynavax; Merck(Merck & Company); Novartis(Novartis); Genentech(Roche HoldingGenentech); Human Genome Sciences(GlaxoSmithKline); Celgene(Bristol-Myers SquibbCelgene Corporation); GlaxoSmithKline-Human Genome Sciences; Merck-Essex; Mundipharma; Nycomed; Actelion; Gilead(Gilead Sciences); Roche-Chugai(Roche Holding); CSL Behring; Biotest	Dr Fleischmann reports receiving consulting fees from Amgen, Abbott, Bristol-Myers Squibb, GlaxoSmithKline, Janssen Biotech, Lexicon, Lilly, Pfizer, Roche, Sanofi-Aventis, and UCB and grant support from Amgen, Abbott, Astellas, AstraZeneca, Biogen Idec, Bristol-Myers Squibb, Dynavax, GlaxoSmithKline, Janssen Biotech, Lexicon, Lilly, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, and UCB; Dr. Kremer, receiving consulting fees from Abbott, Genentech, and Pfizer, lecture fees from Abbott, Genentech, and Pfizer, and grant support from Abbott, Bristol-Myers Squibb, Genentech, Human Genome Sciences, Janssen Biotech, and Pfizer; Dr. Cush, receiving consulting fees from Abbott, Amgen, Bristol-Myers Squibb, Celgene, Genentech, Pfizer, and UCB, lecture fees from Abbott, and fees for participation in review activities (including data and safety monitoring boards and statistical analysis and end point committees) from Janssen Biotech and UCB; Dr. Schulze-Koops, receiving fees or honoraria for advisory-board membership from Abbott, Biotest, Bristol-Myers Squibb, GlaxoSmithKline-Human Genome Sciences, Merck-Essex, Mundipharma, Nycomed, Pfizer, and Roche, lecture fees from Abbott, Actelion, Bristol-Myers Squibb, Gilead, GlaxoSmithKline-Human Genome Sciences, Merck-Essex, Mundipharma, Pfizer, Roche-Chugai, and UCB, payment for development of educational presentations from Biotest and Roche-Chugai, and grant support from CSL Behring, Bristol-Myers Squibb, Celgene, Novartis, Pfizer and UCB; Drs. Connell, Bradley, Gruben, and Wallenstein, being employees of and holding stock options in Pfizer; and Drs. Kanik and Zwillich, being employees of and holding stock options in Pfizer and, through employment, being named as coinventors on one or more patents with Pfizer relating to the use of tofacitinib. No other potential conflict of interest relevant to this article was reported.	[Anonymous], DIS ACT SCOR RHEUM A; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Barton JL, 2009, PATIENT PREFER ADHER, V3, P335; Cella D, 2005, J RHEUMATOL, V32, P811; FELSON DT, 1995, ARTHRITIS RHEUM, V38, P727, DOI 10.1002/art.1780380602; Fleischmann R, 2011, ANN RHEUM DIS     S3, V70, P600; Fleischmann R, 2012, ARTHRITIS RHEUM-US, V64, P617, DOI 10.1002/art.33383; FRIES JF, 1982, J RHEUMATOL, V9, P789; HOCHBERG MC, 1992, ARTHRITIS RHEUM, V35, P498, DOI 10.1002/art.1780350502; Kanik K, 2009, ANN RHEUM DIS, V68, P123; Kremer JM, 2012, ARTHRITIS RHEUM-US, V64, P970, DOI 10.1002/art.33419; Kremer JM, 2009, ARTHRITIS RHEUM-US, V60, P1895, DOI 10.1002/art.24567; Meyer DM, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-41; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Simon TA, 2009, ANN RHEUM DIS, V68, P1819, DOI 10.1136/ard.2008.097527; Strand V, 2005, J RHEUMATOL, V32, P590; Strand V, 2007, AM J MANAG CARE, V13, pS237; Tanaka Y, 2009, ANN RHEUM DIS S13, V68, P594; van Gestel AM, 1998, ARTHRITIS RHEUM-US, V41, P1845, DOI 10.1002/1529-0131(199810)41:10<1845::AID-ART17>3.3.CO;2-B; van Vollenhoven RF, 2012, NEW ENGL J MED, V367, P508, DOI 10.1056/NEJMoa1112072; Wolfe F, 2007, ARTHRITIS RHEUM, V56, P2886, DOI 10.1002/art.22864	21	646	690	2	48	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 9	2012	367	6					495	507		10.1056/NEJMoa1109071	http://dx.doi.org/10.1056/NEJMoa1109071			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	986AE	22873530	Bronze			2022-12-28	WOS:000307310800004
J	Mayor, S				Mayor, Susan			Advertising watchdog orders website to remove claims linking MMR vaccine with autism	BRITISH MEDICAL JOURNAL			English	News Item																		BabyJabs, MMR VACC	1	1	1	0	17	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 9	2012	345								e5420	10.1136/bmj.e5420	http://dx.doi.org/10.1136/bmj.e5420			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988NF	22879643				2022-12-28	WOS:000307497000004
J	Rabar, S; Lau, R; O'Flynn, N; Li, LL; Barry, P				Rabar, Silvia; Lau, Rosa; O'Flynn, Norma; Li, Lilian; Barry, Peter		Guideline Dev Grp	Risk assessment of fragility fractures: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Rabar, Silvia; Lau, Rosa; O'Flynn, Norma; Li, Lilian] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England; [Barry, Peter] Leicester Royal Infirm, Dept Child Hlth, Leicester LE2 7LX, Leics, England	Royal College of Physicians; University of Leicester	Rabar, S (corresponding author), Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England.	silvia.rabar@rcplondon.ac.uk	Collins, Gary Stephen/A-2258-2014	Collins, Gary Stephen/0000-0002-2772-2316; Selby, Peter/0000-0001-9465-9268				Kanis JA, 2007, 20041068 USGS; National Institute for Health and Care Excellence, 2012, NICE CLIN GUID 146 O	2	55	54	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 8	2012	345								e3698	10.1136/bmj.e3698	http://dx.doi.org/10.1136/bmj.e3698			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988ND	22875946				2022-12-28	WOS:000307496800008
J	Thorne, KS				Thorne, Kip S.			Classical Black Holes: The Nonlinear Dynamics of Curved Spacetime	SCIENCE			English	Editorial Material								Numerical simulations have revealed two types of physical structures, made from curved spacetime, that are attached to black holes: tendexes, which stretch or squeeze anything they encounter, and vortexes, which twist adjacent inertial frames relative to each other. When black holes collide, their tendexes and vortexes interact and oscillate (a form of nonlinear dynamics of curved spacetime). These oscillations generate gravitational waves, which can give kicks up to 4000 kilometers per second to the merged black hole. The gravitational waves encode details of the spacetime dynamics and will soon be observed and studied by the Laser Interferometer Gravitational Wave Observatory and its international partners.	CALTECH, Pasadena, CA 91125 USA	California Institute of Technology	Thorne, KS (corresponding author), CALTECH, Pasadena, CA 91125 USA.	kip@caltech.edu			Division Of Physics [1068881] Funding Source: National Science Foundation	Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))		Campanelli M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.231102; Carter B, 1979, GEN RELATIVITY EINST; Gonzalez JA, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.231101; Jaramillo JL, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.084030; LIGO Scientific Collaboration and Virgo Collaboration, SENS ACH LIGO VIRG G; Lovelace G, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.064031; Owen R, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.151101; Pfeiffer H. P., CLASS QUANT IN PRESS; Wheeler J.A., 1962, GEOMETRODYNAMICS; Witten E, 2012, SCIENCE, V337, P538, DOI 10.1126/science.1221693	10	4	4	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2012	337	6094					536	538		10.1126/science.1225474	http://dx.doi.org/10.1126/science.1225474			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982PU	22859479				2022-12-28	WOS:000307058700031
J	Sobotnik, J; Bourguignon, T; Hanus, R; Demianova, Z; Pytelkova, J; Mares, M; Foltynova, P; Preisler, J; Cvacka, J; Krasulova, J; Roisin, Y				Sobotnik, J.; Bourguignon, T.; Hanus, R.; Demianova, Z.; Pytelkova, J.; Mares, M.; Foltynova, P.; Preisler, J.; Cvacka, J.; Krasulova, J.; Roisin, Y.			Explosive Backpacks in Old Termite Workers	SCIENCE			English	Article									[Sobotnik, J.; Hanus, R.; Demianova, Z.; Pytelkova, J.; Mares, M.; Cvacka, J.; Krasulova, J.] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Prague 16610, Czech Republic; [Bourguignon, T.; Hanus, R.; Roisin, Y.] Univ Libre Bruxelles, B-1050 Brussels, Belgium; [Bourguignon, T.] Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido 0600810, Japan; [Foltynova, P.; Preisler, J.] Masaryk Univ, Fac Sci, CEITEC Cent European Inst Technol, Brno 62500, Czech Republic; [Foltynova, P.; Preisler, J.] Masaryk Univ, Fac Sci, Dept Chem, Brno 62500, Czech Republic; [Krasulova, J.] Charles Univ Prague, Fac Sci, Dept Analyt Chem, Prague 12843, Czech Republic	Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Universite Libre de Bruxelles; Hokkaido University; Masaryk University Brno; Masaryk University Brno; Charles University Prague	Hanus, R (corresponding author), Acad Sci Czech Republ, Inst Organ Chem & Biochem, Prague 16610, Czech Republic.	robert@uochb.cas.cz	Hanus, Robert/D-4765-2013; Preisler, Jan/B-2005-2009; Pytelkova, Jana/G-6179-2014; Cvačka, Josef/A-6126-2014; Krasulova, Jana/G-8107-2014; Mares, Michael/B-2413-2009; Foltynova, Pavla/B-6856-2012	Hanus, Robert/0000-0002-7054-1975; Preisler, Jan/0000-0002-9819-1284; Cvačka, Josef/0000-0002-3590-9009; Mares, Michael/0000-0002-0847-5022; Foltynova, Pavla/0000-0002-4768-1910; demianova, zuzana/0000-0003-2822-2177; Roisin, Yves/0000-0001-6635-3552; Sobotnik, Jan/0000-0002-8581-637X; Bourguignon, Thomas/0000-0002-4035-8977	Fund for Scientific Research (F.R.S.-FNRS, Belgium); Japan Society for Promotion of Science [22-00393]; Grant Agency of the Czech Republic [P600/525/09, P206/12/0538]; Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic [Z40550506]; CEITEC from the European Regional Development Fund [CZ.1.05/1.1.00/02.0068]	Fund for Scientific Research (F.R.S.-FNRS, Belgium)(Fonds de la Recherche Scientifique - FNRS); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic(Czech Academy of Sciences); CEITEC from the European Regional Development Fund	We are grateful to P. Cerdan and the staff of the Hydreco lab at Petit Saut for logistical help. Support was provided by the Fund for Scientific Research (F.R.S.-FNRS, Belgium); the Japan Society for Promotion of Science (no. 22-00393); the Grant Agency of the Czech Republic (P600/525/09, P206/12/0538); the Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic (Z40550506); and the project CEITEC (CZ.1.05/1.1.00/02.0068) from the European Regional Development Fund. The data reported in this paper are presented in the supplementary materials.	Bourguignon T, 2011, ECOL ENTOMOL, V36, P261, DOI 10.1111/j.1365-2311.2011.01265.x; Decker H, 2000, TRENDS BIOCHEM SCI, V25, P392, DOI 10.1016/S0968-0004(00)01602-9; Holldobler B., 1990, pi; Kaiser P., 1956, Mitteilungen der Hamburgischen Zoologischen Museum, V54, P129; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; Shorter JR, 2012, INSECT SOC, V59, P1, DOI 10.1007/s00040-011-0210-x; Sobotnik J, 2010, J INSECT PHYSIOL, V56, P1012, DOI 10.1016/j.jinsphys.2010.02.012	7	46	49	1	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 27	2012	337	6093					436	436		10.1126/science.1219129	http://dx.doi.org/10.1126/science.1219129			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979FS	22837520				2022-12-28	WOS:000306802300034
J	Wong, GKL; Kang, MS; Lee, HW; Biancalana, F; Conti, C; Weiss, T; Russell, PS				Wong, G. K. L.; Kang, M. S.; Lee, H. W.; Biancalana, F.; Conti, C.; Weiss, T.; Russell, P. St J.			Excitation of Orbital Angular Momentum Resonances in Helically Twisted Photonic Crystal Fiber	SCIENCE			English	Article							SINGLE-MODE FIBERS; LONG-PERIOD FIBER; GRATINGS; FABRICATION; LIGHT	Spiral twisting offers additional opportunities for controlling the loss, dispersion, and polarization state of light in optical fibers with noncircular guiding cores. Here, we report an effect that appears in continuously twisted photonic crystal fiber. Guided by the helical lattice of hollow channels, cladding light is forced to follow a spiral path. This diverts a fraction of the axial momentum flow into the azimuthal direction, leading to the formation of discrete orbital angular momentum states at wavelengths that scale linearly with the twist rate. Core-guided light phase-matches topologically to these leaky states, causing a series of dips in the transmitted spectrum. Twisted photonic crystal fiber has potential applications in, for example, band-rejection filters and dispersion control.	[Wong, G. K. L.; Kang, M. S.; Lee, H. W.; Biancalana, F.; Conti, C.; Weiss, T.; Russell, P. St J.] Max Planck Inst Sci Light, D-91058 Erlangen, Germany; [Russell, P. St J.] Univ Erlangen Nurnberg, Dept Phys, D-91058 Erlangen, Germany	Max Planck Society; University of Erlangen Nuremberg	Wong, GKL (corresponding author), Max Planck Inst Sci Light, Guenther Scharowsky Str 1, D-91058 Erlangen, Germany.	gordon.wong@mpl.mpg.de	Kang, Myeongsoo/H-4320-2012; Weiss, Thomas/AAS-9946-2021; Conti, Claudio/E-9899-2012; Russell, Philip St.J./G-5132-2012; Wong, Gordon/AHA-9432-2022; Lee, Ho Wai/I-5409-2012; Lee, Ho Wai/A-9259-2012	Weiss, Thomas/0000-0002-4991-6779; Conti, Claudio/0000-0003-2583-3415; Russell, Philip St.J./0000-0002-8972-2477; Wong, Gordon/0000-0001-7864-4525; Lee, Howard (Ho Wai)/0000-0003-3962-3726; Biancalana, Fabio/0000-0002-4093-7688				Allen L, 1999, PROG OPTICS, V39, P291, DOI 10.1016/s0079-6638(08)70391-3; ALLEN L, 1992, PHYS REV A, V45, P8185, DOI 10.1103/PhysRevA.45.8185; BARLOW AJ, 1981, APPL OPTICS, V20, P2962, DOI 10.1364/AO.20.002962; Barnett SM, 2002, J OPT B-QUANTUM S O, V4, pS7, DOI 10.1088/1464-4266/4/2/361; Birks TA, 1997, OPT LETT, V22, P961, DOI 10.1364/OL.22.000961; Churikov VM, 2010, OPT LETT, V35, P342, DOI 10.1364/OL.35.000342; Ivanov OV, 2005, OPT LETT, V30, P3290, DOI 10.1364/OL.30.003290; Jauregui C, 2005, OPT LETT, V30, P14, DOI 10.1364/OL.30.000014; Kopp VI, 2004, SCIENCE, V305, P74, DOI 10.1126/science.1097631; Ma XQ, 2011, OPT EXPRESS, V19, P26515, DOI 10.1364/OE.19.026515; MONERIE M, 1980, OPT QUANT ELECTRON, V12, P449, DOI 10.1007/BF00619919; Oh ST, 2004, OPT LETT, V29, P1464, DOI 10.1364/OL.29.001464; Russell PSJ, 2006, J LIGHTWAVE TECHNOL, V24, P4729, DOI 10.1109/JLT.2006.885258; Shin W, 2009, OPT COMMUN, V282, P3456, DOI 10.1016/j.optcom.2009.05.063; ULRICH R, 1979, APPL OPTICS, V18, P2241, DOI 10.1364/AO.18.002241	15	224	235	11	230	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2012	337	6093					446	449		10.1126/science.1223824	http://dx.doi.org/10.1126/science.1223824			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979FS	22837523				2022-12-28	WOS:000306802300037
J	Perez-Velez, CM; Marais, BJ				Perez-Velez, Carlos M.; Marais, Ben J.			CURRENT CONCEPTS Tuberculosis in Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							INTRATHORACIC TUBERCULOSIS; PULMONARY TUBERCULOSIS; ANTIRETROVIRAL THERAPY; DRUG-RESISTANT; ISONIAZID PROPHYLAXIS; SOUTH-AFRICA; HIV; EPIDEMIOLOGY; DIAGNOSIS; CONSENSUS	Widespread implementation of the strategy of directly observed treatment short course (DOTS) during the 1990s resulted in improved global control of tuberculosis.(1) However, its effectiveness has been limited in areas where poverty and infection with the human immunodeficiency virus (HIV) or drug-resistant tuberculosis are prevalent, and the emphasis on a positive sputum smear as the diagnostic criterion actually excludes most children from care.(2) Tuberculosis remains a major but often unrecognized cause of disease and death among children in areas where the disease is endemic(3); service delivery in such areas is hampered by the absence of pragmatic strategies to guide diagnosis and management. This article provides a brief overview of basic principles, current controversies, and recent advances related to the care of children with tuberculosis, with an emphasis on intrathoracic disease.	[Marais, Ben J.] Univ Sydney, Sch Clin, Childrens Hosp Westmead, Sydney, NSW 2145, Australia; [Marais, Ben J.] Sydney Emerging Infect & Biosecur Inst, Sydney, NSW, Australia; [Perez-Velez, Carlos M.] IPS Univ Antioquia, Grp TB Valle Colorado & Clin Leon XIII, Medellin, Colombia	University of Sydney; Universidad de Antioquia	Marais, BJ (corresponding author), Univ Sydney, Sch Clin, Childrens Hosp Westmead, Locked Bag 4001, Sydney, NSW 2145, Australia.	ben.marais@health.nsw.gov.au	Marais, Ben/AAX-2626-2021					Andrews JR, 2012, CLIN INFECT DIS, V54, P784, DOI 10.1093/cid/cir951; Andronikou S, 2009, CLIN CHEST MED, V30, P717, DOI 10.1016/j.ccm.2009.08.022; [Anonymous], 2010, GUID NAT TUB HIV PRO; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Cotton MF, 2008, INT J TUBERC LUNG D, V12, P225; Cuevas LE, 2012, J INFECT DIS, V205, pS209, DOI 10.1093/infdis/jir879; Donald PR, 2010, LANCET, V375, P1852, DOI 10.1016/S0140-6736(10)60580-6; Drobniewski F, 2005, JAMA-J AM MED ASSOC, V293, P2726, DOI 10.1001/jama.293.22.2726; Edwards DJ, 2007, INT J TUBERC LUNG D, V11, P263; Ettehad D, 2012, LANCET INFECT DIS, V12, P449, DOI 10.1016/S1473-3099(12)70033-6; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gie R., 2003, DIAGNOSTIC ATLAS INT; Gomes VF, 2011, THORAX, V66, P163, DOI 10.1136/thx.2010.141309; Graham SM, 2012, J INFECT DIS, V205, pS199, DOI 10.1093/infdis/jis008; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hatherill M, 2012, CLIN INFECT DIS, V54, P493, DOI 10.1093/cid/cir823; Hatherill M, 2010, B WORLD HEALTH ORGAN, V88, P312, DOI 10.2471/BLT.09.062893; Hesseling AC, 2009, CLIN INFECT DIS, V48, P108, DOI 10.1086/595012; Hesseling AC, 2002, INT J TUBERC LUNG D, V6, P1038; Hill PC, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001105; International Union Against Tuberculosis and Lung Disease, 2010, DESK GUID DIAGN MAN; Lawn SD, 2006, CLIN INFECT DIS, V42, P1040, DOI 10.1086/501018; Lincoln EM, 1963, TUBERCULOSIS CHILDRE, P1; Madhi SA, 2011, NEW ENGL J MED, V365, P21, DOI 10.1056/NEJMoa1011214; Marais BJ, 2006, PEDIATRICS, V118, pE1350, DOI 10.1542/peds.2006-0519; Marais BJ, 2010, LANCET, V375, P2179, DOI 10.1016/S0140-6736(10)60554-5; Marais BJ, 2010, LANCET, V375, P2057, DOI 10.1016/S0140-6736(10)60579-X; Marais BJ, 2009, CLIN CHEST MED, V30, P827, DOI 10.1016/j.ccm.2009.08.012; Marais BJ, 2004, INT J TUBERC LUNG D, V8, P392; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Menzies HJ, 2010, AM J PUBLIC HEALTH, V100, P1724, DOI 10.2105/AJPH.2009.181289; MIDDLEBROOK G, 1953, SCIENCE, V118, P297, DOI 10.1126/science.118.3063.297; Moss AR, 1997, INT J TUBERC LUNG D, V1, P115; Munoz FM, 2002, INFECT CONT HOSP EP, V23, P568, DOI 10.1086/501972; Nelson LJ, 2004, INT J TUBERC LUNG D, V8, P636; Newton SM, 2008, LANCET INFECT DIS, V8, P498, DOI 10.1016/S1473-3099(08)70182-8; Nicol MP, 2011, LANCET INFECT DIS, V11, P819, DOI 10.1016/S1473-3099(11)70167-0; Nicol MP, 2011, PAEDIATR RESPIR REV, V12, P16, DOI 10.1016/j.prrv.2010.09.008; Perez-Velez CM, 2010, AM J RESP CRIT CARE, V181; Pienaar M, 2009, CHILD NERV SYST, V25, P941, DOI 10.1007/s00381-008-0785-3; Rachow A, 2012, CLIN INFECT DIS, V54, P1388, DOI 10.1093/cid/cis190; Sandgren A, 2011, EUROSURVEILLANCE, V16; Schaaf HS, 2011, PAEDIATR RESPIR REV, V12, P31, DOI 10.1016/j.prrv.2010.09.010; Schaaf HS, 2006, ACTA PAEDIATR, V95, P523, DOI 10.1080/08035250600675741; Spyridis NP, 2007, CLIN INFECT DIS, V45, P715, DOI 10.1086/520983; Sterling TR, 2011, NEW ENGL J MED, V365, P2155, DOI 10.1056/NEJMoa1104875; Torok ME, 2011, CLIN INFECT DIS, V52, P1374, DOI 10.1093/cid/cir230; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; Vargas D, 2005, LANCET, V365, P150, DOI 10.1016/S0140-6736(05)17705-8; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Volmink J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003510.pub2; WALLGREN A, 1948, Tubercle, V29, P245, DOI 10.1016/S0041-3879(48)80033-4; WHO, 2010, WHOHTMTB201013; World Health Organisation, 2011, WHOHTMTB201116; World Health Organization, 2011, GUID INT TB CAS FIND; World Health Organization, 2011, US TUB INT GAMM REL; World Health Organization, 2007, WKLY EPIDEMIOL REC, V82, P193; World Health Organization, 2010, WHOHTMTB20103; Wright CA, 2009, INT J TUBERC LUNG D, V13, P1467; Zar HJ, 2007, BRIT MED J, V334, P136, DOI 10.1136/bmj.39000.486400.55	60	334	351	1	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 26	2012	367	4					348	361		10.1056/NEJMra1008049	http://dx.doi.org/10.1056/NEJMra1008049			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	978KD	22830465				2022-12-28	WOS:000306738300009
J	Sultan, HY; Boyle, AA; Sheppard, N				Sultan, Helen Yasmin; Boyle, Adrian A.; Sheppard, Nicholas			Necrotising fasciitis	BRITISH MEDICAL JOURNAL			English	Editorial Material							SOFT-TISSUE INFECTIONS; DIAGNOSIS; MORTALITY; MANAGEMENT; MICROBIOLOGY; DETERMINANTS; EXPERIENCE		[Boyle, Adrian A.] Addenbrookes Hosp, Emergency Dept, Cambridge CB2 2QQ, England; [Sultan, Helen Yasmin] W Suffolk Hosp, Emergency Dept, Bury St Edmunds IP33 2QZ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Boyle, AA (corresponding author), Addenbrookes Hosp, Emergency Dept, Hills Rd, Cambridge CB2 2QQ, England.	adrian.boyle@addenbrookes.nhs.uk		Boyle, Adrian/0000-0002-9009-5423				Anaya DA, 2007, CLIN INFECT DIS, V44, P705, DOI 10.1086/511638; Angoules AG, 2007, INJURY, V38, pS19, DOI 10.1016/j.injury.2007.10.030; Bilton BD, 1998, AM SURGEON, V64, P397; Childers BJ, 2002, AM SURGEON, V68, P109; Eggert J, 2009, WOUNDS, V21, P74; Elliott DC, 1996, ANN SURG, V224, P672, DOI 10.1097/00000658-199611000-00011; Frazee BW, 2008, J EMERG MED, V34, P139, DOI 10.1016/j.jemermed.2007.03.041; Hasham S, 2005, BMJ-BRIT MED J, V330, P830, DOI 10.1136/bmj.330.7495.830; Haywood CT, 1999, PLAST RECONSTR SURG, V103, P1567, DOI 10.1097/00006534-199905060-00003; Hefny AF, 2007, EUR J EMERG MED, V14, P50, DOI 10.1097/01.mej.0000228447.48276.7b; Hsieh T, 2000, CAN MED ASSOC J, V163, P393; Hung CC, 1996, J FORMOS MED ASSOC, V95, P917; Majeski J, 1997, SOUTHERN MED J, V90, P1065, DOI 10.1097/00007611-199711000-00001; MCHENRY CR, 1995, ANN SURG, V221, P558, DOI 10.1097/00000658-199505000-00013; Navqi G, 2009, SCAND J TRAUMA RESUS, V17, P28; Schmid MR, 1998, AM J ROENTGENOL, V170, P615, DOI 10.2214/ajr.170.3.9490940; Taviloglu Korhan, 2007, World J Emerg Surg, V2, P19, DOI 10.1186/1749-7922-2-19; Tunovic E, 2012, J BURN CARE RES, V33, P93, DOI 10.1097/BCR.0b013e318239d571; Wang YS, 2007, INT J DERMATOL, V46, P1036, DOI 10.1111/j.1365-4632.2007.03201.x; Wong CH, 2004, CRIT CARE MED, V32, P1535, DOI 10.1097/01.CCM.0000129486.35458.7D; Wong CH, 2003, J BONE JOINT SURG AM, V85A, P1454, DOI 10.2106/00004623-200308000-00005; Yen ZS, 2002, ACAD EMERG MED, V9, P1448, DOI 10.1111/j.1553-2712.2002.tb01619.x; Young Michael H, 2005, Expert Rev Anti Infect Ther, V3, P279, DOI 10.1586/14787210.3.2.279; Zacharias N, 2010, ARCH SURG-CHICAGO, V145, P452, DOI 10.1001/archsurg.2010.50	24	31	31	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUL 20	2012	345								e4274	10.1136/bmj.e4274	http://dx.doi.org/10.1136/bmj.e4274			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	978MD	22822005				2022-12-28	WOS:000306744600001
J	Blumberg, N; Heal, JM; Phillips, GL; Phipps, RP				Blumberg, Neil; Heal, Joanna M.; Phillips, Gordon L.; Phipps, Richard P.			Platelets-to transfuse or not to transfuse	LANCET			English	Editorial Material							THROMBOSIS; INFLAMMATION; MORTALITY; OUTCOMES; SURGERY		[Blumberg, Neil; Heal, Joanna M.; Phipps, Richard P.] Univ Rochester, Med Ctr, Dept Pathol, Rochester, NY 14642 USA; [Blumberg, Neil; Heal, Joanna M.; Phipps, Richard P.] Univ Rochester, Med Ctr, Dept Lab Med, Rochester, NY 14642 USA; [Phillips, Gordon L.] Univ Rochester, Med Ctr, Dept Med, Rochester, NY 14642 USA; [Phipps, Richard P.] Univ Rochester, Med Ctr, Dept Environm Med, Rochester, NY 14642 USA; [Phipps, Richard P.] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester	Blumberg, N (corresponding author), Univ Rochester, Med Ctr, Dept Pathol, Rochester, NY 14642 USA.	neil_blumberg@urmc.rochester.edu						Blumberg N, 2008, LEUKEMIA, V22, P631, DOI 10.1038/sj.leu.2404920; Blumberg N, 2001, TRANSFUSION, V41, P790, DOI 10.1046/j.1537-2995.2001.41060790.x; Blumberg N, 2009, IMMUNOL RES, V45, P251, DOI 10.1007/s12026-009-8106-9; Cognasse F, 2006, TRANSFUSION, V46, P1184, DOI 10.1111/j.1537-2995.2006.00869.x; Dineen SP, 2009, J SURG RES, V153, P132, DOI 10.1016/j.jss.2008.04.013; Khorana AA, 2008, ARCH INTERN MED, V168, P2377, DOI 10.1001/archinte.168.21.2377; Refaai MA, 2011, THROMB RES, V127, P287, DOI 10.1016/j.thromres.2010.10.012; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; Slichter SJ, 2010, NEW ENGL J MED, V362, P600, DOI 10.1056/NEJMoa0904084; Spiess BD, 2004, TRANSFUSION, V44, P1143, DOI 10.1111/j.1537-2995.2004.03322.x; Wagner DD, 2003, ARTERIOSCL THROM VAS, V23, P2131, DOI 10.1161/01.ATV.0000095974.95122.EC; Wandt H, 2012, LANCET; Zeidler K, 2011, TRANSFUSION, V51, P2269, DOI 10.1111/j.1537-2995.2011.03147.x	13	21	21	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 13	2012	380	9850					1287	1289		10.1016/S0140-6736(12)60983-0	http://dx.doi.org/10.1016/S0140-6736(12)60983-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	022BZ	22877505				2022-12-28	WOS:000309931400006
J	Brooks, MJ; Iyer, R				Brooks, Matthew J.; Iyer, Ravi			Coronary Arteritis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Brooks, Matthew J.; Iyer, Ravi] Royal Melbourne Hosp, Melbourne, Vic, Australia	Royal Melbourne Hospital	Brooks, MJ (corresponding author), Royal Melbourne Hosp, Melbourne, Vic, Australia.								0	5	5	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 16	2012	367	7					658	658		10.1056/NEJMicm1103097	http://dx.doi.org/10.1056/NEJMicm1103097			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988NB	22894578				2022-12-28	WOS:000307496600009
J	Grosskopf, T; Mohr, W; Baustian, T; Schunck, H; Gill, D; Kuypers, MMM; Lavik, G; Schmitz, RA; Wallace, DWR; LaRoche, J				Grosskopf, Tobias; Mohr, Wiebke; Baustian, Tina; Schunck, Harald; Gill, Diana; Kuypers, Marcel M. M.; Lavik, Gaute; Schmitz, Ruth A.; Wallace, Douglas W. R.; LaRoche, Julie			Doubling of marine dinitrogen-fixation rates based on direct measurements	NATURE			English	Article							TROPICAL NORTH-ATLANTIC; NITROGEN-FIXATION; N-2 FIXATION; OCEAN; SEQUESTRATION; DISTRIBUTIONS; CYCLE; IRON	Biological dinitrogen fixation provides the largest input of nitrogen to the oceans, therefore exerting important control on the ocean's nitrogen inventory and primary productivity(1-3). Nitrogen-isotope data from ocean sediments suggest that the marine-nitrogen inventory has been balanced for the past 3,000 years (ref. 4). Producing a balanced marine-nitrogen budget based on direct measurements has proved difficult, however, with nitrogen loss exceeding the gain from dinitrogen fixation by approximately 200 TgNyr(-1) (refs 5, 6). Here we present data from the Atlantic Ocean and show that the most widely used method of measuring oceanic N-2-fixation rates(7) underestimates the contribution of N-2-fixing microorganisms (diazotrophs) relative to a newly developed method(8). Using molecular techniques to quantify the abundance of specific clades of diazotrophs in parallel with rates of N-15(2) incorporation into particulate organic matter, we suggest that the difference between N-2-fixation rates measured with the established method(7) and those measured with the new method8 can be related to the composition of the diazotrophic community. Our data show that in areas dominated by Trichodesmium, the established method underestimates N-2-fixation rates by an average of 62%. We also find that the newly developed method yields N-2-fixation rates more than six times higher than those from the established method when unicellular, symbiotic cyanobacteria and c-proteobacteria dominate the diazotrophic community. On the basis of average areal rates measured over the Atlantic Ocean, we calculated basin-wide N-2-fixation rates of 14 +/- 1 Tg N yr(-1) and 24 +/- 1 Tg N yr(-1) for the established and new methods, respectively. If our findings can be extrapolated to other ocean basins, this suggests that the global marine N-2-fixation rate derived from direct measurements may increase from 103 +/- 8 Tg N yr(-1) to 177 +/- 8 Tg N yr(-1), and that the contribution of N-2 fixers other than Trichodesmium is much more significant than was previously thought.	[Grosskopf, Tobias; Mohr, Wiebke; Baustian, Tina; Schunck, Harald; Gill, Diana; LaRoche, Julie] Helmholtz Ctr Ocean Res Kiel GEOMAR, D-24105 Kiel, Germany; [Kuypers, Marcel M. M.; Lavik, Gaute] Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany; [Schmitz, Ruth A.] Univ Kiel, Inst Gen Microbiol, D-24118 Kiel, Germany; [Wallace, Douglas W. R.] Dalhousie Univ, Dept Oceanog, Halifax, NS B3H 4R2, Canada	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Max Planck Society; University of Kiel; Dalhousie University	LaRoche, J (corresponding author), Dalhousie Univ, Dept Biol, 1355 Oxford St,POB 1500, Halifax, NS B3H 4R2, Canada.	tgrosskopf@geomar.de; julie.laroche@dal.ca	LaRoche, Julie/A-1109-2010; Lavik, Gaute/F-6578-2013	Schmitz-Streit, Ruth Anne/0000-0002-6788-0829; LaRoche, Julie/0000-0003-4809-6411; Mohr, Wiebke/0000-0002-1126-1455	Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 754]; Max Planck Gesellschaft; Bundesministerium fur Bildung und Forschung (BMBF) [03F0611A]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Gesellschaft(Max Planck Society); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	We thank G. Klockgether and T. Max for mass-spectrometry measurements. We thank S. Fehsenfeld for helping with sampling and H. Nurlaeli for experimental work on Nodularia. We also thank the captain and crew of RV Meteor and RV Polarstern, as well as the chief scientists, P. Brandt and A. Macke. We thank D. Desai for statistical analyses. This work is a contribution of the Sonderforschungsbereich 754 'Climate - Biogeochemistry Interactions in the Tropical Ocean', which is supported by the Deutsche Forschungsgemeinschaft. We thank the Max Planck Gesellschaft for financial support. We thank the Bundesministerium fur Bildung und Forschung (BMBF) for financial support through the SOPRAN II (Surface Ocean Processes in the Anthropocene) project, grant number 03F0611A.	Altabet MA, 2007, BIOGEOSCIENCES, V4, P75, DOI 10.5194/bg-4-75-2007; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Codispoti LA, 2007, BIOGEOSCIENCES, V4, P233, DOI 10.5194/bg-4-233-2007; Deutsch C, 2007, NATURE, V445, P163, DOI 10.1038/nature05392; Duce RA, 2008, SCIENCE, V320, P893, DOI 10.1126/science.1150369; Falkowski PG, 1997, NATURE, V387, P272, DOI 10.1038/387272a0; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Farnelid H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019223; Fernandez C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020539; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Halm H, 2012, ISME J, V6, P1238, DOI 10.1038/ismej.2011.182; Hamersley MR, 2011, AQUAT MICROB ECOL, V63, P193, DOI 10.3354/ame01494; Karl D, 2002, BIOGEOCHEMISTRY, V57, P47, DOI 10.1023/A:1015798105851; Langlois RJ, 2008, APPL ENVIRON MICROB, V74, P1922, DOI 10.1128/AEM.01720-07; Langlois RJ, 2005, APPL ENVIRON MICROB, V71, P7910, DOI 10.1128/AEM.71.12.7910-7919.2005; Luo YW, 2012, EARTH SYST SCI DATA, V4, P47, DOI 10.5194/essd-4-47-2012; Mahaffey C, 2005, AM J SCI, V305, P546, DOI 10.2475/ajs.305.6-8.546; Mills MM, 2004, NATURE, V429, P292, DOI 10.1038/nature02550; Mohr W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012583; Moisander PH, 2010, SCIENCE, V327, P1512, DOI 10.1126/science.1185468; Montoya JP, 1996, APPL ENVIRON MICROB, V62, P986, DOI 10.1128/AEM.62.3.986-993.1996; Moore CM, 2009, NAT GEOSCI, V2, P867, DOI 10.1038/ngeo667; Moore JK, 2006, TELLUS B, V58, P560, DOI 10.1111/j.1600-0889.2006.00209.x; Naqvi SWA, 2000, NATURE, V408, P346, DOI 10.1038/35042551; Subramaniam A, 2008, P NATL ACAD SCI USA, V105, P10460, DOI 10.1073/pnas.0710279105; Zehr JP, 2008, SCIENCE, V322, P1110, DOI 10.1126/science.1165340; Zehr JP, 2001, NATURE, V412, P635, DOI 10.1038/35088063	28	226	233	3	221	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2012	488	7411					361	364		10.1038/nature11338	http://dx.doi.org/10.1038/nature11338			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OS	22878720	Green Accepted			2022-12-28	WOS:000307501000038
J	Ferrannini, E; Cushman, WC				Ferrannini, Ele; Cushman, William C.			Diabetes and hypertension: the bad companions	LANCET			English	Article							BLOOD-PRESSURE CONTROL; CARDIOVASCULAR-DISEASE RISK; CORONARY-HEART-DISEASE; INSULIN-RESISTANCE; MICROVASCULAR COMPLICATIONS; ANTIHYPERTENSIVE TREATMENT; INDUCED VASODILATATION; VASCULAR REACTIVITY; SKELETAL-MUSCLE; MELLITUS	High blood pressure is reported in over two-thirds of patients with type 2 diabetes, and its development coincides with the development of hyperglycaemia. Many pathophysiological mechanisms underlie this association. Of these mechanisms, insulin resistance in the nitric-oxide pathway; the stimulatory effect of hyperinsulinaemia on sympathetic drive, smooth muscle growth, and sodium-fluid retention; and the excitatory effect of hyperglycaemia on the renin-angiotensin-aldosterone system seem to be plausible. In patients with diabetes, hypertension confers an enhanced risk of cardiovascular disease. A blood pressure of lower than 140/85 mm Hg is a reasonable therapeutic goal in patients with type 2 diabetes according to clinical trial evidence. People with controlled diabetes have a similar cardiovascular risk to patients without diabetes but with hypertension. A renin-angiotensin system blocker combined with a thiazide-type diuretic might be the best initial antihypertensive regimen for most people with diabetes. In general, the positive effects of antihypertensive drugs on cardiovascular outcomes outweigh the negative effects of antihypertensive drugs on glucose metabolism.	[Ferrannini, Ele] Univ Pisa, Dept Internal Med, I-56100 Pisa, Italy; [Cushman, William C.] Univ Tennessee, Hlth Sci Ctr, Vet Affairs Med Ctr, Dept Prevent Med, Memphis, TN USA	University of Pisa; University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center	Ferrannini, E (corresponding author), Univ Pisa, Dept Internal Med, I-56100 Pisa, Italy.	ferranni@ifc.cnr.it			Merck	Merck(Merck & Company)	EF declares that he has no conflicts of interest. For the year 2011-12, WCC has been a consultant for Takeda, AstraZeneca, Merck, Omron, and Daiichi Sankyo, and his institution has received a research grant from Merck.	Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; Arguedas JA, 2010, CURR OPIN CARDIOL, V25, P350, DOI 10.1097/HCO.0b013e32833a6dee; Alderman MH, 2003, HYPERTENSION, V42, P239, DOI 10.1161/01.HYP.0000086521.95630.5A; ANDERSON EA, 1991, J CLIN INVEST, V87, P2246, DOI 10.1172/JCI115260; Anfossi Giovanni, 2009, Archives of Physiology and Biochemistry, V115, P199, DOI 10.1080/13813450903136791; [Anonymous], 1967, J AMER MED ASSOC, V202, P1028, DOI 10.1001/jama.1967.03130240070013; [Anonymous], 1985, PREV MED, V14, P312; Avogaro A, 2007, DIABETES CARE, V30, P1241, DOI 10.2337/dc06-2558; Bakris GL, 2004, JAMA-J AM MED ASSOC, V292, P2227, DOI 10.1001/jama.292.18.2227; Bangalore S, 2011, CIRCULATION, V123, P2799, DOI 10.1161/CIRCULATIONAHA.110.016337; BARRETTCONNOR E, 1981, AM J EPIDEMIOL, V113, P276, DOI 10.1093/oxfordjournals.aje.a113097; Barzilay JI, 2012, CIRC-CARDIOVASC QUAL, V5, P153, DOI 10.1161/CIRCOUTCOMES.111.962522; BENHAMOU PY, 1992, DIABETES CARE, V15, P1614, DOI 10.2337/diacare.15.11.1614; Buse JB, 2007, AM J CARDIOL, V99, p21I, DOI 10.1016/j.amjcard.2007.03.003; Carmassi F, 1999, AM J MED, V107, P344, DOI 10.1016/S0002-9343(99)00240-5; Chen GM, 2011, HYPERTENSION, V57, P891, DOI 10.1161/HYPERTENSIONAHA.110.162446; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Conway B, 2010, DIABETIC MED, V27, P398, DOI 10.1111/j.1464-5491.2010.02956.x; Cooper-DeHoff RM, 2010, JAMA-J AM MED ASSOC, V304, P61, DOI 10.1001/jama.2010.884; CREAGER MA, 1990, J CLIN INVEST, V86, P228, DOI 10.1172/JCI114688; Curb JD, 1996, JAMA-J AM MED ASSOC, V276, P1886, DOI 10.1001/jama.276.23.1886; Cushman WC, 2007, AM J CARDIOL S, V99, p4i; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; DEFRONZO RA, 1980, AM J PHYSIOL, V238, pE421, DOI 10.1152/ajpendo.1980.238.5.E421; DENKER PS, 1992, ARCH INTERN MED, V152, P1649, DOI 10.1001/archinte.152.8.1649; DUVFLOREY C, 1976, BRIT MED J, V1, P1368, DOI 10.1136/bmj.1.6022.1368; Effects of treatment on morbidity in hypertension, 1970, JAMA-J AM MED ASSOC, V213, P1143, DOI DOI 10.1001/JAMA.213.7.1143; Elliott WJ, 2007, LANCET, V369, P201, DOI 10.1016/S0140-6736(07)60108-1; Emdin M, 2001, CIRCULATION, V103, P513, DOI 10.1161/01.CIR.103.4.513; FERRANNINI E, 1987, NEW ENGL J MED, V317, P350, DOI 10.1056/NEJM198708063170605; FERRANNINI E, 1991, EUR J CLIN INVEST, V21, P280, DOI 10.1111/j.1365-2362.1991.tb01371.x; FERRANNINI E, 1992, J HYPERTENS, V10, P1417, DOI 10.1097/00004872-199211000-00015; Ferrannini E, 1994, TXB HYPERTENSION, P785; Ferrannini E, 2007, J CLIN ENDOCR METAB, V92, P2885, DOI 10.1210/jc.2007-0334; Fioretto P, 2008, DIABETOLOGIA, V51, P1347, DOI 10.1007/s00125-008-1051-7; Fox CS, 2010, TRENDS CARDIOVAS MED, V20, P90, DOI 10.1016/j.tcm.2010.08.001; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; GALVAN AQ, 1993, METABOLISM, V42, P1359, DOI 10.1016/0026-0495(93)90138-E; Gastaldelli A, 2000, AM J PHYSIOL-REG I, V279, pR2022, DOI 10.1152/ajpregu.2000.279.6.R2022; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Giorda CB, 2008, DIABETES CARE, V31, P2154, DOI 10.2337/dc08-1013; Greenlund KJ, 2004, ARCH INTERN MED, V164, P2113, DOI 10.1001/archinte.164.19.2113; HAFFNER SM, 1989, ARTERIOSCLEROSIS, V9, P928, DOI 10.1161/01.ATV.9.6.928; HAFFNER SM, 1992, HYPERTENSION, V20, P38, DOI 10.1161/01.HYP.20.1.38; HAFFNER SM, 1992, DIABETES CARE, V15, P1277, DOI 10.2337/diacare.15.10.1277; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Heagerty AM, 2010, J CELL MOL MED, V14, P1037, DOI 10.1111/j.1582-4934.2010.01080.x; KANNEL WB, 1986, AM HEART J, V112, P825, DOI 10.1016/0002-8703(86)90481-3; KROLEWSKI AS, 1988, NEW ENGL J MED, V318, P140, DOI 10.1056/NEJM198801213180303; KROLEWSKI AS, 1985, J CHRON DIS, V38, P319, DOI 10.1016/0021-9681(85)90078-5; Kurukulasuriya LR, 2011, MED CLIN N AM, V95, P903, DOI 10.1016/j.mcna.2011.06.004; LEMBO G, 1992, J CLIN INVEST, V90, P24, DOI 10.1172/JCI115842; Lindholm LH, 2002, LANCET, V359, P1004, DOI 10.1016/S0140-6736(02)08090-X; Lindholm LH, 2005, LANCET, V366, P1545, DOI 10.1016/S0140-6736(05)67573-3; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; MEDALIE JH, 1975, ARCH INTERN MED, V135, P811, DOI 10.1001/archinte.135.6.811; MESSERLI FH, 1983, AM J MED, V74, P808, DOI 10.1016/0002-9343(83)91071-9; Muscelli E, 1996, AM J HYPERTENS, V9, P746, DOI 10.1016/0895-7061(96)00098-2; Natali A, 1997, CIRCULATION, V96, P849; NATALI A, 1994, J CLIN INVEST, V94, P1570, DOI 10.1172/JCI117498; Natali A, 2000, ARTERIOSCL THROM VAS, V20, P2401, DOI 10.1161/01.ATV.20.11.2401; Natali A, 2006, DIABETES, V55, P1133, DOI 10.2337/diabetes.55.04.06.db05-1076; Natali A, 1996, EUR J CLIN INVEST, V26, P556, DOI 10.1046/j.1365-2362.1996.1740521.x; NATALI A, 1991, HYPERTENSION, V17, P170, DOI 10.1161/01.HYP.17.2.170; Natali A, 2009, J HYPERTENS, V27, P2394, DOI 10.1097/HJH.0b013e3283316c31; Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8; Peti-Peterdi J, 2010, KIDNEY INT, V78, P1214, DOI 10.1038/ki.2010.333; Potenza MA, 2009, AM J PHYSIOL-ENDOC M, V297, pE568, DOI 10.1152/ajpendo.00297.2009; Price DA, 1999, AM J HYPERTENS, V12, P348, DOI 10.1016/S0895-7061(00)86960-5; Rask-Madsen C, 2012, ARTERIOSCL THROM VAS, V32, P1124, DOI 10.1161/ATVBAHA.111.239558; Rask-Madsen C, 2010, CELL METAB, V11, P379, DOI 10.1016/j.cmet.2010.03.013; REAVEN PD, 1990, DIABETES CARE, V13, P119, DOI 10.2337/diacare.13.2.119; ROWE JW, 1981, DIABETES, V30, P219, DOI 10.2337/diab.30.3.219; Saini SD, 2009, AM J MANAG CARE, V15, pE22; SALOMAA VV, 1991, BMJ-BRIT MED J, V302, P493, DOI 10.1136/bmj.302.6775.493; Schrier RW, 1996, DIABETOLOGIA, V39, P1646, DOI 10.1007/s001250050629; Sica DA, 2011, J CLIN HYPERTENS, V13, P639, DOI 10.1111/j.1751-7176.2011.00512.x; SIMPSON NE, 1969, ANN HUM GENET, V32, P283, DOI 10.1111/j.1469-1809.1969.tb00077.x; Sironi AM, 2004, HYPERTENSION, V44, P127, DOI 10.1161/01.HYP.0000137982.10191.0a; Sironi AM, 2008, HYPERTENSION, V51, P282, DOI 10.1161/HYPERTENSIONAHA.107.098640; Solini A, 2012, DIABETES CARE, V35, P143, DOI 10.2337/dc11-1380; SPRAFKA JM, 1988, DIABETES CARE, V11, P17, DOI 10.2337/diacare.11.1.17; Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6; STAMLER J, 1975, J CHRON DIS, V28, P499, DOI 10.1016/0021-9681(75)90059-4; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Stearne MR, 1998, BRIT MED J, V317, P713; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Steinberg HO, 2002, DIABETOLOGIA, V45, P623, DOI 10.1007/s00125-002-0800-2; TADDEI S, 1995, CIRCULATION, V92, P2911, DOI 10.1161/01.CIR.92.10.2911; TUCK M, 1990, AM J MED, V88, P210, DOI 10.1016/0002-9343(90)90144-3; Turnbull F, 2005, ARCH INTERN MED, V165, P1410; Vargas SL, 2009, J AM SOC NEPHROL, V20, P1002, DOI 10.1681/ASN.2008070740; Weber MA, 2010, J AM COLL CARDIOL, V56, P77, DOI 10.1016/j.jacc.2010.02.046; WELBORN TA, 1966, LANCET, V1, P1336; Whelton PK, 2005, ARCH INTERN MED, V165, P1401, DOI 10.1001/archinte.165.12.1401; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Yki-Jarvinen H, 1998, DIABETOLOGIA, V41, P369, DOI 10.1007/s001250050919; Zanchetti A, 2003, J HYPERTENS, V21, P797, DOI 10.1097/00004872-200304000-00024	99	369	387	5	69	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 11	2012	380	9841					601	610		10.1016/S0140-6736(12)60987-8	http://dx.doi.org/10.1016/S0140-6736(12)60987-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988SQ	22883509				2022-12-28	WOS:000307511400033
J	Goroll, AH; Schoenbaum, SC				Goroll, Allan H.; Schoenbaum, Stephen C.			Payment Reform for Primary Care Within the Accountable Care Organization A Critical Issue for Health System Reform	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Goroll, Allan H.] Massachusetts Gen Hosp, Gen Med Unit, Boston, MA 02114 USA; [Goroll, Allan H.] Harvard Univ, Sch Med, Boston, MA USA; [Schoenbaum, Stephen C.] Josiah Macy Jr Fdn, New York, NY USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Goroll, AH (corresponding author), Massachusetts Gen Hosp, Gen Med Unit, 15 Parkman St,Ste 645, Boston, MA 02114 USA.	ahgoroll@partners.org						American Academy of Family Physicians; American Academy of Pediatrics; American College of Physicians; American Osteopathic Association, 2007, JOINT PRINC PAT CTR; American College of Physicians, 2006, POSITION PAPER; Ash AS, 2012, MED CARE, V50, P643, DOI 10.1097/MLR.0b013e3182549c74; Feldman DS, 1998, ARCH INTERN MED, V158, P1626, DOI 10.1001/archinte.158.15.1626; Goroll AH, 2007, J GEN INTERN MED, V22, P410, DOI 10.1007/s11606-006-0083-2; Hsu J, 2012, MASSACHUSETTS MED SO; Schoenbaum Stephen C, 2011, Hosp Pract (1995), V39, P140, DOI 10.3810/hp.2011.08.589; Shih A., 2008, COMMONWEALTH FUND PU, V1155	8	18	18	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2012	308	6					577	578		10.1001/jama.2012.8696	http://dx.doi.org/10.1001/jama.2012.8696			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	984YA	22871868				2022-12-28	WOS:000307228400023
J	Spence, D				Spence, Des			What is good medicine?	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						General Medical Council, GOOD MED PRACT DUT D; Kipling Rudyard., 1910, IF	2	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 8	2012	345								e5171	10.1136/bmj.e5171	http://dx.doi.org/10.1136/bmj.e5171			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988ND	22875952				2022-12-28	WOS:000307496800009
J	Buxton, OM; Ellenbogen, JM; Wang, W; Carballeira, A; O'Connor, S; Cooper, D; Gordhandas, AJ; McKinney, SM; Solet, JM				Buxton, Orfeu M.; Ellenbogen, Jeffrey M.; Wang, Wei; Carballeira, Andy; O'Connor, Shawn; Cooper, Dan; Gordhandas, Ankit J.; McKinney, Scott M.; Solet, Jo M.			Sleep Disruption due to Hospital Noises A Prospective Evaluation	ANNALS OF INTERNAL MEDICINE			English	Article							NEONATAL INTENSIVE-CARE; AIRCRAFT NOISE; AROUSAL; QUALITY; DEPRIVATION; AGE; IDENTIFICATION; ENVIRONMENT; ACTIVATION; DURATION	Background: Sleep plays a critical role in maintaining health and well-being; however, patients who are hospitalized are frequently exposed to noise that can disrupt sleep. Efforts to attenuate hospital noise have been limited by incomplete information on the interaction between sounds and sleep physiology. Objective: To determine profiles of acoustic disruption of sleep by examining the cortical (encephalographic) arousal responses during sleep to typical hospital noises by sound level and type and sleep stage. Design: 3-day polysomnographic study. Setting: Sound-attenuated sleep laboratory. Participants: Volunteer sample of 12 healthy participants. Intervention: Baseline (sham) night followed by 2 intervention nights with controlled presentation of 14 sounds that are common in hospitals (for example, voice, intravenous alarm, phone, ice machine, outside traffic, and helicopter). The sounds were administered at calibrated, increasing decibel levels (40 to 70 dBA [decibels, adjusted for the range of normal hearing]) during specific sleep stages. Measurements: Encephalographic arousals, by using established criteria, during rapid eye movement (REM) sleep and non-REM (NREM) sleep stages 2 and 3. Results: Sound presentations yielded arousal response curves that varied because of sound level and type and sleep stage. Electronic sounds were more arousing than other sounds, including human voices, and there were large differences in responses by sound type. As expected, sounds in NREM stage 3 were less likely to cause arousals than sounds in NREM stage 2; unexpectedly, the probability of arousal to sounds presented in REM sleep varied less by sound type than when presented in NREM sleep and caused a greater and more sustained elevation of instantaneous heart rate. Limitations: The study included only 12 participants. Results for these healthy persons may underestimate the effects of noise on sleep in patients who are hospitalized. Conclusion: Sounds during sleep influence both cortical brain activity and cardiovascular function. This study systematically quantifies the disruptive capacity of a range of hospital sounds on sleep, providing evidence that is essential to improving the acoustic environments of new and existing health care facilities to enable the highest quality of care.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Brigham & Womens Hosp, Boston, MA USA; Berklee Coll Mus, Boston, MA USA; Cambridge Hlth Alliance, Cambridge, England; Cavanaugh Tocci Assoc, Sudbury, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Massachusetts General Hospital	Buxton, OM (corresponding author), 221 Longwood Ave,BLI438-K, Boston, MA 02115 USA.	orfeu_buxton@hms.harvard.edu		Buxton, Orfeu/0000-0001-5057-633X	Academy of Architecture for Health; Facilities Guidelines Institute; Center for Health Design	Academy of Architecture for Health; Facilities Guidelines Institute; Center for Health Design	This study was funded by investigator-initiated grants (Dr. Solet) from the Academy of Architecture for Health, the Facilities Guidelines Institute, and The Center for Health Design. Sleep laboratory work was completed through the generosity of Massachusetts General Hospital and with acoustic consultation by Cavanaugh Tocci Associates.	Ancoli-Israel S, 2005, J AM GERIATR SOC, V53, pS264, DOI 10.1111/j.1532-5415.2005.53392.x; [Anonymous], GUID DES CONSTR HLTH; Bartick Melissa C, 2010, J Hosp Med, V5, pE20, DOI 10.1002/jhm.549; Basner M, 2008, SLEEP MED, V9, P382, DOI 10.1016/j.sleep.2007.07.002; Basner M, 2007, SLEEP, V30, P1349, DOI 10.1093/sleep/30.10.1349; Basner M, 2006, J ACOUST SOC AM, V119, P2772, DOI 10.1121/1.2184247; Basner M, 2010, NOISE HEALTH, V12, P95, DOI 10.4103/1463-1741.63210; Berg S, 2001, SLEEP, V24, P289, DOI 10.1093/sleep/24.3.289; Bonnet MH, 2007, J CLIN SLEEP MED, V3, P133; Bonnet MH, 2007, J CLIN SLEEP MED, V3, P271; Braun AR, 1997, BRAIN, V120, P1173, DOI 10.1093/brain/120.7.1173; Bruck D, 2009, J SLEEP RES, V18, P196, DOI 10.1111/j.1365-2869.2008.00710.x; Busch-Vishniac IJ, 2005, J ACOUST SOC AM, V118, P3629, DOI 10.1121/1.2118327; Buxton OM, 2010, DIABETES, V59, P2126, DOI 10.2337/db09-0699; Cappuccio FP, 2007, HYPERTENSION, V50, P693, DOI 10.1161/HYPERTENSIONAHA.107.095471; Carpenter Dave, 2010, Health Facil Manage, V23, P11; Catcheside PG, 2002, SLEEP, V25, P797, DOI 10.1093/sleep/25.7.797; Cmiel CA, 2004, AM J NURS, V104, P40, DOI 10.1097/00000446-200402000-00019; Cohen S, 2009, ARCH INTERN MED, V169, P62, DOI 10.1001/archinternmed.2008.505; Colten HR, 2006, SLEEP DISORDERS SLEE; Dang-Vu TT, 2010, CURR BIOL, V20, pR626, DOI 10.1016/j.cub.2010.06.032; DEGENNARO L, 1995, ELECTROEN CLIN NEURO, V95, P252, DOI 10.1016/0013-4694(95)00090-L; Dijk DJ, 2001, SLEEP, V24, P565, DOI 10.1093/sleep/24.5.565; Drummond SPA, 2001, NEUROPSYCHOPHARMACOL, V25, pS68, DOI 10.1016/S0893-133X(01)00325-6; Elmenhorst EM, 2010, INT ARCH OCC ENV HEA, V83, P743, DOI 10.1007/s00420-010-0515-5; Griefahn B, 2008, SLEEP, V31, P569, DOI 10.1093/sleep/31.4.569; Hagerman I, 2005, INT J CARDIOL, V98, P267, DOI 10.1016/j.ijcard.2003.11.006; Halasz P, 2004, J SLEEP RES, V13, P1, DOI 10.1111/j.1365-2869.2004.00388.x; Hoevenaar-Blom MP, 2011, SLEEP, V34, P1487, DOI 10.5665/sleep.1382; Iber C., 2007, RULES TERMINOL TECH, V176, P2012; Inouye SK, 1999, NEW ENGL J MED, V340, P669, DOI 10.1056/NEJM199903043400901; Jha AK, 2008, NEW ENGL J MED, V359, P1921, DOI 10.1056/NEJMsa0804116; Johnson AN, 2003, J PERINAT NEONAT NUR, V17, P280, DOI 10.1097/00005237-200310000-00006; Kahn DM, 1998, CHEST, V114, P535, DOI 10.1378/chest.114.2.535; Landolt HP, 1996, BRAIN RES, V738, P205, DOI 10.1016/S0006-8993(96)00770-6; Mayers AG, 2005, HUM PSYCHOPHARM CLIN, V20, P533, DOI 10.1002/hup.726; McNeer Richard R, 2007, J Clin Monit Comput, V21, P353, DOI 10.1007/s10877-007-9096-6; Montague KN, 2009, AM J NURS, V109, P65, DOI 10.1097/01.NAJ.0000360316.54373.0d; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Perrin F, 1999, CLIN NEUROPHYSIOL, V110, P2153, DOI 10.1016/S1388-2457(99)00177-7; Ryherd EE, 2008, J ACOUST SOC AM, V123, P747, DOI 10.1121/1.2822661; Schweitzer PK, 2010, PRINCIPLES PRACTICE, P542; Sforza E, 2000, CLIN NEUROPHYSIOL, V111, P1611, DOI 10.1016/S1388-2457(00)00363-1; Sforza E, 2004, CLIN NEUROPHYSIOL, V115, P2442, DOI 10.1016/j.clinph.2004.06.002; Siegel JM, 2010, PRINCIPLES PRACTICE, P92; Solet JM, 2012, PROG PEDIATR CARDIOL, V33, P85, DOI 10.1016/j.ppedcard.2011.12.014; SOUTHWELL MT, 1995, J ADV NURS, V21, P1101, DOI 10.1046/j.1365-2648.1995.21061101.x; Topf M, 1996, J ADV NURS, V24, P545, DOI 10.1046/j.1365-2648.1996.22315.x; Topf M, 2001, HEART LUNG, V30, P237, DOI 10.1067/mhl.2001.116592; Weinhouse GL, 2009, CRIT CARE, V13, DOI 10.1186/cc8131; Williams AL, 2007, J ACOUST SOC AM, V121, P2681, DOI 10.1121/1.2717500; Witmans M, 2005, J CLIN SLEEP MED, V1, pE488; World Health Organization Regional Office for Europe, 2010, NIGHT NOIS GUID EUR; YINNON AM, 1992, BRIT J CLIN PRACT, V46, P88	54	94	95	1	28	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 7	2012	157	3					170	+		10.7326/0003-4819-156-12-201208070-00472	http://dx.doi.org/10.7326/0003-4819-156-12-201208070-00472			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	992PB	22868834				2022-12-28	WOS:000307789900004
J	Greene, SM; Reid, RJ; Larson, EB				Greene, Sarah M.; Reid, Robert J.; Larson, Eric B.			Implementing the Learning Health System: From Concept to Action	ANNALS OF INTERNAL MEDICINE			English	Article							MEDICAL HOME; CARE	Clinicians and health systems are facing widespread challenges, including changes in care delivery, escalating health care costs, and the need to keep up with rapid scientific discovery. Reorganizing U.S. health care and changing its practices to render better, more affordable care requires transformation in how health systems generate and apply knowledge. The "rapid-learning health system"-posited as a conceptual strategy to spur such transformation-leverages recent developments in health information technology and a growing health data infrastructure to access and apply evidence in real time, while simultaneously drawing knowledge from real-world care-delivery processes to promote innovation and health system change on the basis of rigorous research. This article describes an evolving learning health system at Group Health Cooperative, the 6 phases characterizing its approach, and examples of organization-wide applications. This practical model promotes bidirectional discovery and an open mind at the system level, resulting in willingness to make changes on the basis of evidence that is both scientifically sound and practice-based. Rapid learning must be valued as a health system property to realize its full potential for knowledge generation and application.	[Greene, Sarah M.; Reid, Robert J.; Larson, Eric B.] Grp Hlth Res Inst, Seattle, WA USA		Greene, SM (corresponding author), Grp Hlth Cooperat Puget Sound, 320 Westlake Ave N,GHQ E2N, Seattle, WA 98109 USA.	greene.sm@ghc.org			Group Health Research Institute	Group Health Research Institute	All authors receive salary support from the Group Health Research Institute.	Abernethy AP, 2010, J CLIN ONCOL, V28, P4268, DOI 10.1200/JCO.2010.28.5478; Arterburn DE, 2011, OBESITY, V19, P1669, DOI 10.1038/oby.2011.65; Berwick DM, 2003, JAMA-J AM MED ASSOC, V289, P1969, DOI 10.1001/jama.289.15.1969; Etheredge LM, 2007, HEALTH AFFAIR, V26, pW107, DOI 10.1377/hlthaff.26.2.w107; Hsu C, 2012, J AMBUL CARE MANAG, V35, P99, DOI 10.1097/JAC.0b013e318249e066; Kamal AH, 2012, CHRON RESP DIS, V9, P51, DOI 10.1177/1479972311433576; Langley GL., 2009, IMPROVEMENT GUIDE PR, V2nd; Larson EB, ENHANCING C IN PRESS; Larson EB, 2010, JAMA-J AM MED ASSOC, V303, P1644, DOI 10.1001/jama.2010.524; Nelson Eugene C, 2002, Jt Comm J Qual Improv, V28, P472; Reid RJ, 2010, HEALTH AFFAIR, V29, P835, DOI 10.1377/hlthaff.2010.0158; Smith-Bindman R, 2008, HEALTH AFFAIR, V27, P1491, DOI 10.1377/hlthaff.27.6.1491; Trescott CE, 2011, HEALTH AFFAIR, V30, P1420, DOI 10.1377/hlthaff.2011.0759; Von Korff M, 2011, ANN INTERN MED, V155, P325, DOI 10.7326/0003-4819-155-5-201109060-00011	14	195	198	0	33	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 7	2012	157	3					207	+		10.7326/0003-4819-157-3-201208070-00012	http://dx.doi.org/10.7326/0003-4819-157-3-201208070-00012			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	992PB	22868839				2022-12-28	WOS:000307789900008
J	Tsugawa, Y; Mukamal, KJ; Davis, RB; Taylor, WC; Wee, CC				Tsugawa, Yusuke; Mukamal, Kenneth J.; Davis, Roger B.; Taylor, William C.; Wee, Christina C.			Should the Hemoglobin A(1c) Diagnostic Cutoff Differ Between Blacks and Whites? A Cross-sectional Study	ANNALS OF INTERNAL MEDICINE			English	Article							HBA(1C) LEVELS; MICROVASCULAR COMPLICATIONS; DIABETIC-RETINOPATHY; ETHNIC-DIFFERENCES; GLUCOSE-TOLERANCE; PLASMA-GLUCOSE; A1C; ADULTS; ASSOCIATION; CHILDREN	Background: Hemoglobin A(1c) (HbA(1c)) levels are known to be consistently higher in black persons than in white persons at any given glycemic level. Whether the optimal diagnostic threshold of HbA1c should differ between blacks and whites is unclear. Objective: To compare the relationships between HbA(1c) level and the prevalence of retinopathy in black and white U. S. adults. Design: Cross-sectional study. Setting: A nationally representative sample of the National Health and Nutrition Examination Survey from 2005 through 2008. Patients: 2804 white persons and 1008 black persons aged 40 years or older in the United States. Measurements: Prevalence of retinopathy. Logistic regression models and restricted cubic spline models were constructed separately for white and black populations to test the HbA(1c) levels at which risk for retinopathy begins to increase. Results: After adjustment for age, sex, hypertension, body mass index, family history of diabetes, and use of antidiabetes medications or insulin, the lowest HbA(1c) category for which the prevalence of retinopathy was significantly higher than the reference category (<5.5%) was 6.0% to 6.4% for white persons (risk difference, 4.8% [95% CI, 0.5% to 9.1%]) and 5.5% to 5.9% for black persons (risk difference, 5.3% [CI, 1.0% to 9.5%]). The restricted cubic spline models indicated that the risk for retinopathy increased at lower HbA(1c) levels in black persons than in white persons. Limitation: The cross-sectional design of the study precluded examining the effect of the duration at each HbA(1c) level. Conclusion: The prevalence of retinopathy begins to increase at a lower HbA(1c) level in black Americans than in white Americans. The findings do not support increasing the diagnostic threshold of HbA(1c) in black persons.	[Tsugawa, Yusuke; Mukamal, Kenneth J.; Davis, Roger B.; Taylor, William C.; Wee, Christina C.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Tsugawa, Y (corresponding author), Harvard Univ, Sch Med, Div Gen Med & Primary Care, Beth Israel Deaconess Med Ctr, 1309 Beacon St, Brookline, MA 02446 USA.	ytsugawa@bidmc.harvard.edu	Mukamal, Kenneth/GVR-7978-2022	Tsugawa, Yusuke/0000-0002-1937-4833	Shigeaki Hinohara, MD, Primary Care Fellowship at Beth Israel Deaconess Medical Center; Joint Japan/World Bank Graduate Scholarship Program; St. Luke's Life Science Institute, Tokyo, Japan; Harvard Catalyst, The Harvard Clinical and Translational Science Center (National Institutes of Health) [UL1 RR 025758]; Harvard University; National Institutes of Health [K24DK087932]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK087932] Funding Source: NIH RePORTER	Shigeaki Hinohara, MD, Primary Care Fellowship at Beth Israel Deaconess Medical Center; Joint Japan/World Bank Graduate Scholarship Program; St. Luke's Life Science Institute, Tokyo, Japan; Harvard Catalyst, The Harvard Clinical and Translational Science Center (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr. Tsugawa is supported by the Shigeaki Hinohara, MD, Primary Care Fellowship at Beth Israel Deaconess Medical Center; the Joint Japan/World Bank Graduate Scholarship Program; and St. Luke's Life Science Institute, Tokyo, Japan. Dr. Davis is supported by Harvard Catalyst, The Harvard Clinical and Translational Science Center (National Institutes of Health Award UL1 RR 025758), and financial contributions from Harvard University and its affiliated academic health care centers. Dr. Wee is supported by a midcareer mentorship award from the National Institutes of Health (K24DK087932).	Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; American Diabetes Association, 2012, DAT 2011 NAT DIAB FA; [Anonymous], 1991, Ophthalmology, V98, P786; Bao YQ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2249; Brown AF, 2005, DIABETES CARE, V28, P2864, DOI 10.2337/diacare.28.12.2864; Centers for Disease Control and Prevention National Center for Health Statistics, 2012, NAT HLTH NUTR EX SUR; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Cohen RM, 2008, BLOOD, V112, P4284, DOI 10.1182/blood-2008-04-154112; Cohen RM, 2007, DIABETES CARE, V30, P2756, DOI 10.2337/dc07-1301; Dagogo-Jack S, 2010, NAT REV ENDOCRINOL, V6, P589, DOI 10.1038/nrendo.2010.126; Davidson MB, 2010, DIABETES RES CLIN PR, V87, P415, DOI 10.1016/j.diabres.2009.12.013; Engelgau MM, 1997, DIABETES CARE, V20, P785, DOI 10.2337/diacare.20.5.785; Gama R, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b5648; Gavin JR, 1997, DIABETES CARE, V20, P1183; Groenwold RHH, 2012, AM J EPIDEMIOL, V175, P210, DOI 10.1093/aje/kwr302; HARRELL FE, 1988, J NATL CANCER I, V80, P1198, DOI 10.1093/jnci/80.15.1198; Herman WH, 2007, DIABETES CARE, V30, P2453, DOI 10.2337/dc06-2003; Herman WH, 2010, ANN INTERN MED, V152, P815, DOI 10.7326/0003-4819-152-12-201006150-00011; Herman WH, 2009, J CLIN ENDOCR METAB, V94, P1689, DOI 10.1210/jc.2008-1940; Kamps JL, 2010, DIABETES CARE, V33, P1025, DOI 10.2337/dc09-1440; Kilpatrick ES, 2009, DIABETES CARE, V32, P1901, DOI [10.2337/dc09-0109, 10.2337/dc09-1231]; Kirk JK, 2006, DIABETES CARE, V29, P2130, DOI 10.2337/dc05-1973; Korn EL., 1999, ANAL HLTH SURVEYS; MCCANCE DR, 1994, BRIT MED J, V308, P1323, DOI 10.1136/bmj.308.6940.1323; McCance DR, 1997, DIABETOLOGIA, V40, P247, DOI 10.1007/s001250050671; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Olabi B, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4354; Porta M, 2002, DIABETOLOGIA, V45, P1617, DOI 10.1007/s00125-002-0990-7; Porta M, 2001, DIABETOLOGIA, V44, P2203, DOI 10.1007/s001250100030; Saaddine JB, 2002, DIABETES CARE, V25, P1326, DOI 10.2337/diacare.25.8.1326; Sacks DB, 2011, DIABETES CARE, V34, P518, DOI 10.2337/dc10-1546; Schwartz RS, 2001, NEW ENGL J MED, V344, P1392, DOI 10.1056/NEJM200105033441810; Selvin E, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-5-201103010-00004; SHAMOON H, 1995, ARCH OPHTHALMOL-CHIC, V113, P36; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Wisdom K, 1997, DIABETES CARE, V20, P971, DOI 10.2337/diacare.20.6.971; Ziemer DC, 2010, ANN INTERN MED, V152, P770, DOI 10.7326/0003-4819-152-12-201006150-00004	40	61	62	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 7	2012	157	3					153	+		10.7326/0003-4819-157-3-201208070-00004	http://dx.doi.org/10.7326/0003-4819-157-3-201208070-00004			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992PB	22868832	Green Accepted			2022-12-28	WOS:000307789900002
J	Lundberg, DS; Lebeis, SL; Paredes, SH; Yourstone, S; Gehring, J; Malfatti, S; Tremblay, J; Engelbrektson, A; Kunin, V; del Rio, TG; Edgar, RC; Eickhorst, T; Ley, RE; Hugenholtz, P; Tringe, SG; Dangl, JL				Lundberg, Derek S.; Lebeis, Sarah L.; Paredes, Sur Herrera; Yourstone, Scott; Gehring, Jase; Malfatti, Stephanie; Tremblay, Julien; Engelbrektson, Anna; Kunin, Victor; del Rio, Tijana Glavina; Edgar, Robert C.; Eickhorst, Thilo; Ley, Ruth E.; Hugenholtz, Philip; Tringe, Susannah Green; Dangl, Jeffery L.			Defining the core Arabidopsis thaliana root microbiome	NATURE			English	Article							BACTERIAL ENDOPHYTES; RHIZOSPHERE; TRAITS; PLANTS	Land plants associate with a root microbiota distinct from the complex microbial community present in surrounding soil. The microbiota colonizing the rhizosphere (immediately surroundingthe root) and the endophytic compartment (within the root) contribute to plant growth, productivity, carbon sequestration and phytoremediation(1-3). Colonization of the root occurs despite a sophisticated plant immune system(4,5), suggesting finely tuned discrimination of mutualists and commensals from pathogens. Genetic principles governing the derivation of host-specific endophyte communities from soil communities are poorly understood. Here we report the pyrosequencing of the bacterial 16S ribosomal RNA gene of more than 600 Arabidopsis thaliana plants to test the hypotheses that the root rhizosphere and endophytic compartmentmicrobiota of plants grown under controlled conditions in natural soils are sufficiently dependent on the host to remain consistent across different soil types and developmental stages, and sufficiently dependent on host genotype to vary between inbred Arabidopsis accessions. We describe different bacterial communities in two geochemically distinct bulk soils and in rhizosphere and endophytic compartments prepared from roots grown in these soils. The communities in each compartment are strongly influenced by soil type. Endophytic compartments fromboth soils feature overlapping, low-complexity communities that are markedly enriched in Actinobacteria and specific families from other phyla, notably Proteobacteria. Some bacteria vary quantitatively between plants of different developmental stage and genotype. Our rigorous definition of an endophytic compartment microbiome should facilitate controlled dissection of plantmicrobe interactions derived from complex soil communities.	[Lundberg, Derek S.; Lebeis, Sarah L.; Paredes, Sur Herrera; Yourstone, Scott; Gehring, Jase; Dangl, Jeffery L.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Lundberg, Derek S.; Dangl, Jeffery L.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Yourstone, Scott] Univ N Carolina, Curriculum Bioinformat & Computat Biol, Chapel Hill, NC 27599 USA; [Malfatti, Stephanie; Tremblay, Julien; Engelbrektson, Anna; Kunin, Victor; del Rio, Tijana Glavina; Hugenholtz, Philip; Tringe, Susannah Green] DOE Joint Genome Inst, Walnut Creek, CA 94598 USA; [Edgar, Robert C.] Taxon Biosci Inc, Tiburon, CA 94920 USA; [Eickhorst, Thilo] Univ Bremen, Fac Biol & Chem, D-28359 Bremen, Germany; [Ley, Ruth E.] Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA; [Hugenholtz, Philip] Univ Queensland, Sch Chem & Mol Biosci, Australian Ctr Ecogen, Brisbane, Qld 4072, Australia; [Hugenholtz, Philip] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Dangl, Jeffery L.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Dangl, Jeffery L.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Dangl, Jeffery L.] Univ N Carolina, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; United States Department of Energy (DOE); University of Bremen; Cornell University; University of Queensland; University of Queensland; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill	Dangl, JL (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA.	dangl@email.unc.edu	Paredes, Sur Herrera/I-8617-2019; Ley, Ruth E/M-8542-2014; Hugenholtz, Philip/AAD-9138-2019; Ariel, Pablo/AGJ-4118-2022; Engelbrektson, Anna/F-1687-2013; Engelbrektson, Anna/K-5563-2012; Eickhorst, Thilo/M-1200-2014; Tringe, Susannah Green/T-9431-2019	Paredes, Sur Herrera/0000-0001-9246-8337; Ley, Ruth E/0000-0002-9087-1672; Hugenholtz, Philip/0000-0001-5386-7925; Tringe, Susannah Green/0000-0001-6479-8427; Tremblay, Julien/0000-0002-6085-3481; Lundberg, Derek/0000-0001-7970-1595; Kunin, Victor/0000-0002-8741-7866; Malfatti, Stephanie/0000-0003-4225-9857	US NSF [IOS-0958245]; JGI Director's Discretionary Grand Challenge Program; HHMI-GBMF Plant Science Program; Office of Science of the US Department of Energy [DE-AC02-05CH11231]; National Institutes of Health, Minority Opportunities in Research division of the National Institute of General Medical Sciences [K12GM000678]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000678] Funding Source: NIH RePORTER; Direct For Biological Sciences [0958245] Funding Source: National Science Foundation	US NSF(National Science Foundation (NSF)); JGI Director's Discretionary Grand Challenge Program; HHMI-GBMF Plant Science Program; Office of Science of the US Department of Energy(United States Department of Energy (DOE)); National Institutes of Health, Minority Opportunities in Research division of the National Institute of General Medical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank A. Smithlund, M. Gonek, V. Madden, H. Schmidt, M. Rott and N. Zvenigorodsky for technical assistance. We thank A. Spor, J. Pfeiffer and J. Rawls for discussions and C. Herring for research field soil. This work was supported by US NSF grant IOS-0958245 (J. L. D.), the JGI Director's Discretionary Grand Challenge Program and the HHMI-GBMF Plant Science Program. J. L. D. is an HHMI-GBMF Plant Science Investigator. Work conducted by the US Department of Energy Joint Genome Institute is supported by the Office of Science of the US Department of Energy under contract no. DE-AC02-05CH11231. S. L. L. was supported by the National Institutes of Health, Minority Opportunities in Research division of the National Institute of General Medical Sciences grant K12GM000678.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chi F, 2005, APPL ENVIRON MICROB, V71, P7271, DOI 10.1128/AEM.71.11.7271-7278.2005; De Deyn GB, 2008, ECOL LETT, V11, P516, DOI 10.1111/j.1461-0248.2008.01164.x; Dennis PG, 2010, FEMS MICROBIOL ECOL, V72, P313, DOI 10.1111/j.1574-6941.2010.00860.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Eickhorst T, 2008, SOIL BIOL BIOCHEM, V40, P1883, DOI 10.1016/j.soilbio.2008.03.024; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; Firakova S, 2007, BIOLOGIA, V62, P251, DOI 10.2478/s11756-007-0044-1; Gottel NR, 2011, APPL ENVIRON MICROB, V77, P5934, DOI 10.1128/AEM.05255-11; Hallmann J, 1997, CAN J MICROBIOL, V43, P895, DOI 10.1139/m97-131; Hardoim PR, 2008, TRENDS MICROBIOL, V16, P463, DOI 10.1016/j.tim.2008.07.008; Inceoglu O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023321; Inceoglu O, 2010, APPL ENVIRON MICROB, V76, P3675, DOI 10.1128/AEM.00040-10; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kunin V, 2010, OPEN J, V1, P1; Lane DJ, 1991, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Levey S, 2005, PLANT CELL ENVIRON, V28, P223, DOI 10.1111/j.1365-3040.2004.01266.x; Loy A, 2007, NUCLEIC ACIDS RES, V35, pD800, DOI 10.1093/nar/gkl856; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; MARSCHNER H, 1986, Z PFLANZ BODENKUNDE, V149, P441, DOI 10.1002/jpln.19861490408; Masclaux C, 2000, PLANTA, V211, P510, DOI 10.1007/s004250000310; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; Motulsky H.J., 2003, PRISM 4 STAT GUIDE S; Oksanen J., 2011, VEGAN R FUNCTIONS VE; Redford AJ, 2010, ENVIRON MICROBIOL, V12, P2885, DOI 10.1111/j.1462-2920.2010.02258.x; Rodriguez RJ, 2008, ISME J, V2, P404, DOI 10.1038/ismej.2007.106; Schulz Barbara J. E., 2006, V9, P1; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Sul WJ, 2011, P NATL ACAD SCI USA, V108, P14637, DOI 10.1073/pnas.1111435108; van der Lelie D, 2009, CRIT REV PLANT SCI, V28, P346, DOI 10.1080/07352680903241204; VANELSAS JD, 1988, FEMS MICROBIOL ECOL, V53, P299, DOI 10.1016/0378-1097(88)90487-9; Warnes GR, 2011, GPLOTS VARIOUS R PRO	36	1513	1629	83	1503	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 2	2012	488	7409					86	+		10.1038/nature11237	http://dx.doi.org/10.1038/nature11237			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ZE	22859206	Green Accepted, Green Submitted			2022-12-28	WOS:000307010700038
J	Yoon, H; Yeung, KYM; Umansky, V; Ham, D				Yoon, Hosang; Yeung, Kitty Y. M.; Umansky, Vladimir; Ham, Donhee			A Newtonian approach to extraordinarily strong negative refraction	NATURE			English	Article							2-DIMENSIONAL ELECTRON-GAS; VISIBLE FREQUENCIES; INDEX METAMATERIAL; CIRCUITS	Metamaterials with negative refractive indices can manipulate electromagnetic waves in unusual ways, and can be used to achieve, for example, sub-diffraction-limit focusing(1), the bending of light in the 'wrong' direction(2), and reversed Doppler and Cerenkov effects(2). These counterintuitive and technologically useful behaviours have spurred considerable efforts to synthesize a broad array of negative-index metamaterials with engineered electric, magnetic or optical properties(1-10). Here we demonstrate another route to negative refraction by exploiting the inertia of electrons in semiconductor two-dimensional electron gases, collectively accelerated by electromagnetic waves according to Newton's second law of motion, where this acceleration effect manifests as kinetic inductance(11,12). Using kinetic inductance to attain negative refraction was theoretically proposed for three-dimensional metallic nanoparticles(13) and seen experimentally with surface plasmons on the surface of a three-dimensional metal(14). The two-dimensional electron gas that we use at cryogenic temperatures has a larger kinetic inductance than three-dimensional metals, leading to extraordinarily strong negative refraction at gigahertz frequencies, with an index as large as -700. This pronounced negative refractive index and the corresponding reduction in the effective wavelength opens a path to miniaturization in the science and technology of negative refraction.	[Yoon, Hosang; Yeung, Kitty Y. M.; Ham, Donhee] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Umansky, Vladimir] Weizmann Inst Sci, Dept Condensed Matter Phys, IL-76100 Rehovot, Israel	Harvard University; Weizmann Institute of Science	Ham, D (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	donhee@seas.harvard.edu	Umansky, Vladimir/P-1334-2019	Umansky, Vladimir/0000-0001-5727-2064; Yoon, Hosang/0000-0002-7552-0479; Ham, Donhee/0000-0001-6925-2466	Air Force Office of Scientific Research [FA 9550-09-1-0369, FA 9550-08-1-0254]	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	The authors are grateful for support for this research by the Air Force Office of Scientific Research under contract numbers FA 9550-09-1-0369 and FA 9550-08-1-0254. Device fabrication was performed in part at the Center for Nanoscale Systems at Harvard University. The authors thank W. F. Andress for assistance with device fabrication and microwave measurements.	Andress WF, 2012, NANO LETT, V12, P2272, DOI 10.1021/nl300046g; Burgos SP, 2010, NAT MATER, V9, P407, DOI [10.1038/nmat2747, 10.1038/NMAT2747]; Burke PJ, 2000, APPL PHYS LETT, V76, P745, DOI 10.1063/1.125881; Caloz C, 2004, IEEE T ANTENN PROPAG, V52, P1159, DOI 10.1109/TAP.2004.827249; Chanda D, 2011, NAT NANOTECHNOL, V6, P402, DOI [10.1038/NNANO.2011.82, 10.1038/nnano.2011.82]; Chen XD, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.016608; Choi M, 2011, NATURE, V470, P369, DOI 10.1038/nature09776; Cubukcu E, 2003, NATURE, V423, P604, DOI 10.1038/423604b; Dean CR, 2010, NAT NANOTECHNOL, V5, P722, DOI 10.1038/nnano.2010.172; Eleftheriades GV, 2002, IEEE T MICROW THEORY, V50, P2702, DOI 10.1109/TMTT.2002.805197; Engheta N, 2007, SCIENCE, V317, P1698, DOI 10.1126/science.1133268; Grbic A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.117403; Hoffman AJ, 2007, NAT MATER, V6, P946, DOI 10.1038/nmat2033; Ju L, 2011, NAT NANOTECHNOL, V6, P630, DOI [10.1038/nnano.2011.146, 10.1038/NNANO.2011.146]; Lezec HJ, 2007, SCIENCE, V316, P430, DOI 10.1126/science.1139266; Linden S, 2006, IEEE J SEL TOP QUANT, V12, P1097, DOI 10.1109/JSTQE.2006.880600; MARKS RB, 1991, IEEE T MICROW THEORY, V39, P1205, DOI 10.1109/22.85388; MESERVEY R, 1969, J APPL PHYS, V40, P2028, DOI 10.1063/1.1657905; Meziani YM, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2919097; Pendry JB, 2004, SCIENCE, V306, P1353, DOI 10.1126/science.1104467; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; Podolskiy VA, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.201101; Shalaev VM, 2007, NAT PHOTONICS, V1, P41, DOI 10.1038/nphoton.2006.49; Shelby RA, 2001, SCIENCE, V292, P77, DOI 10.1126/science.1058847; Smith DR, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.036617; Smith DR, 2000, PHYS REV LETT, V84, P4184, DOI 10.1103/PhysRevLett.84.4184; Soukoulis CM, 2007, SCIENCE, V315, P47, DOI 10.1126/science.1136481; STERN F, 1967, PHYS REV LETT, V18, P546, DOI 10.1103/PhysRevLett.18.546; Valentine J, 2008, NATURE, V455, P376, DOI 10.1038/nature07247; VESELAGO VG, 1968, SOV PHYS USPEKHI, V10, P509, DOI 10.1070/PU1968v010n04ABEH003699	30	33	34	3	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2012	488	7409					65	69		10.1038/nature11297	http://dx.doi.org/10.1038/nature11297			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ZE	22859202				2022-12-28	WOS:000307010700033
J	Duncan, K; Sadanand, A; Davachi, L				Duncan, Katherine; Sadanand, Arhanti; Davachi, Lila			Memory's Penumbra: Episodic Memory Decisions Induce Lingering Mnemonic Biases	SCIENCE			English	Article							MEDIAL TEMPORAL-LOBE; RECOGNITION MEMORY; PROACTIVE-INTERFERENCE; PATTERN SEPARATION; NOVELTY DETECTION; HIPPOCAMPAL; MODULATION; RETRIEVAL; SYSTEMS; REGION	How do we decide if the people we meet and the things we see are familiar or new? If something is new, we need to encode it as a memory distinct from already stored episodes, using a process known as pattern separation. If familiar, it can be used to reactivate a previously stored memory, by a process known as pattern completion. To orchestrate these conflicting processes, current models propose that the episodic memory system uses environmental cues to establish processing biases that favor either pattern separation during encoding or pattern completion during retrieval. To assess this theory, we measured how people's memory formation and decisions are influenced by their recent engagement in episodic encoding and retrieval. We found that the recent encoding of novel objects improved subsequent identification of subtle changes, a task thought to rely on pattern separation. Conversely, recent retrieval of old objects increased the subsequent integration of stored information into new memories, a process thought to rely on pattern completion. These experiments provide behavioral evidence that episodic encoding and retrieval evoke lingering biases that influence subsequent mnemonic processing.	[Sadanand, Arhanti; Davachi, Lila] NYU, Dept Psychol, New York, NY 10003 USA; [Duncan, Katherine] Columbia Univ, Dept Psychol, New York, NY 10027 USA; [Davachi, Lila] NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University; Columbia University; New York University	Davachi, L (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	lila.davachi@nyu.edu		Duncan, Katherine/0000-0003-0456-851X; Davachi, Lila/0000-0003-4317-0889	NIH [RO1 MH074692]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074692] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by NIH grant RO1 MH074692 to L.D. We thank V. Skvortsova, A. Berners-Lee, and M. Inhoff for data collection assistance; K. Ochsner and E. Phelps for their helpful comments on an earlier draft of the manuscript; G. Chin for his useful editorial comments; and C. Stark and W. Suzuki for the use of stimuli developed by their labs.	Allan K, 2005, J NEUROSCI, V25, P8122, DOI 10.1523/JNEUROSCI.1304-05.2005; Atri A, 2004, BEHAV NEUROSCI, V118, P223, DOI 10.1037/0735-7044.118.1.223; Bakker A, 2008, SCIENCE, V319, P1640, DOI 10.1126/science.1152882; Davachi L, 2006, CURR OPIN NEUROBIOL, V16, P693, DOI 10.1016/j.conb.2006.10.012; De Rosa E, 2000, BEHAV NEUROSCI, V114, P32, DOI 10.1037/0735-7044.114.1.32; Duncan K, 2012, HIPPOCAMPUS, V22, P389, DOI 10.1002/hipo.20933; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Hall G, 2003, J EXP PSYCHOL GEN, V132, P266, DOI 10.1037/0096-3445.132.2.266; HASSELMO ME, 1995, J NEUROSCI, V15, P5249; HASSELMO ME, 1994, J NEUROSCI, V14, P3898; Hasselmo ME, 2001, J NEUROPHYSIOL, V86, P1792, DOI 10.1152/jn.2001.86.4.1792; Hasselmo ME, 1996, HIPPOCAMPUS, V6, P693, DOI 10.1002/(SICI)1098-1063(1996)6:6<693::AID-HIPO12>3.0.CO;2-W; Huijbers W, 2009, PLOS BIOL, V7, P63, DOI 10.1371/journal.pbio.1000011; Kirwan CB, 2007, LEARN MEMORY, V14, P625, DOI 10.1101/lm.663507; Kumaran D, 2007, HIPPOCAMPUS, V17, P735, DOI 10.1002/hipo.20326; Kunec S, 2005, J NEUROPHYSIOL, V94, P70, DOI 10.1152/jn.00731.2004; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Lisman J, 2011, TRENDS NEUROSCI, V34, P536, DOI 10.1016/j.tins.2011.07.006; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; MCDONALD RJ, 1993, BEHAV NEUROSCI, V107, P3, DOI 10.1037/0735-7044.107.1.3; Meeter M, 2004, HIPPOCAMPUS, V14, P722, DOI 10.1002/hipo.10214; Myers CE, 2003, J COGNITIVE NEUROSCI, V15, P185, DOI 10.1162/089892903321208123; Norman KA, 2003, PSYCHOL REV, V110, P611, DOI 10.1037/0033-295X.110.4.611; OREILLY RC, 1994, HIPPOCAMPUS, V4, P661, DOI 10.1002/hipo.450040605; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Shohamy D, 2008, NEURON, V60, P378, DOI 10.1016/j.neuron.2008.09.023; Squire LR, 2007, NAT REV NEUROSCI, V8, P872, DOI 10.1038/nrn2154; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Vinogradova OS, 2001, HIPPOCAMPUS, V11, P578, DOI 10.1002/hipo.1073	30	83	83	2	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2012	337	6093					485	487		10.1126/science.1221936	http://dx.doi.org/10.1126/science.1221936			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	979FS	22837528	Green Accepted			2022-12-28	WOS:000306802300048
J	Bingham, RG; Ferraccioli, F; King, EC; Larter, RD; Pritchard, HD; Smith, AM; Vaughan, DG				Bingham, Robert G.; Ferraccioli, Fausto; King, Edward C.; Larter, Robert D.; Pritchard, Hamish D.; Smith, Andrew M.; Vaughan, David G.			Inland thinning of West Antarctic Ice Sheet steered along subglacial rifts	NATURE			English	Article							CRUSTAL STRUCTURE; LAND; SEA; ANOMALIES; DYNAMICS; REGION; BASIN	Current ice loss from the West Antarctic Ice Sheet (WAIS) accounts for about ten per cent of observed global sea-level rise(1). Losses are dominated by dynamic thinning, in which forcings by oceanic or atmospheric perturbations to the ice margin lead to an accelerated thinning of ice along the coastline(2-5). Although central to improving projections of future ice-sheet contributions to global sea-level rise, the incorporation of dynamic thinning into models has been restricted by lack of knowledge of basal topography and subglacial geology so that the rate and ultimate extent of potential WAIS retreat remains difficult to quantify. Here we report the discovery of a subglacial basin under Ferrigno Ice Stream up to 1.5 kilometres deep that connects the ice-sheet interior to the Bellingshausen Sea margin, and whose existence profoundly affects ice loss. We use a suite of ice-penetrating radar, magnetic and gravity measurements to propose a rift origin for the basin in association with the wider development of the West Antarctic rift system. The Ferrigno rift, overdeepened by glacial erosion, is a conduit which fed a major palaeo-ice stream on the adjacent continental shelf during glacial maxima(6). The palaeo-ice stream, in turn, eroded the 'Belgica' trough, which today routes warm open-ocean water back to the ice front(7) to reinforce dynamic thinning. We show that dynamic thinning from both the Bellingshausen and Amundsen Sea region is being steered back to the ice-sheet interior along rift basins. We conclude that rift basins that cut across the WAIS margin can rapidly transmit coastally perturbed change inland, thereby promoting ice-sheet instability.	[Bingham, Robert G.] Univ Aberdeen, Sch Geosci, Aberdeen AB24 3UF, Scotland; [Ferraccioli, Fausto; King, Edward C.; Larter, Robert D.; Pritchard, Hamish D.; Smith, Andrew M.; Vaughan, David G.] British Antarctic Survey, Cambridge CB3 0ET, England	University of Aberdeen; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Bingham, RG (corresponding author), Univ Aberdeen, Sch Geosci, Elphinstone Rd, Aberdeen AB24 3UF, Scotland.	r.bingham@abdn.ac.uk	Bingham, Robert G/G-3576-2017; Vaughan, David/C-8348-2011; Pritchard, Hamish Daniel/AAU-4696-2021	Bingham, Robert G/0000-0002-0630-2021; Vaughan, David/0000-0002-9065-0570; Larter, Robert/0000-0002-8414-7389; Ferraccioli, Fausto/0000-0002-9347-4736	Natural Environment Research Council [NERC/AFI/CGS/11/60]; British Antarctic Survey research programme Polar Science for Planet Earth; NERC [bas0100026] Funding Source: UKRI; Natural Environment Research Council [bas0100026, bas0100027] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); British Antarctic Survey research programme Polar Science for Planet Earth; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was supported by the Natural Environment Research Council (NERC/AFI/CGS/11/60) and British Antarctic Survey research programme Polar Science for Planet Earth. We acknowledge NASA Operation IceBridge for airborne ice-sounding data, A. G. C. Graham for bathymetry data and C. Griffiths for field assistance.	Anandakrishnan S, 1998, NATURE, V394, P62, DOI 10.1038/27889; [Anonymous], 2008, ANTARCTICA KEYSTONE, DOI DOI 10.3133/OFR20071047KP09; Blankenship D. D., 2001, ANTARCT RES SER, V77, P105, DOI DOI 10.1029/AR077P0105; Chen JL, 2009, NAT GEOSCI, V2, P859, DOI 10.1038/ngeo694; Cofaigh CO, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2005JB003619; Dalziel IWD., 2006, TERRA ANTARTICA REPO, V12, P193; De Angelis H, 2007, QUATERNARY SCI REV, V26, P1313, DOI 10.1016/j.quascirev.2007.02.010; Gohl K, 2012, PALAEOGEOGR PALAEOCL, V335, P35, DOI 10.1016/j.palaeo.2011.02.022; Graham AGC, 2011, CRYOSPHERE, V5, P95, DOI 10.5194/tc-5-95-2011; Granot R, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2010GC003105; HARBOR JM, 1992, GEOL SOC AM BULL, V104, P1364, DOI 10.1130/0016-7606(1992)104<1364:NMOTDO>2.3.CO;2; Holland PR, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2008JC005219; Jacobs SS, 2011, NAT GEOSCI, V4, P519, DOI [10.1038/NGEO1188, 10.1038/ngeo1188]; Jordan TA, 2010, GEOL SOC AM BULL, V122, P714, DOI 10.1130/B26417.1; LeMasurier WE, 2008, GEOLOGY, V36, P247, DOI 10.1130/G24363A.1; MASLANYJ MP, 1990, TECTONICS, V9, P1515, DOI 10.1029/TC009i006p01515; Maule CF, 2005, SCIENCE, V309, P464, DOI 10.1126/science.1106888; Meier MF, 2007, SCIENCE, V317, P1064, DOI 10.1126/science.1143906; Muller RD, 2007, AUST J EARTH SCI, V54, P1033, DOI 10.1080/08120090701615691; Olsen K. H., 2006, CONTINENTAL RIFTS EV, P3; Pritchard HD, 2009, NATURE, V461, P971, DOI 10.1038/nature08471; Rignot E, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046583; Rignot E, 2008, NAT GEOSCI, V1, P106, DOI 10.1038/ngeo102; Schoof C, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000664; Schroder H, 2011, GEOSPHERE, V7, P1324, DOI 10.1130/GES00690.1; Studinger M, 2001, GEOPHYS RES LETT, V28, P3493, DOI 10.1029/2000GL011788; Taylor J, 2004, GEOLOGY, V32, P197, DOI 10.1130/G20275.1; Vaughan DG, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025588; Winberry JP, 2004, GEOLOGY, V32, P977, DOI 10.1130/G20768.1; Wingham DJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039126	30	67	67	2	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 26	2012	487	7408					468	471		10.1038/nature11292	http://dx.doi.org/10.1038/nature11292			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979KD	22837002				2022-12-28	WOS:000306815300035
J	MacArthur, D				MacArthur, Daniel			Face up to false positives	NATURE			English	Editorial Material									Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	MacArthur, D (corresponding author), Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA.	macarthur@atgu.mgh.harvard.edu		MacArthur, Daniel/0000-0002-5771-2290				Hunt KA, 2012, NAT GENET, V44, P3, DOI 10.1038/ng.1037; Kleinman CL, 2012, SCIENCE, V335, DOI [10.1126/science.1209658, 10.1126/science.1210624]; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; Lin W, 2012, SCIENCE, V335, DOI 10.1126/science.1210624; Pickrell JK, 2012, SCIENCE, V335, DOI 10.1126/science.1210484; Sebastiani P., 2010, SCIENCE, V2010; Sebastiani P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029848; Sebastiani P, 2011, SCIENCE, V333, P404, DOI 10.1126/science.333.6041.404-a; Surolia I, 2010, NATURE, V466, P243, DOI 10.1038/nature09115	9	39	40	0	16	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 26	2012	487	7408					427	428		10.1038/487427a	http://dx.doi.org/10.1038/487427a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	979KD	22836983				2022-12-28	WOS:000306815300015
J	Mugglestone, MA; Eunson, P; Murphy, MS				Mugglestone, Moira A.; Eunson, Paul; Murphy, M. Stephen		Guideline Dev Grp	Spasticity in children and young people with non-progressive brain disorders: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Mugglestone, Moira A.; Murphy, M. Stephen] Natl Collaborating Ctr Womens & Childrens Hlth, London W1T 2QA, England; [Eunson, Paul] Royal Hosp Sick Children, Edinburgh EH9 1LF, Midlothian, Scotland; [Murphy, M. Stephen] Univ Birmingham, Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England; [Murphy, M. Stephen] Birmingham Childrens Hosp NHS Fdn Trust, Birmingham B4 6NH, W Midlands, England	University of Birmingham; University of Birmingham	Mugglestone, MA (corresponding author), Natl Collaborating Ctr Womens & Childrens Hlth, London W1T 2QA, England.	mmugglestone@ncc-wch.org.uk		Cullen, Katherine/0000-0002-3704-4598				Department of Health, 2005, NAT SERV FRAM LONG T; National Institute for Health and Clinical Excellence, 2012, CLIN GUID, V145; National Institute for Health and Clinical Excellence, 2010, INT PROC GUID, V373; Sanger TD, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.1.e89	4	15	18	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUL 26	2012	345								e4845	10.1136/bmj.e4845	http://dx.doi.org/10.1136/bmj.e4845			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	981UY	22836108				2022-12-28	WOS:000306997700002
J	Duhren-von Minden, M; Ubelhart, R; Schneider, D; Wossning, T; Bach, MP; Buchner, M; Hofmann, D; Surova, E; Follo, M; Kohler, F; Wardemann, H; Zirlik, K; Veelken, H; Jumaa, H				Duehren-von Minden, Marcus; Uebelhart, Rudolf; Schneider, Dunja; Wossning, Thomas; Bach, Martina P.; Buchner, Maike; Hofmann, Daniel; Surova, Elena; Follo, Marie; Koehler, Fabian; Wardemann, Hedda; Zirlik, Katja; Veelken, Hendrik; Jumaa, Hassan			Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling	NATURE			English	Article							B-CELLS; FOSTAMATINIB DISODIUM; RECEPTOR; LYMPHOMA; SYK; PROLIFERATION; INHIBITION; PRECURSORS; EXPRESSION; CLONING	B-cell antigen receptor (BCR) expression is an important feature of chronic lymphocytic leukaemia (CLL), one of the most prevalent B-cell neoplasias in Western countries(1). The presence of stereotyped and quasi-identical BCRs in different CLL patients suggests that recognition of specific antigens might drive CLL pathogenesis. Here we show that, in contrast to other B-cell neoplasias, CLL-derived BCRs induce antigen-independent cell-autonomous signalling, which is dependent on the heavy-chain complementarity-determining region (HCDR3) and an internal epitope of the BCR. Indeed, transferring the HCDR3 of a CLL-derived BCR provides autonomous signalling capacity to a non-autonomously active BCR, whereas mutations in the internal epitope abolish this capacity. Because BCR expression was required for the binding of secreted CLL-derived BCRs to target cells, and mutations in the internal epitope reduced this binding, our results indicate a new model for CLL pathogenesis, with cell-autonomous antigen-independent signalling as a crucial pathogenic mechanism.	[Duehren-von Minden, Marcus; Uebelhart, Rudolf; Schneider, Dunja; Wossning, Thomas; Bach, Martina P.; Hofmann, Daniel; Surova, Elena; Koehler, Fabian; Jumaa, Hassan] Univ Freiburg, Ctr Biol Signaling Studies BIOSS, D-79104 Freiburg, Germany; [Uebelhart, Rudolf; Surova, Elena] Univ Freiburg, Spemann Grad Sch Biol & Med, D-79104 Freiburg, Germany; [Buchner, Maike; Follo, Marie; Zirlik, Katja] Univ Med Ctr Freiburg, Dept Hematol Oncol, D-79106 Freiburg, Germany; [Wardemann, Hedda] Max Planck Inst Infect Biol, Max Planck Res Grp Mol Immunol, D-10117 Berlin, Germany; [Veelken, Hendrik] Leiden Univ, Med Ctr, Dept Hematol, NL-2333 ZA Leiden, Netherlands; [Jumaa, Hassan] Univ Freiburg, Fac Biol, Dept Mol Immunol, D-79108 Freiburg, Germany; [Jumaa, Hassan] Max Planck Inst Immunobiol & Epigenet, D-79108 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; Max Planck Society; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Freiburg; Max Planck Society	Jumaa, H (corresponding author), Univ Freiburg, Ctr Biol Signaling Studies BIOSS, D-79104 Freiburg, Germany.	jumaa@immunbio.mpg.de		Wardemann, Hedda/0000-0003-3921-5933; Veelken, Hendrik/0000-0002-9108-3125; Follo, Marie/0000-0002-3090-7442	Deutsche Krebshilfe [108935]; Deutsche Forschungsgemeinschaft [SFB746, JU463/2-1]; Excellence Initiative of the German Federal and State Governments [GSC-4]	Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal and State Governments	We thank C. Croce for providing the TCL1 mice, M. Reth and P. Nielsen for scientific discussion and reading the manuscript, C. Wehr for help cloning TCL1-derived BCRs, A. Ott, A. Wurch, S. Hopitz and B. Wehrle for help with FACS experiments and cloning, and D. Pfeifer and M. Pantic for providing clinical data. This work was supported by the Deutsche Krebshilfe (Project 108935), the Deutsche Forschungsgemeinschaft (SFB746 and JU463/2-1) and the Excellence Initiative of the German Federal and State Governments (GSC-4, Spemann Graduate School).	Bertinetti C, 2006, EUR J HAEMATOL, V77, P395, DOI 10.1111/j.1600-0609.2006.00740.x; Bichi R, 2002, P NATL ACAD SCI USA, V99, P6955, DOI 10.1073/pnas.102181599; Bikos V, 2012, LEUKEMIA, V26, P1638, DOI 10.1038/leu.2012.3; Binder M, 2011, CANCER-AM CANCER SOC, V117, P1891, DOI 10.1002/cncr.25755; Buchner M, 2010, BLOOD, V115, P4497, DOI 10.1182/blood-2009-07-233692; Friedberg JW, 2010, BLOOD, V115, P2578, DOI 10.1182/blood-2009-08-236471; Ghia P, 2008, J INTERN MED, V264, P549, DOI 10.1111/j.1365-2796.2008.02030.x; Ghiotto F, 2004, J CLIN INVEST, V113, P1008, DOI 10.1172/JCI200419399; Herishanu Y, 2011, BLOOD, V117, P563, DOI 10.1182/blood-2010-05-284984; Herling M, 2009, BLOOD, V114, P4675, DOI 10.1182/blood-2009-03-208256; Herve M, 2005, J CLIN INVEST, V115, P1636, DOI 10.1172/JCI24387; Koehler F, 2008, IMMUNITY, V29, P912, DOI 10.1016/j.immuni.2008.10.013; Kulathu Y, 2009, IMMUNOL REV, V232, P286, DOI 10.1111/j.1600-065X.2009.00837.x; Meixlsperger S, 2007, IMMUNITY, V26, P323, DOI 10.1016/j.immuni.2007.01.012; Morton LM, 2006, BLOOD, V107, P265, DOI 10.1182/blood-2005-06-2508; Osterroth F, 1999, J IMMUNOL METHODS, V229, P141, DOI 10.1016/S0022-1759(99)00111-8; Seiler T, 2009, BLOOD, V114, P3615, DOI 10.1182/blood-2009-01-197822; Stamatopoulos K, 2007, BLOOD, V109, P259, DOI 10.1182/blood-2006-03-012948; Stevenson FK, 2011, BLOOD, V118, P4313, DOI 10.1182/blood-2011-06-338855; STHOEGER ZM, 1989, J EXP MED, V169, P255, DOI 10.1084/jem.169.1.255; Storch B, 2007, EUR J IMMUNOL, V37, P252, DOI 10.1002/eji.200636667; Su YW, 2003, IMMUNITY, V19, P295, DOI 10.1016/S1074-7613(03)00202-4; Suljagic M, 2010, BLOOD, V116, P4894, DOI 10.1182/blood-2010-03-275180; Tiller T, 2010, J EXP MED, V207, P2767, DOI 10.1084/jem.20100171; Ubelhart R, 2010, NAT IMMUNOL, V11, P759, DOI 10.1038/ni.1903; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Widhopf GF, 2004, BLOOD, V104, P2499, DOI 10.1182/blood-2004-03-0818; Yan XJ, 2006, P NATL ACAD SCI USA, V103, P11713, DOI 10.1073/pnas.0604564103	28	357	363	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2012	489	7415					309	+		10.1038/nature11309	http://dx.doi.org/10.1038/nature11309			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003UC	22885698				2022-12-28	WOS:000308635900045
J	Pavord, ID; Korn, S; Howarth, P; Bleecker, ER; Buhl, R; Keene, ON; Ortega, H; Chanez, P				Pavord, Ian D.; Korn, Stephanie; Howarth, Peter; Bleecker, Eugene R.; Buhl, Roland; Keene, Oliver N.; Ortega, Hector; Chanez, Pascal			Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial	LANCET			English	Article							CLUSTER-ANALYSIS; EXACERBATIONS; IDENTIFICATION; ANTIBODY; COUNTS; ADULTS; COSTS	Background Some patients with severe asthma have recurrent asthma exacerbations associated with eosinophilic airway inflammation. Early studies suggest that inhibition of eosinophilic airway inflammation with mepolizumab-a monoclonal antibody against interleukin 5-is associated with a reduced risk of exacerbations. We aimed to establish efficacy, safety, and patient characteristics associated with the response to mepolizumab. Methods We undertook a multicentre, double-blind, placebo-controlled trial at 81 centres in 13 countries between Nov 9, 2009, and Dec 5, 2011. Eligible patients were aged 12-74 years, had a history of recurrent severe asthma exacerbations, and had signs of eosinophilic inflammation. They were randomly assigned (in a 1:1:1:1 ratio) to receive one of three doses of intravenous mepolizumab (75 mg, 250 mg, or 750 mg) or matched placebo (100 mL 0.9% NaCl) with a central telephone-based system and computer-generated randomly permuted block schedule stratified by whether treatment with oral corticosteroids was required. Patients received 13 infusions at 4-week intervals. The primary outcome was the rate of clinically significant asthma exacerbations, which were defined as validated episodes of acute asthma requiring treatment with oral corticosteroids, admission, or a visit to an emergency department. Patients, clinicians, and data analysts were masked to treatment assignment. Analyses were by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT01000506. Findings 621 patients were randomised: 159 were assigned to placebo, 154 to 75 mg mepolizumab, 152 to 250 mg mepolizumab, and 156 to 750 mg mepolizumab. 776 exacerbations were deemed to be clinically significant. The rate of clinically significant exacerbations was 2.40 per patient per year in the placebo group, 1.24 in the 75 mg mepolizumab group (48% reduction, 95% CI 31-61%; p<0.0001), 1.46 in the 250 mg mepolizumab group (39% reduction, 19-54%; p=0.0005), and 1.15 in the 750 mg mepolizumab group (52% reduction, 36-64%; p<0.0001). Three patients died during the study, but the deaths were not deemed to be related to treatment. Interpretation Mepolizumab is an effective and well tolerated treatment that reduces the risk of asthma exacerbations in patients with severe eosinophilic asthma.	[Pavord, Ian D.] Univ Hosp Leicester NHS Trust, Glenfield Hosp, Inst Lung Hlth, Leicester LE3 9QP, Leics, England; [Korn, Stephanie; Buhl, Roland] Mainz Univ Hosp, Dept Pulm, Med Ctr 3, Mainz, Germany; [Howarth, Peter] Southampton Gen Hosp, Fac Med, Southampton SO9 4XY, Hants, England; [Bleecker, Eugene R.] Wake Forest Sch Med, Ctr Genom & Personalized Med, Winston Salem, NC USA; [Keene, Oliver N.] GlaxoSmithKline, Res & Dev, Stockley Pk, Middx, England; [Ortega, Hector] GlaxoSmithKline, Resp & Immunoinflammat, Res Triangle Pk, NC USA; [Chanez, Pascal] Aix Marseille Univ, Dept Resp Dis, UMR INSERM U1067 CNRS 7733, Aix En Provence, France; [Chanez, Pascal] Hop Nord Marseille, Assistance Publ Hop Marseille, Clin Invest Ctr, Marseille, France	University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University Hospital Mainz; University of Southampton; Wake Forest University; GlaxoSmithKline; GlaxoSmithKline; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Pavord, ID (corresponding author), Univ Hosp Leicester NHS Trust, Glenfield Hosp, Inst Lung Hlth, Leicester LE3 9QP, Leics, England.	ian.pavord@uhl-tr.nhs.uk		Pavord, Ian/0000-0002-4288-5973; Keene, Oliver/0000-0003-0016-9773; chanez, pascal/0000-0003-4059-0917; Howarth, Peter/0000-0003-0619-7927	GlaxoSmithKline; AstraZeneca; Boehringer Ingelheim; Napp; Chiesi Farmaceutici; Novartis; Nycomed; Almirall; Centocor; Teva; Schering Plough; MSD; MRC [G0800649, G0900453, G0400473] Funding Source: UKRI; Medical Research Council [G0800649, G0400473, G0900453] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10157] Funding Source: researchfish	GlaxoSmithKline(GlaxoSmithKline); AstraZeneca(AstraZeneca); Boehringer Ingelheim(Boehringer Ingelheim); Napp; Chiesi Farmaceutici(Chiesi Pharmaceuticals Inc); Novartis(Novartis); Nycomed; Almirall(Almirall); Centocor; Teva(Teva Pharmaceutical Industries); Schering Plough(Merck & CompanySchering Plough Corporation); MSD; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	GlaxoSmithKline.; IDP has received honoraria for speaking at sponsored meetings from AstraZeneca, Boehringer Ingelheim, and GlaxoSmithKline; honoraria for attending advisory panels from Admirals, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, MSD, Schering-Plough, Novartis, Dey, and Napp; and sponsorship to attend international scientific meetings from Boehringer Ingelheim, GlaxoSmithKline, AstraZeneca, and Napp. He is Chief Medical Advisor of Asthma UK, a member of the UK Department of Health Asthma Strategy Group, a member of the BTS SIGN Asthma guideline group, and joint editor-in-chief of Thorax. Neither IDP nor any member of his family has any shares in pharmaceutical companies. SK has received reimbursement for attending scientific conferences, fees for speaking, or consulting from AstraZeneca, Boehringer Ingelheim, Chiesi Farmaceutici, GlaxoSmithKline, Novartis, and Nycomed. ERB has consulted with GlaxoSmithKline and MedImmune and has undertaken clinical trials of this biological class of drugs that are managed by his employer (Wake Forest School of Medicine, NC, USA) for GlaxoSmithKline, MedImmune, and Cephalon. RB has served on advisory boards and is a member of speakers' bureau for AstraZeneca, Boehringer Ingelheim, Chiesi Farmaceutici, GlaxoSmithKline, Novartis, and Nycomed. ONK and HO are full-time employees of GlaxoSmithKline and hold shares in the company. PC has provided consultancy services for Almirall, Boehringer Ingelheim, Centocor, GlaxoSmithKline, AstraZeneca, Novartis, Teva, Chiesi Farmaceutici, and Schering Plough; has served on advisory boards for Almirall, Boehringer Ingelheim, Centocor, GlaxoSmithKline, AstraZeneca, Novartis, Teva, Chiesi Farmaceutici, BostonSc, Schering Plough, and MSD; has received lecture fees from Almirall, Boehringer Ingelheim, Centocor, GlaxoSmithKline, AstraZeneca, Novartis, Teva, Chiesi Farmaceutici, Schering Plough, and MSD; and has received industry-sponsored grants from Almirall, Boehringer Ingelheim, Centocor, GlaxoSmithKline, AstraZeneca, Novartis, Teva, Chiesi Farmaceutici, and Schering Plough. PH declares that he has no conflicts of interest.	ADINOFF AD, 1983, NEW ENGL J MED, V309, P265, DOI 10.1056/NEJM198308043090502; Bafadhel M, 2011, AM J RESP CRIT CARE, V184, P662, DOI 10.1164/rccm.201104-0597OC; Barnes PJ, 1996, EUR RESPIR J, V9, P636, DOI 10.1183/09031936.96.09040636; Chanez P, 2007, J ALLERGY CLIN IMMUN, V119, P1337, DOI 10.1016/j.jaci.2006.11.702; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Djukanovic R, 2004, AM J RESP CRIT CARE, V170, P583, DOI 10.1164/rccm.200312-1651OC; Flood-Page P, 2003, J CLIN INVEST, V112, P1029, DOI 10.1172/JCI200317974; Flood-Page P, 2007, AM J RESP CRIT CARE, V176, P1062, DOI 10.1164/rccm.200701-085OC; Flood-Page PT, 2003, AM J RESP CRIT CARE, V167, P199, DOI 10.1164/rccm.200208-789OC; Global Initiative for Asthma, GLOB STRAT ASTHM MAN; Godard P, 2002, EUR RESPIR J, V19, P61, DOI 10.1183/09031936.02.00232001; Green RH, 2002, LANCET, V360, P1715, DOI 10.1016/S0140-6736(02)11679-5; Greulich T, 2012, EUR RESPIR J, V36, p1005s; Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI 10.1164/rccm.200711-1754OC; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; Heaney LG, 2010, THORAX, V65, P787, DOI 10.1136/thx.2010.137414; Jayaram L, 2006, EUR RESPIR J, V27, P483, DOI 10.1183/09031936.06.00137704; Juniper EF, 2005, RESP MED, V99, P553, DOI 10.1016/j.rmed.2004.10.008; Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x; JUNIPER EF, 1993, AM REV RESPIR DIS, V147, P832, DOI 10.1164/ajrccm/147.4.832; Keene ON, 2008, EUR RESPIR J, V32, P17, DOI 10.1183/09031936.00161507; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; Nair P, 2009, NEW ENGL J MED, V360, P985, DOI 10.1056/NEJMoa0805435; Pavord ID, 2010, THORAX, V65, P370, DOI 10.1136/thx.2009.122697; Powell H, 2011, LANCET, V378, P983, DOI 10.1016/S0140-6736(11)60971-9; Proceedings of the ATS workshop on refractory asthma, 2000, AM J RESP CRIT CARE, V162, P2341, DOI DOI 10.1164/AJRCCM.162.6.ATS9-00; Romagnoli M, 2007, CLIN EXP ALLERGY, V37, P552, DOI 10.1111/j.1365-2222.2007.02683.x	28	1427	1491	4	76	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 18	2012	380	9842					651	659		10.1016/S0140-6736(12)60988-X	http://dx.doi.org/10.1016/S0140-6736(12)60988-X			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	991SE	22901886				2022-12-28	WOS:000307721000030
J	Wong, C; Jayaram, L; Karalus, N; Eaton, T; Tong, C; Hockey, H; Milne, D; Fergusson, W; Tuffery, C; Sexton, P; Storey, L; Ashton, T				Wong, Conroy; Jayaram, Lata; Karalus, Noel; Eaton, Tam; Tong, Cecilia; Hockey, Hans; Milne, David; Fergusson, Wendy; Tuffery, Christine; Sexton, Paul; Storey, Louanne; Ashton, Toni			Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial	LANCET			English	Article							LONG-TERM; PSEUDOMONAS-AERUGINOSA; CHILDREN; PARAMETERS; MACROLIDES; THERAPY	Background Azithromycin is a macrolide antibiotic with anti-inflammatory and immunomodulatory properties. We tested the hypothesis that azithromycin would decrease the frequency of exacerbations, increase lung function, and improve health-related quality of life in patients with non-cystic fibrosis bronchiectasis. Methods We undertook a randomised, double-blind, placebo-controlled trial at three centres in New Zealand. Between Feb 12, 2008, and Oct 15, 2009, we enrolled patients who were 18 years or older, had had at least one pulmonary exacerbation requiring antibiotic treatment in the past year, and had a diagnosis of bronchiectasis defined by high-resolution CT scan. We randomly assigned patients to receive 500 mg azithromycin or placebo three times a week for 6 months in a 1: 1 ratio, with a permuted block size of six and sequential assignment stratified by centre. Participants, research assistants, and investigators were masked to treatment allocation. The coprimary endpoints were rate of event-based exacerbations in the 6-month treatment period, change in forced expiratory volume in 1 s (FEV1) before bronchodilation, and change in total score on St George's respiratory questionnaire (SGRQ). Analyses were by intention to treat. This study is registered with the Australian New Zealand Clinical Trials Registry, number ACTRN12607000641493. Findings 71 patients were in the azithromycin group and 70 in the placebo group. The rate of event-based exacerbations was 0.59 per patient in the azithromycin group and 1.57 per patient in the placebo group in the 6-month treatment period (rate ratio 0.38, 95% CI 0.26-0.54; p<0.0001). Prebronchodilator FEV1 did not change from baseline in the azithromycin group and decreased by 0.04 L in the placebo group, but the difference was not significant (0.04 L, 95% CI -0.03 to 0.12; p=0.251). Additionally, change in SGRQ total score did not differ between the azithromycin (-5.17 units) and placebo groups (-1.92 units; difference -3.25, 95% CI -7.21 to 0.72; p=0.108). Interpretation Azithromycin is a new option for prevention of exacerbations in patients with non-cystic fibrosis bronchiectasis with a history of at least one exacerbation in the past year.	[Wong, Conroy] Middlemore Hosp, Dept Resp Med, Counties Manukau Dist Hlth Board, Auckland 2025, New Zealand; [Tong, Cecilia] Middlemore Hosp, Counties Manukau Dist Hlth Board, Ctr Clin Res & Effect Practice, Auckland 2025, New Zealand; [Storey, Louanne] Middlemore Hosp, Counties Manukau Dist Hlth Board, Dept Microbiol, Auckland 2025, New Zealand; [Jayaram, Lata] Monash Med Ctr, Dept Resp Med, Clayton, Vic 3168, Australia; [Karalus, Noel; Tuffery, Christine] Waikato Hosp, Waikato Dist Hlth Board, Dept Resp Med, Hamilton, New Zealand; [Hockey, Hans] Biometr Matters Ltd, Hamilton, New Zealand; [Milne, David] Auckland City Hosp, Auckland Dist Hlth Board, Dept Radiol, Auckland, New Zealand; [Fergusson, Wendy; Sexton, Paul] Auckland City Hosp, Auckland Dist Hlth Board, Dept Resp Med, Auckland, New Zealand; [Ashton, Toni] Univ Auckland, Sch Populat Hlth, Auckland 1, New Zealand	Monash University; Waikato Hospital; Auckland City Hospital; Auckland District Health Board; Auckland City Hospital; Auckland District Health Board; University of Auckland	Wong, C (corresponding author), Middlemore Hosp, Dept Resp Med, Counties Manukau Dist Hlth Board, Auckland 2025, New Zealand.	cawong@middlemore.co.nz		Sexton, Paul/0000-0002-5151-4912	Health Research Council of New Zealand; Auckland District Health Board Charitable Trust	Health Research Council of New Zealand(Health Research Council of New Zealand); Auckland District Health Board Charitable Trust	Health Research Council of New Zealand and Auckland District Health Board Charitable Trust.	Albert RK, 2011, NEW ENGL J MED, V365, P689, DOI 10.1056/NEJMoa1104623; Altenburg J, 2011, RESPIRATION, V81, P75, DOI 10.1159/000320320; Altenburg J, 2011, EUR RESP SOC C AMST, V38; Barker AF, 2002, NEW ENGL J MED, V346, P1383, DOI 10.1056/NEJMra012519; Burge S, 2003, EUR RESPIR J, V21, p46S, DOI 10.1183/09031936.03.00078002; Cai Y, 2011, J ANTIMICROB CHEMOTH, V66, P968, DOI 10.1093/jac/dkr040; Calverley P, 2005, EUR RESPIR J, V26, P406, DOI 10.1183/09031936.05.00143404; Chang AB, 2008, THORAX, V63, P269, DOI 10.1136/thx.2006.060913; Clement A, 2006, THORAX, V61, P895, DOI 10.1136/thx.2005.057950; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Efthimiadis A, 2002, EUR RESPIR J, V20, p19S, DOI 10.1183/09031936.02.00001902; Elizur A, 2008, CHEST, V133, P489, DOI 10.1378/chest.07-1631; Equi A, 2002, LANCET, V360, P978, DOI 10.1016/S0140-6736(02)11081-6; Idris SF, 2009, THORAX, V64, P186, DOI 10.1136/thx.2008.103192; Kanoh S, 2010, CLIN MICROBIOL REV, V23, P590, DOI 10.1128/CMR.00078-09; King PT, 2006, RESP MED, V100, P2183, DOI 10.1016/j.rmed.2006.03.012; Knirsch CA, 2012, NEW ENGL J MED, V367, P772, DOI [10.1056/NEJMoa1003833, 10.1056/NEJMc1207269]; Koh YY, 1997, EUR RESPIR J, V10, P994, DOI 10.1183/09031936.97.10050994; Loebinger MR, 2009, EUR RESPIR J, V34, P843, DOI 10.1183/09031936.00003709; Malhotra-Kumar S, 2007, LANCET, V369, P482, DOI 10.1016/S0140-6736(07)60235-9; Martinez-Garcia MA, 2005, CHEST, V128, P739, DOI 10.1378/chest.128.2.739; Martinez-Garcia MA, 2007, CHEST, V132, P1565, DOI 10.1378/chest.07-0490; MCGUINNESS G, 1995, SEMIN ULTRASOUND CT, V16, P395, DOI 10.1016/0887-2171(95)90028-4; O'Donnell AE, 1998, CHEST, V113, P1329, DOI 10.1378/chest.113.5.1329; Pasteur MC, 2010, THORAX, V65, pI1, DOI 10.1136/thx.2010.136119; Reinert RR, 2005, ANTIMICROB AGENTS CH, V49, P2903, DOI 10.1128/AAC.49.7.2903-2913.2005; Renna M, 2011, J CLIN INVEST, V121, P3554, DOI 10.1172/JCI46095; Roberts HJ, 2010, RESP MED, V104, P981, DOI 10.1016/j.rmed.2010.02.022; Saiman L, 2003, JAMA-J AM MED ASSOC, V290, P1749, DOI 10.1001/jama.290.13.1749; Saiman L, 2010, JAMA-J AM MED ASSOC, V303, P1707, DOI 10.1001/jama.2010.563; Seitz AE, 2012, CHEST, DOI 10.1378/chest.11-2209; Seitz AE, 2010, CHEST, V138, P944, DOI 10.1378/chest.10-0099; Serisier DJ, 2012, AM J RESP CRIT CARE, V185, pA6862; Tsang KWT, 1999, EUR RESPIR J, V13, P361, DOI 10.1183/09031936.99.13236199; Wilson CB, 1997, AM J RESP CRIT CARE, V156, P536, DOI 10.1164/ajrccm.156.2.9607083; Wolter J, 2002, THORAX, V57, P212, DOI 10.1136/thorax.57.3.212; Yalcin E, 2006, J CLIN PHARM THER, V31, P49, DOI 10.1111/j.1365-2710.2006.00708.x	37	384	401	0	62	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 18	2012	380	9842					660	667		10.1016/S0140-6736(12)60953-2	http://dx.doi.org/10.1016/S0140-6736(12)60953-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	991SE	22901887				2022-12-28	WOS:000307721000031
J	Yu, FX; Zhao, B; Panupinthu, N; Jewell, JL; Lian, I; Wang, LH; Zhao, JG; Yuan, HX; Tumaneng, K; Li, HR; Fu, XD; Mills, GB; Guan, KL				Yu, Fa-Xing; Zhao, Bin; Panupinthu, Nattapon; Jewell, Jenna L.; Lian, Ian; Wang, Lloyd H.; Zhao, Jiagang; Yuan, Haixin; Tumaneng, Karen; Li, Hairi; Fu, Xiang-Dong; Mills, Gordon B.; Guan, Kun-Liang			Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling	CELL			English	Article							LYSOPHOSPHATIDIC ACID RECEPTORS; YES-ASSOCIATED PROTEIN; ORGAN SIZE CONTROL; CELL-PROLIFERATION; HEPATOCELLULAR-CARCINOMA; TRANSCRIPTION FACTOR; GROWTH-CONTROL; TISSUE-GROWTH; F-ACTIN; TUMORIGENESIS	The Hippo pathway is crucial in organ size control, and its dysregulation contributes to tumorigenesis. However, upstream signals that regulate the mammalian Hippo pathway have remained elusive. Here, we report that the Hippo pathway is regulated by G-protein-coupled receptor (GPCR) signaling. Serum-borne lysophosphatidic acid (LPA) and sphingosine 1-phosphophate (S1P) act through G12/13-coupled receptors to inhibit the Hippo pathway kinases Lats1/2, thereby activating YAP and TAZ transcription coactivators, which are oncoproteins repressed by Lats1/2. YAP and TAZ are involved in LPA-induced gene expression, cell migration, and proliferation. In contrast, stimulation of Gs-coupled receptors by glucagon or epinephrine activates Lats1/2 kinase activity, thereby inhibiting YAP function. Thus, GPCR signaling can either activate or inhibit the Hippo-YAP pathway depending on the coupled G protein. Our study identifies extracellular diffusible signals that modulate the Hippo pathway and also establishes the Hippo-YAP pathway as a critical signaling branch downstream of GPCR.	[Yu, Fa-Xing; Jewell, Jenna L.; Lian, Ian; Wang, Lloyd H.; Zhao, Jiagang; Yuan, Haixin; Tumaneng, Karen; Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Yu, Fa-Xing; Jewell, Jenna L.; Lian, Ian; Wang, Lloyd H.; Zhao, Jiagang; Yuan, Haixin; Tumaneng, Karen; Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Li, Hairi; Fu, Xiang-Dong] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Zhao, Bin] Zhejiang Univ, Life Sci Inst, Hangzhou 310058, Zhejiang, Peoples R China; [Panupinthu, Nattapon; Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Zhejiang University; University of Texas System; UTMD Anderson Cancer Center	Guan, KL (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	kuguan@ucsd.edu	Guan, Kun-Liang/ADK-7088-2022	Yu, Fa-Xing/0000-0003-4834-9335	NIH [P30 CA23100]; CIRM; Breast Cancer Research Foundation; National Cancer Institute [T32CA121938];  [GM052872]; NATIONAL CANCER INSTITUTE [T32CA121938, R01CA132809, P50CA098258, P30CA016672, P30CA023100] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY022611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752, R01GM052872] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM(California Institute for Regenerative Medicine); Breast Cancer Research Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. Jack Dixon, Edward Dennis, Joan Heller Brown, and Jerold Chun for constructive comments; Dr. Rick Neubig for several G protein constructs; Drs. Ji Zhang, Richard Rivera, Zhongrui Zhou, Sunny Xiang, Andrew Markley, Dong Zhang, and Richard Harkewicz for technical help; and Jean Guan and Drs. Yanhui Xu and Ryan Russell for critical reading of the manuscript. This work was supported by grants from NIH and CIRM to K.-L.G. and GM052872 to X.-D.F. and a grant from Breast Cancer Research Foundation to G. B. M. J.L.J. was supported by the National Cancer Institute Training Grant T32CA121938. The cost of confocal imaging was partially supported by NIH Grant P30 CA23100.	Benhamouche S, 2010, GENE DEV, V24, P1718, DOI 10.1101/gad.1938710; Cai J, 2010, GENE DEV, V24, P2383, DOI 10.1101/gad.1978810; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Cao XW, 2008, GENE DEV, V22, P3320, DOI 10.1101/gad.1726608; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Fernandez BG, 2011, DEVELOPMENT, V138, P2337, DOI 10.1242/dev.063545; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kuang DH, 2005, J NEUROCHEM, V93, P383, DOI 10.1111/j.1471-4159.2005.03025.x; Lee CH, 2007, ANNU REV PHARMACOL, V47, P443, DOI 10.1146/annurev.pharmtox.47.120505.105359; Lee KP, 2010, P NATL ACAD SCI USA, V107, P8248, DOI 10.1073/pnas.0912203107; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Li L, 2007, MOL CELL NEUROSCI, V35, P76, DOI 10.1016/j.mcn.2007.02.004; Liu CY, 2010, J BIOL CHEM, V285, P37159, DOI 10.1074/jbc.M110.152942; Liu SY, 2009, CANCER CELL, V15, P539, DOI 10.1016/j.ccr.2009.03.027; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Ludwig A, 2011, J NEUROSCI, V31, P644, DOI 10.1523/JNEUROSCI.2006-10.2011; Ohta H, 2003, MOL PHARMACOL, V64, P994, DOI 10.1124/mol.64.4.994; Oury F, 2011, CELL, V144, P796, DOI 10.1016/j.cell.2011.02.004; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Prickett TD, 2011, NAT GENET, V43, P1119, DOI 10.1038/ng.950; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Rauskolb C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000624; Rosen H, 2009, ANNU REV BIOCHEM, V78, P743, DOI 10.1146/annurev.biochem.78.072407.103733; Sansores-Garcia L, 2011, EMBO J, V30, P2325, DOI 10.1038/emboj.2011.157; Shida D, 2003, CANCER RES, V63, P1706; Steinhardt AA, 2008, HUM PATHOL, V39, P1582, DOI 10.1016/j.humpath.2008.04.012; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; VANCORVEN EJ, 1989, CELL, V59, P45, DOI 10.1016/0092-8674(89)90868-4; Wellendorph P, 2005, MOL PHARMACOL, V67, P589, DOI 10.1124/mol.104.007559; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Xu MZ, 2009, CANCER-AM CANCER SOC, V115, P4576, DOI 10.1002/cncr.24495; Xu Y, 2010, CANCER RES, V70, P2455, DOI 10.1158/0008-5472.CAN-09-2505; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	47	1054	1100	8	275	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 17	2012	150	4					780	791		10.1016/j.cell.2012.06.037	http://dx.doi.org/10.1016/j.cell.2012.06.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	995IT	22863277	Bronze, Green Accepted			2022-12-28	WOS:000308002300012
J	Vincent, R; Klyatskaya, S; Ruben, M; Wernsdorfer, W; Balestro, F				Vincent, Romain; Klyatskaya, Svetlana; Ruben, Mario; Wernsdorfer, Wolfgang; Balestro, Franck			Electronic read-out of a single nuclear spin using a molecular spin transistor	NATURE			English	Article							MAGNETIC-ANISOTROPY; QUANTUM; BIS(PHTHALOCYANINATO)TERBIUM; SPINTRONICS	Quantum control of individual spins in condensed-matter devices is an emerging field with a wide range of applications, from nanospintronics(1,2) to quantum computing(3). The electron, possessing spin and orbital degrees of freedom, is conventionally used as the carrier of quantum information in proposed devices(4,5,6,7,8,9). However, electrons couple strongly to the environment, and so have very short relaxation and coherence times. It is therefore extremely difficult to achieve quantum coherence and stable entanglement of electron spins. Alternative concepts propose nuclear spins as the building blocks for quantum computing(10), because such spins are extremely well isolated from the environment and less prone to decoherence. However, weak coupling comes at a price: it remains challenging to address and manipulate individual nuclear spins(11,12,13,14). Here we show that the nuclear spin of an individual metal atom embedded in a single-molecule magnet can be read out electronically. The observed long lifetimes ( tens of seconds) and relaxation characteristics of nuclear spin at the single-atom scale open the way to a completely new world of devices in which quantum logic may be implemented.	[Vincent, Romain; Wernsdorfer, Wolfgang; Balestro, Franck] CNRS, Inst Neel, F-38042 Grenoble 9, France; [Vincent, Romain; Wernsdorfer, Wolfgang; Balestro, Franck] Univ Grenoble 1, F-38042 Grenoble 9, France; [Klyatskaya, Svetlana; Ruben, Mario] Karlsruhe Inst Technol, Inst Nanotechnol, D-76344 Eggenstein Leopoldshafen, Germany; [Ruben, Mario] Univ Strasbourg, CNRS, Inst Phys & Chim Mat Strasbourg, F-67034 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Helmholtz Association; Karlsruhe Institute of Technology; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Balestro, F (corresponding author), CNRS, Inst Neel, BP 166, F-38042 Grenoble 9, France.	mario.ruben@kit.edu; franck.balestro@grenoble.cnrs.fr	Ruben, Mario/C-6816-2008; Wernsdorfer, Wolfgang/M-2280-2016	Ruben, Mario/0000-0002-7718-7016; Wernsdorfer, Wolfgang/0000-0003-4602-5257; Cador, Olivier/0000-0003-2064-6223	French National Research Agency National Programme in Nanosciences and Nanotechnologies (ANR-PNANO) project MolNanoSpin [ANR-08-NANO-002]; European Research Council Advanced Grant MolNanoSpin [226558]; Future Emerging Technologies Open, Quantum Information Processing Specific Targeted Research Project [ICT-2007.8.0, 211284 MolSpinQIP]; German Research Foundation programme TRR 88 '3Met'; Cible; Nanosciences Foundation of Grenoble	French National Research Agency National Programme in Nanosciences and Nanotechnologies (ANR-PNANO) project MolNanoSpin(French National Research Agency (ANR)); European Research Council Advanced Grant MolNanoSpin(European Research Council (ERC)); Future Emerging Technologies Open, Quantum Information Processing Specific Targeted Research Project; German Research Foundation programme TRR 88 '3Met'; Cible; Nanosciences Foundation of Grenoble	We thank E. Eyraud, D. Lepoittevin, L. Cagnon, R. Haettel, C. Hoarau, V. Reita and P. Rodiere for technical contributions and discussions. We thank T. Fournier, T. Crozes, B. Fernandez, S. Dufresnes and G. Julie for lithography development; E. Bonet, C. Thirion and R. Piquerel for help with software development and M. Urdampilleta, S. Thiele, N. Roch, A. Varlet and A. Ralko for discussions. Samples were fabricated in the Nanofab facility of the Neel Institute. This work is partially supported by the French National Research Agency National Programme in Nanosciences and Nanotechnologies (ANR-PNANO) project MolNanoSpin, number ANR-08-NANO-002; European Research Council Advanced Grant MolNanoSpin, number 226558; ICT-2007.8.0 Future Emerging Technologies Open, Quantum Information Processing Specific Targeted Research Project number 211284 MolSpinQIP; the German Research Foundation programme TRR 88 '3Met'; Cible 2009; and the Nanosciences Foundation of Grenoble.	Abragam A., 1994, PRINCIPLES NUCL MAGN; Ardavan A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.057201; Awschalom DD, 2002, NANOSCI TECHNOL, P147; Berman GP, 2000, PHYS REV B, V61, P14694, DOI 10.1103/PhysRevB.61.14694; Bertaina S, 2008, NATURE, V453, P203, DOI 10.1038/nature06962; Bogani L, 2008, NAT MATER, V7, P179, DOI 10.1038/nmat2133; Chuang IL, 1998, NATURE, V393, P143, DOI 10.1038/30181; Chuang IL, 1998, PHYS REV LETT, V80, P3408, DOI 10.1103/PhysRevLett.80.3408; DIVINCENZO DP, 1995, PHYS REV A, V51, P1015, DOI 10.1103/PhysRevA.51.1015; Eble B, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.146601; Friedman JR, 1996, PHYS REV LETT, V76, P3830, DOI 10.1103/PhysRevLett.76.3830; Heersche HB, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.206801; Imamoglu A, 1999, PHYS REV LETT, V83, P4204, DOI 10.1103/PhysRevLett.83.4204; Ishikawa N, 2005, ANGEW CHEM INT EDIT, V44, P2931, DOI 10.1002/anie.200462638; Jelezko F., 2004, PHYS REV LETT, V92, P1; Kane BE, 1998, NATURE, V393, P133, DOI 10.1038/30156; Komeda T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1210; Leuenberger MN, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.165317; Leuenberger MN, 2001, NATURE, V410, P789, DOI 10.1038/35071024; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; Neumann P, 2010, SCIENCE, V329, P542, DOI 10.1126/science.1189075; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Otte AF, 2008, NAT PHYS, V4, P847, DOI 10.1038/nphys1072; Park H, 1999, APPL PHYS LETT, V75, P301, DOI 10.1063/1.124354; Stepanow S, 2010, J AM CHEM SOC, V132, P11900, DOI 10.1021/ja105124r; Thomas L, 1996, NATURE, V383, P145, DOI 10.1038/383145a0; Urdampilleta M, 2011, NAT MATER, V10, P502, DOI [10.1038/NMAT3050, 10.1038/nmat3050]; Vrijen R., 2000, PHYS REV A, V62, P1; Wernsdorfer W, 1999, SCIENCE, V284, P133, DOI 10.1126/science.284.5411.133; Zutic I, 2004, REV MOD PHYS, V76, P323, DOI 10.1103/RevModPhys.76.323; Zyazin AS, 2010, NANO LETT, V10, P3307, DOI 10.1021/nl1009603	31	626	629	12	386	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2012	488	7411					357	360		10.1038/nature11341	http://dx.doi.org/10.1038/nature11341			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OS	22895342				2022-12-28	WOS:000307501000037
J	Klevens, J; Kee, R; Trick, W; Garcia, D; Angulo, FR; Jones, R; Sadowski, LS				Klevens, Joanne; Kee, Romina; Trick, William; Garcia, Diana; Angulo, Francisco R.; Jones, Robin; Sadowski, Laura S.			Effect of Screening for Partner Violence on Women's Quality of Life A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DOMESTIC VIOLENCE; PREVALENCE	Context Although partner violence screening has been endorsed by many health organizations, there is insufficient evidence that it has beneficial health outcomes. Objective To determine the effect of computerized screening for partner violence plus provision of a partner violence resource list vs provision of a partner violence list only on women's health in primary care settings, compared with a control group. Design, Setting, and Participants A 3-group blinded randomized controlled trial at 10 primary health care centers in Cook County, Illinois. Participants were enrolled from May 2009-April 2010 and reinterviewed 1 year (range, 48-56 weeks) later. Participants were English- or Spanish-speaking women meeting specific inclusion criteria and seeking clinical services at study sites. Of 3537 women approached, 2727 were eligible, 2708 were randomized (99%), and 2364 (87%) were recontacted 1 year later. Mean age of participants was 39 years. Participants were predominantly non-Latina African American (55%) or Latina (37%), had a high school education or less (57%), and were uninsured (57%). Intervention Randomization into 3 intervention groups: (1) partner violence screen (using the Partner Violence Screen instrument) plus a list of local partner violence resources if screening was positive (n = 909); (2) partner violence resource list only without screen (n = 893); and (3) no-screen, no-partner violence list control group (n = 898). Main Outcome Measures Quality of life (QOL, physical and mental health components) was the primary outcome, measured on the 12-item Short Form (scale range 0-100, mean of 50 for US population). Results At 1-year follow-up, there were no significant differences in the QOL physical health component between the screen plus partner violence resource list group (n = 801; mean score, 46.8; 95% CI, 46.1-47.4), the partner violence resource list only group (n = 772; mean score, 46.4; 95% CI, 45.8-47.1), and the control group (n = 791; mean score, 47.2; 95% CI, 46.5-47.8), or in the mental health component (screen plus partner violence resource list group [mean score, 48.3; 95% CI, 47.5-49.1], the partner violence resource list only group [mean score, 48.0; 95% CI, 47.2-48.9], and the control group [mean score, 47.8; 95% CI, 47.0-48.6]). There were also no differences between groups in days unable to work or complete housework; number of hospitalizations, emergency department, or ambulatory care visits; proportion who contacted a partner violence agency; or recurrence of partner violence. Conclusions Among women receiving care in primary care clinics, providing a partner violence resource list with or without screening did not result in improved health.	[Klevens, Joanne] Ctr Dis Control & Prevent, Div Violence Prevent, Atlanta, GA USA; [Kee, Romina; Trick, William; Garcia, Diana; Angulo, Francisco R.; Sadowski, Laura S.] John H Stroger Jr Hosp Cook Cty, Collaborat Res Unit, Dept Med, Chicago, IL USA; [Jones, Robin] Rush Univ, Dept Obstet & Gynecol, Chicago, IL 60612 USA; [Sadowski, Laura S.] Rush Univ, Dept Internal Med, Chicago, IL 60612 USA	Centers for Disease Control & Prevention - USA; John H Stroger Junior Hospital Cook County; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Rush University; Rush University	Klevens, J (corresponding author), 4770 Buford Hwy,Mailstop F-63, Atlanta, GA 30341 USA.	jklevens@cdc.gov		Trick, William/0000-0002-3243-5098	World Health Organization; Centers for Disease Control and Prevention (CDC), National Center for Injury Prevention and Control, Division of Violence Prevention; DePaul University; George Washington University; Loyola University; Northern Illinois University; Northwestern University; Oberlin College; United Nations University; University of Illinois at Chicago; University of Illinois at Urbana-Champaign; University of Wisconsin-Madison	World Health Organization(World Health Organization); Centers for Disease Control and Prevention (CDC), National Center for Injury Prevention and Control, Division of Violence Prevention; DePaul University; George Washington University; Loyola University; Northern Illinois University; Northwestern University; Oberlin College; United Nations University; University of Illinois at Chicago; University of Illinois at Urbana-Champaign; University of Wisconsin-Madison	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Sadowski reports receipt of consultancy fees from the World Health Organization. The other authors report no disclosures.; This study was supported by the Centers for Disease Control and Prevention (CDC), National Center for Injury Prevention and Control, Division of Violence Prevention.; James Mercy, PhD, and Linda Saltzman dagger, PhD, CDC (dagger Deceased), for study concept, Drs Mercy and Saltzman received no compensation for their work on this article. Gladys Arana-Arriola, BA candidate, Gisselle Rodriguez, MEd, and Yazmin San Miguel, BS, DePaul University; Amalia Turkewitz, BA, George Washington University; Crystal Sanchez, BA, Loyola University; Marycarmen Hernandez, BA, Northern Illinois University; Maria Valdovinos, BA, Northwestern University; Emma Rubin, BA, Oberlin College; Emily McClure, MA, United Nations University; Celia Almazan, MSW, Kate Hawley, MSW, TaCarra Moore, MPH, Magdalena Nava, BA, Elizabeth Perez, MD, MPH, Maria Rodriguez Sanchez, MEd, and Claire Seryak, PhD, University of Illinois at Chicago; Yvette Castaneda, BS, and Maricarmen Herrera, BA, University of Illinois at Urbana-Champaign; and Andrea Larson, BS, and Mary Pawlek, MD, University of Wisconsin-Madison helped in recruitment, assessment, and follow-up of study participants and were financially compensated for their work. Stephanie Love Patterson, Illinois certified domestic violence professional, associate director of the Connections for Abused Women and their Children, Stroger Hospital's in-house partner violence advocacy program, helped develop the partner violence video shown to women screening positive (for a nominal sum); and Ashlesha Patel, MD, MPH, systems director of the Family Planning Services of Cook County Health and Hospital Systems, facilitated access to patients seeking services at the gynecological and family planning outpatient clinics at Stroger Hospital (received no compensation).	American College of Emergency Physicians, 1995, ANN EMERG MED, V25, P442; American College of Nurse Midwives, 1997, POS STAT VIOL WOM; American Congress of Obstetricians and Gynecologists (ACOG), 2011, SCREEN TOOLS DOM VIO; American Medical Association, 2011, H515965 AM MED ASS; American Nursing Association, 2000, SOC CAUS HLTH CAR; American Public Health Association, 1992, POS PAP 9211 PP DOM; [Anonymous], 1994, AM FAM PHYSICIAN, V50, P1636; Bauer HM, 2000, J GEN INTERN MED, V15, P811, DOI 10.1046/j.1525-1497.2000.91217.x; Berg AO, 2004, ANN INTERN MED, V140, P382, DOI 10.7326/0003-4819-140-5-200403020-00021; Committee on Preventive Services for Women Institute of Medicine, 2011, CLIN PREV SERV WOM C, P102; Council on Scientific Affairs American Medical Association, 1992, JAMA-J AM MED ASSOC, V267, P3184, DOI DOI 10.1001/JAMA.1992.03480230076032; Feldhaus KM, 1997, JAMA-J AM MED ASSOC, V277, P1357, DOI 10.1001/jama.277.17.1357; GIN NE, 1991, J GEN INTERN MED, V6, P317, DOI 10.1007/BF02597429; Jacqueline J.M., 2009, PASW CATEGORIES 18; Joint Commission on Accreditation of Healthcare Organizations, 1992, ACCR MAN HOSP, V1, P21; Kiely M, 2010, OBSTET GYNECOL, V115, P273, DOI 10.1097/AOG.0b013e3181cbd482; MacMillan HL, 2009, JAMA-J AM MED ASSOC, V302, P493, DOI 10.1001/jama.2009.1089; MCCAULEY J, 1995, ANN INTERN MED, V123, P737, DOI 10.7326/0003-4819-123-10-199511150-00001; Ramsay J, 2002, BRIT MED J, V325, P314, DOI 10.1136/bmj.325.7359.314; Richardson J, 2002, BRIT MED J, V324, P274, DOI 10.1136/bmj.324.7332.274; Runyan DK, 2002, BMJ; Sadowski L., 2010, BMJ CLIN EVID, V2010, P1013; Saltzman LE, 2000, AM J PREV MED, V19, P325, DOI 10.1016/S0749-3797(00)00241-5; StataCorp, 2011, STAT STAT SOFTW REL; STRAUS MA, 1979, J MARRIAGE FAM, V41, P75, DOI 10.2307/351733; Thackeray JD, 2010, PEDIATRICS, V125, P1094, DOI 10.1542/peds.2010-0451; The AAFP Commission on Special Issues and Clinical Interests, 1994, AM FAM PHYSICIAN, V50, P1644; Tiwari A, 2005, BJOG-INT J OBSTET GY, V112, P1249, DOI 10.1111/j.1471-0528.2005.00709.x; Tjaden P., 2000, FULL REPORT PREVALEN; Ware J. E. J., 2002, SCORE VERSION 2 SF 1; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wathen CN, 2003, JAMA-J AM MED ASSOC, V289, P589, DOI 10.1001/jama.289.5.589	32	93	95	0	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2012	308	7					681	689		10.1001/jama.2012.6434	http://dx.doi.org/10.1001/jama.2012.6434			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988NC	22893165	Green Accepted			2022-12-28	WOS:000307496700023
J	Mills, KL; Teesson, M; Back, SE; Brady, KT; Baker, AL; Hopwood, S; Sannibale, C; Barrett, EL; Merz, S; Rosenfeld, J; Ewer, PL				Mills, Katherine L.; Teesson, Maree; Back, Sudie E.; Brady, Kathleen T.; Baker, Amanda L.; Hopwood, Sally; Sannibale, Claudia; Barrett, Emma L.; Merz, Sabine; Rosenfeld, Julia; Ewer, Philippa L.			Integrated Exposure-Based Therapy for Co-occurring Posttraumatic Stress Disorder and Substance Dependence A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							USE SELF-REPORTS; MENTAL-HEALTH; DRUG-USE; PTSD; VALIDITY; INDIVIDUALS; PREDICTORS; DEPRESSION; USERS	Context There is concern that exposure therapy, an evidence-based cognitive-behavioral treatment for posttraumatic stress disorder (PTSD), may be inappropriate because of risk of relapse for patients with co-occurring substance dependence. Objective To determine whether an integrated treatment for PTSD and substance dependence, Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure (COPE), can achieve greater reductions in PTSD and substance dependence symptom severity compared with usual treatment for substance dependence. Design, Setting, and Participants Randomized controlled trial enrolling 103 participants who met DSM-IV-TR criteria for both PTSD and substance dependence. Participants were recruited from 2007-2009 in Sydney, Australia; outcomes were assessed at 9 months postbaseline, with interim measures collected at 6 weeks and 3 months postbaseline. Interventions Participants were randomized to receive COPE plus usual treatment (n = 55) or usual treatment alone (control) (n = 48). COPE consists of 13 individual 90-minute sessions (ie, 19.5 hours) with a clinical psychologist. Main Outcome Measures Change in PTSD symptom severity as measured by the Clinician-Administered PTSD Scale (CAPS; scale range, 0-240) and change in severity of substance dependence as measured by the number of dependence criteria met according to the Composite International Diagnostic Interview version 3.0 (CIDI; range, 0-7), from baseline to 9-month follow-up. A change of 15 points on the CAPS scale and 1 dependence criterion on the CIDI were considered clinically significant. Results From baseline to 9-month follow-up, significant reductions in PTSD symptom severity were found for both the treatment group (mean difference, -38.24 [95% CI, -47.93 to -28.54]) and the control group (mean difference, -22.14 [95% CI, -30.33 to -13.95]); however, the treatment group demonstrated a significantly greater reduction in PTSD symptom severity (mean difference, -16.09 [95% CI, -29.00 to -3.19]). No significant between-group difference was found in relation to improvement in severity of substance dependence (0.43 vs 0.52; incidence rate ratio, 0.85 [95% CI, 0.60 to 1.21), nor were there any significant between-group differences in relation to changes in substance use, depression, or anxiety. Conclusion Among patients with PTSD and substance dependence, the combined use of COPE plus usual treatment, compared with usual treatment alone, resulted in improvement in PTSD symptom severity without an increase in severity of substance dependence.	[Mills, Katherine L.; Teesson, Maree; Sannibale, Claudia; Barrett, Emma L.; Merz, Sabine; Rosenfeld, Julia; Ewer, Philippa L.] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW 2052, Australia; [Hopwood, Sally] Univ New S Wales, Traumat Stress Clin, Sydney, NSW 2052, Australia; [Back, Sudie E.; Brady, Kathleen T.] Med Univ S Carolina, Charleston, SC USA; [Back, Sudie E.; Brady, Kathleen T.] Ralph H Johnston Vet Affairs Med Ctr, Charleston, SC USA; [Baker, Amanda L.] Univ Newcastle, Ctr Brain & Mental Hlth Res, Newcastle, NSW 2300, Australia	University of New South Wales Sydney; University of New South Wales Sydney; Medical University of South Carolina; University of Newcastle	Mills, KL (corresponding author), Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW 2052, Australia.	k.mills@unsw.edu.au	Teesson, Maree/AFM-2972-2022; Baker, Amanda L/H-2966-2014	Baker, Amanda L/0000-0002-3328-7146; Barrett, Emma/0000-0003-0540-5691; Brady, Kathleen/0000-0002-3944-8051; Teesson, Maree Rose/0000-0002-6744-463X	National Health and Medical Research Council; Alcohol, Tobacco and Other Drugs Council of Tasmania; Cancer Council of New South Wales; Australian-American Fulbright Commission; National Institute on Drug Abuse; University of New South Wales; Australian National Health and Medical Research Council (NHMRC) [455209]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Alcohol, Tobacco and Other Drugs Council of Tasmania; Cancer Council of New South Wales(Cancer Council New South Wales); Australian-American Fulbright Commission; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); University of New South Wales; Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Mills reported that her institution receives funding for her salary from the National Health and Medical Research Council and reported receiving payment for providing lectures for the Richmond Fellowship of New South Wales; receiving payment for the development of educational presentations for the University of New South Wales, the Alcohol Tobacco and Other Drug Association ACT, and the New South Wales Institute of Psychiatry; receiving funding from the Alcohol, Tobacco and Other Drugs Council of Tasmania to present at a symposium; and receiving payment from the Cancer Council of New South Wales to conduct an ethics review. Dr Back reported that her institution received funding from the Australian-American Fulbright Commission to support travel to meetings for this study and other purposes and reported serving as a consultant for California State University and receiving payment for lectures and travel expenses from the National Institute on Drug Abuse. Dr Barrett reported receiving funding from the University of New South Wales for the development of educational presentations and travel expenses. No other authors reported disclosures.; This study was funded by Australian National Health and Medical Research Council (NHMRC) project grant 455209.	[Anonymous], 1997, COMP INT DIAGN INT C; [Anonymous], BRIEF COGNITIVE BEHA; Back SE, 2001, J SUBST ABUSE TREAT, V21, P35, DOI 10.1016/S0740-5472(01)00181-7; Back SE, 2006, J NERV MENT DIS, V194, P690, DOI 10.1097/01.nmd.0000235794.12794.8a; Ballenger JC, 2000, J CLIN PSYCHIAT, V61, P60; Beck A.T., 1996, BDI 2 BECK DEPRESSIO, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Becker CB, 2004, BEHAV RES THER, V42, P277, DOI 10.1016/S0005-7967(03)00138-4; Beynon CM, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-205; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bradley R, 2005, AM J PSYCHIAT, V162, P214, DOI 10.1176/appi.ajp.162.2.214; Brady KT, 2001, J SUBST ABUSE TREAT, V21, P47, DOI 10.1016/S0740-5472(01)00182-9; Cahill S.P., 2009, EFFECTIVE TREATMENTS, P139; Calhoun PS, 2000, J CONSULT CLIN PSYCH, V68, P923, DOI 10.1037/0022-006X.68.5.923; Carroll K, 1998, COGNITIVE BEHAV APPR; Craske MG, 2011, ARCH GEN PSYCHIAT, V68, P378, DOI 10.1001/archgenpsychiatry.2011.25; Darke S, 1998, DRUG ALCOHOL DEPEN, V51, P253, DOI 10.1016/S0376-8716(98)00028-3; DARKE S, 1992, BRIT J ADDICT, V87, P733; Dore G, 2012, DRUG ALCOHOL REV, V31, P294, DOI 10.1111/j.1465-3362.2011.00314.x; Foa E.B., 1998, TREATING TRAUMA RAPE; Foa EB, 2009, EFFECTIVE TREATMENTS, V2nd; Hien DA, 2010, AM J PSYCHIAT, V167, P95, DOI 10.1176/appi.ajp.2009.09091261; Institute of Medicine, 2008, TREATMENT POSTTRAUMA, DOI [10.17226/11955, DOI 10.17226/11955]; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Krystal JH, 2011, JAMA-J AM MED ASSOC, V306, P493, DOI 10.1001/jama.2011.1080; Loranger A.W., 1997, ASSESSMENT DIAGNOSIS; McBride O, 2009, ALCOHOL ALCOHOLISM, V44, P67, DOI 10.1093/alcalc/agn083; Mills KL, 2006, AM J PSYCHIAT, V163, P652, DOI 10.1176/appi.ajp.163.4.652; Mills KL, 2005, DRUG ALCOHOL DEPEN, V77, P243, DOI 10.1016/j.drugalcdep.2004.08.016; Najavits LM, 2005, J PSYCHOACTIVE DRUGS, V37, P425, DOI 10.1080/02791072.2005.10399816; Pietrzak RH, 2011, J ANXIETY DISORD, V25, P456, DOI 10.1016/j.janxdis.2010.11.010; PITMAN RK, 1991, J CLIN PSYCHIAT, V52, P17; Preuss UW, 2003, AM J PSYCHIAT, V160, P56, DOI 10.1176/appi.ajp.160.1.56; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; SHERMAN MF, 1992, DRUG ALCOHOL DEPEN, V30, P1, DOI 10.1016/0376-8716(92)90030-G; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Tate SR, 2011, AM J ADDICTION, V20, P357, DOI 10.1111/j.1521-0391.2011.00137.x; Triffleman E., 2000, ALCOHOLISM TREATMENT, V18, P113, DOI DOI 10.1300/J020V18N03_10; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Weiss RD, 1998, AM J PSYCHIAT, V155, P127, DOI 10.1176/ajp.155.1.127; Zhang P, 2003, INT STAT REV, V71, P581	40	199	199	0	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2012	308	7					690	699		10.1001/jama.2012.9071	http://dx.doi.org/10.1001/jama.2012.9071			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988NC	22893166	Bronze			2022-12-28	WOS:000307496700024
J	Ibrahim, MM; Damasceno, A				Ibrahim, M. Mohsen; Damasceno, Albertino			Hypertension in developing countries	LANCET			English	Article							CARDIOVASCULAR-DISEASE RISK; MIDDLE-INCOME COUNTRIES; LOW-RESOURCE SETTINGS; DIETARY SALT INTAKE; BODY-MASS INDEX; BLOOD-PRESSURE; INCIDENT HYPERTENSION; HEALTH SURVEY; EPIDEMIOLOGIC TRANSITION; AFRICAN-AMERICANS	Data from different national and regional surveys show that hypertension is common in developing countries, particularly in urban areas, and that rates of awareness, treatment, and control are low. Several hypertension risk factors seem to be more common in developing countries than in developed regions. Findings from serial surveys show an increasing prevalence of hypertension in developing countries, possibly caused by urbanisation, ageing of population, changes to dietary habits, and social stress. High illiteracy rates, poor access to health facilities, bad dietary habits, poverty, and high costs of drugs contribute to poor blood pressure control. The health system in many developing countries is inadequate because of low funds, poor infrastructure, and inexperience. Priority is given to acute disorders, child and maternal health care, and control of communicable diseases. Governments, together with medical societies and non-governmental organisations, should support and promote preventive programmes aiming to increase public awareness, educate physicians, and reduce salt intake. Regulations for the food industry and the production and availability of generic drugs should be reinforced.	[Ibrahim, M. Mohsen] Cairo Univ, Dept Cardiol, Cairo, Egypt; [Damasceno, Albertino] Eduardo Mondlane Univ, Fac Med, Maputo, Mozambique	Egyptian Knowledge Bank (EKB); Cairo University; Eduardo Mondlane University	Ibrahim, MM (corresponding author), Egyptian Hypertens Soc, Cairo 11519, Egypt.	ehs@link.net						Abolfotouh MA, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/952537; Addo J, 2007, HYPERTENSION, V50, P1012, DOI 10.1161/HYPERTENSIONAHA.107.093336; Adedoyin RA, 2008, EUR J CARDIOV PREV R, V15, P683, DOI 10.1097/HJR.0b013e32830edc32; Adji A, 2011, AM J HYPERTENS, V24, P5, DOI 10.1038/ajh.2010.192; Agyemang C, 2006, J HUM HYPERTENS, V20, P67, DOI 10.1038/sj.jhh.1001923; Agyemang C, 2006, PUBLIC HEALTH, V120, P525, DOI 10.1016/j.puhe.2006.02.002; Agyemang C, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-7; Ajay Vamadevan S, 2011, J Diabetes Sci Technol, V5, P778; Akpolat T, 2009, AM J KIDNEY DIS, V53, P1103, DOI 10.1053/j.ajkd.2009.03.005; Alcocer Luis, 2008, Ther Adv Cardiovasc Dis, V2, P147, DOI 10.1177/1753944708090572; [Anonymous], 2005, PREV CHRON DIS VIT I; Anselmi M, 2003, LANCET, V361, P1186, DOI 10.1016/S0140-6736(03)12918-2; Arici M, 2010, J HYPERTENS, V28, P240, DOI 10.1097/HJH.0b013e328332c36b; Aubert L, 1998, HYPERTENSION, V31, P1136, DOI 10.1161/01.HYP.31.5.1136; Belue R, 2009, GLOBAL HLTH, V22, P5; Ben Khedda S, 2008, 10 AR C NEPHR REN TR; Bodin T, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-38; BOVET P, 2007, SEYCHELLES HEART STU; Brown IJ, 2009, INT J EPIDEMIOL, V38, P791, DOI 10.1093/ije/dyp139; BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305; Cameron A, 2009, LANCET, V373, P240, DOI 10.1016/S0140-6736(08)61762-6; Damasceno A, 2009, HYPERTENSION, V54, P77, DOI 10.1161/HYPERTENSIONAHA.109.132423; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Department of Cardiology Cairo University Faculty of Medicine and Qalyub Training and Demonstration Centre, 1958, B EGYPT SOC CARDIOL, V1, P99; Dick Jonathan J, 2011, J Diabetes Sci Technol, V5, P1246; Dodani S, 2010, DIABETES EDUCATOR, V36, P465, DOI 10.1177/0145721710366756; Dodani S, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/820101; Doll S, 2002, INT J OBESITY, V26, P48, DOI 10.1038/sj.ijo.0801854; DOWSE GK, 1995, BRIT MED J, V311, P1255, DOI 10.1136/bmj.311.7015.1255; Edwards R, 2000, J HYPERTENS, V18, P145, DOI 10.1097/00004872-200018020-00003; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Erdem Y, 2010, BLOOD PRESSURE, V19, P313, DOI 10.3109/08037051003802541; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Forman JP, 2009, JAMA-J AM MED ASSOC, V302, P401, DOI 10.1001/jama.2009.1060; Forman JP, 2005, JAMA-J AM MED ASSOC, V293, P320, DOI 10.1001/jama.293.3.320; Fuentes R, 2000, J HYPERTENS, V18, P521, DOI 10.1097/00004872-200018050-00003; Gaziano TA, 2005, CIRCULATION, V112, P3569, DOI 10.1161/CIRCULATIONAHA.105.535922; Gaziano TA, 2008, LANCET, V371, P923, DOI 10.1016/S0140-6736(08)60418-3; Gaziano TA, 2007, HEALTH AFFAIR, V26, P13, DOI 10.1377/hlthaff.26.1.13; Giday Araya, 2011, Ethiop Med J, V49, P139; Glassman A, 2010, HEALTH AFFAIR, V29, P2142, DOI 10.1377/hlthaff.2010.1038; Griffin FC, 2009, AM HEART ASS M REP S; Gu DF, 2007, HYPERTENSION, V50, P116, DOI 10.1161/HYPERTENSIONAHA.107.088310; Gupta R, 1996, J HUM HYPERTENS, V10, P465; Harding S, 2006, J HYPERTENS, V24, P1507, DOI 10.1097/01.hjh.0000239285.20315.4d; He FJ, 2009, J HUM HYPERTENS, V23, P363, DOI 10.1038/jhh.2008.144; HE J, 1991, AM J EPIDEMIOL, V134, P1085, DOI 10.1093/oxfordjournals.aje.a116012; Hu JH, 2009, HYPERTENS RES, V32, P282, DOI 10.1038/hr.2009.7; Ibrahim MM, 1996, J HUM HYPERTENS, V10, pS39; Jafar TH, 2009, ANN INTERN MED, V151, P593, DOI 10.7326/0003-4819-151-9-200911030-00004; Jalal DI, 2010, J AM SOC NEPHROL, V21, P1543, DOI 10.1681/ASN.2009111111; Janssens B, 2007, B WORLD HEALTH ORGAN, V85, P880, DOI 10.2471/BLT.06.036574; Johnson RJ, 2007, AM J CLIN NUTR, V86, P899; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; KEIL JE, 1981, AM J PUBLIC HEALTH, V71, P532, DOI 10.2105/AJPH.71.5.532; Knutson KL, 2009, ARCH INTERN MED, V169, P1055, DOI 10.1001/archinternmed.2009.119; Laaksonen DE, 2008, EUR HEART J, V29, P2561, DOI 10.1093/eurheartj/ehn061; Levitt NS, 2011, AM J CLIN NUTR, V94, p1690S, DOI 10.3945/ajcn.111.019075; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Logan AG, 2007, AM J HYPERTENS, V20, P942, DOI 10.1016/j.amjhyper.2007.03.020; Malhotra P, 1999, J HUM HYPERTENS, V13, P467, DOI 10.1038/sj.jhh.1000864; Mayosi B, 2007, Cardiovasc J S Afr, V18, P4; Mbanya JCN, 1998, INT J EPIDEMIOL, V27, P181, DOI 10.1093/ije/27.2.181; Mendis S, 2004, J HYPERTENS, V22, P59, DOI 10.1097/00004872-200401000-00013; Mendis S, 2007, J HYPERTENS, V25, P1578, DOI 10.1097/HJH.0b013e3282861fd3; Mendis S, 2011, J CLIN EPIDEMIOL, V64, P1451, DOI 10.1016/j.jclinepi.2011.02.001; Mosley JD, 2000, HYPERTENSION, V36, P296, DOI 10.1161/01.HYP.36.2.296; Mu J, 2009, AM J HYPERTENS, V22, P943, DOI 10.1038/ajh.2009.136; Mufunda J, 2006, J HUM HYPERTENS, V20, P59, DOI 10.1038/sj.jhh.1001924; Musaiger AO, 2002, MED PRIN PRACT, V11, P9, DOI 10.1159/000066415; Niakara A, 2007, T ROY SOC TROP MED H, V101, P1136, DOI 10.1016/j.trstmh.2007.07.002; O'Donnell MJ, 2011, JAMA-J AM MED ASSOC, V306, P2229, DOI 10.1001/jama.2011.1729; Opie LH, 2005, CIRCULATION, V112, P3562, DOI 10.1161/CIRCULATIONAHA.105.539569; Ordunez-Garcia P, 2006, J HYPERTENS, V24, P845, DOI 10.1097/01.hjh.0000222753.67572.28; Padmavati S, 2002, Indian Heart J, V54, P99; Parati G, 2010, HYPERTENSION, V56, P1047, DOI 10.1161/HYPERTENSIONAHA.110.160408; Pereira M, 2009, J HYPERTENS, V27, P963, DOI 10.1097/HJH.0b013e3283282f65; Perkovic V, 2007, HYPERTENSION, V50, P991, DOI 10.1161/HYPERTENSIONAHA.107.095497; POULTER NR, 1990, BMJ-BRIT MED J, V300, P967, DOI 10.1136/bmj.300.6730.967; Nguyen N, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-325; Radhika G, 2007, J Assoc Physicians India, V55, P405; Sanders PW, 2009, HYPERTENSION, V53, P442, DOI 10.1161/HYPERTENSIONAHA.108.120303; SAUNDERS E, 1991, CIRCULATION, V83, P1465, DOI 10.1161/01.CIR.83.4.1465; Sawaya AL, 2005, MATERN CHILD NUTR, V1, P155, DOI 10.1111/j.1740-8709.2005.00033.x; Schmidhuber J., 2005, 97 SEM EUR ASS AGR E; Sindhu S, 2010, COLLEGIAN, V17, P93, DOI 10.1016/j.colegn.2010.05.003; Siva N, 2010, LANCET, V376, P1725, DOI 10.1016/S0140-6736(10)62118-6; Sobngwi E, 2004, INT J EPIDEMIOL, V33, P769, DOI 10.1093/ije/dyh044; Son PT, 2012, J HUM HYPERTENS, V26, P268, DOI 10.1038/jhh.2011.18; Steyn K, 2008, SAMJ S AFR MED J, V98, P376; Stolarz-Skrzypek K, 2011, JAMA-J AM MED ASSOC, V305, P1777, DOI 10.1001/jama.2011.574; Sun ZQ, 2010, AM J HYPERTENS, V23, P627, DOI 10.1038/ajh.2010.41; SWALES JD, 1991, BMJ-BRIT MED J, V303, P1084, DOI 10.1136/bmj.303.6810.1084; Tesfaye F, 2007, J HUM HYPERTENS, V21, P28, DOI 10.1038/sj.jhh.1002104; Tran J., 2010, CIRCULATION, V122; Wang TJ, 2007, HYPERTENSION, V49, P432, DOI 10.1161/01.HYP.0000256956.61872.aa; Wang ZW, 2004, HYPERTENS RES, V27, P703, DOI 10.1291/hypres.27.703; Webster JL, 2011, J HYPERTENS, V29, P1043, DOI 10.1097/HJH.0b013e328345ed83; WILLIAMS D R, 1992, Ethnicity and Disease, V2, P126; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; Wu YF, 2008, CIRCULATION, V118, P2679, DOI 10.1161/CIRCULATIONAHA.108.788166; Yach D, 2004, JAMA-J AM MED ASSOC, V291, P2616, DOI 10.1001/jama.291.21.2616; ZEIN ZA, 1986, ETHIOPIAN MED J, V24, P169; Zhai F, 2006, REPORT NATL NUTR H 2	104	402	417	4	87	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 11	2012	380	9841					611	619		10.1016/S0140-6736(12)60861-7	http://dx.doi.org/10.1016/S0140-6736(12)60861-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988SQ	22883510				2022-12-28	WOS:000307511400034
J	Liu, JG; Yang, W				Liu, Jianguo; Yang, Wu			Water Sustainability for China and Beyond	SCIENCE			English	Editorial Material							RESOURCES		[Liu, Jianguo; Yang, Wu] Michigan State Univ, Ctr Syst Integrat & Sustainabil, E Lansing, MI 48824 USA	Michigan State University	Liu, JG (corresponding author), Michigan State Univ, Ctr Syst Integrat & Sustainabil, E Lansing, MI 48824 USA.	liuji@msu.edu	Liu, Jianguo/G-5211-2015	Liu, Jianguo/0000-0001-6344-0087; Yang, Wu/0000-0002-1682-3349				Chen X., 2009, SANLIAN LIFE WKLY, V23, P40; Chinese Academy of Sciences, 2007, CHIN SUST DEV STRAT; Gleick P., 2008, WORLDS WATER 2008 20; Gleick PH, 2003, SCIENCE, V302, P1524, DOI 10.1126/science.1089967; Guo F., 2011, CHINA EC WKLY, V33, P26; He DM, 2000, INT RIVERS CHINA; Liu JG, 2003, NATURE, V421, P530, DOI 10.1038/nature01359; Liu JG, 2007, SCIENCE, V317, P1513, DOI 10.1126/science.1144004; Liu JG, 2010, CRIT REV ENV SCI TEC, V40, P823, DOI 10.1080/10643389.2010.502645; MEKONNEN M.M, 2011, NAT WAT FOOTPR ACC G; Ministry of Health of China, 2009, CHIN HLTH STAT YB 20; MWR, 2000, STAT B CHIN WAT ACT; Myint T., 2012, GOVERNING INT RIVERS; National Bureau of Statistics of China, 1985, CHIN STAT YB; National Development and Reform Commission, 2012, 12 5 YEAR PLAN DEV C; Piao SL, 2010, NATURE, V467, P43, DOI 10.1038/nature09364; Reynolds C. T., 2008, P WORLD ENV WAT RES, P1; Ward FA, 2008, P NATL ACAD SCI USA, V105, P18215, DOI 10.1073/pnas.0805554105; Xinhua News Agency, 2011, 400 MOR GOLF COURS H; Xinhua News Agency, 2011, INV WAT CONS CHIN RE; Yang C., 2005, WATER CONSERV EC, V23; Zhao SQ, 2006, FRONT ECOL ENVIRON, V4, P341, DOI 10.1890/1540-9295(2006)004[0341:ECORUE]2.0.CO;2	22	310	340	43	446	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2012	337	6095					649	650		10.1126/science.1219471	http://dx.doi.org/10.1126/science.1219471			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	986PE	22879488				2022-12-28	WOS:000307354500025
J	Rafelson, WM; Rajput, V				Rafelson, William M.; Rajput, Vijay			VIP and UIP	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Rafelson, William M.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Camden, NJ 08103 USA; [Rajput, Vijay] Rowan Univ, Cooper Med Sch, Camden, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rowan University; Cooper Medical School of Rowan University	Rafelson, WM (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Camden, NJ 08103 USA.	rafelswm@umdnj.edu						ENTHOVEN A, 1989, NEW ENGL J MED, V320, P29, DOI 10.1056/NEJM198901053200106; Gawande Atul, 2011, New Yorker, P40; Hwang J, 2008, HEALTH AFFAIR, V27, P1329, DOI 10.1377/hlthaff.27.5.1329; WEINTRAUB W, 1964, J NERV MENT DIS, V138, P181, DOI 10.1097/00005053-196402000-00012	4	1	1	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2012	308	6					579	580		10.1001/jama.2012.8727	http://dx.doi.org/10.1001/jama.2012.8727			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	984YA	22871869				2022-12-28	WOS:000307228400024
J	Blumenthal, JA; Babyak, MA; O'Connor, C; Keteyian, S; Landzberg, J; Howlett, J; Kraus, W; Gottlieb, S; Blackburn, G; Swank, A; Whellan, DJ				Blumenthal, James A.; Babyak, Michael A.; O'Connor, Christopher; Keteyian, Steven; Landzberg, Joel; Howlett, Jonathan; Kraus, William; Gottlieb, Stephen; Blackburn, Gordon; Swank, Ann; Whellan, David J.			Effects of Exercise Training on Depressive Symptoms in Patients With Chronic Heart Failure The HF-ACTION Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MORTALITY; RISK; EFFICACY; OUTCOMES; INTERVENTION; MANAGEMENT; SERTRALINE; REMISSION; PROGNOSIS; RECOVERY	Context Depression is common in patients with cardiac disease, especially in patients with heart failure, and is associated with increased risk of adverse health outcomes. Some evidence suggests that aerobic exercise may reduce depressive symptoms, but to our knowledge the effects of exercise on depression in patients with heart failure have not been evaluated. Objective To determine whether exercise training will result in greater improvements in depressive symptoms compared with usual care among patients with heart failure. Design, Setting, and Participants Multicenter, randomized controlled trial involving 2322 stable patients treated for heart failure at 82 medical clinical centers in the United States, Canada, and France. Patients who had a left ventricular ejection fraction of 35% or lower, had New York Heart Association class I to IV heart failure, and had completed the Beck Depression Inventory II (BDI-II) score were randomized (1:1) between April 2003 and February 2007. Depressive scores ranged from 0 to 59; scores of 14 or higher are considered clinically significant. Interventions Participants were randomized either to supervised aerobic exercise (goal of 90 min/wk for months 1-3 followed by home exercise with a goal of >= 120 min/wk for months 4-12) or to education and usual guideline-based heart failure care. Main Outcome Measures Composite of death or hospitalization due to any cause and scores on the BDI-II at months 3 and 12. Results Over a median follow-up period of 30 months, 789 patients (68%) died or were hospitalized in the usual care group compared with 759 (66%) in the aerobic exercise group (hazard ratio [HR], 0.89; 95% CI, 0.81 to 0.99; P =. 03). The median BDI-II score at study entry was 8, with 28% of the sample having BDI-II scores of 14 or higher. Compared with usual care, aerobic exercise resulted in lower mean BDI-II scores at 3 months (aerobic exercise, 8.95; 95% CI, 8.61 to 9.29 vs usual care, 9.70; 95% CI, 9.34 to 10.06; difference, -0.76; 95% CI, -1.22 to -0.29; P=.002) and at 12 months (aerobic exercise, 8.86; 95% CI, 8.67 to 9.24 vs usual care, 9.54; 95% CI, 9.15 to 9.92; difference, -0.68; 95% CI, -1.20 to -0.16; P=.01). Conclusions Compared with guideline-based usual care, exercise training resulted in a modest reduction in depressive symptoms, although the clinical significance of this improvement is unknown.	[Blumenthal, James A.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA; [Keteyian, Steven] Henry Ford Hosp, Detroit, MI 48202 USA; [Landzberg, Joel] Hackensack Univ, Med Ctr, Dept Med, Hackensack, NJ USA; [Howlett, Jonathan] Queen Elizabeth 2 Hlth Sci Ctr, Halifax, NS, Canada; [Gottlieb, Stephen] Univ Maryland, Baltimore, MD 21201 USA; [Blackburn, Gordon] Cleveland Clin Fdn, Cleveland, OH 44195 USA; [Swank, Ann] Univ Louisville, Louisville, KY 40292 USA; [Whellan, David J.] Thomas Jefferson Med Ctr, Philadelphia, PA USA	Duke University; Henry Ford Health System; Henry Ford Hospital; Hackensack University Medical Center; Queen Elizabeth II Health Sciences Centre; University System of Maryland; University of Maryland Baltimore; Cleveland Clinic Foundation; University of Louisville; Jefferson University	Blumenthal, JA (corresponding author), Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, POB 3119, Durham, NC 27710 USA.	blume003@mc.duke.edu	Howlett, Jonathan/T-2589-2019	Howlett, Jonathan/0000-0002-0535-9771; Kraus, William E/0000-0003-1930-9684	National Heart, Lung, and Blood Institute [HL080664]; 13 National Heart, Lung, and Blood Institute [5U01-HL063747, 5U01HL066461, HL068973, HL066501, HL066482, HL064250, HL066494, HL064257, HL066497, HL068980, HL064265, HL066491, HL064264]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066491, U01HL068973, U01HL066501, U01HL066497, U01HL068980, U01HL066482, U01HL063747, U01HL064257, U01HL066494, U01HL064264, U01HL064250, U01HL066461, U01HL064265, R01HL080664] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); 13 National Heart, Lung, and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr Blumenthal reported that he was compensated for his work by grant HL080664 from the National Heart, Lung, and Blood Institute. The HF-ACTION was funded by 13 National Heart, Lung, and Blood Institute grants: 5U01-HL063747 to the Duke Clinical Research Institute Coordinating Center (Dr C. O'Connor, principal investigator); 5U01HL066461 to the Economic and Quality of Life (K. Schulman, principal investigator); HL068973 to the U grant enrolling centers-Boston Medical Center (W. Colucci, principal investigator); HL066501 to Case Western Reserve University (I. Pina, principal investigator); HL066482 to Emory University (A. Smith, principal investigator); HL064250 to the Henry Ford Hospital (S. Keteyian, principal investigator); HL066494 to the Ohio State University (W. Abraham, principal investigator); HL064257 to Oregon Health Science University (R. Hershberger, principal investigator); HL066497 University of Alabama (V. Bittner, principal investigator); HL068980 to University of California-Los Angeles (G. Fonarow, principal investigator); HL064265 to the University of Colorado (E. Wolfel, principal investigator); HL066491 to Wake Forest University (D. Kitzman, principal investigator); and HL064264 to Washington University of St Louis (G. Ewald, principal investigator).	American Psychiatric Association, 2000, TASK FORC DSM 4 DIAG; Beck A.T., 1996, BECK DEPRESSION INVE, DOI 10.1037/t00742-000; Berkman LF, 2003, JAMA-J AM MED ASSOC, V289, P3106; Blumenthal JA, 2003, LANCET, V362, P604, DOI 10.1016/S0140-6736(03)14190-6; Blumenthal JA, 1999, ARCH INTERN MED, V159, P2349, DOI 10.1001/archinte.159.19.2349; Blumenthal JA, 2007, PSYCHOSOM MED, V69, P587, DOI 10.1097/PSY.0b013e318148c19a; Bush DE, 2001, AM J CARDIOL, V88, P337, DOI 10.1016/S0002-9149(01)01675-7; COX DR, 1972, J R STAT SOC B, V34, P187; Dunn AL, 2005, AM J PREV MED, V28, P1, DOI 10.1016/j.amepre.2004.09.003; FRANK E, 1991, ARCH GEN PSYCHIAT, V48, P851, DOI 10.1001/archpsyc.1991.01810330075011; FRASURESMITH N, 1995, CIRCULATION, V91, P999, DOI 10.1161/01.CIR.91.4.999; Glassman AH, 2002, JAMA-J AM MED ASSOC, V288, P701, DOI 10.1001/jama.288.6.701; Green CP, 2000, J AM COLL CARDIOL, V35, P1245, DOI 10.1016/S0735-1097(00)00531-3; Guck Thomas P, 2003, Congest Heart Fail, V9, P163, DOI 10.1111/j.1527-5299.2003.01356.x; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hoffman BM, 2011, PSYCHOSOM MED, V73, P127, DOI 10.1097/PSY.0b013e31820433a5; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Jiang W, 2001, ARCH INTERN MED, V161, P1849, DOI 10.1001/archinte.161.15.1849; Jiang W, 2007, AM HEART J, V154, P102, DOI 10.1016/j.ahj.2007.03.043; Jiang W, 2011, AM J CARDIOL, V107, P545, DOI 10.1016/j.amjcard.2010.10.013; Lawlor DA, 2001, BMJ-BRIT MED J, V322, P763, DOI 10.1136/bmj.322.7289.763; Lesperance F, 2000, ARCH INTERN MED, V160, P1354, DOI 10.1001/archinte.160.9.1354; Lesperance F, 2002, CIRCULATION, V105, P1049, DOI 10.1161/hc0902.104707; Lichtman JH, 2008, CIRCULATION, V118, P1768, DOI 10.1161/CIRCULATIONAHA.108.190769; Mead GE, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004366.pub4; O'Connor CM, 2010, J AM COLL CARDIOL, V56, P692, DOI 10.1016/j.jacc.2010.03.068; O'Connor CM, 2009, JAMA-J AM MED ASSOC, V301, P1439, DOI 10.1001/jama.2009.454; Rutledge T, 2006, J AM COLL CARDIOL, V48, P1527, DOI 10.1016/j.jacc.2006.06.055; Sherwood A, 2007, ARCH INTERN MED, V167, P367, DOI 10.1001/archinte.167.4.367; Sherwood A, 2011, J AM COLL CARDIOL, V57, P418, DOI 10.1016/j.jacc.2010.09.031; Vaccarino V, 2001, J AM COLL CARDIOL, V38, P199, DOI 10.1016/S0735-1097(01)01334-1; Whellan DJ, 2007, AM HEART J, V153, P201, DOI 10.1016/j.ahj.2006.11.007	33	192	195	1	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2012	308	5					465	474		10.1001/jama.2012.8720	http://dx.doi.org/10.1001/jama.2012.8720			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	981DQ	22851113	Green Accepted, Bronze			2022-12-28	WOS:000306947400024
J	Betthausen, C; Dollinger, T; Saarikoski, H; Kolkovsky, V; Karczewski, G; Wojtowicz, T; Richter, K; Weiss, D				Betthausen, C.; Dollinger, T.; Saarikoski, H.; Kolkovsky, V.; Karczewski, G.; Wojtowicz, T.; Richter, K.; Weiss, D.			Spin-Transistor Action via Tunable Landau-Zener Transitions	SCIENCE			English	Article							SEMICONDUCTORS	Spin-transistor designs relying on spin-orbit interaction suffer from low signal levels resulting from low spin-injection efficiency and fast spin decay. Here, we present an alternative approach in which spin information is protected by propagating this information adiabatically. We demonstrate the validity of our approach in a cadmium manganese telluride diluted magnetic semiconductor quantum well structure in which efficient spin transport is observed over device distances of 50 micrometers. The device is turned "off" by introducing diabatic Landau-Zener transitions that lead to a backscattering of spins, which are controlled by a combination of a helical and a homogeneous magnetic field. In contrast to other spin-transistor designs, we find that our concept is tolerant against disorder.	[Betthausen, C.; Weiss, D.] Univ Regensburg, Dept Expt & Appl Phys, D-93040 Regensburg, Germany; [Dollinger, T.; Saarikoski, H.; Richter, K.] Univ Regensburg, Dept Theoret Phys, D-93040 Regensburg, Germany; [Kolkovsky, V.; Karczewski, G.; Wojtowicz, T.] Polish Acad Sci, Inst Phys, PL-02668 Warsaw, Poland	University of Regensburg; University of Regensburg; Polish Academy of Sciences; Institute of Physics - Polish Academy of Sciences	Weiss, D (corresponding author), Univ Regensburg, Dept Expt & Appl Phys, D-93040 Regensburg, Germany.	dieter.weiss@physik.uni-regensburg.de	Karczewski, Grzegorz/P-8212-2015; Saarikoski, Henri M./J-3479-2013; Weiss, Dieter/G-4883-2016; Kolkovsky, Valery/H-1293-2015; Wojtowicz, Tomasz J/A-2887-2017	Saarikoski, Henri M./0000-0001-6155-0119; Weiss, Dieter/0000-0002-9630-9787; Kolkovsky, Valery/0000-0001-9245-1578; Wojtowicz, Tomasz J/0000-0003-4498-4622; Dollinger, Tobias/0000-0001-7050-6515	Deutsche Forschungsgemeinschaft [SFB 689, WE 247618, FOR 1483]; Elitennetzwerk Bayern; European Union within the European Regional Development Fund, through Innovative Economy grant [POIG.01.01.02-00-008/08]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Elitennetzwerk Bayern; European Union within the European Regional Development Fund, through Innovative Economy grant	We thank M. Wimmer for useful discussions and providing the code for the transport equation solver; M. Kiessling for SQUID measurements; M. Wiater for technical assistance in molecular beam epitaxy growth; and C. Back, G. E. W. Bauer, J. Fabian, V. I. Falko, C. Strunk, and G. Woltersdorf for fruitful discussions. We acknowledge financial support from the Deutsche Forschungsgemeinschaft through SFB 689, WE 247618, FOR 1483, and Elitennetzwerk Bayern. Our research in Poland (V. K., G. K., T. W.) was partially supported by the European Union within the European Regional Development Fund, through Innovative Economy grant POIG.01.01.02-00-008/08.	Awschalom D.D., 2009, SEMICONDUCTOR SPINTR; Bernevig BA, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.236601; BERRY MV, 1984, PROC R SOC LON SER-A, V392, P45, DOI 10.1098/rspa.1984.0023; BETON PH, 1990, PHYS REV B, V42, P9689, DOI 10.1103/PhysRevB.42.9689; Born M, 1928, Z PHYS, V51, P165, DOI 10.1007/BF01343193; CALVO M, 1978, PHYS REV B, V18, P5073, DOI 10.1103/PhysRevB.18.5073; CARDONA M, 1988, PHYS REV B, V38, P1806, DOI 10.1103/PhysRevB.38.1806; DATTA S, 1990, APPL PHYS LETT, V56, P665, DOI 10.1063/1.102730; DAVIS JP, 1976, J CHEM PHYS, V64, P3129, DOI 10.1063/1.432648; Fabian J, 2004, APPL PHYS LETT, V84, P85, DOI 10.1063/1.1637954; FURDYNA JK, 1988, J APPL PHYS, V64, pR29, DOI 10.1063/1.341700; Jia CL, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.052406; Koga T, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.041302; Konig M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.076804; Koo HC, 2009, SCIENCE, V325, P1515, DOI 10.1126/science.1173667; Landau L., 1932, PHYZ SOWJETUNION, V2, P46, DOI DOI 10.1098/RSPA.1932.0165; Ohno H, 2000, NATURE, V408, P944, DOI 10.1038/35050040; Piot BA, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.081307; Popp M, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.041303; Rangaraju N, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.117202; Schliemann J, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.146801; Teran FJ, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.186803; Zaitsev O, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.155325; Zener C, 1932, P R SOC LOND A-CONTA, V137, P696, DOI 10.1098/rspa.1932.0165; Zutic I, 2004, REV MOD PHYS, V76, P323, DOI 10.1103/RevModPhys.76.323	26	66	67	0	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2012	337	6092					324	327		10.1126/science.1221350	http://dx.doi.org/10.1126/science.1221350			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975WQ	22822145				2022-12-28	WOS:000306542600046
J	Singh, D; Chan, JM; Zoppoli, P; Niola, F; Sullivan, R; Castano, A; Liu, EM; Reichel, J; Porrati, P; Pellegatta, S; Qiu, KL; Gao, ZB; Ceccarelli, M; Riccardi, R; Brat, DJ; Guha, A; Aldape, K; Golfinos, JG; Zagzag, D; Mikkelsen, T; Finocchiaro, G; Lasorella, A; Rabadan, R; Iavarone, A				Singh, Devendra; Chan, Joseph Minhow; Zoppoli, Pietro; Niola, Francesco; Sullivan, Ryan; Castano, Angelica; Liu, Eric Minwei; Reichel, Jonathan; Porrati, Paola; Pellegatta, Serena; Qiu, Kunlong; Gao, Zhibo; Ceccarelli, Michele; Riccardi, Riccardo; Brat, Daniel J.; Guha, Abhijit; Aldape, Ken; Golfinos, John G.; Zagzag, David; Mikkelsen, Tom; Finocchiaro, Gaetano; Lasorella, Anna; Rabadan, Raul; Iavarone, Antonio			Transforming Fusions of FGFR and TACC Genes in Human Glioblastoma	SCIENCE			English	Article							RECEPTOR TYROSINE KINASE; CHROMOSOMAL INSTABILITY; SELECTIVE INHIBITOR; CANCER; ANEUPLOIDY; FAMILY; DISCOVERY; POTENT	The brain tumor glioblastoma multiforme (GBM) is among the most lethal forms of human cancer. Here, we report that a small subset of GBMs (3.1%; 3 of 97 tumors examined) harbors oncogenic chromosomal translocations that fuse in-frame the tyrosine kinase coding domains of fibroblast growth factor receptor (FGFR) genes (FGFR1 or FGFR3) to the transforming acidic coiled-coil (TACC) coding domains of TACC1 or TACC3, respectively. The FGFR-TACC fusion protein displays oncogenic activity when introduced into astrocytes or stereotactically transduced in the mouse brain. The fusion protein, which localizes to mitotic spindle poles, has constitutive kinase activity and induces mitotic and chromosomal segregation defects and triggers aneuploidy. Inhibition of FGFR kinase corrects the aneuploidy, and oral administration of an FGFR inhibitor prolongs survival of mice harboring intracranial FGFR3-TACC3-initiated glioma. FGFR-TACC fusions could potentially identify a subset of GBM patients who would benefit from targeted FGFR kinase inhibition.	[Singh, Devendra; Zoppoli, Pietro; Niola, Francesco; Sullivan, Ryan; Castano, Angelica; Lasorella, Anna; Iavarone, Antonio] Columbia Univ, Med Ctr, Inst Canc Genet, New York, NY 10027 USA; [Chan, Joseph Minhow; Liu, Eric Minwei; Reichel, Jonathan; Rabadan, Raul] Columbia Univ, Med Ctr, Dept Biomed Informat, New York, NY USA; [Chan, Joseph Minhow; Liu, Eric Minwei; Reichel, Jonathan; Rabadan, Raul] Columbia Univ, Med Ctr, Ctr Computat Biol & Bioinformat, New York, NY USA; [Reichel, Jonathan] Cornell Univ, Triinst Program Computat Biol & Med, New York, NY 10021 USA; [Reichel, Jonathan] Weill Cornell Med Coll, New York, NY USA; [Porrati, Paola; Pellegatta, Serena; Finocchiaro, Gaetano] Carattere Sci Ist Neurol C, Fdn Ist Ricovero & Cura, Milan, Italy; [Qiu, Kunlong; Gao, Zhibo] Beijing Genome Inst, Bioinformat Ctr, Shenzhen, Peoples R China; [Ceccarelli, Michele] Biogem, Ist Ric Genet Gaetano Salvatore, Ariano Irpino, AV, Italy; [Ceccarelli, Michele] Univ Sannio, Dipartimento Sci Biol & Ambientali, Benevento, Italy; [Riccardi, Riccardo] Univ Cattolica Sacro Cuore, Dept Pediat Oncol, Rome, Italy; [Brat, Daniel J.] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA; [Brat, Daniel J.] Emory Univ, Sch Med, Dept Lab Med, Atlanta, GA 30322 USA; [Guha, Abhijit] Univ Toronto, Univ Hlth Network, Toronto Western Hosp, Div Neurosurg, Toronto, ON M5S 1A1, Canada; [Aldape, Ken] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Golfinos, John G.; Zagzag, David] NYU, Dept Neurosurg, Langone Med Ctr, New York, NY 10016 USA; [Zagzag, David] NYU, Dept Neuropathol, Langone Med Ctr, New York, NY USA; [Mikkelsen, Tom] Henry Ford Hlth Syst, Dept Neurol, Detroit, MI USA; [Mikkelsen, Tom] Henry Ford Hlth Syst, Dept Neurosurg, Detroit, MI USA; [Lasorella, Anna] Columbia Univ, Dept Pediat, Med Ctr, New York, NY 10027 USA; [Lasorella, Anna; Iavarone, Antonio] Columbia Univ, Med Ctr, Dept Pathol, New York, NY USA; [Iavarone, Antonio] Columbia Univ, Med Ctr, Dept Neurol, New York, NY USA	Columbia University; Columbia University; Columbia University; Cornell University; Cornell University; Beijing Genomics Institute (BGI); University of Sannio; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Emory University; Emory University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Texas System; UTMD Anderson Cancer Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Columbia University; Columbia University; Columbia University	Lasorella, A (corresponding author), Columbia Univ, Med Ctr, Inst Canc Genet, New York, NY 10027 USA.	al2179@columbia.edu; rabadan@dbmi.columbia.edu; ai2102@columbia.edu	Finocchiaro, Gaetano/AAG-6791-2020; Zoppoli, Pietro/J-9954-2018; Ceccarelli, Michele/AGP-1739-2022; Liu, Eric Minwei/V-1738-2019; Pellegatta, Serena/AAL-3693-2021; Rabadan, Raul/AAZ-7367-2020	Zoppoli, Pietro/0000-0002-7860-9655; Liu, Eric Minwei/0000-0002-3594-6678; Pellegatta, Serena/0000-0001-7804-9486; RICCARDI, RICCARDO/0000-0001-7515-6622; Chan, Joseph/0000-0001-5249-7395; Rabadan, Raul/0000-0001-7946-9255; Finocchiaro, Gaetano/0000-0003-3583-4040; Iavarone, Antonio/0000-0002-0683-4634; Ceccarelli, Michele/0000-0002-4702-6617	National Cancer Institute [R01CA101644, R01CA131126, R01CA085628, R01CA127643, U54 CA121852-05]; National Library of Medicine [1R01LM010140-01]; National Institute of Neurological Disorders and Stroke [R01NS061776]; Partnership for Cure [7-78947]; Chemotherapy Foundation; Italian Ministry of Welfare/Provincia di Benevento; Associazione Italiana per la Ricerca sul Cancro; Italian Ministry of Health; NATIONAL CANCER INSTITUTE [R01CA190891, U54CA121852, R01CA127643, R01CA131126, R01CA085628, R01CA101644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061776] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010140] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Partnership for Cure; Chemotherapy Foundation; Italian Ministry of Welfare/Provincia di Benevento; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health(Ministry of Health, Italy); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by National Cancer Institute grants R01CA101644 and R01CA131126 (A. L.), R01CA085628 and R01CA127643 (A. I.), U54 CA121852-05 (R. R.), National Library of Medicine grant 1R01LM010140-01 (R. R.), National Institute of Neurological Disorders and Stroke grant R01NS061776 (A. I.), a grant from Partnership for Cure (R. R., 7-78947), and a grant from The Chemotherapy Foundation (A. I.). P.Z. and F.N. are supported by fellowships from the Italian Ministry of Welfare/Provincia di Benevento. G. F. was supported by grants from the Associazione Italiana per la Ricerca sul Cancro and from the Italian Ministry of Health. Three of the authors (A. I., A. L., and R. R.) and Columbia University Medical Center have filed a patent application related to the diagnostic and therapeutic use of FGFR-TACC gene fusions. Next-generation RNA-sequencing data have been deposited into the Database of Genotypes and Phenotypes (accession no. phs000505.v1.p1).	Ablain J, 2011, CANCER DISCOV, V1, P117, DOI 10.1158/2159-8290.CD-11-0087; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Charest A, 2003, GENE CHROMOSOME CANC, V37, P58, DOI 10.1002/gcc.10207; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Coschi CH, 2012, CELL MOL LIFE SCI, V69, P2009, DOI 10.1007/s00018-011-0910-4; Druker BJ, 2009, NAT MED, V15, P1149, DOI 10.1038/nm1009-1149; Duncan CG, 2010, ONCOTARGET, V1, P265, DOI 10.18632/oncotarget.137; Gavine PR, 2012, CANCER RES, V72, P2045, DOI 10.1158/0008-5472.CAN-11-3034; Gerber DE, 2010, CANCER CELL, V18, P548, DOI 10.1016/j.ccr.2010.11.033; Gordon DJ, 2012, NAT REV GENET, V13, P189, DOI 10.1038/nrg3123; Guagnano V, 2011, J MED CHEM, V54, P7066, DOI 10.1021/jm2006222; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Hood Fiona E, 2011, Bioarchitecture, V1, P105; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Marumoto T, 2009, NAT MED, V15, P110, DOI 10.1038/nm.1863; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; Peset I, 2008, TRENDS CELL BIOL, V18, P379, DOI 10.1016/j.tcb.2008.06.005; Sheltzer JM, 2011, TRENDS GENET, V27, P446, DOI 10.1016/j.tig.2011.07.003; Solomon DA, 2011, SCIENCE, V333, P1039, DOI 10.1126/science.1203619; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Still IH, 1999, GENOMICS, V58, P165, DOI 10.1006/geno.1999.5829; Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Weaver BAA, 2009, J CELL BIOL, V185, P934, DOI 10.1083/jcb.200905098; Wesche J, 2011, BIOCHEM J, V437, P199, DOI 10.1042/BJ20101603; Yao R, 2012, ONCOGENE, V31, P135, DOI 10.1038/onc.2011.235	28	519	570	3	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 7	2012	337	6099					1231	1235		10.1126/science.1220834	http://dx.doi.org/10.1126/science.1220834			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	000UJ	22837387	Green Accepted			2022-12-28	WOS:000308414000040
J	Bangalore, S; Kumar, S; Fusaro, M; Amoroso, N; Kirtane, AJ; Byrne, RA; Williams, DO; Slater, J; Cutlip, DE; Feit, F				Bangalore, Sripal; Kumar, Sunil; Fusaro, Mario; Amoroso, Nicholas; Kirtane, Ajay J.; Byrne, Robert A.; Williams, David O.; Slater, James; Cutlip, Donald E.; Feit, Frederick			Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22 844 patient years of follow-up from randomised trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-ARTERY LESIONS; CLINICAL-OUTCOMES; REAL-WORLD; ANGIOGRAPHIC OUTCOMES; UNCOATED STENTS; DOUBLE-BLIND; SIROLIMUS; PACLITAXEL; EVEROLIMUS; DISEASE	Objectives To evaluate the efficacy and safety of currently used drug eluting stents compared with each other and compared with bare metal stents in patients with diabetes. Design Mixed treatment comparison meta-analysis. Data sources and study selection PubMed, Embase, and CENTRAL were searched for randomised clinical trials, until April 2012, of four durable polymer drug eluting stents (sirolimus eluting stents, paclitaxel eluting stents, everolimus eluting stents, and zotarolimus eluting stents) compared with each other or with bare metal stents for the treatment of de novo coronary lesions and enrolling at least 50 patients with diabetes. Primary outcomes Efficacy (target vessel revascularisation) and safety (death, myocardial infarction, stent thrombosis). Results From 42 trials with 22 844 patient years of follow-up, when compared with bare metal stents (reference rate ratio 1) all of the currently used drug eluting stents were associated with a significant reduction in target vessel revascularisation (37% to 69%), though the efficacy varied with the type of stent (everolimus eluting stents-sirolimus eluting stents>paclitaxel eluting stents-zotarolimus eluting stent>bare metal stents). There was about an 87% probability that everolimus eluting stents were the most efficacious compared with all others, though there were limited usable data for the zotarolimus eluting Resolute stent in patients with diabetes. Moreover, there was no increased risk of any safety outcome (including very late stent thrombosis) with any drug eluting stents compared with bare metal stents. There was about a 62% probability that the everolimus eluting stent was the safest stent for the outcome of "any" stent thrombosis. Conclusions Among patients with diabetes treated with coronary stents all currently available drug eluting stents were efficacious without compromising safety compared with bare metal stents. There were relative differences among the drug eluting stents, such that the everolimus eluting stent was the most efficacious and safe.	[Bangalore, Sripal; Fusaro, Mario; Amoroso, Nicholas; Slater, James; Feit, Frederick] NYU, Sch Med, New York, NY 10016 USA; [Kumar, Sunil] Univ Nebraska, Omaha, NE 68182 USA; [Kirtane, Ajay J.] Columbia Univ, Med Ctr, New York Presbyterian Hosp, New York, NY USA; [Williams, David O.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Cutlip, Donald E.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Cutlip, Donald E.] Harvard Clin Res Inst, Boston, MA USA; [Byrne, Robert A.] Univ Munich, Tech Univ, Deutsch Herzzentrum, Munich, Germany	New York University; University of Nebraska System; Columbia University; NewYork-Presbyterian Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; German Heart Center Berlin; German Heart Centre Munich; Technical University of Munich; University of Munich	Bangalore, S (corresponding author), NYU, Sch Med, New York, NY 10016 USA.	sripalbangalore@gmail.com	Bangalore, Sripal/B-6246-2013; Byrne, Robert/C-3902-2016	Byrne, Robert/0000-0001-5224-6393; Bangalore, Sripal/0000-0001-9485-0652; Slater, James/0000-0003-3888-0317				Abizaid A, 1998, J AM COLL CARDIOL, V32, P584, DOI 10.1016/S0735-1097(98)00286-1; Alderman EL, 1996, NEW ENGL J MED, V335, P217; Bari D Study Grp, 2009, NEW ENGL J MED, V360, P2503, DOI 10.1056/NEJMoa0805796; Baumgart D, 2007, J AM COLL CARDIOL, V50, P1627, DOI 10.1016/j.jacc.2007.07.035; Berry C, 2007, J AM COLL CARDIOL, V49, P643, DOI 10.1016/j.jacc.2006.09.045; Billinger M, 2008, EUR HEART J, V29, P718, DOI 10.1093/eurheartj/ehn021; Bradburn M, 1998, STATA TECH B REPRINT, V8, P86; Briguori C, 2011, CIRC-CARDIOVASC INTE, V4, P121, DOI 10.1161/CIRCINTERVENTIONS.110.959924; Byrne RA, 2010, J AM COLL CARDIOL, V55, P2536, DOI 10.1016/j.jacc.2010.03.020; Byrne RA, 2009, EUR HEART J, V30, P923, DOI 10.1093/eurheartj/ehp044; Caldwell DM, 2005, BMJ-BRIT MED J, V331, P897, DOI 10.1136/bmj.331.7521.897; Chan C, 2008, CATHETER CARDIO INTE, V72, P591, DOI 10.1002/ccd.21719; CHRISTENSEN T, 1988, ACTA RADIOL, V29, P299, DOI 10.1177/028418518802900308; Colombo A, 2003, CIRCULATION, V108, P788, DOI 10.1161/01.CIR.0000086926.62288.A6; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Daemen J, 2007, EUR HEART J, V28, P26, DOI 10.1093/eurheartj/ehl412; Dawkins KD, 2005, CIRCULATION, V112, P3306, DOI 10.1161/CIRCULATIONAHA.105.552190; de Lezo JS, 2005, J AM COLL CARDIOL, V45, p75A; de Waha A, 2011, CLIN RES CARDIOL, V100, P561, DOI 10.1007/s00392-010-0278-8; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dibra A, 2005, NEW ENGL J MED, V353, P663, DOI 10.1056/NEJMoa044372; European Society of Congress, 2011, RAND EV SIR EL VERS; Fajadet J, 2006, CIRCULATION, V114, P798, DOI 10.1161/CIRCULATIONAHA.105.591206; Garg S, 2009, JACC-CARDIOVASC INTE, V2, P1190, DOI 10.1016/j.jcin.2009.10.002; Goraya TY, 2002, J AM COLL CARDIOL, V40, P946, DOI 10.1016/S0735-1097(02)02065-X; Goy JJ, 2005, J AM COLL CARDIOL, V45, P308, DOI 10.1016/j.jacc.2004.10.062; Hermiller JB, 2005, J AM COLL CARDIOL, V45, P1172, DOI 10.1016/j.jacc.2004.10.075; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Hong SJ, 2010, CATHETER CARDIO INTE, V76, P924, DOI 10.1002/ccd.22369; Hurst RT, 2003, ANN INTERN MED, V139, P824, DOI 10.7326/0003-4819-139-10-200311180-00010; Jimenez-Quevedo P, 2011, EUR HEART J, V32, P654; Junkers A, 2011, J AM COLL CARDIOL, V58; Kaiser C, 2005, LANCET, V366, P921, DOI 10.1016/S0140-6736(05)67221-2; Kandzari DE, 2011, JACC-CARDIOVASC INTE, V4, P543, DOI 10.1016/j.jcin.2010.12.014; Kastrati A, 2005, JAMA-J AM MED ASSOC, V293, P165, DOI 10.1001/jama.293.2.165; Kelbaek H, 2006, J AM COLL CARDIOL, V47, P449, DOI 10.1016/j.jacc.2005.10.045; Kim MH, 2008, J INTERV CARDIOL, V21, P225, DOI 10.1111/j.1540-8183.2008.00353.x; Kim WJ, 2011, CIRCULATION, V124, P886, DOI 10.1161/CIRCULATIONAHA.110.015453; Kim YH, 2006, CIRCULATION, V114, P2148, DOI 10.1161/CIRCULATIONAHA.106.666396; Kip KE, 1996, CIRCULATION, V94, P1818, DOI 10.1161/01.CIR.94.8.1818; Kirtane AJ, 2009, JACC-CARDIOVASC INTE, V2, P967, DOI 10.1016/j.jcin.2009.08.008; Laarman GJ, 2006, NEW ENGL J MED, V355, P1105, DOI 10.1056/NEJMoa062598; Lee SW, 2008, J AM COLL CARDIOL, V52, P727, DOI 10.1016/j.jacc.2008.04.056; Lee SW, 2011, JACC-CARDIOVASC INTE, V4, P310, DOI 10.1016/j.jcin.2010.12.006; Luscher TF, 2003, CIRCULATION, V108, P1655, DOI 10.1161/01.CIR.0000089189.70578.E2; Maeng M, 2011, AM J CARDIOL, V108, P1232, DOI 10.1016/j.amjcard.2011.06.037; Maeng M, 2009, AM J CARDIOL, V103, P345, DOI 10.1016/j.amjcard.2008.09.084; Maresta A, 2008, AM J CARDIOL, V101, P1560, DOI 10.1016/j.amjcard.2008.01.040; Mehilli J, 2009, J AM COLL CARDIOL, V53, P1760, DOI 10.1016/j.jacc.2009.01.035; Menichelli M, 2007, J AM COLL CARDIOL, V49, P1924, DOI 10.1016/j.jacc.2007.01.081; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Morice MC, 2006, JAMA-J AM MED ASSOC, V295, P895, DOI 10.1001/jama.295.8.895; Moussa I, 2004, CIRCULATION, V109, P2273, DOI 10.1161/01.CIR.0000129767.45513.71; Ong ATL, 2005, AM J CARDIOL, V96, P358, DOI 10.1016/j.amjcard.2005.03.075; Ortolani P, 2005, AM J CARDIOL, V96, P1393, DOI 10.1016/j.amjcard.2005.07.049; Pache J, 2005, EUR HEART J, V26, P1262, DOI 10.1093/eurheartj/ehi098; Sabate M, 2005, CIRCULATION, V112, P2175, DOI 10.1161/CIRCULATIONAHA.105.562421; Scheen AJ, 2004, EUR HEART J, V25, P2167, DOI 10.1016/j.ehj.2004.07.041; Scheen AJ, 2004, DIABETES CARE, V27, P1840, DOI 10.2337/diacare.27.7.1840; Schofer J, 2003, LANCET, V362, P1093, DOI 10.1016/S0140-6736(03)14462-5; Serruys Patrick W, 2006, EuroIntervention, V2, P286; Serruys PW, 2010, NEW ENGL J MED, V363, P136, DOI 10.1056/NEJMoa1004130; Spaulding C, 2007, NEW ENGL J MED, V356, P989, DOI 10.1056/NEJMoa066633; Spaulding C, 2006, NEW ENGL J MED, V355, P1093, DOI 10.1056/NEJMoa062006; Spiegelhalter DJ, 2004, BAYESIAN APPROACHES, DOI DOI 10.1002/0470092602; Stankovic G, 2006, AM J CARDIOL, V98, P362, DOI 10.1016/j.amjcard.2006.01.104; Stettler C, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1331; Stone GW, 2011, CIRCULATION, V124, P893, DOI 10.1161/CIRCULATIONAHA.111.031070; Stone GW, 2011, J AM COLL CARDIOL, V58, P19, DOI 10.1016/j.jacc.2011.02.022; Stone GW, 2009, CIRCULATION, V119, P680, DOI 10.1161/CIRCULATIONAHA.108.803528; Stone GW, 2005, JAMA-J AM MED ASSOC, V294, P1215, DOI 10.1001/jama.294.10.1215; Syeda B, 2002, CORONARY ARTERY DIS, V13, P263, DOI 10.1097/00019501-200208000-00003; Tomai F, 2008, DIABETES CARE, V31, P15, DOI 10.2337/dc07-1377; von Birgelen C, 2012, J AM COLL CARDIOL, V59, P1350, DOI 10.1016/j.jacc.2012.01.008; Wilson SR, 2004, DIABETES CARE, V27, P1137, DOI 10.2337/diacare.27.5.1137; Windecker S, 2005, NEW ENGL J MED, V353, P653, DOI 10.1056/NEJMoa051175; Witzenbichler B, 2011, CIRC-CARDIOVASC INTE, V4, P130, DOI 10.1161/CIRCINTERVENTIONS.110.960245	77	156	163	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 10	2012	345								e5170	10.1136/bmj.e5170	http://dx.doi.org/10.1136/bmj.e5170			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988NG	22885395	Green Published, hybrid			2022-12-28	WOS:000307497100001
J	Schepers, AG; Snippert, HJ; Stange, DE; van den Born, M; van Es, JH; van de Wetering, M; Clevers, H				Schepers, Arnout G.; Snippert, Hugo J.; Stange, Daniel E.; van den Born, Maaike; van Es, Johan H.; van de Wetering, Marc; Clevers, Hans			Lineage Tracing Reveals Lgr5(+) Stem Cell Activity in Mouse Intestinal Adenomas	SCIENCE			English	Article							COLORECTAL-CANCER; HUMAN COLON; DIFFERENTIATION; IDENTIFICATION; ORIGIN; TUMORS; GENE; MICE	The concept that tumors are maintained by dedicated stem cells, the so-called cancer stem cell hypothesis, has attracted great interest but remains controversial. Studying mouse models, we provide direct, functional evidence for the presence of stem cell activity within primary intestinal adenomas, a precursor to intestinal cancer. By "lineage retracing" using the multicolor Cre-reporter R26R-Confetti, we demonstrate that the crypt stem cell marker Lgr5 (leucine-rich repeat-containing heterotrimeric guanine nucleotide-binding protein-coupled receptor 5) also marks a subpopulation of adenoma cells that fuel the growth of established intestinal adenomas. These Lgr5(+) cells, which represent about 5 to 10% of the cells in the adenomas, generate additional Lgr5(+) cells as well as all other adenoma cell types. The Lgr5(+) cells are intermingled with Paneth cells near the adenoma base, a pattern reminiscent of the architecture of the normal crypt niche.	[Clevers, Hans] Koninklijke Nederlandse Akad Wetenschappen, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Clevers, H (corresponding author), Koninklijke Nederlandse Akad Wetenschappen, Hubrecht Inst, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	h.clevers@hubrecht.eu	Stange, Daniel E/O-1837-2015; van+Es, Johan/ABD-5411-2021	Stange, Daniel E/0000-0003-4246-2230; 	KWF (the Dutch Cancer Society); CBG (the Centre for Biomedical Genetics); TI Pharma	KWF (the Dutch Cancer Society); CBG (the Centre for Biomedical Genetics); TI Pharma	We thank C. Kroon-Veenboer for help with mouse experiments. A. G. S and H.J.S. were funded by KWF (the Dutch Cancer Society); D. E. S. by CBG (the Centre for Biomedical Genetics); and M.vdB., J.vE., and M.vdW. by TI Pharma. Array data sets are deposited at Gene Expression Omnibus (accession no. GSE37926).	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dalerba P, 2011, NAT BIOTECHNOL, V29, P1120, DOI 10.1038/nbt.2038; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Ireland H, 2005, DEV DYNAM, V233, P1332, DOI 10.1002/dvdy.20446; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Merritt AJ, 1997, P NATL ACAD SCI USA, V94, P13927, DOI 10.1073/pnas.94.25.13927; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Novelli MR, 1996, SCIENCE, V272, P1187, DOI 10.1126/science.272.5265.1187; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; PIERCE GB, 1988, CANCER RES, V48, P1996; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rothenberg ME, 2012, GASTROENTEROLOGY, V142, P1195, DOI 10.1053/j.gastro.2012.02.006; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	24	778	816	1	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2012	337	6095					730	735		10.1126/science.1224676	http://dx.doi.org/10.1126/science.1224676			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986PE	22855427				2022-12-28	WOS:000307354500054
J	Wilson, RK				Wilson, Rick K.			Elinor Ostrom (1933-2012) RETROSPECTIVE	SCIENCE			English	Biographical-Item									Rice Univ, Dept Polit Sci, Houston, TX 77251 USA	Rice University	Wilson, RK (corresponding author), Rice Univ, Dept Polit Sci, Houston, TX 77251 USA.	rkw@rice.edu		Wilson, Rick/0000-0003-4278-7721				OSTROM E, PUBLICATION LIST	1	1	1	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2012	337	6095					661	661		10.1126/science.1227725	http://dx.doi.org/10.1126/science.1227725			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986PE	22879496				2022-12-28	WOS:000307354500033
J	Barritt, AW; Jackson, MB				Barritt, Andrew W.; Jackson, Mark B.			An unusual case of pneumonia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EOSINOPHILIA		[Barritt, Andrew W.; Jackson, Mark B.] Royal Sussex Cty Hosp, Dept Resp Med, Brighton BN2 5BE, E Sussex, England	University of Brighton	Barritt, AW (corresponding author), Royal Sussex Cty Hosp, Dept Resp Med, Brighton BN2 5BE, E Sussex, England.	awb@doctors.org.uk		Barritt, Andrew/0000-0002-9723-6946				ALLEN JN, 1994, AM J RESP CRIT CARE, V150, P1423, DOI 10.1164/ajrccm.150.5.7952571; Cottin V, 2005, ALLERGY, V60, P841, DOI 10.1111/j.1398-9995.2005.00812.x; Katz U, 2008, CLIN REV ALLERG IMMU, V34, P367, DOI 10.1007/s12016-007-8053-y; Oddo A, 2003, CHEST, V123, P2146, DOI 10.1378/chest.123.6.2146; Swartz J, 2009, RESPIRATION, V77, P102, DOI 10.1159/000109977; Valent P, 2009, BLOOD REV, V23, P157, DOI 10.1016/j.blre.2009.01.001; Ward CM, 2007, ALLERGY ASTHMA PROC, V28, P382, DOI 10.2500/aap.2007.28.2969	7	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 9	2012	345								e5272	10.1136/bmj.e5272	http://dx.doi.org/10.1136/bmj.e5272			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988NF	22879637				2022-12-28	WOS:000307497000005
J	Kluin-Nelemans, HC; Hoster, E; Hermine, O; Walewski, J; Trneny, M; Geisler, CH; Stilgenbauer, S; Thieblemont, C; Vehling-Kaiser, U; Doorduijn, JK; Coiffier, B; Forstpointner, R; Tilly, H; Kanz, L; Feugier, P; Szymczyk, M; Hallek, M; Kremers, S; Lepeu, G; Sanhes, L; Zijlstra, JM; Bouabdallah, R; Lugtenburg, PJ; Macro, M; Pfreundschuh, M; Prochazka, V; Di Raimondo, F; Ribrag, V; Uppenkamp, M; Andre, M; Klapper, W; Hiddemann, W; Unterhalt, M; Dreyling, MH				Kluin-Nelemans, H. C.; Hoster, E.; Hermine, O.; Walewski, J.; Trneny, M.; Geisler, C. H.; Stilgenbauer, S.; Thieblemont, C.; Vehling-Kaiser, U.; Doorduijn, J. K.; Coiffier, B.; Forstpointner, R.; Tilly, H.; Kanz, L.; Feugier, P.; Szymczyk, M.; Hallek, M.; Kremers, S.; Lepeu, G.; Sanhes, L.; Zijlstra, J. M.; Bouabdallah, R.; Lugtenburg, P. J.; Macro, M.; Pfreundschuh, M.; Prochazka, V.; Di Raimondo, F.; Ribrag, V.; Uppenkamp, M.; Andre, M.; Klapper, W.; Hiddemann, W.; Unterhalt, M.; Dreyling, M. H.			Treatment of Older Patients with Mantle-Cell Lymphoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PROSPECTIVE RANDOMIZED-TRIAL; FLUDARABINE; RITUXIMAB; CYCLOPHOSPHAMIDE; COMBINATION; SURVIVAL; THERAPY; FCM	BACKGROUND The long-term prognosis for older patients with mantle-cell lymphoma is poor. Chemoimmunotherapy results in low rates of complete remission, and most patients have a relapse. We investigated whether a fludarabine-containing induction regimen improved the complete-remission rate and whether maintenance therapy with rituximab prolonged remission. METHODS We randomly assigned patients 60 years of age or older with mantle-cell lymphoma, stage II to IV, who were not eligible for high-dose therapy to six cycles of rituximab, fludarabine, and cyclophosphamide (R-FC) every 28 days or to eight cycles of rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) every 21 days. Patients who had a response underwent a second randomization to maintenance therapy with rituximab or interferon alfa, each given until progression. RESULTS Of the 560 patients enrolled, 532 were included in the intention-to-treat analysis for response, and 485 in the primary analysis for response. The median age was 70 years. Although complete-remission rates were similar with R-FC and R-CHOP (40% and 34%, respectively; P = 0.10), progressive disease was more frequent with R-FC (14%, vs. 5% with R-CHOP). Overall survival was significantly shorter with R-FC than with R-CHOP (4-year survival rate, 47% vs. 62%; P = 0.005), and more patients in the R-FC group died during the first remission (10% vs. 4%). Hematologic toxic effects occurred more frequently in the R-FC group than in the R-CHOP group, but the frequency of grade 3 or 4 infections was balanced (17% and 14%, respectively). In 274 of the 316 patients who were randomly assigned to maintenance therapy, rituximab reduced the risk of progression or death by 45% (in remission after 4 years, 58%, vs. 29% with interferon alfa; hazard ratio for progression or death, 0.55; 95% confidence interval, 0.36 to 0.87; P = 0.01). Among patients who had a response to R-CHOP, maintenance therapy with rituximab significantly improved overall survival (4-year survival rate, 87%, vs. 63% with interferon alfa; P = 0.005). CONCLUSIONS R-CHOP induction followed by maintenance therapy with rituximab is effective for older patients with mantle-cell lymphoma. (Funded by the European Commission and others; ClinicalTrials.gov number, NCT00209209.)	[Kluin-Nelemans, H. C.] Univ Groningen, Dept Hematol, Univ Med Ctr Groningen, NL-9700 RB Groningen, Netherlands; [Doorduijn, J. K.] Erasmus Univ, Med Ctr, Dept Hematol, Dr Daniel Den Hoed Canc Ctr, Rotterdam, Netherlands; [Zijlstra, J. M.] Vrije Univ Amsterdam, Med Ctr, Dept Hematol, Amsterdam, Netherlands; [Hoster, E.; Forstpointner, R.; Hiddemann, W.; Unterhalt, M.; Dreyling, M. H.] Univ Hosp, Dept Internal Med 3, Munich, Germany; [Stilgenbauer, S.] Univ Ulm, Dept Internal Med 3, D-7900 Ulm, Germany; [Vehling-Kaiser, U.] Tagesklin Hamatol Onkol, Landshut, Germany; [Kanz, L.] Univ Tubingen, Dept Med 2, Tubingen, Germany; [Hallek, M.] Univ Cologne, Innere Med Klin 1, D-50931 Cologne, Germany; [Kremers, S.] Caritas Krankenhaus, Onkol Zentrum, Lebach, Germany; [Pfreundschuh, M.] Univ Klin Saarlandes, Homburg, Germany; [Uppenkamp, M.] Klinikum Stadt Ludwigshafen, Med Klin A, D-6700 Ludwigshafen, Germany; [Klapper, W.] Univ Kiel, Hematopathol Sect, Dept Pathol, Kiel, Germany; [Klapper, W.] Univ Kiel, Lymph Node Registry, Kiel, Germany; [Hermine, O.] Univ Paris 05, Hop Necker Enfants Malad, AP HP, Dept Hematol, Paris, France; [Thieblemont, C.] Hop St Louis, Dept Hematol, Paris, France; [Coiffier, B.] Ctr Hosp Lyon Sud, Dept Hematol, F-69310 Pierre Benite, France; [Tilly, H.] Ctr Henri Becquerel, F-76038 Rouen, France; [Feugier, P.] Serv Hematol, Vandoevre Les Nancy, France; [Lepeu, G.] Ctr Hosp Henri Duffaut, Avignon, France; [Sanhes, L.] Ctr Hosp Marechal Joffre, Perpignan, France; [Bouabdallah, R.] Serv Hematol, Marseille, France; [Macro, M.] Serv Hematol, Caen, France; [Ribrag, V.] Inst Gustave Roussy, Villejuif, France; [Walewski, J.; Szymczyk, M.] Maria Sklodowska Curie Mem Inst & Canc Ctr, Dept Lymphoproliferat Dis, Warsaw, Poland; [Trneny, M.] Charles Univ Prague, Gen Hosp, Dept Med 1, Prague, Czech Republic; [Prochazka, V.] Palacky Univ, Fac Med & Dent, Dept Hematooncol, CR-77147 Olomouc, Czech Republic; [Geisler, C. H.] Rigshosp, Dept Hematol, DK-2100 Copenhagen, Denmark; [Di Raimondo, F.] Osped Ferratotto, Div Ematol, Catania, Italy; [Andre, M.] Ctr Hosp Univ Mt Godinne, Serv Hematol, Yvoir, Belgium	University of Groningen; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Vrije Universiteit Amsterdam; University of Munich; Ulm University; Eberhard Karls University of Tubingen; University of Cologne; Universitatsklinikum des Saarlandes; Ludwigshafen Hospital; University of Kiel; University of Kiel; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Lyon; UNICANCER; Centre Henri Becquerel; UNICANCER; Gustave Roussy; Charles University Prague; General University Hospital Prague; Palacky University Olomouc; University Hospital Plzen; Rigshospitalet; University of Copenhagen	Kluin-Nelemans, HC (corresponding author), Univ Groningen, Dept Hematol, Univ Med Ctr Groningen, Hanzepl 1, NL-9700 RB Groningen, Netherlands.	j.c.kluin@umcg.nl	Kluin-Nelemans, Johanna C/F-8658-2018; Di Raimondo, Francesco/K-7965-2016; Walewski, Jan/ABC-9523-2020; AndrÃ©, Marc/AAP-2355-2020; Prochazka, Vit/AAI-5809-2020; Thieblemont, Catherine/AAZ-8423-2020; Stilgenbauer, Stephan/ABE-6609-2020; Klapper, Wolfram/S-6314-2016; Hermine, Olivier/Q-7072-2018; Hallek, Michael/Y-3191-2019; Hoster, Eva/M-2795-2019	Kluin-Nelemans, Johanna C/0000-0003-2617-9427; Di Raimondo, Francesco/0000-0002-7749-0293; Thieblemont, Catherine/0000-0002-9941-2448; Hallek, Michael/0000-0002-7425-4455; Hoster, Eva/0000-0002-0749-1389; Prochazka, Vit/0000-0002-9861-3117; Trneny, Marek/0000-0002-6952-6073; Hermine, Olivier/0000-0003-2574-3874; Walewski, Jan/0000-0003-4247-2674	European Commission [LSHC-CT-2004-503351]; Lymphoma Research Foundation; Roche Pharmaceuticals; Bayer Schering Pharma; Schering-Plough	European Commission(European CommissionEuropean Commission Joint Research Centre); Lymphoma Research Foundation; Roche Pharmaceuticals(Roche Holding); Bayer Schering Pharma(Bayer AG); Schering-Plough(Merck & CompanySchering Plough Corporation)	Supported by grants from the European Commission (LSHC-CT-2004-503351), the Lymphoma Research Foundation, Roche Pharmaceuticals, Bayer Schering Pharma, and Schering-Plough.	Catovsky D, 2007, LANCET, V370, P230, DOI 10.1016/S0140-6736(07)61125-8; Cheson BD, 1999, J CLIN ONCOL, V17, P1244, DOI 10.1200/JCO.1999.17.4.1244; Cheson BD, 2000, J CLIN ONCOL, V18, P2531; Cohen BJ, 2001, LEUKEMIA LYMPHOMA, V42, P1015, DOI 10.3109/10428190109097721; Dreyling M, 2005, BLOOD, V105, P2677, DOI 10.1182/blood-2004-10-3883; Dreyling M, 2011, HEMATOL-AM SOC HEMAT, P562, DOI 10.1182/asheducation-2011.1.562; Dreyling Martin, 2009, Hematology Am Soc Hematol Educ Program, P542, DOI 10.1182/asheducation-2009.1.542; Eichhorst B, 2009, LEUKEMIA LYMPHOMA, V50, P171, DOI 10.1080/10428190802688517; Foran JM, 1999, J CLIN ONCOL, V17, P546, DOI 10.1200/JCO.1999.17.2.546; Forstpointner R, 2004, BLOOD, V104, P3064, DOI 10.1182/blood-2004-04-1323; Forstpointner R, 2006, BLOOD, V108, P4003, DOI 10.1182/blood-2006-04-016725; Geisler CH, 2010, HAEMATOL-HEMATOL J, V95, P1241, DOI 10.3324/haematol.2010.025627; Harel S, 2011, SEMIN HEMATOL, V48, P194, DOI 10.1053/j.seminhematol.2011.06.002; Hiddemann W, 2003, SEMIN ONCOL, V30, P16, DOI 10.1053/sonc.2003.50024; Hoster, 2008, BLOOD, V111, P5761; Hoster E, 2008, BLOOD, V111, P558, DOI 10.1182/blood-2007-06-095331; Howard OM, 2002, J CLIN ONCOL, V20, P1288, DOI 10.1200/JCO.20.5.1288; Klapper Wolfram, 2009, J Hematop, V2, P103, DOI 10.1007/s12308-009-0036-x; Lenz G, 2005, J CLIN ONCOL, V23, P1984, DOI 10.1200/JCO.2005.08.133; Perez-Galan P, 2011, BLOOD, V117, P26, DOI 10.1182/blood-2010-04-189977; Rummel MJ, 2010, AM SOC HEM 52 ANN M, P114; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Swerdlow SH, 2008, WHO CLASSIFICATION T, P229; Unterhalt M, 1996, BLOOD, V88, P1801; Weigert O, 2009, LEUKEMIA LYMPHOMA, V50, P716, DOI 10.1080/10428190902856790; Whitehead J, 1997, DESIGN ANAL SEQUENTI; Zinzani PL, 2000, J CLIN ONCOL, V18, P773, DOI 10.1200/JCO.2000.18.4.773	27	359	374	1	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 9	2012	367	6					520	531		10.1056/NEJMoa1200920	http://dx.doi.org/10.1056/NEJMoa1200920			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	986AE	22873532	Green Published			2022-12-28	WOS:000307310800006
J	Masood, E				Masood, Ehsan			Arab liberals must stay in the game	NATURE			English	Editorial Material												news@researchresearch.com						Masood E, 2006, NATURE, V444, P22, DOI 10.1038/444022a	1	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2012	488	7410					131	131		10.1038/488131a	http://dx.doi.org/10.1038/488131a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	985LE	22874928	Bronze			2022-12-28	WOS:000307267000003
J	Shaw, D				Shaw, David			We should not let families stop organ donation from their dead relatives	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Glasgow, Fac Med, Glasgow G2 3JZ, Lanark, Scotland	University of Glasgow	Shaw, D (corresponding author), Univ Glasgow, Fac Med, Glasgow G2 3JZ, Lanark, Scotland.	davidmartinshaw@gmail.com						Bird SM, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2188; De Wispelaere J, 2010, J MED ETHICS, V36, P180, DOI 10.1136/jme.2009.032912; Hughes D, 2012, BBC; Human Tissue Authority, COD PRACT 2 DON SOL; Kirby J, 2009, J BIOETHIC INQ, V6, P123, DOI 10.1007/s11673-009-9136-7; Mason JK, 2006, LAW MED ETHICS, V7th	6	21	21	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 7	2012	345								e5275	10.1136/bmj.e5275	http://dx.doi.org/10.1136/bmj.e5275			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988NA	22872697				2022-12-28	WOS:000307496500012
J	Guerry, MJ; Lemyze, M				Guerry, Mary-Jane; Lemyze, Malcolm			Acute skin failure	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TOXIC EPIDERMAL NECROLYSIS; STEVENS-JOHNSON-SYNDROME; HUMAN-IMMUNODEFICIENCY-VIRUS; MYCOPLASMA-PNEUMONIAE; ERYTHEMA MULTIFORME; CUTANEOUS REACTIONS; DRUGS; RISK		[Lemyze, Malcolm] Schaffner Hosp, Dept Resp & Crit Care Med, F-62300 Lens, France; [Guerry, Mary-Jane] Univ Lille 2, Dept Crit Care Med, Salengro Hosp, Lille, France	Universite de Lille - ISITE; CHU Lille; Universite de Lille	Lemyze, M (corresponding author), Schaffner Hosp, Dept Resp & Crit Care Med, F-62300 Lens, France.	malcolmlemyze@yahoo.fr						AMON RB, 1975, ARCH DERMATOL, V111, P1433, DOI 10.1001/archderm.111.11.1433; Bastuji-Garin S, 2000, J INVEST DERMATOL, V115, P149, DOI 10.1046/j.1523-1747.2000.00061.x; BASTUJIGARIN S, 1993, ARCH DERMATOL, V129, P92, DOI 10.1001/archderm.129.1.92; Di Pascuale MA, 2005, OPHTHALMOLOGY, V112, P904, DOI 10.1016/j.ophtha.2004.11.035; Forman R, 2002, DRUG SAFETY, V25, P965, DOI 10.2165/00002018-200225130-00006; FOURNIER S, 1995, EUR J CLIN MICROBIOL, V14, P558, DOI 10.1007/BF02113442; Garcia-Doval I, 2000, ARCH DERMATOL, V136, P323, DOI 10.1001/archderm.136.3.323; Ghislain Pierre-Dominique, 2002, Dermatol Online J, V8, P5; Harr T, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-39; Litt JZ, 2012, LITTS DRUG ERUPTIONS; Mulvey JM, 2007, ANAESTH INTENS CARE, V35, P414, DOI 10.1177/0310057X0703500317; Pereira FA, 2007, J AM ACAD DERMATOL, V56, P181, DOI 10.1016/j.jaad.2006.04.048; REVUZ J, 1987, ARCH DERMATOL, V123, P1160, DOI 10.1001/archderm.123.9.1160; Rotunda A, 2003, ACTA DERM-VENEREOL, V83, P1, DOI 10.1080/00015550310002611; ROUJEAU JC, 1994, NEW ENGL J MED, V331, P1272, DOI 10.1056/NEJM199411103311906; ROUJEAU JC, 1995, NEW ENGL J MED, V333, P1600, DOI 10.1056/NEJM199512143332404; Rzany B, 1996, BRIT J DERMATOL, V135, P6; SAIAG P, 1992, J AM ACAD DERMATOL, V26, P567, DOI 10.1016/0190-9622(92)70082-Q; Schalock PC, 2005, J AM ACAD DERMATOL, V52, P312, DOI 10.1016/j.jaad.2004.07.044; Urbano FL, 2001, HOSP PHYS, V37, P23; Wetter DA, 2010, MAYO CLIN PROC, V85, P131, DOI 10.4065/mcp.2009.0379; Wolkenstein PE, 1998, CLIN DERMATOL, V16, P399, DOI 10.1016/S0738-081X(98)00011-X	22	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 6	2012	345								e5028	10.1136/bmj.e5028	http://dx.doi.org/10.1136/bmj.e5028			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988MY	22867914				2022-12-28	WOS:000307496300007
J	Riegel, B; Sullivan-Marx, E; Fairman, J				Riegel, Barbara; Sullivan-Marx, Eileen; Fairman, Julie			Meeting global needs in primary care with nurse practitioners	LANCET			English	Editorial Material									[Riegel, Barbara; Fairman, Julie] Univ Penn, Sch Nursing, Philadelphia, PA 19104 USA; [Sullivan-Marx, Eileen] NYU, Coll Nursing, New York, NY USA	University of Pennsylvania; New York University	Riegel, B (corresponding author), Univ Penn, Sch Nursing, Philadelphia, PA 19104 USA.	briegel@nursing.upenn.edu						[Anonymous], PRIM CAR WORKF FACTS; Cooper RA, 2003, JAMA-J AM MED ASSOC, V290, P2992, DOI 10.1001/jama.290.22.2992; De Milt DG, 2011, J AM ACAD NURSE PRAC, V23, P42, DOI 10.1111/j.1745-7599.2010.00570.x; Fairman Julie, 2008, MAKING ROOM CLIN NUR; Fairman JA, 2011, NEW ENGL J MED, V364, P193, DOI 10.1056/NEJMp1012121; Freed GL, 2009, JAMA-J AM MED ASSOC, V301, P1920, DOI 10.1001/jama.2009.619; *I MED, 2009, US COMM GLOB HLTH RE; Institute of Medicine, 1994, DEF PRIM CAR INT REP; International Council of Nurses, DEF CHAR ROL; Laurant M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001271.pub2; Pulcini J, 2010, J NURS SCHOLARSHIP, V42, P31, DOI 10.1111/j.1547-5069.2009.01322.x; Schoen C, 2009, HEALTH AFFAIR, V28, pW1171, DOI 10.1377/hlthaff.28.6.w1171; Sullivan-Marx E. M, 2010, NURSE PRACTITIONERS	13	15	15	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 4	2012	380	9840					449	450		10.1016/S0140-6736(12)60241-4	http://dx.doi.org/10.1016/S0140-6736(12)60241-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	983GY	22863040				2022-12-28	WOS:000307109000004
J	Chaki, M; Airik, R; Ghosh, AK; Giles, RH; Chen, R; Slaats, GG; Wang, H; Hurd, TW; Zhou, WB; Cluckey, A; Gee, HY; Ramaswami, G; Hong, CJ; Hamilton, BA; Cervenka, I; Ganji, RS; Bryja, V; Arts, HH; van Reeuwijk, J; Oud, MM; Letteboer, SJF; Roepman, R; Husson, H; Ibraghimov-Beskrovnaya, O; Yasunaga, T; Walz, G; Eley, L; Sayer, JA; Schermer, B; Liebau, MC; Benzing, T; Le Corre, S; Drummond, I; Janssen, S; Allen, SJ; Natarajan, S; O'Toole, JF; Attanasio, M; Saunier, S; Antignac, C; Koenekoop, RK; Ren, HN; Lopez, I; Nayir, A; Stoetzel, C; Dollfus, H; Massoudi, R; Gleeson, JG; Andreoli, SP; Doherty, DG; Lindstrad, A; Golzio, C; Katsanis, N; Pape, L; Abboud, EB; Al-Rajhi, AA; Lewis, RA; Omran, H; Lee, EYHP; Wang, SH; Sekiguchi, JM; Saunders, R; Johnson, CA; Garner, E; Vanselow, K; Andersen, JS; Shlomai, J; Nurnberg, G; Nurnberg, P; Levy, S; Smogorzewska, A; Otto, EA; Hildebrandt, F				Chaki, Moumita; Airik, Rannar; Ghosh, Amiya K.; Giles, Rachel H.; Chen, Rui; Slaats, Gisela G.; Wang, Hui; Hurd, Toby W.; Zhou, Weibin; Cluckey, Andrew; Gee, Heon Yung; Ramaswami, Gokul; Hong, Chen-Jei; Hamilton, Bruce A.; Cervenka, Igor; Ganji, Ranjani Sri; Bryja, Vitezslav; Arts, Heleen H.; van Reeuwijk, Jeroen; Oud, Machteld M.; Letteboer, Stef J. F.; Roepman, Ronald; Husson, Herve; Ibraghimov-Beskrovnaya, Oxana; Yasunaga, Takayuki; Walz, Gerd; Eley, Lorraine; Sayer, John A.; Schermer, Bernhard; Liebau, Max C.; Benzing, Thomas; Le Corre, Stephanie; Drummond, Iain; Janssen, Sabine; Allen, Susan J.; Natarajan, Sivakumar; O'Toole, John F.; Attanasio, Massimo; Saunier, Sophie; Antignac, Corinne; Koenekoop, Robert K.; Ren, Huanan; Lopez, Irma; Nayir, Ahmet; Stoetzel, Corinne; Dollfus, Helene; Massoudi, Rustin; Gleeson, Joseph G.; Andreoli, Sharon P.; Doherty, Dan G.; Lindstrad, Anna; Golzio, Christelle; Katsanis, Nicholas; Pape, Lars; Abboud, Emad B.; Al-Rajhi, Ali A.; Lewis, Richard A.; Omran, Heymut; Lee, Eva Y. -H. P.; Wang, Shaohui; Sekiguchi, Joann M.; Saunders, Rudel; Johnson, Colin A.; Garner, Elizabeth; Vanselow, Katja; Andersen, Jens S.; Shlomai, Joseph; Nurnberg, Gudrun; Nurnberg, Peter; Levy, Shawn; Smogorzewska, Agata; Otto, Edgar A.; Hildebrandt, Friedhelm			Exome Capture Reveals ZNF423 and CEP164 Mutations, Linking Renal Ciliopathies to DNA Damage Response Signaling	CELL			English	Article							MULTIPOINT LINKAGE ANALYSIS; POLYCYSTIC KIDNEY-DISEASE; ATAXIA-TELANGIECTASIA; SECKEL-SYNDROME; CENTROSOMAL PROTEIN; GENOMIC STABILITY; JOUBERT-SYNDROME; HUMAN-CELLS; GENE; MOUSE	Nephronophthisis-related ciliopathies (NPHP-RC) are degenerative recessive diseases that affect kidney, retina, and brain. Genetic defects in NPHP gene products that localize to cilia and centrosomes defined them as "ciliopathies.'' However, disease mechanisms remain poorly understood. Here, we identify by whole-exome resequencing, mutations of MRE11, ZNF423, and CEP164 as causing NPHP-RC. All three genes function within the DNA damage response (DDR) pathway. We demonstrate that, upon induced DNA damage, the NPHP-RC proteins ZNF423, CEP164, and NPHP10 colocalize to nuclear foci positive for TIP60, known to activate ATM at sites of DNA damage. We show that knockdown of CEP164 or ZNF423 causes sensitivity to DNA damaging agents and that cep164 knockdown in zebrafish results in dysregulated DDR and an NPHP-RC phenotype. Our findings link degenerative diseases of the kidney and retina, disorders of increasing prevalence, to mechanisms of DDR.	[Chaki, Moumita; Airik, Rannar; Ghosh, Amiya K.; Hurd, Toby W.; Zhou, Weibin; Cluckey, Andrew; Gee, Heon Yung; Ramaswami, Gokul; Janssen, Sabine; Allen, Susan J.; Natarajan, Sivakumar; Otto, Edgar A.; Hildebrandt, Friedhelm] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Sekiguchi, Joann M.; Saunders, Rudel; Hildebrandt, Friedhelm] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Giles, Rachel H.; Slaats, Gisela G.] Univ Med Ctr, Dept Hypertens & Nephrol, Utrecht, Netherlands; [Chen, Rui; Wang, Hui] Baylor Coll Med, HGSC Dept Mol & Human Genet, Houston, TX 77030 USA; [Lewis, Richard A.] Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; [Hong, Chen-Jei; Hamilton, Bruce A.] Univ Calif San Diego, Sch Med, Dept Med, Div Med Genet,Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Hong, Chen-Jei; Hamilton, Bruce A.] Univ Calif San Diego, Sch Med, Inst Genom Med, George Palade Labs, La Jolla, CA 92093 USA; [Cervenka, Igor; Ganji, Ranjani Sri; Bryja, Vitezslav] Masaryk Univ, Fac Sci, Inst Expt Biol, CS-61137 Brno, Czech Republic; [Bryja, Vitezslav] Acad Sci Czech Republic, Inst Biophys, Dept Cytokinet, CS-61265 Brno, Czech Republic; [Arts, Heleen H.; van Reeuwijk, Jeroen; Oud, Machteld M.; Letteboer, Stef J. F.; Roepman, Ronald] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands; [Arts, Heleen H.; van Reeuwijk, Jeroen; Oud, Machteld M.; Letteboer, Stef J. F.; Roepman, Ronald] Radboud Univ Nijmegen, Med Ctr, Inst Genet & Metab Dis, NL-6525 GA Nijmegen, Netherlands; [Husson, Herve; Ibraghimov-Beskrovnaya, Oxana] Genzyme Corp, Cell Biol, Framingham, MA 01701 USA; [Yasunaga, Takayuki; Walz, Gerd] Univ Freiburg, Div Renal, Med Ctr, D-79001 Freiburg, Germany; [Eley, Lorraine; Sayer, John A.] Newcastle Univ, Inst Genet Med, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Schermer, Bernhard; Liebau, Max C.; Benzing, Thomas] Univ Cologne, Dept Internal Med 2, D-50937 Cologne, Germany; [Schermer, Bernhard; Liebau, Max C.; Benzing, Thomas] Univ Cologne, Ctr Mol Med, D-50937 Cologne, Germany; [Schermer, Bernhard; Benzing, Thomas; Nurnberg, Gudrun; Nurnberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50937 Cologne, Germany; [Liebau, Max C.] Univ Cologne, Dept Pediat & Adolescent Med, D-50937 Cologne, Germany; [Schermer, Bernhard; Benzing, Thomas] Univ Cologne, Syst Biol Aging, D-50937 Cologne, Germany; [Nurnberg, Gudrun; Nurnberg, Peter] Univ Cologne, Cologne Ctr Genom & Mol Med, D-50937 Cologne, Germany; [Shlomai, Joseph] Hebrew Univ Hadassah Med Sch, Fac Med, Dept Microbiol & Mol Genet, IMRIC, IL-91120 Jerusalem, Israel; [Le Corre, Stephanie; Drummond, Iain] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Nephrol Div, Charlestown, MA 02129 USA; [Le Corre, Stephanie; Drummond, Iain] Harvard Univ, Sch Med, Dept Genet, Charlestown, MA 02129 USA; [O'Toole, John F.] Metrohlth Med Ctr, Dept Internal Med, Div Nephrol, Cleveland, OH 44109 USA; [O'Toole, John F.] Case Western Reserve Univ, Sch Med, Cleveland, OH 44109 USA; [Attanasio, Massimo] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Attanasio, Massimo] Univ Texas SW Med Ctr Dallas, Eugene McDermott Ctr Growth & Dev, Dallas, TX 75390 USA; [Saunier, Sophie; Antignac, Corinne] Paris Descartes Univ, Hop Necker Enfants Malades, Inserm U983, AP HP, Paris, France; [Koenekoop, Robert K.; Ren, Huanan; Lopez, Irma] McGill Univ, Montreal Childrens Hosp, McGill Ocular Genet Lab, Ctr Hlth, Montreal, PQ H3H 1P3, Canada; [Nayir, Ahmet] Istanbul Univ, Fac Med, Dept Pediat Nephrol, Istanbul, Turkey; [Stoetzel, Corinne; Dollfus, Helene] Univ Strasbourg, Fac Med, Lab Genet Med EA3949, Equipe AVENIR Inserm, F-67000 Strasbourg, France; [Massoudi, Rustin; Gleeson, Joseph G.] Univ Calif San Diego, Howard Hughes Med Inst, Dept Pediat, La Jolla, CA 92093 USA; [Andreoli, Sharon P.] Indiana Univ, James Whitcomb Riley Hosp Children, Dept Pediat, Med Ctr, Indianapolis, IN 46202 USA; [Doherty, Dan G.] Univ Washington, Seattle Childrens Hosp, Dept Pediat, Div Genet Med,Ctr Integrat Brain Res, Seattle, WA 98101 USA; [Lindstrad, Anna; Golzio, Christelle; Katsanis, Nicholas] Duke Univ, Ctr Human Dis Modeling, Med Ctr, Durham, NC 27710 USA; [Pape, Lars] Hannover Med Sch, Dept Pediat Nephrol, D-30625 Hannover, Germany; [Abboud, Emad B.; Al-Rajhi, Ali A.] King Khalid Eye Specialist Hosp, Riyadh 11462, Saudi Arabia; [Omran, Heymut] Univ Klinikum Munster, Klin & Poliklin Kinder & Jugendmed Allgemeine Pad, D-48149 Munster, Germany; [Lee, Eva Y. -H. P.; Wang, Shaohui] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; [Johnson, Colin A.] St James Univ Hosp, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England; [Garner, Elizabeth; Smogorzewska, Agata] Rockefeller Univ, Lab Genome Maintenance, New York, NY 10065 USA; [Vanselow, Katja; Andersen, Jens S.] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark; [Levy, Shawn] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Hildebrandt, Friedhelm] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Utrecht University; Utrecht University Medical Center; Baylor College of Medicine; Baylor College of Medicine; University of California System; University of California San Diego; University of California System; University of California San Diego; Masaryk University Brno; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; Radboud University Nijmegen; Radboud University Nijmegen; Sanofi-Aventis; Genzyme Corporation; University of Freiburg; Newcastle University - UK; University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; Hebrew University of Jerusalem; Harvard University; Massachusetts General Hospital; Harvard University; MetroHealth System; Case Western Reserve University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; McGill University; Istanbul University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Howard Hughes Medical Institute; University of California System; University of California San Diego; Indiana University System; Indiana University-Purdue University Indianapolis; James Whitcomb Riley Hospital Children; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Duke University; Hannover Medical School; King Khaled Eye Specialist Hospital; University of Munster; University of California System; University of California Irvine; Saint James's University Hospital; University of Leeds; Rockefeller University; University of Southern Denmark; HudsonAlpha Institute for Biotechnology; Howard Hughes Medical Institute	Hildebrandt, F (corresponding author), Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA.	fhilde@umich.edu	ANTIGNAC, Corinne/H-8945-2017; Bryja, Vítězslav/P-4217-2019; Lindstrand, Anna/J-3566-2012; NAYIR, AHMET NEVZAT/A-9276-2019; Airik, Rannar/AAS-7810-2021; Saunier, Sophie/G-6044-2015; arts, heleen/ACL-6040-2022; Roepman, Ronald/B-1339-2014; Slaats, Gisela/HDO-1608-2022; Katsanis, Nicholas/E-1837-2012; Oud, Machteld/S-9062-2019; Oud, Machteld/P-6939-2015; Pape, Lars/AAF-1477-2021; van Reeuwijk, Jeroen/P-8665-2015; Gee, Heon Yung/K-7781-2019; Liebau, Max Christoph/K-3470-2019; Sayer, John A./AAN-2729-2020; Koenekoop, Robert/AAT-6676-2021; Ganji, Ranjani/AGD-5702-2022; Bryja, Vít?zslav/H-1925-2014; Lindstrand, Anna/AAT-9969-2021; Benzing, Thomas/X-5476-2019; Andersen, Jens S/L-2100-2015; Janssen, S./F-2917-2016; Letteboer, Stef JF/P-8272-2015; Schermer, Bernhard/E-9972-2014	ANTIGNAC, Corinne/0000-0002-9934-4940; Bryja, Vítězslav/0000-0002-9136-5085; Lindstrand, Anna/0000-0003-0806-5602; Airik, Rannar/0000-0002-7055-6325; Saunier, Sophie/0000-0002-1069-0047; Roepman, Ronald/0000-0002-5178-8163; Slaats, Gisela/0000-0002-4567-0134; Oud, Machteld/0000-0003-4864-9346; Pape, Lars/0000-0002-3635-6418; van Reeuwijk, Jeroen/0000-0002-0658-4399; Gee, Heon Yung/0000-0002-8741-6177; Liebau, Max Christoph/0000-0003-0494-9080; Sayer, John A./0000-0003-1881-3782; Bryja, Vít?zslav/0000-0002-9136-5085; Lindstrand, Anna/0000-0003-0806-5602; Andersen, Jens S/0000-0002-6091-140X; Janssen, S./0000-0001-8470-3050; Schermer, Bernhard/0000-0002-5194-9000; Arts, Heleen/0000-0002-9860-3744; Katsanis, Nicholas/0000-0002-2480-0171; Otto, Edgar/0000-0002-2387-9973; Levy, Shawn/0000-0002-1369-5740; Johnson, Colin/0000-0002-2979-8234; Sekiguchi, JoAnn/0000-0002-7178-4258; Golzio, Christelle/0000-0002-4420-3921; Attanasio, Massimo/0000-0002-1278-3650; Dollfus, Helene/0000-0002-2249-895X; Saunders, Rudel/0000-0001-6042-556X; Hamilton, Bruce/0000-0001-5599-9139; Omran, Heymut/0000-0003-0282-6765; Giles, Rachel/0000-0001-9133-2008; Smogorzewska, Agata/0000-0001-6285-1562	NIH [DK068306, DK090917, NS054871, NS060109, HD042601, DK075972, DK072301, DK091405, F32EY19430]; March of Dimes Foundation; Center for Organogenesis of the University of Michigan; Netherlands Organization for Scientific Research [NWO Vidi-91786396, NWO Vidi-917.66.354]; Avenir-INSERM program; Agence Nationale pour la Recherche; Union Nationale pour les Aveugles et Deficients Visuels; RETINA France; Programme Hospitalier de Recherche National; Association Bardet-Biedl, France; European Community [241955, SYSCILIA]; Dutch Kidney Foundation [KJPB09.009, IP11.58]; Retina Research Foundation; National Eye Institute [R01EY018571]; DFG [SCHE1562, SFB832, SFB829, SFB592]; FFB-Canada; CIHR; FRSQ; Reseau Vision; Lundbeck Foundation; Ministry of Education, Youth and Sports of the Czech Republic [MSM0021622430]; Czech Science Foundation [204/09/H058, 204/09/0498]; EMBO Installation Grant; Brno PhD Talent of South Moravian Center for International Mobility; Burroughs Wellcome Fund Career Award for Medical Scientists; Doris Duke Charitable Foundation; MRC [G0700073] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042601] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026550] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY018571, F32EY019430] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095545] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088767, R01DK072301, P30DK020572, R01DK076683, RC4DK090917, K99DK091405, R01DK068306, R00DK091405, R01DK075972, P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054871, R01NS060109] Funding Source: NIH RePORTER; Medical Research Council [G0700073] Funding Source: researchfish; The Sir Jules Thorn Charitable Trust [09JTA] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Foundation(March of Dimes); Center for Organogenesis of the University of Michigan; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Avenir-INSERM program; Agence Nationale pour la Recherche(French National Research Agency (ANR)); Union Nationale pour les Aveugles et Deficients Visuels; RETINA France; Programme Hospitalier de Recherche National; Association Bardet-Biedl, France; European Community(European Commission); Dutch Kidney Foundation; Retina Research Foundation; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); DFG(German Research Foundation (DFG)); FFB-Canada; CIHR(Canadian Institutes of Health Research (CIHR)); FRSQ(Fonds de la Recherche en Sante du Quebec); Reseau Vision; Lundbeck Foundation(Lundbeckfonden); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic); EMBO Installation Grant; Brno PhD Talent of South Moravian Center for International Mobility; Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Sir Jules Thorn Charitable Trust	We are grateful to the study individuals for their contributions. This research was supported by grants from the NIH to F. H. (DK068306, DK090917), B. A. H (NS054871, NS060109), N.K. (HD042601, DK075972, DK072301), and W.Z. (DK091405); the March of Dimes Foundation and the Center for Organogenesis of the University of Michigan to F. H.; the Netherlands Organization for Scientific Research to R. R. (NWO Vidi-91786396) and R. H. G. (NWO Vidi-917.66.354), the Avenir-INSERM program, the Agence Nationale pour la Recherche, the Union Nationale pour les Aveugles et Deficients Visuels, RETINA France, Programme Hospitalier de Recherche National 2007, and the Association Bardet-Biedl, France to H. D. and C. S.; the European Community's Seventh Framework Programme FP7/2009 under grant agreement no: 241955, SYSCILIA (to R. H. G., G. G. S., N.K., R. R., H.O., C.A.J. and G. W.); the Dutch Kidney Foundation (KJPB09.009 and IP11.58 to H. H. A); the Retina Research Foundation and the National Eye Institute (R01EY018571) to R.C.; the NIH to H. W. (F32EY19430); and the DFG (SCHE1562 and SFB832 to B. S.; SFB829 to T. B.; SFB592 to H.O.). R. K. K. is supported by FFB-Canada, CIHR, FRSQ, and Reseau Vision. J.S.A. is supported by the Lundbeck Foundation. V. B. is supported by MSM0021622430 (Ministry of Education, Youth and Sports of the Czech Republic), 204/09/H058, and 204/09/0498 (Czech Science Foundation) and EMBO Installation Grant; I. C. is supported by the programme, Brno PhD Talent of South Moravian Center for International Mobility. S. S. is a laureate of the "Equipe FRM" (DEQ20071210558) and the Agence National de la Recherche (R09087KS, R11012KK). W.Z. is a Carl. W. Gottschalk research scholar of the American Society of Nephrology. J.A.S. is a GlaxoSmithKline clinician scientist. A. S. is supported by the Burroughs Wellcome Fund Career Award for Medical Scientists and the Doris Duke Charitable Foundation Clinical Scientist Development Awards and is a Rita Allen Foundation and an Irma T. Hirschl scholar. F. H. is an Investigator of the Howard Hughes Medical Institute, a Frederick G. L. Huetwell Professor, and a Doris Duke Distinguished Clinical Scientist.	Alcaraz WA, 2006, P NATL ACAD SCI USA, V103, P19424, DOI 10.1073/pnas.0609184103; Alcaraz WA, 2011, HUM MOL GENET, V20, P3822, DOI 10.1093/hmg/ddr300; Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Attanasio M, 2007, NAT GENET, V39, P1018, DOI 10.1038/ng2072; Blachon S, 2008, GENETICS, V180, P2081, DOI 10.1534/genetics.108.095141; Bryja V, 2007, J CELL SCI, V120, P586, DOI 10.1242/jcs.03368; Bukanov NO, 2006, NATURE, V444, P949, DOI 10.1038/nature05348; Chaki M, 2011, KIDNEY INT, V80, P1239, DOI 10.1038/ki.2011.284; Cheng LE, 2007, DEV BIOL, V307, P43, DOI 10.1016/j.ydbio.2007.04.005; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; DOXSEY SJ, 1994, CELL, V76, P639, DOI 10.1016/0092-8674(94)90504-5; Edmond V, 2011, EMBO J, V30, P510, DOI 10.1038/emboj.2010.333; Elias E, 2003, EXP CELL RES, V291, P176, DOI 10.1016/S0014-4827(03)00377-X; Fischer E, 2006, NAT GENET, V38, P21, DOI 10.1038/ng1701; Germino GG, 2005, NAT GENET, V37, P455, DOI 10.1038/ng0505-455; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181; Griffith E, 2008, NAT GENET, V40, P232, DOI 10.1038/ng.2007.80; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Hildebrandt F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000353; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Janderovd-Rossmeislova L, 2007, J STRUCT BIOL, V159, P56, DOI 10.1016/j.jsb.2007.02.008; Kalay E, 2011, NAT GENET, V43, P23, DOI 10.1038/ng.725; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Ku MC, 2003, BIOCHEM BIOPH RES CO, V311, P702, DOI 10.1016/j.bbrc.2003.10.053; Liu Q, 2007, MOL CELL PROTEOMICS, V6, P1299, DOI 10.1074/mcp.M700054-MCP200; Maude SL, 2005, CANCER RES, V65, P780; Murga M, 2009, NAT GENET, V41, P891, DOI 10.1038/ng.420; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Otto EA, 2011, J MED GENET, V48, P105, DOI 10.1136/jmg.2010.082552; Otto EA, 2010, NAT GENET, V42, P840, DOI 10.1038/ng.662; Pan YR, 2009, CELL CYCLE, V8, P655, DOI 10.4161/cc.8.4.7844; Piontek K, 2007, NAT MED, V13, P1490, DOI 10.1038/nm1675; Rauch A, 2008, SCIENCE, V319, P816, DOI 10.1126/science.1151174; Reinhardt HC, 2011, CELL CYCLE, V10, P23, DOI 10.4161/cc.10.1.14351; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Schafer T, 2008, HUM MOL GENET, V17, P3655, DOI 10.1093/hmg/ddn260; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Sivasubramaniam S, 2008, GENE DEV, V22, P587, DOI 10.1101/gad.1627708; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Strauch K, 2000, AM J HUM GENET, V66, P1945, DOI 10.1086/302911; Szczerbal I, 2010, CHROMOSOME RES, V18, P887, DOI 10.1007/s10577-010-9176-1; Valente EM, 2006, NAT GENET, V38, P623, DOI 10.1038/ng1805; Xiao R, 2007, MOL CELL BIOL, V27, P5393, DOI 10.1128/MCB.00288-07; Yu J, 2009, DEVELOPMENT, V136, P161, DOI 10.1242/dev.022087	51	244	258	1	63	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 3	2012	150	3					533	548		10.1016/j.cell.2012.06.028	http://dx.doi.org/10.1016/j.cell.2012.06.028			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	985WO	22863007	Green Accepted, Bronze			2022-12-28	WOS:000307301400013
J	Gray, JA; Nicoll, RA				Gray, John A.; Nicoll, Roger A.			Thinking Outside the Synapse: Glycine at Extrasynaptic NMDA Receptors	CELL			English	Editorial Material							METHYL-D-ASPARTATE; D-SERINE; ACTIVATION; GLUTAMATE; NEURONS	In this issue, Papouin et al. show that glycine is the endogenous coagonist for extrasynaptic NMDA receptors (NMDARs), unlike at synapses where the coagonist is D-serine. By enzymatically degrading endogenous glycine, they begin to address the enigmatic physiological and pathological roles for extrasynaptic NMDARs.	[Gray, John A.; Nicoll, Roger A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Nicoll, Roger A.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Gray, JA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.	john.gray@ucsf.edu; roger.nicoll@ucsf.edu	Gray, John Alan/Y-5730-2019	Gray, John/0000-0002-7287-0748				Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Katsuki H, 2004, J PHARMACOL EXP THER, V311, P836, DOI 10.1124/jpet.104.070912; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; Kwon HB, 2011, NATURE, V474, P100, DOI 10.1038/nature09986; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; SAH P, 1989, SCIENCE, V246, P815, DOI 10.1126/science.2573153; Wolosker H, 2007, MOL NEUROBIOL, V36, P152, DOI 10.1007/s12035-007-0038-6	9	8	8	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 3	2012	150	3					455	456		10.1016/j.cell.2012.07.013	http://dx.doi.org/10.1016/j.cell.2012.07.013			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	985WO	22863001	Bronze			2022-12-28	WOS:000307301400006
J	Thorogood, R; Davies, NB				Thorogood, Rose; Davies, Nicholas B.			Cuckoos Combat Socially Transmitted Defenses of Reed Warbler Hosts with a Plumage Polymorphism	SCIENCE			English	Article							NEST DEFENSE; COLOR POLYMORPHISM; MIMICRY; EVOLUTION; BIRDS; COMMUNICATION; PARASITISM; SELECTION; ECOLOGY; SIGNALS	In predator-prey and host-parasite interactions, an individual's ability to combat an opponent often improves with experience-for example, by learning to identify enemy signals. Although learning occurs through individual experience, individuals can also assess threats from social information. Such recognition could promote the evolution of polymorphisms if socially transmitted defenses depend on enemy morph frequency. This would allow rare variants to evade detection. Female brood parasitic common cuckoos, Cuculus canorus, are either gray or rufous. The gray morph is a Batesian mimic whose hawk-like appearance deters host attack. Hosts reject this disguise through social learning, increasing their own defenses when they witness neighbors mobbing a cuckoo. Our experiments reveal that social learning is specific to the cuckoo morph that neighbors mob. Therefore, while neighbors alert hosts to local cuckoo activity, frequency-dependent social information selects for a cuckoo plumage polymorphism to thwart host detection. Our results suggest that selection for mimicry and polymorphisms comes not only from personal experience but also from social learning.	[Thorogood, Rose; Davies, Nicholas B.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Cambridge	Thorogood, R (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	rt303@cam.ac.uk		Thorogood, Rose/0000-0001-5010-2177	Natural Environment Research Council; NERC [NE/H003444/1] Funding Source: UKRI; Natural Environment Research Council [NE/H003444/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank J. Davies for making the wooden models, illustrations, and help in the field; C. Lindstedt, J. Mappes, and attendees of the Coevolution Symposium at the University of Jyvaskyla (October 2011) for helpful discussion; R. Kilner, M. Stevens, H. Rowland, and three anonymous referees for constructive comments on the manuscript; the National Trust, C. Thorne, and the Wicken Fen Group for facilitating our work at Wicken Fen; Natural England for a license for experimental work at reed warbler nests; and the Natural Environment Research Council for funding. Both authors contributed equally to the work, and data for all analyses are included within the supplementary materials.	Bleay C, 2007, P ROY SOC B-BIOL SCI, V274, P2019, DOI 10.1098/rspb.2007.0361; Campobello D, 2011, BEHAV ECOL, V22, P422, DOI 10.1093/beheco/arq225; Campobello D, 2010, ETHOLOGY, V116, P498, DOI 10.1111/j.1439-0310.2010.01764.x; Chittka L, 2009, TRENDS ECOL EVOL, V24, P400, DOI 10.1016/j.tree.2009.02.010; Comeault AA, 2011, J EVOLUTION BIOL, V24, P1374, DOI 10.1111/j.1420-9101.2011.02258.x; Darst CR, 2006, NATURE, V440, P208, DOI 10.1038/nature04297; Davies NB, 2011, J ZOOL, V284, P1, DOI 10.1111/j.1469-7998.2011.00810.x; Davies NB, 2009, SCIENCE, V324, P1318, DOI 10.1126/science.1172227; Endler JA, 2004, AM NAT, V163, P532, DOI 10.1086/382662; Endler JA, 2009, AM NAT, V173, pE62, DOI 10.1086/596528; Galeotti P, 2003, J EVOLUTION BIOL, V16, P635, DOI 10.1046/j.1420-9101.2003.00569.x; Honza M, 2006, J ORNITHOL, V147, P629, DOI 10.1007/s10336-006-0088-y; Kendal RL, 2005, ADV STUD BEHAV, V35, P333, DOI 10.1016/S0065-3454(05)35008-X; Mallet J, 1999, ANNU REV ECOL SYST, V30, P201, DOI 10.1146/annurev.ecolsys.30.1.201; Olendorf R, 2006, NATURE, V441, P633, DOI 10.1038/nature04646; PAYNE RB, 1967, AM NAT, V101, P363, DOI 10.1086/282504; Pfennig D, 2012, CURR ZOOL, V58, P604, DOI 10.1093/czoolo/58.4.604; Plotnick RE, 2010, PALEOBIOLOGY, V36, P303, DOI 10.1666/08062.1; Roulin A, 2004, BIOL REV, V79, P815, DOI 10.1017/S1464793104006487; Ruxton GD, 2004, AVOIDING ATTACK EVOL; Speed MP, 1999, BIOL J LINN SOC, V67, P281, DOI 10.1006/bijl.1998.0310; Stoddard MC, 2012, CURR ZOOL, V58, P630, DOI 10.1093/czoolo/58.4.630; Voipio P., 1953, ORNIS FENNICA, V30, P99; Welbergen JA, 2011, BEHAV ECOL, V22, P574, DOI 10.1093/beheco/arr008; Welbergen JA, 2009, CURR BIOL, V19, P235, DOI 10.1016/j.cub.2008.12.041; Wiley RH, 2006, ADV STUD BEHAV, V36, P217, DOI 10.1016/S0065-3454(06)36005-6	26	68	70	1	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2012	337	6094					578	580		10.1126/science.1220759	http://dx.doi.org/10.1126/science.1220759			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982PU	22859487				2022-12-28	WOS:000307058700044
J	Richman, BD; Hall, MA; Schulman, KA				Richman, Barak D.; Hall, Mark A.; Schulman, Kevin A.			Overbilling and Informed Financial Consent - A Contractual Solution	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Richman, Barak D.] Duke Univ, Sch Law, Durham, NC 27706 USA; [Richman, Barak D.; Schulman, Kevin A.] Duke Univ, Fuqua Sch Business, Hlth Sect Management Program, Durham, NC 27706 USA; [Schulman, Kevin A.] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USA; [Schulman, Kevin A.] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA; [Hall, Mark A.] Wake Forest Univ, Sch Law, Translat Sci Inst, Winston Salem, NC 27109 USA; [Hall, Mark A.] Wake Forest Univ, Bowman Gray Sch Med, Div Publ Hlth Sci, Dept Social Sci & Hlth Policy, Winston Salem, NC USA	Duke University; Duke University; Duke University; Duke University; Wake Forest University; Wake Forest University; Wake Forest Baptist Medical Center	Richman, BD (corresponding author), Duke Univ, Sch Law, Durham, NC 27706 USA.			Hall, Mark A./0000-0001-6277-144X				Anderson GF, 2007, HEALTH AFFAIR, V26, P780, DOI 10.1377/hlthaff.26.3.780; [Anonymous], PUBL PRIV HOSP RES R; [Anonymous], INF FIN CONS YOUR RI; Posner Richard A., 2014, EC ANAL LAW; Witten JA, 2005, BLOOMBERG BNA HLTH L, V14, P79	5	8	8	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 2	2012	367	5					396	397		10.1056/NEJMp1205225	http://dx.doi.org/10.1056/NEJMp1205225			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	981VZ	22853013	Green Published			2022-12-28	WOS:000307001900004
J	Tseng, VL; Yu, F; Lum, F; Coleman, AL				Tseng, Victoria L.; Yu, Fei; Lum, Flora; Coleman, Anne L.			Risk of Fractures Following Cataract Surgery in Medicare Beneficiaries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RANDOMIZED CONTROLLED-TRIAL; HIP FRACTURE; HEALTH-STATUS; OLDER-ADULTS; 2ND EYE; WOMEN; FALLS; VISION	Context Visual impairment is a known risk factor for fractures. Little is known about the association of cataract surgery with fracture risk. Objective To determine the association of cataract surgery with subsequent fracture risk in US Medicare beneficiaries with a diagnosis of cataract. Design, Setting, and Participants Retrospective study of 1-year fracture incidence in a 5% random sample of Medicare Part B beneficiaries with cataract who received and did not receive cataract surgery from 2002 through 2009. Main Outcome Measures One-year incidence of hip fractures. Analyses were adjusted for age; sex; race/ethnicity; US region of residence; systemic comorbidities, including Charlson Comorbidity Index (CCI) score; ocular comorbidities; cataract severity; and presence of physically limiting conditions. Adjusted odds ratios (ORs) of hip fractures were calculated using logistic regression modeling. Results There were 1 113 640 US Medicare beneficiaries 65 years and older with a diagnosis of cataract between 2002 and 2009 in the 5% random sample; of these patients, 410 809 (36.9%) received cataract surgery during the study period. There were 13 976 patients (1.3%) who sustained a hip fracture during the study period. The most common fracture-related comorbidity was osteoporosis (n = 134 335; 12.1%). The most common ocular comorbidity was glaucoma (n = 212 382; 19.1%). Compared with 1-year hip fracture incidence in patients with cataract who did not have cataract surgery, adjusted OR of hip fracture within 1 year after cataract surgery was 0.84 (95% CI, 0.81-0.87) with an absolute risk difference of 0.20%. Compared with matched subgroups of patients who did not receive cataract surgery, patient subgroups that experienced lower odds of hip fracture after cataract surgery included patients with severe cataract, patients most likely to receive cataract surgery based on propensity score, patients 75 years and older, and patients with a CCI score of 3 or greater. Conclusion In a cohort of US Medicare beneficiaries aged 65 years and older with a diagnosis of cataract, patients who had cataract surgery had lower odds of hip fracture within 1 year after surgery compared with patients who had not undergone cataract surgery. JAMA. 2012;308(5):493-501 www.jama.com	[Yu, Fei; Coleman, Anne L.] Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Ctr Eye Epidemiol, Los Angeles, CA 90095 USA; [Tseng, Victoria L.] Brown Univ, Warren Alpert Med Sch, Div Ophthalmol, Providence, RI 02912 USA; [Yu, Fei] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Biostat, Los Angeles, CA USA; [Coleman, Anne L.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA USA; [Lum, Flora; Coleman, Anne L.] Amer Acad Ophthalmol, H Dunbar Hoskins Jr MD Ctr Qual Eye Care, San Francisco, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Brown University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Coleman, AL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Ctr Eye Epidemiol, 100 Stein Plaza 2-118, Los Angeles, CA 90095 USA.	colemana@ucla.edu			Center for Eye Epidemiology, Jules Stein Eye Institute	Center for Eye Epidemiology, Jules Stein Eye Institute	This study was supported by the Center for Eye Epidemiology, Jules Stein Eye Institute.	Anand V, 2003, INVEST OPHTH VIS SCI, V44, P4670, DOI 10.1167/iovs.03-0455; [Anonymous], 2009, DAT COMP 2010 TABL 4; [Anonymous], 2009, NCEST200901 US CENS; Beebe M, 2007, CURRENT PROCEDURAL T, P282; Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; Bliuc D, 2009, JAMA-J AM MED ASSOC, V301, P513, DOI 10.1001/jama.2009.50; Brannan S, 2003, BRIT J OPHTHALMOL, V87, P560, DOI 10.1136/bjo.87.5.560; Busbee BG, 2003, OPHTHALMOLOGY, V110, P2310, DOI 10.1016/S0161-6420(03)00796-6; Busbee BG, 2002, OPHTHALMOLOGY, V109, P606, DOI 10.1016/S0161-6420(01)00971-X; Centers for Medicare & Medicaid Services, AR YOU HOSP INP OUTP; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Coleman AL, 2009, J AM GERIATR SOC, V57, P1825, DOI 10.1111/j.1532-5415.2009.02432.x; Cox A, 2005, EYE, V19, P652, DOI 10.1038/sj.eye.6701610; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; DargentMolina P, 1996, LANCET, V348, P145, DOI 10.1016/S0140-6736(96)01440-7; Desapriya E, 2010, J CATARACT REFR SURG, V36, P13, DOI 10.1016/j.jcrs.2009.07.032; Ensrud KE, 1997, AM J MED, V103, P274, DOI 10.1016/S0002-9343(97)00025-9; FELSON DT, 1989, J AM GERIATR SOC, V37, P495, DOI 10.1111/j.1532-5415.1989.tb05678.x; Foss AJE, 2006, AGE AGEING, V35, P66, DOI 10.1093/ageing/afj005; GRISSO JA, 1991, NEW ENGL J MED, V324, P1326, DOI 10.1056/NEJM199105093241905; Harwood RH, 2005, BRIT J OPHTHALMOL, V89, P53, DOI 10.1136/bjo.2004.049478; Hodge W, 2007, CAN MED ASSOC J, V176, P1285, DOI 10.1503/cmaj.060962; JAVITT JC, 1992, OPHTHALMOLOGY, V99, P1487, DOI 10.1016/s0161-6420(92)31775-0; McGwin G, 2006, J AM GERIATR SOC, V54, P1089, DOI 10.1111/j.1532-5415.2006.00770.x; SACKS H, 1982, AM J MED, V72, P233, DOI 10.1016/0002-9343(82)90815-4; Stevens JA, 2006, INJURY PREV, V12, P290, DOI 10.1136/ip.2005.011015; Waldo DR, HLTH CARE FINANCING	27	137	139	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2012	308	5					493	501		10.1001/jama.2012.9014	http://dx.doi.org/10.1001/jama.2012.9014			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	981DQ	22851116				2022-12-28	WOS:000306947400027
J	Saltman, RB; Vrangbaek, K; Lehto, J; Winblad, U				Saltman, Richard B.; Vrangbaek, Karsten; Lehto, Juhani; Winblad, Ulrika			Commentary: Denmark's health reforms are part of a wider trend	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Saltman, Richard B.] Emory Univ, Rollins Sch Publ Hlth, Dept Hlth Policy & Management, Atlanta, GA 30338 USA; [Vrangbaek, Karsten] Danish Inst Govt Res, Copenhagen, Denmark; [Lehto, Juhani] Univ Tampere, FIN-33101 Tampere, Finland; [Winblad, Ulrika] Uppsala Univ, Uppsala, Sweden	Emory University; Rollins School Public Health; Uppsala University	Saltman, RB (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Hlth Policy & Management, 1518 Clifton Rd NE, Atlanta, GA 30338 USA.	RSALTMA@emory.edu						Andersen S, 2012, AKF DAN I GOV RES CO; Anell A, 2011, HEALTH ECON POLICY L, V6, P549, DOI 10.1017/S1744133110000216; Magnussen J, 2011, GOVERNING PUBLIC HOS, P201; Magnussen J, 2009, NORDIC HEALTHCARE SY; Rudkjobing A, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4451; Saltman RB, EUROHEALTH IN PRESS	6	0	0	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUL 24	2012	345								e4994	10.1136/bmj.e4994	http://dx.doi.org/10.1136/bmj.e4994			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	981UQ	22833583				2022-12-28	WOS:000306996900008
J	Ko, JH; Chung, WH				Ko, Jui-Hung; Chung, Wen-Hung			Serum sickness	LANCET			English	Editorial Material									[Chung, Wen-Hung] Chang Gung Mem Hosp, Drug Hypersensit Clin & Res Ctr, Taipei 105, Taiwan; [Ko, Jui-Hung; Chung, Wen-Hung] Chang Gung Mem Hosp, Dept Dermatol, Taipei 105, Taiwan; [Ko, Jui-Hung; Chung, Wen-Hung] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Chung, WH (corresponding author), Chang Gung Mem Hosp, Dept Dermatol, 199 Tun Hwa N Rd, Taipei 105, Taiwan.	wenhungchung@yahoo.com		Hung, Shuen-Iu/0000-0001-6531-5538					0	9	9	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 19	2013	381	9862					E1	E1		10.1016/S0140-6736(11)60314-0	http://dx.doi.org/10.1016/S0140-6736(11)60314-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	075LL	22884753				2022-12-28	WOS:000313887600001
J	Murooka, TT; Deruaz, M; Marangoni, F; Vrbanac, VD; Seung, E; von Andrian, UH; Tager, AM; Luster, AD; Mempel, TR				Murooka, Thomas T.; Deruaz, Maud; Marangoni, Francesco; Vrbanac, Vladimir D.; Seung, Edward; von Andrian, Ulrich H.; Tager, Andrew M.; Luster, Andrew D.; Mempel, Thorsten R.			HIV-infected T cells are migratory vehicles for viral dissemination	NATURE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SEXUAL TRANSMISSION; IMMUNE-RESPONSES; DOWN-MODULATION; ENVELOPE; RECEPTOR; CD4(+); TYPE-1; ENV; MOTILITY	After host entry through mucosal surfaces, human immunodeficiency virus-1 (HIV-1) disseminates to lymphoid tissues to establish a generalized infection of the immune system. The mechanisms by which this virus spreads among permissive target cells locally during the early stages of transmission and systemically during subsequent dissemination are not known(1). In vitro studies suggest that the formation of virological synapses during stable contacts between infected and uninfected T cells greatly increases the efficiency of viral transfer(2). It is unclear, however, whether T-cell contacts are sufficiently stable in vivo to allow for functional synapse formation under the conditions of perpetual cell motility in epithelial(3) and lymphoid tissues(4). Here, using multiphoton intravital microscopy, we examine the dynamic behaviour of HIV-infected T cells in the lymph nodes of humanized mice. We find that most productively infected T cells migrate robustly, resulting in their even distribution throughout the lymph node cortex. A subset of infected cells formed multinucleated syncytia through HIV envelope-dependent cell fusion. Both uncoordinated motility of syncytia and adhesion to CD4(+) lymph node cells led to the formation of long membrane tethers, increasing cell lengths to up to ten times that of migrating uninfected T cells. Blocking the egress of migratory T cells from the lymph nodes into efferent lymph vessels, and thus interrupting T-cell recirculation, limited HIV dissemination and strongly reduced plasma viraemia. Thus, we have found that HIV-infected T cells are motile, form syncytia and establish tethering interactions that may facilitate cell-to-cell transmission through virological synapses. Migration of T cells in lymph nodes therefore spreads infection locally, whereas their recirculation through tissues is important for efficient systemic viral spread, suggesting new molecular targets to antagonize HIV infection.	[Murooka, Thomas T.; Deruaz, Maud; Marangoni, Francesco; Vrbanac, Vladimir D.; Seung, Edward; Tager, Andrew M.; Luster, Andrew D.; Mempel, Thorsten R.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Immunol & Inflammatory Dis, Boston, MA 02114 USA; [von Andrian, Ulrich H.] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [von Andrian, Ulrich H.] Harvard Univ, Sch Med, Dept Microbiol & Immunol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School	Mempel, TR (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Immunol & Inflammatory Dis, Boston, MA 02114 USA.	tmempel@mgh.harvard.edu	von Andrian, Ulrich H/A-5775-2008; Luster, Andrew/ABE-6504-2020; Marangoni, Francesco/I-9087-2012	Luster, Andrew/0000-0001-9679-7912; Marangoni, Francesco/0000-0002-2490-849X; Murooka, Thomas/0000-0002-3030-2726	National Institutes of Health (NIH) [P01 AI0178897, R56 AI097052, R01 CA150975, P30 AI060354]; Ragon Institute of Massachusetts General Hospital (MGH); Massachusetts Institute of Technology (MIT); Harvard; MGH ECOR Tosteson Postdoctoral Fellowship Award; NIH [T32 AI007387]; NATIONAL CANCER INSTITUTE [R01CA150975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI097052, R01AI097052, T32AI007387, P30AI060354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR042689] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ragon Institute of Massachusetts General Hospital (MGH); Massachusetts Institute of Technology (MIT); Harvard; MGH ECOR Tosteson Postdoctoral Fellowship Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. Sodroski for the pSVIIIexE7 plasmid and A. Brown for HIV SF162R3; H. S. Shin, T. Tivey, K. Bankert and S. Tanno for technical assistance with the generation of humanized mice; A. Peixoto and D. Alvarez for management of the BL2<SUP>+</SUP> multiphoton microscopy facility; A. Brass, T. Allen and T. Dudek for assistance with virological techniques; and N. Elpek, M. Byrne and A. Finzi for technical assistance. Funding for this study was through National Institutes of Health (NIH) grants P01 AI0178897, R56 AI097052, R01 CA150975 and P30 AI060354, and a Platform Award from the Ragon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT) and Harvard. T. T. M. was supported by the MGH ECOR Tosteson Postdoctoral Fellowship Award and NIH training grant T32 AI007387.	Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Bondanza A, 2006, BLOOD, V107, P1828, DOI 10.1182/blood-2005-09-3716; Brainard DM, 2009, J VIROL, V83, P7305, DOI 10.1128/JVI.02207-08; Brown A, 2005, J LEUKOCYTE BIOL, V78, P675, DOI 10.1189/jlb.0505237; Casartelli N, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000955; Casola S, 2004, NAT IMMUNOL, V5, P317, DOI 10.1038/ni1036; Chen BK, 1996, J VIROL, V70, P6044, DOI 10.1128/JVI.70.9.6044-6053.1996; Chen P, 2007, J VIROL, V81, P12582, DOI 10.1128/JVI.00381-07; Debes GF, 2005, NAT IMMUNOL, V6, P889, DOI 10.1038/ni1238; Denton PW, 2008, PLOS MED, V5, P79, DOI 10.1371/journal.pmed.0050016; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; Haase AT, 2011, ANNU REV MED, V62, P127, DOI 10.1146/annurev-med-080709-124959; Hubner W, 2009, SCIENCE, V323, P1743, DOI 10.1126/science.1167525; HWANG SS, 1991, SCIENCE, V253, P71, DOI 10.1126/science.1905842; Jolly C, 2004, J EXP MED, V199, P283, DOI 10.1084/jem.20030648; Kersh EN, 2009, J ANTIMICROB CHEMOTH, V63, P758, DOI 10.1093/jac/dkp008; Llewellyn GN, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001167; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Mostoslavsky G, 2006, P NATL ACAD SCI USA, V103, P16406, DOI 10.1073/pnas.0608130103; Murooka TT, 2011, METHODS MOL BIOL, V757, P247, DOI 10.1007/978-1-61779-166-6_16; Nobile C, 2010, J VIROL, V84, P2282, DOI 10.1128/JVI.02230-09; Pirounaki M, 2000, J VIROL METHODS, V85, P151, DOI 10.1016/S0166-0934(99)00163-9; Rudnicka D, 2009, J VIROL, V83, P6234, DOI 10.1128/JVI.00282-09; Sattentau Q, 2008, NAT REV MICROBIOL, V6, P815, DOI 10.1038/nrmicro1972; Schindler M, 2005, J VIROL, V79, P5489, DOI 10.1128/JVI.79.9.5489-5498.2005; Schindler M, 2003, J VIROL, V77, P10548, DOI 10.1128/JVI.77.19.10548-10556.2003; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Sherer NM, 2007, NAT CELL BIOL, V9, P310, DOI 10.1038/ncb1544; SODROSKI J, 1986, NATURE, V322, P470, DOI 10.1038/322470a0; Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682; Stolp B, 2009, CELL HOST MICROBE, V6, P174, DOI 10.1016/j.chom.2009.06.004; Sun ZF, 2007, J EXP MED, V204, P705, DOI 10.1084/jem.20062411; THALI M, 1991, J VIROL, V65, P5007, DOI 10.1128/JVI.65.9.5007-5012.1991; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Worbs T, 2007, J EXP MED, V204, P489, DOI 10.1084/jem.20061706; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353	38	234	235	1	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2012	490	7419					283	+		10.1038/nature11398	http://dx.doi.org/10.1038/nature11398			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019IY	22854780	Green Submitted, Green Accepted			2022-12-28	WOS:000309733300054
J	Knaul, FM; Gonzalez-Pier, E; Gomez-Dantes, O; Garcia-Junco, D; Arreola-Ornelas, H; Barraza-Llorens, M; Sandoval, R; Caballero, F; Hernandez-Avila, M; Juan, M; Kershenobich, D; Nigenda, G; Ruelas, E; Sepulveda, J; Tapia, R; Soberon, G; Chertorivski, S; Frenk, J				Marie Knaul, Felicia; Gonzalez-Pier, Eduardo; Gomez-Dantes, Octavio; Garcia-Junco, David; Arreola-Ornelas, Hector; Barraza-Llorens, Mariana; Sandoval, Rosa; Caballero, Francisco; Hernandez-Avila, Mauricio; Juan, Mercedes; Kershenobich, David; Nigenda, Gustavo; Ruelas, Enrique; Sepulveda, Jaime; Tapia, Roberto; Soberon, Guillermo; Chertorivski, Salomon; Frenk, Julio			The quest for universal health coverage: achieving social protection for all in Mexico	LANCET			English	Article							BREAST-CANCER; LATIN-AMERICA; SYSTEM REFORM; INSURANCE; IMPACT; SECURITY; LESSONS; POLICY; COST	Mexico is reaching universal health coverage in 2012. A national health insurance programme called Seguro Popular, introduced in 2003, is providing access to a package of comprehensive health services with financial protection for more than 50 million Mexicans previously excluded from insurance. Universal coverage in Mexico is synonymous with social protection of health. This report analyses the road to universal coverage along three dimensions of protection: against health risks, for patients through quality assurance of health care, and against the financial consequences of disease and injury. We present a conceptual discussion of the transition from labour-based social security to social protection of health, which implies access to effective health care as a universal right based on citizenship, the ethical basis of the Mexican reform. We discuss the conditions that prompted the reform, as well as its design and inception, and we describe the 9-year, evidence-driven implementation process, including updates and improvements to the original programme. The core of the report concentrates on the effects and impacts of the reform, based on analysis of all published and publically available scientific literature and new data. Evidence indicates that Seguro Popular is improving access to health services and reducing the prevalence of catastrophic and impoverishing health expenditures, e specially for the poor. Recent studies also show improvement in effective coverage. This research then addresses persistent challenges, including the need to translate financial resources into more effective, equitable and responsive health services. A next generation of reforms will be required and these include systemic measures to complete the reorganisation of the health system by functions. The paper concludes with a discussion of the implications of the Mexican quest to achieve universal health coverage and its relevance for other low-income and middle-income countries.	[Marie Knaul, Felicia; Nigenda, Gustavo] Harvard Global Equ Initiat, Boston, MA USA; [Marie Knaul, Felicia; Arreola-Ornelas, Hector; Juan, Mercedes; Soberon, Guillermo] Mexican Hlth Fdn, Mexico City, DF, Mexico; [Gonzalez-Pier, Eduardo; Barraza-Llorens, Mariana] Mexican Inst Social Secur, Mexico City, DF, Mexico; [Gomez-Dantes, Octavio; Hernandez-Avila, Mauricio] Natl Inst Publ Hlth Mexico, Cuernavaca, Morelos, Mexico; [Garcia-Junco, David; Sandoval, Rosa] Natl Commiss Social Protect Hlth, Mexico City, DF, Mexico; [Caballero, Francisco; Chertorivski, Salomon] Minist Hlth Mexico, Mexico City, DF, Mexico; [Kershenobich, David] Natl Inst Med Sci & Nutr Salvador Zubiran, Mexico City, DF, Mexico; [Ruelas, Enrique] Natl Acad Med Mexico, Mexico City, DF, Mexico; [Ruelas, Enrique] Inst Healthcare Improvement, Cambridge, MA USA; [Sepulveda, Jaime] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Tapia, Roberto] Carlos Slim Hlth Inst, Mexico City, DF, Mexico; [Frenk, Julio] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Instituto Mexicano del Seguro Social; Instituto Nacional de Salud Publica; Institute for Healthcare Improvement; University of California System; University of California San Francisco; Harvard University; Harvard T.H. Chan School of Public Health	Knaul, FM (corresponding author), Harvard Global Equ Initiat, Boston, MA USA.	felicia_knaul@harvard.edu	Gonzalez Pier, Eduardo/AIB-2488-2022; Arreola Ornelas, Héctor/HCG-9350-2022	Arreola Ornelas, Héctor/0000-0002-7615-6218; Knaul, Felicia/0000-0002-0512-4788	Ministry of Health of Mexico; Centre for Research and Teaching in Economics (Centro de Investigacion y Docencias Economicas); Mexican Health Foundation/Carlos Slim Health Institute Project "Observatorio de la Salud"; Harvard University	Ministry of Health of Mexico; Centre for Research and Teaching in Economics (Centro de Investigacion y Docencias Economicas); Mexican Health Foundation/Carlos Slim Health Institute Project "Observatorio de la Salud"; Harvard University	The research for this paper was partially funded by the Ministry of Health of Mexico and the Centre for Research and Teaching in Economics (Centro de Investigacion y Docencias Economicas) that provided support for FMK, GN, H-AO, MB-L and OGD. FMK and HA-O also received support through the Mexican Health Foundation/Carlos Slim Health Institute Project "Observatorio de la Salud" with complementary support from IDRC Canada and CONACyT. FMK also received support from Harvard University. FMK had full access to all the data in the study and had final responsibility for the decision to submit for publication. FMK as corresponding author confirms that all authors have seen and approved of the final text.	Aguilera-Aburto N, SHORT TERM CAUSAL EF; Anand S, 2012, LANCET, V379, P9, DOI 10.1016/S0140-6736(11)61148-3; [Anonymous], 2012, LANCET, V379, P777; [Anonymous], 2001, MACR HLTH INV HLTH E; [Anonymous], 2012, WORLD BANK SEM WASH; Arce-Salinas C, 2012, REV INVEST CLIN, V64, P9; Asociacion Mexicana de Instituciones de Seguro, EST EST; Atterido R, 2011, 5785 WORLD BANK; Atun R, 2011, CLOSING CANC DIVIDE; Azuara O, INFORM EXPANSION SOC; Baeza CC., 2006, SURVIVAL PROTECTING; Barros R., WEALTHIER NOT MUCH H; Becerril-Montekio V, 2011, SALUD PUBLICA MEXICO, V53, pS132; Bleich SN, 2007, BMJ-BRIT MED J, V335, P875, DOI 10.1136/bmj.39350.617616.BE; Bloom DE, 2004, WORLD DEV, V32, P1, DOI 10.1016/j.worlddev.2003.07.002; Bosch M, 2010, 12 CTR EST EC COL ME; Caballero F, SEGURO POPULAR RESUL; Campos-Vazquez RM, 2010, 14 COL MEX; Cecchini S., 2012, INCLUSIVE SOCIAL PRO; Chen L, 2012, LANCET, V379, P782, DOI 10.1016/S0140-6736(12)60285-2; Comision Nacional de Proteccion Social en Salud, 2011, INF RES 2011; Comision Nacional de Proteccion Social en Salud, 2012, INF RES 2011; Comision Nacional de Proteccion Social en Salud, 2012, ENR POP UP APR 2012; Comision Nacional de Proteccion Social en Salud, 2008, CAT UN SERV SAL; Comision Nacional de Proteccion Social en Salud, INF RES; Comision Nacional de Proteccion Social en Salud, 2011, EST SAT US SIST PROT; Comision Nacional de Proteccion Social en Salud, 2007, INF RES 2006; Comision Nacional de Proteccion Social en Salud, EST PREST SERV DET T; Comision Nacional de Proteccion Social en Salud, 2010, INF RES 2009; Consejo Nacional de Poblacion, 2009, ENC NAC DIN DEM ENA; Consejo Nacional de Poblacion, PRINC IND SAL REPR E; Corporacion Latinobarometro, INF 2011; de Salud Secretaria, 2006, EV PROC, V2006, P39; Duval-Hernandez R, 2011, INFORM SEGURO POPULA; Erus B, 2012, EUR J HEALTH ECON, V13, P337, DOI 10.1007/s10198-011-0306-2; Esteves RJF, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-6; Farmer P, 2010, LANCET, V376, P1186, DOI 10.1016/S0140-6736(10)61152-X; Fernald LCH, 2009, LANCET, V374, P1997, DOI 10.1016/S0140-6736(09)61676-7; Fisher R, 2012, TIME DITCH MEXICAN S; Frenk J, 2003, LANCET, V362, P1667, DOI 10.1016/S0140-6736(03)14803-9; Frenk J., 1989, Health Policy and Planning, V4, P29, DOI 10.1093/heapol/4.1.29; Frenk J, NY TIMES; Frenk J, 2012, NEXOS, V410, P44; Frenk J, 1994, EC SALUD PROPUESTAS; Frenk J, 2006, LANCET, V368, P954, DOI 10.1016/S0140-6736(06)69376-8; Frenk J, 2006, LANCET, V368, P1524, DOI 10.1016/S0140-6736(06)69564-0; Frenk J, 2011, VACCINE, V29, pD149, DOI 10.1016/j.vaccine.2011.03.024; Frenk J, 2009, B WORLD HEALTH ORGAN, V87, P542, DOI 10.2471/BLT.08.053199; Fundacion Mexicana para la Salud, PROYECT U SERV SAL V; Fundacion Mexicana para la Salud, 2012, SAL MEX 2006 2012 VI; Gakidou E, 2006, LANCET, V368, P1920, DOI 10.1016/S0140-6736(06)69568-8; Garrett L, 2009, NEWSWEEK, VCLII, P12; Gobierno Federal Plan Nacional de Desarrollo, PLAN NAC DES INF EJ; Gomez-Dantes O., 2005, SEGURO POPULAR SALUD; Gonzalez-Block M, 2008, SISTEMA PROTECCION S; Gonzalez-Block MA, ALCANCES RETOS UNPUB; Gonzalez-Pier E, 2006, SIST PROT SOC SAL EL; Gonzalez-Pier E, 2006, LANCET, V368, P1608, DOI 10.1016/S0140-6736(06)69567-6; Goodchild M.F., 2006, FUNDAMENTALS SPATIAL, P13; Grogger J, IDENTIFICACION ANAL; Guerrero R, 2006, CUADERNO PROTECCION; Hernandez P, 1994, EC SALUD PROPUESTAS; Hospital Infantil de Mexico Federico Gomez, 2010, AN FACT AS VAR RES S; Huerta Orellan V, 2011, ESTUDIO SATISFACCION; INEGI (Instituto Nacional de Estadistica y Geografia), 2011, CENS POBL VIV 2010 P; Instituto Mexicano del Seguro Social, 2010, INF EJ FED C UN SIT; Instituto Mexicano del Seguro Social, 2009, ENC NAC SAT DER US S, P2009; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, 2010, EV EF SIST PROT SOC; Instituto Nacional de Estadistica y Geografia, CENS POBL VIV 2010 T; Instituto Nacional de Estadistica y Geografia, ENC NAC INGR GAST HO; International Labour Office, 2001, DEC WORK SOC PROT HL; Kapp C, 2009, LANCET, V374, P776, DOI 10.1016/S0140-6736(09)61580-4; Nguyen KT, 2012, AM J PUBLIC HEALTH, V102, P1450, DOI 10.2105/AJPH.2011.300618; King G, 2009, LANCET, V373, P1447, DOI 10.1016/S0140-6736(09)60239-7; Knaul F, 2005, SALUD PUBLICA MEXICO, V47, pS54; Knaul F., 2004, HEALTH POLICY EDUC, V27, P19, DOI [10.1016/0168-8510(94)90155-4, DOI 10.1016/0168-8510(94)90155-4]; Knaul FM, 2006, LANCET, V368, P1828, DOI 10.1016/S0140-6736(06)69565-2; Knaul FM, 2005, SALUD PUBLICA MEXICO, V47, P430; Knaul FM, 2011, FINANCIAMIENTO SISTE; Knaul FM, 2011, HARVARD PUBLIC HLTH, P42; Knaul FM, 2003, COMPETITIVIDAD SALUD; Lazcano-Ponce E, 2008, CANCER EPIDEM BIOMAR, V17, P2808, DOI 10.1158/1055-9965.EPI-07-2659; Levy TS, 2007, RESULTADOS ENSANUT 2; Londono JL, 1997, HEALTH POLICY, V41, P1, DOI 10.1016/S0168-8510(97)00010-9; Lozano R, 2006, LANCET, V368, P1729, DOI 10.1016/S0140-6736(06)69566-4; Knaul FM, 2009, SALUD PUBLICA MEXICO, V51, pS286, DOI 10.1590/S0036-36342009000800019; Knaul FM, 2008, REPROD HEALTH MATTER, V16, P113, DOI 10.1016/S0968-8080(08)32414-8; Martinez S, 2011, SALUD PUBLICA MEXICO, V53, pS78; McIntyre D, 2012, HEALTH POLICY PLANN, V27, pi101, DOI 10.1093/heapol/czs003; Milla A, 2012, LANCET, DOI 10.1016/S0140-6736(12)60357-2; Mohar A, 2009, SALUD PUBLICA MEXICO, V51, pS263; Murayama-Rendon C, 2011, GAC MED MEX, V147, P497; Murray CJL, 2009, WORKING PAPER SERIES, V3; Nigenda G, 2009, EVALUACION PROCESOS; Olaiz G, ENCUESTA NACL SALUD; Ortiz M, 2009, CAMINO DESTINO VISIO, P67; Parker S, 2008, EVALUATION MEXICAN S; Parker S, 2011, IDENTIFICACION ANAL; Perez Estrada J, 2011, LAT AM CAR EC ASS LA; Perez-Cuevas R, SCALING CANC CARE NO; Perez-Salvador JE, 2011, EVOLUCION FINANCIAMI; Planning Commission of India, 2011, HIGH LEV EXP GROUP R; Porter ME, 2009, NEW ENGL J MED, V361, P109, DOI 10.1056/NEJMp0904131; Presidencia de la Republica, 2010, OBJ DES MIL MEX INF; Presidencia de la Republica, 2006, SEXT INF GOB; Presidencia de la Republica, EN 2012 SE APL VAC C; Puentes-Rosas E, 2005, SALUD PUBLICA MEXICO, V47, pS22; Reddy KS, 2011, LANCET, V377, P760, DOI 10.1016/S0140-6736(10)61960-5; Ruelas Enrique, 2006, Healthc Pap, V6, P33; Ruelas-Barajas E., 2005, SALUD TABASCO, V11, P301; Salomon JA, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e355; Salvany Joan Tomas, 1883, NACL DIARIO UNIVERSA, P2; Savedoff WD, 2000, WEALTH HLTH; Scheil-Adlung X, 2011, INT SOC SECUR REV, V64, P21, DOI 10.1111/j.1468-246X.2011.01400.x; Schrecker T, 2012, GLOB PUBLIC HEALTH, V7, P557, DOI 10.1080/17441692.2012.691524; Secretaria de Desarrollo Social, 2010, DOC COMP EV EXT 2008; Secretaria de Desarrollo Social, 2010, OP PROGR RES; Secretaria de Gobernacion, 2007, PRES EGR FED EJ FISC; Secretaria de Salud, SIST NAC INF SAL REC; Secretaria de Salud, 2007, EV SURT MED POBL AF, P59; Secretaria de Salud, 2000, B INF EST, V1; Secretaria de Salud, 2009, B INF EST, V3; Secretaria de Salud, 2009, DECR QUE SE REF ART; Secretaria de Salud, REC FIN CONC; Secretaria de Salud, 2011, OBS DES AMB; Secretaria de Salud, 2012, DIR GEN EV DES IND R; Secretaria de Salud, 2011, REND CUENT SAL 2010; Secretaria de Salud, 2000, B INF EST, V3; Secretaria de Salud, REND CUENT SAL 2006; Secretaria de Salud, 2009, B INF EST, V1; Secretaria de Salud, 2011, QUINT INF LAB; Secretaria de Salud, 2011, REC FIN; Secretaria de Salud, 2003, DECR QUE SE REF AD L; Secretaria de Salud, 2004, B INF EST, V3; Secretaria de Salud, 2012, SUST UN HLTH COV SHA; Secretaria de Salud, 2012, B INF EST 2002, P4; Secretaria de Salud, 2004, B INF EST, V1; Seguro Popular, 2011, NAT MUS ANTHR 2011 J; Sen A, 1997, WORLD DEV, V25, P1959, DOI 10.1016/S0305-750X(97)10014-6; Sepulveda J, 2006, LANCET, V368, P2017, DOI 10.1016/S0140-6736(06)69569-X; Shulman L., 2011, CLOSING CANC DIVIDE; Soberon G, 2008, PREMIO CARLOS SLIM I; Sosa-Rubi SG, 2011, SALUD PUBLICA MEXICO, V53, pS425; Sosa-Rubi SG, 2009, B WORLD HEALTH ORGAN, V87, P512, DOI 10.2471/BLT.08.053256; Sridhar D, 2012, FOREIGN AFFAIRS; Strauss J, 1998, J ECON LIT, V36, P766; Thailand's universal coverage scheme: achievements and challenges, 2012, THAIL UN COV SCHEM A, P1; Torres A., 2003, CALEIDOSCOPIO SALUD, P209; Victora CG, 2009, LANCET, V373, P1404, DOI 10.1016/S0140-6736(09)60564-X; Wagstaff A., 2012, 6116 WORLD BANK DEV; Wagstaff A, 2009, HEALTH ECON, V18, pS7, DOI 10.1002/hec.1518; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2010, COUNTD 2015 MAT NEWB; WHO.World Health Expenditure Database, WORLD HLTH EXP DAT; World Bank, LAB MARK WORK INF EC; World Health Organization, 2000, WORLD HLTH REP 2000; Yip WCM, 2012, LANCET, V379, P833, DOI 10.1016/S0140-6736(11)61880-1; Zurita B, 2001, HACIA MEXICO MAS SAL	158	296	308	7	133	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 6	2012	380	9849					1259	1279		10.1016/S0140-6736(12)61068-X	http://dx.doi.org/10.1016/S0140-6736(12)61068-X			21	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	020NG	22901864	Green Submitted			2022-12-28	WOS:000309817500033
J	Schmitz, R; Young, RM; Ceribelli, M; Jhavar, S; Xiao, WM; Zhang, MZ; Wright, G; Shaffer, AL; Hodson, DJ; Buras, E; Liu, XL; Powell, J; Yang, YD; Xu, WH; Zhao, H; Kohlhammer, H; Rosenwald, A; Kluin, P; Muller-Hermelink, HK; Ott, G; Gascoyne, RD; Connors, JM; Rimsza, LM; Campo, E; Jaffe, ES; Delabie, J; Smeland, EB; Ogwang, MD; Reynolds, SJ; Fisher, RI; Braziel, RM; Tubbs, RR; Cook, JR; Weisenburger, DD; Chan, WC; Pittaluga, S; Wilson, W; Waldmann, TA; Rowe, M; Mbulaiteye, SM; Rickinson, AB; Staudt, LM				Schmitz, Roland; Young, Ryan M.; Ceribelli, Michele; Jhavar, Sameer; Xiao, Wenming; Zhang, Meili; Wright, George; Shaffer, Arthur L.; Hodson, Daniel J.; Buras, Eric; Liu, Xuelu; Powell, John; Yang, Yandan; Xu, Weihong; Zhao, Hong; Kohlhammer, Holger; Rosenwald, Andreas; Kluin, Philip; Mueller-Hermelink, Hans Konrad; Ott, German; Gascoyne, Randy D.; Connors, Joseph M.; Rimsza, Lisa M.; Campo, Elias; Jaffe, Elaine S.; Delabie, Jan; Smeland, Erlend B.; Ogwang, Martin D.; Reynolds, Steven J.; Fisher, Richard I.; Braziel, Rita M.; Tubbs, Raymond R.; Cook, James R.; Weisenburger, Dennis D.; Chan, Wing C.; Pittaluga, Stefania; Wilson, Wyndham; Waldmann, Thomas A.; Rowe, Martin; Mbulaiteye, Sam M.; Rickinson, Alan B.; Staudt, Louis M.			Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics	NATURE			English	Article							CELL; IMMUNOGLOBULIN; REGION	Burkitt's lymphoma (BL) can often be cured by intensive chemotherapy, but the toxicity of such therapy precludes its use in the elderly and in patients with endemic BL in developing countries, necessitating new strategies(1). The normal germinal centre B cell is the presumed cell of origin for both BL and diffuse large B-cell lymphoma (DLBCL), yet gene expression analysis suggests that these malignancies may use different oncogenic pathways(2). BL is subdivided into a sporadic subtype that is diagnosed in developed countries, the Epstein-Barr-virus-associated endemic subtype, and an HIV-associated subtype, but it is unclear whether these subtypes use similar or divergent oncogenic mechanisms. Here we used high-throughput RNA sequencing and RNA interference screening to discover essential regulatory pathways in BL that cooperate with MYC, the defining oncogene of this cancer. In 70% of sporadic BL cases, mutations affecting the transcription factor TCF3 (E2A) or its negative regulator ID3 fostered TCF3 dependency. TCF3 activated the pro-survival phosphatidylinositol-3-OH kinase pathway in BL, in part by augmenting tonic B-cell receptor signalling. In 38% of sporadic BL cases, oncogenic CCND3 mutations produced highly stable cyclin D3 isoforms that drive cell cycle progression. These findings suggest opportunities to improve therapy for patients with BL.	[Schmitz, Roland; Young, Ryan M.; Ceribelli, Michele; Jhavar, Sameer; Zhang, Meili; Shaffer, Arthur L.; Hodson, Daniel J.; Buras, Eric; Yang, Yandan; Xu, Weihong; Zhao, Hong; Kohlhammer, Holger; Wilson, Wyndham; Waldmann, Thomas A.; Staudt, Louis M.] NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Xiao, Wenming; Liu, Xuelu; Powell, John] NIH, Bioinformat & Mol Anal Sect, Div Computat Biosci, Ctr Informat Technol, Bethesda, MD 20892 USA; [Wright, George] NCI, Biometr Res Branch, DCTD, NIH, Bethesda, MD 20892 USA; [Rosenwald, Andreas; Mueller-Hermelink, Hans Konrad] Univ Wurzburg, Dept Pathol, D-97080 Wurzburg, Germany; [Kluin, Philip] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, NL-9713 GZ Groningen, Netherlands; [Ott, German] Robert Bosch Krankenhaus, Dept Clin Pathol, D-70376 Stuttgart, Germany; [Ott, German] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany; [Gascoyne, Randy D.; Connors, Joseph M.] British Columbia Canc Agcy, Vancouver, BC V5Z 1L3, Canada; [Rimsza, Lisa M.] Univ Arizona, Dept Pathol, Tucson, AZ 85724 USA; [Campo, Elias] Univ Barcelona, Hosp Clin, E-08036 Barcelona, Spain; [Jaffe, Elaine S.; Pittaluga, Stefania] NCI, Pathol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Delabie, Jan] Univ Hosp, Rikshosp, Pathol Clin, N-0372 Oslo, Norway; [Smeland, Erlend B.] Univ Hosp, Rikshosp, Inst Canc Res, N-0310 Oslo, Norway; [Smeland, Erlend B.] Univ Oslo, Norwegian Radium Hosp, Fac Div, Ctr Canc Biomed, N-0310 Oslo, Norway; [Ogwang, Martin D.] St Marys Hosp Lacor, Gulu 256, Uganda; [Reynolds, Steven J.] NIAID, Div Intramural Res, NIH, Bethesda, MD 20892 USA; [Fisher, Richard I.] Univ Rochester, Sch Med, James P Wilmot Canc Ctr, Rochester, NY 14642 USA; [Braziel, Rita M.] Oregon Hlth & Sci Univ, Portland, OR 97239 USA; [Tubbs, Raymond R.; Cook, James R.] Cleveland Clin, Pathol & Lab Med Inst, Cleveland, OH 44195 USA; [Weisenburger, Dennis D.; Chan, Wing C.] Univ Nebraska Med Ctr, Dept Pathol, Omaha, NE 68198 USA; [Weisenburger, Dennis D.; Chan, Wing C.] Univ Nebraska Med Ctr, Dept Microbiol, Omaha, NE 68198 USA; [Rowe, Martin; Rickinson, Alan B.] Univ Birmingham, Birmingham Canc Res UK Ctr, Sch Canc Sci, Birmingham B15 2TT, W Midlands, England; [Mbulaiteye, Sam M.] NCI, Infect & Immunoepidemiol Branch, Div Canc Epidemiol & Genet, NIH,US Dept HHS, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Wurzburg; University of Groningen; Bosch; Robert Bosch Krankenhaus; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; British Columbia Cancer Agency; University of Arizona; University of Barcelona; Hospital Clinic de Barcelona; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Rochester; Oregon Health & Science University; Cleveland Clinic Foundation; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Birmingham; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Staudt, LM (corresponding author), NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	lstaudt@mail.nih.gov	Gascoyne, Randy D/A-6009-2013; Smeland, Erlend/AAO-3214-2020; Waldmann, Thomas/AAT-5972-2021; Rowe, Martin/B-2880-2009; Hodson, Daniel J/K-6817-2016; Wright, George W/M-1660-2017; Mbulaiteye, Sam/O-3056-2019; Staudt, Louis/AAC-5324-2019; Connors, Joseph/AAF-5284-2019; Campo, Elias/AAC-5593-2019; Jaffe, Elaine/G-8981-2014	Gascoyne, Randy D/0000-0002-2610-5690; Waldmann, Thomas/0000-0003-4500-6660; Rowe, Martin/0000-0003-4139-7326; Hodson, Daniel J/0000-0001-6225-2033; Mbulaiteye, Sam/0000-0002-8273-9831; Connors, Joseph/0000-0002-1361-7531; Campo, Elias/0000-0001-9850-9793; Delabie, Jan/0000-0001-5023-0689; Jaffe, Elaine/0000-0003-4632-0301; Reynolds, Steven/0000-0002-5403-2759	NIH, National Cancer Institute, Center for Cancer Research, an NCI SPECS grant [UO1-CA 114778]; Foundation for NIH; Cancer Research UK; Lymphoma/Leukemia Molecular Profiling Project (LLMPP); Dr Mildred Scheel Stiftung fur Krebsforschung (Deutsche Krebshilfe); NCI [N01-C0-12400]; CENTER FOR INFORMATION TECHNOLOGY [ZIACT000260] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIASC004002, U01CA114778, ZIASC000550, ZIACP010176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001040, ZIAAI000361] Funding Source: NIH RePORTER; Medical Research Council [G9818340B] Funding Source: researchfish	NIH, National Cancer Institute, Center for Cancer Research, an NCI SPECS grant; Foundation for NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); Lymphoma/Leukemia Molecular Profiling Project (LLMPP); Dr Mildred Scheel Stiftung fur Krebsforschung (Deutsche Krebshilfe)(Deutsche Krebshilfe); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research, an NCI SPECS grant (UO1-CA 114778), by the Foundation for NIH, through a gift from the Richard A. Lauderbaugh Memorial Fund, and by Cancer Research UK. This study was conducted under the auspices of the Lymphoma/Leukemia Molecular Profiling Project (LLMPP). R.S. was supported by the Dr Mildred Scheel Stiftung fur Krebsforschung (Deutsche Krebshilfe). D.J.H. is a Kay Kendall Leukaemia Fund Intermediate research fellow. This study used the high-performance computational capabilities of the Biowulf Linux cluster at the National Institutes of Health (http://biowulf.nih.gov). We thank K. Meyer for help with the GEO submission, T. Ellenberger for the TCF3 crystal structure coordinates, B. Tran (Center for Cancer Research Sequencing Facility) and K. Hartman for DNA sequencing and K. Rajewsky for discussions. The DLBCL data set is part of the Cancer Genomics Characterization Initiative (CGCI), supported by NCI contract N01-C0-12400 (http://cgap.nci.nih.gov/cgci.html/) and was obtained from dbGaP at http://www.ncbi.nlm.nih.gov/gap. We thank the participants in the EMBLEM Study (http://emblem.cancer.gov/) in Uganda, the EMBLEM Study staff for collecting and processing the samples and data, and the Government of Uganda for allowing the study to be done and samples to be exported for research.	Cato MH, 2011, MOL CELL BIOL, V31, P127, DOI 10.1128/MCB.00650-10; Dave SS, 2006, NEW ENGL J MED, V354, P2431, DOI 10.1056/NEJMoa055759; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; ELLENBERGER T, 1994, GENE DEV, V8, P970, DOI 10.1101/gad.8.8.970; Kee BL, 2009, NAT REV IMMUNOL, V9, P175, DOI 10.1038/nri2507; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Orem J, 2008, TROP DOCT, V38, P7, DOI 10.1258/td.2007.060093; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Peled JU, 2010, CELL RES, V20, P631, DOI 10.1038/cr.2010.55; PESCE S, 1993, MOL CELL BIOL, V13, P7874, DOI 10.1128/MCB.13.12.7874; Sander S., 2012, CANC CELL; Srinivasan L, 2009, CELL, V139, P573, DOI 10.1016/j.cell.2009.08.041; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Yustein JT, 2007, CURR OPIN HEMATOL, V14, P375, DOI 10.1097/MOH.0b013e3281bccdee	21	562	574	2	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2012	490	7418					116	120		10.1038/nature11378	http://dx.doi.org/10.1038/nature11378			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015LG	22885699	Green Accepted, Green Submitted			2022-12-28	WOS:000309446800044
J	Kirsner, RS; Marston, WA; Snyder, RJ; Lee, TD; Cargill, DI; Slade, HB				Kirsner, Robert S.; Marston, William A.; Snyder, Robert J.; Lee, Tommy D.; Cargill, D. Innes; Slade, Herbert B.			Spray-applied cell therapy with human allogeneic fibroblasts and keratinocytes for the treatment of chronic venous leg ulcers: a phase 2, multicentre, double-blind, randomised, placebo-controlled trial	LANCET			English	Article							EPIDERMAL-KERATINOCYTES; COMPRESSION; EQUIVALENT; ULCERATION; HEAL	Background Many patients with venous leg ulcers do not heal with standard care. HP802-247 is a novel spray-applied cell therapy containing growth-arrested allogeneic neonatal keratinocytes and fibroblasts. We compared different cell concentrations and dosing frequencies of HP802-247 for benefit and harm when applied to chronic venous leg ulcers. Methods We enrolled adult outpatients from 28 centres in the USA and Canada with up to three ulcers, venous reflux confirmed by doppler ultrasonography, and adequate arterial flow in this phase 2, double-blind, randomised, placebo-controlled trial if at least one ulcer measured 2-12 cm(2) in area and had persisted for 6-104 weeks. Patients were randomly assigned by computer-generated block randomisation in a 1: 1: 1: 1: 1 ratio to 5.0x10(6) cells per mL every 7 days or every 14 days, or 0.5x10(6) cells per mL every 7 days or every 14 days, or to vehicle alone every 7 days. All five groups received four-layer compression bandages. The trial sponsor, trial monitors, statisticians, investigators, centre personnel, and patients were masked to treatment allocation. The primary endpoint was mean percentage change in wound area at the end of 12 weeks. Analyses were by intention to treat, excluding one patient who died of unrelated causes before first treatment. This trial is registered with ClinicalTrials.gov NCT00852995. Findings 45 patients were assigned to 5.0x10(6) cells per mL every 7 days, 44 to 5.0x10(6) cells per mL every 14 days, 43 to 0.5x10(6) cells per mL every 7 days, 46 to 0.5x10(6) cells per mL every 14 days, and 50 to vehicle alone. All required visits were completed by 205 patients. The primary outcome analysis showed significantly greater mean reduction in wound area associated with active treatment compared with vehicle (p=0.0446), with the dose of 0.5x10(6) cells/mL every 14 days showing the largest improvement compared with vehicle (15.98%, 95% CI 5.56-26.41, p=0.0028). Adverse events were much the same across all groups, with only new skin ulcers and cellulitis occurring in more than 5% of patients. Interpretation Venous leg ulcers can be healed with a spray formulation of allogeneic neonatal keratinocytes and fibroblasts without the need for tissue engineering, at an optimum dose of 0.5x10(6) cells per mL every 14 days.	[Lee, Tommy D.; Cargill, D. Innes; Slade, Herbert B.] Healthpoint Biotherapeut, Ft Worth, TX 76107 USA; [Kirsner, Robert S.] Univ Miami, Dept Dermatol & Cutaneous Surg, Leonard M Miller Sch Med, Miami, FL USA; [Kirsner, Robert S.] Univ N Carolina, Sch Med, Div Vasc Surg, Chapel Hill, NC USA; [Snyder, Robert J.] Barry Univ, Sch Podiatr Med, Hialeah, FL USA; [Slade, Herbert B.] Univ N Texas, Dept Pediat, Hlth Sci Ctr, Ft Worth, TX USA	University of Miami; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Texas System; University of North Texas Health Science Center	Slade, HB (corresponding author), Healthpoint Biotherapeut, Ft Worth, TX 76107 USA.	bert.slade@healthpoint.com			Healthpoint Biotherapeutics	Healthpoint Biotherapeutics	Healthpoint Biotherapeutics.	Barber C, 2008, J Wound Care, V17, P517; Barwell JR, 2004, LANCET, V363, P1854, DOI 10.1016/S0140-6736(04)16353-8; Bello Y M, 2001, Am J Clin Dermatol, V2, P305, DOI 10.2165/00128071-200102050-00005; BILLINGHAM RE, 1952, BRIT J PLAST SURG, V5, P25, DOI 10.1016/S0007-1226(52)80004-9; Charles CA, 2008, J AM ACAD DERMATOL, V59, P758, DOI 10.1016/j.jaad.2008.07.018; Cheng CF, 2011, J CLIN INVEST, V121, P4348, DOI 10.1172/JCI46475; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Falanga V, 1998, ARCH DERMATOL, V134, P293, DOI 10.1001/archderm.134.3.293; GILMAN TH, 1990, WOUNDS, V2, P95; Goedkoop R, 2010, DERMATOLOGY, V220, P114, DOI 10.1159/000277380; Groves R W, 2000, Adv Skin Wound Care, V13, P107; HANCOCK K, 1989, BRIT MED J, V299, P1179, DOI 10.1136/bmj.299.6709.1179; Herschthal Jordana, 2008, Surg Technol Int, V17, P77; HUNYADI J, 1988, J DERMATOL SURG ONC, V14, P75, DOI 10.1111/j.1524-4725.1988.tb03343.x; Dominguez-Castillo RI, 2008, IMMUNOLOGY, V125, P370, DOI 10.1111/j.1365-2567.2008.02859.x; Jones JE, 2007, COCHRANE DB SYST REV, V2; Kirsner RS, 2002, DERMATOL SURG, V28, P81, DOI 10.1046/j.1524-4725.2002.01084.x; Lafferty-Whyte K, 2009, BBA-MOL BASIS DIS, V1792, P341, DOI 10.1016/j.bbadis.2009.02.003; LEIGH IM, 1987, BRIT J DERMATOL, V117, P591, DOI 10.1111/j.1365-2133.1987.tb07491.x; Margolis DJ, 1999, ARCH DERMATOL, V135, P920, DOI 10.1001/archderm.135.8.920; Margolis DJ, 2002, J AM ACAD DERMATOL, V46, P381, DOI 10.1067/mjd.2002.121739; Nelson EA, 2005, AM FAM PHYSICIAN, V71, P1365; Nelson EA, 2004, BRIT J SURG, V91, P1292, DOI 10.1002/bjs.4754; O'Meara S, 2009, COCHRANE DB SYST REV, V1, P1; PIERCE GF, 1995, ANNU REV MED, V46, P467; Poon IKH, 2010, CELL DEATH DIFFER, V17, P381, DOI 10.1038/cdd.2009.195; Reynolds AR, 2010, DOSE-RESPONSE, V8, P253, DOI 10.2203/dose-response.09-049.Reynolds; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Seidman C, 2006, ANN VASC SURG, V20, P376, DOI 10.1007/s10016-006-9036-9; Siedler S, 2000, ARCH DERMATOL, V136, P676, DOI 10.1001/archderm.136.5.676; Tausche AK, 2003, WOUND REPAIR REGEN, V11, P248, DOI 10.1046/j.1524-475X.2003.11403.x; Valencia IC, 2001, J AM ACAD DERMATOL, V44, P401, DOI 10.1067/mjd.2001.111633; Wall IB, 2008, J INVEST DERMATOL, V128, P2526, DOI 10.1038/jid.2008.114; Weller CD, 2010, INT WOUND J, V7, P41, DOI 10.1111/j.1742-481X.2009.00645.x; Zaulyanov L, 2007, CLIN INTERV AGING, V2, P93, DOI 10.2147/ciia.2007.2.1.93	35	106	109	0	21	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 15	2012	380	9846					977	985		10.1016/S0140-6736(12)60644-8	http://dx.doi.org/10.1016/S0140-6736(12)60644-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	005JF	22863328				2022-12-28	WOS:000308746000027
J	Daw, R; Finkelstein, J; Helmer, M				Daw, Rosamund; Finkelstein, Joshua; Helmer, Magdalena			CHEMISTRY AND ENERGY	NATURE			English	Editorial Material														Finkelstein, Joshua/0000-0003-2613-9345; Daw, Rosamund/0000-0003-2015-3410					0	3	4	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2012	488	7411					293	293		10.1038/488293a	http://dx.doi.org/10.1038/488293a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OS	22895333	Bronze			2022-12-28	WOS:000307501000051
J	Logan, BE; Rabaey, K				Logan, Bruce E.; Rabaey, Korneel			Conversion of Wastes into Bioelectricity and Chemicals by Using Microbial Electrochemical Technologies	SCIENCE			English	Review							FUEL-CELLS; POWER-GENERATION; ELECTRICITY-GENERATION; HYDROGEN-PRODUCTION; ELECTRON-DONORS; WATER TREATMENT; ENERGY; FERMENTATION; PERFORMANCE; REDUCTION	Waste biomass is a cheap and relatively abundant source of electrons for microbes capable of producing electrical current outside the cell. Rapidly developing microbial electrochemical technologies, such as microbial fuel cells, are part of a diverse platform of future sustainable energy and chemical production technologies. We review the key advances that will enable the use of exoelectrogenic microorganisms to generate biofuels, hydrogen gas, methane, and other valuable inorganic and organic chemicals. Moreover, we examine the key challenges for implementing these systems and compare them to similar renewable energy technologies. Although commercial development is already underway in several different applications, ranging from wastewater treatment to industrial chemical production, further research is needed regarding efficiency, scalability, system lifetimes, and reliability.	[Logan, Bruce E.] Penn State Univ, Dept Civil & Environm Engn, University Pk, PA 16802 USA; [Rabaey, Korneel] Univ Ghent, Lab Microbial Ecol & Technol LabMET, B-9000 Ghent, Belgium; [Rabaey, Korneel] Univ Queensland, Adv Water Management Ctr, Brisbane, Qld 4072, Australia	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Ghent University; University of Queensland	Logan, BE (corresponding author), Penn State Univ, Dept Civil & Environm Engn, 212 Sackett Bldg, University Pk, PA 16802 USA.	blogan@psu.edu		Rabaey, Korneel/0000-0001-8738-7778	King Abdullah University of Science and Technology [KUS-I1-003-13]; Multidisciplinary Research Partnership Ghent Bio-Economy; European Union Framework Programme 7 project "ProEthanol"	King Abdullah University of Science and Technology(King Abdullah University of Science & Technology); Multidisciplinary Research Partnership Ghent Bio-Economy; European Union Framework Programme 7 project "ProEthanol"	This research was supported by award KUS-I1-003-13 from the King Abdullah University of Science and Technology (B.E.L.) and the Multidisciplinary Research Partnership Ghent Bio-Economy and the European Union Framework Programme 7 project "ProEthanol" (K.R.).	Aelterman P, 2006, ENVIRON SCI TECHNOL, V40, P3388, DOI 10.1021/es0525511; Ahn Y, 2010, BIORESOURCE TECHNOL, V101, P469, DOI 10.1016/j.biortech.2009.07.039; Ambler JR, 2011, INT J HYDROGEN ENERG, V36, P160, DOI 10.1016/j.ijhydene.2010.09.044; Call DF, 2011, APPL ENVIRON MICROB, V77, P8791, DOI 10.1128/AEM.06434-11; Cheng SA, 2009, ENVIRON SCI TECHNOL, V43, P3953, DOI 10.1021/es803531g; Clauwaert P, 2008, WATER SCI TECHNOL, V57, P575, DOI 10.2166/wst.2008.084; Clauwaert P, 2007, ENVIRON SCI TECHNOL, V41, P3354, DOI 10.1021/es062580r; Cusick RD, 2012, SCIENCE, V335, P1474, DOI [10.1126/science.1219330, 10.1126/science.1218781]; Cusick RD, 2011, APPL MICROBIOL BIOT, V89, P2053, DOI 10.1007/s00253-011-3130-9; EMDE R, 1990, APPL ENVIRON MICROB, V56, P2771, DOI 10.1128/AEM.56.9.2771-2776.1990; Fan YZ, 2008, ENVIRON SCI TECHNOL, V42, P8101, DOI 10.1021/es801229j; Fan YZ, 2007, ENVIRON SCI TECHNOL, V41, P8154, DOI 10.1021/es071739c; Flynn JM, 2010, MBIO, V1, DOI 10.1128/mBio.00190-10; Foley JM, 2010, ENVIRON SCI TECHNOL, V44, P3629, DOI 10.1021/es100125h; Gorby YA, 2006, P NATL ACAD SCI USA, V103, P11358, DOI 10.1073/pnas.0604517103; Gregory KB, 2004, ENVIRON MICROBIOL, V6, P596, DOI 10.1111/j.1462-2920.2004.00593.x; Hays S, 2011, J POWER SOURCES, V196, P8293, DOI 10.1016/j.jpowsour.2011.06.027; Heidrich ES, 2011, ENVIRON SCI TECHNOL, V45, P827, DOI 10.1021/es103058w; HONGO M, 1979, AGR BIOL CHEM TOKYO, V43, P2075, DOI 10.1080/00021369.1979.10863776; Kiely PD, 2011, CURR OPIN BIOTECH, V22, P378, DOI 10.1016/j.copbio.2011.03.003; Kim JR, 2007, ENVIRON SCI TECHNOL, V41, P1004, DOI 10.1021/es062202m; Kim TW, 2012, DESALINATION, V284, P253, DOI 10.1016/j.desal.2011.09.008; KIM TS, 1988, BIOTECHNOL LETT, V10, P123, DOI 10.1007/BF01024638; Kim Y, 2011, ENERG ENVIRON SCI, V4, P4662, DOI 10.1039/c1ee02451e; Kim Y, 2011, P NATL ACAD SCI USA, V108, P16176, DOI 10.1073/pnas.1106335108; Kim Y, 2011, ENVIRON SCI TECHNOL, V45, P5834, DOI 10.1021/es200979b; Kuleszo J, 2010, J INTEGR ENVIRON SCI, V7, P89, DOI 10.1080/19438151003680850; LETTINGA G, 1995, ANTON LEEUW INT J G, V67, P3, DOI 10.1007/BF00872193; Liu H, 2004, ENVIRON SCI TECHNOL, V38, P4040, DOI 10.1021/es0499344; Logan B.E., 2008, MICROBIAL FUEL CELLS; Logan BE, 2004, ENVIRON SCI TECHNOL, V38, p160A, DOI 10.1021/es040468s; Logan BE, 2006, ENVIRON SCI TECHNOL, V40, P5181, DOI 10.1021/es0605016; Logan BE, 2009, NAT REV MICROBIOL, V7, P375, DOI 10.1038/nrmicro2113; Logan BE, 2008, ENVIRON SCI TECHNOL, V42, P8630, DOI 10.1021/es801553z; Marsili E, 2008, P NATL ACAD SCI USA, V105, P3968, DOI 10.1073/pnas.0710525105; McCarty PL, 2011, ENVIRON SCI TECHNOL, V45, P7100, DOI 10.1021/es2014264; Myers JM, 2001, APPL ENVIRON MICROB, V67, P260, DOI 10.1128/AEM.67.1.260-269.2001; Nam JY, 2011, INT J HYDROGEN ENERG, V36, P15105, DOI 10.1016/j.ijhydene.2011.08.106; Nevin KP, 2011, APPL ENVIRON MICROB, V77, P2882, DOI 10.1128/AEM.02642-10; Nevin KP, 2010, MBIO, V1, DOI 10.1128/mBio.00103-10; Nowak O, 2011, WATER SCI TECHNOL, V64, P1, DOI 10.2166/wst.2011.625; Oh SE, 2007, J POWER SOURCES, V167, P11, DOI 10.1016/j.jpowsour.2007.02.016; Pant D, 2010, BIORESOURCE TECHNOL, V101, P1533, DOI 10.1016/j.biortech.2009.10.017; Parameswaran P, 2010, BIOTECHNOL BIOENG, V105, P69, DOI 10.1002/bit.22508; Park DH, 1999, APPL ENVIRON MICROB, V65, P2912; Perlack RD, 2005, DOEGO1029952135 OAK; Pham TH, 2008, APPL MICROBIOL BIOT, V77, P1119, DOI 10.1007/s00253-007-1248-6; Rabaey K, 2005, TRENDS BIOTECHNOL, V23, P291, DOI 10.1016/j.tibtech.2005.04.008; Rabaey K, 2004, APPL ENVIRON MICROB, V70, P5373, DOI 10.1128/AEM.70.9.5373-5382.2004; Rabaey K, 2010, NAT REV MICROBIOL, V8, P706, DOI 10.1038/nrmicro2422; Rabaey K, 2010, ENVIRON SCI TECHNOL, V44, P4315, DOI 10.1021/es9037963; Rader GK, 2010, INT J HYDROGEN ENERG, V35, P8848, DOI 10.1016/j.ijhydene.2010.06.033; Ramon GZ, 2011, ENERG ENVIRON SCI, V4, P4423, DOI 10.1039/c1ee01913a; Read ST, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-98; Reguera G, 2005, NATURE, V435, P1098, DOI 10.1038/nature03661; Rozendal RA, 2008, ENVIRON SCI TECHNOL, V42, P629, DOI 10.1021/es071720+; Rozendal RA, 2006, ENVIRON SCI TECHNOL, V40, P5206, DOI 10.1021/es060387r; Rozendal RA, 2009, ELECTROCHEM COMMUN, V11, P1752, DOI 10.1016/j.elecom.2009.07.008; Speers AM, 2012, APPL ENVIRON MICROB, V78, P437, DOI 10.1128/AEM.06782-11; Steinbusch KJJ, 2010, ENVIRON SCI TECHNOL, V44, P513, DOI 10.1021/es902371e; Venkataraman A, 2011, ENERG ENVIRON SCI, V4, P4550, DOI 10.1039/c1ee01377g; von Canstein H, 2008, APPL ENVIRON MICROB, V74, P615, DOI 10.1128/AEM.01387-07; Zhang F, 2011, BIOSENS BIOELECTRON, V30, P49, DOI 10.1016/j.bios.2011.08.025; Zhang XY, 2010, ENERG ENVIRON SCI, V3, P659, DOI 10.1039/b927151a	64	1207	1264	81	1919	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2012	337	6095					686	690		10.1126/science.1217412	http://dx.doi.org/10.1126/science.1217412			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986PE	22879507				2022-12-28	WOS:000307354500042
J	Saalmann, YB; Pinsk, MA; Wang, L; Li, X; Kastner, S				Saalmann, Yuri B.; Pinsk, Mark A.; Wang, Liang; Li, Xin; Kastner, Sabine			The Pulvinar Regulates Information Transmission Between Cortical Areas Based on Attention Demands	SCIENCE			English	Article							TOP-DOWN; NEURONAL OSCILLATIONS; VISUAL-PERCEPTION; CORTEX; FREQUENCY; MODULATION; MECHANISMS; MONKEY; SYNCHRONIZATION; SELECTION	Selective attention mechanisms route behaviorally relevant information through large-scale cortical networks. Although evidence suggests that populations of cortical neurons synchronize their activity to preferentially transmit information about attentional priorities, it is unclear how cortical synchrony across a network is accomplished. Based on its anatomical connectivity with the cortex, we hypothesized that the pulvinar, a thalamic nucleus, regulates cortical synchrony. We mapped pulvino-cortical networks within the visual system, using diffusion tensor imaging, and simultaneously recorded spikes and field potentials from these interconnected network sites in monkeys performing a visuospatial attention task. The pulvinar synchronized activity between interconnected cortical areas according to attentional allocation, suggesting a critical role for the thalamus not only in attentional selection but more generally in regulating information transmission across the visual cortex.	[Saalmann, Yuri B.; Pinsk, Mark A.; Wang, Liang; Li, Xin; Kastner, Sabine] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Saalmann, Yuri B.; Pinsk, Mark A.; Wang, Liang; Li, Xin; Kastner, Sabine] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA	Princeton University; Princeton University	Saalmann, YB (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA.	saalmann@princeton.edu	Wang, Liang/AAC-7772-2019; Saalmann, Yuri B/AAW-5814-2021	Saalmann, Yuri/0000-0001-8880-6698; Kastner, Sabine/0000-0002-9742-965X	NIH [R21 EY021078]; NSF [BCS-1025149]; NATIONAL EYE INSTITUTE [R01EY017699, R21EY021078] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank C. D. Brody and C. J. Honey for useful comments on the manuscript and M. Ding for Granger causality routines. Supported by NIH (grant R21 EY021078) and NSF (grant BCS-1025149).	Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; BALEYDIER C, 1992, VISUAL NEUROSCI, V8, P391, DOI 10.1017/S0952523800004922; Bender DB, 2001, J NEUROPHYSIOL, V85, P219, DOI 10.1152/jn.2001.85.1.219; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Busch NA, 2009, J NEUROSCI, V29, P7869, DOI 10.1523/JNEUROSCI.0113-09.2009; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; DESIMONE R, 1990, COLD SPRING HARB SYM, V55, P963; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Hughes SW, 2005, NEUROSCIENTIST, V11, P357, DOI 10.1177/1073858405277450; Jensen O, 2007, TRENDS COGN SCI, V11, P267, DOI 10.1016/j.tics.2007.05.003; Jones EG, 2001, TRENDS NEUROSCI, V24, P595, DOI 10.1016/S0166-2236(00)01922-6; LABERGE D, 1990, J NEUROSCI, V10, P613; Mathewson KE, 2009, J NEUROSCI, V29, P2725, DOI 10.1523/JNEUROSCI.3963-08.2009; Molotchnikoff S, 1996, VISION RES, V36, P2037, DOI 10.1016/0042-6989(95)00311-8; Palva S, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00204; PETERSEN SE, 1985, J NEUROPHYSIOL, V54, P867, DOI 10.1152/jn.1985.54.4.867; PETERSEN SE, 1987, NEUROPSYCHOLOGIA, V25, P97, DOI 10.1016/0028-3932(87)90046-7; ROBINSON DL, 1992, TRENDS NEUROSCI, V15, P127, DOI 10.1016/0166-2236(92)90354-B; Saalmann YB, 2007, SCIENCE, V316, P1612, DOI 10.1126/science.1139140; Saalmann YB, 2011, NEURON, V71, P209, DOI 10.1016/j.neuron.2011.06.027; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Shipp S, 2003, PHILOS T R SOC B, V358, P1605, DOI 10.1098/rstb.2002.1213; Snow JC, 2009, P NATL ACAD SCI USA, V106, P4054, DOI 10.1073/pnas.0810086106; Theyel BB, 2010, NAT NEUROSCI, V13, P84, DOI 10.1038/nn.2449; von Stein A, 2000, P NATL ACAD SCI USA, V97, P14748, DOI 10.1073/pnas.97.26.14748; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Wrobel A, 2007, J NEUROSCI, V27, P2230, DOI 10.1523/JNEUROSCI.4004-06.2007	28	557	564	5	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2012	337	6095					753	756		10.1126/science.1223082	http://dx.doi.org/10.1126/science.1223082			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986PE	22879517	Green Accepted			2022-12-28	WOS:000307354500060
J	Sattelberger, AP; Johnson, MJA				Sattelberger, Alfred P.; Johnson, Marc J. A.			Uncovering the Uranium-Nitrogen Triple Bond	SCIENCE			English	Editorial Material							NITRIDE; ACTIVATION; COMPLEXES; CHEMISTRY		[Sattelberger, Alfred P.; Johnson, Marc J. A.] Argonne Natl Lab, Argonne, IL 60439 USA	United States Department of Energy (DOE); Argonne National Laboratory	Sattelberger, AP (corresponding author), Argonne Natl Lab, 9700 S Cass Ave, Argonne, IL 60439 USA.	asattelberger@anl.gov; mjjohnson@anl.gov						Bart SC, 2008, J AM CHEM SOC, V130, P12536, DOI 10.1021/ja804263w; Bridgeman AJ, 2001, J CHEM SOC DALTON, P2095, DOI 10.1039/b102094n; Evans WJ, 2005, SCIENCE, V309, P1835, DOI 10.1126/science.1116452; Fortier S, 2010, J AM CHEM SOC, V132, P6888, DOI 10.1021/ja101567h; Fox AR, 2010, J AM CHEM SOC, V132, P3250, DOI 10.1021/ja910364u; Fox AR, 2009, J AM CHEM SOC, V131, P5716, DOI 10.1021/ja8095812; Glendening E. D., 2001, NBO 5 0; Graves CR, 2009, CHEM COMMUN, P3831, DOI 10.1039/b902969a; King DM, 2012, SCIENCE, V337, P717, DOI 10.1126/science.1223488; Korobkov I, 2002, ANGEW CHEM INT EDIT, V41, P3433, DOI 10.1002/1521-3773(20020916)41:18<3433::AID-ANIE3433>3.0.CO;2-V; Nugent W. A., 1988, METAL LIGAND MULTIPL; PEPPER M, 1991, CHEM REV, V91, P719, DOI 10.1021/cr00005a005; Silva GWC, 2009, INORG CHEM, V48, P10635, DOI 10.1021/ic901165j; Thomson RK, 2010, NAT CHEM, V2, P723, DOI [10.1038/nchem.705, 10.1038/NCHEM.705]	14	9	9	2	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2012	337	6095					652	653		10.1126/science.1225351	http://dx.doi.org/10.1126/science.1225351			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986PE	22879490				2022-12-28	WOS:000307354500027
J	Tomlinson, CL; Patel, S; Meek, C; Herd, CP; Clarke, CE; Stowe, R; Shah, L; Sackley, C; Deane, KHO; Wheatley, K; Ives, N				Tomlinson, Claire L.; Patel, Smitaa; Meek, Charmaine; Herd, Clare P.; Clarke, Carl E.; Stowe, Rebecca; Shah, Laila; Sackley, Catherine; Deane, Katherine H. O.; Wheatley, Keith; Ives, Natalie			Physiotherapy intervention in Parkinson's disease: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIAL; ATTENTION FOCUSED EXERCISE; QUALITY-OF-LIFE; PHYSICAL-THERAPY; MULTIDISCIPLINARY CARE; PEOPLE; GAIT; PROGRAM; WALKING; PERFORMANCE	Objective To assess the effectiveness of physiotherapy compared with no intervention in patients with Parkinson's disease. Design Systematic review and meta-analysis of randomised controlled trials. Data sources Literature databases, trial registries, journals, abstract books, and conference proceedings, and reference lists, searched up to the end of January 2012. Review methods Randomised controlled trials comparing physiotherapy with no intervention in patients with Parkinson's disease were eligible. Two authors independently abstracted data from each trial. Standard meta-analysis methods were used to assess the effectiveness of physiotherapy compared with no intervention. Tests for heterogeneity were used to assess for differences in treatment effect across different physiotherapy interventions used. Outcome measures were gait, functional mobility and balance, falls, clinician rated impairment and disability measures, patient rated quality of life, adverse events, compliance, and economic analysis outcomes. Results 39 trials of 1827 participants met the inclusion criteria, of which 29 trials provided data for the meta-analyses. Significant benefit from physiotherapy was reported for nine of 18 outcomes assessed. Outcomes which may be clinically significant were speed (0.04 m/s, 95% confidence interval 0.02 to 0.06, P<0.001), Berg balance scale (3.71 points, 2.30 to 5.11, P<0.001), and scores on the unified Parkinson's disease rating scale (total score -6.15 points, -8.57 to -3.73, P<0.001; activities of daily living subscore -1.36, -2.41 to -0.30, P=0.01; motor subscore -5.01, -6.30 to -3.72, P<0.001). Indirect comparisons of the different physiotherapy interventions found no evidence that the treatment effect differed across the interventions for any outcomes assessed, apart from motor subscores on the unified Parkinson's disease rating scale (in which one trial was found to be the cause of the heterogeneity). Conclusions Physiotherapy has short term benefits in Parkinson's disease. A wide range of physiotherapy techniques are currently used to treat Parkinson's disease, with little difference in treatment effects. Large, well designed, randomised controlled trials with improved methodology and reporting are needed to assess the efficacy and cost effectiveness of physiotherapy for treating Parkinson's disease in the longer term.	[Tomlinson, Claire L.; Patel, Smitaa; Meek, Charmaine; Stowe, Rebecca; Shah, Laila; Ives, Natalie] Univ Birmingham, Birmingham Clin Trials Unit, Birmingham B15 2TT, W Midlands, England; [Herd, Clare P.; Clarke, Carl E.] Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Birmingham B15 2TT, W Midlands, England; [Clarke, Carl E.] City Hosp, Sandwell & W Birmingham Hosp NHS Trust, Dept Neurol, Birmingham, W Midlands, England; [Sackley, Catherine; Deane, Katherine H. O.] Univ E Anglia, Norwich NR4 7TJ, Norfolk, England; [Wheatley, Keith] Univ Birmingham, Sch Canc Sci, Canc Res UK Clin Trials Unit, Birmingham B15 2TT, W Midlands, England	University of Birmingham; University of Birmingham; University of Birmingham; University of East Anglia; Cancer Research UK; University of Birmingham	Tomlinson, CL (corresponding author), Univ Birmingham, Birmingham Clin Trials Unit, Birmingham B15 2TT, W Midlands, England.	c.l.smith.1@bham.ac.uk		sackley, catherine/0000-0002-8580-6622; Clarke, Carl/0000-0003-2478-3436; Deane, Katherine/0000-0002-0805-2708; Herd, Clare/0000-0002-1351-1112; Patel, Smitaa/0000-0002-4997-3829; Ives, Natalie/0000-0002-1664-7541; STOWE, REBECCA/0000-0003-4007-6723	Parkinson's UK; UK Department of Health	Parkinson's UK(Parkinson's UK); UK Department of Health	This review was funded by Parkinson's UK and the UK Department of Health, which provided the University of Birmingham Clinical Trials Unit with core support.	Allen NE, 2010, MOVEMENT DISORD, V25, P1217, DOI 10.1002/mds.23082; Almeida QJ, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/508720; Ashburn A, 2007, J NEUROL NEUROSUR PS, V78, P678, DOI 10.1136/jnnp.2006.099333; Bladh S, 2012, J NEUROL, V259, P729, DOI 10.1007/s00415-011-6254-z; Boehm RL, 2011, MOVEMENT DISORD, V26, pS331; Cakit BD, 2007, CLIN REHABIL, V21, P698, DOI 10.1177/0269215507077269; Canning CG, 2012, CLIN REHABIL; Cerri C, 1994, MOV DISORD S1, V9, P68; Chandler C, 1999, PARKINSONS DIS STUDI, P256; Clarke C., 2006, NATL CLIN GUIDELINE; de Bruin N, 2010, MOVEMENT DISORD, V25, pS697; De Bruin N, 2008, MOV DISORD S1, V23, pS667; Deane K, 2001, COCHRANE DB SYST REV, V3; Deeks J.J., 2001, SYSTEMATIC REV HLTH, P285, DOI DOI 10.1002/9780470693926.CH15; Duncan RP, 2012, NEUROREHAB NEURAL RE, V26, P132, DOI 10.1177/1545968311421614; Ellis T, 2005, ARCH PHYS MED REHAB, V86, P626, DOI 10.1016/j.apmr.2004.08.008; Fisher BE, 2008, ARCH PHYS MED REHAB, V89, P1221, DOI 10.1016/j.apmr.2008.01.013; Fleiss J L, 1993, Stat Methods Med Res, V2, P121, DOI 10.1177/096228029300200202; Gage H, 2004, CLIN REHABIL, V18, P463, DOI 10.1191/0269215504cr764oa; Ganesan M, 2010, PARKINSONISM RELA S1, V16, pS66; Goetz CG, 2008, MOVEMENT DISORD, V23, P690, DOI 10.1002/mds.21894; Goodwin VA, 2008, MOVEMENT DISORD, V23, P631, DOI 10.1002/mds.21922; Goodwin VA, 2011, J NEUROL NEUROSUR PS, V82, P1232, DOI 10.1136/jnnp-2011-300919; Haase M, 2011, THESIS PROQUEST; Hackney ME, 2009, PARKINSONISM RELAT D, V15, P644, DOI 10.1016/j.parkreldis.2009.03.003; Homann CN, 1998, MOV DISORD S2, V13, pS234; Keus S, 2004, DUTCH J PHYSIOTHE S1, V114, pS1; Keus SHJ, 2007, PARKINSONISM RELAT D, V13, P115, DOI 10.1016/j.parkreldis.2006.07.007; Keus SHJ, 2007, MOVEMENT DISORD, V22, P451, DOI 10.1002/mds.21244; Keus SHJ, 2009, MOVEMENT DISORD, V24, P1, DOI 10.1002/mds.22141; Klassen L, 2007, PHYSIOTHERAPY S1, V93, pS91; Kurtais Y, 2008, CLIN J SPORT MED, V18, P289, DOI 10.1097/JSM.0b013e318170626d; Kwakkel G, 2007, PARKINSONISM RELAT D, V13, pS478, DOI 10.1016/S1353-8020(08)70053-1; Lehman David A, 2005, J Neurol Phys Ther, V29, P2; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Mak MKY, 2008, MOVEMENT DISORD, V23, P501, DOI 10.1002/mds.21509; Marjama-Lyons J, 2002, MOV DISORD S5, V17, pS190; Meek C, 2010, MOVEMENT DISORD, V25, pS713; Mehrholz J, 2010, COCHRANE DB SYST REV, V1; Morris ME, 2010, PHYS THER, V90, P280, DOI 10.2522/ptj.20090091; Munneke M, 2010, LANCET NEUROL, V9, P46, DOI 10.1016/S1474-4422(09)70327-8; MUTCH WJ, 1986, BRIT MED J, V293, P675, DOI 10.1136/bmj.293.6548.675; Nieuwboer A, 2007, J NEUROL NEUROSUR PS, V78, P134, DOI 10.1136/jnnp.200X.097923; Nijkrake MJ, 2007, PARKINSONISM RELAT D, V13, pS488, DOI 10.1016/S1353-8020(08)70054-3; Parkinson's Disease Society, 2008, LIF PARK TOD ROOM IM; PERRY J, 1995, STROKE, V26, P982, DOI 10.1161/01.STR.26.6.982; Plant R, 2000, PHYSIOTHERAPY PEOPLE; Post B, 2011, POSTGRAD MED J, V87, P575, DOI 10.1136/pgmj.2011.241604rep; Protas EJ, 2005, NEUROREHABILITATION, V20, P183; Purchas MA, 2007, MOV DISORD S16, V22, pS260; Rascol O, 2002, PARKINSONISM RELAT D, V9, P61, DOI 10.1016/S1353-8020(02)00045-7; Robertson D, 2003, NEUROLOGICAL REHABIL; Robertson D, 2008, PARKINSONS DIS OLDER; Rubenis J, 2007, PARKINSONISM RELAT D, V13, pS495, DOI 10.1016/S1353-8020(08)70055-5; Sage MD, 2009, MOVEMENT DISORD, V24, P1132, DOI 10.1002/mds.22469; Schenkman M, 1998, J AM GERIATR SOC, V46, P1207, DOI 10.1111/j.1532-5415.1998.tb04535.x; Schilling BK, 2008, MOV DISORD S1, V23, pS639; Schmitz-Hubsch T, 2006, MOVEMENT DISORD, V21, P543, DOI 10.1002/mds.20705; Schrag A, 2000, MOVEMENT DISORD, V15, P1112, DOI 10.1002/1531-8257(200011)15:6<1112::AID-MDS1008>3.0.CO;2-A; Schrag A, 2006, MOVEMENT DISORD, V21, P1200, DOI 10.1002/mds.20914; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Shankar A, 2009, MOVEMENT DISORD, V24, pS281; Shankar A, 2008, MOV DISORD S1, V23, pS608; Shulman LM, 2010, ARCH NEUROL-CHICAGO, V67, P64, DOI 10.1001/archneurol.2009.295; Stack E, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/360231; Steffen T, 2008, PHYS THER, V88, P733, DOI 10.2522/ptj.20070214; Stozek J, 2003, NEUROL NEUROCHIR S5, V37, pS67; Taheri H, 2011, J ISFAHAN MED SCH, V29, P1183; Talakad S, 2011, MOVEMENT DISORD, V26, pS173; Thaut MH, 1996, MOVEMENT DISORD, V11, P193, DOI 10.1002/mds.870110213; Tomlinson CL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002817.pub2; van der Marck MA, 2009, PARKINSONISM RELAT D, V15, pS219, DOI 10.1016/S1353-8020(09)70819-3; van Nimwegen M, 2011, J NEUROL, V258, P2214, DOI 10.1007/s00415-011-6097-7; Yarrow S, 1999, PARKINSONS DIS STUDI, P79	74	179	185	1	74	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 6	2012	345								e5004	10.1136/bmj.e5004	http://dx.doi.org/10.1136/bmj.e5004			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988MY	22867913	Green Published, Green Submitted, hybrid, Green Accepted			2022-12-28	WOS:000307496300001
J	Barry, C; Bush, D; O'Keefe, J; Burgess, N				Barry, Caswell; Bush, Daniel; O'Keefe, John; Burgess, Neil			Models of grid cells and theta oscillations	NATURE			English	Letter							ENTORHINAL CORTEX; INTERFERENCE		[Barry, Caswell; Bush, Daniel; Burgess, Neil] UCL Inst Cognit Neurosci, London WC1N 3AR, England; [Barry, Caswell; Bush, Daniel; Burgess, Neil] UCL, Inst Neurol, London WC1N 3BG, England; [Barry, Caswell] UCL, Inst Behav Neurosci, London WC1H 0AP, England; [O'Keefe, John] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [O'Keefe, John] UCL, Sainsbury Wellcome Ctr Neural Circuits & Behav, London WC1E 6BT, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London	Barry, C (corresponding author), UCL Inst Cognit Neurosci, 17 Queen Sq, London WC1N 3AR, England.	n.burgess@ucl.ac.uk	Burgess, Neil/B-2420-2009	Burgess, Neil/0000-0003-0646-6584; O'Keefe, John/0000-0001-5697-4881; Bush, Daniel/0000-0002-5097-8117	MRC [G1000854] Funding Source: UKRI; Medical Research Council [G1000854] Funding Source: Medline; Wellcome Trust [095811] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Barry C, 2007, NAT NEUROSCI, V10, P682, DOI 10.1038/nn1905; Boccara CN, 2010, NAT NEUROSCI, V13, P987, DOI 10.1038/nn.2602; Burgess N, 2005, COMP COGN NEUR C; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; Burgess N, 2008, HIPPOCAMPUS, V18, P1157, DOI 10.1002/hipo.20518; Dayan P., 2001, THEORETICAL NEUROSCI, P180; Giocomo LM, 2007, SCIENCE, V315, P1719, DOI 10.1126/science.1139207; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Hasselmo ME, 2008, HIPPOCAMPUS, V18, P1213, DOI 10.1002/hipo.20512; Jeewajee A, 2008, HIPPOCAMPUS, V18, P1175, DOI 10.1002/hipo.20510; O'Keefe J, 2006, HIPPOCAMPUS BOOK, P475; Welday AC, 2011, J NEUROSCI, V31, P16157, DOI 10.1523/JNEUROSCI.0712-11.2011; Yartsev MM, 2011, NATURE, V479, P103, DOI 10.1038/nature10583	14	31	31	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2012	488	7409					E1	E2		10.1038/nature11276	http://dx.doi.org/10.1038/nature11276			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ZE	22859210	Green Submitted, Bronze			2022-12-28	WOS:000307010700001
J	Northcott, PA; Shih, DJH; Peacock, J; Garzia, L; Morrissy, AS; Zichner, T; Stutz, AM; Korshunov, A; Reimand, J; Schumacher, SE; Beroukhim, R; Ellison, DW; Marshall, CR; Lionel, AC; Mack, S; Dubuc, A; Yao, Y; Ramaswamy, V; Luu, B; Rolider, A; Cavalli, FMG; Wang, X; Remke, M; Wu, XC; Chiu, RYB; Chu, A; Chuah, E; Corbett, RD; Hoad, GR; Jackman, SD; Li, YS; Lo, A; Mungall, KL; Nip, KM; Qian, JQ; Raymond, AGJ; Thiessen, N; Varhol, RJ; Birol, I; Moore, RA; Mungall, AJ; Holt, R; Kawauchi, D; Roussel, MF; Kool, M; Jones, DTW; Witt, H; Fernandez-L, A; Kenney, AM; Wechsler-Reya, RJ; Dirks, P; Aviv, T; Grajkowska, WA; Perek-Polnik, M; Haberler, CC; Delattre, O; Reynaud, SS; Doz, FF; Pernet-Fattet, SS; Cho, BK; Kim, SK; Wang, KC; Scheurlen, W; Eberhart, CG; Fevre-Montange, M; Jouvet, A; Pollack, IF; Fan, X; Muraszko, KM; Gillespie, GY; Di Rocco, C; Massimi, L; Michiels, EMC; Kloosterhof, NK; French, PJ; Kros, JM; Olson, JM; Ellenbogen, RG; Zitterbart, K; Kren, L; Thompson, RC; Cooper, MK; Lach, B; McLendon, RE; Bigner, DD; Fontebasso, A; Albrecht, S; Jabado, N; Lindsey, JC; Bailey, S; Gupta, N; Weiss, WA; Bognar, L; Klekner, A; Van Meter, TE; Kumabe, T; Tominaga, T; Elbabaa, SK; Leonard, JR; Rubin, JB; Liau, LM; Van Meir, EG; Fouladi, M; Nakamura, H; Cinalli, G; Garami, M; Hauser, P; Saad, AG; Iolascon, A; Jung, S; Carlotti, CG; Vibhakar, R; Ra, YS; Robinson, S; Zollo, M; Faria, CC; Chan, JA; Levy, ML; Sorensen, PHB; Meyerson, M; Pomeroy, SL; Cho, YJ; Bader, GD; Tabori, U; Hawkins, CE; Bouffet, E; Scherer, SW; Rutka, JT; Malkin, D; Clifford, SC; Jones, SJM; Korbel, JO; Pfister, SM; Marra, MA; Taylor, MD				Northcott, Paul A.; Shih, David J. H.; Peacock, John; Garzia, Livia; Morrissy, A. Sorana; Zichner, Thomas; Stuetz, Adrian M.; Korshunov, Andrey; Reimand, Jueri; Schumacher, Steven E.; Beroukhim, Rameen; Ellison, David W.; Marshall, Christian R.; Lionel, Anath C.; Mack, Stephen; Dubuc, Adrian; Yao, Yuan; Ramaswamy, Vijay; Luu, Betty; Rolider, Adi; Cavalli, Florence M. G.; Wang, Xin; Remke, Marc; Wu, Xiaochong; Chiu, Readman Y. B.; Chu, Andy; Chuah, Eric; Corbett, Richard D.; Hoad, Gemma R.; Jackman, Shaun D.; Li, Yisu; Lo, Allan; Mungall, Karen L.; Nip, Ka Ming; Qian, Jenny Q.; Raymond, Anthony G. J.; Thiessen, Nina; Varhol, Richard J.; Birol, Inanc; Moore, Richard A.; Mungall, Andrew J.; Holt, Robert; Kawauchi, Daisuke; Roussel, Martine F.; Kool, Marcel; Jones, David T. W.; Witt, Hendrick; Fernandez-L, Africa; Kenney, Anna M.; Wechsler-Reya, Robert J.; Dirks, Peter; Aviv, Tzvi; Grajkowska, Wieslawa A.; Perek-Polnik, Marta; Haberler, Christine C.; Delattre, Olivier; Reynaud, Stephanie S.; Doz, Francois F.; Pernet-Fattet, Sarah S.; Cho, Byung-Kyu; Kim, Seung-Ki; Wang, Kyu-Chang; Scheurlen, Wolfram; Eberhart, Charles G.; Fevre-Montange, Michelle; Jouvet, Anne; Pollack, Ian F.; Fan, Xing; Muraszko, Karin M.; Gillespie, G. Yancey; Di Rocco, Concezio; Massimi, Luca; Michiels, Erna M. C.; Kloosterhof, Nanne K.; French, Pim J.; Kros, Johan M.; Olson, James M.; Ellenbogen, Richard G.; Zitterbart, Karel; Kren, Leos; Thompson, Reid C.; Cooper, Michael K.; Lach, Boleslaw; McLendon, Roger E.; Bigner, Darell D.; Fontebasso, Adam; Albrecht, Steffen; Jabado, Nada; Lindsey, Janet C.; Bailey, Simon; Gupta, Nalin; Weiss, William A.; Bognar, Laszlo; Klekner, Almos; Van Meter, Timothy E.; Kumabe, Toshihiro; Tominaga, Teiji; Elbabaa, Samer K.; Leonard, Jeffrey R.; Rubin, Joshua B.; Liau, Linda M.; Van Meir, Erwin G.; Fouladi, Maryam; Nakamura, Hideo; Cinalli, Giuseppe; Garami, Miklos; Hauser, Peter; Saad, Ali G.; Iolascon, Achille; Jung, Shin; Carlotti, Carlos G.; Vibhakar, Rajeev; Ra, Young Shin; Robinson, Shenandoah; Zollo, Massimo; Faria, Claudia C.; Chan, Jennifer A.; Levy, Michael L.; Sorensen, Poul H. B.; Meyerson, Matthew; Pomeroy, Scott L.; Cho, Yoon-Jae; Bader, Gary D.; Tabori, Uri; Hawkins, Cynthia E.; Bouffet, Eric; Scherer, Stephen W.; Rutka, James T.; Malkin, David; Clifford, Steven C.; Jones, Steven J. M.; Korbel, Jan O.; Pfister, Stefan M.; Marra, Marco A.; Taylor, Michael D.			Subgroup-specific structural variation across 1,000 medulloblastoma genomes	NATURE			English	Article							HEDGEHOG PATHWAY INHIBITOR; COPY-NUMBER ALTERATION; ALPHA-SYNUCLEIN; BETA FAMILY; SYNPHILIN-1; PROTEIN; MYC; LANDSCAPE; MUTATION; TARGETS	Medulloblastoma, the most common malignant paediatric brain tumour, is currently treated with nonspecific cytotoxic therapies including surgery, whole-brain radiation, and aggressive chemotherapy. As medulloblastoma exhibits marked intertumoural heterogeneity, with at least four distinct molecular variants, previous attempts to identify targets for therapy have been underpowered because of small samples sizes. Here we report somatic copy number aberrations (SCNAs) in 1,087 unique medulloblastomas. SCNAs are common in medulloblastoma, and are predominantly subgroup-enriched. The most common region of focal copy number gain is a tandem duplication of SNCAIP, a gene associated with Parkinson's disease, which is exquisitely restricted to Group 4 alpha. Recurrent translocations of PVT1, including PVT1-MYC and PVT1-NDRG1, that arise through chromothripsis are restricted to Group 3. Numerous targetable SCNAs, including recurrent events targeting TGF-beta signalling in Group 3, and NF-kappa B signalling in Group 4, suggest future avenues for rational, targeted therapy.	[Holt, Robert; Marra, Marco A.] Michael Smith Genome Sci Ctr, BC Canc Agcy, Vancouver, BC V5Z 1L3, Canada; [Northcott, Paul A.; Shih, David J. H.; Peacock, John; Garzia, Livia; Morrissy, A. Sorana; Mack, Stephen; Dubuc, Adrian; Yao, Yuan; Ramaswamy, Vijay; Luu, Betty; Rolider, Adi; Cavalli, Florence M. G.; Wang, Xin; Remke, Marc; Wu, Xiaochong; Taylor, Michael D.] Hosp Sick Children, Dev & Stem Cell Biol Program, Toronto, ON M5G 1L7, Canada; [Northcott, Paul A.; Kool, Marcel; Jones, David T. W.; Pfister, Stefan M.] German Canc Res Ctr, Div Pediat Neurooncol, D-69120 Heidelberg, Germany; [Shih, David J. H.; Peacock, John; Mack, Stephen; Dubuc, Adrian; Yao, Yuan; Ramaswamy, Vijay; Wang, Xin; Taylor, Michael D.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; [Zichner, Thomas; Stuetz, Adrian M.; Korbel, Jan O.] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Korshunov, Andrey] Heidelberg Univ, German Canc Res Ctr DKFZ, Dept Neuropathol, CCU Neuropathol, D-69120 Heidelberg, Germany; [Reimand, Jueri; Bader, Gary D.] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada; [Schumacher, Steven E.; Beroukhim, Rameen] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Beroukhim, Rameen; Meyerson, Matthew] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Beroukhim, Rameen] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Beroukhim, Rameen] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Beroukhim, Rameen] Broad Inst, Canc Program, Cambridge, MA 02142 USA; [Beroukhim, Rameen] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02215 USA; [Ellison, David W.; Kawauchi, Daisuke; Roussel, Martine F.] St Jude Childrens Res Hosp, Memphis, TN 38105 USA; [Marshall, Christian R.; Bader, Gary D.; Scherer, Stephen W.] Univ Toronto, McLaughlin Ctr, Toronto, ON M5G 1L7, Canada; [Marshall, Christian R.; Bader, Gary D.; Scherer, Stephen W.] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1L7, Canada; [Lionel, Anath C.; Scherer, Stephen W.] Hosp Sick Children, Ctr Appl Genom & Program Genet & Genome Biol, Toronto, ON M5G 1L7, Canada; [Chiu, Readman Y. B.; Chu, Andy; Chuah, Eric; Corbett, Richard D.; Hoad, Gemma R.; Jackman, Shaun D.; Li, Yisu; Lo, Allan; Mungall, Karen L.; Nip, Ka Ming; Qian, Jenny Q.; Raymond, Anthony G. J.; Thiessen, Nina; Varhol, Richard J.; Birol, Inanc; Moore, Richard A.; Mungall, Andrew J.; Jones, Steven J. M.] Michael Smith Genome Sci Ctr, BC Canc Agcy, Vancouver, BC V5Z 4S6, Canada; [Witt, Hendrick; Pfister, Stefan M.] Univ Heidelberg Hosp, Dept Pediat Oncol, D-69120 Heidelberg, Germany; [Witt, Hendrick] Univ Heidelberg Hosp, Dept Hematol, D-69120 Heidelberg, Germany; [Witt, Hendrick] Univ Heidelberg Hosp, Dept Immunol, D-69120 Heidelberg, Germany; [Fernandez-L, Africa] Mem Sloan Kettering Canc Ctr, Pediat Clin Trials Off, New York, NY 10174 USA; [Wechsler-Reya, Robert J.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Dirks, Peter; Rutka, James T.; Taylor, Michael D.] Hosp Sick Children, Dept Surg, Div Neurosurg, Toronto, ON M5G 1X8, Canada; [Dirks, Peter; Rutka, James T.; Taylor, Michael D.] Hosp Sick Children, Labatt Brain Tumour Res Ctr, Toronto, ON M5G 1X8, Canada; [Grajkowska, Wieslawa A.] Childrens Mem Hlth Inst, Dept Pathol, PL-04730 Warsaw, Poland; [Perek-Polnik, Marta] Childrens Mem Hlth Inst, Dept Oncol, Warsaw, Poland; [Haberler, Christine C.] Med Univ Vienna, Inst Neurol, A-1097 Vienna, Austria; [Delattre, Olivier] Inst Curie, INSERM, U830, F-75238 Paris 5, France; [Reynaud, Stephanie S.] Inst Curie, Unit Somat Genet, F-75238 Paris 5, France; [Doz, Francois F.] Inst Curie, Dept Pediat Oncol, F-75248 Paris 5, France; [Pernet-Fattet, Sarah S.] CHUV Univ Hosp, CH-1011 Lausanne, Switzerland; [Cho, Byung-Kyu; Kim, Seung-Ki; Wang, Kyu-Chang] Seoul Natl Univ, Childrens Hosp, Dept Neurosurg, Div Pediat Neurosurg, Seoul 110744, South Korea; [Scheurlen, Wolfram] Cnopfsche Kinderklin, D-90419 Nurnberg, Germany; [Eberhart, Charles G.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Eberhart, Charles G.] Johns Hopkins Univ, Sch Med, Dept Ophthalmol & Oncol, Baltimore, MD 21205 USA; [Fevre-Montange, Michelle] Univ Lyon, Ctr Rech Neurosci, CNRS UMR5292, INSERM U1028, F-69336 Lyon, France; [Jouvet, Anne] Univ Lyon, Grp Hosp EST, Ctr Pathol EST, F-69500 Bron, France; [Pollack, Ian F.] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15224 USA; [Fan, Xing; Muraszko, Karin M.] Univ Michigan, Sch Med, Dept Neurosurg, Ann Arbor, MI 48109 USA; [Fan, Xing] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Gillespie, G. Yancey] Univ Alabama Birmingham, Dept Surg, Div Neurosurg, Birmingham, AL 35294 USA; [Di Rocco, Concezio; Massimi, Luca] Catholic Univ, Sch Med, I-00186 Rome, Italy; [Michiels, Erna M. C.; Kloosterhof, Nanne K.] Erasmus MC, Dept Pediat Oncol & Hematol, NL-3000 Rotterdam, Netherlands; [Kloosterhof, Nanne K.; French, Pim J.] Erasmus MC, Dept Neurol, NL-3000 CA Rotterdam, Netherlands; [Kros, Johan M.] Erasmus MC, Dept Pathol, NL-3015 GE Rotterdam, Netherlands; [Olson, James M.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; [Olson, James M.] Seattle Childrens Hosp, Seattle, WA 98104 USA; [Ellenbogen, Richard G.] Univ Washington, Sch Med, Harborview Med Ctr, Seattle, WA 98104 USA; [Zitterbart, Karel] Masaryk Univ, Sch Med, Dept Pediat Oncol, Brno 61300, Czech Republic; [Zitterbart, Karel] Univ Hosp Brno, Dept Pediat Oncol, Brno 62500, Czech Republic; [Kren, Leos] Univ Hosp Brno, Dept Pathol, Brno 62500, Czech Republic; [Cooper, Michael K.] Vanderbilt Univ Sch Med, Dept Neurol, Nashville, TN 37232 USA; [Lach, Boleslaw] McMaster Univ, Dept Pathol & Mol Med, Div Anat Pathol, Hamilton, ON L8S 4L8, Canada; [Lach, Boleslaw] Hamilton Gen Hosp, Dept Pathol, Hamilton, ON L8L 2X2, Canada; [Lach, Boleslaw] Hamilton Gen Hosp, Lab Med, Hamilton, ON L8L 2X2, Canada; [McLendon, Roger E.; Bigner, Darell D.] Duke Univ, Dept Pathol, DUMC 3712, Durham, NC 27710 USA; [Fontebasso, Adam; Jabado, Nada] McGill Univ, Div Expt Med, Montreal, PQ H3Z 2Z3, Canada; [Albrecht, Steffen] McGill Univ, Dept Pathol, Montreal, PQ H3A 2B4, Canada; [Albrecht, Steffen] Montreal Childrens Hosp, Dept Pathol, Montreal, PQ H3H 1P3, Canada; [Jabado, Nada] McGill Univ, Dept Pediat, Div Hemato Oncol, Montreal, PQ H3H 1P3, Canada; [Lindsey, Janet C.; Bailey, Simon; Clifford, Steven C.] Newcastle Univ, No Inst Canc Res, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Gupta, Nalin] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Gupta, Nalin] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Weiss, William A.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Weiss, William A.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94158 USA; [Weiss, William A.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94158 USA; [Bognar, Laszlo; Klekner, Almos] Univ Debrecen, Med & Hlth Sci Ctr, Dept Neurosurg, H-4032 Debrecen, Hungary; [Van Meter, Timothy E.] Virginia Commonwealthy Univ, Sch Med, Richmond, VA 23298 USA; [Kumabe, Toshihiro; Tominaga, Teiji] Tohoku Univ, Grad Sch Med, Dept Neurosurg, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Elbabaa, Samer K.] St Louis Univ, Sch Med, Dept Neurosurg, Div Pediat Neurosurg, St Louis, MO 63104 USA; [Leonard, Jeffrey R.] Washington Univ, Sch Med, Dept Neurosurg, Div Pediat Neurosurg, St Louis, MO 63110 USA; [Leonard, Jeffrey R.; Rubin, Joshua B.] St Louis Childrens Hosp, St Louis, MO 63110 USA; [Rubin, Joshua B.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Rubin, Joshua B.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Liau, Linda M.] David Geffen Sch Med UCLA, Dept Neurosurg, Los Angeles, CA 90095 USA; [Van Meir, Erwin G.] Emory Univ, Dept Neurosurg, Mol Neurooncol Lab, Atlanta, GA 30322 USA; [Van Meir, Erwin G.] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Van Meir, Erwin G.] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Fouladi, Maryam] Univ Cincinnati, Cincinnati Childrens Hosp, Med Ctr, Div Oncol, Cincinnati, OH 45229 USA; [Nakamura, Hideo] Kumamoto Univ, Grad Sch Med Sci, Dept Neurosurg, Honjo, Kumamoto 8608556, Japan; [Cinalli, Giuseppe] Osped Santobono Pausilipon, I-80145 Naples, Italy; [Garami, Miklos; Hauser, Peter] Semmelweis Univ, Dept Pediat 2, H-1085 Budapest, Hungary; [Saad, Ali G.] Univ Arkansas Med Sci, Little Rock, AR 72202 USA; [Iolascon, Achille; Zollo, Massimo] Univ Naples Federico II, Dipartimento Biochim & Biotecnol Med, I-80145 Naples, Italy; [Iolascon, Achille; Zollo, Massimo] CEINGE Biotecnol Avanzate, I-80145 Naples, Italy; [Jung, Shin] Chonnam Natl Univ, Hwasun Hosp, Res Inst Med Sci, Dept Neurosci, Chungnam 519763, South Korea; [Jung, Shin] Sch Med, Chungnam 519763, South Korea; [Carlotti, Carlos G.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Surg & Anat, BR-14049900 Sao Paulo, Brazil; [Vibhakar, Rajeev] Univ Colorado Denver, Aurora, CO 80045 USA; [Ra, Young Shin] Univ Ulsan, Asan Med Ctr, Dept Neurosurg, Seoul 138736, South Korea; [Robinson, Shenandoah] Div Pediat Neurosurg, Cleveland, OH 44106 USA; [Faria, Claudia C.] Hosp Santa Maria, Ctr Hosp Lisboa Norte EPE, Div Neurosurg, P-1169050 Lisbon, Portugal; [Faria, Claudia C.] Hosp Sick Children, Cell Biol Program, Toronto, ON MSG 1L7, Canada; [Chan, Jennifer A.] Univ Calgary, Dept Pathol, Calgary, AB T2N 4N1, Canada; [Chan, Jennifer A.] Univ Calgary, Lab Med, Calgary, AB T2N 4N1, Canada; [Levy, Michael L.] Rady Childrens Hosp San Diego, UCSD Div Neurosurg, San Diego, CA 92123 USA; [Sorensen, Poul H. B.] British Columbia Canc Res Ctr, Dept Mol Oncol, Vancouver, BC V5Z 1L3, Canada; [Pomeroy, Scott L.] Harvard Univ, Sch Med, Childrens Hosp Boston, Dept Neurol, Boston, MA 02115 USA; [Cho, Yoon-Jae] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Bader, Gary D.] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; [Bader, Gary D.] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON MSG 1X5, Canada; [Tabori, Uri; Bouffet, Eric; Malkin, David] Hosp Sick Children, Dept Haematol & Oncol, Toronto, ON M5G 1X8, Canada; [Hawkins, Cynthia E.] Hosp Sick Children, Dept Pathol, Toronto, ON M5G 1X8, Canada; [Malkin, David] Univ Toronto, Dept Pediat, Toronto, ON M5G 1X8, Canada; [Marra, Marco A.] Univ British Columbia, Dept Med Genet, Vancouver, BC V5Z 1L3, Canada	British Columbia Cancer Agency; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Helmholtz Association; German Cancer Research Center (DKFZ); University of Toronto; European Molecular Biology Laboratory (EMBL); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Toronto; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; St Jude Children's Research Hospital; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); British Columbia Cancer Agency; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Memorial Sloan Kettering Cancer Center; Sanford Burnham Prebys Medical Discovery Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Children's Memorial Health Institute; Children's Memorial Health Institute; Medical University of Vienna; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Seoul National University (SNU); Seoul National University Hospital; Johns Hopkins University; Johns Hopkins University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); CHU Lyon; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Alabama System; University of Alabama Birmingham; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Fred Hutchinson Cancer Center; Seattle Children's Hospital; Harborview Medical Center; University of Washington; University of Washington Seattle; Masaryk University Brno; University Hospital Brno; University Hospital Brno; Vanderbilt University; McMaster University; McMaster University; McMaster University; Duke University; McGill University; McGill University; McGill University; McGill University; Newcastle University - UK; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Debrecen; Tohoku University; Saint Louis University; Washington University (WUSTL); St. Louis Children's Hospital; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Emory University; Emory University; Emory University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Kumamoto University; Semmelweis University; University of Arkansas System; University of Arkansas Medical Sciences; University of Naples Federico II; CEINGE Biotecnologie Avanzate; Chonnam National University; Universidade de Sao Paulo; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Ulsan; Asan Medical Center; Centro Hospitalar de Lisboa Ocidental, EPE; Universidade de Lisboa; Hospital Santa Maria; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Calgary; University of Calgary; Rady Childrens Hospital San Diego; British Columbia Cancer Agency; Harvard University; Boston Children's Hospital; Harvard Medical School; Stanford University; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of British Columbia	Marra, MA (corresponding author), Michael Smith Genome Sci Ctr, BC Canc Agcy, 675 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	mmarra@bcgsc.ca; mdtaylor@sickkids.ca	Malkin, David/AAW-8715-2021; Carlotti, Carlos G/C-1608-2012; Iolascon, Achille/A-4461-2014; Bouffet, Eric/AAB-8999-2020; Wang, Xin/O-8779-2019; Reimand, Jüri/U-9264-2019; Scherer, Stephen W./B-3785-2013; Hawkins, Cynthia/M-2571-2019; Witt, Hendrik/L-7810-2015; Meyerson, Matthew L/E-7123-2012; Birol, Inanc/G-5440-2011; Wang, Kyu-Chang/J-5545-2012; Bader, Gary/C-1176-2009; Garami, Miklós/AAK-5680-2021; Jones, Steven J/C-3621-2009; Pfister, Stefan M/F-6860-2013; Holt, Robert A/C-3303-2009; Wang, Xin/U-7221-2017; Jones, David T. W./Z-1963-2019; Jones, David TW/G-9588-2013; cinalli, giuseppe/AAC-3889-2022; Elbabaa, Samer/X-4709-2019; Mungall, Andrew J./U-7067-2018; Marra, Marco A/B-5987-2008; Korbel, Jan O/G-6470-2012; Kim, Seung-Ki/J-2742-2012; Doz, Francois P/K-8616-2012; Ellison, David/N-4806-2018; Northcott, Paul A/N-4022-2018; Roussel, Martine F/F-1469-2016; Shih, David J H/H-3186-2011; Kool, Marcel/H-2541-2013; Levy, Michael/AAL-4647-2020; Zollo, Massimo/K-5857-2016; Kawauchi, Daisuke/ABE-9133-2021; Shih, David J. H./AAE-8726-2019; Jabado, Nada/AAN-4026-2020; Jackman, Shaun/G-9622-2013	Carlotti, Carlos G/0000-0002-7055-0564; Wang, Xin/0000-0001-6292-3087; Reimand, Jüri/0000-0002-2299-2309; Scherer, Stephen W./0000-0002-8326-1999; Birol, Inanc/0000-0003-0950-7839; Bader, Gary/0000-0003-0185-8861; Jones, Steven J/0000-0003-3394-2208; Pfister, Stefan M/0000-0002-5447-5322; Holt, Robert A/0000-0002-7259-1247; Wang, Xin/0000-0001-6292-3087; Jones, David TW/0000-0002-2036-5141; cinalli, giuseppe/0000-0002-7797-8483; Elbabaa, Samer/0000-0003-1733-1941; Mungall, Andrew J./0000-0002-0905-2742; Marra, Marco A/0000-0001-7146-7175; Korbel, Jan O/0000-0002-2798-3794; Northcott, Paul A/0000-0002-1220-5252; Roussel, Martine F/0000-0002-1740-8139; Shih, David J H/0000-0002-9802-4937; Zollo, Massimo/0000-0002-0970-7243; Shih, David J. H./0000-0002-9802-4937; Cavalli, Florence M. G./0000-0002-4409-9642; Clifford, Steve/0000-0003-4893-2184; French, Pim/0000-0002-0668-9529; Grajkowska, Wieslawa/0000-0001-8318-5781; Faria, Claudia/0000-0003-1259-9922; Meyerson, Matthew/0000-0002-9133-8108; Taylor, Michael/0000-0001-7009-3466; Perek-Polnik, Marta/0000-0001-9043-6956; Liau, Linda/0000-0002-4053-0052; Remke, Marc/0000-0002-9404-9993; Tabori, Uri/0000-0002-5019-2683; Ramaswamy, Vijay/0000-0002-6557-895X; Weiss, William/0000-0003-2230-9132; Gillespie, George/0000-0001-6436-9542; Mack, Stephen C./0000-0001-9620-4742; delattre, olivier/0000-0002-8730-2276; Korshunov, Andrey/0000-0002-5257-3623; Jackman, Shaun/0000-0002-9275-5966; Zichner, Thomas/0000-0001-9848-7598; Doz, Francois/0000-0001-9286-4831; Wang, Xin/0000-0001-8783-4080; Stuetz, Adrian/0000-0001-7650-3470; Van Meir, Erwin G./0000-0003-2444-7707; iolascon, achille/0000-0002-9558-0356	CIHR Clinician-Scientist Phase II award; Sontag Foundation; Pediatric Brain Tumour Foundation; National Institutes of Health [CA159859]; The Family of Kathleen Lorette; Clark H. Smith Brain Tumour Centre; Montreal Children's Hospital Foundation; Hospital for Sick Children: Sonia and Arthur Labatt Brain Tumour Research Centre; Chief of Research Fund; Cancer Genetics Program; Garron Family Cancer Centre; B.R.A.I.N. Child; CIHR [ATE-110814]; University of Toronto McLaughlin Centre; CIHR Institute of Cancer Research [AT1-112286]; BC Cancer Foundation; Children's Discovery Institute; Restracomp Fellowship (Hospital for Sick Children); Ontario Institute for Cancer Research; Government of Ontario; NIH [CA86335, CA116804, CA138292]; NCI [28XS100, 29XS193]; Southeastern Brain Tumour Foundation; Brain Tumour Foundation for Children; UK Children's Cancer and Leukaemia Group (CCLG) [BS-2007-04]; German Cancer Aid [109252]; Cancer Research UK [13457] Funding Source: researchfish; The Brain Tumour Charity [16/92] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA116804, R01CA121941, P20CA151129, R01CA163737, R01CA148621, P30CA138292, R01CA086335, R01CA109467, R01CA159859, R01CA155360, R01CA114567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061070, K08NS059790] Funding Source: NIH RePORTER	CIHR Clinician-Scientist Phase II award(Canadian Institutes of Health Research (CIHR)); Sontag Foundation; Pediatric Brain Tumour Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Family of Kathleen Lorette; Clark H. Smith Brain Tumour Centre; Montreal Children's Hospital Foundation; Hospital for Sick Children: Sonia and Arthur Labatt Brain Tumour Research Centre; Chief of Research Fund; Cancer Genetics Program; Garron Family Cancer Centre; B.R.A.I.N. Child; CIHR(Canadian Institutes of Health Research (CIHR)); University of Toronto McLaughlin Centre; CIHR Institute of Cancer Research(Canadian Institutes of Health Research (CIHR)); BC Cancer Foundation; Children's Discovery Institute; Restracomp Fellowship (Hospital for Sick Children); Ontario Institute for Cancer Research; Government of Ontario; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Southeastern Brain Tumour Foundation; Brain Tumour Foundation for Children; UK Children's Cancer and Leukaemia Group (CCLG); German Cancer Aid(Deutsche Krebshilfe); Cancer Research UK(Cancer Research UK); The Brain Tumour Charity; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	M. D. T. is the recipient of a CIHR Clinician-Scientist Phase II award, and was formerly a Sontag Distinguished Scholar with funds from the Sontag Foundation. Funding is acknowledged from the Pediatric Brain Tumour Foundation (M. D. T. and J.T.R.), and the National Institutes of Health (CA159859 to M. D. T., R. W. R. and B. W.), The Canadian Cancer Society, Genome Canada, Genome BC, Terry Fox Research Institute, Ontario Institute for Cancer Research, Pediatric Oncology Group Ontario, Funds from 'The Family of Kathleen Lorette' and the Clark H. Smith Brain Tumour Centre, Montreal Children's Hospital Foundation, Hospital for Sick Children: Sonia and Arthur Labatt Brain Tumour Research Centre, Chief of Research Fund, Cancer Genetics Program, Garron Family Cancer Centre, B.R.A.I.N. Child, CIHR (grant no. ATE-110814); the University of Toronto McLaughlin Centre, CIHR Institute of Cancer Research (grant no. AT1-112286) and C17 through the Advancing Technology Innovation through Discovery competition (Project Title: The Canadian Pediatric Cancer Genome Consortium: Translating next-generation sequencing technologies into improved therapies for high-risk childhood cancer). Canada's Michael Smith Genome Sciences Centre is supported by the BC Cancer Foundation. J.R. is supported by The Children's Discovery Institute. P.A.N. was supported by a Restracomp Fellowship (Hospital for Sick Children) and is currently a Roman-Herzog Postdoctoral Fellow (Hertie Foundation). Salary support for L. G. was provided by the Ontario Institute for Cancer Research through funding provided by the Government of Ontario. E. V. G. M. is supported by NIH grants CA86335, CA116804, CA138292, NCI contracts 28XS100 and 29XS193, the Southeastern Brain Tumour Foundation, and the Brain Tumour Foundation for Children. This study includes samples provided by the UK Children's Cancer and Leukaemia Group (CCLG) as part of CCLG-approved biological study BS-2007-04. J.K. and S. P. were supported by a grant from the German Cancer Aid (109252). We thank C. Lu, K. Otaka and The Centre for Applied Genomics for technical assistance. We thank N. S. Devi and Z. Zhang for technical assistance. We thank D. Stoll for project management, S. Archer for technical writing, and P. Paroutis for artwork. The MAGIC project is part of the International Cancer Genome Consortium.	Adamson DC, 2010, CANCER RES, V70, P181, DOI 10.1158/0008-5472.CAN-09-2331; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bizet AA, 2011, BBA-MOL CELL RES, V1813, P742, DOI 10.1016/j.bbamcr.2011.01.028; Bredel M, 2011, NEW ENGL J MED, V364, P627, DOI 10.1056/NEJMoa1006312; Buonamici S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001599; Carramusa L, 2007, J CELL PHYSIOL, V213, P511, DOI 10.1002/jcp.21133; Cho YJ, 2011, J CLIN ONCOL, V29, P1424, DOI 10.1200/JCO.2010.28.5148; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Engelender S, 1999, NAT GENET, V22, P110, DOI 10.1038/8820; Gajjar A, 2006, LANCET ONCOL, V7, P813, DOI 10.1016/S1470-2045(06)70867-1; Giaime E, 2006, J BIOL CHEM, V281, P11515, DOI 10.1074/jbc.M508619200; HANN SR, 1988, CELL, V52, P185, DOI 10.1016/0092-8674(88)90507-7; Jia SJ, 2009, DEV BIOL, V333, P273, DOI 10.1016/j.ydbio.2009.06.037; Li X, 2010, NEUROSCIENCE, V165, P455, DOI 10.1016/j.neuroscience.2009.10.042; Mabbott DJ, 2005, J CLIN ONCOL, V23, P2256, DOI 10.1200/JCO.2005.01.158; Marx FP, 2003, HUM MOL GENET, V12, P1223, DOI 10.1093/hmg/ddg134; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; MOLLER H, 1995, BRIT MED J, V310, P1500, DOI 10.1136/bmj.310.6993.1500; Northcott PA, 2012, NAT REV NEUROL, V8, P340, DOI 10.1038/nrneurol.2012.78; Northcott PA, 2012, ACTA NEUROPATHOL, V123, P615, DOI 10.1007/s00401-011-0899-7; Northcott PA, 2011, ACTA NEUROPATHOL, V122, P231, DOI 10.1007/s00401-011-0846-7; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Northcott PA, 2009, NAT GENET, V41, P465, DOI 10.1038/ng.336; Olsen JH, 2005, BRIT J CANCER, V92, P201, DOI 10.1038/sj.bjc.6602279; Parks WT, 2001, J BIOL CHEM, V276, P19332, DOI 10.1074/jbc.M100606200; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Remke M, 2011, J CLIN ONCOL, V29, P3852, DOI 10.1200/JCO.2011.36.2798; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; SHTIVELMAN E, 1989, MOL CELL BIOL, V9, P1148, DOI 10.1128/MCB.9.3.1148; SHTIVELMAN E, 1990, MOL CELL BIOL, V10, P1835, DOI 10.1128/MCB.10.4.1835; Smith WW, 2010, HUM MOL GENET, V19, P2087, DOI 10.1093/hmg/ddq086; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; Veeriah S, 2010, NAT GENET, V42, P77, DOI 10.1038/ng.491; WANG TW, 1994, SCIENCE, V265, P674, DOI 10.1126/science.7518616; Xiao N, 2012, BIOCHEM J, V441, P979, DOI 10.1042/BJ20111358; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386	40	582	595	1	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 2	2012	488	7409					49	56		10.1038/nature11327	http://dx.doi.org/10.1038/nature11327			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ZE	22832581	Green Published, Green Submitted, Green Accepted, hybrid			2022-12-28	WOS:000307010700030
J	Sheridan, SL; Ware, RS; Grimwood, K; Lambert, SB				Sheridan, Sarah L.; Ware, Robert S.; Grimwood, Keith; Lambert, Stephen B.			Number and Order of Whole Cell Pertussis Vaccines in Infancy and Disease Protection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							VACCINATION		[Sheridan, Sarah L.; Ware, Robert S.; Grimwood, Keith; Lambert, Stephen B.] Univ Queensland, Queensland Childrens Med Res Inst, Brisbane, Qld, Australia	University of Queensland	Sheridan, SL (corresponding author), Univ Queensland, Queensland Childrens Med Res Inst, Brisbane, Qld, Australia.	s.sheridan@uq.edu.au	Lambert, Stephen/N-7819-2019; Hall, Madeline/AGZ-8446-2022; Hall, Madeline/D-1345-2017; Grimwood, Keith/F-9334-2011; Ware, Robert S./B-2024-2014	Lambert, Stephen/0000-0002-2709-193X; Hall, Madeline/0000-0003-1533-5594; Hall, Madeline/0000-0003-1533-5594; Ware, Robert S./0000-0002-6129-6736; Sheridan, Sarah/0000-0002-8451-3027; Grimwood, Keith/0000-0003-3174-9834				Cherry JD, 2010, CLIN VACCINE IMMUNOL, V17, P741, DOI 10.1128/CVI.00469-09; Mascart F, 2007, VACCINE, V25, P391, DOI 10.1016/j.vaccine.2006.06.046; Octavia S, 2012, J INFECT DIS, V205, P1220, DOI 10.1093/infdis/jis178; Torvaldsen S, 2003, EUR J EPIDEMIOL, V18, P63, DOI 10.1023/A:1022588118030; Witt MA, 2012, CLIN INFECT DIS, V54, P1730, DOI 10.1093/cid/cis287; Zhang LJ, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001478.pub4	6	203	206	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2012	308	5					454	456		10.1001/jama.2012.6364	http://dx.doi.org/10.1001/jama.2012.6364			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	981DQ	22851107	Bronze			2022-12-28	WOS:000306947400018
J	Ouellette, AJ; Selsted, ME				Ouellette, Andre J.; Selsted, Michael E.			HD6 Defensin Nanonets	SCIENCE			English	Editorial Material							ALPHA-DEFENSINS; MICROBIOTA		[Ouellette, Andre J.; Selsted, Michael E.] Univ So Calif, USC Norris Canc Ctr, Keck Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90089 USA	University of Southern California	Ouellette, AJ (corresponding author), Univ So Calif, USC Norris Canc Ctr, Keck Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90089 USA.	aouellet@usc.edu						Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Chu HT, 2012, SCIENCE, V337, P477, DOI 10.1126/science.1218831; Ericksen B, 2005, ANTIMICROB AGENTS CH, V49, P269, DOI 10.1128/AAC.49.1.269-275.2005; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Ouellette AJ, 2011, CELL MOL LIFE SCI, V68, P2215, DOI 10.1007/s00018-011-0714-6; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206	9	2	4	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2012	337	6093					420	421		10.1126/science.1225906	http://dx.doi.org/10.1126/science.1225906			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979FS	22837514				2022-12-28	WOS:000306802300028
J	Timmann, C; Thye, T; Vens, M; Evans, J; May, J; Ehmen, C; Sievertsen, J; Muntau, B; Ruge, G; Loag, W; Ansong, D; Antwi, S; Asafo-Adjei, E; Nguah, SB; Kwakye, KO; Akoto, AOY; Sylverken, J; Brendel, M; Schuldt, K; Loley, C; Franke, A; Meyer, CG; Agbenyega, T; Ziegler, A; Horstmann, RD				Timmann, Christian; Thye, Thorsten; Vens, Maren; Evans, Jennifer; May, Juergen; Ehmen, Christa; Sievertsen, Juergen; Muntau, Birgit; Ruge, Gerd; Loag, Wibke; Ansong, Daniel; Antwi, Sampson; Asafo-Adjei, Emanuel; Nguah, Samuel Blay; Kwakye, Kingsley Osei; Akoto, Alex Osei Yaw; Sylverken, Justice; Brendel, Michael; Schuldt, Kathrin; Loley, Christina; Franke, Andre; Meyer, Christian G.; Agbenyega, Tsiri; Ziegler, Andreas; Horstmann, Rolf D.			Genome-wide association study indicates two novel resistance loci for severe malaria	NATURE			English	Article							CEREBRAL MALARIA; ACTIVATION; DISEASES	Malaria causes approximately one million fatalities per year, mostly among African children(1). Although highlighted by the strong protective effect of the sickle-cell trait(2,3), the full impact of human genetics on resistance to the disease remains largely unexplored(4). Genome-wide association (GWA) studies are designed to unravel relevant genetic variants comprehensively; however, in malaria, as in other infectious diseases, these studies have been only partly successful(5). Here we identify two previously unknown loci associated with severe falciparum malaria in patients and controls from Ghana, West Africa. We applied the GWA approach to the diverse clinical syndromes of severe falciparum malaria, thereby targeting human genetic variants influencing any step in the complex pathogenesis of the disease. One of the loci was identified on chromosome 1q32 within the ATP2B4 gene, which encodes the main calcium pump of erythrocytes(6), the host cells of the pathogenic stage of malaria parasites. The second was indicated by an intergenic single nucleotide polymorphism on chromosome 16q22.2, possibly linked to a neighbouring gene encoding the tight-junction protein MARVELD3. The protein is expressed on endothelial cells(7) and might therefore have a role in microvascular damage caused by endothelial adherence of parasitized erythrocytes. We also confirmed previous reports on protective effects of the sickle-cell trait and blood group O-5,O-8,O-9. Our findings underline the potential of the GWA approach to provide candidates for the development of control measures against infectious diseases in humans.	[Timmann, Christian; Thye, Thorsten; Evans, Jennifer; Ehmen, Christa; Sievertsen, Juergen; Muntau, Birgit; Ruge, Gerd; Brendel, Michael; Schuldt, Kathrin; Meyer, Christian G.; Horstmann, Rolf D.] Bernhard Nocht Inst Trop Med, Dept Mol Med, D-20359 Hamburg, Germany; [Timmann, Christian; Thye, Thorsten; Vens, Maren; Brendel, Michael; Loley, Christina; Ziegler, Andreas] Med Univ Lubeck, Inst Med Biometry & Stat, D-23562 Lubeck, Germany; [Evans, Jennifer] Kumasi Ctr Collaborat Res Trop Med, Kumasi, Ghana; [May, Juergen; Loag, Wibke] Bernhard Nocht Inst Trop Med, Infect Dis Epidemiol Grp, D-20359 Hamburg, Germany; [Ansong, Daniel; Antwi, Sampson; Asafo-Adjei, Emanuel; Nguah, Samuel Blay; Kwakye, Kingsley Osei; Akoto, Alex Osei Yaw; Sylverken, Justice; Agbenyega, Tsiri] Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Kumasi, Ghana; [Franke, Andre] Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany	Bernhard Nocht Institut fur Tropenmedizin; University of Lubeck; Kumasi Center for Collaborative Research; Bernhard Nocht Institut fur Tropenmedizin; Kwame Nkrumah University Science & Technology; University of Kiel	Timmann, C (corresponding author), Bernhard Nocht Inst Trop Med, Dept Mol Med, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.	timmann@bnitm.de	Franke, Andre/B-2151-2010; Nguah, Samuel/AAQ-9725-2020; Ziegler, Andreas/G-4246-2012	Franke, Andre/0000-0003-1530-5811; Ziegler, Andreas/0000-0002-8386-5397; ANSONG, Daniel/0000-0003-1328-9117; May, Jurgen/0000-0001-7831-8420	National Genome Research Network of the German Ministry for Education and Research (BMBF) [NGFN1, NGFN2]; Wellcome Trust [WT077383/Z/05/Z]; Foundation for the National Institutes of Health, Bill & Melinda Gates' Grand Challenges in Global Health Initiative [566]	National Genome Research Network of the German Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Wellcome Trust(Wellcome TrustEuropean Commission); Foundation for the National Institutes of Health, Bill & Melinda Gates' Grand Challenges in Global Health Initiative	We thank the participating children, their parents and guardians; L. N. Badu, S. Opoku, M. Attan-Ayibo and D. Sambian for technical assistance. Ethical approval was obtained from the Committee for Research, Publications and Ethics of the School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana. Informed consent was obtained from the parents or guardians of the children and documented by signature, or thumbprint in cases of illiteracy. The study complied with the Ethical Principles for Medical Research Involving Human Subjects as laid out in the Declaration of Helsinki. The study was supported by the National Genome Research Network (NGFN1, NGFN2) of the German Ministry for Education and Research (BMBF). In addition, this study makes use of data generated by MalariaGEN<SUP>5</SUP>. A full list of the investigators who contributed to the generation of the data is available from http://www.malariagen.net. The MalariaGEN Project is supported by the Wellcome Trust (WT077383/Z/05/Z) and by the Foundation for the National Institutes of Health (566) as part of the Bill & Melinda Gates' Grand Challenges in Global Health Initiative.	[Anonymous], 2010, LANCET INFECT DIS, V10, P577, DOI 10.1016/S1473-3099(10)70171-7; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Bridges DJ, 2010, BLOOD, V115, P1472, DOI 10.1182/blood-2009-07-235150; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; Cinel I, 2007, CURR OPIN INFECT DIS, V20, P345, DOI 10.1097/QCO.0b013e32818be70a; de Bakker PIW, 2010, NAT GENET, V42, P731, DOI 10.1038/ng0910-731; Fry AE, 2008, HUM MOL GENET, V17, P567, DOI 10.1093/hmg/ddm331; Gazarini ML, 2003, J CELL BIOL, V161, P103, DOI 10.1083/jcb.200212130; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Idro R, 2010, PEDIATR RES, V68, P267, DOI 10.1203/00006450-201011001-00524; Jallow M, 2009, NAT GENET, V41, P657, DOI 10.1038/ng.388; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Loscertales MP, 2007, ADV PARASIT, V65, P1, DOI 10.1016/S0065-308X(07)65001-5; Mackinnon MJ, 2005, PLOS MED, V2, P1253, DOI 10.1371/journal.pmed.0020340; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; May J, 2007, JAMA-J AM MED ASSOC, V297, P2220, DOI 10.1001/jama.297.20.2220; McMorran BJ, 2009, SCIENCE, V323, P797, DOI 10.1126/science.1166296; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; MOLYNEUX ME, 1989, Q J MED, V71, P441; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; STAUFFER TP, 1995, J BIOL CHEM, V270, P12184, DOI 10.1074/jbc.270.20.12184; Steed E, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-95; Szewczyk MM, 2007, J CELL MOL MED, V11, P129, DOI 10.1111/j.1582-4934.2007.00010.x; Varga-Szabo D, 2009, J THROMB HAEMOST, V7, P1057, DOI 10.1111/j.1538-7836.2009.03455.x; Wassmer SC, 2005, PLOS MED, V2, P885, DOI 10.1371/journal.pmed.0020245	27	165	165	1	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 20	2012	489	7416					443	446		10.1038/nature11334	http://dx.doi.org/10.1038/nature11334			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AK	22895189				2022-12-28	WOS:000308860900048
J	Barthelme, D; Sauer, RT				Barthelme, Dominik; Sauer, Robert T.			Identification of the Cdc48 center dot 20S Proteasome as an Ancient AAA+ Proteolytic Machine	SCIENCE			English	Article							REGULATORY PARTICLE; N-DOMAIN; ATPASE; DEGRADATION; P97/VCP; P97	Proteasomes are the major energy-dependent proteolytic machines in the eukaryotic and archaeal domains of life. To execute protein degradation, the 20S core peptidase combines with the AAA+ ring of the 19S regulatory particle in eukarya or with the AAA+ proteasome-activating nucleotidase ring in some archaea. Here, we find that Cdc48 and 20S from the archaeon Thermoplasma acidophilum interact to form a functional proteasome. Cdc48 is an abundant and essential double-ring AAA+ molecular machine ubiquitously present in archaea, where its function has been uncertain, and in eukarya where Cdc48 participates by largely unknown mechanisms in diverse cellular processes, including multiple proteolytic pathways. Thus, proteolysis in collaboration with the 20S peptidase may represent an ancestral function of the Cdc48 family.	[Barthelme, Dominik; Sauer, Robert T.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Sauer, RT (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	bobsauer@mit.edu	Barthelme, Dominik/E-8452-2010	Sauer, Robert/0000-0002-1719-5399	NIH [AI-16892]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI016892] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank C. Hill, A. Horwich, H. Huber, S. Kim, K. Schmitz, B. Stinson, and M. Wohlever for materials and discussions. Supported by NIH grant AI-16892. The data reported in this manuscript are presented in the main paper and supplementary materials.	Davies JM, 2008, STRUCTURE, V16, P715, DOI 10.1016/j.str.2008.02.010; Gerega A, 2005, J BIOL CHEM, V280, P42856, DOI 10.1074/jbc.M510592200; Kenniston JA, 2003, CELL, V114, P511, DOI 10.1016/S0092-8674(03)00612-3; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Niwa H, 2012, J BIOL CHEM, V287, P8561, DOI 10.1074/jbc.M111.302778; Religa TL, 2010, SCIENCE, V328, P98, DOI 10.1126/science.1184991; Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623; Smith DM, 2005, MOL CELL, V20, P687, DOI 10.1016/j.molcel.2005.10.019; Stadtmueller BM, 2011, MOL CELL, V41, P8, DOI 10.1016/j.molcel.2010.12.020; Stadtmueller BM, 2010, J BIOL CHEM, V285, P13, DOI 10.1074/jbc.C109.070425; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Tang WK, 2010, EMBO J, V29, P2217, DOI 10.1038/emboj.2010.104; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Zhang F, 2009, MOL CELL, V34, P473, DOI 10.1016/j.molcel.2009.04.021; Zhou GY, 2008, J BACTERIOL, V190, P8096, DOI 10.1128/JB.01180-08; Zwickl P, 1999, J BIOL CHEM, V274, P26008, DOI 10.1074/jbc.274.37.26008	17	89	92	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2012	337	6096					843	846		10.1126/science.1224352	http://dx.doi.org/10.1126/science.1224352			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	989BQ	22837385	Green Accepted, Green Submitted			2022-12-28	WOS:000307535600043
J	Watson, RO; Manzanillo, PS; Cox, JS				Watson, Robert O.; Manzanillo, Paolo S.; Cox, Jeffery S.			Extracellular M. tuberculosis DNA Targets Bacteria for Autophagy by Activating the Host DNA-Sensing Pathway	CELL			English	Article							INNATE IMMUNE-RESPONSE; ESX-1 SECRETION SYSTEM; MYCOBACTERIUM-TUBERCULOSIS; PHAGOSOME MATURATION; IL-1-BETA PRODUCTION; MYELOID CELLS; BCG; MACROPHAGES; RECOGNITION; INFECTION	Eukaryotic cells sterilize the cytosol by using autophagy to route invading bacterial pathogens to the lysosome. During macrophage infection with Mycobacterium tuberculosis, a vacuolar pathogen, exogenous induction of autophagy can limit replication, but the mechanism of autophagy targeting and its role in natural infection remain unclear. Here we show that phagosomal permeabilization mediated by the bacterial ESX-1 secretion system allows cytosolic components of the ubiquitin-mediated autophagy pathway access to phagosomal M. tuberculosis. Recognition of extracelluar bacterial DNA by the STING-dependent cytosolic pathway is required for marking bacteria with ubiquitin, and delivery of bacilli to autophagosomes requires the ubiquitin-autophagy receptors p62 and NDP52 and the DNA-responsive kinase TBK1. Remarkably, mice with monocytes incapable of delivering bacilli to the autophagy pathway are extremely susceptible to infection. Our results reveal an unexpected link between DNA sensing, innate immunity, and autophagy and indicate a major role for this autophagy pathway in resistance to M. tuberculosis infection.	[Watson, Robert O.; Manzanillo, Paolo S.; Cox, Jeffery S.] Univ Calif San Francisco, Dept Microbiol & Immunol, Program Microbial Pathogenesis & Host Def, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Cox, JS (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, Program Microbial Pathogenesis & Host Def, San Francisco, CA 94158 USA.	jeffery.cox@ucsf.edu			NIH [PO1 AI063302, RO1 AI081727]; Heiser Foundation Fellowship; Genentech Research Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI063302, R01AI081727] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heiser Foundation Fellowship; Genentech Research Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Vance, G. Barton, D. Monack, G. Barber, N. Mizushima, H. Virgin, and J. Debnath for mice and reagents. We are grateful to S. Johnson and J. Rubenstein for use of their microscopes. We thank S. Bell for critical reading of the manuscript. This work was supported by NIH grants PO1 AI063302 and RO1 AI081727, the Heiser Foundation Fellowship, and the Genentech Research Fellowship.	ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; Barber GN, 2011, NAT IMMUNOL, V12, P929, DOI 10.1038/ni.2118; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Lerena MC, 2011, CELL MICROBIOL, V13, P814, DOI 10.1111/j.1462-5822.2011.01581.x; Cemma M, 2011, AUTOPHAGY, V7, P341, DOI 10.4161/auto.7.3.14046; Collins CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000430; de Jonge MI, 2007, J BACTERIOL, V189, P6028, DOI 10.1128/JB.00469-07; Deretic V, 2009, CURR TOP MICROBIOL, V335, P169, DOI 10.1007/978-3-642-00302-8_8; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Guinn KM, 2004, MOL MICROBIOL, V51, P359, DOI 10.1046/j.1365-2958.2003.03844.x; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hagstrom JE, 1997, J CELL SCI, V110, P2323; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Jagannath C, 2009, NAT MED, V15, P267, DOI 10.1038/nm.1928; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Kudchodkar SB, 2009, REV MED VIROL, V19, P359, DOI 10.1002/rmv.630; Kumar D, 2010, CELL, V140, P731, DOI 10.1016/j.cell.2010.02.012; MacGurn JA, 2007, INFECT IMMUN, V75, P2668, DOI 10.1128/IAI.01872-06; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Manzanillo PS, 2012, CELL HOST MICROBE, V11, P469, DOI 10.1016/j.chom.2012.03.007; McFarlane S, 2011, J VIROL, V85, P4212, DOI 10.1128/JVI.02435-10; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Ohol YM, 2010, CELL HOST MICROBE, V7, P210, DOI 10.1016/j.chom.2010.02.006; Okabe Y, 2009, NATURE, V460, P520, DOI 10.1038/nature08138; Py BF, 2007, AUTOPHAGY, V3, P117, DOI 10.4161/auto.3618; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; Rasmussen SB, 2011, J IMMUNOL, V187, P5268, DOI 10.4049/jimmunol.1100949; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Ryzhakov G, 2007, EMBO J, V26, P3180, DOI 10.1038/sj.emboj.7601743; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Singh R, 2008, NATURE, V455, P1244, DOI 10.1038/nature07344; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Smith J, 2008, INFECT IMMUN, V76, P5478, DOI 10.1128/IAI.00614-08; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; SturgillKoszycki S, 1996, EMBO J, V15, P6960, DOI 10.1002/j.1460-2075.1996.tb01088.x; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tan T, 2006, CELL MICROBIOL, V8, P1417, DOI 10.1111/j.1462-5822.2006.00721.x; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; Tsuchida T, 2010, IMMUNITY, V33, P765, DOI 10.1016/j.immuni.2010.10.013; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Wong KW, 2011, CELL MICROBIOL, V13, P1371, DOI 10.1111/j.1462-5822.2011.01625.x; Yoshikawa Y, 2009, NAT CELL BIOL, V11, P1233, DOI 10.1038/ncb1967; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Yuk JM, 2009, CELL HOST MICROBE, V6, P231, DOI 10.1016/j.chom.2009.08.004; Zhao ZJ, 2008, CELL HOST MICROBE, V4, P458, DOI 10.1016/j.chom.2008.10.003; Zheng YT, 2009, J IMMUNOL, V183, P5909, DOI 10.4049/jimmunol.0900441	55	518	537	4	94	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 17	2012	150	4					803	815		10.1016/j.cell.2012.06.040	http://dx.doi.org/10.1016/j.cell.2012.06.040			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	995IT	22901810	Green Accepted, Bronze			2022-12-28	WOS:000308002300014
J	Yang, WW; Xia, Y; Hawke, D; Li, XJ; Liang, J; Xing, DM; Aldape, K; Hunter, T; Yung, WKA; Lu, ZM				Yang, Weiwei; Xia, Yan; Hawke, David; Li, Xinjian; Liang, Ji; Xing, Dongming; Aldape, Kenneth; Hunter, Tony; Yung, W. K. Alfred; Lu, Zhimin			PKM2 Phosphorylates Histone H3 and Promotes Gene Transcription and Tumorigenesis	CELL			English	Article							PYRUVATE-KINASE M2; BETA-CATENIN TRANSACTIVATION; NUCLEAR TRANSLOCATION; DOWN-REGULATION; METABOLISM; ACTIVATION; EXPRESSION; MITOSIS; GROWTH; EGFR	Tumor-specific pyruvate kinase M2 (PKM2) is essential for the Warburg effect. In addition to its well-established role in aerobic glycolysis, PKM2 directly regulates gene transcription. However, the mechanism underlying this nonmetabolic function of PKM2 remains elusive. We show here that PKM2 directly binds to histone H3 and phosphorylates histone H3 at T11 upon EGF receptor activation. This phosphorylation is required for the dissociation of HDAC3 from the CCND1 and MYC promoter regions and subsequent acetylation of histone H3 at K9. PKM2-dependent histone H3 modifications are instrumental in EGF-induced expression of cyclin D1 and c-Myc, tumor cell proliferation, cell-cycle progression, and brain tumorigenesis. In addition, levels of histone H3 T11 phosphorylation correlate with nuclear PKM2 expression levels, glioma malignancy grades, and prognosis. These findings highlight the role of PKM2 as a protein kinase in its nonmetabolic functions of histone modification, which is essential for its epigenetic regulation of gene expression and tumorigenesis.	[Yang, Weiwei; Xia, Yan; Li, Xinjian; Liang, Ji; Yung, W. K. Alfred; Lu, Zhimin] Univ Texas MD Anderson Canc Ctr, Brain Tumor Ctr, Houston, TX 77030 USA; [Yang, Weiwei; Xia, Yan; Li, Xinjian; Liang, Ji; Yung, W. K. Alfred; Lu, Zhimin] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA; [Hawke, David] Univ Texas MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77030 USA; [Aldape, Kenneth] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Lu, Zhimin] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Xing, Dongming] Tsinghua Univ, Sch Life Sci, Lab Pharmaceut Sci, Beijing 100084, Peoples R China; [Hunter, Tony] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; [Lu, Zhimin] Univ Texas Grad Sch Biomed Sci Houston, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Tsinghua University; Salk Institute	Lu, ZM (corresponding author), Univ Texas MD Anderson Canc Ctr, Brain Tumor Ctr, Houston, TX 77030 USA.	zhiminlu@mdanderson.org		Yang, Weiwei/0000-0002-1661-9137; Hawke, David/0000-0002-6102-7843	National Cancer Institute [2R01CA109035, 5 P50 CA127001-03, CA16672, 2R01CA082683]; Cancer Prevention and Research Institute of Texas (CPRIT) [RP110252]; American Cancer Society Research Scholar Award [RSG-09-277-01-CSM]; University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE [R01CA109035, P30CA016672, P50CA127001, R01CA082683] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Prevention and Research Institute of Texas (CPRIT); American Cancer Society Research Scholar Award(American Cancer Society); University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute grants 2R01CA109035 (Z.L.), 5 P50 CA127001-03, and CA16672 (Cancer Center Support Grant); a research grant (RP110252; Z.L.) from the Cancer Prevention and Research Institute of Texas (CPRIT); an American Cancer Society Research Scholar Award RSG-09-277-01-CSM (Z.L.); and a Sister Institution Network Fund from The University of Texas MD Anderson Cancer Center (Z.L.). T. H. is a Frank and Else Schilling American Cancer Society Professor, and work in his group was supported by National Cancer Institute grant 2R01CA082683.	Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Baek SH, 2011, MOL CELL, V42, P274, DOI 10.1016/j.molcel.2011.03.022; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Dombrauckas JD, 2005, BIOCHEMISTRY-US, V44, P9417, DOI 10.1021/bi0474923; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; Gomez-Manzano C, 2006, CLIN CANCER RES, V12, P556, DOI 10.1158/1078-0432.CCR-05-1892; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hoshino A, 2007, J BIOL CHEM, V282, P17706, DOI 10.1074/jbc.M700094200; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Ji HT, 2009, MOL CELL, V36, P547, DOI 10.1016/j.molcel.2009.09.034; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Lee JS, 2010, CELL, V142, P682, DOI 10.1016/j.cell.2010.08.011; Lee JW, 2008, INT J BIOCHEM CELL B, V40, P1043, DOI 10.1016/j.biocel.2007.11.009; Lu ZM, 2004, CELL CYCLE, V3, P571; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Lu ZM, 1998, MOL CELL BIOL, V18, P839, DOI 10.1128/MCB.18.2.839; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Mazurek S, 2008, ERNST SCHERING FOUND, V4, P99, DOI 10.1007/2789_2008_091; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; MELLATI AA, 1992, CANCER BIOCHEM BIOPH, V13, P33; Metzger E, 2008, NAT CELL BIOL, V10, P53, DOI 10.1038/ncb1668; MOSCATELLO DK, 1995, CANCER RES, V55, P5536; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; NOGUCHI T, 1986, J BIOL CHEM, V261, P3807; Perez-Cadahia B, 2009, BIOCHEM CELL BIOL, V87, P695, DOI 10.1139/O09-053; Preuss U, 2003, NUCLEIC ACIDS RES, V31, P878, DOI 10.1093/nar/gkg176; RESNITZKY D, 1995, MOL CELL BIOL, V15, P3463; Shimada M, 2008, CELL CYCLE, V7, P1555, DOI 10.4161/cc.7.11.6062; Shimada M, 2008, CELL, V132, P221, DOI 10.1016/j.cell.2007.12.013; Stetak A, 2007, CANCER RES, V67, P1602, DOI 10.1158/0008-5472.CAN-06-2870; Suganuma T, 2008, CELL, V135, P604, DOI 10.1016/j.cell.2008.10.036; Taus T, 2011, J PROTEOME RES, V10, P5354, DOI 10.1021/pr200611n; WILLIAMSON JR, 1966, P NATL ACAD SCI USA, V56, P247, DOI 10.1073/pnas.56.1.247; Wykosky Jill, 2011, Chin J Cancer, V30, P5; Xia Y, 2007, MOL CELL, V25, P219, DOI 10.1016/j.molcel.2007.01.005; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598	42	512	533	4	128	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 17	2012	150	4					685	696		10.1016/j.cell.2012.07.018	http://dx.doi.org/10.1016/j.cell.2012.07.018			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	995IT	22901803	Green Accepted, Bronze			2022-12-28	WOS:000308002300005
J	Stark, L; Wessells, M				Stark, Lindsay; Wessells, Mike			Sexual Violence as a Weapon of War	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							WOMEN; CONGO		[Stark, Lindsay; Wessells, Mike] Columbia Univ, Mailman Sch Publ Hlth, Program Forced Migrat & Hlth, New York, NY 10032 USA	Columbia University	Stark, L (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Program Forced Migrat & Hlth, 60 Haven Ave, New York, NY 10032 USA.	ls2302@columbia.edu						Amnesty International, 2004, LIV BLOWN AP CRIM WO; Baaz ME, 2009, INT STUD QUART, V53, P495, DOI 10.1111/j.1468-2478.2009.00543.x; El Jack A., 2003, GENDER ARMED CONFLIC; Harvard Humanitarian Initiative, 2009, CHAR SEX VIOL DEM RE; Human Rights Watch, 2000, KOS RAP WEAP ETHN CL; Johnson K, 2010, JAMA-J AM MED ASSOC, V304, P553, DOI 10.1001/jama.2010.1086; Rees S, 2011, JAMA-J AM MED ASSOC, V306, P513, DOI 10.1001/jama.2011.1098; Stark L, 2010, J EPIDEMIOL COMMUN H, V64, P1056, DOI 10.1136/jech.2009.093799	8	29	29	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2012	308	7					677	678		10.1001/jama.2012.9733	http://dx.doi.org/10.1001/jama.2012.9733			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988NC	22893163				2022-12-28	WOS:000307496700021
J	LaFerla, FM				LaFerla, Frank M.			Preclinical Success against Alzheimer's Disease with an Old Drug	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							BETA		Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Irvine, CA 92717 USA	University of California System; University of California Irvine	LaFerla, FM (corresponding author), Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Irvine, CA 92717 USA.							Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Lowenthal J, 2012, NEW ENGL J MED, V367, P488, DOI 10.1056/NEJMp1203104; Querfurth HW, 2011, NEW ENGL J MED, V364, P588; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142	5	24	24	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 9	2012	367	6					570	572		10.1056/NEJMcibr1204890	http://dx.doi.org/10.1056/NEJMcibr1204890			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	986AE	22873540				2022-12-28	WOS:000307310800014
J	Rai, A				Rai, Arti			Use Patents, Carve-Outs, and Incentives - A New Battle in the Drug-Patent Wars	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Duke Univ, Sch Law, Durham, NC 27706 USA	Duke University	Rai, A (corresponding author), Duke Univ, Sch Law, Durham, NC 27706 USA.							Eisenberg Rebecca S, 2005, Yale J Health Policy Law Ethics, V5, P717; Radley DC, 2006, ARCH INTERN MED, V166, P1021, DOI 10.1001/archinte.166.9.1021; Stevens AJ, 2011, NEW ENGL J MED, V364, P535, DOI 10.1056/NEJMsa1008268; 2003, FED REG, V68, P36683	4	11	11	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 9	2012	367	6					491	493		10.1056/NEJMp1206573	http://dx.doi.org/10.1056/NEJMp1206573			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	986AE	22873529	Green Published			2022-12-28	WOS:000307310800003
J	van Vollenhoven, RF; Fleischmann, R; Cohen, S; Lee, EB; Meijide, JA; Wagner, S; Forejtova, S; Zwillich, SH; Gruben, D; Koncz, T; Wallenstein, GV; Krishnaswami, S; Bradley, JD; Wilkinson, B				van Vollenhoven, Ronald F.; Fleischmann, Roy; Cohen, Stanley; Lee, Eun Bong; Garcia Meijide, Juan A.; Wagner, Sylke; Forejtova, Sarka; Zwillich, Samuel H.; Gruben, David; Koncz, Tamas; Wallenstein, Gene V.; Krishnaswami, Sriram; Bradley, John D.; Wilkinson, Bethanie		ORAL Standard Investigators	Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MODIFYING ANTIRHEUMATIC DRUGS; JAK INHIBITOR; RECOMMENDATIONS; CP-690,550	BACKGROUND Tofacitinib (CP-690,550) is a novel oral Janus kinase inhibitor that is being investigated for the treatment of rheumatoid arthritis. METHODS In this 12-month, phase 3 trial, 717 patients who were receiving stable doses of methotrexate were randomly assigned to 5 mg of tofacitinib twice daily, 10 mg of tofacitinib twice daily, 40 mg of adalimumab once every 2 weeks, or placebo. At month 3, patients in the placebo group who did not have a 20% reduction from baseline in the number of swollen and tender joints were switched in a blinded fashion to either 5 mg or 10 mg of tofacitinib twice daily; at month 6, all patients still receiving placebo were switched to tofacitinib in a blinded fashion. The three primary outcome measures were a 20% improvement at month 6 in the American College of Rheumatology scale (ACR 20); the change from baseline to month 3 in the score on the Health Assessment Questionnaire-Disability Index (HAQ-DI) (which ranges from 0 to 3, with higher scores indicating greater disability); and the percentage of patients at month 6 who had a Disease Activity Score for 28-joint counts based on the erythrocyte sedimentation rate (DAS28-4[ESR]) of less than 2.6 (with scores ranging from 0 to 9.4 and higher scores indicating greater disease activity). RESULTS At month 6, ACR 20 response rates were higher among patients receiving 5 mg or 10 mg of tofacitinib (51.5% and 52.6%, respectively) and among those receiving adalimumab (47.2%) than among those receiving placebo (28.3%) (P<0.001 for all comparisons). There were also greater reductions in the HAQ-DI score at month 3 and higher percentages of patients with a DAS28-4(ESR) below 2.6 at month 6 in the active-treatment groups than in the placebo group. Adverse events occurred more frequently with tofacitinib than with placebo, and pulmonary tuberculosis developed in two patients in the 10-mg tofacitinib group. Tofacitinib was associated with an increase in both low-density and high-density lipoprotein cholesterol levels and with reductions in neutrophil counts. CONCLUSIONS In patients with rheumatoid arthritis receiving background methotrexate, tofacitinib was significantly superior to placebo and was numerically similar to adalimumab in efficacy. (Funded by Pfizer; ORAL Standard ClinicalTrials.govnumber, NCT00853385.)	[van Vollenhoven, Ronald F.] Karolinska Inst, Stockholm, Sweden; [Fleischmann, Roy; Cohen, Stanley] Metroplex Clin Res Ctr, Dallas, TX USA; [Lee, Eun Bong] Seoul Natl Univ, Seoul, South Korea; [Garcia Meijide, Juan A.] Hosp Nuestra Senora Esperanza, Santiago De Compostela, Spain; [Wagner, Sylke] Univ Leipzig, Dept Med 2, Leipzig, Germany; [Forejtova, Sarka] Revmatolog Ustav No 5, Prague, Czech Republic; [Zwillich, Samuel H.; Gruben, David; Wallenstein, Gene V.; Krishnaswami, Sriram; Bradley, John D.; Wilkinson, Bethanie] Pfizer, Groton, CT USA; [Koncz, Tamas] Pfizer, New York, NY USA	Karolinska Institutet; Metroplex Clinical Research Center; Seoul National University (SNU); Leipzig University; Pfizer; Pfizer	Wilkinson, B (corresponding author), Pfizer Inc, 445 Eastern Point Rd,Bldg 98 MS 8260-2517, Groton, CT 06340 USA.	bethanie.wilkinson@pfizer.com	van Vollenhoven, Ronald/ABE-1244-2021; Batalov, Anastas/J-4921-2019; Blanco, Francisco J./C-3192-2014; Forejtova, Sarka/N-7448-2017; Nemec, Petr/B-2483-2013; Lee, Eun Bong/J-2780-2012	Batalov, Anastas/0000-0001-8857-0574; Blanco, Francisco J./0000-0001-9821-7635; Forejtova, Sarka/0000-0002-7510-7895; Lee, Eun Bong/0000-0003-0703-1208; Abud-Mendoza, Carlos/0000-0002-3749-5831	Pfizer	Pfizer(Pfizer)	Supported by Pfizer.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bathon JM, 2008, ARTHRIT RHEUM-ARTHR, V59, P757, DOI 10.1002/art.23723; Breedveld F, 2011, CLIN RHEUMATOL, V30, pS33, DOI 10.1007/s10067-010-1638-5; FELSON DT, 1995, ARTHRITIS RHEUM, V38, P727, DOI 10.1002/art.1780380602; Flanagan ME, 2010, J MED CHEM, V53, P8468, DOI 10.1021/jm1004286; Fleischmann R, 2012, NEW ENGL J MED, V367, P495, DOI 10.1056/NEJMoa1109071; Fransen J, 2005, CLIN EXP RHEUMATOL, V23, pS93; FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202; Ghoreschi K, 2011, J IMMUNOL, V186, P4234, DOI 10.4049/jimmunol.1003668; Hochberg MC, 2008, CURR MED RES OPIN, V24, P469, DOI [10.1185/030079908X261177, 10.1185/030079908X261177 ]; Meyer DM, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-41; O'Dell JR, 2004, NEW ENGL J MED, V350, P2591, DOI 10.1056/NEJMra040226; Saag KG, 2008, ARTHRIT RHEUM-ARTHR, V59, P762, DOI 10.1002/art.23721; Sewgobind VDKD, 2010, AM J TRANSPLANT, V10, P1785, DOI 10.1111/j.1600-6143.2010.03200.x; Simon TA, 2009, ANN RHEUM DIS, V68, P1819, DOI 10.1136/ard.2008.097527; Smolen JS, 2010, ANN RHEUM DIS, V69, P964, DOI 10.1136/ard.2009.126532; Smolen JS, 2011, ANN RHEUM DIS, V70, P1519; Strand V, 2007, AM J MANAG CARE, V13, pS237; Wolfe F, 2007, ARTHRITIS RHEUM, V56, P2886, DOI 10.1002/art.22864	19	633	662	4	56	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 9	2012	367	6					508	519		10.1056/NEJMoa1112072	http://dx.doi.org/10.1056/NEJMoa1112072			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	986AE	22873531				2022-12-28	WOS:000307310800005
J	Naci, H; Cylus, J; Vandoros, S; Sato, A; Perampaladas, K				Naci, Huseyin; Cylus, Jonathan; Vandoros, Sotiris; Sato, Azusa; Perampaladas, Kumar			Raising the bar for market authorisation of new drugs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							COMPARATIVE EFFICACY; INNOVATION; APPROVAL; PRICE; COST		[Naci, Huseyin; Cylus, Jonathan; Vandoros, Sotiris; Sato, Azusa] Univ London London Sch Econ & Polit Sci, LSE Hlth, London WC2A 2AE, England; [Cylus, Jonathan] European Observ Hlth Syst & Policies, London, England; [Perampaladas, Kumar] Natl Inst Hlth & Clin Excellence, London, England	University of London; London School Economics & Political Science; European Observatory on Health Systems & Policies; National Institute for Health & Care Excellence	Cylus, J (corresponding author), Univ London London Sch Econ & Polit Sci, LSE Hlth, Houghton St, London WC2A 2AE, England.	j.d.cylus@lse.ac.uk	Vandoros, Sotiris/AAH-1246-2019	Cylus, Jonathan/0000-0001-8269-1578				Alexander GC, 2011, ANN INTERN MED, V154, P833, DOI 10.7326/0003-4819-154-12-201106210-00012; Angell M., 2005, TRUTH DRUG CO THEY D; Carpenter D, 2010, PRINC STUD AM POLIT, P1; Carrier E, 2010, COMP EFFECTIVENESS R; Cockburn IM, 2006, INNOV POLICY ECON, V7, P1; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Economist Intelligence Unit, 2012, REINV BIOPH STRAT EV; ECORYS Research and Consulting, 2011, COMP EU MARK IND PHA, V1; Eichler HG, 2010, NAT REV DRUG DISCOV, V9, P277, DOI 10.1038/nrd3079; European Medicines Agency, 2010, REFL PAP NEED ACT CO; Gagne JJ, 2011, JAMA-J AM MED ASSOC, V305, P711, DOI 10.1001/jama.2011.152; Gagnon MA, 2008, PLOS MED, V5, P29, DOI 10.1371/journal.pmed.0050001; Garattini S, 2002, BMJ-BRIT MED J, V325, P269, DOI 10.1136/bmj.325.7358.269; Goldberg NH, 2011, JAMA-J AM MED ASSOC, V305, P1786, DOI 10.1001/jama.2011.539; Gottlieb S, 2011, FDA SHOULD NOT COMP; IMAP, PHARM BIOT IND GLOB; Light DW, 2011, BIOSOCIETIES, V6, P34, DOI 10.1057/biosoc.2010.40; Morgan SG, 2005, BMJ-BRIT MED J, V331, P815, DOI 10.1136/bmj.38582.703866.AE; Munos B, 2009, NAT REV DRUG DISCOV, V8, P959, DOI 10.1038/nrd2961; O'Connor AB, 2010, JAMA-J AM MED ASSOC, V303, P979, DOI 10.1001/jama.2010.257; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; Sorenson C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4849; Stafford RS, 2009, NEW ENGL J MED, V361, P1230, DOI 10.1056/NEJMp0906490; US Food and Drug Administration, SIGN DAT US FOOD DRU; van Luijn JCF, 2010, EUR J CLIN PHARMACOL, V66, P445, DOI 10.1007/s00228-010-0808-3; Vernon JA, 2005, HEALTH ECON, V14, P1, DOI 10.1002/hec.897	26	16	16	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 7	2012	345								e4261	10.1136/bmj.e4261	http://dx.doi.org/10.1136/bmj.e4261			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988NA	22872693	Green Submitted			2022-12-28	WOS:000307496500009
J	Abrams, EW; Zhang, H; Marlow, FL; Kapp, L; Lu, SM; Mullins, MC				Abrams, Elliott W.; Zhang, Hong; Marlow, Florence L.; Kapp, Lee; Lu, Sumei; Mullins, Mary C.			Dynamic Assembly of Brambleberry Mediates Nuclear Envelope Fusion during Early Development	CELL			English	Article							MITOTIC SPINDLE; MEMBRANE-FUSION; PROTEIN; ZEBRAFISH; TRANSITION; CLEAVAGE; ZYGOTE; REORGANIZATION; CONGRESSION; INTERPHASE	To accommodate the large cells following zygote formation, early blastomeres employ modified cell divisions. Karyomeres are one such modification, mitotic intermediates wherein individual chromatin masses are surrounded by nuclear envelope; the karyomeres then fuse to form a single mononucleus. We identified brambleberry, a maternal-effect zebrafish mutant that disrupts karyomere fusion, resulting in formation of multiple micronuclei. As karyomeres form, Brambleberry protein localizes to the nuclear envelope, with prominent puncta evident near karyomere-karyomere interfaces corresponding to membrane fusion sites. brambleberry corresponds to an unannotated gene with similarity to Kar5p, a protein that participates in nuclear fusion in yeast. We also demonstrate that Brambleberry is required for pronuclear fusion following fertilization in zebrafish. Our studies provide insight into the machinery required for karyomere fusion and suggest that specialized proteins are necessary for proper nuclear division in large dividing blastomeres.	[Abrams, Elliott W.; Zhang, Hong; Marlow, Florence L.; Kapp, Lee; Lu, Sumei; Mullins, Mary C.] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Mullins, MC (corresponding author), Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, 1211 BRB 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	mullins@mail.med.upenn.edu			NRSA postdoctoral fellowships [5F32GM77835, 1F32GM080926, DRG1826-04];  [R21HD062952];  [R01HD050901];  [R01HD065600];  [T32-HD007516]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007516, R01HD065600] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD050901, R21HD062952] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM077835, F32GM080926] Funding Source: NIH RePORTER	NRSA postdoctoral fellowships; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank V. Lemon for technical assistance; P. Klein, E. Bi, S. DiNardo, and P. Tran for critical reading of the manuscript; the Mullins Lab for thoughtful discussions; and the fish facility staff for maintaining the fish stocks. This work was supported by grants R21HD062952, R01HD050901, and R01HD065600 to M.C.M., training grant T32-HD007516 to E.W.A., and NRSA postdoctoral fellowships 5F32GM77835 to E. W. A., 1F32GM080926 to L. K., and DRG1826-04 to F.L.M.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Anderson DJ, 2008, J CELL BIOL, V182, P911, DOI 10.1083/jcb.200805140; Anderson DJ, 2007, NAT CELL BIOL, V9, P1160, DOI 10.1038/ncb1636; Balakier H, 1997, HUM REPROD, V12, P800, DOI 10.1093/humrep/12.4.800; Baur T, 2007, J CELL SCI, V120, P2895, DOI 10.1242/jcs.010181; Beh CT, 1997, J CELL BIOL, V139, P1063, DOI 10.1083/jcb.139.5.1063; Bownds C, 2010, J EXP BIOL, V213, P3796, DOI 10.1242/jeb.043356; Buch C, 2009, J CELL SCI, V122, P2100, DOI 10.1242/jcs.047373; BURKE B, 1986, CELL, V44, P639, DOI 10.1016/0092-8674(86)90273-4; Cummins J M, 2002, Reprod Biomed Online, V4, P176; Dekens MPS, 2003, DEVELOPMENT, V130, P3907, DOI 10.1242/dev.00606; Dosch R, 2004, DEV CELL, V6, P771, DOI 10.1016/j.devcel.2004.05.002; Ellenberg J, 1997, J CELL BIOL, V138, P1193, DOI 10.1083/jcb.138.6.1193; FERNANDEZ J, 1995, DEV BIOL, V171, P541, DOI 10.1006/dbio.1995.1303; Fichtman B, 2010, MOL BIOL CELL, V21, P4197, DOI 10.1091/mbc.E10-04-0309; Gard DL, 1995, CURR TOP DEV BIOL, V31, P383; GONDOS B, 1972, J CELL SCI, V10, P61; Griffin Jeanine, 2006, J Exp Clin Assist Reprod, V3, P2, DOI 10.1186/1743-1050-3-2; GULYAS BJ, 1972, J CELL BIOL, V55, P533, DOI 10.1083/jcb.55.3.533; HAREL A, 1989, J CELL SCI, V94, P463; Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086; Hetzer MW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000539; Hofmann K., 1993, BIOL CHEM H-S, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Huang QM, 2010, BIOCHEM BIOPH RES CO, V391, P542, DOI 10.1016/j.bbrc.2009.11.094; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jasik Krzysztof, 2006, Wiadomosci Parazytologiczne, V52, P291; Knapik EW, 1996, DEVELOPMENT, V123, P451; KURIHARA LJ, 1994, J CELL BIOL, V126, P911, DOI 10.1083/jcb.126.4.911; Larijani B, 2009, ANNU REV BIOPHYS, V38, P107, DOI 10.1146/annurev.biophys.050708.133625; Lemaitre JM, 1998, J CELL BIOL, V142, P1159, DOI 10.1083/jcb.142.5.1159; LONGO FJ, 1972, J MORPHOL, V138, P207, DOI 10.1002/jmor.1051380206; Lu L, 2011, J CELL BIOL, V194, P425, DOI 10.1083/jcb.201012063; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Malhas A, 2011, TRENDS CELL BIOL, V21, P362, DOI 10.1016/j.tcb.2011.03.008; Melloy P, 2009, MOL BIOL CELL, V20, P3773, DOI 10.1091/mbc.E09-02-0163; MONTAG M, 1988, CHROMOSOMA, V96, P187, DOI 10.1007/BF00302357; Mora-Bermudez F, 2007, NAT CELL BIOL, V9, P822, DOI 10.1038/ncb1606; NEWPORT J, 1992, J CELL BIOL, V116, P295, DOI 10.1083/jcb.116.2.295; NEWPORT J, 1987, CELL, V48, P205, DOI 10.1016/0092-8674(87)90424-7; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; Ohsugi M, 2008, CELL, V132, P771, DOI 10.1016/j.cell.2008.01.029; Pelegri F, 2004, METHOD CELL BIOL, V77, P21; Ramadan K, 2007, NATURE, V450, P1258, DOI 10.1038/nature06388; Rotem A, 2009, MOL BIOL CELL, V20, P4031, DOI 10.1091/mbc.E09-02-0150; ROTHMAN JE, 1994, CURR BIOL, V4, P220, DOI 10.1016/S0960-9822(00)00051-8; Schoft VK, 2003, J CELL SCI, V116, P2505, DOI 10.1242/jcs.00450; TELFORD NA, 1990, MOL REPROD DEV, V26, P90, DOI 10.1002/mrd.1080260113; Tokai N, 1996, EMBO J, V15, P457, DOI 10.1002/j.1460-2075.1996.tb00378.x; Wuhr M, 2008, CURR BIOL, V18, P1256, DOI 10.1016/j.cub.2008.07.092; Wuhr M, 2010, CURR BIOL, V20, P2040, DOI 10.1016/j.cub.2010.10.024; ZAMBONI L, 1972, BIOL REPROD, V7, P170, DOI 10.1093/biolreprod/7.2.170	51	35	36	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 3	2012	150	3					521	532		10.1016/j.cell.2012.05.048	http://dx.doi.org/10.1016/j.cell.2012.05.048			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	985WO	22863006	Green Accepted, Bronze			2022-12-28	WOS:000307301400012
J	Sanchis-Ojeda, R; Fabrycky, DC; Winn, JN; Barclay, T; Clarke, BD; Ford, EB; Fortney, JJ; Geary, JC; Holman, MJ; Howard, AW; Jenkins, JM; Koch, D; Lissauer, JJ; Marcy, GW; Mullally, F; Ragozzine, D; Seader, SE; Still, M; Thompson, SE				Sanchis-Ojeda, Roberto; Fabrycky, Daniel C.; Winn, Joshua N.; Barclay, Thomas; Clarke, Bruce D.; Ford, Eric B.; Fortney, Jonathan J.; Geary, John C.; Holman, Matthew J.; Howard, Andrew W.; Jenkins, Jon M.; Koch, David; Lissauer, Jack J.; Marcy, Geoffrey W.; Mullally, Fergal; Ragozzine, Darin; Seader, Shawn E.; Still, Martin; Thompson, Susan E.			Alignment of the stellar spin with the orbits of a three-planet system	NATURE			English	Article							EXTRASOLAR PLANETS; STAR; STARSPOTS; TRANSITS; MASS	The Sun's equator and the planets' orbital planes are nearly aligned, which is presumably a consequence of their formation from a single spinning gaseous disk. For exoplanetary systems this well-aligned configuration is not guaranteed: dynamical interactions may tilt planetary orbits, or stars may be misaligned with the protoplanetary disk through chaotic accretion(1), magnetic interactions(2) or torques from neighbouring stars. Indeed, isolated 'hot Jupiters' are often misaligned and even orbiting retrograde(3,4). Here we report an analysis of transits of planets over starspots(5-7) on the Sun-like star Kepler-30 (ref. 8), and show that the orbits of its three planets are aligned with the stellar equator. Furthermore, the orbits are aligned with one another to within a few degrees. This configuration is similar to that of our Solar System, and contrasts with the isolated hot Jupiters. The orderly alignment seen in the Kepler-30 system suggests that high obliquities are confined to systems that experienced disruptive dynamical interactions. Should this be corroborated by observations of other coplanar multi-planet systems, then star-disk misalignments would be ruled out as the explanation for the high obliquities of hot Jupiters, and dynamical interactions would be implicated as the origin of hot Jupiters.	[Sanchis-Ojeda, Roberto; Winn, Joshua N.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Fabrycky, Daniel C.; Fortney, Jonathan J.] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Barclay, Thomas; Still, Martin] Bay Area Environm Res Inst, Sonoma, CA 95476 USA; [Barclay, Thomas; Clarke, Bruce D.; Jenkins, Jon M.; Koch, David; Lissauer, Jack J.; Mullally, Fergal; Seader, Shawn E.; Still, Martin; Thompson, Susan E.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Clarke, Bruce D.; Jenkins, Jon M.; Mullally, Fergal; Seader, Shawn E.; Thompson, Susan E.] SETI Inst, Mountain View, CA USA; [Ford, Eric B.] Univ Florida, Bryant Space Sci Ctr 211, Gainesville, FL 32611 USA; [Geary, John C.; Holman, Matthew J.; Ragozzine, Darin] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Howard, Andrew W.; Marcy, Geoffrey W.] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA	Massachusetts Institute of Technology (MIT); University of California System; University of California Santa Cruz; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; State University System of Florida; University of Florida; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of California System; University of California Berkeley	Sanchis-Ojeda, R (corresponding author), MIT, Dept Phys, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	rsanchis86@gmail.com; daniel.fabrycky@gmail.com	Ford, Eric B./AAB-5479-2019; Sanchis-Ojeda, Roberto/B-6574-2013; Ragozzine, Darin/C-4926-2013; Marcy, Geoff/AAC-6050-2019; Fortney, Jonathan/F-8813-2014	Ford, Eric B./0000-0001-6545-639X; Sanchis-Ojeda, Roberto/0000-0002-6193-972X; Barclay, Thomas/0000-0001-7139-2724; Fabrycky, Daniel/0000-0003-3750-0183; Fortney, Jonathan/0000-0002-9843-4354	NASA's Science Mission Directorate; NASA [NAS5-26555]; NASA Office of Space Science [NNX09AF08G]; NASA through Hubble Fellowship [HF-51272.01-A]; STScI; NASA through the Kepler Participating Scientist programme	NASA's Science Mission Directorate; NASA(National Aeronautics & Space Administration (NASA)); NASA Office of Space Science(National Aeronautics & Space Administration (NASA)); NASA through Hubble Fellowship(National Aeronautics & Space Administration (NASA)); STScI(Space Telescope Science Institute); NASA through the Kepler Participating Scientist programme	Kepler was competitively selected as the tenth Discovery mission. Funding for this mission was provided by NASA's Science Mission Directorate. The data presented in this Letter were obtained from the Mikulski Archive for Space Telescopes (MAST). STScI is operated by the Association of Universities for Research in Astronomy, Inc., under NASA contract NAS5-26555. Support for MAST for non-HST data is provided by the NASA Office of Space Science via grant NNX09AF08G and by other grants and contracts. S. Albrecht, E. Agol, J. A. Carter, L. Doyle and A. Shporer provided comments on the manuscript. D. C. F. acknowledges NASA support through Hubble Fellowship grant HF-51272.01-A, awarded by STScI. D. R. acknowledges the Harvard Institute for Theory and Computation. E. B. F., M. J. H. and J.N.W. acknowledge NASA support through the Kepler Participating Scientist programme.	Agol E, 2005, MON NOT R ASTRON SOC, V359, P567, DOI 10.1111/j.1365-2966.2005.08922.x; Bate MR, 2010, MON NOT R ASTRON SOC, V401, P1505, DOI 10.1111/j.1365-2966.2009.15773.x; Borucki WJ, 2010, SCIENCE, V327, P977, DOI 10.1126/science.1185402; Desert JM, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/1/14; Fabrycky DC, 2012, ASTROPHYS J, V750, DOI 10.1088/0004-637X/750/2/114; Fabrycky DC, 2009, ASTROPHYS J, V696, P1230, DOI 10.1088/0004-637X/696/2/1230; Holman MJ, 2010, SCIENCE, V330, P51, DOI 10.1126/science.1195778; Holman MJ, 2005, SCIENCE, V307, P1288, DOI 10.1126/science.1107822; Lissauer JJ, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/1/8; LISSAUER JJ, 1993, ANNU REV ASTRON ASTR, V31, P129, DOI 10.1146/annurev.aa.31.090193.001021; Mandel K, 2002, ASTROPHYS J, V580, pL171, DOI 10.1086/345520; Nutzman PA, 2011, ASTROPHYS J LETT, V740, DOI 10.1088/2041-8205/740/1/L10; Sanchis-Ojeda R, 2011, ASTROPHYS J, V733, DOI 10.1088/0004-637X/733/2/127; SCARGLE JD, 1982, ASTROPHYS J, V263, P835, DOI 10.1086/160554; Triaud AHMJ, 2010, ASTRON ASTROPHYS, V524, DOI 10.1051/0004-6361/201014525; Winn JN, 2005, ASTROPHYS J, V631, P1215, DOI 10.1086/432571; Winn JN, 2010, ASTROPHYS J LETT, V718, pL145, DOI 10.1088/2041-8205/718/2/L145	20	145	146	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2012	487	7408					449	453		10.1038/nature11301	http://dx.doi.org/10.1038/nature11301			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979KD	22836999	Green Submitted, Green Accepted			2022-12-28	WOS:000306815300031
J	Ott, HC				Ott, Harald C.			Engineering tissues for children: building grafts that grow	LANCET			English	Editorial Material							RECONSTRUCTION; AGE		Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Surg, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Ott, HC (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Surg, Boston, MA 02114 USA.	hott@partners.org						Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Boogaard R, 2005, CHEST, V128, P3391, DOI 10.1378/chest.128.5.3391; BOROW KM, 1980, CIRCULATION, V61, P1150, DOI 10.1161/01.CIR.61.6.1150; Cebotari S, 2006, CIRCULATION, V114, pI132, DOI 10.1161/CIRCULATIONAHA.105.001065; Elliott MJ, 2012, J GERONTOL B; Favorito LA, 2004, EARLY HUM DEV, V79, P41, DOI 10.1016/j.earlhumdev.2004.02.004; Grillo HC, 2002, J THORAC CARDIOV SUR, V123, P145, DOI 10.1067/mtc.2002.119068; GRISCOM NT, 1986, AM J ROENTGENOL, V146, P233, DOI 10.2214/ajr.146.2.233; Hibino N, 2010, J THORAC CARDIOV SUR, V139, P431, DOI 10.1016/j.jtcvs.2009.09.057; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Homann M, 2000, EUR J CARDIO-THORAC, V17, P624, DOI 10.1016/S1010-7940(00)00414-0; KALTER H, 1983, NEW ENGL J MED, V308, P424, DOI 10.1056/NEJM198302243080804; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6; Shin'oka T, 2001, NEW ENGL J MED, V344, P532, DOI 10.1056/NEJM200102153440717	15	9	9	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 15	2012	380	9846					957	958		10.1016/S0140-6736(12)60951-9	http://dx.doi.org/10.1016/S0140-6736(12)60951-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	005JF	22841418				2022-12-28	WOS:000308746000010
J	Kahan, D				Kahan, Dan			Why we are poles apart on climate change	NATURE			English	Editorial Material									Yale Univ, Sch Law, New Haven, CT 06520 USA	Yale University	Kahan, D (corresponding author), Yale Univ, Sch Law, New Haven, CT 06520 USA.	dmkahan@gmail.com						Goebbert K, 2012, WEATHER CLIM SOC, V4, P132, DOI 10.1175/WCAS-D-11-00044.1; Kahan DM, 2012, NAT CLIM CHANGE, V2, P732, DOI 10.1038/NCLIMATE1547; Kahan DM, 2011, J RISK RES, V14, P147, DOI 10.1080/13669877.2010.511246	3	112	112	1	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2012	488	7411					255	255		10.1038/488255a	http://dx.doi.org/10.1038/488255a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	988OS	22895298	Bronze			2022-12-28	WOS:000307501000003
J	Hanfling, D; Altevogt, BM; Gostin, LO				Hanfling, Dan; Altevogt, Bruce M.; Gostin, Lawrence O.			A Framework for Catastrophic Disaster Response	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gostin, Lawrence O.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA; [Altevogt, Bruce M.] Georgetown Univ, Ctr Law, Inst Med, Washington, DC 20001 USA; [Hanfling, Dan] Inova Hlth Syst, Falls Church, VA USA	Georgetown University; Georgetown University; Inova Health System	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				[Anonymous], 2009, GUIDANCE ESTABLISHIN; Committee on Guidance for Establishing Crisis Standards of Care for Use in Disaster Situations; Institute of Medicine, 2012, CRISIS STANDARDS CAR; Gostin LO, 2009, JAMA-J AM MED ASSOC, V302, P2365, DOI 10.1001/jama.2009.1780; Hick JL, 2009, DISASTER MED PUBLIC, V3, pS59, DOI 10.1097/DMP.0b013e31819f1ae2; U.S. Department of Health and Human Services (HHS), 2007, MED SURG CAP CAP MAN	5	11	12	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2012	308	7					675	676		10.1001/jama.2012.8171	http://dx.doi.org/10.1001/jama.2012.8171			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988NC	22893162				2022-12-28	WOS:000307496700020
J	Cargnello, M; Jaen, JJD; Garrido, JCH; Bakhmutsky, K; Montini, T; Gamez, JJC; Gorte, RJ; Fornasiero, P				Cargnello, M.; Delgado Jaen, J. J.; Hernandez Garrido, J. C.; Bakhmutsky, K.; Montini, T.; Calvino Gamez, J. J.; Gorte, R. J.; Fornasiero, P.			Exceptional Activity for Methane Combustion over Modular Pd@CeO2 Subunits on Functionalized Al2O3	SCIENCE			English	Article							CATALYTIC COMBUSTION; LOW-TEMPERATURE; NOBLE-METALS; CERIA; OXIDATION; NANOSTRUCTURES; CO; ACTIVATION; DEPOSITION; REDUCTION	There is a critical need for improved methane-oxidation catalysts to both reduce emissions of methane, a greenhouse gas, and improve the performance of gas turbines. However, materials that are currently available either have low activity below 400 degrees C or are unstable at higher temperatures. Here, we describe a supramolecular approach in which single units composed of a palladium (Pd) core and a ceria (CeO2) shell are preorganized in solution and then homogeneously deposited onto a modified hydrophobic alumina. Electron microscopy and other structural methods revealed that the Pd cores remained isolated even after heating the catalyst to 850 degrees C. Enhanced metal-support interactions led to exceptionally high methane oxidation, with complete conversion below 400 degrees C and outstanding thermal stability under demanding conditions.	[Bakhmutsky, K.; Gorte, R. J.] Univ Penn, Dept Chem & Biomol Engn, Philadelphia, PA 19104 USA; [Cargnello, M.; Montini, T.; Fornasiero, P.] Univ Trieste, Consortium INSTM, ICCOM CNR, Dept Chem & Pharmaceut Sci, I-34127 Trieste, Italy; [Delgado Jaen, J. J.; Hernandez Garrido, J. C.; Calvino Gamez, J. J.] Univ Cadiz, Fac Ciencias, Dept Ciencia Mat & Ingn Met & Quim Inorgan, Cadiz 11510, Spain	University of Pennsylvania; Consiglio Nazionale delle Ricerche (CNR); Isituto di Chimica dei Composti Organometallici (ICCOM-CNR); University of Trieste; Universidad de Cadiz	Gorte, RJ (corresponding author), Univ Penn, Dept Chem & Biomol Engn, 311A Towne Bldg,220 S 33rd St, Philadelphia, PA 19104 USA.	gorte@seas.upenn.edu; pfornasiero@units.it	Calvino, José J/L-2605-2017; Hernández-Garrido, J. C./C-5804-2009; Fornasiero, Paolo/J-5758-2019; Cargnello, Matteo/A-2991-2012; Jaen, Juan Jose Delgado/C-4086-2015; Fornasiero, Paolo/B-7279-2011; Montini, Tiziano/G-3363-2011	Hernández-Garrido, J. C./0000-0001-8499-0395; Fornasiero, Paolo/0000-0003-1082-9157; Jaen, Juan Jose Delgado/0000-0001-7956-1166; Fornasiero, Paolo/0000-0003-1082-9157; Montini, Tiziano/0000-0001-9515-566X; Calvino, Jose Juan/0000-0002-0989-1335; Cargnello, Matteo/0000-0002-7344-9031	University of Trieste through FRA; Consorzio Interuniversitario Nazionale per la Scienza e Tecnologia dei Materiali (INSTM); Air Force Office of Scientific Research (Multidisciplinary University Research Initiative) [FA9550-08-1-0309]; Ministry of Science and Innovation of Spain [CSD2009-00013]	University of Trieste through FRA; Consorzio Interuniversitario Nazionale per la Scienza e Tecnologia dei Materiali (INSTM); Air Force Office of Scientific Research (Multidisciplinary University Research Initiative)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)MURI); Ministry of Science and Innovation of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	M. Graziani (University of Trieste) is acknowledged for discussions. M. C., T. M., and P. F. acknowledge financial support from the University of Trieste through FRA 2011 project and Consorzio Interuniversitario Nazionale per la Scienza e Tecnologia dei Materiali (INSTM). R.J.G. and K. B. acknowledge support from the Air Force Office of Scientific Research (Multidisciplinary University Research Initiative) grant FA9550-08-1-0309. J.J.D.J., J.C.H.G., and J.J.C.G. acknowledge financial support through research project CSD2009-00013 from the Ministry of Science and Innovation of Spain. The Electron Microscopy Division of SCCyT at University of Cadiz is acknowledged. Author contributions: M. C., R.J.G., and P. F. conceived the idea for the study. M. C. synthesized the materials. J.J.D.J. performed TEM and STEM investigations, J.C.H.G. performed tomography investigations, and J.J.C.G coordinated the TEM characterization. M. C. performed catalytic tests and characterization of the materials. K. B. and T. M. contributed to the characterization and catalytic testing. M. C., R.J.G., and P. F. wrote the manuscript. All the authors commented on the data and the manuscript.	Bakhmutsky K, 2012, CHEMSUSCHEM, V5, P140, DOI 10.1002/cssc.201100491; Cargnello M, 2010, J AM CHEM SOC, V132, P1402, DOI 10.1021/ja909131k; Colussi S, 2007, CATAL COMMUN, V8, P1263, DOI 10.1016/j.catcom.2006.11.020; Colussi S, 2009, ANGEW CHEM INT EDIT, V48, P8481, DOI 10.1002/anie.200903581; De Rogatis L, 2010, CHEMSUSCHEM, V3, P24, DOI 10.1002/cssc.200900151; Esch F, 2005, SCIENCE, V309, P752, DOI 10.1126/science.1111568; FARRAUTO RJ, 1992, APPL CATAL A-GEN, V81, P227, DOI 10.1016/0926-860X(92)80095-T; Forzatti P, 2003, CATAL TODAY, V83, P3, DOI 10.1016/S0920-5861(03)00211-6; Gelin P, 2002, APPL CATAL B-ENVIRON, V39, P1, DOI 10.1016/S0926-3373(02)00076-0; Gombac V, 2010, J PHYS CHEM A, V114, P3916, DOI 10.1021/jp907242q; Green IX, 2011, SCIENCE, V333, P736, DOI 10.1126/science.1207272; Hinokuma S, 2010, CHEM MATER, V22, P6183, DOI 10.1021/cm102355x; LEHN JM, 1993, SCIENCE, V260, P1762, DOI 10.1126/science.8511582; Lu JL, 2012, SCIENCE, V335, P1205, DOI 10.1126/science.1212906; Mayernick AD, 2011, J CATAL, V278, P16, DOI 10.1016/j.jcat.2010.11.006; Parker AA, 2002, J ADHES SCI TECHNOL, V16, P679, DOI 10.1163/156856102760099889; Paul B, 2011, J COLLOID INTERF SCI, V360, P132, DOI 10.1016/j.jcis.2011.04.055; Rocchini E, 2002, J CATAL, V211, P407, DOI 10.1006/jcat.2002.3719; Sayle TXT, 2012, CHEM MATER, V24, P1811, DOI 10.1021/cm3003436; Tedsree K, 2011, NAT NANOTECHNOL, V6, P302, DOI [10.1038/NNANO.2011.42, 10.1038/nnano.2011.42]; Trovarelli A, 1996, CATAL REV, V38, P439, DOI 10.1080/01614949608006464; Tsyganenko AA, 1996, J CHEM SOC FARADAY T, V92, P4843, DOI 10.1039/ft9969204843; Wei JM, 2004, J PHYS CHEM B, V108, P4094, DOI 10.1021/jp036985z; Wieder NL, 2011, J PHYS CHEM C, V115, P915, DOI 10.1021/jp102965e; Xiao LH, 2005, CATAL COMMUN, V6, P796, DOI 10.1016/j.catcom.2005.07.015; Yeung CMY, 2005, J AM CHEM SOC, V127, P18010, DOI 10.1021/ja056102c; Zarur AJ, 2000, NATURE, V403, P65, DOI 10.1038/47450; Zhou G, 2007, SURF SCI, V601, P2512, DOI 10.1016/j.susc.2007.04.238	28	683	705	61	1344	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2012	337	6095					713	717		10.1126/science.1222887	http://dx.doi.org/10.1126/science.1222887			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986PE	22879514				2022-12-28	WOS:000307354500049
J	Fathi, AT; Chen, YB; Carter, BW; Ryan, RJH				Fathi, Amir T.; Chen, Yi-Bin; Carter, Brett W.; Ryan, Russell J. H.			Case 24-2012: A 38-Year-Old Man with Abdominal Pain and Altered Mental Status	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							T-CELL LEUKEMIA; UMBILICAL-CORD BLOOD; INTERFERON-ALPHA; ARSENIC TRIOXIDE; COMPLETE RESPONSE; BIWEEKLY CHOP; LONG-TERM; PHASE-II; HTLV-I; LEUKEMIA/LYMPHOMA		[Fathi, Amir T.; Chen, Yi-Bin] Massachusetts Gen Hosp, Div Hematol & Med Oncol, Boston, MA 02114 USA; [Fathi, Amir T.; Chen, Yi-Bin] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Carter, Brett W.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Ryan, Russell J. H.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Fathi, Amir T.; Chen, Yi-Bin] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Carter, Brett W.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Ryan, Russell J. H.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Fathi, AT (corresponding author), Massachusetts Gen Hosp, Div Hematol & Med Oncol, Boston, MA 02114 USA.			Ryan, Russell/0000-0001-8174-3962	Otsuka; Seattle Genetics; Millennium; Bayer	Otsuka(Otsuka Pharmaceutical); Seattle Genetics; Millennium(Takeda Pharmaceutical Company Ltd); Bayer(Bayer AG)	Dr. Fathi reports serving as a consultant on advisory boards for Genzyme, Seattle Genetics, Teva Pharmaceuticals, and Concert Pharmaceuticals. Dr. Chen reports receiving consulting fees from Otsuka and Seattle Genetics and grant support to his institution from Otsuka, Millennium, Bayer, and Seattle Genetics. No other potential conflict of interest relevant to this article was reported.	Arisawa K, 2000, INT J CANCER, V85, P319, DOI 10.1002/(SICI)1097-0215(20000201)85:3<319::AID-IJC4>3.0.CO;2-B; Bazarbachi A, 2010, J CLIN ONCOL, V28, P4177, DOI 10.1200/JCO.2010.28.0669; Brunstein CG, 2011, BLOOD, V118, P282, DOI 10.1182/blood-2011-03-344853; Brunstein CG, 2010, BLOOD, V116, P4693, DOI 10.1182/blood-2010-05-285304; Chen YB, 2012, BIOL BLOOD MARROW TR, V18, P805, DOI 10.1016/j.bbmt.2011.10.016; De Oliveira MSP, 1999, INT J CANCER, V83, P291, DOI 10.1002/(SICI)1097-0215(19991029)83:3&lt;291::AID-IJC1&gt;3.0.CO;2-P; Evens AM, 2007, CLIN LYMPHOMA MYELOM, V7, P472, DOI 10.3816/CLM.2007.n.030; Fukushima T, 2005, LEUKEMIA, V19, P829, DOI 10.1038/sj.leu.2403682; GERARD Y, 1995, INT J CANCER, V60, P773, DOI 10.1002/ijc.2910600607; Hanchard B, 1996, J ACQ IMMUN DEF SYND, V13, pS20, DOI 10.1097/00042560-199600001-00005; Harashima N, 2004, CANCER RES, V64, P391, DOI 10.1158/0008-5472.CAN-03-1452; Hermine O, 2004, HEMATOL J, V5, P130, DOI 10.1038/sj.thj.6200374; Hermine Olivier, 2002, Hematol J, V3, P276, DOI 10.1038/sj.thj.6200195; Hishizawa M, 2010, BLOOD, V116, P1369, DOI 10.1182/blood-2009-10-247510; Ishitsuka K, 2007, HAEMATOL-HEMATOL J, V92, P719, DOI 10.3324/haematol.10703; Itoh K, 2002, ANN ONCOL, V13, P1347, DOI 10.1093/annonc/mdf287; Kchour G, 2009, BLOOD, V113, P6528, DOI 10.1182/blood-2009-03-211821; Mahieux R, 2007, HEMATOL MALIG REP, V2, P257; Matsumoto K, 2008, EXP HEMATOL, V36, P390, DOI 10.1016/j.exphem.2007.11.013; Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111; Matsushima T, 1999, INTERNAL MED, V38, P820, DOI 10.2169/internalmedicine.38.820; Matutes E, 2007, J CLIN PATHOL, V60, P1373, DOI 10.1136/jcp.2007.052456; Mone A, 2005, BLOOD, V106, P3380, DOI 10.1182/blood-2005-01-0335; MURPHY EL, 1989, INT J CANCER, V43, P250, DOI 10.1002/ijc.2910430214; Nosaka K, 2002, BLOOD, V99, P634, DOI 10.1182/blood.V99.2.634; O'Connor OA, 2011, J CLIN ONCOL, V29, P1182, DOI 10.1200/JCO.2010.29.9024; Okada Y, 2004, J BONE MINER RES, V19, P1105, DOI 10.1359/JBMR.040314; Okamura J, 2005, BLOOD, V105, P4143, DOI 10.1182/blood-2004-11-4193; Piekarz RL, 2011, BLOOD, V117, P5827, DOI 10.1182/blood-2010-10-312603; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Ravandi F, 2006, LEUKEMIA RES, V30, P103, DOI 10.1016/j.leukres.2005.05.008; Richard V, 2005, LEUKEMIA, V19, P1175, DOI 10.1038/sj.leu.2403787; SHIMOYAMA M, 1991, BRIT J HAEMATOL, V79, P428, DOI 10.1111/j.1365-2141.1991.tb08051.x; Swerdlow SH, 2008, WHO CLASSIFICATION T; TAJIMA K, 1988, INT J CANCER, V41, P505; Takasaki Y, 2010, BLOOD, V115, P4337, DOI 10.1182/blood-2009-09-242347; Tsukasaki K, 2007, J CLIN ONCOL, V25, P5458, DOI 10.1200/JCO.2007.11.9958; UCHIYAMA T, 1977, BLOOD, V50, P481, DOI 10.1182/blood.V50.3.481.481; WATANABE T, 1990, J EXP MED, V172, P759, DOI 10.1084/jem.172.3.759; White JD, 2001, LEUKEMIA LYMPHOMA, V40, P287, DOI 10.3109/10428190109057927; YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031	41	1	1	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 9	2012	367	6					552	563		10.1056/NEJMcpc1110049	http://dx.doi.org/10.1056/NEJMcpc1110049			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	986AE	22873536				2022-12-28	WOS:000307310800011
J	Cruz, M				Cruz, Maria			Inescapable Pull INTRODUCTION	SCIENCE			English	Editorial Material																			0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2012	337	6094					535	535		10.1126/science.337.6094.535	http://dx.doi.org/10.1126/science.337.6094.535			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982PU	22859478				2022-12-28	WOS:000307058700030
J	Bast, B; van Bommel-Slee, D				Bast, Bertine; van Bommel-Slee, Danielle			A Scalp Nevus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bast, Bertine; van Bommel-Slee, Danielle] Ziekenhuis Grp Twente Hosp, Almelo, Netherlands		Bast, B (corresponding author), Ziekenhuis Grp Twente Hosp, Almelo, Netherlands.	d.vbommel@zgt.nl							0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 26	2012	367	4					362	362		10.1056/NEJMicm1109149	http://dx.doi.org/10.1056/NEJMicm1109149			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	978KD	22830466				2022-12-28	WOS:000306738300010
J	Leslie, T; Mikhail, A; Mayan, I; Anwar, M; Bakhtash, S; Nader, M; Chandler, C; Whitty, CJM; Rowland, M				Leslie, Toby; Mikhail, Amy; Mayan, Ismail; Anwar, Mohammed; Bakhtash, Sayed; Nader, Mohammed; Chandler, Clare; Whitty, Christopher J. M.; Rowland, Mark			Overdiagnosis and mistreatment of malaria among febrile patients at primary healthcare level in Afghanistan: observational study	BRITISH MEDICAL JOURNAL			English	Article							RAPID DIAGNOSTIC-TESTS; PLASMODIUM-VIVAX; CHILDREN; TANZANIA; AREA; TRANSMISSION; MISDIAGNOSIS; CHALLENGES; MICROSCOPY; MANAGEMENT	Objective To assess the accuracy of malaria diagnosis and treatment at primary level clinics in Afghanistan. Design Prospective observational study. Setting 22 clinics in two Afghan provinces, one in the north (adjoining Tajikistan) and one in the east (adjoining Pakistan); areas with seasonal transmission of Plasmodium vivax and Plasmodium falciparum. Participants 2357 patients of all ages enrolled if clinicians suspected malaria. Interventions Established (>5 years) microscopy (12 clinics in east Afghanistan), newly established microscopy (five clinics in north Afghanistan), and no laboratory (five clinics in north Afghanistan). All clinics used the national malaria treatment guidelines. Main outcome measures Proportion of patients positive and negative for malaria who received a malaria drug; sensitivity and specificity of clinic based diagnosis; prescriber's response to the result of the clinic slide; and proportion of patients positive and negative for malaria who were prescribed antibiotics. Outcomes were measured against a double read reference blood slide. Results In health centres using clinical diagnosis, although 413 of 414 patients were negative by the reference slide, 412 (99%) received a malaria drug and 47 (11%) received an antibiotic. In clinics using new microscopy, 37% (75/202) of patients who were negative by the reference slide received a malaria drug and 60% (103/202) received an antibiotic. In clinics using established microscopy, 50.8% (645/1269) of patients who were negative by the reference slide received a malaria drug and 27.0% (342/1269) received an antibiotic. Among the patients who tested positive for malaria, 94% (443/472) correctly received a malaria drug but only 1 of 6 cases of falciparum malaria was detected and appropriately treated. The specificity of established and new microscopy was 72.9% and 79.9%, respectively. In response to negative clinic slide results, malaria drugs were prescribed to 270/905 (28.8%) and 32/154 (21%) and antibiotics to 347/930 (37.3%) and 99/154 (64%) patients in established and new microscopy arms, respectively. Nurses were less likely to misprescribe than doctors. Conclusions Despite a much lower incidence of malaria in Afghanistan than in Africa, fever was substantially misdiagnosed as malaria in this south Asian setting. Inaccuracy was attributable to false positive laboratory diagnoses of malaria and the clinicians' disregard of negative slide results. Rare but potentially fatal cases of falciparum malaria were not detected, emphasising the potential role of rapid diagnostic tests. Microscopy increased the proportion of patients treated with antibiotics producing a trade-off between overtreatment with malaria drugs and probable overtreatment with antibiotics.	[Leslie, Toby; Mikhail, Amy; Chandler, Clare; Whitty, Christopher J. M.; Rowland, Mark] London Sch Hyg & Trop Med, London WC1E 7HT, England; [Leslie, Toby; Mikhail, Amy; Mayan, Ismail] Hlth Protect & Res Org, Kabul, Afghanistan; [Anwar, Mohammed; Nader, Mohammed] HealthNet TPO, Karte Se, Kabul, Afghanistan; [Bakhtash, Sayed] Med Emergency Relief Int, Kabul, Afghanistan	University of London; London School of Hygiene & Tropical Medicine	Leslie, T (corresponding author), London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	toby.leslie@lshtm.ac.uk	nader, mohammed/AAH-3475-2021	nader, mohammed/0000-0002-9994-9077; Chandler, Clare/0000-0001-6499-7522; Whitty, Christopher/0000-0002-6076-5027; Mikhail, Amy Frances Wahid/0000-0003-3414-2173	Bill and Melinda Gates Foundation as part of the ACT Consortium; London School of Hygiene and Tropical Medicine	Bill and Melinda Gates Foundation as part of the ACT Consortium; London School of Hygiene and Tropical Medicine	The study was funded by a grant from the Bill and Melinda Gates Foundation as part of the ACT Consortium (www.actconsortium.org) and sponsored by the London School of Hygiene and Tropical Medicine. Neither the funder nor sponsor had any role in the design or conduct of the study, analysis or interpretation of the data, or in the decision to publish.	A-Elgayoum SME, 2009, DIAGN MICR INFEC DIS, V64, P20, DOI 10.1016/j.diagmicrobio.2009.01.029; Acerra JR, 2009, INT J EMERG MED, V2, P77, DOI 10.1007/s12245-009-0106-y; Ansah EK, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c930; Anstey NM, 2009, TRENDS PARASITOL, V25, P220, DOI 10.1016/j.pt.2009.02.003; Ashton RA, MALAR J, V9, P297; Bailey MS, 2011, J ROY ARMY MED CORPS, V157, P150, DOI 10.1136/jramc-157-02-05; Berkley JA, 2005, BMJ-BRIT MED J, V330, P995, DOI 10.1136/bmj.38408.471991.8F; Bisoffi Z, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000063; Brent AJ, 2006, LANCET, V367, P482, DOI 10.1016/S0140-6736(06)68180-4; Brooker S, 2006, EMERG INFECT DIS, V12, P1600, DOI 10.3201/eid1210.060051; Chandler CI, MALAR J, V9, P95; Chandler CIR, 2008, TROP MED INT HEALTH, V13, P1131, DOI 10.1111/j.1365-3156.2008.02118.x; Chandler CIR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-53; Chandramohan D, 2002, TROP MED INT HEALTH, V7, P45, DOI 10.1046/j.1365-3156.2002.00827.x; Guerra CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000774; Hamer DH, 2007, JAMA-J AM MED ASSOC, V297, P2227, DOI 10.1001/jama.297.20.2227; Hay SI, PLOS MED, V7; Joshi R, 2008, AM J TROP MED HYG, V78, P393, DOI 10.4269/ajtmh.2008.78.393; Kolaczinski J, 2005, LANCET, V365, P1506, DOI 10.1016/S0140-6736(05)66423-9; Lubell Y, 2008, BMJ-BRIT MED J, V336, P202, DOI 10.1136/bmj.39395.696065.47; Luxemburger C, 1998, T ROY SOC TROP MED H, V92, P45, DOI 10.1016/S0035-9203(98)90950-6; Mtove G, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-290; Mtove G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009244; Nadjm B, BMJ             0617, V340, pc1350; Nankabirwa J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-66; Peters DH, 2007, B WORLD HEALTH ORGAN, V85, P146, DOI 10.2471/BLT.06.033746; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Rowland M, 2002, SOC SCI MED, V55, P2061, DOI 10.1016/S0277-9536(01)00341-0; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; Wallace MR, 2002, CLIN INFECT DIS, V34, pS171, DOI 10.1086/340704; Weber MW, 1997, B WORLD HEALTH ORGAN, V75, P25; Whitty CJM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S7; WHO, 2010, GUID TREATM MAL; WHO, 2010, GUID TREATM MAL, V2nd; Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119, DOI 10.4269/ajtmh.2007.77.119; Yeboah-Antwi K, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000340; Zurovac D, 2008, AM J TROP MED HYG, V78, P884, DOI 10.4269/ajtmh.2008.78.884	37	47	49	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUL 24	2012	345								e4389	10.1136/bmj.e4389	http://dx.doi.org/10.1136/bmj.e4389			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	981UQ	22833603	Green Published, Green Submitted, Green Accepted, hybrid			2022-12-28	WOS:000306996900001
J	Sare, J				Sare, Jeremy			Tensions between drug use policies and infection control	BRITISH MEDICAL JOURNAL			English	Editorial Material												jeremysare@btinternet.com						Cseste J, 2012, INT J DRUG POLICY, V23, P82; Glaister Dan, 2009, GUARDIAN; Global Commission on Drug Policy, 2012, WAR DRUGS HIV AIDS C; Hughes CE, 2010, BRIT J CRIMINOL, V50, P999, DOI 10.1093/bjc/azq038; Inter-Ministerial Group on Drugs, 2012, PUTT FULL REC 1; Mozynski P, 2012, BMJ             0617, V344; United Nations Office on Drugs and Crime, WORLD DRUG REP 2012	7	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUL 23	2012	345								e4930	10.1136/bmj.e4930	http://dx.doi.org/10.1136/bmj.e4930			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	981UP	22826579				2022-12-28	WOS:000306996800010
J	Whipple, C				Whipple, Clinton			Defining the Plant Germ Line-Nature or Nurture?	SCIENCE			English	Editorial Material							ARABIDOPSIS; SPOROGENESIS; ROXY1; GENE		Brigham Young Univ, Dept Biol, Provo, UT 84602 USA	Brigham Young University	Whipple, C (corresponding author), Brigham Young Univ, Dept Biol, Provo, UT 84602 USA.	whipple@byu.edu	Whipple, Clinton/C-3972-2016	Whipple, Clinton/0000-0001-7879-235X				Hord CLH, 2006, PLANT CELL, V18, P1667, DOI 10.1105/tpc.105.036871; Hord Carey L. H., 2008, V9, P361, DOI 10.1007/7089_2007_136; Juliano C, 2010, SCIENCE, V329, P640, DOI 10.1126/science.1194037; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Kelliher T, 2012, SCIENCE, V337, P345, DOI 10.1126/science.1220080; Li S, 2009, PLANT CELL, V21, P429, DOI 10.1105/tpc.108.064477; Schiefthaler U, 1999, P NATL ACAD SCI USA, V96, P11664, DOI 10.1073/pnas.96.20.11664; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Tsukagoshi H, 2010, CELL, V143, P606, DOI 10.1016/j.cell.2010.10.020; Xing S, 2008, PLANT J, V53, P790, DOI 10.1111/j.1365-313X.2007.03375.x; Yang SL, 2003, PLANT CELL, V15, P2792, DOI 10.1105/tpc.016618; Yang WC, 1999, GENE DEV, V13, P2108, DOI 10.1101/gad.13.16.2108	12	14	14	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2012	337	6092					301	302		10.1126/science.1224362	http://dx.doi.org/10.1126/science.1224362			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975WQ	22822136				2022-12-28	WOS:000306542600036
J	Wandt, H; Schaefer-Eckart, K; Wendelin, K; Pilz, B; Wilhelm, M; Thalheimer, M; Mahlknecht, U; Ho, A; Schaich, M; Kramer, M; Kaufmann, M; Leimer, L; Schwerdtfeger, R; Conradi, R; Dolken, G; Klenner, A; Hanel, M; Herbst, R; Junghanss, C; Ehninger, G				Wandt, Hannes; Schaefer-Eckart, Kerstin; Wendelin, Knut; Pilz, Bettina; Wilhelm, Martin; Thalheimer, Markus; Mahlknecht, Ulrich; Ho, Anthony; Schaich, Markus; Kramer, Michael; Kaufmann, Martin; Leimer, Lothar; Schwerdtfeger, Rainer; Conradi, Roland; Doelken, Gottfried; Klenner, Anne; Haenel, Mathias; Herbst, Regina; Junghanss, Christian; Ehninger, Gerhard		Study Alliance Leukemia	Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study	LANCET			English	Article							STRATEGY; CANCER; SAFE	Background Routine prophylactic platelet transfusion is the standard of care for patients with severe thrombocytopenia. We assessed the effect of a new strategy of therapeutic platelet transfusion on the number of transfusions and safety in patients with hypoproliferative thrombocytopenia. Methods We did a multicentre, open-label, randomised parallel-group trial at eight haematology centres in Germany. Patients aged 16-80 years, who were undergoing intensive chemotherapy for acute myeloid leukaemia or autologous haemopoietic stem-cell transplantation for haematological cancers, were randomly assigned via a computer-generated randomisation sequence to receive either platelet transfusion when bleeding occurred (therapeutic strategy) or when morning platelet counts were 10x10(9) per L or lower (prophylactic strategy). Investigators undertaking interventions were not masked to group assignment. The primary endpoint was the number of platelet transfusions. Analysis was by intention to treat. This trial is registered, NCT00521664. Findings 197 patients were assigned the prophylactic strategy and 199 the therapeutic strategy. Of 391 patients analysed, the therapeutic strategy reduced the mean number of platelet transfusions by 33.5% (95% CI 22.2-43.1; p<0.0001) in all patients (2.44 [2.22-2.67] in prophylactic group vs 1.63 [1.42-1.83] in therapeutic group), 31.6% (18.6-42.6; p<0.0001) in those with acute myeloid leukaemia (2.68 [2.35-3.01] vs 1.83 [1.58-2.10]), and 34.2% (6.6-53.7; p=0.0193) in those who had had autologous transplantation (1.80 [1.45-2.15] vs 1.18 [0.82-1.55]. We noted no increased risk of major haemorrhage in patients who had undergone autologous transplantation. In those with acute myeloid leukaemia, risk of non-fatal grade 4 (mostly CNS) bleeding was increased. We recorded 15 cases of non-fatal haemorrhage: four retinal in each transfusion group, and one vaginal and six cerebral in the therapeutic group. 12 patients died in the study: two from fatal cerebral haemorrhages in the therapeutic group, and ten (five in each treatment group) unrelated to major bleeding. Interpretation The therapeutic strategy could become a new standard of care after autologous stem-cell transplantation; however, prophylactic platelet transfusion should remain the standard for patients with acute myeloid leukaemia. The new strategy should be used by some haematology centres only if the staff are well educated and experienced in the new approach and can react in a timely way to first signs of CNS bleeding.	[Wandt, Hannes; Schaefer-Eckart, Kerstin; Wendelin, Knut; Wilhelm, Martin] Klinikum Nurnberg, Med Klin 5, D-90419 Nurnberg, Germany; [Thalheimer, Markus; Mahlknecht, Ulrich; Ho, Anthony] Heidelberg Univ, Med Dept 5, Heidelberg, Germany; [Schaich, Markus; Kramer, Michael; Ehninger, Gerhard] Tech Univ Dresden, Med Clin 1, D-01062 Dresden, Germany; [Kaufmann, Martin; Leimer, Lothar] Robert Bosch Krankenhaus, Stuttgart, Germany; [Schwerdtfeger, Rainer; Conradi, Roland] Deutsch Klin Diagnost, Med Ctr, Wiesbaden, Germany; [Doelken, Gottfried; Klenner, Anne] Ernst Moritz Arndt Univ Greifswald, Greifswald, Germany; [Haenel, Mathias] Klinikum Chemnitz, Med Clin 3, Chemnitz, Germany; [Junghanss, Christian] Univ Rostock, Med Clin 3, Rostock, Germany	Klinikum Nurnberg Nord; Ruprecht Karls University Heidelberg; Technische Universitat Dresden; Bosch; Robert Bosch Krankenhaus; Ernst Moritz Arndt Universitat Greifswald; Chemnitz Clinic; University of Rostock	Wandt, H (corresponding author), Klinikum Nurnberg, Med Klin 5, D-90419 Nurnberg, Germany.	wandt@klinikum-nuernberg.de	Haenel, Mathias Hänel/AAF-2220-2021; Wilhelm, Martin/J-3964-2014	Conradi, Roland/0000-0003-4645-3569; Kramer, Michael/0000-0002-0251-2726	Deutsche Krebshilfe eV (German Cancer Aid); Deutsche Krebshilfe [106226]	Deutsche Krebshilfe eV (German Cancer Aid)(Deutsche Krebshilfe); Deutsche Krebshilfe(Deutsche Krebshilfe)	Deutsche Krebshilfe eV (German Cancer Aid).; The study was supported by a grant from the Deutsche Krebshilfe (number 106226).	Bernstein SH, 1998, BLOOD, V91, P3509, DOI 10.1182/blood.V91.9.3509.3509_3509_3517; Blajchman Morris A, 2008, Hematology Am Soc Hematol Educ Program, P198, DOI 10.1182/asheducation-2008.1.198; Bux J, 2005, VOX SANG, V89, P1, DOI 10.1111/j.1423-0410.2005.00648.x; Friedmann AM, 2002, TRANSFUS MED REV, V16, P34, DOI 10.1053/tmrv.2002.29403; Heddle NM, 2006, TRANSFUSION, V46, P903, DOI 10.1111/j.1537-2995.2006.00822.x; Higby DJ, 1974, TRANSFUSION, V43, P742; McCullough J, 2004, BLOOD, V104, P1534, DOI 10.1182/blood-2003-12-4443; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; MURPHY S, 1982, AM J HEMATOL, V12, P347, DOI 10.1002/ajh.2830120406; PATTEN E, 1992, TRANSFUSION, V32, P381, DOI 10.1046/j.1537-2995.1992.32492263455.x; Rebulla P, 1997, NEW ENGL J MED, V337, P1870, DOI 10.1056/NEJM199712253372602; Sagmeister M, 1999, BLOOD, V93, P3124; Schiffer CA, 2001, J CLIN ONCOL, V19, P1519, DOI 10.1200/JCO.2001.19.5.1519; SCHIFFER CA, 1992, TRANSFUSION, V32, P295, DOI 10.1046/j.1537-2995.1992.32492263438.x; Slichter SJ, 2010, NEW ENGL J MED, V362, P600, DOI 10.1056/NEJMoa0904084; Slichter SJ, 2004, TRANSFUS MED REV, V18, P153, DOI 10.1016/j.tmrv.2004.03.003; SOLOMON J, 1978, LANCET, V1, P267; Stanworth SJ, 2005, BRIT J HAEMATOL, V131, P588, DOI 10.1111/j.1365-2141.2005.05769.x; STANWORTH SJ, 2004, COCHRANE DB SYST REV, V2; Wandt H, 2005, BLOOD, V106, p129A; Wandt H, 2006, BONE MARROW TRANSPL, V37, P387, DOI 10.1038/sj.bmt.1705246	21	218	218	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 13	2012	380	9850					1309	1316		10.1016/S0140-6736(12)60689-8	http://dx.doi.org/10.1016/S0140-6736(12)60689-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	022BZ	22877506				2022-12-28	WOS:000309931400029
J	Lane, JE; Kruuk, LEB; Charmantier, A; Murie, JO; Dobson, FS				Lane, Jeffrey E.; Kruuk, Loeske E. B.; Charmantier, Anne; Murie, Jan O.; Dobson, F. Stephen			Delayed phenology and reduced fitness associated with climate change in a wild hibernator	NATURE			English	Article							COLUMBIAN GROUND-SQUIRRELS; SPERMOPHILUS-COLUMBIANUS; PHENOTYPIC PLASTICITY; SPRING EMERGENCE; MIGRATORY BIRD; BODY-MASS; POPULATION; PATTERNS	The most commonly reported ecological effects of climate change are shifts in phenologies, in particular of warmer spring temperatures leading to earlier timing of key events(1,2). Among animals, however, these reports have been heavily biased towards avian phenologies, whereas we still know comparatively little about other seasonal adaptations, such as mammalian hibernation. Here we show a significant delay (0.47 days per year, over a 20-year period) in the hibernation emergence date of adult females in a wild population of Columbian ground squirrels in Alberta, Canada. This finding was related to the climatic conditions at our study location: owing to within-individual phenotypic plasticity, females emerged later during years of lower spring temperature and delayed snowmelt. Although there has not been a significant annual trend in spring temperature, the date of snowmelt has become progressively later owing to an increasing prevalence of late-season snowstorms. Importantly, years of later emergence were also associated with decreased individual fitness. There has consequently been a decline in mean fitness (that is, population growth rate) across the past two decades. Our results show that plastic responses to climate change may be driven by climatic trends other than increasing temperature, and may be associated with declines in individual fitness and, hence, population viability.	[Lane, Jeffrey E.; Kruuk, Loeske E. B.] Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland; [Lane, Jeffrey E.; Charmantier, Anne; Dobson, F. Stephen] CNRS, Ctr Ecol Fonct & Evolut, Unite Mixte Rech 5175, F-34293 Montpellier 5, France; [Lane, Jeffrey E.; Murie, Jan O.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Dobson, F. Stephen] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA	University of Edinburgh; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; University of Alberta; Auburn University System; Auburn University	Lane, JE (corresponding author), Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland.	u.columbianus@hotmail.com	Kruuk, Loeske/AAB-8714-2019; Dobson, F. Stephen/R-7310-2019; Murie, Jan/F-3663-2014; Kruuk, Loeske E. B./J-3295-2012	Kruuk, Loeske/0000-0001-8588-1123; Murie, Jan/0000-0002-2658-4986; Kruuk, Loeske E. B./0000-0001-8588-1123; Dobson, F. Stephen/0000-0001-5562-6316	Natural Sciences and Engineering Research Council of Canada (NSERC); National Science Foundation [DEB-0089473]; Royal Society of London; Agence Nationale de la Recherche of France [ANR-08-JCJC-0041-01]; Alberta Conservation Association	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Science Foundation(National Science Foundation (NSF)); Royal Society of London(Royal Society of London); Agence Nationale de la Recherche of France(French National Research Agency (ANR)); Alberta Conservation Association	We thank the volunteers and assistants who helped with fieldwork, and the University of Calgary for providing accommodation at the Biogeosciences Institute (E. Johnson and J. Buchanan-Mappin). D. Stralberg, S. Boutin and E. Bayne provided comments and assistance that improved an earlier version of this paper, and M. Low wrote the R script to calculate the spring temperature climate window. Funding was provided by the Natural Sciences and Engineering Research Council of Canada (NSERC) (J.O.M. and S. Boutin (University of Alberta)), National Science Foundation (DEB-0089473) (F. S. D.), the Royal Society of London (J. E. L. and L. E. B. K) and Agence Nationale de la Recherche of France (ANR-08-JCJC-0041-01) (A. C., F. S. D. and J. E. L.) and the Alberta Conservation Association (J. E. L.). All protocols were approved by the Life and Environmental Sciences Animal Care Committee at the University of Calgary as well as the Animal Care and Use Committee at the University of Alberta (1992 to 1998) or the Institutional Animal Care and Use Committee at Auburn University (1999 to 2011).	BOAG DA, 1981, CAN J ZOOL, V59, P999, DOI 10.1139/z81-139; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Both C, 2009, J ANIM ECOL, V78, P73, DOI 10.1111/j.1365-2656.2008.01458.x; Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; CHRISTENSEN JH, 2007, PHYS SCI BASIS CONTR, P847; Dai B., 2008, IME4 LINEAR MIXED EF; DOBSON FS, 1992, CAN J ZOOL, V70, P1364, DOI 10.1139/z92-192; DOBSON FS, 1987, AM NAT, V129, P382, DOI 10.1086/284643; GEISER F, 1995, PHYSIOL ZOOL, V68, P935, DOI 10.1086/physzool.68.6.30163788; Humphries MM, 2003, PHYSIOL BIOCHEM ZOOL, V76, P165, DOI 10.1086/367950; Intergovernmental Panel on Climate Change, 2007, PHYS SCI BAS CONTR W; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.2307/2408842; Lane JE, 2011, J EVOLUTION BIOL, V24, P1949, DOI 10.1111/j.1420-9101.2011.02334.x; MICHENER GR, 1983, BEHAV ECOL SOCIOBIOL, V14, P29, DOI 10.1007/BF00366653; MICHENER GR, 1977, CAN J ZOOL, V55, P693, DOI 10.1139/z77-091; Moller AP, 2008, P NATL ACAD SCI USA, V105, P16195, DOI 10.1073/pnas.0803825105; MURIE JO, 1982, J MAMMAL, V63, P431, DOI 10.2307/1380440; MURIE JO, 1980, J MAMMAL, V61, P237, DOI 10.2307/1380044; Nussey DH, 2007, J EVOLUTION BIOL, V20, P831, DOI 10.1111/j.1420-9101.2007.01300.x; Ozgul A, 2010, NATURE, V466, P482, DOI 10.1038/nature09210; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Qvarnstrom A, 2006, NATURE, V441, P84, DOI 10.1038/nature04564; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Saether BE, 1999, J ANIM ECOL, V68, P628, DOI 10.1046/j.1365-2656.1999.00314.x; Saino N, 2011, P ROY SOC B-BIOL SCI, V278, P835, DOI 10.1098/rspb.2010.1778; Thackeray SJ, 2010, GLOBAL CHANGE BIOL, V16, P3304, DOI 10.1111/j.1365-2486.2010.02165.x; van de Pol MV, 2009, ANIM BEHAV, V77, P753, DOI 10.1016/j.anbehav.2008.11.006; Visser ME, 2008, P ROY SOC B-BIOL SCI, V275, P649, DOI 10.1098/rspb.2007.0997; Whiteman C.D., 2000, MOUNTAIN METEOROLOGY; WIGGETT DR, 1989, CAN J ZOOL, V67, P42, DOI 10.1139/z89-007	31	168	172	4	266	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2012	489	7417					554	+		10.1038/nature11335	http://dx.doi.org/10.1038/nature11335			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	046RG	22878721				2022-12-28	WOS:000311781500001
J	Fairall, L; Bachmann, MO; Lombard, C; Timmerman, V; Uebel, K; Zwarenstein, M; Boulle, A; Georgeu, D; Colvin, CJ; Lewin, S; Faris, G; Cornick, R; Draper, B; Tshabalala, M; Kotze, E; van Vuuren, C; Steyn, D; Chapman, R; Bateman, E				Fairall, Lara; Bachmann, Max O.; Lombard, Carl; Timmerman, Venessa; Uebel, Kerry; Zwarenstein, Merrick; Boulle, Andrew; Georgeu, Daniella; Colvin, Christopher J.; Lewin, Simon; Faris, Gill; Cornick, Ruth; Draper, Beverly; Tshabalala, Mvula; Kotze, Eduan; van Vuuren, Cloete; Steyn, Dewald; Chapman, Ronald; Bateman, Eric			Task shifting of antiretroviral treatment from doctors to primary-care nurses in South Africa (STRETCH): a pragmatic, parallel, cluster-randomised trial	LANCET			English	Article							EDUCATIONAL OUTREACH; STREAMLINING TASKS; CLINICAL-OUTCOMES; EXPAND TREATMENT; HIV/AIDS CARE; PALSA PLUS; HIV-CARE; PROGRAM; INTERVENTION; INTEGRATION	Background Robust evidence of the effectiveness of task shifting of antiretroviral therapy (ART) from doctors to other health workers is scarce. We aimed to assess the effects on mortality, viral suppression, and other health outcomes and quality indicators of the Streamlining Tasks and Roles to Expand Treatment and Care for HIV (STRETCH) programme, which provides educational outreach training of nurses to initiate and represcribe ART, and to decentralise care. Methods We undertook a pragmatic, parallel, cluster-randomised trial in South Africa between Jan 28, 2008, and June 30, 2010. We randomly assigned 31 primary-care ART clinics to implement the STRETCH programme (intervention group) or to continue with standard care (control group). The ratio of randomisation depended on how many clinics were in each of nine strata. Two cohorts were enrolled: eligible patients in cohort 1 were adults (aged >= 16 years) with CD4 counts of 350 cells per mu L or less who were not receiving ART; those in cohort 2 were adults who had already received ART for at least 6 months and were being treated at enrolment. The primary outcome in cohort 1 was time to death (superiority analysis). The primary outcome in cohort 2 was the proportion with undetectable viral loads (<400 copies per mL) 12 months after enrolment (equivalence analysis, prespecified difference <6%). Patients and clinicians could not be masked to group assignment. The interim analysis was blind, but data analysts were not masked after the database was locked for final analysis. Analyses were done by intention to treat. This trial is registered, number ISRCTN46836853. Findings 5390 patients in cohort 1 and 3029 in cohort 2 were in the intervention group, and 3862 in cohort 1 and 3202 in cohort 2 were in the control group. Median follow-up was 16.3 months (IQR 12.2-18.0) in cohort 1 and 18.0 months (18.0-18.0) in cohort 2. In cohort 1, 997 (20%) of 4943 patients analysed in the intervention group and 747 (19%) of 3862 in the control group with known vital status at the end of the trial had died. Time to death did not differ (hazard ratio [HR] 0.94, 95% CI 0.76-1.15). In a preplanned subgroup analysis of patients with baseline CD4 counts of 201-350 cells per mu L, mortality was slightly lower in the intervention group than in the control group (0.73, 0.54-1.00; p=0.052), but it did not diff er between groups in patients with baseline CD4 of 200 cells per mu L or less (0.94, 0.76-1.15; p=0.577). In cohort 2, viral load suppression 12 months after enrolment was equivalent in intervention (2156 [71%] of 3029 patients) and control groups (2230 [70%] of 3202; risk difference 1.1%, 95% CI-2.4 to 4.6). Interpretation Expansion of primary-care nurses' roles to include ART initiation and represcription can be done safely, and improve health outcomes and quality of care, but might not reduce time to ART or mortality.	[Bachmann, Max O.] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Fairall, Lara; Timmerman, Venessa; Uebel, Kerry; Zwarenstein, Merrick; Georgeu, Daniella; Faris, Gill; Cornick, Ruth; Draper, Beverly] Univ Cape Town, Lung Inst, Knowledge Translat Unit, ZA-7925 Cape Town, South Africa; [Fairall, Lara; Bateman, Eric] Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa; [Boulle, Andrew; Colvin, Christopher J.] Univ Cape Town, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa; [Lombard, Carl] MRC, Div Biostat, Cape Town, South Africa; [Lewin, Simon] MRC, Hlth Syst Res Unit, Cape Town, South Africa; [Zwarenstein, Merrick] Univ Toronto, Sunnybrook Res Inst, Toronto, ON, Canada; [Zwarenstein, Merrick] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Zwarenstein, Merrick] Karolinska Inst, Stockholm, Sweden; [Zwarenstein, Merrick] Univ Western Ontario, Dept Family Med, London, ON, Canada; [Lewin, Simon] Norwegian Knowledge Ctr Hlth Serv, Oslo, Norway; [Tshabalala, Mvula; Chapman, Ronald] Free State Dept Hlth, Bloemfontein, South Africa; [Kotze, Eduan] Univ Orange Free State, Dept Informat & Comp Sci, Bloemfontein, South Africa; [Uebel, Kerry; van Vuuren, Cloete; Steyn, Dewald] Univ Orange Free State, Dept Med, Bloemfontein, South Africa	University of East Anglia; University of Cape Town; University of Cape Town; University of Cape Town; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Karolinska Institutet; Western University (University of Western Ontario); Norwegian Knowledge Centre for Health Services; University of the Free State; University of the Free State	Bachmann, MO (corresponding author), Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England.	m.bachmann@uea.ac.uk	Zwarenstein, Merrick F/P-5210-2014; Kotzé, Eduan/M-3286-2016; Colvin, Christopher/AAB-8276-2019; Colvin, Christopher/AAQ-1607-2021; Boulle, Andrew/C-1413-2008	Zwarenstein, Merrick F/0000-0003-0162-7027; Kotzé, Eduan/0000-0002-5572-4319; Colvin, Christopher/0000-0002-8930-7863; Boulle, Andrew/0000-0002-7713-8062; Lombard, Carl/0000-0002-2136-6533; Bachmann, Max Oscar/0000-0003-1770-3506; van Vuuren, Cloete/0000-0002-9095-0039; Fairall, Lara/0000-0002-7460-4670	UK Medical Research Council; Development Cooperation Ireland; Canadian International Development Agency; MRC [G0800605] Funding Source: UKRI; Medical Research Council [G0800605] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Development Cooperation Ireland; Canadian International Development Agency; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	UK Medical Research Council, Development Cooperation Ireland, and Canadian International Development Agency.	[Anonymous], 2009, SAMJ S AFR MED J, V99, P284; [Anonymous], 2011, IMPLEMENT SCI, V6, P82; Bachmann MO, 2010, INT J TUBERC LUNG D, V14, P311; Boseley S., 2011, CRISIS LOOMS GLOBAL; Callaghan M, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-8; Chang LW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010923; Colvin CJ, 2010, SAMJ S AFR MED J, V100, P210, DOI 10.7196/SAMJ.4124; Cornell M, 2010, AIDS, V24, P2263, DOI 10.1097/QAD.0b013e32833d45c5; Donner A., STAT MED, V198, P199; Fairall LR, 2008, ARCH INTERN MED, V168, P86, DOI 10.1001/archinternmed.2007.10; Fairall LR, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-21; Fairall LR, 2005, BMJ-BRIT MED J, V331, P750, DOI 10.1136/bmj.331.7519.750; Haines A, 2000, PERSONAL INFORM MED; Ingle SM, 2010, AIDS, V24, P2717, DOI 10.1097/QAD.0b013e32833fb71f; Jaffar S, 2009, LANCET, V374, P2080, DOI 10.1016/S0140-6736(09)61674-3; Knowledge Translation Unit University of Cape Town Lung Institute, 2006, PRACT APPR LUNG HLTH; Medical Research Council, 2002, CLUST RAND TRIALS ME; Sanne I, 2010, LANCET, V376, P33, DOI 10.1016/S0140-6736(10)60894-X; Schull MJ, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-82; Schull MJ, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-118; Selke HM, 2010, JAIDS-J ACQ IMM DEF, V55, P483, DOI 10.1097/QAI.0b013e3181eb5edb; South African National Department of Health, 2004, NAT ANT TREATM GUID; Statistics South Africa, 2005, MORT CAUS DEATH S AF; Uebel KE, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-86; Vickers AJ, 2001, BMJ-BRIT MED J, V323, P1123, DOI 10.1136/bmj.323.7321.1123; World Health Organisation, 2008, TASK SHIFT GLOB REC; Zwarenstein M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2022	27	210	212	5	32	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 8	2012	380	9845					889	898		10.1016/S0140-6736(12)60730-2	http://dx.doi.org/10.1016/S0140-6736(12)60730-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	002QL	22901955	Green Published, Bronze			2022-12-28	WOS:000308547300031
J	Seshagiri, S; Stawiski, EW; Durinck, S; Modrusan, Z; Storm, EE; Conboy, CB; Chaudhuri, S; Guan, YH; Janakiraman, V; Jaiswal, BS; Guillory, J; Ha, C; Dijkgraaf, GJP; Stinson, J; Gnad, F; Huntley, MA; Degenhardt, JD; Haverty, PM; Bourgon, R; Wang, WR; Koeppen, H; Gentleman, R; Starr, TK; Zhang, ZM; Largaespada, DA; Wu, TD; de Sauvage, FJ				Seshagiri, Somasekar; Stawiski, Eric W.; Durinck, Steffen; Modrusan, Zora; Storm, Elaine E.; Conboy, Caitlin B.; Chaudhuri, Subhra; Guan, Yinghui; Janakiraman, Vasantharajan; Jaiswal, Bijay S.; Guillory, Joseph; Ha, Connie; Dijkgraaf, Gerrit J. P.; Stinson, Jeremy; Gnad, Florian; Huntley, Melanie A.; Degenhardt, Jeremiah D.; Haverty, Peter M.; Bourgon, Richard; Wang, Weiru; Koeppen, Hartmut; Gentleman, Robert; Starr, Timothy K.; Zhang, Zemin; Largaespada, David A.; Wu, Thomas D.; de Sauvage, Frederic J.			Recurrent R-spondin fusions in colon cancer	NATURE			English	Article							CIRCULAR BINARY SEGMENTATION; COLORECTAL-CANCER; WNT/BETA-CATENIN; HUMAN BREAST; RECEPTORS; LGR5; MUTATIONS; ALGORITHM; DISCOVERY; SEQUENCES	Identifying and understanding changes in cancer genomes is essential for the development of targeted therapeutics(1). Here we analyse systematically more than 70 pairs of primary human colon tumours by applying next-generation sequencing to characterize their exomes, transcriptomes and copy-number alterations. We have identified 36,303 protein-altering somatic changes that include several new recurrent mutations in the Wnt pathway gene TCF7L2, chromatin-remodelling genes such as TET2 and TET3 and receptor tyrosine kinases including ERBB3. Our analysis for significantly mutated cancer genes identified 23 candidates, including the cell cycle checkpoint kinase ATM. Copy-number and RNA-seq data analysis identified amplifications and corresponding overexpression of IGF2 in a subset of colon tumours. Furthermore, using RNA-seq data we identified multiple fusion transcripts including recurrent gene fusions involving R-spondin family members RSPO2 and RSPO3 that together occur in 10% of colon tumours. The RSPO fusions were mutually exclusive with APC mutations, indicating that they probably have a role in the activation of Wnt signalling and tumorigenesis. Consistent with this we show that the RSPO fusion proteins were capable of potentiating Wnt signalling. The R-spondin gene fusions and several other gene mutations identified in this study provide new potential opportunities for therapeutic intervention in colon cancer.	[Seshagiri, Somasekar; Stawiski, Eric W.; Durinck, Steffen; Modrusan, Zora; Storm, Elaine E.; Chaudhuri, Subhra; Guan, Yinghui; Janakiraman, Vasantharajan; Jaiswal, Bijay S.; Guillory, Joseph; Ha, Connie; Dijkgraaf, Gerrit J. P.; Stinson, Jeremy; de Sauvage, Frederic J.] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Conboy, Caitlin B.; Largaespada, David A.] Univ Minnesota, Masonic Canc Ctr, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Gnad, Florian; Huntley, Melanie A.; Degenhardt, Jeremiah D.; Haverty, Peter M.; Bourgon, Richard; Gentleman, Robert; Zhang, Zemin; Wu, Thomas D.] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Wang, Weiru] Genentech Inc, Dept Biol Struct, San Francisco, CA 94080 USA; [Koeppen, Hartmut] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Starr, Timothy K.] Univ Minnesota, Masonic Canc Ctr, Dept Obstet Gynecol & Womens Hlth, Minneapolis, MN 55455 USA	Roche Holding; Genentech; University of Minnesota System; University of Minnesota Twin Cities; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; University of Minnesota System; University of Minnesota Twin Cities	Seshagiri, S (corresponding author), Genentech Inc, Dept Mol Biol, 1 DNA Way, San Francisco, CA 94080 USA.	sekar@gene.com; sauvage@gene.com	de Sauvage, Frederic/ABE-8400-2020; Largaespada, David/C-9832-2014; Starr, Tim/AAX-9342-2021	de Sauvage, Frederic/0000-0002-5275-2584; Bourgon, Richard/0000-0002-5890-4374; Seshagiri, Somasekar/0000-0003-4272-6443; Wang, Weiru/0000-0001-8845-301X; Starr, Timothy/0000-0002-6308-3451; Gnad, Florian/0000-0002-2287-2251; Conboy, Caitlin/0000-0001-8280-056X	National Institutes of Health [R01-CA134759]; NATIONAL CANCER INSTITUTE [R00CA151672, R01CA113636, T32CA009138, R01CA134759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors would like to acknowledge Genentech DNA Sequencing, Oligo, Microarray and gCell laboratories for their help with the project. We thank the Genentech Bioinformatics group for informatics infrastructure support and the Pathology Core Labs for providing histology, immunohistochemistry and tissue-management support. We also thank M. Costa, M. Callow, P. Polakis and the de Sauvage and Seshagiri laboratories for comments and suggestions. Work in the Largaespada laboratory was supported by National Institutes of Health grant R01-CA134759 (to D.A.L.).	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Chin L, 2011, NAT MED, V17, P297, DOI 10.1038/nm.2323; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Greenman CD, 2010, BIOSTATISTICS, V11, P164, DOI 10.1093/biostatistics/kxp045; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kaneda H, 2010, CANCER RES, V70, P2053, DOI 10.1158/0008-5472.CAN-09-2161; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; March HN, 2011, NAT GENET, V43, P1202, DOI 10.1038/ng.990; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Mohr F, 2011, EXP HEMATOL, V39, P272, DOI 10.1016/j.exphem.2010.12.004; Morgan M, 2009, BIOINFORMATICS, V25, P2607, DOI 10.1093/bioinformatics/btp450; Nacu S, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-11; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Pichiorri F, 2008, FUTURE ONCOL, V4, P815, DOI 10.2217/14796694.4.6.815; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Starr TK, 2009, SCIENCE, V323, P1747, DOI 10.1126/science.1163040; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Timmermann B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015661; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Yoon JK, 2012, CELL SIGNAL, V24, P369, DOI 10.1016/j.cellsig.2011.09.023; Yue P, 2010, HUM MUTAT, V31, P264, DOI 10.1002/humu.21194; Zhang YN, 2009, NAT CHEM BIOL, V5, P217, DOI 10.1038/nchembio.152	38	679	736	1	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2012	488	7413					660	+		10.1038/nature11282	http://dx.doi.org/10.1038/nature11282			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996NC	22895193	Green Accepted, hybrid			2022-12-28	WOS:000308095100057
J	Hashimoto, S; Bel, EH				Hashimoto, Simone; Bel, Elisabeth H.			Targeting IL-5 in severe asthma: a DREAM come true?	LANCET			English	Editorial Material							REFRACTORY EOSINOPHILIC ASTHMA; SPUTUM EOSINOPHILIA; CLUSTER-ANALYSIS; MEPOLIZUMAB; EXACERBATIONS; IDENTIFICATION; PHENOTYPES; DISEASE		[Hashimoto, Simone; Bel, Elisabeth H.] Univ Amsterdam, Acad Med Ctr, Dept Resp Med, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Hashimoto, S (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Resp Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	s.hashimoto@amc.nl	Hashimoto, Simone/AAO-8863-2020	Hashimoto, Simone/0000-0001-8995-3817				Anderson GP, 2008, LANCET, V372, P1107, DOI 10.1016/S0140-6736(08)61452-X; Bafadhel M, 2011, AM J RESP CRIT CARE, V184, P662, DOI 10.1164/rccm.201104-0597OC; Gevaert P, 2011, J ALLERGY CLIN IMMUN, V128, P989, DOI 10.1016/j.jaci.2011.07.056; Green RH, 2002, LANCET, V360, P1715, DOI 10.1016/S0140-6736(02)11679-5; Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI 10.1164/rccm.200711-1754OC; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; Nair P, 2009, NEW ENGL J MED, V360, P985, DOI 10.1056/NEJMoa0805435; Pavord ID, 2010, THORAX, V65, P370, DOI 10.1136/thx.2009.122697; Pavord ID, 2012, LANCET, V380, P651, DOI 10.1016/S0140-6736(12)60988-X; Sorkness RL, 2008, J APPL PHYSIOL, V104, P394, DOI 10.1152/japplphysiol.00329.2007; ten Brinke A, 2001, AM J RESP CRIT CARE, V164, P744, DOI 10.1164/ajrccm.164.5.2011026; van Veen IH, 2009, J ALLERGY CLIN IMMUN, V124, P615, DOI 10.1016/j.jaci.2009.06.029; Wenzel SE, 2009, NEW ENGL J MED, V360, P1026, DOI 10.1056/NEJMe0900334	14	10	10	1	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 18	2012	380	9842					626	627		10.1016/S0140-6736(12)61132-5	http://dx.doi.org/10.1016/S0140-6736(12)61132-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	991SE	22901871				2022-12-28	WOS:000307721000006
J	Oberlander, J				Oberlander, Jonathan			Unfinished Journey - A Century of Health Care Reform in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ N Carolina, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	Oberlander, J (corresponding author), Univ N Carolina, Chapel Hill, NC 27515 USA.							ALTMAN STUART, 2011, POWER POLITICS UNIVE; [Anonymous], 2011, INSIDE NATL HLTH REF; Blumenthal David, 2009, HEART POWER HLTH POL; Committee on Energy and Commerce Subcommittee on Oversights and Investigations U.S. House of Representatives, 2009, TERM IND HLTH INS PO; Oberlander J., 2012, J GEN INTERN MED; Starr P, 1982, SOCIAL TRANSFORMATIO	6	29	28	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 16	2012	367	7					585	590		10.1056/NEJMp1202111	http://dx.doi.org/10.1056/NEJMp1202111			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988NB	22894571				2022-12-28	WOS:000307496600001
J	Roehrig, C; Turner, A; Hughes-Cromwick, P; Miller, G				Roehrig, Charles; Turner, Ani; Hughes-Cromwick, Paul; Miller, George			When the Cost Curve Bent - Pre-Recession Moderation in Health Care Spending	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Roehrig, Charles; Turner, Ani; Hughes-Cromwick, Paul; Miller, George] Altarum Inst, Ctr Sustainable Hlth Spending, Ann Arbor, MI USA		Roehrig, C (corresponding author), Altarum Inst, Ctr Sustainable Hlth Spending, Ann Arbor, MI USA.							Altarum Institute, 2012, HLTH SECT EC IND SPE; Kaufman K, 2012, BENDING HLTH CARE CO; Lowry Annie, 2012, NY TIMES, pA1; Roehrig C, 2012, ALTARUM HLTH PO 0607; Roehrig C, 2011, CASE TRACKING HLTH S	5	21	21	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 16	2012	367	7					590	593		10.1056/NEJMp1205958	http://dx.doi.org/10.1056/NEJMp1205958			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988NB	22873429				2022-12-28	WOS:000307496600002
J	Zella, GC; Gee, MS; Badizadegan, K				Zella, Garrett C.; Gee, Michael S.; Badizadegan, Kamran			Case 25-2012: A 15-Year-Old Boy with Abdominal Pain, Hematochezia, and Anemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PEUTZ-JEGHERS-SYNDROME; COLONIC POLYPS; GASTRIC-MUCOSA; INTUSSUSCEPTION; MANAGEMENT; DIAGNOSIS; CHILDREN; ILEUM		[Zella, Garrett C.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Gee, Michael S.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Badizadegan, Kamran] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Zella, Garrett C.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Gee, Michael S.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Badizadegan, Kamran] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Zella, GC (corresponding author), Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA.							ANDREYEV HJN, 1994, AM J GASTROENTEROL, V89, P1552; Begos DG, 1997, AM J SURG, V173, P88, DOI 10.1016/S0002-9610(96)00419-9; BILLINGHAM RP, 1980, DIS COLON RECTUM, V23, P26; Brandt LJ, 2010, SLEISENGER FORDTRANS, P593; BURT RW, 1992, CANCER, V70, P1296, DOI 10.1002/1097-0142(19920901)70:3+<1296::AID-CNCR2820701516>3.0.CO;2-3; Chu A, 2011, NELSON TXB PEDIAT, P1287; Cunningham JD, 1998, SURG LAPAROSC ENDOSC, V8, P17, DOI 10.1097/00019509-199802000-00005; DOBERNECK RC, 1976, J PEDIATR SURG, V11, P99, DOI 10.1016/0022-3468(76)90180-9; EIN SH, 1986, J PEDIATR SURG, V21, P786, DOI 10.1016/S0022-3468(86)80367-0; Gallinger S, 2004, GASTROENTEROLOGY, V126, P576, DOI 10.1053/j.gastro.2003.11.008; Green PHR, 2007, NEW ENGL J MED, V357, P1731, DOI 10.1056/NEJMra071600; Ingram CJE, 2009, HUM GENET, V124, P579, DOI 10.1007/s00439-008-0593-6; Kastner-Cole D, 2005, J PEDIATR-US, V147, P402, DOI 10.1016/j.jpeds.2005.06.003; Kumar N, 1990, J Assoc Physicians India, V38, P272; LATT TT, 1993, ARCH DIS CHILD, V69, P144, DOI 10.1136/adc.69.1.144; Merchant FT, 1939, ARCH SURG-CHICAGO, V39, P1031, DOI 10.1001/archsurg.1939.01200180132013; MESTRE JR, 1986, AM J GASTROENTEROL, V81, P312; Pillai RB, 1998, CLIN PEDIATR, V37, P253, DOI 10.1177/000992289803700406; Poddar U, 1998, AM J GASTROENTEROL, V93, P619; Pomerantz B, 2007, PEDIATR SURG INT, V23, P763, DOI 10.1007/s00383-007-1953-3; Rasquin A, 2006, GASTROENTEROLOGY, V130, P1527, DOI 10.1053/j.gastro.2005.08.063; Rodriguez-Jurado R, 2010, J PEDIATR SURG, V45, pE9, DOI 10.1016/j.jpedsurg.2009.10.048; Trimbath J D, 2001, Fam Cancer, V1, P101; TURCK D, 1990, J PEDIATR GASTR NUTR, V11, P275, DOI 10.1097/00005176-199008000-00019; Westerman AM, 1999, LANCET, V353, P1211, DOI 10.1016/S0140-6736(98)08018-0; Zbuk KM, 2007, NAT CLIN PRACT GASTR, V4, P492, DOI 10.1038/ncpgasthep0902; Zubaidi A, 2006, DIS COLON RECTUM, V49, P1546, DOI 10.1007/s10350-006-0664-5	27	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 16	2012	367	7					659	667		10.1056/NEJMcpc1111578	http://dx.doi.org/10.1056/NEJMcpc1111578			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988NB	22894579				2022-12-28	WOS:000307496600011
J	Kamerow, D				Kamerow, Douglas			The myth of an AIDS free world	BRITISH MEDICAL JOURNAL			English	Editorial Material									RTI Int, Res Triangle Pk, NC USA	Research Triangle Institute	Kamerow, D (corresponding author), RTI Int, Res Triangle Pk, NC USA.	dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957				Brown D., 2012, WASHINGTON POST, pWashington; Roehr B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5265; Roehr B, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4879	3	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 14	2012	345								e5479	10.1136/bmj.e5479	http://dx.doi.org/10.1136/bmj.e5479			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	992CD	22893652				2022-12-28	WOS:000307752000002
J	Watts, G				Watts, Geoff			Ernesto Schiffrin: essential player in hypertension	LANCET			English	Biographical-Item																		SCHIFFRIN E, PUBLICATION LIST	1	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 11	2012	380	9841					555	555		10.1016/S0140-6736(12)61317-8	http://dx.doi.org/10.1016/S0140-6736(12)61317-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988SQ	22883494				2022-12-28	WOS:000307511400014
J	Fender, R; Belloni, T				Fender, Rob; Belloni, Tomaso			Stellar-Mass Black Holes and Ultraluminous X-ray Sources	SCIENCE			English	Review							DOMINATED ACCRETION; XTE J1550-564; JET; STATE; POWER; DISC; SPIN; ADVECTION; EMISSION; BINARIES	We review the likely population, observational properties, and broad implications of stellar-mass black holes and ultraluminous x-ray sources. We focus on the clear empirical rules connecting accretion and outflow that have been established for stellar-mass black holes in binary systems in the past decade and a half. These patterns of behavior are probably the keys that will allow us to understand black hole feedback on the largest scales over cosmological time scales.	[Fender, Rob] Univ Southampton, Southampton SO17 1BJ, Hants, England; [Belloni, Tomaso] Osserv Astron Brera, Ist Nazl Astrofis, I-23807 Merate, LC, Italy	University of Southampton; Istituto Nazionale Astrofisica (INAF)	Fender, R (corresponding author), Univ Southampton, Southampton SO17 1BJ, Hants, England.	r.fender@soton.ac.uk			Science and Technology Facilities Council [ST/J001600/1] Funding Source: researchfish; STFC [ST/J001600/1] Funding Source: UKRI	Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Belloni TM, 2011, ASTRON NACHR, V332, P324, DOI 10.1002/asna.201011492; Belloni TM, 2010, LECT NOTES PHYS, V794, P53, DOI 10.1007/978-3-540-76937-8_3; Bloom JS, 2011, SCIENCE, V333, P203, DOI 10.1126/science.1207150; Carilli C., 2004, NEW ASTRON REV, V48, P1063; CASARES J, 1992, NATURE, V355, P614, DOI 10.1038/355614a0; Corbel S, 2002, SCIENCE, V298, P196, DOI 10.1126/science.1075857; Fabian A. C., 2012, MON NOT R ASTRON SOC; Falcke H, 2004, ASTRON ASTROPHYS, V414, P895, DOI 10.1051/0004-6361:20031683; Farrell SA, 2009, NATURE, V460, P73, DOI 10.1038/nature08083; Fender R, 2004, ANNU REV ASTRON ASTR, V42, P317, DOI 10.1146/annurev.astro.42.053102.134031; Fender R, 1999, ASTROPHYS J, V519, pL165, DOI 10.1086/312128; Fender RP, 2010, MON NOT R ASTRON SOC, V406, P1425, DOI 10.1111/j.1365-2966.2010.16754.x; Fender RP, 2009, MON NOT R ASTRON SOC, V396, P1370, DOI 10.1111/j.1365-2966.2009.14841.x; Fender RP, 2004, MON NOT R ASTRON SOC, V355, P1105, DOI 10.1111/j.1365-2966.2004.08384.x; Fender RP, 2003, MON NOT R ASTRON SOC, V343, pL99, DOI 10.1046/j.1365-8711.2003.06950.x; Fender RP, 2001, MON NOT R ASTRON SOC, V322, P31, DOI 10.1046/j.1365-8711.2001.04080.x; Feng H, 2011, NEW ASTRON REV, V55, P166, DOI 10.1016/j.newar.2011.08.002; Gallo E, 2005, NATURE, V436, P819, DOI 10.1038/nature03879; Gallo E., 2012, MON NOT R ASTRON SOC; Gou LJ, 2011, ASTROPHYS J, V742, DOI 10.1088/0004-637X/742/2/85; Kaaret P, 2004, MON NOT R ASTRON SOC, V351, pL83, DOI 10.1111/j.1365-2966.2004.08020.x; Kording EG, 2006, MON NOT R ASTRON SOC, V372, P1366, DOI 10.1111/j.1365-2966.2006.10954.x; Maccarone TJ, 2003, ASTRON ASTROPHYS, V409, P697, DOI 10.1051/0004-6361:20031146; McClintock J.E., 2006, BLACK HOLE BINARIES, V39, P157; MCCLINTOCK JE, 1986, ASTROPHYS J, V308, P110, DOI 10.1086/164482; McNamara BR, 2007, ANNU REV ASTRON ASTR, V45, P117, DOI 10.1146/annurev.astro.45.051806.110625; Merloni A, 2003, MON NOT R ASTRON SOC, V345, P1057, DOI 10.1046/j.1365-2966.2003.07017.x; Miller JM, 2004, ASTROPHYS J, V614, pL117, DOI 10.1086/425316; Miller-Jones JCA, 2012, MON NOT R ASTRON SOC, V421, P468, DOI 10.1111/j.1365-2966.2011.20326.x; MIRABEL IF, 1994, NATURE, V371, P46, DOI 10.1038/371046a0; NARAYAN R, 1995, ASTROPHYS J, V452, P710, DOI 10.1086/176343; Narayan R, 2012, MON NOT R ASTRON SOC, V419, pL69, DOI 10.1111/j.1745-3933.2011.01181.x; Neilsen J, 2009, NATURE, V458, P481, DOI 10.1038/nature07680; Ponti G, 2012, MON NOT R ASTRON SOC, V422, pL11, DOI 10.1111/j.1745-3933.2012.01224.x; Psaltis D, 2008, LIVING REV RELATIV, V11, DOI 10.12942/lrr-2008-9; Reid MJ, 2011, ASTROPHYS J, V742, DOI 10.1088/0004-637X/742/2/83; Russell DM, 2011, MON NOT R ASTRON SOC, V416, P2311, DOI 10.1111/j.1365-2966.2011.19204.x; Shapiro S.L., 1983, BLACK HOLES WHITE DW; Steiner JF, 2011, MON NOT R ASTRON SOC, V416, P941, DOI 10.1111/j.1365-2966.2011.19089.x; Webb N, 2012, SCIENCE, V337, P554, DOI 10.1126/science.1222779; Zauderer BA, 2011, NATURE, V476, P425, DOI 10.1038/nature10366	42	67	67	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 3	2012	337	6094					540	544		10.1126/science.1221790	http://dx.doi.org/10.1126/science.1221790			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982PU	22859481	Green Submitted			2022-12-28	WOS:000307058700033
J	Barry, CL; Gollust, SE; Niederdeppe, J				Barry, Colleen L.; Gollust, Sarah E.; Niederdeppe, Jeff			Are Americans Ready to Solve the Weight of the Nation?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEALTH		[Barry, Colleen L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA; [Gollust, Sarah E.] Univ Minnesota, Sch Publ Hlth, Div Hlth Policy & Management, Minneapolis, MN USA; [Niederdeppe, Jeff] Cornell Univ, Dept Commun, Ithaca, NY USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Minnesota System; University of Minnesota Twin Cities; Cornell University	Barry, CL (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA.							Bleich S, 2011, AM PUBLIC OPINION HL; Center for Consumer Freedom, 2012, I MED NEW OB PREV ST; DOWNS A, 1972, PUBLIC INTEREST, P38; Madison KM, 2011, J LAW MED ETHICS, V39, P450, DOI 10.1111/j.1748-720X.2011.00614.x; Puhl RM, 2007, PSYCHOL BULL, V133, P557, DOI 10.1037/0033-2909.133.4.557	5	32	32	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 2	2012	367	5					389	391		10.1056/NEJMp1206519	http://dx.doi.org/10.1056/NEJMp1206519			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	981VZ	22853011				2022-12-28	WOS:000307001900001
J	Coburn, B; Morris, AM; Tomlinson, G; Detsky, AS				Coburn, Bryan; Morris, Andrew M.; Tomlinson, George; Detsky, Allan S.			Does This Adult Patient With Suspected Bacteremia Require Blood Cultures?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INFLAMMATORY RESPONSE SYNDROME; PREDICTING BACTEREMIA; STREAM INFECTIONS; CLINICAL-SIGNIFICANCE; EMERGENCY-DEPARTMENT; COMPREHENSIVE ANALYSIS; DIAGNOSTIC-VALUE; RISK-FACTORS; 500 EPISODES; BACTERIAL	Context Clinicians order blood cultures liberally among patients in whom bacteremia is suspected, though a small proportion of blood cultures yield true-positive results. Ordering blood cultures inappropriately may be both wasteful and harmful. Objective To review the accuracy of easily obtained clinical and laboratory findings to inform the decision to obtain blood cultures in suspected bacteremia. Data Sources and Study Selection A MEDLINE and EMBASE search (inception to April 2012) yielded 35 studies that met inclusion criteria for evaluating the accuracy of clinical variables for bacteremia in adult immunocompetent patients, representing 4566 bacteremia and 25 946 negative blood culture episodes. Data Extraction Data were extracted to determine the prevalence and likelihood ratios (LRs) of findings for bacteremia. Data Synthesis The pretest probability of bacteremia varies depending on the clinical context, from low (eg, cellulitis: 2%) to high (eg, septic shock: 69%). Elevated temperatures alone do not accurately predict bacteremia (for >= 38 degrees C [>100.3 degrees F], LR, 1.9 [95% CI, 1.4-2.4]; for >= 38.5 degrees C [>101.2 degrees F], LR, 1.4 [95% CI, 1.1-2.0]), nor does isolated leukocytosis (LR, <1.7). The severity of chills graded on an ordinal scale (shaking chills, LR, 4.7; 95% CI, 3.0-7.2) may be more useful. Both the systemic inflammatory response syndrome (SIRS) and a multivariable decision rule with major and minor criteria are sensitive (but not specific) predictors of bacteremia (SIRS, negative LR, 0.09 [95% CI, 0.03-0.26]; decision rule, negative LR, 0.08 [95% CI, 0.04-0.17]). Conclusions Blood cultures should not be ordered for adult patients with isolated fever or leukocytosis without considering the pretest probability. SIRS and the decision rule may be helpful in identifying patients who do not need blood cultures. These conclusions do not apply to immunocompromised patients or when endocarditis is suspected. JAMA. 2012;308(5):502-511 www.jama.com	[Morris, Andrew M.; Tomlinson, George; Detsky, Allan S.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Coburn, Bryan; Morris, Andrew M.; Tomlinson, George; Detsky, Allan S.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Coburn, Bryan; Morris, Andrew M.] Univ Toronto, Div Infect Dis, Toronto, ON, Canada; [Detsky, Allan S.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Morris, Andrew M.; Tomlinson, George; Detsky, Allan S.] Univ Hlth Network, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Detsky, AS (corresponding author), Mt Sinai Hosp, Dept Med, 600 Univ Ave,Ste 429, Toronto, ON M5G 1X5, Canada.	adetsky@mtsinai.on.ca	Tomlinson, George A/L-5432-2016	Tomlinson, George A/0000-0002-9328-6399; Coburn, Bryan/0000-0003-0150-4510				Al-Gwaiz LA, 2007, MED PRIN PRACT, V16, P344, DOI 10.1159/000104806; Apostolopoulou E, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-135; Bahagon Y, 2007, EUR J CLIN MICROBIOL, V26, P349, DOI 10.1007/s10096-007-0287-3; BATES DW, 1990, ANN INTERN MED, V113, P495, DOI 10.7326/0003-4819-113-7-495; Bates DW, 1997, J INFECT DIS, V176, P1538, DOI 10.1086/514153; BATES DW, 1991, JAMA-J AM MED ASSOC, V265, P365, DOI 10.1001/jama.265.3.365; Booth CM, 2004, JAMA-J AM MED ASSOC, V291, P870, DOI 10.1001/jama.291.7.870; Bossink AWJ, 1999, CLIN INFECT DIS, V29, P398, DOI 10.1086/520222; Cham G, 2009, ANN ACAD MED SINGAP, V38, P508; Chen Y, 2006, J INFECTION, V53, P235, DOI 10.1016/j.jinf.2005.12.005; Chirouze C, 2002, CLIN INFECT DIS, V35, P156, DOI 10.1086/341023; Crabtree TD, 2001, WORLD J SURG, V25, P739, DOI 10.1007/s00268-001-0025-4; de Jager CPC, 2010, CRIT CARE, V14, DOI 10.1186/cc9309; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Edgeworth JD, 1999, CRIT CARE MED, V27, P1421, DOI 10.1097/00003246-199908000-00002; Falguera M, 2009, CLIN INFECT DIS, V49, P409, DOI 10.1086/600291; FONTANAROSA PB, 1992, ANN EMERG MED, V21, P842, DOI 10.1016/S0196-0644(05)81032-7; Groeneveld ABJ, 2001, CLIN DIAGN LAB IMMUN, V8, P1189, DOI 10.1128/CDLI.8.6.1189-1195.2001; Ha YE, 2011, SUPPORT CARE CANCER, V19, P1761, DOI 10.1007/s00520-010-1017-4; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jaimes F, 2004, CLIN INFECT DIS, V38, P357, DOI 10.1086/380967; Jones GR, 1996, QJM-MON J ASSOC PHYS, V89, P515; Kaye KS, 2011, J AM GERIATR SOC, V59, P622, DOI 10.1111/j.1532-5415.2010.03289.x; Kim KS, 2011, J INFECTION, V63, P124, DOI 10.1016/j.jinf.2011.06.007; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Laupland KB, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-35; Laupland KB, 2004, INFECTION, V32, P59, DOI 10.1007/s15010-004-3064-6; Laupland KB, 2002, CRIT CARE MED, V30, P2462, DOI 10.1097/00003246-200211000-00010; Lee A, 2007, J CLIN MICROBIOL, V45, P3546, DOI 10.1128/JCM.01555-07; Lee CC, 2007, MEDICINE, V86, P138, DOI 10.1097/SHK.0b013e318067da56; LEIBOVICI L, 1991, ARCH INTERN MED, V151, P1801; MELLORS JW, 1987, ARCH INTERN MED, V147, P666, DOI 10.1001/archinte.147.4.666; Metersky ML, 2004, AM J RESP CRIT CARE, V169, P342, DOI 10.1164/rccm.200309-1248OC; MUDER RR, 1992, CLIN INFECT DIS, V14, P647, DOI 10.1093/clinids/14.3.647; Murray CK, 2007, ARCH SURG-CHICAGO, V142, P639, DOI 10.1001/archsurg.142.7.639; Nakamura T, 2006, J EVAL CLIN PRACT, V12, P692, DOI 10.1111/j.1365-2753.2006.00637.x; Peralta G, 2006, Eur J Clin Microbiol Infect Dis, V25, P619, DOI 10.1007/s10096-006-0186-z; Perl B, 1999, CLIN INFECT DIS, V29, P1483, DOI 10.1086/313525; PFITZENMEYER P, 1995, J AM GERIATR SOC, V43, P230, DOI 10.1111/j.1532-5415.1995.tb07327.x; PITTET D, 1994, JAMA-J AM MED ASSOC, V271, P1598, DOI 10.1001/jama.271.20.1598; Proulx N, 2005, QJM-INT J MED, V98, P291, DOI 10.1093/qjmed/hci047; RANGELFRAUSTO MS, 1995, JAMA-J AM MED ASSOC, V273, P117, DOI 10.1001/jama.273.2.117; Roque P, 2012, AM J EMERG MED, V30, P110, DOI 10.1016/j.ajem.2010.10.022; Roth A, 2010, J CLIN MICROBIOL, V48, P4552, DOI 10.1128/JCM.00877-10; SACKETT DL, 1992, JAMA-J AM MED ASSOC, V267, P2638, DOI 10.1001/jama.267.19.2638; Sands KE, 1997, JAMA-J AM MED ASSOC, V278, P234, DOI 10.1001/jama.278.3.234; Seebach JD, 1997, AM J CLIN PATHOL, V107, P582; Shapiro NI, 2008, J EMERG MED, V35, P255, DOI 10.1016/j.jemermed.2008.04.001; Smith WR, 1997, AM J MED SCI, V313, P50, DOI 10.1097/00000441-199701000-00008; Stryjewski ME, 2009, AM J MED, V122, P281, DOI 10.1016/j.amjmed.2008.09.040; Su CP, 2011, J MICROBIOL IMMUNOL, V44, P449, DOI 10.1016/j.jmii.2011.04.006; Tokuda Yasuharu, 2005, Am J Med, V118, P1417, DOI 10.1016/j.amjmed.2005.06.043; Van Dissel JT, 1998, LANCET, V352, P374, DOI 10.1016/S0140-6736(05)60475-8; Velasco M, 2003, CLIN INFECT DIS, V37, P1127, DOI 10.1086/378291; Wallet F, 2010, CLIN MICROBIOL INFEC, V16, P774, DOI 10.1111/j.1469-0691.2009.02940.x; Weinstein MP, 1997, CLIN INFECT DIS, V24, P584, DOI 10.1093/clind/24.4.584; WEINSTEIN MP, 1983, REV INFECT DIS, V5, P54; WEINSTEIN MP, 1983, REV INFECT DIS, V5, P35, DOI 10.1093/clinids/5.1.35; Wildi K, 2011, EUR J CLIN MICROBIOL, V30, P1615, DOI 10.1007/s10096-011-1268-0; Wyllie DH, 2004, J CLIN PATHOL, V57, P950, DOI 10.1136/jcp.2004.017335; Yehezkelli Y, 1996, J GEN INTERN MED, V11, P98, DOI 10.1007/BF02599585; Yoshida T, 2005, INTERNAL MED, V44, P1157, DOI 10.2169/internalmedicine.44.1157	62	192	195	0	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2012	308	5					502	511		10.1001/jama.2012.8262	http://dx.doi.org/10.1001/jama.2012.8262			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	981DQ	22851117				2022-12-28	WOS:000306947400028
J	Grover, S; Kastrinos, F; Steyerberg, EW; Cook, EF; Dewanwala, A; Burbidge, LA; Wenstrup, RJ; Syngal, S				Grover, Shilpa; Kastrinos, Fay; Steyerberg, Ewout W.; Cook, E. Francis; Dewanwala, Akriti; Burbidge, Lynn Anne; Wenstrup, Richard J.; Syngal, Sapna			Prevalence and Phenotypes of APC and MUTYH Mutations in Patients With Multiple Colorectal Adenomas	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GERM-LINE MUTATIONS; MYH GENE-MUTATIONS; POLYPOSIS PATIENTS; CANCER PATIENTS; FAMILIES; FAP; CHROMOSOME-5Q21; IDENTIFICATION; EXPRESSION; GUIDELINES	Context Patients with multiple colorectal adenomas may carry germline mutations in the APC or MUTYH genes. Objectives To determine the prevalence of pathogenic APC and MUTYH mutations in patients with multiple colorectal adenomas who had undergone genetic testing and to compare the prevalence and clinical characteristics of APC and MUTYH mutation carriers. Design, Setting, and Participants Cross-sectional study conducted among 8676 individuals who had undergone full gene sequencing and large rearrangement analysis of the APC gene and targeted sequence analysis for the 2 most common MUTYH mutations (Y179C and G396D) between 2004 and 2011. Individuals with either mutation underwent full MUTYH gene sequencing. APC and MUTYH mutation prevalence was evaluated by polyp burden; the clinical characteristics associated with a pathogenic mutation were evaluated using logistic regression analyses. Main Outcome Measure Prevalence of pathogenic mutations in APC and MUTYH genes. Results Colorectal adenomas were reported in 7225 individuals; 1457 with classic polyposis (>= 100 adenomas) and 3253 with attenuated polyposis (20-99 adenomas). The prevalence of pathogenic APC and biallelic MUTYH mutations was 95 of 119 (80% [95% CI, 71%-87%]) and 2 of 119 (2% [95% CI, 0.2%-6%]), respectively, among individuals with 1000 or more adenomas, 756 of 1338 (56% [95% CI, 54%-59%]) and 94 of 1338 (7% [95% CI, 6%-8%]) among those with 100 to 999 adenomas, 326 of 3253 (10% [95% CI, 9%-11%]) and 233 of 3253 (7% [95% CI, 6%-8%]) among those with 20 to 99 adenomas, and 50 of 970 (5% [95% CI, 4%-7%]) and 37 of 970 (4% [95% CI, 3%-5%]) among those with 10 to 19 adenomas. Adenoma count was strongly associated with a pathogenic mutation in multivariable analyses. Conclusions Among patients with multiple colorectal adenomas, pathogenic APC and MUTYH mutation prevalence varied considerably by adenoma count, including within those with a classic polyposis phenotype. APC mutations predominated in patients with classic polyposis, whereas prevalence of APC and MUTYH mutations was similar in attenuated polyposis. These findings require external validation. JAMA. 2012;308(5):485-492 www.jama.com	[Grover, Shilpa; Dewanwala, Akriti; Syngal, Sapna] Dana Farber Canc Inst, Div Populat Sci, Boston, MA 02215 USA; [Grover, Shilpa; Syngal, Sapna] Brigham & Womens Hosp, Div Gastroenterol, Boston, MA 02115 USA; [Grover, Shilpa; Syngal, Sapna] Harvard Univ, Sch Med, Boston, MA USA; [Cook, E. Francis] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Grover, Shilpa] Massachusetts Gen Hosp, Program Canc Outcomes Res Training, Boston, MA 02114 USA; [Kastrinos, Fay] Columbia Univ, Med Ctr, New York, NY USA; [Kastrinos, Fay] Herbert Irving Comprehens Canc Ctr, New York, NY USA; [Steyerberg, Ewout W.] Erasmus MC, Ctr Med Decis Making, Rotterdam, Netherlands; [Burbidge, Lynn Anne; Wenstrup, Richard J.] Myriad Genet Labs Inc, Salt Lake City, UT USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Columbia University; Erasmus University Rotterdam; Erasmus MC; Myriad Genetics, Inc	Syngal, S (corresponding author), Dana Farber Canc Inst, Div Populat Sci, 450 Brookline Ave, Boston, MA 02215 USA.	ssyngal@partners.org	Steyerberg, Ewout/C-1509-2018	Steyerberg, Ewout/0000-0002-7787-0122	National Cancer Institute [R25 CA 092203, K07 CA151769]; National Institutes of Health [K24113433]; Myriad Genetics Laboratories Inc.; NATIONAL CANCER INSTITUTE [R25CA092203, K07CA151769, K24CA113433] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Myriad Genetics Laboratories Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Cancer Institute grants R25 CA 092203 (Dr Grover) and K07 CA151769 (Dr Kastrinos) and by National Institutes of Health grant K24113433 (Dr Syngal).; Independent Statistical Analysis: Data sets were forwarded by investigators at Myriad Genetics Laboratories Inc to independent investigators at the Dana-Farber Cancer Institute, Boston, Massachusetts (Drs Grover and Syngal) and the Herbert Irving Comprehensive Cancer Center, New York, New York (Dr Kastrinos). Drs Grover, Kastrinos, and Steyerberg (Center for Medical Decision Making, Erasmus Medical Center, Rotterdam, the Netherlands) performed independent statistical analyses. All results reported in the article are from the independent statistical analyses. None of the coauthors not employed by Myriad Genetics Laboratories Inc received any funding for the study from Myriad Genetics Laboratories Inc.	Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828; Armstrong JG, 1997, HUM MUTAT, V10, P376, DOI 10.1002/(SICI)1098-1004(1997)10:5<376::AID-HUMU7>3.0.CO;2-D; Balaguer F, 2008, GASTROENTEROLOGY, V134, P39, DOI 10.1053/j.gastro.2007.10.042; Balmana J, 2006, JAMA-J AM MED ASSOC, V296, P1469, DOI 10.1001/jama.296.12.1469; Boparai KS, 2008, GASTROENTEROLOGY, V135, P2014, DOI 10.1053/j.gastro.2008.09.020; Burt RW, 2010, J NATL COMPR CANC NE, V8, P8, DOI 10.6004/jnccn.2010.0003; Bussey H.J.R., 1975, FAMILIAL POLYPOSIS C; Castellsague E, 2010, GASTROENTEROLOGY, V139, P439, DOI 10.1053/j.gastro.2010.04.047; Cleary SP, 2009, GASTROENTEROLOGY, V136, P1251, DOI 10.1053/j.gastro.2008.12.050; Croitoru ME, 2007, J SURG ONCOL, V95, P499, DOI 10.1002/jso.20724; Croitoru ME, 2004, JNCI-J NATL CANCER I, V96, P1631, DOI 10.1093/jnci/djh288; Farrington SM, 2005, AM J HUM GENET, V77, P112, DOI 10.1086/431213; Filipe B, 2009, CLIN GENET, V76, P242, DOI 10.1111/j.1399-0004.2009.01241.x; Fleischmann C, 2004, INT J CANCER, V109, P554, DOI 10.1002/ijc.20020; Giardiello FM, 1997, NEW ENGL J MED, V336, P823, DOI 10.1056/NEJM199703203361202; Giardiello FM, 2001, GASTROENTEROLOGY, V121, P198, DOI 10.1053/gast.2001.25581; Giarola M, 1999, HUM MUTAT, V13, P116, DOI 10.1002/(SICI)1098-1004(1999)13:2<116::AID-HUMU3>3.0.CO;2-2; Gismondi V, 2004, INT J CANCER, V109, P680, DOI 10.1002/ijc.20054; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Jo WS, 2005, CLIN GASTROENTEROL H, V3, P1022, DOI 10.1016/S1542-3565(05)00411-8; Jones S, 2002, HUM MOL GENET, V11, P2961, DOI 10.1093/hmg/11.23.2961; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; MIYOSHI Y, 1992, P NATL ACAD SCI USA, V89, P4452, DOI 10.1073/pnas.89.10.4452; Nagase Hiroki, 1992, Human Mutation, V1, P467, DOI 10.1002/humu.1380010603; Nielsen M, 2007, CLIN GENET, V71, P427, DOI 10.1111/j.1399-0004.2007.00766.x; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; POWELL SM, 1993, NEW ENGL J MED, V329, P1982, DOI 10.1056/NEJM199312303292702; Rex DK, 2009, AM J GASTROENTEROL, V104, P739, DOI 10.1038/ajg.2009.104; Russell AM, 2006, INT J CANCER, V118, P1937, DOI 10.1002/ijc.21470; Sampson JR, 2003, LANCET, V362, P39, DOI 10.1016/S0140-6736(03)13805-6; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Sieber OM, 2003, NEW ENGL J MED, V348, P791, DOI 10.1056/NEJMoa025283; vanderLuijt RB, 1997, HUM MUTAT, V9, P7, DOI 10.1002/(SICI)1098-1004(1997)9:1<7::AID-HUMU2>3.0.CO;2-8; Vasen HFA, 2008, GUT, V57, DOI 10.1136/gut.2007.136127; Venesio T, 2004, GASTROENTEROLOGY, V126, P1681, DOI 10.1053/j.gastro.2004.02.022; Wang L, 2004, GASTROENTEROLOGY, V127, P9, DOI 10.1053/j.gastro.2004.03.070	36	128	130	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2012	308	5					485	492		10.1001/jama.2012.8780	http://dx.doi.org/10.1001/jama.2012.8780			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	981DQ	22851115	Bronze, Green Accepted			2022-12-28	WOS:000306947400026
J	Landon, BE; Grumbach, K; Wallace, PJ				Landon, Bruce E.; Grumbach, Kevin; Wallace, Paul J.			Integrating Public Health and Primary Care Systems Potential Strategies From an IOM Report	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Landon, Bruce E.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Landon, Bruce E.] Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02215 USA; [Grumbach, Kevin] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA; [Wallace, Paul J.] Lewin Grp, Falls Church, VA USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; University of California System; University of California San Francisco	Landon, BE (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	landon@hcp.med.harvard.edu	Grumbach, Kevin/L-9222-2016					Frieden TR, 2011, NEW ENGL J MED, V365, DOI [10.1056/NEJMp1110421, 10.1056/NEJMP1110421]; Institute of Medicine, 2012, PRIM CAR PUBL HLTH E	2	23	23	1	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2012	308	5					461	462		10.1001/jama.2012.8227	http://dx.doi.org/10.1001/jama.2012.8227			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	981DQ	22851111				2022-12-28	WOS:000306947400022
J	Sana, H; de Mink, SE; de Koter, A; Langer, N; Evans, CJ; Gieles, M; Gosset, E; Izzard, RG; Le Bouquin, JB; Schneider, FRN				Sana, H.; de Mink, S. E.; de Koter, A.; Langer, N.; Evans, C. J.; Gieles, M.; Gosset, E.; Izzard, R. G.; Le Bouquin, J. -B.; Schneider, F. R. N.			Binary Interaction Dominates the Evolution of Massive Stars	SCIENCE			English	Article							YOUNG OPEN CLUSTERS; GAMMA-RAY BURSTS; O-TYPE STARS; CLOSE BINARIES; PROGENITOR STARS; OB2 ASSOCIATION; MULTIPLICITY; FRACTION; SYSTEMS; NEBULA	The presence of a nearby companion alters the evolution of massive stars in binary systems, leading to phenomena such as stellar mergers, x-ray binaries, and gamma-ray bursts. Unambiguous constraints on the fraction of massive stars affected by binary interaction were lacking. We simultaneously measured all relevant binary characteristics in a sample of Galactic massive O stars and quantified the frequency and nature of binary interactions. More than 70% of all massive stars will exchange mass with a companion, leading to a binary merger in one-third of the cases. These numbers greatly exceed previous estimates and imply that binary interaction dominates the evolution of massive stars, with implications for populations of massive stars and their supernovae.	[Sana, H.; de Koter, A.] Univ Amsterdam, Astron Inst Anton Pannekoek, NL-1098 XH Amsterdam, Netherlands; [de Mink, S. E.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [de Mink, S. E.] Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA; [de Koter, A.] Univ Utrecht, Astron Inst, NL-3584 CC Utrecht, Netherlands; [Langer, N.; Izzard, R. G.; Schneider, F. R. N.] Univ Bonn, Argelander Inst Astron, D-53121 Bonn, Germany; [Evans, C. J.] Royal Observ Edinburgh, UK Astron Technol Ctr, Edinburgh EH9 3HJ, Midlothian, Scotland; [Gieles, M.] Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England; [Gosset, E.] Univ Liege, Inst Astrophys, Fonds Rech Sci FNRS, B-4000 Liege, Belgium; [Le Bouquin, J. -B.] Univ Grenoble 1, CNRS, Inst Natl Sci Univers, Inst Planetol & Astrophys Grenoble,UMR 5274, Grenoble, France	University of Amsterdam; Space Telescope Science Institute; Johns Hopkins University; Utrecht University; University of Bonn; University of Edinburgh; University of Cambridge; Fonds de la Recherche Scientifique - FNRS; University of Liege; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Planetologie et d'Astrophysique de Grenoble (IPAG); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Sana, H (corresponding author), Univ Amsterdam, Astron Inst Anton Pannekoek, Sci Pk 904, NL-1098 XH Amsterdam, Netherlands.	h.sana@uva.nl	Langer, Norbert/ABD-7263-2021; Porosnicu, Corneliu/C-3358-2011; Prodan, Gabriel/F-5455-2010; Vladoiu, Rodica N/B-5232-2012; Sana, Hugues/B-2664-2013; Gieles, Mark/AAP-6403-2020; Vasile, Eugeniu M./I-6164-2016	Prodan, Gabriel/0000-0002-9323-7562; Sana, Hugues/0000-0001-6656-4130; Gieles, Mark/0000-0002-9716-1868; Vasile, Eugeniu M./0000-0002-5868-1932; Izzard, Robert/0000-0003-0378-4843; Le Bouquin, Jean-Baptiste/0000-0002-0493-4674; Schneider, Fabian/0000-0002-5965-1022; de Mink, Selma/0000-0001-9336-2825	NASA through Hubble Fellowship by the Space Telescope Science Institute [HST-HF-51270.01-A]; NASA [NAS 5-26555]; Royal Society; ESO Paranal Observatory; User Support Department; SARA Computing and Networking Services	NASA through Hubble Fellowship by the Space Telescope Science Institute; NASA(National Aeronautics & Space Administration (NASA)); Royal Society(Royal Society of London); ESO Paranal Observatory; User Support Department; SARA Computing and Networking Services	Support for this work was provided by NASA through Hubble Fellowship grant HST-HF-51270.01-A awarded by the Space Telescope Science Institute, which is operated by the Association of Universities for Research in Astronomy for NASA, under contract NAS 5-26555. S.E.d.M. is a Hubble fellow. M.G. acknowledges financial support from The Royal Society. This work is based on European Southern Observatory (ESO) observations, and we acknowledge support from the ESO Paranal Observatory and the User Support Department. H.S. also acknowledges support from SARA Computing and Networking Services. Measurements used in this work have been made available at the Centre de Donnees astronomiques de Strasbourg (http://cdsweb.u-strasbg.fr/).	Bastian N, 2010, ANNU REV ASTRON ASTR, V48, P339, DOI 10.1146/annurev-astro-082708-101642; Belczynski K, 2002, ASTROPHYS J, V572, P407, DOI 10.1086/340304; Brott I, 2011, ASTRON ASTROPHYS, V530, DOI 10.1051/0004-6361/201016113; Cantiello M, 2007, ASTRON ASTROPHYS, V465, pL29, DOI 10.1051/0004-6361:20077115; Chiappini C, 2011, NATURE, V472, P454, DOI 10.1038/nature10000; Claeys JSW, 2011, ASTRON ASTROPHYS, V528, DOI 10.1051/0004-6361/201015410; Becker M, 2006, ASTRON ASTROPHYS, V456, P1121, DOI 10.1051/0004-6361:20065300; de Mink SE, 2007, ASTRON ASTROPHYS, V467, P1181, DOI 10.1051/0004-6361:20067007; De Rossi ME, 2010, ASTRON ASTROPHYS, V519, DOI 10.1051/0004-6361/201014058; Eldridge JJ, 2009, MON NOT R ASTRON SOC, V400, P1019, DOI 10.1111/j.1365-2966.2009.15514.x; GARMANY CD, 1980, ASTROPHYS J, V242, P1063, DOI 10.1086/158537; Hillwig TC, 2006, ASTROPHYS J, V639, P1069, DOI 10.1086/499771; Kiminki DC, 2012, ASTROPHYS J, V751, DOI 10.1088/0004-637X/751/1/4; Kobulnicky HA, 2007, ASTROPHYS J, V670, P747, DOI 10.1086/522073; Kratter KM, 2010, ASTROPHYS J, V708, P1585, DOI 10.1088/0004-637X/708/2/1585; Kroupa P, 2003, ASTROPHYS J, V598, P1076, DOI 10.1086/379105; Krumholz MR, 2009, SCIENCE, V323, P754, DOI 10.1126/science.1165857; Martins F, 2005, ASTRON ASTROPHYS, V436, P1049, DOI 10.1051/0004-6361:20042386; Mason BD, 2009, ASTRON J, V137, P3358, DOI 10.1088/0004-6256/137/2/3358; Pfalzner S, 2007, ASTRON ASTROPHYS, V475, P875, DOI 10.1051/0004-6361:20078458; Pinsonneault MH, 2006, ASTROPHYS J, V639, pL67, DOI 10.1086/502799; PODSIADLOWSKI P, 1992, ASTROPHYS J, V391, P246, DOI 10.1086/171341; POLS OR, 1994, ASTRON ASTROPHYS, V290, P119; Rauw G, 2009, MON NOT R ASTRON SOC, V398, P1582, DOI 10.1111/j.1365-2966.2009.15226.x; Sana H, 2008, MON NOT R ASTRON SOC, V386, P447, DOI 10.1111/j.1365-2966.2008.13037.x; Sana H, 2011, MON NOT R ASTRON SOC, V416, P817, DOI 10.1111/j.1365-2966.2011.18698.x; Sana H, 2009, MON NOT R ASTRON SOC, V400, P1479, DOI 10.1111/j.1365-2966.2009.15545.x; Sana H, 2011, IAU SYMP P SERIES, P474, DOI 10.1017/S1743921311011124; Smith N, 2011, MON NOT R ASTRON SOC, V412, P1522, DOI 10.1111/j.1365-2966.2011.17229.x; Wellstein S, 1999, ASTRON ASTROPHYS, V350, P148; Wellstein S, 2001, ASTRON ASTROPHYS, V369, P939, DOI 10.1051/0004-6361:20010151; Woosley SE, 2006, ANNU REV ASTRON ASTR, V44, P507, DOI 10.1146/annurev.astro.43.072103.150558; Woosley SE, 2006, ASTROPHYS J, V637, P914, DOI 10.1086/498500; Zinnecker H, 2007, ANNU REV ASTRON ASTR, V45, P481, DOI 10.1146/annurev.astro.44.051905.092549	34	1176	1179	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 27	2012	337	6093					444	446		10.1126/science.1223344	http://dx.doi.org/10.1126/science.1223344			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979FS	22837522	Green Accepted, Green Submitted			2022-12-28	WOS:000306802300036
J	Collins, MG; Teo, E; Cole, SR; Chan, CY; McDonald, SP; Russ, GR; Young, GP; Bampton, PA; Coates, PT				Collins, Michael G.; Teo, Edward; Cole, Stephen R.; Chan, Choy-Yoke; McDonald, Stephen P.; Russ, Graeme R.; Young, Graeme P.; Bampton, Peter A.; Coates, P. Toby			Screening for colorectal cancer and advanced colorectal neoplasia in kidney transplant recipients: cross sectional prevalence and diagnostic accuracy study of faecal immunochemical testing for haemoglobin and colonoscopy	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OCCULT BLOOD-TEST; SERVICES TASK-FORCE; HIGH-RISK GROUPS; GENERAL-POPULATION; SURVEILLANCE; SURVIVAL; METAANALYSIS; AUSTRALIA; OUTCOMES; UPDATE	Objective To investigate whether screening kidney transplant recipients aged over 50 years for colorectal cancer with a faecal immunochemical test for haemoglobin might be justified, by determining the prevalence of advanced colorectal neoplasia and evaluating the diagnostic accuracy of faecal haemoglobin testing compared with colonoscopy in a population of kidney transplant recipients at otherwise average risk. Design Cross sectional prevalence and diagnostic accuracy study with index test of faecal haemoglobin and reference standard of colonoscopy. Setting Outpatient clinics in metropolitan and regional hospitals in South Australia. Participants 229 kidney transplant recipients aged 50 years and over, who were at least 6 months (mean 9.0 (SD 8.4) years) post-transplant and otherwise at average risk of colorectal cancer, completed the study between June 2008 and October 2011. Interventions Faecal immunochemical testing (Enterix Insure) for human haemoglobin, followed by colonoscopy with histological evaluation of retrieved samples. Main outcome measures Prevalence of advanced colorectal neoplasia, defined as an adenoma at least 10 mm in diameter, villous features, high grade dysplasia, or colorectal cancer; sensitivity, specificity, and predictive values of faecal haemoglobin testing for advanced neoplasia compared with colonoscopy. Results Advanced colorectal neoplasia was found in 29 (13%, 95% confidence interval 9% to 18%) participants, including 2% (n=4) with high grade dysplasia and 2% (n=5) with colorectal cancer. Faecal testing for haemoglobin was positive in 12% (n=28); sensitivity, specificity, and positive and negative predictive values for advanced neoplasia were 31.0% (15.3% to 50.8%), 90.5% (85.6% to 94.2%), 32.1% (15.9% to 52.4%), and 90.1% (85.1% to 93.8%). Colonoscopy was well tolerated, with no significant adverse outcomes. To identify one case of advanced neoplasia, 8 (6 to 12) colonoscopies were needed. Conclusions Kidney transplant recipients aged over 50 years have a high prevalence of advanced colorectal neoplasia. Faecal haemoglobin screening for colorectal neoplasia has similar performance characteristics in transplant recipients to those reported in general population studies, with poor sensitivity but reasonable specificity. Surveillance colonoscopy might be a more appropriate approach in this population.	[Collins, Michael G.; Chan, Choy-Yoke; McDonald, Stephen P.; Russ, Graeme R.; Coates, P. Toby] Royal Adelaide Hosp, Cent No Adelaide Renal & Transplantat Serv, Adelaide, SA 5000, Australia; [Collins, Michael G.; McDonald, Stephen P.; Russ, Graeme R.; Coates, P. Toby] Univ Adelaide, Sch Med, Adelaide, SA 5005, Australia; [Teo, Edward] Queen Elizabeth Hosp, Dept Gastroenterol, Woodville, SA 5011, Australia; [Cole, Stephen R.; Young, Graeme P.] Repatriat Gen Hosp, Bowel Hlth Serv, Daw Pk, SA 5041, Australia; [Cole, Stephen R.; Young, Graeme P.; Bampton, Peter A.] Flinders Univ S Australia, Flinders Clin & Mol Med, Bedford Pk, SA 5042, Australia; [McDonald, Stephen P.] Univ Adelaide, Sch Populat Hlth & Clin Practice, Adelaide, SA 5005, Australia; [Young, Graeme P.; Bampton, Peter A.] Flinders Med Ctr, Dept Gastroenterol & Hepatol, Bedford Pk, SA 5042, Australia	Royal Adelaide Hospital; University of Adelaide; Flinders University South Australia; University of Adelaide; Flinders Medical Centre	Coates, PT (corresponding author), Royal Adelaide Hosp, Cent No Adelaide Renal & Transplantat Serv, Adelaide, SA 5000, Australia.	toby.coates@health.sa.gov.au	Collins, Michael/HGB-1347-2022; McDonald, Stephen/G-4010-2013	McDonald, Stephen/0000-0001-6103-1386; Young, Graeme/0000-0001-9458-8383; Collins, Michael/0000-0003-2169-9087	Queen Elizabeth Hospital Research Foundation; Roche Products Pty Australia through the CellCept Australia Research Grants (CARG)	Queen Elizabeth Hospital Research Foundation; Roche Products Pty Australia through the CellCept Australia Research Grants (CARG)	This study was funded by the Queen Elizabeth Hospital Research Foundation and also by Roche Products Pty Australia through the CellCept Australia Research Grants (CARG). Enterix Australia generously supplied the Insure kits and processed the faecal samples at no cost. Most colonoscopy procedures were done through the public healthcare system as "standard of care," where such procedures are available for colorectal cancer screening of patients thought to be at increased risk. None of the sponsors had any role in study design, data collection, analysis, interpretation, or the writing of the manuscript. This research was conducted completely independently from funders.	Australian Cancer Network Colorectal Cancer Guidelines Revision Committee, 2005, GUID PREV EARL DET M; Buell JF, 2005, TRANSPL P, V37, P960, DOI 10.1016/j.transproceed.2004.12.122; Burch JA, 2007, J MED SCREEN, V14, P132, DOI 10.1258/096914107782066220; Cairns SR, 2010, GUT, V59, P666, DOI 10.1136/gut.2009.179804; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; Cole SR, 2003, J MED SCREEN, V10, P117, DOI 10.1258/096914103769011003; Colorectal Cancer Screening, 2001, CMAJ, V165, P206; Commonwealth of Australia, 2005, AUSTR BOW CANC SCREE; Eckardt KU, 2009, AM J TRANSPLANT, V9, pS1, DOI 10.1111/j.1600-6143.2009.02834.x; Edge SB, 2010, AJCC CANC STAGING MA; Flitcroft KL, 2011, J MED SCREEN, V18, P193, DOI 10.1258/jms.2011.011066; Forbes GM, 2006, MED J AUSTRALIA, V184, P546, DOI 10.5694/j.1326-5377.2006.tb00377.x; Hewitson P, 2008, AM J GASTROENTEROL, V103, P1541, DOI 10.1111/j.1572-0241.2008.01875.x; Hol L, 2010, GUT, V59, P62, DOI 10.1136/gut.2009.177089; Israni AK, 2010, AM J TRANSPLANT, V10, P338, DOI 10.1111/j.1600-6143.2009.02949.x; Johnson EE, 2007, J GASTROINTEST SURG, V11, P272, DOI 10.1007/s11605-007-0084-4; Kasiske BL, 2004, AM J TRANSPLANT, V4, P905, DOI 10.1111/j.1600-6143.2004.00450.x; Kiberd BA, 2003, AM J TRANSPLANT, V3, P619, DOI 10.1034/j.1600-6143.2003.00118.x; Lane JM, 2010, GASTROENTEROLOGY, V139, P1918, DOI 10.1053/j.gastro.2010.08.005; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Lieberman DA, 2009, NEW ENGL J MED, V361, P1179, DOI 10.1056/NEJMcp0902176; Loganayagam A, 2008, INT J CLIN PRACT, V62, P454, DOI 10.1111/j.1742-1241.2007.01532.x; McDonald SP, 2002, NEPHROL DIAL TRANSPL, V17, P2212, DOI 10.1093/ndt/17.12.2212; McDonald Stephen, 2009, ANZDATA REGISTRY REP; Miao Y, 2009, TRANSPLANTATION, V87, P1347, DOI 10.1097/TP.0b013e3181a238f6; Morikawa T, 2005, GASTROENTEROLOGY, V129, P422, DOI 10.1053/j.gastro.2005.05.056; Nelson DB, 2002, GASTROINTEST ENDOSC, V55, P307, DOI 10.1067/mge.2002.121883; Niv Y, 2008, DIGEST DIS SCI, V53, P3049, DOI 10.1007/s10620-008-0286-y; Papaconstantinou HT, 2004, DIS COLON RECTUM, V47, P1898, DOI 10.1007/s10350-004-0674-0; Park JM, 2010, AM J TRANSPLANT, V10, P2043, DOI 10.1111/j.1600-6143.2010.03231.x; Poggio ED, 2006, AM J TRANSPLANT, V6, P100, DOI 10.1111/j.1600-6143.2005.01140.x; Regula J, 2006, NEW ENGL J MED, V355, P1863, DOI 10.1056/NEJMoa054967; Rosman AS, 2010, J GEN INTERN MED, V25, P1211, DOI 10.1007/s11606-010-1375-0; Schoenfeld P, 2005, NEW ENGL J MED, V352, P2061, DOI 10.1056/NEJMoa042990; Smith A, 2006, CANCER, V107, P2152, DOI 10.1002/cncr.22230; Tran B, 2011, INTERN MED J; Vajdic CM, 2006, JAMA-J AM MED ASSOC, V296, P2823, DOI 10.1001/jama.296.23.2823; Webster AC, 2007, AM J TRANSPLANT, V7, P2140, DOI 10.1111/j.1600-6143.2007.01908.x; Whitlock EP, 2008, ANN INTERN MED, V149, P638, DOI 10.7326/0003-4819-149-9-200811040-00245; Winawer Sidney J, 2002, Gastrointest Endosc Clin N Am, V12, P1, DOI 10.1016/S1052-5157(03)00053-9; Wong G, 2008, TRANSPLANTATION, V85, P532, DOI 10.1097/TP.0b013e3181639d35; World Health Organization, 2011, CANC FACT SHEET 297	43	31	31	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 25	2012	345								e4657	10.1136/bmj.e4657	http://dx.doi.org/10.1136/bmj.e4657			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	981UW	22833618	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000306997500003
J	Bogunovic, D; Byun, M; Durfee, LA; Abhyankar, A; Sanal, O; Mansouri, D; Salem, S; Radovanovic, I; Grant, AV; Adimi, P; Mansouri, N; Okada, S; Bryant, VL; Kong, XF; Kreins, A; Velez, MM; Boisson, B; Khalilzadeh, S; Ozcelik, U; Darazam, IA; Schoggins, JW; Rice, CM; Al-Muhsen, S; Behr, M; Vogt, G; Puel, A; Bustamante, J; Gros, P; Huibregtse, JM; Abel, L; Boisson-Dupuis, S; Casanova, JL				Bogunovic, Dusan; Byun, Minji; Durfee, Larissa A.; Abhyankar, Avinash; Sanal, Ozden; Mansouri, Davood; Salem, Sandra; Radovanovic, Irena; Grant, Audrey V.; Adimi, Parisa; Mansouri, Nahal; Okada, Satoshi; Bryant, Vanessa L.; Kong, Xiao-Fei; Kreins, Alexandra; Velez, Marcela Moncada; Boisson, Bertrand; Khalilzadeh, Soheila; Ozcelik, Ugur; Darazam, Ilad Alavi; Schoggins, John W.; Rice, Charles M.; Al-Muhsen, Saleh; Behr, Marcel; Vogt, Guillaume; Puel, Anne; Bustamante, Jacinta; Gros, Philippe; Huibregtse, Jon M.; Abel, Laurent; Boisson-Dupuis, Stephanie; Casanova, Jean-Laurent			Mycobacterial Disease and Impaired IFN-gamma Immunity in Humans with Inherited ISG15 Deficiency	SCIENCE			English	Article							UBIQUITIN-LIKE PROTEIN; INFECTIOUS-DISEASES; LYMPHOCYTES; MACROPHAGES; MUTATIONS; MONOCYTES; CYTOKINE; GENETICS	ISG15 is an interferon (IFN)-alpha/beta-inducible, ubiquitin-like intracellular protein. Its conjugation to various proteins (ISGylation) contributes to antiviral immunity in mice. Here, we describe human patients with inherited ISG15 deficiency and mycobacterial, but not viral, diseases. The lack of intracellular ISG15 production and protein ISGylation was not associated with cellular susceptibility to any viruses that we tested, consistent with the lack of viral diseases in these patients. By contrast, the lack of mycobacterium-induced ISG15 secretion by leukocytes-granulocyte, in particular-reduced the production of IFN-gamma by lymphocytes, including natural killer cells, probably accounting for the enhanced susceptibility to mycobacterial disease. This experiment of nature shows that human ISGylation is largely redundant for antiviral immunity, but that ISG15 plays an essential role as an IFN-gamma-inducing secreted molecule for optimal antimycobacterial immunity.	[Bogunovic, Dusan; Byun, Minji; Abhyankar, Avinash; Mansouri, Nahal; Okada, Satoshi; Bryant, Vanessa L.; Kong, Xiao-Fei; Kreins, Alexandra; Velez, Marcela Moncada; Boisson, Bertrand; Vogt, Guillaume; Abel, Laurent; Boisson-Dupuis, Stephanie; Casanova, Jean-Laurent] Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, New York, NY 10021 USA; [Durfee, Larissa A.; Huibregtse, Jon M.] Univ Texas Austin, Inst Cellular & Mol Biol, Sect Mol Genet & Microbiol, Austin, TX 78712 USA; [Sanal, Ozden; Ozcelik, Ugur] Hacettepe Univ, Childrens Hosp, Div Immunol, TR-06100 Ankara, Turkey; [Sanal, Ozden; Ozcelik, Ugur] Hacettepe Univ, Childrens Hosp, Pediat Chest Dis Dept, TR-06100 Ankara, Turkey; [Mansouri, Davood; Adimi, Parisa; Mansouri, Nahal; Khalilzadeh, Soheila; Darazam, Ilad Alavi] Shahid Beheshti Univ Med Sci, Natl Res Inst TB & Lung Dis, Div Infect Dis & Clin Immunol, Tehran, Iran; [Salem, Sandra; Radovanovic, Irena; Gros, Philippe] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Grant, Audrey V.; Vogt, Guillaume; Puel, Anne; Bustamante, Jacinta; Abel, Laurent; Boisson-Dupuis, Stephanie; Casanova, Jean-Laurent] Univ Paris 05, INSERM, U980, Lab Human Genet Infect Dis,Necker Branch,Necker M, F-75015 Paris, France; [Schoggins, John W.; Rice, Charles M.] Rockefeller Univ, Lab Virol & Infect Dis, Ctr Study Hepatitis C, New York, NY 10021 USA; [Al-Muhsen, Saleh] King Saud Univ, Coll Med, Dept Pediat, Prince Naif Ctr Immunol Res, Riyadh 11211, Saudi Arabia; [Al-Muhsen, Saleh] King Faisal Specialist Hosp & Res Ctr, Dept Pediat, Riyadh 11211, Saudi Arabia; [Behr, Marcel] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada; [Bustamante, Jacinta] Hop Necker Enfants Malad, AP HP, Ctr Study Primary Immunodeficiencies, Paris, France; [Casanova, Jean-Laurent] Hop Necker Enfants Malad, Pediat Hematol Immunol Unit, F-75015 Paris, France	Rockefeller University; University of Texas System; University of Texas Austin; Hacettepe University; Hacettepe University; Shahid Beheshti University Medical Sciences; McGill University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Rockefeller University; King Saud University; King Faisal Specialist Hospital & Research Center; McGill University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Casanova, JL (corresponding author), Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, 1230 York Ave, New York, NY 10021 USA.	casanova@rockefeller.edu	Darazam, Ilad Alavi/K-6593-2014; Puel, Anne/H-7305-2017; OZCELIK, HAYRIYE UGUR/I-9320-2013; adimi-naghan, parisa/G-5849-2017; mansouri, davood/G-6471-2017; Casanova, Jean-Laurent/I-3418-2017; Boisson, Bertrand/AAC-6058-2019; adimi, Parisa/AAN-1103-2020; Abel, Laurent/H-8888-2017; Bustamante, Jacinta/H-7877-2017; Boisson, Bertrand/I-2485-2017; Vogt, Guillaume/L-6046-2015; Boisson-Dupuis, Stéphanie/I-2040-2017; Bryant, Vanessa/S-5333-2019; Boisson-Dupuis, Stephanie/AAF-5066-2021; Okada, Satoshi/B-8901-2011; Al-muhsen, saleh/E-9315-2014	Darazam, Ilad Alavi/0000-0002-4440-335X; Puel, Anne/0000-0003-2603-0323; OZCELIK, HAYRIYE UGUR/0000-0003-1587-5216; adimi-naghan, parisa/0000-0002-4201-2822; mansouri, davood/0000-0002-0564-8282; Boisson, Bertrand/0000-0001-5240-3555; Abel, Laurent/0000-0001-7016-6493; Bustamante, Jacinta/0000-0002-3439-2482; Boisson, Bertrand/0000-0001-5240-3555; Vogt, Guillaume/0000-0001-8192-1247; Boisson-Dupuis, Stéphanie/0000-0002-7115-116X; Bryant, Vanessa/0000-0002-4697-7410; Okada, Satoshi/0000-0002-4622-5657; Al-muhsen, saleh/0000-0003-3698-9968; Kong, Xiao-Fei/0000-0001-9983-2373; Kreins, Alexandra/0000-0001-8748-5837; Radovanovic, Irena/0000-0002-3823-3729; Byun, Minji/0000-0002-2830-4079; Casanova, Jean-Laurent/0000-0002-7782-4169; khalilzadeh, soheila/0000-0002-3365-2449	French National Agency for Research (ANR); European Union [HEALTH-F32008-200732]; Bill and Melinda Gates Foundation; St. Giles Foundation; Jeffrey Model Foundation; Talecris Biotherapeutics; National Center for Research Resources and the National Center for Advancing Sciences (NCATS); NIH [8UL1TR000043]; Rockefeller University; National Institute of Allergy and Infectious Diseases (NIAID) [1R37AI095983-01, 5RO1AI035237-15]; National Cancer Institute [CA072943]; NIAID [AI096090]; Empire State Stem Cell fund through New York State Department of Health [C023046]; Charles H. Revson Foundation; Cancer Research Institute; Stony Wold-Herbert Fund; Fondation Medicale Medische Stichting Mathilde E. Horlait-Dapens; NATIONAL CANCER INSTITUTE [R01CA072943] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091707, R01AI035237, R01AI096090, R37AI095983] Funding Source: NIH RePORTER	French National Agency for Research (ANR)(French National Research Agency (ANR)); European Union(European Commission); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); St. Giles Foundation; Jeffrey Model Foundation; Talecris Biotherapeutics; National Center for Research Resources and the National Center for Advancing Sciences (NCATS); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rockefeller University; National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Empire State Stem Cell fund through New York State Department of Health; Charles H. Revson Foundation; Cancer Research Institute; Stony Wold-Herbert Fund; Fondation Medicale Medische Stichting Mathilde E. Horlait-Dapens; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank E. Borden, A. Garcia-Sastre, E. Jouanguy, C. Picard, F. Casadio, I. Marazzi, V. Sancho-Shimizu, M. Leruez, J. Feinberg, L. Janniere, M. de Surmain, T. Kochetkov, H. Kyung Lim, Y. Nemirovskaya, M. Courat, T. Nivare, E. Anderson, and the Bio-Imaging and Flow Cytometry Resource Centers for their invaluable assistance; the physicians for taking care of the patients; the patients themselves for participating; and C. Nathan for providing BCG. The Laboratory of Human Genetics of Infectious Diseases is supported in part by grants from the French National Agency for Research (ANR), the European Union grant HOMITB (HEALTH-F32008-200732), the Bill and Melinda Gates Foundation, the St. Giles Foundation, the Jeffrey Model Foundation and Talecris Biotherapeutics, the National Center for Research Resources and the National Center for Advancing Sciences (NCATS), the NIH (grant no. 8UL1TR000043), The Rockefeller University, the National Institute of Allergy and Infectious Diseases (NIAID) [grant nos. 1R37AI095983-01 (all to J.-L. C.) and 5RO1AI035237-15 (to P. G.)], grants from the National Cancer Institute (CA072943) and NIAID (AI096090) (both to J. M. H.), and the Empire State Stem Cell fund through New York State Department of Health contract no. C023046 to The Rockefeller Univ. Flow Cytometry Resource Center. M. Byun was supported by the Charles H. Revson Foundation and the Cancer Research Institute, V. L. B. and X.-F.K. by the Stony Wold-Herbert Fund, and A. K. by the Fondation Medicale Medische Stichting Mathilde E. Horlait-Dapens. All of the data presented in this manuscript are tabulated in the main text and in the supplementarymaterials, and sequence data are available from the National Center for Biotechnology Information database with accession no. SRA053225.	Alcais A, 2010, ANN NY ACAD SCI, V1214, P18, DOI 10.1111/j.1749-6632.2010.05834.x; Alcais A, 2009, J CLIN INVEST, V119, P2506, DOI 10.1172/JCI38111; Boisson-Dupuis S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018524; Bustamante J, 2011, NAT IMMUNOL, V12, P213, DOI 10.1038/ni.1992; Byun M, 2010, J EXP MED, V207, P2307, DOI 10.1084/jem.20101597; Casanova JL, 2007, SCIENCE, V317, P617, DOI 10.1126/science.1142963; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; DCunha J, 1996, P NATL ACAD SCI USA, V93, P211, DOI 10.1073/pnas.93.1.211; DCunha J, 1996, J IMMUNOL, V157, P4100; de Beaucoudrey L, 2010, MEDICINE, V89, P381, DOI 10.1097/MD.0b013e3181fdd832; Durfee LA, 2010, MOL CELL, V38, P722, DOI 10.1016/j.molcel.2010.05.002; Feinberg J, 2004, EUR J IMMUNOL, V34, P3276, DOI 10.1002/eji.200425221; Grant AV, 2011, J MED GENET, V48, P567, DOI 10.1136/jmg.2011.089128; Hager M, 2010, J INTERN MED, V268, P25, DOI 10.1111/j.1365-2796.2010.02237.x; Hambleton S, 2011, NEW ENGL J MED, V365, P127, DOI 10.1056/NEJMoa1100066; Hamerman JA, 2002, J IMMUNOL, V168, P2415, DOI 10.4049/jimmunol.168.5.2415; Harty RN, 2009, J INNATE IMMUN, V1, P397, DOI 10.1159/000226245; Jeon YJ, 2010, BBA-MOL BASIS DIS, V1802, P485, DOI 10.1016/j.bbadis.2010.02.006; KNIGHT E, 1991, J IMMUNOL, V146, P2280; Lenschow DJ, 2007, P NATL ACAD SCI USA, V104, P1371, DOI 10.1073/pnas.0607038104; Okumura A, 2006, P NATL ACAD SCI USA, V103, P1440, DOI 10.1073/pnas.0510518103; Osiak A, 2005, MOL CELL BIOL, V25, P6338, DOI 10.1128/MCB.25.15.6338-6345.2005; Pitha-Rowe IF, 2007, CYTOKINE GROWTH F R, V18, P409, DOI 10.1016/j.cytogfr.2007.06.017; Quintana-Murci L, 2007, NAT IMMUNOL, V8, P1165, DOI 10.1038/ni1535; Skaug B, 2010, CELL, V143, P187, DOI 10.1016/j.cell.2010.09.033; Tabarsi P, 2011, J CLIN IMMUNOL, V31, P537, DOI 10.1007/s10875-011-9523-9; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Zhang DX, 2011, J INTERF CYTOK RES, V31, P119, DOI 10.1089/jir.2010.0110	29	329	348	2	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2012	337	6102					1684	1688		10.1126/science.1224026	http://dx.doi.org/10.1126/science.1224026			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	22859821	Green Accepted			2022-12-28	WOS:000309215400053
J	Chirdan, LB; Ameh, EA				Chirdan, Lohfa B.; Ameh, Emmanuel A.			Untreated surgical conditions: time for global action	LANCET			English	Editorial Material							SURGERY; AFRICA; BURDEN		[Chirdan, Lohfa B.] Univ Jos, Teaching Hosp, Dept Surg, Jos, Nigeria; [Ameh, Emmanuel A.] Ahmadu Bello Univ, Teaching Hosp, Dept Surg, Zaria, Nigeria	University of Jos; Ahmadu Bello University	Chirdan, LB (corresponding author), Univ Jos, Teaching Hosp, Dept Surg, PMB 2076, Jos, Nigeria.	lohfab@yahoo.com		Ameh, Emmanuel/0000-0003-2386-3039				Chirdan LB, 2010, J PEDIATR SURG, V45, P610, DOI 10.1016/j.jpedsurg.2009.11.007; Debas HT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1245; Farmer PE, 2008, WORLD J SURG, V32, P533, DOI 10.1007/s00268-008-9525-9; Groen RS, 2012, WORLD J SURG, V36, P771, DOI 10.1007/s00268-012-1448-9; Groen RS, 2012, J GERONTOL B, P61081; NORDBERG E, 1994, E AFR MED J, V71, P339; Ozgediz D, 2008, B WORLD HEALTH ORGAN, V86, P646, DOI 10.2471/BLT.07.050435; Taira B, 2009, WORLD J SURG, V33, P893, DOI 10.1007/s00268-009-9981-x; UNDP, MILL DEV REP 2012; Walker IA, 2010, B WORLD HEALTH ORGAN, V88, P897, DOI 10.2471/BLT.10.076703; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8	11	12	12	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 22	2012	380	9847					1040	1041		10.1016/S0140-6736(12)61305-1	http://dx.doi.org/10.1016/S0140-6736(12)61305-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	007VL	22898075				2022-12-28	WOS:000308916400008
J	Augustin, M; Vanscheidt, W				Augustin, Matthias; Vanscheidt, Wolfgang			Chronic venous leg ulcers: the future of cell-based therapies	LANCET			English	Editorial Material									[Augustin, Matthias] Univ Med Ctr Hamburg, Inst Hlth Serv Res Dermatol & Nursing, D-20246 Hamburg, Germany; [Augustin, Matthias] Univ Med Ctr Hamburg, Comprehens Wound Ctr, D-20246 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Augustin, M (corresponding author), Univ Med Ctr Hamburg, Inst Hlth Serv Res Dermatol & Nursing, D-20246 Hamburg, Germany.	m.augustin@uke.de						Boulton AJM, 2005, LANCET, V366, P1719, DOI 10.1016/S0140-6736(05)67698-2; Dieckmann C, 2010, EXP DERMATOL, V19, P697, DOI 10.1111/j.1600-0625.2010.01087.x; Grey JE, 2006, BRIT MED J, V332, P347, DOI 10.1136/bmj.332.7537.347; Herberger K, 2012, J EUR ACAD DERMATOL, V26, P495, DOI 10.1111/j.1468-3083.2011.04110.x; Kirsner RS, 2012, J GERONTOL B; Langer A, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-115; LINDHOLM C, 1992, ACTA DERM-VENEREOL, V72, P227; Margolis DJ, 1999, ARCH DERMATOL, V135, P920, DOI 10.1001/archderm.135.8.920; Meaume S, 2012, J WOUND CARE, V21, P62, DOI 10.12968/jowc.2012.21.2.62; O'Meara S, 2009, COCHRANE DB SYST REV, V1, P1; Ohno T, 2012, J ATHEROSCLER THROMB; PHILLIPS T, 1994, J AM ACAD DERMATOL, V31, P49, DOI 10.1016/S0190-9622(94)70134-2; Phillips TJ, 2000, J AM ACAD DERMATOL, V43, P627, DOI 10.1067/mjd.2000.107496; Purwins S, 2010, INT WOUND J, V7, P97, DOI 10.1111/j.1742-481X.2010.00660.x; Tennvall GR, 2005, WOUND REPAIR REGEN, V13, P13, DOI 10.1111/j.1067-1927.2005.130103.x	15	10	11	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 15	2012	380	9846					953	955		10.1016/S0140-6736(12)61255-0	http://dx.doi.org/10.1016/S0140-6736(12)61255-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	005JF	22863327				2022-12-28	WOS:000308746000008
J	Song, J; Zhong, C; Bonaguidi, MA; Sun, GJ; Hsu, D; Gu, Y; Meletis, K; Huang, ZJ; Ge, SY; Enikolopov, G; Deisseroth, K; Luscher, B; Christian, KM; Ming, GL; Song, HJ				Song, Juan; Zhong, Chun; Bonaguidi, Michael A.; Sun, Gerald J.; Hsu, Derek; Gu, Yan; Meletis, Konstantinos; Huang, Z. Josh; Ge, Shaoyu; Enikolopov, Grigori; Deisseroth, Karl; Luscher, Bernhard; Christian, Kimberly M.; Ming, Guo-li; Song, Hongjun			Neuronal circuitry mechanism regulating adult quiescent neural stem-cell fate decision	NATURE			English	Article							NEWLY GENERATED NEURONS; IMMUNOREACTIVE NEURONS; NEUROGENESIS; BRAIN; RECEPTORS; SYSTEM	Adult neurogenesis arises from neural stem cells within specialized niches(1-3). Neuronal activity and experience, presumably acting on this local niche, regulate multiple stages of adult neurogenesis, from neural progenitor proliferation to new neuron maturation, synaptic integration and survival(1,3). It is unknown whether local neuronal circuitry has a direct impact on adult neural stem cells. Here we show that, in the adult mouse hippocampus, nestin-expressing radial glia-like quiescent neural stem cells(4-9) (RGLs) respond tonically to the neurotransmitter gamma-aminobutyric acid (GABA) by means of gamma(2)-subunit-containing GABA(A) receptors. Clonal analysis(9) of individual RGLs revealed a rapid exit from quiescence and enhanced symmetrical self-renewal after conditional deletion of gamma(2). RGLs are in close proximity to terminals expressing 67-kDa glutamic acid decarboxylase (GAD67) of parvalbumin-expressing (PV+) interneurons and respond tonically to GABA released from these neurons. Functionally, optogenetic control of the activity of dentate PV+ interneurons, but not that of somatostatin-expressing or vasoactive intestinal polypeptide (VIP)-expressing interneurons, can dictate the RGL choice between quiescence and activation. Furthermore, PV+ interneuron activation restores RGL quiescence after social isolation, an experience that induces RGL activation and symmetrical division(8). Our study identifies a niche cell-signal-receptor trio and a local circuitry mechanism that control the activation and self-renewal mode of quiescent adult neural stem cells in response to neuronal activity and experience.	[Song, Juan; Zhong, Chun; Bonaguidi, Michael A.; Sun, Gerald J.; Hsu, Derek; Christian, Kimberly M.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA; [Song, Juan; Zhong, Chun; Bonaguidi, Michael A.; Christian, Kimberly M.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Sun, Gerald J.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Gu, Yan; Ge, Shaoyu] SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA; [Meletis, Konstantinos] Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden; [Huang, Z. Josh; Enikolopov, Grigori] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Luscher, Bernhard] Penn State Univ, Dept Biol, University Pk, PA 16802 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Karolinska Institutet; Cold Spring Harbor Laboratory; Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Song, HJ (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA.	gming1@jhmi.edu; shongju1@jhmi.edu	Meletis, Konstantinos/ABE-6777-2020; Luscher, Bernhard/C-3528-2009; Ming, Guo-li/J-7880-2013; Enikolopov, Grigori/P-5731-2019; Core, Vector/CAF-4832-2022; Gu, Yan/K-4702-2017	Luscher, Bernhard/0000-0003-1375-1906; Enikolopov, Grigori/0000-0001-8178-8917; Gu, Yan/0000-0001-5562-6279; Huang, Z. Josh/0000-0003-0592-028X; Meletis, Konstantinos/0000-0001-5665-4781	National Institutes of Health (NIH) [NS047344, NS048271, HD069184, MH089111, AG040209]; National Alliance for Research on Schizophrenia and Depression; Adelson Medical Research Foundation; New York State Stem Cell Science; Ellison Medical Foundation; Life Sciences Research Foundation; Maryland Stem Cell Research Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES021957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RC1MH089111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048271, R56NS047344, R01NS065915, R01NS047344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040209] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Alliance for Research on Schizophrenia and Depression(NARSAD); Adelson Medical Research Foundation; New York State Stem Cell Science; Ellison Medical Foundation(Lawrence Ellison Foundation); Life Sciences Research Foundation; Maryland Stem Cell Research Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank L. H. Tsai for initial help in the study; members of the Song and Ming laboratories for discussion; H. Davoudi for help; and Q. Hussaini, Y. Cai and L. Liu for technical support. This work was supported by grants from the National Institutes of Health (NIH) (NS047344) to H. S., the NIH (NS048271, HD069184), the National Alliance for Research on Schizophrenia and Depression and the Adelson Medical Research Foundation to G. L. M., the NIH (MH089111) to B. L., the NIH (AG040209) and New York State Stem Cell Science and the Ellison Medical Foundation to G. E., and by postdoctoral fellowships from the Life Sciences Research Foundation to J.S. and from the Maryland Stem Cell Research Fund to J.S., C.Z. and K.C.	Andang M, 2008, NATURE, V451, P460, DOI 10.1038/nature06488; Andre V, 2001, HIPPOCAMPUS, V11, P452, DOI 10.1002/hipo.1060.abs; BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Caraiscos VB, 2004, P NATL ACAD SCI USA, V101, P3662, DOI 10.1073/pnas.0307231101; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Dranovsky A, 2011, NEURON, V70, P908, DOI 10.1016/j.neuron.2011.05.022; Encinas JM, 2006, P NATL ACAD SCI USA, V103, P8233, DOI 10.1073/pnas.0601992103; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Fernando RN, 2011, P NATL ACAD SCI USA, V108, P5837, DOI 10.1073/pnas.1014993108; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gasser EMS, 2006, NAT PROTOC, V1, P1887, DOI 10.1038/nprot.2006.265; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gonzalez-Burgos G, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/723184; Ibi D, 2008, J NEUROCHEM, V105, P921, DOI 10.1111/j.1471-4159.2007.05207.x; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Jagasia R, 2009, J NEUROSCI, V29, P7966, DOI 10.1523/JNEUROSCI.1054-09.2009; Kim JY, 2009, NEURON, V63, P761, DOI 10.1016/j.neuron.2009.08.008; Knable MB, 2004, MOL PSYCHIATR, V9, P609, DOI 10.1038/sj.mp.4001471; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; LOLOVA I, 1992, MECH AGEING DEV, V66, P195, DOI 10.1016/0047-6374(92)90136-2; Masiulis I, 2011, MOL NEUROBIOL, V44, P287, DOI 10.1007/s12035-011-8207-z; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; SATOH J, 1991, ACTA NEUROPATHOL, V81, P388, DOI 10.1007/BF00293459; Schweizer C, 2003, MOL CELL NEUROSCI, V24, P442, DOI 10.1016/S1044-7431(03)00202-1; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	30	349	362	4	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2012	489	7414					150	U216		10.1038/nature11306	http://dx.doi.org/10.1038/nature11306			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999WW	22842902	Green Accepted			2022-12-28	WOS:000308347000053
J	Brantut, JP; Meineke, J; Stadler, D; Krinner, S; Esslinger, T				Brantut, Jean-Philippe; Meineke, Jakob; Stadler, David; Krinner, Sebastian; Esslinger, Tilman			Conduction of Ultracold Fermions Through a Mesoscopic Channel	SCIENCE			English	Article							BOSE-EINSTEIN CONDENSATE; ANDERSON LOCALIZATION; COLLECTIVE EXCITATIONS; POINT CONTACTS; QUANTUM WIRES; ATOMS; TRANSPORT; MATTER; GAS; QUANTIZATION	In a mesoscopic conductor, electric resistance is detected even if the device is defect-free. We engineered and studied a cold-atom analog of a mesoscopic conductor. It consists of a narrow channel connecting two macroscopic reservoirs of fermions that can be switched from ballistic to diffusive. We induced a current through the channel and found ohmic conduction, even when the channel is ballistic. We measured in situ the density variations resulting from the presence of a current and observed that density remains uniform and constant inside the ballistic channel. In contrast, for the diffusive case with disorder, we observed a density gradient extending through the channel. Our approach opens the way toward quantum simulation of mesoscopic devices with quantum gases.	[Brantut, Jean-Philippe; Meineke, Jakob; Stadler, David; Krinner, Sebastian; Esslinger, Tilman] ETH, Inst Quantum Elect, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Esslinger, T (corresponding author), ETH, Inst Quantum Elect, CH-8093 Zurich, Switzerland.	esslinger@phys.ethz.ch	Brantut, Jean-Philippe/G-2793-2013; Esslinger, Tilman/M-9022-2016	Esslinger, Tilman/0000-0002-8333-107X; Brantut, Jean-Philippe/0000-0002-4610-6682	National Centers for Competence in Research Materials with Novel Electronic Properties (NCCR MaNEP); Quantum Science and Technology (QSIT), European Research Council (ERC) project Synthetic Quantum Many-Body Systems (SQMS), Framework Program 7 (FP7) project Nanodesigning of Atomic and Molecular Quantum Matter; ETH Zurich; European Union (EU) through a Marie Curie Fellowship	National Centers for Competence in Research Materials with Novel Electronic Properties (NCCR MaNEP); Quantum Science and Technology (QSIT), European Research Council (ERC) project Synthetic Quantum Many-Body Systems (SQMS), Framework Program 7 (FP7) project Nanodesigning of Atomic and Molecular Quantum Matter; ETH Zurich(ETH Zurich); European Union (EU) through a Marie Curie Fellowship	We acknowledge fruitful discussions with J. Blatter, A. Georges, H. Moritz, A. Rosch, and W. Zwerger and the help of T. Muller during the early stage of the experiment. We are grateful to the group of F. Merkt for the loan of a 532-nm laser. We acknowledge financing from National Centers for Competence in Research Materials with Novel Electronic Properties (NCCR MaNEP) and Quantum Science and Technology (QSIT), European Research Council (ERC) project Synthetic Quantum Many-Body Systems (SQMS), Framework Program 7 (FP7) project Nanodesigning of Atomic and Molecular Quantum Matter, and ETH Zurich. J. P. B. acknowledges support from the European Union (EU) through a Marie Curie Fellowship.	Abrahams E, 2001, REV MOD PHYS, V73, P251, DOI 10.1103/RevModPhys.73.251; Albiez M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.010402; BenDahan M, 1996, PHYS REV LETT, V76, P4508, DOI 10.1103/PhysRevLett.76.4508; Billy J, 2008, NATURE, V453, P891, DOI 10.1038/nature07000; Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; Bruderer M, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.013623; Das KK, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.123007; Datta S., 1997, ELECT TRANSPORT MESO; Esslinger T, 2010, ANNU REV CONDEN MA P, V1, P129, DOI 10.1146/annurev-conmatphys-070909-104059; Gao B, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.196802; Imry Y, 1999, REV MOD PHYS, V71, pS306, DOI 10.1103/RevModPhys.71.S306; Imry Y., 1997, INTRO MESOSCOPIC PHY; Jendrzejewski F, 2012, NAT PHYS, V8, P398, DOI [10.1038/NPHYS2256, 10.1038/nphys2256]; Jin DS, 1996, PHYS REV LETT, V77, P420, DOI 10.1103/PhysRevLett.77.420; Kondov SS, 2011, SCIENCE, V334, P66, DOI 10.1126/science.1209019; Kuhn RC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.250403; Levy S, 2007, NATURE, V449, P579, DOI 10.1038/nature06186; Mewes MO, 1996, PHYS REV LETT, V77, P988, DOI 10.1103/PhysRevLett.77.988; Meyrath TP, 2005, OPT EXPRESS, V13, P2843, DOI 10.1364/OPEX.13.002843; Muller T, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.040401; Ott H, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.160601; Roati G, 2008, NATURE, V453, P895, DOI 10.1038/nature07071; Robert-de-Saint-Vincent M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.220602; Schneider U, 2012, NAT PHYS, V8, P213, DOI [10.1038/nphys2205, 10.1038/NPHYS2205]; Schumm T, 2005, NAT PHYS, V1, P57, DOI 10.1038/nphys125; Seaman BT, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.023615; Smith NL, 2005, J PHYS B-AT MOL OPT, V38, P223, DOI 10.1088/0953-4075/38/3/007; Sommer A, 2011, NATURE, V472, P201, DOI 10.1038/nature09989; Tans SJ, 1997, NATURE, V386, P474, DOI 10.1038/386474a0; Thywissen JH, 1999, PHYS REV LETT, V83, P3762, DOI 10.1103/PhysRevLett.83.3762; VANWEES BJ, 1988, PHYS REV LETT, V60, P848, DOI 10.1103/PhysRevLett.60.848; WHARAM DA, 1988, J PHYS C SOLID STATE, V21, pL209, DOI 10.1088/0022-3719/21/8/002; Yacoby A, 1996, PHYS REV LETT, V77, P4612, DOI 10.1103/PhysRevLett.77.4612; Zimmermann B, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/4/043007	34	227	228	2	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2012	337	6098					1069	1071		10.1126/science.1223175	http://dx.doi.org/10.1126/science.1223175			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22859818	Green Submitted			2022-12-28	WOS:000308125800039
J	Holmes, D				Holmes, David			Profile Oliver Eickelberg: a rising star of respiratory medicine	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 18	2012	380	9842					641	641		10.1016/S0140-6736(12)61359-2	http://dx.doi.org/10.1016/S0140-6736(12)61359-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	991SE	22901875				2022-12-28	WOS:000307721000014
J	Cole, TB; Flanagin, A				Cole, Thomas B.; Flanagin, Annette			Evolving Research on the Treatment of Health Effects of Violence and Human Rights Abuses From Observational Studies to Randomized Trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INTIMATE PARTNER VIOLENCE; MENTAL-HEALTH; NORTHERN UGANDA; UNITED-STATES; SYMPTOMS; INTERVENTION; DISABILITY; ATTITUDES; BEHAVIORS; SURVIVORS					tbcole@bellsouth.net						Bleich A, 2003, JAMA-J AM MED ASSOC, V290, P612, DOI 10.1001/jama.290.5.612; Bolton P, 2007, JAMA-J AM MED ASSOC, V298, P519, DOI 10.1001/jama.298.5.519; Brackbill RM, 2009, JAMA-J AM MED ASSOC, V302, P502, DOI 10.1001/jama.2009.1121; Brener ND, 1999, JAMA-J AM MED ASSOC, V282, P440, DOI 10.1001/jama.282.5.440; Cardozo BL, 2004, JAMA-J AM MED ASSOC, V292, P575, DOI 10.1001/jama.292.5.575; Cole TB, 1999, JAMA-J AM MED ASSOC, V282, P481, DOI 10.1001/jama.282.5.481; Ertl V, 2011, JAMA-J AM MED ASSOC, V306, P503, DOI 10.1001/jama.2011.1060; Herman-Giddens ME, 1999, JAMA-J AM MED ASSOC, V282, P463, DOI 10.1001/jama.282.5.463; Johnson K, 2010, JAMA-J AM MED ASSOC, V304, P553, DOI 10.1001/jama.2010.1086; Klevens J, 2012, JAMA-J AM MED ASSOC, V308, P681, DOI 10.1001/jama.2012.6434; Krystal JH, 2011, JAMA-J AM MED ASSOC, V306, P493, DOI 10.1001/jama.2011.1080; MacMillan HL, 2009, JAMA-J AM MED ASSOC, V302, P493, DOI 10.1001/jama.2009.1089; Mills KL, 2012, JAMA-J AM MED ASSOC, V308, P690, DOI 10.1001/jama.2012.9071; Mollica RF, 1999, JAMA-J AM MED ASSOC, V282, P433, DOI 10.1001/jama.282.5.433; Monson CM, 2012, JAMA-J AM MED ASSOC, V308, P700, DOI 10.1001/jama.2012.9307; Najavits LM, 2012, JAMA-J AM MED ASSOC, V308, P714, DOI 10.1001/2012.jama.10368; National Library of Medicine, PUBMED; Pham PN, 2004, JAMA-J AM MED ASSOC, V292, P602, DOI 10.1001/jama.292.5.602; Rodriguez MA, 1999, JAMA-J AM MED ASSOC, V282, P468, DOI 10.1001/jama.282.5.468; Shigemura J, 2012, JAMA-J AM MED ASSOC, V308, P667, DOI 10.1001/jama.2012.9699; Sonis J, 2009, JAMA-J AM MED ASSOC, V302, P527, DOI 10.1001/jama.2009.1085; Tiwari A, 2010, JAMA-J AM MED ASSOC, V304, P536, DOI 10.1001/jama.2010.1052; Tol WA, 2008, JAMA-J AM MED ASSOC, V300, P655, DOI 10.1001/jama.300.6.655; Tsubokura M, 2012, JAMA-J AM MED ASSOC, V308, P669, DOI 10.1001/jama.2012.9839; van Griensven F, 2006, JAMA-J AM MED ASSOC, V296, P537, DOI 10.1001/jama.296.5.537; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Wathen CN, 2012, JAMA-J AM MED ASSOC, V308, P712, DOI 10.1001/jama.2012.9913	27	1	1	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2012	308	7					716	717		10.1001/jama.2012.10078	http://dx.doi.org/10.1001/jama.2012.10078			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988NC	22893171				2022-12-28	WOS:000307496700029
J	Zimmerman, M; Shakya, R; Pokhrel, BM; Eyal, N; Rijal, BP; Shrestha, RN; Sayami, A				Zimmerman, Mark; Shakya, Rabina; Pokhrel, Bharat M.; Eyal, Nir; Rijal, Basista P.; Shrestha, Ratindra N.; Sayami, Arun			Medical students' characteristics as predictors of career practice location: retrospective cohort study tracking graduates of Nepal's first medical college	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEALTH; PROFESSIONALS; PHYSICIANS; UNIVERSITY; RETENTION	Objective To determine, in one low income country (Nepal), which characteristics of medical students are associated with graduate doctors staying to practise in the country or in its rural areas. Design Observational cohort study. Setting Medical college registry, with internet, phone, and personal follow-up of graduates. Participants 710 graduate doctors from the first 22 classes (1983-2004) of Nepal's first medical college, the Institute of Medicine. Main outcome measures Career practice location (foreign or in Nepal; in or outside of the capital city Kathmandu) compared with certain pre-graduation characteristics of medical student. Results 710 (97.7%) of the 727 graduates were located: 193 (27.2%) were working in Nepal in districts outside the capital city Kathmandu, 261 (36.8%) were working in Kathmandu, and 256 (36.1%) were working in foreign countries. Of 256 working abroad, 188 (73%) were in the United States. Students from later graduating classes were more likely to be working in foreign countries. Those with pre-medical education as paramedics were twice as likely to be working in Nepal and 3.5 times as likely to be in rural Nepal, compared with students with a college science background. Students who were academically in the lower third of their medical school class were twice as likely to be working in rural Nepal as those from the upper third. In a regression analysis adjusting for all variables, paramedical background (odds ratio 4.4, 95% confidence interval 1.7 to 11.6) was independently associated with a doctor remaining in Nepal. Rural birthplace (odds ratio 3.8, 1.3 to 11.5) and older age at matriculation (1.1, 1.0 to 1.2) were each independently associated with a doctor working in rural Nepal. Conclusions A cluster of medical students' characteristics, including paramedical background, rural birthplace, and lower academic rank, was associated with a doctor remaining in Nepal and with working outside the capital city of Kathmandu. Policy makers in medical education who are committed to producing doctors for underserved areas of their country could use this evidence to revise their entrance criteria for medical school.	[Zimmerman, Mark; Shakya, Rabina] Nick Simons Inst, Kathmandu, Nepal; [Pokhrel, Bharat M.; Rijal, Basista P.; Shrestha, Ratindra N.; Sayami, Arun] Inst Med, Kathmandu, Nepal; [Eyal, Nir] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Harvard Medical School	Zimmerman, M (corresponding author), Nick Simons Inst, Box 8975,EPC 1813, Kathmandu, Nepal.	markz@nsi.edu.np		Rijal, Basista/0000-0003-3451-1899	Nick Simons Institute	Nick Simons Institute	Funding came entirely from the Nick Simons Institute, a charitable organisation that works to train and support healthcare workers for rural Nepal (www.ndi.edu.np). Neither the Nick Simons Institute nor the authors stands to receive material gain from the publication of this study. The Nick Simons Institute carried out this study as part of its mission to train and support healthcare workers for rural Nepal. It will use the study results to lobby for changes in medical education policy, in Nepal and internationally.	Adkoli BV, 2006, INREGIONAL HLTH FORU, V10, P49; Akl EA, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-49; [Anonymous], 2004, HUM RES HLTH OV CRIS; [Anonymous], 2010, 63 WORLD HLTH ASS MA; Awofeso N, 2010, RURAL REMOTE HEALTH, V10; Clemens MA, 2008, HUM RESOUR HEALTH, V6, DOI 10.1186/1478-4491-6-1; Cristobal F, 2012, RURAL REMOTE HEALTH, V12; de Vries E, 2003, SAMJ S AFR MED J, V93, P789; Dieleman M., 2011, REALIST REV SYNTHESI; Dixit, 2005, NEPALS QUEST HLTH; DOVLO D, 1999, HUMAN RESOURCES HLTH, V3, P40; Eley D, 2006, Rural Remote Health, V6, P511; Grobler L, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005314.pub2; Hagopian Amy, 2004, Hum Resour Health, V2, P17, DOI 10.1186/1478-4491-2-17; Huish R, 2008, PUBLIC HEALTH, V122, P552, DOI 10.1016/j.puhe.2008.03.001; Igumbor Ehi U, 2005, Rural Remote Health, V5, P417; Iputo JE, 2008, MEDICC REV, V10, P25, DOI 10.37757/MR2008.V10.N4.6; Laven Gillian, 2003, Aust J Rural Health, V11, P277, DOI 10.1111/j.1440-1584.2003.00534.x; Matsumoto M, 2008, RURAL REMOTE HEALTH, V8; Mullan F, 2005, NEW ENGL J MED, V353, P1810, DOI 10.1056/NEJMsa050004; Nepal Ministry of Health and Population, 2010, NEP HLTH SECT PROGR; Polasek Ozren, 2006, Rural Remote Health, V6, P530; Rabinowitz HK, 2005, ACAD MED, V80, P728, DOI 10.1097/00001888-200508000-00004; Speybroeck N., 2006, REASSESSING RELATSH, P1; Walker JH, 2012, RURAL REMOTE HEALTH, V12; WHO, 2010, INCREASING ACCESS TO HEALTH WORKERS IN REMOTE AND RURAL AREAS THROUGH IMPROVED RETENTION: GLOBAL POLICY RECOMMENDATIONS, P1; WHO, WORLD HLTH STAT 2011; Wilson NW, 2009, RURAL REMOTE HEALTH, V9; Woloschuk W, 2004, MED EDUC, V38, P259, DOI 10.1046/j.1365-2923.2004.01764.x	29	24	24	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 14	2012	345								e4826	10.1136/bmj.e4826	http://dx.doi.org/10.1136/bmj.e4826			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992CD	22893566	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000307752000006
J	Conrad, T; Cavalli, FMG; Vaquerizas, JM; Luscombe, NM; Akhtar, A				Conrad, Thomas; Cavalli, Florence M. G.; Vaquerizas, Juan M.; Luscombe, Nicholas M.; Akhtar, Asifa			Drosophila Dosage Compensation Involves Enhanced Pol II Recruitment to Male X-Linked Promoters	SCIENCE			English	Article							MSL COMPLEX; H4K16 ACETYLATION; RNA-POLYMERASE; CHROMOSOME; MELANOGASTER; GENOME; GENES; TRANSCRIPTION; EXPRESSION; MOF	Through hyperacetylation of histone H4 lysine 16 (H4K16), the male-specific lethal (MSL) complex in Drosophila approximately doubles transcription from the single male X chromosome in order to match X-linked expression in females and expression from diploid autosomes. By obtaining accurate measurements of RNA polymerase II (Pol II) occupancies and short promoter-proximal RNA production, we detected a consistent, genome-scale increase in Pol II activity at the promoters of male X-linked genes. Moreover, we found that enhanced Pol II recruitment to male X-linked promoters is largely dependent on the MSL complex. These observations provide insights into how global modulation of chromatin structure by histone acetylation contributes to the precise control of Pol II function.	[Cavalli, Florence M. G.; Vaquerizas, Juan M.; Luscombe, Nicholas M.] EMBL European Bioinformat Inst, Cambridge CB10 1SD, England; [Conrad, Thomas; Akhtar, Asifa] Max Planck Inst Immunobiol & Epigenet, D-79108 Freiburg, Germany; [Luscombe, Nicholas M.] Okinawa Inst Sci & Technol, Onna Son, Okinawa 9040495, Japan; [Luscombe, Nicholas M.] Canc Res UK, London Res Inst, Lincolns Inn Fields 44, London WC2A 3LY, England; [Luscombe, Nicholas M.] UCL, UCL Genet Inst, Dept Genet Evolut & Environm, London WC1E 6BT, England	European Molecular Biology Laboratory (EMBL); Max Planck Society; Okinawa Institute of Science & Technology Graduate University; Cancer Research UK; University of London; University College London	Luscombe, NM (corresponding author), EMBL European Bioinformat Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SD, England.	luscombe@ebi.ac.uk; akhtar@immunbio.mpg.de	Vaquerizas, Juan M/F-2676-2011; Vaquerizas, Juan M/AAY-2339-2020	Vaquerizas, Juan M/0000-0002-6583-6541; Vaquerizas, Juan M/0000-0002-6583-6541; Conrad, Thomas/0000-0001-5618-6295; Cavalli, Florence M. G./0000-0002-4409-9642	European Union; EMBL; Okinawa Institute of Science and Technology; Cancer Research UK; EMBL Ph.D. program; European Science Foundation Exchange Grant program; Cancer Research UK [16358] Funding Source: researchfish	European Union(European Commission); EMBL; Okinawa Institute of Science and Technology(Okinawa Institute of Science & Technology Graduate University); Cancer Research UK(Cancer Research UK); EMBL Ph.D. program; European Science Foundation Exchange Grant program; Cancer Research UK(Cancer Research UK)	We thank K. Adelman and J. Lis for kindly providing Rpb3 antibodies, the European Molecular Biology Laboratory (EMBL) GeneCore facility and I. De la Rosa for Illumina sequencing services, and the members of our groups for critical reading of the manuscript and helpful discussions. Supported by the European Union-funded EpiGeneSys (N.M.L. and A. A.); EMBL, Okinawa Institute of Science and Technology, and Cancer Research UK (N.M.L.); the EMBL Ph.D. program (T. C. and F. M. G. C.); and the European Science Foundation Exchange Grant program (J.M.V.). The Pol II ChIP-seq data are available in ArrayExpress under accession no. E-MTAB-1112.	Bell O, 2010, NAT STRUCT MOL BIOL, V17, P894, DOI 10.1038/nsmb.1825; Conrad T, 2012, DEV CELL, V22, P610, DOI 10.1016/j.devcel.2011.12.016; Conrad T, 2012, NAT REV GENET, V13, P123, DOI 10.1038/nrg3124; Gelbart ME, 2009, NAT STRUCT MOL BIOL, V16, P825, DOI 10.1038/nsmb.1644; Hamada FN, 2005, GENE DEV, V19, P2289, DOI 10.1101/gad.1343705; Johansson AM, 2012, MOL CELL BIOL, V32, P2121, DOI 10.1128/MCB.06622-11; Kind J, 2008, CELL, V133, P813, DOI 10.1016/j.cell.2008.04.036; Larschan E, 2011, NATURE, V471, P115, DOI 10.1038/nature09757; Laverty C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020455; Lucchesi JC, 1998, CURR OPIN GENET DEV, V8, P179, DOI 10.1016/S0959-437X(98)80139-1; Malone JH, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-r28; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Park SW, 2010, BIOCHEM BIOPH RES CO, V399, P227, DOI 10.1016/j.bbrc.2010.07.059; Straub T, 2005, GENE DEV, V19, P2284, DOI 10.1101/gad.1343105; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	16	53	53	2	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2012	337	6095					742	746		10.1126/science.1221428	http://dx.doi.org/10.1126/science.1221428			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986PE	22821985				2022-12-28	WOS:000307354500057
J	Evans, N; Hamilton, A; Bello-Villalba, MJ; Bingham, C				Evans, Nicholas; Hamilton, Alexander; Bello-Villalba, Maria J.; Bingham, Coralie			Irreversible renal damage from accidental mushroom poisoning	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Hamilton, Alexander; Bello-Villalba, Maria J.; Bingham, Coralie] Royal Devon & Exeter NHS Fdn Trust, Renal Unit, Exeter EX2 5DW, Devon, England	University of Exeter	Hamilton, A (corresponding author), Royal Devon & Exeter NHS Fdn Trust, Renal Unit, Exeter EX2 5DW, Devon, England.	alexander.hamilton@nhs.net	Hamilton, Alexander/AAD-3596-2020	Hamilton, Alexander/0000-0002-0730-4897	National Institute for Health Research [ACF-2011-23-003] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))			0	5	5	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 10	2012	345								e5262	10.1136/bmj.e5262	http://dx.doi.org/10.1136/bmj.e5262			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988NG	22885396	Bronze			2022-12-28	WOS:000307497100003
J	Grant, SB; Saphores, JD; Feldman, DL; Hamilton, AJ; Fletcher, TD; Cook, PLM; Stewardson, M; Sanders, BF; Levin, LA; Ambrose, RF; Deletic, A; Brown, R; Jiang, SC; Rosso, D; Cooper, WJ; Marusic, I				Grant, Stanley B.; Saphores, Jean-Daniel; Feldman, David L.; Hamilton, Andrew J.; Fletcher, Tim D.; Cook, Perran L. M.; Stewardson, Michael; Sanders, Brett F.; Levin, Lisa A.; Ambrose, Richard F.; Deletic, Ana; Brown, Rebekah; Jiang, Sunny C.; Rosso, Diego; Cooper, William J.; Marusic, Ivan			Taking the "Waste" Out of "Wastewater" for Human Water Security and Ecosystem Sustainability	SCIENCE			English	Review							POTABLE WATER; ENERGY; REUSE; CONSUMPTION; MANAGEMENT; BALANCE; SAVINGS; STREAM	Humans create vast quantities of wastewater through inefficiencies and poor management of water systems. The wasting of water poses sustainability challenges, depletes energy reserves, and undermines human water security and ecosystem health. Here we review emerging approaches for reusing wastewater and minimizing its generation. These complementary options make the most of scarce freshwater resources, serve the varying water needs of both developed and developing countries, and confer a variety of environmental benefits. Their widespread adoption will require changing how freshwater is sourced, used, managed, and priced.	[Grant, Stanley B.; Saphores, Jean-Daniel; Sanders, Brett F.; Jiang, Sunny C.; Rosso, Diego; Cooper, William J.] Univ Calif Irvine, Dept Civil & Environm Engn, Irvine, CA 92697 USA; [Grant, Stanley B.; Stewardson, Michael] Univ Melbourne, Melbourne Sch Engn, Dept Infrastruct Engn, Parkville, Vic 3010, Australia; [Saphores, Jean-Daniel; Feldman, David L.] Univ Calif Irvine, Dept Planning Policy & Design, Irvine, CA 92697 USA; [Hamilton, Andrew J.] Univ Melbourne, Dept Agr & Food Syst, Dookie Coll, Melbourne, Vic 3647, Australia; [Fletcher, Tim D.] Univ Melbourne, Melbourne Sch Land & Environm, Richmond, Vic 3121, Australia; [Cook, Perran L. M.] Monash Univ, Sch Chem, Water Studies Ctr, Clayton, Vic 3800, Australia; [Levin, Lisa A.] Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, La Jolla, CA 92093 USA; [Ambrose, Richard F.] Univ Calif Los Angeles, Environm Sci & Engn Program, Los Angeles, CA 90095 USA; [Deletic, Ana] Monash Univ, Dept Civil Engn, Monash Water Liveabil, Clayton, Vic 3800, Australia; [Brown, Rebekah] Monash Univ, Sch Geog & Environm Sci, Monash Water Liveabil, Clayton, Vic 3800, Australia; [Marusic, Ivan] Univ Melbourne, Melbourne Sch Engn, Dept Mech Engn, Parkville, Vic 3010, Australia	University of California System; University of California Irvine; University of Melbourne; University of California System; University of California Irvine; University of Melbourne; University of Melbourne; Monash University; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California Los Angeles; Monash University; Monash University; University of Melbourne	Grant, SB (corresponding author), Univ Calif Irvine, Dept Civil & Environm Engn, E4130 Engn Gateway, Irvine, CA 92697 USA.	sbgrant@uci.edu	Stewardson, Michael J/C-8678-2015; Deletic, Ana/CAG-2385-2022; Rosso, Diego/F-6453-2012; Marusic, Ivan/M-1903-2015; Cooper, William J/D-4502-2011; Fletcher, Tim/AAB-8356-2019; Marusic, Ivan/N-8456-2019; Sanders, Brett/K-7153-2012; Saphores, Jean Daniel/Q-5445-2019; Jiang, Sunny/H-7702-2012; Sanders, Brett/AAW-8266-2020; Grant, Stanley B/K-8179-2016; Ambrose, Richard F./AAQ-1192-2020	Stewardson, Michael J/0000-0003-1356-0472; Deletic, Ana/0000-0002-3535-7451; Rosso, Diego/0000-0002-6879-3110; Marusic, Ivan/0000-0003-2700-8435; Fletcher, Tim/0000-0001-8819-5567; Marusic, Ivan/0000-0003-2700-8435; Saphores, Jean Daniel/0000-0001-9514-0994; Jiang, Sunny/0000-0002-4993-8038; Sanders, Brett/0000-0002-1592-5204; Grant, Stanley B/0000-0001-6221-7211; Ambrose, Richard F./0000-0001-8653-6487; Cook, Perran/0000-0002-0444-3488; Brown, Rebekah/0000-0002-8689-7562; Levin, Lisa/0000-0002-2858-8622; Hamilton, Andrew/0000-0002-4923-6335	University of California, Irvine, HSSoE Research Ignition Fund	University of California, Irvine, HSSoE Research Ignition Fund	The authors thank H.-F. Mok and C. Jayasuriya for preparation of Fig. 2; J. Famiglietti, K. Low, and three anonymous reviewers for providing comments on the paper; and the University of California, Irvine, HSSoE Research Ignition Fund for funding to S.B.G.	Aguilar-Benitez I, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006225; Anand C, 2011, J ENVIRON MANAGE, V92, P419, DOI 10.1016/j.jenvman.2010.08.005; [Anonymous], 2011, LIV MELB LIV VICT RO; [Anonymous], 2008, PROGR DRINK WAT SAN; Bithas K, 2008, ECOL ECON, V68, P221, DOI 10.1016/j.ecolecon.2008.02.021; Brooks DB, 2011, INT J WATER RESOUR D, V27, P315, DOI 10.1080/07900627.2011.571235; Bunn SE, 2002, ENVIRON MANAGE, V30, P492, DOI 10.1007/s00267-002-2737-0; California Energy Commission, 2006, CEC5002006118; Carpenter SR, 2011, ANNU REV ENV RESOUR, V36, P75, DOI 10.1146/annurev-environ-021810-094524; Dolnicar S, 2009, WATER SCI TECHNOL, V60, P1433, DOI 10.2166/wst.2009.325; du Pisani PL, 2006, DESALINATION, V188, P79, DOI 10.1016/j.desal.2005.04.104; Elcock D, 2010, J AM WATER RESOUR AS, V46, P447, DOI 10.1111/j.1752-1688.2009.00413.x; Farrelly M, 2011, GLOBAL ENVIRON CHANG, V21, P721, DOI 10.1016/j.gloenvcha.2011.01.007; Gleick PH, 2003, ANNU REV ENV RESOUR, V28, P275, DOI 10.1146/annurev.energy.28.040202.122849; Gleick PH, 2003, SCIENCE, V302, P1524, DOI 10.1126/science.1089967; Hanak E., 2011, MANAGING CALIFORNIAS; Imteaz MA, 2011, RESOUR CONSERV RECY, V56, P80, DOI 10.1016/j.resconrec.2011.09.008; Jackson RB, 2001, ECOL APPL, V11, P1027, DOI 10.1890/1051-0761(2001)011[1027:WIACW]2.0.CO;2; Kadlec R.H., 2008, TREATMENT WETLANDS, DOI [10.1201/9781420012514, DOI 10.1201/9781420012514]; Kingdom Bill, 2006, WATER SUPPLY SANITAT; Larson KL, 2009, ENVIRON MANAGE, V44, P921, DOI 10.1007/s00267-009-9353-1; Leung RWK, 2012, WATER SCI TECHNOL, V65, P410, DOI 10.2166/wst.2012.768; Leverenz HL, 2011, J WATER REUSE DESAL, V1, P2, DOI 10.2166/wrd.2011.000; Makropoulos CK, 2010, WATER RESOUR MANAG, V24, P2795, DOI 10.1007/s11269-010-9580-5; Marsalek J, 2009, WATER QUAL RES J CAN, V44, pV, DOI 10.2166/wqrj.2009.001; Milesi C, 2005, ENVIRON MANAGE, V36, P426, DOI 10.1007/s00267-004-0316-2; Mitchell VG, 2008, HYDROL PROCESS, V22, P2891, DOI 10.1002/hyp.6868; Monash University, 2008, SUBM VICT ENV NAT RE; Murray CG, 2010, J APPL ECOL, V47, P976, DOI 10.1111/j.1365-2664.2010.01853.x; Muthukumaran S, 2011, RESOUR CONSERV RECY, V55, P945, DOI 10.1016/j.resconrec.2011.04.013; National Research Council, 2012, WAT REUS POT EXP NAT, DOI [10.17226/13303, DOI 10.17226/13303]; Proenca LC, 2011, RESOUR CONSERV RECY, V55, P960, DOI 10.1016/j.resconrec.2011.05.003; Razavi B, 2011, WATER RES, V45, P625, DOI 10.1016/j.watres.2010.08.012; Reed RH, 2004, ADV APPL MICROBIOL, V54, P333, DOI 10.1016/S0065-2164(04)54012-1; Reheis MC, 1997, J GEOPHYS RES-ATMOS, V102, P25999, DOI 10.1029/97JD01967; Saliba C., 2012, E6109 YARR VALL WAT; Schnoor JL, 2009, ENVIRON SCI TECHNOL, V43, P6441, DOI 10.1021/es902153f; Schroeder E., 2012, DIRECT POTABLE REUSE; Srinivasan V, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR008698; Stokes JR, 2009, ENVIRON SCI TECHNOL, V43, P2680, DOI 10.1021/es801802h; Suero FJ, 2012, J WATER RES PL-ASCE, V138, P299, DOI 10.1061/(ASCE)WR.1943-5452.0000182; Tal A, 2006, SCIENCE, V313, P1081, DOI 10.1126/science.1126011; U.S. Environmental Protection Agency (EPA), 2004, EPA624R04108 US EPA; Varon M. P., 2004, WASTE STABILISATION; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Walsh CJ, 2005, J N AM BENTHOL SOC, V24, P706, DOI 10.1899/04-020.1; Whittington D., 2008, SANITATION WATER; WHO, 2006, WHO GUID SAF US WAST; Wong T.H.F., 2011, STORMWATER MANAGEMEN	49	383	400	72	778	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2012	337	6095					681	686		10.1126/science.1216852	http://dx.doi.org/10.1126/science.1216852			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986PE	22879506	Green Published			2022-12-28	WOS:000307354500041
J	Xanthos, M				Xanthos, Marino			Recycling of the #5 Polymer	SCIENCE			English	Editorial Material								Polypropylene (PP) is a widely used plastic with consumer applications ranging from food packaging to automotive parts, including car battery casings. To differentiate it from other recyclable plastics, it is designated as #5. Here, the factors contributing to PP recycling rates are briefly reviewed. Considerations include collection and separation efficiency, processing chemistry, and market dynamics for the products derived from recyclates.	New Jersey Inst Technol, Dept Chem Biol & Pharmaceut Engn, Newark, NJ 07102 USA	New Jersey Institute of Technology	Xanthos, M (corresponding author), New Jersey Inst Technol, Dept Chem Biol & Pharmaceut Engn, Newark, NJ 07102 USA.	xanthos@njit.edu						Akovali G., 1998, NATO ADV STUDY I S E, V351; Akovali G., 1998, NATO ADV STUDY I S E, V351; [Anonymous], 2010, AX INV CARP REC OPT; [Anonymous], US REC RAT PLAST BOT; Berry J., PLASTIC 5 RECYCLING; Bisio A. L., 1994, MANAGE PLASTICS WAST; Bisio A. L., 1994, MANAGE PLASTICS WAST; Chanda M., 2007, PLASTICS TECHNOLOGY; New polymer offers closed loop recycling to automotive industry, 2012, NEW POL OFF CLOS LOO; Stones M., FOOD GRADE PP RECYCL; Straus S., INFORM RM5 POLYM BAN; Strom S., 2012, NY TIMES, pB1; U.S. EPA, PLASTICS; Xanthos M., 2009, MIXING COMPOUNDING P, P757	14	35	41	2	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2012	337	6095					700	702		10.1126/science.1221806	http://dx.doi.org/10.1126/science.1221806			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986PE	22879510				2022-12-28	WOS:000307354500045
J	Barron, AB; Brown, MJF				Barron, Andrew B.; Brown, Mark J. F.			Let's talk about sex	NATURE			English	Editorial Material									[Barron, Andrew B.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Brown, Mark J. F.] Royal Holloway Univ London, Sch Biol Sci, London, England	Macquarie University; University of London; Royal Holloway University London	Barron, AB (corresponding author), Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia.	andrew.barron@mq.edu.au		Barron, Andrew/0000-0002-8135-6628	Biotechnology and Biological Sciences Research Council [BB/J019453/1] Funding Source: researchfish; BBSRC [BB/J019453/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Bailey NW, 2009, TRENDS ECOL EVOL, V24, P439, DOI 10.1016/j.tree.2009.03.014; Brennan Zoe, 2010, DAILY MAIL; Casselman A, 2007, NATL GEOGR      1025; Cloud J., 2007, TIME MAGAZINE; Dolgin E., 2007, NATURE, DOI org/10.1038/news070917-7; Fox M, 2005, REUTERS         0624; Holmes B, 2008, NEW SCI; Hooper Rowan, 2007, NEW SCI; Levan KE, 2009, J EVOLUTION BIOL, V22, P60, DOI 10.1111/j.1420-9101.2008.01616.x; Milius S, 2001, SCIENCENEWS, V160, P311; Mooallem J., 2010, INDEPENDENT; Mooallem J, 2010, NY TIMES; Oakeshott I., 2006, SUNDAY TIMES; Perkins A, 2007, HORM BEHAV, V52, P70, DOI 10.1016/j.yhbeh.2007.03.016; Reinhardt K, 2007, AM NAT, V170, P931, DOI 10.1086/522844; Saletan William, 2007, WASHINGTON POST; Schwartz J, 2007, NY TIMES        0330; Shine R, 2001, NATURE, V414, P267, DOI 10.1038/35104687; White JQ, 2007, CURR BIOL, V17, P1847, DOI 10.1016/j.cub.2007.09.011; Young LC, 2008, BIOL LETTERS, V4, P323, DOI 10.1098/rsbl.2008.0191	20	8	8	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 9	2012	488	7410					151	152		10.1038/488151a	http://dx.doi.org/10.1038/488151a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	985LE	22874947	Bronze			2022-12-28	WOS:000307267000011
J	Longrich, NR; Bhullar, BAS; Gauthier, JA				Longrich, Nicholas R.; Bhullar, Bhart-Anjan S.; Gauthier, Jacques A.			A transitional snake from the Late Cretaceous period of North America	NATURE			English	Article							MOLECULAR EVIDENCE; EVOLUTION; ORIGIN; SKULL	Snakes are the most diverse group of lizards(1), but their origins and early evolution remain poorly understood owing to a lack of transitional forms. Several major issues remain outstanding, such as whether snakes originated in a marine(2-4) or terrestrial(5,6) environment and how their unique feeding mechanism evolved(1,7,8). The Cretaceous Coniophis precedens was among the first Mesozoic snakes discovered(9), but until now only an isolated vertebra has been described(9,10) and it has therefore been overlooked in discussions of snake evolution. Here we report on previously undescribed material(11) from this ancient snake, including the maxilla, dentary and additional vertebrae. Coniophis is not an anilioid as previously thought(11); a revised phylogenetic analysis of Ophidia shows that it instead represents the most primitive known snake. Accordingly, its morphology and ecology are critical to understanding snake evolution. Coniophis occurs in a continental floodplain environment, consistent with a terrestrial rather than a marine origin; furthermore, its small size and reduced neural spines indicate fossorial habits, suggesting that snakes evolved from burrowing lizards. The skull is intermediate between that of lizards and snakes. Hooked teeth and an intramandibular joint indicate that Coniophis fed on relatively large, soft-bodied prey. However, the maxilla is firmly united with the skull, indicating an akinetic rostrum. Coniophis therefore represents a transitional snake, combining a snake-like body and a lizard-like head. Subsequent to the evolution of a serpentine body and carnivory, snakes evolved a highly specialized, kinetic skull, which was followed by a major adaptive radiation in the Early Cretaceous period. This pattern suggests that the kinetic skull was a key innovation that permitted the diversification of snakes.	[Longrich, Nicholas R.; Gauthier, Jacques A.] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; [Bhullar, Bhart-Anjan S.] Harvard Univ, Dept Organism & Evolutionary Biol, Biol Labs, Cambridge, MA 02138 USA	Yale University; Harvard University	Longrich, NR (corresponding author), Yale Univ, Dept Geol & Geophys, POB 208109, New Haven, CT 06520 USA.	nicholas.longrich@yale.edu		Longrich, Nicholas/0000-0002-9586-8907	US NSF [DEB-0132227]; Yale Institute for Biospheric Studies	US NSF(National Science Foundation (NSF)); Yale Institute for Biospheric Studies	We thank the curators and staff of the American Museum of Natural History, the University of California Museum of Paleontology and the Yale Peabody Museum of Natural History, and the staff of Digimorph at the University of Texas at Austin, for specimen access. We are especially grateful to J. Head for discussions about snake vertebrae, which prevented a major error in the assignment of material to Coniophis. This research was funded in part by US NSF grant DEB-0132227 to J.A.G. N.R.L. was funded by the Yale Institute for Biospheric Studies.	Apesteguia S, 2006, NATURE, V440, P1037, DOI 10.1038/nature04413; Caldwell MW, 2001, ACTA PALAEONTOL POL, V46, P203; Caldwell MW, 1997, NATURE, V386, P705, DOI 10.1038/386705a0; CoPE E. D., 1869, P BOSTON SOC NATURAL, V12, P250; CUNDALL D, 1995, J ZOOL, V237, P353, DOI 10.1111/j.1469-7998.1995.tb02767.x; Cundall D., 2008, BIOL REPTILIA, V20, P349; Cundall David, 2000, P293, DOI 10.1016/B978-012632590-4/50010-1; Estes R, 1964, U CALIF PUBL GEOL SC, V49, P140; Gardner JD, 1999, SP PALAEONT, P87; Gilmore C. W., 1938, Geological Society of America Special Paper, V9, P1; Greene H. W., 1997, SNAKES EVOLUTION MYS; Hoffstetter R., 1969, P201; Kearney M, 2003, HERPETOL MONOGR, V17, P1, DOI 10.1655/0733-1347(2003)017[0001:SOTALB]2.0.CO;2; Lee MSY, 2005, BIOL LETTERS, V1, P227, DOI 10.1098/rsbl.2004.0282; Lee MSY, 1999, NATURE, V400, P655, DOI 10.1038/23236; MARSH OC, 1892, AM J SCI 3, V43, P449, DOI DOI 10.2475/AJS.S3-43.257.449; Piveteau, 1955, TRAITE PALEONTOL, P606; PRASAD GVR, 1995, CRETACEOUS RES, V16, P95, DOI 10.1006/cres.1995.1006; Rage J.C., 1999, Palaeontologia Africana, V35, P85; Rage J.-C., 1989, NEUES JB GEOLOGIE PA, V1989, P433; RAGE JC, 2003, CARNETS GEOL; Rage JC, 2010, GEOBIOS-LYON, V43, P253, DOI 10.1016/j.geobios.2009.08.002; Scanlon JD, 2006, NATURE, V439, P839, DOI 10.1038/nature04137; Scanlon JD, 2002, J HERPETOL, V36, P100; Scanlon JD, 2000, NATURE, V403, P416, DOI 10.1038/35000188; Vidal N, 2004, P ROY SOC B-BIOL SCI, V271, pS226, DOI 10.1098/rsbl.2003.0151; Wilson JA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000322; Zaher H, 2012, ZOOL J LINN SOC-LOND, V164, P194, DOI 10.1111/j.1096-3642.2011.00755.x; Zaher H, 2009, ZOOL J LINN SOC-LOND, V156, P801, DOI 10.1111/j.1096-3642.2009.00511.x	29	64	64	0	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 9	2012	488	7410					205	208		10.1038/nature11227	http://dx.doi.org/10.1038/nature11227			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985LE	22832579	Green Accepted			2022-12-28	WOS:000307267000032
J	Scully, C; Brooke, AE				Scully, Crispian; Brooke, A. E.			Halitosis and Sensory Loss	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Scully, Crispian; Brooke, A. E.] Bristol Dent Hosp, Bristol, Avon, England	University of Bristol	Scully, C (corresponding author), Bristol Dent Hosp, Bristol, Avon, England.	crispian.scully@ucl.ac.uk							0	0	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 9	2012	367	6					551	551		10.1056/NEJMicm1110795	http://dx.doi.org/10.1056/NEJMicm1110795			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	986AE	22873535				2022-12-28	WOS:000307310800009
J	Desai, CS; Bonow, RO				Desai, Chintan S.; Bonow, Robert O.			Transcatheter Valve Replacement for Aortic Stenosis Balancing Benefits, Risks, and Expectations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							IMPLANTATION; REGISTRY; OUTCOMES		[Bonow, Robert O.] Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, Chicago, IL 60611 USA; [Bonow, Robert O.] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA; [Desai, Chintan S.] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Bonow, RO (corresponding author), Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, 645 N Michigan Ave,Ste 1006, Chicago, IL 60611 USA.	r-bonow@northwestern.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069771] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32 HL 69771-8] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Gilard M, 2012, NEW ENGL J MED, V366, P1705, DOI 10.1056/NEJMoa1114705; Kodali SK, 2012, NEW ENGL J MED, V366, P1686, DOI 10.1056/NEJMoa1200384; Mack MJ, 2011, JAMA-J AM MED ASSOC, V306, P2149, DOI 10.1001/jama.2011.1675; Moat NE, 2011, J AM COLL CARDIOL, V58, P2130, DOI 10.1016/j.jacc.2011.08.050; Nietlispach F, 2010, JACC-CARDIOVASC INTE, V3, P1133, DOI 10.1016/j.jcin.2010.05.022; Piazza N, 2010, HEART, V96, P19, DOI 10.1136/hrt.2009.172809; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Tamburino C, 2011, CIRCULATION, V123, P299, DOI 10.1161/CIRCULATIONAHA.110.946533; Zahn R, 2011, EUR HEART J, V32, P198, DOI 10.1093/eurheartj/ehq339	9	11	12	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2012	308	6					573	574		10.1001/jama.2012.9427	http://dx.doi.org/10.1001/jama.2012.9427			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	984YA	22871866				2022-12-28	WOS:000307228400021
J	Mendillo, ML; Santagata, S; Koeva, M; Bell, GW; Hu, R; Tamimi, RM; Fraenkel, E; Ince, TA; Whitesell, L; Lindquist, S				Mendillo, Marc L.; Santagata, Sandro; Koeva, Martina; Bell, George W.; Hu, Rong; Tamimi, Rulla M.; Fraenkel, Ernest; Ince, Tan A.; Whitesell, Luke; Lindquist, Susan			HSF1 Drives a Transcriptional Program Distinct from Heat Shock to Support Highly Malignant Human Cancers	CELL			English	Article							INVASIVE BREAST-CANCER; GENOME-WIDE ANALYSIS; GENE-EXPRESSION; FACTOR-1; STRESS; TRANSFORMATION; ACTIVATION; RESPONSES; PROTEINS; GROWTH	Heat-Shock Factor 1 (HSF1), master regulator of the heat-shock response, facilitates malignant transformation, cancer cell survival, and proliferation in model systems. The common assumption is that these effects are mediated through regulation of heat-shock protein (HSP) expression. However, the transcriptional network that HSF1 coordinates directly in malignancy and its relationship to the heat-shock response have never been defined. By comparing cells with high and low malignant potential alongside their nontransformed counterparts, we identify an HSF1-regulated transcriptional program specific to highly malignant cells and distinct from heat shock. Cancer-specific genes in this program support oncogenic processes: cell-cycle regulation, signaling, metabolism, adhesion and translation. HSP genes are integral to this program, however, many are uniquely regulated in malignancy. This HSF1 cancer program is active in breast, colon and lung tumors isolated directly from human patients and is strongly associated with metastasis and death. Thus, HSF1 rewires the transcriptome in tumorigenesis, with prognostic and therapeutic implications.	[Mendillo, Marc L.; Santagata, Sandro; Koeva, Martina; Bell, George W.; Whitesell, Luke; Lindquist, Susan] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Santagata, Sandro] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Koeva, Martina; Fraenkel, Ernest] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Lindquist, Susan] MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Hu, Rong; Tamimi, Rulla M.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Hu, Rong; Tamimi, Rulla M.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Hu, Rong; Tamimi, Rulla M.] Brigham & Womens Hosp, Channing Lab, Dept Med, Boston, MA 02115 USA; [Ince, Tan A.] Univ Miami, Miller Sch Med, Dept Pathol, Braman Family Breast Canc Inst, Miami, FL 33136 USA; [Ince, Tan A.] Univ Miami, Miller Sch Med, Interdisciplinary Stem Cell Inst, Miami, FL 33136 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Brigham & Women's Hospital; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Miami; University of Miami	Whitesell, L (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	whitesell@wi.mit.edu; lindquist_admin@wi.mit.edu		Mendillo, Marc/0000-0001-8128-0128; Fraenkel, Ernest/0000-0001-9249-8181; Santagata, Sandro/0000-0002-7528-9668; Ince, Tan/0000-0003-0315-6425	J&J COSAT focused funding program; Marble Fund; American Cancer Society New England Division-SpinOdyssey [PF-09-253-01-DMC]; NIH [K08NS064168]; Brain Science Foundation; V Foundation; GSK [WE234 EPI40307]; Public Health Service Grants [CA087969]; SPORE in Breast Cancer NCI, NIH, Dept. of Health and Human Services [CA089393]; Breast Cancer Research Foundation, NCI [R01-CA146445-01]; DoD-CDMRP Breast Cancer Research Program [W81XWH-08-1-0282 BC-07456]; NATIONAL CANCER INSTITUTE [R01CA146445, P01CA087969, P50CA089393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS064168] Funding Source: NIH RePORTER	J&J COSAT focused funding program; Marble Fund; American Cancer Society New England Division-SpinOdyssey; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain Science Foundation; V Foundation; GSK(GlaxoSmithKline); Public Health Service Grants(United States Department of Health & Human ServicesUnited States Public Health Service); SPORE in Breast Cancer NCI, NIH, Dept. of Health and Human Services; Breast Cancer Research Foundation, NCI; DoD-CDMRP Breast Cancer Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank G. Frampton, I. Barrasa and S.Gupta for bioinformatic assistance. We thank T. Mazor, T. Volkert and the WIBR-GTC for sequencing support. We thank the Lindquist lab and T. Lee for discussion and K. Allendoerfer, B. Bevis, G. Karras, R. Shouval and K. Matlack for comments. The work was supported by the J&J COSAT focused funding program (L. W.) and the Marble Fund (S. L.). S. L. is an Investigator of the Howard Hughes Medical Institute. M. L. M. is supported by American Cancer Society New England Division-SpinOdyssey (PF-09-253-01-DMC). S. S. is supported by NIH (K08NS064168), the Brain Science Foundation and the V Foundation. Additional support was provided by GSK (WE234 EPI40307); Public Health Service Grants CA087969, and SPORE in Breast Cancer CA089393, from the NCI, NIH, Dept. of Health and Human Services. T. A. I is supported by the Breast Cancer Research Foundation, NCI (R01-CA146445-01) and DoD-CDMRP Breast Cancer Research Program (W81XWH-08-1-0282 BC-07456). T. A. Ince receivse royalty payments for WIT medium and was a consultant to Stemgent Inc. during 2008-2010. We thank the participants and staff of the NHS, and state cancer registries: AL, AZ, AR, CA, CO, CT, DE, FL, GA, ID, IL, IN, IA, KY, LA, ME, MD, MA, MI, NE, NH, NJ, NY, NC, ND, OH, OK, OR, PA, RI, SC, TN, TX, VA, WA, WY.	Anckar J, 2011, ANNU REV BIOCHEM, V80, P1089, DOI 10.1146/annurev-biochem-060809-095203; Chiang WC, 2012, CELL, V148, P322, DOI 10.1016/j.cell.2011.12.019; Christians ES, 2002, CRIT CARE MED, V30, pS43, DOI 10.1097/00003246-200201001-00006; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Day A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008491; Dowhan DH, 2005, MOL CELL, V17, P429, DOI 10.1016/j.molcel.2004.12.025; Guettouche Toumy, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-4; Hahn JS, 2004, J BIOL CHEM, V279, P5169, DOI 10.1074/jbc.M311005200; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; Hu R, 2011, CLIN CANCER RES, V17, P1867, DOI 10.1158/1078-0432.CCR-10-2021; Ince TA, 2007, CANCER CELL, V12, P160, DOI 10.1016/j.ccr.2007.06.013; Ishikawa N, 2007, CANCER RES, V67, P11601, DOI 10.1158/0008-5472.CAN-07-3243; Jin XJ, 2011, CELL METAB, V14, P91, DOI 10.1016/j.cmet.2011.03.025; Kalager M, 2012, ANN INTERN MED, V156, P491, DOI 10.7326/0003-4819-156-7-201204030-00005; Khaleque M, 2008, ONCOGENE, V27, P1886, DOI 10.1038/sj.onc.1210834; Kim C, 2010, NAT REV CLIN ONCOL, V7, P340, DOI 10.1038/nrclinonc.2010.61; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Lee YJ, 2008, ONCOGENE, V27, P2999, DOI 10.1038/sj.onc.1210966; Liberal V, 2012, P NATL ACAD SCI USA, V109, P2754, DOI 10.1073/pnas.1102434108; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; MacIsaac KD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000773; Maruyama M, 2010, BIOCHEM BIOPH RES CO, V402, P75, DOI 10.1016/j.bbrc.2010.09.117; Meng L, 2010, ONCOGENE, V29, P5204, DOI 10.1038/onc.2010.277; Min JN, 2007, ONCOGENE, V26, P5086, DOI 10.1038/sj.onc.1210317; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Page TJ, 2006, MOL BIOSYST, V2, P627, DOI 10.1039/b606129j; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; PELHAM HRB, 1982, CELL, V30, P517, DOI 10.1016/0092-8674(82)90249-5; RITOSSA F, 1962, EXPERIENTIA, V18, P571, DOI 10.1007/BF02172188; Rokavec M, 2012, MOL CELL, V45, P777, DOI 10.1016/j.molcel.2012.01.015; Sakurai H, 2010, FEBS J, V277, P4140, DOI 10.1111/j.1742-4658.2010.07829.x; Santagata S, 2012, ACS CHEM BIOL, V7, P339, DOI 10.1021/cb200353m; Santagata S, 2011, P NATL ACAD SCI USA, V108, P18378, DOI 10.1073/pnas.1115031108; Scott KL, 2011, CANCER CELL, V20, P92, DOI 10.1016/j.ccr.2011.05.025; Shamovsky I, 2008, CELL MOL LIFE SCI, V65, P855, DOI 10.1007/s00018-008-7458-y; Solimini NL, 2007, CELL, V130, P986, DOI 10.1016/j.cell.2007.09.007; Stanhill A, 2006, ONCOGENE, V25, P1485, DOI 10.1038/sj.onc.1209193; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tamimi RM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2128; Venet D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002240; Volovik Y, 2012, AGING CELL, V11, P491, DOI 10.1111/j.1474-9726.2012.00811.x; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Xiao XZ, 1999, EMBO J, V18, P5943, DOI 10.1093/emboj/18.21.5943; Zhao YH, 2009, ONCOGENE, V28, P3689, DOI 10.1038/onc.2009.229; Zhao YH, 2011, CANCER RES, V71, P4585, DOI 10.1158/0008-5472.CAN-11-0127; Zhou JD, 2008, CHINESE MED J-PEKING, V121, P1269, DOI 10.1097/00029330-200807020-00004	49	458	470	2	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 3	2012	150	3					549	562		10.1016/j.cell.2012.06.031	http://dx.doi.org/10.1016/j.cell.2012.06.031			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	985WO	22863008	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000307301400014
J	Mebrahtu, HT; Borzenets, IV; Liu, DE; Zheng, HX; Bomze, YV; Smirnov, AI; Baranger, HU; Finkelstein, G				Mebrahtu, Henok T.; Borzenets, Ivan V.; Liu, Dong E.; Zheng, Huaixiu; Bomze, Yuriy V.; Smirnov, Alex I.; Baranger, Harold U.; Finkelstein, Gleb			Quantum phase transition in a resonant level coupled to interacting leads	NATURE			English	Article							COULOMB-BLOCKADE; TUNNEL-JUNCTIONS; LUTTINGER LIQUID	A Luttinger liquid is an interacting one-dimensional electronic system, quite distinct from the 'conventional' Fermi liquids formed by interacting electrons in two and three dimensions(1). Some of the most striking properties of Luttinger liquids are revealed in the process of electron tunnelling. For example, as a function of the applied bias voltage or temperature, the tunnelling current exhibits a non-trivial power-law suppression(2,3). (There is no such suppression in a conventional Fermi liquid.) Here, using a carbon nanotube connected to resistive leads, we create a system that emulates tunnelling in a Luttinger liquid, by controlling the interaction of the tunnelling electron with its environment. We further replace a single tunnelling barrier with a double-barrier, resonant-level structure and investigate resonant tunnelling between Luttinger liquids. At low temperatures, we observe perfect transparency of the resonant level embedded in the interacting environment, and the width of the resonance tends to zero. We argue that this behaviour results from many-body physics of interacting electrons, and signals the presence of a quantum phase transition(4,5). Given that many parameters, including the interaction strength, can be precisely controlled in our samples, this is an attractive model system for studying quantum critical phenomena in general, with wide-reaching implications for understanding quantum phase transitions in more complex systems, such as cold atoms(6) and strongly correlated bulk materials(7).	[Mebrahtu, Henok T.; Borzenets, Ivan V.; Liu, Dong E.; Zheng, Huaixiu; Bomze, Yuriy V.; Baranger, Harold U.; Finkelstein, Gleb] Duke Univ, Dept Phys, Durham, NC 27708 USA; [Smirnov, Alex I.] N Carolina State Univ, Dept Chem, Raleigh, NC 27695 USA	Duke University; University of North Carolina; North Carolina State University	Finkelstein, G (corresponding author), Duke Univ, Dept Phys, Durham, NC 27708 USA.	gleb@phy.duke.edu	Smirnov, Alex I/Q-9818-2016; Baranger, Harold U/O-2370-2013; Borzenets, Ivan/M-9912-2015; Liu, Dong/G-2629-2017; Zheng, Huaixiu/D-3449-2013	Smirnov, Alex I/0000-0002-0037-2555; Baranger, Harold U/0000-0002-1458-2756; Borzenets, Ivan/0000-0002-1577-8312; Liu, Dong/0000-0002-1295-2362	US DOE [DE-SC0002765, DE-SC0005237, DE-FG02-02ER15354]	US DOE(United States Department of Energy (DOE))	We appreciate discussions with I. Affleck, D. V. Averin, A. M. Chang, C. H. Chung, S. Florens, M. Goldstein, L. I. Glazman, K. Ingersent, K. Le Hur, M. Lavagna, A. H. MacDonald, Yu. V. Nazarov, D. G. Polyakov and M. Vojta. We thank J. Liu for providing the nanotube growth facilities and W. Zhou for helping to optimize the nanotube synthesis. The work was supported by US DOE awards DE-SC0002765, DE-SC0005237 and DE-FG02-02ER15354.	Bloch I, 2005, NAT PHYS, V1, P23, DOI 10.1038/nphys138; Bomze Y, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.241402; Chang AM, 2003, REV MOD PHYS, V75, P1449, DOI 10.1103/RevModPhys.75.1449; Deshpande VV, 2010, NATURE, V464, P209, DOI 10.1038/nature08918; EGGERT S, 1992, PHYS REV B, V46, P10866, DOI 10.1103/PhysRevB.46.10866; FLENSBERG K, 1992, PHYS SCRIPTA, VT42, P189, DOI 10.1088/0031-8949/1992/T42/032; Florens S, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.155321; GIAMARCHI T., 2004, INT SERIES MONOGRAPH; Goldstein M, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.161307; Hewson A. C., 1997, KONDO PROBLEM HEAVY, V2; INGOLD GL, 1992, NATO ADV SCI I B-PHY, V294, P21; Joyez P, 1998, PHYS REV LETT, V80, P1956, DOI 10.1103/PhysRevLett.80.1956; KANE CL, 1992, PHYS REV B, V46, P15233, DOI 10.1103/PhysRevB.46.15233; KASTNER MA, 1993, PHYS TODAY, V46, P24, DOI 10.1063/1.881393; Komnik A, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.246403; Kouwenhoven LP, 1997, NATO ADV SCI I E-APP, V345, P105; Le Hur K, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.073305; LEGGETT AJ, 1987, REV MOD PHYS, V59, P1, DOI 10.1103/RevModPhys.59.1; Maasilta IJ, 1997, PHYS REV B, V55, P4081, DOI 10.1103/PhysRevB.55.4081; Milliken FP, 1996, SOLID STATE COMMUN, V97, P309, DOI 10.1016/0038-1098(95)00181-6; Nazarov YV, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.126804; Polyakov DG, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.035421; Roch N, 2008, NATURE, V453, P633, DOI 10.1038/nature06930; Sachdev S., 2011, QUANTUM PHASE TRANSI; Safi I, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.126602; SASSETTI M, 1995, PHYS REV B, V52, P11213, DOI 10.1103/PhysRevB.52.11213; Si QM, 2010, SCIENCE, V329, P1161, DOI 10.1126/science.1191195; Vojta M, 2006, PHILOS MAG, V86, P1807, DOI 10.1080/14786430500070396; Zheng W, 1998, SOLID STATE COMMUN, V108, P839, DOI 10.1016/S0038-1098(98)00439-6	30	59	59	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2012	488	7409					61	64		10.1038/nature11265	http://dx.doi.org/10.1038/nature11265			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ZE	22859201	Green Submitted			2022-12-28	WOS:000307010700032
J	Endres, M; Fukuhara, T; Pekker, D; Cheneau, M; Schauss, P; Gross, C; Demler, E; Kuhr, S; Bloch, I				Endres, Manuel; Fukuhara, Takeshi; Pekker, David; Cheneau, Marc; Schauss, Peter; Gross, Christian; Demler, Eugene; Kuhr, Stefan; Bloch, Immanuel			The 'Higgs' amplitude mode at the two-dimensional superfluid/Mott insulator transition	NATURE			English	Article							CHARGE-DENSITY WAVES; OPTICAL LATTICES; MOTT INSULATOR; GASES	Spontaneous symmetry breaking plays a key role in our understanding of nature. In relativistic quantum field theory, a broken continuous symmetry leads to the emergence of two types of fundamental excitation: massless Nambu-Goldstone modes and a massive 'Higgs' amplitude mode. An excitation of Higgs type is of crucial importance in the standard model of elementary particle physics(1), and also appears as a fundamental collective mode in quantum many-body systems(2). Whether such a mode exists in low-dimensional systems as a resonance-like feature, or whether it becomes overdamped through coupling to Nambu-Goldstone modes, has been a subject of debate(2-9). Here we experimentally find and study a Higgs mode in a two-dimensional neutral superfluid close to a quantum phase transition to a Mott insulating phase. We unambiguously identify the mode by observing the expected reduction in frequency of the onset of spectral response when approaching the transition point. In this regime, our system is described by an effective relativistic field theory with a two-component quantum field(2,7), which constitutes a minimal model for spontaneous breaking of a continuous symmetry. Additionally, all microscopic parameters of our system are known from first principles and the resolution of our measurement allows us to detect excited states of the many-body system at the level of individual quasi-particles. This allows for an in-depth study of Higgs excitations that also addresses the consequences of the reduced dimensionality and confinement of the system. Our work constitutes a step towards exploring emergent relativistic models with ultracold atomic gases.	[Endres, Manuel; Fukuhara, Takeshi; Cheneau, Marc; Schauss, Peter; Gross, Christian; Kuhr, Stefan; Bloch, Immanuel] Max Planck Inst Quantum Opt, D-85748 Garching, Germany; [Pekker, David] CALTECH, Dept Phys, Pasadena, CA 91125 USA; [Demler, Eugene] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Kuhr, Stefan] Univ Strathclyde, SUPA, Glasgow G4 0NG, Lanark, Scotland; [Bloch, Immanuel] Univ Munich, D-80799 Munich, Germany	Max Planck Society; California Institute of Technology; Harvard University; University of Strathclyde; University of Munich	Endres, M (corresponding author), Max Planck Inst Quantum Opt, D-85748 Garching, Germany.	manuel.endres@mpq.mpg.de	Kuhr, Stefan/ABC-8654-2020; Kuhr, Stefan/F-7296-2011; Demler, Eugene/ABG-1933-2021; Fukuhara, Takeshi/A-6254-2014; Schauss, Peter/AAV-1298-2020; Cheneau, Marc/O-9312-2014; Bloch, Immanuel/N-9169-2019; Bloch, Immanuel/G-3174-2010; Gross, Christian/P-5475-2014	Kuhr, Stefan/0000-0001-8386-5357; Kuhr, Stefan/0000-0001-8386-5357; Demler, Eugene/0000-0002-2499-632X; Fukuhara, Takeshi/0000-0002-6702-9882; Schauss, Peter/0000-0002-8505-5195; Cheneau, Marc/0000-0001-7261-566X; Bloch, Immanuel/0000-0002-0679-4759; Gross, Christian/0000-0003-2292-5234	MPG; DFG; EU; JSPS; California Institute of Technology (IQIM	MPG(Max Planck Society); DFG(German Research Foundation (DFG)); EU(European Commission); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); California Institute of Technology (IQIM	We thank C. Weitenberg and J. F. Sherson for their contribution to the design and construction of the apparatus. We thank D. Podolsky, W. Zwerger, S. Sachdev, R. Sensarma, W. Hofstetter, U. Bissbort, L. Pollet and N. Prokof'ev for discussions. We acknowledge funding by the MPG, DFG, EU (NAMEQUAM, AQUTE, Marie Curie Fellowship to M. C.), JSPS (Postdoctoral Fellowship for Research Abroad to T. F.) and California Institute of Technology (IQIM and Lee A. DuBridge fellowship to D. P.). The computations in this paper were done on the Odyssey cluster supported by the FAS Science Division Research Computing Group at Harvard University.	Altman E, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.250404; Bakr WS, 2010, SCIENCE, V329, P547, DOI 10.1126/science.1192368; Bissbort U, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.205303; Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; Capogrosso-Sansone B, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.015602; Cazalilla MA, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/8/158; CHUBUKOV AV, 1994, PHYS REV B, V49, P11919, DOI 10.1103/PhysRevB.49.11919; Endres M, 2011, SCIENCE, V334, P200, DOI [10.1126/science.1209284, 10.1126/science.1210268]; Gerbier F, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.120405; Grass TD, 2011, LASER PHYS, V21, P1459, DOI 10.1134/S1054660X11150096; Huber SD, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.050404; Huber SD, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.085106; LITTLEWOOD PB, 1981, PHYS REV LETT, V47, P811, DOI 10.1103/PhysRevLett.47.811; Menotti C, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.235120; Podolsky D, 2012, FEATURE REMOVAL ISOL; Podolsky D, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.174522; Pollet L, 2012, FEATURE REMOVAL ISOL; Randall L, 1999, PHYS REV LETT, V83, P3370, DOI 10.1103/PhysRevLett.83.3370; Ruegg C, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.205701; Sachdev S, 1999, PHYS REV B, V59, P14054, DOI 10.1103/PhysRevB.59.14054; Sachdev S., 2011, QUANTUM PHASE TRANSI; Schori C, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.240402; Sengupta K, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.033629; Sherson JF, 2010, NATURE, V467, P68, DOI 10.1038/nature09378; SOORYAKUMAR R, 1980, PHYS REV LETT, V45, P660, DOI 10.1103/PhysRevLett.45.660; Spielman IB, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.080404; Stoferle T, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.130403; Varma CM, 2002, J LOW TEMP PHYS, V126, P901, DOI 10.1023/A:1013890507658; Weinberg S., 2013, QUANTUM THEORY FIELD, V2; Zwerger W, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.027203	30	229	229	4	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2012	487	7408					454	U64		10.1038/nature11255	http://dx.doi.org/10.1038/nature11255			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979KD	22837000	Green Submitted, Green Accepted			2022-12-28	WOS:000306815300032
J	Hollands, GJ; Whitwell, SCL; Parker, RA; Prescott, NJ; Forbes, A; Sanderson, J; Mathew, CG; Lewis, CM; Watts, S; Sutton, S; Armstrong, D; Kinmonth, AL; Prevost, AT; Marteau, TM				Hollands, Gareth J.; Whitwell, Sophia C. L.; Parker, Richard A.; Prescott, Natalie J.; Forbes, Alastair; Sanderson, Jeremy; Mathew, Christopher G.; Lewis, Cathryn M.; Watts, Sally; Sutton, Stephen; Armstrong, David; Kinmonth, Ann Louise; Prevost, A. Toby; Marteau, Theresa M.			Effect of communicating DNA based risk assessments for Crohn's disease on smoking cessation: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRIMARY-CARE; IMPACT; INTERVENTION; MOTIVATION; BEHAVIOR; METAANALYSIS; POPULATION; PREDICTION; SMOKERS	Objective To test the hypothesis that communicating risk of developing Crohn's disease based on genotype and that stopping smoking can reduce this risk, motivates behaviour change among smokers at familial risk. Design Parallel group, cluster randomised controlled trial. Setting Families with Crohn's disease in the United Kingdom. Participants 497 smokers (mean age 42.6 (SD 14.4) years) who were first degree relatives of probands with Crohn's disease, with outcomes assessed on 209/251 (based on DNA analysis) and 217/246 (standard risk assessment). Intervention Communication of risk assessment for Crohn's disease by postal booklet based on family history of the disease and smoking status alone, or with additional DNA analysis for the NOD2 genotype. Participants were then telephoned by a National Health Service Stop Smoking counsellor to review the booklet and deliver brief standard smoking cessation intervention. Calls were tape recorded and a random subsample selected to assess fidelity to the clinical protocol. Main outcome measure The primary outcome was smoking cessation for 24 hours or longer, assessed at six months. Results The proportion of participants stopping smoking for 24 hours or longer did not differ between arms: 35% (73/209) in the DNA arm versus 36% (78/217) in the non-DNA arm (difference -1%, 95% confidence interval -10% to 8%, P=0.83). The proportion making a quit attempt within the DNA arm did not differ between those who were told they had mutations putting them at increased risk (36%), those told they had none (35%), and those in the non-DNA arm (36%). Conclusion Among relatives of patients with Crohn's disease, feedback of DNA based risk assessments does not motivate behaviour change to reduce risk any more or less than standard risk assessment. These findings accord with those across a range of populations and behaviours. They do not support the promulgation of commercial DNA based tests nor the search for gene variants that confer increased risk of common complex diseases on the basis that they effectively motivate health related behaviour change.	[Hollands, Gareth J.; Whitwell, Sophia C. L.; Marteau, Theresa M.] Kings Coll London, Sect Hlth Psychol, Dept Psychol Guys, London SE1 9RT, England; [Parker, Richard A.; Sutton, Stephen; Kinmonth, Ann Louise] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Prescott, Natalie J.; Mathew, Christopher G.; Lewis, Cathryn M.] Kings Coll London, Sch Med, Dept Med & Mol Genet, London WC2R 2LS, England; [Forbes, Alastair] Univ Coll Hosp, Dept Gastroenterol & Clin Nutr, London, England; [Sanderson, Jeremy] St Thomas Hosp, Dept Gastroenterol, London, England; [Watts, Sally] Guys Hosp, London SE1 9RT, England; [Armstrong, David; Prevost, A. Toby] Kings Coll London, Dept Primary Care & Publ Hlth Sci, London WC2R 2LS, England	University of London; King's College London; University of Cambridge; University of London; King's College London; University of London; University College London; Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Marteau, TM (corresponding author), Kings Coll London, Sect Hlth Psychol, Dept Psychol Guys, London SE1 9RT, England.	theresa.marteau@kcl.ac.uk	Mathew, Christopher G/G-3434-2015; Armstrong, David/AAI-4476-2021; Prescott, Natalie J/F-6490-2011; Prescott, Natalie/AHE-5121-2022; Lewis, Cathryn M/A-5225-2010; Lewis, Cathryn/M-8766-2019	Mathew, Christopher G/0000-0003-4178-1838; Armstrong, David/0000-0003-3652-9662; Prescott, Natalie J/0000-0002-5901-7371; Prescott, Natalie/0000-0002-5901-7371; Lewis, Cathryn M/0000-0002-8249-8476; Lewis, Cathryn/0000-0002-8249-8476; Forbes, Alastair/0000-0001-7416-9843; Hollands, Gareth/0000-0002-0492-3924; Sutton, Stephen/0000-0003-1610-0404; Marteau, Theresa/0000-0003-3025-1129; Prevost, A. Toby/0000-0003-1723-0796	Medical Research Council, UK [G0500274]; National Institutes of Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust; King's College London; NIHR through the Comprehensive Biomedical Research Centre at UCLH/UCL; MRC [G0500274, G0200391] Funding Source: UKRI; Medical Research Council [G0500274, G0200391] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust; King's College London; NIHR through the Comprehensive Biomedical Research Centre at UCLH/UCL; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded as part of a grant from the Medical Research Council, UK (Risk communication in preventive medicine: optimising the impact of DNA risk information; G0500274). NJP and CGM are supported by the National Institutes of Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London. AF is supported by NIHR through the Comprehensive Biomedical Research Centre at UCLH/UCL. The trial protocol was peer reviewed by the Council. Other than as indicated, the funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Audrain J, 1997, ADDICT BEHAV, V22, P741, DOI 10.1016/S0306-4603(97)00060-9; Balmford J, 2010, HEALTH EDUC RES, V25, P698, DOI 10.1093/her/cyq013; Bates BR, 2003, WHAT DOES GENE HEART, P156; Bloss CS, 2011, NEW ENGL J MED, V364, P524, DOI 10.1056/NEJMoa1011893; Brant SR, 2007, AM J GASTROENTEROL, V102, P313, DOI 10.1111/j.1572-0241.2006.00926.x; CALKINS BM, 1989, DIGEST DIS SCI, V34, P1841, DOI 10.1007/BF01536701; Cameron LD, 2009, HEALTH PSYCHOL, V28, P307, DOI 10.1037/a0013947; Chao S, 2008, ALZ DIS ASSOC DIS, V22, P94, DOI 10.1097/WAD.0b013e31815a9dcc; Chen S, 1999, DUAL-PROCESS THEORIES IN SOCIAL PSYCHOLOGY, P73; Collins F, 2010, NATURE, V464, P674, DOI 10.1038/464674a; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; Collins RE, 2011, GENET MED, V13, P273, DOI 10.1097/GIM.0b013e3181f710ca; Department of Health, 2012, NHS STOP SMOK SERV; Department of Health (DoH), 2011, HLTH LIV HLTH PEOPL; DONNER A, 1981, AM J EPIDEMIOL, V114, P906, DOI 10.1093/oxfordjournals.aje.a113261; Evans JP, 2011, SCIENCE, V331, P861, DOI 10.1126/science.1198039; Fanshawe TR, 2008, GENET TEST, V12, P381, DOI 10.1089/gte.2007.0103; Fidler JA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-479; Floyd DL, 2000, J APPL SOC PSYCHOL, V30, P407, DOI 10.1111/j.1559-1816.2000.tb02323.x; Forbes A., 2001, INFLAMMATORY BOWEL D; Gramling R, 2003, GENET MED, V5, P172, DOI 10.1097/01.GIM.0000068986.03217.BB; Hishida A, 2010, CANCER EPIDEMIOL, V34, P96, DOI 10.1016/j.canep.2009.11.008; Jolly K, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6500; Lewis CM, 2007, J MED GENET, V44, P689, DOI 10.1136/jmg.2007.051672; Marteau TM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007275.pub2; Marteau TM, 2005, RISK ANAL, V25, P397, DOI 10.1111/j.1539-6924.2005.00598.x; Mathew CG, 2008, NAT REV GENET, V9, P9, DOI 10.1038/nrg2203; Meiser Bettina, 2005, J Genet Couns, V14, P453, DOI 10.1007/s10897-005-6192-y; Milne S, 2000, J APPL SOC PSYCHOL, V30, P106, DOI 10.1111/j.1559-1816.2000.tb02308.x; National Preventative Health Taskforce, 2010, TAK PREV ACT RESP AU; Reid EP, 2006, EUR J HUM GENET, V14, P1263, DOI 10.1038/sj.ejhg.5201699; Sanderson SC, 2008, J HEALTH PSYCHOL, V13, P481, DOI 10.1177/1359105308088519; Shiloh S, 2002, J BEHAV MED, V25, P373, DOI 10.1023/A:1015818532390; Stead LF, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002850.pub2; Watson M, 1998, J MED GENET, V35, P731, DOI 10.1136/jmg.35.9.731; West R, 2005, ADDICTION, V100, P299, DOI 10.1111/j.1360-0443.2004.00995.x; West R, 2001, ADDICTION, V96, P891, DOI 10.1046/j.1360-0443.2001.96689110.x; West R, 2012, SMOKING ENGLAND; Whitwell SCL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-44; World Health Organization, 2003, WHO FRAM CONV TOB CO; Wright AJ, 2008, CLIN GENET, V73, P306, DOI 10.1111/j.1399-0004.2008.00964.x	41	23	23	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 20	2012	345								e4708	10.1136/bmj.e4708	http://dx.doi.org/10.1136/bmj.e4708			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	978MD	22822007	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000306744600003
J	Boyd, MA; Cooper, DA				Boyd, Mark A.; Cooper, David A.			Optimisation of HIV care and service delivery: doing more with less	LANCET			English	Review							RESOURCE-LIMITED SETTINGS; NON-INFERIORITY TRIAL; ANTIRETROVIRAL THERAPY; CLINICAL-OUTCOMES; INFECTED ADULTS; 400/100 MG; PHARMACOKINETICS; FAILURE; HEALTH; COMBINATION	The unprecedented, successful collaborative international effort to provide universal access to HIV care, including effective antiretroviral therapy, has reached a crucial point. Global economic downturn, changing donor priorities, and competing priorities in the health sector threaten the target of provision of 15 million people with HIV/AIDS with treatment by 2015, as agreed by the UN General Assembly. This aspiration has received added impetus from the finding that treatment prevents transmission by reduction of infectiousness of patients. In this report we critically review success thus far and examine efforts to optimise delivery of HIV care including antiretroviral therapy in low-income and middle-income countries for four main domains: treatment strategy, drug dosing, monitoring, and service delivery.	[Boyd, Mark A.; Cooper, David A.] Univ New S Wales, Kirby Inst, Sydney, NSW 2052, Australia; [Boyd, Mark A.; Cooper, David A.] St Vincents Hosp, Darlinghurst, NSW 2010, Australia; [Cooper, David A.] St Vincents Ctr Appl Med Res, Darlinghurst, NSW 2010, Australia	University of New South Wales Sydney; Kirby Institute; St Vincents Hospital Sydney	Boyd, MA (corresponding author), Univ New S Wales, Kirby Inst, Sydney, NSW 2052, Australia.	mboyd@kirby.unsw.edu.au		Boyd, Mark/0000-0002-6848-3307	Abbott; Gilead; Merck	Abbott(Abbott Laboratories); Gilead(Gilead Sciences); Merck(Merck & Company)	DAC has received grant support and honoraria from Abbott, Gilead, and Merck. MAB has received honoraria for services provided to Abbott, Boehringer-Ingelheim, Bristol-Myers Squibb, Gilead, Janssen, and Merck.	Alberts B, 2011, SCIENCE, V334, P1604, DOI 10.1126/science.1217831; [Anonymous], STOP TB PARTN; Bartlett JA, 2006, AIDS, V20, P2051, DOI 10.1097/01.aids.0000247578.08449.ff; Boyd M, 2005, ANTIVIR THER, V10, P301; Boyd MA, 2009, CURR OPIN HIV AIDS, V4, P194, DOI 10.1097/COH.0b013e328329fc8d; Brennan AT, 2011, AIDS, V25, P2027, DOI 10.1097/QAD.0b013e32834b6480; Cain LE, 2011, ANN INTERN MED, V154, P509, DOI 10.7326/0003-4819-154-8-201104190-00001; Calmy A, 2007, LANCET, V370, P12, DOI 10.1016/S0140-6736(07)61027-7; CEPAC-International Investigators, 2010, PLOS MED, V7; Chang LW, 2010, COCHRANE DB SYST REV, V4; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cooper D, 2007, LANCET, V370, P7, DOI 10.1016/S0140-6736(07)61024-1; Crawford KW, 2012, LANCET INFECT DIS, V12, P550, DOI 10.1016/S1473-3099(12)70134-2; Crisp Nigel., 2010, TURNING WORLD UPSIDE; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Else LJ, 2012, ANTIMICROB AGENTS CH, V56, P1427, DOI 10.1128/AAC.05599-11; Emery S, 2008, J INFECT DIS, V197, P1133, DOI 10.1086/586713; Funk MJ, 2011, ARCH INTERN MED, V171, P1560, DOI 10.1001/archinternmed.2011.401; Gogtay JA, 2007, IDRUGS, V10, P881; Hill A, 2007, EXPERT OPIN PHARMACO, V8, P679, DOI 10.1517/14656566.8.5.679; Hosseinipour MC, 2009, AIDS, V23, P1127, DOI 10.1097/QAD.0b013e32832ac34e; Howard AA, 2010, CLIN INFECT DIS, V50, pS238, DOI 10.1086/651497; Humphreys EH, 2010, COCHRANE DB SYST REV, V6; Institute for Health Metrics and Evaluation, FIN GLOB HLTH 2011 C; Jackson A, 2011, J ANTIMICROB CHEMOTH, V66, P635, DOI 10.1093/jac/dkq468; Jaffar S, 2009, LANCET, V374, P2080, DOI 10.1016/S0140-6736(09)61674-3; Jourdain G, 2011, 18 C RETR OPP INF BO; Kantor R, 2009, CLIN INFECT DIS, V49, P454, DOI 10.1086/600396; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Koenig SP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001095; Laurent C, 2011, LANCET INFECT DIS, V11, P825, DOI 10.1016/S1473-3099(11)70168-2; Leach-Kemon K, 2012, HEALTH AFFAIR, V31, P228, DOI 10.1377/hlthaff.2011.1154; Long L, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001055; Medecins Sans Frontieres, UNT WEB ANT PRIC RED; Mermin J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6792; Min S, 2011, AIDS, V25, P1737, DOI 10.1097/QAD.0b013e32834a1dd9; Mtapuri-Zinyowera S, 2010, JAIDS-J ACQ IMM DEF, V55, P1, DOI 10.1097/QAI.0b013e3181e93071; Mugyenyi P, 2010, LANCET, V375, P123, DOI 10.1016/S0140-6736(09)62067-5; Nuesch R, 2006, J ANTIMICROB CHEMOTH, V58, P637, DOI 10.1093/jac/dkl313; Parienti JJ, 2009, CLIN INFECT DIS, V48, P484, DOI 10.1086/596482; Political Declaration on HIV/AIDS: Intensifying Our Eff orts to Eliminate HIV/AIDS, 2011, UN GEN ASS HIGH LEV; Protocol 004 Part II Study Team, 2007, J ACQ IMMUN DEF SYND, V46, P125; Sanne I, 2010, LANCET, V376, P33, DOI 10.1016/S0140-6736(10)60894-X; Severe P, 2010, NEW ENGL J MED, V363, P257, DOI 10.1056/NEJMoa0910370; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; Sukapirom K, 2011, JAIDS-J ACQ IMM DEF, V58, P141, DOI 10.1097/QAI.0b013e31822866a2; Sungkanuparph S, 2007, CLIN INFECT DIS, V44, P447, DOI 10.1086/510745; Taiwo B, 2012, 19 C RETR OPP INF SE; The Global Fund, GLOB FUND IS AL WELL; The Global Fund, GLOB FUND FOR 1 6 BI; The Kaiser Family Foundation and UNAIDS, FUND RESP AIDS LOW M; UN General Assembly, POL DECL HIGH LEV M; *US DEP HHS, GUID US ANT AG HIV 1; Vidya M, 2009, ANTIVIR THER, V14, P1005, DOI 10.3851/IMP1411; WHO, 2002, SCAL ANT THER RES LI; WHO, ANT THER HIV INF AD; WHO HIV/AIDS Programme, DIAGN TREATM IN WHO; WHO HIV/ AIDS Programme, SHORT TERM PRIOR ANT; WHO UNAIDS, 3 5 IN TREAT 5 MILL; World Health Organization, PROGR REP 2011 GLOB; World Health Organization, 2006, ANT THER HIV INF AD; World Health Organization/UNAIDS, TREATM 2 0 FRAM ACT	62	12	12	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 24	2012	380	9856					1860	1866		10.1016/S0140-6736(12)61154-4	http://dx.doi.org/10.1016/S0140-6736(12)61154-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	041XK	22828482				2022-12-28	WOS:000311435000032
J	Hsieh, MT; Wu, WS				Hsieh, Ming-Ta; Wu, Wen-Shiann			Pulsation of the nailbed	LANCET			English	Editorial Material									[Hsieh, Ming-Ta] Chi Mei Med Ctr, Dept Family Med, Tainan 710, Taiwan; [Wu, Wen-Shiann] Chi Mei Med Ctr, Dept Cardiol, Tainan 710, Taiwan	Chi Mei Hospital; Chi Mei Hospital	Hsieh, MT (corresponding author), Chi Mei Med Ctr, Dept Family Med, Tainan 710, Taiwan.	kaplan210@yahoo.com.tw							0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 17	2012	380	9855					1767	1767		10.1016/S0140-6736(12)61153-2	http://dx.doi.org/10.1016/S0140-6736(12)61153-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	038CV	22841298	Bronze			2022-12-28	WOS:000311153700033
J	Cherry, JD				Cherry, James D.			Epidemic Pertussis in 2012-The Resurgence of a Vaccine-Preventable Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Cherry, JD (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA.							[Anonymous], 2012, MMWR MORB MORTAL WKL, V61, P517; Cherry JD, 2012, PEDIATRICS, V129, P968, DOI 10.1542/peds.2011-2594; Cherry JD, 2010, CLIN INFECT DIS, V51, P663, DOI 10.1086/655826; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; Winter K., 2012, J PEDIAT	5	339	363	2	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 30	2012	367	9					785	787		10.1056/NEJMp1209051	http://dx.doi.org/10.1056/NEJMp1209051			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	996EN	22894554				2022-12-28	WOS:000308067400013
J	Walser, PJ; Ariotti, N; Howes, M; Ferguson, C; Webb, R; Schwudke, D; Leneva, N; Cho, KJ; Cooper, L; Rae, J; Floetenmeyer, M; Oorschot, VMJ; Skoglund, U; Simons, K; Hancock, JF; Parton, RG				Walser, Piers J.; Ariotti, Nicholas; Howes, Mark; Ferguson, Charles; Webb, Richard; Schwudke, Dominik; Leneva, Natalya; Cho, Kwang-Jin; Cooper, Leanne; Rae, James; Floetenmeyer, Matthias; Oorschot, Viola M. J.; Skoglund, Ulf; Simons, Kai; Hancock, John F.; Parton, Robert G.			Constitutive Formation of Caveolae in a Bacterium	CELL			English	Article							CLATHRIN-COATED PITS; C-TERMINAL DOMAIN; IN-VIVO; MOLECULAR DISSECTION; MEMBRANE-BINDING; COPII CAGE; NULL MICE; BIOGENESIS; PROTEINS; CELLS	Caveolin plays an essential role in the formation of characteristic surface pits, caveolae, which cover the surface of many animal cells. The fundamental principles of caveola formation are only slowly emerging. Here we show that caveolin expression in a prokaryotic host lacking any intracellular membrane system drives the formation of cytoplasmic vesicles containing polymeric caveolin. Vesicle formation is induced by expression of wild-type caveolins, but not caveolin mutants defective in caveola formation in mammalian systems. In addition, cryo-electron tomography shows that the induced membrane domains are equivalent in size and caveolin density to native caveolae and reveals a possible polyhedral arrangement of caveolin oligomers. The caveolin-induced vesicles or heterologous caveolae (h-caveolae) form by budding in from the cytoplasmic membrane, generating a membrane domain with distinct lipid composition. Periplasmic solutes are encapsulated in the budding h-caveola, and purified h-caveolae can be tailored to be targeted to specific cells of interest.	[Walser, Piers J.; Ariotti, Nicholas; Howes, Mark; Ferguson, Charles; Leneva, Natalya; Cho, Kwang-Jin; Hancock, John F.; Parton, Robert G.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Webb, Richard; Rae, James; Floetenmeyer, Matthias] Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld 4072, Australia; [Schwudke, Dominik; Cooper, Leanne; Parton, Robert G.] GKVK, Natl Ctr Biol Sci, TIFR, Bangalore 560065, Karnataka, India; [Oorschot, Viola M. J.] Univ Med Ctr Utrecht, Dept Cell Biol, Cell Microscopy Ctr, NL-3584 CX Utrecht, Netherlands; [Skoglund, Ulf] Grad Univ, Okinawa Inst Sci & Technol, Struct Cellular Biol Unit, Okinawa 9040495, Japan; [Simons, Kai] Tech Univ Dresden, Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	University of Queensland; University of Queensland; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Utrecht University; Utrecht University Medical Center; Okinawa Institute of Science & Technology Graduate University; Max Planck Society; Technische Universitat Dresden	Walser, PJ (corresponding author), NHSBT, Bristol Inst Transfus Sci, Bristol BS34 7QH, Avon, England.	piers.walser@nhsbt.nhs.uk; r.parton@imb.uq.edu.au	Ariotti, Nicholas/GXH-4833-2022; Cho, Kwang-jin/AAI-4923-2020; Schwudke, Dominik/B-3478-2013; Parton, Robert G/C-5673-2009; Skoglund, Ulf/B-5829-2015	Schwudke, Dominik/0000-0002-1379-9451; Parton, Robert G/0000-0002-7494-5248; Hancock, John/0000-0003-0542-4710; Floetenmeyer, Matthias/0000-0002-0133-1632; Leneva, Natalya/0000-0001-8102-9769; Ariotti, Nicholas/0000-0003-3901-0831; Skoglund, Ulf/0000-0002-3407-0053; Howes, Mark/0000-0002-9666-3364	National Health and Medical Research Council of Australia; Australian Research Council; Swiss National Science Foundation [PA00-109094]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by grants from the National Health and Medical Research Council of Australia (to R.G.P. and J.F.H.), the Australian Research Council (R.G.P.). P.J.W. was supported by a fellowship for advanced researchers by the Swiss National Science Foundation (PA00-109094). Confocal microscopy was performed at the Australian Cancer Research Foundation (ACRF)/Institute for Molecular Bioscience Dynamic Imaging Facility for Cancer Biology, which was established with the support of the ACRF. The Institute for Molecular Bioscience is a Special Research Centre of the Australian Research Council. The authors acknowledge the facilities as well as scientific and technical assistance from staff in the Australian Microscopy and Microanalysis Facility (AMMRF) at the Centre for Microscopy and Microanalysis at The University of Queensland. We would like to thank Alejandra Castillo-Alvarez and Angela Gardner for technical assistance. We are particularly grateful to Alasdair McDowall for help with preliminary cryo-TEM studies and Yoshinori Akiyama for providing ftsH depletion strain AD368. We thank Neil Marshall, Murray Stewart, Chris Fielding, Deborah Brown and for providing constructs.	Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Bastiani M, 2010, J CELL SCI, V123, P3831, DOI 10.1242/jcs.070102; Boucrot E, 2012, CELL, V149, P124, DOI 10.1016/j.cell.2012.01.047; Brett TJ, 2006, CURR OPIN CELL BIOL, V18, P395, DOI 10.1016/j.ceb.2006.06.014; Cheng YF, 2007, J MOL BIOL, V365, P892, DOI 10.1016/j.jmb.2006.10.036; Cronan JE, 2002, CURR OPIN MICROBIOL, V5, P202, DOI 10.1016/S1369-5274(02)00297-7; Das K, 1999, J BIOL CHEM, V274, P18721, DOI 10.1074/jbc.274.26.18721; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; DUPREE P, 1993, EMBO J, V12, P1597, DOI 10.1002/j.1460-2075.1993.tb05804.x; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Fath S, 2007, CELL, V129, P1325, DOI 10.1016/j.cell.2007.05.036; Fernandez I, 2002, P NATL ACAD SCI USA, V99, P11193, DOI 10.1073/pnas.172196599; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; FORNSTEDT N, 1975, FEBS LETT, V57, P187, DOI 10.1016/0014-5793(75)80713-7; Fotin A, 2006, J STRUCT BIOL, V156, P453, DOI 10.1016/j.jsb.2006.07.001; FRA AM, 1995, P NATL ACAD SCI USA, V92, P8655, DOI 10.1073/pnas.92.19.8655; Fujimoto T, 2000, J CELL SCI, V113, P3509; Galbiati F, 2001, J BIOL CHEM, V276, P21425, DOI 10.1074/jbc.M100828200; Gurkan C, 2006, NAT REV MOL CELL BIO, V7, P727, DOI 10.1038/nrm2025; Hagiwara Y, 2000, HUM MOL GENET, V9, P3047, DOI 10.1093/hmg/9.20.3047; Hansen CG, 2011, J CELL SCI, V124, P2777, DOI 10.1242/jcs.084319; Hayashi K, 2001, CANCER RES, V61, P2361; Hayer A, 2010, TRAFFIC, V11, P361, DOI 10.1111/j.1600-0854.2009.01023.x; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Ito K, 2005, ANNU REV MICROBIOL, V59, P211, DOI 10.1146/annurev.micro.59.030804.121316; Kirkham M, 2008, J CELL SCI, V121, P2075, DOI 10.1242/jcs.024588; Lee C, 2010, CELL, V142, P123, DOI 10.1016/j.cell.2010.05.030; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; MONIER S, 1995, MOL BIOL CELL, V6, P911, DOI 10.1091/mbc.6.7.911; Parton RG, 2006, J CELL SCI, V119, P787, DOI 10.1242/jcs.02853; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Quiocho FA, 1997, STRUCTURE, V5, P997, DOI 10.1016/S0969-2126(97)00253-0; Razani B, 2001, J BIOL CHEM, V276, P38121; Ren XY, 2004, MOL BIOL CELL, V15, P4556, DOI 10.1091/mbc.E04-06-0480; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Russell C, 2010, TRAFFIC, V11, P303, DOI 10.1111/j.1600-0854.2009.01026.x; SARGIACOMO M, 1995, P NATL ACAD SCI USA, V92, P9407, DOI 10.1073/pnas.92.20.9407; Scheiffele P, 1998, J CELL BIOL, V140, P795, DOI 10.1083/jcb.140.4.795; Schlegel A, 2000, J BIOL CHEM, V275, P21605, DOI 10.1074/jbc.M002558200; Senju Y, 2011, J CELL SCI, V124, P2032, DOI 10.1242/jcs.086264; Song KS, 1997, J BIOL CHEM, V272, P4398, DOI 10.1074/jbc.272.7.4398; Stagg SM, 2007, CURR OPIN STRUC BIOL, V17, P221, DOI 10.1016/j.sbi.2007.03.010; Thomas CM, 2008, J CELL MOL MED, V12, P796, DOI 10.1111/j.1582-4934.2008.00295.x; Vogel U, 1998, J CELL SCI, V111, P825; Wanaski SP, 2003, BIOCHEMISTRY-US, V42, P42, DOI 10.1021/bi012097n	46	93	91	0	45	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 17	2012	150	4					752	763		10.1016/j.cell.2012.06.042	http://dx.doi.org/10.1016/j.cell.2012.06.042			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	995IT	22901807	Bronze			2022-12-28	WOS:000308002300010
J	Kirby, T				Kirby, Tony			Paul Ridker: reaching the end game	LANCET			English	Biographical-Item																		RIDKER P, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 11	2012	380	9841					556	556		10.1016/S0140-6736(12)61318-X	http://dx.doi.org/10.1016/S0140-6736(12)61318-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988SQ	22883495				2022-12-28	WOS:000307511400015
J	Willner, AE; Wang, J; Huang, H				Willner, Alan E.; Wang, Jian; Huang, Hao			A Different Angle on Light Communications	SCIENCE			English	Editorial Material							ORBITAL ANGULAR-MOMENTUM		[Willner, Alan E.; Huang, Hao] Univ So Calif, Dept Elect Engn, Los Angeles, CA 90089 USA; [Wang, Jian] Huazhong Univ Sci & Technol, Wuhan Natl Lab Optoelect, Coll Optoelect Sci & Engn, Wuhan 430074, Hubei, Peoples R China	University of Southern California; Huazhong University of Science & Technology	Willner, AE (corresponding author), Univ So Calif, Dept Elect Engn, Los Angeles, CA 90089 USA.	willner@usc.edu; jwang@mail.hust.edu.cn						ALLEN L, 1992, PHYS REV A, V45, P8185, DOI 10.1103/PhysRevA.45.8185; Anguita JA, 2008, APPL OPTICS, V47, P2414, DOI 10.1364/AO.47.002414; Bozinovic N., 2011, P C LAS EL 2011; Fazal I. M., 2011, P FRONT OPT 2011; Fontaine N. K., 2012, P OPT FIB C 2012; Gibson G, 2004, OPT EXPRESS, V12, P5448, DOI 10.1364/OPEX.12.005448; Gnauck AH, 2011, J LIGHTWAVE TECHNOL, V29, P373, DOI 10.1109/JLT.2010.2080259; Mair A, 2001, NATURE, V412, P313, DOI 10.1038/35085529; Paterson C, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.153901; Qian DY, 2012, J LIGHTWAVE TECHNOL, V30, P1540, DOI 10.1109/JLT.2012.2189096; Su TH, 2012, OPT EXPRESS, V20, DOI 10.1364/OE.20.009396; Tamburini F, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/3/033001; Wang J., 2011, P EUR C EXH OPT COMM; Wang J, 2012, NAT PHOTONICS, V6, P488, DOI [10.1038/nphoton.2012.138, 10.1038/NPHOTON.2012.138]; Yao AM, 2011, ADV OPT PHOTONICS, V3, P161, DOI 10.1364/AOP.3.000161	15	108	115	3	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2012	337	6095					655	656		10.1126/science.1225460	http://dx.doi.org/10.1126/science.1225460			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986PE	22879492				2022-12-28	WOS:000307354500029
J	Jing, SS; Newman, SDS; Baghla, DPS				Jing, S. S.; Newman, S. D. S.; Baghla, D. P. S.			Shoulder injury	BRITISH MEDICAL JOURNAL			English	Editorial Material							PROXIMAL HUMERAL FRACTURES; CLASSIFICATION; AXILLARY		[Jing, S. S.; Newman, S. D. S.; Baghla, D. P. S.] Ealing Gen Hosp, Dept Trauma & Orthopaed Surg, Southall UB1 3HW, Middx, England		Jing, SS (corresponding author), Ealing Gen Hosp, Dept Trauma & Orthopaed Surg, Southall UB1 3HW, Middx, England.	shanshan.jing@gmail.com						Bahrs C, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-33; BLOOM MH, 1967, J BONE JOINT SURG AM, VA 49, P943, DOI 10.2106/00004623-196749050-00011; Brorson S, 2009, INT ORTHOP, V33, P323, DOI 10.1007/s00264-008-0591-2; Cornell Charles N, 2003, J Am Acad Orthop Surg, V11, P109; Court-Brown CM, 2001, ACTA ORTHOP SCAND, V72, P365, DOI 10.1080/000164701753542023; Hodgson S, 2006, CLIN ORTHOP RELAT R, P131, DOI 10.1097/01.blo.0000194677.02506.45; Iyengar JJ, 2011, PHYSICIAN SPORTSMED, V39, P52, DOI 10.3810/psm.2011.02.1862; Kralinger F, 2004, J BONE JOINT SURG BR, V86B, P217, DOI 10.1302/0301-620X.86B2.14553; Mathei J, 2008, ACTA CHIR BELG, V108, P625, DOI 10.1080/00015458.2008.11680305; Monga Puneet, 2009, J Orthop Surg (Hong Kong), V17, P142; Muller ME, 1991, MANUAL INTERNAL FIXA, P118; Murray IR, 2011, J BONE JOINT SURG BR, V93B, P1, DOI 10.1302/0301-620X.93B1.25702; NEER CS, 1970, J BONE JOINT SURG AM, VA 52, P1077, DOI 10.2106/00004623-197052060-00001; Rohilla M, 2008, PAK J MED SCI, V24, P609; STROMQVIST B, 1987, INJURY, V18, P423, DOI 10.1016/0020-1383(87)90298-1; YOUNG TB, 1985, J BONE JOINT SURG BR, V67, P373, DOI 10.1302/0301-620X.67B3.3997943	16	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 3	2012	345								e3172	10.1136/bmj.e3172	http://dx.doi.org/10.1136/bmj.e3172			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	985XF	22864305				2022-12-28	WOS:000307303100001
J	Chklovskii, DB; Bargmann, CI				Chklovskii, Dmitri B.; Bargmann, Cornelia I.			The Mind of a Male?	SCIENCE			English	Editorial Material									[Chklovskii, Dmitri B.] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Bargmann, Cornelia I.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA	Howard Hughes Medical Institute; Howard Hughes Medical Institute; Rockefeller University	Chklovskii, DB (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA 20147 USA.	chklovskiid@janelia.hhmi.org; cori@mail.rockefeller.edu		Bargmann, Cornelia/0000-0002-8484-0618	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Jarrell TA, 2012, SCIENCE, V337, P437, DOI 10.1126/science.1221762; Lee KH, 2007, CURR BIOL, V17, P1858, DOI 10.1016/j.cub.2007.10.015; LIU KS, 1995, NEURON, V14, P79, DOI 10.1016/0896-6273(95)90242-2; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Newman M.E.J., 2010, NETWORKS INTRO; Reigl M, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-25; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Sporns O, 2004, PLOS BIOL, V2, P1910, DOI 10.1371/journal.pbio.0020369; Varshney LR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001066; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	10	0	0	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 27	2012	337	6093					416	417		10.1126/science.1225853	http://dx.doi.org/10.1126/science.1225853			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979FS	22837511				2022-12-28	WOS:000306802300025
J	Zhou, Q; Bachtrog, D				Zhou, Qi; Bachtrog, Doris			Sex-Specific Adaptation Drives Early Sex Chromosome Evolution in Drosophila	SCIENCE			English	Article							Y-CHROMOSOME; X-CHROMOSOMES; NEO-Y; MIRANDA; DEGENERATION; PATTERNS; GENES	Most species' sex chromosomes are derived from ancient autosomes and show few signatures of their origins. We studied the sex chromosomes of Drosophila miranda, where a neo-Y chromosome originated only approximately 1 million years ago. Whole-genome and transcriptome analysis reveals massive degeneration of the neo-Y, that male-beneficial genes on the neo-Y are more likely to undergo accelerated protein evolution, and that neo-Y genes evolve biased expression toward male-specific tissues-the shrinking gene content of the neo-Y becomes masculinized. In contrast, although older X chromosomes show a paucity of genes expressed in male tissues, neo-X genes highly expressed in male-specific tissues undergo increased rates of protein evolution if haploid in males. Thus, the response to sex-specific selection can shift at different stages of X differentiation, resulting in masculinization or demasculinization of the X-chromosomal gene content.	[Zhou, Qi; Bachtrog, Doris] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Bachtrog, D (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	dbachtrog@berkeley.edu	Zhou, Qi/D-3469-2014	Zhou, Qi/0000-0002-7419-2047	NIH [R01GM076007, R01GM093182]; Packard Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076007, R01GM093182] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Packard Fellowship(The David & Lucile Packard Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Nielsen, M. Eisen, X. Xun, and L. Tian for help and discussion. This work was funded by NIH grants (R01GM076007 and R01GM093182) and a Packard Fellowship to D. B. All DNA/RNA-seq reads are deposited at www.ncbi.nlm.nih.gov/sra under accession no. SRA048115. The genome assembly and annotation is available at the National Center for Biotechnology Information under BioProject ID PRJNA77213.	Bachtrog D, 2004, NAT GENET, V36, P518, DOI 10.1038/ng1347; Bachtrog D, 2003, GENETICS, V165, P1221; Bachtrog D, 2003, NAT GENET, V34, P215, DOI 10.1038/ng1164; Bachtrog D, 2002, NATURE, V416, P323, DOI 10.1038/416323a; Bachtrog D, 2008, MOL BIOL EVOL, V25, P617, DOI 10.1093/molbev/msn020; Bachtrog D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r30; Bachtrog D, 2010, CURR BIOL, V20, P1476, DOI 10.1016/j.cub.2010.06.076; Betran E, 2002, GENOME RES, V12, P1854, DOI 10.1101/gr.6049; Bull J.J., 1983, EVOLUTION SEX DETERM; Carvalho AB, 2005, SCIENCE, V307, P108, DOI 10.1126/science.1101675; CHARLESWORTH B, 1987, AM NAT, V130, P113, DOI 10.1086/284701; Charlesworth B, 2000, PHILOS T R SOC B, V355, P1563, DOI 10.1098/rstb.2000.0717; Huxley J, 1940, NEW SYSTEMATICS, P185; Innocenti P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000335; Koerich LB, 2008, NATURE, V456, P949, DOI 10.1038/nature07463; Kondrashov FA, 2004, TRENDS GENET, V20, P287, DOI 10.1016/j.tig.2004.05.001; LIFSCHYTZ E, 1972, P NATL ACAD SCI USA, V69, P182, DOI 10.1073/pnas.69.1.182; Marin I, 1996, NATURE, V383, P160, DOI 10.1038/383160a0; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Steinemann M, 1998, GENETICA, V102-3, P409, DOI 10.1023/A:1017058119760; STEINEMANN M, 1993, P NATL ACAD SCI USA, V90, P5737, DOI 10.1073/pnas.90.12.5737; Sturgill D, 2007, NATURE, V450, P238, DOI 10.1038/nature06330; Vicoso B, 2006, NAT REV GENET, V7, P645, DOI 10.1038/nrg1914; Zhang YE, 2010, GENOME RES, V20, P1526, DOI 10.1101/gr.107334.110	24	120	122	2	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2012	337	6092					341	345		10.1126/science.1225385	http://dx.doi.org/10.1126/science.1225385			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975WQ	22822149	Green Accepted			2022-12-28	WOS:000306542600051
J	Broz, P; Ruby, T; Belhocine, K; Bouley, DM; Kayagaki, N; Dixit, VM; Monack, DM				Broz, Petr; Ruby, Thomas; Belhocine, Kamila; Bouley, Donna M.; Kayagaki, Nobuhiko; Dixit, Vishva M.; Monack, Denise M.			Caspase-11 increases susceptibility to Salmonella infection in the absence of caspase-1	NATURE			English	Article							INFLAMMASOME RECEPTORS; HOST-DEFENSE; INTERLEUKIN-1-BETA; ACTIVATION; TYPHIMURIUM; FLAGELLIN; NEUTROPHILS; SECRETION; ADAPTERS; FAMILY	Inflammasomes are cytosolic multiprotein complexes assembled by intracellular nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs) and they initiate innate immune responses to invading pathogens and danger signals by activating caspase-1 (ref. 1). Caspase-1 activation leads to the maturation and release of the pro-inflammatory cytokines interleukin (IL)-1 beta and IL-18, as well as lytic inflammatory cell death known as pyroptosis(2). Recently, a new non-canonical inflammasome was described that activates caspase-11, a pro-inflammatory caspase required for lipopolysaccharide-induced lethality(3). This study also highlighted that previously generated caspase-1 knockout mice lack a functional allele of Casp11 (also known as Casp4), making them functionally Casp1 Casp11 double knockouts(3-6). Previous studies have shown that these mice are more susceptible to infections with microbial pathogens(1), including the bacterial pathogen Salmonella enterica serovar Typhimurium (S. typhimurium)(7,8), but the individual contributions of caspase-1 and caspase-11 to this phenotype are not known. Here we show that non-canonical caspase-11 activation contributes to macrophage death during S. typhimurium infection. Toll-like receptor 4 (TLR4)-dependent and TIR-domaincontaining adaptor-inducing interferon-beta (TRIF)-dependent interferon-beta production is crucial for caspase-11 activation in macrophages, but is only partially required for pro-caspase-11 expression, consistent with the existence of an interferon-inducible activator of caspase-11. Furthermore, Casp1(-/-) mice were significantly more susceptible to infection with S. typhimurium than mice lacking both pro-inflammatory caspases (Casp1(-/-) Casp11(-/-)). This phenotype was accompanied by higher bacterial counts, the formation of extracellular bacterial microcolonies in the infected tissue and a defect in neutrophil-mediated clearance. These results indicate that caspase-11-dependent cell death is detrimental to the host in the absence of caspase-1-mediated innate immunity, resulting in extracellular replication of a facultative intracellular bacterial pathogen.	[Broz, Petr; Ruby, Thomas; Belhocine, Kamila; Monack, Denise M.] Stanford Univ, Dept Microbiol & Immunol, Stanford Sch Med, Stanford, CA 94305 USA; [Bouley, Donna M.] Stanford Univ, Dept Comparat Med, Stanford Sch Med, Stanford, CA 94305 USA; [Kayagaki, Nobuhiko; Dixit, Vishva M.] Genentech Inc, San Francisco, CA 94080 USA	Stanford University; Stanford University; Roche Holding; Genentech	Monack, DM (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Stanford Sch Med, Stanford, CA 94305 USA.	dmonack@stanford.edu	Broz, Petr/AAC-7940-2019; dixit, vishva m/A-4496-2012	Broz, Petr/0000-0002-2334-7790; dixit, vishva m/0000-0001-6983-0326; Monack, Denise/0000-0003-3804-2209	National Institute of Allergy and Infectious Diseases (NIAID) [AI095396, AI08972]; Stanford Digestive Disease Center (DDC) pilot grant; Human Frontiers in Science Program (HFSP) [LT000636/2009-L]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI008972, R01AI095396, R01AI089722] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Stanford Digestive Disease Center (DDC) pilot grant; Human Frontiers in Science Program (HFSP)(Human Frontier Science Program); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Dong, M. Wong, P. Chu and H. Matthew for technical support, G. Barton for Tlr4<SUP>-/-</SUP> and Tlr2<SUP>-/-</SUP> mice, and all members of the Monack laboratory for discussions and help with animal experiments. This work was supported by awards AI095396 and AI08972 from the National Institute of Allergy and Infectious Diseases (NIAID) to D. M. M., a Stanford Digestive Disease Center (DDC) pilot grant to P. B. and a long-term fellowship (LT000636/2009-L) from the Human Frontiers in Science Program (HFSP) to P.B.	Akhter A, 2012, IMMUNITY; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Conlan JW, 1996, INFECT IMMUN, V64, P1043, DOI 10.1128/IAI.64.3.1043-1047.1996; Conlan JW, 1997, INFECT IMMUN, V65, P630, DOI 10.1128/IAI.65.2.630-635.1997; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Kang SJ, 2000, J CELL BIOL, V149, P613, DOI 10.1083/jcb.149.3.613; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Lamkanfi M, 2011, NAT REV IMMUNOL, V11, P213, DOI 10.1038/nri2936; Lara-Tejero M, 2006, J EXP MED, V203, P1407, DOI 10.1084/jem.20060206; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Monack DM, 2001, CELL MICROBIOL, V3, P825, DOI 10.1046/j.1462-5822.2001.00162.x; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Raupach B, 2006, INFECT IMMUN, V74, P4922, DOI 10.1128/IAI.00417-06; Schauvliege R, 2002, J BIOL CHEM, V277, P41624, DOI 10.1074/jbc.M207852200; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Valdez Y, 2009, CURR TOP MICROBIOL, V337, P93, DOI 10.1007/978-3-642-01846-6_4; Wang SY, 1996, J BIOL CHEM, V271, P20580, DOI 10.1074/jbc.271.34.20580; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	23	380	387	3	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2012	490	7419					288	+		10.1038/nature11419	http://dx.doi.org/10.1038/nature11419			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019IY	22895188	Green Accepted			2022-12-28	WOS:000309733300055
J	Gupta, RK; Jordan, MR; Sultan, BJ; Hill, A; Davis, DHJ; Gregson, J; Sawyer, AW; Hamers, RL; Ndembi, N; Pillay, D; Bertagnolio, S				Gupta, Ravindra K.; Jordan, Michael R.; Sultan, Binta J.; Hill, Andrew; Davis, Daniel H. J.; Gregson, John; Sawyer, Anthony W.; Hamers, Raph L.; Ndembi, Nicaise; Pillay, Deenan; Bertagnolio, Silvia			Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis	LANCET			English	Article							SUB-SAHARAN AFRICA; TRANSCRIPTASE INHIBITOR RESISTANCE; PUBLIC-HEALTH APPROACH; DRUG-RESISTANCE; VIRAL LOAD; THERAPY; MUTATIONS; SURVEILLANCE; PREVENTION; EMERGENCE	Background The emergence and spread of high levels of HIV-1 drug resistance in resource-limited settings where combination antiretroviral treatment has been scaled up could compromise the effectiveness of national HIV treatment programmes. We aimed to estimate changes in the prevalence of HIV-1 drug resistance in treatment-naive individuals with HIV since initiation of rollout in resource-limited settings. Methods We did a systematic search for studies and conference abstracts published between January, 2001, and July, 2011, and included additional data from the WHO HIV drug resistance surveillance programme. We assessed the prevalence of drug-resistance mutations in untreated individuals with respect to time since rollout in a series of random-effects meta-regression models. Findings Study-level data were available for 26 102 patients from sub-Saharan Africa, Asia, and Latin America. We recorded no difference between chronic and recent infection on the prevalence of one or more drug-resistance mutations for any region. East Africa had the highest estimated rate of increase at 29% per year (95% CI 15 to 45; p=0.0001) since rollout, with an estimated prevalence of HIV-1 drug resistance at 8 years after rollout of 7.4% (4.3 to 12.7). We recorded an annual increase of 14% (0% to 29%; p=0.054) in southern Africa and a non-significant increase of 3% (-0.9 to 16; p=0.618) in west and central Africa. There was no change in resistance over time in Latin America, and because of much country-level heterogeneity the meta-regression analysis was not appropriate for Asia. With respect to class of antiretroviral, there were substantial increases in resistance to non-nucleoside reverse transcriptase inhibitors (NNRTI) in east Africa (36% per year [21 to 52]; p<0.0001) and southern Africa (23% per year [7 to 42]; p=0.0049). No increase was noted for the other drug classes in any region. Interpretation Our findings suggest a significant increase in prevalence of drug resistance over time since antiretroviral rollout in regions of sub-Saharan Africa; this rise is driven by NNRTI resistance in studies from east and southern Africa. The findings are of concern and draw attention to the need for enhanced surveillance and drug-resistance prevention efforts by national HIV treatment programmes. Nevertheless, estimated levels, although increasing, are not unexpected in view of the large expansion of antiretroviral treatment coverage seen in low-income and middle-income countries-no changes in antiretroviral treatment guidelines are warranted at the moment.	[Gupta, Ravindra K.; Pillay, Deenan] UCL, Dept Infect, London, England; [Jordan, Michael R.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Sultan, Binta J.] Camden Provider Serv PCT, Mortimer Market Ctr, London, England; [Hill, Andrew] Univ Liverpool, Pharmacol Res Labs, Liverpool L69 3BX, Merseyside, England; [Davis, Daniel H. J.; Gregson, John] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Sawyer, Anthony W.] MetaVirology Ltd, London, England; [Hamers, Raph L.] Univ Amsterdam, Acad Med Ctr, PharmAccess Fdn, Amsterdam Inst Global Hlth & Dev, NL-1105 AZ Amsterdam, Netherlands; [Ndembi, Nicaise] Inst Human Virol, Abuja, Nigeria; [Bertagnolio, Silvia] WHO, HIV Dept, CH-1211 Geneva, Switzerland	University of London; University College London; Tufts University; University of Liverpool; University of Cambridge; University of Amsterdam; Academic Medical Center Amsterdam; World Health Organization	Bertagnolio, S (corresponding author), WHO, HIV Dept, CH-1211 Geneva, Switzerland.	bertagnolios@who.int	Gupta, Ravindra K/G-5529-2015; Davis, Daniel/F-9995-2012; NDEMBI, Nicaise/AAE-4383-2020	Gupta, Ravindra K/0000-0001-9751-1808; Davis, Daniel/0000-0002-1560-1955; Hamers, Raph/0000-0002-5007-7896	Bill & Melinda Gates Foundation [38180]; European Community [223131]; Wellcome Trust [WT093722MA, WT090661/Z/09/Z]; National Institutes of Health [K23 AI074423-05]; MRC; GlaxoSmithKline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI074423] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); European Community(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); GlaxoSmithKline(GlaxoSmithKline); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	SB is a staff member at WHO, but the views expressed in this paper do not necessarily represent the decisions or stated policies of WHO. This study largely funded by the Bill & Melinda Gates Foundation (grant number 38180 to the WHO), and funded in part by the European Community's Seventh Framework Programme (FP7/2007-2013) under the project "Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN)"-grant agreement number 223131. RKG and DD received funding from the Wellcome Trust (WT093722MA and WT090661/Z/09/Z, respectively), and MRJ from the National Institutes of Health (K23 AI074423-05). JG is funded by a joint MRC and GlaxoSmithKline industrial CASE studentship. We thank the ministries of health who have contributed data for this analysis.	Aghokeng AF, 2011, AIDS, V25, P2183, DOI 10.1097/QAD.0b013e32834bbbe9; Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; Bennett DE, 2008, ANTIVIR THER, V13, P25; Bennett DE, 2008, ANTIVIR THER, V13, P1; Bennett DE, 2012, CLIN INFECT DIS, V54, pS280, DOI 10.1093/cid/cis207; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Bertagnolio S, 2010, AIDS REV, V12, P195; Erali M, 2001, J CLIN MICROBIOL, V39, P2157, DOI 10.1128/JCM.39.6.2157-2165.2001; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Goodman DD, 2011, AIDS, V25, P325, DOI 10.1097/QAD.0b013e3283427dcb; Green H, 2008, JAIDS-J ACQ IMM DEF, V49, P196, DOI 10.1097/QAI.0b013e318185725f; Gupta R, 2011, 18 C RETR OPP INF BO; Gupta R, 2008, CLIN INFECT DIS, V47, P712, DOI 10.1086/590943; Gupta RK, 2009, LANCET INFECT DIS, V9, P409, DOI 10.1016/S1473-3099(09)70136-7; Hamers RL, 2012, CLIN INFECT DIS, V54, P1660, DOI 10.1093/cid/cis254; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Hamers RL, 2009, ANTIVIR THER, V14, P619; Hoffmann CJ, 2009, CLIN INFECT DIS, V49, P1928, DOI 10.1086/648444; Hosseinipour MC, 2009, AIDS, V23, P1127, DOI 10.1097/QAD.0b013e32832ac34e; Jahn A, 2008, LANCET, V371, P1603, DOI 10.1016/S0140-6736(08)60693-5; Jaynes ET, 1976, CONFIDENCE INTERVALS; Joint United Nations Programme on HIV/AIDS, 2012, TOG WE WILL END AIDS; Jordan MR, 2008, ANTIVIR THER, V13, P15; Li JZ, 2012, AIDS, V26, P185, DOI 10.1097/QAD.0b013e32834e9d7d; Miller MD, 2004, J INFECT DIS, V189, P837, DOI 10.1086/381784; Ndembi N, 2011, AIDS, V25, P905, DOI 10.1097/QAD.0b013e328346260f; Parkin N, 2012, CLIN INFECT DIS, V54, pS266, DOI 10.1093/cid/cir992; Price MA, 2011, AIDS RES HUM RETROV, V27, P5, DOI 10.1089/aid.2010.0030; Rangel HR, 2009, MEM I OSWALDO CRUZ, V104, P522, DOI 10.1590/S0074-02762009000300020; Sigaloff KC, 2012, AIDS RES HUM RETROVI; Stijnen T, 2010, STAT MED, V29, P3046, DOI 10.1002/sim.4040; Stuart A, 1994, KENDALLS ADV THEORY; UNAIDS, US GEN ASS SPEC SESS; von Wyl V, 2012, PLOS ONE IN PRESS; Von Wyl V, 2007, ARCH INTERN MED, V167, P1782, DOI 10.1001/archinte.167.16.1782; WHO, ANT THER HIV INF AD; Wittkop L, 2011, LANCET INFECT DIS, V377, P1580	37	257	270	1	42	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 6	2012	380	9849					1250	1258		10.1016/S0140-6736(12)61038-1	http://dx.doi.org/10.1016/S0140-6736(12)61038-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	020NG	22828485	Green Published			2022-12-28	WOS:000309817500032
J	Townsend, W; Linch, D				Townsend, William; Linch, David			Hodgkin's lymphoma in adults	LANCET			English	Article							STEM-CELL-TRANSPLANTATION; POSITRON-EMISSION-TOMOGRAPHY; INVOLVED-FIELD RADIOTHERAPY; HIGH-DOSE CHEMOTHERAPY; AUTOLOGOUS BONE-MARROW; PHASE-II TRIAL; LONG-TERM; 2 CYCLES; PROGNOSTIC SCORE; LIMITED-STAGE	Management of Hodgkin's lymphoma continues to develop. Outcomes for patients with favourable-risk, early-stage disease are excellent, and serial reductions in intensity of treatment have been made to retain the excellent prognosis while reducing the late effects of treatment. Prognosis is also very good in advanced-stage disease but the rate of relapse is higher than in early-stage disease, and the optimum first-line treatment is unclear. Workers are investigating the role of functional imaging to assess whether treatment can be tailored according to response, with the most intensive therapies reserved for patients predicted to have poor outcomes. In this Seminar we critically appraise the management of Hodgkin's lymphoma in early-stage disease, advanced-stage disease, and at relapse, with a focus on late effects of treatment.	[Townsend, William; Linch, David] UCL, Sch Med, Inst Canc, Dept Haematol, London WC1E 6BT, England	University of London; University College London; UCL Medical School	Linch, D (corresponding author), UCL, Sch Med, Inst Canc, Dept Haematol, 72 Huntley St, London WC1E 6BT, England.	d.linch@ucl.ac.uk		Townsend, William Mathew/0000-0003-3975-2448	Roche; Chugai; Lymphoma Research Trust; Cancer Research UK; Leukaemia and Lymphoma Research; National Institute for Health Research Biomedical Research Centre at University College London Hospitals	Roche(Roche Holding); Chugai; Lymphoma Research Trust; Cancer Research UK(Cancer Research UK); Leukaemia and Lymphoma Research; National Institute for Health Research Biomedical Research Centre at University College London Hospitals(General Electric)	DL has served on advisory boards for Roche and Millennium Pharmaceuticals, and has received travel grants from Roche and Chugai. WT declares that he has no conflicts of interest.; WT is a clinical lymphoma fellow at the Cancer Research UK and UCL Cancer Trials Centre and is funded by the Lymphoma Research Trust. DL is a National Institute for Health Research senior clinical fellow and receives funding from Cancer Research UK, the Lymphoma Research Trust, Leukaemia and Lymphoma Research, and the National Institute for Health Research Biomedical Research Centre at University College London Hospitals.	Al-Mansour M, 2010, J CLIN ONCOL, V28, P793, DOI 10.1200/JCO.2009.24.9516; Aleman BMP, 2007, INT J RADIAT ONCOL, V67, P19, DOI 10.1016/j.ijrobp.2006.08.041; Aleman BMP, 2003, NEW ENGL J MED, V348, P2396, DOI 10.1056/NEJMoa022628; Andre MPE, 2009, BLOOD, V114, P44, DOI 10.1182/blood.V114.22.97.97; Avigdor A, 2010, ANN ONCOL, V21, P126, DOI 10.1093/annonc/mdp271; Bauer K, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD007941, 10.1002/14651858.CD007941.pub2]; Baxi SS, 2010, CURR ONCOL REP, V12, P366, DOI 10.1007/s11912-010-0123-2; Behringer K, 2005, J CLIN ONCOL, V23, P7555, DOI 10.1200/JCO.2005.08.138; Behringer K, 2010, ANN ONCOL, V21, P2052, DOI 10.1093/annonc/mdq066; Bhatia S, 2003, J CLIN ONCOL, V21, P4386, DOI 10.1200/JCO.2003.11.059; Biasoli I, 2010, CANCER-AM CANCER SOC, V116, P631, DOI 10.1002/cncr.24819; Blum KA, 2007, LEUKEMIA LYMPHOMA, V48, P1313, DOI 10.1080/10428190701411458; Boll B, 2010, BRIT J HAEMATOL, V148, P480, DOI 10.1111/j.1365-2141.2009.07963.x; Bonadonna G, 2004, J CLIN ONCOL, V22, P2835, DOI 10.1200/JCO.2004.12.170; Borchmann P, 2010, HAEMATOL-HEMATOL J, V95, P473; Borchmann P, 2011, J CLIN ONCOL, V29, P4234, DOI 10.1200/JCO.2010.33.9549; Cancer Research UK, 2011, CANC STATS INC 2008; CANELLOS GP, 1992, NEW ENGL J MED, V327, P1478, DOI 10.1056/NEJM199211193272102; Cardonick E, 2004, LANCET ONCOL, V5, P283, DOI 10.1016/S1470-2045(04)01466-4; Carella AM, 2009, HAEMATOL-HEMATOL J, V94, P146, DOI 10.3324/haematol.13484; Cavalieri E, 2009, LEUKEMIA LYMPHOMA, V50, P1803, DOI 10.3109/10428190903254383; Cerci JJ, 2011, CL LYMPH MYELOM LEUK, V11, P314, DOI 10.1016/j.clml.2011.06.006; Cerci JJ, 2010, J NUCL MED, V51, P1337, DOI 10.2967/jnumed.109.073197; Chen R, 2010, BLOOD, V116, P283, DOI [10.1182/blood.v116, DOI 10.1182/BLOOD.V116]; Chen RC, 2010, J CLIN ONCOL, V28, P136, DOI 10.1200/JCO.2009.24.0945; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Chisesi T, 2011, J CLIN ONCOL, V29, P4227, DOI 10.1200/JCO.2010.30.9799; ClinicalTrials. gov, HD18 ADV STAG HODGK; Cote GM, 2011, CURR HEMATOL MALIG R, V6, P180, DOI 10.1007/s11899-011-0088-8; Dickinson M, 2009, BRIT J HAEMATOL, V147, P97, DOI 10.1111/j.1365-2141.2009.07837.x; Duggan DB, 2003, J CLIN ONCOL, V21, P607, DOI 10.1200/JCO.2003.12.086; Eghbali H, 2005, BLOOD, V106, P814; Eich HT, 2010, J CLIN ONCOL, V28, P4199, DOI 10.1200/JCO.2010.29.8018; Eichenauer DA, 2011, BLOOD, V118, P4363, DOI 10.1182/blood-2011-06-361055; El-Galaly TC, 2012, HAEMATOL-HEMATOL J, V97, P931, DOI 10.3324/haematol.2011.056010; Engert A, 2003, J CLIN ONCOL, V21, P3601, DOI 10.1200/JCO.2003.03.023; Engert A, 2007, J CLIN ONCOL, V25, P3495, DOI 10.1200/JCO.2006.07.0482; Engert A, 2012, LANCET, V379, P1791, DOI 10.1016/S0140-6736(11)61940-5; Engert A, 2010, NEW ENGL J MED, V363, P640, DOI 10.1056/NEJMoa1000067; Engert A, 2009, J CLIN ONCOL, V27, P4548, DOI 10.1200/JCO.2008.19.8820; Farrell K, 2011, HISTOPATHOLOGY, V58, P15, DOI 10.1111/j.1365-2559.2010.03705.x; Favier O, 2009, CANCER-AM CANCER SOC, V115, P1680, DOI 10.1002/cncr.24178; Federico M, 2003, J CLIN ONCOL, V21, P2320, DOI 10.1200/JCO.2003.11.103; Federico M, 2009, J CLIN ONCOL, V27, P805, DOI 10.1200/JCO.2008.17.0910; Ferme C, 2007, NEW ENGL J MED, V357, P1916, DOI 10.1056/NEJMoa064601; Franklin J, 2006, ANN ONCOL, V17, P1749, DOI 10.1093/annonc/mdl302; Franklin JG, 2005, COCHRANE DB SYST REV, V4; Gallamini A, 2011, ANN ONCOL, V22, P139; Gallamini A, 2007, J CLIN ONCOL, V25, P3746, DOI 10.1200/JCO.2007.11.6525; Gallamini A, 2011, BRIT J HAEMATOL, V152, P551, DOI 10.1111/j.1365-2141.2010.08485.x; Harel S, 2011, HAEMATOL-HEMATOL J, V96, P1692, DOI 10.3324/haematol.2011.045856; Hasenclever D, 1998, NEW ENGL J MED, V339, P1506, DOI 10.1056/NEJM199811193392104; Hawkes EA, 2012, LEUKEMIA LYMPHOMA, V53, P354, DOI 10.3109/10428194.2011.608455; Herbst C, 2011, COCHRANE DB SYST REV, V2; Hjalgrim H, 2001, LANCET, V358, P297, DOI 10.1016/S0140-6736(01)05498-8; Hodgson DC, 2007, J CLIN ONCOL, V25, P1489, DOI 10.1200/JCO.2006.09.0936; Hoskin PJ, 2009, J CLIN ONCOL, V27, P5390, DOI 10.1200/JCO.2009.23.3239; Howell SJ, 2009, BRIT J CANCER, V101, P582, DOI 10.1038/sj.bjc.6605215; Howell SJ, 2002, BRIT J HAEMATOL, V119, P408, DOI 10.1046/j.1365-2141.2002.03842.x; Hutchings M, 2006, BLOOD, V107, P52, DOI 10.1182/blood-2005-06-2252; Hutchings M, 2011, ANN ONCOL         S4, V22, P163; Hutchings M, 2006, HAEMATOLOGICA, V91, P482; Jackson C, 2010, ANN ONCOL, V21, P2061, DOI 10.1093/annonc/mdq063; Johnson PWM, 2010, J CLIN ONCOL, V28, P3352, DOI 10.1200/JCO.2009.26.0323; Johnson PWM, 2005, J CLIN ONCOL, V23, P9208, DOI 10.1200/JCO.2005.03.2151; Johnston PB, 2010, AM J HEMATOL, V85, P320, DOI 10.1002/ajh.21664; Josting A, 2002, J CLIN ONCOL, V20, P221, DOI 10.1200/JCO.20.1.221; Josting A, 2000, BLOOD, V96, P1280, DOI 10.1182/blood.V96.4.1280.h8001280_1280_1286; Josting A, 2005, J CLIN ONCOL, V23, P1522, DOI 10.1200/JCO.2005.05.022; Josting A, 2010, J CLIN ONCOL, V28, P5074, DOI 10.1200/JCO.2010.30.5771; Khan A, 2011, ANN ONCOL         S4, V22, P43; Kobe C, 2008, BLOOD, V112, P3989, DOI 10.1182/blood-2008-06-155820; Kuppers R, 2009, NAT REV CANCER, V9, P15, DOI 10.1038/nrc2542; Kuruvilla J, 2011, BLOOD, V117, P4208, DOI 10.1182/blood-2010-09-288373; Lavoie JC, 2005, BLOOD, V106, P1473, DOI 10.1182/blood-2004-12-4689; Levis A, 2004, CLIN LYMPHOMA, V5, P50, DOI 10.3816/CLM.2004.n.010; Levis A, 2004, ANN ONCOL, V15, P123, DOI 10.1093/annonc/mdh012; LINCH DC, 1993, LANCET, V341, P1051, DOI 10.1016/0140-6736(93)92411-L; MAUCH PM, 1993, CANCER-AM CANCER SOC, V71, P2062, DOI 10.1002/1097-0142(19930315)71:6<2062::AID-CNCR2820710622>3.0.CO;2-0; Mauz-Korholz C, 2007, CANCER-AM CANCER SOC, V110, P179, DOI 10.1002/cncr.22762; Meignan M, 2009, LEUKEMIA LYMPHOMA, V50, P1257, DOI 10.1080/10428190903040048; Meyer RM, 2012, NEW ENGL J MED, V366, P399, DOI 10.1056/NEJMoa1111961; Meyer RM, 2005, J CLIN ONCOL, V23, P4634, DOI 10.1200/JCO.2005.09.085; Morschhauser F, 2008, J CLIN ONCOL, V26, P5980, DOI 10.1200/JCO.2007.15.5887; Morton LM, 2006, BLOOD, V107, P265, DOI 10.1182/blood-2005-06-2508; Moskowitz CH, 2010, BRIT J HAEMATOL, V148, P890, DOI 10.1111/j.1365-2141.2009.08037.x; National Cancer Institute, SEER STAT FACT SHEET; National Comprehensive Cancer Network, NCCN CLIN PRACT GUID; Ng AK, 2002, J CLIN ONCOL, V20, P2101, DOI 10.1200/JCO.2002.08.021; Noordijk EM, 2006, J CLIN ONCOL, V24, P3128, DOI 10.1200/JCO.2005.05.2746; North London Cancer Network, N LOND CANC NETW NLC; Oki Y, 2008, CANCER-AM CANCER SOC, V112, P831, DOI 10.1002/cncr.23237; Peggs KS, 2007, BRIT J HAEMATOL, V139, P70, DOI 10.1111/j.1365-2141.2007.06759.x; Peggs KS, 2005, LANCET, V365, P1934, DOI 10.1016/S0140-6736(05)66659-7; Pereg D, 2007, HAEMATOLOGICA, V92, P1230, DOI 10.3324/haematol.11097; Press OW, 2001, J CLIN ONCOL, V19, P4238, DOI 10.1200/JCO.2001.19.22.4238; Proctor SJ, 2002, EUR J CANCER, V38, P795, DOI 10.1016/S0959-8049(02)00006-0; Proctor SJ, 2012, BLOOD, V119, P6005, DOI 10.1182/blood-2011-12-396556; Punnett A, 2010, SEMIN RADIAT ONCOL, V20, P30, DOI 10.1016/j.semradonc.2009.09.006; Rigacci L, 2007, ANN HEMATOL, V86, P897, DOI 10.1007/s00277-007-0356-9; Santoro A, 2000, J CLIN ONCOL, V18, P2615, DOI 10.1200/JCO.2000.18.13.2615; Sarina B, 2010, BLOOD, V115, P3671, DOI 10.1182/blood-2009-12-253856; Schmitz N, 2002, LANCET, V359, P2065, DOI 10.1016/S0140-6736(02)08938-9; Schulz H, 2008, BLOOD, V111, P109, DOI 10.1182/blood-2007-03-078725; Shenoy P, 2011, ADV HEMATOL, DOI DOI 10.1155/2011/725219]; Sieniawski M, 2008, BLOOD, V111, P71, DOI 10.1182/blood-2007-02-073544; Specht L, 1998, J CLIN ONCOL, V16, P830, DOI 10.1200/JCO.1998.16.3.830; Steidl C, 2011, J CLIN ONCOL, V29, P1812, DOI 10.1200/JCO.2010.32.8401; Straus DJ, 2004, BLOOD, V104, P3483, DOI 10.1182/blood-2004-04-1311; Sureda A, 2008, J CLIN ONCOL, V26, P455, DOI 10.1200/JCO.2007.13.2415; Swerdlow AJ, 2007, J NATL CANCER I, V99, P206, DOI 10.1093/jnci/djk029; Swerdlow AJ, 2011, J CLIN ONCOL, V29, P4096, DOI 10.1200/JCO.2011.34.8268; Swerdlow S, 2008, HODGKIN LYMPHOMA WHO; Tanaka PY, 2007, CLIN LYMPHOMA MYELOM, V7, P364, DOI 10.3816/CLM.2007.n.014; Terasawa T, 2009, J CLIN ONCOL, V27, P1906, DOI 10.1200/JCO.2008.16.0861; Tesch H, 1998, BLOOD, V92, P4560, DOI 10.1182/blood.V92.12.4560.424k07_4560_4567; Thomas J, 2007, HAEMATOL-HEMATOL J, V92, P27; Travis LB, 2005, JNCI-J NATL CANCER I, V97, P1428, DOI 10.1093/jnci/dji290; UK Clinical Research Network Study Portfolio UCRNP, 2011, PAIRED PIL ALL IMM R; UK Clinical Research Network Study Portfolio UCRNS, RATHL TRIAL; UK Clinical Research Nework Study Portfolio, RAPID TRIAL; van der Kaaij MAE, 2007, J CLIN ONCOL, V25, P2825, DOI 10.1200/JCO.2006.10.2020; Vermoolen MA, 2010, AM J HEMATOL, V85, P443, DOI 10.1002/ajh.21677; VIVIANI S, 1985, EUR J CANCER CLIN ON, V21, P601, DOI 10.1016/0277-5379(85)90088-4; Viviani S, 2011, NEW ENGL J MED, V365, P203, DOI 10.1056/NEJMoa1100340; Viviani S, 2010, LEUKEMIA LYMPHOMA, V51, P1251, DOI 10.3109/10428194.2010.486090; von Tresckow B, 2012, J CLIN ONCOL, V30, P907, DOI 10.1200/JCO.2011.38.5807; Xicoy B, 2007, HAEMATOLOGICA, V92, P191, DOI 10.3324/haematol.10479; Younes A, 2011, ANN ONCOL, V22, P138; Younes A, 2010, NEW ENGL J MED, V363, P1812, DOI 10.1056/NEJMoa1002965; Yung L, 2003, LANCET, V361, P943, DOI 10.1016/S0140-6736(03)12777-8; Zinzani PL, 2007, HAEMATOLOGICA, V92, P771, DOI 10.3324/haematol.10798	133	89	95	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 1	2012	380	9844					836	847		10.1016/S0140-6736(12)60035-X	http://dx.doi.org/10.1016/S0140-6736(12)60035-X			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	000OP	22835602	Bronze			2022-12-28	WOS:000308396300033
J	Hu, ZT; Hom, S; Kudze, T; Tong, XJ; Choi, S; Aramuni, G; Zhang, WQ; Kaplan, JM				Hu, Zhitao; Hom, Sabrina; Kudze, Tambudzai; Tong, Xia-Jing; Choi, Seungwon; Aramuni, Gayane; Zhang, Weiqi; Kaplan, Joshua M.			Neurexin and Neuroligin Mediate Retrograde Synaptic Inhibition in C. elegans	SCIENCE			English	Article							SPECTRUM DISORDERS; AUTISM; MATURATION; MUTATIONS; CELL	The synaptic adhesion molecules neurexin and neuroligin alter the development and function of synapses and are linked to autism in humans. Here, we found that Caenorhabditis elegans neurexin (NRX-1) and neuroligin (NLG-1) mediated a retrograde synaptic signal that inhibited neurotransmitter release at neuromuscular junctions. Retrograde signaling was induced in mutants lacking a muscle microRNA (miR-1) and was blocked in mutants lacking NLG-1 or NRX-1. Release was rapid and abbreviated when the retrograde signal was on, whereas release was slow and prolonged when retrograde signaling was blocked. The retrograde signal adjusted release kinetics by inhibiting exocytosis of synaptic vesicles (SVs) that are distal to the site of calcium entry. Inhibition of release was mediated by increased presynaptic levels of tomosyn, an inhibitor of SV fusion.	[Hu, Zhitao; Hom, Sabrina; Kudze, Tambudzai; Tong, Xia-Jing; Choi, Seungwon; Kaplan, Joshua M.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Hu, Zhitao; Hom, Sabrina; Tong, Xia-Jing; Choi, Seungwon; Kaplan, Joshua M.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Hom, Sabrina; Choi, Seungwon; Kaplan, Joshua M.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Aramuni, Gayane] Max Planck Inst Neurobiol, D-82152 Martinsried, Germany; [Zhang, Weiqi] Univ Munster, Dept Psychiat, D-48149 Munster, Germany	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Max Planck Society; University of Munster	Kaplan, JM (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	kaplan@molbio.mgh.harvard.edu		Choi, Seungwon/0000-0002-8644-3659; Hu, Zhitao/0000-0002-2948-3339	NSF; NIH [NS32196]; Simons Foundation for Autism Research [SF177948]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032196, R37NS032196] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation for Autism Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the following for strains, advice, reagents, and comments on the manuscript: C. elegans stock center, S. Mitani, S. Sassi, B. Seed, and members of the Kaplan and Ruvkun labs. This work was supported by an NSF predoctoral fellowship (S. H.) and by research grants to J.M.K. from the NIH (NS32196) and from the Simons Foundation for Autism Research (SF177948). Additional data described in the manuscript are presented in the supplementary materials.	Arnold PD, 2006, ARCH GEN PSYCHIAT, V63, P769, DOI 10.1001/archpsyc.63.7.769; Atluri PP, 1996, J NEUROSCI, V16, P5661; Bai JH, 2010, CELL, V143, P430, DOI 10.1016/j.cell.2010.09.024; Chen KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011115; Etherton M, 2011, P NATL ACAD SCI USA, V108, P13764, DOI 10.1073/pnas.1111093108; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Foss-Feig JH, 2010, EXP BRAIN RES, V203, P381, DOI 10.1007/s00221-010-2240-4; Futai K, 2007, NAT NEUROSCI, V10, P186, DOI 10.1038/nn1837; Gracheva EO, 2006, PLOS BIOL, V4, P1426, DOI 10.1371/journal.pbio.0040261; Hoon M, 2011, P NATL ACAD SCI USA, V108, P3053, DOI 10.1073/pnas.1006946108; Hunter JW, 2010, DIS MODEL MECH, V3, P366, DOI 10.1242/dmm.003442; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kattenstroth G, 2004, P NATL ACAD SCI USA, V101, P2607, DOI 10.1073/pnas.0308626100; Liu Q, 2005, J NEUROSCI, V25, P6745, DOI 10.1523/JNEUROSCI.1730-05.2005; McEwen JM, 2006, NEURON, V51, P303, DOI 10.1016/j.neuron.2006.06.025; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Novara F, 2010, CLIN GENET, V78, P471, DOI 10.1111/j.1399-0004.2010.01413.x; Roberts TPL, 2010, AUTISM RES, V3, P8, DOI 10.1002/aur.111; Simon DJ, 2008, CELL, V133, P903, DOI 10.1016/j.cell.2008.04.035; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Taniguchi H, 2007, J NEUROSCI, V27, P2815, DOI 10.1523/JNEUROSCI.0032-07.2007; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104; Wittenmayer N, 2009, P NATL ACAD SCI USA, V106, P13564, DOI 10.1073/pnas.0905819106	24	72	75	2	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 24	2012	337	6097					980	984		10.1126/science.1224896	http://dx.doi.org/10.1126/science.1224896			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992VI	22859820	Green Accepted			2022-12-28	WOS:000307807600049
J	Goedhals, D; Rossouw, I; Hallbauer, U; Mamabolo, M; de Oliveira, T				Goedhals, Dominique; Rossouw, Inez; Hallbauer, Ute; Mamabolo, Mitta; de Oliveira, Tulio			The tainted milk of human kindness	LANCET			English	Editorial Material							HIV; EXPOSURE; INFANTS		[Goedhals, Dominique; Rossouw, Inez; Mamabolo, Mitta] Univ Orange Free State, Natl Hlth Lab Serv, Dept Med Microbiol & Virol, ZA-9300 Bloemfontein, South Africa; [Hallbauer, Ute] Univ Orange Free State, Dept Pediat & Child Hlth, ZA-9300 Bloemfontein, South Africa; [de Oliveira, Tulio] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Mtubatuba, South Africa; [de Oliveira, Tulio] UCL, Res Dept Infect, Div Immun, London, England	University of the Free State; University of the Free State; University of Kwazulu Natal; University of London; University College London	Goedhals, D (corresponding author), Univ Orange Free State, Natl Hlth Lab Serv, Dept Med Microbiol & Virol, Box 339 G23, ZA-9300 Bloemfontein, South Africa.	gnvrdg@ufs.ac.za; tdeoliveira@africacentre.ac.za			Wellcome Trust [097410] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		de Oliveira T, 2006, NATURE, V444, P836, DOI 10.1038/444836a; Neveu D, 2011, CLIN INFECT DIS, V52, P819, DOI 10.1093/cid/ciq203; Richardson BA, 2008, CLIN INFECT DIS, V46, P289, DOI 10.1086/524748; Shisana O, 2008, AIDS CARE, V20, P755, DOI 10.1080/09540120701771705	4	8	8	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 18	2012	380	9842					702	702		10.1016/S0140-6736(12)60957-X	http://dx.doi.org/10.1016/S0140-6736(12)60957-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	991SE	22901892				2022-12-28	WOS:000307721000036
J	Kadauke, S; Udugama, MI; Pawlicki, JM; Achtman, JC; Jain, DP; Cheng, Y; Hardison, RC; Blobel, GA				Kadauke, Stephan; Udugama, Maheshi I.; Pawlicki, Jan M.; Achtman, Jordan C.; Jain, Deepti P.; Cheng, Yong; Hardison, Ross C.; Blobel, Gerd A.			Tissue-Specific Mitotic Bookmarking by Hematopoietic Transcription Factor GATA1	CELL			English	Article							LOCUS-CONTROL REGION; ZINC-FINGER PROTEIN; ACTIVE GENES; HISTONE H3; DYNAMIC CHANGES; LIVING CELLS; STEM-CELLS; CHROMATIN; MITOSIS; CHROMOSOMES	Tissue-specific transcription patterns are preserved throughout cell divisions to maintain lineage fidelity. We investigated whether transcription factor GATA1 plays a role in transmitting hematopoietic gene expression programs through mitosis when transcription is transiently silenced. Live-cell imaging revealed that a fraction of GATA1 is retained focally within mitotic chromatin. ChIP-seq of highly purified mitotic cells uncovered that key hematopoietic regulatory genes are occupied by GATA1 in mitosis. The GATA1 coregulators FOG1 and TAL1 dissociate from mitotic chromatin, suggesting that GATA1 functions as platform for their postmitotic recruitment. Mitotic GATA1 target genes tend to reactivate more rapidly upon entry into G1 than genes from which GATA1 dissociates. Mitosis-specific destruction of GATA1 delays reactivation selectively of genes that retain GATA1 during mitosis. These studies suggest a requirement of mitotic "bookmarking" by GATA1 for the faithful propagation of cell-type-specific transcription programs through cell division.	[Kadauke, Stephan; Udugama, Maheshi I.; Pawlicki, Jan M.; Achtman, Jordan C.; Blobel, Gerd A.] Childrens Hosp, Div Hematol, Philadelphia, PA 19104 USA; [Kadauke, Stephan; Blobel, Gerd A.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Jain, Deepti P.; Cheng, Yong; Hardison, Ross C.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Blobel, GA (corresponding author), Childrens Hosp, Div Hematol, Philadelphia, PA 19104 USA.	blobel@email.chop.edu	cheng, yong/I-4270-2012; Kadauke, Stephan/V-6197-2019; Hardison, Ross C/G-1142-2010	Hardison, Ross C/0000-0003-4084-7516; Udugama, Maheshi/0000-0003-0412-4142; Kadauke, Stephan/0000-0003-2996-8034	AHA predoctoral fellowship [90PRE2300139]; NIH [DK058044, DK054937, DK065806, HG005573]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK065806, R01DK058044, R01DK065806, R37DK058044, R01DK054937] Funding Source: NIH RePORTER	AHA predoctoral fellowship(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Alan Lau, Margaret Chou, Jordan Orange, Aline Disimone, Paul Gadue, Rena Zheng, Joanna Balcerek, Chris Thom, Ariel Yang, and Merav Socolovsky for technical assistance and advice; and Christopher Vakoc, Mitchell Weiss, Mitchell Lazar, and members of the laboratory for comments on the manuscript. This work was supported by an AHA predoctoral fellowship (90PRE2300139, S. K.), NIH grants DK058044 and DK054937 (G. A. B.), and DK065806 and HG005573 (R. C. H.). Author contributions: S. K., M. I. U., J.M.P., J.C.A. performed experiments; S. K., D.P.J., Y.C. performed computational analyses; S. K., R. C. H. and G. A. B. conceived the study and wrote the manuscript.	Aoto T, 2008, J BIOL CHEM, V283, P18905, DOI 10.1074/jbc.M709322200; Blobel GA, 2009, MOL CELL, V36, P970, DOI 10.1016/j.molcel.2009.12.001; Bonenfant D, 2007, MOL CELL PROTEOMICS, V6, P1917, DOI 10.1074/mcp.M700070-MCP200; Bruce K, 2005, NUCLEIC ACIDS RES, V33, P5633, DOI 10.1093/nar/gki874; Chang AN, 2002, P NATL ACAD SCI USA, V99, P9237, DOI 10.1073/pnas.142302099; Chen DY, 2005, J CELL BIOL, V168, P41, DOI 10.1083/jcb.200407182; Chen DY, 2002, MOL BIOL CELL, V13, P276, DOI 10.1091/mbc.01-10-0523; Cheng Y, 2009, GENOME RES, V19, P2172, DOI 10.1101/gr.098921.109; Christova R, 2002, NAT CELL BIOL, V4, P79, DOI 10.1038/ncb733; Delcuve GP, 2008, J CELL BIOCHEM, V105, P1, DOI 10.1002/jcb.21806; Dey A, 2000, MOL CELL BIOL, V20, P6537, DOI 10.1128/MCB.20.17.6537-6549.2000; Dey A, 2009, MOL BIOL CELL, V20, P4899, DOI 10.1091/mbc.E09-05-0380; Egli D, 2008, NAT REV MOL CELL BIO, V9, P505, DOI 10.1038/nrm2439; Elnitski L, 1997, J BIOL CHEM, V272, P369; Ferreira R, 2005, MOL CELL BIOL, V25, P1215, DOI 10.1128/MCB.25.4.1215-1227.2005; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Gottesfeld JM, 1997, TRENDS BIOCHEM SCI, V22, P197, DOI 10.1016/S0968-0004(97)01045-1; Grass JA, 2003, P NATL ACAD SCI USA, V100, P8811, DOI 10.1073/pnas.1432147100; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; HOLLOWAY SL, 1993, CELL, V73, P1393, DOI 10.1016/0092-8674(93)90364-V; Jing HI, 2008, MOL CELL, V29, P232, DOI 10.1016/j.molcel.2007.11.020; Johnson KD, 2007, BLOOD, V109, P5230, DOI 10.1182/blood-2007-02-072983; Kanno T, 2004, MOL CELL, V13, P33, DOI 10.1016/S1097-2765(03)00482-9; Kelly TK, 2010, MOL CELL, V39, P901, DOI 10.1016/j.molcel.2010.08.026; Komura JI, 2007, P NATL ACAD SCI USA, V104, P15741, DOI 10.1073/pnas.0702363104; Kouskouti A, 2005, EMBO J, V24, P347, DOI 10.1038/sj.emboj.7600516; Kruhlak MJ, 2001, J BIOL CHEM, V276, P38307; KUO MT, 1982, NUCLEIC ACIDS RES, V10, P4565, DOI 10.1093/nar/10.15.4565; Lecuyer E, 2004, EXP HEMATOL, V32, P11, DOI 10.1016/j.exphem.2003.10.010; Letting DL, 2004, P NATL ACAD SCI USA, V101, P476, DOI 10.1073/pnas.0306315101; Letting DL, 2003, MOL CELL BIOL, V23, P1334, DOI 10.1128/MCB.23.4.1334-1340.2003; MARTINEZBALBAS MA, 1995, CELL, V83, P29, DOI 10.1016/0092-8674(95)90231-7; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; McManus KJ, 2006, J BIOL CHEM, V281, P8888, DOI 10.1074/jbc.M505323200; Michelotti EF, 1997, NATURE, V388, P895, DOI 10.1038/42282; Munugalavadla V, 2005, MOL CELL BIOL, V25, P6747, DOI 10.1128/MCB.25.15.6747-6759.2005; Nichols KE, 2000, NAT GENET, V24, P266, DOI 10.1038/73480; Pal S, 2004, P NATL ACAD SCI USA, V101, P980, DOI 10.1073/pnas.0307612100; Pilon AM, 2011, BLOOD, V118, pE139, DOI 10.1182/blood-2011-05-355107; Pop R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000484; Porcher C, 1999, DEVELOPMENT, V126, P4603; PRESCOTT DM, 1962, EXP CELL RES, V26, P260, DOI 10.1016/0014-4827(62)90176-3; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Sarge KD, 2009, CELL CYCLE, V8, P818, DOI 10.4161/cc.8.6.7849; Sasaki K, 2009, P NATL ACAD SCI USA, V106, P16257, DOI 10.1073/pnas.0902150106; Segil N, 1996, GENE DEV, V10, P2389, DOI 10.1101/gad.10.19.2389; STAMATOYANNOPOULOS JA, 1995, EMBO J, V14, P106, DOI 10.1002/j.1460-2075.1995.tb06980.x; TAYLOR JH, 1960, ANN NY ACAD SCI, V90, P409, DOI 10.1111/j.1749-6632.1960.tb23259.x; Tripic T, 2009, BLOOD, V113, P2191, DOI 10.1182/blood-2008-07-169417; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; Valls E, 2005, J BIOL CHEM, V280, P42592, DOI 10.1074/jbc.M507407200; Varier RA, 2010, EMBO J, V29, P3967, DOI 10.1038/emboj.2010.261; Wechsler J, 2002, NAT GENET, V32, P148, DOI 10.1038/ng955; WEISS MJ, 1994, GENE DEV, V8, P1184, DOI 10.1101/gad.8.10.1184; Weiss MJ, 1997, MOL CELL BIOL, V17, P1642, DOI 10.1128/MCB.17.3.1642; Welch JJ, 2004, BLOOD, V104, P3136, DOI 10.1182/blood-2004-04-1603; Wu WS, 2011, GENOME RES, V21, P1659, DOI 10.1101/gr.125088.111; Xin L, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-31; Xing HY, 2008, NAT CELL BIOL, V10, P1318, DOI 10.1038/ncb1790; Xing HY, 2005, SCIENCE, V307, P421, DOI 10.1126/science.1106478; Yan JZ, 2006, MOL CELL BIOL, V26, P155, DOI 10.1128/MCB.26.1.155-168.2006; Yang ZY, 2008, MOL CELL BIOL, V28, P967, DOI 10.1128/MCB.01020-07; Young DW, 2007, P NATL ACAD SCI USA, V104, P3189, DOI 10.1073/pnas.0611419104; Young DW, 2007, NATURE, V445, P442, DOI 10.1038/nature05473; Zaidi SK, 2010, NAT REV GENET, V11, P583, DOI 10.1038/nrg2827; Zaidi SK, 2003, P NATL ACAD SCI USA, V100, P14852, DOI 10.1073/pnas.2533076100	67	160	162	0	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 17	2012	150	4					725	737		10.1016/j.cell.2012.06.038	http://dx.doi.org/10.1016/j.cell.2012.06.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	995IT	22901805	Bronze, Green Accepted			2022-12-28	WOS:000308002300008
J	Cai, WJ; Lengaigne, M; Borlace, S; Collins, M; Cowan, T; McPhaden, MJ; Timmermann, A; Power, S; Brown, J; Menkes, C; Ngari, A; Vincent, EM; Widlansky, MJ				Cai, Wenju; Lengaigne, Matthieu; Borlace, Simon; Collins, Matthew; Cowan, Tim; McPhaden, Michael J.; Timmermann, Axel; Power, Scott; Brown, Josephine; Menkes, Christophe; Ngari, Arona; Vincent, Emmanuel M.; Widlansky, Matthew J.			More extreme swings of the South Pacific convergence zone due to greenhouse warming	NATURE			English	Article							EL-NINO; CLIMATE-CHANGE; OSCILLATION; OCEAN; ATMOSPHERE; MORTALITY; FUTURE; SPCZ	The South Pacific convergence zone (SPCZ) is the Southern Hemisphere's most expansive and persistent rain band, extending from the equatorial western Pacific Ocean southeastward towards French Polynesia(1,2). Owing to its strong rainfall gradient, a small displacement in the position of the SPCZ causes drastic changes to hydroclimatic conditions and the frequency of extreme weather events-such as droughts, floods and tropical cyclones-experienced by vulnerable island countries in the region(1-7). The SPCZ position varies from its climatological mean location with the El Nino/Southern Oscillation (ENSO), moving a few degrees northward during moderate El Nino events and southward during La Nina events(2,5,6). During strong El Nino events, however, the SPCZ undergoes an extreme swing-by up to ten degrees of latitude toward the Equator-and collapses to a more zonally oriented structure(5) with commensurately severe weather impacts(5,8-11). Understanding changes in the characteristics of the SPCZ in a changing climate is therefore of broad scientific and socioeconomic interest. Here we present climate modelling evidence for a near doubling in the occurrences of zonal SPCZ events between the periods 1891-1990 and 1991-2090 in response to greenhouse warming, even in the absence of a consensus on how ENSO will change(12-14). We estimate the increase in zonal SPCZ events from an aggregation of the climate models in the Coupled Model Intercomparison Project phases 3 and 5 (CMIP3(15) and CMIP5) multi-model database that are able to simulate such events. The change is caused by a projected enhanced equatorial warming in the Pacific(16) and may lead to more frequent occurrences of extreme events across the Pacific island nations most affected by zonal SPCZ events.	[Cai, Wenju; Lengaigne, Matthieu; Cowan, Tim] CSIRO Marine & Atmospher Res, Aspendale, Vic 3195, Australia; [Lengaigne, Matthieu; Vincent, Emmanuel M.] UPMC, LOCEAN, F-75252 Paris 05, France; [Collins, Matthew] Univ Exeter, Coll Engn Math & Phys Sci, Exeter EX4 4QF, Devon, England; [Collins, Matthew] Met Off Hadley Ctr, Exeter EX1 3PB, Devon, England; [McPhaden, Michael J.] NOAA, Pacific Marine Environm Lab, Seattle, WA 98115 USA; [Timmermann, Axel] Univ Hawaii, SOEST, Dept Oceanog, IPRC, Honolulu, HI 96822 USA; [Power, Scott; Brown, Josephine] Bur Meteorol, Ctr Australian Weather & Climate Res, Melbourne, Vic 3001, Australia; [Menkes, Christophe] Inst Rech Dev, Noumea 98848, New Caledonia; [Ngari, Arona] Meteorol Serv, Avarua, Rarotonga, Cook Islands; [Widlansky, Matthew J.] Univ Hawaii Manoa, Int Pacific Res Ctr, Honolulu, HI 96822 USA	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; University of Exeter; Met Office - UK; Hadley Centre; National Oceanic Atmospheric Admin (NOAA) - USA; University of Hawaii System; Bureau of Meteorology - Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Institut de Recherche pour le Developpement (IRD); University of Hawaii System; University of Hawaii Manoa	Cai, WJ (corresponding author), CSIRO Marine & Atmospher Res, Aspendale, Vic 3195, Australia.	wenju.cai@csiro.au	menkes, christophe/X-6073-2019; McPhaden, Michael J/D-9799-2016; Cowan, Timothy D/AAA-7372-2019; Timmermann, Axel/Y-2799-2019; Lengaigne, Matthieu/K-4345-2013; Vincent, Emmanuel/J-9855-2012; Power, Scott Brendan/AAF-3370-2019; Cowan, Tim/A-5797-2013; Collins, Matthew/F-8473-2011; Cai, Wenju/C-2864-2012; Timmermann, Axel/F-4977-2011; menkes, christophe/H-9085-2016	menkes, christophe/0000-0002-1457-9696; McPhaden, Michael J/0000-0002-8423-5805; Cowan, Timothy D/0000-0002-8376-4879; Timmermann, Axel/0000-0003-0657-2969; Lengaigne, Matthieu/0000-0002-0044-036X; Vincent, Emmanuel/0000-0003-4529-5490; Power, Scott Brendan/0000-0002-9596-4368; Collins, Matthew/0000-0003-3785-6008; Cai, Wenju/0000-0001-6520-0829; Timmermann, Axel/0000-0003-0657-2969; menkes, christophe/0000-0002-1457-9696; Brown, Josephine/0000-0002-1100-7457	Australian Climate Change Science Program; CSIRO Office of Chief Executive Science Leader programme; Pacific-Australia Climate Change Science and Adaptation Planning Program; Office of Science (BER) US Department of Energy [DE-FG02-07ER64469]; US National Science Foundation [1049219]; Japan Agency for Marine-Earth Science and Technology (JAMSTEC); NOAA; CSIRO; Institut de Recherche pour le Developpement (IRD);  [3830]	Australian Climate Change Science Program; CSIRO Office of Chief Executive Science Leader programme; Pacific-Australia Climate Change Science and Adaptation Planning Program; Office of Science (BER) US Department of Energy(United States Department of Energy (DOE)); US National Science Foundation(National Science Foundation (NSF)); Japan Agency for Marine-Earth Science and Technology (JAMSTEC); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Institut de Recherche pour le Developpement (IRD); 	This work was supported by the Australian Climate Change Science Program, CSIRO Office of Chief Executive Science Leader programme, and the Pacific-Australia Climate Change Science and Adaptation Planning Program. A. T. and M.J.W. were supported by the Office of Science (BER) US Department of Energy, grant DE-FG02-07ER64469, the US National Science Foundation under grant 1049219 and by the Japan Agency for Marine-Earth Science and Technology (JAMSTEC). M.J.M. was supported by NOAA and by CSIRO as a visiting scholar. M. L., C. M. and E. M. V. were supported by the Institut de Recherche pour le Developpement (IRD). This is PMEL contribution number 3830.	Adler RF, 2003, J HYDROMETEOROL, V4, P1147, DOI 10.1175/1525-7541(2003)004<1147:TVGPCP>2.0.CO;2; Ashok K, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050232; Ashok K, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003798; Austin PC, 2004, AM STAT, V58, P131, DOI 10.1198/0003130043277; Barnett J, 2011, REG ENVIRON CHANGE, V11, pS229, DOI 10.1007/s10113-010-0160-2; Brown JR, 2012, CLIM DYNAM, V39, P1, DOI 10.1007/s00382-011-1192-0; Cane MA, 1997, SCIENCE, V275, P957, DOI 10.1126/science.275.5302.957; Collins M, 2010, NAT GEOSCI, V3, P391, DOI 10.1038/NGEO868; Folland CK, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014201; GLYNN PW, 1984, ENVIRON CONSERV, V11, P133, DOI 10.1017/S0376892900013825; Guilyardi E, 2009, B AM METEOROL SOC, V90, P325, DOI 10.1175/2008BAMS2387.1; Hennessy K., 2011, CLIMATE CHANGE PACIF, V1; Hennessy K., 2011, CLIMATE CHANGE PACIF, V2; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; KILADIS GN, 1989, J CLIMATE, V2, P1185, DOI 10.1175/1520-0442(1989)002<1185:OOTSPC>2.0.CO;2; Kumar VV, 2006, ATMOS SCI LETT, V7, P53, DOI 10.1002/asl.131; Lehodey P, 1997, NATURE, V389, P715, DOI 10.1038/39575; Lengaigne M, 2006, J CLIMATE, V19, P1850, DOI 10.1175/JCLI3706.1; Liu ZY, 2005, J CLIMATE, V18, P4684, DOI 10.1175/JCLI3579.1; Lorenz E. N., 1956, EMPIRICAL ORTHOGONAL; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Mumby PJ, 2001, MAR BIOL, V139, P183; Salinger MJ, 2001, INT J CLIMATOL, V21, P1705, DOI 10.1002/joc.691; Spencer H, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021619; Takahashi K, 2007, J CLIMATE, V20, P5696, DOI 10.1175/2007JCLI1656.1; Timmermann A, 2010, J CLIMATE, V23, P4429, DOI 10.1175/2010JCLI3519.1; Vecchi GA, 2006, NATURE, V441, P73, DOI 10.1038/nature04744; VINCENT DG, 1994, MON WEATHER REV, V122, P1949, DOI 10.1175/1520-0493(1994)122<1949:TSPCZA>2.0.CO;2; Vincent EM, 2011, CLIM DYNAM, V36, P1881, DOI 10.1007/s00382-009-0716-3; Xie SP, 2010, J CLIMATE, V23, P966, DOI 10.1175/2009JCLI3329.1; Yeh SW, 2009, NATURE, V461, P511, DOI 10.1038/nature08316	31	142	145	2	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2012	488	7411					365	+		10.1038/nature11358	http://dx.doi.org/10.1038/nature11358			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OS	22895343				2022-12-28	WOS:000307501000039
J	Georgianna, DR; Mayfield, SP				Georgianna, D. Ryan; Mayfield, Stephen P.			Exploiting diversity and synthetic biology for the production of algal biofuels	NATURE			English	Review							TECHNOECONOMIC ANALYSIS; BIODIESEL PRODUCTION; MASS CULTIVATION; MICROALGAE; TEMPERATURE; BIOMASS; OIL; PHOTOSYNTHESIS; BIOSYNTHESIS; ACCUMULATION	Modern life is intimately linked to the availability of fossil fuels, which continue to meet the world's growing energy needs even though their use drives climate change, exhausts finite reserves and contributes to global political strife. Biofuels made from renewable resources could be a more sustainable alternative, particularly if sourced from organisms, such as algae, that can be farmed without using valuable arable land. Strain development and process engineering are needed to make algal biofuels practical and economically viable.	[Georgianna, D. Ryan; Mayfield, Stephen P.] Univ Calif San Diego, Div Biol Sci, San Diego Ctr Algae Biotechnol SD CAB, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Mayfield, SP (corresponding author), Univ Calif San Diego, Div Biol Sci, San Diego Ctr Algae Biotechnol SD CAB, 9500 Gilman Dr, La Jolla, CA 92093 USA.	smayfield@ucsd.edu			US Department of Energy [DE-EE-0003373]; California Energy Commission Initiative for Large Molecule Sustainable Fuels [500-10-039]	US Department of Energy(United States Department of Energy (DOE)); California Energy Commission Initiative for Large Molecule Sustainable Fuels	This work was supported by the US Department of Energy, grant number DE-EE-0003373, and the California Energy Commission Initiative for Large Molecule Sustainable Fuels, Agreement Number: 500-10-039.	Amer L, 2011, BIORESOURCE TECHNOL, V102, P9350, DOI 10.1016/j.biortech.2011.08.010; Amin S, 2009, ENERG CONVERS MANAGE, V50, P1834, DOI 10.1016/j.enconman.2009.03.001; Andrianov V, 2010, PLANT BIOTECHNOL J, V8, P277, DOI 10.1111/j.1467-7652.2009.00458.x; Atsumi S, 2009, NAT BIOTECHNOL, V27, P1177, DOI 10.1038/nbt.1586; Bechet Q, 2010, ENVIRON SCI TECHNOL, V44, P2197, DOI 10.1021/es903214u; Beckmann J, 2009, J BIOTECHNOL, V142, P70, DOI 10.1016/j.jbiotec.2009.02.015; Boyle NR, 2012, J BIOL CHEM, V287, P15811, DOI 10.1074/jbc.M111.334052; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; 배진희, 2011, Fisheries and Aquatic Sciences, V14, P323; Butterwick C, 2005, FRESHWATER BIOL, V50, P291; Cardol P, 2008, P NATL ACAD SCI USA, V105, P7881, DOI 10.1073/pnas.0802762105; Castruita M, 2011, PLANT CELL, V23, P1273, DOI 10.1105/tpc.111.084400; Chen H, 2004, P NATL ACAD SCI USA, V101, P5048, DOI 10.1073/pnas.0401416101; Chen YH, 2011, BIOTECHNOL LETT, V33, P1973, DOI 10.1007/s10529-011-0672-y; Chowdhury R, 2012, BIORESOURCE TECHNOL, V108, P102, DOI 10.1016/j.biortech.2011.12.099; Christenson L, 2011, BIOTECHNOL ADV, V29, P686, DOI 10.1016/j.biotechadv.2011.05.015; Coleman AW, 1997, J MOL EVOL, V45, P168, DOI 10.1007/PL00006217; Darzins A., 2010, IEA BIOENERGY TASK, V39; Davis R, 2011, APPL ENERG, V88, P3524, DOI 10.1016/j.apenergy.2011.04.018; Doucha J, 2012, J APPL PHYCOL, V24, P35, DOI 10.1007/s10811-010-9643-2; Duan PG, 2011, BIORESOURCE TECHNOL, V102, P1899, DOI 10.1016/j.biortech.2010.08.013; Eroglu E, 2010, BIORESOURCE TECHNOL, V101, P2359, DOI 10.1016/j.biortech.2009.11.043; Gachon CMM, 2010, TRENDS PLANT SCI, V15, P633, DOI 10.1016/j.tplants.2010.08.005; Genkov T, 2010, J BIOL CHEM, V285, P19833, DOI 10.1074/jbc.M110.124230; Gilbert N, 2009, NATURE, V461, P716, DOI 10.1038/461716a; Gonzalez-Ballester D, 2010, PLANT CELL, V22, P2058, DOI 10.1105/tpc.109.071167; Grabski K, 2008, J APPL PHYCOL, V20, P323, DOI 10.1007/s10811-007-9260-x; Griffiths MJ, 2009, J APPL PHYCOL, V21, P493, DOI 10.1007/s10811-008-9392-7; Guschina IA, 2006, PROG LIPID RES, V45, P160, DOI 10.1016/j.plipres.2006.01.001; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Jaycor, 1985, REV EV IMM ALG SYST; Johnson X, 2011, PLANT MOL BIOL, V76, P397, DOI 10.1007/s11103-011-9783-z; Keasling JD, 2008, NAT BIOTECHNOL, V26, P298, DOI 10.1038/nbt0308-298; Khoo HH, 2011, BIORESOURCE TECHNOL, V102, P5800, DOI 10.1016/j.biortech.2011.02.055; Kilian O, 2011, P NATL ACAD SCI USA, V108, P21265, DOI 10.1073/pnas.1105861108; Knothe G, 2009, ENERG ENVIRON SCI, V2, P759, DOI 10.1039/b903941d; La Russa M, 2012, J BIOTECHNOL; Lan EI, 2012, P NATL ACAD SCI USA, V109, P6018, DOI 10.1073/pnas.1200074109; Larkum AWD, 2012, TRENDS BIOTECHNOL, V30, P198, DOI 10.1016/j.tibtech.2011.11.003; Lee JT, 2009, APPL ENVIRON MICROB, V75, P1703, DOI 10.1128/AEM.02081-08; Legrand C, 2003, PHYCOLOGIA, V42, P406, DOI 10.2216/i0031-8884-42-4-406.1; Leonard A, 2011, CHEM SOC REV, V40, P860, DOI 10.1039/c0cs00024h; Levine RB, 2010, ENERG FUEL, V24, P5235, DOI 10.1021/ef1008314; Li Q, 2012, METAB ENG, V14, P1, DOI 10.1016/j.ymben.2011.12.003; Lohr M, 2012, PLANT SCI, V185, P9, DOI 10.1016/j.plantsci.2011.07.018; Luo Y, 2010, FUEL PROCESS TECHNOL, V91, P613, DOI 10.1016/j.fuproc.2010.01.007; Melis A, 2000, PLANT PHYSIOL, V122, P127, DOI 10.1104/pp.122.1.127; Miller R, 2010, PLANT PHYSIOL, V154, P1737, DOI 10.1104/pp.110.165159; MIYAMOTO K, 1979, APPL ENVIRON MICROB, V37, P454, DOI 10.1128/AEM.37.3.454-458.1979; Montagnes DJS, 2008, AQUAT MICROB ECOL, V53, P211, DOI 10.3354/ame01245; Moose SP, 2008, PLANT PHYSIOL, V147, P969, DOI 10.1104/pp.108.118232; Moseley JL, 2002, EMBO J, V21, P6709, DOI 10.1093/emboj/cdf666; Murphy CF, 2011, ENVIRON SCI TECHNOL, V45, P5861, DOI 10.1021/es200109z; Mutanda T, 2011, BIORESOURCE TECHNOL, V102, P57, DOI 10.1016/j.biortech.2010.06.077; Natrah FMI, 2011, AQUACULTURE, V317, P53, DOI 10.1016/j.aquaculture.2011.04.038; NYSE Euronext, 2012, LOND INT FIN FUT OPT; O'Neill BM, 2012, NUCLEIC ACIDS RES, V40, P2782, DOI 10.1093/nar/gkr1008; Ort DR, 2011, PLANT PHYSIOL, V155, P79, DOI 10.1104/pp.110.165886; Pohnert G, 2007, TRENDS ECOL EVOL, V22, P198, DOI 10.1016/j.tree.2007.01.005; Radakovits R, 2010, EUKARYOT CELL, V9, P486, DOI 10.1128/EC.00364-09; Rajamani S, 2008, MOL PLANT MICROBE IN, V21, P1184, DOI 10.1094/MPMI-21-9-1184; Ras M, 2011, BIORESOURCE TECHNOL, V102, P200, DOI 10.1016/j.biortech.2010.06.146; Rodolfi L, 2009, BIOTECHNOL BIOENG, V102, P100, DOI 10.1002/bit.22033; Rosch C, 2012, BIORESOURCE TECHNOL, V107, P191, DOI 10.1016/j.biortech.2011.12.016; Savage N, 2011, NATURE, V474, pS15, DOI 10.1038/474S015a; Scott SA, 2010, CURR OPIN BIOTECH, V21, P277, DOI 10.1016/j.copbio.2010.03.005; Searchinger T, 2008, SCIENCE, V319, P1238, DOI 10.1126/science.1151861; Shen Y, 2009, T ASABE, V52, P1275, DOI 10.13031/2013.27771; Shirvani T, 2011, ENERG ENVIRON SCI, V4, P3773, DOI 10.1039/c1ee01791h; STITT M, 1994, PLANT CELL ENVIRON, V17, P465, DOI 10.1111/j.1365-3040.1994.tb00144.x; Sukenik A, 2009, AQUAT MICROB ECOL, V56, P297, DOI 10.3354/ame01309; Teplitski M, 2004, PLANT PHYSIOL, V134, P137, DOI 10.1104/pp.103.029918; Tirichine L, 2011, PLANT J, V66, P45, DOI 10.1111/j.1365-313X.2011.04540.x; U.S. Department of Energy, 2010, NAT ALG BIOF TECHN R; US Department of Energy, 2010, SOL INT BIOR DIS FUE; VANETTEN JL, 1983, SCIENCE, V219, P994, DOI 10.1126/science.219.4587.994; Vardi A, 2006, PLOS BIOL, V4, P411, DOI 10.1371/journal.pbio.0040060; Vardi A, 2007, ENVIRON MICROBIOL, V9, P360, DOI 10.1111/j.1462-2920.2006.01146.x; Wahlen BD, 2011, BIORESOURCE TECHNOL, V102, P2724, DOI 10.1016/j.biortech.2010.11.026; Wei D, 2004, BIOTECHNOL APPL BIOC, V40, P187, DOI 10.1042/BA20030142; Wigmosta MS, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR009966; Wijffels RH, 2010, SCIENCE, V329, P796, DOI 10.1126/science.1189003; WOLF FR, 1985, PHYTOCHEMISTRY, V24, P733; Wu ZC, 2012, BIORESOURCE TECHNOL, V110, P496, DOI 10.1016/j.biortech.2012.01.101; Yang Y, 2011, BIORESOURCE TECHNOL, V102, P5076, DOI 10.1016/j.biortech.2011.02.014; Zamalloa C, 2012, APPL ENERG, V92, P733, DOI 10.1016/j.apenergy.2011.08.017; Zhu XG, 2010, ANNU REV PLANT BIOL, V61, P235, DOI 10.1146/annurev-arplant-042809-112206	87	478	502	19	642	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2012	488	7411					329	335		10.1038/nature11479	http://dx.doi.org/10.1038/nature11479			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OS	22895338				2022-12-28	WOS:000307501000032
J	Lasker, SS; Chowdhury, TA				Lasker, Shawarna S.; Chowdhury, Tahseen A.			Myalgia while taking statins	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Chowdhury, Tahseen A.] Royal London Hosp, Dept Diabet & Metab, London E1 1BB, England	Barts Health NHS Trust; Royal London Hospital	Chowdhury, TA (corresponding author), Royal London Hosp, Dept Diabet & Metab, London E1 1BB, England.	Tahseen.Chowdhury@bartshealth.nhs.uk						Eckel RH, 2010, J CLIN ENDOCR METAB, V95, P2015, DOI 10.1210/jc.2009-2689; Stein EA, 2008, AM J CARDIOL, V101, P490, DOI 10.1016/j.amjcard.2007.09.099	2	5	5	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 14	2012	345								e5348	10.1136/bmj.e5348	http://dx.doi.org/10.1136/bmj.e5348			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992CD	22893641				2022-12-28	WOS:000307752000005
J	Baldwin, AJ; Kay, LE				Baldwin, Andrew J.; Kay, Lewis E.			STRUCTURAL BIOLOGY Dynamic binding	NATURE			English	Editorial Material							PROTEIN; ALLOSTERY; DOMAIN		[Baldwin, Andrew J.; Kay, Lewis E.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Baldwin, Andrew J.; Kay, Lewis E.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Baldwin, Andrew J.; Kay, Lewis E.] Univ Toronto, Dept Chem, Toronto, ON M5S 1A8, Canada; [Kay, Lewis E.] Hosp Sick Children, Toronto, ON M5G 1X8, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Baldwin, AJ (corresponding author), Univ Toronto, Dept Mol Genet, 100 Coll St, Toronto, ON M5S 1A8, Canada.	kay@pound.med.utoronto.ca	Baldwin, Andrew/A-5830-2015	Baldwin, Andrew/0000-0001-7579-8844	BBSRC [BB/J014346/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J014346/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Frederick KK, 2007, NATURE, V448, P325, DOI 10.1038/nature05959; Karplus M, 2005, P NATL ACAD SCI USA, V102, P6679, DOI 10.1073/pnas.0408930102; Li PL, 2008, NAT STRUCT MOL BIOL, V15, P613, DOI 10.1038/nsmb.1428; Masterson LR, 2011, J MOL BIOL, V412, P155, DOI 10.1016/j.jmb.2011.06.041; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; Popovych N, 2009, P NATL ACAD SCI USA, V106, P6927, DOI 10.1073/pnas.0900595106; Selvaratnam R, 2011, P NATL ACAD SCI USA, V108, P6133, DOI 10.1073/pnas.1017311108; Sharma H, 2009, P NATL ACAD SCI USA, V106, P16604, DOI 10.1073/pnas.0908380106; Tzeng SR, 2012, NATURE, V488, P236, DOI 10.1038/nature11271; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429	10	11	11	0	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2012	488	7410					165	166		10.1038/488165a	http://dx.doi.org/10.1038/488165a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985LE	22874961				2022-12-28	WOS:000307267000023
J	Becker, WC; Fiellin, DA				Becker, William C.; Fiellin, David A.			Federal Plan for Prescriber Education on Opioids Misses Opportunities	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							OVERDOSE; PAIN		[Becker, William C.; Fiellin, David A.] Yale Univ, Sch Med, New Haven, CT 06520 USA	Yale University	Becker, WC (corresponding author), Yale Univ, Sch Med, 367 Cedar St,POB 208056, New Haven, CT 06520 USA.	william.becker@yale.edu		Becker, William/0000-0002-0788-1467; Fiellin, David/0000-0002-4006-010X	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA020795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020576, R01DA025991] Funding Source: NIH RePORTER; NIAAA NIH HHS [U01 AA020795] Funding Source: Medline; NIDA NIH HHS [R01 DA020576, R01 DA025991] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		American Medical Association, 2011, 1 AM MED ASS COUNC E; Center for Substance Abuse Treatment, 2004, TREATM IMPR PROT TIP, V40; Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P869; Dunn KM, 2010, ANN INTERN MED, V152, P85, DOI 10.7326/0003-4819-152-2-201001190-00006; Egan JE, 2010, J GEN INTERN MED, V25, P936, DOI 10.1007/s11606-010-1377-y; FDA, 2011, FED REG; Food and Drug Administration, BLUEPR PRESCR CONT E; Holmboe ES, 2008, J CONTIN EDUC HEALTH, V28, pS4, DOI 10.1002/chp.200; Institute of Medicine, 2009, CONFL INT MED RES ED; Institute of Medicine, 2007, FUT DRUG SAF PROM PR; McLellan AT, 2010, ANN INTERN MED, V152, P123, DOI 10.7326/0003-4819-152-2-201001190-00012; Meier Barry, 2007, NY TIMES; Office of National Drug Control Policy US Executive Office of the President, 2011, EP RESP AM PRESCR DR; Rothman DJ, 2009, JAMA-J AM MED ASSOC, V301, P1367, DOI 10.1001/jama.2009.407	14	9	9	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 7	2012	157	3					205	+		10.7326/0003-4819-156-11-201206050-00448	http://dx.doi.org/10.7326/0003-4819-156-11-201206050-00448			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992PB	22868838				2022-12-28	WOS:000307789900007
J	Feinmann, J				Feinmann, Jane			Heartfile: using technology to get healthcare funding to poor patients in Pakistan	BRITISH MEDICAL JOURNAL			English	Editorial Material												jane@janefeinmann.com						Nishtar S, 2004, J HEALTH COMMUN, V9, P355, DOI 10.1080/10810730490468603; Nishtar S, 2010, CHOKED PIPES REFORMI	2	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 7	2012	345								e5156	10.1136/bmj.e5156	http://dx.doi.org/10.1136/bmj.e5156			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988NA	22872712				2022-12-28	WOS:000307496500014
J	Macilwain, C				Macilwain, Colin			The time is right to confront misconduct	NATURE			English	Editorial Material												cfmworldview@gmail.com						Fanelli D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005738; ROSSNER M, 2006, J CELL BIOL, V20, P24	2	7	7	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2012	488	7409					7	7		10.1038/488007a	http://dx.doi.org/10.1038/488007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	981ZE	22859166	Bronze			2022-12-28	WOS:000307010700005
J	Moynihan, R				Moynihan, Ray			Job insecurity contributes to poor health	BRITISH MEDICAL JOURNAL			English	Editorial Material							WORK		Bond Univ, Southport, Qld 4229, Australia	Bond University	Moynihan, R (corresponding author), Bond Univ, Southport, Qld 4229, Australia.	RayMoynihan@bond.edu.au	Moynihan, Ray/ABC-3010-2020					Australian Council of Trade Unions, 2012, LIV HOLD IND INQ INS; Broom DH, 2006, SOC SCI MED, V63, P575, DOI 10.1016/j.socscimed.2006.02.003; Butterworth P, 2011, OCCUP ENVIRON MED, V68, P806, DOI 10.1136/oem.2010.059030; Council of the European Union, 2009, 2947 EMPL SOC POL HL; D'Souza RM, 2003, J EPIDEMIOL COMMUN H, V57, P849, DOI 10.1136/jech.57.11.849; Ferrie JE, 2002, J EPIDEMIOL COMMUN H, V56, P450, DOI 10.1136/jech.56.6.450; Laszlo KD, 2010, SOC SCI MED, V70, P867, DOI 10.1016/j.socscimed.2009.11.022	7	4	4	0	12	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 1	2012	345								e5183	10.1136/bmj.e5183	http://dx.doi.org/10.1136/bmj.e5183			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	985XC	22859778				2022-12-28	WOS:000307302800014
J	O'Dowd, A				O'Dowd, Adrian			The "self funding" NHS patient: thin end of the wedge?	BRITISH MEDICAL JOURNAL			English	Editorial Material												adrianodowd@hotmail.com						East and North Hertfordshire, CYBERKNIFE; Epsom and St Helier University Hopsitals, FUND DEC WHO PAYS YO; Homerton University Hospital, FUND YOUR TREATM; Kingston Hospital, FUND; O'Dowd A, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4711; University College London Hospitals, UCLH OV CANC SCREEN; University Hospitals Bristol, SPEC SELF FUND DEXA	7	4	4	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 1	2012	345								e5128	10.1136/bmj.e5128	http://dx.doi.org/10.1136/bmj.e5128			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	985XC	22859774				2022-12-28	WOS:000307302800011
J	de Graaf, J; Manna, L				de Graaf, Joost; Manna, Liberato			A Roadmap for the Assembly of Polyhedral Particles	SCIENCE			English	Editorial Material							NANOCRYSTAL SUPERLATTICE; COLLOIDAL NANOCRYSTALS; INTERFACE; PACKINGS		[de Graaf, Joost] Univ Utrecht, Debye Inst Nanomat Sci, NL-3584 CC Utrecht, Netherlands; [Manna, Liberato] Ist Italiano Tecnol, I-16145 Genoa, Italy; [Manna, Liberato] Delft Univ Technol, Kavli Inst NanoSci, NL-2628 CJ Delft, Netherlands	Utrecht University; Istituto Italiano di Tecnologia - IIT; Delft University of Technology	de Graaf, J (corresponding author), Univ Utrecht, Debye Inst Nanomat Sci, NL-3584 CC Utrecht, Netherlands.	j.degraaf1@uu.nl; liberato.manna@iit.it	Manna, Liberato/G-2339-2010; de Graaf, Joost/C-5364-2012	Manna, Liberato/0000-0003-4386-7985; de Graaf, Joost/0000-0002-8781-7368				Agarwal U, 2011, NAT MATER, V10, P230, DOI [10.1038/nmat2959, 10.1038/NMAT2959]; Damasceno PF, 2012, SCIENCE, V337, P453, DOI 10.1126/science.1220869; Damasceno PF, 2012, ACS NANO, V6, P609, DOI 10.1021/nn204012y; Dong AG, 2010, NATURE, V466, P474, DOI 10.1038/nature09188; Evers WH, 2009, ANGEW CHEM INT EDIT, V48, P9655, DOI 10.1002/anie.200904821; Glotzer SC, 2004, SCIENCE, V306, P419, DOI 10.1126/science.1099988; Glotzer SC, 2007, NAT MATER, V6, P557, DOI 10.1038/nmat1949; He Y, 2008, NATURE, V452, P198, DOI 10.1038/nature06597; Henzie J, 2012, NAT MATER, V11, P131, DOI [10.1038/nmat3178, 10.1038/NMAT3178]; Miszta K, 2011, NAT MATER, V10, P872, DOI [10.1038/NMAT3121, 10.1038/nmat3121]; Nie ZH, 2010, NAT NANOTECHNOL, V5, P15, DOI [10.1038/NNANO.2009.453, 10.1038/nnano.2009.453]; ONSAGER L, 1949, ANN NY ACAD SCI, V51, P627, DOI 10.1111/j.1749-6632.1949.tb27296.x; Rupich SM, 2011, NAT MATER, V10, P815, DOI 10.1038/nmat3158; Talapin DV, 2010, CHEM REV, V110, P389, DOI 10.1021/cr900137k; Torquato S, 2009, NATURE, V460, P876, DOI 10.1038/nature08239; Woodley SM, 2008, NAT MATER, V7, P937, DOI 10.1038/nmat2321; Yin Y, 2005, NATURE, V437, P664, DOI 10.1038/nature04165	17	13	13	3	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2012	337	6093					417	418		10.1126/science.1226162	http://dx.doi.org/10.1126/science.1226162			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979FS	22837512				2022-12-28	WOS:000306802300026
J	Taylor, B				Taylor, Bridget			We must give children a voice in advance care planning	BRITISH MEDICAL JOURNAL			English	Editorial Material									Oxford Brookes Univ, Fac Hlth & Life Sci, Oxford OX3 0FL, England	Oxford Brookes University	Taylor, B (corresponding author), Oxford Brookes Univ, Fac Hlth & Life Sci, Oxford OX3 0FL, England.	bmtaylor@brookes.ac.uk						Hammes Bernard J, 2005, J Palliat Med, V8, P766, DOI 10.1089/jpm.2005.8.766; Kreicbergs U, 2004, NEW ENGL J MED, V351, P1175, DOI 10.1056/NEJMoa040366	2	3	3	0	9	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUL 27	2012	345								e5111	10.1136/bmj.e5111	http://dx.doi.org/10.1136/bmj.e5111			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	981UZ	22842355				2022-12-28	WOS:000306997800002
J	Borgia, G; Coyle, BJ; Keagy, J				Borgia, Gerald; Coyle, Brian J.; Keagy, Jason			Comment on "Illusions Promote Mating Success in Great Bowerbirds"	SCIENCE			English	Editorial Material							SPOTTED BOWERBIRD; PTILONORHYNCHUS-VIOLACEUS; DISPLAY TRAITS; FEMALE CHOICE; DECORATIONS		[Borgia, Gerald; Coyle, Brian J.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Keagy, Jason] Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA	University System of Maryland; University of Maryland College Park; Michigan State University	Borgia, G (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.	Borgia@umd.edu	Keagy, Jason/H-7462-2019; Keagy, Jason/C-4117-2014	Keagy, Jason/0000-0003-1235-4837; Keagy, Jason/0000-0003-1235-4837; Coyle, Brian/0000-0003-0663-7988				Anderson BL, 2012, SCIENCE, V335, P292, DOI 10.1126/science.1217451; BORGIA G, 1985, ANIM BEHAV, V33, P266, DOI 10.1016/S0003-3472(85)80140-8; BORGIA G, 1995, ANIM BEHAV, V49, P1291, DOI 10.1006/anbe.1995.0161; BORGIA G, 1992, EMU, V92, P11, DOI 10.1071/MU9920011; Borgia G, 1998, ANIM BEHAV, V56, P1121, DOI 10.1006/anbe.1998.0908; BORGIA G, 1995, AM SCI, V83, P542; Coleman SW, 2007, BIOL LETTERS, V3, P463, DOI 10.1098/rsbl.2007.0234; Kelley LA, 2012, SCIENCE, V335, P335, DOI 10.1126/science.1212443; Madden JR, 2003, BEHAV ECOL SOCIOBIOL, V53, P269, DOI 10.1007/s00265-003-0583-6; Patricelli GL, 2004, BEHAV ECOL, V15, P297, DOI 10.1093/beheco/arh013; Uy JAC, 2000, EVOLUTION, V54, P273, DOI 10.1111/j.0014-3820.2000.tb00027.x	11	3	4	0	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2012	337	6092								10.1126/science.1220775	http://dx.doi.org/10.1126/science.1220775			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975WQ	22822134				2022-12-28	WOS:000306542600025
J	Benn, CS; Aaby, P				Benn, Christine Stabell; Aaby, Peter			Does IPTi decrease malaria morbidity but not mortality?	LANCET			English	Editorial Material							INTERMITTENT PREVENTIVE TREATMENT; SULFADOXINE-PYRIMETHAMINE; INFANTS; IMPLEMENTATION; KOLOKANI; TANZANIA; DISTRICT		[Benn, Christine Stabell; Aaby, Peter] Statens Serum Inst, Bandim Hlth Project, Res Ctr Vitamins & Vaccines, DK-2300 Copenhagen, Denmark	Statens Serum Institut	Benn, CS (corresponding author), Statens Serum Inst, Bandim Hlth Project, Res Ctr Vitamins & Vaccines, DK-2300 Copenhagen, Denmark.	cb@ssi.dk			European Research Council [243149] Funding Source: Medline	European Research Council(European Research Council (ERC)European Commission)		Akhwale W, 2008, LANCET, V372, P1383, DOI 10.1016/S0140-6736(08)61583-4; Aponte JJ, 2009, LANCET, V374, P1533, DOI 10.1016/S0140-6736(09)61258-7; Bahl R, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-22; Benn CS, 2009, INT J EPIDEMIOL, V38, P586, DOI 10.1093/ije/dyn364; Chandramohan D, 2005, BMJ-BRIT MED J, V331, P727, DOI 10.1136/bmj.331.7519.727; Crawley J, 2012, J GERONTOL B; Dicko A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-73; Dicko A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-573; Gosling RD, 2009, LANCET, V374, P1521, DOI 10.1016/S0140-6736(09)60997-1; Kobbe R, 2007, CLIN INFECT DIS, V45, pS16, DOI 10.1086/518575; Schellenberg JRMA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-387; *WHO, 2009, REP TECHN CONS INT P; Wilson AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016976; World Health Organization (WHO), 2010, WHO POL REC INT PREV	14	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 15	2012	380	9846					958	960		10.1016/S0140-6736(12)61184-2	http://dx.doi.org/10.1016/S0140-6736(12)61184-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	005JF	22850359				2022-12-28	WOS:000308746000011
J	Zalatan, JG; Coyle, SM; Rajan, S; Sidhu, SS; Lim, WA				Zalatan, Jesse G.; Coyle, Scott M.; Rajan, Saravanan; Sidhu, Sachdev S.; Lim, Wendell A.			Conformational Control of the Ste5 Scaffold Protein Insulates Against MAP Kinase Misactivation	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; SIGNALING SPECIFICITY; CASCADE ACTIVATION; YEAST; PATHWAYS; MODULES; DOMAIN; TRANSDUCTION; ORGANIZATION; COMPONENTS	Cells reuse signaling proteins in multiple pathways, raising the potential for improper cross talk. Scaffold proteins are thought to insulate against such miscommunication by sequestering proteins into distinct physical complexes. We show that the scaffold protein Ste5, which organizes the yeast mating mitogen-activated protein kinase (MAPK) pathway, does not use sequestration to prevent misactivation of the mating response. Instead, Ste5 appears to use a conformation mechanism: Under basal conditions, an intramolecular interaction of the pleckstrin homology (PH) domain with the von Willebrand type A (VWA) domain blocks the ability to coactivate the mating-specific MAPK Fus3. Pheromone-induced membrane binding of Ste5 triggers release of this autoinhibition. Thus, in addition to serving as a conduit guiding kinase communication, Ste5 directly receives input information to decide if and when signal can be transmitted to mating output.	[Zalatan, Jesse G.; Coyle, Scott M.; Lim, Wendell A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Coyle, Scott M.] Univ Calif San Francisco, Program Biol Sci, San Francisco, CA 94158 USA; [Lim, Wendell A.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Rajan, Saravanan; Sidhu, Sachdev S.] Univ Toronto, Dept Mol Genet, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Rajan, Saravanan; Sidhu, Sachdev S.] Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of Toronto; University of Toronto	Lim, WA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, 600 16th St, San Francisco, CA 94158 USA.	lim@cmp.ucsf.edu		Zalatan, Jesse/0000-0002-1458-0654	Damon Runyon Cancer Research Foundation [DRG 2012-09]; National Science Foundation; Canadian Institutes for Health Research [MOPS-93725]; NIH [RO1 GM55040, RO1 GM62583, PN2 EY016546, P50 GM081879]; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001614] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY016546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081879, R01GM055040, R01GM062583] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; National Science Foundation(National Science Foundation (NSF)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	J.G.Z. is supported by the Damon Runyon Cancer Research Foundation (DRG 2012-09). S. M. C. is supported by a National Science Foundation Graduate Research Fellowship. S. S. S. and S. R. are supported by a grant from the Canadian Institutes for Health Research (MOPS-93725). This work was also supported by NIH grants RO1 GM55040, RO1 GM62583, PN2 EY016546, and P50 GM081879 (W. A. L.) and by the Howard Hughes Medical Institute (W. A. L.). We thank G. Narlikar, H. Madhani, and M. Good for helpful discussions and comments; N. Helman and S. Vidal for plasmids; H. Madhani for providing yeast strains; and C. Waddling for assistance with x-ray data collection. Coordinates have been submitted to the Protein Data Bank (4F2H).	Bao MZ, 2004, CELL, V119, P991, DOI 10.1016/j.cell.2004.11.052; Bardwell L, 2005, PEPTIDES, V26, P337, DOI 10.1016/j.peptides.2004.10.001; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; CAIRNS BR, 1992, GENE DEV, V6, P1305, DOI 10.1101/gad.6.7.1305; CHOI KY, 1994, CELL, V78, P499; Chou S, 2004, CELL, V119, P981, DOI 10.1016/j.cell.2004.11.053; Dhanasekaran DN, 2007, ONCOGENE, V26, P3185, DOI 10.1038/sj.onc.1210411; ELION EA, 1991, P NATL ACAD SCI USA, V88, P9392, DOI 10.1073/pnas.88.21.9392; Flatauer LJ, 2005, MOL CELL BIOL, V25, P1793, DOI 10.1128/MCB.25.5.1793-1803.2005; Garrenton LS, 2006, GENE DEV, V20, P1946, DOI 10.1101/gad.1413706; Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3; Good M, 2009, CELL, V136, P1085, DOI 10.1016/j.cell.2009.01.049; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Harris K, 2001, CURR BIOL, V11, P1815, DOI 10.1016/S0960-9822(01)00567-X; Inouye C, 1997, GENETICS, V147, P479; Inouye C, 1997, SCIENCE, V278, P103, DOI 10.1126/science.278.5335.103; Jansen G, 2001, MOL GENET GENOMICS, V265, P102, DOI 10.1007/s004380000394; Lamson RE, 2006, CURR BIOL, V16, P618, DOI 10.1016/j.cub.2006.02.060; Lyons DM, 1996, MOL CELL BIOL, V16, P4095; MARCUS S, 1994, P NATL ACAD SCI USA, V91, P7762, DOI 10.1073/pnas.91.16.7762; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Qi MS, 2005, J CELL SCI, V118, P3569, DOI 10.1242/jcs.02470; Saito H, 2010, CURR OPIN MICROBIOL, V13, P677, DOI 10.1016/j.mib.2010.09.001; Schwartz MA, 2004, ANNU REV GENET, V38, P725, DOI 10.1146/annurev.genet.39.073003.112634; Shaw AS, 2009, NAT REV IMMUNOL, V9, P47, DOI 10.1038/nri2473; TAYLOR SS, 1993, TRENDS BIOCHEM SCI, V18, P84, DOI 10.1016/0968-0004(93)80001-R; Whitmarsh AJ, 1998, TRENDS BIOCHEM SCI, V23, P481, DOI 10.1016/S0968-0004(98)01309-7	28	59	61	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2012	337	6099					1218	1222		10.1126/science.1220683	http://dx.doi.org/10.1126/science.1220683			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	000UJ	22878499	Green Accepted			2022-12-28	WOS:000308414000036
J	Chan, KL; Roig, MB; Hu, B; Beckouet, F; Metson, J; Nasmyth, K				Chan, Kok-Lung; Roig, Maurici B.; Hu, Bin; Beckouet, Frederic; Metson, Jean; Nasmyth, Kim			Cohesin's DNA Exit Gate Is Distinct from Its Entrance Gate and Is Regulated by Acetylation	CELL			English	Article							SISTER-CHROMATID COHESION; SACCHAROMYCES-CEREVISIAE; CHROMOSOME ARMS; ATP HYDROLYSIS; REPLICATION; YEAST; PROTEINS; COMPLEX; BINDING; ESTABLISHMENT	Sister chromatid cohesion is mediated by entrapment of sister DNAs by a tripartite ring composed of cohesin's Smc1, Smc3, and alpha-kleisin subunits. Cohesion requires acetylation of Smc3 by Eco1, whose role is to counteract an inhibitory (antiestablishment) activity associated with cohesin's Wapl subunit. We show that mutations abrogating antiestablishment activity also reduce turnover of cohesin on pericentric chromatin. Our results reveal a "releasing" activity inherent to cohesin complexes transiently associated with Wapl that catalyzes their dissociation from chromosomes. Fusion of Smc3's nucleotide binding domain to alpha-kleisin's N-terminal domain also reduces cohesin turnover within pericentric chromatin and permits establishment of Wapl-resistant cohesion in the absence of Eco1. We suggest that releasing activity opens the Smc3/alpha-kleisin interface, creating a DNA exit gate distinct from its proposed entry gate at the Smc1/3 interface. According to this notion, the function of Smc3 acetylation is to block its dissociation from alpha-kleisin. The functional implications of regulated ring opening are discussed.	[Chan, Kok-Lung; Roig, Maurici B.; Hu, Bin; Beckouet, Frederic; Metson, Jean; Nasmyth, Kim] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Oxford	Nasmyth, K (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	kim.nasmyth@bioch.ox.ac.uk	Beckouet, Frederic/P-5389-2016; Hu, Bin/GWZ-8912-2022	Beckouet, Frederic/0000-0002-9009-1852; Hu, Bin/0000-0001-6316-2830; Nasmyth, Kim/0000-0001-7030-4403; chan, kok-lung/0000-0002-8796-8385	Cancer Research UK; Wellcome Trust; Croucher Foundation Fellowship; Cancer Research UK [12386] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); Croucher Foundation Fellowship; Cancer Research UK(Cancer Research UK)	This study is supported by Cancer Research UK and Wellcome Trust. We thank all members of the Nasmyth group for invaluable discussion; Raquel Oliveira for critical comments on the manuscript; MICRON unit for microscopy support. We specially thank Mike Tyers for a gift of sic1(9 m) plasmid, Haruo Takahashi for the plasmids of the improved galactose-inducible system, and Tongli Zhang for advice and discussion of photobleaching data. K.-L.C. was supported by the Croucher Foundation Fellowship.	Arumugam P, 2003, CURR BIOL, V13, P1941, DOI 10.1016/j.cub.2003.10.036; Beckouet F, 2010, MOL CELL, V39, P689, DOI 10.1016/j.molcel.2010.08.008; Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Farcas AM, 2011, MOL CELL, V44, P97, DOI 10.1016/j.molcel.2011.07.034; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; Gerlich D, 2006, CURR BIOL, V16, P1571, DOI 10.1016/j.cub.2006.06.068; Gruber S, 2006, CELL, V127, P523, DOI 10.1016/j.cell.2006.08.048; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Haering CH, 2004, MOL CELL, V15, P951, DOI 10.1016/j.molcel.2004.08.030; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Hu B, 2011, CURR BIOL, V21, P12, DOI 10.1016/j.cub.2010.12.004; Ivanov D, 2002, CURR BIOL, V12, P323, DOI 10.1016/S0960-9822(02)00681-4; Ivanov D, 2007, MOL CELL, V27, P300, DOI 10.1016/j.molcel.2007.07.002; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kucej M, 2010, NUCLEUS-PHILA, V1, P4, DOI 10.4161/nucl.1.1.10010; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Matsuyama T, 2011, J BIOSCI BIOENG, V111, P175, DOI 10.1016/j.jbiosc.2010.09.014; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Mishra A, 2010, CURR BIOL, V20, P279, DOI 10.1016/j.cub.2009.12.059; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Nasmyth K, 2004, PHILOS T R SOC B, V359, P99, DOI 10.1098/rstb.2003.1417; Nasmyth K, 2011, NAT CELL BIOL, V13, P1170, DOI 10.1038/ncb2349; Panizza S, 2000, CURR BIOL, V10, P1557, DOI 10.1016/S0960-9822(00)00854-X; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Pauli A, 2008, DEV CELL, V14, P239, DOI 10.1016/j.devcel.2007.12.009; Pehlivan D, 2012, GENET MED, V14, P313, DOI 10.1038/gim.2011.13; Rowland BD, 2009, MOL CELL, V33, P763, DOI 10.1016/j.molcel.2009.02.028; Seitan VC, 2011, NATURE, V476, P467, DOI 10.1038/nature10312; Shintomi K, 2009, GENE DEV, V23, P2224, DOI 10.1101/gad.1844309; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Sutani T, 2009, CURR BIOL, V19, P492, DOI 10.1016/j.cub.2009.01.062; Tachibana-Konwalski K, 2010, GENE DEV, V24, P2505, DOI 10.1101/gad.605910; Tanaka K, 2001, EMBO J, V20, P5779, DOI 10.1093/emboj/20.20.5779; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Unal E, 2008, SCIENCE, V321, P566, DOI 10.1126/science.1157880; Weitzer S, 2003, CURR BIOL, V13, P1930, DOI 10.1016/j.cub.2003.10.030; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Yeh E, 2008, CURR BIOL, V18, P81, DOI 10.1016/j.cub.2007.12.019; Zhang JL, 2008, MOL CELL, V31, P143, DOI 10.1016/j.molcel.2008.06.006; Zhang NG, 2008, J CELL BIOL, V183, P1019, DOI 10.1083/jcb.200801157	49	161	162	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 31	2012	150	5					961	974		10.1016/j.cell.2012.07.028	http://dx.doi.org/10.1016/j.cell.2012.07.028			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	001ZU	22901742	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000308500200011
J	McDonald, M; Bayliss, M; Benson, BA; Foley, RJ; Ruel, J; Sullivan, P; Veilleux, S; Aird, KA; Ashby, MLN; Bautz, M; Bazin, G; Bleem, LE; Brodwin, M; Carlstrom, JE; Chang, CL; Cho, HM; Clocchiatti, A; Crawford, TM; Crites, AT; Dehaan, T; Desai, S; Dobbs, MA; Dudley, JP; Egami, E; Forman, WR; Garmire, GP; George, EM; Gladders, MD; Gonzalez, AH; Halverson, NW; Harrington, NL; High, FW; Holder, GP; Holzapfel, WL; Hoover, S; Hrubes, JD; Jones, C; Joy, M; Keisler, R; Knox, L; Lee, AT; Leitch, EM; Liu, J; Lueker, M; Luong-Van, D; Mantz, A; Marrone, DP; McMahon, JJ; Mehl, J; Meyer, SS; Miller, ED; Mocanu, L; Mohr, JJ; Montroy, TE; Murray, SS; Natoli, T; Padin, S; Plagge, T; Pryke, C; Rawle, TD; Reichardt, CL; Rest, A; Rex, M; Ruhl, JE; Saliwanchik, BR; Saro, A; Sayre, JT; Schaffer, KK; Shaw, L; Shirokoff, E; Simcoe, R; Song, J; Spieler, HG; Stalder, B; Staniszewski, Z; Stark, AA; Story, K; Stubbs, CW; Suhada, R; van Engelen, A; Vanderlinde, K; Vieira, JD; Vikhlinin, A; Williamson, R; Zahn, O; Zenteno, A				McDonald, M.; Bayliss, M.; Benson, B. A.; Foley, R. J.; Ruel, J.; Sullivan, P.; Veilleux, S.; Aird, K. A.; Ashby, M. L. N.; Bautz, M.; Bazin, G.; Bleem, L. E.; Brodwin, M.; Carlstrom, J. E.; Chang, C. L.; Cho, H. M.; Clocchiatti, A.; Crawford, T. M.; Crites, A. T.; Dehaan, T.; Desai, S.; Dobbs, M. A.; Dudley, J. P.; Egami, E.; Forman, W. R.; Garmire, G. P.; George, E. M.; Gladders, M. D.; Gonzalez, A. H.; Halverson, N. W.; Harrington, N. L.; High, F. W.; Holder, G. P.; Holzapfel, W. L.; Hoover, S.; Hrubes, J. D.; Jones, C.; Joy, M.; Keisler, R.; Knox, L.; Lee, A. T.; Leitch, E. M.; Liu, J.; Lueker, M.; Luong-Van, D.; Mantz, A.; Marrone, D. P.; McMahon, J. J.; Mehl, J.; Meyer, S. S.; Miller, E. D.; Mocanu, L.; Mohr, J. J.; Montroy, T. E.; Murray, S. S.; Natoli, T.; Padin, S.; Plagge, T.; Pryke, C.; Rawle, T. D.; Reichardt, C. L.; Rest, A.; Rex, M.; Ruhl, J. E.; Saliwanchik, B. R.; Saro, A.; Sayre, J. T.; Schaffer, K. K.; Shaw, L.; Shirokoff, E.; Simcoe, R.; Song, J.; Spieler, H. G.; Stalder, B.; Staniszewski, Z.; Stark, A. A.; Story, K.; Stubbs, C. W.; Suhada, R.; van Engelen, A.; Vanderlinde, K.; Vieira, J. D.; Vikhlinin, A.; Williamson, R.; Zahn, O.; Zenteno, A.			A massive, cooling-flow-induced starburst in the core of a luminous cluster of galaxies	NATURE			English	Article							H-ALPHA FILAMENTS; X-RAY; GAS; SPECTROSCOPY; EMISSION	In the cores of some clusters of galaxies the hot intracluster plasma is dense enough that it should cool radiatively in the cluster's lifetime(1-3), leading to continuous 'cooling flows' of gas sinking towards the cluster centre, yet no such cooling flow has been observed. The low observed star-formation rates(4,5) and cool gas masses(6) for these 'cool-core' clusters suggest that much of the cooling must be offset by feedback to prevent the formation of a runaway cooling flow(7-10). Here we report X-ray, optical and infrared observations of the galaxy cluster SPT-CLJ2344-4243 (ref. 11) at redshift z = 0.596. These observations reveal an exceptionally luminous (8.2 x 10(45) erg s(-1)) galaxy cluster that hosts an extremely strong cooling flow (around 3,820 solar masses a year). Further, the central galaxy in this cluster appears to be experiencing a massive starburst (formation of around 740 solar masses a year), which suggests that the feedback source responsible for preventing runaway cooling in nearby cool-core clusters may not yet be fully established in SPT-CLJ2344-4243. This large starformation rate implies that a significant fraction of the stars in the central galaxy of this cluster may form through accretion of the intracluster medium, rather than (as is currently thought) assembling entirely via mergers.	[McDonald, M.; Sullivan, P.; Bautz, M.; Miller, E. D.; Simcoe, R.] MIT, MIT Kavli Inst Astrophys & Space Res, Cambridge, MA 02139 USA; [Bayliss, M.; Ruel, J.; Stubbs, C. W.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Benson, B. A.; Bleem, L. E.; Carlstrom, J. E.; Chang, C. L.; Crawford, T. M.; Crites, A. T.; Gladders, M. D.; High, F. W.; Hoover, S.; Keisler, R.; Leitch, E. M.; Mantz, A.; McMahon, J. J.; Mehl, J.; Meyer, S. S.; Mocanu, L.; Natoli, T.; Padin, S.; Plagge, T.; Schaffer, K. K.; Story, K.; Vieira, J. D.; Williamson, R.] Univ Chicago, Kavli Inst Cosmol Phys, Chicago, IL 60637 USA; [Benson, B. A.; Carlstrom, J. E.; Chang, C. L.; Hoover, S.; McMahon, J. J.; Meyer, S. S.; Schaffer, K. K.] Univ Chicago, Enrico Fermi Inst, Chicago, IL 60637 USA; [Foley, R. J.; Ashby, M. L. N.; Forman, W. R.; Jones, C.; Murray, S. S.; Stalder, B.; Stark, A. A.; Stubbs, C. W.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Veilleux, S.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Veilleux, S.] NASA, Astroparticle Phys Lab, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Bazin, G.; Desai, S.; Liu, J.; Mohr, J. J.; Saro, A.; Zenteno, A.] Univ Munich, Dept Phys, D-81679 Munich, Germany; [Bazin, G.; Desai, S.; Liu, J.; Mohr, J. J.; Saro, A.; Zenteno, A.] Excellence Cluster Universe, D-85748 Garching, Germany; [Bleem, L. E.; Carlstrom, J. E.; Keisler, R.; Meyer, S. S.; Natoli, T.; Story, K.; Vieira, J. D.] Univ Chicago, Dept Phys, Chicago, IL 60637 USA; [Brodwin, M.] Univ Missouri, Dept Phys & Astron, Kansas City, MO 64110 USA; [Carlstrom, J. E.; Crawford, T. M.; Crites, A. T.; Gladders, M. D.; High, F. W.; Leitch, E. M.; Meyer, S. S.; Mocanu, L.; Padin, S.; Plagge, T.; Williamson, R.] Univ Chicago, Dept Astron & Astrophys, Chicago, IL 60637 USA; [Carlstrom, J. E.] Argonne Natl Lab, Argonne, IL 60439 USA; [Cho, H. M.] NIST Quantum Devices Grp, Boulder, CO 80305 USA; [Clocchiatti, A.] Pontificia Univ Catolica, Dept Astron & Astrofis, Santiago, Chile; [Dehaan, T.; Dobbs, M. A.; Dudley, J. P.; Holder, G. P.; Shaw, L.; van Engelen, A.; Vanderlinde, K.] McGill Univ, Dept Phys, Montreal, PQ H3A 2T8, Canada; [Egami, E.; Marrone, D. P.; Rawle, T. D.; Rex, M.] Univ Arizona, Steward Observ, Tucson, AZ 85721 USA; [Garmire, G. P.; Lueker, M.] Penn State Univ, Dept Astron & Astrophys, University Pk, PA 16802 USA; [George, E. M.; Harrington, N. L.; Holzapfel, W. L.; Reichardt, C. L.; Shirokoff, E.; Zahn, O.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Gonzalez, A. H.] Univ Florida, Dept Astron, Gainesville, FL 32611 USA; [Halverson, N. W.] Univ Colorado, Dept Astrophys & Planetary Sci, Boulder, CO 80309 USA; [Halverson, N. W.] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Joy, M.] NASA Marshall Space Flight Ctr, Dept Space Sci, Huntsville, AL 35812 USA; [Knox, L.] Univ Calif Davis, Dept Phys, Davis, CA 95616 USA; [Lee, A. T.; Spieler, H. G.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Div, Berkeley, CA 94720 USA; [Lueker, M.; Padin, S.; Vieira, J. D.] CALTECH, Pasadena, CA 91125 USA; [McMahon, J. J.] Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA; [Mohr, J. J.] Max Planck Inst Extraterr Phys, D-85748 Garching, Germany; [Montroy, T. E.; Ruhl, J. E.; Saliwanchik, B. R.; Staniszewski, Z.] Case Western Reserve Univ, Ctr Educ & Res Cosmol & Astrophys, Phys Dept, Cleveland, OH 44106 USA; [Pryke, C.] Univ Minnesota, Phys Dept, Minneapolis, MN 55455 USA; [Rest, A.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Schaffer, K. K.] Inst Chicago, Sch Art, Liberal Arts Dept, Chicago, IL 60603 USA; [Shaw, L.] Yale Univ, Dept Phys, New Haven, CT 06520 USA; [Zahn, O.] Univ Calif Berkeley, Dept Phys, Berkeley Ctr Cosmol Phys, Berkeley, CA 94720 USA; [Zahn, O.] Lawrence Berkeley Natl Labs, Berkeley, CA 94720 USA	Massachusetts Institute of Technology (MIT); Harvard University; University of Chicago; University of Chicago; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University System of Maryland; University of Maryland College Park; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Munich; University of Munich; University of Chicago; University of Missouri System; University of Missouri Kansas City; University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory; Pontificia Universidad Catolica de Chile; McGill University; University of Arizona; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of California System; University of California Berkeley; State University System of Florida; University of Florida; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center; University of California System; University of California Davis; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; California Institute of Technology; University of Michigan System; University of Michigan; Max Planck Society; Case Western Reserve University; University of Minnesota System; University of Minnesota Twin Cities; Space Telescope Science Institute; School of the Art Institute of Chicago; Yale University; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	McDonald, M (corresponding author), MIT, MIT Kavli Inst Astrophys & Space Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	mcdonald@space.mit.edu	Rest, Armin/ABE-6469-2020; Liu, Jiayi/AAS-8748-2020; Stubbs, Christopher W/C-2829-2012; Holzapfel, William L/I-4836-2015; saro, Alex/AAL-3998-2020; Williamson, Ross/H-1734-2015; George, Elizabeth/AAR-7371-2021; Ruhl, John/HHS-2212-2022	Liu, Jiayi/0000-0001-6007-5256; Stubbs, Christopher W/0000-0003-0347-1724; saro, Alex/0000-0002-9288-862X; Williamson, Ross/0000-0002-6945-2975; George, Elizabeth/0000-0001-7874-0445; Ruhl, John/0000-0001-5875-4751; Chang, Clarence/0000-0002-6311-0448; Saliwanchik, Benjamin/0000-0002-5089-7472; Reichardt, Christian/0000-0003-2226-9169; Aird, Kenneth/0000-0003-1441-9518; Bleem, Lindsey/0000-0001-7665-5079; Mohr, Joseph/0000-0002-6875-2087; Clocchiatti, Alejandro/0000-0003-3068-4258; Stark, Antony/0000-0002-2718-9996; Benson, Bradford/0000-0002-5108-6823; Mantz, Adam/0000-0002-8031-1217; CRAWFORD, THOMAS/0000-0001-9000-5013; Foley, Ryan/0000-0002-2445-5275; Dobbs, Matt/0000-0001-7166-6422; Forman, William/0000-0002-9478-1682; Marrone, Daniel/0000-0002-2367-1080; Bayliss, Matthew/0000-0003-1074-4807; Rawle, Timothy/0000-0002-7028-5588	MIT by NASA; National Science Foundation; Kavli Foundation; Moore Foundation; NSERC; CRC programme; CIfAR; Harvard University by the NSF; NASA Hubble Fellowship; KICP Fellowship; Alfred P. Sloan Research Fellowship; BCCP fellowship; Direct For Mathematical & Physical Scien [1109115, 1009012] Funding Source: National Science Foundation; Division Of Astronomical Sciences [1009649] Funding Source: National Science Foundation	MIT by NASA; National Science Foundation(National Science Foundation (NSF)); Kavli Foundation; Moore Foundation(Gordon and Betty Moore Foundation); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CRC programme; CIfAR(Canadian Institute for Advanced Research (CIFAR)); Harvard University by the NSF; NASA Hubble Fellowship(National Aeronautics & Space Administration (NASA)); KICP Fellowship; Alfred P. Sloan Research Fellowship(Alfred P. Sloan Foundation); BCCP fellowship; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	M.McD. was supported at MIT by NASA through the Chandra X-ray Observatory. The South Pole Telescope is supported by the National Science Foundation, with partial support provided by the Kavli Foundation, and the Moore Foundation. Support for X-ray analysis was provided by NASA. Work at McGill University is supported by NSERC, the CRC programme, and CIfAR, and at Harvard University by the NSF. S. V. acknowledges a Senior NPP Award held at the NASA Goddard Space Flight Center. R. K. acknowledges a NASA Hubble Fellowship, B. A. B. acknowledges a KICP Fellowship, M. A. D. acknowledges an Alfred P. Sloan Research Fellowship, and O.Z. acknowledges a BCCP fellowship.	Allen SW, 2000, MON NOT R ASTRON SOC, V315, P269, DOI 10.1046/j.1365-8711.2000.03395.x; Allen SW, 1996, MON NOT R ASTRON SOC, V279, P615, DOI 10.1093/mnras/279.2.615; Carlstrom JE, 2011, PUBL ASTRON SOC PAC, V123, P568, DOI 10.1086/659879; COWIE LL, 1977, ASTROPHYS J, V215, P723, DOI 10.1086/155406; Edge AC, 2001, MON NOT R ASTRON SOC, V328, P762, DOI 10.1046/j.1365-8711.2001.04802.x; Fabian A. C., 2012, ANN REV AST IN PRESS; FABIAN AC, 1977, MON NOT R ASTRON SOC, V180, P479, DOI 10.1093/mnras/180.3.479; Foley RJ, 2011, ASTROPHYS J, V731, DOI 10.1088/0004-637X/731/2/86; Gitti M, 2004, ASTRON ASTROPHYS, V427, pL9, DOI 10.1051/0004-6361:200400086; Gomez PL, 2002, ASTROPHYS J, V569, P122, DOI 10.1086/339280; HECKMAN TM, 1989, ASTROPHYS J, V338, P48, DOI 10.1086/167181; HU EM, 1985, ASTROPHYS J SUPPL S, V59, P447, DOI 10.1086/191081; LEA SM, 1973, ASTROPHYS J, V184, pL105, DOI 10.1086/181300; Mathews WG, 2009, ASTROPHYS J LETT, V695, pL49, DOI 10.1088/0004-637X/695/1/L49; McDonald M, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/2/153; McDonald M, 2011, ASTROPHYS J LETT, V742, DOI 10.1088/2041-8205/742/2/L35; McDonald M, 2011, ASTROPHYS J, V734, DOI 10.1088/0004-637X/734/2/95; McDonald M, 2010, ASTROPHYS J, V721, P1262, DOI 10.1088/0004-637X/721/2/1262; McNamara BR, 2007, ANNU REV ASTRON ASTR, V45, P117, DOI 10.1146/annurev.astro.45.051806.110625; McNamara BR, 2006, ASTROPHYS J, V648, P164, DOI 10.1086/505859; Menanteau F, 2012, ASTROPHYS J, V748, DOI 10.1088/0004-637X/748/1/7; O'Dea CP, 2008, ASTROPHYS J, V681, P1035, DOI 10.1086/588212; Polletta M, 2007, ASTROPHYS J, V663, P81, DOI 10.1086/518113; Santos JS, 2008, ASTRON ASTROPHYS, V483, P35, DOI 10.1051/0004-6361:20078815; Sparks WB, 1996, ASTROPHYS J, V473, P254, DOI 10.1086/178141; Vikhlinin A, 2007, ESO ASTROPHY SYMP, P48, DOI 10.1007/978-3-540-73484-0_9; Vikhlinin A, 2009, ASTROPHYS J, V692, P1033, DOI 10.1088/0004-637X/692/2/1033; Williamson R, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/2/139	30	131	133	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2012	488	7411					349	352		10.1038/nature11379	http://dx.doi.org/10.1038/nature11379			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OS	22895340	Green Submitted			2022-12-28	WOS:000307501000035
J	Wilson, NR; Runyan, CA; Wang, FL; Sur, M				Wilson, Nathan R.; Runyan, Caroline A.; Wang, Forea L.; Sur, Mriganka			Division and subtraction by distinct cortical inhibitory networks in vivo	NATURE			English	Article							CAT VISUAL-CORTEX; ORIENTATION SELECTIVITY; DIRECTION SELECTIVITY; NORMALIZATION MODEL; NEURONS; INTERNEURONS; EXCITATION; DYNAMICS; INPUT; MOUSE	Brain circuits process information through specialized neuronal subclasses interacting within a network. Revealing their interplay requires activating specific cells while monitoring others in a functioning circuit. Here we use a new platform for two-way light-based circuit interrogation in visual cortex in vivo to show the computational implications of modulating different subclasses of inhibitory neurons during sensory processing. We find that soma-targeting, parvalbumin-expressing (PV) neurons principally divide responses but preserve stimulus selectivity, whereas dendrite-targeting, somatostatin-expressing (SOM) neurons principally subtract from excitatory responses and sharpen selectivity. Visualized in vivo cell-attached recordings show that division by PV neurons alters response gain, whereas subtraction by SOM neurons shifts response levels. Finally, stimulating identified neurons while scanning many target cells reveals that single PV and SOM neurons functionally impact only specific subsets of neurons in their projection fields. These findings provide direct evidence that inhibitory neuronal subclasses have distinct and complementary roles in cortical computations.	[Wilson, Nathan R.; Runyan, Caroline A.; Wang, Forea L.; Sur, Mriganka] MIT, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health	Sur, M (corresponding author), MIT, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	nathan1@mit.edu; msur@mit.edu			US National Institutes of Health (NIH); Simons Foundation; NIH; NATIONAL EYE INSTITUTE [R01EY018648, R01EY007023] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank J. Huang for providing the SOM-Cre mouse line; C. Le for performing animal care support and viral injections; S. Yan and Y. Deng for help in the development of optogenetics and imaging methods in vitro; S. El-Boustani for collecting data for in vivo deconvolution; J. Sharma, M. Goard and A. Banerjee for comments and discussions on the manuscript; L.-H. Tsai, K. Meletis and M. Carlen for early provision of viral constructs and PV-Cre viral injections; and James Schummers and Hiroki Sugihara for participating in early pilot experiments testing optogenetics stimulation in vivo. This work was supported by postdoctoral fellowships from the US National Institutes of Health (NIH) and the Simons Foundation (N.R.W.), an NIH predoctoral fellowship (C. A. R.) and grants from the NIH and the Simons Foundation (M.S.).	Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; CARANDINI M, 1994, SCIENCE, V264, P1333, DOI 10.1126/science.8191289; Crook JM, 1998, EUR J NEUROSCI, V10, P2056, DOI 10.1046/j.1460-9568.1998.00218.x; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; Fino E, 2011, NEURON, V69, P1188, DOI 10.1016/j.neuron.2011.02.025; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gentet LJ, 2010, NEURON, V65, P422, DOI 10.1016/j.neuron.2010.01.006; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Hofer SB, 2011, NAT NEUROSCI, V14, P1045, DOI 10.1038/nn.2876; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Katzner S, 2011, J NEUROSCI, V31, P5931, DOI 10.1523/JNEUROSCI.5753-10.2011; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; KOCH C, 1983, P NATL ACAD SCI-BIOL, V80, P2799, DOI 10.1073/pnas.80.9.2799; Kulik A, 2006, J NEUROSCI, V26, P4289, DOI 10.1523/JNEUROSCI.4178-05.2006; Lewis DA, 2000, BRAIN RES REV, V31, P270, DOI 10.1016/S0165-0173(99)00042-9; Lillis KP, 2008, J NEUROSCI METH, V172, P178, DOI 10.1016/j.jneumeth.2008.04.024; Liu BH, 2011, NEURON, V71, P542, DOI 10.1016/j.neuron.2011.06.017; Louie K, 2010, J NEUROSCI, V30, P5498, DOI 10.1523/JNEUROSCI.5742-09.2010; Mao R, 2012, CEREB CORTEX, V22, P493, DOI 10.1093/cercor/bhr057; Marino J, 2005, NAT NEUROSCI, V8, P194, DOI 10.1038/nn1391; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; NELSON S, 1994, SCIENCE, V265, P774, DOI 10.1126/science.8047882; Nusser Z, 1996, P NATL ACAD SCI USA, V93, P11939, DOI 10.1073/pnas.93.21.11939; Ohshiro T, 2011, NAT NEUROSCI, V14, P775, DOI 10.1038/nn.2815; Okun M, 2008, NAT NEUROSCI, V11, P535, DOI 10.1038/nn.2105; Packer AM, 2011, J NEUROSCI, V31, P13260, DOI 10.1523/JNEUROSCI.3131-11.2011; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; Rudy B, 2011, DEV NEUROBIOL, V71, P45, DOI 10.1002/dneu.20853; Runyan CA, 2010, NEURON, V67, P847, DOI 10.1016/j.neuron.2010.08.006; Schummers J, 2008, SCIENCE, V320, P1638, DOI 10.1126/science.1156120; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P305, DOI 10.1113/jphysiol.1975.sp011056; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Tan AYY, 2011, J NEUROSCI, V31, P12339, DOI 10.1523/JNEUROSCI.2039-11.2011; Tan AYY, 2004, J NEUROPHYSIOL, V92, P630, DOI 10.1152/jn.01020.2003; TSUMOTO T, 1979, EXP BRAIN RES, V34, P351; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Xing DJ, 2011, J NEUROSCI, V31, P15972, DOI 10.1523/JNEUROSCI.2245-11.2011; Xu XM, 2010, J COMP NEUROL, V518, P389, DOI 10.1002/cne.22229; Yazaki-Sugiyama Y, 2009, NATURE, V462, P218, DOI 10.1038/nature08485; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565	45	354	354	1	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2012	488	7411					343	348		10.1038/nature11347	http://dx.doi.org/10.1038/nature11347			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OS	22878717	Green Accepted, Green Published			2022-12-28	WOS:000307501000034
J	Basu, S; Hassenplug, JC				Basu, Saptarshi; Hassenplug, John C.			Patient Access to Medical Devices - A Comparison of U.S. and European Review Processes	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Basu, Saptarshi; Hassenplug, John C.] US FDA, Off Commissioner, Off Planning, White Oak, MD USA	US Food & Drug Administration (FDA)	Basu, S (corresponding author), US FDA, Off Commissioner, Off Planning, White Oak, MD USA.							[Anonymous], 2012, FDA MED PROD APPR TI; Centers for Medicare & Medicaid Services, COV INF EXCH REP FY; Kramer DB, 2012, NEW ENGL J MED, V366, P848, DOI 10.1056/NEJMhle1113918; Medical Device Network, 2008, PAYB TIM; Schreyogg J, 2010, HEALTH POLICY, V94, P90, DOI 10.1016/j.healthpol.2009.09.008; Schreyogg J, 2009, HEALTH POLICY, V92, P218, DOI 10.1016/j.healthpol.2009.03.016	6	35	36	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 9	2012	367	6					485	488		10.1056/NEJMp1204170	http://dx.doi.org/10.1056/NEJMp1204170			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	986AE	22852882				2022-12-28	WOS:000307310800001
J	Wong, L; Yano, S				Wong, Lawrence; Yano, Shoji			Silvery-Gray Hair in a Newborn	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GRISCELLI-SYNDROME		[Wong, Lawrence; Yano, Shoji] Univ So Calif, Keck Sch Med, LAC USC Med Ctr, Dept Pediat,Genet Div, Los Angeles, CA 90033 USA	Los Angeles County+USC Medical Center; University of Southern California	Yano, S (corresponding author), Univ So Calif, Keck Sch Med Pediat, Div Genet, Gen Lab, 1801 Marengo St,Bldg RM1G-24, Los Angeles, CA 90033 USA.	syano@usc.edu	Yano, Shoji/AAG-2771-2021	Yano, Shoji/0000-0001-5565-9572				Al-Ahmari A, 2010, BONE MARROW TRANSPL, V45, P1294, DOI 10.1038/bmt.2009.358; Bizario JCS, 2004, J CLIN IMMUNOL, V24, P397, DOI 10.1023/B:JOCI.0000029119.83799.cb; Boxer L, 2011, NELSON TXB PEDIAT, P744; King RA, 2002, EMERY RIMOINS PRINCI, P3731; Rezvani I, 2011, NELSON TXB PEDIAT, P424; Wei ML, 2006, PIGM CELL RES, V19, P19, DOI 10.1111/j.1600-0749.2005.00289.x	6	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2012	308	6					617	618		10.1001/jama.2012.8136	http://dx.doi.org/10.1001/jama.2012.8136			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	984YA	22871872				2022-12-28	WOS:000307228400029
J	Clemson, L; Singh, MAF; Bundy, A; Cumming, RG; Manollaras, K; O'Loughlin, P; Black, D				Clemson, Lindy; Singh, Maria A. Fiatarone; Bundy, Anita; Cumming, Robert G.; Manollaras, Kate; O'Loughlin, Patricia; Black, Deborah			Integration of balance and strength training into daily life activity to reduce rate of falls in older people (the LiFE study): randomised parallel trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PHYSICAL-ACTIVITY; DISABILITY INSTRUMENT; ELDERLY-PATIENTS; PREVENT FALLS; EXERCISE; PROGRAM; STYLE; INTERVENTIONS; ASSOCIATION; PERFORMANCE	Objectives To determine whether a lifestyle integrated approach to balance and strength training is effective in reducing the rate of falls in older, high risk people living at home. Design Three arm, randomised parallel trial; assessments at baseline and after six and 12 months. Randomisation done by computer generated random blocks, stratified by sex and fall history and concealed by an independent secure website. Setting Residents in metropolitan Sydney, Australia. Participants Participants aged 70 years or older who had two or more falls or one injurious fall in past 12 months, recruited from Veteran's Affairs databases and general practice databases. Exclusion criteria were moderate to severe cognitive problems, inability to ambulate independently, neurological conditions that severely influenced gait and mobility, resident in a nursing home or hostel, or any unstable or terminal illness that would affect ability to do exercises. Interventions Three home based interventions: Lifestyle integrated Functional Exercise (LiFE) approach (n=107; taught principles of balance and strength training and integrated selected activities into everyday routines), structured programme (n=105; exercises for balance and lower limb strength, done three times a week), sham control programme (n=105; gentle exercise). LiFE and structured groups received five sessions with two booster visits and two phone calls; controls received three home visits and six phone calls. Assessments made at baseline and after six and 12 months. Main outcome measures Primary measure: rate of falls over 12 months, collected by self report. Secondary measures: static and dynamic balance; ankle, knee and hip strength; balance self efficacy; daily living activities; participation; habitual physical activity; quality of life; energy expenditure; body mass index; and fat free mass. Results After 12 months' follow-up, we recorded 172, 193, and 224 falls in the LiFE, structured exercise, and control groups, respectively. The overall incidence of falls in the LiFE programme was 1.66 per person years, compared with 1.90 in the structured programme and 2.28 in the control group. We saw a significant reduction of 31% in the rate of falls for the LiFE programme compared with controls (incidence rate ratio 0.69 (95% confidence interval 0.48 to 0.99)); the corresponding difference between the structured group and controls was non-significant (0.81 (0.56 to 1.17)). Static balance on an eight level hierarchy scale, ankle strength, function, and participation were significantly better in the LiFE group than in controls. LiFE and structured groups had a significant and moderate improvement in dynamic balance, compared with controls. Conclusions The LiFE programme provides an alternative to traditional exercise to consider for fall prevention. Functional based exercise should be a focus for interventions to protect older, high risk people from falling and to improve and maintain functional capacity.	[Clemson, Lindy] Univ Sydney, Ageing Work & Hlth Res Unit, Fac Hlth Sci, Lidcombe, NSW 2141, Australia; [Clemson, Lindy] Univ Sydney, Ctr Excellence Populat Ageing Res, Fac Hlth Sci, Lidcombe, NSW 2141, Australia; [Singh, Maria A. Fiatarone; Bundy, Anita; Manollaras, Kate; O'Loughlin, Patricia; Black, Deborah] Univ Sydney, Fac Hlth Sci, Sydney, NSW 2006, Australia; [Cumming, Robert G.] Univ Sydney, CERA, Sydney, NSW 2006, Australia; [Cumming, Robert G.] Univ Sydney, Fac Med, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; University of Sydney; University of Sydney; University of Sydney	Clemson, L (corresponding author), Univ Sydney, Ageing Work & Hlth Res Unit, Fac Hlth Sci, Lidcombe, NSW 2141, Australia.	lindy.clemson@sydney.edu.au	black, deborah/C-2829-2017; Cumming, Robert G/R-1548-2016	black, deborah/0000-0001-9174-1565; Cumming, Robert G/0000-0002-0261-6103; Bundy, Anita/0000-0003-4743-9144	National Health and Medical Research Council	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The trial was funded by a project grant from the National Health and Medical Research Council.	Andersen RE, 1999, JAMA-J AM MED ASSOC, V281, P335, DOI 10.1001/jama.281.4.335; [Anonymous], 2006, STAT MOD DES RAND CO; Baker PS, 2003, J AM GERIATR SOC, V51, P1610, DOI 10.1046/j.1532-5415.2003.51512.x; Beauchet O, 2009, EUR J NEUROL, V16, P786, DOI 10.1111/j.1468-1331.2009.02612.x; Bleijlevens MHC, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-40; BUCHNER DM, 1993, J AM GERIATR SOC, V41, P321, DOI 10.1111/j.1532-5415.1993.tb06711.x; Campbell AJ, 1997, BMJ-BRIT MED J, V315, P1065, DOI 10.1136/bmj.315.7115.1065; Clemson L, 2004, J AM GERIATR SOC, V52, P1487, DOI 10.1111/j.1532-5415.2004.52411.x; Clemson L, 2012, ENCY BEHAV MED; Clemson L, 2007, LIFESTYLE INTEGRATED; Clemson L, 2010, AUST OCCUP THER J, V57, P42, DOI 10.1111/j.1440-1630.2009.00848.x; Davis JC, 2009, BMJ; Dunn AL, 1999, JAMA-J AM MED ASSOC, V281, P327, DOI 10.1001/jama.281.4.327; Fairhall N, 2011, AGE AGEING, V40, P666, DOI 10.1093/ageing/afr077; Faulkner KA, 2007, J AM GERIATR SOC, V55, P570, DOI 10.1111/j.1532-5415.2007.01147.x; Fiatarone Singh MA, 2003, HELPING ELDERS ACTIV; Finucane F, 1990, VITAL HLTH STAT 1, V25, P1; Friery L, 2007, RASCH ANAL LIFE ASSE; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Haley SM, 2002, J GERONTOL A-BIOL, V57, pM217, DOI 10.1093/gerona/57.4.M217; Irwin M, 2008, METHODOLOGICAL ISSUE; Jaques-Dalcroze E, 1967, RHYTHM MUSIC ED; Jette AM, 2002, J GERONTOL A-BIOL, V57, pM209, DOI 10.1093/gerona/57.4.M209; Kuptniratsaikul V, 2011, CLIN INTERV AGING, V6, P111, DOI 10.2147/CIA.S17851; Linacre JM, 2015, WINSTEPS RASCH MEASU; Liu-Ambrose T, 2012, BR J SPORTS MED; Lord SR, 2003, J AM GERIATR SOC, V51, P1685, DOI 10.1046/j.1532-5415.2003.51551.x; Menz HB, 2005, J GERONTOL A-BIOL, V60, P1546, DOI 10.1093/gerona/60.12.1546; Moher David, 2012, Int J Surg, V10, P28, DOI 10.1016/j.ijsu.2011.10.001; NSW Department of Health, 2007, NSW DEP HLTH ANN REP; Opdenacker J, 2008, PREV MED, V46, P518, DOI 10.1016/j.ypmed.2008.02.017; PAFFENBARGER RS, 1978, AM J EPIDEMIOL, V108, P161, DOI 10.1093/oxfordjournals.aje.a112608; PROVINCE MA, 1995, JAMA-J AM MED ASSOC, V273, P1341, DOI 10.1001/jama.273.17.1341; Robertson MC, 2005, J GERONTOL A-BIOL, V60, P530, DOI 10.1093/gerona/60.4.530; Sherrington C, 2008, J AM GERIATR SOC, V56, P2234, DOI 10.1111/j.1532-5415.2008.02014.x; Silsupadol P, 2009, GAIT POSTURE, V29, P634, DOI 10.1016/j.gaitpost.2009.01.006; Sun SS, 2003, AM J CLIN NUTR, V77, P331, DOI 10.1093/ajcn/77.2.331; Talley KMC, 2008, J AM GERIATR SOC, V56, P328, DOI 10.1111/j.1532-5415.2007.01550.x; Thalheimer W., 2002, CALCULATE EFFECT SIZ; Trombetti A, 2011, ARCH INTERN MED, V171, P525, DOI 10.1001/archinternmed.2010.446; Washburn RA, 1999, J CLIN EPIDEMIOL, V52, P643, DOI 10.1016/S0895-4356(99)00049-9; Watson W, 2010, INCIDENCE COST FALLS; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	43	256	258	0	114	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 7	2012	345								e4547	10.1136/bmj.e4547	http://dx.doi.org/10.1136/bmj.e4547			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988NA	22872695	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000307496500001
J	Van Handel, B; Montel-Hagen, A; Sasidharan, R; Nakano, H; Ferrari, R; Boogerd, CJ; Schredelseker, J; Wang, YL; Hunter, S; Org, T; Zhou, J; Li, XM; Pellegrini, M; Chen, JN; Orkin, SH; Kurdistani, SK; Evans, SM; Nakano, A; Mikkola, HKA				Van Handel, Ben; Montel-Hagen, Amelie; Sasidharan, Rajkumar; Nakano, Haruko; Ferrari, Roberto; Boogerd, Cornelis J.; Schredelseker, Johann; Wang, Yanling; Hunter, Sean; Org, Tonis; Zhou, Jian; Li, Xinmin; Pellegrini, Matteo; Chen, Jau-Nian; Orkin, Stuart H.; Kurdistani, Siavash K.; Evans, Sylvia M.; Nakano, Atsushi; Mikkola, Hanna K. A.			Scl Represses Cardiomyogenesis in Prospective Hemogenic Endothelium and Endocardium	CELL			English	Article							HEMATOPOIETIC STEM-CELLS; AORTIC ENDOTHELIUM; PROGENITOR CELLS; CARDIOVASCULAR PROGENITORS; HAEMOGENIC ENDOTHELIUM; DEFINED FACTORS; SMOOTH-MUSCLE; MOUSE EMBRYO; DIFFERENTIATION; BLOOD	Endothelium in embryonic hematopoietic tissues generates hematopoietic stem/progenitor cells; however, it is unknown how its unique potential is specified. We show that transcription factor Scl/Tal1 is essential for both establishing the hematopoietic transcriptional program in hemogenic endothelium and preventing its misspecification to a cardiomyogenic fate. Scl(-/-) embryos activated a cardiac transcriptional program in yolk sac endothelium, leading to the emergence of CD31(+)Pdgfr alpha(+) cardiogenic precursors that generated spontaneously beating cardiomyocytes. Ectopic cardiogenesis was also observed in Scl(-/-) hearts, where the disorganized endocardium precociously differentiated into cardiomyocytes. Induction of mosaic deletion of Scl in Scl(fl/fl)Rosa26Cre-ERT2 embryos revealed a cell-intrinsic, temporal requirement for Scl to prevent cardiomyogenesis from endothelium. Scl(-/-) endothelium also upregulated the expression of Wnt antagonists, which promoted rapid cardiomyocyte differentiation of ectopic cardiogenic cells. These results reveal unexpected plasticity in embryonic endothelium such that loss of a single master regulator can induce ectopic cardiomyogenesis from endothelial cells.	[Van Handel, Ben; Montel-Hagen, Amelie; Sasidharan, Rajkumar; Nakano, Haruko; Schredelseker, Johann; Wang, Yanling; Hunter, Sean; Org, Tonis; Pellegrini, Matteo; Chen, Jau-Nian; Nakano, Atsushi; Mikkola, Hanna K. A.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Ferrari, Roberto; Kurdistani, Siavash K.] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Zhou, Jian; Li, Xinmin] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Pellegrini, Matteo; Kurdistani, Siavash K.; Nakano, Atsushi; Mikkola, Hanna K. A.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Pellegrini, Matteo; Kurdistani, Siavash K.; Nakano, Atsushi; Mikkola, Hanna K. A.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Pellegrini, Matteo; Kurdistani, Siavash K.; Nakano, Atsushi; Mikkola, Hanna K. A.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Mikkola, Hanna K. A.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Boogerd, Cornelis J.; Evans, Sylvia M.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Boogerd, Cornelis J.; Evans, Sylvia M.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Orkin, Stuart H.] Harvard Univ, Sch Med, Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Orkin, Stuart H.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Orkin, Stuart H.] Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California San Diego; University of California System; University of California San Diego; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute	Mikkola, HKA (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	hmikkola@mcdb.ucla.edu	Ferrari, Roberto/O-8143-2015; Boogerd, Cornelis/A-7470-2016; Org, Tõnis/E-8596-2010; Boogerd, Cornelis J/D-3244-2009; Evans, Sylvia/G-1980-2015; Chen, Jau-Nian/AAM-7808-2020	Ferrari, Roberto/0000-0002-0453-0899; Org, Tõnis/0000-0003-3071-2183; Boogerd, Cornelis J/0000-0002-7119-5381; Chen, Jau-Nian/0000-0001-8807-3607; Pellegrini, Matteo/0000-0001-9355-9564; Schredelseker, Johann/0000-0002-6657-0466; Yamada-Hunter, Sean/0000-0002-4372-6587	California Institute for Regenerative Medicine (CIRM) New Faculty Award; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA Innovation Award; NIH [HL097766-01]; Ruth L. Kirschstein National Research Service Award [GM07185]; NIH/National Heart, Lung, and Blood Institute [T32 HL69766]; European Molecular Biology Organisation; Human Frontier Science Program; CIRM; Netherlands Organization for Scientific Research [825.10.016]; European Union [MJD284]; Center of Excellence in Molecular Hematology award from the National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097766, T32HL069766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine (CIRM) New Faculty Award; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA Innovation Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); European Molecular Biology Organisation; Human Frontier Science Program(Human Frontier Science Program); CIRM(California Institute for Regenerative Medicine); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Union(European Commission); Center of Excellence in Molecular Hematology award from the National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Joshua Bloomekatz and Dr. Deborah Yelon for critical reading of the manuscript and sharing unpublished data and Guillaume Hagen for preparing the movies. The authors thank the Broad Stem Cell Research Center Flow Cytometry Core for FACS sorting. This work was funded by the California Institute for Regenerative Medicine (CIRM) New Faculty Award, the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA Innovation Award and NIH/RO1 (HL097766-01) grants to H. K. A. M. B. V. H. was supported by the Ruth L. Kirschstein National Research Service Award GM07185 and NIH/National Heart, Lung, and Blood Institute Grant T32 HL69766. A. M.-H was supported by successive fellowships from the European Molecular Biology Organisation and the Human Frontier Science Program. R. F. was funded in part by a CIRM grant to S. K. K. C.J.B. was funded by Rubicon Grant 825.10.016 from the Netherlands Organization for Scientific Research. T.O. was supported by the European Union through the European Social Fund (Mobilitas Grant No. MJD284). S.H.O., an Investigator of the Howard Hughes Medical Institute, is supported in part by a Center of Excellence in Molecular Hematology award from the National Institute of Diabetes and Digestive and Kidney Diseases.	Ahnfelt-Ronne J, 2007, J HISTOCHEM CYTOCHEM, V55, P925, DOI 10.1369/jhc.7A7226.2007; Alva JA, 2006, DEV DYNAM, V235, P759, DOI 10.1002/dvdy.20643; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Bertrand JY, 2005, P NATL ACAD SCI USA, V102, P134, DOI 10.1073/pnas.0402270102; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; David R, 2008, NAT CELL BIOL, V10, P338, DOI 10.1038/ncb1696; de Lange FJ, 2004, CIRC RES, V95, P645, DOI 10.1161/01.RES.0000141429.13560.cb; Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Ismailoglu I, 2008, EXP HEMATOL, V36, P1593, DOI 10.1016/j.exphem.2008.07.005; Jaspard B, 2000, MECH DEVELOP, V90, P263, DOI 10.1016/S0925-4773(99)00236-1; Kassouf MT, 2010, GENOME RES, V20, P1064, DOI 10.1101/gr.104935.110; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Kinder SJ, 2001, TRENDS CARDIOVAS MED, V11, P177, DOI 10.1016/S1050-1738(01)00091-3; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Lancrin C, 2009, NATURE, V457, P892, DOI 10.1038/nature07679; Lindsley RC, 2008, CELL STEM CELL, V3, P55, DOI 10.1016/j.stem.2008.04.004; Mikkola HKA, 2003, BLOOD, V101, P508, DOI 10.1182/blood-2002-06-1699; Mikkola HKA, 2003, NATURE, V421, P547, DOI 10.1038/nature01345; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Nostro MC, 2008, CELL STEM CELL, V2, P60, DOI 10.1016/j.stem.2007.10.011; Palencia-Desai S, 2011, DEVELOPMENT, V138, P4721, DOI 10.1242/dev.064998; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Qyang Y, 2007, CELL STEM CELL, V1, P165, DOI 10.1016/j.stem.2007.05.018; Rasmussen TL, 2011, DEVELOPMENT, V138, P4801, DOI 10.1242/dev.070912; Rhodes KE, 2008, CELL STEM CELL, V2, P252, DOI 10.1016/j.stem.2008.01.001; Schlaeger TM, 2005, BLOOD, V105, P3871, DOI 10.1182/blood-2004-11-4467; Schneider VA, 2001, GENE DEV, V15, P304, DOI 10.1101/gad.855601; Schoenebeck JJ, 2007, DEV CELL, V13, P254, DOI 10.1016/j.devcel.2007.05.012; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; Simoes FC, 2011, DEVELOPMENT, V138, P3235, DOI 10.1242/dev.059634; Souroullas GP, 2009, CELL STEM CELL, V4, P180, DOI 10.1016/j.stem.2009.01.001; Stadtfeld M, 2005, DEVELOPMENT, V132, P203, DOI 10.1242/dev.01558; Takeuchi JK, 2009, NATURE, V459, P708, DOI 10.1038/nature08039; Tian Y, 2010, DEV CELL, V18, P275, DOI 10.1016/j.devcel.2010.01.008; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; Visvader JE, 1998, GENE DEV, V12, P473, DOI 10.1101/gad.12.4.473; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Yamagishi T, 2009, ANAT SCI INT, V84, P77, DOI 10.1007/s12565-009-0027-0; Zeigler BM, 2006, DEVELOPMENT, V133, P4183, DOI 10.1242/dev.02596; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	47	118	120	1	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 3	2012	150	3					590	605		10.1016/j.cell.2012.06.026	http://dx.doi.org/10.1016/j.cell.2012.06.026			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	985WO	22863011	Bronze, Green Accepted			2022-12-28	WOS:000307301400017
J	Baker, DN				Baker, Daniel N.			Let academia lead space science	NATURE			English	Editorial Material									[Baker, Daniel N.] Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80309 USA; [Baker, Daniel N.] NASAs Goddard Space Flight Ctr, Extraterr Phys Lab, Greenbelt, MD USA	University of Colorado System; University of Colorado Boulder; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Baker, DN (corresponding author), Univ Colorado, Atmospher & Space Phys Lab, Campus Box 392, Boulder, CO 80309 USA.	daniel.baker@lasp.colorado.edu							0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2012	488	7409					27	28		10.1038/488027a	http://dx.doi.org/10.1038/488027a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	981ZE	22859186	Bronze			2022-12-28	WOS:000307010700016
J	Jones, DTW; Jager, N; Kool, M; Zichner, T; Hutter, B; Sultan, M; Cho, YJ; Pugh, TJ; Hovestadt, V; Stutz, AM; Rausch, T; Warnatz, HJ; Ryzhova, M; Bender, S; Sturm, D; Pleier, S; Cin, H; Pfaff, E; Sieber, L; Wittmann, A; Remke, M; Witt, H; Hutter, S; Tzaridis, T; Weischenfeldt, J; Raeder, B; Avci, M; Amstislavskiy, V; Zapatka, M; Weber, UD; Wang, Q; Lasitschka, B; Bartholomae, CC; Schmidt, M; von Kalle, C; Ast, V; Lawerenz, C; Eils, J; Kabbe, R; Benes, V; van Sluis, P; Koster, J; Volckmann, R; Shih, D; Betts, MJ; Russell, RB; Coco, S; Tonini, GP; Schuller, U; Hans, V; Graf, N; Kim, YJ; Monoranu, C; Roggendorf, W; Unterberg, A; Herold-Mende, C; Milde, T; Kulozik, AE; von Deimling, A; Witt, O; Maass, E; Rossler, J; Ebinger, M; Schuhmann, MU; Fruhwald, MC; Hasselblatt, M; Jabado, N; Rutkowski, S; von Bueren, AO; Williamson, D; Clifford, SC; McCabe, MG; Collins, VP; Wolf, S; Wiemann, S; Lehrach, H; Brors, B; Scheurlen, W; Felsberg, J; Reifenberger, G; Northcott, PA; Taylor, MD; Meyerson, M; Pomeroy, SL; Yaspo, ML; Korbel, JO; Korshunov, A; Eils, R; Pfister, SM; Lichter, P				Jones, David T. W.; Jaeger, Natalie; Kool, Marcel; Zichner, Thomas; Hutter, Barbara; Sultan, Marc; Cho, Yoon-Jae; Pugh, Trevor J.; Hovestadt, Volker; Stuetz, Adrian M.; Rausch, Tobias; Warnatz, Hans-Joerg; Ryzhova, Marina; Bender, Sebastian; Sturm, Dominik; Pleier, Sabrina; Cin, Huriye; Pfaff, Elke; Sieber, Laura; Wittmann, Andrea; Remke, Marc; Witt, Hendrik; Hutter, Sonja; Tzaridis, Theophilos; Weischenfeldt, Joachim; Raeder, Benjamin; Avci, Meryem; Amstislavskiy, Vyacheslav; Zapatka, Marc; Weber, Ursula D.; Wang, Qi; Lasitschka, Baerbel; Bartholomae, Cynthia C.; Schmidt, Manfred; von Kalle, Christof; Ast, Volker; Lawerenz, Chris; Eils, Juergen; Kabbe, Rolf; Benes, Vladimir; van Sluis, Peter; Koster, Jan; Volckmann, Richard; Shih, David; Betts, Matthew J.; Russell, Robert B.; Coco, Simona; Tonini, Gian Paolo; Schueller, Ulrich; Hans, Volkmar; Graf, Norbert; Kim, Yoo-Jin; Monoranu, Camelia; Roggendorf, Wolfgang; Unterberg, Andreas; Herold-Mende, Christel; Milde, Till; Kulozik, Andreas E.; von Deimling, Andreas; Witt, Olaf; Maass, Eberhard; Roessler, Jochen; Ebinger, Martin; Schuhmann, Martin U.; Fruehwald, Michael C.; Hasselblatt, Martin; Jabado, Nada; Rutkowski, Stefan; von Bueren, Andre O.; Williamson, Dan; Clifford, Steven C.; McCabe, Martin G.; Collins, V. Peter; Wolf, Stephan; Wiemann, Stefan; Lehrach, Hans; Brors, Benedikt; Scheurlen, Wolfram; Felsberg, Joerg; Reifenberger, Guido; Northcott, Paul A.; Taylor, Michael D.; Meyerson, Matthew; Pomeroy, Scott L.; Yaspo, Marie-Laure; Korbel, Jan O.; Korshunov, Andrey; Eils, Roland; Pfister, Stefan M.; Lichter, Peter			Dissecting the genomic complexity underlying medulloblastoma	NATURE			English	Article							TETRAPLOID TUMOR-CELLS; MUTATIONS; ACTIVATION; SUBGROUPS; LANDSCAPE; GENES; TBR1	Medulloblastoma is an aggressively growing tumour, arising in the cerebellum or medulla/brain stem. It is the most common malignant brain tumour in children, and shows tremendous biological and clinical heterogeneity(1). Despite recent treatment advances, approximately 40% of children experience tumour recurrence, and 30% will die from their disease. Those who survive often have a significantly reduced quality of life. Four tumour subgroups with distinct clinical, biological and genetic profiles are currently identified(2,3). WNT tumours, showing activated wingless pathway signalling, carry a favourable prognosis under current treatment regimens(4). SHH tumours show hedgehog pathway activation, and have an intermediate prognosis(2). Group 3 and 4 tumours are molecularly less well characterized, and also present the greatest clinical challenges(2,3,5). The full repertoire of genetic events driving this distinction, however, remains unclear. Here we describe an integrative deep-sequencing analysis of 125 tumour-normal pairs, conducted as part of the International Cancer Genome Consortium (ICGC) PedBrain Tumor Project. Tetraploidy was identified as a frequent early event in Group 3 and 4 tumours, and a positive correlation between patient age and mutation rate was observed. Several recurrent mutations were identified, both in known medulloblastoma-related genes (CTNNB1, PTCH1, MLL2, SMARCA4) and in genes not previously linked to this tumour (DDX3X, CTDNEP1, KDM6A, TBR1), often in subgroup-specific patterns. RNA sequencing confirmed these alterations, and revealed the expression of what are, to our knowledge, the first medulloblastoma fusion genes identified. Chromatin modifiers were frequently altered across all subgroups. These findings enhance our understanding of the genomic complexity and heterogeneity underlying medulloblastoma, and provide several potential targets for new therapeutics, especially for Group 3 and 4 patients.	[Jaeger, Natalie; Hutter, Barbara; Wang, Qi; Kabbe, Rolf; Brors, Benedikt; Eils, Roland] German Canc Res Ctr, Div Theoret Bioinformat, D-69120 Heidelberg, Germany; [Jones, David T. W.; Kool, Marcel; Bender, Sebastian; Sturm, Dominik; Pleier, Sabrina; Cin, Huriye; Pfaff, Elke; Sieber, Laura; Wittmann, Andrea; Remke, Marc; Witt, Hendrik; Hutter, Sonja; Tzaridis, Theophilos; Pfister, Stefan M.] German Canc Res Ctr, Div Pediat Neurooncol, D-69120 Heidelberg, Germany; [Zichner, Thomas; Stuetz, Adrian M.; Weischenfeldt, Joachim; Raeder, Benjamin; Korbel, Jan O.] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Sultan, Marc; Warnatz, Hans-Joerg; Avci, Meryem; Amstislavskiy, Vyacheslav; Lehrach, Hans; Yaspo, Marie-Laure] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Cho, Yoon-Jae] Stanford Univ, Div Child Neurol, Palo Alto, CA 94304 USA; [Pugh, Trevor J.; Meyerson, Matthew; Pomeroy, Scott L.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Hovestadt, Volker; Zapatka, Marc; Weber, Ursula D.; Lichter, Peter] German Canc Res Ctr, Div Mol Genet, D-69120 Heidelberg, Germany; [Ryzhova, Marina] NN Burdenko Inst Neurosurg, Dept Neuropathol, Moscow 125047, Russia; [Witt, Hendrik; Milde, Till; Kulozik, Andreas E.; Pfister, Stefan M.] Univ Heidelberg Hosp, Dept Pediat Oncol Hematol & Immunol, D-69120 Heidelberg, Germany; [Bartholomae, Cynthia C.; Schmidt, Manfred; von Kalle, Christof] German Canc Res Ctr, Div Translat Oncol, D-69120 Heidelberg, Germany; [Bartholomae, Cynthia C.; Schmidt, Manfred; von Kalle, Christof] Natl Ctr Tumor Dis NCT, D-69120 Heidelberg, Germany; [van Sluis, Peter; Koster, Jan; Volckmann, Richard] Univ Amsterdam, AMC, Dept Oncogenom, NL-1105 AZ Amsterdam, Netherlands; [Shih, David; Northcott, Paul A.] Hosp Sick Children, Arthur & Sonia Labbatt Brain Tumor Res Ctr, Toronto, ON M5G 1X8, Canada; [Betts, Matthew J.; Russell, Robert B.] Heidelberg Univ, Cell Networks Cluster Excellence, D-69120 Heidelberg, Germany; [Coco, Simona; Tonini, Gian Paolo] IRCCS Azienda Osped Univ San Martino, IST Ist Nazl Ric Canc, Dept Adv Diagnost Technol, I-16132 Genoa, Italy; [Schueller, Ulrich] Univ Munich, Ctr Neuropathol & Prion Res, D-81377 Munich, Germany; [Hans, Volkmar] Evangel Krankenhaus, Inst Neuropathol, D-33617 Bielefeld, Germany; [Graf, Norbert] Saarland Univ Hosp, Dept Paediat Oncol & Haematol, D-66421 Homburg, Germany; [Kim, Yoo-Jin] Saarland Univ Hosp, Inst Pathol, D-66424 Homburg, Germany; [Monoranu, Camelia; Roggendorf, Wolfgang] Inst Pathol, Dept Neuropathol, D-97080 Wurzburg, Germany; [Unterberg, Andreas; Herold-Mende, Christel] Univ Heidelberg Hosp, Dept Neurosurg, D-69120 Heidelberg, Germany; [Milde, Till; Witt, Olaf] German Canc Res Ctr, Clin Cooperat Unit Pediat Oncol, D-69120 Heidelberg, Germany; [von Deimling, Andreas; Korshunov, Andrey] Heidelberg Univ, Dept Neuropathol, D-69120 Heidelberg, Germany; [von Deimling, Andreas; Korshunov, Andrey] German Canc Res Ctr, Clin Cooperat Unit Neuropathol, D-69120 Heidelberg, Germany; [Maass, Eberhard] Klinikum Stuttgart Olgahosp, Dept Pediat Oncol Hematol & Immunol, D-70176 Stuttgart, Germany; [Roessler, Jochen] Univ Hosp Freiburg, Dept Paediat Haematol & Oncol, D-79106 Freiburg, Germany; [Ebinger, Martin] Childrens Univ Hosp, Dept Hematol & Oncol, D-72076 Tubingen, Germany; [Schuhmann, Martin U.] Univ Hosp, Dept Neurosurg, D-72076 Tubingen, Germany; [Fruehwald, Michael C.] Childrens Hosp Augsburg, D-86156 Augsburg, Germany; [Hasselblatt, Martin] Univ Hosp Munster, Inst Neuropathol, D-48149 Munster, Germany; [Jabado, Nada] McGill Univ, Dept Pediat, Montreal, PQ H3Z 2Z3, Canada; [Jabado, Nada] McGill Univ, Dept Human Genet, Montreal, PQ H3Z 2Z3, Canada; [Jabado, Nada] McGill Univ Hlth Ctr Res Inst, Montreal, PQ H3Z 2Z3, Canada; [Rutkowski, Stefan; von Bueren, Andre O.] Univ Med Ctr Hamburg Eppendorf, Dept Paediat Haematol & Oncol, D-20246 Hamburg, Germany; [Williamson, Dan; Clifford, Steven C.] Newcastle Univ, Royal Victoria Infirm, No Inst Canc Res, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [McCabe, Martin G.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Sch Canc & Enabling Sci, Manchester M13 9PL, Lancs, England; [Collins, V. Peter] Univ Cambridge, Dept Pathol, Div Mol Histopathol, Cambridge CB2 0QQ, England; [Wiemann, Stefan] German Canc Res Ctr, Div Mol Genome Anal, D-69120 Heidelberg, Germany; [Scheurlen, Wolfram] Nurnberg Childrens Hosp, Cnopfsche Kinderklinik, D-90419 Nurnberg, Germany; [Felsberg, Joerg; Reifenberger, Guido] Univ Dusseldorf, Dept Neuropathol, D-40225 Dusseldorf, Germany; [Taylor, Michael D.] Hosp Sick Children, Div Neurosurg, Toronto, ON M5G 1X8, Canada; [Taylor, Michael D.] Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Toronto, ON M5G 1X8, Canada; [Meyerson, Matthew] Dana Farber Canc Inst, Boston, MA 02215 USA; [Pomeroy, Scott L.] Childrens Hosp, Boston, MA 02115 USA; [Eils, Roland] Heidelberg Univ, Inst Pharm & Mol Biotechnol, D-69120 Heidelberg, Germany; [Eils, Roland] Heidelberg Univ, Bioquant Ctr, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); European Molecular Biology Laboratory (EMBL); Max Planck Society; Stanford University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Helmholtz Association; German Cancer Research Center (DKFZ); Russian Academy of Medical Sciences; N.N.Burdenko National Medical Research Center of Neurosurgery; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Amsterdam; Academic Medical Center Amsterdam; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Ruprecht Karls University Heidelberg; University of Genoa; IRCCS AOU San Martino IST; University of Munich; Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes; University of Wurzburg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Klinikum Stuttgart; University of Freiburg; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; University of Hamburg; University Medical Center Hamburg-Eppendorf; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Munster; McGill University; McGill University; McGill University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Newcastle University - UK; University of Manchester; University of Cambridge; Helmholtz Association; German Cancer Research Center (DKFZ); Heinrich Heine University Dusseldorf; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Eils, R (corresponding author), German Canc Res Ctr, Div Theoret Bioinformat, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	r.eils@dkfz-heidelberg.de; s.pfister@dkfz-heidelberg.de; m.macleod@dkfz-heidelberg.de	Ebinger, Martin/O-4936-2016; Korbel, Jan O/G-6470-2012; von Deimling, Andreas/F-7774-2013; Northcott, Paul A/N-4022-2018; Pfister, Stefan M/F-6860-2013; Jabado, Nada/AAN-4026-2020; wang, edwin/G-5372-2010; Sturm, Dominik/AAL-3689-2020; Pugh, Trevor/Y-2535-2019; Kulozik, Andreas/AAO-2432-2020; Milde, Till/L-7755-2015; Brors, Benedikt/E-5620-2013; Eils, Roland/B-6121-2009; McCabe, Martin/P-5896-2015; Russell, Robert/GWU-6389-2022; Reifenberger, Guido/AAE-3599-2019; Wiemann, Stefan/E-4424-2013; Jones, David TW/G-9588-2013; Russell, Rob/AAH-9145-2019; Shih, David J H/H-3186-2011; Kool, Marcel/H-2541-2013; Jones, David T. W./Z-1963-2019; Graf, Norbert/H-1328-2011; Weischenfeldt, Joachim/O-3681-2015; Witt, Hendrik/L-7810-2015; Shih, David J. H./AAE-8726-2019; Zapatka, Marc/G-9896-2013; Rausch, Tobias/H-6511-2019; Ryzhova, Marina/G-4178-2014; von Bueren, Andre/AAF-2065-2020; Koster, Jan/C-5934-2008; Coco, Simona/J-6051-2016; Meyerson, Matthew L/E-7123-2012; Milde, Till/AAR-4528-2021	Ebinger, Martin/0000-0002-4229-8058; Korbel, Jan O/0000-0002-2798-3794; von Deimling, Andreas/0000-0002-5863-540X; Northcott, Paul A/0000-0002-1220-5252; Pfister, Stefan M/0000-0002-5447-5322; Sturm, Dominik/0000-0003-0250-1696; Pugh, Trevor/0000-0002-8073-5888; Brors, Benedikt/0000-0001-5940-3101; Eils, Roland/0000-0002-0034-4036; McCabe, Martin/0000-0002-5138-0707; Russell, Robert/0000-0002-7213-1398; Wiemann, Stefan/0000-0003-4683-3174; Jones, David TW/0000-0002-2036-5141; Russell, Rob/0000-0002-1905-4717; Shih, David J H/0000-0002-9802-4937; Graf, Norbert/0000-0002-2248-323X; Weischenfeldt, Joachim/0000-0002-3917-5524; Shih, David J. H./0000-0002-9802-4937; Zapatka, Marc/0000-0001-8287-5967; Rausch, Tobias/0000-0001-5773-5620; Ryzhova, Marina/0000-0001-7206-6365; Koster, Jan/0000-0002-0890-7585; Coco, Simona/0000-0002-5296-4325; Milde, Till/0000-0002-7267-1052; Wang, Qi/0000-0002-6420-1720; von Bueren, Andre/0000-0003-4197-6264; Taylor, Michael/0000-0001-7009-3466; Rossler, Jochen/0000-0003-4022-4917; Zichner, Thomas/0000-0001-9848-7598; Clifford, Steve/0000-0003-4893-2184; Tzaridis, Theophilos/0000-0001-9651-1144; Jaeger, Natalie/0000-0002-9589-7580; Hasselblatt, Martin/0000-0003-2707-8484; Hovestadt, Volker/0000-0002-3480-6649; Hutter, Barbara/0000-0002-9034-0329; Stuetz, Adrian/0000-0001-7650-3470; Benes, Vladimir/0000-0002-0352-2547; Schuller, Ulrich/0000-0002-8731-1121; Remke, Marc/0000-0002-9404-9993; Meyerson, Matthew/0000-0002-9133-8108; Raeder, Benjamin/0000-0002-9494-8884; Korshunov, Andrey/0000-0002-5257-3623; Warnatz, Hans-Jorg/0000-0002-0327-9209	PedBrain Tumor Project contributing to the International Cancer Genome Consortium (ICGC PedBrain Tumor Project); German Cancer Aid [109252]; German Federal Ministry of Education and Research (BMBF) [01GS0883]; German Cancer Research Center-Heidelberg Center for Personalized Oncology (DKFZ-HIPO); Max Planck Society; Pediatric Brain Tumor Foundation; Italian Neuroblastoma Foundation; Samantha Dickson Brain Tumour Trust; UK Children's Cancer and Leukaemia Group (CCLG) [BS-2007-04]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA109467] Funding Source: NIH RePORTER; Cancer Research UK [13457] Funding Source: researchfish; The Brain Tumour Charity [16/92, 10/106] Funding Source: researchfish	PedBrain Tumor Project contributing to the International Cancer Genome Consortium (ICGC PedBrain Tumor Project); German Cancer Aid(Deutsche Krebshilfe); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Cancer Research Center-Heidelberg Center for Personalized Oncology (DKFZ-HIPO); Max Planck Society(Max Planck Society); Pediatric Brain Tumor Foundation; Italian Neuroblastoma Foundation; Samantha Dickson Brain Tumour Trust; UK Children's Cancer and Leukaemia Group (CCLG); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); The Brain Tumour Charity	We thank GATC Biotech AG for sequencing services. For technical support and expertise we thank: B. Haase, D. Pavlinic, B. Baying, M. Wahlers, R. Luck, I. Kutschera, K. Schlangen, M. Metsger, K. Schulz, A. Nurnberger, A. Kovacsovics, M. Linser, J. C. Lindsey, S. Bailey, D. M. Pearson, the EMBL Genomics Core Facility, the EMBL High-performance Computing Core Facility and the DKFZ Genomics and Proteomics Core Facility. This work was principally supported by the PedBrain Tumor Project contributing to the International Cancer Genome Consortium (ICGC PedBrain Tumor Project, http://www.pedbraintumor.org/), funded by German Cancer Aid (109252) and the German Federal Ministry of Education and Research (BMBF, NGFN<SUP>plus</SUP> #01GS0883). Additional support came from the German Cancer Research Center-Heidelberg Center for Personalized Oncology (DKFZ-HIPO), the Max Planck Society, the Pediatric Brain Tumor Foundation, the Italian Neuroblastoma Foundation and the Samantha Dickson Brain Tumour Trust. This study included samples provided by the UK Children's Cancer and Leukaemia Group (CCLG) as part of CCLG-approved biological study BS-2007-04.	Clifford SC, 2006, CELL CYCLE, V5, P2666, DOI 10.4161/cc.5.22.3446; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Gilbertson RJ, 1997, CANCER RES, V57, P3272; Han S, 2012, J BIOL CHEM, V287, P3123, DOI 10.1074/jbc.M111.324350; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Kim YJ, 2007, P NATL ACAD SCI USA, V104, P6596, DOI 10.1073/pnas.0702099104; Kool M, 2012, ACTA NEUROPATHOL, V123, P473, DOI 10.1007/s00401-012-0958-8; Kool M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003088; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Northcott PA, 2009, NAT GENET, V41, P465, DOI 10.1038/ng.336; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Pfister S, 2009, J CLIN ONCOL, V27, P1627, DOI 10.1200/JCO.2008.17.9432; Pietsch T, 1997, CANCER RES, V57, P2085; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Rello-Varona S, 2009, CELL CYCLE, V8, P1030, DOI 10.4161/cc.8.7.7950; Satow R, 2006, DEV CELL, V11, P763, DOI 10.1016/j.devcel.2006.10.001; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; Thompson MC, 2006, J CLIN ONCOL, V24, P1924, DOI 10.1200/JCO.2005.04.4974; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Vitale I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001337; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016	25	598	611	2	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 2	2012	488	7409					100	105		10.1038/nature11284	http://dx.doi.org/10.1038/nature11284			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ZE	22832583	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000307010700041
J	Brewer, C				Brewer, Colin			"Beau de Jour"-a male doctor who bought and sold sex	BRITISH MEDICAL JOURNAL			English	Editorial Material									Stapleford Ctr, London SW1W 9NP, England		Brewer, C (corresponding author), Stapleford Ctr, London SW1W 9NP, England.								0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 1	2012	345								e5115	10.1136/bmj.e5115	http://dx.doi.org/10.1136/bmj.e5115			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	985XC	22859772				2022-12-28	WOS:000307302800009
J	VanLare, JM; Conway, PH				VanLare, Jordan M.; Conway, Patrick H.			Value-Based Purchasing - National Programs to Move from Volume to Value	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[VanLare, Jordan M.; Conway, Patrick H.] Ctr Medicare, Baltimore, MD USA; [VanLare, Jordan M.; Conway, Patrick H.] Ctr Medicaid Sev, Baltimore, MD USA; [VanLare, Jordan M.] Columbia Univ, Coll Physicians & Surg, New York, NY USA; [Conway, Patrick H.] Cincinnati Childrens Hosp, Med Ctr, Cincinnati, OH USA	Centers for Medicare & Medicaid Services; Columbia University; Cincinnati Children's Hospital Medical Center	VanLare, JM (corresponding author), Ctr Medicare, Baltimore, MD USA.							Health Services Advisory Group, 2012, NAT IMP ASS MED QUAL; Jha AK, 2012, NEW ENGL J MED, V366, P1606, DOI 10.1056/NEJMsa1112351; Lindenauer PK, 2007, NEW ENGL J MED, V356, P486, DOI 10.1056/NEJMsa064964; Martin AB, 2012, HEALTH AFFAIR, V31, P208, DOI 10.1377/hlthaff.2011.1135; Ryan AM, 2012, MED CARE, V50, P191, DOI 10.1097/MLR.0b013e318244e6b5	5	207	208	0	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 26	2012	367	4					292	295		10.1056/NEJMp1204939	http://dx.doi.org/10.1056/NEJMp1204939			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	978KD	22830460				2022-12-28	WOS:000306738300002
J	Mougi, A; Kondoh, M				Mougi, A.; Kondoh, M.			Diversity of Interaction Types and Ecological Community Stability	SCIENCE			English	Article							FOOD WEBS; PREDATOR-PREY; NETWORKS; ECOSYSTEMS; BIODIVERSITY; ARCHITECTURE; COMPETITION; COMPLEXITY; LINKS; MODEL	Ecological theory predicts that a complex community formed by a number of species is inherently unstable, guiding ecologists to identify what maintains species diversity in nature. Earlier studies often assumed a community with only one interaction type, either an antagonistic, competitive, or mutualistic interaction, leaving open the question of what the diversity of interaction types contributes to the community maintenance. We show theoretically that the multiple interaction types might hold the key to understanding community dynamics. A moderate mixture of antagonistic and mutualistic interactions can stabilize population dynamics. Furthermore, increasing complexity leads to increased stability in a "hybrid" community. We hypothesize that the diversity of species and interaction types may be the essential element of biodiversity that maintains ecological communities.	[Mougi, A.; Kondoh, M.] Ryukoku Univ, Fac Sci & Technol, Dept Environm Solut Technol, Otsu, Shiga 5202194, Japan; [Kondoh, M.] Japanese Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan	Ryukoku University; Japan Science & Technology Agency (JST)	Kondoh, M (corresponding author), Ryukoku Univ, Fac Sci & Technol, Dept Environm Solut Technol, 1-5 Yokoya,Seta Oe Cho, Otsu, Shiga 5202194, Japan.	mkondoh@rins.ryukoku.ac.jp	Kondoh, Michio/AAE-4332-2019		Ministry of the Environment, Japan [D-1102]; Japan Society for the Promotion of Science [23657019, 30388160];  [20370012]; Grants-in-Aid for Scientific Research [23657019] Funding Source: KAKEN	Ministry of the Environment, Japan(Ministry of the Environment, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Environment Research and Technology Development Fund (grant D-1102) of the Ministry of the Environment, Japan; a Grant-in-Aid for Scientific Research (B) (no. 20370012); and a Grant-in-Aid for Challenging Exploratory Research (no. 23657019, 30388160) of the Japan Society for the Promotion of Science. The authors declare no competing financial interests.	ADDICOTT JF, 1984, THEOR POPUL BIOL, V26, P320, DOI 10.1016/0040-5809(84)90037-6; Allesina S, 2008, SCIENCE, V320, P658, DOI 10.1126/science.1156269; Allesina S, 2008, THEOR ECOL-NETH, V1, P55, DOI 10.1007/s12080-007-0007-8; Allesina S, 2012, NATURE, V483, P205, DOI 10.1038/nature10832; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Brose U, 2006, ECOL LETT, V9, P1228, DOI 10.1111/j.1461-0248.2006.00978.x; Chase JM, 2002, ECOL LETT, V5, P302, DOI 10.1046/j.1461-0248.2002.00315.x; Chen X, 2001, P ROY SOC B-BIOL SCI, V268, P869, DOI 10.1098/rspb.2001.1596; Fontaine C, 2011, ECOL LETT, V14, P1170, DOI 10.1111/j.1461-0248.2011.01688.x; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; Lafferty KD, 2008, ECOL LETT, V11, P533, DOI 10.1111/j.1461-0248.2008.01174.x; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Martinez ND, 2006, SFI S SCI C, P163; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Melian CJ, 2009, OIKOS, V118, P122, DOI 10.1111/j.1600-0706.2008.16751.x; Neutel AM, 2002, SCIENCE, V296, P1120, DOI 10.1126/science.1068326; Okuyama T, 2008, ECOL LETT, V11, P208, DOI 10.1111/j.1461-0248.2007.01137.x; Pimm S.L., 1991, BALANCE NATURE; Pimm SL, 2002, FOOD WEBS; Ringel MS, 1996, THEOR POPUL BIOL, V50, P281, DOI 10.1006/tpbi.1996.0032; Strauss SY, 2004, ANNU REV ECOL EVOL S, V35, P435, DOI 10.1146/annurev.ecolsys.35.112202.130215; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Thompson JN, 2006, SCIENCE, V312, P372, DOI 10.1126/science.1126904; Townsend SE, 2010, J THEOR BIOL, V267, P243, DOI 10.1016/j.jtbi.2010.08.018; Zhang F, 2011, ECOL LETT, V14, P797, DOI 10.1111/j.1461-0248.2011.01647.x	26	423	442	41	432	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2012	337	6092					349	351		10.1126/science.1220529	http://dx.doi.org/10.1126/science.1220529			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975WQ	22822151				2022-12-28	WOS:000306542600053
J	Moyer, VA				Moyer, Virginia A.		US Preventive Serv	Screening for Hearing Loss in Older Adults: US Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-LIFE; RANDOMIZED-TRIAL; IMPAIRMENT; AMPLIFICATION	Description: Update of the 1996 U.S. Preventive Services Task Force (USPSTF) recommendation statement on screening for hearing impairment in older adults. Methods: The USPSTF reviewed evidence published between 1950 and January 2010 on screening for age-related sensorineural hearing impairment in adults aged 50 years or older without diagnosed hearing loss in the primary care setting. Population: This recommendation applies to asymptomatic adults aged 50 years or older. It does not apply to persons seeking evaluation for perceived hearing problems or for cognitive or affective symptoms that may be related to hearing loss. Recommendation: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for hearing loss in asymptomatic adults aged 50 years or older (I statement).	[Moyer, Virginia A.; US Preventive Serv] US Prevent Serv Task Force, Rockville, MD USA		Moyer, VA (corresponding author), US Prevent Serv Task Force, Rockville, MD USA.							American Speech-Language-Hearing Association, 1997, GUID AUD SCREEN; [Anonymous], 2011, Obstet Gynecol, V117, P1008, DOI 10.1097/AOG.0b013e318219226e; Boatman DF, 2007, NEUROLOGY, V68, P1311, DOI 10.1212/01.wnl.0000259524.08148.16; CARABELLESE C, 1993, J AM GERIATR SOC, V41, P401, DOI 10.1111/j.1532-5415.1993.tb06948.x; Chou R, 2011, AHRQ PUBLICATION; Chou R, 2011, ANN INTERN MED, V154, P347, DOI 10.7326/0003-4819-154-5-201103010-00009; Gates GA, 2005, LANCET, V366, P1111, DOI 10.1016/S0140-6736(05)67423-5; Jerger J, 1996, EAR HEARING, V17, P490, DOI 10.1097/00003446-199612000-00005; MULROW CD, 1990, ANN INTERN MED, V113, P188, DOI 10.7326/0003-4819-113-3-188; MULROW CD, 1990, J AM GERIATR SOC, V38, P45, DOI 10.1111/j.1532-5415.1990.tb01595.x; MULROW CD, 1992, J SPEECH HEAR RES, V35, P1402, DOI 10.1044/jshr.3506.1402; Tolson Debbie, 2002, Br J Nurs, V11, P1021; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18; WEINSTEIN BE, 1982, J SPEECH HEAR RES, V25, P593, DOI 10.1044/jshr.2504.593; Yueh B, 2003, JAMA-J AM MED ASSOC, V289, P1976, DOI 10.1001/jama.289.15.1976; Yueh B, 2001, ARCH OTOLARYNGOL, V127, P1197, DOI 10.1001/archotol.127.10.1197; Yueh B, 2010, J AM GERIATR SOC, V58, P427, DOI 10.1111/j.1532-5415.2010.02738.x	17	41	44	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 6	2012	157	9					655	+		10.7326/0003-4819-157-9-201211060-00526	http://dx.doi.org/10.7326/0003-4819-157-9-201211060-00526			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	033GX	22893115				2022-12-28	WOS:000310783300006
J	Diacon, AH; Dawson, R; von Groote-Bidlingmaier, F; Symons, G; Venter, A; Donald, PR; van Niekerk, C; Everitt, D; Winter, H; Becker, P; Mendel, CM; Spigelman, MK				Diacon, Andreas H.; Dawson, Rodney; von Groote-Bidlingmaier, Florian; Symons, Gregory; Venter, Amour; Donald, Peter R.; van Niekerk, Christo; Everitt, Daniel; Winter, Helen; Becker, Piet; Mendel, Carl M.; Spigelman, Melvin K.			14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial	LANCET			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; PULMONARY TUBERCULOSIS; MURINE MODEL; PHASE-II; MYCOBACTERIUM-TUBERCULOSIS; DIARYLQUINOLINE TMC207; MOUSE MODEL; ETHAMBUTOL; DRUGS; PHARMACOKINETICS	Background New drugs, but also shorter, better-tolerated regimens are needed to tackle the high global burden of tuberculosis complicated by drug resistance and retroviral disease. We investigated new multiple-agent combinations over the first 14 days of treatment to assess their suitability for future development. Methods In this prospective, randomised, early bactericidal activity (EBA) study, treatment-naive, drug-susceptible patients with uncomplicated pulmonary tuberculosis were admitted to hospitals in Cape Town, South Africa, between Oct 7, 2010, and Aug 19, 2011. Patients were randomised centrally by computer-generated randomisation sequence to receive bedaquiline, bedaquiline-pyrazinamide, PA-824-pyrazinamide, bedaquiline-PA-824, PA-824-moxifloxacin-pyrazinamide, or unmasked standard antituberculosis treatment as positive control. The primary outcome was the 14-day EBA assessed in a central laboratory from the daily fall in colony forming units (CFU) of M tuberculosis per mL of sputum in daily overnight sputum collections. Bilinear regression curves were fitted for each group separately and groups compared with ANOVA for ranks, followed by pair-wise comparisons adjusted for multiplicity. Clinical staff were partially masked but laboratory personnel were fully masked. This study is registered, NCT01215851. Findings The mean 14-day EBA of PA-824-moxifloxacin-pyrazinamide (n=13; 0.233 [SD 0.128]) was significantly higher than that of bedaquiline (14; 0.061 [0.068]), bedaquiline-pyrazinamide (15; 0.131 [0.102]), bedaquiline-PA-824 (14; 0.114 [0.050]), but not PA-824-pyrazinamide (14; 0.154 [0.040]), and comparable with that of standard treatment (ten; 0.140 [0.094]). Treatments were well tolerated and appeared safe. One patient on PA-824-moxifloxacin-pyrazinamide was withdrawn because of corrected QT interval changes exceeding criteria prespecified in the protocol. Interpretation PA-824-moxifloxacin-pyrazinamide is potentially suitable for treating drug-sensitive and multidrug-resistant tuberculosis. Multiagent EBA studies can contribute to reducing the time needed to develop new antituberculosis regimens.	[Diacon, Andreas H.] Univ Stellenbosch, Div Physiol, Dept Med Biochem, Fac Med & Hlth Sci, Cape Town, South Africa; [Venter, Amour] Univ Stellenbosch, MRC Ctr Mol & Cellular Biol, Fac Med & Hlth Sci, Cape Town, South Africa; [Donald, Peter R.] Univ Stellenbosch, Dept Paediat & Child Hlth, Fac Med & Hlth Sci, Cape Town, South Africa; [Diacon, Andreas H.; von Groote-Bidlingmaier, Florian] Karl Bremer Hosp, Cape Town, South Africa; [Dawson, Rodney; Symons, Gregory] Groote Schuur Hosp, Div Pulmonol, Dept Med, ZA-7925 Cape Town, South Africa; [Dawson, Rodney; Symons, Gregory] Univ Cape Town, Lung Inst, ZA-7925 Cape Town, South Africa; [Everitt, Daniel; Mendel, Carl M.; Spigelman, Melvin K.] Global Alliance TB Drug Dev, New York, NY USA; [van Niekerk, Christo] Global Alliance TB Drug Dev, Pretoria, South Africa; [Winter, Helen] Univ Otago, Sch Pharm, Dunedin, New Zealand; [Becker, Piet] MRC, Pretoria, South Africa	Stellenbosch University; Stellenbosch University; Stellenbosch University; University of Cape Town; University of Cape Town; University of Otago	Diacon, AH (corresponding author), Univ Stellenbosch, Div Physiol, Dept Biomed Sci, Fac Med & Hlth Sci, POB 19063, ZA-7505 Tygerberg, South Africa.	ahd@sun.ac.za	Trajman, Anete/C-7679-2016	Trajman, Anete/0000-0002-4000-4984	Global Alliance for TB Drug Development (TB Alliance)	Global Alliance for TB Drug Development (TB Alliance)	The Global Alliance for TB Drug Development (TB Alliance).	Bazett HC, 1920, HEART-J STUD CIRC, V7, P353; Botha FJH, 1996, S AFR MED J, V86, P155; Burman WJ, 2006, AM J RESP CRIT CARE, V174, P331, DOI 10.1164/rccm.200603-360OC; Conde MB, 2009, LANCET, V373, P1183, DOI 10.1016/S0140-6736(09)60333-0; Diacon AH, 2012, ANTIMICROB AGENTS CH, V56, P3271, DOI 10.1128/AAC.06126-11; Diacon AH, 2012, ANTIMICROB AGENTS CH, V56, P3027, DOI 10.1128/AAC.06125-11; Diacon AH, 2010, ANTIMICROB AGENTS CH, V54, P3402, DOI 10.1128/AAC.01354-09; Diacon AH, 2009, NEW ENGL J MED, V360, P2397, DOI 10.1056/NEJMoa0808427; Donald PR, 2008, TUBERCULOSIS, V88, pS75, DOI 10.1016/S1472-9792(08)70038-6; Donald P R, 2003, Expert Rev Anti Infect Ther, V1, P141, DOI 10.1586/14787210.1.1.141; Dorman SE, 2009, AM J RESP CRIT CARE, V180, P273, DOI 10.1164/rccm.200901-0078OC; Fridericia LS, 1920, ACTA MED SCAND, V15, P335; Gosling RD, 2003, AM J RESP CRIT CARE, V168, P1342, DOI 10.1164/rccm.200305-682OC; Ibrahim M, 2007, ANTIMICROB AGENTS CH, V51, P1011, DOI 10.1128/AAC.00898-06; *INT UN TUB LUNG D, 2007, PRIOR TUB BACT SERV; Ji BH, 1998, ANTIMICROB AGENTS CH, V42, P2066, DOI 10.1128/AAC.42.8.2066; JINDANI A, 1980, AM REV RESPIR DIS, V121, P939; Johnson JL, 2006, INT J TUBERC LUNG D, V10, P605; Lounis N, 2008, ANTIMICROB AGENTS CH, V52, P3568, DOI 10.1128/AAC.00566-08; Mitchison DA, 2000, INT J TUBERC LUNG D, V4, P796; MITCHISON DA, 1998, MYCOBACTERIA, V2, P15; Miyazaki E, 1999, ANTIMICROB AGENTS CH, V43, P85, DOI 10.1128/AAC.43.1.85; Nuermberger EL, 2004, AM J RESP CRIT CARE, V169, P421, DOI 10.1164/rccm.200310-1380OC; Nuermberger E, 2008, ANTIMICROB AGENTS CH, V52, P1522, DOI 10.1128/AAC.00074-08; Pletz MWR, 2004, ANTIMICROB AGENTS CH, V48, P780, DOI 10.1128/AAC.48.3.780-782.2004; Rustomjee R, 2008, ANTIMICROB AGENTS CH, V52, P2831, DOI 10.1128/AAC.01204-07; Rustomjee R, 2008, INT J TUBERC LUNG D, V12, P128; Tasneen R, 2008, ANTIMICROB AGENTS CH, V52, P3664, DOI 10.1128/AAC.00686-08; Tyagi S, 2005, ANTIMICROB AGENTS CH, V49, P2289, DOI 10.1128/AAC.49.6.2289-2293.2005; Warren RM, 2006, INT J TUBERC LUNG D, V10, P818; World Health Organisation, 2011, WHOHTMTB201116	31	325	338	1	68	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 15	2012	380	9846					986	993		10.1016/S0140-6736(12)61080-0	http://dx.doi.org/10.1016/S0140-6736(12)61080-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	005JF	22828481				2022-12-28	WOS:000308746000028
J	Ramirez, EM; Ackermann, D; Blaum, K; Block, M; Droese, C; Dullmann, CE; Dworschak, M; Eibach, M; Eliseev, S; Haettner, E; Herfurth, F; Hessberger, FP; Hofmann, S; Ketelaer, J; Marx, G; Mazzocco, M; Nesterenko, D; Novikov, YN; Plass, WR; Rodriguez, D; Scheidenberger, C; Schweikhard, L; Thirolf, PG; Weber, C				Ramirez, E. Minaya; Ackermann, D.; Blaum, K.; Block, M.; Droese, C.; Duellmann, Ch. E.; Dworschak, M.; Eibach, M.; Eliseev, S.; Haettner, E.; Herfurth, F.; Hessberger, F. P.; Hofmann, S.; Ketelaer, J.; Marx, G.; Mazzocco, M.; Nesterenko, D.; Novikov, Yu. N.; Plass, W. R.; Rodriguez, D.; Scheidenberger, C.; Schweikhard, L.; Thirolf, P. G.; Weber, C.			Direct Mapping of Nuclear Shell Effects in the Heaviest Elements	SCIENCE			English	Article							DIRECT MASS MEASUREMENTS; SUPERHEAVY NUCLEI; SHIPTRAP	Quantum-mechanical shell effects are expected to strongly enhance nuclear binding on an "island of stability" of superheavy elements. The predicted center at proton number Z = 114, 120, or 126 and neutron number N = 184 has been substantiated by the recent synthesis of new elements up to Z = 118. However, the location of the center and the extension of the island of stability remain vague. High-precision mass spectrometry allows the direct measurement of nuclear binding energies and thus the determination of the strength of shell effects. Here, we present such measurements for nobelium and lawrencium isotopes, which also pin down the deformed shell gap at N = 152.	[Ramirez, E. Minaya; Ackermann, D.; Block, M.; Duellmann, Ch. E.; Dworschak, M.; Haettner, E.; Herfurth, F.; Hessberger, F. P.; Hofmann, S.; Plass, W. R.; Scheidenberger, C.] Schwerionenforschung GmbH, GSI Helmholtzzentrum, D-64291 Darmstadt, Germany; [Ramirez, E. Minaya; Duellmann, Ch. E.; Hessberger, F. P.] Helmholtz Inst Mainz, D-55099 Mainz, Germany; [Blaum, K.; Eliseev, S.; Ketelaer, J.] Max Planck Inst Kernphys, D-69117 Heidelberg, Germany; [Blaum, K.; Eibach, M.] Heidelberg Univ, D-69120 Heidelberg, Germany; [Droese, C.; Marx, G.; Schweikhard, L.] Ernst Moritz Arndt Univ Greifswald, D-17487 Greifswald, Germany; [Duellmann, Ch. E.; Eibach, M.] Johannes Gutenberg Univ Mainz, D-55099 Mainz, Germany; [Haettner, E.; Plass, W. R.; Scheidenberger, C.] Univ Giessen, D-35392 Giessen, Germany; [Mazzocco, M.] Univ Padua, Dipartimento Fis, I-35131 Padua, Italy; [Mazzocco, M.] Ist Nazl Fis Nucl, Sez Padova, I-35131 Padua, Italy; [Nesterenko, D.; Novikov, Yu. N.] Petersburg Nucl Phys Inst, St Petersburg 188300, Russia; [Rodriguez, D.] Univ Granada, E-18071 Granada, Spain; [Thirolf, P. G.; Weber, C.] Univ Munich, D-85748 Garching, Germany	Helmholtz Association; GSI Helmholtz-Center for Heavy Ion Research; Max Planck Society; Ruprecht Karls University Heidelberg; Ernst Moritz Arndt Universitat Greifswald; Johannes Gutenberg University of Mainz; Justus Liebig University Giessen; University of Padua; Istituto Nazionale di Fisica Nucleare (INFN); National Research Centre - Kurchatov Institute; Petersburg Nuclear Physics Institute; University of Granada; University of Munich	Block, M (corresponding author), Schwerionenforschung GmbH, GSI Helmholtzzentrum, D-64291 Darmstadt, Germany.	m.block@gsi.de	eliseev, sergey/AAC-3801-2022; Novikov, Iurii N/M-7784-2013; Block, Michael/I-2782-2015; Ackermann, Dieter/AAW-6913-2021; Schweikhard, Lutz/AAX-3044-2021; Rodríguez, Daniel/A-1692-2009; Mazzocco, Marco/J-4393-2012; RODRIGUEZ, Daniel/GWC-3563-2022; Düllmann, Christoph E/L-3401-2017	eliseev, sergey/0000-0003-0210-7082; Novikov, Iurii N/0000-0002-5369-7142; Block, Michael/0000-0001-9282-8347; Ackermann, Dieter/0000-0001-6284-1516; Rodríguez, Daniel/0000-0002-2989-7566; Düllmann, Christoph E/0000-0002-1194-0423; Plass, Wolfgang/0000-0003-2744-2645; Nesterenko, Dmitrii/0000-0002-6103-2845	Helmholtz-Institut Mainz; GSI Helmholtzzentrum fur Schwerionenforschung GmbH; German Federal Ministry of Education and Research (BMBF); Max-Planck Society; Russian Minobrnauki; ExtreMe Matter Institute (EMMI)	Helmholtz-Institut Mainz; GSI Helmholtzzentrum fur Schwerionenforschung GmbH; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Max-Planck Society(Max Planck Society); Russian Minobrnauki; ExtreMe Matter Institute (EMMI)	The project was supported in part by the Helmholtz-Institut Mainz, the GSI Helmholtzzentrum fur Schwerionenforschung GmbH, the German Federal Ministry of Education and Research (BMBF), the Max-Planck Society, the Russian Minobrnauki, and the ExtreMe Matter Institute (EMMI). Y.N.N. acknowledges support by EMMI.	Ackermann D., 2011, GSI ANN REP 2010, P200; Audi G, 2003, NUCL PHYS A, V729, P337, DOI 10.1016/j.nuclphysa.2003.11.003; Audi G, 2006, INT J MASS SPECTROM, V251, P85, DOI 10.1016/j.ijms.2006.01.048; Bender M, 1999, PHYS REV C, V60, DOI 10.1103/PhysRevC.60.034304; Blaum K, 2006, PHYS REP, V425, P1, DOI 10.1016/j.physrep.2005.10.011; Block M, 2007, EUR PHYS J D, V45, P39, DOI 10.1140/epjd/e2007-00189-2; Block M, 2010, NATURE, V463, P785, DOI 10.1038/nature08774; Chaudhuri A, 2007, EUR PHYS J D, V45, P47, DOI 10.1140/epjd/e2007-00001-5; Cwiok S, 2005, NATURE, V433, P705, DOI 10.1038/nature03336; Dvorak J, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.242501; Dworschak M, 2010, PHYS REV C, V81, DOI 10.1103/PhysRevC.81.064312; Goppert-Mayer M., 1948, PHYS REV, V74, P235; Goppert-Mayer M., 1955, ELEMENTARY THEORY NU; GRAFF G, 1969, Z PHYS, V222, P201, DOI 10.1007/BF01392119; Hessberger FP, 2007, EUR PHYS J D, V45, P33, DOI 10.1140/epjd/e2007-00146-1; Hofmann S, 2000, REV MOD PHYS, V72, P733, DOI 10.1103/RevModPhys.72.733; Hofmann S, 2001, EUR PHYS J A, V10, P5, DOI 10.1007/s100500170137; Lunney D, 2003, REV MOD PHYS, V75, P1021, DOI 10.1103/RevModPhys.75.1021; MOLLER P, 1995, ATOM DATA NUCL DATA, V59, P185, DOI 10.1006/adnd.1995.1002; Muntian I, 2003, ACTA PHYS POL B, V34, P2073; Oganessian Y, 2011, RADIOCHIM ACTA, V99, P429, DOI 10.1524/ract.2011.1860; PATYK Z, 1989, NUCL PHYS A, V491, P267, DOI 10.1016/0375-9474(89)90702-1; Rutz K, 1997, PHYS REV C, V56, P238, DOI 10.1103/PhysRevC.56.238; Sobiczewski A, 2007, PROG PART NUCL PHYS, V58, P292, DOI 10.1016/j.ppnp.2006.05.001; STRUTINSKY VM, 1967, NUCL PHYS A, VA 95, P420, DOI 10.1016/0375-9474(67)90510-6; Zhang W, 2005, NUCL PHYS A, V753, P106, DOI 10.1016/j.nuclphysa.2005.02.086	26	101	103	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2012	337	6099					1207	1210		10.1126/science.1225636	http://dx.doi.org/10.1126/science.1225636			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	000UJ	22878498	Green Submitted			2022-12-28	WOS:000308414000032
J	Shankland, KR; Armitage, JO; Hancock, BW				Shankland, Kate R.; Armitage, James O.; Hancock, Barry W.			Non-Hodgkin lymphoma	LANCET			English	Article							B-CELL LYMPHOMA; POSITRON-EMISSION-TOMOGRAPHY; TERM-FOLLOW-UP; PERIPHERAL T-CELL; CHRONIC LYMPHOCYTIC-LEUKEMIA; ANTI-CD20 MONOCLONAL-ANTIBODY; ADVANCED FOLLICULAR LYMPHOMA; PROSPECTIVE RANDOMIZED-TRIAL; DETUDE-DES-LYMPHOMES; STAGE-I	Lymphomas are solid tumours of the immune system. Hodgkin's lymphoma accounts for about 10% of all lymphomas, and the remaining 90% are referred to as non-Hodgkin lymphoma. Non-Hodgkin lymphomas have a wide range of histological appearances and clinical features at presentation, which can make diagnosis difficult. Lymphomas are not rare, and most physicians, irrespective of their specialty, will probably have come across a patient with lymphoma. Timely diagnosis is important because effective, and often curative, therapies are available for many subtypes. In this Seminar we discuss advances in the understanding of the biology of these malignancies and new, available treatments.	[Shankland, Kate R.; Hancock, Barry W.] Weston Pk Hosp, Acad Unit Clin Oncol, Sheffield S10 2SJ, S Yorkshire, England; [Armitage, James O.] Univ Nebraska Med Ctr, Omaha, NE USA	Weston Park Hospital; University of Nebraska System; University of Nebraska Medical Center	Shankland, KR (corresponding author), Weston Pk Hosp, Acad Unit Clin Oncol, Whitham Rd, Sheffield S10 2SJ, S Yorkshire, England.	kate.shankland@sth.nhs.uk			Seattle Genetics; Roche; Genentech	Seattle Genetics; Roche(Roche Holding); Genentech(Roche HoldingGenentech)	JOA has been a consultant for Ziopharm, Seattle Genetics, Eisai, GlaxoSmithKline, Allos Therapeutics, Genentech, and Roche. BWH was, until 2009, taking part in studies done or supported by Seattle Genetics, Roche, and Genentech. KRS declares that she has no conflicts of interest.	Advani RH, 2010, 53 ASH ANN M EXP SAN; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Ambinder RF, 2010, NONHODGKIN LYMPHOMAS, P83; ANDERSON JR, 1993, J CLIN ONCOL, V11, P1024, DOI 10.1200/JCO.1993.11.6.1024; Anderson JR, 1998, ANN ONCOL, V9, P717, DOI 10.1023/A:1008265532487; [Anonymous], 1990, IARC Monogr Eval Carcinog Risks Hum, V50, P265; Ardeshna KM, 2003, LANCET, V362, P516, DOI 10.1016/S0140-6736(03)14110-4; ARMITAGE JO, 1989, CANCER, V63, P158, DOI 10.1002/1097-0142(19890101)63:1<158::AID-CNCR2820630125>3.0.CO;2-B; Armitage JO, 1998, J CLIN ONCOL, V16, P2780, DOI 10.1200/JCO.1998.16.8.2780; BAYERDORFFER E, 1995, LANCET, V345, P1591, DOI 10.1016/S0140-6736(95)90113-2; Bernstein Steven H, 2009, Hematology Am Soc Hematol Educ Program, P532, DOI 10.1182/asheducation-2009.1.532; BINET JL, 1990, BLOOD, V75, P1422; Buchmann I, 2001, CANCER, V91, P889; Cancer Research UK, NONH LYMPH NHL STAT; Cancer Research UK, NONH LYMPH UK INC ST; CARBONE PP, 1971, CANCER RES, V31, P1860; Cartwright R, 1999, EUR J CANCER, V35, P627, DOI 10.1016/S0959-8049(98)00401-8; Cheson BD, 2010, NONHODGKIN LYMPHOMAS, P172; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; COIFFIER B, 1994, ANN ONCOL, V5, P873; Deconinck E, 2005, BLOOD, V105, P3817, DOI 10.1182/blood-2004-10-3920; DEVESA SS, 1992, CANCER RES, V52, pS5432; DIXON DO, 1986, J CLIN ONCOL, V4, P295, DOI 10.1200/JCO.1986.4.3.295; Elstrom R, 2003, BLOOD, V101, P3875, DOI 10.1182/blood-2002-09-2778; Evans LS, 2003, LANCET, V362, P139, DOI 10.1016/S0140-6736(03)13868-8; Falini B, 2010, NONHODGKIN LYMPHOMAS, P415; Federico M, 2012, J CLIN ONCO IN PRESS; Fenaux P, 1996, LANCET, V347, P1432; Feugier P, 2005, J CLIN ONCOL, V23, P4117, DOI 10.1200/JCO.2005.09.131; Foran JM, 2000, J CLIN ONCOL, V18, P317, DOI 10.1200/JCO.2000.18.2.317; Freedman AS, 2010, NONHODGKIN LYMPHOMAS, P266; Gascoyne RD, 2010, NONHODGKIN LYMPHOMAS, P334; Geisler CH, 2008, BLOOD, V112, P2687, DOI 10.1182/blood-2008-03-147025; Lenz Georg, 2010, N Engl J Med, V362, P1417, DOI 10.1056/NEJMra0807082; Glass AG, 1997, CANCER, V80, P2311; GOSPODAROWICZ MK, 1987, J CLIN ONCOL, V5, P875, DOI 10.1200/JCO.1987.5.6.875; GREER JP, 1984, J CLIN ONCOL, V2, P788, DOI 10.1200/JCO.1984.2.7.788; Hallek M, 2010, LANCET, V376, P1164, DOI 10.1016/S0140-6736(10)61381-5; Herold M, 2007, J CLIN ONCOL, V25, P1986, DOI 10.1200/JCO.2006.06.4618; Hiddemann W, 2005, BLOOD, V106, P3725, DOI 10.1182/blood-2005-01-0016; Hillmen P, 2007, J CLIN ONCOL, V25, P5616, DOI 10.1200/JCO.2007.12.9098; Horning SJ, 2008, J CLIN ONCOL, V26, P4537, DOI 10.1200/JCO.2008.16.1398; Howard OM, 2002, J CLIN ONCOL, V20, P1288, DOI 10.1200/JCO.20.5.1288; HUDSON BV, 1994, BRIT J CANCER, V69, P1088, DOI 10.1038/bjc.1994.213; Jaffe Elaine S, 2009, Hematology Am Soc Hematol Educ Program, P523, DOI 10.1182/asheducation-2009.1.523; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; Juweid ME, 2007, J CLIN ONCOL, V25, P571, DOI 10.1200/JCO.2006.08.2305; Juweid ME, 2005, J CLIN ONCOL, V23, P4652, DOI 10.1200/JCO.2005.01.891; Keating MJ, 2002, BLOOD, V99, P3554, DOI 10.1182/blood.V99.10.3554; Komrokji RS, 2011, CL LYMPH MYELOM LEUK, V11, P257, DOI 10.1016/j.clml.2011.03.012; Kuppers R, 2010, NONHODGKIN LYMPHOMAS, P26; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Lenz G, 2004, J CLIN ONCOL, V22, P4926, DOI 10.1200/JCO.2004.06.016; Lenz G, 2005, J CLIN ONCOL, V23, P1984, DOI 10.1200/JCO.2005.08.133; Leporrier M, 2001, BLOOD, V98, P2319, DOI 10.1182/blood.V98.8.2319; MacManus MP, 1996, J CLIN ONCOL, V14, P1282, DOI 10.1200/JCO.1996.14.4.1282; Marcus R, 2008, J CLIN ONCOL, V26, P4579, DOI 10.1200/JCO.2007.13.5376; Martinelli G, 2010, J CLIN ONCOL, V28, P4480, DOI 10.1200/JCO.2010.28.4786; McLaughlin P, 1998, J CLIN ONCOL, V16, P2825, DOI 10.1200/JCO.1998.16.8.2825; MONFARDINI S, 1980, INT J RADIAT ONCOL, V6, P125, DOI 10.1016/0360-3016(80)90027-9; Morschhauser F, 2008, J CLIN ONCOL, V26, P5156, DOI 10.1200/JCO.2008.17.2015; Mourad N, 2008, BLOOD, V111, P4463, DOI 10.1182/blood-2007-08-105759; Moynihan MJ, 1996, AM J SURG PATHOL, V20, P442, DOI 10.1097/00000478-199604000-00007; Narayanan S, 2010, NONHODGKIN LYMPHOMAS, V2, P149; Naresh KN, 2000, ANN ONCOL, V11, P63, DOI 10.1023/A:1008325827059; National Cancer Institute, SEER STAT FACT SHEET; NEWMAN JS, 1994, RADIOLOGY, V190, P111, DOI 10.1148/radiology.190.1.8259386; NISSEN NI, 1983, CANCER, V52, P1, DOI 10.1002/1097-0142(19830701)52:1<1::AID-CNCR2820520102>3.0.CO;2-M; Office for National Statistics, 2010, SER MB1; PENDLEBURY S, 1995, RADIOTHER ONCOL, V36, P167, DOI 10.1016/0167-8140(95)01600-L; Pfreundschuh M, 2006, LANCET ONCOL, V7, P379, DOI 10.1016/S1470-2045(06)70664-7; Rai KR, 2000, NEW ENGL J MED, V343, P1750, DOI 10.1056/NEJM200012143432402; RAPHAEL B, 1991, J CLIN ONCOL, V9, P770, DOI 10.1200/JCO.1991.9.5.770; Reyes F, 2005, NEW ENGL J MED, V352, P1197, DOI 10.1056/NEJMoa042040; Salles GA, 2010, 2010 ASCO ANN M CHIC; Savage KJ, 2008, BLOOD, V111, P5496, DOI 10.1182/blood-2008-01-134270; Sehn LH, 2007, BLOOD, V109, P1857, DOI 10.1182/blood-2006-08-038257; Sehn LH, 2005, J CLIN ONCOL, V23, P5027, DOI 10.1200/JCO.2005.09.137; Seidemann K, 2001, BLOOD, V97, P3699, DOI 10.1182/blood.V97.12.3699; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Solal-Celigny P, 2004, BLOOD, V104, P1258, DOI 10.1182/blood-2003-12-4434; Spaepen K, 2001, J CLIN ONCOL, V19, P414, DOI 10.1200/JCO.2001.19.2.414; Spaepen K, 2001, BRIT J HAEMATOL, V115, P272, DOI 10.1046/j.1365-2141.2001.03169.x; STEIN H, 1985, BLOOD, V66, P848; Sweetenham JW, 2010, NONHODGKIN LYMPHOMAS, P185; Swenson WT, 2005, J CLIN ONCOL, V23, P5019, DOI 10.1200/JCO.2005.04.503; VECCHI V, 1993, MED PEDIATR ONCOL, V21, P402, DOI 10.1002/mpo.2950210603; VOSE JM, 1988, J CLIN ONCOL, V6, P1838, DOI 10.1200/JCO.1988.6.12.1838; Vose JM, 2008, J CLIN ONCOL, V26, P4124, DOI 10.1200/JCO.2008.16.4558; White LM, 1998, AM J ROENTGENOL, V170, P1243, DOI 10.2214/ajr.170.5.9574594; Wierda WG, 2011, BLOOD, V118, P5126, DOI 10.1182/blood-2011-04-348656; Zain J, 2010, NONHODGKIN LYMPHOMAS, P284; Zinzani PL, 1999, ANN ONCOL, V10, P1181, DOI 10.1023/A:1008327127033	95	386	408	14	86	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 1	2012	380	9844					848	857		10.1016/S0140-6736(12)60605-9	http://dx.doi.org/10.1016/S0140-6736(12)60605-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	000OP	22835603				2022-12-28	WOS:000308396300034
J	Nour-Eldin, HH; Andersen, TG; Burow, M; Madsen, SR; Jorgensen, ME; Olsen, CE; Dreyer, I; Hedrich, R; Geiger, D; Halkier, BA				Nour-Eldin, Hussam Hassan; Andersen, Tonni Grube; Burow, Meike; Madsen, Svend Roesen; Jorgensen, Morten Egevang; Olsen, Carl Erik; Dreyer, Ingo; Hedrich, Rainer; Geiger, Dietmar; Halkier, Barbara Ann			NRT/PTR transporters are essential for translocation of glucosinolate defence compounds to seeds	NATURE			English	Article							ARABIDOPSIS-THALIANA; PHLOEM; ACCUMULATION; PRODUCTS; PATHWAY; NITRATE; CLONING; GROWTH; FIBER; FOOD	In plants, transport processes are important for the reallocation of defence compounds to protect tissues of high value(1), as demonstrated in the plant model Arabidopsis, in which the major defence compounds, glucosinolates(2), are translocated to seeds on maturation(3). The molecular basis for long-distance transport of glucosinolates and other defence compounds, however, remains unknown. Here we identify and characterize two members of the nitrate/peptide transporter family, GTR1 and GTR2, as high-affinity, proton-dependent glucosinolate-specific transporters. The gtr1 gtr2 double mutant did not accumulate glucosinolates in seeds and had more than tenfold over-accumulation in source tissues such as leaves and silique walls, indicating that both plasma membrane-localized transporters are essential for long-distance transport of glucosinolates. We propose that GTR1 and GTR2 control the loading of glucosinolates from the apoplasm into the phloem. Identification of the glucosinolate transporters has agricultural potential as a means to control allocation of defence compounds in a tissue-specific manner.	[Nour-Eldin, Hussam Hassan; Andersen, Tonni Grube; Burow, Meike; Madsen, Svend Roesen; Jorgensen, Morten Egevang; Olsen, Carl Erik; Halkier, Barbara Ann] Univ Copenhagen, Fac Sci, Dept Plant & Environm Sci, VKR Res Ctr Proact Plants, DK-1871 Frederiksberg C, Denmark; [Nour-Eldin, Hussam Hassan; Andersen, Tonni Grube; Burow, Meike; Madsen, Svend Roesen; Jorgensen, Morten Egevang; Olsen, Carl Erik; Halkier, Barbara Ann] Univ Copenhagen, Fac Sci, Dept Plant & Environm Sci, DynaMo Ctr Excellence, DK-1871 Frederiksberg C, Denmark; [Dreyer, Ingo] Univ Politecn Madrid, Ctr Plant Biotechnol & Genom, E-28223 Pozuelo De Alarcon, Madrid, Spain; [Hedrich, Rainer; Geiger, Dietmar] Univ Wurzburg, Julius von Sachs Inst, D-97082 Wurzburg, Germany	University of Copenhagen; University of Copenhagen; Universidad Politecnica de Madrid; Centro de Investigacion en Biotecnologia Genomica de Plantas (CBGP); University of Wurzburg	Halkier, BA (corresponding author), Univ Copenhagen, Fac Sci, Dept Plant & Environm Sci, VKR Res Ctr Proact Plants, Thorvaldsensvej 40, DK-1871 Frederiksberg C, Denmark.	bah@life.ku.dk	Geiger, Dietmar/AAH-8140-2019; Burow, Meike/A-6949-2010; Jørgensen, Morten Egevang/A-2795-2016; Dreyer, Ingo/N-4747-2014; Geiger, Dietmar/D-6914-2014; Hedrich, Rainer/G-8771-2011; Nour-Eldin, Hussam/I-1214-2014; Halkier, Barbara A/H-3196-2014; Olsen, Carl E/H-3031-2014	Geiger, Dietmar/0000-0003-0715-5710; Burow, Meike/0000-0002-2350-985X; Jørgensen, Morten Egevang/0000-0001-6503-0495; Dreyer, Ingo/0000-0002-2781-0359; Geiger, Dietmar/0000-0003-0715-5710; Hedrich, Rainer/0000-0003-3224-1362; Nour-Eldin, Hussam/0000-0001-6660-0509; Halkier, Barbara A/0000-0002-3742-702X; Olsen, Carl E/0000-0002-2275-0596; Andersen, Tonni/0000-0002-8905-0850	Danish Research Council for Technology and Production (FTP) [09-065827/274-08-0354]; Marie Curie fellowship [PIEF-GA-2008-221236]; European Union [303674]; Deutsche Forschungsgemeinschaft [GE2195/1-1, FOR 1061]; Villum Kann Rasmussen Foundation; Danish National Research Foundation	Danish Research Council for Technology and Production (FTP); Marie Curie fellowship(European Commission); European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Villum Kann Rasmussen Foundation(Villum Fonden); Danish National Research Foundation(Danmarks Grundforskningsfond)	We thank M. Palmgren, A. Schulz and D. Kliebenstein for comments on the manuscript and H. K. S. Jepsen, L. B. Moller and A. Kraus for technical assistance. We thank D. Klaerke and technicians T. K. Soland, B. L. Christensen, M. Olsen and C. Derrer for providing X. laevis oocytes. We thank the Salk, Stanford, Plant Gene Expression Center (SSP) Consortium and the RIKEN Genome Science Center for providing full-length cDNAs. Imaging data were achieved at the Center for Advanced Bioimaging, University of Copenhagen. H.H.N-.E. was supported by the Danish Research Council for Technology and Production (FTP) grant 09-065827/274-08-0354. M.B. was supported by a Marie Curie fellowship (grant PIEF-GA-2008-221236). I.D. was supported by a Marie-Curie Career Integration Grant of the European Union (FP7-PEOPLE-2011-CIG No. 303674 (Regopoc)). D.G. was supported by the Deutsche Forschungsgemeinschaft grant GE2195/1-1 and R.H. by Deutsche Forschungsgemeinschaft grants within FOR 1061. B.A.H. is partner of The VKR Research Centre for Pro-Active Plants funded by the Villum Kann Rasmussen Foundation. Funding for DynaMo Center of Excellence is provided by the Danish National Research Foundation.	Balbi V, 2008, NEW PHYTOL, V177, P301, DOI 10.1111/j.1469-8137.2007.02292.x; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Brown PD, 2003, PHYTOCHEMISTRY, V62, P471, DOI 10.1016/S0031-9422(02)00549-6; Chen SX, 2001, PLANT PHYSIOL, V127, P194, DOI 10.1104/pp.127.1.194; Clarke DB, 2010, ANAL METHODS-UK, V2, P310, DOI 10.1039/b9ay00280d; Ellerbrock BLJ, 2007, PLANT SIGNAL BEHAV, V2, P282, DOI 10.4161/psb.2.4.4014; Fan SC, 2009, PLANT CELL, V21, P2750, DOI 10.1105/tpc.109.067603; Feeny P., 1976, BIOCH INTERACTION PL, P1, DOI [DOI 10.1007/978-1-4684-2646-5_1, 10.1007/978-1-4684-2646-5_1]; Foster R, 2009, NUTR BULL, V34, P4, DOI 10.1111/j.1467-3010.2008.01738.x; Geu-Flores F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm106; Gottwald JR, 2000, P NATL ACAD SCI USA, V97, P13979, DOI 10.1073/pnas.250473797; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Koroleva OA, 2000, PLANT PHYSIOL, V124, P599, DOI 10.1104/pp.124.2.599; Mailer RJ, 2008, J AM OIL CHEM SOC, V85, P937, DOI 10.1007/s11746-008-1268-0; MCKEY D, 1974, AM NAT, V108, P305, DOI 10.1086/282909; Norholm MHH, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-21; Nour-Eldin HH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl635; Nour-Eldin HH, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-17; Nour-Eldin HH, 2009, PHYTOCHEM REV, V8, P53, DOI 10.1007/s11101-008-9110-8; Ohnmeiss TE, 2000, ECOLOGY, V81, P1765, DOI 10.1890/0012-9658(2000)081[1765:ODTPTO]2.0.CO;2; Snowdon R., 2007, Oilseeds, P55; Townsend BJ, 2007, TRENDS BIOTECHNOL, V25, P239, DOI 10.1016/j.tibtech.2007.03.012; Vert G, 2002, PLANT CELL, V14, P1223, DOI 10.1105/tpc.001388; Wang YY, 2011, PLANT CELL, V23, P1945, DOI 10.1105/tpc.111.083618; WINK M, 1983, Z NATURFORSCH C, V38, P905; Wittkop B, 2009, EUPHYTICA, V170, P131, DOI 10.1007/s10681-009-9940-5; Wu SQ, 2008, CURR OPIN BIOTECH, V19, P145, DOI 10.1016/j.copbio.2008.02.007; Zhang JX, 2011, PHYTOCHEMISTRY, V72, P1767, DOI 10.1016/j.phytochem.2011.06.002; Zust T, 2011, P ROY SOC B-BIOL SCI, V278, P2598, DOI 10.1098/rspb.2010.2475	30	312	326	10	231	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 23	2012	488	7412					531	534		10.1038/nature11285	http://dx.doi.org/10.1038/nature11285			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992FS	22864417				2022-12-28	WOS:000307761600041
J	Wilson, R; Wells, AU				Wilson, Robert; Wells, Athol U.			Azithromycin in bronchiectasis: when should it be used?	LANCET			English	Editorial Material							PULMONARY-FUNCTION; CT		[Wilson, Robert; Wells, Athol U.] Royal Brompton Hosp, London SW3 6NP, England	Royal Brompton Hospital	Wells, AU (corresponding author), Royal Brompton Hosp, London SW3 6NP, England.	a.wells@rbh.nthames.nhs.uk						Albert RK, 2011, NEW ENGL J MED, V365, P689, DOI 10.1056/NEJMoa1104623; BHALLA M, 1991, RADIOLOGY, V179, P783, DOI 10.1148/radiology.179.3.2027992; Davies G, 2006, EUR RESPIR J, V28, P974, DOI 10.1183/09031936.06.00074605; Habesoglu MA, 2011, ANN THORAC MED, V6, P131, DOI 10.4103/1817-1737.82443; Loebinger MR, 2009, EUR RESPIR J, V34, P843, DOI 10.1183/09031936.00003709; Malhotra-Kumar S, 2007, LANCET, V369, P482, DOI 10.1016/S0140-6736(07)60235-9; Ooi GC, 2002, RADIOLOGY, V225, P663, DOI 10.1148/radiol.2253011575; Reinert RR, 2005, ANTIMICROB AGENTS CH, V49, P2903, DOI 10.1128/AAC.49.7.2903-2913.2005; Roberts HR, 2000, THORAX, V55, P198, DOI 10.1136/thorax.55.3.198; Wong C, 2012, LANCET, V380, P660, DOI 10.1016/S0140-6736(12)60953-2	10	10	10	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 18	2012	380	9842					627	629		10.1016/S0140-6736(12)61261-6	http://dx.doi.org/10.1016/S0140-6736(12)61261-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	991SE	22901872				2022-12-28	WOS:000307721000007
J	Gao, H; Chakraborty, G; Lee-Lim, AP; Mo, QX; Decker, M; Vonica, A; Shen, RL; Brogi, E; Brivanlou, AH; Giancotti, FG				Gao, Hua; Chakraborty, Goutam; Lee-Lim, Ai Ping; Mo, Qianxing; Decker, Markus; Vonica, Alin; Shen, Ronglai; Brogi, Edi; Brivanlou, Ali H.; Giancotti, Filippo G.			The BMP Inhibitor Coco Reactivates Breast Cancer Cells at Lung Metastatic Sites	CELL			English	Article							GENE-EXPRESSION SIGNATURE; STEM-CELLS; TGF-BETA; PROLIFERATION; DISSEMINATION; SURVIVAL; GROWTH; NICHE	The mechanistic underpinnings of metastatic dormancy and reactivation are poorly understood. A gain-of-function cDNA screen reveals that Coco, a secreted antagonist of TGF-beta ligands, induces dormant breast cancer cells to undergo reactivation in the lung. Mechanistic studies indicate that Coco exerts this effect by blocking lung-derived BMP ligands. Whereas Coco enhances the manifestation of traits associated with cancer stem cells, BMP signaling suppresses it. Coco induces a discrete gene expression signature, which is strongly associated with metastatic relapse to the lung, but not to the bone or brain in patients. Experiments in mouse models suggest that these latter organs contain niches devoid of bioactive BMP. These findings reveal that metastasis-initiating cells need to overcome organ-specific antimetastatic signals in order to undergo reactivation.	[Gao, Hua; Chakraborty, Goutam; Lee-Lim, Ai Ping; Decker, Markus; Giancotti, Filippo G.] Mem Sloan Kettering Canc Ctr, Cell Biol Program, Sloan Kettering Inst Canc Res, New York, NY 10065 USA; [Mo, Qianxing; Shen, Ronglai] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA; [Brogi, Edi] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Vonica, Alin; Brivanlou, Ali H.] Rockefeller Univ, Lab Mol Embryol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Rockefeller University	Giancotti, FG (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, Sloan Kettering Inst Canc Res, New York, NY 10065 USA.	f-giancotti@ski.mskcc.org	Chakraborty, Goutam/U-5559-2019; Chakraborty, Goutam/B-5099-2014	Gao, Hua/0000-0002-9698-5830	Geoffrey Beene Cancer Center at MSKCC; NIH [P01 CA094060]; NATIONAL CANCER INSTITUTE [P01CA094060, R01CA175712] Funding Source: NIH RePORTER	Geoffrey Beene Cancer Center at MSKCC; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank G. Daley, J. Massague, and F. Miller for reagents, X. Zhang and X. Jing for help with X-ray imaging, M. Akram for Coco staining of human TMAs, members of the Giancotti laboratory for discussions, and the staff of the Genomics and the Molecular Cytology Facilities for their help. This work was supported by the Geoffrey Beene Cancer Center at MSKCC and NIH grant P01 CA094060.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Bell E, 2003, DEVELOPMENT, V130, P1381, DOI 10.1242/dev.00344; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Birkenkamp-Demtroder K, 2011, BRIT J CANCER, V105, P552, DOI 10.1038/bjc.2011.268; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Buijs JT, 2012, ONCOGENE, V31, P2164, DOI 10.1038/onc.2011.400; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Danesh SM, 2009, GENE EXPR PATTERNS, V9, P255, DOI 10.1016/j.gep.2009.04.002; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Ellen TP, 2008, CARCINOGENESIS, V29, P2, DOI 10.1093/carcin/bgm200; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Gupta GP, 2007, P NATL ACAD SCI USA, V104, P19506, DOI 10.1073/pnas.0709185104; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Hata A, 1998, GENE DEV, V12, P186, DOI 10.1101/gad.12.2.186; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Kobielak K, 2007, P NATL ACAD SCI USA, V104, P10063, DOI 10.1073/pnas.0703004104; Koh EY, 2004, ONCOGENE, V23, P1214, DOI 10.1038/sj.onc.1207209; Koh EY, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf142; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Lo PK, 2012, ONCOGENE, V31, P2614, DOI [10.1038/onc.2011.439, 10.1038/onc.2012.147]; Lu X, 2011, CANCER CELL, V20, P701, DOI 10.1016/j.ccr.2011.11.002; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Pang R, 2010, CELL STEM CELL, V6, P603, DOI 10.1016/j.stem.2010.04.001; Pearce JJH, 1999, DEV BIOL, V209, P98, DOI 10.1006/dbio.1999.9240; Pylayeva Y, 2009, J CLIN INVEST, V119, P252, DOI 10.1172/JCI37160; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Shibue T, 2009, P NATL ACAD SCI USA, V106, P10290, DOI 10.1073/pnas.0904227106; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Varga AC, 2005, ONCOGENE, V24, P5713, DOI 10.1038/sj.onc.1208919; Walsh DW, 2010, TRENDS CELL BIOL, V20, P244, DOI 10.1016/j.tcb.2010.01.008; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017	46	291	295	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 17	2012	150	4					764	779		10.1016/j.cell.2012.06.035	http://dx.doi.org/10.1016/j.cell.2012.06.035			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	995IT	22901808	Green Accepted, Bronze			2022-12-28	WOS:000308002300011
J	Roth, JR; Andersson, DI				Roth, John R.; Andersson, D. I.			Poxvirus Use a "Gene Accordion" to Tune Out Host Defenses	CELL			English	Editorial Material							ANTIBIOTIC-RESISTANCE; AMPLIFICATION; EVOLUTION; MUTATION; SELECTION	A multistep process of gene amplification, mutation, and reduction allows poxvirus to overcome host antiviral defenses. The mechanism speeds genetic adaptation and promises to be broadly applicable in many biological settings.	[Roth, John R.] Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA; [Andersson, D. I.] Uppsala Univ, Dept Med Biochem, S-75123 Uppsala, Sweden	University of California System; University of California Davis; Uppsala University	Roth, JR (corresponding author), Univ Calif Davis, Dept Microbiol, 1 Shields Ave, Davis, CA 95616 USA.	jrroth@ucdavis.edu		Andersson, Dan/0000-0001-6640-2174	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027068] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersson DI, 2009, ANNU REV GENET, V43, P167, DOI 10.1146/annurev-genet-102108-134805; Andersson DI, 1998, SCIENCE, V282, P1133, DOI 10.1126/science.282.5391.1133; Bergthorsson U, 2007, P NATL ACAD SCI USA, V104, P17004, DOI 10.1073/pnas.0707158104; CAIRNS J, 1991, GENETICS, V128, P695; Copley SD, 2012, BIOESSAYS, V34, P578, DOI 10.1002/bies.201100191; Copley SD, 2012, J BIOL CHEM, V287, P3, DOI 10.1074/jbc.R111.254714; Elde NC, 2012, CELL, V150, P831, DOI 10.1016/j.cell.2012.05.049; Pranting M, 2011, MOL MICROBIOL, V79, P305, DOI 10.1111/j.1365-2958.2010.07458.x; Roth JR, 2011, MOL MICROBIOL, V79, P279, DOI 10.1111/j.1365-2958.2010.07459.x; Sandegren L, 2009, NAT REV MICROBIOL, V7, P578, DOI 10.1038/nrmicro2174; Slechta ES, 2003, P NATL ACAD SCI USA, V100, P12847, DOI 10.1073/pnas.1735464100	11	7	7	1	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 17	2012	150	4					671	672		10.1016/j.cell.2012.07.026	http://dx.doi.org/10.1016/j.cell.2012.07.026			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	995IT	22901801	Bronze			2022-12-28	WOS:000308002300003
J	Logan, BE; Elimelech, M				Logan, Bruce E.; Elimelech, Menachem			Membrane-based processes for sustainable power generation using water	NATURE			English	Review							MICROBIAL FUEL-CELLS; PRESSURE-RETARDED OSMOSIS; AMMONIA-CARBON DIOXIDE; ELECTRODIALYSIS ELECTROLYSIS CELLS; REVERSE-ELECTRODIALYSIS; SALINITY GRADIENTS; HYDROGEN-PRODUCTION; OSMOTIC POWER; BIOELECTROCHEMICAL SYSTEMS; ENERGY EFFICIENCY	Water has always been crucial to combustion and hydroelectric processes, but it could become the source of power in membrane-based systems that capture energy from natural and waste waters. Two processes are emerging as sustainable methods for capturing energy from sea water: pressure-retarded osmosis and reverse electrodialysis. These processes can also capture energy from waste heat by generating artificial salinity gradients using synthetic solutions, such as thermolytic salts. A further source of energy comes from organic matter in waste waters, which can be harnessed using microbial fuel-cell technology, allowing both wastewater treatment and power production.	[Logan, Bruce E.] Penn State Univ, Dept Civil & Environm Engn, University Pk, PA 16802 USA; [Elimelech, Menachem] Yale Univ, Dept Chem & Environm Engn, New Haven, CT 06520 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Yale University	Logan, BE (corresponding author), Penn State Univ, Dept Civil & Environm Engn, 212 Sackett Bldg, University Pk, PA 16802 USA.	blogan@psu.edu	Elimelech, Menachem/E-7137-2012	Elimelech, Menachem/0000-0003-4186-1563	King Abdullah University of Science and Technology (KAUST) [KUS-I1-003-13]; National Research Foundation of Korea; Ministry of Education, Science and Technology [R33-10046]	King Abdullah University of Science and Technology (KAUST)(King Abdullah University of Science & Technology); National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	The authors acknowledge support from the King Abdullah University of Science and Technology (KAUST) by Award KUS-I1-003-13 (BEL), and the World Class University (WCU) Program (Case III) through the National Research Foundation of Korea and the Ministry of Education, Science and Technology (R33-10046) (ME).	Achilli A, 2010, J MEMBRANE SCI, V364, P233, DOI 10.1016/j.memsci.2010.08.010; Achilli A, 2010, DESALINATION, V261, P205, DOI 10.1016/j.desal.2010.06.017; Achilli A, 2009, J MEMBRANE SCI, V343, P42, DOI 10.1016/j.memsci.2009.07.006; Alkhudhiri A, 2012, DESALINATION, V287, P2, DOI 10.1016/j.desal.2011.08.027; Borole AP, 2011, BIOFUEL BIOPROD BIOR, V5, P28, DOI 10.1002/bbb.265; Brogioli D, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.058501; Cath T. Y., 2011, US Patent, Patent No. [8,029,671, 8029671]; Cath TY, 2006, J MEMBRANE SCI, V281, P70, DOI 10.1016/j.memsci.2006.05.048; Cheng SA, 2011, BIORESOURCE TECHNOL, V102, P4468, DOI 10.1016/j.biortech.2010.12.104; Chou SR, 2012, J MEMBRANE SCI, V389, P25, DOI 10.1016/j.memsci.2011.10.002; Clauwaert P, 2007, ENVIRON SCI TECHNOL, V41, P3354, DOI 10.1021/es062580r; Cusick RD, 2012, SCIENCE, V335, P1474, DOI [10.1126/science.1219330, 10.1126/science.1218781]; Dekker A, 2009, ENVIRON SCI TECHNOL, V43, P9038, DOI 10.1021/es901939r; Dlugolecki P, 2010, J MEMBRANE SCI, V347, P101, DOI 10.1016/j.memsci.2009.10.011; Elimelech M, 2011, SCIENCE, V333, P712, DOI 10.1126/science.1200488; Fan YZ, 2008, ENVIRON SCI TECHNOL, V42, P8101, DOI 10.1021/es801229j; Fan YZ, 2007, ENVIRON SCI TECHNOL, V41, P8154, DOI 10.1021/es071739c; Gerstandt K, 2008, DESALINATION, V224, P64, DOI 10.1016/j.desal.2007.02.080; Heidrich ES, 2011, ENVIRON SCI TECHNOL, V45, P827, DOI 10.1021/es103058w; Hoover LA, 2011, ENVIRON SCI TECHNOL, V45, P9824, DOI 10.1021/es202576h; Jiang DQ, 2011, INT J HYDROGEN ENERG, V36, P876, DOI 10.1016/j.ijhydene.2010.08.074; Kim Y, 2011, P NATL ACAD SCI USA, V108, P16176, DOI 10.1073/pnas.1106335108; Kim Y, 2011, ENVIRON SCI TECHNOL, V45, P5834, DOI 10.1021/es200979b; La Mantia F, 2011, NANO LETT, V11, P1810, DOI 10.1021/nl200500s; Lalaurette E, 2009, INT J HYDROGEN ENERG, V34, P6201, DOI 10.1016/j.ijhydene.2009.05.112; Lay WCL, 2011, DESALINATION, V283, P123, DOI 10.1016/j.desal.2011.01.036; Lee KP, 2011, J MEMBRANE SCI, V370, P1, DOI 10.1016/j.memsci.2010.12.036; LEE KL, 1981, J MEMBRANE SCI, V8, P141, DOI 10.1016/S0376-7388(00)82088-8; Liu H, 2005, ENVIRON SCI TECHNOL, V39, P4317, DOI 10.1021/es050244p; Liu H, 2004, ENVIRON SCI TECHNOL, V38, P4040, DOI 10.1021/es0499344; Liu H, 2008, J POWER SOURCES, V179, P274, DOI 10.1016/j.jpowsour.2007.12.120; LOEB S, 1975, SCIENCE, V189, P654, DOI 10.1126/science.189.4203.654; Loeb S., 1980, US Patent, Patent No. [4,193,267, 4193267]; Logan B.E., 2008, MICROBIAL FUEL CELLS; Logan B, 2007, ENVIRON SCI TECHNOL, V41, P3341, DOI 10.1021/es062644y; Logan BE, 2006, ENVIRON SCI TECHNOL, V40, P5181, DOI 10.1021/es0605016; Logan BE, 2006, ENVIRON SCI TECHNOL, V40, P5172, DOI 10.1021/es0627592; Logan BE, 2010, APPL MICROBIOL BIOT, V85, P1665, DOI 10.1007/s00253-009-2378-9; Logan BE, 2009, NAT REV MICROBIOL, V7, P375, DOI 10.1038/nrmicro2113; Lu L, 2009, BIOSENS BIOELECTRON, V24, P3055, DOI 10.1016/j.bios.2009.03.024; McCarty PL, 2011, ENVIRON SCI TECHNOL, V45, P7100, DOI 10.1021/es2014264; McCutcheon JR, 2005, DESALINATION, V174, P1, DOI 10.1016/j.desal.2004.11.002; McGinnis RL, 2007, J MEMBRANE SCI, V305, P13, DOI 10.1016/j.memsci.2007.08.027; McGinnis RL, 2007, DESALINATION, V207, P370, DOI 10.1016/j.desal.2006.08.012; McGinnis RL, 2008, ENVIRON SCI TECHNOL, V42, P8625, DOI 10.1021/es800812m; Nam JY, 2012, ENVIRON SCI TECHNOL, V46, P5240, DOI 10.1021/es300228m; Nevin KP, 2011, APPL ENVIRON MICROB, V77, P2882, DOI 10.1128/AEM.02642-10; Nevin KP, 2010, MBIO, V1, DOI 10.1128/mBio.00103-10; Nijmeijer K, 2010, SUSTAIN SCI ENG, V2, P95, DOI 10.1016/S1871-2711(09)00205-0; Pant D, 2010, BIORESOURCE TECHNOL, V101, P1533, DOI 10.1016/j.biortech.2009.10.017; PATTLE RE, 1954, NATURE, V174, P660, DOI 10.1038/174660a0; Perlack R.D., 2005, BIOMASS FEEDSTOCK BI; Post JW, 2008, ENVIRON SCI TECHNOL, V42, P5785, DOI 10.1021/es8004317; Rabaey K, 2010, NAT REV MICROBIOL, V8, P706, DOI 10.1038/nrmicro2422; Ramon GZ, 2011, ENERG ENVIRON SCI, V4, P4423, DOI 10.1039/c1ee01913a; Ren ZY, 2007, ENVIRON SCI TECHNOL, V41, P4781, DOI 10.1021/es070577h; Rozendal RA, 2006, INT J HYDROGEN ENERG, V31, P1632, DOI 10.1016/j.ijhydene.2005.12.006; Sales BB, 2010, ENVIRON SCI TECHNOL, V44, P5661, DOI 10.1021/es100852a; Skilhagen SE, 2010, DESALIN WATER TREAT, V15, P271, DOI 10.5004/dwt.2010.1759; Souhaimi M.K., 2011, MEMBRANE DISTILLATIO; STOUGHTON RW, 1965, J CHEM ENG DATA, V10, P254, DOI 10.1021/je60026a016; Ter Heijne A, 2006, ENVIRON SCI TECHNOL, V40, P5200, DOI 10.1021/es0608545; Ter Heijne A, 2010, ENVIRON SCI TECHNOL, V44, P4376, DOI 10.1021/es100526g; Thorsen T, 2009, J MEMBRANE SCI, V335, P103, DOI 10.1016/j.memsci.2009.03.003; Veerman J, 2010, J APPL ELECTROCHEM, V40, P1461, DOI 10.1007/s10800-010-0124-8; Veerman J, 2009, J MEMBRANE SCI, V343, P7, DOI 10.1016/j.memsci.2009.05.047; Veerman J, 2009, J MEMBRANE SCI, V327, P136, DOI 10.1016/j.memsci.2008.11.015; Veerman J, 2010, ENVIRON SCI TECHNOL, V44, P9207, DOI 10.1021/es1009345; Velasquez-Orta SB, 2009, BIOTECHNOL BIOENG, V103, P1068, DOI 10.1002/bit.22346; Vermaas DA, 2011, J MEMBRANE SCI, V385, P234, DOI 10.1016/j.memsci.2011.09.043; Vermaas DA, 2011, ENVIRON SCI TECHNOL, V45, P7089, DOI 10.1021/es2012758; WICK GL, 1978, SCIENCE, V199, P1436, DOI 10.1126/science.199.4336.1436; Xie X, 2012, ENERG ENVIRON SCI, V5, P5265, DOI 10.1039/c1ee02122b; Xu Y, 2010, J MEMBRANE SCI, V348, P298, DOI 10.1016/j.memsci.2009.11.013; Yip NY, 2012, ENVIRON SCI TECHNOL, V46, P5230, DOI 10.1021/es300060m; Yip NY, 2011, ENVIRON SCI TECHNOL, V45, P10273, DOI 10.1021/es203197e; Yip NY, 2011, ENVIRON SCI TECHNOL, V45, P4360, DOI 10.1021/es104325z; Yip NY, 2010, ENVIRON SCI TECHNOL, V44, P3812, DOI 10.1021/es1002555; Zhang BG, 2012, J POWER SOURCES, V204, P34, DOI 10.1016/j.jpowsour.2012.01.013; Zhang F, 2011, BIOSENS BIOELECTRON, V30, P49, DOI 10.1016/j.bios.2011.08.025; Zhang F, 2009, ELECTROCHEM COMMUN, V11, P2177, DOI 10.1016/j.elecom.2009.09.024; Zhang F, 2011, ENVIRON SCI TECHNOL, V45, P6690, DOI 10.1021/es201505t; Zhao SF, 2012, J MEMBRANE SCI, V396, P1, DOI 10.1016/j.memsci.2011.12.023	83	1010	1038	98	1760	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2012	488	7411					313	319		10.1038/nature11477	http://dx.doi.org/10.1038/nature11477			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OS	22895336				2022-12-28	WOS:000307501000030
J	Olesen, JB; Lip, GYH; Kamper, AL; Hommel, K; Kober, L; Lane, DA; Lindhardsen, J; Gislason, GH; Torp-Pedersen, C				Olesen, Jonas Bjerring; Lip, Gregory Y. H.; Kamper, Anne-Lise; Hommel, Kristine; Kober, Lars; Lane, Deirdre A.; Lindhardsen, Jesper; Gislason, Gunnar Hilmar; Torp-Pedersen, Christian			Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; RISK STRATIFICATION; PREDICTING STROKE; MORTALITY; VALIDITY; WARFARIN; ASPIRIN; THROMBOEMBOLISM; CLOPIDOGREL; PREVENTION	BACKGROUND Both atrial fibrillation and chronic kidney disease increase the risk of stroke and systemic thromboembolism. However, these risks, and the effects of antithrombotic treatment, have not been thoroughly investigated in patients with both conditions. METHODS Using Danish national registries, we identified all patients discharged from the hospital with a diagnosis of nonvalvular atrial fibrillation between 1997 and 2008. The risk of stroke or systemic thromboembolism and bleeding associated with non-end-stage chronic kidney disease and with end-stage chronic kidney disease (i.e., disease requiring renal-replacement therapy) was estimated with the use of time-dependent Cox regression analyses. In addition, the effects of treatment with warfarin, aspirin, or both in patients with chronic kidney disease were compared with the effects in patients with no renal disease. RESULTS Of 132,372 patients included in the analysis, 3587 (2.7%) had non-end-stage chronic kidney disease and 901 (0.7%) required renal-replacement therapy at the time of inclusion. As compared with patients who did not have renal disease, patients with non-end-stage chronic kidney disease had an increased risk of stroke or systemic thromboembolism (hazard ratio, 1.49; 95% confidence interval [CI], 1.38 to 1.59; P<0.001), as did those requiring renal-replacement therapy (hazard ratio, 1.83; 95% CI, 1.57 to 2.14; P<0.001); this risk was significantly decreased for both groups of patients with warfarin but not with aspirin. The risk of bleeding was also increased among patients who had non-end-stage chronic kidney disease or required renal-replacement therapy and was further increased with warfarin, aspirin, or both. CONCLUSIONS Chronic kidney disease was associated with an increased risk of stroke or systemic thromboembolism and bleeding among patients with atrial fibrillation. Warfarin treatment was associated with a decreased risk of stroke or systemic thromboembolism among patients with chronic kidney disease, whereas warfarin and aspirin were associated with an increased risk of bleeding. (Funded by the Lundbeck Foundation.)	[Olesen, Jonas Bjerring; Lindhardsen, Jesper; Gislason, Gunnar Hilmar; Torp-Pedersen, Christian] Univ Copenhagen, Gentofte Hosp, Dept Cardiol, DK-2900 Hellerup, Denmark; [Kamper, Anne-Lise; Hommel, Kristine] Univ Copenhagen, Rigshosp, Dept Nephrol, DK-2100 Copenhagen, Denmark; [Kober, Lars] Univ Copenhagen, Rigshosp, Ctr Heart, DK-2100 Copenhagen, Denmark; [Olesen, Jonas Bjerring; Lip, Gregory Y. H.; Lane, Deirdre A.] Univ Birmingham, Ctr Cardiovasc Sci, City Hosp, Birmingham, W Midlands, England	University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Birmingham	Olesen, JB (corresponding author), Univ Copenhagen, Gentofte Hosp, Dept Cardiol, Post 635,Niels Andersens Vej 65, DK-2900 Hellerup, Denmark.	jo@heart.dk	Torp-Pedersen, Christian/E-5931-2013; Lane, Deirdre/AAX-1866-2020; Gislason, Gunnar/B-7561-2009	Lane, Deirdre/0000-0002-5604-9378; Gislason, Gunnar/0000-0002-0548-402X; Kober, Lars/0000-0002-6635-1466; Kamper, Anne-Lise/0000-0001-7523-6569	Lundbeck Foundation; Bristol-Myers Squibb; Bayer HealthCare	Lundbeck Foundation(Lundbeckfonden); Bristol-Myers Squibb(Bristol-Myers Squibb); Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals)	(Funded by the Lundbeck Foundation.); Supported by the Lundbeck Foundation.; Dr. Olesen reports receiving travel support from AstraZeneca and Boehringer Ingelheim on behalf of his institution; Dr. Lip, receiving consulting fees from Astellas, AstraZeneca, Bayer, Biotronik, Bristol-Myers Squibb/Pfizer, Boehringer Ingelheim, Merck, Portola, and Sanofi Aventis, and being on speakers bureaus for Bayer, Bristol-Myers Squibb/Pfizer, Boehringer Ingelheim, and Sanofi Aventis; Dr. Kober, being on a speakers bureau for Servier; Dr. Lane, receiving grant support from Bayer HealthCare on behalf of her institution, lecture fees from Bayer HealthCare, Bristol-Myers Squibb/Pfizer, and Boehringer Ingelheim, and payment for the development of educational presentations from Bayer HealthCare, Bristol-Myers Squibb/Pfizer, and Boehringer Ingelheim; and Dr. Torp-Pedersen, receiving consulting fees from Cardiome and Merck on behalf of himself and from Sanofi Aventis on behalf of himself and his institution, grant support from Bristol-Myers Squibb on behalf of his institution, lecture fees from Cardiome, Merck, and Sanofi Aventis, and travel support from Bristol-Myers Squibb/Pfizer. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 1994, ARCH INTERN MED, V154, P2254; Atar I, 2006, INT J CARDIOL, V106, P47, DOI 10.1016/j.ijcard.2004.12.048; Camm AJ, 2011, EUR HEART J, V32, P1172, DOI 10.1093/eurheartj/ehq512; Camm AJ, 2010, EUR HEART J, V31, P2369, DOI [10.1093/eurheartj/ehq278, 10.1093/europace/euq350]; Chan KE, 2009, J AM SOC NEPHROL, V20, P2223, DOI 10.1681/ASN.2009030319; Conen D, 2011, JAMA-J AM MED ASSOC, V305, P2080, DOI 10.1001/jama.2011.659; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Di Angelantonio E, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4986; FEINBERG WM, 1995, ARCH INTERN MED, V155, P469, DOI 10.1001/archinte.155.5.469; Frost L, 2007, AM J MED, V120, P47, DOI 10.1016/j.amjmed.2005.12.027; Gaist D, 1997, DAN MED BULL, V44, P445; Hansen ML, 2010, ARCH INTERN MED, V170, P1433, DOI 10.1001/archinternmed.2010.271; Hommel K, 2010, NEPHROL DIAL TRANSPL, V25, P947, DOI 10.1093/ndt/gfp571; Krarup LH, 2007, NEUROEPIDEMIOLOGY, V28, P150, DOI 10.1159/000102143; LAUPACIS A, 1994, ARCH INTERN MED, V154, P1449; Lee M, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4249; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; Marinigh R, 2011, J AM COLL CARDIOL, V57, P1339, DOI 10.1016/j.jacc.2010.12.013; Olesen JB, 2011, J THROMB HAEMOST, V9, P1460, DOI 10.1111/j.1538-7836.2011.04378.x; Olesen JB, 2011, THROMB HAEMOSTASIS, V106, P739, DOI 10.1160/TH11-05-0364; Olesen JB, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d124; Olesen JB, 2011, PHARMACOEPIDEM DR S, V20, P146, DOI 10.1002/pds.2073; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Reinecke H, 2009, J AM SOC NEPHROL, V20, P705, DOI 10.1681/ASN.2007111207; Rietbrock S, 2009, THROMB HAEMOSTASIS, V101, P527, DOI 10.1160/TH08-08-0499; Rocket Af Study Investigators, 2010, AM HEART J, V159; Soliman EZ, 2010, AM HEART J, V159, P1102, DOI 10.1016/j.ahj.2010.03.027; Sorensen R, 2009, LANCET, V374, P1967, DOI 10.1016/S0140-6736(09)61751-7; US Renal Data System, 2006, USRDS 2006 ANN DAT R; Wizemann V, 2010, KIDNEY INT, V77, P1098, DOI 10.1038/ki.2009.477; Yang F, 2010, EUROPACE, V12, P1666, DOI 10.1093/europace/euq387	32	655	683	3	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 16	2012	367	7					625	635		10.1056/NEJMoa1105594	http://dx.doi.org/10.1056/NEJMoa1105594			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988NB	22894575				2022-12-28	WOS:000307496600006
J	Loffler, S; Korber, J; Nubbemeyer, U; Fehsel, K				Loeffler, Stefan; Koerber, Jochen; Nubbemeyer, Udo; Fehsel, Karin			Comment on "Impaired Respiratory and Body Temperature Control Upon Acute Serotonergic Neuron Inhibition"	SCIENCE			English	Editorial Material							INDUCED METABOLIC ALTERATIONS; CLOZAPINE-N-OXIDE; POSSIBLE MECHANISM; ENERGY-METABOLISM; CAUSES OXIDATION; IN-VIVO; RECEPTOR; CELLS; DOPAMINE; RAT		[Loeffler, Stefan] Goethe Univ Frankfurt, Dept Psychiat & Psychotherapy, Clin Offenbach, Teaching Hosp, D-63069 Offenbach, Germany; [Koerber, Jochen; Nubbemeyer, Udo] Johannes Gutenberg Univ Mainz, Dept Organ Chem, D-55128 Mainz, Germany; [Fehsel, Karin] Univ Dusseldorf, Neurobiochem Res Unit, Clin & Polyclin Psychiat & Psychotherapy, D-40629 Dusseldorf, Germany	Goethe University Frankfurt; Sana Klinikum Offenbach; Johannes Gutenberg University of Mainz; Heinrich Heine University Dusseldorf	Loffler, S (corresponding author), Goethe Univ Frankfurt, Dept Psychiat & Psychotherapy, Clin Offenbach, Teaching Hosp, D-63069 Offenbach, Germany.	stefloeffler@t-online.de						Ahmed MR, 2008, J PHARMACOL EXP THER, V325, P276, DOI 10.1124/jpet.107.131987; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Baig MR, 2010, J PSYCHIATR PRACT, V16, P325, DOI 10.1097/01.pra.0000388627.36781.6a; BENDER D, 1994, NUCL MED BIOL, V21, P921, DOI 10.1016/0969-8051(94)90080-9; BICKEL MH, 1969, PHARMACOL REV, V21, P325; BOLDEN C, 1992, J PHARMACOL EXP THER, V260, P576; Brenner-Lavie H, 2009, BIOCHEM PHARMACOL, V78, P85, DOI 10.1016/j.bcp.2009.03.024; Casademont J, 2007, J CLIN PSYCHOPHARM, V27, P284, DOI 10.1097/JCP.0b013e318054753e; Devoto P, 2003, PSYCHOPHARMACOLOGY, V167, P79, DOI 10.1007/s00213-002-1381-y; Dong E, 2008, P NATL ACAD SCI USA, V105, P13614, DOI 10.1073/pnas.0805493105; Ferno J, 2009, PSYCHOPHARMACOLOGY, V203, P73, DOI 10.1007/s00213-008-1370-x; FISCHER V, 1991, MOL PHARMACOL, V40, P846; Hampson LJ, 2007, DIABETOLOGIA, V50, P1743, DOI 10.1007/s00125-007-0696-y; Henning U, 2003, PHARMACOPSYCHIATRY, V36, P233; Houseknecht KL, 2007, NEUROPSYCHOPHARMACOL, V32, P289, DOI 10.1038/sj.npp.1301209; JANN MW, 1994, ARCH INT PHARMACOD T, V328, P243; Kobayashi T., 2010, ION CHANNELS STRUCTU, P448; Koopman T. S. M., 2007, Patent Application Publication, Patent No. [US 2007/0043059 A1, 20070043059]; Masri B, 2008, P NATL ACAD SCI USA, V105, P13656, DOI 10.1073/pnas.0803522105; McGuire M, 2004, AM J PHYSIOL-REG I, V286, pR334, DOI 10.1152/ajpregu.00463.2003; MILLAN MJ, 1995, J PHARMACOL EXP THER, V275, P885; Monda M, 2004, PHYSIOL RES, V53, P507; Nawaratne V, 2008, MOL PHARMACOL, V74, P1119, DOI 10.1124/mol.108.049353; PIRMOHAMED M, 1995, J PHARMACOL EXP THER, V272, P984; Rane A, 1996, BBA-GEN SUBJECTS, V1291, P60, DOI 10.1016/0304-4165(96)00046-3; RAY, 2011, SCI             0729, P637; Ray RS, 2011, SCIENCE, V333, P637, DOI 10.1126/science.1205295; Robertson GS, 2004, EUR J NEUROSCI, V20, P3189, DOI 10.1111/j.1460-9568.2004.03774.x; Salmi P, 1996, EUR J PHARMACOL, V307, P27, DOI 10.1016/0014-2999(96)00181-1; Sur C, 2003, P NATL ACAD SCI USA, V100, P13674, DOI 10.1073/pnas.1835612100; Takekawa K, 2001, XENOBIOTICA, V31, P11, DOI 10.1080/00498250010024997; Vik-Mo Audun O., 2009, BMC Pharmacology, V9, P10, DOI 10.1186/1471-2210-9-10; Vondracek J, 2011, CURR DRUG METAB, V12, P89, DOI 10.2174/138920011795016827; Walss-Bass C, 2008, INT J NEUROPSYCHOPH, V11, P1097, DOI 10.1017/S1461145708008882	34	17	17	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2012	337	6095								10.1126/science.1221810	http://dx.doi.org/10.1126/science.1221810			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986PE	22879486				2022-12-28	WOS:000307354500021
J	Flamand, M; Duchaine, TF				Flamand, Mathieu; Duchaine, Thomas F.			SnapShot: Endogenous RNAi Machinery and Mechanisms	CELL			English	Editorial Material							INTERFERENCE; PATHWAYS; PROTEINS; ELEGANS; PIRNAS		[Flamand, Mathieu; Duchaine, Thomas F.] McGill Univ, Dept Biochem, Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada	McGill University	Flamand, M (corresponding author), McGill Univ, Dept Biochem, Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada.		Flamand, Mathieu/R-6102-2019; Duchaine, Thomas/U-2399-2019	Duchaine, Thomas/0000-0002-3454-1839	Canadian Institutes of Health Research Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Couvillion MT, 2009, GENE DEV, V23, P2016, DOI 10.1101/gad.1821209; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Ketting RF, 2011, DEV CELL, V20, P148, DOI 10.1016/j.devcel.2011.01.012; Li LD, 2011, METHODS MOL BIOL, V764, P169, DOI 10.1007/978-1-61779-188-8_11; Martienssen RA, 2005, TRENDS GENET, V21, P450, DOI 10.1016/j.tig.2005.06.005; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Tushir JS, 2009, CELL, V139, P830, DOI 10.1016/j.cell.2009.10.042	10	2	2	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 3	2012	150	3					662	+		10.1016/j.cell.2012.07.016	http://dx.doi.org/10.1016/j.cell.2012.07.016			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	985WO	22863015	Bronze			2022-12-28	WOS:000307301400023
J	Qiang, L; Wang, LH; Kon, N; Zhao, WH; Lee, S; Zhang, YY; Rosenbaum, M; Zhao, YM; Gu, W; Farmer, SR; Accili, D				Qiang, Li; Wang, Liheng; Kon, Ning; Zhao, Wenhui; Lee, Sangkyu; Zhang, Yiying; Rosenbaum, Michael; Zhao, Yingming; Gu, Wei; Farmer, Stephen R.; Accili, Domenico			Brown Remodeling of White Adipose Tissue by SirT1-Dependent Deacetylation of Ppar gamma	CELL			English	Article							ACTIVATED-RECEPTOR-GAMMA; INSULIN-RESISTANCE; SIRT1; FAT; PGC-1-ALPHA; METABOLISM; ADIPOCYTES; OBESITY; MICE; THERMOGENESIS	Brown adipose tissue (BAT) can disperse stored energy as heat. Promoting BAT-like features in white adipose (WAT) is an attractive, if elusive, therapeutic approach to staunch the current obesity epidemic. Here we report that gain of function of the NAD-dependent deacetylase SirT1 or loss of function of its endogenous inhibitor Deleted in breast cancer-1 (Dbc1) promote "browning" of WAT by deacetylating peroxisome proliferator-activated receptor (Ppar)-gamma on Lys268 and Lys293. SirT1-dependent deacetylation of Lys268 and Lys293 is required to recruit the BAT program coactivator Prdm16 to Ppar gamma, leading to selective induction of BAT genes and repression of visceral WAT genes associated with insulin resistance. An acetylation-defective Pparg mutant induces a brown phenotype in white adipocytes, whereas an acetylated mimetic fails to induce "brown" genes but retains the ability to activate "white" genes. We propose that SirT1-dependent Pparg deacetylation is a form of selective Ppar gamma modulation of potential therapeutic import.	[Qiang, Li; Wang, Liheng; Accili, Domenico] Columbia Univ, Dept Med, Naomi Berrie Diabet Ctr, Coll Phys & Surg, New York, NY 10032 USA; [Kon, Ning; Zhao, Wenhui; Gu, Wei] Columbia Univ, Dept Pathol, Inst Canc Genet, Coll Phys & Surg, New York, NY 10032 USA; [Zhang, Yiying; Rosenbaum, Michael] Columbia Univ, Coll Phys & Surg, Dept Pediat, Div Mol Genet, New York, NY 10032 USA; [Lee, Sangkyu; Zhao, Yingming] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Farmer, Stephen R.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Columbia University; Columbia University; Columbia University; University of Chicago; Boston University	Accili, D (corresponding author), Columbia Univ, Dept Med, Naomi Berrie Diabet Ctr, Coll Phys & Surg, New York, NY 10032 USA.	da230@columbia.edu	Qiang, Li/C-9560-2012	Qiang, Li/0000-0001-8322-1797; ZHAO, WENHUI/0000-0002-7703-7106; Farmer, Stephen/0000-0003-2483-2795	NIH [HL087123, DK58282, DK64773, DK063608, RR024156]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024156] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL087123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064773, R37DK058282, R01DK058282, P30DK026687, P30DK063608, R01DK064819, R01DK057539] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank K. Tsuchiya and L. Ozcan for help with different aspects of this work, T. Kolar and A. Flete for technical support, Q. Zhang for help with structural analysis, U. Pajvani and G. Heinrich for comments on the manuscript, and members of the Accili laboratory for discussion of the data. We thank B. Spiegelman for providing HIB-1B cells. This work was supported by NIH grants HL087123, DK58282, DK64773, DK063608 (Columbia Diabetes Research Center), and RR024156 (Columbia University CTSA).	Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Barroso I, 1999, NATURE, V402, P880, DOI 10.1038/47254; Bartness TJ, 2010, INT J OBESITY, V34, pS36, DOI 10.1038/ijo.2010.182; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; Chen W, 2009, MOL CELL, V35, P755, DOI 10.1016/j.molcel.2009.09.015; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Dutchak PA, 2012, CELL, V148, P556, DOI 10.1016/j.cell.2011.11.062; Escande C, 2010, J CLIN INVEST, V120, P545, DOI 10.1172/JCI39319; Farmer SR, 2009, NATURE, V458, P839, DOI 10.1038/458839a; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Hauser S, 2000, J BIOL CHEM, V275, P18527, DOI 10.1074/jbc.M001297200; Tran KV, 2012, CELL METAB, V15, P222, DOI 10.1016/j.cmet.2012.01.008; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Kim-Muller JY, 2011, SCIENCE, V331, P1529, DOI 10.1126/science.1204504; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Kozak LP, 2010, CELL METAB, V11, P263, DOI 10.1016/j.cmet.2010.03.009; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Liu JJ, 2006, MOL CELL BIOL, V26, P5827, DOI 10.1128/MCB.00441-06; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nakae J, 2006, J CLIN INVEST, V116, P2473, DOI 10.1172/JCI25518; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Powelka AM, 2006, J CLIN INVEST, V116, P125, DOI 10.1172/JCI26040; Qiang L, 2012, CELL, V148, P397, DOI 10.1016/j.cell.2012.01.020; Qiang L, 2011, CELL METAB, V14, P758, DOI 10.1016/j.cmet.2011.10.007; Qiang L, 2010, J BIOL CHEM, V285, P27396, DOI 10.1074/jbc.M110.140228; Ravussin E, 2011, ANNU REV NUTR, V31, P33, DOI 10.1146/annurev-nutr-072610-145209; Rosen CJ, 2010, NEW ENGL J MED, V363, P803, DOI 10.1056/NEJMp1008233; Scime A, 2005, CELL METAB, V2, P283, DOI 10.1016/j.cmet.2005.10.002; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Timmers S, 2011, CELL METAB, V14, P612, DOI 10.1016/j.cmet.2011.10.002; TONTONOZ P, 1994, NUCLEIC ACIDS RES, V22, P5628, DOI 10.1093/nar/22.25.5628; Tsukiyama-Kohara K, 2001, NAT MED, V7, P1128, DOI 10.1038/nm1001-1128; Vernochet C, 2009, MOL CELL BIOL, V29, P4714, DOI 10.1128/MCB.01899-08; Virtanen KA, 2011, CURR OPIN LIPIDOL, V22, P49, DOI 10.1097/MOL.0b013e3283425243; Waku T, 2009, J MOL BIOL, V385, P188, DOI 10.1016/j.jmb.2008.10.039; Wang H, 2008, MOL CELL BIOL, V28, P188, DOI 10.1128/MCB.00992-07; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Yamauchi T, 2002, NAT GENET, V30, P221, DOI 10.1038/ng829; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515	48	533	572	13	126	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 3	2012	150	3					620	632		10.1016/j.cell.2012.06.027	http://dx.doi.org/10.1016/j.cell.2012.06.027			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	985WO	22863012	Green Accepted, Bronze			2022-12-28	WOS:000307301400019
J	Bergland, M; Klyczek, K; Lin, CC; Lundeberg, M; Tosado-Acevedo, R; Toro, A; White, D; Wolter, B				Bergland, Mark; Klyczek, Karen; Lin, Chi-Cheng; Lundeberg, Mary; Tosado-Acevedo, Rafael; Toro, Arlin; White, Dinitra; Wolter, Bjorn			Engaging Students in Molecular Biology via Case-Based Learning	SCIENCE			English	Editorial Material									[Bergland, Mark; Klyczek, Karen; Lundeberg, Mary] Univ Wisconsin, Dept Biol, River Falls, WI 54022 USA; [Lin, Chi-Cheng] Winona State Univ, Dept Comp Sci, Winona, MN 55987 USA; [Tosado-Acevedo, Rafael] Inter Amer Univ Puerto Rico, Fac Sci & Technol, San Juan, PR 00919 USA; [Toro, Arlin] Inter Amer Univ Puerto Rico, Dept Biol Chem & Environm Sci, San German, PR 00683 USA; [White, Dinitra] N Carolina Agr & Tech State Univ, Dept Biol, Greensboro, NC 27411 USA; [Wolter, Bjorn] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA	University of Wisconsin System; Minnesota State Colleges & Universities; Winona State University; Inter American University of Puerto Rico-San German; Inter American University of Puerto Rico-San German; University of North Carolina; North Carolina A&T State University; Michigan State University	Bergland, M (corresponding author), Univ Wisconsin, Dept Biol, River Falls, WI 54022 USA.	mark.s.bergland@uwrf.edu		Klyczek, Karen/0000-0001-7882-0429				Bergland M., 2002, AM BIOL TEACH, V682, P81; Hatfull GF, 2006, PLOS GENET, V2, P835, DOI 10.1371/journal.pgen.0020092; Hoffman D, 2003, J INTERACT ONLINE LE, V1; Kang H, 2010, J RES SCI TEACH, V47, P1116, DOI 10.1002/tea.20371; Lundeberg M. A., 2002, J COLL SCI TEACH, V32, P64; *NAT CTR BIOT INF, NAT CTR BIOT INF DAT; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wolter B. H. K., 2012, J SCI EDUC TECHNOL, DOI [10.1007/s/0956-012-9387-7, DOI 10.1007/S/0956-012-9387-7]	8	2	2	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 27	2012	337	6093					426	427		10.1126/science.1215225	http://dx.doi.org/10.1126/science.1215225			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	979FS	22837518				2022-12-28	WOS:000306802300032
J	Chokshi, DA; Farley, TA				Chokshi, Dave A.; Farley, Thomas A.			The Cost-Effectiveness of Environmental Approaches to Disease Prevention	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEALTH		[Chokshi, Dave A.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Chokshi, Dave A.] Harvard Univ, Sch Med, Boston, MA USA; [Farley, Thomas A.] New York City Dept Hlth & Mental Hyg, New York, NY USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; New York City Department of Health & Mental Hygiene	Chokshi, DA (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.			Chokshi, Dave/0000-0001-7467-4591				Brownson RC, 2006, ANNU REV PUBL HEALTH, V27, P341, DOI 10.1146/annurev.publhealth.27.021405.102137; Cohen JT, 2008, NEW ENGL J MED, V358, P661, DOI 10.1056/NEJMp0708558; Ford ES, 2011, ANNU REV PUBL HEALTH, V32, P5, DOI 10.1146/annurev-publhealth-031210-101211; Maciosek MV, 2006, AM J PREV MED, V31, P52, DOI 10.1016/j.amepre.2006.03.012; Smith-Spangler CM, 2010, ANN INTERN MED, V152, P481, DOI 10.7326/0003-4819-152-8-201004200-00212	5	59	59	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 26	2012	367	4					295	297		10.1056/NEJMp1206268	http://dx.doi.org/10.1056/NEJMp1206268			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	978KD	22830461				2022-12-28	WOS:000306738300003
J	Hashimoto, T; Perlot, T; Rehman, A; Trichereau, J; Ishiguro, H; Paolino, M; Sigl, V; Hanada, T; Hanada, R; Lipinski, S; Wild, B; Camargo, SMR; Singer, D; Richter, A; Kuba, K; Fukamizu, A; Schreiber, S; Clevers, H; Verrey, F; Rosenstiel, P; Penninger, JM				Hashimoto, Tatsuo; Perlot, Thomas; Rehman, Ateequr; Trichereau, Jean; Ishiguro, Hiroaki; Paolino, Magdalena; Sigl, Verena; Hanada, Toshikatsu; Hanada, Reiko; Lipinski, Simone; Wild, Birgit; Camargo, Simone M. R.; Singer, Dustin; Richter, Andreas; Kuba, Keiji; Fukamizu, Akiyoshi; Schreiber, Stefan; Clevers, Hans; Verrey, Francois; Rosenstiel, Philip; Penninger, Josef M.			ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation	NATURE			English	Article							ANGIOTENSIN-CONVERTING-ENZYME; MAMMALIAN TARGET; HARTNUP DISORDER; CROHNS-DISEASE; BLOOD-PRESSURE; IN-VIVO; MICE; COLITIS; CARBOXYPEPTIDASE; RAPAMYCIN	Malnutrition affects up to one billion people in the world and is a major cause of mortality(1,2). In many cases, malnutrition is associated with diarrhoea and intestinal inflammation, further contributing to morbidity and death(2). The mechanisms by which unbalanced dietary nutrients affect intestinal homeostasis are largely unknown. Here we report that deficiency in murine angiotensin I converting enzyme (peptidyl-dipeptidase A) 2 (Ace2), which encodes a key regulatory enzyme of the renin-angiotensin system (RAS), results in highly increased susceptibility to intestinal inflammation induced by epithelial damage. The RAS is known to be involved in acute lung failure(3), cardiovascular functions(4) and SARS infections(5). Mechanistically, ACE2 has a RAS-independent function, regulating intestinal amino acid homeostasis, expression of antimicrobial peptides, and the ecology of the gut microbiome. Transplantation of the altered microbiota from Ace2 mutant mice into germ-free wild-type hosts was able to transmit the increased propensity to develop severe colitis. ACE2-dependent changes in epithelial immunity and the gut microbiota can be directly regulated by the dietary amino acid tryptophan. Our results identify ACE2 as a key regulator of dietary amino acid homeostasis, innate immunity, gut microbial ecology, and transmissible susceptibility to colitis. These results provide a molecular explanation for how amino acid malnutrition can cause intestinal inflammation and diarrhoea.	[Hashimoto, Tatsuo; Perlot, Thomas; Trichereau, Jean; Paolino, Magdalena; Sigl, Verena; Hanada, Toshikatsu; Hanada, Reiko; Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol, IMBA, A-1030 Vienna, Austria; [Hashimoto, Tatsuo; Ishiguro, Hiroaki] Yokohama City Univ, Grad Sch Med, Dept Med Sci & Cardiorenal Med, Yokohama, Kanagawa 2360004, Japan; [Hashimoto, Tatsuo; Ishiguro, Hiroaki] Sch Med, Yokohama, Kanagawa 2360004, Japan; [Rehman, Ateequr; Lipinski, Simone; Schreiber, Stefan; Rosenstiel, Philip] Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Wild, Birgit; Richter, Andreas] Univ Vienna, Ctr Ecol, Dept Chem Ecol & Ecosyst Res, A-1090 Vienna, Austria; [Camargo, Simone M. R.; Singer, Dustin; Verrey, Francois] Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland; [Camargo, Simone M. R.; Singer, Dustin; Verrey, Francois] Univ Zurich, Ctr Integrat Human Physiol, CH-8057 Zurich, Switzerland; [Kuba, Keiji] Akita Univ, Grad Sch Med, Dept Biol Informat & Expt Therapeut, Akita 0108543, Japan; [Fukamizu, Akiyoshi] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058577, Japan; [Clevers, Hans] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Yokohama City University; University of Kiel; University of Vienna; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Akita University; University of Tsukuba; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Penninger, JM (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, IMBA, A-1030 Vienna, Austria.	p.rosenstiel@mucosa.de; josef.penninger@imba.oeaw.ac.at	Rosenstiel, Philip/A-5137-2009; Paolino, Magdalena/AAN-9417-2020; Rehman, Ateequr/O-3727-2016; Richter, Andreas/D-8483-2012; Penninger, Josef M/I-6860-2013; fukamizu, akiyoshi/J-5350-2012; Lipinski, Simone/L-9818-2017; Wild, Birgit/E-6476-2012	Rosenstiel, Philip/0000-0002-9692-8828; Rehman, Ateequr/0000-0002-5664-4628; Richter, Andreas/0000-0003-3282-4808; Penninger, Josef M/0000-0002-8194-3777; fukamizu, akiyoshi/0000-0002-8786-6020; Lipinski, Simone/0000-0002-9322-7372; Wild, Birgit/0000-0002-9611-0815; Verrey, Francois/0000-0003-3250-9824; Paolino, Magdalena/0000-0001-9724-9029; Camargo, Simone/0000-0003-0091-7380	European Respiratory Society; EuGeneHeart; SENSHIN; Marie Curie IIF; IMBA; Austrian Ministry of Sciences; Austrian Academy of Sciences; GEN-AU (AustroMouse); EU ERC; EU network grants EuGeneHeart, ApoSys and INFLA-Care; BMBF Network 'Systematic genomics of chronic inflammation'; DFG Cluster of Excellence Inflammation at Interfaces [SPP1399, SFB877]; DFG [RO1394]	European Respiratory Society; EuGeneHeart; SENSHIN(SENSHIN Medical Research FoundationKayamori FoundationKayamori Foundation of Informational Science AdvancementMukai Science and Technology FoundationFukuda Foundation for Medical TechnologyInoue Foundation for Science); Marie Curie IIF(European Commission); IMBA; Austrian Ministry of Sciences; Austrian Academy of Sciences; GEN-AU (AustroMouse); EU ERC(European Research Council (ERC)European Commission); EU network grants EuGeneHeart, ApoSys and INFLA-Care; BMBF Network 'Systematic genomics of chronic inflammation'(Federal Ministry of Education & Research (BMBF)); DFG Cluster of Excellence Inflammation at Interfaces(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	We thank all members of our laboratories for discussions. T. Hashimoto was supported by grants from the European Respiratory Society, EuGeneHeart, and SENSHIN. T. P. was supported by a Marie Curie IIF. J.M.P. was supported by grants from IMBA, the Austrian Ministry of Sciences, the Austrian Academy of Sciences, GEN-AU (AustroMouse), an EU ERC Advanced Grant, and the EU network grants EuGeneHeart, ApoSys and INFLA-Care. P. R. was supported by the BMBF Network 'Systematic genomics of chronic inflammation', the DFG Cluster of Excellence Inflammation at Interfaces, SPP1399, SFB877, and the DFG project RO1394.	AbuQurshin R, 1997, AM J MED SCI, V313, P111, DOI 10.1097/00000441-199702000-00008; Attia E, 2005, BIOL PSYCHIAT, V57, P674, DOI 10.1016/j.biopsych.2004.11.045; Broer A, 2011, J BIOL CHEM, V286, P26638, DOI 10.1074/jbc.M111.241323; Camargo SMR, 2009, GASTROENTEROLOGY, V136, P872, DOI 10.1053/j.gastro.2008.10.055; Chalaris A, 2010, J EXP MED, V207, P1617, DOI 10.1084/jem.20092366; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; COOPER HS, 1993, LAB INVEST, V69, P238; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; Danilczyk U, 2006, NATURE, V444, P1088, DOI 10.1038/nature05475; DARBY WJ, 1975, NUTR REV, V33, P289; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Farkas S, 2006, INT J COLORECTAL DIS, V21, P747, DOI 10.1007/s00384-005-0793-7; Ghosh HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009199; Giongo A, 2010, ISME J, V4, P852, DOI 10.1038/ismej.2010.16; HAMMER O, 2004, PALAEONTOL ELECTRON, V4; Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712; Ishida J, 2004, J BIOL CHEM, V279, P26274, DOI 10.1074/jbc.M404149200; ITO M, 1995, P NATL ACAD SCI USA, V92, P3521, DOI 10.1073/pnas.92.8.3521; Khan Y, 2010, PEDIATR CLIN N AM, V57, P1409, DOI 10.1016/j.pcl.2010.09.016; Kleta R, 2004, NAT GENET, V36, P999, DOI 10.1038/ng1405; Kowalczuk S, 2008, FASEB J, V22, P2880, DOI 10.1096/fj.08-107300; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; Kuba K, 2007, CIRC RES, V101, pE32, DOI 10.1161/CIRCRESAHA.107.158659; Mastroianni JR, 2009, J BIOL CHEM, V284, P27848, DOI 10.1074/jbc.M109.050773; McCaffery DM, 1999, GUT, V45, P864, DOI 10.1136/gut.45.6.864; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Osterreicher CH, 2009, HEPATOLOGY, V50, P929, DOI 10.1002/hep.23104; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rehman A, 2011, GUT, V60, P1354, DOI 10.1136/gut.2010.216259; Reinisch W, 2008, AM J GASTROENTEROL, V103, P2284, DOI 10.1111/j.1572-0241.2008.02024.x; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2004, MICROBIOL MOL BIOL R, V68, P686, DOI 10.1128/MMBR.68.4.686-691.2004; SEGAL I, 1986, INT J COLORECTAL DIS, V1, P238, DOI 10.1007/BF01648345; STRATIGOS JD, 1977, BRIT J DERMATOL, V96, P99, DOI 10.1111/j.1365-2133.1977.tb05197.x; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tipnis SR, 2000, J BIOL CHEM, V275, P33238, DOI 10.1074/jbc.M002615200; Vickers C, 2002, J BIOL CHEM, V277, P14838, DOI 10.1074/jbc.M200581200; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weichhart T, 2012, METHODS MOL BIOL, V821, P1, DOI 10.1007/978-1-61779-430-8_1; Weisstaub G, 2008, J PEDIATR GASTR NUTR, V47, pS10, DOI 10.1097/MPG.0b013e3181818e78	43	734	793	12	191	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 26	2012	487	7408					477	U89		10.1038/nature11228	http://dx.doi.org/10.1038/nature11228			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979KD	22837003	Green Accepted, Green Published			2022-12-28	WOS:000306815300037
J	Wang, TJ				Wang, Thomas J.			The Natriuretic Peptides and Fat Metabolism	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Wang, TJ (corresponding author), Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA.			Wang, Thomas/0000-0003-4063-6508				Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Chen-Tournoux A, 2010, AM J CARDIOL, V106, P1450, DOI 10.1016/j.amjcard.2010.06.076; Miyashita K, 2009, DIABETES, V58, P2880, DOI 10.2337/db09-0393; Neumayr G, 2005, AM J CARDIOL, V96, P732, DOI 10.1016/j.amjcard.2005.04.054; Wang TJ, 2004, CIRCULATION, V109, P594, DOI 10.1161/01.CIR.0000112582.16683.EA	5	48	51	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 26	2012	367	4					377	378		10.1056/NEJMcibr1204796	http://dx.doi.org/10.1056/NEJMcibr1204796			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	978KD	22830469				2022-12-28	WOS:000306738300014
J	Makela, KT; Visuri, T; Pulkkinen, P; Eskelinen, A; Remes, V; Virolainen, P; Junnila, M; Pukkala, E				Makela, Keijo T.; Visuri, Tuomo; Pulkkinen, Pekka; Eskelinen, Antti; Remes, Ville; Virolainen, Petri; Junnila, Mika; Pukkala, Eero			Risk of cancer with metal-on-metal hip replacements: population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							KNEE ARTHROPLASTY; WEAR DEBRIS; FOLLOW-UP; OSTEOARTHRITIS; DISSEMINATION; POLYETHYLENE; NATIONWIDE; FAILURE; COHORT	Objective To assess the risk of cancer associated with modern primary metal-on-metal hip replacements. Design Population based study. Setting Nationwide retrospective comparative register. Participants 10 728 patients who underwent metal-on-metal total hip arthroplasty and 18 235 patients who underwent conventional metal-on-polyethylene, ceramic-on-polyethylene, and ceramic-on-ceramic total hip arthroplasty (the non-metal-on-metal cohort) in the Finnish Arthroplasty Register 2001-10. Data on cancer cases up to 2010 for these cohorts were extracted from the Finnish Cancer Registry. Main outcome measures The relative risk of cancer was expressed as the ratio of observed to expected number of cases from the Finnish population-that is, the standardised incidence ratio. The relative risk of cancer in the metal-on-metal cohort compared with the non-metal-on-metal cohort was estimated with analyses of these ratios and Poisson regression. Results The overall risk of cancer in patients with metal-on-metal hip implants was similar to that in the Finnish population (378 observed v 400 expected, standardised incidence ratio 0.95, 95% confidence interval 0.85 to 1.04). The overall risk of cancer in patients with metal-on-metal hip implants was also no higher than in patients who had received non-metal-on-metal hip implants (relative risk 0.92, 0.81 to 1.05). Conclusions Metal-on-metal hip replacements are not associated with an increased overall risk of cancer during a mean follow-up of four years.	[Makela, Keijo T.; Virolainen, Petri; Junnila, Mika] Turku Univ Hosp, Surg Hosp, Dept Orthopaed & Traumatol, FI-20701 Turku, Finland; [Visuri, Tuomo; Pulkkinen, Pekka] Univ Helsinki, Hjelt Inst, FI-00014 Helsinki, Finland; [Eskelinen, Antti] Coxa Hosp Joint Replacement, FI-33101 Tampere, Finland; [Remes, Ville] Univ Helsinki, Cent Hosp, Peijas Hosp, Dept Orthopaed & Traumatol, FI-00029 Helsinki, Finland; [Pukkala, Eero] Univ Tampere, Sch Hlth Sci, FI-33100 Tampere, Finland; [Pukkala, Eero] Finnish Canc Registry, Inst Stat & Epidemiol Canc Res, FI-00130 Helsinki, Finland	University of Turku; University of Helsinki; Coxa Hospital for Joint Replacement; University of Helsinki; Helsinki University Central Hospital; Tampere University; Finnish Cancer Registry	Makela, KT (corresponding author), Turku Univ Hosp, Surg Hosp, Dept Orthopaed & Traumatol, FI-20701 Turku, Finland.	keijo.makela@fimnet.fi	Eskelinen, Antti/E-6433-2015; Eskelinen, Antti/AAW-9209-2021; Eskelinen, Antti/AAW-9223-2021	Eskelinen, Antti/0000-0003-0302-0253; Eskelinen, Antti/0000-0003-0302-0253; Makela, Keijo/0000-0002-4115-1767	Turku University Hospital; Sigrid Juselius Foundation; Helsinki University Central Hospital	Turku University Hospital; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Helsinki University Central Hospital	This study was funded by Turku University Hospital (KTM) and Sigrid Juselius Foundation and Helsinki University Central Hospital (VR).	Australian Orthopaedic Association, 2010, ANN REP 2010; Bonassi S, 2000, CANCER RES, V60, P1619; CASE CP, 1994, J BONE JOINT SURG BR, V76B, P701, DOI 10.1302/0301-620X.76B5.8083255; Case CP, 1996, CLIN ORTHOP RELAT R, pS269; Cohen D, 2011, BMJ-BRIT MED J, V13, P342; Cohen D, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1410; Daley B, 2004, J BONE JOINT SURG BR, V86B, P598, DOI 10.1302/0301-620X.86B4.14368; Garbuz DS, 2010, CLIN ORTHOP RELAT R, V468, P318, DOI 10.1007/s11999-009-1029-x; GILLESPIE WJ, 1988, J BONE JOINT SURG BR, V70, P539, DOI 10.1302/0301-620X.70B4.3403594; Gillispie WJ, 1996, CLIN ORTHOP S, V329s, P290; Goldacre MJ, 2005, BRIT J CANCER, V92, P1298, DOI 10.1038/sj.bjc.6602511; Grammatopoulos G, 2009, J BONE JOINT SURG BR, V91B, P1019, DOI 10.1302/0301-620X.91B8.22562; Gross TP, 2012, J ARTHROPLASTY, V27, P533, DOI 10.1016/j.arth.2011.06.019; Hart AJ, 2009, J BONE JOINT SURG BR, V91B, P835, DOI 10.1302/0301-620X.91B6.21844; Jarvholm B, 2005, EUR J EPIDEMIOL, V20, P537, DOI 10.1007/s10654-005-4263-x; Kauppi MJ, 1996, ACTA PAEDIATR, V85, P248, DOI 10.1111/j.1651-2227.1996.tb14004.x; Kwasniak LA, 2011, INT J DERMATOL, V50, P645, DOI 10.1111/j.1365-4632.2010.04826.x; LANGKAMER VG, 1992, J BONE JOINT SURG BR, V74, P831, DOI 10.1302/0301-620X.74B6.1447243; MacDonald SJ, 2003, CLIN ORTHOP RELAT R, P282, DOI 10.1097/01.blo.0000043066.62337.9d; Meding JB, 2012, CLIN ORTHOP RELAT R, V470, P388, DOI 10.1007/s11999-011-2069-6; Min WK, 2008, JOINT BONE SPINE, V75, P319, DOI 10.1016/j.jbspin.2007.05.007; National Joint Registry for England and Wales (NJR England-Wales), 2011, 8 NJR ENGL WAL; NYREN O, 1995, JNCI-J NATL CANCER I, V87, P28, DOI 10.1093/jnci/87.1.28; Ollivere B, 2009, J BONE JOINT SURG BR, V91B, P1025, DOI 10.1302/0301-620X.91B8.21701; Olsen JH, 1999, INT J CANCER, V81, P719, DOI 10.1002/(SICI)1097-0215(19990531)81:5<719::AID-IJC8>3.0.CO;2-D; Onega T, 2006, CANCER EPIDEM BIOMAR, V15, P1532, DOI 10.1158/1055-9965.EPI-06-0127; PAAVOLAINEN P, 1991, ACTA ORTHOP SCAND, V62, P27, DOI 10.3109/17453679109155101; Paavolainen P, 1999, J ARTHROPLASTY, V14, P272, DOI 10.1016/S0883-5403(99)90051-7; Pandit H, 2008, J BONE JOINT SURG BR, V90B, P847, DOI 10.1302/0301-620X.90B7.20213; SANTANA V, 1992, CLIN IMMUNOL IMMUNOP, V63, P205, DOI 10.1016/0090-1229(92)90224-C; Seppanen M, 2012, ACTA ORTHOP, V83, P207, DOI 10.3109/17453674.2012.693016; Shea KG, 1997, CLIN ORTHOP RELAT R, P219; Shimmin AJ, 2005, ORTHOP CLIN N AM, V36, P187, DOI 10.1016/j.ocl.2005.01.002; Treacy RBC, 2011, J BONE JOINT SURG BR, V93B, P27, DOI 10.1302/0301-620X.93B1.24134; Urban RM, 2000, J BONE JOINT SURG AM, V82A, P457, DOI 10.2106/00004623-200004000-00002; VISURI T, 1991, ORTHOPEDICS, V14, P137; Visuri T, 2006, J ARTHROPLASTY, V21, P311, DOI 10.1016/j.arth.2005.03.046; Visuri T, 2003, ACTA ORTHOP SCAND, V74, P351, DOI 10.1080/00016470310014300; Visuri T, 1996, CLIN ORTHOP RELAT R, pS280; Visuri T, 2010, ACTA ORTHOP, V81, P77, DOI 10.3109/17453671003667150; Zahiri CA, 1999, J ARTHROPLASTY, V14, P326, DOI 10.1016/S0883-5403(99)90059-1	41	41	41	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 25	2012	345								e4646	10.1136/bmj.e4646	http://dx.doi.org/10.1136/bmj.e4646			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	981UW	22833626	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000306997500002
J	Nohr, EA				Nohr, Ellen A.			Maternal obesity and neonatal mortality in an African setting	LANCET			English	Editorial Material							INFANT-DEATH; RISK		Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, DK-8000 Aarhus C, Denmark	Aarhus University	Nohr, EA (corresponding author), Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, DK-8000 Aarhus C, Denmark.	ean@soci.au.dk						Chen A, 2009, EPIDEMIOLOGY, V20, P74, DOI 10.1097/EDE.0b013e3181878645; Cresswell JA, 2012, LANCET; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Flenady V, 2011, LANCET, V377, P1331, DOI 10.1016/S0140-6736(10)62233-7; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Nohr EA, 2012, MATERNAL OBESITY PRE, P209; Nohr EA, 2007, OBSTET GYNECOL, V110, P1083, DOI 10.1097/01.AOG.0000286760.46679.f8; Nohr EA, 2012, ACTA OBSTET GYN SCAN, V91, P363, DOI 10.1111/j.1600-0412.2011.01331.x; Tennant PWG, 2011, HUM REPROD, V26, P1501, DOI 10.1093/humrep/der052	11	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 13	2012	380	9850					1292	1293		10.1016/S0140-6736(12)61181-7	http://dx.doi.org/10.1016/S0140-6736(12)61181-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	022BZ	22884608				2022-12-28	WOS:000309931400008
J	Bremner, WJ				Bremner, William J.			Contraception for Men: A Breakthrough New Approach	CELL			English	Editorial Material							1ST BROMODOMAIN; SPERMATOGENESIS; INHIBITION; BRDT	There has not been a new reversible contraceptive for men since the development of the condom, centuries ago. Matzuk et al. describe a new molecular approach using administration of a small molecule to directly and reversibly inhibit spermatogenesis in mice by blocking the function of a testicular bromodomain without apparent adverse effect on the organism or offspring.	Univ Washington, Dept Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Bremner, WJ (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	wbremner@uw.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD042454] Funding Source: NIH RePORTER; NICHD NIH HHS [U54 HD042454] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Amory JK, 2011, J ANDROL, V32, P111, DOI 10.2164/jandrol.110.010751; Berkovits BD, 2011, DEV BIOL, V360, P358, DOI 10.1016/j.ydbio.2011.10.005; Chung SSW, 2011, ENDOCRINOLOGY, V152, P2492, DOI 10.1210/en.2010-0941; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Goldberg M., 2012, NEWSWEEK, P44; Matzuk MM, 2012, CELL, V150, P673, DOI 10.1016/j.cell.2012.06.045; Page ST, 2008, ENDOCR REV, V29, P465, DOI 10.1210/er.2007-0041; Piccinino LJ, 1998, FAM PLANN PERSPECT, V30, P4, DOI 10.2307/2991517; Shang EY, 2007, DEVELOPMENT, V134, P3507, DOI 10.1242/dev.004481	9	9	10	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 17	2012	150	4					667	668		10.1016/j.cell.2012.07.027	http://dx.doi.org/10.1016/j.cell.2012.07.027			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	995IT	22901799	Green Accepted, Bronze			2022-12-28	WOS:000308002300001
J	Elde, NC; Child, SJ; Eickbush, MT; Kitzman, JO; Rogers, KS; Shendure, J; Geballe, AP; Malik, HS				Elde, Nels C.; Child, Stephanie J.; Eickbush, Michael T.; Kitzman, Jacob O.; Rogers, Kelsey S.; Shendure, Jay; Geballe, Adam P.; Malik, Harmit S.			Poxviruses Deploy Genomic Accordions to Adapt Rapidly against Host Antiviral Defenses	CELL			English	Article							DOUBLE-STRANDED-RNA; PROTEIN-KINASE PKR; VACCINIA VIRUS; GENE AMPLIFICATION; EXPERIMENTAL EVOLUTION; SEQUENCE; RESISTANCE; MUTATION; K3L; DUPLICATION	In contrast to RNA viruses, double-stranded DNA viruses have low mutation rates yet must still adapt rapidly in response to changing host defenses. To determine mechanisms of adaptation, we subjected the model poxvirus vaccinia to serial propagation in human cells, where its antihost factor K3L is malad-apted against the antiviral protein kinase R (PKR). Viruses rapidly acquired higher fitness via recurrent K3L gene amplifications, incurring up to 7%-10% increases in genome size. These transient gene expansions were necessary and sufficient to counteract human PKR and facilitated the gain of an adaptive amino acid substitution in K3L that also defeats PKR. Subsequent reductions in gene amplifications offset the costs associated with larger genome size while retaining adaptive substitutions. Our discovery of viral "gene-accordions" explains how poxviruses can rapidly adapt to defeat different host defenses despite low mutation rates and reveals how classical Red Queen conflicts can progress through unrecognized intermediates.	[Elde, Nels C.; Eickbush, Michael T.; Malik, Harmit S.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Child, Stephanie J.; Geballe, Adam P.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; [Geballe, Adam P.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; [Elde, Nels C.; Rogers, Kelsey S.] Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84112 USA; [Kitzman, Jacob O.; Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Geballe, Adam P.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Geballe, Adam P.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Malik, Harmit S.] Howard Hughes Med Inst, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Utah System of Higher Education; University of Utah; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute	Elde, NC (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.	nelde@genetics.utah.edu; hsmalik@fhcrc.org	Shendure, Jay/AAU-3684-2021; Malik, Harmit S/I-5591-2019; Malik, Harmit S/E-8519-2012	Malik, Harmit S/0000-0001-6005-0016; Child, Stephanie/0000-0002-1987-9540; Shendure, Jay/0000-0002-1516-1865; Kitzman, Jacob/0000-0002-6145-882X; Eickbush, Michael/0000-0001-9057-9156	National Institutes of Health (NIH) [GM090042, 1R21CA160080-01, AI26672]; National Science Foundation (NSF) Graduate Research Fellowship; NSF CAREER award; NATIONAL CANCER INSTITUTE [R21CA160080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026672, R29AI026672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM090042, R00GM090042] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF) Graduate Research Fellowship(National Science Foundation (NSF)); NSF CAREER award(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Jacobs for virus strains, J. Tartaglia for K3L antibody, B. Moss for vaccinia-reactive rabbit serum, and G. Smith for RecBCD and advice on recombination. We thank M. Daugherty, M. Dunham, M. Emerman, A. Frost, J. Kerns, M. Patel, and S. Sawyer for critical reading of the manuscript and B. Stackhouse for technical assistance with sequencing library preparation. This work is supported by the National Institutes of Health (NIH) K99/R00 award (GM090042 to N.C.E.), NIH grant (1R21CA160080-01 to J. S.), NIH grant (AI26672 to A. P. G.), a National Science Foundation (NSF) Graduate Research Fellowship (J.O.K.), and an NSF CAREER award (H. S. M.). H. S. M. is an Early Career Scientist of Howard Hughes Medical Institute. J. S. is a member of the scientific advisory board or serves as a consultant for Ariosa Diagnostics, Stratos Genomics, Good Start Genetics, and Adaptive TCR.	Adey A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r119; Afonso CL, 2000, J VIROL, V74, P3815, DOI 10.1128/JVI.74.8.3815-3831.2000; Andersson DI, 1998, SCIENCE, V282, P1133, DOI 10.1126/science.282.5391.1133; Bahar MW, 2011, J STRUCT BIOL, V175, P127, DOI 10.1016/j.jsb.2011.03.010; BEATTIE E, 1995, J VIROL, V69, P499, DOI 10.1128/JVI.69.1.499-505.1995; Beaumont HJE, 2009, NATURE, V462, P90, DOI 10.1038/nature08504; Bergthorsson U, 2007, P NATL ACAD SCI USA, V104, P17004, DOI 10.1073/pnas.0707158104; Bratke KA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-67; CAIRNS J, 1988, NATURE, V335, P142, DOI 10.1038/335142a0; Crotty S, 2001, P NATL ACAD SCI USA, V98, P6895, DOI 10.1073/pnas.111085598; Dar AC, 2002, MOL CELL, V10, P295, DOI 10.1016/S1097-2765(02)00590-7; DAVIES MV, 1993, J VIROL, V67, P1688, DOI 10.1128/JVI.67.3.1688-1692.1993; DAWKINS R, 1979, PROC R SOC SER B-BIO, V205, P489, DOI 10.1098/rspb.1979.0081; Demuth JP, 2009, BIOESSAYS, V31, P29, DOI 10.1002/bies.080085; Drake JW, 1999, P NATL ACAD SCI USA, V96, P13910, DOI 10.1073/pnas.96.24.13910; Drake JW, 1998, GENETICS, V148, P1667; Drummond JT, 1997, P NATL ACAD SCI USA, V94, P10144, DOI 10.1073/pnas.94.19.10144; Dunham MJ, 2002, P NATL ACAD SCI USA, V99, P16144, DOI 10.1073/pnas.242624799; EICHLER DC, 1977, J BIOL CHEM, V252, P499; Elde NC, 2009, NAT REV MICROBIOL, V7, P787, DOI 10.1038/nrmicro2222; Elde NC, 2009, NATURE, V457, P485, DOI 10.1038/nature07529; Emerman M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000301; ESPOSITO J, 1981, J VIROL METHODS, V2, P175, DOI 10.1016/0166-0934(81)90036-7; Esposito JJ, 2006, SCIENCE, V313, P807, DOI 10.1126/science.1125134; FOSTER PL, 1994, GENETICS, V138, P253; Goebel S.J., 1990, VIROLOGY, V179, P517; GOEBEL SJ, 1990, VIROLOGY, V179, P247, DOI 10.1016/0042-6822(90)90294-2; Hakki M, 2005, J VIROL, V79, P7311, DOI 10.1128/JVI.79.12.7311-7318.2005; Harrison SC, 2004, P NATL ACAD SCI USA, V101, P11178, DOI 10.1073/pnas.0403600101; Hastings PJ, 2000, CELL, V103, P723, DOI 10.1016/S0092-8674(00)00176-8; Hendrickson H, 2002, P NATL ACAD SCI USA, V99, P2164, DOI 10.1073/pnas.032680899; Hendrickson RC, 2010, VIRUSES-BASEL, V2, P1933, DOI 10.3390/v2091933; Kaufman RJ, 2000, COLD SPRING HARBOR M, V39, P503; KawagishiKobayashi M, 1997, MOL CELL BIOL, V17, P4146, DOI 10.1128/MCB.17.7.4146; Kerr PJ, 2010, VET MICROBIOL, V143, P167, DOI 10.1016/j.vetmic.2009.11.025; Kugelberg E, 2010, GENETICS, V185, P65, DOI 10.1534/genetics.110.114074; Langland J.O., 2002, BIOINFORMATICS, V299, P133; Li Y, 2007, P NATL ACAD SCI USA, V104, P15787, DOI 10.1073/pnas.0609268104; Lipinski KJ, 2011, CURR BIOL, V21, P306, DOI 10.1016/j.cub.2011.01.026; Lynch M, 2008, P NATL ACAD SCI USA, V105, P9272, DOI 10.1073/pnas.0803466105; McLysaght A, 2003, P NATL ACAD SCI USA, V100, P15655, DOI 10.1073/pnas.2136653100; Meisinger-Henschel C, 2007, J GEN VIROL, V88, P3249, DOI 10.1099/vir.0.83156-0; Meyer JR, 2012, SCIENCE, V335, P428, DOI 10.1126/science.1214449; Meyerson NR, 2011, TRENDS MICROBIOL, V19, P286, DOI 10.1016/j.tim.2011.03.006; Montville R, 2005, PLOS BIOL, V3, P1939, DOI 10.1371/journal.pbio.0030381; MOSS B, 1981, P NATL ACAD SCI-BIOL, V78, P1614, DOI 10.1073/pnas.78.3.1614; Moss B, 2007, FIELDS VIROLOGY; Nair S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000243; Pfeiffer JK, 2005, PLOS PATHOG, V1, P102, DOI 10.1371/journal.ppat.0010011; Pranting M, 2011, MOL MICROBIOL, V79, P305, DOI 10.1111/j.1365-2958.2010.07458.x; Rothenburg S, 2009, NAT STRUCT MOL BIOL, V16, P63, DOI 10.1038/nsmb.1529; Sandegren L, 2009, NAT REV MICROBIOL, V7, P578, DOI 10.1038/nrmicro2174; SCHIMKE RT, 1986, CANCER, V57, P1912, DOI 10.1002/1097-0142(19860515)57:10<1912::AID-CNCR2820571004>3.0.CO;2-O; Searles RP, 1999, J VIROL, V73, P3040, DOI 10.1128/JVI.73.4.3040-3053.1999; SLABAUGH MB, 1986, J VIROL, V60, P506, DOI 10.1128/JVI.60.2.506-514.1986; SLABAUGH MB, 1989, NUCLEIC ACIDS RES, V17, P7073, DOI 10.1093/nar/17.17.7073; SMITH GL, 1983, GENE, V25, P21, DOI 10.1016/0378-1119(83)90163-4; SMITH GR, 1995, PHILOS T ROY SOC B, V347, P13, DOI 10.1098/rstb.1995.0003; Stambuk BU, 2009, GENOME RES, V19, P2271, DOI 10.1101/gr.094276.109; Sun S, 2009, GENETICS, V182, P1183, DOI 10.1534/genetics.109.103028; Van Valen L., 1973, EVOL THEORY REV, V1, P1, DOI DOI 10.1038/344864A0; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Vignuzzi M, 2005, VIRUS RES, V107, P173, DOI 10.1016/j.virusres.2004.11.007; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Werden SJ, 2008, ADV VIRUS RES, V71, P135, DOI 10.1016/S0065-3527(08)00003-1; Wichman HA, 1999, SCIENCE, V285, P422, DOI 10.1126/science.285.5426.422	66	190	193	2	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 17	2012	150	4					831	841		10.1016/j.cell.2012.05.049	http://dx.doi.org/10.1016/j.cell.2012.05.049			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	995IT	22901812	Bronze, Green Accepted			2022-12-28	WOS:000308002300016
J	Wang, ET; Cody, NAL; Jog, S; Biancolella, M; Wang, TT; Treacy, DJ; Luo, SJ; Schroth, GP; Housman, DE; Reddy, S; Lecuyer, E; Burge, CB				Wang, Eric T.; Cody, Neal A. L.; Jog, Sonali; Biancolella, Michela; Wang, Thomas T.; Treacy, Daniel J.; Luo, Shujun; Schroth, Gary P.; Housman, David E.; Reddy, Sita; Lecuyer, Eric; Burge, Christopher B.			Transcriptome-wide Regulation of Pre-mRNA Splicing and mRNA Localization by Muscleblind Proteins	CELL			English	Article							MYOTONIC-DYSTROPHY; ENDOPLASMIC-RETICULUM; GENE-EXPRESSION; STEM-CELLS; SYNAPSE FORMATION; MBNL1; TRANSLATION; DROSOPHILA; REVEALS; BINDING	The muscleblind-like (Mbnl) family of RNA-binding proteins plays important roles in muscle and eye development and in myotonic dystrophy (DM), in which expanded CUG or CCUG repeats functionally deplete Mbnl proteins. We identified transcriptome-wide functional and biophysical targets of Mbnl proteins in brain, heart, muscle, and myoblasts by using RNA-seq and CLIP-seq approaches. This analysis identified several hundred splicing events whose regulation depended on Mbnl function in a pattern indicating functional interchangeability between Mbnl1 and Mbnl2. A nucleotide resolution RNA map associated repression or activation of exon splicing with Mbnl binding near either 30 splice site or near the downstream 50 splice site, respectively. Transcriptomic analysis of subcellular compartments uncovered a global role for Mbnls in regulating localization of mRNAs in both mouse and Drosophila cells, and Mbnl-dependent translation and protein secretion were observed for a subset of mRNAs with Mbnl-dependent localization. These findings hold several new implications for DM pathogenesis.	[Wang, Eric T.; Wang, Thomas T.; Treacy, Daniel J.; Housman, David E.; Burge, Christopher B.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Wang, Eric T.; Housman, David E.; Burge, Christopher B.] MIT, Div Hlth Sci & Technol, Cambridge, MA 02142 USA; [Wang, Eric T.; Wang, Thomas T.; Housman, David E.; Burge, Christopher B.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA; [Burge, Christopher B.] MIT, Dept Biol Engn, Cambridge, MA 02142 USA; [Cody, Neal A. L.; Lecuyer, Eric] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Jog, Sonali; Biancolella, Michela; Reddy, Sita] Univ So Calif, Los Angeles, CA 90033 USA; [Luo, Shujun; Schroth, Gary P.] Illumina Inc, Hayward, CA 94545 USA; [Lecuyer, Eric] Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; University of Southern California; Illumina; Universite de Montreal	Burge, CB (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02142 USA.	cburge@mit.edu	Burge, Christopher B./AAH-2177-2020		Poitras Fellowship; National Science Foundation [0821391]; National Institutes of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002439, RC2HG005624] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085319] Funding Source: NIH RePORTER	Poitras Fellowship; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Tom Cooper for the anti-Mbnl1 antibody used to perform CLIP. We thank Andy Berglund and David Brook for insightful conversations about muscleblinds and Phil Sharp and Bob Brown Jr. for their comments and suggestions to perform cellular fractionation experiments. We thank Michael Zuker for suggestions on depleting ribosomal RNAs during ribosome footprint library preparation. We thank the MIT Biomicro Center and the IRCM molecular biology core facility for assistance with deep sequencing and the Koch Institute Swanson Biotechnology Center for microscopy assistance. This work was supported by a Poitras Fellowship (E. T. W.), by equipment grant 0821391 from the National Science Foundation, and by grants from the National Institutes of Health to C. B. B. E. T. W. performed CLIP-seq, cellular fractionation of mouse cells, ribosome footprint profiling, and luciferase assays and also analyzed RNA-seq, CLIP-seq, and footprint data. N.A.L.C. performed cellular fractionation of fly cells. S.J., M. B., and S. R. isolated RNA from mouse tissues and performed splicing RT-PCR assays. T. T. W. performed lentiviral knockdown of Mbnls in mouse cells. D.J.T. and S. L. prepared RNA-seq libraries. N.C., E. L., S. R., D. E. H., and G. P. S. contributed to study design. E. T. W. and C. B. B. designed the study and wrote the paper with contributions from E. L. and N.C.	Adereth Y, 2005, NAT CELL BIOL, V7, P1240, DOI 10.1038/ncb1335; Amenta AR, 2012, J NEUROSCI, V32, P2324, DOI 10.1523/JNEUROSCI.4610-11.2012; Andreassi C, 2009, TRENDS CELL BIOL, V19, P465, DOI 10.1016/j.tcb.2009.06.001; Artero R, 1998, DEV BIOL, V195, P131, DOI 10.1006/dbio.1997.8833; ASHIZAWA T, 1993, NEUROLOGY, V43, P2674, DOI 10.1212/WNL.43.12.2674; Begemann G, 1997, DEVELOPMENT, V124, P4321; BERGERON JJM, 1994, TRENDS BIOCHEM SCI, V19, P124, DOI 10.1016/0968-0004(94)90205-4; Besse F, 2008, NAT REV MOL CELL BIO, V9, P971, DOI 10.1038/nrm2548; BLOBEL G, 1975, J CELL BIOL, V67, P852, DOI 10.1083/jcb.67.3.852; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; Cenik C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001366; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; Du HQ, 2010, NAT STRUCT MOL BIOL, V17, P187, DOI 10.1038/nsmb.1720; Fardaei M, 2002, HUM MOL GENET, V11, P805, DOI 10.1093/hmg/11.7.805; FFRENCHCONSTANT C, 1989, J CELL BIOL, V109, P903, DOI 10.1083/jcb.109.2.903; FFRENCHCONSTANT C, 1989, DEVELOPMENT, V106, P375; Goers ES, 2010, NUCLEIC ACIDS RES, V38, P2467, DOI 10.1093/nar/gkp1209; Gunning PW, 2005, TRENDS CELL BIOL, V15, P333, DOI 10.1016/j.tcb.2005.04.007; HESKETH J, 1994, MOL BIOL REP, V19, P233, DOI 10.1007/BF00986965; Hino S, 2007, HUM MOL GENET, V16, P2834, DOI 10.1093/hmg/ddm239; Ho TH, 2004, EMBO J, V23, P3103, DOI 10.1038/sj.emboj.7600300; Holt I, 2009, AM J PATHOL, V174, P216, DOI 10.2353/ajpath.2009.080520; Horne-Badovinac S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040008; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Jagannathan S, 2011, METHODS MOL BIOL, V714, P301, DOI 10.1007/978-1-61779-005-8_19; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Kanadia RN, 2003, GENE EXPR PATTERNS, V3, P459, DOI 10.1016/S1567-133X(03)00064-4; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kishore S, 2011, NAT METHODS, V8, P559, DOI [10.1038/NMETH.1608, 10.1038/nmeth.1608]; Kislauskis EH, 1997, J CELL BIOL, V136, P1263, DOI 10.1083/jcb.136.6.1263; Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Lecuyer E, 2009, CURR OPIN CELL BIOL, V21, P409, DOI 10.1016/j.ceb.2009.01.027; Lin XY, 2006, HUM MOL GENET, V15, P2087, DOI 10.1093/hmg/ddl132; Marteyn A, 2011, CELL STEM CELL, V8, P434, DOI 10.1016/j.stem.2011.02.004; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Martin KC, 2006, J NEUROSCI, V26, P7131, DOI 10.1523/JNEUROSCI.1801-06.2006; Masuda A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00209; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Myotonic Dystrophy Foundation, 2017, VOIC PAT REP MYOT DY; Osborne RJ, 2009, HUM MOL GENET, V18, P1471, DOI 10.1093/hmg/ddp058; PACHTER J S, 1992, Critical Reviews in Eukaryotic Gene Expression, V2, P1; Palazzo AF, 2007, PLOS BIOL, V5, P2862, DOI 10.1371/journal.pbio.0050322; Panaite PA, 2008, J NEUROPATH EXP NEUR, V67, P763, DOI 10.1097/NEN.0b013e318180ec64; Pascual M, 2006, DIFFERENTIATION, V74, P65, DOI 10.1111/j.1432-0436.2006.00060.x; Pizon V, 2002, J CELL SCI, V115, P4469, DOI 10.1242/jcs.00131; Pyhtila B, 2008, RNA, V14, P445, DOI 10.1261/rna.721108; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Sen S, 2010, J BIOL CHEM, V285, P25426, DOI 10.1074/jbc.M109.095224; Spilker KA, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-7; Squillace RM, 2002, DEV BIOL, V250, P218, DOI 10.1006/dbio.2002.0798; SUNDELL CL, 1991, SCIENCE, V253, P1275, DOI 10.1126/science.1891715; Teplova M, 2008, NAT STRUCT MOL BIOL, V15, P1343, DOI 10.1038/nsmb.1519; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; VEDELER A, 1991, MOL CELL BIOCHEM, V100, P183; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang ZF, 2006, MOL CELL, V23, P61, DOI 10.1016/j.molcel.2006.05.018; Wang Z, 2009, METHODS, V48, P287, DOI 10.1016/j.ymeth.2009.02.021; Warf MB, 2007, RNA, V13, P2238, DOI 10.1261/rna.610607; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; Zhang CL, 2010, SCIENCE, V329, P439, DOI 10.1126/science.1191150; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999	65	332	338	3	53	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 17	2012	150	4					710	724		10.1016/j.cell.2012.06.041	http://dx.doi.org/10.1016/j.cell.2012.06.041			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	995IT	22901804	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000308002300007
J	Oxborrow, M; Breeze, JD; Alford, NM				Oxborrow, Mark; Breeze, Jonathan D.; Alford, Neil M.			Room-temperature solid-state maser	NATURE			English	Article							PHOTO-EXCITED TRIPLET; P-TERPHENYL; AMPLIFIERS; PENTACENE; POLARIZATION; CRYSTALS; EPR	The invention of the laser has resulted in many innovations, and the device has become ubiquitous. However, the maser, which amplifies microwave radiation rather than visible light, has not had as large an impact, despite being instrumental in the laser's birth(1,2). The maser's relative obscurity has mainly been due to the inconvenience of the operating conditions needed for its various realizations: atomic(3) and free-electron(4) masers require vacuum chambers and pumping; and solid-state masers(5), although they excel as low-noise amplifiers(6) and are occasionally incorporated in ultrastable oscillators(7,8), typically require cryogenic refrigeration. Most realizations of masers also require strong magnets, magnetic shielding or both. Overcoming these various obstacles would pave the way for improvements such as more-sensitive chemical assays, more-precise determinations of biomolecular structure and function, and more-accurate medical diagnostics (including tomography) based on enhanced magnetic resonance spectrometers(9) incorporating maser amplifiers and oscillators. Here we report the experimental demonstration of a solid-state maser operating at room temperature in pulsed mode. It works on a laboratory bench, in air, in the terrestrial magnetic field and amplifies at around 1.45 gigahertz. In contrast to the cryogenic ruby maser(6), in our maser the gain medium is an organic mixed molecular crystal, p-terphenyl doped with pentacene, the latter being photo-excited by yellow light. The maser's pumping mechanism exploits spin-selective molecular intersystem crossing(10) into pentacene's triplet ground state(11,12). When configured as an oscillator, the solid-state maser's measured output power of around -10 decibel milliwatts is approximately 100 million times greater than that of an atomic hydrogen maser(3), which oscillates at a similar frequency (about 1.42 gigahertz). By exploiting the high levels of spin polarization readily generated by intersystem crossing in photo-excited pentacene and other aromatic molecules, this new type of maser seems to be capable of amplifying with a residual noise temperature far below room temperature.	[Oxborrow, Mark] Natl Phys Lab, Teddington TW11 0LW, Middx, England; [Breeze, Jonathan D.; Alford, Neil M.] Imperial Coll London, Dept Mat, London SW7 2AZ, England	National Physical Laboratory - UK; Imperial College London	Oxborrow, M (corresponding author), Natl Phys Lab, Hampton Rd, Teddington TW11 0LW, Middx, England.	mo@npl.co.uk; n.alford@imperial.ac.uk		Breeze, Jonathan/0000-0002-3962-270X	NMS Pathfinder Metrology Programme; Engineering and Physical Sciences Research Council	NMS Pathfinder Metrology Programme; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	M.O. thanks J. Sherwood, R. Ferguson and C. Langham for advice on the growth of molecular crystals, for help in cutting and polishing the crystalline p-terphenyl boule and for designing the metal components of the microwave resonator, respectively. M.O. and J. D. B. thank C. Kay for discussions and guidance on pulsed electron paramagnetic resonance spectroscopy. This work was supported by the NMS Pathfinder Metrology Programme and by the Engineering and Physical Sciences Research Council.	Antipov S., 2009, P 23 PART ACC C, P4535; Blank A, 2001, APPL PHYS LETT, V79, P1694, DOI 10.1063/1.1401790; Blank A, 1998, IEEE T MICROW THEORY, V46, P2137, DOI 10.1109/22.739295; Blank A., 2002, RIKEN REV, V44, P128; Bogle G. S., 1959, AUST J PHYS, V12, P1; Bourgeois PY, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2137452; Clauss R. C., 2008, LOW NOISE SYSTEMS DE; DICK GJ, 1991, IEEE T INSTRUM MEAS, V40, P174, DOI 10.1109/TIM.1990.1032909; HSU H, 1963, P IEEE, V51, P185, DOI 10.1109/PROC.1963.1678; Kagawa A, 2009, J MAGN RESON, V197, P9, DOI 10.1016/j.jmr.2008.11.009; KLEPPNER D, 1962, APPL OPTICS, V1, P55, DOI 10.1364/AO.1.000055; Kohler J, 1996, CHEM PHYS LETT, V250, P137, DOI 10.1016/0009-2614(95)01393-8; Konoplev IV, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.035002; Korolev AM, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3518974; Lang J, 2005, J MAGN RESON, V176, P249, DOI 10.1016/j.jmr.2005.06.012; MAIMAN TH, 1960, NATURE, V187, P493, DOI 10.1038/187493a0; MOLLIER JC, 1973, REV SCI INSTRUM, V44, P1763, DOI 10.1063/1.1686050; Oxborrow M, 2007, IEEE T MICROW THEORY, V55, P1209, DOI 10.1109/TMTT.2007.897850; PURCELL EM, 1946, PHYS REV, V69, P681; SABISKY ES, 1966, APPL PHYS LETT, V8, P298, DOI 10.1063/1.1754447; SCHAWLOW AL, 1958, PHYS REV, V112, P1940, DOI 10.1103/PhysRev.112.1940; Selvakumar S, 2005, J CRYST GROWTH, V275, pE265, DOI 10.1016/j.jcrysgro.2004.10.120; Siegman A., 1964, MICROWAVE SOLID STAT; SLOOP DJ, 1981, J CHEM PHYS, V75, P3746, DOI 10.1063/1.442520; SMITH BA, 1982, SCIENCE, V215, P504, DOI 10.1126/science.215.4532.504; Takeda K, 2002, J CHEM PHYS, V117, P4940, DOI 10.1063/1.1499124; van der Waals JH, 2001, APPL MAGN RESON, V20, P545, DOI 10.1007/BF03162337; Wadefalk N, 2003, IEEE T MICROW THEORY, V51, P1705, DOI 10.1109/TMTT.2003.812570; Whelehan JJ, 2002, IEEE T MICROW THEORY, V50, P806, DOI 10.1109/22.989964	30	68	72	6	163	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2012	488	7411					353	+		10.1038/nature11339	http://dx.doi.org/10.1038/nature11339			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OS	22895341	Green Submitted			2022-12-28	WOS:000307501000036
J	Carnethon, MR; De Chavez, PJD; Biggs, ML; Lewis, CE; Pankow, JS; Bertoni, AG; Golden, SH; Liu, K; Mukamal, KJ; Campbell-Jenkins, B; Dyer, AR				Carnethon, Mercedes R.; De Chavez, Peter John D.; Biggs, Mary L.; Lewis, Cora E.; Pankow, James S.; Bertoni, Alain G.; Golden, Sherita H.; Liu, Kiang; Mukamal, Kenneth J.; Campbell-Jenkins, Brenda; Dyer, Alan R.			Association of Weight Status With Mortality in Adults With Incident Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; ATHEROSCLEROSIS RISK; FASTING INSULIN; WHITE ADULTS; OBESITY; HEMODIALYSIS; FAT; COMMUNITIES; PREVALENCE; PARADOX	Context Type 2 diabetes in normal-weight adults (body mass index [BMI] <25) is a representation of the metabolically obese normal-weight phenotype with unknown mortality consequences. Objective To test the association of weight status with mortality in adults with new-onset diabetes in order to minimize the influence of diabetes duration and voluntary weight loss on mortality. Design, Setting, and Participants Pooled analysis of 5 longitudinal cohort studies: Atherosclerosis Risk in Communities study, 1990-2006; Cardiovascular Health Study, 1992-2008; Coronary Artery Risk Development in Young Adults, 1987-2011; Framingham Offspring Study, 1979-2007; and Multi-Ethnic Study of Atherosclerosis, 2002-2011. A total of 2625 participants with incident diabetes contributed 27 125 person-years of follow-up. Included were men and women (age >40 years) who developed incident diabetes based on fasting glucose 126 mg/dL or greater or newly initiated diabetes medication and who had concurrent measurements of BMI. Participants were classified as normal weight if their BMI was 18.5 to 24.99 or overweight/obese if BMI was 25 or greater. Main Outcome Measures Total, cardiovascular, and noncardiovascular mortality. Results The proportion of adults who were normal weight at the time of incident diabetes ranged from 9% to 21% (overall 12%). During follow-up, 449 participants died: 178 from cardiovascular causes and 253 from noncardiovascular causes (18 were not classified). The rates of total, cardiovascular, and noncardiovascular mortality were higher in normal-weight participants (284.8, 99.8, and 198.1 per 10 000 person-years, respectively) than in overweight/obese participants (152.1, 67.8, and 87.9 per 10 000 person-years, respectively). After adjustment for demographic characteristics and blood pressure, lipid levels, waist circumference, and smoking status, hazard ratios comparing normal-weight participants with overweight/obese participants for total, cardiovascular, and noncardiovascular mortality were 2.08 (95% CI, 1.52-2.85), 1.52 (95% CI, 0.89-2.58), and 2.32 (95% CI, 1.55-3.48), respectively. Conclusion Adults who were normal weight at the time of incident diabetes had higher mortality than adults who are overweight or obese.	[Carnethon, Mercedes R.; De Chavez, Peter John D.; Liu, Kiang; Dyer, Alan R.] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, 680 N Lake Shore Dr,Ste 1400, Chicago, IL 60611 USA; [Biggs, Mary L.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Lewis, Cora E.] Univ Alabama Birmingham, Sch Med, Dept Prevent Med, Birmingham, AL USA; [Pankow, James S.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Bertoni, Alain G.] Wake Forest Univ, Div Epidemiol, Dept Hlth Studies, Winston Salem, NC 27109 USA; [Golden, Sherita H.] Johns Hopkins Univ, Dept Med, Div Endocrinol, Baltimore, MD USA; [Golden, Sherita H.] Johns Hopkins Univ, Welch Ctr Prevent, Baltimore, MD USA; [Mukamal, Kenneth J.] Harvard Univ, Dept Med, Div Internal Med, Brookline, MA USA; [Mukamal, Kenneth J.] Beth Israel Deaconess Med Ctr, Brookline, MA USA; [Campbell-Jenkins, Brenda] Jackson State Univ, Jackson Heart Study Coordinating Ctr, Jackson, MS USA	Northwestern University; Feinberg School of Medicine; University of Washington; University of Washington Seattle; University of Alabama System; University of Alabama Birmingham; University of Minnesota System; University of Minnesota Twin Cities; Wake Forest University; Johns Hopkins University; Johns Hopkins University; Harvard University; Harvard University; Beth Israel Deaconess Medical Center; Jackson State University	Carnethon, MR (corresponding author), Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, 680 N Lake Shore Dr,Ste 1400, Chicago, IL 60611 USA.	carnethon@northwestern.edu	Mukamal, Kenneth/GVR-7978-2022	Bertoni, Alain/0000-0002-7503-6273; Pankow, James/0000-0001-7076-483X; Carnethon, Mercedes/0000-0001-7035-0848	National Institute of Diabetes and Digestive and Kidney Disease [R21DK082903]; National Heart, Lung, and Blood Institute (NHLBI) [N01-HC-95159, N01-HC-95165, N01-HC-95169, N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022, 5 R01 HL078972, N01-HC-85239, N01-HC-85079]; NHLBI/National Institutes of Health [N01-HC-48047, N01-HC-48048, N01-HC-48049, N01-HC-48050, N01-HC-95095]; National Institute of Neurological Disorders and Stroke; National Institute on Aging [AG-023629, AG-15928, AG-20098, AG-027058]; NHLBI [N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, HL080295]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC048050, N01HC048049, N01HC095160, N01HC048047, N01HC055018, N01HC075150, N01HC035129, N01HC085085, N01HC055016, N01HC085079, N01HC055019, N01HC085083, N01HC095165, N01HC015103, N01HC085082, N01HC048048, N01HC085084, N01HC095163, N01HC095164, N01HC055020, N01HC055021, N01HC055222, N01HC055022, N01HC095095, N01HC045133, N01HC085081, N01HC085080, N01HC095161, N01HC095169, N01HC095162, N01HC055015, N01HC095159, N01HC085086] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL095165, R43HL095169, R44HL095169, R01HL048048, R41HL055019, R01HL048049, R29HL048048, R01HL080295, R41HL055018, R01HL078972, R42HL055018, U01HL080295, R01HL048050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK082903, P30DK079637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015928, R56AG020098, R01AG027058, R01AG023629, R01AG020098, R56AG023629] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research is funded by the National Institute of Diabetes and Digestive and Kidney Disease grant R21DK082903.r MESA was supported by contracts N01-HC-95159 through N01-HC-95165 and N01-HC-95169 from the National Heart, Lung, and Blood Institute (NHLBI). We thank the other investigators, the staff, and the participants of the MESA study for their valuable contributions. A full list of participating MESA investigators and institutions can be found at http://www.mesa-nhlbi.org. The Atherosclerosis Risk in Communities study is carried out as a collaborative study supported by NHLBI contracts N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, and N01-HC-55022. We thank the staff and participants of the ARIC study for their important contributions. CARDIA is supported by grant 5 R01 HL078972 from the NHLBI and was partially supported by contracts N01-HC-48047, N01-HC-48048, N01-HC-48049, N01-HC-48050, and N01-HC-95095 from the NHLBI/National Institutes of Health. We gratefully acknowledge the CARDIA study participants and staff for their valuable contributions. The CHS research reported in this article was supported by contracts N01-HC-85239, N01-HC-85079 through N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, and grant HL080295 from the NHLBI, with additional contribution from the National Institute of Neurological Disorders and Stroke. Additional support was provided through AG-023629, AG-15928, AG-20098, and AG-027058 from the National Institute on Aging. A full list of principal CHS investigators and institutions can be found at http://www.chs-nhlbi.org/pi.htm.	Abate N, 2001, J DIABETES COMPLICAT, V15, P320, DOI 10.1016/S1056-8727(01)00161-1; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc35-S011, 10.2337/dc12-s004]; ATTVALL S, 1993, J INTERN MED, V233, P327, DOI 10.1111/j.1365-2796.1993.tb00680.x; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Brancati FL, 2000, JAMA-J AM MED ASSOC, V283, P2253, DOI 10.1001/jama.283.17.2253; Carnethon MR, 2002, DIABETES CARE, V25, P1358, DOI 10.2337/diacare.25.8.1358; CUSHMAN M, 1995, CLIN CHEM, V41, P264; Doehner W, 2012, INT J CARDIOL, V162, P20, DOI 10.1016/j.ijcard.2011.09.039; Donato KA, 1998, ARCH INTERN MED, V158, P1855, DOI 10.1001/archinte.158.17.1855; Dyer AR, 2004, ANN EPIDEMIOL, V14, P101, DOI 10.1016/S1047-2797(03)00121-2; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; Folsom AR, 1997, DIABETES CARE, V20, P935, DOI 10.2337/diacare.20.6.935; Folsom AR, 1999, DIABETES CARE, V22, P1077, DOI 10.2337/diacare.22.7.1077; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Gregg EW, 2004, DIABETES CARE, V27, P2806, DOI 10.2337/diacare.27.12.2806; Klein R, 1997, ARCH INTERN MED, V157, P650, DOI 10.1001/archinte.157.6.650; Kleinbaum D.G., 2008, APPL REGRESSION ANAL; Kopple JD, 1999, KIDNEY INT, V56, P1136, DOI 10.1046/j.1523-1755.1999.00615.x; Lavie CJ, 2010, MAYO CLIN PROC, V85, P605, DOI 10.4065/mcp.2010.0333; Leavey SF, 2001, NEPHROL DIAL TRANSPL, V16, P2386, DOI 10.1093/ndt/16.12.2386; Lloyd-Jones DM, 1999, LANCET, V353, P89, DOI 10.1016/S0140-6736(98)10279-9; McEwen LN, 2007, DIABETES CARE, V30, P1736, DOI 10.2337/dc07-0305; Naik RG, 2009, J CLIN ENDOCR METAB, V94, P4635, DOI 10.1210/jc.2009-1120; Perry JRB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002741; Ross C, 1997, DIABETES CARE, V20, P650, DOI 10.2337/diacare.20.4.650; RUDERMAN NB, 1981, AM J CLIN NUTR, V34, P1617, DOI 10.1093/ajcn/34.8.1617; Ruige JB, 1998, CIRCULATION, V97, P996; Schmidt D, 2007, NUTR CLIN PRACT, V22, P11, DOI 10.1177/011542650702200111; Shamliyan T, 2013, AGEING RES REV, V12, P719, DOI 10.1016/j.arr.2012.03.001; Uretsky S, 2007, AM J MED, V120, P863, DOI 10.1016/j.amjmed.2007.05.011; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wolfe RA, 2000, AM J KIDNEY DIS, V35, P80, DOI 10.1016/S0272-6386(00)70305-2	35	374	391	2	36	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2012	308	6					581	590		10.1001/jama.2012.9282	http://dx.doi.org/10.1001/jama.2012.9282			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	984YA	22871870	Green Accepted, Bronze			2022-12-28	WOS:000307228400025
J	Swain, S; Hughes, R; Perry, M; Harrison, S				Swain, Sharon; Hughes, Ralph; Perry, Mark; Harrison, Simon		Guideline Dev Grp	Management of lower urinary tract dysfunction in neurological disease: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Swain, Sharon; Hughes, Ralph; Perry, Mark] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England; [Harrison, Simon] Mid Yorkshire Hosp NHS Trust, Pinderfields Hosp, Dept Urol, Wakefield WF1 4DG, England	Royal College of Physicians; Pinderfields Hospital	Swain, S (corresponding author), Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England.	Sharon.Swain@rcplondon.co.uk		McClurg, Doreen/0000-0002-2872-1702				National Institute for Health and Clinical Excellence, 2012, MAN UR INC NEUR DIS	1	8	8	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 8	2012	345								e5074	10.1136/bmj.e5074	http://dx.doi.org/10.1136/bmj.e5074			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988ND	22875951				2022-12-28	WOS:000307496800007
J	Phoenix, G; Das, S; Joshi, M				Phoenix, Gokulan; Das, Saroj; Joshi, Meera			Diagnosis and management of cellulitis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RESISTANT STAPHYLOCOCCUS-AUREUS; SOFT-TISSUE INFECTIONS; PRACTICE GUIDELINES; COST-EFFECTIVENESS; RISK-FACTORS; SKIN; ERYSIPELAS; LYMPHEDEMA; SEVERITY; OUTCOMES		[Phoenix, Gokulan] Chelsea & Westminster Hosp, Dept Gen Surg, London SW10 9NH, England; [Das, Saroj] Hillingdon Hosp, Dept Gen Surg, London, England; [Joshi, Meera] Wexham Pk Hosp, Dept Gen Surg, Oxford, England	Imperial College London; Brunel University; Imperial College London	Phoenix, G (corresponding author), Chelsea & Westminster Hosp, Dept Gen Surg, London SW10 9NH, England.	gokulan.phoenix@nhs.net						Agency for Healthcare Research and Quality, 2012, HCUP DAT; Australian Institute of Health and Welfare, 2003, AUSTR HOSP STAT 2001; Blunt I, 2010, TRENDS EMERGENCY ADM; Chan Yi-Ling, 2002, Chang Gung Med J, V25, P437; Chapman ALN, 2009, J ANTIMICROB CHEMOTH, V64, P1316, DOI 10.1093/jac/dkp343; Chira S, 2010, EPIDEMIOL INFECT, V138, P313, DOI 10.1017/S0950268809990483; Clinical Resource Efficiency Support Team, 2005, GUID MAN CELL AD; Cox NH, 1998, J ROY SOC MED, V91, P634, DOI 10.1177/014107689809101206; David Consuelo V, 2011, Dermatol Online J, V17, P1; Department of Health, 2010, HOSP EP STAT PRIM DI; Dupuy A, 1999, BRIT MED J, V318, P1591, DOI 10.1136/bmj.318.7198.1591; Eron LJ, 2000, CLIN INFECT DIS, V31, P287; Forcade NA, 2011, J AM BOARD FAM MED, V24, P543, DOI 10.3122/jabfm.2011.05.110073; Halpern J, 2008, BRIT J DERMATOL, V158, P1288, DOI 10.1111/j.1365-2133.2008.08489.x; Hersh AL, 2008, ARCH INTERN MED, V168, P1585, DOI 10.1001/archinte.168.14.1585; Holzapfel L, 1999, J ACCID EMERG MED, V16, P32; HOOK EW, 1986, ARCH INTERN MED, V146, P295, DOI 10.1001/archinte.146.2.295; JORUPRONSTROM C, 1987, INFECTION, V15, P105, DOI 10.1007/BF01650206; Keeley VL, 2008, BRIT J DERMATOL, V158, P1175, DOI 10.1111/j.1365-2133.2008.08590.x; Kilburn SA, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004299.pub2; King MD, 2006, ANN INTERN MED, V144, P309, DOI 10.7326/0003-4819-144-5-200603070-00005; Ko DSC, 1998, ARCH SURG-CHICAGO, V133, P452, DOI 10.1001/archsurg.133.4.452; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; Marwick C, 2011, J ANTIMICROB CHEMOTH, V66, P387, DOI 10.1093/jac/dkq362; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; National Hospital Ambulatory Medical Care Survey, 2008, NAT HOSP AMB MED CAR; NHS. Institute for innovation and improvement, 2008, QUAL SERV IMPR TOOLS; Otter JA, 2010, LANCET INFECT DIS, V10, P227, DOI 10.1016/S1473-3099(10)70053-0; Perl B, 1999, CLIN INFECT DIS, V29, P1483, DOI 10.1086/313525; Rabuka Curtis E, 2003, Can J Infect Dis, V14, P210; RAHMOUNI A, 1994, RADIOLOGY, V192, P493, DOI 10.1148/radiology.192.2.8029421; Ruhe JJ, 2007, ANTIMICROB AGENTS CH, V51, P3298, DOI 10.1128/AAC.00262-07; Stevens DL, 2005, CLIN INFECT DIS, V41, P1373, DOI 10.1086/497143; Tayal VS, 2006, ACAD EMERG MED, V13, P384, DOI 10.1197/j.aem.2005.11.074; Thomas K, 2012, BRIT J DERMATOL, V166, P169, DOI 10.1111/j.1365-2133.2011.10586.x	35	29	31	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 7	2012	345								e4955	10.1136/bmj.e4955	http://dx.doi.org/10.1136/bmj.e4955			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988NA	22872711				2022-12-28	WOS:000307496500011
J	Herbst, CT; Stoeger, AS; Frey, R; Lohscheller, J; Titze, IR; Gumpenberger, M; Fitch, WT				Herbst, Christian T.; Stoeger, Angela S.; Frey, Roland; Lohscheller, Joerg; Titze, Ingo R.; Gumpenberger, Michaela; Fitch, W. Tecumseh			How Low Can You Go? Physical Production Mechanism of Elephant Infrasonic Vocalizations	SCIENCE			English	Article							AFRICAN ELEPHANTS; LONG-DISTANCE; ACOUSTIC CUES; RED DEER; COMMUNICATION; EVOLUTION; LARYNGES; IDENTITY; WEIGHT; CALLS	Elephants can communicate using sounds below the range of human hearing ("infrasounds" below 20 hertz). It is commonly speculated that these vocalizations are produced in the larynx, either by neurally controlled muscle twitching (as in cat purring) or by flow-induced self-sustained vibrations of the vocal folds (as in human speech and song). We used direct high-speed video observations of an excised elephant larynx to demonstrate flow-induced self-sustained vocal fold vibration in the absence of any neural signals, thus excluding the need for any "purring" mechanism. The observed physical principles of voice production apply to a wide variety of mammals, extending across a remarkably large range of fundamental frequencies and body sizes, spanning more than five orders of magnitude.	[Herbst, Christian T.; Stoeger, Angela S.; Fitch, W. Tecumseh] Univ Vienna, Dept Cognit Biol, A-1090 Vienna, Austria; [Frey, Roland] Leibniz Inst Zoo & Wildlife Res, D-10252 Berlin, Germany; [Lohscheller, Joerg] Univ Appl Sci, Dept Comp Sci, D-54293 Trier, Germany; [Titze, Ingo R.] Univ Utah, Natl Ctr Voice & Speech, Salt Lake City, UT USA; [Gumpenberger, Michaela] Univ Vet Med Vienna, Clin Diagnost Imaging, A-1210 Vienna, Austria; [Fitch, W. Tecumseh] Univ Vet Med Vienna, Haidlhof Res Stn, Univ Vienna, Bad Voslau, Austria	University of Vienna; Leibniz Institut fur Zoo und Wildtierforschung; Utah System of Higher Education; University of Utah; University of Veterinary Medicine Vienna; University of Vienna	Herbst, CT (corresponding author), Univ Vienna, Dept Cognit Biol, Althanstr 14, A-1090 Vienna, Austria.	christian.herbst@univie.ac.at; tecumseh.fitch@univie.ac.at	Herbst, Christian T/D-6470-2011	Stoeger, Angela S/0000-0002-6714-8291; Gumpenberger, Michaela/0000-0003-2412-0501; Herbst, Christian/0000-0001-9095-3953	European Research Council Advanced Grant SOMACCA; University of Vienna; Austrian Science Fund (FWF) [P 23099]; Deutsche Forschungsgemeinschaft [LO1413/2]; National Institute for Deafness and Other Communication Disorders [R01 DC 008612]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008612] Funding Source: NIH RePORTER	European Research Council Advanced Grant SOMACCA; University of Vienna; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institute for Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by European Research Council Advanced Grant SOMACCA and a startup grant from the University of Vienna (W. T. F.); an Austrian Science Fund (FWF) grant, P 23099 (A. S.); grant no. LO1413/2 by the Deutsche Forschungsgemeinschaft (J.L.); and grant R01 DC 008612 (A Simulator for Sound Production in Airways) from the National Institute for Deafness and Other Communication Disorders (I. R. T.). Our sincere thanks go to B. Blaszkiewitz (Direktor, Tierpark Berlin Friedrichsfelde) for supplying us with the elephant larynx. We thank R. Hofer for contributing to the setup of the excised larynx experiment, P. Pesak for assisting in the computed tomography scan of the larynx specimen, and N. Kavcik for creating the artwork in Fig. 1 and the figure of the excised larynx setup in Fig. 2. The data reported in this manuscript are available in the supplementary materials.	Alipour F, 2009, J VOICE, V23, P40, DOI 10.1016/j.jvoice.2007.03.007; Elemans CPH, 2010, J NEUROSCI, V30, P13246, DOI 10.1523/JNEUROSCI.1130-10.2010; Fee MS, 1998, NATURE, V395, P67, DOI 10.1038/25725; Garstang M, 2004, J COMP PHYSIOL A, V190, P791, DOI 10.1007/s00359-004-0553-0; GRIFFITHS TA, 1983, MAMMALIA, V47, P377; Harrison D.F.N., 1995, ANATOMY PHYSL MAMMAL; HAUSER MD, 1993, AM NAT, V142, P528, DOI 10.1086/285553; Husson R., 1950, THESIS; Jones G, 1999, J EXP BIOL, V202, P3359; Langbauer WR, 2000, ZOO BIOL, V19, P425, DOI 10.1002/1098-2361(2000)19:5&lt;425::AID-ZOO11&gt;3.0.CO;2-A; Leong K. M., 2003, Bioacoustics, V13, P213; McComb K, 2003, ANIM BEHAV, V65, P317, DOI 10.1006/anbe.2003.2047; MCCOMB KE, 1991, ANIM BEHAV, V41, P79, DOI 10.1016/S0003-3472(05)80504-4; Mellinger DK, 2003, J ACOUST SOC AM, V114, P1108, DOI 10.1121/1.1593066; Mohres F. P., 1967, SYSTEMES SONARS ANIM, P401; PAYNE KB, 1986, BEHAV ECOL SOCIOBIOL, V18, P297, DOI 10.1007/BF00300007; Peters G, 2002, MAMMAL REV, V32, P245, DOI 10.1046/j.1365-2907.2002.00113.x; POOLE JH, 1988, BEHAV ECOL SOCIOBIOL, V22, P385, DOI 10.1007/BF00294975; Reby D, 2003, ANIM BEHAV, V65, P519, DOI 10.1006/anbe.2003.2078; REMMERS JE, 1972, RESP PHYSIOL, V16, P351, DOI 10.1016/0034-5687(72)90064-3; Shoshani J, 1998, TRENDS ECOL EVOL, V13, P480, DOI 10.1016/S0169-5347(98)01491-8; Shoshani J., ENCY BRITANNICA; SISSOM DEF, 1991, J ZOOL, V223, P67, DOI 10.1111/j.1469-7998.1991.tb04749.x; Soltis J, 2005, ANIM BEHAV, V70, P589, DOI 10.1016/j.anbehav.2004.11.016; Stoeger-Horwath AS, 2007, J ACOUST SOC AM, V121, P3922, DOI 10.1121/1.2722216; Titze I., 2006, MYOELASTIC AERODYNAM; Titze I. R., 2000, PRINCIPLES VOICE PRO; Titze IR, 2010, J EXP BIOL, V213, P3866, DOI 10.1242/jeb.044982; TITZE IR, 1988, J ACOUST SOC AM, V83, P1536, DOI 10.1121/1.395910; VANDENBERG J, 1958, J SPEECH HEAR RES, V1, P227, DOI 10.1044/jshr.0103.227	30	84	84	3	125	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2012	337	6094					595	599		10.1126/science.1219712	http://dx.doi.org/10.1126/science.1219712			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982PU	22859490				2022-12-28	WOS:000307058700049
J	Koch, C				Koch, Christof			Modular Biological Complexity	SCIENCE			English	Editorial Material									[Koch, Christof] Allen Inst Brain Sci, Seattle, WA 98103 USA; [Koch, Christof] CALTECH, Div Biol, Pasadena, CA 91125 USA	Allen Institute for Brain Science; California Institute of Technology	Koch, C (corresponding author), Allen Inst Brain Sci, Seattle, WA 98103 USA.	christofk@alleninstitute.org		Koch, Christof/0000-0001-6482-8067	Paul G. Allen Family Foundation	Paul G. Allen Family Foundation	I thank N. Joshi for the plot. Supported by the Paul G. Allen Family Foundation.	Allen P. G., 2011, TECHNOL REV, V12; Balduzzi D, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000091; Buxhoeveden DP, 2002, BRAIN, V125, P935, DOI 10.1093/brain/awf110; DE BRUIJIN N.G, 1958, ASYMPTOTIC METHODS A; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Koch C, 2012, NATURE, V483, P397, DOI 10.1038/483397a; Kurzweil R., 2005, SINGULARITY IS NEAR; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Qian JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017013; Sanchez C, 1999, NUCLEIC ACIDS RES, V27, P89, DOI 10.1093/nar/27.1.89	10	37	38	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2012	337	6094					531	532		10.1126/science.1218616	http://dx.doi.org/10.1126/science.1218616			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982PU	22859475				2022-12-28	WOS:000307058700027
J	Lee, TH				Lee, Thomas H.			Care Redesign - A Path Forward for Providers	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lee, Thomas H.] Partners HealthCare Syst, Boston, MA USA; [Lee, Thomas H.] Harvard Univ, Sch Med, Boston, MA USA	Partners Healthcare System; Harvard University; Harvard Medical School	Lee, TH (corresponding author), Partners HealthCare Syst, Boston, MA USA.							Bohmer R. M., 2009, DESIGNING CARE; Bohmer RMJ, 2011, NEW ENGL J MED, V365, P2045, DOI 10.1056/NEJMp1111087; Gawande A., 2009, CHECKLIST MANIFESTO; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; Joynt KE, 2012, JAMA-J AM MED ASSOC, V307, P1082, DOI 10.1001/jama.2012.287; Kaplan RS, 2011, HARVARD BUS REV, V89, P46; Lee TH, 2010, NEW ENGL J MED, V363, P2481, DOI 10.1056/NEJMp1013111; Porter M.E., 2006, REDEFINING HLTH CARE; Porter ME, 2010, NEW ENGL J MED, V363, P2477, DOI 10.1056/NEJMp1011024; RANKIN J, 1957, Scott Med J, V2, P200	10	25	25	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 2	2012	367	5					466	472		10.1056/NEJMhpr1204386	http://dx.doi.org/10.1056/NEJMhpr1204386			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	981VZ	22839740				2022-12-28	WOS:000307001900015
J	Yu, XM; Luo, LQ				Yu, Xiaomeng Milton; Luo, Liqun			dSarm-ing Axon Degeneration	SCIENCE			English	Editorial Material							UBIQUITIN-PROTEASOME SYSTEM; WALLERIAN DEGENERATION; WLD(S); GENE		[Yu, Xiaomeng Milton; Luo, Liqun] Stanford Univ, Howard Hughes Med Inst, Dept Biol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University	Yu, XM (corresponding author), Stanford Univ, Howard Hughes Med Inst, Dept Biol, Stanford, CA 94305 USA.	lluo@stanford.edu		Luo, Liqun/0000-0001-5467-9264	Howard Hughes Medical Institute Funding Source: Medline; NIDCD NIH HHS [R01 DC005982] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005982] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Akhouayri I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002319; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Coleman MP, 2010, ANNU REV NEUROSCI, V33, P245, DOI 10.1146/annurev-neuro-060909-153248; Hoopfer ED, 2006, NEURON, V50, P883, DOI 10.1016/j.neuron.2006.05.013; LUNN ER, 1989, EUR J NEUROSCI, V1, P27, DOI 10.1111/j.1460-9568.1989.tb00771.x; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; Miller BR, 2009, NAT NEUROSCI, V12, P387, DOI 10.1038/nn.2290; Osterloh JM, 2012, SCIENCE, V337, P481, DOI 10.1126/science.1223899; Waller A., 1850, PHIL T R SOC, V140, P423, DOI DOI 10.1098/RSTL.1850.0021; Watts RJ, 2003, NEURON, V38, P871, DOI 10.1016/S0896-6273(03)00295-2; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; Zhai QW, 2003, NEURON, V39, P217, DOI 10.1016/S0896-6273(03)00429-X	13	3	7	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2012	337	6093					418	419		10.1126/science.1226150	http://dx.doi.org/10.1126/science.1226150			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979FS	22837513				2022-12-28	WOS:000306802300027
J	Wenzel, RP; Fowler, AA; Edmond, MB				Wenzel, Richard P.; Fowler, Alpha A., III; Edmond, Michael B.			Antibiotic Prevention of Acute Exacerbations of COPD	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; BRONCHIAL MICROBIAL PATTERNS; SENSORINEURAL HEARING-LOSS; LOW-DOSE AZITHROMYCIN; LONG-TERM TREATMENT; MACROLIDE RESISTANCE; CYSTIC-FIBROSIS; STAPHYLOCOCCUS-AUREUS; AIRWAY INFLAMMATION; DRUG-INTERACTIONS	A 55-year-old man presents with a history of recurrent exacerbations of chronic obstructive pulmonary disease (COPD) during the past year. These episodes were characterized by increased shortness of breath, cough, and sputum production. The diagnosis of COPD was made 2 years previously. Pulmonary-function testing then revealed a forced expiratory volume in 1 second (FEV1) of 50% of the predicted value after bronchodilator inhalation, with a ratio of FEV1 to forced vital capacity (FVC) of 60%. The patient had a 30-pack-year smoking history but stopped smoking after chronic lung disease was diagnosed. On the current visit, he is afebrile and has a resting pulse of 84 beats per minute. A careful review confirms that he is knowledgeable about proper inhaler use and that he is compliant with his medications, which include maintenance therapy with salmeterol and fluticasone as well as albuterol plus ipratropium as needed for intermittent therapy for increased dyspnea. His physician recommends the use of azithromycin at a dose of 250 mg daily to reduce the frequency of acute exacerbations.	[Wenzel, Richard P.; Fowler, Alpha A., III; Edmond, Michael B.] Virginia Commonwealth Univ, Med Ctr, Dept Internal Med, Richmond, VA 23284 USA	Virginia Commonwealth University	Wenzel, RP (corresponding author), 1 Capital Sq,830 E Main St, Richmond, VA 23219 USA.	rwenzel@mcvh-vcu.edu	Cervera, Miguel/I-4686-2014; vidal, carolina garcia/A-7290-2012	Cervera, Miguel/0000-0003-3437-6703; Edmond, Michael/0000-0002-4144-8974				Abu-Gharbieh E, 2004, PHARMACOL RES, V50, P211, DOI 10.1016/j.phrs.2004.01.008; Albert RK, 2012, NEW ENGL J MED, V366, P1356; Albert RK, 2011, NEW ENGL J MED, V365, P689, DOI 10.1056/NEJMoa1104623; ANTHONISEN NR, 1987, ANN INTERN MED, V106, P196, DOI 10.7326/0003-4819-106-2-196; Anwar GA, 2008, RESP MED, V102, P1494, DOI 10.1016/j.rmed.2008.06.005; Barnes PJ, 2008, J CLIN INVEST, V118, P3546, DOI 10.1172/JCI36130; Benfield T, 2008, CHEST, V134, P46, DOI 10.1378/chest.07-2933; Berkius J, 2008, ACTA ANAESTH SCAND, V52, P759, DOI 10.1111/j.1399-6576.2008.01632.x; Bizjak ED, 1999, PHARMACOTHERAPY, V19, P245, DOI 10.1592/phco.19.3.245.30930; Bresser P, 2000, AM J RESP CRIT CARE, V162, P947, DOI 10.1164/ajrccm.162.3.9908103; Brown BA, 1997, CLIN INFECT DIS, V24, P958, DOI 10.1093/clinids/24.5.958; Coulston J, 2005, POSTGRAD MED J, V81, P58, DOI 10.1136/pgmj.2004.020412; Davies G, 2004, THORAX, V59, P540; Desai H, 2010, COPD, V7, P337, DOI 10.3109/15412555.2010.510162; Donaldson GC, 2006, THORAX, V61, P164, DOI 10.1136/thx.2005.041806; FAGON JY, 1990, AM REV RESPIR DIS, V142, P1004, DOI 10.1164/ajrccm/142.5.1004; FOULDS G, 1990, J ANTIMICROB CHEMOTH, V25, P73, DOI 10.1093/jac/25.suppl_A.73; Global Initiative for Chronic Obstructive Lung Disease, 2011, GLOB STRAT DIAGN MAN; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Hansen CR, 2009, J CYST FIBROS, V8, P58, DOI 10.1016/j.jcf.2008.09.001; Kanoh S, 2010, CLIN MICROBIOL REV, V23, P590, DOI 10.1128/CMR.00078-09; Keicho Naoto, 2002, Am J Respir Med, V1, P119; Knirsch CA, 2012, NEW ENGL J MED, V367, P772, DOI [10.1056/NEJMoa1003833, 10.1056/NEJMc1207269]; Kudoh S, 1998, AM J RESP CRIT CARE, V157, P1829, DOI 10.1164/ajrccm.157.6.9710075; MACNEE W, 1994, AM J RESP CRIT CARE, V150, P833, DOI 10.1164/ajrccm.150.3.8087359; Mamikoglu B, 2001, ANN OTO RHINOL LARYN, V110, P102, DOI 10.1177/000348940111000119; Martinez Fernando J, 2008, Int J Chron Obstruct Pulmon Dis, V3, P331; Mathers CD, 2009, BRIT MED BULL, V92, P7, DOI 10.1093/bmb/ldp028; McDonough JE, 2011, NEW ENGL J MED, V365, P1567, DOI 10.1056/NEJMoa1106955; Milstone Aaron P, 2008, Int J Chron Obstruct Pulmon Dis, V3, P515; Mittmann N, 2008, RESP MED, V102, P413, DOI 10.1016/j.rmed.2007.10.010; MONSO E, 1995, AM J RESP CRIT CARE, V152, P1316, DOI 10.1164/ajrccm.152.4.7551388; Murphy S. L., 2012, NATL VITAL STAT REP, V60, P4; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; OShaughnessy TC, 1997, AM J RESP CRIT CARE, V155, P852, DOI 10.1164/ajrccm.155.3.9117016; Park SJ, 2004, BIOCHEM BIOPH RES CO, V324, P114, DOI 10.1016/j.bbrc.2004.09.018; Pela R, 1998, Monaldi Arch Chest Dis, V53, P262; Phaff SJ, 2006, J ANTIMICROB CHEMOTH, V57, P741, DOI 10.1093/jac/dkl014; Puhan MA, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-30; Puhan MA, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-81; Qaseem A, 2011, ANN INTERN MED, V155, P179, DOI 10.7326/0003-4819-155-3-201108020-00008; Ress BD, 2000, ANN OTO RHINOL LARYN, V109, P435, DOI 10.1177/000348940010900416; RETSEMA JA, 1990, J ANTIMICROB CHEMOTH, V25, P83, DOI 10.1093/jac/25.suppl_A.83; Rohde G, 2003, THORAX, V58, P37, DOI 10.1136/thorax.58.1.37; Rubinstein E, 2001, INT J ANTIMICROB AG, V18, pS71, DOI 10.1016/S0924-8579(01)00397-1; Saiman L, 2003, JAMA-J AM MED ASSOC, V290, P1749, DOI 10.1001/jama.290.13.1749; Samarendra P, 2001, PACE, V24, P1572, DOI 10.1046/j.1460-9592.2001.01572.x; Seemungal TAR, 2008, AM J RESP CRIT CARE, V178, P1139, DOI 10.1164/rccm.200801-145OC; Sethi S, 2008, NEW ENGL J MED, V359, P2355, DOI 10.1056/NEJMra0800353; Sethi S, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-88; Sethi S, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-10; Soler N, 1999, EUR RESPIR J, V14, P1015, DOI 10.1183/09031936.99.14510159; Soler N, 1998, AM J RESP CRIT CARE, V157, P1498, DOI 10.1164/ajrccm.157.5.9711044; Tramper-Stranders GA, 2007, PEDIATR INFECT DIS J, V26, P8, DOI 10.1097/01.inf.0000247109.44249.ac; Tseng AL, 1997, CLIN INFECT DIS, V24, P76, DOI 10.1093/clinids/24.1.76; Vestbo J, 2011, NEW ENGL J MED, V365, P1184, DOI 10.1056/NEJMoa1105482; Volberg WA, 2002, J PHARMACOL EXP THER, V302, P320, DOI 10.1124/jpet.302.1.320; VONROSENSTIEL NA, 1995, DRUG SAFETY, V13, P105, DOI 10.2165/00002018-199513020-00005; WALLACE MR, 1994, LANCET, V343, P241, DOI 10.1016/S0140-6736(94)91030-8; Westphal JF, 2000, BRIT J CLIN PHARMACO, V50, P285, DOI 10.1046/j.1365-2125.2000.00261.x; Williams JD, 2001, INT J ANTIMICROB AG, V18, pS77; Wolter J, 2002, THORAX, V57, P212, DOI 10.1136/thorax.57.3.212	62	51	52	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 26	2012	367	4					340	347		10.1056/NEJMct1115170	http://dx.doi.org/10.1056/NEJMct1115170			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	978KD	22830464	Green Submitted, Green Published			2022-12-28	WOS:000306738300008
J	Sokol, DK				Sokol, Daniel K.			A passion for accuracy	BRITISH MEDICAL JOURNAL			English	Editorial Material												daniel.sokol@talk21.com							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUL 23	2012	345								e4977	10.1136/bmj.e4977	http://dx.doi.org/10.1136/bmj.e4977			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	981UP	22826581				2022-12-28	WOS:000306996800017
J	Jay, JS; Gostin, LO				Jay, Jonathan S.; Gostin, Lawrence O.			Ethical Challenges of Preexposure Prophylaxis for HIV	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PREVENTION; INFECTION		[Jay, Jonathan S.; Gostin, Lawrence O.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044; Jay, Jonathan/0000-0002-7543-4247				Anderson P., 2012, 19 C RETR OPP INF MA; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Juusola JL, 2012, ANN INTERN MED, V156, P541, DOI [10.7326/0003-4819-156-8-201204170-00004, 10.7326/0003-4819-156-8-201204170-00001]; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E	10	19	19	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 5	2012	308	9					867	868		10.1001/2012.jama.10158	http://dx.doi.org/10.1001/2012.jama.10158			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999ET	22847147	Green Published, Bronze			2022-12-28	WOS:000308292900013
J	Doege, CA; Inoue, K; Yamashita, T; Rhee, DB; Travis, S; Fujita, R; Guarnieri, P; Bhagat, G; Vanti, WB; Shih, A; Levine, RL; Nik, S; Chen, EI; Abeliovich, A				Doege, Claudia A.; Inoue, Keiichi; Yamashita, Toru; Rhee, David B.; Travis, Skylar; Fujita, Ryousuke; Guarnieri, Paolo; Bhagat, Govind; Vanti, William B.; Shih, Alan; Levine, Ross L.; Nik, Sara; Chen, Emily I.; Abeliovich, Asa			Early-stage epigenetic modification during somatic cell reprogramming by Parp1 and Tet2	NATURE			English	Article							CHROMATIN-STRUCTURE; DNA DEMETHYLATION; SELF-RENEWAL; 5-HYDROXYMETHYLCYTOSINE; MAPS; 5-METHYLCYTOSINE; PLURIPOTENT; CONVERSION; REVEALS; GENES	Somatic cells can be reprogrammed into induced pluripotent stem cells (iPSCs) by using the pluripotency factors Oct4, Sox2, Klf4 and c-Myc (together referred to as OSKM)(1). iPSC reprogramming erases somatic epigenetic signatures-as typified by DNA methylation or histone modification at silent pluripotency loci-and establishes alternative epigenetic marks of embryonic stem cells (ESCs)(2). Here we describe an early and essential stage of somatic cell reprogramming, preceding the induction of transcription at endogenous pluripotency loci such as Nanog and Esrrb. By day 4 after transduction with OSKM, two epigenetic modification factors necessary for iPSC generation, namely poly(ADP-ribose) polymerase-1 (Parp1) and ten-eleven translocation-2 (Tet2), are recruited to the Nanog and Esrrb loci. These epigenetic modification factors seem to have complementary roles in the establishment of early epigenetic marks during somatic cell reprogramming: Parp1 functions in the regulation of 5-methylcytosine (5mC) modification, whereas Tet2 is essential for the early generation of 5-hydroxymethylcytosine (5hmC) by the oxidation of 5mC (refs 3,4). Although 5hmC has been proposed to serve primarily as an intermediate in 5mC demethylation to cytosine in certain contexts(5-7), our data, and also studies of Tet2-mutant human tumour cells(8), argue in favour of a role for 5hmC as an epigenetic mark distinct from 5mC. Consistent with this, Parp1 and Tet2 are each needed for the early establishment of histone modifications that typify an activated chromatin state at pluripotency loci, whereas Parp1 induction further promotes accessibility to the Oct4 reprogramming factor. These findings suggest that Parp1 and Tet2 contribute to an epigenetic program that directs subsequent transcriptional induction at pluripotency loci during somatic cell reprogramming.	[Doege, Claudia A.; Inoue, Keiichi; Yamashita, Toru; Rhee, David B.; Travis, Skylar; Fujita, Ryousuke; Bhagat, Govind; Vanti, William B.; Abeliovich, Asa] Columbia Univ, Dept Pathol & Cell Biol, Taub Inst Aging, New York, NY 10032 USA; [Doege, Claudia A.; Inoue, Keiichi; Yamashita, Toru; Rhee, David B.; Travis, Skylar; Fujita, Ryousuke; Bhagat, Govind; Vanti, William B.; Abeliovich, Asa] Columbia Univ, Dept Neurol, Taub Inst Aging, New York, NY 10032 USA; [Guarnieri, Paolo] Columbia Univ, Bioinformat Div, New York, NY 10032 USA; [Guarnieri, Paolo; Bhagat, Govind] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA; [Shih, Alan; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10016 USA; [Nik, Sara; Chen, Emily I.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Chen, Emily I.] SUNY Stony Brook, Prote Ctr, Sch Med, Stony Brook, NY 11794 USA	Columbia University; Columbia University; Columbia University; Columbia University; Memorial Sloan Kettering Cancer Center; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Abeliovich, A (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, Taub Inst Aging, New York, NY 10032 USA.	aa900@columbia.edu	Bhagat, Govind/AAE-9493-2021; Vanti, William/E-6518-2016; levine, ross/AAE-7658-2019	Bhagat, Govind/0000-0001-6250-048X; Vanti, William/0000-0002-5591-5350; Inoue, Keiichi/0000-0002-7101-486X; Yamashita, Toru/0000-0003-3634-5679	New York State Stem Cell Science (NYSTEM) [C024402, C024403]; National Institutes of Health (NIH) [RO1 NS064433]; NYSTEM Institution Development [N08G-071]; NIH [RO1 138424]; NIH/National Center for Research Resources [1 S10 RR023680-1]; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA173636] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064433] Funding Source: NIH RePORTER	New York State Stem Cell Science (NYSTEM); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYSTEM Institution Development; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank G. Q. Daley, A. P. Feinberg, A. Doi, R. M. Santella and M. A. Kappil for reagents and for technical assistance with pyrosequencing; A. Califano and A. Lachmann for assistance with the bioinformatics analyses; E. O. Mazzoni for assistance with the ChIP analyses; and O. Hobert for critical reading of the manuscript. This work was supported by New York State Stem Cell Science (NYSTEM) grants C024402 and C024403 and National Institutes of Health (NIH) grant RO1 NS064433 to A. A., NYSTEM Institution Development Grant N08G-071 to E. I. C., NIH grant RO1 138424 to R. L. L, and a shared NIH/National Center for Research Resources instrument grant for mass spectrometry, 1 S10 RR023680-1.	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bhutani N, 2011, CELL, V146, P866, DOI 10.1016/j.cell.2011.08.042; Davis T, 2011, JOVE-J VIS EXP, DOI 10.3791/2661; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Langelier MF, 2010, J BIOL CHEM, V285, P18877, DOI 10.1074/jbc.M110.105668; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Smith ZD, 2010, NAT BIOTECHNOL, V28, P521, DOI 10.1038/nbt.1632; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wacker DA, 2007, MOL CELL BIOL, V27, P7475, DOI 10.1128/MCB.01314-07; WANG ZQ, 1995, GENE DEV, V9, P509, DOI 10.1101/gad.9.5.509; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011; Yildirim O, 2011, CELL, V147, P1498, DOI 10.1016/j.cell.2011.11.054	30	288	301	0	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2012	488	7413					652	655		10.1038/nature11333	http://dx.doi.org/10.1038/nature11333			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996NC	22902501	Green Accepted			2022-12-28	WOS:000308095100055
J	Chen, J; Li, YJ; Yu, TS; McKay, RM; Burns, DK; Kernie, SG; Parada, LF				Chen, Jian; Li, Yanjiao; Yu, Tzong-Shiue; McKay, Renee M.; Burns, Dennis K.; Kernie, Steven G.; Parada, Luis F.			A restricted cell population propagates glioblastoma growth after chemotherapy	NATURE			English	Article							EXPRESSING PROGENITORS; INITIATING CELLS; MOUSE MODELS; STEM-CELLS; NEUROGENESIS; GLIOMA; ASTROCYTOMAS; BRAIN; RARE	Glioblastoma multiforme is the most common primary malignant brain tumour, with a median survival of about one year(1). This poor prognosis is due to therapeutic resistance and tumour recurrence after surgical removal. Precisely how recurrence occurs is unknown. Using a genetically engineered mouse model of glioma, here we identify a subset of endogenous tumour cells that are the source of new tumour cells after the drug temozolomide (TMZ) is administered to transiently arrest tumour growth. A nestin-Delta TK-IRES-GFP (Nes-Delta TK-GFP) transgene that labels quiescent subventricular zone adult neural stem cells also labels a subset of endogenous glioma tumour cells. On arrest of tumour cell proliferation with TMZ, pulse-chase experiments demonstrate a tumour re-growth cell hierarchy originating with the Nes-Delta TK-GFP transgene subpopulation. Ablation of the GFP(+) cells with chronic ganciclovir administration significantly arrested tumour growth, and combined TMZ and ganciclovir treatment impeded tumour development. Thus, a relatively quiescent subset of endogenous glioma cells, with properties similar to those proposed for cancer stem cells, is responsible for sustaining long-term tumour growth through the production of transient populations of highly proliferative cells.	[Chen, Jian; Li, Yanjiao; Yu, Tzong-Shiue; McKay, Renee M.; Kernie, Steven G.; Parada, Luis F.] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Chen, Jian; Li, Yanjiao; Yu, Tzong-Shiue; McKay, Renee M.; Kernie, Steven G.; Parada, Luis F.] Univ Texas SW Med Ctr Dallas, Kent Waldrep Ctr Basic Res Nerve Growth & Regener, Dallas, TX 75390 USA; [Yu, Tzong-Shiue; Kernie, Steven G.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Burns, Dennis K.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Parada, LF (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA.	luis.parada@utsouthwestern.edu	Parada, luis F/B-9400-2014; Kernie, Steven/AAT-9912-2020	Kernie, Steven/0000-0003-1371-0549; Yu, Tzong-Shiue/0000-0003-4277-6213	James S. McDonnell Foundation [JSMF-220020206]; Goldhirsh Foundation; Cancer Prevention Research Institute of Texas [RP 100782]; National Institutes of Health [R01 CA131313];  [RO1 NS048192-01]; NATIONAL CANCER INSTITUTE [R01CA131313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048192] Funding Source: NIH RePORTER	James S. McDonnell Foundation; Goldhirsh Foundation; Cancer Prevention Research Institute of Texas; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank S. McKinnon, A. Deshaw, L. McClellan, S. Kennedy and P. Leake for technical assistance, and Parada laboratory members for helpful suggestions and discussion. CldU and IdU preparation and staining protocol was provided by D.A. Peterson at Rosalind Franklin University. This work was supported by grants awarded to S.G.K. (RO1 NS048192-01) and to L.F.P. by the Goldhirsh Foundation, the James S. McDonnell Foundation (JSMF-220020206), Cancer Prevention Research Institute of Texas (RP 100782) and the National Institutes of Health (R01 CA131313). L.F.P. is an American Cancer Society Research Professor.	Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Chen J, 2012, CELL, V149, P36, DOI 10.1016/j.cell.2012.03.009; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Deng W, 2009, J NEUROSCI, V29, P13532, DOI 10.1523/JNEUROSCI.3362-09.2009; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; IshiiMorita H, 1997, GENE THER, V4, P244, DOI 10.1038/sj.gt.3300379; Ishizawa K, 2010, CELL STEM CELL, V7, P279, DOI 10.1016/j.stem.2010.08.009; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kwon CH, 2008, CANCER RES, V68, P3286, DOI 10.1158/0008-5472.CAN-07-6867; Liu C, 2011, CELL, V146, P209, DOI 10.1016/j.cell.2011.06.014; Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Singer BH, 2011, P NATL ACAD SCI USA, V108, P5437, DOI 10.1073/pnas.1015425108; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Vega CJ, 2005, NAT METHODS, V2, P167, DOI 10.1038/NMETH741; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008; Zhu Y, 2005, CANCER CELL, V8, P119, DOI 10.1016/j.ccr.2005.07.004	19	1483	1542	8	321	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2012	488	7412					522	+		10.1038/nature11287	http://dx.doi.org/10.1038/nature11287			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992FS	22854781	Green Accepted			2022-12-28	WOS:000307761600039
J	Castanon, A; Brocklehurst, P; Evans, H; Peebles, D; Singh, N; Walker, P; Patnick, J; Sasieni, P				Castanon, Alejandra; Brocklehurst, Peter; Evans, Heather; Peebles, Donald; Singh, Naveena; Walker, Patrick; Patnick, Julietta; Sasieni, Peter		PaCT Study Grp	Risk of preterm birth after treatment for cervical intraepithelial neoplasia among women attending colposcopy in England: retrospective-prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LARGE LOOP EXCISION; PRECANCEROUS CHANGES; TRANSFORMATION ZONE; PREGNANCY; METAANALYSIS; CONIZATION; DELIVERY; OUTCOMES	Objective To explore the association between preterm delivery and treatment at colposcopy. Design Retrospective-prospective cohort study using record linkage. Setting 12 National Health Service hospitals in England. Participants Women who had a cervical histology sample taken between 1987 and 2009. These women were linked by hospital episode statistics to hospital obstetric records between 1998 and 2009 for the whole of England to identify singleton live births between 20-43 gestational weeks before or after cervical histology. Main outcome measures Proportion of preterm births (<37 weeks); the relative risk for the strength of association between preterm births and treatment for cervical intraepithelial neoplasia. Results 18 441 singleton births occurred: 4176 before histology and 14 265 after histology. Of the singleton births after histology, 9.0% (n=1284) were preterm compared with 6.7% of all births in England over the same period (excess risk 2.3 per 100 births, 95% confidence interval 1.8% to 2.8%). Among first births after histology, the adjusted relative risk associated with previous treatment was 1.19 (95% confidence interval 1.01 to 1.41); among first births before histology the relative risk associated with subsequent treatment was 1.47 (1.05 to 2.05). Combining these, the relative risk associated with treatment adjusted for timing relative to histology was 0.91 (0.66 to 1.26) corresponding to an absolute difference of -0.25 (-2.61 to 2.11) per 100 singleton births. Among 372 women who gave birth both before and after treatment, there were 30 preterm births after treatment and 32 before treatment (relative risk 0.94, 0.62 to 1.43). Conclusion The risk of preterm delivery in women treated by colposcopy in England was substantially less than that in many other studies, predominantly from Nordic countries. The increased risk may be a consequence of confounding and not caused by treatment. Although this study is reassuring for large loop excision of the transformation zone overall, it is possible that deep conisation or repeated treatment leads to an increased risk of preterm delivery.	[Castanon, Alejandra; Sasieni, Peter] Queen Mary Univ London, Wolfson Inst Prevent Med, Ctr Canc Prevent, London EC1M 6BQ, England; [Brocklehurst, Peter; Peebles, Donald] Inst Womens Hlth UCL, London, England; [Evans, Heather; Walker, Patrick] Royal Free Hampstead NHS Trust, Dept Gynaecol, London, England; [Singh, Naveena] Barts Hlth NHS Trust, Div Cellular Pathol, London, England; [Patnick, Julietta] NHS Canc Screening Programmes, Sheffield, S Yorkshire, England	University of London; Queen Mary University London; University of London; University College London; University of London; University College London; Barts Health NHS Trust	Sasieni, P (corresponding author), Queen Mary Univ London, Wolfson Inst Prevent Med, Ctr Canc Prevent, London EC1M 6BQ, England.	p.sasieni@qmul.ac.uk	Wood, Nicholas/E-7124-2018; Singh, Naveena/AAH-2651-2020; Castanon, Alejandra/G-1506-2013	Wood, Nicholas/0000-0002-5909-7885; Sasieni, Peter/0000-0003-1509-8744; Castanon, Alejandra/0000-0002-1101-6548	National Institute for Health Research (NIHR) [PB-PG-1208-16187]; National Institute for Health Research [PB-PG-1208-16187] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This manuscript presents independent research funded by the National Institute for Health Research (NIHR) under its research for patient benefit programme (No PB-PG-1208-16187). The views expressed are those of the authors and not necessarily those of the National Health Service, the NIHR, or the Department of Health. Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; and no other relationships or activities that could appear to have influenced the submitted work. Ethical approval: This study was approved by the Brompton, Harefield, and NHLI research ethics committee, Charing Cross Hospital, London (No 09/H0708/65).	Acharya Ganesh, 2005, Archives of Gynecology and Obstetrics, V272, P109, DOI 10.1007/s00404-005-0727-1; Albrechtsen S, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1343; British Society for Colposcopy and Cervical Pathology, 1975, CONST BSCCP; Bruinsma FJ, 2011, BJOG-INT J OBSTET GY, V118, P1031, DOI 10.1111/j.1471-0528.2011.02944.x; CRUICKSHANK ME, 1995, BRIT J OBSTET GYNAEC, V102, P467, DOI 10.1111/j.1471-0528.1995.tb11319.x; HAFFENDEN DK, 1993, BRIT J OBSTET GYNAEC, V100, P1059, DOI 10.1111/j.1471-0528.1993.tb15153.x; HES Online, 2011, WHAT IS HES 2005 200; Jakobsson M, 2009, OBSTET GYNECOL, V114, P504, DOI 10.1097/AOG.0b013e3181b052de; Kyrgiou M, 2006, LANCET, V367, P489, DOI 10.1016/S0140-6736(06)68181-6; Lancucki L, 2006, CERVICAL SCREENING P; Luesley D, 2004, GUIDELINES NHS CERVI; NHS Information Centre, 2010, NHS MAT STAT 2000 20; Noehr B, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.02.004; Office for National Statistics, 2009, GEST SPEC INF MORT E; Ortoft G, 2010, BJOG-INT J OBSTET GY, V117, P258, DOI 10.1111/j.1471-0528.2009.02438.x; Reilly R, 2012, BJOG-INT J OBSTET GY, V119, P236, DOI 10.1111/j.1471-0528.2011.03052.x; Sadler L, 2004, JAMA-J AM MED ASSOC, V291, P2100, DOI 10.1001/jama.291.17.2100; Shanbhag S, 2009, OBSTET GYNECOL, V114, P727, DOI 10.1097/AOG.0b013e3181b5cba3; Tan Linda, 2004, J Obstet Gynaecol, V24, P25	19	83	91	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 17	2012	345								e5174	10.1136/bmj.e5174	http://dx.doi.org/10.1136/bmj.e5174			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992CV	22899563	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000307754000002
J	Graetzel, M; Janssen, RAJ; Mitzi, DB; Sargent, EH				Graetzel, Michael; Janssen, Rene A. J.; Mitzi, David B.; Sargent, Edward H.			Materials interface engineering for solution-processed photovoltaics	NATURE			English	Review							SENSITIZED SOLAR-CELLS; OPEN-CIRCUIT VOLTAGE; CHARGE-TRANSFER EXCITONS; QUANTUM DOTS; EFFICIENCY; POLYMER; BULK; RECOMBINATION; STATES; CDSE	Advances in solar photovoltaics are urgently needed to increase the performance and reduce the cost of harvesting solar power. Solution-processed photovoltaics are cost-effective to manufacture and offer the potential for physical flexibility. Rapid progress in their development has increased their solar-power conversion efficiencies. The nanometre (electron) and micrometre (photon) scale interfaces between the crystalline domains that make up solution-processed solar cells are crucial for efficient charge transport. These interfaces include large surface area junctions between photoelectron donors and acceptors, the intralayer grain boundaries within the absorber, and the interfaces between photoactive layers and the top and bottom contacts. Controlling the collection and minimizing the trapping of charge carriers at these boundaries is crucial to efficiency.	[Sargent, Edward H.] Univ Toronto, Dept Elect & Comp Engn, Toronto, ON M5S 3G4, Canada; [Graetzel, Michael] Swiss Fed Inst Technol, Inst Photon & Interfaces, CH-1015 Lausanne, Switzerland; [Janssen, Rene A. J.] Eindhoven Univ Technol, NL-5600 MB Eindhoven, Netherlands; [Mitzi, David B.] IBM Corp, Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA	University of Toronto; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Eindhoven University of Technology; International Business Machines (IBM)	Sargent, EH (corresponding author), Univ Toronto, Dept Elect & Comp Engn, Toronto, ON M5S 3G4, Canada.	ted.sargent@utoronto.ca	Mitzi, David B/B-6260-2012; Janssen, Rene A. J./W-2959-2017; Sargent, Edward H./O-9520-2014	Mitzi, David B/0000-0001-5189-4612; Janssen, Rene A. J./0000-0002-1920-5124; Sargent, Edward H./0000-0003-0396-6495	King Abdullah University of Science and Technology (KAUST) [KUS-11-009-21]; Ontario Research Fund Research Excellence Program; Natural Sciences and Engineering Research Council (NSERC) of Canada; Stanford University Center of Advanced Molecular Photovoltaics (CAMP) [KUS-C1-015-21]; European Research Council (ERC) [247404]	King Abdullah University of Science and Technology (KAUST)(King Abdullah University of Science & Technology); Ontario Research Fund Research Excellence Program; Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Stanford University Center of Advanced Molecular Photovoltaics (CAMP); European Research Council (ERC)(European Research Council (ERC))	E.H.S acknowledges that this Review is based, in part, on work supported by an award (no. KUS-11-009-21) made by King Abdullah University of Science and Technology (KAUST), by the Ontario Research Fund Research Excellence Program and by the Natural Sciences and Engineering Research Council (NSERC) of Canada. E. H. S acknowledges the contribution of I. Kramer, S. Thon and O. Voznyy to the figures and text. M. G. acknowledges that this Review is based, in part, on work supported by the Stanford University Center of Advanced Molecular Photovoltaics (CAMP) under an award (no. KUS-C1-015-21) made by KAUST and by the European Research Council (ERC) under the Advanced Research Grant No. 247404 (Mesolight project).	Arakawa Hironori, 2009, Fujikura Technical Review, P55; Atwater HA, 2010, NAT MATER, V9, P205, DOI [10.1038/nmat2629, 10.1038/NMAT2629]; Barkhouse DAR, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4714737; Barkhouse DAR, 2012, PROG PHOTOVOLTAICS, V20, P6, DOI 10.1002/pip.1160; Barkhouse DAR, 2011, ADV MATER, V23, P3134, DOI 10.1002/adma.201101065; Barkhouse DAR, 2008, ACS NANO, V2, P2356, DOI 10.1021/nn800471c; Bisquert J, 2002, J PHYS CHEM B, V106, P325, DOI [10.1021/jp011941g, 10.1021/jp01194lg]; Brabec CJ, 2001, CHEM PHYS LETT, V340, P232, DOI 10.1016/S0009-2614(01)00431-6; Brown MD, 2011, NANO LETT, V11, P438, DOI 10.1021/nl1031106; Cao Q, 2011, ADV ENERGY MATER, V1, P845, DOI 10.1002/aenm.201100344; Chen SY, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3275796; Clifford JP, 2009, NAT NANOTECHNOL, V4, P40, DOI 10.1038/NNANO.2008.313; Dou LT, 2012, NAT PHOTONICS, V6, P180, DOI [10.1038/nphoton.2011.356, 10.1038/NPHOTON.2011.356]; Fabregat-Santiago F, 2009, J AM CHEM SOC, V131, P558, DOI 10.1021/ja805850q; Feldt SM, 2010, J AM CHEM SOC, V132, P16714, DOI 10.1021/ja1088869; Ferry VE, 2011, NANO LETT, V11, P4239, DOI 10.1021/nl202226r; Frenzel J, 2005, EUR J INORG CHEM, P3585, DOI 10.1002/ejic.200500390; Gelinas S, 2011, J PHYS CHEM C, V115, P7114, DOI 10.1021/jp200466y; Gilot J, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2719668; Gratzel M, 2009, ACCOUNTS CHEM RES, V42, P1788, DOI 10.1021/ar900141y; Green MA, 2012, PROG PHOTOVOLTAICS, V20, P12, DOI 10.1002/pip.2163; Guha S, 1999, APPL PHYS LETT, V74, P1860, DOI 10.1063/1.123693; Gunawan O, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3522884; Guo Q., 2011, P 37 IEEE PHOT SPEC; Haight R, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3600776; Han LY, 2012, ENERG ENVIRON SCI, V5, P6057, DOI 10.1039/c2ee03418b; He ZC, 2011, ADV MATER, V23, P4636, DOI 10.1002/adma.201103006; Heath JT, 2004, J APPL PHYS, V95, P1000, DOI 10.1063/1.1633982; Hetzer MJ, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1906331; Hibberd CJ, 2010, PROG PHOTOVOLTAICS, V18, P434, DOI 10.1002/pip.914; Hyun BR, 2008, ACS NANO, V2, P2206, DOI 10.1021/nn800336b; Irwin MD, 2008, P NATL ACAD SCI USA, V105, P2783, DOI 10.1073/pnas.0711990105; Jeong KS, 2012, ACS NANO, V6, P89, DOI 10.1021/nn2039164; Johnston KW, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2896295; Johnston KW, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2912340; Kapoor V. K., 2001, MATER RES SOC S P, pH261; Katagiri H, 2009, THIN SOLID FILMS, V517, P2455, DOI 10.1016/j.tsf.2008.11.002; Kim JY, 2007, SCIENCE, V317, P222, DOI 10.1126/science.1141711; Klem EJD, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4707377; Klem EJD, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2735674; Koleilat GI, 2008, ACS NANO, V2, P833, DOI 10.1021/nn800093v; Koleilat GI, 2011, NANO LETT, V11, P5173, DOI 10.1021/nl202337a; Konstantatos G, 2007, NAT PHOTONICS, V1, P531, DOI 10.1038/nphoton.2007.147; Konstantatos G, 2006, NATURE, V442, P180, DOI 10.1038/nature04855; Kramer IJ, 2012, ADV MATER, V24, P2315, DOI 10.1002/adma.201104832; Lee J, 2010, J AM CHEM SOC, V132, P11878, DOI 10.1021/ja1045742; Liao DX, 2003, J APPL PHYS, V93, P9380, DOI 10.1063/1.1570500; Liu H, 2011, ADV MATER, V23, P3832, DOI 10.1002/adma.201101783; Luther JM, 2008, NANO LETT, V8, P3488, DOI 10.1021/nl802476m; Ma WL, 2005, ADV FUNCT MATER, V15, P1617, DOI 10.1002/adfm.200500211; Maturova K, 2011, ADV FUNCT MATER, V21, P261, DOI 10.1002/adfm.201001515; Maturova K, 2010, ACS NANO, V4, P1385, DOI 10.1021/nn100039r; McDonald SA, 2005, NAT MATER, V4, P138, DOI 10.1038/nmat1299; Minemoto T, 2001, J APPL PHYS, V89, P8327, DOI 10.1063/1.1366655; Mitzi DB, 2009, THIN SOLID FILMS, V517, P2158, DOI 10.1016/j.tsf.2008.10.079; Mora-Sero I, 2009, ACCOUNTS CHEM RES, V42, P1848, DOI 10.1021/ar900134d; Murray IP, 2011, J PHYS CHEM LETT, V2, P3006, DOI 10.1021/jz201493d; Nagpal P, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1492; Nazeeruddin MK, 2011, SOL ENERGY, V85, P1172, DOI 10.1016/j.solener.2011.01.018; Nelson J, 2011, MATER TODAY, V14, P462, DOI 10.1016/S1369-7021(11)70210-3; O'Malley KM, 2012, ADV ENERGY MATER, V2, P82, DOI 10.1002/aenm.201100522; Oosterhout SD, 2009, NAT MATER, V8, P818, DOI [10.1038/nmat2533, 10.1038/NMAT2533]; OREGAN B, 1991, NATURE, V353, P737, DOI 10.1038/353737a0; Park SH, 2009, NAT PHOTONICS, V3, P297, DOI 10.1038/NPHOTON.2009.69; Pattantyus-Abraham AG, 2010, ACS NANO, V4, P3374, DOI 10.1021/nn100335g; Persson P, 2006, J CHEM THEORY COMPUT, V2, P441, DOI 10.1021/ct050141x; Pillai S, 2007, J APPL PHYS, V101, DOI 10.1063/1.2734885; Puzder A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.217401; Rockett A, 2005, THIN SOLID FILMS, V480, P2, DOI 10.1016/j.tsf.2004.11.038; Rusu M, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3253419; Sargent EH, 2012, NAT PHOTONICS, V6, P133, DOI 10.1038/nphoton.2012.33; Scragg JJ, 2011, CHEM MATER, V23, P4625, DOI 10.1021/cm202379s; Semonin OE, 2011, SCIENCE, V334, P1530, DOI 10.1126/science.1209845; Shaheen SE, 2001, APPL PHYS LETT, V78, P841, DOI 10.1063/1.1345834; SHOCKLEY W, 1961, J APPL PHYS, V32, P510, DOI 10.1063/1.1736034; TANG CW, 1986, APPL PHYS LETT, V48, P183, DOI 10.1063/1.96937; Tang J, 2011, NAT MATER, V10, P765, DOI [10.1038/NMAT3118, 10.1038/nmat3118]; Todorov T. K., 2012, PROG PHOTOVOLT RES A; Todorov T, 2010, EUR J INORG CHEM, P17, DOI 10.1002/ejic.200900837; Todorov TK, 2010, ADV MATER, V22, pE156, DOI 10.1002/adma.200904155; Van Duren J. K. J., 2002, MATER RES SOC S P, P259; Vandewal K, 2009, NAT MATER, V8, P904, DOI [10.1038/NMAT2548, 10.1038/nmat2548]; Veldman D, 2008, J AM CHEM SOC, V130, P7721, DOI 10.1021/ja8012598; Veldman D, 2009, ADV FUNCT MATER, V19, P1939, DOI 10.1002/adfm.200900090; Villanueva-Cab J, 2010, J PHYS CHEM LETT, V1, P748, DOI 10.1021/jz1000243; Voznyy O, 2011, J PHYS CHEM C, V115, P15927, DOI 10.1021/jp205784g; Wada T, 2001, THIN SOLID FILMS, V387, P118, DOI 10.1016/S0040-6090(00)01846-0; Wang Q, 2006, J PHYS CHEM B, V110, P25210, DOI 10.1021/jp064256o; Wang XH, 2011, NAT PHOTONICS, V5, P480, DOI [10.1038/nphoton.2011.123, 10.1038/NPHOTON.2011.123]; YABLONOVITCH E, 1982, IEEE T ELECTRON DEV, V29, P300, DOI 10.1109/T-ED.1982.20700; Yang J, 2011, ACS NANO, V5, P6210, DOI 10.1021/nn202144b; Yang XN, 2005, NANO LETT, V5, P579, DOI 10.1021/nl048120i; Yella A, 2011, SCIENCE, V334, P629, DOI 10.1126/science.1209688; YU G, 1995, SCIENCE, V270, P1789, DOI 10.1126/science.270.5243.1789; Yu M, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2209195; Yuan M, 2010, THIN SOLID FILMS, V519, P852, DOI 10.1016/j.tsf.2010.08.135	96	892	907	27	1141	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2012	488	7411					304	312		10.1038/nature11476	http://dx.doi.org/10.1038/nature11476			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OS	22895335				2022-12-28	WOS:000307501000029
J	Sandborn, WJ; Ghosh, S; Panes, J; Vranic, I; Su, CY; Rousell, S; Niezychowski, W				Sandborn, William J.; Ghosh, Subrata; Panes, Julian; Vranic, Ivana; Su, Chinyu; Rousell, Samantha; Niezychowski, Wojciech		Study A3921063 Investigators	Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INFLAMMATORY-BOWEL-DISEASE; JAK INHIBITOR; RHEUMATOID-ARTHRITIS; DOUBLE-BLIND; CP-690,550; PLACEBO; EFFICACY; THERAPY; INFLIXIMAB; TRIAL	Background Ulcerative colitis is a chronic inflammatory disease of the colon for which current treatments are not universally effective. One additional treatment may be tofacitinib (CP-690,550), an oral inhibitor of Janus kinases 1, 2, and 3 with in vitro functional specificity for kinases 1 and 3 over kinase 2, which is expected to block signaling involving gamma chain-containing cytokines including interleukins 2, 4, 7, 9, 15, and 21. These cytokines are integral to lymphocyte activation, function, and proliferation. Methods In a double-blind, placebo-controlled, phase 2 trial, we evaluated the efficacy of tofacitinib in 194 adults with moderately to severely active ulcerative colitis. Patients were randomly assigned to receive tofacitinib at a dose of 0.5 mg, 3 mg, 10 mg, or 15 mg or placebo twice daily for 8 weeks. The primary outcome was a clinical response at 8 weeks, defined as an absolute decrease from baseline in the score on the Mayo scoring system for assessment of ulcerative colitis activity (possible score, 0 to 12, with higher scores indicating more severe disease) of 3 or more and a relative decrease from baseline of 30% or more with an accompanying decrease in the rectal bleeding subscore of 1 point or more or an absolute rectal bleeding subscore of 0 or 1. Results The primary outcome, clinical response at 8 weeks, occurred in 32%, 48%, 61%, and 78% of patients receiving tofacitinib at a dose of 0.5 mg (P = 0.39), 3 mg (P = 0.55), 10 mg (P = 0.10), and 15 mg (P < 0.001), respectively, as compared with 42% of patients receiving placebo. Clinical remission (defined as a Mayo score <= 2, with no subscore > 1) at 8 weeks occurred in 13%, 33%, 48%, and 41% of patients receiving tofacitinib at a dose of 0.5 mg (P = 0.76), 3 mg (P = 0.01), 10 mg (P < 0.001), and 15 mg (P < 0.001), respectively, as compared with 10% of patients receiving placebo. There was a dose-dependent increase in both low-density and high-density lipoprotein cholesterol. Three patients treated with tofacitinib had an absolute neutrophil count of less than 1500. Conclusions Patients with moderately to severely active ulcerative colitis treated with tofacitinib were more likely to have clinical response and remission than those receiving placebo. (Funded by Pfizer; ClinicalTrials.gov number, NCT00787202.)	[Sandborn, William J.] Univ Calif San Diego, Div Gastroenterol, La Jolla, CA 92093 USA; [Ghosh, Subrata] Univ Calgary, Calgary, AB, Canada; [Panes, Julian] Hosp Clin Barcelona, Inst Invest Biomed August Pi & Sunyer, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain; [Vranic, Ivana; Rousell, Samantha] Pfizer Ltd, Sandwich CT13 9NJ, Kent, England	University of California System; University of California San Diego; University of Calgary; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Pfizer	Sandborn, WJ (corresponding author), Univ Calif San Diego, Div Gastroenterol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	wsandborn@ucsd.edu	Sandborn, William/ABE-8342-2020; Ghosh, Subrata/AAC-2676-2021; Panes, Julian/H-5991-2015	Ghosh, Subrata/0000-0002-1713-7797; Panes, Julian/0000-0002-4971-6902; Guardiola, Jordi/0000-0002-0464-241X	Pfizer	Pfizer(Pfizer)	Supported by Pfizer.; We thank the patients who were involved in this study; the A3921063 investigators and study team, including Bernita Davies, Kawleen Oberoi, and Jacqui Spanton; and Martin Goulding, Ph.D., at Complete Medical Communications for editorial support (funded by Pfizer).	Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X; Boy MG, 2009, J INVEST DERMATOL, V129, P2299, DOI 10.1038/jid.2009.25; Changelian PS, 2008, BLOOD, V111, P2155, DOI 10.1182/blood-2007-09-115030; Changelian PS, 2009, BLOOD, V114, P3132, DOI 10.1182/blood-2009-03-210922; Changelian PS, 2003, SCIENCE, V302, P875, DOI 10.1126/science.1087061; D'Haens G, 2007, GASTROENTEROLOGY, V132, P763, DOI 10.1053/j.gastro.2006.12.038; Flanagan ME, 2010, J MED CHEM, V53, P8468, DOI 10.1021/jm1004286; Fleischmann R, 2012, NEW ENGL J MED, V367, P495, DOI 10.1056/NEJMoa1109071; Ghoreschi K, 2011, J IMMUNOL, V186, P4234, DOI 10.4049/jimmunol.1003668; IRVINE EJ, 1994, GASTROENTEROLOGY, V106, P287, DOI 10.1016/0016-5085(94)90585-1; Kornbluth A, 2010, AM J GASTROENTEROL, V105, P500, DOI 10.1038/ajg.2010.52; Kremer JM, 2009, ARTHRITIS RHEUM-US, V60, P1895, DOI 10.1002/art.24567; LANGHOLZ E, 1994, GASTROENTEROLOGY, V107, P3, DOI 10.1016/0016-5085(94)90054-X; Lichtenstein GR, 2006, GASTROENTEROLOGY, V130, P940, DOI 10.1053/j.gastro.2006.01.048; Meyer DM, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-41; Papp K, BR J DERMAT IN PRESS; Reinisch W, 2011, GUT, V60, P780, DOI 10.1136/gut.2010.221127; Rutgeerts P, 2006, NEW ENGL J MED, V354, P2200; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Sandborn WJ, 2011, GASTROENTEROLOGY, V140, pS124; SCHROEDER KW, 1987, NEW ENGL J MED, V317, P1625, DOI 10.1056/NEJM198712243172603; Sewgobind VDKD, 2010, AM J TRANSPLANT, V10, P1785, DOI 10.1111/j.1600-6143.2010.03200.x; Tanaka Y, 2011, ARTHRIT CARE RES, V63, P1150, DOI 10.1002/acr.20494; Travis SPL, 2008, J CROHNS COLITIS, V2, P24, DOI 10.1016/j.crohns.2007.11.002; van Vollenhoven RF, 2012, NEW ENGL J MED, V367, P508, DOI 10.1056/NEJMoa1112072; Vincenti F, 2012, AM J TRANSPLANT	27	533	569	2	35	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 16	2012	367	7					616	624		10.1056/NEJMoa1112168	http://dx.doi.org/10.1056/NEJMoa1112168			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988NB	22894574	Green Submitted, Green Published			2022-12-28	WOS:000307496600005
J	Franco, SJ; Gil-Sanz, C; Martinez-Garay, I; Espinosa, A; Harkins-Perry, SR; Ramos, C; Muller, U				Franco, Santos J.; Gil-Sanz, Cristina; Martinez-Garay, Isabel; Espinosa, Ana; Harkins-Perry, Sarah R.; Ramos, Cynthia; Mueller, Ulrich			Fate-Restricted Neural Progenitors in the Mammalian Cerebral Cortex	SCIENCE			English	Article							INTERMEDIATE PROGENITORS; LAMINAR FATE; STEM-CELLS; NEOCORTEX; NEURONS; MOUSE; CRE; RECOMBINATION; SPECIFICATION; EXPRESSION	During development of the mammalian cerebral cortex, radial glial cells (RGCs) generate layer-specific subtypes of excitatory neurons in a defined temporal sequence, in which lower-layer neurons are formed before upper-layer neurons. It has been proposed that neuronal subtype fate is determined by birthdate through progressive restriction of the neurogenic potential of a common RGC progenitor. Here, we demonstrate that the murine cerebral cortex contains RGC sublineages with distinct fate potentials. Using in vivo genetic fate mapping and in vitro clonal analysis, we identified an RGC lineage that is intrinsically specified to generate only upper-layer neurons, independently of niche and birthdate. Because upper cortical layers were expanded during primate evolution, amplification of this RGC pool may have facilitated human brain evolution.	[Mueller, Ulrich] Scripps Res Inst, Dorris Neurosci Ctr, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Muller, U (corresponding author), Scripps Res Inst, Dorris Neurosci Ctr, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	umueller@scripps.edu	Garay, Isabel Martinez/AAI-8951-2021; Franco, Santos/V-3413-2019; Gil-Sanz, Cristina/AAX-3558-2021; Gil-Sanz, Cristina/K-9859-2017; Espinosa Martínez, Ana Belén/AAD-4487-2021	Garay, Isabel Martinez/0000-0001-6849-7496; Franco, Santos/0000-0002-4478-5634; Gil-Sanz, Cristina/0000-0002-7827-5480; Gil-Sanz, Cristina/0000-0002-7827-5480; Espinosa Martínez, Ana Belén/0000-0002-3738-3514	NIH [NS060355, NS046456, MH078833]; Generalitat Valenciana [APOSTD/2010/064]; Ministerio de Educacion [EX2009-0416, FU-2006-1238]; CIRM; Skaggs Institute for Chemical Biology; Dorris Neuroscience Center; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH078833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS060355, R01NS046456] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Ministerio de Educacion; CIRM(California Institute for Regenerative Medicine); Skaggs Institute for Chemical Biology; Dorris Neuroscience Center; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank G. Fishell for Nestin-CreERT2 mice; H. Zeng for Ai9 reporter mice; P. Chambon for pCreERT2; A. Maximov for the FLEx backbone; T. Wagner, S. Courtes, and P. Kazmierczak for experiments that did not appear in the final manuscript; and F. Polleux, E. Grove, N. Grillet, and S. Courtes for critical comments. This work was supported by the NIH (S.J.F., NS060355; U. M., NS046456 and MH078833), Generalitat Valenciana (C.G.-S., APOSTD/2010/064), Ministerio de Educacion (C.G.-S., EX2009-0416; I. M.-G., FU-2006-1238), CIRM training grant (I. M.-G. and A. E.), the Skaggs Institute for Chemical Biology (U. M.), and the Dorris Neuroscience Center (U. M.). S.J.F., I. M.-G., C.G.-S., and U. M. conceived the project; S.J.F., C.G.-S., I. M.-G., and A. E. designed, performed, and analyzed experiments with assistance from S. R. H.-P. and C. R.; and S.J.F. and U. M. prepared the manuscript, with revisions from C.G.-S., I. M.-G., and A.E.	Alcamo EA, 2008, NEURON, V57, P364, DOI 10.1016/j.neuron.2007.12.012; Balordi F, 2007, J NEUROSCI, V27, P14248, DOI 10.1523/JNEUROSCI.4531-07.2007; Britanova O, 2008, NEURON, V57, P378, DOI 10.1016/j.neuron.2007.12.028; Costa MR, 2009, CEREB CORTEX, V19, pI135, DOI 10.1093/cercor/bhp046; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Franco SJ, 2011, NEURON, V69, P482, DOI 10.1016/j.neuron.2011.01.003; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hevner RF, 2003, DEV NEUROSCI-BASEL, V25, P139, DOI 10.1159/000072263; Kowalczyk T, 2009, CEREB CORTEX, V19, P2439, DOI 10.1093/cercor/bhn260; Leone DP, 2008, CURR OPIN NEUROBIOL, V18, P28, DOI 10.1016/j.conb.2008.05.006; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322; Schnutgen F, 2003, NAT BIOTECHNOL, V21, P562, DOI 10.1038/nbt811; Takahashi T, 1999, J NEUROSCI, V19, P10357; Woodhead GJ, 2006, J NEUROSCI, V26, P12620, DOI 10.1523/JNEUROSCI.3180-06.2006; Yoon KJ, 2008, NEURON, V58, P519, DOI 10.1016/j.neuron.2008.03.018; Zervas M, 2004, NEURON, V43, P345, DOI 10.1016/j.neuron.2004.07.010; Zimmer C, 2004, CEREB CORTEX, V14, P1408, DOI 10.1093/cercor/bhh102	20	213	214	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2012	337	6095					746	749		10.1126/science.1223616	http://dx.doi.org/10.1126/science.1223616			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986PE	22879516	Green Accepted			2022-12-28	WOS:000307354500058
J	Patel, K				Patel, Kinesh			Profit is not a dirty word	BRITISH MEDICAL JOURNAL			English	Editorial Material												kinesh_patel@yahoo.co.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 8	2012	345								e5376	10.1136/bmj.e5376	http://dx.doi.org/10.1136/bmj.e5376			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988ND	22875960				2022-12-28	WOS:000307496800011
J	Howitt, P; Darzi, A; Yang, GZ; Ashrafian, H; Atun, R; Barlow, J; Blakemore, A; Bull, AMJ; Car, J; Conteh, L; Cooke, GS; Ford, N; Gregson, SAJ; Kerr, K; King, D; Kulendran, M; Malkin, RA; Majeed, A; Matlin, S; Merrifield, R; Penfold, HA; Reid, SD; Smith, PC; Stevens, MM; Templeton, MR; Vincent, C; Wilson, E				Howitt, Peter; Darzi, Ara; Yang, Guang-Zhong; Ashrafian, Hutan; Atun, Rifat; Barlow, James; Blakemore, Alex; Bull, Anthony M. J.; Car, Josip; Conteh, Lesong; Cooke, Graham S.; Ford, Nathan; Gregson, Simon A. J.; Kerr, Karen; King, Dominic; Kulendran, Myutan; Malkin, Robert A.; Majeed, Azeem; Matlin, Stephen; Merrifield, Robert; Penfold, Hugh A.; Reid, Steven D.; Smith, Peter C.; Stevens, Molly M.; Templeton, Michael R.; Vincent, Charles; Wilson, Elizabeth			Technologies for global health	LANCET			English	Review							LOW-INCOME; GUIDELINE IMPLEMENTATION; MALARIA MORTALITY; CARE TECHNOLOGIES; MENTAL-HEALTH; LOW-RESOURCE; CANCER; COUNTRIES; TUBERCULOSIS; PREVENTION		[Howitt, Peter; Darzi, Ara; Yang, Guang-Zhong; Conteh, Lesong; Kerr, Karen; Matlin, Stephen; Merrifield, Robert] Univ London Imperial Coll Sci Technol & Med, Inst Global Hlth Innovat, London, England; [Wilson, Elizabeth] Univ London Imperial Coll Sci Technol & Med, Ctr Environm Policy, London, England; [King, Dominic; Kulendran, Myutan; Smith, Peter C.] Univ London Imperial Coll Sci Technol & Med, Ctr Hlth Policy, London, England; [Bull, Anthony M. J.; Malkin, Robert A.; Stevens, Molly M.] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England; [Templeton, Michael R.] Univ London Imperial Coll Sci Technol & Med, Dept Civil & Environm Engn, London, England; [Cooke, Graham S.; Ford, Nathan; Reid, Steven D.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis, London, England; [Gregson, Simon A. J.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Stevens, Molly M.] Univ London Imperial Coll Sci Technol & Med, Dept Mat, London, England; [Blakemore, Alex] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Majeed, Azeem] Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London, England; [Ashrafian, Hutan; Vincent, Charles] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England; [Atun, Rifat] Univ London Imperial Coll Sci Technol & Med, Fac Med, London, England; [Car, Josip] Univ London Imperial Coll Sci Technol & Med, Global EHlth Unit, London, England; [Atun, Rifat; Barlow, James] Univ London Imperial Coll Sci Technol & Med, Imperial Coll Business Sch, London, England; [Penfold, Hugh A.] Univ London Imperial Coll Sci Technol & Med, Imperial Innovat, London, England	Imperial College London; Imperial College London; Imperial College London; Imperial College London; Imperial College London; Imperial College London; Imperial College London; Imperial College London; Imperial College London; Imperial College London; Imperial College London; Imperial College London; Imperial College London; Imperial College London; Imperial College London	Howitt, P (corresponding author), St Marys Hosp, QEQM, Praed St, London W2 1NY, England.	p.howitt@imperial.ac.uk	Bull, Anthony M J/C-2317-2008; Car, Josip/H-6755-2015; Blakemore, Alexandra I F/D-2253-2009; Atun, Rifat/AAH-5537-2021; Greaves, Felix/A-1324-2012; Conteh, Lesong/ABE-9550-2020; Vincent, Charles A/D-1134-2010	Bull, Anthony M J/0000-0002-4473-8264; Car, Josip/0000-0001-8969-371X; Blakemore, Alexandra I F/0000-0003-0661-564X; Greaves, Felix/0000-0001-9393-3122; Conteh, Lesong/0000-0002-0719-3672; Vincent, Charles A/0000-0003-0270-0222; Smith, Peter/0000-0003-0058-7588; Majeed, Azeem/0000-0002-2357-9858; Gregson, Simon/0000-0003-2707-0714; Atun, Rifat/0000-0002-1531-5983; Reid, Steven/0000-0002-8585-4894; Barlow, James/0000-0003-4984-0126; Cooke, Graham/0000-0001-6475-5056	EPSRC [EP/I029788/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I029788/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Abdel-Kader H, 2011, BUSINESS WIRE   0523; Adeyi O, 2010, LANCET, V376, P1869, DOI 10.1016/S0140-6736(10)61189-0; Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Akachi Y, 2012, J INFECT DIS, V205, pS284, DOI 10.1093/infdis/jis189; Akachi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021309; Allegranzi B, 2009, AM J INFECT CONTROL, V37, P28, DOI 10.1016/j.ajic.2008.01.014; Amadi HO, 2007, ANN TROP PAEDIATR, V27, P207, DOI 10.1179/146532807X220325; Amadi HO, 2010, INT J PEDIAT, V2010, DOI 10.1155/2010/269293; Anand G., 2009, WALL STREET J 1125; Anderson BO, 2011, LANCET ONCOL, V12, P387, DOI 10.1016/S1470-2045(11)70031-6; [Anonymous], 2010, LANCET, V376, P1799, DOI 10.1016/S0140-6736(10)62148-4; [Anonymous], 2012, 8 GOALS 2015; [Anonymous], 2003, CHILD FAM WELLN SHOP; [Anonymous], 2011, PUBL PRIV PARTN DEV; [Anonymous], 2011, INNOVATING EVERY WOM; [Anonymous], 2010, 1 WHO REP NEGL TROP; [Anonymous], 2005, GOING GROWTH SCI TEC; [Anonymous], 2005, PREV CHRON DIS VIT I; [Anonymous], 2002, J ISLAMIC FIQH COUNC, V13; [Anonymous], 2012, MAGNETIC RESONANCE P; [Anonymous], 2009, ECONOMIST; Antillon F, 2005, PEDIATR BLOOD CANCER, V45, P107, DOI 10.1002/pbc.20280; Apple J, 2010, INDOOR AIR, V20, P399, DOI 10.1111/j.1600-0668.2010.00664.x; Ashraf H, TREATMENT CHILDHOOD; Attaran A, 2004, HEALTH AFFAIR, V23, P155, DOI 10.1377/hlthaff.23.3.155; Atun R, 2010, HEALTH POLICY PLANN, V25, P104, DOI 10.1093/heapol/czp055; AVERT, 2011, RED PRIC HIV AIDS TR; Barlow J, 2011, J HEALTH SERV RES PO, V16, P129, DOI 10.1258/jhsrp.2011.011018; Barone MA, 2011, JAIDS-J ACQ IMM DEF, V57, pE7, DOI 10.1097/QAI.0b013e3182158967; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Bill & Melinda Gates Foundation, 2012, PROF PROGR GHAN; Bines JE, 2005, CURR OPIN GASTROEN, V21, P20; Bloom DE, 2011, ADV EXP MED BIOL, V697, P1, DOI 10.1007/978-1-4419-7185-2_1; Bloom Gerald, 2010, SCALING PATHWAYS UNI; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Cabinet Office, 2010, APPL BEH INS HLTH; Cabinet Office and Institute for Government MINDSPACE, 2010, MINDSPACE INFL BEH P; Calmy A, 2004, AIDS, V18, P2353; Center for Global Development, 2007, MILL SAV PROV SUCC G; Cernuschi TF, 2011, GAVI ALLIANCE WHITE; Chandisarewa W, 2007, B WORLD HEALTH ORGAN, V85, P843, DOI 10.2471/BLT.06.035188; Chassin MR, 1998, MILBANK Q, V76, P565, DOI 10.1111/1468-0009.00106; Chirac P, 2006, LANCET, V367, P1560, DOI 10.1016/S0140-6736(06)68672-8; Christensen C, 2009, INNOVATORS PRESCRIPT; Christensen C.M., 2000, HARVARD BUSINESS REV; Chung JW, 2009, JAMA-J AM MED ASSOC, V302, P1970, DOI 10.1001/jama.2009.1610; Cohen D, 2012, RESCUSITATION; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Concept Foundation, 2009, ACC HORM CONTR; Conway G., 2010, SCI INNOVATION DEV; Coughlin SS, 2009, CANCER EPIDEMIOL, V33, P315, DOI 10.1016/j.canep.2009.10.003; Creek TL, 2007, JAIDS-J ACQ IMM DEF, V45, P102, DOI 10.1097/QAI.0b013e318047df88; Crisp Nigel., 2010, TURNING WORLD UPSIDE; CUTLER DM, 2001, HEALTH AFFAIR, V20, P11; Dass R, 2011, INT J USER DRIVEN HL, V1, P42; De Jong R, 2011, HLTH CARE CHRONICLES; DeCock KM, 2009, WHO 2009 HIV AIDS IM; Denny L, 2006, VACCINE, V24, P71, DOI 10.1016/j.vaccine.2006.05.121; Development Media International, 2012, MASS MED CAN SAV MIL; Draper BH, 2006, COCHRANE DB SYST REV, V3; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Eisele TP, 2010, INT J EPIDEMIOL, V39, P88, DOI 10.1093/ije/dyq026; Engineering World Health, 2011, ENG WORLD HLTH PROJE; Engineering World Health, 2011, BMET TRAIN RWAND; Eniu A, 2008, CANCER-AM CANCER SOC, V113, P2269, DOI 10.1002/cncr.23843; Esrey C, 2000, WATER SANITATION HLT; Foroushani PS, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-131; Foundation for Innovative New Diagnostics, 2010, FIND NEG PRIC XPERT; Free C, 2011, LANCET, V378, P49, DOI 10.1016/S0140-6736(11)60701-0; Free MJ, 2004, INT J GYNECOL OBSTET, V85, pS3, DOI 10.1016/j.ijgo.2004.01.009; Frew SE, 2009, HEALTH AFFAIR, V28, P1760, DOI 10.1377/hlthaff.28.6.1760; Fry C, 2011, HLTH INNOVATION TRAN; Gates B, 2012, COMMUNICATION   0905; Gatt B, 2011, BLOOMBERG       0606; GAVI Alliance, 2012, PNEUM AMC INN FIN ME; General Assembly, 2011, PREV CONTR NONC DIS; General Electric Company, 2007, MAC 400 REST ECG AN; Glaziou P, 2011, B WORLD HEALTH ORGAN, V89, P573, DOI 10.2471/BLT.11.087510; Godlee F, 2004, LANCET, V364, P295, DOI 10.1016/S0140-6736(04)16681-6; Goemaere E, 2004, HEALTH AFFAIR, V23, P279, DOI 10.1377/hlthaff.23.5.279-a; Gold ER, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000208; Goodman CS, 2014, HTA 101 INTRO HLTH T; Grace C., 2009, GLOBAL FORUM UPDATE, V6, P147; Grand Challenges in Global Health, 2012, GRAND CHALL GLOB HLT; Gyekye K, 1995, PHILOS TECHNOLOGY; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; Hazin R, 2010, LANCET ONCOL, V11, P204, DOI 10.1016/S1470-2045(09)70288-8; Hill A, 2011, GLAXOSMITHKLINE MERC; Hoaglin M, 2006, INTEGRATED DIGITAL X; Hofman JJ, 2008, INT J GYNECOL OBSTET, V102, P191, DOI 10.1016/j.ijgo.2008.04.001; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; Howie SR, 2008, B WORLD HEALTH ORGAN, V86, P52, DOI 10.2471/BLT.07.042994; Institute E, 2009, TOP 10 HOSP TECHN C; International Aids Vaccine Initiative, EST IMP AIDS VACC DE; International Energy Agency, 2011, ACC EL; International Vaccine Access Centre, 2011, PNEUM PROGR REP INT; Internet World Stats, 2011, INT US STAT AFR; Jennings M, 2011, BEDNET PRODUCTIN TAN; Juma C, 2005, WE NEED REINVENT AFR; JustMilk, 2012, COMB MOTH TO CHILD H; Kaltenthaler E, 2008, BRIT J PSYCHIAT, V193, P181, DOI 10.1192/bjp.bp.106.025981; Kannan S, 2011, COUNTERFEIT DRUGS TA; Kazatchkine M, 2009, GLOBAL FORUM UPDATE, V6, P138; Khambete N, 2011, COMMUNICATION   0905; Kickbusch I, 2007, B WORLD HEALTH ORGAN, V85, P230, DOI 10.2471/BLT.06.039222; Kwankem Y, 2001, WHO SERIES; LaForce FM, 2009, VACCINE, V27, pB13, DOI 10.1016/j.vaccine.2009.04.062; Lengeler C, 2007, LANCET, V370, P1009, DOI 10.1016/S0140-6736(07)61454-8; Lister M, 2004, INDIAN J PRACTISING, V1, P69; Lonn E, 2010, CIRCULATION, V122, P2078, DOI 10.1161/CIRCULATIONAHA.109.873232; Madala J, 2012, NET WORKS; Malkin RA, 2007, ANNU REV BIOMED ENG, V9, P567, DOI 10.1146/annurev.bioeng.9.060906.151913; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Matlin SA, 2009, LANCET, V374, P1662, DOI 10.1016/S0140-6736(09)61912-7; Medical Device and Diagnostic Industry, 2010, MAN MED DEV CONF CHI; Medicines and Healthcare products Regulatory Agency (MHRA), 2012, COUNT MED DEV; MEDIKits, 2011, MEDIKITS; Microensure: Health Insurance, 2011, HLTH INS; Mitcham C., 1994, THINKING TECHNOLOGY, DOI [10.7208/chicago/9780226825397.001.0001, DOI 10.7208/CHICAGO/9780226825397.001.0001]; Mittra I, 2011, PREV MED, V53, P121, DOI 10.1016/j.ypmed.2011.06.010; mobiThinking, GLOB MOB STAT 2012; Mullan F, 2007, LANCET, V370, P2158, DOI 10.1016/S0140-6736(07)60785-5; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Naeem F, 2010, INT J MENT HEALTH SY, V4, DOI 10.1186/1752-4458-4-2; Nantulya VM, 2002, BRIT MED J, V324, P1139, DOI 10.1136/bmj.324.7346.1139; Nestel P, 2006, J NUTR, V136, P1064, DOI 10.1093/jn/136.4.1064; Ng'ang'a PN, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-64; Niessen L, 2009, B WORLD HEALTH ORGAN, V87, P472, DOI 10.2471/BLT.08.050872; O'Neill B, 2002, BRIT MED J, V324, P1142, DOI 10.1136/bmj.324.7346.1142; OECD, 2011, OECD HLTH DAT FREQ R; Parati G, 2010, HYPERTENSION, V56, P1047, DOI 10.1161/HYPERTENSIONAHA.110.160408; Patel V, 2007, LANCET, V370, P991, DOI 10.1016/S0140-6736(07)61240-9; Perry L, 2011, MED BIOL ENG COMPUT, V49, P719, DOI 10.1007/s11517-011-0786-3; Pierce NF, 2001, J HEALTH POPUL NUTR, V19, P1; Polisena J., 2018, HLTH TECHNOLOGY ASSE; Prahalad C. K., 2006, STRATEGY BUSINESS, V44; Prahalad C. K., 2010, WHART SCH PUB; Predicting Future Demands for Radiotherapy, 2007, PRED FUT DEM RAD REP; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Program for Appropriate Technology in Health, 2011, RAD SIMPL UN INJ SYS; Program for Appropriate Technology in Health, 2011, INCR CONTR OPT PROV; QIAGEN Group, 2009, CAREHPVTM TEST; Rabbani F, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-31; Rabkin M, 2010, JAIDS-J ACQ IMM DEF, V55, pS141, DOI 10.1097/QAI.0b013e3181fbcb76; Rahimy MC, 2009, J CLIN PATHOL, V62, P46, DOI 10.1136/jcp.2008.059113; Rangan K, 1993, HARVARD BUSINESS REV; Republic of Kenya Ministry of Health, 2003, ASS PHARM SIT KEN BA; Resch S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025310; Reyburn H, 2007, BRIT MED J, V334, P403, DOI 10.1136/bmj.39073.496829.AE; Rice X, 2007, GUARDIAN        0529; Ridley DB, 2006, HEALTH AFFAIR, V25, P313, DOI 10.1377/hlthaff.25.2.313; Rodgers A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019857; Roll Back Malaria Partnership, 2011, PROGR IMP SER DEC PA; Royal Brompton and Harefield NHS Foundation Trust Neonatal Incubator Appeal, 2010, ROYAL BROMPTON HAREF; RUXIN JN, 1994, MED HIST, V38, P363, DOI 10.1017/S0025727300036905; Sachs JD, 2009, SCI AM, V301, P29, DOI 10.1038/scientificamerican0809-38; Sanchez-Padilla E, 2009, LANCET INFECT DIS, V9, P567, DOI 10.1016/S1473-3099(09)70179-3; Sanitation Ventures, 2011, PROJ TIG; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Sanofi-Aventis, 2011, DRUG COUNT; Santa Clara University, 2011, FIL COR COMP; Scudellari M, 2011, NAT MED, V17, P139, DOI 10.1038/nm0211-139; Sehgal V., 2010, STRATEGY BUSINESS, V59, P1; Sequist TD, 2006, ARCH INTERN MED, V166, P2237, DOI 10.1001/archinte.166.20.2237; Shelton JD, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7023; Shulman LN, 2010, J ONCOL, V2010, DOI 10.1155/2010/595167; Shyyan R, 2008, CANCER-AM CANCER SOC, V113, P2257, DOI 10.1002/cncr.23840; Simiyu K, 2010, SCIENCE, V330, P1483, DOI 10.1126/science.1195401; SIMONETTI R, 1995, SCIENTOMETRICS, V32, P77, DOI 10.1007/BF02020190; Simonsen L, 2005, J INFECT DIS, V192, pS36, DOI 10.1086/431512; Smith S, 2009, HEALTH AFFAIR, V28, P1276, DOI 10.1377/hlthaff.28.5.1276; Spector JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035151; Taskforce on Innovative International Financing for Health Systems, 2009, INT FIN HLTH SYST MO; Tediosi F, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-127; The American National Redcross, 2009, AM NAT REDCR; The Medicines Transparency Alliance Zambia, 2010, DISCL STAT PHARM SEC; The Royal Society, 2011, TANZ SCI WINS ROYAL; Thomson J, 2010, SCI SOC; Thye YP, 2011, CRIT REV ENV SCI TEC, V41, P1793, DOI 10.1080/10643389.2010.481593; Tran J, 2007, NEXT BILLION DEV ENT; UN, 2001, HUM DEV REP 2001 MAK; UN, 2011, MILL DEV GOAL REP UN; UN, 2011, MILL DEV GOALS REP A; UNAIDS WHO and UNDP, 2011, US TRIPS FLEX IMPR A; UNICEF, 2012, PROGR DRINK WAT SAN; Urdea Mickey, 2006, Nature, V444 Suppl 1, P73, DOI 10.1038/nature05448; US Office of Health and Consumer Goods, 2010, MED DEV IND ASS; USAID, 2011, USAID REQ APPL TECHN; Voltaire, 1772, BEGUEULE; Waage J, 2010, LANCET, V376, P991, DOI 10.1016/S0140-6736(10)61196-8; Walensky RP, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000382; Waning B, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-35; Wardlaw JM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000213.pub2; Weinberg J, 2009, PAN AFR MED J, V3; WHITIA, 2009, ESS HLTH TECHN SAF N; WHO, 2009, MAKING PREGNANCY SAF, V7, P3; WHO, 2005, WHO DRUG INFORM, V19, P236; WHO, 2012, SAF CHILDB CHECKL WH; WHO, 2006, REC PREV POSTP HAEM; WHO, 2011, REP CONS EXP WORK GO; WHO, 2008, INF CONS CLIN USE OX; WHO, 2010, MED DEV MAN MISM OUT; WHO, 2011, COMP NEW EM HLTH TEC; *WHO, WORLD HLTH REP 1999; WHO, 1991, WHO TEST SCHED OX CO; WHO, 2011, WHO GUID US CRYOTH C; WHO, 2006, PUBL HLTH INN INT PR; WHO, 2012, SHAR EHEALTH INT PRO; WHO, 2010, INN TECHN ADD GLOB H; WHO, WORLD MAL REP WHO; WHO, 1995, OX THER MAN CHILD AC; WHO, 2000, WHO GUID HLTH CAR EQ; WHO, 2009, NEW HIV REC IMPR HLT; WHO. HINARI, 2012, HINARI; Wilson P., 2010, GIVING DEV COUNTRIES; World Bank, 2012, WORLD BANK SEES PROG; World Health Organization, GLOB PRIC REP MECH H; World Health Organization, WORLD HLTH STAT 2009; World Health Organization, 2009, WHO GUID HAND HYG HL; World Health Organization, 2012, SPUR FALS LAB FALS C; World Health Organization, 2008, 1 INT CONS M; World Health Organization, 2008, GLOB BURD DIS 2004 U; World Health Organization, 2016, MHGAP INT GUID MENT; World Health Organization, 2010, LANDSC AN BARR DEV A; World Health Organization, GLOB HIV AIDS RESP E; World Health Organization, 2012, REP CONS EXP WORK GR; World Health Organization, 2009, GLOB STAT REP ROAD S; World Health Organization, 2008, REP GLOB TOB EP MPOW; World Health Organization, 2009, GLOBAL OBSERVATORY E; World Health Organization, 2010, SICKL CELL DIS STRAT; World Health Organization, 2011, WHO PROGRESS REPORT; World Health Organization (WHO), 2010, MENT HLTH DEV TARG P; World Health Organization (WHO), 2011, POL DECL HIGH LEV M; Yamey G, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001049; Zachariah R, 2011, TROP MED INT HEALTH, V16, P37, DOI 10.1111/j.1365-3156.2010.02669.x; Zeschky M, 2011, RES TECHNOL MANAGE, V54, P38, DOI 10.5437/08956308X5404007	237	205	211	2	79	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 4	2012	380	9840					507	535		10.1016/S0140-6736(12)61127-1	http://dx.doi.org/10.1016/S0140-6736(12)61127-1			29	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	983GY	22857974				2022-12-28	WOS:000307109000033
J	Koren, O; Goodrich, JK; Cullender, TC; Spor, A; Laitinen, K; Backhed, HK; Gonzalez, A; Werner, JJ; Angenent, LT; Knight, R; Backhed, F; Isolauri, E; Salminen, S; Ley, RE				Koren, Omry; Goodrich, Julia K.; Cullender, Tyler C.; Spor, Ayme; Laitinen, Kirsi; Backhed, Helene Kling; Gonzalez, Antonio; Werner, Jeffrey J.; Angenent, Largus T.; Knight, Rob; Backhed, Fredrik; Isolauri, Erika; Salminen, Seppo; Ley, Ruth E.			Host Remodeling of the Gut Microbiome and Metabolic Changes during Pregnancy	CELL			English	Article							MATERNAL METABOLISM; INSULIN-RESISTANCE; OBESITY; ASSOCIATIONS; INFLAMMATION; MECHANISMS; CYTOKINES; WEIGHT; DIET	Many of the immune and metabolic changes occurring during normal pregnancy also describe metabolic syndrome. Gut microbiota can cause symptoms of metabolic syndrome in nonpregnant hosts. Here, to explore their role in pregnancy, we characterized fecal bacteria of 91 pregnant women of varying prepregnancy BMIs and gestational diabetes status and their infants. Similarities between infant-mother microbiotas increased with children's age, and the infant microbiota was unaffected by mother's health status. Gut microbiota changed dramatically from first (T1) to third (T3) trimesters, with vast expansion of diversity between mothers, an overall increase in Proteobacteria and Actinobacteria, and reduced richness. T3 stool showed strongest signs of inflammation and energy loss; however, microbiome gene repertoires were constant between trimesters. When transferred to germ-free mice, T3 microbiota induced greater adiposity and insulin insensitivity compared to T1. Our findings indicate that host-microbial interactions that impact host metabolism can occur and may be beneficial in pregnancy.	[Koren, Omry; Goodrich, Julia K.; Cullender, Tyler C.; Spor, Ayme; Ley, Ruth E.] Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA; [Koren, Omry; Goodrich, Julia K.; Cullender, Tyler C.; Spor, Ayme; Ley, Ruth E.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Werner, Jeffrey J.; Angenent, Largus T.] Cornell Univ, Dept Biol & Environm Engn, Ithaca, NY 14853 USA; [Laitinen, Kirsi] Univ Turku, Inst Biomed, Turku 20610, Finland; [Laitinen, Kirsi; Salminen, Seppo] Univ Turku, Funct Foods Forum, Turku 20610, Finland; [Isolauri, Erika] Turku Univ Hosp, Dept Pediat, Turku 20521, Finland; [Backhed, Helene Kling; Backhed, Fredrik] Sahlgrenska Ctr Cardiovasc & Metab Res, Wallenberg Lab, SE-41345 Gothenburg, Sweden; [Backhed, Helene Kling; Backhed, Fredrik] Univ Gothenburg, Dept Mol & Clin Med, SE-40530 Gothenburg, Sweden; [Gonzalez, Antonio] Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA; [Knight, Rob] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Knight, Rob] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA	Cornell University; Cornell University; Cornell University; University of Turku; University of Turku; University of Turku; University of Gothenburg; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Ley, RE (corresponding author), Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA.	rel222@cornell.edu	Gonzalez, Antonio/A-6421-2018; Ley, Ruth E/M-8542-2014; Koren, Omry/A-5222-2016; Goodrich, Julia/ABD-8368-2021; Spor, Aymé/A-6271-2012; Knight, Rob/D-1299-2010; Backhed, Fredrik/ABE-6613-2020; Angenent, Largus T/A-6219-2018	Ley, Ruth E/0000-0002-9087-1672; Koren, Omry/0000-0002-7738-1337; Spor, Aymé/0000-0002-4707-9559; Backhed, Fredrik/0000-0002-4871-8818; Angenent, Largus T/0000-0003-0180-1865; Laitinen, Kirsi/0000-0001-5245-8118; Knight, Rob/0000-0002-0975-9019	Hartwell Foundation; NIH Human Microbiome Project DACC; David and Lucile Packard Foundation; Arnold and Mabel Beckman Foundation; Cornell Center for Comparative Population Genomics; Ragnar Soderberg Foundation; Paivikki and Sakari Sohlberg Foundation; Academy of Finland; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093595] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007444] Funding Source: NIH RePORTER	Hartwell Foundation; NIH Human Microbiome Project DACC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Arnold and Mabel Beckman Foundation; Cornell Center for Comparative Population Genomics; Ragnar Soderberg Foundation; Paivikki and Sakari Sohlberg Foundation; Academy of Finland(Academy of Finland); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Mary-Claire King, Andrew Clark, and Andrew Gewirtz for their contributions to the manuscript, and we thank Daniel McDonlad and Nick Scalfone for technical assistance. This research was supported by The Hartwell Foundation, the NIH Human Microbiome Project DACC, the David and Lucile Packard Foundation, the Arnold and Mabel Beckman Foundation, the Cornell Center for Comparative Population Genomics, the Ragnar Soderberg Foundation, the Paivikki and Sakari Sohlberg Foundation, and the Academy of Finland.	Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Barbour LA, 2007, DIABETES CARE, V30, pS112, DOI 10.2337/dc07-s202; Beigi RH, 2007, J INFECT DIS, V196, P1355, DOI 10.1086/521628; Caesar R, 2012, GUT; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Collado MC, 2010, AM J CLIN NUTR, V92, P1023, DOI 10.3945/ajcn.2010.29877; Carvalho FA, 2012, CELL HOST MICROBE; Collado MC, 2008, AM J CLIN NUTR, V88, P894, DOI 10.1093/ajcn/88.4.894; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Di Cianni G, 2003, DIABETES-METAB RES, V19, P259, DOI 10.1002/dmrr.390; Greenblum S, 2012, P NATL ACAD SCI USA, V109, P594, DOI 10.1073/pnas.1116053109; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132; Kirwan JP, 2002, DIABETES, V51, P2207, DOI 10.2337/diabetes.51.7.2207; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Kuczynski J, 2012, NAT REV GENET, V13, P47, DOI 10.1038/nrg3129; Lain KY, 2007, CLIN OBSTET GYNECOL, V50, P938, DOI 10.1097/GRF.0b013e31815a5494; Laitinen K, 2009, BRIT J NUTR, V101, P1679, DOI 10.1017/S0007114508111461; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Mor G, 2010, AM J REPROD IMMUNOL, V63, P425, DOI 10.1111/j.1600-0897.2010.00836.x; Mukhopadhya I, 2012, NAT REV GASTRO HEPAT, V9, P219, DOI 10.1038/nrgastro.2012.14; Nelson SM, 2010, HUM REPROD UPDATE, V16, P255, DOI 10.1093/humupd/dmp050; Newbern D, 2011, CURR OPIN ENDOCRINOL, V18, P409, DOI 10.1097/MED.0b013e32834c800d; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Saiki T, 1998, SCAND J GASTROENTERO, V33, P616; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Sim K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032543; Slack E, 2009, SCIENCE, V325, P617, DOI 10.1126/science.1172747; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Straka M, 2011, NEUROENDOCRINOL LETT, V32, P34; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; van Nimwegen FA, 2011, J ALLERGY CLIN IMMUN, V128, P948, DOI 10.1016/j.jaci.2011.07.027; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	46	1080	1180	19	355	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 3	2012	150	3					470	480		10.1016/j.cell.2012.07.008	http://dx.doi.org/10.1016/j.cell.2012.07.008			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	985WO	22863002	Green Accepted, Bronze			2022-12-28	WOS:000307301400008
J	Mehta, RS; Barlow, WE; Albain, KS; Vandenberg, TA; Dakhil, SR; Tirumali, NR; Lew, DL; Hayes, DF; Gralow, JR; Livingston, RB; Hortobagyi, GN				Mehta, Rita S.; Barlow, William E.; Albain, Kathy S.; Vandenberg, Ted A.; Dakhil, Shaker R.; Tirumali, Nagendra R.; Lew, Danika L.; Hayes, Daniel F.; Gralow, Julie R.; Livingston, Robert B.; Hortobagyi, Gabriel N.			Combination Anastrozole and Fulvestrant in Metastatic Breast Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FIRST-LINE THERAPY; POSTMENOPAUSAL WOMEN; PHASE-III; ENDOCRINE THERAPY; DOUBLE-BLIND; HORMONAL-THERAPY; RANDOMIZED-TRIAL; 1ST-LINE THERAPY; TAMOXIFEN; ANTIESTROGEN	Background The aromatase inhibitor anastrozole inhibits estrogen synthesis. Fulvestrant binds and accelerates degradation of estrogen receptors. We hypothesized that these two agents in combination might be more effective than anastrozole alone in patients with hormone-receptor (HR)-positive metastatic breast cancer. Methods Postmenopausal women with previously untreated metastatic disease were randomly assigned, in a 1: 1 ratio, to receive either 1 mg of anastrozole orally every day (group 1), with crossover to fulvestrant alone strongly encouraged if the disease progressed, or anastrozole and fulvestrant in combination (group 2). Patients were stratified according to prior or no prior receipt of adjuvant tamoxifen therapy. Fulvestrant was administered intramuscularly at a dose of 500 mg on day 1 and 250 mg on days 14 and 28 and monthly thereafter. The primary end point was progression-free survival, with overall survival designated as a prespecified secondary outcome. Results The median progression-free survival was 13.5 months in group 1 and 15.0 months in group 2 (hazard ratio for progression or death with combination therapy, 0.80; 95% confidence interval [CI], 0.68 to 0.94; P = 0.007 by the log-rank test). The combination therapy was generally more effective than anastrozole alone in all subgroups, with no significant interactions. Overall survival was also longer with combination therapy (median, 41.3 months in group 1 and 47.7 months in group 2; hazard ratio for death, 0.81; 95% CI, 0.65 to 1.00; P = 0.05 by the log-rank test), despite the fact that 41% of the patients in group 1 crossed over to fulvestrant after progression. Three deaths that were possibly associated with treatment occurred in group 2. The rates of grade 3 to 5 toxic effects did not differ significantly between the two groups. Conclusions The combination of anastrozole and fulvestrant was superior to anastrozole alone or sequential anastrozole and fulvestrant for the treatment of HR-positive metastatic breast cancer, despite the use of a dose of fulvestrant that was below the current standard. (Funded by the National Cancer Institute and AstraZeneca; SWOG ClinicalTrials.gov number, NCT00075764.)	[Mehta, Rita S.] Univ Calif Irvine, Med Ctr, Chao Family Comprehens Canc Ctr, Orange, CA 92868 USA; [Barlow, William E.; Lew, Danika L.] SWOG Stat Ctr, Seattle, WA USA; [Gralow, Julie R.] Seattle Canc Care Alliance, Puget Sound Canc Consortium, Seattle, WA USA; [Albain, Kathy S.] Loyola Univ Chicago, Stritch Sch Med, Maywood, IL USA; [Vandenberg, Ted A.] Natl Canc Inst Canada, Clin Trials Grp, London Hlth Sci Ctr, London, ON, Canada; [Dakhil, Shaker R.] Wichita Community Clin Oncol Program CCOP, Wichita, KS USA; [Tirumali, Nagendra R.] NW CCOP NW Permanente, Portland, OR USA; [Hayes, Daniel F.] Univ Michigan, Ann Arbor, MI 48109 USA; [Livingston, Robert B.] Univ Arizona, Arizona Canc Ctr, Tucson, AZ USA; [Hortobagyi, Gabriel N.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	University of California System; University of California Irvine; Southwest Oncology Group; Seattle Cancer Care Alliance; Loyola University Chicago; London Health Sciences Centre; Queens University - Canada; Canadian Cancer Trials Group; University of Michigan System; University of Michigan; Arizona Center Cancer Care; University of Arizona; University of Texas System; UTMD Anderson Cancer Center	Mehta, RS (corresponding author), Univ Calif Irvine, Med Ctr, Chao Family Comprehens Canc Ctr, 101 City Dr,Bldg 23, Orange, CA 92868 USA.	rsmehta@uci.edu	Hayes, Daniel/ABE-1129-2020		National Cancer Institute [CA32102, CA38926, CA35431, CA35281, CA20319, CA04919, CA67575, CA58861, CA37981, CA46368, CA86780, CA46282, CA63848, CA12644, CA27057, CA95860, CA35119, CA46441, CA11083, CA45450, CA35178]; AstraZeneca; NCI [CA13612, CA58882, CA45377, CA45807, CA58723, C14028, CA128567, CA63844, CA76447, CA58416, CA63850, CA76462, CA35262, CA77202, CCSRI155469]; NATIONAL CANCER INSTITUTE [U10CA037981, U10CA035261, P30CA062203, U10CA086780, U10CA004919, U10CA035090, U10CA058723, U10CA045808, U10CA011083, U10CA073590, U10CA063845, U10CA042777, U10CA035128, U10CA045807, U10CA046368, U10CA012644, U10CA035281, U10CA128567, UG1CA189808, U10CA035176, U10CA076447, U10CA077202, U10CA035119, U10CA035431, U10CA067575, U10CA016385, U10CA032102, U10CA063844, U10CA020319, U10CA038926, U10CA052654, U10CA058416, U10CA046282, U10CA063848, U10CA035178, U10CA045560, U10CA035192, U10CA035262, U10CA095860, U10CA022433, U10CA045450, U10CA027057, U10CA058882, U10CA058861, U10CA013612, U10CA045377, U10CA046441, U10CA063850] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); AstraZeneca(AstraZeneca); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by grants from the National Cancer Institute (CA32102, CA38926, CA35431, CA35281, CA20319, CA04919, CA67575, CA58861, CA37981, CA46368, CA86780, CA46282, CA63848, CA12644, CA27057, CA95860, CA35119, CA46441, CA11083, CA45450, CA35178, CA13612, CA58882, CA45377, CA45807, CA58723, C14028, CA128567, CA22433, CA52654, CA45560, CA35261, CA073590, CA45808, CA35192, CA42777, CA16385, CA35176, CA63845, CA35128, CA35090, CA63844, CA76447, CA58416, CA63850, CA76462, CA35262, CA77202, and CCSRI155469) and AstraZeneca.	Baum M, 2002, LANCET, V359, P2131; Baum M, 2002, LANCET, V360, P1520; Bergh J, 2012, J CLIN ONCOL, V30, P1919, DOI 10.1200/JCO.2011.38.1095; Bonneterre J, 2000, J CLIN ONCOL, V18, P3748, DOI 10.1200/JCO.2000.18.22.3748; Bonneterre J, 2001, CANCER, V92, P2247, DOI 10.1002/1097-0142(20011101)92:9<2247::AID-CNCR1570>3.0.CO;2-Y; Dawood S, 2010, ANN ONCOL, V21, P2169, DOI 10.1093/annonc/mdq220; Di Leo A, 2011, J CLIN ONCOL, V29, P2293, DOI 10.1200/JCO.2011.36.8522; Di Leo A, 2010, J CLIN ONCOL, V28, P4594, DOI 10.1200/JCO.2010.28.8415; Goss P, 2007, J CLIN ONCOL, V25, P4961, DOI 10.1200/JCO.2006.09.5455; Howell A, 2004, J CLIN ONCOL, V22, P1605, DOI 10.1200/JCO.2004.02.112; Howell A, 2002, J CLIN ONCOL, V20, P3396, DOI 10.1200/JCO.2002.10.057; INGLE JN, 1991, CANCER-AM CANCER SOC, V67, P886, DOI 10.1002/1097-0142(19910215)67:4<886::AID-CNCR2820670405>3.0.CO;2-O; INGLE JN, 1986, J CLIN ONCOL, V4, P958, DOI 10.1200/JCO.1986.4.6.958; Jelovac D, 2005, CANCER RES, V65, P5439, DOI 10.1158/0008-5472.CAN-04-2782; Macedo LF, 2008, CANCER RES, V68, P3516, DOI 10.1158/0008-5472.CAN-07-6807; Mauri D, 2006, JNCI-J NATL CANCER I, V98, P1285, DOI 10.1093/jnci/djj357; Mouridsen H, 2003, J CLIN ONCOL, V21, P2101, DOI 10.1200/JCO.2003.04.194; Nabholtz JM, 2000, J CLIN ONCOL, V18, P3758, DOI 10.1200/JCO.2000.18.22.3758; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Osborne CK, 2002, J CLIN ONCOL, V20, P3386, DOI 10.1200/JCO.2002.10.058; OSBORNE CK, 1995, J NATL CANCER I, V87, P746, DOI 10.1093/jnci/87.10.746; Paridaens RJ, 2008, J CLIN ONCOL, V26, P4883, DOI 10.1200/JCO.2007.14.4659; Robertson JF, 2001, CANCER RES, V61, P6739; Robertson JFR, 2009, J CLIN ONCOL, V27, P4530, DOI 10.1200/JCO.2008.21.1136; RUBENS RD, 1988, BRIT J CANCER, V58, P626, DOI 10.1038/bjc.1988.273; Rubens RD, 1985, P AN M AM SOC CLIN, V4, P53; Russell CA, 1997, J CLIN ONCOL, V15, P2494, DOI 10.1200/JCO.1997.15.7.2494; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; TORMEY DC, 1983, ANN INTERN MED, V98, P139, DOI 10.7326/0003-4819-98-2-139; Vergote I, 2012, J CLIN ONCOL, V30, P343, DOI 10.1200/JCO.2011.41.3302; WAKELING AE, 1991, CANCER RES, V51, P3867	31	284	302	1	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 2	2012	367	5					435	444		10.1056/NEJMoa1201622	http://dx.doi.org/10.1056/NEJMoa1201622			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	981VZ	22853014	Green Accepted, Bronze			2022-12-28	WOS:000307001900008
J	McAleer, MA; Flohr, C; Irvine, AD				McAleer, M. A.; Flohr, C.; Irvine, A. D.			Management of difficult and severe eczema in childhood	BMJ-BRITISH MEDICAL JOURNAL			English	Review							SEVERE ATOPIC ECZEMA; STAPHYLOCOCCUS-AUREUS; SYSTEMATIC REVIEWS; DOUBLE-BLIND; DERMATITIS; AZATHIOPRINE; METHOTREXATE; DISEASE; MECHANISMS		[McAleer, M. A.; Irvine, A. D.] Our Ladys Hosp Sick Children, Dept Paediat Dermatol, Dublin 12, Ireland; [Flohr, C.] Guys & St Thomas Hosp NHS Fdn Trust, St Johns Inst Dermatol, Dept Paediat Dermatol, London, England; [Flohr, C.] Kings Coll London, London WC2R 2LS, England; [Irvine, A. D.] Trinity Coll Dublin, Med Clin, Dublin, Ireland; [Irvine, A. D.] Natl Childrens Res Ctr, Dublin, Ireland	Our Ladys Children Hospital Crumlin; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; King's College London; Trinity College Dublin; National Children's Research Centre (NCRC); Trinity College Dublin	Irvine, AD (corresponding author), Our Ladys Hosp Sick Children, Dept Paediat Dermatol, Dublin 12, Ireland.	irvinea@tcd.ie	Irvine, Alan D/A-3982-2008	Irvine, Alan D/0000-0002-9048-2044				Bath-Hextall FJ, 2010, BRIT J DERMATOL, V163, P12, DOI 10.1111/j.1365-2133.2010.09743.x; Berth-Jones J, 2002, BRIT J DERMATOL, V147, P324, DOI 10.1046/j.1365-2133.2002.04989.x; Meduri NB, 2007, PHOTODERMATOL PHOTO, V23, P106, DOI 10.1111/j.1600-0781.2007.00291.x; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; BIRNIE AJ, 2008, COCHRANE DB SYST REV, V3; Carroll CL, 2005, PEDIATR DERMATOL, V22, P192, DOI 10.1111/j.1525-1470.2005.22303.x; Darsow U, 2010, J EUR ACAD DERMATOL, V24, P317, DOI 10.1111/j.1468-3083.2009.03415.x; Ersser SJ, 2007, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD004054.PUB2; Heller M, 2007, BRIT J DERMATOL, V157, P127, DOI 10.1111/j.1365-2133.2007.07947.x; Hoare C, 2000, Health Technol Assess, V4, P1; Huang JT, 2009, PEDIATRICS, V123, pE808, DOI 10.1542/peds.2008-2217; Irvine AD, 2011, NEW ENGL J MED, V365, P1315, DOI 10.1056/NEJMra1011040; Krakowski AC, 2008, PEDIATRICS, V122, P812, DOI 10.1542/peds.2007-2232; Lewis-Jones S, 2006, INT J CLIN PRACT, V60, P984, DOI 10.1111/j.1742-1241.2006.01047.x; Lewis-Jones S, 2007, ATOPIC ECZEMA CHILDR; Meggitt SJ, 2006, LANCET, V367, P839, DOI 10.1016/S0140-6736(06)68340-2; Roberts H, 2010, AUSTRALAS J DERMATOL, V51, P128, DOI 10.1111/j.1440-0960.2010.00634.x; Schmitt J, 2007, J EUR ACAD DERMATOL, V21, P606, DOI 10.1111/j.1468-3083.2006.02023.x; Schmitt J, 2011, BRIT J DERMATOL, V164, P415, DOI 10.1111/j.1365-2133.2010.10030.x; Schmitt J, 2007, J ALLERGY CLIN IMMUN, V120, P1389, DOI 10.1016/j.jaci.2007.08.011; Schmitt J, 2007, ACTA DERM-VENEREOL, V87, P100, DOI 10.2340/00015555-0207; Schram ME, 2011, J ALLERGY CLIN IMMUN, V128, P353, DOI 10.1016/j.jaci.2011.03.024; Shams K, 2011, CLIN EXP DERMATOL, V36, P573, DOI 10.1111/j.1365-2230.2011.04078.x; Staab D, 2006, BMJ-BRIT MED J, V332, P933, DOI 10.1136/bmj.332.7547.933; Waxweiler WT, 2011, PEDIATR DERMATOL, V28, P689, DOI 10.1111/j.1525-1470.2011.01488.x; Weatherhead SC, 2007, BRIT J DERMATOL, V156, P346, DOI 10.1111/j.1365-2133.2006.07686.x; Williams HC, 2008, CLIN EXP DERMATOL, V33, P685, DOI 10.1111/j.1365-2230.2008.02906.x; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P383, DOI 10.1111/j.1365-2133.1994.tb08530.x; Williams HC, 2009, CLIN EXP DERMATOL, V35, P12; Williams HC, 2007, BRIT MED J, V334, P1272, DOI 10.1136/bmj.39195.636319.80	30	31	32	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 23	2012	345								e4770	10.1136/bmj.e4770	http://dx.doi.org/10.1136/bmj.e4770			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	981UP	22826585	Green Submitted			2022-12-28	WOS:000306996800002
J	Liu, B; Du, HW; Rutkowski, R; Gartner, A; Wang, XC				Liu, Bin; Du, Hongwei; Rutkowski, Rachael; Gartner, Anton; Wang, Xiaochen			LAAT-1 Is the Lysosomal Lysine/Arginine Transporter That Maintains Amino Acid Homeostasis	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; C. ELEGANS; CYSTINE; PROTEIN; DEGRADATION; AUTOPHAGY; KINASE; FIBROBLASTS; ENDOCYTOSIS; REMOVAL	Defective catabolite export from lysosomes results in lysosomal storage diseases in humans. Mutations in the cystine transporter gene CTNS cause cystinosis, but other lysosomal amino acid transporters are poorly characterized at the molecular level. Here, we identified the Caenorhabditis elegans lysosomal lysine/arginine transporter LAAT-1. Loss of laat-1 caused accumulation of lysine and arginine in enlarged, degradation-defective lysosomes. In mutants of ctns-1 (C. elegans homolog of CTNS), LAAT-1 was required to reduce lysosomal cystine levels and suppress lysosome enlargement by cysteamine, a drug that alleviates cystinosis by converting cystine to a lysine analog. LAAT-1 also maintained availability of cytosolic lysine/arginine during embryogenesis. Thus, LAAT-1 is the lysosomal lysine/arginine transporter, which suggests a molecular explanation for how cysteamine alleviates a lysosomal storage disease.	[Liu, Bin; Du, Hongwei; Wang, Xiaochen] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Liu, Bin] Chinese Acad Med Sci, Grad Program, Beijing, Peoples R China; [Liu, Bin] Peking Union Med Coll, Beijing, Peoples R China; [Du, Hongwei] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol & Dev Biol, Beijing 100101, Peoples R China; [Du, Hongwei] Chinese Acad Sci, Grad Sch, Beijing 100039, Peoples R China; [Rutkowski, Rachael; Gartner, Anton] Univ Dundee, Coll Life Sci, Wellcome Trust Ctr Gene Regulat & Express, Dundee DD1 5EH, Scotland	National Institute of Biological Sciences, Beijing; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Dundee	Wang, XC (corresponding author), Natl Inst Biol Sci, 7 Sci Pk Rd,Zhongguancun Life Sci Pk, Beijing 102206, Peoples R China.	wangxiaochen@nibs.ac.cn	Du, Hongwei/K-9074-2019; liu, Bin/V-3391-2019	liu, Bin/0000-0001-7489-9125; Gartner, Anton/0000-0003-4639-9902; , Hongwei/0000-0002-7997-4507	Ministry of Science and Technology [2010CB835201]; CR-UK Career Development Award [C11852/A4500]; CR-UK Project Grant [C11852/A5991]; Wellcome Trust [0909444/Z/09/Z]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); CR-UK Career Development Award; CR-UK Project Grant; Wellcome Trust(Wellcome Trust)	We thank B. Zhu and X. Wang for discussion and critical reading of the manuscript; M. Dong for antibodies; B. Grant, H. Fares, D. Xue, H. Zhang, and the C. elegans Genetic Center (CGC) for strains; the Moerman laboratory (University of British Columbia) for performing the comparative genomic hybridization array; and I. Hanson for editing services. Data described in the paper are presented in the main text and the supplementary materials. This work was supported by a Ministry of Science and Technology grant (2010CB835201) to X. W. and a CR-UK Career Development Award (C11852/A4500), a CR-UK Project Grant (C11852/A5991), and a Wellcome Trust Senior Research Fellowship (0909444/Z/09/Z) to A.G.	Audhya A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000956; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; GAHL WA, 1985, BIOCHEM J, V228, P545, DOI 10.1042/bj2280545; GAHL WA, 1982, SCIENCE, V217, P1263, DOI 10.1126/science.7112129; Grant B, 1999, MOL BIOL CELL, V10, P4311, DOI 10.1091/mbc.10.12.4311; Guo PF, 2010, P NATL ACAD SCI USA, V107, P18016, DOI 10.1073/pnas.1008946107; JONAS AJ, 1982, P NATL ACAD SCI-BIOL, V79, P4442, DOI 10.1073/pnas.79.14.4442; Kalatzis V, 2001, EMBO J, V20, P5940, DOI 10.1093/emboj/20.21.5940; KIMBLE J, 1983, DEV BIOL, V96, P189, DOI 10.1016/0012-1606(83)90322-6; Mangahas PM, 2008, J CELL BIOL, V180, P357, DOI 10.1083/jcb.200708130; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; PISONI RL, 1985, J BIOL CHEM, V260, P4791; Sagne C, 2008, J INHERIT METAB DIS, V31, P258, DOI 10.1007/s10545-008-0879-9; Syntichaki P, 2007, NATURE, V445, P922, DOI 10.1038/nature05603; THOENE JG, 1976, J CLIN INVEST, V58, P180, DOI 10.1172/JCI108448; Tian Y, 2010, CELL, V141, P1042, DOI 10.1016/j.cell.2010.04.034; Treusch S, 2004, P NATL ACAD SCI USA, V101, P4483, DOI 10.1073/pnas.0400709101; WEK SA, 1995, MOL CELL BIOL, V15, P4497; Wu YC, 2000, GENE DEV, V14, P536; Zhai YF, 2001, BBA-BIOMEMBRANES, V1511, P206, DOI 10.1016/S0005-2736(00)00389-8; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002; Zhang YH, 2001, MOL BIOL CELL, V12, P2011, DOI 10.1091/mbc.12.7.2011; Zhang YX, 2009, CELL, V136, P308, DOI 10.1016/j.cell.2008.12.022	24	99	104	3	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2012	337	6092					351	354		10.1126/science.1220281	http://dx.doi.org/10.1126/science.1220281			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975WQ	22822152	Green Accepted			2022-12-28	WOS:000306542600054
J	Sonenberg, N; Filipowicz, W				Sonenberg, Nahum; Filipowicz, Witold			Aaron Shatkin (1934-2012)	SCIENCE			English	Biographical-Item									[Sonenberg, Nahum] McGill Univ, Goodman Canc Res Ctr, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Filipowicz, Witold] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland	McGill University; Friedrich Miescher Institute for Biomedical Research	Sonenberg, N (corresponding author), McGill Univ, Goodman Canc Res Ctr, Dept Biochem, Montreal, PQ H3A 1A3, Canada.	nahum.sonenberg@mcgill.ca; witold.filipowicz@fmi.ch						SHATKIN A, PUBLICATION LIST	1	1	1	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2012	337	6092					309	309		10.1126/science.1226820	http://dx.doi.org/10.1126/science.1226820			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975WQ	22822142	Green Published			2022-12-28	WOS:000306542600042
J	Lesku, JA; Rattenborg, NC; Valcu, M; Vyssotski, AL; Kuhn, S; Kuemmeth, F; Heidrich, W; Kempenaers, B				Lesku, John A.; Rattenborg, Niels C.; Valcu, Mihai; Vyssotski, Alexei L.; Kuhn, Sylvia; Kuemmeth, Franz; Heidrich, Wolfgang; Kempenaers, Bart			Adaptive Sleep Loss in Polygynous Pectoral Sandpipers	SCIENCE			English	Article							LOCAL SLEEP; POLYMORPHISM; HOMEOSTASIS	The functions of sleep remain elusive. Extensive evidence suggests that sleep performs restorative processes that sustain waking brain performance. An alternative view proposes that sleep simply enforces adaptive inactivity to conserve energy when activity is unproductive. Under this hypothesis, animals may evolve the ability to dispense with sleep when ecological demands favor wakefulness. Here, we show that male pectoral sandpipers (Calidris melanotos), a polygynous Arctic breeding shorebird, are able to maintain high neurobehavioral performance despite greatly reducing their time spent sleeping during a 3-week period of intense male-male competition for access to fertile females. Males that slept the least sired the most offspring. Our results challenge the view that decreased performance is an inescapable outcome of sleep loss.	[Valcu, Mihai; Kuhn, Sylvia; Kempenaers, Bart] Max Planck Inst Ornithol, Dept Behav Ecol & Evolutionary Genet, D-82319 Seewiesen, Germany; [Lesku, John A.; Rattenborg, Niels C.] Max Planck Inst Ornithol, Avian Sleep Grp, D-82319 Seewiesen, Germany; [Vyssotski, Alexei L.] Univ Zurich, Inst Neuroinformat, ETH, CH-8092 Zurich, Switzerland; [Kuemmeth, Franz; Heidrich, Wolfgang] E Obs GmbH, D-82031 Gruenwald, Germany	Max Planck Society; Max Planck Society; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Kempenaers, B (corresponding author), Max Planck Inst Ornithol, Dept Behav Ecol & Evolutionary Genet, D-82319 Seewiesen, Germany.	b.kempenaers@orn.mpg.de	Valcu, Mihai/AAX-8842-2021; /ABD-1334-2021; Valcu, Mihai/B-6497-2014	Valcu, Mihai/0000-0002-6907-7802; Kempenaers, Bart/0000-0002-7505-5458; Vyssotski, Alexei/0000-0002-9021-1471; Lesku, John/0000-0001-5073-6954	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	We thank R. Barth, E. Bolund, W. Forstmeier, A. Jacot, L. Langlois, P. Loes, C. Muck, A. Mutzel, M. Oltrogge, H. Schielzeth, X. Schleuning, S. Steiger, K. Teltscher, K. Temnow, and A. Wittenzellner for help in the field; R. Lanctot from the U.S. Fish and Wildlife Service (Anchorage) and G. Sheehan from Barrow Arctic Science Consortium for logistical support; and four anonymous reviewers for comments. W. Forstmeier kindly made his photos available. This work was funded by the Max Planck Society. B. K. and M. V. designed the study. B. K., J.A.L., and N.C.R. designed the EEG/EMG component. B. K. and M. V. collected and analyzed the activity/interaction data. J.A.L. and N.C.R. conducted the surgeries and analyzed the EEG/EMG data. A. L. V. developed and provided Neurologgers. S. K. incubated eggs and genetically determined paternity. W. H. and F. K. developed the iTags. B. K., J.A.L., N.C.R., and M. V. wrote the manuscript. Data from this study can be found in the supplementary materials.	Andersson Malte, 1994; Bachmann V, 2012, CEREB CORTEX, V22, P962, DOI 10.1093/cercor/bhr173; Barske J, 2011, P ROY SOC B-BIOL SCI, V278, P3523, DOI 10.1098/rspb.2011.0382; Byers J, 2010, ANIM BEHAV, V79, P771, DOI 10.1016/j.anbehav.2010.01.009; Cirelli C, 2008, PLOS BIOL, V6, P1605, DOI 10.1371/journal.pbio.0060216; Daan S, 2011, SLEEP BIOL RHYTHMS, V9, P1, DOI 10.1111/j.1479-8425.2010.00482.x; Dawson D, 1997, NATURE, V388, P235, DOI 10.1038/40775; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; Fuchs T, 2009, BIOL LETTERS, V5, P77, DOI 10.1098/rsbl.2008.0405; Horne J, 2011, BIOL PSYCHOL, V87, P1, DOI 10.1016/j.biopsycho.2010.10.004; Johnsen A, 2007, MOL ECOL, V16, P4867, DOI 10.1111/j.1365-294X.2007.03552.x; Jones SG, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-87; Jung CM, 2011, J PHYSIOL-LONDON, V589, P235, DOI 10.1113/jphysiol.2010.197517; Klein BA, 2010, P NATL ACAD SCI USA, V107, P22705, DOI 10.1073/pnas.1009439108; Kripke DF, 2011, SLEEP MED, V12, P28, DOI 10.1016/j.sleep.2010.04.016; Leemburg S, 2010, P NATL ACAD SCI USA, V107, P15939, DOI 10.1073/pnas.1002570107; Lesku JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023203; Lesku JA, 2011, P ROY SOC B-BIOL SCI, V278, P2419, DOI 10.1098/rspb.2010.2316; Lima SL, 2005, ANIM BEHAV, V70, P723, DOI 10.1016/j.anbehav.2005.01.008; Lyamin O, 2005, NATURE, V435, P1177, DOI 10.1038/4351177a; Lyamin OI, 2008, NEUROSCI BIOBEHAV R, V32, P1451, DOI 10.1016/j.neubiorev.2008.05.023; PITELKA FA, 1974, AM ZOOL, V14, P185; Rattenborg NC, 2004, PLOS BIOL, V2, P924, DOI 10.1371/journal.pbio.0020212; Rolls A, 2011, P NATL ACAD SCI USA, V108, P13305, DOI 10.1073/pnas.1015633108; Siegel JM, 2009, NAT REV NEUROSCI, V10, P747, DOI 10.1038/nrn2697; Vyazovskiy VV, 2011, NATURE, V472, P443, DOI 10.1038/nature10009; Vyssotski AL, 2009, CURR BIOL, V19, P1159, DOI 10.1016/j.cub.2009.05.070	27	145	148	2	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2012	337	6102					1654	1658		10.1126/science.1220939	http://dx.doi.org/10.1126/science.1220939			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	22878501				2022-12-28	WOS:000309215400045
J	Scher, HI; Fizazi, K; Saad, F; Taplin, ME; Sternberg, CN; Miller, K; de Wit, R; Mulders, P; Chi, KN; Shore, ND; Armstrong, AJ; Flaig, TW; Flechon, A; Mainwaring, P; Fleming, M; Hainsworth, JD; Hirmand, M; Selby, B; Seely, L; de Bono, JS				Scher, Howard I.; Fizazi, Karim; Saad, Fred; Taplin, Mary-Ellen; Sternberg, Cora N.; Miller, Kurt; de Wit, Ronald; Mulders, Peter; Chi, Kim N.; Shore, Neal D.; Armstrong, Andrew J.; Flaig, Thomas W.; Flechon, Aude; Mainwaring, Paul; Fleming, Mark; Hainsworth, John D.; Hirmand, Mohammad; Selby, Bryan; Seely, Lynn; de Bono, Johann S.		AFFIRM Investigators	Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANDROGEN-RECEPTOR; FUNCTIONAL ASSESSMENT; CLINICAL-TRIALS; THERAPY; MECHANISMS; ANTIANDROGEN; ABIRATERONE; INSTRUMENT; RESISTANCE; CARCINOMA	BACKGROUND Enzalutamide (formerly called MDV3100) targets multiple steps in the androgen-receptor-signaling pathway, the major driver of prostate-cancer growth. We aimed to evaluate whether enzalutamide prolongs survival in men with castration-resistant prostate cancer after chemotherapy. METHODS In our phase 3, double-blind, placebo-controlled trial, we stratified 1199 men with castration-resistant prostate cancer after chemotherapy according to the Eastern Cooperative Oncology Group performance-status score and pain intensity. We randomly assigned them, in a 2: 1 ratio, to receive oral enzalutamide at a dose of 160 mg per day (800 patients) or placebo (399 patients). The primary end point was overall survival. RESULTS The study was stopped after a planned interim analysis at the time of 520 deaths. The median overall survival was 18.4 months (95% confidence interval [CI], 17.3 to not yet reached) in the enzalutamide group versus 13.6 months (95% CI, 11.3 to 15.8) in the placebo group (hazard ratio for death in the enzalutamide group, 0.63; 95% CI, 0.53 to 0.75; P<0.001). The superiority of enzalutamide over placebo was shown with respect to all secondary end points: the proportion of patients with a reduction in the prostate-specific antigen (PSA) level by 50% or more (54% vs. 2%, P<0.001), the soft-tissue response rate (29% vs. 4%, P<0.001), the quality-of-life response rate (43% vs. 18%, P<0.001), the time to PSA progression (8.3 vs. 3.0 months; hazard ratio, 0.25; P<0.001), radiographic progression-free survival (8.3 vs. 2.9 months; hazard ratio, 0.40; P<0.001), and the time to the first skeletal-related event (16.7 vs. 13.3 months; hazard ratio, 0.69; P<0.001). Rates of fatigue, diarrhea, and hot flashes were higher in the enzalutamide group. Seizures were reported in five patients (0.6%) receiving enzalutamide. CONCLUSIONS Enzalutamide significantly prolonged the survival of men with metastatic castration-resistant prostate cancer after chemotherapy. (Funded by Medivation and Astellas Pharma Global Development; AFFIRM ClinicalTrials. gov number, NCT00974311.)	[Scher, Howard I.] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Scher, Howard I.] Weill Cornell Med Coll, New York, NY USA; [Fizazi, Karim] Univ Paris Sud, Inst Gustave Roussy, Villejuif, France; [Saad, Fred] Univ Montreal, Ctr Hosp, Montreal, PQ, Canada; [Taplin, Mary-Ellen] Dana Farber Canc Inst, Boston, MA 02115 USA; [Sternberg, Cora N.] San Camillo Forlanini Hosp, Rome, Italy; [Miller, Kurt] Charite, D-13353 Berlin, Germany; [de Wit, Ronald] Erasmus Univ, Med Ctr, Rotterdam, Netherlands; [Mulders, Peter] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Chi, Kim N.] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada; [Shore, Neal D.] Carolina Urol Res Ctr, Myrtle Beach, SC USA; [Armstrong, Andrew J.] Duke Univ, Duke Canc Inst, Durham, NC USA; [Flaig, Thomas W.] Univ Colorado, Ctr Canc, Aurora, CO USA; [Flechon, Aude] Ctr Reg Lutte Canc Rhone Alpes, Ctr Leon Berard, Lyon, France; [Mainwaring, Paul] Mater Private Hosp, Brisbane, Australia; [Fleming, Mark] Virginia Oncol Associates, Norfolk, VA USA; [Hainsworth, John D.] Sarah Cannon Res Inst, Nashville, TN USA; [Hirmand, Mohammad; Selby, Bryan; Seely, Lynn] Medivation, San Francisco, CA USA; [de Bono, Johann S.] Royal Marsden Hosp, Sutton, Surrey, England; [de Bono, Johann S.] Inst Canc Res, Sutton, Surrey, England	Memorial Sloan Kettering Cancer Center; Cornell University; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Universite de Montreal; Harvard University; Dana-Farber Cancer Institute; Azienda Ospedaliera San Camillo-Forlanini; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Erasmus University Rotterdam; Erasmus MC; Radboud University Nijmegen; British Columbia Cancer Agency; Carolina Urologic Research Center; Duke University; University of Colorado System; University of Colorado Anschutz Medical Campus; UNICANCER; Centre Leon Berard; Sarah Cannon Research Institute; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Scher, HI (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10065 USA.	scherh@mskcc.org	Stockler, Martin R/N-3859-2016; Aragon-Ching, Jeanny/AAL-2501-2020; Mulders, Peter F.A./H-8076-2014; Gil-Bazo, Ignacio/E-4581-2019; gerritsen, Winald/H-8031-2014; Aragon-Ching, Jeanny/AAJ-4969-2020; Gravis, Gwenaelle/CAG-3019-2022	Stockler, Martin R/0000-0003-3793-8724; Aragon-Ching, Jeanny/0000-0002-6714-141X; Gil-Bazo, Ignacio/0000-0002-2626-5109; Aragon-Ching, Jeanny/0000-0002-6714-141X; Gravis, Gwenaelle/0000-0002-3127-1554; Lacombe, Louis/0000-0003-4811-0308; de Bono, Johann S/0000-0002-2034-595X; OUDARD, Stephane/0000-0003-0893-285X; colombel, marc/0000-0002-0152-8021; Hadaschik, Boris/0000-0002-1052-2692; Joshua, Anthony/0000-0001-5159-4580; Krainer, Michael/0000-0002-7011-4957; Bompas, Emmanuelle/0000-0003-4414-7760; joly, florence/0000-0001-6168-4942; Carles, Joan/0000-0002-9983-5934; DURAN, IGNACIO/0000-0001-8571-7163	Medivation and Astellas Pharma Global Development; Aragon Pharmaceuticals and Centocor Ortho Biotech; Cougar Biotechnology; Exelixis; Medivation; Janssen Pharmaceuticals; Veridex (a Johnson & Johnson company); Amgen; Millennium; Novartis; Bristol-Myers Squibb; Orion-Endo Pharmaceuticals; Sanofi-Aventis; Dendreon; AstraZeneca; Astellas Pharma; Roche; Ferring Pharmaceuticals; GlaxoSmithKline; Eli Lilly; Johnson Johnson; Bayer; ImClone; Pfizer; Active Biotech; Veridex; Prometheus; Celgene; Eisai; Teva Pharmaceuticals; Topotarget; bioTheranostics	Medivation and Astellas Pharma Global Development; Aragon Pharmaceuticals and Centocor Ortho Biotech; Cougar Biotechnology; Exelixis; Medivation; Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Veridex (a Johnson & Johnson company); Amgen(Amgen); Millennium(Takeda Pharmaceutical Company Ltd); Novartis(Novartis); Bristol-Myers Squibb(Bristol-Myers Squibb); Orion-Endo Pharmaceuticals; Sanofi-Aventis(Sanofi-Aventis); Dendreon; AstraZeneca(AstraZeneca); Astellas Pharma(Astellas Pharmaceuticals); Roche(Roche Holding); Ferring Pharmaceuticals(Ferring Pharmaceuticals); GlaxoSmithKline(GlaxoSmithKline); Eli Lilly(Eli Lilly); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Bayer(Bayer AG); ImClone; Pfizer(Pfizer); Active Biotech; Veridex; Prometheus; Celgene(Bristol-Myers SquibbCelgene Corporation); Eisai(Eisai Co Ltd); Teva Pharmaceuticals(Teva Pharmaceutical Industries); Topotarget; bioTheranostics	Supported by Medivation and Astellas Pharma Global Development.; Dr. Scher reports receiving grant support and consulting fees from Aragon Pharmaceuticals and Centocor Ortho Biotech, grant support from Cougar Biotechnology, Exelixis, Medivation, Janssen Pharmaceuticals, and Veridex (a Johnson & Johnson company), consulting fees from Amgen, Millennium, Novartis, Bristol-Myers Squibb, Orion-Endo Pharmaceuticals, Sanofi-Aventis, and Dendreon, and reimbursement of travel expenses from AstraZeneca; and holding stock or stock options in Johnson & Johnson. Dr. Fizazi reports serving on advisory boards for or receiving lecture fees from AstraZeneca, Amgen, Novartis, Medivation-Astellas Pharma, Bayer, Janssen Pharmaceuticals, Dendreon, and Sanofi-Aventis. Dr. Saad reports receiving consulting fees and payment for the development of educational presentations from Astellas Pharma, Janssen Pharmaceuticals, and Sanofi-Aventis and consulting fees from Medivation. Dr. Taplin reports receiving consulting fees from Sanofi-Aventis and serving on advisory boards for Dendreon, Tokai Pharmaceuticals, Johnson & Johnson, and Medivation. Dr. Sternberg reports receiving consulting fees from Johnson & Johnson, Sanofi-Aventis, Amgen, and Millennium. Dr. Miller reports receiving consulting fees and lecture fees from Amgen, Astellas Pharma, Bayer, Janssen-Cilag, and Novartis, and consulting fees from Roche, AstraZeneca, and Ferring Pharmaceuticals. Dr. de Wit reports receiving consulting fees (directly and on behalf of his institution) and lecture fees from Janssen Pharmaceuticals, consulting fees (directly and on behalf of his institution) from Sanofi-Aventis, consulting fees from GlaxoSmithKline and Eli Lilly, grant support and reimbursement of travel expenses from Merck, and grant support from Millennium. Dr. Mulders reports receiving consulting fees from GlaxoSmithKline, AstraZeneca, Johnson & Johnson, and Novartis, lecture fees from CorePharma and Prime Oncology, and grant support from Bayer. Dr. Chi reports receiving grant support, consulting fees, and lecture fees from Janssen Pharmaceuticals and consulting fees from Astellas Pharma. Dr. Shore reports receiving consulting fees from Medivation, Astellas Pharma, Janssen Pharmaceuticals, Amgen, Bayer, Millennium, and Nymox Pharmaceutical. Dr. Armstrong reports receiving grant support, consulting fees, and lecture fees from Sanofi-Aventis, grant support and consulting fees from Bristol-Myers Squibb, grant support and lecture fees from Janssen Pharmaceuticals and Dendreon, consulting fees and lecture fees from Amgen, consulting fees from Bayer, and grant support from Medivation, ImClone, Pfizer, Novartis, Active Biotech, and Veridex. Dr. Flaig reports receiving grant support and consulting fees from Sanofi-Aventis, grant support and lecture fees from Amgen, and grant support from Cougar Biotechnology. Dr. Flechon reports serving as a board member for and receiving reimbursement of travel expenses and payment for the development of educational presentations from Novartis and Janssen-Cilag, serving as a board member for and receiving payment for the development of educational presentations from Sanofi-Aventis, receiving reimbursement of travel expenses and payment for the development of educational presentations from Pfizer, serving as a board member for Ferring Pharmaceuticals and Dendreon, receiving grant support from Chugai Pharmaceutical, receiving reimbursement of travel expenses from Astellas Pharma, and receiving payment for the development of educational presentations from Bayer. Dr.; Mainwaring reports receiving consulting fees, lecture fees, and payment for the development of educational presentations from Janssen Pharmaceuticals, lecture fees and payment for the development of educational presentations from Novartis and Roche, and lecture fees from Pfizer. Dr. Fleming reports receiving lecture fees from Sanofi-Aventis, Johnson & Johnson, and McKesson Specialty Health. Dr. Hainsworth reports receiving grant support from Novartis, Sanofi-Aventis, Genentech, Bristol-Myers Squibb, Eli Lilly, Prometheus, Celgene, Cougar Biotechnology, Eisai, Johnson & Johnson, Teva Pharmaceuticals, Roche, GlaxoSmithKline, Topotarget, bioTheranostics, and ImClone. Dr. Hirmand, Mr. Selby, and Dr. Seely report being employees of and holding stock or stock options in Medivation. Dr. de Bono reports receiving consulting fees from Astellas Pharma, AstraZeneca, and Johnson & Johnson. No other potential conflict of interest relevant to this article was reported.	Atkinson TM, 2011, J PAIN SYMPTOM MANAG, V41, P558, DOI 10.1016/j.jpainsymman.2010.05.008; Attard G, 2011, CLIN CANCER RES, V17, P1649, DOI 10.1158/1078-0432.CCR-10-0567; Cella D, 2009, VALUE HEALTH, V12, P124, DOI 10.1111/j.1524-4733.2008.00409.x; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; de Bono JS, 2010, LANCET, V376, P1147, DOI 10.1016/S0140-6736(10)61389-X; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Esper P, 1997, UROLOGY, V50, P920, DOI 10.1016/S0090-4295(97)00459-7; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Foster WR, 2011, PROSTATE, V71, P480, DOI 10.1002/pros.21263; Grossmann M, 2011, ENDOCRIN METAB CLIN, V40, P655, DOI 10.1016/j.ecl.2011.05.004; Grossmann ME, 2001, JNCI-J NATL CANCER I, V93, P1687, DOI 10.1093/jnci/93.22.1687; Holzbeierlein J, 2004, AM J PATHOL, V164, P217, DOI 10.1016/S0002-9440(10)63112-4; Jung ME, 2010, J MED CHEM, V53, P2779, DOI 10.1021/jm901488g; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kumar Ravi J, 2005, Rev Urol, V7 Suppl 5, pS37; Morganroth J, 2004, J ELECTROCARDIOL, V37, P25, DOI 10.1016/j.jelectrocard.2003.11.004; Morris MJ, 2009, CLIN GENITOURIN CANC, V7, P51, DOI 10.3816/CGC.2009.n.009; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Pienta KJ, 2006, CLIN CANCER RES, V12, P1665, DOI 10.1158/1078-0432.CCR-06-0067; Richards J, 2012, CANCER RES, V72, P2176, DOI 10.1158/0008-5472.CAN-11-3980; Saad F, 2002, JNCI-J NATL CANCER I, V94, P1458, DOI 10.1093/jnci/94.19.1458; Scher HI, 2004, ENDOCR-RELAT CANCER, V11, P459, DOI 10.1677/erc.1.00525; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Scher HI, 2008, J CLIN ONCOL, V26, P1148, DOI 10.1200/JCO.2007.12.4487; Scher HI, 2010, LANCET, V375, P1437, DOI 10.1016/S0140-6736(10)60172-9; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Treiman DM, 2001, EPILEPSIA, V42, P8, DOI 10.1046/j.1528-1157.2001.042suppl.3008.x; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401	29	3171	3271	7	236	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 27	2012	367	13					1187	1197		10.1056/NEJMoa1207506	http://dx.doi.org/10.1056/NEJMoa1207506			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	011JO	22894553	Bronze, Green Published			2022-12-28	WOS:000309161100005
J	Chang, SM; Carey, TS; Kato, EU; Guise, JM; Sanders, GD				Chang, Stephanie M.; Carey, Timothy S.; Kato, Elisabeth Uphoff; Guise, Jeanne-Marie; Sanders, Gillian D.			Identifying Research Needs for Improving Health Care	ANNALS OF INTERNAL MEDICINE			English	Article							CUMULATIVE METAANALYSES; SYSTEMATIC REVIEWS; PROGRAM; AHRQ; TIME; TRIALS	Insights from systematic reviews can help new studies better meet the priorities and needs of patients and communities. However, systematic reviews unfortunately have not yet achieved this position to direct and guide new research studies. The Agency for Healthcare Research and Quality's Evidence-based Practice Center Program uses systematic reviews to identify gaps in current evidence and has developed a systematic process of prioritizing these gaps with stakeholder input into clearly defined "future research needs." Eight Evidence-based Practice Centers began to apply this effort in 2010 to various clinical and policy topics. Gaps that prevented systematic reviewers from answering central questions of the review may include insufficient studies on sub-populations, insufficient studies with appropriate comparators, lack of appropriate outcomes measured, and methods problems. Stakeholder panels, consisting of advocacy groups, patients, researchers, clinicians, funders, and policymakers, help refine the gaps through multiple conference calls and prioritization exercises. Each report highlights a focused set of 4 to 15 high-priority needs with an accompanying description of possible considerations for study design. Identification of high-priority research needs could potentially speed the development and implementation of high-priority, stakeholder-engaged research.	[Chang, Stephanie M.] Agcy Healthcare Res & Qual, Ctr Outcomes & Evidence, Rockville, MD 20850 USA; Univ N Carolina, Chapel Hill, NC USA; Oregon Hlth & Sci Univ, Portland, OR 97201 USA; Duke Univ, Durham, NC USA	Agency for Healthcare Research & Quality; University of North Carolina; University of North Carolina Chapel Hill; Oregon Health & Science University; Duke University	Chang, SM (corresponding author), Agcy Healthcare Res & Qual, Ctr Outcomes & Evidence, 540 Gaither Rd, Rockville, MD 20850 USA.			Guise, Jeanne-Marie/0000-0002-8961-488X	AHRQ, U.S. Department of Health and Human Services [290-2007-10056-1, 290-2007-10057-1, 290-2007-10066-1]	AHRQ, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This project was funded in part under contracts 290-2007-10056-1, 290-2007-10057-1, and 290-2007-10066-1 from the AHRQ, U.S. Department of Health and Human Services.	[Anonymous], AHRQ PUBLICATION; Bennett WL, 2010, AHRQ PUBLICATION; Brasure M, 2010, AHRQ PUBLICATION; Butler M, 2010, AHRQ PUBLICATION; Carey T. S., 2010, AHRQ PUBLICATION; Chang S., 2012, AHRQ PUBLICATION; Clarke M, 2010, LANCET, V376, P20, DOI 10.1016/S0140-6736(10)61045-8; Gaynes BN, 2012, AHRQ PUBLICATION; Ioannidis JPA, 2001, P NATL ACAD SCI USA, V98, P831, DOI 10.1073/pnas.021529998; Mauger Rothenberg B, 2010, AHRQ PUBLICATION; McKoy JN, 2010, AHRQ PUBLICATION; McKoy N. A., 2011, AHRQ PUBLICATION, V11-EHC043-EF; Meltzer DO, 2011, AHRQ PUBLICATION; Moorthy D., 2011, AHRQ PUBLICATION; Morris ZS, 2011, J ROY SOC MED, V104, P510, DOI 10.1258/jrsm.2011.110180; O'Haire C, 2011, AHRQ PUBLICATION; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Ravi D., 2011, METHODS FUTURE RES N, V5; Sanders GD, 2010, AHRQ PUBLICATION; Slutsky J, 2010, J CLIN EPIDEMIOL, V63, P481, DOI 10.1016/j.jclinepi.2008.06.009; Tatsioni A, 2007, JAMA-J AM MED ASSOC, V298, P2517, DOI 10.1001/jama.298.21.2517; Trikalinos TA, 2004, J CLIN EPIDEMIOL, V57, P1124, DOI 10.1016/j.jclinepi.2004.02.018; Trikalinos TA, 2010, AHRQ PUBLICATION; Viswanathan M, 2011, AHRQ PUBLICATION; Whitlock EP, 2010, J CLIN EPIDEMIOL, V63, P491, DOI 10.1016/j.jclinepi.2009.03.008	25	27	27	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 18	2012	157	6					439	U106		10.7326/0003-4819-157-6-201209180-00515	http://dx.doi.org/10.7326/0003-4819-157-6-201209180-00515			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007UB	22847017				2022-12-28	WOS:000308912800018
J	Dreyfus, C; Laursen, NS; Kwaks, T; Zuijdgeest, D; Khayat, R; Ekiert, DC; Lee, JH; Metlagel, Z; Bujny, MV; Jongeneelen, M; van der Vlugt, R; Lamrani, M; Korse, HJWM; Geelen, E; Sahin, O; Sieuwerts, M; Brakenhoff, JPJ; Vogels, R; Li, OTW; Poon, LLM; Peiris, M; Koudstaal, W; Ward, AB; Wilson, IA; Goudsmit, J; Friesen, RHE				Dreyfus, Cyrille; Laursen, Nick S.; Kwaks, Ted; Zuijdgeest, David; Khayat, Reza; Ekiert, Damian C.; Lee, Jeong Hyun; Metlagel, Zoltan; Bujny, Miriam V.; Jongeneelen, Mandy; van der Vlugt, Remko; Lamrani, Mohammed; Korse, Hans J. W. M.; Geelen, Eric; Sahin, Ozcan; Sieuwerts, Martijn; Brakenhoff, Just P. J.; Vogels, Ronald; Li, Olive T. W.; Poon, Leo L. M.; Peiris, Malik; Koudstaal, Wouter; Ward, Andrew B.; Wilson, Ian A.; Goudsmit, Jaap; Friesen, Robert H. E.			Highly Conserved Protective Epitopes on Influenza B Viruses	SCIENCE			English	Article							A VIRUSES; ANTIBODY; HEMAGGLUTININ; BROAD; NEUTRALIZATION; RECOGNIZES; LINEAGES; HIV-1; CELLS	Identification of broadly neutralizing antibodies against influenza A viruses has raised hopes for the development of monoclonal antibody-based immunotherapy and "universal" vaccines for influenza. However, a substantial part of the annual flu burden is caused by two cocirculating, antigenically distinct lineages of influenza B viruses. Here, we report human monoclonal antibodies, CR8033, CR8071, and CR9114, that protect mice against lethal challenge from both lineages. Antibodies CR8033 and CR8071 recognize distinct conserved epitopes in the head region of the influenza B hemagglutinin (HA), whereas CR9114 binds a conserved epitope in the HA stem and protects against lethal challenge with influenza A and B viruses. These antibodies may inform on development of monoclonal antibody-based treatments and a universal flu vaccine for all influenza A and B viruses.	[Dreyfus, Cyrille; Laursen, Nick S.; Khayat, Reza; Ekiert, Damian C.; Lee, Jeong Hyun; Metlagel, Zoltan; Ward, Andrew B.; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Laursen, Nick S.] Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus, Denmark; [Kwaks, Ted; Zuijdgeest, David; Bujny, Miriam V.; Jongeneelen, Mandy; van der Vlugt, Remko; Lamrani, Mohammed; Korse, Hans J. W. M.; Geelen, Eric; Sahin, Ozcan; Sieuwerts, Martijn; Brakenhoff, Just P. J.; Vogels, Ronald; Koudstaal, Wouter; Goudsmit, Jaap; Friesen, Robert H. E.] Janssen Ctr Excellence Immunoprophylaxis, Crucell Vaccine Inst, NL-2301 CA Leiden, Netherlands; [Li, Olive T. W.; Poon, Leo L. M.; Peiris, Malik] Univ Hong Kong, State Key Lab Emerging Infect Dis, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China; [Li, Olive T. W.; Poon, Leo L. M.; Peiris, Malik] Univ Hong Kong, Sch Publ Hlth, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Aarhus University; University of Hong Kong; University of Hong Kong; Scripps Research Institute	Wilson, IA (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wilson@scripps.edu; jaap.goudsmit@crucell.com	Ward, Andrew B/F-9203-2014; Laursen, Nick Stub/Q-5051-2017; Poon, Leo Lit Man/C-4382-2009; Ward, Andrew/ABD-7728-2021; Poon, Leo/AAP-6887-2020; Peiris, Joseph Sriyal Malik/C-4380-2009	Ward, Andrew B/0000-0001-7153-3769; Laursen, Nick Stub/0000-0002-7512-2649; Poon, Leo Lit Man/0000-0002-9101-7953; Ward, Andrew/0000-0001-7153-3769; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995; Ekiert, Damian/0000-0002-2570-0404; Lee, Jeong Hyun/0000-0001-7371-845X; Kwaks, Ted/0000-0003-1608-9372	National Institute of General Medical Sciences (NIGMS) Protein Structure Initiative [U54 GM094586]; NIH through the National Center for Research Resources' P41 program [RR017573]; Area of Excellence Scheme of the University Grants Committee, Hong Kong [AoE/M-12/06]; Achievement Rewards for College Scientists Foundation; NIH Molecular Evolution Training Program [GM080209]; Danish Council for Independent Research, Natural Sciences; Skaggs Institute; DOE Office of Biological and Environmental Research; NIH, National Center for Research Resources, Biomedical Technology Program [P41RR001209]; NIGMS [Y1-GM-1104]; National Cancer Institute [Y1-CO-1020]; DOE, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; Office of Science, Office of Basic Energy Sciences, of the DOE [DE-AC02-05CH11231]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573, P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094586, T32GM080209] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS) Protein Structure Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH through the National Center for Research Resources' P41 program; Area of Excellence Scheme of the University Grants Committee, Hong Kong; Achievement Rewards for College Scientists Foundation(General Electric); NIH Molecular Evolution Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Council for Independent Research, Natural Sciences(Det Frie Forskningsrad (DFF)); Skaggs Institute; DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH, National Center for Research Resources, Biomedical Technology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DOE, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); Office of Science, Office of Basic Energy Sciences, of the DOE(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Juraszek; B. Brandenburg; M. Koldijk; K. Hegmans; J. Meijer; N. Hafkemeier; A. Apetri; J. Dulos; L. Dekking; H. Vietsch; G. Perdok; H. Tien; D. Marciano; the staff of the Advanced Photon Source (APS) GM/CA-CAT 23ID-B and 23ID-D, Stanford Synchrotron Radiation Lightsource (SSRL) BL11-1 and SSRL BL7-1, and Advanced Light Source (ALS); X. Dai; R. Stanfield; W. Yu; J. P. Julien; R. N. Kirchdoerfer; and E. Brown of Ottawa University, Canada, for the mouse-adapted A/Hong Kong/1/68 strain. Crystallization experiments were carried out on the Rigaku Crystalmation system at the Joint Center for Structural Genomics, which is supported by the National Institute of General Medical Sciences (NIGMS) Protein Structure Initiative U54 GM094586. The EM and image analysis was conducted by R. K., J. H. L., and Z.M. at the National Resource for Automated Molecular Microscopy, which is supported by NIH through the National Center for Research Resources' P41 program (RR017573). This project has been funded in part by the Area of Excellence Scheme of the University Grants Committee, Hong Kong (grant AoE/M-12/06); a predoctoral fellowship from the Achievement Rewards for College Scientists Foundation (D. C. E.); grant GM080209 from the NIH Molecular Evolution Training Program (D. C. E.); a Saper Aude Postdoc grant from the Danish Council for Independent Research, Natural Sciences (N. S. L.), and the Skaggs Institute (I. A. W.). Portions of this research were carried out at the SSRL, a national user facility operated by Stanford University on behalf of the U.S. Department of Energy (DOE), Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by NIH, National Center for Research Resources, Biomedical Technology Program (P41RR001209), and the NIGMS. The GM/CA CAT 23-ID-B beamline has been funded in whole or in part with federal funds from National Cancer Institute (Y1-CO-1020) and NIGMS (Y1-GM-1104). Use of the APS was supported by the DOE, Basic Energy Sciences, Office of Science, under contract no. DE-AC02-06CH11357. The content is solely the responsibility of the authors and does not necessarily represent the official views of NIGMS or the NIH. The ALS is supported by the director, Office of Science, Office of Basic Energy Sciences, of the DOE under contract no. DE-AC02-05CH11231. Coordinates and structure factors are deposited in the Protein Data Bank (PDB code 4FQH for CR9114 Fab, 4FQI for CR9114 Fab-A/H5 HA, 4FQJ for CR8071 Fab-B/Florida HA1, 4FQK for CR8059 Fab-B/Brisbane HA, 4FQL for CR8033 Fab, 4FQM for B/Brisbane HA, 4FQY for CR9114 Fab-A/H3 HA, and 4FQV for CR9114 Fab-A/H7 HA). Image reconstructions have been deposited at the EMDataBank under accession numbers EMD-2143 (CR8033/Florida), EMD-2144 (CR8071/Florida), EMD-2145 (CR8071/Malaysia), EMD-2146 (CR9114/Florida), EMD-2147 (CR9114/H1), EMD-2148 (CR9114/H3), EMD-2149 (CR9114/H9), and EMD-2150 (CR9114/H7). Nucleotide sequences for the CR8033, CR8059 (CR8071), and CR9114 variable regions have been deposited in GenBank [accession numbers JX213635 (CR8033, VH), JX213636 (CR8033, Vk), JX213637 (CR8059, VH), JX213638 (CR8059, Vl), JX213639 (CR9114, VH), and JX213640 (CR9114, Vl)]. Patent applications relating to antibodies CR8033, CR8059, CR8071, and CR9114 have been filed (CR8033, CR8059, and CR8071 are claimed in EP 12158525.1 and U.S. 61/608,414. CR9114 is claimed in EP 11173953.8 and U.S. 61/572,417). Sharing will be subject to standard material transfer agreements.; This is publication 21741 from the Scripps Research Institute.	Ambrose CS, 2012, HUM VACC IMMUNOTHER, V8, P81, DOI 10.4161/hv.8.1.17623; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Gubareva LV, 2000, LANCET, V355, P827, DOI 10.1016/S0140-6736(99)11433-8; Ha Y, 2003, VIROLOGY, V309, P209, DOI 10.1016/S0042-6822(03)00068-0; Krause JC, 2011, J VIROL, V85, P10905, DOI 10.1128/JVI.00700-11; Lowen Anice C., 2007, Infectious Disorders - Drug Targets, V7, P318; Osterhaus ADME, 2000, SCIENCE, V288, P1051, DOI 10.1126/science.288.5468.1051; ROTA PA, 1990, VIROLOGY, V175, P59, DOI 10.1016/0042-6822(90)90186-U; Salzberg S, 2008, NATURE, V454, P160, DOI 10.1038/454160a; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang QH, 2008, J VIROL, V82, P3011, DOI 10.1128/JVI.02477-07; Wang TT, 2009, NAT STRUCT MOL BIOL, V16, P233, DOI 10.1038/nsmb.1574; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; Whittle JRR, 2011, P NATL ACAD SCI USA, V108, P14216, DOI 10.1073/pnas.1111497108; World Health Organization (WHO), 2009, FACT SHEET 211 INFL; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; YAMASHITA M, 1988, VIROLOGY, V163, P112, DOI 10.1016/0042-6822(88)90238-3; Yang H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001081; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	25	544	590	9	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2012	337	6100					1343	1348		10.1126/science.1222908	http://dx.doi.org/10.1126/science.1222908			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	004TW	22878502	Green Accepted			2022-12-28	WOS:000308705000043
J	Halpern, BS; Longo, C; Hardy, D; McLeod, KL; Samhouri, JF; Katona, SK; Kleisner, K; Lester, SE; O'Leary, J; Ranelletti, M; Rosenberg, AA; Scarborough, C; Selig, ER; Best, BD; Brumbaugh, DR; Chapin, FS; Crowder, LB; Daly, KL; Doney, SC; Elfes, C; Fogarty, MJ; Gaines, SD; Jacobsen, KI; Karrer, LB; Leslie, HM; Neeley, E; Pauly, D; Polasky, S; Ris, B; St Martin, K; Stone, GS; Sumaila, UR; Zeller, D				Halpern, Benjamin S.; Longo, Catherine; Hardy, Darren; McLeod, Karen L.; Samhouri, Jameal F.; Katona, Steven K.; Kleisner, Kristin; Lester, Sarah E.; O'Leary, Jennifer; Ranelletti, Marla; Rosenberg, Andrew A.; Scarborough, Courtney; Selig, Elizabeth R.; Best, Benjamin D.; Brumbaugh, Daniel R.; Chapin, F. Stuart; Crowder, Larry B.; Daly, Kendra L.; Doney, Scott C.; Elfes, Cristiane; Fogarty, Michael J.; Gaines, Steven D.; Jacobsen, Kelsey I.; Karrer, Leah Bunce; Leslie, Heather M.; Neeley, Elizabeth; Pauly, Daniel; Polasky, Stephen; Ris, Bud; St Martin, Kevin; Stone, Gregory S.; Sumaila, U. Rashid; Zeller, Dirk			An index to assess the health and benefits of the global ocean	NATURE			English	Article							SAFE OPERATING SPACE; ECOSYSTEM HEALTH; INDICATORS; FRAMEWORK; IMPACTS	The ocean plays a critical role in supporting human well-being, from providing food, livelihoods and recreational opportunities to regulating the global climate. Sustainable management aimed at maintaining the flow of a broad range of benefits from the ocean requires a comprehensive and quantitative method to measure and monitor the health of coupled human-ocean systems. We created an index comprising ten diverse public goals for a healthy coupled human-ocean system and calculated the index for every coastal country. Globally, the overall index score was 60 out of 100 (range 36-86), with developed countries generally performing better than developing countries, but with notable exceptions. Only 5% of countries scored higher than 70, whereas 32% scored lower than 50. The index provides a powerful tool to raise public awareness, direct resource management, improve policy and prioritize scientific research.	[Halpern, Benjamin S.; Longo, Catherine; Hardy, Darren; O'Leary, Jennifer; Ranelletti, Marla; Scarborough, Courtney] Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA; [Halpern, Benjamin S.] Univ Calif Santa Barbara, Ctr Marine Assessment & Planning, Santa Barbara, CA 93106 USA; [McLeod, Karen L.] Oregon State Univ, Dept Zool, COMPASS, Corvallis, OR 97331 USA; [Samhouri, Jameal F.] NOAA, Conservat Biol Div, NW Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98112 USA; [Katona, Steven K.; Rosenberg, Andrew A.; Selig, Elizabeth R.; Karrer, Leah Bunce; Stone, Gregory S.] Conservat Int, Arlington, VA 22202 USA; [Kleisner, Kristin; Pauly, Daniel; Sumaila, U. Rashid; Zeller, Dirk] Univ British Columbia, Fisheries Ctr, Sea Us Project, Vancouver, BC V6T 1Z4, Canada; [Lester, Sarah E.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Lester, Sarah E.; Gaines, Steven D.; Jacobsen, Kelsey I.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Best, Benjamin D.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Brumbaugh, Daniel R.] Amer Museum Nat Hist, Ctr Biodivers & Conservat, New York, NY 10024 USA; [Chapin, F. Stuart] Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK 99775 USA; [Crowder, Larry B.] Stanford Univ, Ctr Ocean Solut, Monterey, CA 93940 USA; [Crowder, Larry B.] Stanford Univ, Hopkins Marine Stn, Monterey, CA 93940 USA; [Daly, Kendra L.] Univ S Florida, Coll Marine Sci, St Petersburg, FL 33705 USA; [Doney, Scott C.] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; [Elfes, Cristiane] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Elfes, Cristiane] Conservat Int, IUCN Global Species Programme, Biodivers Assessment Unit, Arlington, VA 22202 USA; [Fogarty, Michael J.] NE Fisheries Sci Ctr, Woods Hole, MA 02453 USA; [Leslie, Heather M.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Leslie, Heather M.] Brown Univ, Ctr Environm Studies, Providence, RI 02912 USA; [Neeley, Elizabeth] Univ Washington, Sch Aquat & Fisheries Sci, COMPASS, Seattle, WA 98195 USA; [Polasky, Stephen] Univ Minnesota, Dept Appl Econ, St Paul, MN 55108 USA; [Ris, Bud] New England Aquarium, Cent Wharf, Boston, MA 02110 USA; [St Martin, Kevin] Rutgers State Univ, Dept Geog, Piscataway, NJ 08854 USA	National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; Oregon State University; National Oceanic Atmospheric Admin (NOAA) - USA; Conservation International; University of British Columbia; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Duke University; American Museum of Natural History (AMNH); University of Alaska System; University of Alaska Fairbanks; Stanford University; Stanford University; State University System of Florida; University of South Florida; Woods Hole Oceanographic Institution; University of California System; University of California Santa Barbara; Conservation International; National Oceanic Atmospheric Admin (NOAA) - USA; Brown University; Brown University; University of Washington; University of Washington Seattle; University of Minnesota System; University of Minnesota Twin Cities; Rutgers State University New Brunswick	Halpern, BS (corresponding author), Natl Ctr Ecol Anal & Synth, 735 State St,Suite 300, Santa Barbara, CA 93101 USA.	halpern@nceas.ucsb.edu	O'Leary, Jennifer/C-9653-2013; Chapin, F Stuart/AAZ-3931-2020; Neeley, Liz/AAT-2019-2020; Sumaila, U. Rashid/ABE-6475-2020; Leslie, Heather M./I-7812-2019; Leslie, Heather/B-4980-2014; Gaines, Steven/Y-3234-2019; Doney, Scott C/F-9247-2010; Polasky, Stephen/AAC-5341-2019; Pauly, Daniel Marc/AAY-2316-2021	O'Leary, Jennifer/0000-0002-1975-7893; Chapin, F Stuart/0000-0002-2558-9910; Neeley, Liz/0000-0002-3031-1470; Leslie, Heather M./0000-0003-4512-9417; Doney, Scott C/0000-0002-3683-2437; Pauly, Daniel/0000-0003-3756-4793; Zeller, Dirk/0000-0001-7304-4125; Scarborough, Courtney/0000-0001-7270-9228; St. Martin, Kevin/0000-0003-3775-1601	Pacific Life Foundation; Thomas W. Haas Fund of the New Hampshire Charitable Foundation; Oak Foundation; Akiko Shiraki Dynner Fund for Ocean Exploration and Conservation; Darden Restaurants Inc. Foundation; Conservation International; New England Aquarium; National Geographic; National Center for Ecological Analysis and Synthesis; David and Lucile Packard Foundation; Pew Charitable Trusts; Direct For Social, Behav & Economic Scie [0949710] Funding Source: National Science Foundation	Pacific Life Foundation; Thomas W. Haas Fund of the New Hampshire Charitable Foundation; Oak Foundation; Akiko Shiraki Dynner Fund for Ocean Exploration and Conservation; Darden Restaurants Inc. Foundation; Conservation International; New England Aquarium; National Geographic(National Geographic Society); National Center for Ecological Analysis and Synthesis; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Pew Charitable Trusts; Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	B. Wrigley and H. Wrigley provided the founding grant. Additional financial and in-kind support was provided by the Pacific Life Foundation, Thomas W. Haas Fund of the New Hampshire Charitable Foundation, the Oak Foundation, Akiko Shiraki Dynner Fund for Ocean Exploration and Conservation, Darden Restaurants Inc. Foundation, Conservation International, New England Aquarium, National Geographic, and the National Center for Ecological Analysis and Synthesis, which supported the Ecosystem Health Working Group as part of the Science of Ecosystem-Based Management project funded by the David and Lucile Packard Foundation. We would like to thank L. Bergen, J. Bort, B. Bronson, C. Costello, N. Crone, A. Dickson, J. Francis, A. Ghermandi, R. Haskell, L. Kaufman, K. Law, L. Madin, P. Nunes, D. Obura, L. Onofri, J. Packard, R. Portela, N. Rao, J. Regetz, S. Running, K. Selkoe, L. Speer, B. Spitzer, P. Stevick, H. Tallis, H. Tausig, S. Troeng and D. Zeyen for helpful discussions and logistical support during development of the index. Individual authors also acknowledge additional support from NSF, NASA, NOAA, Stanford's Center for Ocean Solutions and the Jaffe Family Foundation. K. K., D. P., U. R. S. and D.Z. thank the Sea Around Us Project, with support from the Pew Charitable Trusts. Data reported in this paper are tabulated in the Supplementary Information and archived at http://ohi.nceas.ucsb.edu/data. Results can be explored and visualized at http://oceanhealthindex.org.	Alder J, 2010, MAR POLICY, V34, P468, DOI 10.1016/j.marpol.2009.10.001; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; CAIRNS J, 1993, HYDROBIOLOGIA, V263, P1, DOI 10.1007/BF00006084; Convention on Biological Diversity, 2010, STRAT PLAN BIOD 2011; Costanza R, 1992, ECOSYSTEM HLTH NEW G, P239; Donoghue J., 1997, ANN M AM SOC INT LAW; Emerson J., 2008, STATE NATIONS ECOSYS; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Glover D. M., 2011, MODELING METHODS MAR; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2009, CONSERV LETT, V2, P138, DOI 10.1111/j.1755-263X.2009.00058.x; Heinz H.J, 2013, STATE NATIONS ECOSYS; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kareiva P, 2011, NATURAL CAPITAL: THEORY & PRACTICE OF MAPPING ECOSYSTEM SERVICES, P1, DOI 10.1093/acprof:oso/9780199588992.001.0001; Kareiva P, 2007, SCIENCE, V316, P1866, DOI 10.1126/science.1140170; KELLY JR, 1990, ENVIRON MANAGE, V14, P527, DOI 10.1007/BF02394708; Kershner J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025248; McLeod K., 2009, ECOSYSTEM BASED MANA; Michelle Marvier, 2011, BREAKTHROUGH J; Millennium, 2005, EC HUM WELL BEING SY; Munoz-Erickson TA, 2007, ECOL SOC, V12; National Ocean Council, 2012, DRAFT NAT OC POL IMP; Nellemann C., 2008, DEAD WATER MERGING C; Newton AC, 2011, CONSERV LETT, V4, P264, DOI 10.1111/j.1755-263X.2011.00167.x; Niemeijer D, 2008, ECOL INDIC, V8, P14, DOI 10.1016/j.ecolind.2006.11.012; Obama Barack H., 2010, 13547 ADM BH OB; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Rapport DJ, 1998, TRENDS ECOL EVOL, V13, P397, DOI 10.1016/S0169-5347(98)01449-9; Rapport DJ, 1999, ECOSYST HEALTH, V5, P82, DOI 10.1046/j.1526-0992.1999.09913.x; Rice JC, 2005, ICES J MAR SCI, V62, P516, DOI 10.1016/j.icesjms.2005.01.003; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Samhouri JF, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00366.1; Shackeroff J. M., 2009, ECOSYSTEM BASED MANA, P33; United Nations Development Programme, 2010, HUM DEV REP; World Bank Group, 2010, WORLDW GOV IND; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146	37	577	620	34	645	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 30	2012	488	7413					615	+		10.1038/nature11397	http://dx.doi.org/10.1038/nature11397			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996NC	22895186				2022-12-28	WOS:000308095100048
J	Pearce, TM; Moran, DW				Pearce, Thomas M.; Moran, Daniel W.			Strategy-Dependent Encoding of Planned Arm Movements in the Dorsal Premotor Cortex	SCIENCE			English	Article							MOTOR CORTICAL REPRESENTATION; REACHING MOVEMENTS; SPATIAL ATTENTION; DELAY PERIOD; DIRECTION; POSITION; PARIETAL; PRIMATE; AREA; HAND	The kinematic strategy encoded in motor cortical areas for classic straight-line reaching is remarkably simple and consistent across subjects, despite the complicated musculoskeletal dynamics that are involved. As tasks become more challenging, however, different conscious strategies may be used to improve perceived behavioral performance. We identified additional spatial information that appeared both in single neurons and in the population code of monkey dorsal premotor cortex when obstacles impeded direct reach paths. The neural correlate of movement planning varied between subjects in a manner consistent with the use of different strategies to optimize task completion. These distinct planning strategies were manifested in the timing and strength of the information contained in the neural population code.	[Pearce, Thomas M.; Moran, Daniel W.] Washington Univ, St Louis, MO 63130 USA	Washington University (WUSTL)	Moran, DW (corresponding author), Washington Univ, St Louis, MO 63130 USA.	dmoran@wustl.edu		Pearce, Thomas/0000-0002-5712-9492	NIH [R01NS057813, F30 NS071690-01]; NSF [IGERT 0548890]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS071690, R01NS057813] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful for the support of NIH grant R01NS057813, NIH F30 NS071690-01, and NSF IGERT 0548890.	Baldauf D, 2011, NEUROPSYCHOLOGIA, V49, P1383, DOI 10.1016/j.neuropsychologia.2011.01.041; Busan P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004621; Catalan MJ, 1998, BRAIN, V121, P253, DOI 10.1093/brain/121.2.253; Churchland MM, 2007, J NEUROPHYSIOL, V97, P4235, DOI 10.1152/jn.00095.2007; Churchland MM, 2007, J NEUROPHYSIOL, V97, P348, DOI 10.1152/jn.00808.2006; Cisek P, 2005, NEURON, V45, P801, DOI 10.1016/j.neuron.2005.01.027; Crammond DJ, 2000, J NEUROPHYSIOL, V84, P986, DOI 10.1152/jn.2000.84.2.986; DIPELLEGRINO G, 1993, SOMATOSENS MOT RES, V10, P245; FOGASSI L, 1992, EXP BRAIN RES, V89, P686, DOI 10.1007/BF00229894; GEORGOPOULOS AP, 1989, EXP BRAIN RES, V75, P183; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; HOCHERMAN S, 1991, EXP BRAIN RES, V83, P285; KALASKA JF, 1992, SCIENCE, V255, P1517, DOI 10.1126/science.1549781; Kurata K, 2000, J NEUROPHYSIOL, V84, P1667, DOI 10.1152/jn.2000.84.3.1667; Lebedev MA, 2001, EUR J NEUROSCI, V13, P1002, DOI 10.1046/j.0953-816x.2001.01457.x; Moran DW, 1999, J NEUROPHYSIOL, V82, P2676, DOI 10.1152/jn.1999.82.5.2676; Ochiai T, 2002, J NEUROPHYSIOL, V88, P2167, DOI 10.1152/jn.2002.88.4.2167; Pesaran B, 2006, NEURON, V51, P125, DOI 10.1016/j.neuron.2006.05.025; Schaal S, 2007, PROG BRAIN RES, V165, P425, DOI 10.1016/S0079-6123(06)65027-9; Schwartz AB, 2004, SCIENCE, V303, P380, DOI 10.1126/science.1087788; Shadmehr R., 2005, COMPUTATIONAL NEUROB; Shen LM, 1997, J NEUROPHYSIOL, V77, P1195, DOI 10.1152/jn.1997.77.3.1195; Simon SR, 2002, J NEUROPHYSIOL, V88, P2047, DOI 10.1152/jn.2002.88.4.2047; Wang W, 2007, J NEUROPHYSIOL, V97, P4258, DOI 10.1152/jn.01180.2006; WEINRICH M, 1982, J NEUROSCI, V2, P1329; Wise SP, 1997, ANNU REV NEUROSCI, V20, P25, DOI 10.1146/annurev.neuro.20.1.25; WISE SP, 1985, ANNU REV NEUROSCI, V8, P1, DOI 10.1146/annurev.ne.08.030185.000245	27	46	46	2	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 24	2012	337	6097					984	988		10.1126/science.1220642	http://dx.doi.org/10.1126/science.1220642			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992VI	22821987	Green Accepted			2022-12-28	WOS:000307807600050
J	Wang, Y; Kim, E; Wang, XJ; Novitch, BG; Yoshikawa, K; Chang, LS; Zhu, Y				Wang, Yuan; Kim, Edward; Wang, Xiaojing; Novitch, Bennett G.; Yoshikawa, Kazuaki; Chang, Long-Sheng; Zhu, Yuan			ERK Inhibition Rescues Defects in Fate Specification of Nf1-Deficient Neural Progenitors and Brain Abnormalities	CELL			English	Article							NEUROFIBROMATOSIS TYPE-1; SUBVENTRICULAR ZONE; SIGNALING PATHWAYS; CORPUS-CALLOSUM; SONIC HEDGEHOG; NF1; RAS; OLIGODENDROCYTES; NEURONS; NEUROGENESIS	Germline mutations in the RAS/ERK signaling pathway underlie several related developmental disorders collectively termed neuro-cardio-facial-cutaneous (NCFC) syndromes. NCFC patients manifest varying degrees of cognitive impairment, but the developmental basis of their brain abnormalities remains largely unknown. Neurofibromatosis type 1 (NF1), an NCFC syndrome, is caused by loss-of-function heterozygous mutations in the NF1 gene, which encodes neurofibromin, a RAS GTPase-activating protein. Here, we show that biallelic Nf1 inactivation promotes Erk-dependent, ectopic Olig2 expression specifically in transit-amplifying progenitors, leading to increased gliogenesis at the expense of neurogenesis in neonatal and adult subventricular zone (SVZ). Nf1-deficient brains exhibit enlarged corpus callosum, a structural defect linked to severe learning deficits in NF1 patients. Strikingly, these NF1-associated developmental defects are rescued by transient treatment with an MEK/ERK inhibitor during neonatal stages. This study reveals a critical role for Nf1 in maintaining postnatal SVZ-derived neurogenesis and identifies a potential therapeutic window for treating NF1-associated brain abnormalities.	[Wang, Yuan; Kim, Edward; Wang, Xiaojing; Zhu, Yuan] Univ Michigan, Sch Med, Div Mol Med & Genet, Dept Internal Med, Ann Arbor, MI 48109 USA; [Wang, Yuan; Kim, Edward; Wang, Xiaojing; Zhu, Yuan] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Novitch, Bennett G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Yoshikawa, Kazuaki] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Chang, Long-Sheng] Nationwide Childrens Hosp, Dept Pediat, Columbus, OH 43205 USA; [Chang, Long-Sheng] Ohio State Univ, Columbus, OH 43205 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Osaka University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University	Zhu, Y (corresponding author), Univ Michigan, Sch Med, Div Mol Med & Genet, Dept Internal Med, Ann Arbor, MI 48109 USA.	yuanzhu@umich.edu	Chang, Long-sheng/E-2871-2011; Zhu, Yuan/ABF-8405-2020; Wang, Yuan/I-7717-2014	Chang, Long-Sheng/0000-0002-5178-2992; Wang, Yuan/0000-0002-6324-6134; Novitch, Bennett/0000-0002-2696-3708; Wang, Yuan/0000-0003-1681-9566	NIH [1R01 NS053900]; DOD [W81XWH-11-1-0251]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072804, R01NS053976, R01NS053900, R01NS073762] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Best, L. Cregan, and G. Tomasek for technical assistance; members of the Y.Z. lab for support; J. Harrison, D. Sorenson, and S. Meshinchi at the MIL core facility for EM analysis; A. Messing for providing hGFAP-cre mice; and Dr. H. Song, D. Wellik, K. S. O'Shea, J. Sebolt-Leopold, and E. Fearon for critically reading the manuscript. This work is supported by grants from the NIH (1R01 NS053900) and DOD (W81XWH-11-1-0251) (to Y.Z.).	Bentires-Alj M, 2006, NAT MED, V12, P283, DOI 10.1038/nm0306-283; Bilican B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002863; BOS JL, 1989, CANCER RES, V49, P4682; Burns KA, 2007, CEREB CORTEX, V17, P2585, DOI 10.1093/cercor/bhl164; Cai J, 2007, DEVELOPMENT, V134, P1887, DOI 10.1242/dev.02847; Chandran S, 2003, DEVELOPMENT, V130, P6599, DOI 10.1242/dev.00871; Cichowski K, 2001, CELL, V104, P593, DOI 10.1016/S0092-8674(01)00245-8; Cui YJ, 2008, CELL, V135, P549, DOI 10.1016/j.cell.2008.09.060; Davis S, 2006, GENES BRAIN BEHAV, V5, P61, DOI 10.1111/j.1601-183X.2006.00230.x; De Schepper S, 2008, J INVEST DERMATOL, V128, P1050, DOI 10.1038/sj.jid.5701095; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; Hegedus B, 2007, CELL STEM CELL, V1, P443, DOI 10.1016/j.stem.2007.07.008; Hyman SL, 2005, NEUROLOGY, V65, P1037, DOI 10.1212/01.wnl.0000179303.72345.ce; Ihrie RA, 2011, NEURON, V70, P674, DOI 10.1016/j.neuron.2011.05.004; Kessaris N, 2004, DEVELOPMENT, V131, P1289, DOI 10.1242/dev.01027; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Lee DY, 2010, GENE DEV, V24, P2317, DOI 10.1101/gad.1957110; Listernick R, 1999, AM J MED GENET, V89, P38, DOI 10.1002/(SICI)1096-8628(19990326)89:1<38::AID-AJMG8>3.0.CO;2-M; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; Marshall CAG, 2005, J NEUROSCI, V25, P7289, DOI 10.1523/JNEUROSCI.1924-05.2005; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Moore BD, 2000, NEUROLOGY, V54, P914, DOI 10.1212/WNL.54.4.914; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; Payne JM, 2010, J NEUROL NEUROSUR PS, V81, P304, DOI 10.1136/jnnp.2009.179630; Petryniak MA, 2007, NEURON, V55, P417, DOI 10.1016/j.neuron.2007.06.036; Pride N, 2010, J CHILD NEUROL, V25, P834, DOI 10.1177/0883073809350723; Riccardi V. M., 1992, NEUROFIBROMATOSIS PH; Richards LJ, 2004, CLIN GENET, V66, P276, DOI 10.1111/j.1399-0004.2004.00354.x; Richardson WD, 2006, NAT REV NEUROSCI, V7, P11, DOI 10.1038/nrn1826; Rowitch DH, 2010, NATURE, V468, P214, DOI 10.1038/nature09611; Rubinfeld H, 2005, MOL BIOTECHNOL, V31, P151, DOI 10.1385/MB:31:2:151; Samuels IS, 2008, J NEUROSCI, V28, P6983, DOI 10.1523/JNEUROSCI.0679-08.2008; Samuels IS, 2009, NEURON, V61, P160, DOI 10.1016/j.neuron.2009.01.001; Satoh Y, 2011, J NEUROSCI, V31, P1149, DOI 10.1523/JNEUROSCI.2243-10.2011; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Stevenson DA, 2006, AM J HUM GENET, V79, P143, DOI 10.1086/504441; Tan MJ, 2011, DEV CELL, V21, P1062, DOI 10.1016/j.devcel.2011.09.014; Tidyman WE, 2009, CURR OPIN GENET DEV, V19, P230, DOI 10.1016/j.gde.2009.04.001; Waggoner DJ, 2000, AM J MED GENET, V92, P132, DOI 10.1002/(SICI)1096-8628(20000515)92:2<132::AID-AJMG10>3.0.CO;2-6; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3; Zhu Y, 2005, DEVELOPMENT, V132, P5577, DOI 10.1242/dev.02162; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	48	98	102	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 17	2012	150	4					816	830		10.1016/j.cell.2012.06.034	http://dx.doi.org/10.1016/j.cell.2012.06.034			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	995IT	22901811	Green Accepted, Bronze			2022-12-28	WOS:000308002300015
J	Muller, FL; Colla, S; Aquilanti, E; Manzo, VE; Genovese, G; Lee, J; Eisenson, D; Narurkar, R; Deng, PN; Nezi, L; Lee, MA; Hu, BL; Hu, J; Sahin, E; Ong, D; Fletcher-Sananikone, E; Ho, D; Kwong, L; Brennan, C; Wang, YA; Chin, L; DePinho, RA				Muller, Florian L.; Colla, Simona; Aquilanti, Elisa; Manzo, Veronica E.; Genovese, Giannicola; Lee, Jaclyn; Eisenson, Daniel; Narurkar, Rujuta; Deng, Pingna; Nezi, Luigi; Lee, Michelle A.; Hu, Baoli; Hu, Jian; Sahin, Ergun; Ong, Derrick; Fletcher-Sananikone, Eliot; Ho, Dennis; Kwong, Lawrence; Brennan, Cameron; Wang, Y. Alan; Chin, Lynda; DePinho, Ronald A.			Passenger deletions generate therapeutic vulnerabilities in cancer	NATURE			English	Article							ENOLASE DEFICIENCY; INHIBITION; REGIONS; CELLS	Inactivation of tumour-suppressor genes by homozygous deletion is a prototypic event in the cancer genome, yet such deletions often encompass neighbouring genes. We propose that homozygous deletions in such passenger genes can expose cancer-specific therapeutic vulnerabilities when the collaterally deleted gene is a member of a functionally redundant family of genes carrying out an essential function. The glycolytic gene enolase 1 (ENO1) in the 1p36 locus is deleted in glioblastoma (GBM), which is tolerated by the expression of ENO2. Here we show that short-hairpin-RNA-mediated silencing of ENO2 selectively inhibits growth, survival and the tumorigenic potential of ENO1-deleted GBM cells, and that the enolase inhibitor phosphonoacetohydroxamate is selectively toxic to ENO1-deleted GBM cells relative to ENO1-intact GBM cells or normal astrocytes. The principle of collateral vulnerability should be applicable to other passenger-deleted genes encoding functionally redundant essential activities and provide an effective treatment strategy for cancers containing such genomic events.	[Muller, Florian L.; Colla, Simona; Aquilanti, Elisa; Manzo, Veronica E.; Genovese, Giannicola; Lee, Jaclyn; Eisenson, Daniel; Narurkar, Rujuta; Deng, Pingna; Nezi, Luigi; Lee, Michelle A.; Hu, Baoli; Hu, Jian; Sahin, Ergun; Ong, Derrick; Fletcher-Sananikone, Eliot; Ho, Dennis; Kwong, Lawrence; Wang, Y. Alan; Chin, Lynda; DePinho, Ronald A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Muller, Florian L.; Colla, Simona; Genovese, Giannicola; Deng, Pingna; Nezi, Luigi; Hu, Baoli; Hu, Jian; Ong, Derrick; Fletcher-Sananikone, Eliot; Kwong, Lawrence; Wang, Y. Alan; Chin, Lynda] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Muller, Florian L.; Colla, Simona; Hu, Jian; Sahin, Ergun; Ong, Derrick; Ho, Dennis; DePinho, Ronald A.] Harvard Univ, Sch Med, Dept Genet & Med, Boston, MA 02115 USA; [Lee, Michelle A.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Hu, Baoli; Wang, Y. Alan; Chin, Lynda; DePinho, Ronald A.] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA; [Brennan, Cameron] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10065 USA; [DePinho, Ronald A.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA	Harvard University; Dana-Farber Cancer Institute; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Memorial Sloan Kettering Cancer Center; University of Texas System; UTMD Anderson Cancer Center	DePinho, RA (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	rdepinho@mdanderson.org	Nezi, Luigi/AAB-1957-2019; Brennan, Cameron/R-7082-2019	Nezi, Luigi/0000-0002-4670-7656; Brennan, Cameron/0000-0003-4064-8891; DePinho, Ronald/0000-0002-5625-577X; Lee, Jaclyn/0000-0001-9804-6995; Genovese, Giannicola/0000-0003-1392-9954; Colla, Simona/0000-0001-6583-8910; Eisenson, Daniel/0000-0003-3868-0403; Muller, Florian/0000-0001-7568-2948	National Institutes of Health (NIH) [T32-CA009361, P01CA95616]; American Cancer Society [115992-PF-08-261-01-TBE]; Dana-Farber Cancer Institute/Harvard Cancer Center Myeloma SPORE career development grant; Howard Hughes Medical Institute Medical Research Fellowship [57006984]; Harvard PRISE fellowship; Diversity in Health-Related research award [3 P01 CA095616-08S1]; Ben and Catherine Ivy Foundation; NATIONAL CANCER INSTITUTE [T32CA009361, P01CA095616] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Dana-Farber Cancer Institute/Harvard Cancer Center Myeloma SPORE career development grant; Howard Hughes Medical Institute Medical Research Fellowship(Howard Hughes Medical Institute); Harvard PRISE fellowship; Diversity in Health-Related research award; Ben and Catherine Ivy Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank K. Ligon, C. Maire, D. N. Louis, J. Kimand G. Mohapatra for sharing bioinformatics data from their tumour neurosphere banks. We also thank D. Bigner for sharing the D423-MG and D502-MG cell lines and D. N. Louis and J. Kim for sharing the Gli56 cell line. We thank G. Chu and D. Jakubosky for assistance with necropsy and histopathological analysis. F. L. M. was supported by a training grant from the National Institutes of Health (NIH T32-CA009361) and a fellowship from the American Cancer Society (115992-PF-08-261-01-TBE). S. C. was supported by a Dana-Farber Cancer Institute/Harvard Cancer Center Myeloma SPORE career development grant. E. A. was supported by a Howard Hughes Medical Institute Medical Research Fellowship (57006984). V. M. was supported by a Harvard PRISE fellowship. M. A. L. was supported by a Diversity in Health-Related research award (3 P01 CA095616-08S1). F. L. M. thanks J. Mohr for assistance with figure preparations. We also thank K. Muller for assistance with manuscript editing. We thank all members of the DePinho and Chin laboratories for suggestions and discussions. This work is supported by the NIH (P01CA95616 to C. B., L. C. and R. A. D.) and by the Ben and Catherine Ivy Foundation (to R. A. D. and L.C.).	ANDERSON VE, 1984, BIOCHEMISTRY-US, V23, P2779, DOI 10.1021/bi00307a038; Bagchi A, 2008, CANCER RES, V68, P2551, DOI 10.1158/0008-5472.CAN-07-2095; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Brookfield JFY, 1997, ADV GENET, V36, P137, DOI 10.1016/S0065-2660(08)60308-9; Buszczak M, 2007, GENETICS, V175, P1505, DOI 10.1534/genetics.106.065961; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Comi GP, 2001, ANN NEUROL, V50, P202, DOI 10.1002/ana.1095; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Cox C, 2005, P NATL ACAD SCI USA, V102, P4542, DOI 10.1073/pnas.0408593102; De Soto Joseph A, 2006, Int J Med Sci, V3, P117; DeLuna A, 2008, NAT GENET, V40, P676, DOI 10.1038/ng.123; Deutscher D, 2006, NAT GENET, V38, P993, DOI 10.1038/ng1856; Druker BJ, 2008, BLOOD, V112, P4808, DOI 10.1182/blood-2008-07-077958; Duncan CD, 2010, ADVANCED CRIME SCENE PHOTOGRAPHY, P1; Guha M, 2011, NAT BIOTECHNOL, V29, P373, DOI 10.1038/nbt0511-373; GuhaChowdhury N, 1997, ORAL MICROBIOL IMMUN, V12, P91, DOI 10.1111/j.1399-302X.1997.tb00623.x; Henrich KO, 2011, CANCER RES, V71, P3142, DOI 10.1158/0008-5472.CAN-10-3014; Jing M, 2007, AM J PHYSIOL-CELL PH, V292, pC477, DOI 10.1152/ajpcell.00196.2006; Joseph J, 1996, J NEUROCHEM, V66, P2484; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Kotliarov Y, 2006, CANCER RES, V66, P9428, DOI 10.1158/0008-5472.CAN-06-1691; Mueller W, 2007, ONCOGENE, V26, P583, DOI 10.1038/sj.onc.1209805; Navarro MVDS, 2007, FEBS J, V274, P5077, DOI 10.1111/j.1742-4658.2007.06027.x; Peng W. X., 2007, CANCER SCI, V96, P661; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; POYNER RR, 1992, BIOCHEMISTRY-US, V31, P7166, DOI 10.1021/bi00146a020; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; STEFANINI M, 1972, AM J CLIN PATHOL, V58, P408; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; Vavouri T, 2008, TRENDS GENET, V24, P485, DOI 10.1016/j.tig.2008.08.005; Weidle UH, 2011, CANCER GENOM PROTEOM, V8, P159; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Yin D, 2009, MOL CANCER RES, V7, P665, DOI 10.1158/1541-7786.MCR-08-0270; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443	37	224	235	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2012	488	7411					337	+		10.1038/nature11331	http://dx.doi.org/10.1038/nature11331			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OS	22895339	Green Accepted			2022-12-28	WOS:000307501000033
J	Glasziou, PP; Buchan, H; Del Mar, C; Doust, J; Harris, M; Knight, R; Scott, A; Scott, IA; Stockwell, A				Glasziou, Paul P.; Buchan, Heather; Del Mar, Chris; Doust, Jenny; Harris, Mark; Knight, Rosemary; Scott, Anthony; Scott, Ian A.; Stockwell, Alexis			When financial incentives do more good than harm: a checklist	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PRIMARY-CARE; HEALTH-CARE; QUALITY; IMPACT; PERFORMANCE; IMPLEMENTATION; INDICATORS; ENGLAND; PAY		[Glasziou, Paul P.; Del Mar, Chris; Doust, Jenny] Bond Univ, Fac Hlth Sci & Med, Ctr Res Evidence Based Practice, Gold Coast, Qld 4229, Australia; [Buchan, Heather] Australian Commiss Safety & Qual Hlth Care, Sydney, NSW, Australia; [Harris, Mark; Knight, Rosemary] Univ New S Wales, Sydney, NSW, Australia; [Scott, Anthony] Univ Melbourne, Melbourne, Vic 3010, Australia; [Scott, Ian A.] Univ Queensland, Brisbane, Qld, Australia; [Stockwell, Alexis] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia	Bond University; University of New South Wales Sydney; University of Melbourne; University of Queensland; Queensland University of Technology (QUT)	Glasziou, PP (corresponding author), Bond Univ, Fac Hlth Sci & Med, Ctr Res Evidence Based Practice, Gold Coast, Qld 4229, Australia.	Paul_Glasziou@bond.edu.au	Glasziou, Paul/A-7832-2008; Scott, Anthony/E-6636-2010; Doust, Jenny/AGI-8773-2022; Scott, Ian A/F-1482-2011; Scott, Ian/Z-4577-2019; Harris, Mark F/I-2793-2019; Del Mar, Chris/B-1136-2008	Glasziou, Paul/0000-0001-7564-073X; Scott, Anthony/0000-0002-2851-5378; Doust, Jenny/0000-0002-4024-9308; Harris, Mark F/0000-0002-0705-8913; Del Mar, Chris/0000-0003-3821-8163; Scott, Ian/0000-0002-7596-0837				Achat H, 1999, AUST NZ J PUBL HEAL, V23, P285, DOI 10.1111/j.1467-842X.1999.tb01257.x; Baker R, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005470.pub2; Benabou R, 2003, REV ECON STUD, V70, P489, DOI 10.1111/1467-937X.00253; Campbell SM, 2009, NEW ENGL J MED, V361, P368, DOI 10.1056/NEJMsa0807651; Chen Judy Ying, 2010, J Healthc Qual, V32, P13; *COMM RED HLTH INS, 2006, PERF MEAS ACC IMPR; Doran T, 2008, LANCET, V372, P728, DOI 10.1016/S0140-6736(08)61123-X; Flodgren G, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009255; Gerstein HC, 2011, NEW ENGL J MED, V364, P818, DOI 10.1056/NEJMoa1006524; Grimshaw JM, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8060; Health Policy and Economic Research Unit, 2005, BMA SURV A E WAIT TI; Hutchison Brian, 2008, Healthc Policy, V4, P10; Jenkins GD, 1998, J APPL PSYCHOL, V83, P777, DOI 10.1037/0021-9010.83.5.777; Jha AK, 2012, NEW ENGL J MED, V366, P1606, DOI 10.1056/NEJMsa1112351; Lester H, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1898; McDonald J, 2008, MED J AUSTRALIA, V188, pS69, DOI 10.5694/j.1326-5377.2008.tb01749.x; McDonald R., 2010, IMPACT INCENTIVES BE; McDonald R, 2007, BMJ-BRIT MED J, V334, P1357, DOI 10.1136/bmj.39238.890810.BE; McDonald R, 2009, ANN FAM MED, V7, P121, DOI 10.1370/afm.946; Oxman AD, 2007, LANCET, V369, P1883, DOI 10.1016/S0140-6736(07)60675-8; Roski J, 2003, PREV MED, V36, P291, DOI 10.1016/S0091-7435(02)00052-X; Scott A, 2011, COCHRANE DB SYST REV, V9, DOI DOI 10.1002/14651858.CD008451.PUB2; Tricoci P, 2009, JAMA-J AM MED ASSOC, V301, P831, DOI 10.1001/jama.2009.205; Van Herck P, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-247	24	54	54	0	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 14	2012	345								e5047	10.1136/bmj.e5047	http://dx.doi.org/10.1136/bmj.e5047			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	992CD	22893568	Green Submitted			2022-12-28	WOS:000307752000003
J	Hariz, MI; Hariz, GM				Hariz, Marwan I.; Hariz, Gun-Marie			Hyping deep brain stimulation in psychiatry could lead to its demise	BRITISH MEDICAL JOURNAL			English	Editorial Material							OBSESSIVE-COMPULSIVE DISORDER; SURGERY; NUCLEUS; DISEASE		[Hariz, Marwan I.] UCL Inst Neurol, London, England; [Hariz, Gun-Marie] Umea Univ, Dept Community Med & Rehabil, Umea, Sweden	University of London; University College London; Umea University	Hariz, MI (corresponding author), UCL Inst Neurol, Queen Sq, London, England.	m.hariz@ucl.ac.uk						Baumeister A A, 2000, J Hist Neurosci, V9, P262, DOI 10.1076/jhin.9.3.262.1787; BENABID AL, 1987, APPL NEUROPHYSIOL, V50, P344; BRICE J, 1980, LANCET, V1, P1221; Delgado J. M. R., 1969, PHYS CONTROL MIND PS; Fins JJ, 2011, HEALTH AFFAIR, V30, P302, DOI 10.1377/hlthaff.2010.0157; Fodstad H, 2007, ACTA NEUROCHIR SUPPL, V97, P11; Fumagalli M, 2012, BRAIN, V135, P2006, DOI 10.1093/brain/awr334; Hariz MI, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.4.FOCUS10106; Krack P, 2010, TRENDS NEUROSCI, V33, P474, DOI 10.1016/j.tins.2010.07.002; Krauss JK, 1999, LANCET, V354, P837, DOI 10.1016/S0140-6736(99)80022-1; LIMOUSIN P, 1995, LANCET, V345, P91, DOI 10.1016/S0140-6736(95)90062-4; Lipsman N, 2011, STEREOT FUNCT NEUROS, V89, P103, DOI 10.1159/000323545; MOAN CE, 1972, J BEHAV THER EXP PSY, V3, P23, DOI 10.1016/0005-7916(72)90029-8; Nuttin B, 1999, LANCET, V354, P1526, DOI 10.1016/S0140-6736(99)02376-4; Valenstein E.S., 1973, BRAIN CONTROL CRITIC; Vandewalle V, 1999, LANCET, V353, P724, DOI 10.1016/S0140-6736(98)05964-9	16	6	6	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 13	2012	345								e5447	10.1136/bmj.e5447	http://dx.doi.org/10.1136/bmj.e5447			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992BK	22890031				2022-12-28	WOS:000307750100001
J	Bian, ZF; Miao, XX; Lei, SG; Chen, SE; Wang, WF; Struthers, S				Bian, Zhengfu; Miao, Xiexing; Lei, Shaogang; Chen, Shen-en; Wang, Wenfeng; Struthers, Sue			The Challenges of Reusing Mining and Mineral-Processing Wastes	SCIENCE			English	Editorial Material							ENVIRONMENTAL-IMPACT	Mining and mineral-processing wastes are one of the world's largest chronic waste concerns. Their reuse should be included in future sustainable development plans, but the potential impacts on a number of environmental processes are highly variable and must be thoroughly assessed. The chemical composition and geotechnical properties of the source rock determine which uses are most appropriate and whether reuse is economically feasible. If properly evaluated, mining waste can be reused to reextract minerals, provide additional fuel for power plants, supply construction materials, and repair surface and subsurface land structures altered by mining activities themselves.	[Bian, Zhengfu] China Univ Min & Technol, Inst Land Resources, Xuzhou 221116, Jiangsu, Peoples R China; [Miao, Xiexing] China Univ Min & Technol, State Key Lab Geomechan & Deep Underground Engn, Xuzhou 221116, Jiangsu, Peoples R China; [Lei, Shaogang] China Univ Min & Technol, Jiangsu Key Lab Resources & Environm Informat Eng, Xuzhou 221116, Jiangsu, Peoples R China; [Chen, Shen-en] Univ N Carolina, Dept Civil & Environm Engn, Charlotte, NC 28223 USA; [Wang, Wenfeng] China Univ Min & Technol, Sch Resource & Earth Sci, Xuzhou 221116, Jiangsu, Peoples R China; [Struthers, Sue] Skapa Min Serv Ltd, Burray KW17 2SX, Orkney, England	China University of Mining & Technology; China University of Mining & Technology; China University of Mining & Technology; University of North Carolina; University of North Carolina Charlotte; China University of Mining & Technology	Bian, ZF (corresponding author), China Univ Min & Technol, Inst Land Resources, Xuzhou 221116, Jiangsu, Peoples R China.	zfbian@cumt.edu.cn	wang, wenfeng/M-9186-2018	wang, wenfeng/0000-0002-2200-0250				[Anonymous], 2008, D510608 ASTM; Armienta M. A., 2012, APPL GEOCHEM; Bian Z.F., 2007, J MINING SAF ENG, V24, P132; BP 2011, 2011, STAT REV WORLD EN 20; Chen YL, 2011, CONSTR BUILD MATER, V25, P2107, DOI 10.1016/j.conbuildmat.2010.11.025; Franks DM, 2011, RESOUR POLICY, V36, P114, DOI 10.1016/j.resourpol.2010.12.001; Frias M, 2012, CEMENT CONCRETE COMP, V34, P678, DOI 10.1016/j.cemconcomp.2012.02.006; Geise G, 2011, ENVIRON EARTH SCI, V62, P185, DOI 10.1007/s12665-010-0513-7; Golev A, 2012, MINER ENG, V29, P58, DOI 10.1016/j.mineng.2011.10.018; GOODMAN GT, 1978, ENV MANAGEMENT MINER; Heynen J. J. M., 1994, WASTE MAT CONSTRUCTI, P655; Hudson-Edwards KA, 2011, ELEMENTS, V7, P375, DOI 10.2113/gselements.7.6.375; Jamieson HE, 2011, ELEMENTS, V7, P381, DOI 10.2113/gselements.7.6.381; Liu HB, 2010, RESOUR CONSERV RECY, V54, P1331, DOI 10.1016/j.resconrec.2010.05.005; Lottermoser BG, 2011, ELEMENTS, V7, P405, DOI 10.2113/gselements.7.6.405; Miao X., 2008, J CHINA U MIN TECHNO, V18, P479, DOI [10.1016/S1006-1266(08)60279-5, DOI 10.1016/S1006-1266(08)60279-5, DOI 10.3969/J.ISSN.2095-2686.2008.04.001]; Miao XX, 2010, METHOD TECHNOLOGY FU; Palmer MA, 2010, SCIENCE, V327, P148, DOI 10.1126/science.1180543; SKARZYNSKA KM, 1995, WASTE MANAGE, V15, P83, DOI 10.1016/0956-053X(95)00008-N; Smith ML, 1996, ENG GEOL, V43, P11, DOI 10.1016/0013-7952(96)00029-4; Tiruta-Barna L, 2007, RESOUR CONSERV RECY, V50, P351, DOI 10.1016/j.resconrec.2007.01.009; Zhang J.R., 2002, COMPREHENSIVE UTILIZ	22	244	268	35	475	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2012	337	6095					702	703		10.1126/science.1224757	http://dx.doi.org/10.1126/science.1224757			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	986PE	22879511				2022-12-28	WOS:000307354500046
J	Chakraborty, A; Wang, DY; Ebright, YW; Korlann, Y; Kortkhonjia, E; Kim, T; Chowdhury, S; Wigneshweraraj, S; Irschik, H; Jansen, R; Nixon, BT; Knight, J; Weiss, S; Ebright, RH				Chakraborty, Anirban; Wang, Dongye; Ebright, Yon W.; Korlann, You; Kortkhonjia, Ekaterine; Kim, Taiho; Chowdhury, Saikat; Wigneshweraraj, Sivaramesh; Irschik, Herbert; Jansen, Rolf; Nixon, B. Tracy; Knight, Jennifer; Weiss, Shimon; Ebright, Richard H.			Opening and Closing of the Bacterial RNA Polymerase Clamp	SCIENCE			English	Article							ALTERNATING-LASER EXCITATION; 3.3 ANGSTROM RESOLUTION; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; TRANSCRIPTION ELONGATION; SINGLE MOLECULES; SWITCH REGION; INITIATION; PROTEIN	Using single-molecule fluorescence resonance energy transfer, we have defined bacterial RNA polymerase (RNAP) clamp conformation at each step in transcription initiation and elongation. We find that the clamp predominantly is open in free RNAP and early intermediates in transcription initiation but closes upon formation of a catalytically competent transcription initiation complex and remains closed during initial transcription and transcription elongation. We show that four RNAP inhibitors interfere with clamp opening. We propose that clamp opening allows DNA to be loaded into and unwound in the RNAP active-center cleft, that DNA loading and unwinding trigger clamp closure, and that clamp closure accounts for the high stability of initiation complexes and the high stability and processivity of elongation complexes.	[Chakraborty, Anirban; Wang, Dongye; Ebright, Yon W.; Kortkhonjia, Ekaterine; Ebright, Richard H.] Rutgers State Univ, Waksman Inst, Howard Hughes Med Inst, Piscataway, NJ 08854 USA; [Chakraborty, Anirban; Wang, Dongye; Ebright, Yon W.; Kortkhonjia, Ekaterine; Ebright, Richard H.] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA; [Korlann, You; Kortkhonjia, Ekaterine; Weiss, Shimon] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Kim, Taiho] Nesher Technol Inc, Los Angeles, CA 90057 USA; [Chowdhury, Saikat; Nixon, B. Tracy] Penn State Univ, Dept Biochem, University Pk, PA 16802 USA; [Wigneshweraraj, Sivaramesh] Univ London Imperial Coll Sci Technol & Med, Ctr Mol Microbiol & Infect, London SW7 2AZ, England; [Irschik, Herbert; Jansen, Rolf] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany; [Knight, Jennifer] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA	Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of California System; University of California Los Angeles; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Imperial College London; Helmholtz Association; Helmholtz-Center for Infection Research; University of Michigan System; University of Michigan	Ebright, RH (corresponding author), Rutgers State Univ, Waksman Inst, Howard Hughes Med Inst, POB 759, Piscataway, NJ 08854 USA.	ebright@waksman.rutgers.edu	weiss, shimon/B-4164-2009; Jansen, Rolf/C-1570-2011; CHOWDHURY, SAIKAT/J-6016-2019; Ebright, Richard/O-3321-2019	weiss, shimon/0000-0002-0720-5426; Jansen, Rolf/0000-0002-3592-4807; CHOWDHURY, SAIKAT/0000-0001-8043-5028; Ebright, Richard/0000-0001-8915-7140; Wigneshweraraj, Sivaramesh/0000-0002-1418-4029	NIH [GM037554, GM069937, GM069709, GM41376, AI072766]; Howard Hughes Medical Institute Investigatorship; BBSRC [BB/K000233/1, BB/E023703/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E023703/1, BB/K000233/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069937, R01GM069709, R01GM041376, R37GM041376, R01GM037554] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute Investigatorship(Howard Hughes Medical Institute); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Schultz and R. Mehl for plasmids and A. Reitmar for assistance with instrument set-up. This work was funded by NIH grants GM037554 to C. L. Brooks III, GM069937 to B.T.N., GM069709 to S. W., and GM41376 and AI072766 to R. H. E., and a Howard Hughes Medical Institute Investigatorship to R.H.E.	Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Belogurov GA, 2009, NATURE, V457, P332, DOI 10.1038/nature07510; Camara B, 2010, P NATL ACAD SCI USA, V107, P2247, DOI 10.1073/pnas.0907908107; Chakraborty A, 2010, METHOD ENZYMOL, V472, P19, DOI 10.1016/S0076-6879(10)72018-8; Chin JW, 2002, J AM CHEM SOC, V124, P9026, DOI 10.1021/ja027007w; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Darst SA, 2002, P NATL ACAD SCI USA, V99, P4296, DOI 10.1073/pnas.052054099; Ghosh T, 2010, FEMS MICROBIOL REV, V34, P611, DOI 10.1111/j.1574-6976.2010.00239.x; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Hartzog GA, 2011, MOL CELL, V43, P161, DOI 10.1016/j.molcel.2011.07.002; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; Kapanidis AN, 2005, MOL CELL, V20, P347, DOI 10.1016/j.molcel.2005.10.012; Kapanidis AN, 2004, P NATL ACAD SCI USA, V101, P8936, DOI 10.1073/pnas.0401690101; Landick R, 2001, CELL, V105, P567, DOI 10.1016/S0092-8674(01)00381-6; Lee NK, 2007, BIOPHYS J, V92, P303, DOI 10.1529/biophysj.106.093211; Lee NK, 2005, BIOPHYS J, V88, P2939, DOI 10.1529/biophysj.104.054114; Mariani R, 2009, CURR MED CHEM, V16, P430, DOI 10.2174/092986709787315559; Mekler V, 2011, J MOL BIOL, V413, P1016, DOI 10.1016/j.jmb.2011.09.029; Mukhopadhyay J, 2008, CELL, V135, P295, DOI 10.1016/j.cell.2008.09.033; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; Saecker RM, 2011, J MOL BIOL, V412, P754, DOI 10.1016/j.jmb.2011.01.018; Saxon E, 2000, SCIENCE, V287, P2007, DOI 10.1126/science.287.5460.2007; Srivastava A, 2011, CURR OPIN MICROBIOL, V14, P532, DOI 10.1016/j.mib.2011.07.030; Tagami S, 2010, NATURE, V468, P978, DOI 10.1038/nature09573; TANG H, 1995, P NATL ACAD SCI USA, V92, P4902, DOI 10.1073/pnas.92.11.4902; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	29	151	155	0	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2012	337	6094					591	595		10.1126/science.1218716	http://dx.doi.org/10.1126/science.1218716			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982PU	22859489	Green Accepted, Green Submitted			2022-12-28	WOS:000307058700048
J	Hedin, LO				Hedin, Lars O.			F. Herbert Bormann (1922-2012)	SCIENCE			English	Biographical-Item									Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	Princeton University	Hedin, LO (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	lhedin@princeton.edu						Bormann F. H., 1993, REDESIGNING AM LAWN; Bormann F.H., 1979, PATTERN PROCESS FORE, DOI DOI 10.1007/978-1-4612-6232-9; BORMANN FH, 1967, SCIENCE, V155, P424, DOI 10.1126/science.155.3761.424; BORMANN FH, PUBLICATION LIST; LIKENS G E, 1974, Science (Washington D C), V184, P1176, DOI 10.1126/science.184.4142.1176; LIKENS GE, 1969, SCIENCE, V163, P1205, DOI 10.1126/science.163.3872.1205	6	0	0	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2012	337	6094					534	534		10.1126/science.1226088	http://dx.doi.org/10.1126/science.1226088			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982PU	22859477				2022-12-28	WOS:000307058700029
J	Lachance, J; Vernot, B; Elbers, CC; Ferwerda, B; Froment, A; Bodo, JM; Lema, G; Fu, WQ; Nyambo, TB; Rebbeck, TR; Zhang, K; Akey, JM; Tishkoff, SA				Lachance, Joseph; Vernot, Benjamin; Elbers, Clara C.; Ferwerda, Bart; Froment, Alain; Bodo, Jean-Marie; Lema, Godfrey; Fu, Wenqing; Nyambo, Thomas B.; Rebbeck, Timothy R.; Zhang, Kun; Akey, Joshua M.; Tishkoff, Sarah A.			Evolutionary History and Adaptation from High-Coverage Whole-Genome Sequences of Diverse African Hunter-Gatherers	CELL			English	Article							POPULATION-STRUCTURE; GROWTH-HORMONE; MODERN HUMANS; GENETIC-VARIATION; WIDE ASSOCIATION; DISORDERS; MUTATIONS; ADMIXTURE; SELECTION; VARIANCE	To reconstruct modern human evolutionary history and identify loci that have shaped hunter-gatherer adaptation, we sequenced the whole genomes of five individuals in each of three different hunter-gatherer populations at >60x coverage: Pygmies from Cameroon and Khoesan-speaking Hadza and Sandawe from Tanzania. We identify 13.4 million variants, substantially increasing the set of known human variation. We found evidence of archaic intro-gression in all three populations, and the distribution of time to most recent common ancestors from these regions is similar to that observed for introgressed regions in Europeans. Additionally, we identify numerous loci that harbor signatures of local adaptation, including genes involved in immunity, metabolism, olfactory and taste perception, reproduction, and wound healing. Within the Pygmy population, we identify multiple highly differentiated loci that play a role in growth and anterior pituitary function and are associated with height.	[Lachance, Joseph; Elbers, Clara C.; Ferwerda, Bart; Tishkoff, Sarah A.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Lachance, Joseph; Elbers, Clara C.; Ferwerda, Bart; Tishkoff, Sarah A.] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; [Rebbeck, Timothy R.] Univ Penn, Abramson Canc Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA; [Vernot, Benjamin; Fu, Wenqing; Akey, Joshua M.] Univ Washington, Dept Genome Sci, Seattle, WA 98185 USA; [Froment, Alain] Musee Homme Paris, IRD MNHN, F-75116 Paris, France; [Bodo, Jean-Marie] Minist Rech Sci & Innovat, Yaounde, Cameroon; [Lema, Godfrey; Nyambo, Thomas B.] Muhimbili Univ, Dept Biochem, Coll Hlth Sci, Dar Es Salaam, Tanzania; [Zhang, Kun] Univ Calif San Diego, Inst Genom Med, Dept Bioengn, San Diego, CA 92093 USA; [Zhang, Kun] Univ Calif San Diego, Inst Engn Med, San Diego, CA 92093 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Washington; University of Washington Seattle; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); University of California System; University of California San Diego; University of California System; University of California San Diego	Tishkoff, SA (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	tishkoff@mail.med.upenn.edu	Rebbeck, Timothy/GLU-8348-2022; Zhang, Kun/ABE-6349-2020; Vernot, Benjamin/ABH-1495-2021	Rebbeck, Timothy/0000-0002-4799-1900; Zhang, Kun/0000-0002-7596-5224; Vernot, Benjamin/0000-0002-6820-2181; Akey, Joshua/0000-0002-4411-1330; Ferwerda, Bart/0000-0002-7050-5931; Lachance, Joseph/0000-0002-4650-3741	NSF [BCS-0827436]; NIH [R01GM076637, 8 DP1 ES022577-04]; NIH NRSA postdoctoral fellowship [F32HG006648-01]; Netherlands Organization of Scientific Research; Center of Excellence in Environmental Toxicology at the University of Pennsylvania [P30-ES013508-07]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG006648] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508, DP1ES022577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076637] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NRSA postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organization of Scientific Research(Netherlands Organization for Scientific Research (NWO)); Center of Excellence in Environmental Toxicology at the University of Pennsylvania; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NSF (BCS-0827436) and NIH (R01GM076637, 8 DP1 ES022577-04) grants to S.A.T., an NIH NRSA postdoctoral fellowship (F32HG006648-01) to J.L., Rubicon Grants of the Netherlands Organization of Scientific Research to C.C.E. and B.F., and support from the Center of Excellence in Environmental Toxicology at the University of Pennsylvania, P30-ES013508-07. We thank J. Hirbo, J. Jarvis, A. Rawlings, L. Scheinfeld, and S. Soi for their critical feedback and advice and K. Addya, D. Baldwin, and B. Beggs for assistance in genotyping the samples. We also thank the 15 individuals who graciously supplied their DNA.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; Barreiro LB, 2010, NAT REV GENET, V11, P17, DOI 10.1038/nrg2698; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Berniell-Lee G, 2009, MOL BIOL EVOL, V26, P1581, DOI 10.1093/molbev/msp069; Brickman JM, 2001, DEVELOPMENT, V128, P5189; Burger R, 2011, THEOR POPUL BIOL, V80, P272, DOI 10.1016/j.tpb.2011.07.002; Campbell MC, 2010, CURR BIOL, V20, pR166, DOI 10.1016/j.cub.2009.11.050; Dattani MT, 2005, CLIN ENDOCRINOL, V63, P121, DOI 10.1111/j.1365-2265.2005.02289.x; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Falush D, 2003, GENETICS, V164, P1567; Galli GG, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002711; Gat-Yablonski G, 2009, HORM RES, V72, P302, DOI 10.1159/000245932; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Hammer MF, 2011, P NATL ACAD SCI USA, V108, P15123, DOI 10.1073/pnas.1109300108; Henn BM, 2011, P NATL ACAD SCI USA, V108, P5154, DOI 10.1073/pnas.1017511108; Henn BM, 2010, HUM MOL GENET, V19, pR221, DOI 10.1093/hmg/ddq403; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hudson RR, 2007, J MOL EVOL, V64, P702, DOI 10.1007/s00239-006-0261-1; Hunsaker TL, 2012, J MOL BIOL, V415, P29, DOI 10.1016/j.jmb.2011.11.001; Jarvis JP, 2012, PLOS GENET, V8, P299, DOI 10.1371/journal.pgen.1002641; JONES NGB, 1992, AM J PHYS ANTHROPOL, V89, P159, DOI 10.1002/ajpa.1330890204; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kiess W, 2011, HORM RES PAEDIAT, V76, P11, DOI 10.1159/000330140; Lam HYK, 2012, NAT BIOTECHNOL, V30, P78, DOI 10.1038/nbt.2065; Lohmueller KE, 2008, NATURE, V451, P994, DOI 10.1038/nature06611; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Mantovani G, 2006, MOL CELL ENDOCRINOL, V247, P135, DOI 10.1016/j.mce.2005.12.036; Marlowe F., 2010, HADZA HUNTER GATHERE, DOI DOI 10.1152/physiol.00027.2018; Migliano AB, 2007, P NATL ACAD SCI USA, V104, P20216, DOI 10.1073/pnas.0708024105; Pemberton T.J., 2012, AM J HUM GENET; Perry GH, 2009, TRENDS ECOL EVOL, V24, P218, DOI 10.1016/j.tree.2008.11.008; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Plagnol V, 2006, PLOS GENET, V2, P972, DOI 10.1371/journal.pgen.0020105; Rand DM, 1996, MOL BIOL EVOL, V13, P735, DOI 10.1093/oxfordjournals.molbev.a025634; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Rosenbloom KR, 2012, NUCLEIC ACIDS RES, V40, pD912, DOI 10.1093/nar/gkr1012; Sands B., 1998, LANGUAGE IDENTITY CO, P265; Schuster SC, 2010, NATURE, V463, P943, DOI 10.1038/nature08795; Shimada MK, 2007, MOL BIOL EVOL, V24, P687, DOI 10.1093/molbev/msl196; Shriver Mark D, 2004, Hum Genomics, V1, P274; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Teo YY, 2010, NAT REV GENET, V11, P149, DOI 10.1038/nrg2731; Thomson R, 2000, P NATL ACAD SCI USA, V97, P7360, DOI 10.1073/pnas.97.13.7360; Tishkoff SA, 2007, MOL BIOL EVOL, V24, P2180, DOI 10.1093/molbev/msm155; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Veeramah KR, 2012, MOL BIOL EVOL, V29, P617, DOI 10.1093/molbev/msr212; Verdu P, 2009, CURR BIOL, V19, P312, DOI 10.1016/j.cub.2008.12.049; Wall JD, 2009, MOL BIOL EVOL, V26, P1823, DOI 10.1093/molbev/msp096; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]	53	207	210	0	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 3	2012	150	3					457	469		10.1016/j.cell.2012.07.009	http://dx.doi.org/10.1016/j.cell.2012.07.009			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	985WO	22840920	Green Accepted, Bronze			2022-12-28	WOS:000307301400007
J	Papouin, T; Ladepeche, L; Ruel, J; Sacchi, S; Labasque, M; Hanini, M; Groc, L; Pollegioni, L; Mothet, JP; Oliet, SHR				Papouin, Thomas; Ladepeche, Laurent; Ruel, Jerome; Sacchi, Silvia; Labasque, Marilyne; Hanini, Marwa; Groc, Laurent; Pollegioni, Loredano; Mothet, Jean-Pierre; Oliet, Stephane H. R.			Synaptic and Extrasynaptic NMDA Receptors Are Gated by Different Endogenous Coagonists	CELL			English	Article							METHYL-D-ASPARTATE; LONG-TERM POTENTIATION; D-SERINE; GLYCINE TRANSPORTER; SUBUNIT COMPOSITION; AMBIENT GLUTAMATE; TONIC ACTIVATION; RELEASE; DEPRESSION; SYNAPSES	N-methyl-D-aspartate receptors (NMDARs) are located in neuronal cell membranes at synaptic and extrasynaptic locations, where they are believed to mediate distinct physiological and pathological processes. Activation of NMDARs requires glutamate and a coagonist whose nature and impact on NMDAR physiology remain elusive. We report that synaptic and extrasynaptic NMDARs are gated by different endogenous coagonists, D-serine and glycine, respectively. The regionalized availability of the coagonists matches the preferential affinity of synaptic NMDARs for D-serine and extrasynaptic NMDARs for glycine. Furthermore, glycine and D-serine inhibit NMDAR surface trafficking in a subunit-dependent manner, which is likely to influence NMDARs subcellular location. Taking advantage of this coagonist segregation, we demonstrate that long-term potentiation and NMDA-induced neurotoxicity rely on synaptic NMDARs only. Conversely, long-term depression requires both synaptic and extrasynaptic receptors. Our observations provide key insights into the operating mode of NMDARs, emphasizing functional distinctions between synaptic and extrasynaptic NMDARs in brain physiology.	[Papouin, Thomas; Mothet, Jean-Pierre; Oliet, Stephane H. R.] INSERM, U862, Neuroctr Magendie, F-33077 Bordeaux, France; [Papouin, Thomas; Ladepeche, Laurent; Groc, Laurent; Mothet, Jean-Pierre; Oliet, Stephane H. R.] Univ Bordeaux, F-33077 Bordeaux, France; [Ladepeche, Laurent; Groc, Laurent] CNRS, Interdisciplinary Inst NeuroSci, UMR 5297, F-33077 Bordeaux, France; [Ruel, Jerome; Labasque, Marilyne; Hanini, Marwa; Mothet, Jean-Pierre] CNRS, CRN2M UMR 6231, F-13344 Marseille, France; [Ruel, Jerome; Mothet, Jean-Pierre] Univ Aix Marseille, F-13344 Marseille, France; [Pollegioni, Loredano] Univ Insubria, Dipartimento Biotecnol & Sci Mol, Varese, Italy; [Pollegioni, Loredano] Politecn Milan, Prot Factory, Ctr Interuniv Biotecnol Prot, Varese, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; University of Insubria; Polytechnic University of Milan	Oliet, SHR (corresponding author), INSERM, U862, Neuroctr Magendie, F-33077 Bordeaux, France.	stephane.oliet@inserm.fr	Labasque, Marilyne/AAE-2498-2022; Papouin, Thomas/W-2769-2019; Mothet, Jean-Pierre/ABE-3066-2020; Ladépêche, Laurent/G-3418-2015	Papouin, Thomas/0000-0001-5288-1944; Ladépêche, Laurent/0000-0002-2566-1206; MOTHET, Jean-Pierre/0000-0003-4991-0614; Ruel, Jerome/0000-0003-2871-7321; Labasque, Marilyne/0000-0002-1467-2866; SACCHI, SILVIA/0000-0002-2338-2561; POLLEGIONI, LOREDANO/0000-0003-1733-7243; Oliet, Stephane/0000-0003-0595-9029	INSERM; CNRS; Agence National pour la Recherche; Conseil Regional d'Aquitaine; Universite Bordeaux Segalen; Universite Aix-Marseille; NARSAD; Fondation pour la Recherche Medicale (Equipe FRM); Federation pour la Recherche sur le Cerveau; Human Frontier Science Program; Ministere de l'Enseignement Superieur et de la Recherche; Fondo di Ateneo per la Ricerca (Universita dell'Insubria); Fondazione Cariplo	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence National pour la Recherche(French National Research Agency (ANR)); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); Universite Bordeaux Segalen; Universite Aix-Marseille; NARSAD(NARSAD); Fondation pour la Recherche Medicale (Equipe FRM)(Fondation pour la Recherche Medicale); Federation pour la Recherche sur le Cerveau; Human Frontier Science Program(Human Frontier Science Program); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Fondo di Ateneo per la Ricerca (Universita dell'Insubria); Fondazione Cariplo(Fondazione Cariplo)	We thank Dr. Henneberger, Pr. Rusakov, and Pr. Voisin for critical reading of the manuscript and M. P. Blanchard and Dr. Choquet for their technical assistance. We are very grateful to Drs. Abrous and Sage for performing pilot experiments. This work was supported by grants from INSERM, CNRS, Agence National pour la Recherche, Conseil Regional d'Aquitaine, Universite Bordeaux Segalen, Universite Aix-Marseille, NARSAD, Fondation pour la Recherche Medicale (Equipe FRM), Federation pour la Recherche sur le Cerveau, and the Human Frontier Science Program. TP and LL were recipients of studentships from the Ministere de l'Enseignement Superieur et de la Recherche. S. S. and L. P. were supported by grants from Fondo di Ateneo per la Ricerca (Universita dell'Insubria) and from Fondazione Cariplo.	Ahmadi S, 2003, SCIENCE, V300, P2094, DOI 10.1126/science.1083970; Angulo MC, 2004, J NEUROSCI, V24, P6920, DOI 10.1523/JNEUROSCI.0473-04.2004; Arundine M, 2003, CELL CALCIUM, V34, P325, DOI 10.1016/S0143-4160(03)00141-6; Atkinson BN, 2001, MOL PHARMACOL, V60, P1414, DOI 10.1124/mol.60.6.1414; Bard L, 2010, P NATL ACAD SCI USA, V107, P19561, DOI 10.1073/pnas.1002690107; Basu AC, 2009, MOL PSYCHIATR, V14, P719, DOI 10.1038/mp.2008.130; Berberich S, 2005, J NEUROSCI, V25, P6907, DOI 10.1523/JNEUROSCI.1905-05.2005; Berger AJ, 1998, J NEUROPHYSIOL, V80, P3336, DOI 10.1152/jn.1998.80.6.3336; Bergeron R, 1998, P NATL ACAD SCI USA, V95, P15730, DOI 10.1073/pnas.95.26.15730; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bordji K, 2010, J NEUROSCI, V30, P15927, DOI 10.1523/JNEUROSCI.3021-10.2010; Cubelos B, 2005, CEREB CORTEX, V15, P448, DOI 10.1093/cercor/bhh147; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; FORSYTHE ID, 1988, J NEUROSCI, V8, P3733; Fossat P, 2012, CEREB CORTEX, V22, P595, DOI 10.1093/cercor/bhr130; Ge YA, 2010, P NATL ACAD SCI USA, V107, P16697, DOI 10.1073/pnas.1008200107; Groc L, 2007, J NEUROSCI, V27, P12433, DOI 10.1523/JNEUROSCI.3349-07.2007; Groc L, 2006, P NATL ACAD SCI USA, V103, P18769, DOI 10.1073/pnas.0605238103; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Harris AZ, 2008, J NEUROPHYSIOL, V99, P524, DOI 10.1152/jn.01169.2007; Harris AZ, 2007, J PHYSIOL-LONDON, V584, P509, DOI 10.1113/jphysiol.2007.137679; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Horio M, 2011, NEUROCHEM INT, V59, P853, DOI 10.1016/j.neuint.2011.08.017; Inoue R, 2008, J NEUROSCI, V28, P14486, DOI 10.1523/JNEUROSCI.5034-08.2008; Job V, 2002, EUR J BIOCHEM, V269, P1456, DOI 10.1046/j.1432-1033.2002.02790.x; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Kalbaugh TL, 2009, J NEUROSCI, V29, P1469, DOI 10.1523/JNEUROSCI.4240-08.2009; Katsuki H, 2004, J PHARMACOL EXP THER, V311, P836, DOI 10.1124/jpet.104.070912; Kirson ED, 1996, J PHYSIOL-LONDON, V497, P437, DOI 10.1113/jphysiol.1996.sp021779; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; Kohr G, 2006, CELL TISSUE RES, V326, P439, DOI 10.1007/s00441-006-0273-6; Le Meur K, 2007, J PHYSIOL-LONDON, V580, P373, DOI 10.1113/jphysiol.2006.123570; Leveille F, 2008, FASEB J, V22, P4258, DOI 10.1096/fj.08-107268; Lin CH, 2012, PHARMACOL BIOCHEM BE, V100, P665, DOI 10.1016/j.pbb.2011.03.023; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Madry C, 2007, MOL PHARMACOL, V72, P1535, DOI 10.1124/mol.107.040071; Massey PV, 2004, J NEUROSCI, V24, P7821, DOI 10.1523/JNEUROSCI.1697-04.2004; MATSUI T, 1995, J NEUROCHEM, V65, P454; Milnerwood AJ, 2010, NEURON, V65, P178, DOI 10.1016/j.neuron.2010.01.008; Molla G, 2000, J BIOL CHEM, V275, P24715, DOI 10.1074/jbc.M908193199; Molla G, 1998, PROTEIN EXPRES PURIF, V14, P289, DOI 10.1006/prep.1998.0956; Morishita W, 2007, NEUROPHARMACOLOGY, V52, P71, DOI 10.1016/j.neuropharm.2006.07.005; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; Mustafa AK, 2010, J NEUROSCI, V30, P1413, DOI 10.1523/JNEUROSCI.4297-09.2010; Nong Y, 2003, NATURE, V422, P302, DOI 10.1038/nature01497; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Paoletti P, 1997, J NEUROSCI, V17, P5711; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; Petralia RS, 2010, NEUROSCIENCE, V167, P68, DOI 10.1016/j.neuroscience.2010.01.022; POLLEGIONI L, 1992, BIOCHIM BIOPHYS ACTA, V1120, P11, DOI 10.1016/0167-4838(92)90418-D; PRIESTLEY T, 1995, MOL PHARMACOL, V48, P841; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Rusakov DA, 2004, SCIENCE, V305, p1912B, DOI 10.1126/science.1101128; SAH P, 1989, SCIENCE, V246, P815, DOI 10.1126/science.2573153; SCHELL MJ, 1995, P NATL ACAD SCI USA, V92, P3948, DOI 10.1073/pnas.92.9.3948; Shleper M, 2005, J NEUROSCI, V25, P9413, DOI 10.1523/JNEUROSCI.3190-05.2005; Stevens ER, 2010, EUR J NEUROSCI, V31, P808, DOI 10.1111/j.1460-9568.2010.07135.x; Stocca G, 1998, J PHYSIOL-LONDON, V507, P13, DOI 10.1111/j.1469-7793.1998.013bu.x; Tovar KR, 1999, J NEUROSCI, V19, P4180; Tsai GC, 2004, BIOL PSYCHIAT, V55, P452, DOI 10.1016/j.biopsych.2003.09.012; WAFFORD KA, 1995, MOL PHARMACOL, V47, P374; Wake K, 2001, NEUROSCI LETT, V297, P25, DOI 10.1016/S0304-3940(00)01658-X; Weitlauf C, 2005, J NEUROSCI, V25, P8386, DOI 10.1523/JNEUROSCI.2388-05.2005; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Yamamoto S, 2010, J PSYCHIATR RES, V44, P1069, DOI 10.1016/j.jpsychires.2010.03.013; Yang YL, 2003, P NATL ACAD SCI USA, V100, P15194, DOI 10.1073/pnas.2431073100; ZAFRA F, 1995, EUR J NEUROSCI, V7, P1342, DOI 10.1111/j.1460-9568.1995.tb01125.x; Zhang Z, 2008, CEREB CORTEX, V18, P2391, DOI 10.1093/cercor/bhn008; Zhao JP, 2007, J NEUROSCI, V27, P13649, DOI 10.1523/JNEUROSCI.3153-07.2007	72	468	474	2	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 3	2012	150	3					633	646		10.1016/j.cell.2012.06.029	http://dx.doi.org/10.1016/j.cell.2012.06.029			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	985WO	22863013	Green Submitted, Bronze			2022-12-28	WOS:000307301400020
J	Xiol, J; Pillai, RS				Xiol, Jordi; Pillai, Ramesh S.			Outsourcing Genome Protection	SCIENCE			English	Editorial Material							EPIGENETIC MEMORY; PIRNAS; GERMLINE		[Xiol, Jordi; Pillai, Ramesh S.] European Mol Biol Lab, F-38042 Grenoble, France	European Molecular Biology Laboratory (EMBL)	Xiol, J (corresponding author), European Mol Biol Lab, 6 Rue Jules Horowitz,BP 181, F-38042 Grenoble, France.	pillai@embl.fr						Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Ashe A, 2012, CELL, V150, P88, DOI 10.1016/j.cell.2012.06.018; Bagijn MP, 2012, SCIENCE, V337, P574, DOI 10.1126/science.1220952; Buckley BA, 2012, NATURE, V489, P447, DOI 10.1038/nature11352; Claycomb JM, 2009, CELL, V139, P123, DOI 10.1016/j.cell.2009.09.014; Lee HC, 2012, CELL, V150, P78, DOI 10.1016/j.cell.2012.06.016; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033	8	2	2	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 3	2012	337	6094					529	530		10.1126/science.1227095	http://dx.doi.org/10.1126/science.1227095			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	982PU	22859473				2022-12-28	WOS:000307058700025
J	Annas, GJ				Annas, George J.			Doctors, Patients, and Lawyers - Two Centuries of Health Law	NEW ENGLAND JOURNAL OF MEDICINE			English	Review									Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02118 USA	Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02118 USA.	annasgj@bu.edu		Annas, George/0000-0001-5836-7831				Annas George J., 1992, NAZI DOCTORS NUREMBE; Beauchamp TL, 2001, PRINCIPLES BIOMEDICA, P31; Beck TR, 1823, ELEMENTS MED JURISPR, V2; Bliss M., 2011, MAKING MODERN MED; Burns CR, 1977, LEGACIES ETHICS MED, P107; Channing W., 1860, BOSTON MED SURG J, V62, P259; Channing W, 1860, BOSTON MED SURG J, V62, P233; Channing W., 1860, BOSTON MED SURG J, V62, P300; Curran WJ, 1989, LAW MED NOTES PROGR; Derbyshire Robert, 1969, MED LICENSURE DISCIP, P76; Dickens B M, 1987, Law Med Health Care, V15, P110; Elwell JJ, 1860, MEDICOLEGAL TREATISE; FURROW B, 2008, HLTH LAW CASES MAT P; Kass AM, 2002, MIDWIFERY BOSTON W C; Mann J.M., 1999, HLTH HUMAN RIGHTS RE; Mehlman MJ, 2006, J LEGAL MED, V27, P17, DOI 10.1080/01947640500533218; Percival T, 1803, MED ETHICS, P7; Sage WM, 2003, HEALTH AFFAIR, V22, P26, DOI 10.1377/hlthaff.22.4.26; Sanbar S. S., 2007, LEGAL MED; Skloot R., 2010, IMMORTAL LIFE HENRIE	20	27	29	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 2	2012	367	5					445	450		10.1056/NEJMra1108646	http://dx.doi.org/10.1056/NEJMra1108646			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	981VZ	22853015				2022-12-28	WOS:000307001900009
J	Appleby, J				Appleby, John			What do NHS staff think about the NHS?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Fund, London, England		Appleby, J (corresponding author), Kings Fund, London, England.	j.appleby@kingsfund.org.uk						Appleby J., 2012, PUBLIC SATISFACTION; GfK NOP Social Research, 2012, NHS STAFF TRACK RES; Ipsos Mori Social Research Institute, 2011, PUBL PERC NHS SOC CA	3	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 1	2012	345								e5130	10.1136/bmj.e5130	http://dx.doi.org/10.1136/bmj.e5130			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	985XC	22859775	Bronze, Green Submitted			2022-12-28	WOS:000307302800012
J	Farrell, L				Farrell, Liam			The dance of death	BRITISH MEDICAL JOURNAL			English	Editorial Material												drfarrell@hotmail.co.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUL 24	2012	345								e4956	10.1136/bmj.e4956	http://dx.doi.org/10.1136/bmj.e4956			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	981UQ	22833582				2022-12-28	WOS:000306996900007
J	Lange, KK; Tellgren, EI; Hoffmann, MR; Helgaker, T				Lange, Kai K.; Tellgren, E. I.; Hoffmann, M. R.; Helgaker, T.			A Paramagnetic Bonding Mechanism for Diatomics in Strong Magnetic Fields	SCIENCE			English	Article							POTENTIAL-ENERGY SURFACES; GAUSSIAN-BASIS SETS; CORRELATED MOLECULAR CALCULATIONS; NMR CHEMICAL-SHIFTS; LOCALIZED QUANTITIES; HYDROGEN MOLECULE; H-2(+) ION; ATOMS; SUSCEPTIBILITIES; TERMS	Elementary chemistry distinguishes two kinds of strong bonds between atoms in molecules: the covalent bond, where bonding arises from valence electron pairs shared between neighboring atoms, and the ionic bond, where transfer of electrons from one atom to another leads to Coulombic attraction between the resulting ions. We present a third, distinct bonding mechanism: perpendicular paramagnetic bonding, generated by the stabilization of antibonding orbitals in their perpendicular orientation relative to an external magnetic field. In strong fields such as those present in the atmospheres of white dwarfs (on the order of 10(5) teslas) and other stellar objects, our calculations suggest that this mechanism underlies the strong bonding of H-2 in the (3)Sigma(+)(u)(1 sigma(g)1 sigma*(u)) triplet state and of He-2 in the (1)Sigma(+)(g)(1 sigma(2)(g)1 sigma*(2)(u)) singlet state, as well as their preferred perpendicular orientation in the external field.	[Lange, Kai K.; Tellgren, E. I.; Hoffmann, M. R.; Helgaker, T.] Univ Oslo, Ctr Theoret & Computat Chem, Dept Chem, N-0315 Oslo, Norway; [Hoffmann, M. R.] Univ N Dakota, Dept Chem, Grand Forks, ND 58202 USA	University of Oslo; University of North Dakota Grand Forks	Helgaker, T (corresponding author), Univ Oslo, Ctr Theoret & Computat Chem, Dept Chem, N-0315 Oslo, Norway.	trygve.helgaker@kjemi.uio.no	Helgaker, Trygve/N-7575-2019; Helgaker, Trygve/I-2062-2012	Helgaker, Trygve/0000-0002-5032-8392; Helgaker, Trygve/0000-0002-5032-8392; Tellgren, Erik/0000-0002-0019-4330	Norwegian Research Council through Centre for Theoretical and Computational Chemistry (CTCC) [179568/V30, 197446/V30]; European Research Council (ERC) under the European Union's Seventh Framework Program through the advanced grant ABACUS, ERC [267683]; CTCC during a sabbatical stay at the University of Oslo; EPSCoR [0814442] Funding Source: National Science Foundation	Norwegian Research Council through Centre for Theoretical and Computational Chemistry (CTCC); European Research Council (ERC) under the European Union's Seventh Framework Program through the advanced grant ABACUS, ERC; CTCC during a sabbatical stay at the University of Oslo; EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD))	Supported by the Norwegian Research Council through Centre for Theoretical and Computational Chemistry (CTCC) grant 179568/V30 and through grant 197446/V30 and by the European Research Council (ERC) under the European Union's Seventh Framework Program through the advanced grant ABACUS, ERC grant agreement 267683. M. R. H. acknowledges support from the CTCC during a sabbatical stay at the University of Oslo in 2010.	BASILE S, 1987, NUOVO CIMENTO D, V9, P457, DOI 10.1007/BF02667941; DITCHFIELD R, 1972, J CHEM PHYS, V56, P5688, DOI 10.1063/1.1677088; DUCH W, 1986, GRMS GRAPHICAL REPRE; DUNNING TH, 1989, J CHEM PHYS, V90, P1007, DOI 10.1063/1.456153; GARSTANG RH, 1977, REP PROG PHYS, V40, P105, DOI 10.1088/0034-4885/40/2/001; Helgaker T., 2000, MOL ELECT STRUCTURE; Helgaker T, 2008, MOL PHYS, V106, P2107, DOI 10.1080/00268970802258591; Jeziorska M, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2770721; Jordan S, 2001, ASTRON ASTROPHYS, V376, P614, DOI 10.1051/0004-6361:20010970; Jordan S, 1998, ASTRON ASTROPHYS, V336, pL33; Kappes U, 1996, PHYS REV A, V53, P3869, DOI 10.1103/PhysRevA.53.3869; KAPPES U, 1994, J CHEM PHYS, V100, P2878, DOI 10.1063/1.466430; Kappes U, 1996, PHYS REV A, V54, P1313, DOI 10.1103/PhysRevA.54.1313; Kappes U, 1996, PHYS LETT A, V210, P409, DOI 10.1016/0375-9601(95)00908-6; KENNEDY PK, 1984, PHYS REV A, V30, P51, DOI 10.1103/PhysRevA.30.51; KNOWLES PJ, 1984, CHEM PHYS LETT, V111, P315, DOI 10.1016/0009-2614(84)85513-X; Kubo A, 2007, J PHYS CHEM A, V111, P5572, DOI 10.1021/jp070809z; KUTZELNIGG W, 1980, ISRAEL J CHEM, V19, P193; Lai D, 2001, REV MOD PHYS, V73, P629, DOI 10.1103/RevModPhys.73.629; London F, 1937, J PHYS-PARIS, V8, P397, DOI 10.1051/jphysrad:01937008010039700; LOZOVIK YE, 1978, PHYS LETT A, V66, P282, DOI 10.1016/0375-9601(78)90237-2; OLSEN J, 1988, J CHEM PHYS, V89, P2185, DOI 10.1063/1.455063; SCHINDLER M, 1982, J CHEM PHYS, V76, P1919, DOI 10.1063/1.443165; SCHMELCHER P, 1990, PHYS REV A, V41, P4936, DOI 10.1103/PhysRevA.41.4936; SCHMELCHER P, 1988, PHYS REV A, V37, P672, DOI 10.1103/PhysRevA.37.672; Tellgren EI, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2996525; Tellgren EI, 2009, PHYS CHEM CHEM PHYS, V11, P5489, DOI 10.1039/b822262b; WOLINSKI K, 1990, J AM CHEM SOC, V112, P8251, DOI 10.1021/ja00179a005; WOON DE, 1994, J CHEM PHYS, V100, P2975, DOI 10.1063/1.466439; ZAUCER M, 1978, PHYS REV A, V18, P1320, DOI 10.1103/PhysRevA.18.1320	30	98	98	0	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2012	337	6092					327	331		10.1126/science.1219703	http://dx.doi.org/10.1126/science.1219703			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975WQ	22822146				2022-12-28	WOS:000306542600047
J	Bach, PB; Gould, MK				Bach, Peter B.; Gould, Michael K.			When the Average Applies to No One: Personalized Decision Making About Potential Benefits of Lung Cancer Screening	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RISK PREDICTION; MORTALITY; MODEL		Mem Sloan Kettering Canc Ctr, New York, NY USA; Kaiser Permanente So Calif, Pasadena, CA USA	Memorial Sloan Kettering Cancer Center; Kaiser Permanente	Bach, PB (corresponding author), 1275 York Ave, New York, NY 10065 USA.							Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; American Lung Association, 2012, PROV GUID LUNG CANC; Bach PB, 2003, JNCI-J NATL CANCER I, V95, P470, DOI 10.1093/jnci/95.6.470; Bach PB, 2004, CHEST, V126, P1742, DOI 10.1378/chest.126.6.1742; Bach PB, 2012, JAMA-J AM MED ASSOC, P1; Bach PB, 2007, JAMA-J AM MED ASSOC, V297, P953, DOI 10.1001/jama.297.9.953; Cronin KA, 2006, JNCI-J NATL CANCER I, V98, P637, DOI 10.1093/jnci/djj163; Elmore JG, 2005, NEW ENGL J MED, V353, P297, DOI 10.1056/NEJMe058111; Etzel CJ, 2011, SEMIN RESP CRIT CARE, V32, P3, DOI 10.1055/s-0031-1272864; Gigerenzer G, 2009, B WORLD HEALTH ORGAN, V87, P567, DOI 10.2471/BLT.09.069872; Gohagan JK, 2005, LUNG CANCER, V47, P9, DOI 10.1016/j.lungcan.2004.06.007; Schwartz Lisa M., 1999, Journal of the National Cancer Institute Monographs, P124; Spitz MR, 2007, JNCI-J NATL CANCER I, V99, P715, DOI 10.1093/jnci/djk153; Tammemagi CM, 2011, JNCI-J NATL CANCER I, V103, P1058, DOI 10.1093/jnci/djr173	14	71	70	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2012	157	8					571	+		10.7326/0003-4819-157-8-201210160-00524	http://dx.doi.org/10.7326/0003-4819-157-8-201210160-00524			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021SP	22893040				2022-12-28	WOS:000309906000018
J	Shiba, Y; Fernandes, S; Zhu, WZ; Filice, D; Muskheli, V; Kim, J; Palpant, NJ; Gantz, J; Moyes, KW; Reinecke, H; Van Biber, B; Dardas, T; Mignone, JL; Izawa, A; Hanna, R; Viswanathan, M; Gold, JD; Kotlikoff, MI; Sarvazyan, N; Kay, MW; Murry, CE; Laflamme, MA				Shiba, Yuji; Fernandes, Sarah; Zhu, Wei-Zhong; Filice, Dominic; Muskheli, Veronica; Kim, Jonathan; Palpant, Nathan J.; Gantz, Jay; Moyes, Kara White; Reinecke, Hans; Van Biber, Benjamin; Dardas, Todd; Mignone, John L.; Izawa, Atsushi; Hanna, Ramy; Viswanathan, Mohan; Gold, Joseph D.; Kotlikoff, Michael I.; Sarvazyan, Narine; Kay, Matthew W.; Murry, Charles E.; Laflamme, Michael A.			Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts	NATURE			English	Article							EMBRYONIC STEM-CELLS; RAT HEARTS; INFARCTION; TRANSPLANTATION; BLEBBISTATIN; REPERFUSION; INTEGRATION; MYOCARDIUM; INDICATORS; MYOCYTES	Transplantation studies in mice and rats have shown that human embryonic-stem-cell-derived cardiomyocytes (hESC-CMs) can improve the function of infarcted hearts(1-3), but two critical issues related to their electrophysiological behaviour in vivo remain unresolved. First, the risk of arrhythmias following hESC-CM transplantation in injured hearts has not been determined. Second, the electromechanical integration of hESC-CMs in injured hearts has not been demonstrated, so it is unclear whether these cells improve contractile function directly through addition of new force-generating units. Here we use a guinea-pig model to show that hESC-CM grafts in injured hearts protect against arrhythmias and can contract synchronously with host muscle. Injured hearts with hESC-CM grafts show improved mechanical function and a significantly reduced incidence of both spontaneous and induced ventricular tachycardia. To assess the activity of hESC-CM grafts in vivo, we transplanted hESC-CMs expressing the genetically encoded calcium sensor, GCaMP3 (refs 4, 5). By correlating the GCaMP3 fluorescent signal with the host ECG, we found that grafts in uninjured hearts have consistent 1:1 host-graft coupling. Grafts in injured hearts are more heterogeneous and typically include both coupled and uncoupled regions. Thus, human myocardial grafts meet physiological criteria for true heart regeneration, providing support for the continued development of hESC-based cardiac therapies for both mechanical and electrical repair.	[Shiba, Yuji; Fernandes, Sarah; Zhu, Wei-Zhong; Filice, Dominic; Muskheli, Veronica; Kim, Jonathan; Palpant, Nathan J.; Gantz, Jay; Moyes, Kara White; Reinecke, Hans; Van Biber, Benjamin; Murry, Charles E.; Laflamme, Michael A.] Univ Washington, Dept Pathol, Ctr Cardiovasc Biol, Inst Stem Cell & Regenerat Med, Seattle, WA 98109 USA; [Shiba, Yuji; Izawa, Atsushi] Shinshu Univ, Dept Cardiovasc Med, Matsumoto, Nagano 3908621, Japan; [Filice, Dominic; Gantz, Jay; Murry, Charles E.] Univ Washington, Inst Stem Cell & Regenerat Med, Ctr Cardiovasc Biol, Dept Bioengn, Seattle, WA 98109 USA; [Dardas, Todd; Mignone, John L.; Hanna, Ramy; Viswanathan, Mohan; Murry, Charles E.] Univ Washington, Inst Stem Cell & Regenerat Med, Ctr Cardiovasc Biol, Dept Med & Cardiol, Seattle, WA 98195 USA; [Gold, Joseph D.] Geron Corp, Menlo Pk, CA 94025 USA; [Kotlikoff, Michael I.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA; [Sarvazyan, Narine; Kay, Matthew W.] George Washington Univ, Dept Pharmacol & Physiol, Washington, DC 20037 USA; [Kay, Matthew W.] George Washington Univ, Dept Elect & Comp Engn, Washington, DC 20037 USA	University of Washington; University of Washington Seattle; Shinshu University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Geron Corporation; Cornell University; George Washington University; George Washington University	Laflamme, MA (corresponding author), Univ Washington, Dept Pathol, Ctr Cardiovasc Biol, Inst Stem Cell & Regenerat Med, 850 Republican St, Seattle, WA 98109 USA.	murry@uw.edu; laflamme@u.washington.edu	Zhu, Wei-Zhong/G-4919-2011; Gantz, Jay A/B-3581-2009; Kay, Matthew Wyatt/AAH-7336-2019; Laflamme, Michael/AAV-6791-2021; Palpant, Nathan/B-1641-2017	Kay, Matthew Wyatt/0000-0003-2756-5055; Laflamme, Michael/0000-0001-5908-880X; Palpant, Nathan/0000-0002-9334-8107; Shiba, Yuji/0000-0002-0311-2919; Kay, Mark/0000-0002-2799-2615; Sarvazyan, Narine/0000-0002-2002-5630	Geron Corporation; US National Institutes of Health [K08-HL80431, R01-HL064387, P01-HL094374, R01-HL084642, P01-GM81619, U01-HL100405, R01-HL095828]; University of Washington's Mouse Metabolic Phenotyping Center [U24-DK076126]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL094374, R01HL095828, K08HL080431, R01HL084642, R01HL064387, U01HL100405] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK076126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081619] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23591035] Funding Source: KAKEN	Geron Corporation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington's Mouse Metabolic Phenotyping Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Y. Tallini, L. Linares, B. Johnson and S. Dupras for advice and technical assistance. This work was partly supported by a grant from Geron Corporation(M. A. L.), as well as by US National Institutes of Health grants K08-HL80431 (M. A. L.), R01-HL064387 (M. A. L. and C. E. M.), P01-HL094374 (M. A. L. and C. E. M.), R01-HL084642 (C. E. M.), P01-GM81619 (C. E. M.), U01-HL100405 (M. A. L. and C. E. M.) and R01-HL095828 (N.S. and M. W. K.). Animal experiments were supported in part by the University of Washington's Mouse Metabolic Phenotyping Center, U24-DK076126.	Asfour H, 2011, IEEE T BIO-MED ENG, V58, P2083, DOI 10.1109/TBME.2011.2143713; Biermann M, 1998, J CARDIOVASC ELECTR, V9, P1348, DOI 10.1111/j.1540-8167.1998.tb00110.x; Caspi O, 2007, J AM COLL CARDIOL, V50, P1884, DOI 10.1016/j.jacc.2007.07.054; Chen HSV, 2009, CIRCULATION, V120, P2496, DOI 10.1161/CIRCULATIONAHA.107.751412; Fedorov VV, 2007, HEART RHYTHM, V4, P619, DOI 10.1016/j.hrthm.2006.12.047; Fernandes S, 2010, J MOL CELL CARDIOL, V49, P941, DOI 10.1016/j.yjmcc.2010.09.008; Gepstein L, 2011, STEM CELLS, V29, P1475, DOI 10.1002/stem.702; Gutstein DE, 2003, AM J PHYSIOL-HEART C, V285, pH1091, DOI 10.1152/ajpheart.00100.2003; He JQ, 2003, CIRC RES, V93, P32, DOI 10.1161/01.RES.0000080317.92718.99; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Jonsson MKB, 2010, STEM CELL RES, V4, P189, DOI 10.1016/j.scr.2010.02.001; Kay M, 2008, AM J PHYSIOL-HEART C, V294, pH2400, DOI 10.1152/ajpheart.01158.2007; Kehat I, 2004, NAT BIOTECHNOL, V22, P1282, DOI 10.1038/nbt1014; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Kolega J, 2004, BIOCHEM BIOPH RES CO, V320, P1020, DOI 10.1016/j.bbrc.2004.06.045; Kotlikoff MI, 2007, J PHYSIOL-LONDON, V578, P55, DOI 10.1113/jphysiol.2006.120212; Kuznetsov SA, 2001, J CELL BIOL, V153, P1133, DOI 10.1083/jcb.153.5.1133; Laflamme MA, 2005, AM J PATHOL, V167, P663, DOI 10.1016/S0002-9440(10)62041-X; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Laurita KR, 2001, AM J PHYSIOL-HEART C, V280, pH2053, DOI 10.1152/ajpheart.2001.280.5.H2053; Li Y, 2005, BIOTECHNOL BIOENG, V91, P688, DOI 10.1002/bit.20536; Liao SY, 2010, HEART RHYTHM, V7, P1852, DOI 10.1016/j.hrthm.2010.09.006; Lieu DK, 2009, STEM CELLS DEV, V18, P1493, DOI 10.1089/scd.2009.0052; Mandel Y, 2012, CIRCULATION, V125, P883, DOI 10.1161/CIRCULATIONAHA.111.045146; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; Roell W, 2007, NATURE, V450, P819, DOI 10.1038/nature06321; Shiotani Motohiro, 2005, Journal of Toxicological Sciences, V30, P239, DOI 10.2131/jts.30.239; Shiotani Motohiro, 2007, Journal of Pharmacological and Toxicological Methods, V55, P27, DOI 10.1016/j.vascn.2006.04.008; Swift L, 2008, PHYSIOL MEAS, V29, P269, DOI 10.1088/0967-3334/29/2/009; Swoap SJ, 2004, AM J PHYSIOL-REG I, V287, pR391, DOI 10.1152/ajpregu.00731.2003; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; van Laake LW, 2007, STEM CELL RES, V1, P9, DOI 10.1016/j.scr.2007.06.001; WALKER MJA, 1988, CARDIOVASC RES, V22, P447, DOI 10.1093/cvr/22.7.447; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu CH, 2011, REGEN MED, V6, P53, DOI 10.2217/RME.10.91; Xue T, 2005, CIRCULATION, V111, P11, DOI 10.1161/01.CIR.0000151313.18547.A2; Zhu WZ, 2011, METHODS MOL BIOL, V767, P419, DOI 10.1007/978-1-61779-201-4_31; Zhu WZ, 2010, CIRC RES, V107, P776, DOI 10.1161/CIRCRESAHA.110.223917	40	505	526	2	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2012	489	7415					322	+		10.1038/nature11317	http://dx.doi.org/10.1038/nature11317			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003UC	22864415	Green Accepted			2022-12-28	WOS:000308635900048
J	Oldenburg, M; Kruger, A; Ferstl, R; Kaufmann, A; Nees, G; Sigmund, A; Bathke, B; Lauterbach, H; Suter, M; Dreher, S; Koedel, U; Akira, S; Kawai, T; Buer, J; Wagner, H; Bauer, S; Hochrein, H; Kirschning, CJ				Oldenburg, Marina; Krueger, Anne; Ferstl, Ruth; Kaufmann, Andreas; Nees, Gernot; Sigmund, Anna; Bathke, Barbara; Lauterbach, Henning; Suter, Mark; Dreher, Stefan; Koedel, Uwe; Akira, Shizuo; Kawai, Taro; Buer, Jan; Wagner, Hermann; Bauer, Stefan; Hochrein, Hubertus; Kirschning, Carsten J.			TLR13 Recognizes Bacterial 23S rRNA Devoid of Erythromycin Resistance-Forming Modification	SCIENCE			English	Article							TOLL-LIKE RECEPTORS; MACROLIDE RESISTANCE; DENDRITIC CELLS; LIPOPROTEINS; INFECTION; MUTATION; IMMUNITY; COMPLEX; SENSOR	Host protection from infection relies on the recognition of pathogens by innate pattern-recognition receptors such as Toll-like receptors (TLRs). Here, we show that the orphan receptor TLR13 in mice recognizes a conserved 23S ribosomal RNA (rRNA) sequence that is the binding site of macrolide, lincosamide, and streptogramin group (MLS) antibiotics (including erythromycin) in bacteria. Notably, 23S rRNA from clinical isolates of erythromycin-resistant Staphylococcus aureus and synthetic oligoribonucleotides carrying methylated adenosine or a guanosine mimicking a MLS resistance-causing modification failed to stimulate TLR13. Thus, our results reveal both a natural TLR13 ligand and specific mechanisms of antibiotic resistance as potent bacterial immune evasion strategy, avoiding recognition via TLR13.	[Oldenburg, Marina; Krueger, Anne; Sigmund, Anna; Buer, Jan; Kirschning, Carsten J.] Univ Duisburg Essen, Inst Med Microbiol, D-45147 Essen, Germany; [Ferstl, Ruth; Dreher, Stefan; Wagner, Hermann] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany; [Kaufmann, Andreas; Nees, Gernot; Bauer, Stefan] Univ Marburg, Inst Immunol, D-35043 Marburg, Germany; [Bathke, Barbara; Lauterbach, Henning; Suter, Mark] Bavarian Nord GmbH, Dept Res Immunol, D-82152 Martinsried, Germany; [Suter, Mark] Univ Zurich, Inst Virol, CH-8006 Zurich, Switzerland; [Koedel, Uwe] Clin Univ Munich, Dept Neurol, D-81377 Munich, Germany; [Akira, Shizuo; Kawai, Taro] Osaka Univ, World Premier Int Immunol Frontier Res Ctr, Osaka 5650871, Japan	University of Duisburg Essen; Technical University of Munich; Philipps University Marburg; Bavarian Nordic; University of Zurich; University of Munich; Osaka University	Kirschning, CJ (corresponding author), Univ Duisburg Essen, Inst Med Microbiol, D-45147 Essen, Germany.	carsten.kirschning@uk-essen.de	Akira, Shizuo/C-3134-2009; Ferstl, Ruth/ABB-9679-2021; Hochrein, Hubertus/L-3697-2013	Kruger, Anne/0000-0002-2103-4686; Buer, Jan/0000-0002-7602-1698; Lauterbach, Henning/0000-0002-6062-5163; Oldenburg, Marina/0000-0001-5163-1724; Bauer, Stefan/0000-0002-8462-1845; Kawai, Taro/0000-0001-7510-4662; Hochrein, Hubertus/0000-0001-9904-1934	German research foundation (Deutsche Forschungsgemeinschaft) [KI 591/4-1, GK1045, BA 1618/5-1]; Japanese Government; Behring Rontgen Stiftung [56-0034]; Coley Pharmaceuticals/Pfizer	German research foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Japanese Government; Behring Rontgen Stiftung; Coley Pharmaceuticals/Pfizer(Pfizer)	We thank S. Schimanski, J. Patzold, R. Kassub, T. Scholtysik, and P. Juszczak, as well as C. Chebrolu for technical work; M. Freudenberg, J. Steinmann, and J. Kehrmann for provision of mice and bacteria; R. Lang for advice; the German research foundation (Deutsche Forschungsgemeinschaft) for funding of KI 591/4-1 and GK1045 (to C. J. K.) and BA 1618/5-1 (to S. B.), as well as to U.K.; and the Japanese Government for funding to S. A. and T. K. The Behring Rontgen Stiftung funded grant 56-0034 (to S. B.). The Univ. of Duisburg-Essen (C. J. K.), Bavarian Nordic GmbH (H. H.), and the Philipps Univ. of Marburg (S. B.) filed a patent on TLR13 activators (U. S. Patent 61/597,063; agonists and antagonists of TLR13). H. W. and S. B. had an advisory contract with Coley Pharmaceuticals/Pfizer that ended in 2010. The data presented in this paper are tabulated in the main paper and in the supplementary materials.	Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Buriankova K, 2004, ANTIMICROB AGENTS CH, V48, P143, DOI 10.1128/AAC.48.1.143-150.2004; Crozat K, 2004, P NATL ACAD SCI USA, V101, P6835, DOI 10.1073/pnas.0401347101; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; Deshmukh SD, 2011, EMBO REP, V12, P71, DOI 10.1038/embor.2010.189; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Klinge S, 2011, SCIENCE, V334, P941, DOI 10.1126/science.1211204; Lauterbach H, 2010, J EXP MED, V207, P2703, DOI 10.1084/jem.20092720; Luber CA, 2010, IMMUNITY, V32, P279, DOI 10.1016/j.immuni.2010.01.013; Mancuso G, 2009, NAT IMMUNOL, V10, P587, DOI 10.1038/ni.1733; Munoz-Planillo R, 2009, J IMMUNOL, V183, P3942, DOI 10.4049/jimmunol.0900729; Pfister P, 2005, P NATL ACAD SCI USA, V102, P5180, DOI 10.1073/pnas.0501598102; Ruland J, 2008, ANN NY ACAD SCI, V1143, P35, DOI 10.1196/annals.1443.024; Sergiev PV, 2008, J MOL BIOL, V375, P291, DOI 10.1016/j.jmb.2007.10.051; Shi ZC, 2011, J BIOL CHEM, V286, P4517, DOI 10.1074/jbc.M110.159590; SKINNER RH, 1982, J GEN MICROBIOL, V128, P2411; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; WEISBLUM B, 1995, ANTIMICROB AGENTS CH, V39, P577, DOI 10.1128/AAC.39.3.577	25	288	315	2	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2012	337	6098					1111	1115		10.1126/science.1220363	http://dx.doi.org/10.1126/science.1220363			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22821982				2022-12-28	WOS:000308125800052
J	Ayanian, JZ; Van der Wees, PJ				Ayanian, John Z.; Van der Wees, Philip J.			Tackling Rising Health Care Costs in Massachusetts	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ayanian, John Z.; Van der Wees, Philip J.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Ayanian, John Z.] Brigham & Womens Hosp, Div Gen Med & Primary Care, Boston, MA 02115 USA; [Ayanian, John Z.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Van der Wees, Philip J.] Radboud Univ Nijmegen, Med Ctr, Sci Inst Qual Healthcare, NL-6525 ED Nijmegen, Netherlands; [Van der Wees, Philip J.] Maastricht Univ, Sch Publ Hlth & Primary Care CAPHRI, Maastricht, Netherlands	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Radboud University Nijmegen; Maastricht University	Ayanian, JZ (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA.		van der Wees, Philip Jan/L-4748-2015					Ayanian JZ, 2012, J GEN INTERN MED, V27, P139, DOI 10.1007/s11606-011-1940-1; Commonwealth of Massachusetts, ACT IMPR QUAL HLTH C; Cuckler Gigi, 2011, Medicare Medicaid Res Rev, V1, DOI 10.5600/mmrr.001.04.a03; Fisher ES, 2009, NEW ENGL J MED, V360, P849, DOI 10.1056/NEJMp0809794; Song ZR, 2012, HEALTH AFFAIR, V31, P1885, DOI 10.1377/hlthaff.2012.0327	5	17	17	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 30	2012	367	9					790	793		10.1056/NEJMp1208710	http://dx.doi.org/10.1056/NEJMp1208710			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	996EN	22894555				2022-12-28	WOS:000308067400015
J	Rabe, KF; Ward, B				Rabe, Klaus F.; Ward, Brian			Uncovering and tackling Europe's hidden respiratory illness	LANCET			English	Editorial Material									[Rabe, Klaus F.] Univ Kiel, D-24118 Kiel, Germany; [Ward, Brian] European Resp Soc, Brussels, Belgium	University of Kiel	Rabe, KF (corresponding author), Univ Kiel, D-24118 Kiel, Germany.	k.f.rabe@kh-grosshansdorf.de	Rabe, Klaus F./AAW-6296-2021	Rabe, Klaus F./0000-0002-7020-1401				Department of Health, 2011, OUTC STRAT CHRON OBS; European Commission, 2012, REV EU AIR POL; European Respiratory Roadmap, PREV; London Health Observatory, 2010, JUB LIN HLTH IN 2004; Mackenbach J.P, 2007, EC IMPLICATIONS SOCI; Samolinski B, 2012, LANCET, V379, pE45, DOI 10.1016/S0140-6736(12)60514-5; World Health Organization, 2008, TALL CHART HLTH SYST	7	8	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 18	2012	380	9842					623	624		10.1016/S0140-6736(12)61306-3	http://dx.doi.org/10.1016/S0140-6736(12)61306-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	991SE	22901869				2022-12-28	WOS:000307721000004
J	Peralta-Yahya, PP; Zhang, FZ; del Cardayre, SB; Keasling, JD				Peralta-Yahya, Pamela P.; Zhang, Fuzhong; del Cardayre, Stephen B.; Keasling, Jay D.			Microbial engineering for the production of advanced biofuels	NATURE			English	Review							MODULAR POLYKETIDE SYNTHASE; ESCHERICHIA-COLI; SYNTHETIC BIOLOGY; SACCHAROMYCES-CEREVISIAE; BUTANOL PRODUCTION; BACILLUS-SUBTILIS; BIOSYNTHESIS; PRECURSOR; ACID; CONVERSION	Advanced biofuels produced by microorganisms have similar properties to petroleum-based fuels, and can 'drop in' to the existing transportation infrastructure. However, producing these biofuels in yields high enough to be useful requires the engineering of the microorganism's metabolism. Such engineering is not based on just one specific feedstock or host organism. Data-driven and synthetic-biology approaches can be used to optimize both the host and pathways to maximize fuel production. Despite some success, challenges still need to be met to move advanced biofuels towards commercialization, and to compete with more conventional fuels.	[Peralta-Yahya, Pamela P.; Zhang, Fuzhong; Keasling, Jay D.] Joint BioEnergy Inst, Emeryville, CA 94608 USA; [Peralta-Yahya, Pamela P.; Zhang, Fuzhong; Keasling, Jay D.] Univ Calif Berkeley, Inst QB3, Berkeley, CA 94720 USA; [del Cardayre, Stephen B.] LS9, San Francisco, CA 94080 USA; [Keasling, Jay D.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Keasling, Jay D.] Univ Calif Berkeley, Dept Bioengn, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Keasling, JD (corresponding author), Joint BioEnergy Inst, 5885 Hollis St, Emeryville, CA 94608 USA.	keasling@berkeley.edu	Keasling, Jay D/J-9162-2012	Keasling, Jay D/0000-0003-4170-6088; Zhang, Fuzhong/0000-0001-6979-7909	Joint BioEnergy Institute; U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]; Synthetic Biology Engineering Research Center; National Science Foundation [0540879]	Joint BioEnergy Institute; U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Synthetic Biology Engineering Research Center; National Science Foundation(National Science Foundation (NSF))	P.P.P.-Y. and F.Z. contributed equally to this work. This work was supported in part by the Joint BioEnergy Institute, which is funded by the U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DE-AC02-05CH11231, and by the Synthetic Biology Engineering Research Center, which is funded by National Science Foundation Award No. 0540879.	Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; Asadollahi MA, 2009, METAB ENG, V11, P328, DOI 10.1016/j.ymben.2009.07.001; Atsumi S, 2008, METAB ENG, V10, P305, DOI 10.1016/j.ymben.2007.08.003; Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; Atsumi S, 2009, NAT BIOTECHNOL, V27, P1177, DOI 10.1038/nbt.1586; Banerjee A, 2002, CRIT REV BIOTECHNOL, V22, P245, DOI 10.1080/07388550290789513; Beller HR, 2010, APPL ENVIRON MICROB, V76, P1212, DOI 10.1128/AEM.02312-09; Berezina OV, 2010, APPL MICROBIOL BIOT, V87, P635, DOI 10.1007/s00253-010-2480-z; Betancor L, 2008, CHEMBIOCHEM, V9, P2962, DOI 10.1002/cbic.200800475; Bokinsky G, 2011, P NATL ACAD SCI USA, V108, P19949, DOI 10.1073/pnas.1106958108; Bond-Watts BB, 2011, NAT CHEM BIOL, V7, P222, DOI 10.1038/NCHEMBIO.537; Buelter T., 2012, US patent, Patent No. [0,058,532 A1, 0058532]; CARAFA YD, 1990, J MOL BIOL, V216, P835, DOI 10.1016/S0022-2836(99)80005-9; Chen X, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-21; Davis MS, 2001, J BACTERIOL, V183, P1499, DOI 10.1128/JB.183.4.1499-1503.2001; de Jong B., 2011, CURR OPIN BIOTECHNOL; De Mey M, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-34; Dellomonaco C, 2011, NATURE, V476, P355, DOI 10.1038/nature10333; Donaldson G. K., 2007, US Patent, Patent No. [0313206, 0,313,206 A1]; Donaldson G. K., 2011, US patent, Patent No. [0,313,206 A1, 0313206]; Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557; Dunlop MJ, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.21; Ezeji T, 2010, APPL MICROBIOL BIOT, V85, P1697, DOI 10.1007/s00253-009-2390-0; Ezeji TC, 2007, J IND MICROBIOL BIOT, V34, P771, DOI 10.1007/s10295-007-0253-1; Festel G., 2011, US patent, Patent No. [0,053,235 A1, 0053235]; Fortman JL, 2008, TRENDS BIOTECHNOL, V26, P375, DOI 10.1016/j.tibtech.2008.03.008; Goh EB, 2012, APPL ENVIRON MICROB, V78, P70, DOI 10.1128/AEM.06785-11; Griffith KL, 2008, MOL MICROBIOL, V70, P1012, DOI 10.1111/j.1365-2958.2008.06467.x; Handke P, 2011, METAB ENG, V13, P28, DOI 10.1016/j.ymben.2010.10.007; Harvey BG, 2010, ENERG FUEL, V24, P267, DOI 10.1021/ef900799c; Higashide W, 2011, APPL ENVIRON MICROB, V77, P2727, DOI 10.1128/AEM.02454-10; Holtz WJ, 2010, CELL, V140, P19, DOI 10.1016/j.cell.2009.12.029; Hong K. K., 2012, CELL MOL LIFE SCI; Jacobsen JR, 1997, SCIENCE, V277, P367, DOI 10.1126/science.277.5324.367; Jones KL, 2000, METAB ENG, V2, P328, DOI 10.1006/mben.2000.0161; Kalscheuer R, 2006, MICROBIOL-SGM, V152, P2529, DOI 10.1099/mic.0.29028-0; Katz L., 2011, US patent, Patent No. [CN102014623, 102014623]; Keasling JD, 2010, SCIENCE, V330, P1355, DOI 10.1126/science.1193990; Kerr RA, 2007, SCIENCE, V316, P188, DOI 10.1126/science.316.5822.188; Kirby J, 2009, ANNU REV PLANT BIOL, V60, P335, DOI 10.1146/annurev.arplant.043008.091955; Knothe G, 2010, PROG ENERG COMBUST, V36, P364, DOI 10.1016/j.pecs.2009.11.004; Kopke M, 2010, P NATL ACAD SCI USA, V107, P13087, DOI 10.1073/pnas.1004716107; Kuzuyama T, 2002, BIOSCI BIOTECH BIOCH, V66, P1619, DOI 10.1271/bbb.66.1619; Lan EI, 2012, P NATL ACAD SCI USA, V109, P6018, DOI 10.1073/pnas.1200074109; Lee SY, 2008, BIOTECHNOL BIOENG, V101, P209, DOI 10.1002/bit.22003; Lee SK, 2008, CURR OPIN BIOTECH, V19, P556, DOI 10.1016/j.copbio.2008.10.014; Lee TS, 2011, J BIOL ENG, V5, DOI 10.1186/1754-1611-5-12; Lennen RM, 2010, BIOTECHNOL BIOENG, V106, P193, DOI 10.1002/bit.22660; Leonard E, 2010, P NATL ACAD SCI USA, V107, P13654, DOI 10.1073/pnas.1006138107; Li H, 2012, SCIENCE, V335, P1596, DOI 10.1126/science.1217643; Liu TG, 2010, METAB ENG, V12, P378, DOI 10.1016/j.ymben.2010.02.003; Lutke-Eversloh T, 2011, CURR OPIN BIOTECH, V22, P634, DOI 10.1016/j.copbio.2011.01.011; Malaviya A, 2012, APPL MICROBIOL BIOT, V93, P1485, DOI 10.1007/s00253-011-3629-0; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; McAndrew RP, 2011, STRUCTURE, V19, P1876, DOI 10.1016/j.str.2011.09.013; Meades G, 2010, NUCLEIC ACIDS RES, V38, P1217, DOI 10.1093/nar/gkp1079; Mendez-Perez D, 2011, APPL ENVIRON MICROB, V77, P4264, DOI 10.1128/AEM.00467-11; Menzella HG, 2005, NAT BIOTECHNOL, V23, P1171, DOI 10.1038/nbt1128; Michener JK, 2012, METAB ENG, V14, P212, DOI 10.1016/j.ymben.2011.09.004; Nawabi P, 2011, APPL ENVIRON MICROB, V77, P8052, DOI 10.1128/AEM.05046-11; Nielsen DR, 2009, METAB ENG, V11, P262, DOI 10.1016/j.ymben.2009.05.003; Nielsen J, 2011, NAT BIOTECHNOL, V29, P693, DOI 10.1038/nbt.1937; Peralta-Yahya PP, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1494; Peralta-Yahya PP, 2010, BIOTECHNOL J, V5, P147, DOI 10.1002/biot.200900220; Pfeifer BA, 2001, MICROBIOL MOL BIOL R, V65, P106, DOI 10.1128/MMBR.65.1.106-118.2001; Pfleger BF, 2006, NAT BIOTECHNOL, V24, P1027, DOI 10.1038/nbt1226; Primak YA, 2011, APPL ENVIRON MICROB, V77, P7772, DOI 10.1128/AEM.05761-11; Qureshi N, 1999, BIOTECHNOL PROGR, V15, P594, DOI 10.1021/bp990080e; Redding-Johanson AM, 2011, METAB ENG, V13, P194, DOI 10.1016/j.ymben.2010.12.005; Reiser S, 1997, J BACTERIOL, V179, P2969, DOI 10.1128/jb.179.9.2969-2975.1997; Renninger N, 2008, U.S. Patent, Patent No. 7399323; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Rude MA, 2011, APPL ENVIRON MICROB, V77, P1718, DOI 10.1128/AEM.02580-10; Rude MA, 2009, CURR OPIN MICROBIOL, V12, P274, DOI 10.1016/j.mib.2009.04.004; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Seregina TA, 2010, APPL BIOCHEM MICRO+, V46, P745, DOI 10.1134/S000368381008003X; Shen CR, 2011, APPL ENVIRON MICROB, V77, P2905, DOI 10.1128/AEM.03034-10; Smith KM, 2010, APPL MICROBIOL BIOT, V87, P1045, DOI 10.1007/s00253-010-2522-6; Smolke CD, 2000, APPL ENVIRON MICROB, V66, P5399, DOI 10.1128/AEM.66.12.5399-5405.2000; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Steen EJ, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-36; Stephanopoulos G, 2007, SCIENCE, V315, P801, DOI 10.1126/science.1139612; Sukovich DJ, 2010, APPL ENVIRON MICROB, V76, P3850, DOI 10.1128/AEM.00436-10; Sun J., 2012, US patent, Patent No. [0,040,426 A1, 0040426]; Tan XM, 2011, METAB ENG, V13, P169, DOI 10.1016/j.ymben.2011.01.001; Tracewell CA, 2009, CURR OPIN CHEM BIOL, V13, P3, DOI 10.1016/j.cbpa.2009.01.017; Trimbur D., 2011, US patent, Patent No. [0,047,863 A1, 0047863]; Tsukahara K, 1999, J BIOSCI BIOENG, V87, P554, DOI 10.1016/S1389-1723(99)80112-1; Tsuruta H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004489; Tyo KEJ, 2009, NAT BIOTECHNOL, V27, P760, DOI 10.1038/nbt.1555; Ubersax J., 2010, Genetically modified microbes producing isoprenoids patent world, Patent No. [1,414,52 A1, 141452]; Westfall PJ, 2012, P NATL ACAD SCI USA, V109, P111, DOI 10.1073/pnas.1110740109; Withers ST, 2007, APPL ENVIRON MICROB, V73, P6277, DOI 10.1128/AEM.00861-07; Yan Y, 2009, J IND MICROBIOL BIOT, V36, P471, DOI 10.1007/s10295-009-0532-0; Yu XY, 2011, P NATL ACAD SCI USA, V108, P18643, DOI 10.1073/pnas.1110852108; Yuzawa S., CURR OPIN BIOTECHNOL; Yuzawa S., 2012, CURR OPIN BIOTECHNOL; Zhang FZ, 2012, NAT BIOTECHNOL, V30, P354, DOI 10.1038/nbt.2149	100	749	783	22	873	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2012	488	7411					320	328		10.1038/nature11478	http://dx.doi.org/10.1038/nature11478			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OS	22895337				2022-12-28	WOS:000307501000031
J	Hoge, CW; Castro, CA				Hoge, Charles W.; Castro, Carl A.			Preventing Suicides in US Service Members and Veterans Concerns After a Decade of War	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DEPLOYMENT; MILITARY		[Hoge, Charles W.] Walter Reed Army Inst Res, Silver Spring, MD 20910 USA; [Castro, Carl A.] USA, Med Res & Mat Command, Ft Detrick, MD USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Hoge, CW (corresponding author), Walter Reed Army Inst Res, 501 Robert Grant Ave, Silver Spring, MD 20910 USA.	charles.hoge@us.army.mil						[Anonymous], REP BLUE RIBB WORK G; [Anonymous], DEP DEF SUIC EV REP; Bray RM, 2008, 2008 DOD SURVEY HLTH; Eaton KM, 2006, SUICIDE LIFE-THREAT, V36, P182, DOI 10.1521/suli.2006.36.2.182; Hoge CW, 2011, JAMA-J AM MED ASSOC, V306, P549, DOI 10.1001/jama.2011.1096; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Miller M, 2012, AM J PUBLIC HEALTH, V102, pS20, DOI 10.2105/AJPH.2011.300572; Pirkis J, 2011, INTERNATIONAL HANDBOOK OF SUICIDE PREVENTION: RESEARCH, POLICY AND PRACTICE, P531; Warner CH, 2011, ARCH GEN PSYCHIAT, V68, P1065, DOI 10.1001/archgenpsychiatry.2011.112; Warner CH, 2011, AM J PSYCHIAT, V168, P378, DOI 10.1176/appi.ajp.2010.10091303	10	80	80	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2012	308	7					671	672		10.1001/jama.2012.9955	http://dx.doi.org/10.1001/jama.2012.9955			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988NC	22893160				2022-12-28	WOS:000307496700018
J	Jones, DS				Jones, David S.			The art of medicine How much CABG is good for us?	LANCET			English	Editorial Material									Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Jones, DS (corresponding author), Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02115 USA.	dsjones@harvard.edu							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 11	2012	380	9841					557	558		10.1016/S0140-6736(12)61319-1	http://dx.doi.org/10.1016/S0140-6736(12)61319-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988SQ	22891375	Green Submitted, Bronze			2022-12-28	WOS:000307511400016
J	Hawkes, N				Hawkes, Nigel			Why are the media so soft on Circle?	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						Adams S., 2012, DAILY TELEGRAPH; [Anonymous], 2012, NEWSNIGHT       0801; BBC Radio 4, 2012, TODAY           0801; Borland S, 2012, DAILY MAIL; NHS Cambridgeshire and NHS Peterborough, PERF IND REP 2011 12; O'Dowd A, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e842; Torjesen I, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5307	7	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 8	2012	345								e5351	10.1136/bmj.e5351	http://dx.doi.org/10.1136/bmj.e5351			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988ND	22875959				2022-12-28	WOS:000307496800005
J	Rist, PM; Kang, JH; Buring, JE; Glymour, MM; Grodstein, F; Kurth, T				Rist, Pamela M.; Kang, Jae H.; Buring, Julie E.; Glymour, M. Maria; Grodstein, Fran; Kurth, Tobias			Migraine and cognitive decline among women: prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							LOW-DOSE ASPIRIN; CARDIOVASCULAR-DISEASE; PRIMARY PREVENTION; RANDOMIZED-TRIAL; BRAIN INFARCTS; OLDER-ADULTS; VITAMIN-E; HEALTH; RISK; HEADACHE	Objective To evaluate the association between migraine and cognitive decline among women. Design Prospective cohort study. Setting Women's Health Study, United States. Participants 6349 women aged 65 or older enrolled in the Women's Health Study who provided information about migraine status at baseline and participated in cognitive testing during follow-up. Participants were classified into four groups: no history of migraine, migraine with aura, migraine without aura, and past history of migraine (reports of migraine history but no migraine in the year prior to baseline). Main outcome measures Cognitive testing was carried out at two year intervals up to three times using the telephone interview for cognitive status, immediate and delayed recall trials of the east Boston memory test, delayed recall trial of the telephone interview for cognitive status 10 word list, and a category fluency test. All tests were combined into a global cognitive score, and tests assessing verbal memory were combined to create a verbal memory score. Results Of the 6349 women, 853 (13.4%) reported any migraine; of these, 195 (22.9%) reported migraine with aura, 248 (29.1%) migraine without aura, and 410 (48.1%) a past history of migraine. Compared with women with no history of migraine, those who experienced migraine with or without aura or had a past history of migraine did not have significantly different rates of cognitive decline in any of the cognitive scores: values for the rate of change of the global cognitive score between baseline and the last observation ranged from -0.01 (SE 0.04) for past history of migraine to 0.08 (SE 0.04) for migraine with aura when compared with women without any history of migraine. Women who experienced migraine were also not at increased risk of substantial cognitive decline (worst 10% of the distribution of decline). When compared with women without a history of migraine, the relative risks for the global score ranged from 0.77 (95% confidence interval 0.46 to 1.28) for women with migraine without aura to 1.17 (0.84 to 1.63) for women with a past history of migraine. Conclusion In this prospective cohort of women, migraine status was not associated with faster rates of cognitive decline.	[Kurth, Tobias] Univ Bordeaux Segalen, INSERM, Unit Neuroepidemiol 708, F-33076 Bordeaux, France; [Rist, Pamela M.; Buring, Julie E.; Kurth, Tobias] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Prevent Med,Dept Med, Boston, MA 02115 USA; [Rist, Pamela M.; Buring, Julie E.; Grodstein, Fran; Kurth, Tobias] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Kang, Jae H.; Grodstein, Fran] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Glymour, M. Maria] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Cambridge, MA 02138 USA; [Kurth, Tobias] Univ Bordeaux, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; UDICE-French Research Universities; Universite de Bordeaux	Kurth, T (corresponding author), Univ Bordeaux Segalen, INSERM, Unit Neuroepidemiol 708, 146 Rue Leo Saignat,Case 11, F-33076 Bordeaux, France.	tobias.kurth@univ-bordeaux.fr	Kurth, Tobias/A-9243-2012	Kurth, Tobias/0000-0001-7169-2620	National Heart, Lung, and Blood Institute [HL-043851, HL-080467, HL-099355]; National Cancer Institute [CA-47988]; National Institute of Aging [AG-15933, AG-00158]; Chair of Excellence grant of the French National Research Agency (Agence Nationale de la Recherche) [R09177DD]; NATIONAL CANCER INSTITUTE [R01CA047988] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL099355, R01HL080467, R01HL043851] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015933] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Chair of Excellence grant of the French National Research Agency (Agence Nationale de la Recherche)(French National Research Agency (ANR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Women's Health Study is supported by grants from the National Heart, Lung, and Blood Institute (HL-043851, HL-080467, HL-099355) and the National Cancer Institute (CA-47988). The cognitive substudy of the Women's Health Study was supported by a grant from the National Institute of Aging (AG-15933). PMR was supported by a training grant from the National Institute of Aging (AG-00158). TK is supported in part by a Chair of Excellence grant of the French National Research Agency (Agence Nationale de la Recherche, R09177DD).	ALBERT M, 1991, INT J NEUROSCI, V57, P167, DOI 10.3109/00207459109150691; Baars MAE, 2010, HEADACHE, V50, P176, DOI 10.1111/j.1526-4610.2009.01572.x; Bigal ME, 2009, NEUROL CLIN, V27, P321, DOI 10.1016/j.ncl.2008.11.011; Calandre EP, 2002, CEPHALALGIA, V22, P291, DOI 10.1046/j.1468-2982.2002.00370.x; de Jager CA, 2003, INT J GERIATR PSYCH, V18, P318, DOI 10.1002/gps.830; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gaist D, 2005, NEUROLOGY, V64, P600, DOI 10.1212/01.WNL.0000151858.15482.66; Haverkamp F, 2002, HEADACHE, V42, P776, DOI 10.1046/j.1526-4610.2002.02179.x; HOOKER WD, 1986, ARCH NEUROL-CHICAGO, V43, P709, DOI 10.1001/archneur.1986.00520070065020; Jelicic M, 2000, HEADACHE, V40, P715, DOI 10.1046/j.1526-4610.2000.00124.x; Kalaydjian A, 2007, NEUROLOGY, V68, P1417, DOI 10.1212/01.wnl.0000268250.10171.b3; Kang JH, 2007, BMJ-BRIT MED J, V334, P987, DOI 10.1136/bmj.39166.597836.BE; Kang JH, 2006, ARCH INTERN MED, V166, P2462, DOI 10.1001/archinte.166.22.2462; Kruit MC, 2004, JAMA-J AM MED ASSOC, V291, P427, DOI 10.1001/jama.291.4.427; Kurth T, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7357; Kurth T, 2006, JAMA-J AM MED ASSOC, V296, P283, DOI 10.1001/jama.296.3.283; Le Pira F, 2000, CEPHALALGIA, V20, P475, DOI 10.1046/j.1468-2982.2000.00074.x; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Lee SM, 2006, NEUROEPIDEMIOLOGY, V26, P93, DOI 10.1159/000090254; LEIJDEKKERS MLA, 1990, HEADACHE, V30, P352, DOI 10.1111/j.1526-4610.1990.hed3006352.x; Lipton RB, 2004, JAMA-J AM MED ASSOC, V291, P493, DOI 10.1001/jama.291.4.493; Lopez Oscar L, 2010, Neuroepidemiology, V34, P63, DOI 10.1159/000264678; Mulder EJCM, 1999, CEPHALALGIA, V19, P557, DOI 10.1046/j.1468-2982.1999.019006557.x; Okereke OI, 2008, J AM GERIATR SOC, V56, P1028, DOI 10.1111/j.1532-5415.2008.01686.x; Ott A, 1998, AM J EPIDEMIOL, V147, P574; Palmer JE, 1998, CEPHALALGIA, V18, P125, DOI 10.1046/j.1468-2982.1998.1803125.x; Pearson AJ, 2006, CEPHALALGIA, V26, P74, DOI 10.1111/j.1468-2982.2005.01001.x; Rexrode KM, 2000, J WOMEN HEALTH GEN-B, V9, P19, DOI 10.1089/152460900318911; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Rist PM, 2011, CEPHALALGIA, V31, P1291, DOI 10.1177/0333102411417466; Scher AI, 2009, JAMA-J AM MED ASSOC, V301, P2563, DOI 10.1001/jama.2009.932; Schurks M, 2009, CEPHALALGIA, V29, P1086, DOI 10.1111/j.1468-2982.2008.01835.x; Schurks M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3914; Vermeer SE, 2003, NEW ENGL J MED, V348, P1215, DOI 10.1056/NEJMoa022066; Weuve J, 2006, EPIDEMIOLOGY, V17, P183, DOI 10.1097/01.ede.0000198183.60572.c9; ZEITLIN C, 1984, BRIT J CLIN PSYCHOL, V23, P27, DOI 10.1111/j.2044-8260.1984.tb00623.x	36	31	32	0	18	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 8	2012	345								e5027	10.1136/bmj.e5027	http://dx.doi.org/10.1136/bmj.e5027			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988ND	22875950	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000307496800002
J	Kjaer, KH; Khan, SA; Korsgaard, NJ; Wahr, J; Bamber, JL; Hurkmans, R; van den Broeke, M; Timm, LH; Kjeldsen, KK; Bjork, AA; Larsen, NK; Jorgensen, LT; Faerch-Jensen, A; Willerslev, E				Kjaer, Kurt H.; Khan, Shfaqat A.; Korsgaard, Niels J.; Wahr, John; Bamber, Jonathan L.; Hurkmans, Ruud; van den Broeke, Michiel; Timm, Lars H.; Kjeldsen, Kristian K.; Bjork, Anders A.; Larsen, Nicolaj K.; Jorgensen, Lars Tyge; Faerch-Jensen, Anders; Willerslev, Eske			Aerial Photographs Reveal Late-20th-Century Dynamic Ice Loss in Northwestern Greenland	SCIENCE			English	Article							RESOLUTION CLIMATE MODEL; JAKOBSHAVN ISBRAE; MASS-LOSS	Global warming is predicted to have a profound impact on the Greenland Ice Sheet and its contribution to global sea-level rise. Recent mass loss in the northwest of Greenland has been substantial. Using aerial photographs, we produced digital elevation models and extended the time record of recent observed marginal dynamic thinning back to the mid-1980s. We reveal two independent dynamic ice loss events on the northwestern Greenland Ice Sheet margin: from 1985 to 1993 and 2005 to 2010, which were separated by limited mass changes. Our results suggest that the ice mass changes in this sector were primarily caused by short-lived dynamic ice loss events rather than changes in the surface mass balance. This finding challenges predictions about the future response of the Greenland Ice Sheet to increasing global temperatures.	[Kjaer, Kurt H.; Korsgaard, Niels J.; Timm, Lars H.; Kjeldsen, Kristian K.; Bjork, Anders A.; Willerslev, Eske] Univ Copenhagen, Ctr GeoGenet, Nat Hist Museum, Copenhagen, Denmark; [Khan, Shfaqat A.] Tech Univ Denmark, DTU Space Natl Space Inst, Dept Geodesy, DK-2800 Lyngby, Denmark; [Wahr, John] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Wahr, John] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Bamber, Jonathan L.; Hurkmans, Ruud] Univ Bristol, Bristol Glaciol Ctr, Bristol, Avon, England; [van den Broeke, Michiel] Univ Utrecht, Inst Marine & Atmospher Res, Utrecht, Netherlands; [Larsen, Nicolaj K.] Aarhus Univ, Dept Geosci, Aarhus, Denmark; [Jorgensen, Lars Tyge; Faerch-Jensen, Anders] Danish Natl Cadastre & Survey, Copenhagen, Denmark	University of Copenhagen; Technical University of Denmark; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Bristol; Utrecht University; Aarhus University	Kjaer, KH (corresponding author), Univ Copenhagen, Ctr GeoGenet, Nat Hist Museum, Copenhagen, Denmark.	kurtk@snm.ku.dk	Khan, Shfaqat A/B-2664-2012; Bjørk, Anders/B-1625-2013; Khan, Shfaqat Abbas/AAP-6627-2021; Larsen, Nicolaj K./A-3509-2012; Hurkmans, Ruud/B-8286-2012; Van den Broeke, Michiel R./F-7867-2011; Korsgaard, Niels Jákup/D-8256-2013; Willerslev, Eske/A-9619-2011; Willerslev, Eske/AAA-5686-2019; Kjaer, Kurt/A-4199-2013; Kjeldsen, Kristian Kjellerup/A-9592-2013; Bamber, Jonathan/C-7608-2011	Khan, Shfaqat A/0000-0002-2689-8563; Bjørk, Anders/0000-0002-4919-792X; Khan, Shfaqat Abbas/0000-0002-2689-8563; Larsen, Nicolaj K./0000-0002-0117-1106; Hurkmans, Ruud/0000-0002-9164-7445; Van den Broeke, Michiel R./0000-0003-4662-7565; Korsgaard, Niels Jákup/0000-0002-8700-7023; Willerslev, Eske/0000-0002-7081-6748; Kjaer, Kurt/0000-0002-8871-5179; Kjeldsen, Kristian Kjellerup/0000-0002-8557-5131; Bamber, Jonathan/0000-0002-2280-2819	Danish Research Council [272-08-0415]; Commission for Scientific Research in Greenland; European Union [226375]; NASA [NNX08AF02G, NNXI0AR66G]; NASA's Making Earth Science Data Records for Use in Research Environments (MEaSUREs) program; Utrecht University; Netherlands Polar Program	Danish Research Council(Det Frie Forskningsrad (DFF)); Commission for Scientific Research in Greenland; European Union(European Commission); NASA(National Aeronautics & Space Administration (NASA)); NASA's Making Earth Science Data Records for Use in Research Environments (MEaSUREs) program; Utrecht University; Netherlands Polar Program	This work is a part of the RinkProject, within the Centre for GeoGenetics, funded by the Danish Research Council, grant no. 272-08-0415, and the Commission for Scientific Research in Greenland. J.L.B. and R. H. were supported by funding from the ice2sea program from the European Union 7th Framework Programme, grant number 226375. J.W. was partially supported by NASA grants NNX08AF02G and NNXI0AR66G, and by NASA's Making Earth Science Data Records for Use in Research Environments (MEaSUREs) program. M.v.d.B. acknowledges support from Utrecht University and the Netherlands Polar Program. Finally, we extend our gratitude toward the Danish National Cadastre and Survey for facilitating the erection of AirBase: a database containing registrations of aerial photographs from Greenland and their metadata. K. H. K., S. A. K., N.K.L., and E. W. wrote the majority of the main text with significant input from all authors. All authors contributed with interpretation and discussion of results. N.J.K. completed the aerial photogrammetric and validation analyses together with L. H. T., K. H. K., L.T.J., and A.F.-J. J.W. provided the GRACE data and analyses. K. K. K. handled the Geographical Information System and database management. J.B., M.v.d.B., and R. H. provided SMB and firn density data. A. A. B., L. H. T., and N.K.L. collected ice marginal data and analyzed their long-term significance.	AMAP, 2009, GREENL IC SHEET CHAN; Carstensen L. S., 2011, 1110 DMI TR; Chen JL, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB007789; Ettema J, 2010, CRYOSPHERE, V4, P511, DOI 10.5194/tc-4-511-2010; Ettema J, 2010, CRYOSPHERE, V4, P529, DOI 10.5194/tc-4-529-2010; Ettema J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038110; Ewert H., 2011, J GEODYN; Holland DM, 2008, NAT GEOSCI, V1, P659, DOI 10.1038/ngeo316; Howat IM, 2007, SCIENCE, V315, P1559, DOI 10.1126/science.1138478; Howat IM, 2011, J GLACIOL, V57, P389, DOI 10.3189/002214311796905631; Jacob T, 2012, NATURE, V482, P514, DOI 10.1038/nature10847; Joughin I, 2010, J GLACIOL, V56, P415, DOI 10.3189/002214310792447734; Khan SA, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042460; Krabill W.B, 2010, ICEBRIDGE ATM L2 ICE; Murray T, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001522; Nick FM, 2009, NAT GEOSCI, V2, P110, DOI 10.1038/NGEO394; Pritchard HD, 2009, NATURE, V461, P971, DOI 10.1038/nature08471; Reeh N, 2005, ANN GLACIOL-SER, V42, P101, DOI 10.3189/172756405781812871; Reeh N, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2007JF000746; Rignot E, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046583; Sasgen I, 2012, EARTH PLANET SC LETT, V333, P293, DOI 10.1016/j.epsl.2012.03.033; Straneo F, 2010, NAT GEOSCI, V3, P182, DOI 10.1038/NGEO764; Thomas RH, 2003, J GLACIOL, V49, P231, DOI 10.3189/172756503781830764; van As D, 2011, J GLACIOL, V57, P208, DOI 10.3189/002214311796405898; van den Broeke M, 2009, SCIENCE, V326, P984, DOI 10.1126/science.1178176; Velicogna I, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040222; Wahr J, 1998, J GEOPHYS RES-SOL EA, V103, P30205, DOI 10.1029/98JB02844; Wouters B, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034816; Zwally H. J., 2011, GLAS ICESAT L2 ANTAR; Zwally HJ, 2011, J GLACIOL, V57, P88, DOI 10.3189/002214311795306682	30	68	68	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 3	2012	337	6094					569	573		10.1126/science.1220614	http://dx.doi.org/10.1126/science.1220614			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982PU	22859486				2022-12-28	WOS:000307058700042
J	Rupar, PA; Chabanne, L; Winnik, MA; Manners, I				Rupar, Paul A.; Chabanne, Laurent; Winnik, Mitchell A.; Manners, Ian			Non-Centrosymmetric Cylindrical Micelles by Unidirectional Growth	SCIENCE			English	Article							BLOCK-COPOLYMER MICELLES; DIBLOCK COPOLYMERS; CONTROLLED LENGTH; ARCHITECTURES; MORPHOLOGIES; COMPLEX; WATER; CORE	Although solution self-assembly of block copolymers (BCPs) represents one of the most promising approaches to the creation of nanoparticles from soft matter, the formation of non-centrosymmetric nanostructures with shape anisotropy remains a major challenge. Through a combination of crystallization-driven self-assembly of crystalline-coil BCPs in solution and selective micelle corona cross-linking, we have created short (about 130 nanometers), monodisperse cylindrical seed micelles that grow unidirectionally. These nanostructures grow to form long, non-centrosymmetric cylindrical A-B and A-B-C block co-micelles upon the addition of further BCPs. We also illustrate the formation of amphiphilic cylindrical A-B-C block co-micelles, which spontaneously self-assemble into hierarchical star-shaped supermicelle architectures with a diameter of about 3 micrometers. The method described enables the rational creation of non-centrosymmetric, high aspect ratio, colloidally stable core-shell nanoparticles in a manner that until now has been restricted to the biological domain.	[Winnik, Mitchell A.] Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada; [Rupar, Paul A.; Chabanne, Laurent; Manners, Ian] Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England	University of Toronto; University of Bristol	Winnik, MA (corresponding author), Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada.	mwinnik@chem.utoronto.ca; ian.manners@bristol.ac.uk	Winnik, Mitchell A/R-8621-2018; Rupar, Paul/E-6496-2010	Rupar, Paul/0000-0002-9532-116X; Manners, Ian/0000-0002-3794-967X	Natural Science and Engineering Research Council (NSERC) of Canada; European Union (EU); Engineering and Physical Sciences Research Council; European Research Council Advanced Investigator Grant; Royal Society for a Wolfson Research Merit Award; NSERC of Canada	Natural Science and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); European Union (EU)(CGIAREuropean Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Research Council Advanced Investigator Grant(European Research Council (ERC)); Royal Society for a Wolfson Research Merit Award(Royal Society of London); NSERC of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	P.A.R. is grateful to the Natural Science and Engineering Research Council (NSERC) of Canada for a postdoctoral fellowship and the European Union (EU) for a Marie Curie fellowship. L. C. thanks the EU and Engineering and Physical Sciences Research Council for support. I. M. thanks the EU for a Marie Curie Chair, a Reintegration Grant, and a European Research Council Advanced Investigator Grant and the Royal Society for a Wolfson Research Merit Award. M. A. W. thanks the NSERC of Canada for financial support. The authors also thank T. Gadt for synthesizing PFS<INF>28</INF>-b-PDMS<INF>560</INF> and PFS<INF>64</INF>-b-P2VP<INF>837</INF>.	Chen Q, 2011, SCIENCE, V331, P199, DOI 10.1126/science.1197451; Cheng L, 2008, ANGEW CHEM INT EDIT, V47, P10171, DOI 10.1002/anie.200803315; Christian DA, 2009, NAT MATER, V8, P843, DOI [10.1038/NMAT2512, 10.1038/nmat2512]; Cui HG, 2007, SCIENCE, V317, P647, DOI 10.1126/science.1141768; Du ZX, 2007, MACROMOLECULES, V40, P7633, DOI 10.1021/ma070977p; Dupont J, 2010, SOFT MATTER, V6, P3654, DOI 10.1039/c0sm00044b; Gadt T, 2009, NAT MATER, V8, P144, DOI [10.1038/NMAT2356, 10.1038/nmat2356]; Gilroy JB, 2010, NAT CHEM, V2, P566, DOI [10.1038/NCHEM.664, 10.1038/nchem.664]; Glotzer SC, 2007, NAT MATER, V6, P557, DOI 10.1038/nmat1949; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; Jain S, 2003, SCIENCE, V300, P460, DOI 10.1126/science.1082193; Lazzari M, 2008, MACROMOL RAPID COMM, V29, P352, DOI 10.1002/marc.200700818; Lee E, 2011, J AM CHEM SOC, V133, P10390, DOI 10.1021/ja2038547; Li ZB, 2004, SCIENCE, V306, P98, DOI 10.1126/science.1103350; O'Reilly RK, 2006, CHEM SOC REV, V35, P1068, DOI 10.1039/b514858h; Park S, 2004, SCIENCE, V303, P348, DOI 10.1126/science.1093276; Patra SK, 2011, J AM CHEM SOC, V133, P8842, DOI 10.1021/ja202408w; Petzetakis N, 2011, CHEM SCI, V2, P955, DOI 10.1039/c0sc00596g; Pochan DJ, 2011, SOFT MATTER, V7, P2500, DOI 10.1039/c0sm00960a; Qian JS, 2011, ANGEW CHEM INT EDIT, V50, P1622, DOI 10.1002/anie.201006223; Rupar PA, 2011, J AM CHEM SOC, V133, P16947, DOI 10.1021/ja206370k; Schmelz J, 2011, ACS NANO, V5, P9523, DOI 10.1021/nn202638t; Voets IK, 2006, ANGEW CHEM INT EDIT, V45, P6673, DOI 10.1002/anie.200601000; Walther A, 2008, SOFT MATTER, V4, P663, DOI 10.1039/b718131k; Walther A, 2007, J AM CHEM SOC, V129, P6187, DOI 10.1021/ja068153v; Walther A, 2009, J AM CHEM SOC, V131, P4720, DOI 10.1021/ja808614q; Walther A, 2009, SOFT MATTER, V5, P385, DOI 10.1039/b812321g; Wang H, 2007, MACROMOLECULES, V40, P3784, DOI 10.1021/ma062728r; Wang XS, 2007, SCIENCE, V317, P644, DOI 10.1126/science.1141382; Wang XS, 2007, J AM CHEM SOC, V129, P5630, DOI 10.1021/ja068730f; Xia Y, 2009, J AM CHEM SOC, V131, P18525, DOI 10.1021/ja908379q; ZHANG LF, 1995, SCIENCE, V268, P1728, DOI 10.1126/science.268.5218.1728; Zhang W, 2011, SCIENCE, V334, P340, DOI 10.1126/science.1210369	33	301	301	7	499	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 3	2012	337	6094					559	562		10.1126/science.1221206	http://dx.doi.org/10.1126/science.1221206			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982PU	22859484				2022-12-28	WOS:000307058700039
J	Holahan, J; McMorrow, S				Holahan, John; McMorrow, Stacey			Medicare and Medicaid Spending Trends and the Deficit Debate	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Holahan, John; McMorrow, Stacey] Urban Inst, Washington, DC 20037 USA	Urban Institute	Holahan, J (corresponding author), Urban Inst, Washington, DC 20037 USA.							[Anonymous], 2012, LONG TERM BUDG IMP P; Berenson RA, 2011, PRESERVING MEDICARE; Frakt AB, 2011, MILBANK Q, V89, P90, DOI 10.1111/j.1468-0009.2011.00621.x; Keehan SP, 2012, HLTH AFF MILLWOOD; McMorrow S, 2012, MEDICARE MEDICAID DE	5	11	11	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 2	2012	367	5					393	395		10.1056/NEJMp1204899	http://dx.doi.org/10.1056/NEJMp1204899			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	981VZ	22853012				2022-12-28	WOS:000307001900003
J	Fardet, L; Petersen, I; Nazareth, I				Fardet, Laurence; Petersen, Irene; Nazareth, Irwin			Risk of cardiovascular events in people prescribed glucocorticoids with iatrogenic Cushing's syndrome: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORTICOSTEROID-INDUCED LIPODYSTROPHY; ACQUIRED GENERALIZED LIPODYSTROPHY; ORAL CORTICOSTEROIDS; ADVERSE EVENTS; DISEASE; VALIDATION; DATABASE; MORTALITY; DIAGNOSES; FEATURES	Objective To investigate whether there is an increased risk of cardiovascular events in people who exhibit iatrogenic Cushing's syndrome during treatment with glucocorticoids. Design Cohort study. Setting 424 UK general practices contributing to The Health Improvement Network database. Participants People prescribed systemic glucocorticoids and with a diagnosis of iatrogenic Cushing's syndrome (n=547) and two comparison groups: those prescribed glucocorticoids and with no diagnosis of iatrogenic Cushing's syndrome (n=3231) and those not prescribed systemic glucocorticoids (n=3282). Main outcome measures Incidence of cardiovascular events within a year after diagnosis of iatrogenic Cushing's syndrome or after a randomly selected date, and association between iatrogenic Cushing's syndrome and risk of cardiovascular events. Results 417 cardiovascular events occurred in 341 patients. Taking into account only the first event by patient (coronary heart disease n=177, heart failure n=101, ischaemic stroke n=63), the incidence rates of cardiovascular events per 100 person years at risk were 15.1 (95% confidence interval 11.8 to 18.4) in those prescribed glucocorticoids and with a diagnosis of iatrogenic Cushing's syndrome, 6.4 (5.5 to 7.3) in those prescribed glucocorticoids without a diagnosis of iatrogenic Cushing's syndrome, and 4.1 (3.4 to 4.8) in those not prescribed glucocorticoids. In multivariate analyses adjusted for sex, age, intensity of glucocorticoid use, underlying disease, smoking status, and use of aspirin, diabetes drugs, antihypertensive drugs, lipid lowering drugs, or oral anticoagulant drugs, the relation between iatrogenic Cushing's syndrome and cardiovascular events was strong (adjusted hazard ratios 2.27 (95% confidence interval 1.48 to 3.47) for coronary heart disease, 3.77 (2.41 to 5.90) for heart failure, and 2.23 (0.96 to 5.17) for ischaemic cerebrovascular events). The adjusted hazard ratio for any cardiovascular event was 4.16 (2.98 to 5.82) when the group prescribed glucocorticoids and with iatrogenic Cushing's syndrome was compared with the group not prescribed glucocorticoids. Conclusion People who use glucocorticoids and exhibit iatrogenic Cushing's syndrome should be aggressively targeted for early screening and management of cardiovascular risk factors.	[Fardet, Laurence; Nazareth, Irwin] UCL, Sch Med, MRC Gen Practice Res Framework, London W1N 8AA, England; [Fardet, Laurence] Hosp St Antoine, AP HP, Serv Med Interne, Paris, France; [Fardet, Laurence] Univ Paris 06, UPMC Paris 6, Fac Med, Paris, France; [Fardet, Laurence; Petersen, Irene; Nazareth, Irwin] UCL, Sch Med, Res Dept Primary Care & Populat Hlth, London W1N 8AA, England	University of London; University College London; UCL Medical School; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; University of London; University College London; UCL Medical School	Fardet, L (corresponding author), UCL, Sch Med, MRC Gen Practice Res Framework, Mortimer St, London W1N 8AA, England.	laurence.fardet@sat.aphp.fr	Petersen, Irene/C-5702-2009	Petersen, Irene/0000-0002-0037-7524; Nazareth, Irwin/0000-0003-2146-9628	MRC [G0900701] Funding Source: UKRI; Medical Research Council [G0900701] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Arena C, 2010, BRIT J DERMATOL, V163, P832, DOI 10.1111/j.1365-2133.2010.09877.x; Bourke Alison, 2004, Inform Prim Care, V12, P171; Bujalska IJ, 1997, LANCET, V349, P1210, DOI 10.1016/S0140-6736(96)11222-8; Capeau J, 2005, BIOCHEM SOC T, V33, P1073, DOI 10.1042/BST0331073; Capeau J, 2010, ENDOCR DEV, V19, P1, DOI 10.1159/000316893; Dave S, 2009, PHARMACOEPIDEM DR S, V18, P704, DOI 10.1002/pds.1770; Donaldson GC, 2010, CHEST, V137, P1091, DOI 10.1378/chest.09-2029; Fardet L, 2007, RHEUMATOLOGY, V46, P1102, DOI 10.1093/rheumatology/kem062; Fardet L, 2007, BRIT J DERMATOL, V157, P142, DOI 10.1111/j.1365-2133.2007.07950.x; Fardet L, 2012, CLIN ENDOCRINOL OXF; Fardet L, 2007, J AM ACAD DERMATOL, V57, P604, DOI 10.1016/j.jaad.2007.04.018; Fardet L, 2011, RHEUMATOLOGY, V50, P1982, DOI 10.1093/rheumatology/ker017; Garg A, 2004, NEW ENGL J MED, V350, P1220, DOI 10.1056/NEJMra025261; Guaraldi G, 2010, ATHEROSCLEROSIS, V208, P222, DOI 10.1016/j.atherosclerosis.2009.06.011; Hegele RA, 2001, CIRCULATION, V103, P2225; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; HORBER FF, 1986, AM J CLIN NUTR, V43, P758, DOI 10.1093/ajcn/43.5.758; Krikorian A, 2010, REV ENDOCR METAB DIS, V11, P141, DOI 10.1007/s11154-010-9142-4; Lewis JD, 2007, PHARMACOEPIDEM DR S, V16, P393, DOI 10.1002/pds.1335; Lewis JD, 2005, PHARMACOEPIDEM DR S, V14, P443, DOI 10.1002/pds.1115; LIS Y, 1995, J CLIN EPIDEMIOL, V48, P431, DOI 10.1016/0895-4356(94)00137-F; Lupsa BC, 2010, MEDICINE, V89, P245, DOI 10.1097/MD.0b013e3181e9442f; McGavock JM, 2007, CIRCULATION, V116, P1170, DOI 10.1161/CIRCULATIONAHA.106.645614; Misra A, 2003, MEDICINE, V82, P129, DOI 10.1097/00005792-200303000-00007; Ruigomez A, 2010, PHARMACOEPIDEM DR S, V19, P579, DOI 10.1002/pds.1919; Schou AJ, 2003, STEROIDS, V68, P525, DOI 10.1016/S0039-128X(03)00086-2; Souverein PC, 2004, HEART, V90, P859, DOI 10.1136/hrt.2003.020180; Strohmayer EA, 2011, ENDOCRIN METAB CLIN, V40, P409, DOI 10.1016/j.ecl.2011.01.011; Szczepaniak LS, 2007, CIRC RES, V101, P759, DOI 10.1161/CIRCRESAHA.107.160457; Thiebaut R, 2000, CLIN INFECT DIS, V31, P1482, DOI 10.1086/317477; Toren K, 1996, INT J EPIDEMIOL, V25, P617, DOI 10.1093/ije/25.3.617; Trementino L, 2010, NEUROENDOCRINOLOGY, V92, P55, DOI 10.1159/000314349; Uddhammar A, 2002, J RHEUMATOL, V29, P737; Utz W, 2011, HEART, V97, P1585, DOI 10.1136/hrt.2011.224451; van Staa TP, 2000, QJM-MON J ASSOC PHYS, V93, P105, DOI 10.1093/qjmed/93.2.105; Varas-Lorenzo C, 2007, ATHEROSCLEROSIS, V192, P376, DOI 10.1016/j.atherosclerosis.2006.05.019; Wei L, 2004, ANN INTERN MED, V141, P764, DOI 10.7326/0003-4819-141-10-200411160-00007; WOLFE F, 1994, ARTHRITIS RHEUM-US, V37, P481, DOI 10.1002/art.1780370408	39	69	72	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 30	2012	345								e4928	10.1136/bmj.e4928	http://dx.doi.org/10.1136/bmj.e4928			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	985XA	22846415	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000307302600002
J	Moore, M				Moore, Mike			Looking for a good night's sleep	LANCET			English	Editorial Material							CHRONIC INSOMNIA; THERAPY; TRIAL		Pacific NW Univ Hlth Sci, Dept Clin Sci, Washington, WA 98901 USA		Moore, M (corresponding author), Pacific NW Univ Hlth Sci, Dept Clin Sci, Washington, WA 98901 USA.	mmoore@pnwu.edu						Espie CA, 2007, SLEEP, V30, P574, DOI 10.1093/sleep/30.5.574; Espie CA, 2012, SLEEP, V35, P769, DOI 10.5665/sleep.1872; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Perlis ML, 2008, J CLIN SLEEP MED, V4, P11; Riemann D, 2009, SLEEP MED REV, V13, P205, DOI 10.1016/j.smrv.2008.06.001; Rosekind MR, 2010, AM J MANAG CARE, V16, P617; Wilson SJ, 2010, J PSYCHOPHARMACOL, V24, P1577, DOI 10.1177/0269881110379307	7	6	8	1	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 28	2012	380	9839					322	323		10.1016/S0140-6736(12)61220-3	http://dx.doi.org/10.1016/S0140-6736(12)61220-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	979TN	22841325				2022-12-28	WOS:000306842800011
J	White, BT				White, Brian T.			Aipotu: Simulation from Nucleotides to Populations and Back Again	SCIENCE			English	Editorial Material									Univ Massachusetts, Dept Biol, Boston, MA 02125 USA	University of Massachusetts System; University of Massachusetts Boston	White, BT (corresponding author), Univ Massachusetts, Dept Biol, 100 Morrissey Blvd, Boston, MA 02125 USA.	brian.white@umb.edu						White B, 2010, BIOCHEM MOL BIOL EDU, V38, P284, DOI 10.1002/bmb.20410; White BT, 2008, BIOCHEM MOL BIOL EDU, V36, P77, DOI 10.1002/bmb.20152	2	2	2	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2012	337	6093					424	425		10.1126/science.1215105	http://dx.doi.org/10.1126/science.1215105			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979FS	22837517	Bronze			2022-12-28	WOS:000306802300031
J	Baconguis, I; Gouaux, E				Baconguis, Isabelle; Gouaux, Eric			Structural plasticity and dynamic selectivity of acid-sensing ion channel-spider toxin complexes	NATURE			English	Article							EPITHELIAL SODIUM-CHANNEL; GATED CATION CHANNEL; FUNCTIONAL EXPRESSION; EXTRACELLULAR DOMAIN; TARANTULA PEPTIDE; ASIC1A CHANNELS; NERVOUS-SYSTEM; P2X RECEPTORS; NA+ CHANNEL; PORE	Acid-sensing ion channels (ASICs) are voltage-independent, amiloride-sensitive channels involved in diverse physiological processes ranging from nociception to taste. Despite the importance of ASICs in physiology, we know little about the mechanism of channel activation. Here we show that psalmotoxin activates non-selective and Na+-selective currents in chicken ASIC1a at pH 7.25 and 5.5, respectively. Crystal structures of ASIC1a-psalmotoxin complexes map the toxin binding site to the extracellular domain and show how toxin binding triggers an expansion of the extracellular vestibule and stabilization of the open channel pore. At pH 7.25 the pore is approximately 10 angstrom in diameter, whereas at pH 5.5 the pore is largely hydrophobic and elliptical in cross-section with dimensions of approximately 5 by 7 angstrom, consistent with a barrier mechanism for ion selectivity. These studies define mechanisms for activation of ASICs, illuminate the basis for dynamic ion selectivity and provide the blueprints for new therapeutic agents.	[Baconguis, Isabelle; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	gouauxe@ohsu.edu	Baconguis, Isabelle/AAH-3790-2021; Gouaux, Eric/Y-4370-2019	Baconguis, Isabelle/0000-0002-5440-2289; Gouaux, Eric/0000-0002-8549-2360	National Institute of Neurological Disorders and Stroke; NIH; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS070597, P30NS061800, R37NS038631] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We appreciate assistance in the initial characterization of the action of PcTx1 on chicken ASIC1a by D. Samways and T. Egan, mass spectrometry analysis by D. King, together with comments from C. Jahr and R. MacKinnon. We are grateful to K. C. Garcia, C. Lee and A. Goehring for assistance with protein expression in mammalian cells. We thank L. Vaskalis for assistance with figures, H. Owen for help with manuscript preparation, H. Krishnamurthy for assistance in initial data collection, and Gouaux lab members for helpful discussion. This work was supported by an individual National Research Service Award from the National Institute of Neurological Disorders and Stroke (I. B.) and by the NIH (E. G.). E. G. is an investigator with the Howard Hughes Medical Institute.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bohlen CJ, 2011, NATURE, V479, P410, DOI 10.1038/nature10607; CANESSA CM, 1993, NATURE, V361, P467, DOI 10.1038/361467a0; Chang SS, 1996, NAT GENET, V12, P248, DOI 10.1038/ng0396-248; Chen XM, 2006, J GEN PHYSIOL, V127, P267, DOI 10.1085/jgp.200509409; Chen XM, 2005, J GEN PHYSIOL, V126, P71, DOI 10.1085/jgp.200509303; Coryell MW, 2008, J NEUROSCI, V28, P13738, DOI 10.1523/JNEUROSCI.3907-08.2008; Cushman KA, 2007, J GEN PHYSIOL, V129, P345, DOI 10.1085/jgp.200709757; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dawson RJP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1917; de la Rosa DA, 2003, J PHYSIOL-LONDON, V546, P77, DOI 10.1113/jphysiol.2002.030692; de Weille JR, 1998, FEBS LETT, V433, P257, DOI 10.1016/S0014-5793(98)00916-8; Deval E, 2010, PHARMACOL THERAPEUT, V128, P549, DOI 10.1016/j.pharmthera.2010.08.006; Dukkipati A, 2008, PROTEIN EXPRES PURIF, V62, P160, DOI 10.1016/j.pep.2008.08.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; Escoubas P, 2003, PROTEIN SCI, V12, P1332, DOI 10.1110/ps.0307003; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Grunder Stefan, 2010, Int J Physiol Pathophysiol Pharmacol, V2, P73; Hattori M, 2012, NATURE, V485, P207, DOI 10.1038/nature11010; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kashlan OB, 2011, AM J PHYSIOL-RENAL, V301, pF684, DOI 10.1152/ajprenal.00259.2011; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Khakh BS, 1999, NEURON, V23, P653, DOI 10.1016/S0896-6273(01)80025-8; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; KRISHTAL OA, 1980, NEUROSCIENCE, V5, P2325, DOI 10.1016/0306-4522(80)90149-9; Li JQ, 2003, J BIOL CHEM, V278, P13867, DOI 10.1074/jbc.M300149200; Li TB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1409; Li TB, 2011, J GEN PHYSIOL, V137, P289, DOI 10.1085/jgp.201010576; Li TB, 2010, J BIOL CHEM, V285, P31285, DOI 10.1074/jbc.M110.160382; Li TB, 2010, J BIOL CHEM, V285, P22706, DOI 10.1074/jbc.M110.134114; Li TB, 2010, AM J PHYSIOL-CELL PH, V299, pC66, DOI 10.1152/ajpcell.00100.2010; Li WG, 2011, J BIOL CHEM, V286, P42635, DOI 10.1074/jbc.M111.289058; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; Mazzuca M, 2007, NAT NEUROSCI, V10, P943, DOI 10.1038/nn1940; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PALMER LG, 1982, J MEMBRANE BIOL, V67, P91, DOI 10.1007/BF01868651; Pietra F, 2009, J CHEM INF MODEL, V49, P972, DOI 10.1021/ci800463h; Poet M, 2001, EMBO J, V20, P5595, DOI 10.1093/emboj/20.20.5595; Saez NJ, 2011, MOL PHARMACOL, V80, P796, DOI 10.1124/mol.111.072207; Salinas M, 2006, J PHYSIOL-LONDON, V570, P339, DOI 10.1113/jphysiol.2005.095810; Samways DSK, 2009, CELL CALCIUM, V45, P319, DOI 10.1016/j.ceca.2008.12.002; Schild L, 2010, BBA-MOL BASIS DIS, V1802, P1159, DOI 10.1016/j.bbadis.2010.06.014; Sherwood T, 2009, J BIOL CHEM, V284, P27899, DOI 10.1074/jbc.M109.029009; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; SNYDER PM, 1995, CELL, V83, P969, DOI 10.1016/0092-8674(95)90212-0; Springauf A, 2011, J BIOL CHEM, V286, P24374, DOI 10.1074/jbc.M111.230797; Waldmann R, 2001, ADV EXP MED BIOL, V502, P293; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; WALDMANN R, 1995, J BIOL CHEM, V270, P27411, DOI 10.1074/jbc.270.46.27411; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yagi J, 2006, CIRC RES, V99, P501, DOI 10.1161/01.RES.0000238388.79295.4c; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P6752, DOI 10.1073/pnas.0308636100; Yu Y, 2010, NEURON, V68, P61, DOI 10.1016/j.neuron.2010.09.001	58	201	205	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2012	489	7416					400	U86		10.1038/nature11375	http://dx.doi.org/10.1038/nature11375			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AK	22842900	Green Accepted			2022-12-28	WOS:000308860900038
J	Monson, CM; Fredman, SJ; Macdonald, A; Pukay-Martin, ND; Resick, PA; Schnurr, PP				Monson, Candice M.; Fredman, Steffany J.; Macdonald, Alexandra; Pukay-Martin, Nicole D.; Resick, Patricia A.; Schnurr, Paula P.			Effect of Cognitive-Behavioral Couple Therapy for PTSD A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSTTRAUMATIC-STRESS-DISORDER; PSYCHOTHERAPY; CLINICIAN; SYMPTOMS; METAANALYSIS; MARRIAGE; QUALITY; SCALES	Context Posttraumatic stress disorder (PTSD) is a prevalent condition associated with intimate relationship problems, and intimate relationship factors have been shown to affect individual PTSD treatment outcomes. Objective To compare cognitive-behavioral conjoint therapy for PTSD (a manualized couple therapy delivered to patients with PTSD and their significant others to simultaneously treat PTSD symptoms and enhance relationship satisfaction) with a wait-list condition. Design, Setting, and Participants Randomized controlled trial of heterosexual and same-sex couples (n = 40 couples; n = 80 individuals) in which one partner met criteria for PTSD according to the Clinician-Administered PTSD Scale, conducted from 2008 to 2012 in a Department of Veterans Affairs outpatient hospital setting in Boston, Massachusetts, and a university-based research center in Toronto, Ontario, Canada. Symptoms of PTSD, comorbid conditions, and relationship satisfaction were collected by blinded assessors at baseline, at mid treatment (median, 8.00 weeks [range, 1.71-20.43 weeks] after baseline), and at posttreatment (median, 15.86 weeks [range, 7.14-38.57 weeks] after baseline). An uncontrolled 3-month follow-up (median, 38.21 weeks [range, 28.43-50.57 weeks] after baseline) was also completed. Intervention Couples were randomly assigned to take part in the 15-session cognitive-behavioral conjoint therapy for PTSD protocol immediately (n = 20) or were placed on a wait list for the therapy (n = 20). Main Outcome Measures Clinician-rated PTSD symptom severity was the primary outcome and was assessed with the Clinician-Administered PTSD Scale. Intimate relationship satisfaction, assessed with the Dyadic Adjustment Scale, patient- and partner-rated PTSD symptoms, and comorbid symptoms were secondary outcomes. Results PTSD symptom severity (score range, 0-136) was significantly more improved in the couple therapy condition than in the wait-list condition (mean change difference, -23.21; 95% CI, -37.87 to -8.55). Similarly, patients' intimate relationship satisfaction (score range, 0-151) was significantly more improved in couple therapy than in the wait-list condition (mean change difference, 9.43; 95% CI, 0.04-18.83). The time x condition interaction effect in the multilevel model predicting PTSD symptoms (t(37.5) = -3.09; P = .004) and patient-reported relationship satisfaction (t(68.5) = 2.00; P = .049) revealed superiority of the couple therapy compared with the wait list. Treatment effects were maintained at 3-month follow-up. Conclusion Among couples in which one partner was diagnosed as having PTSD, a disorder-specific couple therapy, compared with a wait list for the therapy, resulted in decreased PTSD symptom severity and patient comorbid symptom severity and increased patient relationship satisfaction.	[Monson, Candice M.] Ryerson Univ, Dept Psychol, Toronto, ON M5B 2K3, Canada; [Monson, Candice M.; Fredman, Steffany J.; Macdonald, Alexandra; Resick, Patricia A.; Schnurr, Paula P.] Natl Ctr PTSD, Dept Vet Affairs VA, Washington, DC USA; [Fredman, Steffany J.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Fredman, Steffany J.] Harvard Univ, Sch Med, Boston, MA USA; [Macdonald, Alexandra] VA Boston Healthcare Syst, Boston, MA USA; [Macdonald, Alexandra] Boston Univ, Sch Med, Boston, MA 02118 USA; [Schnurr, Paula P.] Geisel Sch Med Dartmouth, Hanover, NH USA	Toronto Metropolitan University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Boston University; Dartmouth College	Monson, CM (corresponding author), Ryerson Univ, Dept Psychol, 350 Victoria Ave, Toronto, ON M5B 2K3, Canada.	candice.monson@psych.ryerson.ca		FREDMAN, STEFFANY/0000-0002-2053-8700	Centers for Disease Control and Prevention; Department of Defense; Canadian Institute of Health Research; National Institute of Mental Health [5R34MH076813]; US Department of Veterans Affairs; NATIONAL INSTITUTE OF MENTAL HEALTH [R34MH076813] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Department of Defense(United States Department of Defense); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); US Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Monson reports that she receives research funding from the Centers for Disease Control and Prevention, Department of Defense, Canadian Institute of Health Research, and National Institute of Mental Health. Drs Monson and Fredman report that they receive royalties for a published book describing CBCT for PTSD. Dr Resick reports that she receives research funding from the Department of Defense and US Department of Veterans Affairs. Dr Schnurr reports that she receives research funding from US Department of Veterans Affairs. Drs Resick and Schnurr report that they have published books on PTSD and its treatment for which they receive income. No other disclosures were reported.; This study was supported by National Institute of Mental Health grant 5R34MH076813 to Dr Monson.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Beck A.T., 1996, MANUAL BECK DEPRESSI; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bradley R, 2005, AM J PSYCHIAT, V162, P214, DOI 10.1176/appi.ajp.162.2.214; Caska CM, 2011, J ANXIETY DISORD, V25, P346, DOI 10.1016/j.janxdis.2010.10.008; Cason D., 2002, GENDER PTSD, P305; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; First M.B., 2016, STRUCTURED CLIN INTE; Hedges L.V., 1985, STAT METHODS METAANA, DOI [10.1016/C2009-0-03396-0, DOI 10.1016/C2009-0-03396-0]; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Kiecolt-Glaser JK, 2001, PSYCHOL BULL, V127, P472, DOI 10.1037//0033-2909.127.4.472; MacIntosh HB, 2008, J MARITAL FAM THER, V34, P298, DOI 10.1111/j.1752-0606.2008.00074.x; Monson C. M., 2012, COGNITIVE BEHAV CONJ; Monson CM, 2008, PSYCHOL ASSESSMENT, V20, P131, DOI 10.1037/1040-3590.20.2.131; Monson CM, 2011, J TRAUMA STRESS, V24, P97, DOI 10.1002/jts.20604; Monson CM, 2004, J TRAUMA STRESS, V17, P341, DOI 10.1023/B:JOTS.0000038483.69570.5b; Price M, 2013, PSYCHOL TRAUMA-US, V5, P93, DOI 10.1037/a0026244; SAS Institute Inc, 2008, STAT AN SYST SAS STA; Sautter FJ, 2009, J MARITAL FAM THER, V35, P343, DOI 10.1111/j.1752-0606.2009.00125.x; Schnurr PR, 2007, J TRAUMA STRESS, V20, P779, DOI 10.1002/jts.20292; Schnurr PP, 2006, J CONSULT CLIN PSYCH, V74, P707, DOI 10.1037/0022-006X.74.4.707; Shadish WR, 2003, J MARITAL FAM THER, V29, P547, DOI 10.1111/j.1752-0606.2003.tb01694.x; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; SPANIER GB, 1976, J MARRIAGE FAM, V38, P15, DOI 10.2307/350547; Spielberger C.D., 1988, STATE TRAIT ANGER EX; Spielberger C.D., 1983, MANUAL STATE TRAIT A, DOI DOI 10.1002/9780470479216.CORPSY0943; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; Taft CT, 2011, J CONSULT CLIN PSYCH, V79, P22, DOI 10.1037/a0022196; Tarrier N, 1999, PSYCHOL MED, V29, P801, DOI 10.1017/S0033291799008569; Weathers F. W., 1993, P 9 ANN C INT SOC TR; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029	32	183	184	3	50	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2012	308	7					700	709		10.1001/jama.2012.9307	http://dx.doi.org/10.1001/jama.2012.9307			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988NC	22893167	Green Accepted			2022-12-28	WOS:000307496700025
J	Elderfield, H; Ferretti, P; Greaves, M; Crowhurst, S; McCave, IN; Hodell, D; Piotrowski, AM				Elderfield, H.; Ferretti, P.; Greaves, M.; Crowhurst, S.; McCave, I. N.; Hodell, D.; Piotrowski, A. M.			Evolution of Ocean Temperature and Ice Volume Through the Mid-Pleistocene Climate Transition	SCIENCE			English	Article							DEEP-SEA TEMPERATURE; SOUTHERN-OCEAN; ANTARCTIC CLIMATE; CARBON-DIOXIDE; PLEISTOCENE; VARIABILITY; DELTA-O-18; ISOTOPE; FLUCTUATIONS; CIRCULATION	Earth's climate underwent a fundamental change between 1250 and 700 thousand years ago, the mid-Pleistocene transition (MPT), when the dominant periodicity of climate cycles changed from 41 thousand to 100 thousand years in the absence of substantial change in orbital forcing. Over this time, an increase occurred in the amplitude of change of deep-ocean foraminiferal oxygen isotopic ratios, traditionally interpreted as defining the main rhythm of ice ages although containing large effects of changes in deep-ocean temperature. We have separated the effects of decreasing temperature and increasing global ice volume on oxygen isotope ratios. Our results suggest that the MPT was initiated by an abrupt increase in Antarctic ice volume 900 thousand years ago. We see no evidence of a pattern of gradual cooling, but near-freezing temperatures occur at every glacial maximum.	[Elderfield, H.; Ferretti, P.; Greaves, M.; Crowhurst, S.; McCave, I. N.; Hodell, D.; Piotrowski, A. M.] Univ Cambridge, Dept Earth Sci, Godwin Lab Palaeoclimate Res, Cambridge CB2 3EQ, England	University of Cambridge	Elderfield, H (corresponding author), Univ Cambridge, Dept Earth Sci, Godwin Lab Palaeoclimate Res, Downing St, Cambridge CB2 3EQ, England.	he101@cam.ac.uk	McCave, I. Nick/O-3992-2018; McCave, Nick N/G-7323-2016	McCave, I. Nick/0000-0002-4702-5489; McCave, Nick N/0000-0002-4702-5489; Hodell, David/0000-0001-8537-1588; Greaves, Mervyn/0000-0001-8014-8627; FERRETTI, Patrizia/0000-0002-4814-3655	Natural Environment Research Council (UK); European Research Council (ERC) [2010-ADG-267931]; European Community's Seventh Framework Programme [211384]; EPICA-MIS (Enhanced Palaeoreconstruction and Integrated Climate Analysis Through Marine and Ice Core Studies) program; Royal Society Leverhulme Trust Senior Research Fellowship; CORC-ARCHES (Consortium on the Ocean's Role in Climate/Abrupt climate Change Studies) Visiting Scientist post at Lamont Doherty Earth Observatory of Columbia University; NERC [NE/D002206/1, NE/H009930/1] Funding Source: UKRI; Natural Environment Research Council [NE/D002206/1, NE/H009930/1] Funding Source: researchfish	Natural Environment Research Council (UK)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); European Research Council (ERC)(European Research Council (ERC)European Commission); European Community's Seventh Framework Programme(European Commission); EPICA-MIS (Enhanced Palaeoreconstruction and Integrated Climate Analysis Through Marine and Ice Core Studies) program; Royal Society Leverhulme Trust Senior Research Fellowship; CORC-ARCHES (Consortium on the Ocean's Role in Climate/Abrupt climate Change Studies) Visiting Scientist post at Lamont Doherty Earth Observatory of Columbia University; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded in part by The Natural Environment Research Council (UK) and The European Research Council (ERC grant 2010-ADG-267931) and is a contribution to the European Project on Ocean Acidification (EPOCA), which received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 211384 and from the EPICA-MIS (Enhanced Palaeoreconstruction and Integrated Climate Analysis Through Marine and Ice Core Studies) program. Funding was also provided by a Royal Society Leverhulme Trust Senior Research Fellowship and a CORC-ARCHES (Consortium on the Ocean's Role in Climate/Abrupt climate Change Studies) Visiting Scientist post at Lamont Doherty Earth Observatory of Columbia University, for which H. E. is grateful to W. Broecker. We thank J. Firth and colleagues at the IODP core repository, College Station, for help in sampling ODP 1123. L. Booth and C. Daunt, and additionally J. Clegg, J. Day, M. Hall, J. Nicholson, N. Roberts, J. Rolfe, J. Smith, S. Smith, and S. Sounef-Ureta provided crucial laboratory support in Cambridge. We thank L. Booth and I. Weidle for their work on Uvigerina morphologies. G. Bayon, E. Ponzeve, and N. Freslon provided help during epsilon Nd analysis at IFREMER (Institut francais de recherche pour l'exploitation de la mer) Brest, France. D. Maraun helped with use of Sowas software, and F. Joos, H. Palike, R. Rickaby, T. Stocker, and G. Weedon helped with discussions. The reviews of the manuscript were very valuable, especially in encouraging us to focus on interpretation of the delta<SUP>18</SUP>O<INF>C</INF> record.	Adkins JF, 2002, SCIENCE, V298, P1769, DOI 10.1126/science.1076252; [Anonymous], 2003, ERATHS CLIMATE ORBIT; Bintanja R, 2005, NATURE, V437, P125, DOI 10.1038/nature03975; CHAPPELL J, 1986, NATURE, V324, P137, DOI 10.1038/324137a0; Clark PU, 2006, QUATERNARY SCI REV, V25, P3150, DOI 10.1016/j.quascirev.2006.07.008; Ditlevsen PD, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001673; Elderfield H, 2006, EARTH PLANET SC LETT, V250, P633, DOI 10.1016/j.epsl.2006.07.041; Elderfield H, 2010, QUATERNARY SCI REV, V29, P160, DOI 10.1016/j.quascirev.2009.07.013; Gasson E, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000358; Hall IR, 2001, NATURE, V412, P809, DOI 10.1038/35090552; Hodell DA, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000367; Honisch B, 2009, SCIENCE, V324, P1551, DOI 10.1126/science.1171477; Hoogakker BAA, 2006, EARTH PLANET SC LETT, V248, P15, DOI 10.1016/j.epsl.2006.05.007; Jouzel J, 2007, SCIENCE, V317, P793, DOI 10.1126/science.1141038; Kohler P, 2006, CLIM PAST, V2, P57; Lawrence KT, 2010, EARTH PLANET SC LETT, V300, P329, DOI 10.1016/j.epsl.2010.10.013; Lisiecki LE, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045109; Lisiecki L.E., 2005, PALEOCEANOGRAPHY, V20, DOI [10.1029/2004PA001071, DOI 10.1029/2004PA001071]; Maraun D, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.016707; Maraun D, 2004, NONLINEAR PROC GEOPH, V11, P505, DOI 10.5194/npg-11-505-2004; Martin PA, 2002, EARTH PLANET SC LETT, V198, P193, DOI 10.1016/S0012-821X(02)00472-7; Martinez-Garcia A, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001657; Masson-Delmotte V, 2010, QUATERNARY SCI REV, V29, P113, DOI 10.1016/j.quascirev.2009.09.030; McCave IN, 2008, QUATERNARY SCI REV, V27, P1886, DOI 10.1016/j.quascirev.2008.07.010; McKay R, 2012, QUATERNARY SCI REV, V34, P93, DOI 10.1016/j.quascirev.2011.12.012; Naish T, 2009, NATURE, V458, P322, DOI 10.1038/nature07867; Paillard D, 1998, NATURE, V391, P378, DOI 10.1038/34891; Parrenin F, 2007, CLIM PAST, V3, P485, DOI 10.5194/cp-3-485-2007; Piotrowski AM, 2005, SCIENCE, V307, P1933, DOI 10.1126/science.1104883; Pollard D, 2009, NATURE, V458, P329, DOI 10.1038/nature07809; Raymo ME, 2006, SCIENCE, V313, P492, DOI 10.1126/science.1123296; Raymo ME, 1997, PALEOCEANOGRAPHY, V12, P546, DOI 10.1029/97PA01019; SHACKLETON N, 1967, NATURE, V215, P15, DOI 10.1038/215015a0; Shackleton N. J., 1973, Quaternary Research, V3, P39, DOI 10.1016/0033-5894(73)90052-5; Shackleton NJ, 2000, SCIENCE, V289, P1897, DOI 10.1126/science.289.5486.1897; SHACKLETON NJ, 1977, FATE FOSSIL FUEL OCE; Siddall M, 2003, NATURE, V423, P853, DOI 10.1038/nature01690; Siddall M, 2006, QUATERNARY SCI REV, V25, P3185, DOI 10.1016/j.quascirev.2005.12.014; Sima A, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026923; Sosdian S, 2010, SCIENCE, V328, DOI 10.1126/science.1186768; Sosdian S, 2009, SCIENCE, V325, P306, DOI 10.1126/science.1169938; Thomas AL, 2009, SCIENCE, V324, P1186, DOI 10.1126/science.1168754; Thompson WG, 2006, QUATERNARY SCI REV, V25, P3207, DOI 10.1016/j.quascirev.2006.02.007; Venz KA, 2002, PALAEOGEOGR PALAEOCL, V182, P197, DOI 10.1016/S0031-0182(01)00496-5; Wang PX, 2010, EARTH PLANET SC LETT, V290, P319, DOI 10.1016/j.epsl.2009.12.028; Whitworth T, 1999, PROG OCEANOGR, V43, P1, DOI 10.1016/S0079-6611(99)00005-1; Yu JM, 2010, SCIENCE, V328, DOI 10.1126/science.1186544	47	487	505	8	309	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2012	337	6095					704	709		10.1126/science.1221294	http://dx.doi.org/10.1126/science.1221294			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986PE	22879512				2022-12-28	WOS:000307354500047
J	Regensburger, A; Bersch, C; Miri, MA; Onishchukov, G; Christodoulides, DN; Peschel, U				Regensburger, Alois; Bersch, Christoph; Miri, Mohammad-Ali; Onishchukov, Georgy; Christodoulides, Demetrios N.; Peschel, Ulf			Parity-time synthetic photonic lattices	NATURE			English	Article							OPTICAL BLOCH OSCILLATIONS; NON-HERMITIAN HAMILTONIANS; SYMMETRY; LIGHT; REAL; PROPAGATION; AMPLIFIERS; SPECTRA	The development of new artificial structures and materials is today one of the major research challenges in optics. In most studies so far, the design of such structures has been based on the judicious manipulation of their refractive index properties. Recently, the prospect of simultaneously using gain and loss was suggested as a new way of achieving optical behaviour that is at present unattainable with standard arrangements. What facilitated these quests is the recently developed notion of 'parity-time symmetry' in optical systems, which allows a controlled interplay between gain and loss. Here we report the experimental observation of light transport in large-scale temporal lattices that are parity-time symmetric. In addition, we demonstrate that periodic structures respecting this symmetry can act as unidirectional invisible media when operated near their exceptional points. Our experimental results represent a step in the application of concepts from parity-time symmetry to a new generation of multifunctional optical devices and networks.	[Regensburger, Alois; Bersch, Christoph; Peschel, Ulf] Univ Erlangen Nurnberg, Inst Opt Informat & Photon, D-91058 Erlangen, Germany; [Regensburger, Alois; Bersch, Christoph; Onishchukov, Georgy] Max Planck Inst Sci Light, D-91058 Erlangen, Germany; [Miri, Mohammad-Ali; Christodoulides, Demetrios N.] Univ Cent Florida, Coll Opt & Photon, CREOL, Orlando, FL 32816 USA	University of Erlangen Nuremberg; Max Planck Society; State University System of Florida; University of Central Florida	Peschel, U (corresponding author), Univ Erlangen Nurnberg, Inst Opt Informat & Photon, Staudtstr 7-B2, D-91058 Erlangen, Germany.	demetri@creol.ucf.edu; ulf.peschel@physik.uni-erlangen.de	Peschel, Ulf/C-3356-2013; Miri, Mohammad-Ali/F-8202-2012; Onishchukov, Georgy/AAA-5762-2019	Regensburger, Alois/0000-0003-3273-2751	DFG [Forschergruppe 760]; Cluster of Excellence Engineering of Advanced Materials, SAOT; German-Israeli Foundation; NSF [ECCS-1128520]; AFOSR [FA95501210148]	DFG(German Research Foundation (DFG)); Cluster of Excellence Engineering of Advanced Materials, SAOT; German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); NSF(National Science Foundation (NSF)); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	We acknowledge financial support from DFG Forschergruppe 760, the Cluster of Excellence Engineering of Advanced Materials, SAOT and the German-Israeli Foundation. This work was also supported by NSF grant ECCS-1128520 and by AFOSR grant FA95501210148. Moreover, we thank J. Nager for technical support.	Ahmed Z, 2001, PHYS LETT A, V282, P343, DOI 10.1016/S0375-9601(01)00218-3; Barnes WL, 2003, NATURE, V424, P824, DOI 10.1038/nature01937; Bender CM, 2007, REP PROG PHYS, V70, P947, DOI 10.1088/0034-4885/70/6/R03; Bender CM, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.270401; Bender CM, 1998, PHYS REV LETT, V80, P5243, DOI 10.1103/PhysRevLett.80.5243; Berini P, 2012, NAT PHOTONICS, V6, P16, DOI 10.1038/nphoton.2011.285; Berry MV, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/24/244007; Bittner S, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.024101; CHIAO RY, 1993, PHYS REV A, V48, pR34, DOI 10.1103/PhysRevA.48.R34; Chong YD, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.093902; El-Ganainy R, 2007, OPT LETT, V32, P2632, DOI 10.1364/OL.32.002632; Graefe EM, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.013818; Guo A, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.093902; Joannopoulos JD, 1997, NATURE, V386, P143, DOI 10.1038/386143a0; Klaiman S, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.080402; Knight JC, 1998, SCIENCE, V282, P1476, DOI 10.1126/science.282.5393.1476; Kottos T, 2010, NAT PHYS, V6, P166, DOI 10.1038/nphys1612; Kulishov M, 2005, OPT EXPRESS, V13, P3068, DOI 10.1364/OPEX.13.003068; Levai G, 2000, J PHYS A-MATH GEN, V33, P7165, DOI 10.1088/0305-4470/33/40/313; Lin Z, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.213901; Longhi S, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.123601; Longhi S, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.031801; Makris KG, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.103904; Makris KG, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.063807; Miri MA, 2012, OPT LETT, V37, P764, DOI 10.1364/OL.37.000764; Miroshnichenko AE, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.012123; Morandotti R, 1999, PHYS REV LETT, V83, P4756, DOI 10.1103/PhysRevLett.83.4756; Mostafazadeh A, 2002, J MATH PHYS, V43, P205, DOI 10.1063/1.1418246; Noginov MA, 2009, NATURE, V460, P1110, DOI 10.1038/nature08318; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; Pertsch T, 1999, PHYS REV LETT, V83, P4752, DOI 10.1103/PhysRevLett.83.4752; Ramezani H, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.043803; Regensburger A, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.233902; Ruter CE, 2010, NAT PHYS, V6, P192, DOI 10.1038/NPHYS1515; Sansoni L, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.010502; Schindler J, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.040101; Schreiber A, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.050502; Scott DD, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.050102; Stockman MI, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.156802; Suchkov SV, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.033825; Szameit A, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.021806; Uzdin R, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.031804; Wang LJ, 2000, NATURE, V406, P277, DOI 10.1038/35018520; Zheng MC, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.010103	45	1322	1335	23	328	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 9	2012	488	7410					167	171		10.1038/nature11298	http://dx.doi.org/10.1038/nature11298			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985LE	22874962				2022-12-28	WOS:000307267000024
J	Hu, LT				Hu, Linden T.			In the Clinic Lyme Disease	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							BORRELIA-BURGDORFERI; ERYTHEMA MIGRANS; TICK BITES; CEFUROXIME AXETIL; CONTROLLED-TRIAL; DOUBLE-BLIND; DOXYCYCLINE; PREVENTION; PROPHYLAXIS; TRANSMISSION						Hu, Linden/L-6314-2016	Hu, Linden/0000-0003-1659-5558				AGRE F, 1993, AM J DIS CHILD, V147, P945, DOI 10.1001/archpedi.1993.02160330035013; Bacon RM, 2003, J INFECT DIS, V187, P1187, DOI 10.1086/374395; Branda JA, 2011, CLIN INFECT DIS, V53, P541, DOI 10.1093/cid/cir464; Burke GS, 2005, EMERG INFECT DIS, V11, P36; CAMPBELL GL, 1995, J INFECT DIS, V172, P470, DOI 10.1093/infdis/172.2.470; Connally NP, 2009, AM J PREV MED, V37, P201, DOI 10.1016/j.amepre.2009.04.026; COSTELLO CM, 1989, J INFECT DIS, V159, P136, DOI 10.1093/infdis/159.1.136; Dattwyler RJ, 1997, NEW ENGL J MED, V337, P289, DOI 10.1056/NEJM199707313370501; DATTWYLER RJ, 1990, LANCET, V336, P1404, DOI 10.1016/0140-6736(90)93103-V; des Vignes F, 2001, J INFECT DIS, V183, P773, DOI 10.1086/318818; Fallon BA, 2008, NEUROLOGY, V70, P992, DOI 10.1212/01.WNL.0000284604.61160.2d; Feder HM, 2007, NEW ENGL J MED, V357, P1422, DOI 10.1056/NEJMra072023; Felz MW, 1999, ARCH DERMATOL, V135, P1317, DOI 10.1001/archderm.135.11.1317; HANSEN K, 1992, ACTA DERM-VENEREOL, V72, P297; Kalish RA, 2001, CLIN INFECT DIS, V33, P780, DOI 10.1086/322669; Kaplan RF, 2003, NEUROLOGY, V60, P1916, DOI 10.1212/01.WNL.0000068030.26992.25; Kirkland KB, 1997, ARCH INTERN MED, V157, P2635, DOI 10.1001/archinte.157.22.2635; Klempner MS, 2001, NEW ENGL J MED, V345, P85, DOI 10.1056/NEJM200107123450202; Krause PJ, 2006, AM J TROP MED HYG, V75, P1090, DOI 10.4269/ajtmh.2006.75.1090; Krause PJ, 1996, JAMA-J AM MED ASSOC, V275, P1657, DOI 10.1001/jama.275.21.1657; Krupp LB, 2003, NEUROLOGY, V60, P1923, DOI 10.1212/01.WNL.0000071227.23769.9E; Ljostad U, 2008, LANCET NEUROL, V7, P690, DOI 10.1016/S1474-4422(08)70119-4; Luft BJ, 1996, ANN INTERN MED, V124, P785, DOI 10.7326/0003-4819-124-9-199605010-00002; LUGER SW, 1995, ANTIMICROB AGENTS CH, V39, P661, DOI 10.1128/AAC.39.3.661; MAGID D, 1992, NEW ENGL J MED, V327, P534, DOI 10.1056/NEJM199208203270806; MASSAROTTI EM, 1992, AM J MED, V92, P396, DOI 10.1016/0002-9343(92)90270-L; Nadelman RB, 2001, NEW ENGL J MED, V345, P79, DOI 10.1056/NEJM200107123450201; NADELMAN RB, 1992, ANN INTERN MED, V117, P273, DOI 10.7326/0003-4819-117-4-273; PIESMAN J, 1993, J INFECT DIS, V167, P1082, DOI 10.1093/infdis/167.5.1082; Piesman J, 2012, TICKS TICK-BORNE DIS; Platonov AE, 2011, EMERG INFECT DIS, V17, P1816, DOI 10.3201/eid1710.101474; Ramsey AH, 2004, ANN FAM MED, V2, P341, DOI 10.1370/afm.117; Seltzer, 2000, JAMA, V283, P3068; Shadick NA, 1999, ANN INTERN MED, V131, P919, DOI 10.7326/0003-4819-131-12-199912210-00003; SHAPIRO ED, 1992, NEW ENGL J MED, V327, P1769, DOI 10.1056/NEJM199212173272501; Sigal LH, 1998, NEW ENGL J MED, V339, P216, DOI 10.1056/NEJM199807233390402; STEERE AC, 1993, JAMA-J AM MED ASSOC, V269, P1812, DOI 10.1001/jama.269.14.1812; Steere AC, 1998, NEW ENGL J MED, V339, P209, DOI 10.1056/NEJM199807233390401; STEERE AC, 1983, ANN INTERN MED, V99, P22, DOI 10.7326/0003-4819-99-1-22; STEERE AC, 1987, ANN INTERN MED, V107, P725, DOI 10.7326/0003-4819-107-5-725; Tavakoli NP, 2009, NEW ENGL J MED, V360, P2099, DOI 10.1056/NEJMoa0806326; Tugwell P, 1997, ANN INTERN MED, V127, P1109, DOI 10.7326/0003-4819-127-12-199712150-00011; Vazquez M, 2008, EMERG INFECT DIS, V14, P210, DOI 10.3201/eid1402.070725; Wang TJ, 2000, CLIN INFECT DIS, V31, P1149, DOI 10.1086/317465; Warshafsky S, 2010, J ANTIMICROB CHEMOTH, V65, P1137, DOI 10.1093/jac/dkq097; Wormser GP, 2008, CLIN INFECT DIS, V47, P910, DOI 10.1086/591529; WORMSER GP, 1995, MT SINAI J MED, V62, P188	47	16	16	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 7	2012	157	3							ITC2-2	10.7326/0003-4819-157-3-201208070-01002	http://dx.doi.org/10.7326/0003-4819-157-3-201208070-01002			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992PB	22868858				2022-12-28	WOS:000307789900001
J	Garrouste, R; Clement, G; Nel, P; Engel, MS; Grandcolas, P; D'Haese, C; Lagebro, L; Denayer, J; Gueriau, P; Lafaite, P; Olive, S; Prestianni, C; Nel, A				Garrouste, Romain; Clement, Gael; Nel, Patricia; Engel, Michael S.; Grandcolas, Philippe; D'Haese, Cyrille; Lagebro, Linda; Denayer, Julien; Gueriau, Pierre; Lafaite, Patrick; Olive, Sebastien; Prestianni, Cyrille; Nel, Andre			A complete insect from the Late Devonian period	NATURE			English	Article							ARTHROPOD; MORPHOLOGY; TETRAPOD; SYNAPOMORPHIES; EPHEMEROPTERA; ODONATOPTERA; PLANT	After terrestrialization, the diversification of arthropods and vertebrates is thought to have occurred in two distinct phases(1), the first between the Silurian and the Frasnian stages (Late Devonian period) (425-385 million years (Myr) ago), and the second characterized by the emergence of numerous new major taxa, during the Late Carboniferous period (after 345 Myr ago). These two diversification periods bracket the depauperate vertebrate Romer's gap (360-345 Myr ago) and arthropod gap (385-325 Myr ago)(1), which could be due to preservational artefact(2,3). Although a recent molecular dating has given an age of 390 Myr for the Holometabola(4), the record of hexapods during the Early-Middle Devonian (411.5-391 Myr ago, Pragian to Givetian stages) is exceptionally sparse and based on fragmentary remains, which hinders the timing of this diversification. Indeed, although Devonian Archaeognatha are problematic(5,6), the Pragian of Scotland has given some Collembola and the incomplete insect Rhyniognatha, with its diagnostic dicondylic, metapterygotan mandibles(5,7). The oldest, definitively winged insects are from the Serpukhovian stage (latest Early Carboniferous period)(8). Here we report the first complete Late Devonian insect, which was probably a terrestrial species. Its 'orthopteroid' mandibles are of an omnivorous type, clearly not modified for a solely carnivorous diet. This discovery narrows the 45-Myr gap in the fossil record of Hexapoda, and demonstrates [GRAPHICS] further a first Devonian phase of diversification for the Hexapoda, as in vertebrates, and suggests that the Pterygota diversified before and during Romer's gap.	[Garrouste, Romain; Nel, Patricia; Grandcolas, Philippe; D'Haese, Cyrille; Nel, Andre] Museum Natl Hist Nat, CNRS, UMR 7205, CP 50, F-75005 Paris, France; [Clement, Gael; Gueriau, Pierre] Museum Natl Hist Nat, CNRS, UMR 7207, F-75005 Paris, France; [Engel, Michael S.] Univ Kansas, Nat Hist Museum, Div Entomol, Lawrence, KS 66045 USA; [Engel, Michael S.] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [Lagebro, Linda] Uppsala Univ, Dept Earth Sci, SE-75236 Uppsala, Sweden; [Denayer, Julien; Olive, Sebastien] Univ Liege, Dept Geol, Serv Paleontol Anim & Humaine, B-4000 Liege, Belgium; [Gueriau, Pierre] Minist Culture & Commun, CNRS, USR 3461, IPANEMA, F-91190 Saint Aubin, France; [Lafaite, Patrick] CNRS MNHN DICAP, Serv Multimedia, CP 27, F-75005 Paris, France; [Olive, Sebastien; Prestianni, Cyrille] Royal Belgian Inst Nat Sci, Dept Palaeontol, B-1000 Brussels, Belgium	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; University of Kansas; University of Kansas; Uppsala University; University of Liege; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Royal Belgian Institute of Natural Sciences	Garrouste, R (corresponding author), Museum Natl Hist Nat, CNRS, UMR 7205, CP 50, 45 Rue Buffon, F-75005 Paris, France.	garroust@mnhn.fr; anel@mnhn.fr	Gueriau, Pierre/X-6682-2019; Engel, Michael S/C-5461-2012; GARROUSTE, Romain/AAK-3692-2021; D'HAESE, Cyrille A./D-4896-2012	Gueriau, Pierre/0000-0002-7529-3456; Engel, Michael S/0000-0003-3067-077X; GARROUSTE, Romain/0000-0002-0880-5781; D'HAESE, Cyrille A./0000-0001-6065-0927; Grandcolas, Philippe/0000-0003-1374-1222; Nel, Patricia/0000-0002-7530-5138	French National Agency under the TERRES project [ANR-2010-BLAN-607]; US National Science Foundation [DEB-0542909]	French National Agency under the TERRES project; US National Science Foundation(National Science Foundation (NSF))	We thank O. Bethoux who discovered and prepared most of the arthropod material from Strud including the specimen described herein. We also thank G. Budd and G. Edgecombe for discussion on the fossil material and improving the first version of the paper, Gesves local council staff and field workers of the Strud expeditions, G. Odebert and S. Fernandez for preparing illustrations, and C. Lemzaouda and O. Bethoux for photographs of the associated arthropod fauna. Thanks are due to A. Folie for our request of a catalogue number for the specimen described herein (requests for materials can be sent to afolie@naturalsciences.be). This work was partly supported by the French National Agency under the TERRES project (number ANR-2010-BLAN-607). Support for M. S. E. was provided by US National Science Foundation grant DEB-0542909.	Bechly G, 2001, J ZOOL SYST EVOL RES, V39, P209, DOI 10.1046/j.1439-0469.2001.00165.x; Bitsch C, 2004, ZOOL SCR, V33, P511, DOI 10.1111/j.0300-3256.2004.00162.x; Bitsch J, 2001, ANN SOC ENTOMOL FR, V37, P305; Blieck A, 2010, GEOL SOC SPEC PUBL, V339, P129, DOI 10.1144/SP339.11; Brauckmann Carsten, 2003, Geologie und Palaeontologie in Westfalen, V59, P1; Clement G, 2004, NATURE, V427, P412, DOI 10.1038/427412a; Engel MS, 2004, NATURE, V427, P627, DOI 10.1038/nature02291; GANGWERE S. K., 1965, EOS REV ESPAN ENTOMOL, V41, P67; Grimaldi David, 2005, pi; Guthrie D., 1968, BIOL COCKROACH; Imms AD, 1939, Q J MICROSC SCI, V81, P273; Kukalova-Peck J, 2008, EVOL BIOL, V35, P4, DOI 10.1007/s11692-007-9013-4; Kukalova-Peck Jarmila, 2009, Palaeodiversity, P169; Labandeira C, 2007, INSECT SCI, V14, P259, DOI 10.1111/j.1744-7917.2007.00152.x; Labandeira Conrad, 2006, Arthropod Systematics & Phylogeny, V64, P53; Martinez-Delclos X, 2004, PALAEOGEOGR PALAEOCL, V203, P19, DOI 10.1016/S0031-0182(03)00643-6; McLaughlin PA, 1980, COMP MORPHOLOGY RECE; Prestianni Cyrille, 2007, Carnets de Geologie, P43; Prokop J, 2005, GEOBIOS-LYON, V38, P383, DOI 10.1016/j.geobios.2003.11.006; Rehm P, 2011, MOL PHYLOGENET EVOL, V61, P880, DOI 10.1016/j.ympev.2011.09.003; Retallack GJ, 2011, J GEOL, V119, P235, DOI 10.1086/659144; Shear W. A., 2001, PLANTS INVADE LAND, P29, DOI DOI 10.7312/GENS11160-004; Smithson TR, 2012, P NATL ACAD SCI USA, V109, P4532, DOI 10.1073/pnas.1117332109; Snodgrass R. E, 1952, SMITHSON MISC C, V116, P1; Staniczek AH, 2000, ZOOL ANZ, V239, P147; Stein WE, 2012, NATURE, V483, P78, DOI 10.1038/nature10819; Sturm Helmut, 2001, Handbuch der Zoologie (Berlin), V4, pi; von Lieven AF, 2000, ZOOL ANZ, V239, P139; Ward P, 2006, P NATL ACAD SCI USA, V103, P16818, DOI 10.1073/pnas.0607824103; Yack JE, 2004, MICROSC RES TECHNIQ, V63, P315, DOI 10.1002/jemt.20051	30	52	57	1	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 2	2012	488	7409					82	85		10.1038/nature11281	http://dx.doi.org/10.1038/nature11281			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ZE	22859205				2022-12-28	WOS:000307010700037
J	Damasceno, PF; Engel, M; Glotzer, SC				Damasceno, Pablo F.; Engel, Michael; Glotzer, Sharon C.			Predictive Self-Assembly of Polyhedra into Complex Structures	SCIENCE			English	Article							QUASI-CRYSTALLINE; DENSEST PACKINGS; PHASE; ENTROPY; SUPERLATTICES; NANOCRYSTALS	Predicting structure from the attributes of a material's building blocks remains a challenge and central goal for materials science. Isolating the role of building block shape for self-assembly provides insight into the ordering of molecules and the crystallization of colloids, nanoparticles, proteins, and viruses. We investigated 145 convex polyhedra whose assembly arises solely from their anisotropic shape. Our results demonstrate a remarkably high propensity for thermodynamic self-assembly and structural diversity. We show that from simple measures of particle shape and local order in the fluid, the assembly of a given shape into a liquid crystal, plastic crystal, or crystal can be predicted.	[Damasceno, Pablo F.; Glotzer, Sharon C.] Univ Michigan, Appl Phys Program, Ann Arbor, MI 48109 USA; [Engel, Michael; Glotzer, Sharon C.] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA; [Glotzer, Sharon C.] Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Glotzer, SC (corresponding author), Univ Michigan, Appl Phys Program, Ann Arbor, MI 48109 USA.	sglotzer@umich.edu	Engel, Michael/G-1778-2010	Engel, Michael/0000-0002-7031-3825; Damasceno, Pablo/0000-0001-5615-121X	Defense for Research and Engineering, U.S. Department of Defense [DOD/ASD(RE)] [N00244-09-1-0062]; U.S. Army Research Office [W911NF-10-1-0518]; Deutsche Forschungsgemeinschaft [EN 905-1/1]; U.S. Air Force Office of Scientific Research under Multidisciplinary University Research Initiative [FA9550-06-1-0337, 444286-P061716]	Defense for Research and Engineering, U.S. Department of Defense [DOD/ASD(RE)](United States Department of Defense); U.S. Army Research Office; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); U.S. Air Force Office of Scientific Research under Multidisciplinary University Research Initiative	This material is based in part upon work supported by the Assistant Secretary of Defense for Research and Engineering, U.S. Department of Defense [DOD/ASD(R&E)] (N00244-09-1-0062). Any opinions, findings, and conclusions or recommendations expressed in this publication are those of the authors and do not necessarily reflect the views of the DOD/ASD(R&E). S.C.G. acknowledges support by the U.S. Army Research Office under Grant Award no. W911NF-10-1-0518. M.E. acknowledges support from the Deutsche Forschungsgemeinschaft (EN 905-1/1). P.F.D. was supported in part by the U.S. Air Force Office of Scientific Research under Multidisciplinary University Research Initiative no. FA9550-06-1-0337, subaward no. 444286-P061716. We thank R. G. Petschek and J. M. Millunchick for comments on the original manuscript.	Agarwal U, 2011, NAT MATER, V10, P230, DOI [10.1038/nmat2959, 10.1038/NMAT2959]; ALDER BJ, 1957, J CHEM PHYS, V27, P1208, DOI 10.1063/1.1743957; Blunt MO, 2008, SCIENCE, V322, P1077, DOI 10.1126/science.1163338; Damasceno PF, 2012, ACS NANO, V6, P609, DOI 10.1021/nn204012y; de Graaf J, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.155501; ELDRIDGE MD, 1993, NATURE, V365, P35, DOI 10.1038/365035a0; Elenius M, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.144201; Frenkel D, 1999, PHYSICA A, V263, P26, DOI 10.1016/S0378-4371(98)00501-9; FRENKEL D, 1988, NATURE, V332, P822, DOI 10.1038/332822a0; FRENKEL D, 1985, MOL PHYS, V55, P1171, DOI 10.1080/00268978500101971; Gerbode SJ, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.058302; Glotzer SC, 2007, NAT MATER, V6, P557, DOI 10.1038/nmat1949; Haji-Akbari A, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3651370; Haji-Akbari A, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.215702; Haji-Akbari A, 2009, NATURE, V462, P773, DOI 10.1038/nature08641; Henzie J, 2012, NAT MATER, V11, P131, DOI [10.1038/nmat3178, 10.1038/NMAT3178]; Huang MH, 2012, ADV FUNCT MATER, V22, P14, DOI 10.1002/adfm.201101784; Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P535, DOI 10.1016/B978-0-12-375182-9.10020-X; Lee S, 2010, SCIENCE, V330, P349, DOI 10.1126/science.1195552; Li F, 2011, ANGEW CHEM INT EDIT, V50, P360, DOI 10.1002/anie.201001451; Marechal M, 2010, NANO LETT, V10, P1907, DOI 10.1021/nl100783g; Miller WL, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3518976; NEZBEDA I, 1976, CHEM PHYS LETT, V41, P55, DOI 10.1016/0009-2614(76)85246-3; ONSAGER L, 1949, ANN NY ACAD SCI, V51, P627, DOI 10.1111/j.1749-6632.1949.tb27296.x; Pauling L, 1929, J AM CHEM SOC, V51, P1010, DOI 10.1021/ja01379a006; Polya G., 1954, INDUCTION ANALOGY MA, P188; Quan ZW, 2010, NANO TODAY, V5, P390, DOI 10.1016/j.nantod.2010.08.011; Rohrer G., 2004, STRUCTURE BONDING CR; Rossi L, 2011, SOFT MATTER, V7, P4139, DOI 10.1039/c0sm01246g; Talapin DV, 2009, NATURE, V461, P964, DOI 10.1038/nature08439; Torquato S, 2009, NATURE, V460, P876, DOI 10.1038/nature08239; Ungar G, 2003, SCIENCE, V299, P1208, DOI 10.1126/science.1078849; Woodley SM, 2008, NAT MATER, V7, P937, DOI 10.1038/nmat2321; Young KL, 2012, P NATL ACAD SCI USA, V109, P2240, DOI 10.1073/pnas.1119301109; Zhang YG, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.135701; Zhao K, 2011, P NATL ACAD SCI USA, V108, P2684, DOI 10.1073/pnas.1014942108; Ziherl P, 2001, J PHYS CHEM B, V105, P10147, DOI 10.1021/jp010944q	37	746	750	11	600	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 27	2012	337	6093					453	457		10.1126/science.1220869	http://dx.doi.org/10.1126/science.1220869			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979FS	22837525				2022-12-28	WOS:000306802300039
J	Miller, G; Luo, RF; Zhang, LX; Sylvia, S; Shi, YJ; Foo, P; Zhao, QR; Martorell, R; Medina, A; Rozelle, S				Miller, Grant; Luo, Renfu; Zhang, Linxiu; Sylvia, Sean; Shi, Yaojiang; Foo, Patricia; Zhao, Qiran; Martorell, Reynaldo; Medina, Alexis; Rozelle, Scott			Effectiveness of provider incentives for anaemia reduction in rural China: a cluster randomised trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PAY-FOR-PERFORMANCE; HEALTH SYSTEM; CHILD HEALTH; CARE; PAYMENT; CONTRACTS; PROGRAMS; RWANDA; WILL	Objectives To test the impact of provider performance pay for anaemia reduction in rural China. Design A cluster randomised trial of information, subsidies, and incentives for school principals to reduce anaemia among their students. Enumerators and study participants were not informed of study arm assignment. Setting 72 randomly selected rural primary schools across northwest China. Participants 3553 fourth and fifth grade students aged 9-11 years. All fourth and fifth grade students in sample schools participated in the study. Interventions Sample schools were randomly assigned to a control group, with no intervention, or one of three treatment arms: (a) an information arm, in which principals received information about anaemia; (b) a subsidy arm, in which principals received information and unconditional subsidies; and (c) an incentive arm, in which principals received information, subsidies, and financial incentives for reducing anaemia among students. Twenty seven schools were assigned to the control arm (1816 students at baseline, 1623 at end point), 15 were assigned to the information arm (659 students at baseline, 596 at end point), 15 to the subsidy arm (726 students at baseline, 667 at end point), and 15 to the incentive arm (743 students at baseline, 667 at end point). Main outcome measures Student haemoglobin concentrations. Results Mean student haemoglobin concentration rose by 1.5 g/L (95% CI-1.1 to 4.1) in information schools, 0.8 g/L (-1.8 to 3.3) in subsidy schools, and 2.4 g/L (0 to 4.9) in incentive schools compared with the control group. This increase in haemoglobin corresponded to a reduction in prevalence of anaemia (Hb < 115 g/L) of 24% in incentive schools. Interactions with pre-existing incentives for principals to achieve good academic performance led to substantially larger gains in the information and incentive arms: when combined with incentives for good academic performance, associated effects on student haemoglobin concentration were 9.8 g/L (4.1 to 15.5) larger in information schools and 8.6 g/L (2.1 to 15.1) larger in incentive schools. Conclusions Financial incentives for health improvement were modestly effective. Understanding interactions with other motives and pre-existing incentives is critical.	[Miller, Grant] Stanford Univ, Stanford Med Sch, Ctr Primary Care & Outcomes Res, Ctr Hlth Policy, Stanford, CA 94305 USA; [Miller, Grant] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Luo, Renfu; Zhang, Linxiu; Zhao, Qiran] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Ctr Chinese Agr Policy, Beijing 100101, Peoples R China; [Sylvia, Sean] Univ Maryland, Dept Agr & Resource Econ, College Pk, MD 20742 USA; [Sylvia, Sean; Shi, Yaojiang] Northwest Univ, NW Socioecon Dev Res Ctr, Xian 710127, Peoples R China; [Foo, Patricia] Stanford Univ, Dept Econ, Stanford, CA 94305 USA; [Foo, Patricia] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Zhao, Qiran] Leibniz Inst Agr Dev Cent & Eastern Europe IAMO, D-06120 Halle, Saale, Germany; [Martorell, Reynaldo] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Medina, Alexis; Rozelle, Scott] Stanford Univ, Freeman Spogli Inst Int Studies, Stanford, CA 94305 USA; [Rozelle, Scott] Katholieke Univ Leuven, LICOS Ctr Inst & Econ Performance, B-3000 Louvain, Belgium	Stanford University; National Bureau of Economic Research; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; University System of Maryland; University of Maryland College Park; Northwest University Xi'an; Stanford University; Stanford University; Leibniz Institut fur Agrarentwicklung in Transformationsokonomien (IAMO); Emory University; Rollins School Public Health; Stanford University; KU Leuven	Miller, G (corresponding author), Stanford Univ, Stanford Med Sch, Ctr Primary Care & Outcomes Res, Ctr Hlth Policy, Stanford, CA 94305 USA.	ngmiller@stanford.edu	Martorell, Reynaldo/I-2539-2012; ZHANG, LIN/GYD-9123-2022; zhao, qiran/GSI-5490-2022; , IAMO/G-2328-2012	, IAMO/0000-0001-7922-9665; Zhao, Qiran/0000-0003-1526-2057	International Initiative for Impact Evaluation (3IE); Leibniz Institute of Agricultural Development in Central and Eastern Europe (IAMO); Stanford University; Pfizer	International Initiative for Impact Evaluation (3IE); Leibniz Institute of Agricultural Development in Central and Eastern Europe (IAMO); Stanford University(Stanford University); Pfizer(Pfizer)	The project was funded by the International Initiative for Impact Evaluation (3IE), the Leibniz Institute of Agricultural Development in Central and Eastern Europe (IAMO), and Stanford University (the China Fund at the Freeman Spogli Institute for International Studies, the Stanford Center for International Development, and the Presidential Fund for Innovation in International Studies). Supplemental funding to the Rural Education Action Project (REAP) was provided by Pfizer. None of the funders or material contributors to this project played any role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, or approval of the manuscript.	Alderman H, 2001, J HUM RESOUR, V36, P185, DOI 10.2307/3069675; BABU SC, 1989, FOOD POLICY, V14, P58, DOI 10.1016/0306-9192(89)90026-2; Basinga P, 2011, LANCET, V377, P1421, DOI 10.1016/S0140-6736(11)60177-3; Bloom E., 2006, CONTRACTING HLTH EVI; Bobonis GJ, 2006, J HUM RESOUR, V41, P692, DOI 10.3368/jhr.XLI.4.692; Boulton F, 1997, TRANSFUSION MED, V4, P221; Bruhn M, 2009, AM ECON J-APPL ECON, V1, P200, DOI 10.1257/app.1.4.200; Bundy DAP, 2006, DIS CONTROL PRIORITI, P20; Chen Junshi, 2005, Food and Nutrition Bulletin, V26, P177; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208; DUNNETT CW, 1964, BIOMETRICS, V20, P482, DOI 10.2307/2528490; Education law of the People's Republic of China, 1995, ED LAW CHINA; GIBBONS R, 1992, J POLIT ECON, V100, P468, DOI 10.1086/261826; Guterman S, 2009, HEALTH AFFAIR, V28, pW238, DOI 10.1377/hlthaff.28.2.w238; Hall BJ, 1998, Q J ECON, V113, P653, DOI 10.1162/003355398555702; Halterman JS, 2001, PEDIATRICS, V107, P1381, DOI 10.1542/peds.107.6.1381; Jacoby HG, 2002, ECON J, V112, P196, DOI 10.1111/1468-0297.0j679; JENSEN MC, 1990, HARVARD BUS REV, V68, P138; Kroke A, 1999, AM J CLIN NUTR, V70, P439; Leonard KL, 2007, J HUM RESOUR, V42, P682; Loevinsohn B, 2005, LANCET, V366, P676, DOI 10.1016/S0140-6736(05)67140-1; Luo R, EC DEV CULT IN PRESS; Luo RF, 2010, ECOL FOOD NUTR, V49, P357, DOI 10.1080/03670244.2010.507437; Maynard A, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c88; Montagu D, 2011, LANCET, V377, P1383, DOI 10.1016/S0140-6736(11)60544-8; Morris SS, 1999, AM J CLIN NUTR, V69, P1243; Raith M, 2008, RAND J ECON, V39, P1059, DOI 10.1111/j.1756-2171.2008.00050.x; Rasmussen OD, 2011, J DEV EFFECT, V3, P502, DOI 10.1080/19439342.2011.605160; Rosenthal MB, 2007, JAMA-J AM MED ASSOC, V297, P740, DOI 10.1001/jama.297.7.740; Soeters R, 2006, B WORLD HEALTH ORGAN, V84, P884; Stoltzfus RJ, 2011, J NUTR, V141, p756S, DOI 10.3945/jn.110.128793; Stoltzfus RJ, 2001, J NUTR, V131, p697S, DOI 10.1093/jn/131.2.697S; Wang L., 2005, GEN SURVEY REPORT NU; Wang W., 2007, NUTR STATUS QUO SCH; World Health Organization, 2011, IR DEF AN ASS PREV C; Yang, 2004, HOLDING CHINA TOGETH, DOI DOI 10.1017/CBO9780511617157; Yip R, 2001, PRESENT KNOWLEDGE NU, P311	39	34	36	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 27	2012	345								e4809	10.1136/bmj.e4809	http://dx.doi.org/10.1136/bmj.e4809			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	981UZ	22842354	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000306997800001
J	Euvrard, S; Morelon, E; Rostaing, L; Goffin, E; Brocard, A; Tromme, I; Broeders, N; del Marmol, V; Chatelet, V; Dompmartin, A; Kessler, M; Serra, AL; Hofbauer, GFL; Pouteil-Noble, C; Campistol, JM; Kanitakis, J; Roux, AS; Decullier, E; Dantal, J				Euvrard, Sylvie; Morelon, Emmanuel; Rostaing, Lionel; Goffin, Eric; Brocard, Anabelle; Tromme, Isabelle; Broeders, Nilufer; del Marmol, Veronique; Chatelet, Valerie; Dompmartin, Anne; Kessler, Michele; Serra, Andreas L.; Hofbauer, Guenther F. L.; Pouteil-Noble, Claire; Campistol, Josep M.; Kanitakis, Jean; Roux, Adeline S.; Decullier, Evelyne; Dantal, Jacques		TUMORAPA Study Grp	Sirolimus and Secondary Skin-Cancer Prevention in Kidney Transplantation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EARLY CYCLOSPORINE WITHDRAWAL; SQUAMOUS-CELL CARCINOMA; ORGAN-TRANSPLANTATION; CALCINEURIN INHIBITORS; CONVERT TRIAL; RECIPIENTS; IMMUNOSUPPRESSION; RAPAMYCIN; EFFICACY; THERAPY	BACKGROUND Transplant recipients in whom cutaneous squamous-cell carcinomas develop are at high risk for multiple subsequent skin cancers. Whether sirolimus is useful in the prevention of secondary skin cancer has not been assessed. METHODS In this multicenter trial, we randomly assigned transplant recipients who were taking calcineurin inhibitors and had at least one cutaneous squamous-cell carcinoma either to receive sirolimus as a substitute for calcineurin inhibitors (in 64 patients) or to maintain their initial treatment (in 56). The primary end point was survival free of squamous-cell carcinoma at 2 years. Secondary end points included the time until the onset of new squamous-cell carcinomas, occurrence of other skin tumors, graft function, and problems with sirolimus. RESULTS Survival free of cutaneous squamous-cell carcinoma was significantly longer in the sirolimus group than in the calcineurin-inhibitor group. Overall, new squamous-cell carcinomas developed in 14 patients (22%) in the sirolimus group (6 after withdrawal of sirolimus) and in 22 (39%) in the calcineurin-inhibitor group (median time until onset, 15 vs. 7 months; P = 0.02), with a relative risk in the sirolimus group of 0.56 (95% confidence interval, 0.32 to 0.98). There were 60 serious adverse events in the sirolimus group, as compared with 14 such events in the calcineurin-inhibitor group (average, 0.938 vs. 0.250). There were twice as many serious adverse events in patients who had been converted to sirolimus with rapid protocols as in those with progressive protocols. In the sirolimus group, 23% of patients discontinued the drug because of adverse events. Graft function remained stable in the two study groups. CONCLUSIONS Switching from calcineurin inhibitors to sirolimus had an antitumoral effect among kidney-transplant recipients with previous squamous-cell carcinoma. These observations may have implications concerning immunosuppressive treatment of patients with cutaneous squamous-cell carcinomas. (Funded by Hospices Civils de Lyon and others; TUMORAPA ClinicalTrials.gov number, NCT00133887.)	[Euvrard, Sylvie; Kanitakis, Jean] Edouard Herriot Hosp Grp, Hosp Civils Lyon, Dept Dermatol, F-69437 Lyon 03, France; [Morelon, Emmanuel] Edouard Herriot Hosp Grp, Hosp Civils Lyon, Dept Nephrol & Transplantat, F-69437 Lyon 03, France; [Rostaing, Lionel] Toulouse Univ Hosp, Nephrol Dialysis & Organ Transplant Unit, Toulouse, France; [Rostaing, Lionel] Inst Fed Rech Biomed Toulouse, INSERM, U563, Toulouse, France; [Brocard, Anabelle] Hop Hotel Dieu, Dept Dermatocancerol, Nantes, France; [Chatelet, Valerie] Univ Hosp Caen, Dept Nephrol, Caen, France; [Dompmartin, Anne] Univ Hosp Caen, Dept Dermatol, Caen, France; [Kessler, Michele] Univ Hosp Nancy, Dept Nephrol, Vandoeuvre Les Nancy, France; [Pouteil-Noble, Claire] Univ Lyon, Lyon Sud Hosp, Dept Nephrol & Transplantat, Lyon, France; [Roux, Adeline S.; Decullier, Evelyne] Hosp Civils Lyon, Unite Rech Clin, Lyon, France; [Morelon, Emmanuel; Roux, Adeline S.; Decullier, Evelyne] Univ Lyon, Lyon, France; [Dantal, Jacques] Univ Hosp Nantes, Inst Transplantat Urol & Nephrol, Nantes, France; [Morelon, Emmanuel] INSERM, U851, F-69008 Lyon, France; [Goffin, Eric] Catholic Univ Louvain, St Luc Univ Hosp, Dept Nephrol, B-1200 Brussels, Belgium; [Tromme, Isabelle] Catholic Univ Louvain, St Luc Univ Hosp, Dept Dermatol, B-1200 Brussels, Belgium; [Broeders, Nilufer] Univ Libre Brussels, Erasme Hosp, Dept Nephrol, Brussels, Belgium; [del Marmol, Veronique] Univ Libre Brussels, Erasme Hosp, Dept Dermatol, Brussels, Belgium; [Serra, Andreas L.] Univ Zurich Hosp, Dept Nephrol, CH-8091 Zurich, Switzerland; [Hofbauer, Guenther F. L.] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland; [Campistol, Josep M.] Clin & Provencal Hosp, Dept Nephrol, Barcelona, Spain	CHU Lyon; CHU Lyon; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU de Nancy; Universite de Lorraine; CHU Lyon; CHU Lyon; Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; Universite Libre de Bruxelles; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Euvrard, S (corresponding author), Edouard Herriot Hosp Grp, Hosp Civils Lyon, Dept Dermatol, 5 Pl Arsonval, F-69437 Lyon 03, France.	sylvie.euvrard@numericable.fr	decullier, evelyne/AAL-5861-2021; Chatelet, Valerie/ABD-8719-2020; Abramowicz, Daniel/F-7578-2017; Kanitakis, Jean/Q-3450-2019; del marmol, veronique/AAZ-8117-2020; Hofbauer, Gunther/B-2671-2010; Mamzer, Marie-France/V-1713-2017; Kamar, Nassim/L-6462-2014	Chatelet, Valerie/0000-0002-3107-9087; Abramowicz, Daniel/0000-0002-6556-9199; Hofbauer, Gunther/0000-0003-0542-7989; Mamzer, Marie-France/0000-0001-7570-1803; Mascaro, Jose-Manuel/0000-0001-9327-2555; Kamar, Nassim/0000-0003-1930-8964; Josep M, Campistol/0000-0001-6244-0253; Kanitakis, Jean/0000-0003-0469-257X; Leccia, M.Therese/0000-0003-1222-0396	Hospices Civils de Lyon; French Ministry of Health; French Society of Dermatology; Pfizer	Hospices Civils de Lyon; French Ministry of Health; French Society of Dermatology; Pfizer(Pfizer)	Supported by Hospices Civils de Lyon and grants from the French Ministry of Health, the French Society of Dermatology, and Pfizer (formerly Wyeth).	Alberu J, 2011, TRANSPLANTATION, V92, P303, DOI 10.1097/TP.0b013e3182247ae2; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; Brennan D C, 2011, Am J Transplant, V11, P2453, DOI 10.1111/j.1600-6143.2011.03674.x; Budde K, 2011, LANCET, V377, P837, DOI 10.1016/S0140-6736(10)62318-5; Campbell SB, 2012, AM J TRANSPLANT, V12, P1146, DOI 10.1111/j.1600-6143.2012.04004.x; Campistol JM, 2006, J AM SOC NEPHROL, V17, P581, DOI 10.1681/ASN.2005090993; Cattaneo D, 2005, AM J TRANSPLANT, V5, P2937, DOI 10.1111/j.1600-6143.2005.01107.x; Clippinger AJ, 2011, J VIROL, V85, P3930, DOI 10.1128/JVI.01913-10; Dantal J, 2005, NEW ENGL J MED, V352, P1371, DOI 10.1056/NEJMe058018; Dantal J, 1998, LANCET, V351, P623, DOI 10.1016/S0140-6736(97)08496-1; de Gruijl FR, 2010, INT J CANCER, V127, P796, DOI 10.1002/ijc.25097; Duncan FJ, 2007, AM J TRANSPLANT, V7, P2693, DOI 10.1111/j.1600-6143.2007.02004.x; Euvrard S, 2006, TRANSPLANTATION, V81, P1093, DOI 10.1097/01.tp.0000209921.60305.d9; Euvrard S, 2003, NEW ENGL J MED, V348, P1681, DOI 10.1056/NEJMra022137; Geissler EK, 2008, AM J TRANSPLANT, V8, P2212, DOI 10.1111/j.1600-6143.2008.02391.x; Guba M, 2004, TRANSPLANTATION, V77, P1777, DOI 10.1097/01.tp.0000120181.89206.54; Hofbauer GFL, 2010, EXP DERMATOL, V19, P473, DOI 10.1111/j.1600-0625.2010.01086.x; Hojo M, 1999, NATURE, V397, P530, DOI 10.1038/17401; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Kauffman HM, 2005, TRANSPLANTATION, V80, P883, DOI 10.1097/01.TP.0000184006.43152.8D; Koehl GE, 2004, TRANSPLANTATION, V77, P1319, DOI 10.1097/00007890-200405150-00002; Kreis H, 2004, J AM SOC NEPHROL, V15, P809, DOI 10.1097/01.ASN.0000113248.59077.76; Maluccio M, 2003, TRANSPLANTATION, V76, P597, DOI 10.1097/01.TP.0000081399.75231.3B; Mathew T, 2004, CLIN TRANSPLANT, V18, P446, DOI 10.1111/j.1399-0012.2004.00188.x; Moorman NJ, 2010, J VIROL, V84, P5260, DOI 10.1128/JVI.02733-09; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Nichols LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014535; Otley CC, 2005, DERMATOL SURG, V31, P163, DOI 10.1097/00042728-200502000-00008; Proby CM, 2011, AM J TRANSPLANT, V11, P1498, DOI 10.1111/j.1600-6143.2011.03589.x; Rival-Tringali AL, 2009, ANTICANCER RES, V29, P1927; Salgo R, 2010, AM J TRANSPLANT, V10, P1385, DOI 10.1111/j.1600-6143.2009.02997.x; Schena FP, 2009, TRANSPLANTATION, V87, P233, DOI 10.1097/TP.0b013e3181927a41; Serra AL, 2010, NEW ENGL J MED, V363, P820, DOI 10.1056/NEJMoa0907419; Spangle JM, 2010, J VIROL, V84, P9398, DOI 10.1128/JVI.00974-10; Sun JG, 1996, STAT MED, V15, P1387, DOI 10.1002/(SICI)1097-0258(19960715)15:13&lt;1387::AID-SIM268&gt;3.0.CO;2-R; Ulrich C, 2008, AM J TRANSPLANT, V8, P2192, DOI 10.1111/j.1600-6143.2008.02386.x; Wisgerhof HC, 2010, TRANSPLANTATION, V89, P1231, DOI 10.1097/TP.0b013e3181d84cdc; Wu XW, 2010, NATURE, V465, P368, DOI 10.1038/nature08996	38	377	383	0	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 26	2012	367	4					329	339		10.1056/NEJMoa1204166	http://dx.doi.org/10.1056/NEJMoa1204166			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	978KD	22830463	Green Published, Green Accepted			2022-12-28	WOS:000306738300007
J	Xavier, RJ; Gala, MK; Bronzo, BK; Kelly, PJ				Xavier, Ramnik J.; Gala, Manish K.; Bronzo, Brian K.; Kelly, Paul J.			Case 23-2012: A 59-Year-Old Man with Abdominal Pain and Weight Loss Strongyloides stercoralis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COMMON VARIABLE IMMUNODEFICIENCY; CELIAC-DISEASE; TROPICAL SPRUE; CROHNS-DISEASE; SPECTRUM		[Xavier, Ramnik J.; Gala, Manish K.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Bronzo, Brian K.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Kelly, Paul J.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Xavier, Ramnik J.; Gala, Manish K.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Bronzo, Brian K.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Kelly, Paul J.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Xavier, RJ (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.							Agarwal S, 2009, J ALLERGY CLIN IMMUN, V124, P658, DOI 10.1016/j.jaci.2009.06.018; BOOTH CC, 1964, GUT, V5, P45, DOI 10.1136/gut.5.1.45; Carvalho BS, 2010, BIOINFORMATICS, V26, P242, DOI 10.1093/bioinformatics/btp624; Conley ME, 1999, CLIN IMMUNOL, V93, P190, DOI 10.1006/clim.1999.4799; Cunningham-Rundles C, 1999, CLIN IMMUNOL, V92, P34, DOI 10.1006/clim.1999.4725; Daniels JA, 2007, AM J SURG PATHOL, V31, P1800, DOI 10.1097/PAS.0b013e3180cab60c; DETHE G, 1993, AIDS RES HUM RETROV, V9, P381, DOI 10.1089/aid.1993.9.381; FARMER RG, 1975, GASTROENTEROLOGY, V68, P627; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; GENTA RM, 1989, REV INFECT DIS, V11, P755; GORBACH SL, 1969, LANCET, V1, P74; Green PHR, 2001, AM J GASTROENTEROL, V96, P126, DOI 10.1111/j.1572-0241.2001.03462.x; HANKEY GL, 1994, GUT, V35, P65, DOI 10.1136/gut.35.1.65; Khalili H, 2012, GUT; KLIPSTEIN FA, 1969, MEDICINE, V48, P475, DOI 10.1097/00005792-196948060-00003; KURATA JH, 1992, GASTROENTEROLOGY, V102, P1940, DOI 10.1016/0016-5085(92)90317-R; MARSH MN, 1992, GASTROENTEROLOGY, V102, P330, DOI 10.1016/0016-5085(92)91819-P; Mirdha B R, 2009, Trop Gastroenterol, V30, P1; Porto AF, 2001, PARASITE IMMUNOL, V23, P503, DOI 10.1046/j.1365-3024.2001.00407.x; SCHENK EA, 1965, AM J PATHOL, V47, P765; Sulkanen S, 1998, GASTROENTEROLOGY, V115, P1322, DOI 10.1016/S0016-5085(98)70008-3; Thompson BF, 2004, GASTROINTEST ENDOSC, V59, P906, DOI 10.1016/S0016-5107(04)00337-2	22	2	2	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 26	2012	367	4					363	373		10.1056/NEJMcpc1109275	http://dx.doi.org/10.1056/NEJMcpc1109275			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	978KD	22830467				2022-12-28	WOS:000306738300012
J	Boniol, M; Autier, P; Boyle, P; Gandini, S				Boniol, Mathieu; Autier, Philippe; Boyle, Peter; Gandini, Sara			Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ICELAND POSSIBLE INFLUENCE; BASAL-CELL CARCINOMA; MALIGNANT-MELANOMA; ULTRAVIOLET-RADIATION; SKIN CANCERS; RISK-FACTORS; INTERMITTENT EXPOSURE; PROTECTIVE FACTOR; NORTHERN-IRELAND; TANNING DEVICES	Objective To estimate the burden of melanoma resulting from sunbed use in western Europe. Design Systematic review and meta-analysis. Data sources PubMed, ISI Web of Science (Science Citation Index Expanded), Embase, Pascal, Cochrane Library, LILACS, and MedCarib, along with published surveys reporting prevalence of sunbed use at national level in Europe. Study selection Observational studies reporting a measure of risk for skin cancer (cutaneous melanoma, squamous cell carcinoma, basal cell carcinoma) associated with ever use of sunbeds. Results Based on 27 studies ever use of sunbeds was associated with a summary relative risk of 1.20 (95% confidence interval 1.08 to 1.34). Publication bias was not evident. Restricting the analysis to cohorts and population based studies, the summary relative risk was 1.25 (1.09 to 1.43). Calculations for dose-response showed a 1.8% (95% confidence interval 0% to 3.8%) increase in risk of melanoma for each additional session of sunbed use per year. Based on 13 informative studies, first use of sunbeds before age 35 years was associated with a summary relative risk of 1.87 (1.41 to 2.48), with no indication of heterogeneity between studies. By using prevalence data from surveys and data from GLOBOCAN 2008, in 2008 in the 15 original member countries of the European Community plus three countries that were members of the European Free Trade Association, an estimated 3438 cases of melanoma could be attributable to sunbed use, most (n=2341) occurring among women. Conclusions Sunbed use is associated with a significant increase in risk of melanoma. This risk increases with number of sunbed sessions and with initial usage at a young age (<35 years). The cancerous damage associated with sunbed use is substantial and could be avoided by strict regulations.	[Boniol, Mathieu; Autier, Philippe; Boyle, Peter] Int Prevent Res Inst, F-69006 Lyon, France; [Gandini, Sara] European Inst Oncol, Milan, Italy	IRCCS European Institute of Oncology (IEO)	Boniol, M (corresponding author), Int Prevent Res Inst, 95 Cours Lafayette, F-69006 Lyon, France.	mathieu.boniol@i-pri.org	Autier, Philippe/A-4402-2014; Boyle, Peter/A-4380-2014; Boniol, Mathieu/F-9623-2011; gandini, sara/J-4916-2018	Autier, Philippe/0000-0003-1538-5321; Boyle, Peter/0000-0001-6251-0610; Boniol, Mathieu/0000-0003-1052-5604; gandini, sara/0000-0002-1348-4548				ADAM SA, 1981, BRIT J CANCER, V44, P45, DOI 10.1038/bjc.1981.145; Alberg AJ, 2011, AM J EPIDEMIOL, V173, P845, DOI 10.1093/aje/kwr031; ANVISA, 2009, DIARIO OFICIAL  1111, V1; AUBRY F, 1985, CANCER-AM CANCER SOC, V55, P907, DOI 10.1002/1097-0142(19850215)55:4<907::AID-CNCR2820550433>3.0.CO;2-5; Autier P, 2004, EUR J CANCER, V40, P2367, DOI 10.1016/j.ejca.2004.07.018; AUTIER P, 1994, INT J CANCER, V58, P809, DOI 10.1002/ijc.2910580610; Autier P, 2008, NAT CLIN PRACT ONCOL, V5, P178, DOI 10.1038/ncponc1069; Autier P, 2011, LANCET, V377, P1299, DOI 10.1016/S0140-6736(10)61966-6; Autier P, 2011, CURR OPIN ONCOL, V23, P189, DOI 10.1097/CCO.0b013e3283436e5d; Bajdik CD, 1996, BRIT J CANCER, V73, P1612, DOI 10.1038/bjc.1996.303; Bataille V, 2004, EUR J CANCER, V40, P429, DOI 10.1016/j.ejca.2003.09.030; Bataille W, 2005, EUR J CANCER, V41, P2141, DOI 10.1016/j.ejca.2005.04.038; BEITNER H, 1990, BRIT J DERMATOL, V122, P43, DOI 10.1111/j.1365-2133.1990.tb08238.x; Boyle R, 2010, BRIT J DERMATOL, V163, P1269, DOI 10.1111/j.1365-2133.2010.09977.x; Bradford PT, 2010, CANCER EPIDEM BIOMAR, V19, P2401, DOI 10.1158/1055-9965.EPI-10-0503; Buller DB, 2011, J AM ACAD DERMATOL, V65, pS114, DOI 10.1016/j.jaad.2011.05.033; Chen YT, 1998, INT J EPIDEMIOL, V27, P758, DOI 10.1093/ije/27.5.758; Clough-Gorr KM, 2008, CANCER CAUSE CONTROL, V19, P659, DOI 10.1007/s10552-008-9129-6; Cokkinides V, 2009, CANCER-AM CANCER SOC, V115, P190, DOI 10.1002/cncr.24010; Corona R, 2001, ARCH DERMATOL, V137, P1162; Cumberland S, 2009, B WORLD HEALTH ORGAN, V87, P574, DOI 10.2471/BLT.09.030809; Cust AE, 2011, INT J CANCER, V128, P2425, DOI 10.1002/ijc.25576; Dal H, 2007, EUR J DERMATOL, V17, P428, DOI 10.1684/ejd.2007.0242; Diffey BL, 2003, BRIT J DERMATOL, V149, P578, DOI 10.1046/j.1365-2133.2003.05420.x; DUNNLANE J, 1993, IRISH MED J, V86, P57; El Ghissassi F, 2009, LANCET ONCOL, V10, P751, DOI 10.1016/S1470-2045(09)70213-X; Elliott F, 2012, INT J CANCER, V130, P3011, DOI 10.1002/ijc.26347; Ezzedine K, 2008, J EUR ACAD DERMATOL, V22, P186, DOI 10.1111/j.1468-3083.2007.02367.x; Federal Trade Commission, 2010, IND TANN FTC CONS AL; Ferlay J, 2010, IARC CANCERBASE, V10; Galan I, 2011, GAC SANIT, V25, P44, DOI 10.1016/j.gaceta.2010.07.013; Gallagher R P, 1986, Recent Results Cancer Res, V102, P38; GARBE C, 1993, RECENT RES CANCER, V128, P69; Green A, 2007, INT J CANCER, V120, P1116, DOI 10.1002/ijc.22453; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; GREENLAND S, 1987, EPIDEMIOL REV, V9, P1; Greenman J, 2010, J AM ACAD DERMATOL, V62, P685; Guy GP, 2011, PREV CHRONIC DIS, V8; Han JL, 2006, INT J EPIDEMIOL, V35, P1514, DOI 10.1093/ije/dyl197; Hery C, 2010, AM J EPIDEMIOL, V172, P762, DOI 10.1093/aje/kwq238; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; HOLLY EA, 1987, J AM ACAD DERMATOL, V17, P459, DOI 10.1016/S0190-9622(87)70230-8; HOLLY EA, 1995, AM J EPIDEMIOL, V141, P923, DOI 10.1093/oxfordjournals.aje.a117359; Holman C D, 1986, Recent Results Cancer Res, V102, P18; IARC (International Agency for Research on Cancer), 1992, MON EV CARC RISKS HU, V55; INPES, 2011, BAR CANC 2010; International Agency for Research on Cancer (IARC), 2006, IARC WORK GROUP REP, V1; Karagas MR, 2002, J NATL CANCER I, V94, P224, DOI 10.1093/jnci/94.3.224; Kaskel P, 2001, BRIT J DERMATOL, V145, P602, DOI 10.1046/j.1365-2133.2001.04432.x; KLEPP O, 1979, INT J CANCER, V23, P482, DOI 10.1002/ijc.2910230407; Koster B, 2011, J EUR ACAD DERMATOL, V25, P1351, DOI 10.1111/j.1468-3083.2010.03960.x; Krarup AF, 2011, BRIT J DERMATOL, V165, P214, DOI 10.1111/j.1365-2133.2011.10352.x; Lazovich D, 2010, CANCER EPIDEM BIOMAR, V19, P1557, DOI 10.1158/1055-9965.EPI-09-1249; LEVIN M L, 1953, Acta Unio Int Contra Cancrum, V9, P531; Lim HW, 2011, J AM ACAD DERMATOL, V64, P893, DOI 10.1016/j.jaad.2011.03.007; Macaskill P, 2001, STAT MED, V20, P641, DOI 10.1002/sim.698; MACKIE RM, 1989, LANCET, V2, P487; Mayer JA, 2011, AM J PUBLIC HEALTH, V101, P930, DOI 10.2105/AJPH.2010.300079; Montella A, 2009, EUR J CANCER, V45, P2360, DOI 10.1016/j.ejca.2009.03.004; Mouret S, 2006, P NATL ACAD SCI USA, V103, P13765, DOI 10.1073/pnas.0604213103; Mouret S, 2012, PHOTOCH PHOTOBIO SCI, V11, P155, DOI 10.1039/c1pp05185g; Mowbray M, 2007, BRIT J CANCER, V96, P832, DOI 10.1038/sj.bjc.6603612; Naldi L, 2000, EUR J CANCER PREV, V9, P133, DOI 10.1097/00008469-200004000-00011; Nielsen K, 2012, INT J CANCER, V131, P706, DOI 10.1002/ijc.26408; OFSP, 2011, OFSP B; OSTERLIND A, 1988, INT J CANCER, V42, P319, DOI 10.1002/ijc.2910420303; Paul CL, 2005, EUR J CANCER, V41, P1178, DOI 10.1016/j.ejca.2005.01.019; Paul CL, 2004, AUST NZ J PUBL HEAL, V28, P90, DOI 10.1111/j.1467-842X.2004.tb00641.x; Ridley AJ, 2009, INT J RADIAT BIOL, V85, P177, DOI 10.1080/09553000902740150; Runger TM, 2008, PHOTODERMATOL PHOTO, V24, P2, DOI 10.1111/j.1600-0781.2008.00319.x; Schneider S, 2010, J EUR ACAD DERMATOL, V24, P639, DOI 10.1111/j.1468-3083.2009.03509.x; Schneider S, 2009, ACTA DERM-VENEREOL, V89, P470, DOI 10.2340/00015555-0689; Sigurdsson T, 2008, P NSFS 15 C AL NORW; SWERDLOW AJ, 1988, BMJ-BRIT MED J, V297, P647, DOI 10.1136/bmj.297.6649.647; Ting W, 2007, INT J DERMATOL, V46, P1253, DOI 10.1111/j.1365-4632.2007.03408.x; van Houwelingen HC, 2002, STAT MED, V21, P589, DOI 10.1002/sim.1040; Veierod MB, 2010, CANCER EPIDEM BIOMAR, V19, P111, DOI 10.1158/1055-9965.EPI-09-0567; Veierod MB, 2003, J NATL CANCER I, V95, P1530, DOI 10.1093/jnci/djg075; Walter SD, 1999, INT J EPIDEMIOL, V28, P418, DOI 10.1093/ije/28.3.418; WALTER SD, 1990, AM J EPIDEMIOL, V131, P232, DOI 10.1093/oxfordjournals.aje.a115493; Walther U, 2004, BRIT J DERMATOL, V151, P170, DOI 10.1111/j.1365-2133.2004.06030.x; WESTERDAHL J, 1994, AM J EPIDEMIOL, V140, P691, DOI 10.1093/oxfordjournals.aje.a117317; Westerdahl J, 2000, BRIT J CANCER, V82, P1593; ZANETTI R, 1988, REV EPIDEMIOL SANTE, V36, P309; Zhang MF, 2012, J CLIN ONCOL, V30, P1588, DOI 10.1200/JCO.2011.39.3652	85	289	295	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 24	2012	345								e4757	10.1136/bmj.e4757	http://dx.doi.org/10.1136/bmj.e4757			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	981UQ	22833605	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000306996900004
J	Kelliher, T; Walbot, V				Kelliher, Timothy; Walbot, Virginia			Hypoxia Triggers Meiotic Fate Acquisition in Maize	SCIENCE			English	Article							STEM-CELLS; ANTHER; GERMLINE; DIFFERENTIATION; PROLIFERATION; ROXY1	Evidence from confocal microscopic reconstruction of maize anther development in fertile, mac1 (excess germ cells), and msca1 (no germ cells) flowers indicates that the male germ line is multiclonal and uses the MAC1 protein to organize the somatic niche. Furthermore, we identified redox status as a determinant of germ cell fate, defining a mechanism distinct from the animal germ cell lineage. Decreasing oxygen or H2O2 increases germ cell numbers, stimulates superficial germ cell formation, and rescues germinal differentiation in msca1 flowers. Conversely, oxidizing environments inhibit germ cell specification and cause ectopic differentiation in deeper tissues. We propose that hypoxia, arising naturally within growing anther tissue, acts as a positional cue to set germ cell fate.	[Kelliher, Timothy; Walbot, Virginia] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University	Kelliher, T (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	tkellih1@stanford.edu; walbot@stanford.edu		Walbot, Virginia/0000-0002-1596-7279	NSF [PGRP07-01880]; NIH [5-T32-GM008412-17]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008412] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supplementary figures, tables, and experimental procedures are available on Science Online. We thank R. Wang for MAC1 immunohistolocalization, B. Marchant for tassel treatments, D. Tollenor for oxygen measurements, and R. Egger and W. James Nelson for discussions. Transcriptome data were deposited in the Gene Expression Omnibus (accession no. GSE39101). T. K. and V. W. are inventors on a patent application (61/598.544) filed by Stanford University entitled "Method for Modulating the Number of Archesporial Cells in a Developing Anther." Supported by NSF grant PGRP07-01880. T. K. was supported by an NIH Biotechnology Training Grant (5-T32-GM008412-17).	Albertsen MC, 2011, US Patent Application, Patent No. [US007915478B2, 007915478]; Albrecht C, 2005, PLANT CELL, V17, P3337, DOI 10.1105/tpc.105.036814; BAGUNA J, 1989, DEVELOPMENT, V107, P77; Bedinger Patricia A., 2009, P57, DOI 10.1007/978-0-387-79418-1_4; Bertoni G, 2011, PLANT CELL, V23, P3562, DOI 10.1105/tpc.111.231011; Boavida LC, 2005, INT J DEV BIOL, V49, P595, DOI 10.1387/ijdb.052019lb; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Extavour CG, 2003, DEVELOPMENT, V130, P5869, DOI 10.1242/dev.00804; Feng XQ, 2007, TRENDS GENET, V23, P503, DOI 10.1016/j.tig.2007.08.005; Feng XQ, 2010, DEVELOPMENT, V137, P2409, DOI 10.1242/dev.049320; GOLDBERG RB, 1993, PLANT CELL, V5, P1217, DOI 10.1105/tpc.5.10.1217; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Hong LL, 2012, PLANT CELL, V24, P577, DOI 10.1105/tpc.111.093740; Hord Carey L. H., 2008, V9, P361, DOI 10.1007/7089_2007_136; Juliano C, 2010, SCIENCE, V329, P640, DOI 10.1126/science.1194037; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Kelliher T, 2011, DEV BIOL, V350, P32, DOI 10.1016/j.ydbio.2010.11.005; Leatherman JL, 2010, NAT CELL BIOL, V12, P806, DOI 10.1038/ncb2086; Li S, 2009, PLANT CELL, V21, P429, DOI 10.1105/tpc.108.064477; Miller G, 2008, PHYSIOL PLANTARUM, V133, P481, DOI 10.1111/j.1399-3054.2008.01090.x; Morrison SJ, 2000, J NEUROSCI, V20, P7370; Murmu J, 2010, PLANT PHYSIOL, V154, P1492, DOI 10.1104/pp.110.159111; Nan GL, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-120; Sheridan WF, 1999, GENETICS, V153, P933; Tsukagoshi H, 2010, CELL, V143, P606, DOI 10.1016/j.cell.2010.10.020; Wang CJR, 2012, DEVELOPMENT, V139, P2594, DOI 10.1242/dev.077891; Wang JW, 2005, PLANT CELL PHYSIOL, V46, P923, DOI 10.1093/pcp/pci098	27	141	146	2	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2012	337	6092					345	348		10.1126/science.1220080	http://dx.doi.org/10.1126/science.1220080			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975WQ	22822150	Green Accepted			2022-12-28	WOS:000306542600052
J	Hartling, L; Abou-Setta, AM; Dursun, S; Mousavi, SS; Pasichnyk, D; Newton, AS				Hartling, Lisa; Abou-Setta, Ahmed M.; Dursun, Serdar; Mousavi, Shima S.; Pasichnyk, Dion; Newton, Amanda S.			Antipsychotics in Adults With Schizophrenia: Comparative Effectiveness of First-Generation Versus Second-Generation Medications A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							RANDOMIZED CONTROLLED-TRIAL; INDUCED WEIGHT-GAIN; TREATMENT-RESISTANT SCHIZOPHRENIA; QUALITY-OF-LIFE; DOUBLE-BLIND; LONG-TERM; 1ST-EPISODE SCHIZOPHRENIA; ACUTE AGITATION; SCHIZOAFFECTIVE DISORDER; ACUTE EXACERBATION	Background: Debate continues about the comparative benefits and harms of first-generation antipsychotics (FGAs) and second-generation antipsychotics (SGAs) in treating schizophrenia. Purpose: To compare the effects of FGAs with those of SGAs in the treatment of adults aged 18 to 64 years with schizophrenia and related psychosis on illness symptoms, diabetes mellitus, mortality, tardive dyskinesia, and a major metabolic syndrome. Data Sources: English-language studies from 10 electronic databases to March 2012, reference lists of relevant articles, and gray literature. Study Selection: Randomized trials for efficacy and cohort studies at least 2 years in duration for adverse events. Data Extraction: Two independent reviewers extracted data from 114 studies involving 22 comparisons and graded the strength of evidence for primary outcomes as insufficient, low, moderate, or high using the Grading of Recommendations Assessment, Development and Evaluation approach. Data Synthesis: Few differences of clinical importance were found for core illness symptoms; lack of precision in effect estimates precluded firm conclusions for many comparisons. Moderate-strength evidence showed a clinically important benefit of haloperidol over olanzapine for improving positive symptoms, but the benefit was scale-dependent: It was seen when the Scale for the Assessment of Positive Symptoms was used but not when the Positive and Negative Syndrome Scale (PANSS) was used. Moderate-strength evidence showed a clinically important benefit of olanzapine over haloperidol in improving negative symptoms when the PANSS and the Scale for the Assessment of Negative Symptoms were used. Low-strength evidence showed no difference in mortality for chlorpromazine verus clozapine or haloperidol versus aripiprazole, increased incidence of the metabolic syndrome for olanzapine versus haloperidol (risk differences, 2% and 22%), and higher incidence of tardive dyskinesia for chlorpromazine versus clozapine (risk differences, 5% and 9%). Evidence was insufficient to draw conclusions for diabetes mellitus. Limitations: All studies had high or unclear risk of bias. Length of study follow-up was often too brief to adequately measure adverse events. Medication comparisons, dosage, and outcome measurement were heterogenous for head-to-head comparisons. Selective patient populations limit generalizability. Conclusion: Clear benefits of FGAs versus SGAs for treating schizophrenia remain inconclusive because of variation in assessing outcomes and lack of clinically important differences for most comparisons. The strength of evidence on safety for major medical events is low or insufficient.	[Hartling, Lisa] Univ Alberta, Edmonton, AB T6G 1C9, Canada; Univ Manitoba, Winnipeg, MB, Canada	University of Alberta; University of Manitoba	Hartling, L (corresponding author), Univ Alberta, ECHA 4-472,11405 87 Ave, Edmonton, AB T6G 1C9, Canada.	hartling@ualberta.ca	Pasichnyk, Dion/AAP-2716-2020		Agency for Healthcare Research and Quality; Agency for Healthcare Research and Quality (AHRQ), U.S. Department of Health and Human Services [290-2007-10021]; AHRQ; CIHR-Canada; Norlien Foundation	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Agency for Healthcare Research and Quality (AHRQ), U.S. Department of Health and Human Services; AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); CIHR-Canada(Canadian Institutes of Health Research (CIHR)); Norlien Foundation	Agency for Healthcare Research and Quality.; By the Agency for Healthcare Research and Quality (AHRQ) (contract 290-2007-10021), U.S. Department of Health and Human Services.; Dr. Hartling: Contract (money to institution): AHRQ. Dr. Abou-Setta: Grant (money to institution): AHRQ. Dr. Dursun: Grants/grants pending (money to institution): CIHR-Canada, Norlien Foundation; Patents (planned, pending, or issued): sodium nitroprusside for the treatment of schizophrenia, in partnership with the University of Alberta, TEC Edmonton Office. Dr. Newton: Grant (money to institution): AHRQ; Other (money paid to author): University of Alberta Evidence-based Practice Center. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum = M12 -0362.	Abdollahian EM, 2004, WORLD PSYCH ASS INT; Agency for Healthcare Research and Quality, 2012, WHAT IS RES PROC; Agency for Healthcare Research and Quality, 2010, COMP EFF 1 2 GEN ANT; Allison DB, 1999, AM J PSYCHIAT, V156, P1686; Altamura AC, 2002, INT J PSYCHIAT CLIN, V6, P107, DOI 10.1080/136515002753724117; Alvarez-Jimenez M, 2006, J CLIN PSYCHIAT, V67, P1253, DOI 10.4088/JCP.v67n0812; American Psychiatric Association, 2004, PRACT GUID TREATM PA; Andrezina R, 2006, PSYCHOPHARMACOLOGY, V188, P281, DOI 10.1007/s00213-006-0541-x; Apiquian R, 2008, BIOL RHYTHM RES, V39, P69, DOI 10.1080/09291010701318253; Arvanitis LA, 1997, BIOL PSYCHIAT, V42, P233, DOI 10.1016/S0006-3223(97)00190-X; Ascher-Svanum H, 2008, CLIN SCHIZOPHR RELAT, V2, P226; Atmaca M, 2002, ARCH MED RES, V33, P562, DOI 10.1016/S0188-4409(02)00403-4; Avasthi A, 2001, Indian J Psychiatry, V43, P257; Barnes TRE, 2011, J PSYCHOPHARMACOL, V25, P567, DOI 10.1177/0269881110391123; Beasley CM, 1997, EUR NEUROPSYCHOPHARM, V7, P125, DOI 10.1016/S0924-977X(96)00392-6; Beasley CM, 1996, NEUROPSYCHOPHARMACOL, V14, P111, DOI 10.1016/0893-133X(95)00069-P; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bernardo M, 2001, PSYCHIAT RES-NEUROIM, V107, P87, DOI 10.1016/S0925-4927(01)00085-3; BHATTACHARJEE J, 2008, COCHRANE DATABASE SY; Blin O, 1996, J CLIN PSYCHOPHARM, V16, P38, DOI 10.1097/00004714-199602000-00007; BORISON RL, 1992, PSYCHOPHARMACOL BULL, V28, P213; Boulay Luc J, 2007, Cogn Neuropsychiatry, V12, P322, DOI 10.1080/13546800601069534; BREIER A, 1994, AM J PSYCHIAT, V151, P20; Breier A, 2002, ARCH GEN PSYCHIAT, V59, P441, DOI 10.1001/archpsyc.59.5.441; Brook S, 2005, PSYCHOPHARMACOLOGY, V178, P514, DOI 10.1007/s00213-004-2082-5; Buchanan RW, 2005, AM J PSYCHIAT, V162, P124, DOI 10.1176/appi.ajp.162.1.124; Cavallaro R, 2001, HUM PSYCHOPHARM CLIN, V16, P439, DOI 10.1002/hup.322; CESKOVA E, 1993, PHARMACOPSYCHIATRY, V26, P121, DOI 10.1055/s-2007-1014355; CHIU E, 1976, AUST NZ J PSYCHIAT, V10, P343, DOI 10.3109/00048677609159524; CHOUINARD G, 1993, J CLIN PSYCHOPHARM, V13, P25; Cipriani A, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006324.pub2; Citrome L, 2001, PSYCHIATR SERV, V52, P1510, DOI 10.1176/appi.ps.52.11.1510; CLAGHORN J, 1987, J CLIN PSYCHOPHARM, V7, P377; CLAUS A, 1992, ACTA PSYCHIAT SCAND, V85, P295, DOI 10.1111/j.1600-0447.1992.tb01473.x; Conley RR, 2005, CLIN NEUROPHARMACOL, V28, P163, DOI 10.1097/01.wnf.0000172993.89879.0f; Conley RR, 1998, AM J PSYCHIAT, V155, P914, DOI 10.1176/ajp.155.7.914; Copolov DL, 2000, PSYCHOL MED, V30, P95, DOI 10.1017/S0033291799001476; Corripio I, 2005, PROG NEURO-PSYCHOPH, V29, P91, DOI 10.1016/j.pnpbp.2004.10.010; Covington L, 2000, SEX DISABIL, V18, P41, DOI 10.1023/A:1005425728062; Crespo-Facorro B, 2006, J CLIN PSYCHIAT, V67, P1511, DOI 10.4088/JCP.v67n1004; Crespo-Facorro B, 2012, PSYCHOPHARMACOLOGY, V219, P225, DOI 10.1007/s00213-011-2392-3; Csernansky JG, 2002, NEW ENGL J MED, V346, P16, DOI 10.1056/NEJMoa002028; Daniel David G, 2007, J Psychiatr Pract, V13, P170, DOI 10.1097/01.pra.0000271658.86845.81; Davidson M, 2009, AM J PSYCHIAT, V166, P675, DOI 10.1176/appi.ajp.2008.08060806; de Haan L, 2003, AM J PSYCHIAT, V160, P303, DOI 10.1176/appi.ajp.160.2.303; de Oliveira IR, 2009, CNS SPECTRUMS, V14, P93, DOI 10.1017/S1092852900000249; Sena Eduardo Pondé de, 2003, Rev. Bras. Psiquiatr., V25, P220, DOI 10.1590/S1516-44462003000400007; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; EKBLOM B, 1974, CURR THER RES CLIN E, V16, P945; Emsley R, 2005, INT J NEUROPSYCHOPH, V8, P175, DOI 10.1017/S1461145705005067; Emsley RA, 2000, INT CLIN PSYCHOPHARM, V15, P121, DOI 10.1097/00004850-200015030-00001; Emsley RA, 1999, SCHIZOPHRENIA BULL, V25, P721, DOI 10.1093/oxfordjournals.schbul.a033413; Essali A, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000059.pub2; Fakra E, 2008, PSYCHOPHARMACOLOGY, V200, P261, DOI 10.1007/s00213-008-1203-y; Gartlehner G., 2006, AHRQ PUBLICATION; Gaszner N, 2004, PROG NEURO-PSYCHOPH, V28, P465, DOI 10.1016/j.pnpbp.2003.11.011; GELENBERG AJ, 1979, J CLIN PSYCHIAT, V40, P238; Gentile S, 2006, DRUG SAFETY, V29, P303, DOI 10.2165/00002018-200629040-00002; Ghaleiha A, 2011, HUM PSYCHOPHARM CLIN, V26, P120, DOI 10.1002/hup.1176; Gilbody S, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002306; Girgis RR, 2011, BRIT J PSYCHIAT, V199, P281, DOI 10.1192/bjp.bp.110.081471; Glick ID, 2011, J CLIN PSYCHIAT, V72, P1616, DOI 10.4088/JCP.11r06927; Goff DC, 1998, J CLIN PSYCHOPHARM, V18, P296, DOI 10.1097/00004714-199808000-00009; Goldman MB, 2004, J CLIN PSYCHOPHARM, V24, P678, DOI 10.1097/01.jcp.0000145337.07676.2f; GUIRGUIS E, 1977, CURR THER RES CLIN E, V21, P707; Hayashino Y, 2005, J EPIDEMIOL, V15, P235, DOI 10.2188/jea.15.235; Heck AH, 2000, SCHIZOPHR RES, V46, P97, DOI 10.1016/S0920-9964(00)00009-8; Heila H, 1997, AM J PSYCHIAT, V154, P1235; Hennessy S, 2002, BRIT MED J, V325, P1070, DOI 10.1136/bmj.325.7372.1070; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Hirsch SR, 2002, J CLIN PSYCHIAT, V63, P516, DOI 10.4088/JCP.v63n0609; Hong CJ, 1997, INT CLIN PSYCHOPHARM, V12, P123, DOI 10.1097/00004850-199705000-00001; Institute of Medicine, 2011, FIND WHAT WORKS HLTH; Ishigooka J, 2001, PSYCHIAT CLIN NEUROS, V55, P403, DOI 10.1046/j.1440-1819.2001.00882.x; ITOH H, 1977, FOLIA PSYCHIAT NEU J, V31, P17; Jakovljevic M, 1999, PSYCHIAT DANUB, V11, P3; Jones PB, 2006, ARCH GEN PSYCHIAT, V63, P1079, DOI 10.1001/archpsyc.63.10.1079; Kahn RS, 2008, LANCET, V371, P1085, DOI 10.1016/S0140-6736(08)60486-9; KANE J, 1988, ARCH GEN PSYCHIAT, V45, P789; Kane JM, 2006, INT CLIN PSYCHOPHARM, V21, P21, DOI 10.1097/01.yic.0000182114.65134.81; Kane JM, 2002, J CLIN PSYCHIAT, V63, P763, DOI 10.4088/JCP.v63n0903; Kane JM, 2001, ARCH GEN PSYCHIAT, V58, P965, DOI 10.1001/archpsyc.58.10.965; Kane JM, 2007, J CLIN PSYCHIAT, V68, P213, DOI 10.4088/JCP.v68n0206; Kane JM, 2010, J CLIN PSYCHIAT, V71, P1115, DOI 10.4088/JCP.10r06264yel; Kane JM, 2010, J CLIN PSYCHOPHARM, V30, P106, DOI 10.1097/JCP.0b013e3181d35d6b; Kasper S, 2003, INT J NEUROPSYCHOPH, V6, P325, DOI 10.1017/S1461145703003651; Kee KS, 1998, SCHIZOPHR RES, V31, P159, DOI 10.1016/S0920-9964(98)00026-7; Keefe RSE, 2006, SCHIZOPHR RES, V81, P1, DOI 10.1016/j.schres.2005.07.038; Keefe RSE, 2003, PSYCHOPHARMACOLOGY, V169, P383, DOI 10.1007/s00213-003-1476-0; Kim SH, 2010, HUM PSYCHOPHARM CLIN, V25, P187, DOI 10.1002/hup.1089; Klemp M, 2011, J CLIN PSYCHOPHARM, V31, P698, DOI 10.1097/JCP.0b013e31823657d9; KLIESER E, 1994, ACTA PSYCHIAT SCAND, V89, P68, DOI 10.1111/j.1600-0447.1994.tb05836.x; Komossa K, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006624.pub2; Komossa K, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006654.pub2; Komossa K, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006625.pub2; Komossa K, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006627.pub2; Kongsakon Ronnachai, 2006, Journal of the Medical Association of Thailand, V89, P1157; Krakowski MI, 2006, ARCH GEN PSYCHIAT, V63, P622, DOI 10.1001/archpsyc.63.6.622; Lahti AC, 2009, NEUROPSYCHOPHARMACOL, V34, P2675, DOI 10.1038/npp.2009.94; Lee SM, 2007, PROG NEURO-PSYCHOPH, V31, P1101, DOI 10.1016/j.pnpbp.2007.03.016; LEON CA, 1979, ACTA PSYCHIAT SCAND, V59, P471, DOI 10.1111/j.1600-0447.1979.tb00246.x; Leucht S, 2009, MOL PSYCHIATR, V14, P429, DOI 10.1038/sj.mp.4002136; Leucht S, 2009, AM J PSYCHIAT, V166, P152, DOI 10.1176/appi.ajp.2008.08030368; Leucht S, 2009, LANCET, V373, P31, DOI 10.1016/S0140-6736(08)61764-X; Lieberman JA, 2003, AM J PSYCHIAT, V160, P1396, DOI 10.1176/appi.ajp.160.8.1396; Lieberman JA, 2003, NEUROPSYCHOPHARMACOL, V28, P995, DOI 10.1038/sj.npp.1300157; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Lieberman JA, 2011, AM J PSYCHIAT, V168, P770, DOI 10.1176/appi.ajp.2011.11010039; Lindenmayer JP, 2007, J CLIN PSYCHIAT, V68, P368, DOI 10.4088/JCP.v68n0303; Liu SK, 2000, NEUROPSYCHOPHARMACOL, V22, P311, DOI 10.1016/S0893-133X(99)00137-2; Ljubin T, 2000, HUM PSYCHOPHARM CLIN, V15, P513, DOI 10.1002/1099-1077(200010)15:7<513::AID-HUP213>3.0.CO;2-Y; MARDER SR, 1994, AM J PSYCHIAT, V151, P825; Marder SR, 2003, AM J PSYCHIAT, V160, P1405, DOI 10.1176/appi.ajp.160.8.1405; McCue RE, 2006, BRIT J PSYCHIAT, V189, P433, DOI 10.1192/bjp.bp.105.019307; McDonagh M., 2010, DRUG CLASS REV ATYPI; Meltzer Herbert Y, 2002, Curr Psychiatry Rep, V4, P279, DOI 10.1007/s11920-996-0047-6; Miceli JJ, 2010, CLIN THER, V32, P472, DOI 10.1016/j.clinthera.2010.03.003; Min Sung Kil, 1993, Yonsei Medical Journal, V34, P179; Moller HJ, 2008, INT J NEUROPSYCHOPH, V11, P985, DOI 10.1017/S1461145708008791; Mortimer AM, 2007, BRIT J PSYCHIAT, V191, pS7, DOI 10.1192/bjp.191.50.s7; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Peuskens J, 1997, ACTA PSYCHIAT SCAND, V96, P265, DOI 10.1111/j.1600-0447.1997.tb10162.x; PEUSKENS J, 1995, BRIT J PSYCHIAT, V166, P712, DOI 10.1192/bjp.166.6.712; PEUSKENS J, 1995, BRIT J PSYCHIAT, V166, P727; Pompili Maurizio, 2007, Ann Gen Psychiatry, V6, P10, DOI 10.1186/1744-859X-6-10; Potkin SG, 2009, INT J NEUROPSYCHOPH, V12, P1233, DOI 10.1017/S1461145709000352; Purdon SE, 2000, ARCH GEN PSYCHIAT, V57, P249, DOI 10.1001/archpsyc.57.3.249; Purdon SE, 2001, J PSYCHIATR NEUROSCI, V26, P137; Remillard S, 2008, J INT NEUROPSYCH SOC, V14, P110, DOI 10.1017/S1355617708080090; RINIERIS P, 1980, NEUROPSYCHOBIOLOGY, V6, P29; Rosenheck R, 2003, JAMA-J AM MED ASSOC, V290, P2693, DOI 10.1001/jama.290.20.2693; Rosenheck R, 1997, NEW ENGL J MED, V337, P809, DOI 10.1056/NEJM199709183371202; Saddichha S, 2008, J CLIN PSYCHOPHARM, V28, P27, DOI 10.1097/jcp.0b013e3181602fe6; Sayers SL, 2005, J NERV MENT DIS, V193, P379, DOI 10.1097/01.nmd.0000165089.14736.bf; Schooler N, 2005, AM J PSYCHIAT, V162, P947, DOI 10.1176/appi.ajp.162.5.947; Sergi MJ, 2007, AM J PSYCHIAT, V164, P1585, DOI 10.1176/appi.ajp.2007.06091515; SHOPSIN B, 1979, ARCH GEN PSYCHIAT, V36, P657; Shrivastava A, 2000, Indian J Psychiatry, V42, P52; SINGER K, 1974, J INT MED RES, V2, P433; Sismondo S, 2008, CONTEMP CLIN TRIALS, V29, P109, DOI 10.1016/j.cct.2007.08.001; Smelson DA, 2006, J CLIN PSYCHOPHARM, V26, P9, DOI 10.1097/01.jcp.0000194624.07611.5e; Smith M, 2008, BRIT J PSYCHIAT, V192, P406, DOI 10.1192/bjp.bp.107.037184; Smith RC, 2001, INT J NEUROPSYCHOPH, V4, P239; Tamrakar S M, 2006, Kathmandu Univ Med J (KUMJ), V4, P152; Tandon R, 2008, SCHIZOPHR RES, V100, P20, DOI 10.1016/j.schres.2007.11.033; Taylor DM, 2000, ACTA PSYCHIAT SCAND, V101, P416, DOI 10.1034/j.1600-0447.2000.101006416.x; Tollefson GD, 1997, AM J PSYCHIAT, V154, P457; Tran-Johnson TK, 2007, J CLIN PSYCHIAT, V68, P111, DOI 10.4088/JCP.v68n0115; Velligan DI, 2002, SCHIZOPHR RES, V53, P239, DOI 10.1016/S0920-9964(01)00268-7; Volavka J, 2002, AM J PSYCHIAT, V159, P255, DOI 10.1176/appi.ajp.159.2.255; Wells G.A., 2000, VIS COMMUN Q; Wirshing DA, 1999, AM J PSYCHIAT, V156, P1374; Wright P, 2001, AM J PSYCHIAT, V158, P1149, DOI 10.1176/appi.ajp.158.7.1149; Wynn JK, 2007, SCHIZOPHR RES, V95, P134, DOI 10.1016/j.schres.2007.05.039; Yen YC, 2004, PROG NEURO-PSYCHOPH, V28, P285, DOI 10.1016/j.pnpbp.2003.10.006; Zhang XY, 2001, INT CLIN PSYCHOPHARM, V16, P325, DOI 10.1097/00004850-200111000-00002	157	90	96	0	50	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 2	2012	157	7					498	U100		10.7326/0003-4819-157-7-201210020-00525	http://dx.doi.org/10.7326/0003-4819-157-7-201210020-00525			25	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	016MQ	22893011				2022-12-28	WOS:000309523200005
J	Krakower, D; Mayer, KH				Krakower, Douglas; Mayer, Kenneth H.			What Primary Care Providers Need to Know About Preexposure Prophylaxis for HIV Prevention A Narrative Review	ANNALS OF INTERNAL MEDICINE			English	Review							ANTIRETROVIRAL THERAPY; COST-EFFECTIVENESS; GENITAL-TRACT; UNITED-STATES; INFECTION; MEN; WOMEN; RISK; SEX; INITIATION	As HIV prevalence climbs globally, including more than 50 000 new infections per year in the United States, we need more effective HIV prevention strategies. The use of antiretrovirals for preexposure prophylaxis (PrEP) among high-risk persons without HIV is emerging as one such strategy. Randomized, controlled trials have demonstrated that once-daily oral PrEP decreased HIV incidence among at-risk men who have sex with men and African heterosexuals, including serodiscordant couples. An additional randomized, controlled trial of a topical pericoital antiretroviral microbicide gel decreased HIV incidence among at-risk heterosexual South African women. Two other studies in African women did not demonstrate the efficacy of oral or topical PrEP, raising concerns about adherence patterns and efficacy in this population. The U.S. Food and Drug Administration (FDA) Antiviral Drugs Advisory Committee reviewed these studies and additional data in May 2012 and voted to advise the approval of oral tenofovir-emtricitabine for PrEP in high-risk populations. On 16 July 2012, the FDA recommended that this combination medication be approved for use as PrEP in high-risk persons without HIV. Patients may seek PrEP from their primary care providers, and those receiving PrEP require monitoring. Thus, primary care providers should become familiar with PrEP. This review outlines current knowledge about PrEP as it pertains to primary care, including identifying persons likely to benefit from PrEP; counseling to maximize adherence and reduce potential increases in risky behavior; and monitoring for potential drug toxicities, HIV acquisition, and antiretroviral drug resistance. Issues related to cost and insurance coverage are also discussed. Recent data suggest that PrEP, combined with other prevention strategies, holds promise in helping to curtail the HIV epidemic.	[Mayer, Kenneth H.] Fenway Hlth, Fenway Inst, Boston, MA 02215 USA; Harvard Univ, Beth Israel Deaconess Med Ctr, Med Ctr, Boston, MA 02215 USA	Fenway Health; Harvard University; Beth Israel Deaconess Medical Center	Mayer, KH (corresponding author), Fenway Hlth, Fenway Inst, 1340 Boylston St, Boston, MA 02215 USA.	kmayer@fenwayhealth.org			Harvard T32 postdoctoral HIV Clinical Research Fellowship grant [NIAID AI 007433]; National Institutes of Health Center for AIDS Research grant [P30AI42853]; National Institutes of Health Clinical Trial Unit for HIV Prevention and Microbicide Research grant [U01AI069480]; Harvard T32 postdoctoral HIV Clinical Research Fellowship [NIAID AI 007433]; Gilead Sciences; Bristol-Myers Squibb; National Institute of Health Center for AIDS Research [P30AI42853]; National Institute of Health Clinical Trial Unit for HIV Prevention and Microbicide Research [U01AI069480]; Merck; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007433, U01AI069480, P30AI042853] Funding Source: NIH RePORTER	Harvard T32 postdoctoral HIV Clinical Research Fellowship grant; National Institutes of Health Center for AIDS Research grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Clinical Trial Unit for HIV Prevention and Microbicide Research grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard T32 postdoctoral HIV Clinical Research Fellowship; Gilead Sciences(Gilead Sciences); Bristol-Myers Squibb(Bristol-Myers Squibb); National Institute of Health Center for AIDS Research; National Institute of Health Clinical Trial Unit for HIV Prevention and Microbicide Research; Merck(Merck & Company); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the Harvard T32 postdoctoral HIV Clinical Research Fellowship grant NIAID AI 007433 to Dr. Krakower and the National Institutes of Health Center for AIDS Research grant P30AI42853 and National Institutes of Health Clinical Trial Unit for HIV Prevention and Microbicide Research grant U01AI069480 to Dr. Mayer. The funding sources had no role in the design, conduct, or analysis of this work or the decision to submit this manuscript for publication.; Dr. Krakower: Grant (money to institution): Harvard T32 postdoctoral HIV Clinical Research Fellowship (grant NIAID AI 007433); Grants/grants pending (money to institution): Gilead Sciences, Bristol-Myers Squibb. Dr. Mayer: Grant (money to institution): National Institute of Health Center for AIDS Research (grant P30AI42853), National Institute of Health Clinical Trial Unit for HIV Prevention and Microbicide Research (grant U01AI069480); Grants/grants pending (money to institution): Gilead Sciences, Bristol-Myers Squibb, Merck. Disclosures can be also viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum = M12-1390.	Abbas U, 2011, 18 C RETR OPP INF BO; AIDS Vaccine Advocacy Coalition, 2009, SUMM AVAC THINK TANK; AIDS Vaccine Advocacy Coalition, 2012, ONG PLANN PREEXP PRO; Amico KR, 2011, 18 C RETR OPP INF BO; [Anonymous], 18 INT AIDS C VIENN; [Anonymous], 18 C RETR OPP INF BO; [Anonymous], 2011, 360 FHI; [Anonymous], 19 C RETR OPP INF SE; [Anonymous], 2011, 18 C RETR OPP INF BO; Baeten JM, 2012, NEW ENGL J MED; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Cardo DM, 1997, NEW ENGL J MED, V337, P1485, DOI 10.1056/NEJM199711203372101; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Crane M, 2009, J INFECT DIS, V199, P974, DOI 10.1086/597276; Dariotis JK, 2008, PERSPECT SEX REPRO H, V40, P218, DOI 10.1363/4021808; Desai K, 2008, AIDS, V22, P1829, DOI 10.1097/QAD.0b013e32830e00f5; Donnell D, 2012, 19 C RETR OPP INF SE; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Dumond JB, 2007, AIDS, V21, P1899, DOI 10.1097/QAD.0b013e328270385a; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; El-Sadr WM, 2010, NEW ENGL J MED, V362, P967, DOI 10.1056/NEJMp1000069; Epstein RM, 1998, ANN INTERN MED, V128, P435, DOI 10.7326/0003-4819-128-6-199803150-00003; Follow-on African Consortium for Tenofovir Studies, FACTS 001; Grant R, 2011, 18 C RETR OPP INF BO; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hallett TB, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001123; HIV Prevention Trials Network, HTPN 067 ADAPT STUD; Jacobson DL, 2008, JAIDS-J ACQ IMM DEF, V49, P298, DOI 10.1097/QAI.0b013e3181893e8e; Joint United Nations Programme on HIV/AIDS, UNAIDS REP GLOB AIDS; JUUSOLA JL, 2012, ANN INTERN MED, V156, P541, DOI DOI 10.1059/0003-4819-156-8-201204170-00001; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Kashuba ADM, 2012, LANCET, V379, P2409, DOI 10.1016/S0140-6736(11)61852-7; Krakower DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033119; Kurth Ann E, 2011, Curr HIV/AIDS Rep, V8, P62, DOI 10.1007/s11904-010-0063-3; Kwara A, 2008, CLIN INFECT DIS, V46, P719, DOI 10.1086/527387; Liu AY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023688; LOFT J, 1994, JAMA-J AM MED ASSOC, V271, P261; Mallal S, 2002, LANCET, V359, P727, DOI 10.1016/S0140-6736(02)07873-X; Mayer K, 2011, 49 ANN M INF DIS SOC; Mayer KH, 2006, AIDS, V20, P543, DOI 10.1097/01.aids.0000210608.70762.c3; Metzger DS, 2000, AM J EPIDEMIOL, V152, P99, DOI 10.1093/aje/152.2.99; Mutua G, 2010, 18 INT AIDS C VIENN; National Alliance of State & Territorial AIDS Directors, 2012, ADAP WATCH; Nel A, 2009, JAIDS-J ACQ IMM DEF, V51, P416, DOI 10.1097/QAI.0b013e3181acb536; Nuesch R, 2008, AIDS, V22, P152, DOI 10.1097/QAD.0b013e3282f303bf; Patel SM, 2004, JAIDS-J ACQ IMM DEF, V35, P120, DOI 10.1097/00126334-200402010-00003; Peterson Leigh, 2007, PLoS Clin Trials, V2, pe27, DOI 10.1371/journal.pctr.0020027; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Roberts L, 2011, 18 C RETR OPP INF BO; Shannon K, 2010, JAMA-J AM MED ASSOC, V304, P573, DOI 10.1001/jama.2010.1090; Siegfried N, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003510.pub3; Siegfried N, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003362.pub2; Smith D. K., 2011, Morbidity and Mortality Weekly Report, V60, P65; Szczech Lynda A, 2008, Top HIV Med, V16, P122; Thigpen MC, 2012, N ENGL J MED; United Nations General Assembly Special Session on HIV/AIDS, UNGASS COUNT PROGR R; Van Damme L, 2012, N ENGL J MED; Vastag B., 2012, WASH POST; Vergeront J M, 1998, WMJ, V97, P52; Walensky RP, 2012, CLIN INFECT DIS, V54, P1504, DOI 10.1093/cid/cis225; White JM, 2012, AIDS PATIENT CARE ST, V26, P395, DOI 10.1089/apc.2012.0030	61	26	26	0	21	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 2	2012	157	7					490	U75		10.7326/0003-4819-157-7-201210020-00510	http://dx.doi.org/10.7326/0003-4819-157-7-201210020-00510			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	016MQ	22821365	Green Accepted			2022-12-28	WOS:000309523200004
J	Krumholz, HM; Selby, JV				Krumholz, Harlan M.; Selby, Joe V.		Patient-Centered Outcomes Res Inst	Seeing Through the Eyes of Patients: The Patient-Centered Outcomes Research Institute Funding Announcements	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Yale Univ, Yale New Haven Hosp, Ctr Outcomes Res & Evaluat, Sch Med,Yale Sch Publ Hlth, New Haven, CT USA; Patient Centered Outcomes Res Inst, Washington, DC USA	Yale University	Krumholz, HM (corresponding author), 1 Church St,Suite 200, New Haven, CT 06510 USA.	harlan.krumholz@yale.edu	, Harlan/AAI-2875-2020		National Heart, Lung, and Blood Institute [U01 HL105270-02]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr. Krumholz is supported by grant U01 HL105270-02 (Center for Cardiovascular Outcomes Research at Yale University) from the National Heart, Lung, and Blood Institute.		0	19	19	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 18	2012	157	6					446	448		10.7326/0003-4819-157-6-201209180-00519	http://dx.doi.org/10.7326/0003-4819-157-6-201209180-00519			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007UB	22847044				2022-12-28	WOS:000308912800019
J	Raghu, G				Raghu, Ganesh			Idiopathic pulmonary fibrosis: new evidence and an improved standard of care in 2012	LANCET			English	Editorial Material							GASTROESOPHAGEAL-REFLUX THERAPY; PLACEBO-CONTROLLED TRIAL; ACETYLCYSTEINE; AZATHIOPRINE; GUIDELINES; PREDNISONE; STATEMENT; SURVIVAL; BOSENTAN		[Raghu, Ganesh] Univ Washington, Med Ctr, Div Pulm & Crit Care Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Raghu, G (corresponding author), Box 356175,1959 Pacific Ave, Seattle, WA 98195 USA.	graghu@uw.edu						Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646; Demedts M, 2005, NEW ENGL J MED, V353, P2229, DOI 10.1056/NEJMoa042976; Hunninghake GW, 2005, NEW ENGL J MED, V353, P2285, DOI 10.1056/NEJMe058210; King TE, 2008, AM J RESP CRIT CARE, V177, P75, DOI 10.1164/rccm.200705-732OC; King TE, 2011, AM J RESP CRIT CARE, V184, P92, DOI 10.1164/rccm.201011-1874OC; King TE, 2009, LANCET, V374, P222, DOI 10.1016/S0140-6736(09)60551-1; Kubo H, 2005, CHEST, V128, P1475, DOI 10.1378/chest.128.3.1475; Lee JS, 2012, EUR RESPIR J, V39, P352, DOI 10.1183/09031936.00050911; Lee JS, 2011, AM J RESP CRIT CARE, V184, P1390, DOI 10.1164/rccm.201101-0138OC; Noble PW, 2011, LANCET, V377, P1760, DOI 10.1016/S0140-6736(11)60405-4; Noth I, 2012, EUR RESPIR J, V39, P344, DOI 10.1183/09031936.00099910; Noth I, 2012, AM J RESP CRIT CARE, V186, P88, DOI 10.1164/rccm.201202-0314OC; Raghu G, 2004, NEW ENGL J MED, V350, P125, DOI 10.1056/NEJMoa030511; RAGHU G, 1991, AM REV RESPIR DIS, V144, P291, DOI 10.1164/ajrccm/144.2.291; Raghu G, 2012, EUR RESPIR J, V39, P242, DOI 10.1183/09031936.00211311; Raghu G, 2012, AM J RESP CRIT CARE, V185, pA3632; Raghu G, 2012, AM J RESP CRIT CARE, V185, pA3631; Raghu G, 2008, AM J RESP CRIT CARE, V178, P948, DOI 10.1164/rccm.200709-1446OC; Raghu G, 2012, NEW ENGL J MED, V366, P1968, DOI 10.1056/NEJMoa1113354; Raghu G, 2012, AM J RESP CRIT CARE, V185, P1044, DOI 10.1164/rccm.201201-0006PP; Raghu G, 2011, AM J RESP CRIT CARE, V184, P1330, DOI 10.1164/rccm.201110-1842ED; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Richeldi L, 2011, NEW ENGL J MED, V365, P1079, DOI 10.1056/NEJMoa1103690; Schunemann HJ, 2006, AM J RESP CRIT CARE, V174, P605, DOI 10.1164/rccm.200602-197ST; Zisman DA, 2010, NEW ENGL J MED, V363, P620, DOI 10.1056/NEJMoa1002110	25	19	19	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 18	2012	380	9842					699	701		10.1016/S0140-6736(12)61256-2	http://dx.doi.org/10.1016/S0140-6736(12)61256-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	991SE	22901891				2022-12-28	WOS:000307721000035
J	Emlen, DJ; Warren, IA; Johns, A; Dworkin, I; Lavine, LC				Emlen, Douglas J.; Warren, Ian A.; Johns, Annika; Dworkin, Ian; Lavine, Laura Corley			A Mechanism of Extreme Growth and Reliable Signaling in Sexually Selected Ornaments and Weapons	SCIENCE			English	Article							STATIC ALLOMETRY; CONDITION DEPENDENCE; HANDICAP PRINCIPLE; EVOLUTION; SIZE; SHAPE; EXPRESSION; PATTERNS; CAPTURE; TRAITS	Many male animals wield ornaments or weapons of exaggerated proportions. We propose that increased cellular sensitivity to signaling through the insulin/insulin-like growth factor (IGF) pathway may be responsible for the extreme growth of these structures. We document how rhinoceros beetle horns, a sexually selected weapon, are more sensitive to nutrition and more responsive to perturbation of the insulin/IGF pathway than other body structures. We then illustrate how enhanced sensitivity to insulin/IGF signaling in a growing ornament or weapon would cause heightened condition sensitivity and increased variability in expression among individuals-critical properties of reliable signals of male quality. The possibility that reliable signaling arises as a by-product of the growth mechanism may explain why trait exaggeration has evolved so many different times in the context of sexual selection.	[Emlen, Douglas J.; Johns, Annika] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Warren, Ian A.; Lavine, Laura Corley] Washington State Univ, Dept Entomol, Pullman, WA 99164 USA; [Dworkin, Ian] Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA	University of Montana System; University of Montana; Washington State University; Michigan State University	Emlen, DJ (corresponding author), Univ Montana, Div Biol Sci, 104 Hlth Sci Bldg, Missoula, MT 59812 USA.	doug.emlen@mso.umt.edu		Dworkin, Ian/0000-0002-2874-287X; Lavine, Laura/0000-0002-0262-359X	National Science Foundation [IOS-0919781, IOS-0919730, IOS-0920142]; Direct For Biological Sciences [0919781] Funding Source: National Science Foundation; Division Of Integrative Organismal Systems [0920142] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank C. E. Allen, C. Breuner, K. L. Bright, S. T. Emlen, E. McCullough, A. Perkins, A. Shingleton, and three anonymous reviewers for helpful comments on the manuscript; Y. Hongo, H. Gotoh, and N. Kubota for help purchasing beetles; E. Paul (Echo Medical Media) for artwork on Figs. 1B, 2, and 3; and the National Science Foundation (IOS-0919781, IOS-0919730, and IOS-0920142) for funding. Images in Fig. 1A used under license from Shutterstock.com (rhinoceros beetle, NH; widowbird, Simon_g; elk, W. Aston; stag beetle, H. Larsson; fiddler crab, Manamana). Sequences are deposited in GenBank (accession nos. JX141307 to JX141311).	ALATALO RV, 1988, BIOL J LINN SOC, V34, P363, DOI 10.1111/j.1095-8312.1988.tb01969.x; ANDERSSON M, 1986, EVOLUTION, V40, P804, DOI 10.1111/j.1558-5646.1986.tb00540.x; Bonduriansky R, 2005, EVOLUTION, V59, P138, DOI 10.1111/j.0014-3820.2005.tb00901.x; Bonduriansky R, 2003, EVOLUTION, V57, P2450, DOI 10.1111/j.0014-3820.2003.tb01490.x; Bonduriansky R, 2007, AM NAT, V169, P9, DOI 10.1086/510214; Bradbury J. W., 2011, PRINCIPLES ANIMAL CO; Cotton S, 2004, P ROY SOC B-BIOL SCI, V271, P771, DOI 10.1098/rspb.2004.2688; Cotton S, 2004, EVOLUTION, V58, P1038, DOI 10.1111/j.0014-3820.2004.tb00437.x; Cuervo JJ, 2009, J EVOLUTION BIOL, V22, P1503, DOI 10.1111/j.1420-9101.2009.01758.x; Darwin C., 1871, P475; ENQUIST M, 1983, J THEOR BIOL, V102, P387, DOI 10.1016/0022-5193(83)90376-4; Fitzpatrick S, 1997, BIOL J LINN SOC, V62, P145; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; Husak JF, 2011, BEHAVIOUR, V148, P1, DOI 10.1163/000579510X541265; Iwasa Y, 1999, J THEOR BIOL, V200, P97, DOI 10.1006/jtbi.1999.0979; JOHNSTONE RA, 1995, BIOL REV, V70, P1, DOI 10.1111/j.1469-185X.1995.tb01439.x; Knell RJ, 1999, ECOL ENTOMOL, V24, P323, DOI 10.1046/j.1365-2311.1999.00200.x; Kodric-Brown A, 2006, P NATL ACAD SCI USA, V103, P8733, DOI 10.1073/pnas.0602994103; Kotiaho JS, 2001, BIOL REV, V76, P365, DOI 10.1017/S1464793101005711; Lorch PD, 2003, EVOL ECOL RES, V5, P867; Oufiero CE, 2007, FUNCT ECOL, V21, P676, DOI 10.1111/j.1365-2435.2007.01259.x; PARKER GA, 1974, J THEOR BIOL, V47, P223, DOI 10.1016/0022-5193(74)90111-8; POMIANKOWSKI A, 1987, PROC R SOC SER B-BIO, V231, P123, DOI 10.1098/rspb.1987.0038; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; Searcy W., 2005, EVOLUTION ANIMAL COM; Shingleton AW, 2008, P ROY SOC B-BIOL SCI, V275, P1875, DOI 10.1098/rspb.2008.0227; Shingleton AW, 2007, BIOESSAYS, V29, P536, DOI 10.1002/bies.20584; Shingleton AW, 2005, PLOS BIOL, V3, P1607, DOI 10.1371/journal.pbio.0030289; Smith JM, 2004, ANIMAL SIGNALS, V1; Tang HY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002373; Tomkins JL, 2004, TRENDS ECOL EVOL, V19, P323, DOI 10.1016/j.tree.2004.03.029; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	32	318	322	7	232	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	2012	337	6096					860	864		10.1126/science.1224286	http://dx.doi.org/10.1126/science.1224286			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	989BQ	22837386				2022-12-28	WOS:000307535600048
J	Gudjonsson, T; Altmeyer, M; Savic, V; Toledo, L; Dinant, C; Grofte, M; Bartkova, J; Poulsen, M; Oka, Y; Bekker-Jensen, S; Mailand, N; Neumann, B; Heriche, JK; Shearer, R; Saunders, D; Bartek, J; Lukas, J; Lukas, C				Gudjonsson, Thorkell; Altmeyer, Matthias; Savic, Velibor; Toledo, Luis; Dinant, Christoffel; Grofte, Merete; Bartkova, Jirina; Poulsen, Maria; Oka, Yasuyoshi; Bekker-Jensen, Simon; Mailand, Niels; Neumann, Beate; Heriche, Jean-Karim; Shearer, Robert; Saunders, Darren; Bartek, Jiri; Lukas, Jiri; Lukas, Claudia			TRIP12 and UBR5 Suppress Spreading of Chromatin Ubiquitylation at Damaged Chromosomes	CELL			English	Article							E3 UBIQUITIN LIGASE; DOUBLE-STRAND BREAKS; END RULE PATHWAY; DNA-DAMAGE; HOMOLOGOUS RECOMBINATION; GENOMIC INSTABILITY; S-PHASE; 53BP1; REPAIR; EDD	Histone ubiquitylation is a prominent response to DNA double-strand breaks (DSBs), but how these modifications are confined to DNA lesions is not understood. Here, we show that TRIP12 and UBR5, two HECT domain ubiquitin E3 ligases, control accumulation of RNF168, a rate-limiting component of a pathway that ubiquitylates histones after DNA breakage. We find that RNF168 can be saturated by increasing amounts of DSBs. Depletion of TRIP12 and UBR5 allows accumulation of RNF168 to supra-physiological levels, followed by massive spreading of ubiquitin conjugates and hyperaccumulation of ubiquitin-regulated genome caretakers such as 53BP1 and BRCA1. Thus, regulatory and proteolytic ubiquitylations are wired in a self-limiting circuit that promotes histone ubiquitylation near the DNA lesions but at the same time counteracts its excessive spreading to undamaged chromosomes. We provide evidence that this mechanism is vital for the homeostasis of ubiquitin-controlled events after DNA breakage and can be subverted during tumorigenesis.	[Gudjonsson, Thorkell; Altmeyer, Matthias; Savic, Velibor; Toledo, Luis; Grofte, Merete; Lukas, Jiri; Lukas, Claudia] Danish Canc Soc Res Ctr, Chromosome Biol Unit, DK-2100 Copenhagen, Denmark; [Dinant, Christoffel; Bartkova, Jirina; Bartek, Jiri] Danish Canc Soc Res Ctr, Genome Integr Unit, DK-2100 Copenhagen, Denmark; [Dinant, Christoffel; Bartkova, Jirina; Bartek, Jiri] Ctr Genotox Stress Res, DK-2100 Copenhagen, Denmark; [Poulsen, Maria; Oka, Yasuyoshi; Bekker-Jensen, Simon; Mailand, Niels; Lukas, Jiri] Univ Copenhagen, Novo Nordisk Fdn, Ctr Prot Res, DK-2200 Copenhagen, Denmark; [Neumann, Beate; Heriche, Jean-Karim] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Shearer, Robert; Saunders, Darren] Univ New S Wales, Canc Res Program, Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia; [Shearer, Robert; Saunders, Darren] Univ New S Wales, St Vincents Clin Sch, Fac Med, Darlinghurst, NSW 2010, Australia; [Bartek, Jiri] Palacky Univ, Fac Med, Inst Mol & Translat Med, CZ-77515 Olomouc, Czech Republic	Danish Cancer Society; Danish Cancer Society; Novo Nordisk Foundation; University of Copenhagen; European Molecular Biology Laboratory (EMBL); Garvan Institute of Medical Research; University of New South Wales Sydney; University of New South Wales Sydney; Palacky University Olomouc	Lukas, J (corresponding author), Danish Canc Soc Res Ctr, Chromosome Biol Unit, Strandblvd 49, DK-2100 Copenhagen, Denmark.	jiri.lukas@cpr.ku.dk	Saunders, Darren/B-7677-2008; Altmeyer, Matthias/AAE-8186-2019; Bartek, Jiri/G-5870-2014; Toledo, Luis/R-2065-2016; Toledo, Luis/M-6685-2019	Altmeyer, Matthias/0000-0003-3780-1170; Toledo, Luis/0000-0001-9509-9944; Toledo, Luis/0000-0001-9509-9944; Dinant, Christoffel/0000-0001-7531-183X; Saunders, Darren/0000-0003-0924-0513; Bekker-Jensen, Simon/0000-0002-7308-4597; Lukas, Claudia/0000-0001-7169-6883; Heriche, Jean-Karim/0000-0001-6867-9425; Lukas, Jiri/0000-0001-9087-506X; Savic, Velibor/0000-0002-4830-3591; Gudjonsson, Thorarinn/0000-0001-9645-9665; Gudjonsson, Thorkell/0000-0002-5230-4263; Neumann, Beate/0000-0002-6899-502X	Danish Cancer Society; Danish National Research Foundation; Lundbeck Foundation [R44-A4400]; Novo Nordisk Foundation; Danish Council for Independent Research-Medical Sciences; John and Birthe Meyer Foundation; European Commission (DDR Response, Biomedreg, and Infla-Care); Cancer Institute NSW; NSW Office of Science and Medical Research; EMBO fellowships	Danish Cancer Society(Danish Cancer Society); Danish National Research Foundation(Danmarks Grundforskningsfond); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Council for Independent Research-Medical Sciences(Det Frie Forskningsrad (DFF)); John and Birthe Meyer Foundation; European Commission (DDR Response, Biomedreg, and Infla-Care)(European Commission); Cancer Institute NSW; NSW Office of Science and Medical Research; EMBO fellowships	We thank D. Durocher, X. Yu, T. Halazonetis, E. Soutoglou, J. Lippincott Schwartz, S. Watanabe, T. Kohno, and R. Strauss for reagents and technical advice, and we thank members of the Center Genotoxic Stress Research for helpful discussions. This work was supported by the Danish Cancer Society, the Danish National Research Foundation, the Lundbeck Foundation (R44-A4400), the Novo Nordisk Foundation, the Danish Council for Independent Research-Medical Sciences, the John and Birthe Meyer Foundation, European Commission (DDR Response, Biomedreg, and Infla-Care), Cancer Institute NSW, and the NSW Office of Science and Medical Research. M. A., L. T., and C. D. are recipients of long-term EMBO fellowships. Special thanks go to Jan Ellenberg, Rainer Pepperkok, and the Advanced Light Microscopy Facility (ALMF) at EMBL, Heidelberg, for generously supporting this project and for providing the siRNA arrays.	Acs K, 2011, NAT STRUCT MOL BIOL, V18, P1345, DOI 10.1038/nsmb.2188; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Bekker-Jensen S, 2010, NAT CELL BIOL, V12, P80, DOI 10.1038/ncb2008; Bothmer A, 2011, MOL CELL, V42, P319, DOI 10.1016/j.molcel.2011.03.019; Bothmer A, 2010, J EXP MED, V207, P855, DOI 10.1084/jem.20100244; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Bunting SF, 2012, MOL CELL, V46, P125, DOI 10.1016/j.molcel.2012.02.015; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Cao L, 2009, MOL CELL, V35, P534, DOI 10.1016/j.molcel.2009.06.037; Chen DL, 2010, NATURE, V464, P624, DOI 10.1038/nature08820; Clancy JL, 2003, ONCOGENE, V22, P5070, DOI 10.1038/sj.onc.1206775; Coleman KA, 2011, J BIOL CHEM, V286, P13669, DOI 10.1074/jbc.M110.213728; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Goodarzi AA, 2010, DNA REPAIR, V9, P1273, DOI 10.1016/j.dnarep.2010.09.013; Harrigan JA, 2011, J CELL BIOL, V193, P97, DOI 10.1083/jcb.201011083; Henderson MJ, 2006, J BIOL CHEM, V281, P39990, DOI 10.1074/jbc.M602818200; Henderson MJ, 2002, J BIOL CHEM, V277, P26468, DOI 10.1074/jbc.M203527200; Hu YD, 2011, GENE DEV, V25, P685, DOI 10.1101/gad.2011011; Hwang CS, 2010, NAT CELL BIOL, V12, P1177, DOI 10.1038/ncb2121; Hwang CS, 2009, P NATL ACAD SCI USA, V106, P2142, DOI 10.1073/pnas.0812316106; Keppler BR, 2010, J BIOL CHEM, V285, P35665, DOI 10.1074/jbc.M110.173997; Lau IF, 2003, MOL MICROBIOL, V49, P731, DOI 10.1046/j.1365-2958.2003.03640.x; Lilley CE, 2010, EMBO J, V29, P943, DOI 10.1038/emboj.2009.400; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Lukas C, 2011, NAT CELL BIOL, V13, P243, DOI 10.1038/ncb2201; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Matsuda K, 2011, HISTOPATHOLOGY, V59, P441, DOI 10.1111/j.1365-2559.2011.03963.x; Meerang M, 2011, NAT CELL BIOL, V13, P1376, DOI 10.1038/ncb2367; Moudry P, 2012, CELL DEATH DIFFER, V19, P798, DOI 10.1038/cdd.2011.150; Munoz MA, 2007, CELL CYCLE, V6, P3070, DOI 10.4161/cc.6.24.5021; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Nicassio F, 2007, CURR BIOL, V17, P1972, DOI 10.1016/j.cub.2007.10.034; O'Brien PM, 2008, BRIT J CANCER, V98, P1085, DOI 10.1038/sj.bjc.6604281; Park Y, 2008, BIOCHEM BIOPH RES CO, V374, P294, DOI 10.1016/j.bbrc.2008.07.019; Pegoraro G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031684; Peuscher MH, 2011, NAT CELL BIOL, V13, P1139, DOI 10.1038/ncb2326; Pinato S, 2011, MOL CELL BIOL, V31, P118, DOI 10.1128/MCB.00818-10; Poulsen M, 2012, J CELL BIOL, V197, P189, DOI 10.1083/jcb.201109100; Shanbhag NM, 2010, CELL, V141, P970, DOI 10.1016/j.cell.2010.04.038; Shao G, 2009, P NATL ACAD SCI USA, V106, P3166, DOI 10.1073/pnas.0807485106; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Varshavsky A, 2011, PROTEIN SCI, V20, P1298, DOI 10.1002/pro.666; Yoo NJ, 2011, PATHOLOGY, V43, P753, DOI 10.1097/PAT.0b013e32834c7e78	47	222	232	1	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 17	2012	150	4					697	709		10.1016/j.cell.2012.06.039	http://dx.doi.org/10.1016/j.cell.2012.06.039			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	995IT	22884692	Bronze			2022-12-28	WOS:000308002300006
J	Matzuk, MM; McKeown, MR; Filippakopoulos, P; Li, QL; Ma, L; Agno, JE; Lemieux, ME; Picaud, S; Yu, RN; Qi, J; Knapp, S; Bradner, JE				Matzuk, Martin M.; McKeown, Michael R.; Filippakopoulos, Panagis; Li, Qinglei; Ma, Lang; Agno, Julio E.; Lemieux, Madeleine E.; Picaud, Sarah; Yu, Richard N.; Qi, Jun; Knapp, Stefan; Bradner, James E.			Small-Molecule Inhibition of BRDT for Male Contraception	CELL			English	Article							BET BROMODOMAINS; 1ST BROMODOMAIN; BINDING; TESTIS; MYC; DIFFERENTIATION; IDENTIFICATION; INFERTILITY; EXPRESSION; CHROMATIN	A pharmacologic approach to male contraception remains a longstanding challenge in medicine. Toward this objective, we explored the spermatogenic effects of a selective small-molecule inhibitor (JQ1) of the bromodomain and extraterminal (BET) subfamily of epigenetic reader proteins. Here, we report potent inhibition of the testis-specific member BRDT, which is essential for chromatin remodeling during spermatogenesis. Biochemical and crystallographic studies confirm that occupancy of the BRDT acetyl-lysine binding pocket by JQ1 prevents recognition of acetylated histone H4. Treatment of mice with JQ1 reduced seminiferous tubule area, testis size, and spermatozoa number and motility without affecting hormone levels. Although JQ1-treated males mate normally, inhibitory effects of JQ1 evident at the spermatocyte and round spermatid stages cause a complete and reversible contraceptive effect. These data establish a new contraceptive that can cross the blood: testis boundary and inhibit bromodomain activity during spermatogenesis, providing a lead compound targeting the male germ cell for contraception.	[Matzuk, Martin M.; Ma, Lang; Agno, Julio E.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Matzuk, Martin M.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Matzuk, Martin M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Matzuk, Martin M.] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA; [Matzuk, Martin M.] Baylor Coll Med, Ctr Drug Discovery, Houston, TX 77030 USA; [Matzuk, Martin M.] Baylor Coll Med, Ctr Reprod Med, Houston, TX 77030 USA; [McKeown, Michael R.; Lemieux, Madeleine E.; Qi, Jun; Bradner, James E.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Filippakopoulos, Panagis; Picaud, Sarah; Knapp, Stefan] Univ Oxford, Nuffield Dept Clin Med, Struct Genom Consortium, Oxford OX3 7DQ, England; [Li, Qinglei] Texas A&M Univ, Dept Vet Integrat Biosci, Coll Vet Med & Biomed Sci, College Stn, TX 77843 USA; [Lemieux, Madeleine E.] Bioinfo, Ottawa, ON K1J 8G4, Canada; [Yu, Richard N.] Childrens Hosp, Dept Urol, Boston, MA 02115 USA; [Knapp, Stefan] George Washington Univ, Sch Med & Hlth Sci, Dept Biochem & Mol Biol, Washington, DC 20037 USA; [Bradner, James E.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Harvard University; Dana-Farber Cancer Institute; University of Oxford; Texas A&M University System; Texas A&M University College Station; Harvard University; Boston Children's Hospital; George Washington University; Harvard University; Harvard Medical School	Matzuk, MM (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.	mmatzuk@bcm.edu; james_bradner@dfci.harvard.edu	Knapp, Stefan/AAG-2347-2019	Knapp, Stefan/0000-0001-5995-6494; Filippakopoulos, Panagis/0000-0002-1515-1317; Lemieux, Madeleine/0000-0001-6355-8691	Eunice Kennedy Shriver NICHD/NIH [U01-HD060496]; Alkek Award for Pilot Projects in Experimental Therapeutics; Fidelity Foundation; Burroughs Wellcome Fund; NIH [K08CA128972]; Smith Family Foundation; Damon-Runyon Cancer Research Foundation; CIHR [1097737]; Canada Foundation for Innovation; Genome Canada; GlaxoSmithKline; Pfizer; Eli Lilly; Abbott; Takeda; Novartis Research Foundation; Ontario Ministry of Research and Innovation; Wellcome Trust; Wellcome Trust Career Development Fellowship [095751/Z/11/Z]; NICHD (SCCPRR) [U54-HD28934]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD060496, U54HD028934] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [K08CA128972] Funding Source: NIH RePORTER	Eunice Kennedy Shriver NICHD/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Alkek Award for Pilot Projects in Experimental Therapeutics; Fidelity Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Smith Family Foundation; Damon-Runyon Cancer Research Foundation; CIHR(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Genome Canada(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Pfizer(Pfizer); Eli Lilly(Eli Lilly); Abbott(Abbott Laboratories); Takeda(Takeda Pharmaceutical Company Ltd); Novartis Research Foundation; Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust Career Development Fellowship(Wellcome Trust); NICHD (SCCPRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to Drs. J. Brown and J. Plutzky for pharmacodynamic data; Dr. A. Roy for advice on the spermatozoa assays; Y. Vasquez and Dr. Z. Yu for technical help; J. Marineau, K. Shaw, and W. Smith for support of peptide synthesis; Dr. S. Kistler for the generous gift of the anti-TNP2 antibody; and Dr. S. Khochbin for helpful comments. These studies were supported, in part, by the Eunice Kennedy Shriver NICHD/NIH through cooperative agreement U01-HD060496 as part of the Cooperative Program in Male Contraception; an Alkek Award for Pilot Projects in Experimental Therapeutics; and a grant from the Fidelity Foundation (to M. M. M.), the Burroughs Wellcome Fund, the NIH (K08CA128972), the Smith Family Foundation, and Damon-Runyon Cancer Research Foundation (to J. E. B.). The SGC is a registered charity (number 1097737) that receives funds from the CIHR, Canada Foundation for Innovation, Genome Canada, GlaxoSmithKline, Pfizer, Eli Lilly, Abbott, Takeda, Novartis Research Foundation, Ontario Ministry of Research and Innovation, and Wellcome Trust. P. F. is supported by a Wellcome Trust Career Development Fellowship (095751/Z/11/Z). Serum FSH, LH, and testosterone analyses were performed at the University of Virginia Center for Research in Reproduction Ligand Assay and Analysis Core supported by NICHD (SCCPRR) grant U54-HD28934. Baylor College of Medicine and Dana-Farber Cancer Institute have filed patent applications on technologies relating to this work, which have been licensed to Tensha Therapeutics.	Aitken RJ, 2008, J CLIN INVEST, V118, P1330, DOI 10.1172/JCI33873; Aston KI, 2010, HUM REPROD, V25, P1383, DOI 10.1093/humrep/deq081; Berkovits BD, 2011, DEV BIOL, V360, P358, DOI 10.1016/j.ydbio.2011.10.005; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Dieterich K, 2007, NAT GENET, V39, P661, DOI 10.1038/ng2027; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kumar TR, 1997, NAT GENET, V15, P201, DOI 10.1038/ng0297-201; Lin YN, 2007, MOL CELL BIOL, V27, P6794, DOI 10.1128/MCB.01029-07; Liu D, 1998, NAT GENET, V20, P377, DOI 10.1038/3855; Ma L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000635; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Miki K, 2002, DEV BIOL, V248, P331, DOI 10.1006/dbio.2002.0728; Moriniere J, 2009, NATURE, V461, P664, DOI 10.1038/nature08397; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Roy A, 2007, FASEB J, V21, P1013, DOI 10.1096/fj.06-7035com; Schultz N, 2003, P NATL ACAD SCI USA, V100, P12201, DOI 10.1073/pnas.1635054100; Shang EY, 2007, DEVELOPMENT, V134, P3507, DOI 10.1242/dev.004481; Shang EY, 2004, GENE EXPR PATTERNS, V4, P513, DOI 10.1016/j.modgep.2004.03.002; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; WOLFES H, 1989, SCIENCE, V245, P740, DOI 10.1126/science.2475907; Yang JX, 2005, P NATL ACAD SCI USA, V102, P5755, DOI 10.1073/pnas.0408718102; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69; Zhao M, 2004, BIOL REPROD, V71, P1016, DOI 10.1095/biolreprod.104.028191; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	29	274	353	2	97	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 17	2012	150	4					673	684		10.1016/j.cell.2012.06.045	http://dx.doi.org/10.1016/j.cell.2012.06.045			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	995IT	22901802	Green Published, hybrid			2022-12-28	WOS:000308002300004
J	Rabinovich, L; Sigal, N; Borovok, I; Nir-Paz, R; Herskovits, AA				Rabinovich, Lev; Sigal, Nadejda; Borovok, Ilya; Nir-Paz, Ran; Herskovits, Anat A.			Prophage Excision Activates Listeria Competence Genes that Promote Phagosomal Escape and Virulence	CELL			English	Article							DEVELOPMENTAL TRANSCRIPTION FACTOR; SUBTILIS K-STATE; BACILLUS-SUBTILIS; DNA UPTAKE; REGULATORY PROTEIN; ESCHERICHIA-COLI; MONOCYTOGENES; HEMOLYSIN; BACTERIA; SYSTEM	The DNA uptake competence (Com) system of the intracellular bacterial pathogen Listeria monocytogenes is considered nonfunctional. There are no known conditions for DNA transformation, and the Com master activator gene, comK, is interrupted by a temperate prophage. Here, we show that the L. monocytogenes Com system is required during infection to promote bacterial escape from macrophage phagosomes in a manner that is independent of DNA uptake. Further, we find that regulation of the Com system relies on the formation of a functional comK gene via prophage excision. Prophage excision is specifically induced during intracellular growth, primarily within phagosomes, yet, in contrast to classic prophage induction, progeny virions are not produced. This study presents the characterization of an active prophage that serves as a genetic switch to modulate the virulence of its bacterial host in the course of infection.	[Rabinovich, Lev; Sigal, Nadejda; Borovok, Ilya; Herskovits, Anat A.] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel; [Nir-Paz, Ran] Hadassah Hebrew Univ, Med Ctr, Dept Clin Microbiol & Infect Dis, IL-91120 Jerusalem, Israel	Tel Aviv University; Hebrew University of Jerusalem; Hadassah University Medical Center	Herskovits, AA (corresponding author), Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel.	anathe@post.tau.ac.il	BOROVOK, ILYA/ABB-7370-2022; Nir-Paz, Ran/I-5003-2012; Nir-Paz, Ran/Q-6244-2019; Nir-Paz, Ran/GYA-4148-2022	Nir-Paz, Ran/0000-0002-1567-2550; BOROVOK, ILYA/0000-0003-1602-4499	ERA-NET PathoGenoMics; Israel Science Foundation; European Union FP7 (IRG) program; Legacy Heritage Fund, Israel Science Foundation	ERA-NET PathoGenoMics; Israel Science Foundation(Israel Science Foundation); European Union FP7 (IRG) program; Legacy Heritage Fund, Israel Science Foundation	We thank Avigdor Eldar, Martin Kupiec, and Gil Segal for critical reviews of the manuscript; Tamar Burg Golani and Millie Kaplan Zeevi for their kind help; and Daniel Portnoy, Howard Goldfine, and Helene Marquis for supplying us with antibodies. This study was partially funded by grants from the ERA-NET PathoGenoMics, the Israel Science Foundation and European Union FP7 (IRG) program (to A. A. H.), and the Legacy Heritage Fund, Israel Science Foundation (to R.N.-P.).	Berka RM, 2002, MOL MICROBIOL, V43, P1331, DOI 10.1046/j.1365-2958.2002.02833.x; Birmingham CL, 2008, NATURE, V451, P350, DOI 10.1038/nature06479; Borezee E, 2000, J BACTERIOL, V182, P5931, DOI 10.1128/JB.182.20.5931-5934.2000; Borezee E, 2001, MICROBIOL-SGM, V147, P2913, DOI 10.1099/00221287-147-11-2913; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; Claverys JP, 2006, ANNU REV MICROBIOL, V60, P451, DOI 10.1146/annurev.micro.60.080805.142139; COSSART P, 1989, INFECT IMMUN, V57, P3629, DOI 10.1128/IAI.57.11.3629-3636.1989; Dorscht J, 2009, J BACTERIOL, V191, P7206, DOI 10.1128/JB.01041-09; Dubnau D, 1999, ANNU REV MICROBIOL, V53, P217, DOI 10.1146/annurev.micro.53.1.217; Fronzes R, 2009, NAT REV MICROBIOL, V7, P703, DOI 10.1038/nrmicro2218; Glomski IJ, 2002, J CELL BIOL, V156, P1029, DOI 10.1083/jcb.200201081; GOLDEN JW, 1985, NATURE, V314, P419, DOI 10.1038/314419a0; Grundling A, 2003, J BACTERIOL, V185, P6295, DOI 10.1128/JB.185.21.6295-6307.2003; Hahn J, 2005, CELL, V122, P59, DOI 10.1016/j.cell.2005.04.035; Hamoen LW, 1998, GENE DEV, V12, P1539, DOI 10.1101/gad.12.10.1539; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; Herskovits AA, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030051; Hodgson DA, 2000, MOL MICROBIOL, V35, P312, DOI 10.1046/j.1365-2958.2000.01643.x; JOHNSON AD, 1981, NATURE, V294, P217, DOI 10.1038/294217a0; KATHARIOU S, 1987, J BACTERIOL, V169, P1291, DOI 10.1128/jb.169.3.1291-1297.1987; KIRBY JE, 1994, J BACTERIOL, V176, P2068, DOI 10.1128/jb.176.7.2068-2081.1994; KROOS L, 1989, SCIENCE, V243, P526, DOI 10.1126/science.2492118; KUNKEL B, 1990, GENE DEV, V4, P525, DOI 10.1101/gad.4.4.525; Lauer P, 2002, J BACTERIOL, V184, P4177, DOI 10.1128/JB.184.15.4177-4186.2002; Leber JH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040006; LITTLE JW, 1982, CELL, V29, P11, DOI 10.1016/0092-8674(82)90085-X; Loessner MJ, 2000, MOL MICROBIOL, V35, P324, DOI 10.1046/j.1365-2958.2000.01720.x; LOESSNER MJ, 1995, MOL MICROBIOL, V16, P1231, DOI 10.1111/j.1365-2958.1995.tb02345.x; Maamar H, 2005, MOL MICROBIOL, V56, P615, DOI 10.1111/j.1365-2958.2005.04592.x; Miner MD, 2008, MICROBIOL-SGM, V154, P3579, DOI 10.1099/mic.0.2008/021063-0; O'Riordan M, 2002, P NATL ACAD SCI USA, V99, P13861, DOI 10.1073/pnas.202476699; PORTNOY DA, 1988, J EXP MED, V167, P1459, DOI 10.1084/jem.167.4.1459; Ripio MT, 1997, J BACTERIOL, V179, P7174, DOI 10.1128/jb.179.22.7174-7180.1997; Scott J, 2008, J BACTERIOL, V190, P6290, DOI 10.1128/JB.01569-07; SMITH GA, 1995, INFECT IMMUN, V63, P4231, DOI 10.1128/IAI.63.11.4231-4237.1995; STRAGIER P, 1989, SCIENCE, V243, P507, DOI 10.1126/science.2536191; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; VANSINDEREN D, 1995, MOL MICROBIOL, V15, P455; Wendlinger G, 1996, MICROBIOL-UK, V142, P985, DOI 10.1099/00221287-142-4-985; ZINK R, 1992, APPL ENVIRON MICROB, V58, P296, DOI 10.1128/AEM.58.1.296-302.1992	41	145	149	2	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 17	2012	150	4					792	802		10.1016/j.cell.2012.06.036	http://dx.doi.org/10.1016/j.cell.2012.06.036			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	995IT	22901809	Bronze			2022-12-28	WOS:000308002300013
J	Schiffrin, EL				Schiffrin, Ernesto L.			Hypertension: treatments, diabetes, and developing regions	LANCET			English	Editorial Material							BLOOD-PRESSURE; PREVALENCE; COMMITTEE; BURDEN; RISK		[Schiffrin, Ernesto L.] McGill Univ, Jewish Gen Hosp, Dept Med, Montreal, PQ H3T 1E2, Canada; [Schiffrin, Ernesto L.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada	McGill University; Lady Davis Institute; McGill University	Schiffrin, EL (corresponding author), McGill Univ, Jewish Gen Hosp, Dept Med, Montreal, PQ H3T 1E2, Canada.	ernesto.schiffrin@mcgill.ca	Schiffrin, Ernesto L/AAB-9061-2019	Schiffrin, Ernesto L/0000-0002-4502-2823				[Anonymous], 2005, PREV CHRON DIS VIT I; Chapman N, 2007, HYPERTENSION, V49, P839, DOI 10.1161/01.HYP.0000259805.18468.8c; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Cloutier L, 2012, CURR CARDIOVASC RISK, V6, P267, DOI 10.1007/s12170-012-0247-z; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Daskalopoulou SS, 2012, CAN J CARDIOL, V28, P270, DOI 10.1016/j.cjca.2012.02.018; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Fagard RH, 2010, J HYPERTENS, V28, P635, DOI 10.1097/01.hjh.0000368700.79444.c1; Ferrannini E, 2012, LANCET, V380, P601, DOI 10.1016/S0140-6736(12)60987-8; Ibrahim MM, 2012, LANCET, V380, P611, DOI 10.1016/S0140-6736(12)60861-7; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Laurent S, 2012, LANCET, V380, P591, DOI 10.1016/S0140-6736(12)60825-3; Leenen FHH, 2010, HYPERTENSION, V56, P571, DOI 10.1161/HYPERTENSIONAHA.110.157818; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; National Institute for Health and Clinical Excellence, 2011, HYPERT CLIN MAN PRI; Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8; Roush GC, 2012, HYPERTENSION, V59, P1110, DOI 10.1161/HYPERTENSIONAHA.112.191106; Sadowski J, 2011, HYPERTENSION, V57, P911, DOI 10.1161/HYPERTENSIONAHA.110.163014; TARNOW L, 1994, DIABETES CARE, V17, P1247, DOI 10.2337/diacare.17.11.1247; Tran C. L., 2012, HYPERTENSION	22	9	9	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 11	2012	380	9841					539	541		10.1016/S0140-6736(12)61219-7	http://dx.doi.org/10.1016/S0140-6736(12)61219-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988SQ	22883490				2022-12-28	WOS:000307511400004
J	Hebert, C; Beaumont, J; Schwartz, G; Robicsek, A				Hebert, Courtney; Beaumont, Jennifer; Schwartz, Gene; Robicsek, Ari			The Influence of Context on Antimicrobial Prescribing for Febrile Respiratory Illness A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							TRACT INFECTIONS; DIAGNOSTIC-ACCURACY; ANTIBIOTICS; PREDICTORS; BRONCHITIS; A(H1N1); COLDS	Background: Little is known about the influence of contextual factors on a physician's likelihood to prescribe antimicrobials for febrile respiratory illness (FRI). Context includes epidemiologic context (for example, a pandemic period) and personal context (for example, recent exposure to other patients with FRI). Objective: To examine the association between contextual factors and antimicrobial prescribing for FRI. Design: 5.5-year retrospective cohort study. Setting: A network of Midwestern primary care providers. Patients: All patients presenting with FRI during influenza seasons between 2006 and 2011. Measurements: Antimicrobial prescribing for FRI during pandemic and seasonal influenza periods. Results: 28 301 unique patient encounters for FRI with 69 physicians in 26 practices were included. An antibiotic was prescribed in 12 795 (45.2%) cases. The range of prescribing among physicians was 17.9% to 83.7%. Antibiotics were prescribed in 47.5% of encounters during the seasonal period and 39.2% during the pandemic period (P < 0.001). After multivariable adjustment for patient and physician characteristics, antibiotic prescribing was lower in the pandemic period (odds ratio [OR], 0.72 [95% CI, 0.68 to 0.77]) than in the seasonal period. The likelihood of prescribing an antibiotic decreased as the number of FRI cases that a physician had seen in the previous week increased (OR, 0.93 [CI, 0.86 to 1.01] for 2 to 3 patients with FRI seen in the previous week; OR, 0.84 [CI, 0.77 to 0.91] for 4 to 6 patients; OR, 0.71 [CI, 0.64 to 0.78] for 7 to 11 patients; and OR, 0.57 [CI, 0.51 to 0.63] for >= 12 patients compared with the reference range of 0 to 1 patients). Pandemic season and recent personal context were also associated with antiviral prescribing. Limitation: Retrospective study in a single geographic area. Conclusion: Epidemiologic context and the number of cases of FRI that a physician had recently seen were associated with his or her likelihood to prescribe antimicrobials for FRI. Interventions that enhance a physician's contextual awareness may improve antimicrobial use.	[Hebert, Courtney] Ohio State Univ, Wexner Med Ctr, Dept Biomed Informat, Columbus, OH 43210 USA; Northwestern Univ, Feinberg Sch Med, Evanston, IL 60208 USA; Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA; NorthShore Univ HealthSyst, Evanston, IL USA	Ohio State University; Northwestern University; Feinberg School of Medicine; University of Chicago; NorthShore University Health System	Hebert, C (corresponding author), Ohio State Univ, Wexner Med Ctr, Dept Biomed Informat, 3190 Graves Hall,333 W 10th Ave, Columbus, OH 43210 USA.	courtney.hebert@osumc.edu	Beaumont, Jennifer/AAA-2825-2020; Hebert, Courtney/G-4900-2016	Beaumont, Jennifer/0000-0002-1484-260X; Schwartz, Gene/0000-0001-6918-1987	NorthShore University HealthSystem	NorthShore University HealthSystem	Dr. Robicsek was supported by a NorthShore University HealthSystem Research Career Development Award.	Aspinall SL, 2009, AM J EMERG MED, V27, P544, DOI 10.1016/j.ajem.2008.04.015; Butler CC, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2242; Cadieux G, 2007, CAN MED ASSOC J, V177, P877, DOI 10.1503/cmaj.070151; *CDCP, 2009, UPD INT REC US ANT M; Centers for Disease Control and Prevention, CDC GIS FLUVIEW; Centers for Disease Control and Prevention, 2009, INV INT REC SWIN FLU; Centers for Disease Control and Prevention, 2010, 2009 H1N1 PANDEMIC S; Centers for Medicare & Medicaid Services (CMS) HHS, 2010, Fed Regist, V75, P44313; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; degli Atti MLC, 2006, EUR J CLIN PHARMACOL, V62, P1055, DOI 10.1007/s00228-006-0198-8; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Dosh SA, 2000, J FAM PRACTICE, V49, P407; Fine AM, 2011, ANN INTERN MED, V155, P345, DOI 10.7326/0003-4819-155-6-201109200-00002; Fischer Thomas, 2005, BMC Fam Pract, V6, P6, DOI 10.1186/1471-2296-6-6; Ganestam F, 2003, SCAND J INFECT DIS, V35, P836, DOI 10.1080/00365540310016880; Glass SK, 2010, J ANTIMICROB CHEMOTH, V65, P148, DOI 10.1093/jac/dkp391; Gonzales R, 1997, JAMA-J AM MED ASSOC, V278, P901, DOI 10.1001/jama.278.11.901; Hopstaken RM, 2006, FAM PRACT, V23, P180, DOI 10.1093/fampra/cmi100; Hopstaken RM, 2005, J CLIN EPIDEMIOL, V58, P175, DOI 10.1016/j.jclinepi.2004.08.004; Horst MA, 2010, J AM BOARD FAM MED, V23, P32, DOI 10.3122/jabfm.2010.01.090137; Illinois Department of Public Health, H1N1 FLU; Khiabanian H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012658; Korppi M, 2008, ACTA PAEDIATR, V97, P943, DOI 10.1111/j.1651-2227.2008.00789.x; Linder JA, 2005, PHARMACOEPIDEM DR S, V14, P531, DOI 10.1002/pds.1067; Linder JA, 2009, J GEN INTERN MED, V24, P504, DOI 10.1007/s11606-009-0933-9; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Macfarlane J, 1997, BMJ-BRIT MED J, V315, P1211, DOI 10.1136/bmj.315.7117.1211; Mamede S, 2010, JAMA-J AM MED ASSOC, V304, P1198, DOI 10.1001/jama.2010.1276; Misurski DA, 2011, AM J MANAG CARE, V17, P601; Moro ML, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-69; Neuzil KM, 2000, NEW ENGL J MED, V342, P225, DOI 10.1056/NEJM200001273420401; Nyquist AC, 1998, JAMA-J AM MED ASSOC, V279, P875, DOI 10.1001/jama.279.11.875; Polgreen PM, 2011, INFECT CONT HOSP EP, V32, P706, DOI 10.1086/660859; Strahilevitz J, 2005, CLIN MICROBIOL INFEC, V11, P955, DOI 10.1111/j.1469-0691.2005.01255.x; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Watson RL, 1999, PEDIATRICS, V104, P1251, DOI 10.1542/peds.104.6.1251	36	12	12	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 7	2012	157	3					160	+		10.7326/0003-4819-157-3-201208070-00005	http://dx.doi.org/10.7326/0003-4819-157-3-201208070-00005			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992PB	22868833				2022-12-28	WOS:000307789900003
J	Light, DW; Lexchin, JR				Light, Donald W.; Lexchin, Joel R.			Pharmaceutical research and development: what do we get for all that money?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INDUSTRY; INNOVATION; PROMOTION; PRICE		[Light, Donald W.] Univ Med & Dent New Jersey, Dept Psychiat, Cherry Hill, NJ 08002 USA; [Lexchin, Joel R.] York Univ, Sch Hlth Policy & Management, Toronto, ON M3J 2R7, Canada	Rutgers State University New Brunswick; Rutgers State University Medical Center; York University - Canada	Light, DW (corresponding author), Univ Med & Dent New Jersey, Dept Psychiat, 2250 Chapel Ave, Cherry Hill, NJ 08002 USA.	dlight@princeton.edu						Abraham J, 2009, J HEALTH POLIT POLIC, V34, P931, DOI 10.1215/03616878-2009-032; Adamini S, 2009, J HEALTH POLIT POLIC, V34, P979, DOI 10.1215/03616878-2009-033; Angell M., 2004, TRUTH DRUG CO THEY D; [Anonymous], 2010, Prescrire Int, V19, P89; Applbaum K, 2006, PLOS MED, V3, P445, DOI 10.1371/journal.pmed.0030189; Applbaum K, 2009, HASTINGS CENT REP, V39, P13; Applbaum K, 2009, CULT MED PSYCHIAT, V33, P185, DOI 10.1007/s11013-009-9129-3; Approval Label, 2012, MYRB ORIG 1 DRUGS FD; BARRAL PE, 1996, 20 YEARS PHARM RES R; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; DUKES MNG, 1981, EUR J CLIN PHARMACOL, V19, P3, DOI 10.1007/BF00558371; Gagnon M-A, 2011, 2 BILLION EXTRA PRIC; Gagnon MA, 2008, PLOS MED, V5, P29, DOI 10.1371/journal.pmed.0050001; Giezen TJ, 2008, JAMA-J AM MED ASSOC, V300, P1887, DOI 10.1001/jama.300.16.1887; Harris G, 2002, WALL STREET J; Harrison C, 2011, NAT REV DRUG DISCOV, V10, P12, DOI 10.1038/nrd3356; Hopkins MM, 2007, RES POLICY, V36, P566, DOI 10.1016/j.respol.2007.02.013; Hunt MI, 2000, PRESCRIPTION DRUGS I; JOLDAL B, 1984, J SOCIAL ADM PHARM, V2, P81; Kaiser Family Foundation, 2009, PROF PHARM MAN; KAITIN KI, 1991, J CLIN PHARMACOL, V31, P17; Lexchin J, 2012, HEALTH POLICY, V105, P221, DOI 10.1016/j.healthpol.2012.02.005; Light D., 2010, RISKS PRESCRIPTION D; Light DW, 2011, BIOSOCIETIES, V6, P34, DOI 10.1057/biosoc.2010.40; Light DW, 2005, BRIT MED J, V331, P958, DOI 10.1136/bmj.331.7522.958; Light DW, 2006, MONITORING FINANCIAL, P27; Love J, 2011, SENATOR SANDERS INTR; Morgan SG, 2005, BMJ-BRIT MED J, V331, P815, DOI 10.1136/bmj.38582.703866.AE; Morgan Stanley, 2010, PHARM EX RES CREAT R; Motola D, 2006, BRIT J CLIN PHARMACO, V62, P610, DOI 10.1111/j.1365-2125.2006.02700.x; Munos B, 2009, NAT REV DRUG DISCOV, V8, P959, DOI 10.1038/nrd2961; Pfizer, 2012, PERF REP 4 QUART; Pharmaceutical Research and Manufacturers of America, 2011, 2011 PROF PHARM IND; Regnstrom J, 2010, EUR J CLIN PHARMACOL, V66, P39, DOI 10.1007/s00228-009-0756-y; Schmid EF, 2005, DRUG DISCOV TODAY, V10, P1031, DOI 10.1016/S1359-6446(05)03524-5; Steinman MA, 2006, ANN INTERN MED, V145, P284, DOI 10.7326/0003-4819-145-4-200608150-00008; United States Government Accounting Office, 2006, NEW DRUG DEV; US Food and Drug Administration, 2012, DRUG BIOL APPR REP; van Luijn JCF, 2010, EUR J CLIN PHARMACOL, V66, P445, DOI 10.1007/s00228-010-0808-3; Wilson D, 2011, NY TIMES        0330; [No title captured]	41	133	134	0	27	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 7	2012	345								e4348	10.1136/bmj.e4348	http://dx.doi.org/10.1136/bmj.e4348			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988NA	22872694				2022-12-28	WOS:000307496500010
J	Rounbehler, RJ; Fallahi, M; Yang, CY; Steeves, MA; Li, WM; Doherty, JR; Schaub, FX; Sanduja, S; Dixon, DA; Blackshear, PJ; Cleveland, JL				Rounbehler, Robert J.; Fallahi, Mohammad; Yang, Chunying; Steeves, Meredith A.; Li, Weimin; Doherty, Joanne R.; Schaub, Franz X.; Sanduja, Sandhya; Dixon, Dan A.; Blackshear, Perry J.; Cleveland, John L.			Tristetraprolin Impairs Myc-Induced Lymphoma and Abolishes the Malignant State	CELL			English	Article							MESSENGER-RNA STABILITY; ELEMENT-BINDING PROTEIN; AU-RICH ELEMENTS; C-MYC; BURKITT-LYMPHOMA; CANCER-CELLS; TRANSCRIPTION FACTOR; TRANSGENIC MICE; GENE; EXPRESSION	Myc oncoproteins directly regulate transcription by binding to target genes, yet this only explains a fraction of the genes affected by Myc. mRNA turnover is controlled via AU-binding proteins (AUBPs) that recognize AU-rich elements (AREs) found within many transcripts. Analyses of precancerous and malignant Myc-expressing B cells revealed that Myc regulates hundreds of ARE-containing (ARED) genes and select AUBPs. Notably, Myc directly suppresses transcription of Tristetraprolin (TTP/ZFP36), an mRNA-destabilizing AUBP, and this circuit is also operational during B lymphopoiesis and IL7 signaling. Importantly, TTP suppression is a hallmark of cancers with MYC involvement, and restoring TTP impairs Myc-induced lymphomagenesis and abolishes maintenance of the malignant state. Further, there is a selection for TTP loss in malignancy; thus, TTP functions as a tumor suppressor. Finally, Myc/TTP-directed control of select cancer-associated ARED genes is disabled during lymphomagenesis. Thus, Myc targets AUBPs to regulate ARED genes that control tumorigenesis.	[Rounbehler, Robert J.; Fallahi, Mohammad; Yang, Chunying; Steeves, Meredith A.; Li, Weimin; Doherty, Joanne R.; Schaub, Franz X.; Cleveland, John L.] Scripps Florida, Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA; [Sanduja, Sandhya; Dixon, Dan A.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Sanduja, Sandhya; Dixon, Dan A.] Univ S Carolina, Ctr Colon Canc Res, Columbia, SC 29208 USA; [Blackshear, Perry J.] NIEHS, Lab Signal Transduct, Res Triangle Pk, NC 27709 USA	Scripps Research Institute; State University System of Florida; University of Florida; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Cleveland, JL (corresponding author), Scripps Florida, Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA.	jcleve@scripps.edu	Doherty, Joanne/AAU-3288-2020; li, wj/HGD-7322-2022; 黎, 伟/GXM-4040-2022; Blackshear, Perry J./C-6206-2019	Blackshear, Perry J./0000-0002-9561-8529	NIH [DK44158, CA167093, F32-CA115075, CA134609]; ThinkPink Kids Foundation; State of Florida; NIH, NIEHS; National City Postdoctoral Fellowship; Glenn W. Bailey Postdoctoral Fellowship; PGA National Women's Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA134609, R01CA167093, F32CA115075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090080] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ThinkPink Kids Foundation; State of Florida; NIH, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National City Postdoctoral Fellowship; Glenn W. Bailey Postdoctoral Fellowship; PGA National Women's Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Jerry Adams for providing the pE mu SR alpha plasmid; Mihaela Onciu and John Sandlund for providing Burkitt lymphoma samples; J. Alan Diehl for providing MSCV-cyclin D1a retrovirus; Thomas Saunders and the Transgenic Animal Model Core of the University of Michigan's Biomedical Research Core Facilities for generating the E mu-TTP and E mu-Tis11b transgenics; Wi Lai and Deborah Stumpo for technical assistance; Shannon Sunday of the Scripps Florida ARC for assistance; Brandon Young and Brad Long of the Scripps Florida Genomics Core; Bivian Torres and Kim Lowe of the Scripps Florida Flow Cytometry Core; Frank C. Dorsey for helpful discussions; and Marika Kernick for editing. This work was supported by NIH grants (DK44158 and CA167093 to J. L. C., F32-CA115075 to R. J. R. and CA134609 to D. A. D.), by monies from the ThinkPink Kids Foundation, and by monies from the State of Florida to TSRI. P. J. B. is supported by the Intramural Research Program of the NIH, NIEHS. R. J. R. also received support from the National City Postdoctoral Fellowship, the Glenn W. Bailey Postdoctoral Fellowship, and the PGA National Women's Cancer Foundation.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; BODRUG SE, 1994, EMBO J, V13, P2124, DOI 10.1002/j.1460-2075.1994.tb06488.x; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Brennan SE, 2009, CANCER RES, V69, P5168, DOI 10.1158/0008-5472.CAN-08-4238; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Carballo E, 2001, BLOOD, V98, P2389, DOI 10.1182/blood.V98.8.2389; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Chen K, 2008, J BIOL CHEM, V283, P2508, DOI 10.1074/jbc.M707307200; DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P7824, DOI 10.1073/pnas.79.24.7824; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Dang CV, 1999, MOL CELL BIOL, V19, P1; Dean JLE, 2002, BIOCHEM J, V366, P709, DOI 10.1042/BJ20020402; Dixon DA, 2001, J CLIN INVEST, V108, P1657, DOI 10.1172/JCI200112973; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Fawal M, 2006, BLOOD, V108, P2780, DOI 10.1182/blood-2006-04-014902; Franks TM, 2007, GENE DEV, V21, P719, DOI 10.1101/gad.1494707; Gorrini C, 2007, NATURE, V448, P1063, DOI 10.1038/nature06055; Gouble A, 2002, CANCER RES, V62, P1489; Halees AS, 2008, NUCLEIC ACIDS RES, V36, pD137, DOI 10.1093/nar/gkm959; Hemelaar J, 2003, J BIOL CHEM, V278, P51841, DOI 10.1074/jbc.M308762200; Hodson DJ, 2010, NAT IMMUNOL, V11, P717, DOI 10.1038/ni.1901; Hummel M, 2006, NEW ENGL J MED, V354, P2419, DOI 10.1056/NEJMoa055351; Katz M, 2007, NAT CELL BIOL, V9, P961, DOI 10.1038/ncb1622; Keller UB, 2007, EMBO J, V26, P2562, DOI 10.1038/sj.emboj.7601691; LAI WS, 1995, J BIOL CHEM, V270, P25266, DOI 10.1074/jbc.270.42.25266; Lee HH, 2010, J BIOL CHEM, V285, P17329, DOI 10.1074/jbc.M109.094235; Marderosian M, 2006, ONCOGENE, V25, P6277, DOI 10.1038/sj.onc.1209645; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Miyamae T, 2006, J IMMUNOL, V177, P4758, DOI 10.4049/jimmunol.177.7.4758; MORROW MA, 1992, GENE DEV, V6, P61, DOI 10.1101/gad.6.1.61; Nilsson JA, 2005, CANCER CELL, V7, P433, DOI 10.1016/j.ccr.2005.03.036; Painter MW, 2011, J IMMUNOL, V186, P3047, DOI 10.4049/jimmunol.1002695; Pajic A, 2000, INT J CANCER, V87, P787, DOI 10.1002/1097-0215(20000915)87:6<787::AID-IJC4>3.0.CO;2-6; PETERS G, 1994, J CELL SCI, P89; Rosenbloom KR, 2010, NUCLEIC ACIDS RES, V38, pD620, DOI 10.1093/nar/gkp961; Sakai T, 2004, J BIOL CHEM, V279, P41131, DOI 10.1074/jbc.M402902200; Sanduja S, 2009, AGING-US, V1, P803, DOI 10.18632/aging.100086; Sengupta TK, 2004, J BIOL CHEM, V279, P10855, DOI 10.1074/jbc.M309111200; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Stoecklin G, 2003, ONCOGENE, V22, P3554, DOI 10.1038/sj.onc.1206418; Tabrizifard S, 2004, J IMMUNOL, V173, P1094, DOI 10.4049/jimmunol.173.2.1094; TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Tobias ES, 2001, ONCOGENE, V20, P2844, DOI 10.1038/sj.onc.1204433; Wang Q, 2006, CANCER RES, V66, P6050, DOI 10.1158/0008-5472.CAN-05-4618; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69	49	86	87	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 3	2012	150	3					563	574		10.1016/j.cell.2012.06.033	http://dx.doi.org/10.1016/j.cell.2012.06.033			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	985WO	22863009	Green Accepted, Bronze			2022-12-28	WOS:000307301400015
J	Huang, WC; Fu, CY				Huang, Wen Cheng; Fu, Chih-Yuan			Hernia through the Foramen of Winslow	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Huang, Wen Cheng; Fu, Chih-Yuan] Taipei Med Univ, Wan Fang Hosp, Taipei, Taiwan	Taipei Medical University; Taipei Municipal WanFang Hospital	Huang, WC (corresponding author), Taipei Med Univ, Wan Fang Hosp, Taipei, Taiwan.		Huang, Wen-Cheng/AAM-2191-2021						0	3	3	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 2	2012	367	5					E7	E7		10.1056/NEJMicm1112142	http://dx.doi.org/10.1056/NEJMicm1112142			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	981VZ	22853035				2022-12-28	WOS:000307001900011
J	Nelson, LS; Perrone, J				Nelson, Lewis S.; Perrone, Jeanmarie			Curbing the Opioid Epidemic in the United States The Risk Evaluation and Mitigation Strategy (REMS)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PRESCRIPTION; ABUSE		[Nelson, Lewis S.] NYU, Sch Med, Dept Emergency Med, New York, NY 10016 USA; [Perrone, Jeanmarie] Univ Penn, Perelman Sch Med, Dept Emergency Med, Philadelphia, PA 19104 USA	New York University; University of Pennsylvania; Pennsylvania Medicine	Nelson, LS (corresponding author), NYU, Sch Med, Dept Emergency Med, 455 1st Ave,Room 123, New York, NY 10016 USA.	lewis.nelson@nyumc.org		Nelson, Lewis/0000-0001-9551-3922				Cai R., 2010, Morbidity and Mortality Weekly Report, V59, P705; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Gugelmann HM, 2011, JAMA-J AM MED ASSOC, V306, P2258, DOI 10.1001/jama.2011.1712; Paulozzi Leonard, 2012, Morbidity and Mortality Weekly Report, V61, P10; Purdue Pharma, PURD PHARM; Slevin Kieran A, 2011, J Opioid Manag, V7, P109; United States Food and Drug Administration, 2010, JOINT M AN LIF SUPP; US Food and Drug Administration, RISK EV MIT STRAT RE; Wolf MS, 2012, J GEN INTERN MED, V27, P1714, DOI 10.1007/s11606-012-2068-7; Zgierska A, 2012, JAMA-J AM MED ASSOC, V307, P1377, DOI 10.1001/jama.2012.419	10	71	72	1	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2012	308	5					457	458		10.1001/jama.2012.8165	http://dx.doi.org/10.1001/jama.2012.8165			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	981DQ	22851109				2022-12-28	WOS:000306947400020
J	Nakano, M; Shibuya, K; Okuyama, D; Hatano, T; Ono, S; Kawasaki, M; Iwasa, Y; Tokura, Y				Nakano, M.; Shibuya, K.; Okuyama, D.; Hatano, T.; Ono, S.; Kawasaki, M.; Iwasa, Y.; Tokura, Y.			Collective bulk carrier delocalization driven by electrostatic surface charge accumulation	NATURE			English	Article							ELECTRIC-FIELD CONTROL; METAL-INSULATOR-TRANSITION; MOTT TRANSITION; PHASE-TRANSITION; VO2; SUPERCONDUCTIVITY; TEMPERATURE; PEIERLS; HUBBARD; COBALT	In the classic transistor, the number of electric charge carriers-and thus the electrical conductivity-is precisely controlled by external voltage, providing electrical switching capability. This simple but powerful feature is essential for information processing technology, and also provides a platform for fundamental physics research(1-16). As the number of charges essentially determines the electronic phase of a condensed-matter system, transistor operation enables reversible and isothermal changes in the system's state, as successfully demonstrated in electric-field-induced ferromagnetism(2-4) and superconductivity(5-10). However, this effect of the electric field is limited to a channel thickness of nanometres or less, owing to the presence of Thomas-Fermi screening. Here we show that this conventional picture does not apply to a class of materials characterized by inherent collective interactions between electrons and the crystal lattice. We prepared metal-insulator-semiconductor field-effect transistors based on vanadium dioxide-a strongly correlated-material with a thermally driven, first-order metal-insulator transition well above room temperature(17-23)-and found that electrostatic charging at a surface drives all the previously localized charge carriers in the bulk material into motion, leading to the emergence of a three-dimensional metallic ground state. This non-local switching of the electronic state is achieved by applying a voltage of only about one volt. In a voltage-sweep measurement, the first-order nature of the metal-insulator transition provides a non-volatilememory effect, which is operable at room temperature. Our results demonstrate a conceptually new field-effect device, extending the concept of electric-field control to macroscopic phase control.	[Nakano, M.; Shibuya, K.; Okuyama, D.; Hatano, T.; Ono, S.; Kawasaki, M.; Iwasa, Y.; Tokura, Y.] RIKEN Adv Sci Inst, CERG, Wako, Saitama 3510198, Japan; [Nakano, M.; Shibuya, K.; Okuyama, D.; Hatano, T.; Ono, S.; Kawasaki, M.; Iwasa, Y.; Tokura, Y.] RIKEN Adv Sci Inst, Cross Correlated Mat Res Grp CMRG, Wako, Saitama 3510198, Japan; [Ono, S.] Cent Res Inst Elect Power Ind, Komae, Tokyo 2018511, Japan; [Kawasaki, M.; Iwasa, Y.; Tokura, Y.] Univ Tokyo, Quantum Phase Elect Ctr, Tokyo 1138656, Japan; [Kawasaki, M.; Iwasa, Y.; Tokura, Y.] Univ Tokyo, Dept Appl Phys, Tokyo 1138656, Japan	RIKEN; RIKEN; Central Research Institute of Electric Power Industry - Japan; University of Tokyo; University of Tokyo	Nakano, M (corresponding author), RIKEN Adv Sci Inst, CERG, Wako, Saitama 3510198, Japan.	mnakano@riken.jp; iwasa@ap.t.u-tokyo.ac.jp	Hatano, Takafumi/B-3647-2013; Kawasaki, Masashi/B-5826-2008; Ono, Shimpei/D-2918-2017; Shibuya, Keisuke/K-2079-2012; Iwasa, Yoshihiro/C-1719-2009; Nakano, Masaki/K-6112-2012; Okuyama, Daisuke/A-2796-2010; Tokura, Yoshinori/C-7352-2009; Ishida, Mari/AAU-3379-2020	Shibuya, Keisuke/0000-0001-5067-5952; Tokura, Yoshinori/0000-0002-2732-4983; Ono, Shimpei/0000-0003-1514-8879; Nakano, Masaki/0000-0002-7461-860X	Japan Society for the Promotion of Science (JSAP) through 'Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)'; RIKEN through the Incentive Research Grant;  [22760016];  [21224009]; Grants-in-Aid for Scientific Research [23684031] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSAP) through 'Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)'; RIKEN through the Incentive Research Grant; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are grateful to K. Ueno, H. T. Yuan, J. T. Ye, H. Shimotani, Y. Kasahara and T. Takenobu for discussions, and to T. Arima, H. Ohsumi, S. Takeshita, S. Tardif and Y. Kitagawa for support for X-ray diffraction measurements. This work was supported by the Japan Society for the Promotion of Science (JSAP) through its 'Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)'. M.N. was supported by RIKEN through the Incentive Research Grant. K. S. was supported by Grants-in-Aid for young scientists (category B, grant number 22760016). Y. I. was partly supported by Grants-in-Aid for Scientific Research (category S, grant number 21224009). The synchrotron X-ray diffraction experiments were performed at BL19LXU in SPring-8 with approval of RIKEN (proposal number 20110091).	Ahn CH, 2006, REV MOD PHYS, V78, P1185, DOI 10.1103/RevModPhys.78.1185; Ahn CH, 1999, SCIENCE, V284, P1152, DOI 10.1126/science.284.5417.1152; Asanuma S, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3496458; BARKER AS, 1966, PHYS REV LETT, V17, P1286, DOI 10.1103/PhysRevLett.17.1286; BERGLUND CN, 1969, PHYS REV, V185, P1022, DOI 10.1103/PhysRev.185.1022; Bollinger AT, 2011, NATURE, V472, P458, DOI 10.1038/nature09998; Boriskov PP, 2002, TECH PHYS LETT+, V28, P406, DOI 10.1134/1.1482750; Cavalleri A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.067405; Cavalleri A, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.237401; Caviglia AD, 2008, NATURE, V456, P624, DOI 10.1038/nature07576; Chiba D, 2011, NAT MATER, V10, P853, DOI [10.1038/NMAT3130, 10.1038/nmat3130]; GLOVER RE, 1960, PHYS REV LETT, V5, P248, DOI 10.1103/PhysRevLett.5.248; GOODENOUGH JB, 1971, J SOLID STATE CHEM, V3, P490, DOI 10.1016/0022-4596(71)90091-0; Hong X, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.134415; Kawasugi Y, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.116801; Kim HT, 2004, NEW J PHYS, V6, DOI 10.1088/1367-2630/6/1/052; Mathews S, 1997, SCIENCE, V276, P238, DOI 10.1126/science.276.5310.238; MORIN FJ, 1959, PHYS REV LETT, V3, P34, DOI 10.1103/PhysRevLett.3.34; Muraoka Y, 2002, APPL PHYS LETT, V80, P583, DOI 10.1063/1.1446215; Newns DM, 1998, APPL PHYS LETT, V73, P780, DOI 10.1063/1.121999; Ohno H, 2000, NATURE, V408, P944, DOI 10.1038/35050040; Qazilbash MM, 2007, SCIENCE, V318, P1750, DOI 10.1126/science.1150124; RICE TM, 1994, PHYS REV LETT, V73, P3042, DOI 10.1103/PhysRevLett.73.3042; Ruzmetov D, 2010, J APPL PHYS, V107, DOI 10.1063/1.3408899; Scherwitzl R, 2010, ADV MATER, V22, P5517, DOI 10.1002/adma.201003241; Shibuya K, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3291053; Ueno K, 2008, NAT MATER, V7, P855, DOI 10.1038/nmat2298; WENTZCOVITCH RM, 1994, PHYS REV LETT, V72, P3389, DOI 10.1103/PhysRevLett.72.3389; Yamada Y, 2011, SCIENCE, V332, P1065, DOI 10.1126/science.1202152; Ye JT, 2010, NAT MATER, V9, P125, DOI [10.1038/NMAT2587, 10.1038/nmat2587]	30	580	586	19	564	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 26	2012	487	7408					459	462		10.1038/nature11296	http://dx.doi.org/10.1038/nature11296			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979KD	22837001				2022-12-28	WOS:000306815300033
J	Crawley, J; Sismanidis, C; Goodman, T; Milligan, P				Crawley, Jane; Sismanidis, Charalambos; Goodman, Tracey; Milligan, Paul		Who Advisory Comm Serological Resp	Effect of intermittent preventive treatment for malaria during infancy on serological responses to measles and other vaccines used in the Expanded Programme on Immunization: results from five randomised controlled trials	LANCET			English	Article							PLACEBO-CONTROLLED TRIAL; VITAMIN-A SUPPLEMENTATION; ROUTINE VACCINATIONS; SULFADOXINE-PYRIMETHAMINE; NEUTRALIZATION TEST; TANZANIAN INFANTS; SOUTHERN TANZANIA; VIRUS; INFECTION; IPTI	Background Intermittent preventive treatment for malaria during infancy (IPTi) is the administration of a full therapeutic course of antimalarial drugs to infants living in settings where malaria is endemic, at the time of routine vaccination in the first year of life. We investigated whether IPTi with sulfadoxine-pyrimethamine or other antimalarial drug combinations adversely affected serological responses to vaccines used in the Expanded Programme on Immunization (EPI). Methods The study was done in a subset of children enrolled in five randomised controlled trials in Navrongo, Ghana; Kilimanjaro, Tanzania; Manhica, Mozambique; Kisumu, Kenya; and Bungoma, Kenya. All infants presenting for the second dose of the diphtheria-tetanus-pertussis vaccination (given at 8-10 weeks of age) were eligible, and analyses included all children who had received measles vaccination (at 9 months of age) and at least one dose of IPTi or placebo. Blood samples were collected before and after vaccination, and antibody titres were measured by plaque reduction neutralisation (measles, yellow fever), microneutralisation (polio serotypes 1 and 3), and ELISA (all other EPI antigens). Laboratory personnel were unaware of the randomisation groups. We compared the proportion of infants in the IPTi and placebo groups who did not attain protective antibody titres after vaccination, using a one-sided significance non-inferiority margin of 5% for measles (the primary endpoint) and 10% for other EPI antigens. Findings Between September, 2000, and May, 2008, 8416 children were enrolled in the five studies. Paired samples from 2368 children from sites where sulfadoxine-pyrimethamine was compared with placebo were analysed for measles antibodies. 464 children with detectable measles antibody in their sample before vaccination were excluded, leaving 1904 individuals (934 placebo and 970 sulfadoxine-pyrimethamine) in the study. IPTi with sulfadoxine-pyrimethamine did not have a clinically significant effect on immune responses to measles vaccine; 61 of 970 (6.3%) children who received IPTi did not develop a protective antibody response after measles vaccination compared with 60 of 934 (6.4%) who received placebo, a difference of -0.14% (95% CI -2.3 to 2.1). When other antimalarial drugs were used for IPTi the results were much the same. Among 2396 children from whom serological response data for other EPI antigens were available, we identified no evidence of an adverse effect of IPTi with sulfadoxine-pyrimethamine or other antimalarial drugs on the proportion achieving protective antibody concentrations. Interpretation IPTi with sulfadoxine-pyrimethamine does not affect serological responses to EPI vaccines. This analysis, therefore, supports the WHO recommendation for coadministration of IPTi with sulfadoxine-pyrimethamine to infants at the time of the second and third doses of DTP and measles vaccination, in areas of sub-Saharan Africa with moderate to high malaria transmission and where malaria parasites are sensitive to these drugs. It also suggests that treatment of clinical malaria at or around the time of vaccination does not compromise vaccine responsiveness.	[Goodman, Tracey] World Hlth Org, Dept Immunizat Vaccines & Other Biol, CH-1211 Geneva, Switzerland; [Crawley, Jane] Univ Oxford, Nuffield Dept Clin Med, Oxford, England; [Crawley, Jane] World Hlth Org, Global Malaria Programme, CH-1211 Geneva, Switzerland; [Sismanidis, Charalambos] World Hlth Org, STOP TB Dept, CH-1211 Geneva, Switzerland; [Milligan, Paul] Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Infect Dis, London WC1E 7HT, England	World Health Organization; University of Oxford; World Health Organization; World Health Organization; University of London; London School of Hygiene & Tropical Medicine	Goodman, T (corresponding author), World Hlth Org, Dept Immunizat Vaccines & Other Biol, CH-1211 Geneva, Switzerland.	goodmant@who.int	Milligan, Paul/D-8985-2017	Milligan, Paul/0000-0003-3430-3395	Bill & Melinda Gates Foundation; National Institute for Health Research [NF-SI-0611-10066] Funding Source: researchfish	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institute for Health Research(National Institute for Health Research (NIHR))	Bill & Melinda Gates Foundation.	ALBRECHT P, 1981, J VIROL METHODS, V3, P251, DOI 10.1016/0166-0934(81)90062-8; [Anonymous], WHO GLOB MAL PROGR; Aponte JJ, 2009, LANCET, V374, P1533, DOI 10.1016/S0140-6736(09)61258-7; Barnes KI, 2006, CLIN PHARMACOL THER, V80, P582, DOI 10.1016/j.clpt.2006.08.016; Bell DJ, 2011, CLIN PHARMACOL THER, V89, P268, DOI 10.1038/clpt.2010.297; Benn CS, 2009, AM J CLIN NUTR, V90, P629, DOI 10.3945/ajcn.2009.27477; Benn CS, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1101; Carneiro I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008988; Chandramohan D, 2005, BMJ-BRIT MED J, V331, P727, DOI 10.1136/bmj.331.7519.727; CHEN RT, 1990, J INFECT DIS, V162, P1036, DOI 10.1093/infdis/162.5.1036; Cohen BJ, 2008, VACCINE, V26, P6392, DOI 10.1016/j.vaccine.2008.08.074; Cunnington AJ, 2010, EXPERT REV VACCINES, V9, P409, DOI 10.1586/ERV.10.16; Dicko A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-73; FARRINGTON CP, 1990, STAT MED, V9, P1447, DOI 10.1002/sim.4780091208; GALLAGHER MR, 1981, AM J DIS CHILD, V135, P48, DOI 10.1001/archpedi.1981.02130250036012; Gosling RD, 2009, LANCET, V374, P1521, DOI 10.1016/S0140-6736(09)60997-1; Hutton G, 2009, B WORLD HEALTH ORGAN, V87, P123, DOI 10.2471/BLT.08.051961; Klein SL, 2010, LANCET INFECT DIS, V10, P338, DOI 10.1016/S1473-3099(10)70049-9; Macete E, 2006, J INFECT DIS, V194, P276, DOI 10.1086/505431; MASON RA, 1973, APPL MICROBIOL, V25, P539, DOI 10.1128/AEM.25.4.539-544.1973; Moss WJ, 2003, B WORLD HEALTH ORGAN, V81, P61; Odhiambo FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010016; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Pool R, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-213; Prymula R, 2009, LANCET, V374, P1339, DOI 10.1016/S0140-6736(09)61208-3; REICH A, 1992, IMMUNOLOGY, V76, P185; Roper C, 2004, SCIENCE, V305, P1124, DOI 10.1126/science.1098876; Rosen JB, 2004, LANCET, V363, P1386, DOI 10.1016/S0140-6736(04)16052-2; Savy M, 2009, J NUTR, V139, p2154S, DOI 10.3945/jn.109.105312; Schellenberg D, 2005, LANCET, V365, P1481, DOI 10.1016/S0140-6736(05)66418-5; Schellenberg D, 2001, LANCET, V357, P1471, DOI 10.1016/S0140-6736(00)04643-2; Schellenberg JRMA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-387; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2006, GUID TREATM MAL; *WHO, 2009, WKLY EPIDEMIOL REC, V84, P349; WHO, 2009, WKLY EPIDEMIOL REC, V84, P529; WHO, 2009, SAGE M OCT 27 29; WHO, MAL WHO POL REC INT; Wilson AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016976; World Health Organization, **NON-TRADITIONAL**; World Health Organization, IMM SURV ASS MON DAT	42	10	10	0	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 15	2012	380	9846					1001	1010		10.1016/S0140-6736(12)60775-2	http://dx.doi.org/10.1016/S0140-6736(12)60775-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	005JF	22850358				2022-12-28	WOS:000308746000030
J	Chen, ZH; Schaap, P				Chen, Zhi-hui; Schaap, Pauline			The prokaryote messenger c-di-GMP triggers stalk cell differentiation in Dictyostelium	NATURE			English	Article							GENE-EXPRESSION; PHYLOGENY; PHOSPHODIESTERASE; EVOLUTION; PATTERN	Cyclic di-(3':5')-guanosine monophosphate (c-di-GMP) is a major prokaryote signalling intermediate that is synthesized by diguanylate cyclases and triggers sessility and biofilm formation(1,2). We detected the first eukaryote diguanylate cyclases in all major groups of Dictyostelia. On food depletion, Dictyostelium discoideum amoebas collect into aggregates, which first transform into migrating slugs and then into sessile fruiting structures(3). These structures consist of a spherical spore mass that is supported by a column of stalk cells and a basal disk. Apolyketide, DIF-1, which induces stalklike cells in vitro, was isolated earlier(4). However, its role in vivo proved recently to be restricted to basal disk formation(5). Here we show that the Dictyostelium diguanylate cyclase, DgcA, produces c-di-GMP as the morphogen responsible for stalk cell differentiation. Dictyostelium discoideum DgcA synthesized c-di-GMP in a GTP-dependent manner and was expressed at the slug tip, which is the site of stalk cell differentiation. Disruption of the DgcA gene blocked the transition from slug migration to fructification and the expression of stalk genes. Fructification and stalk formation were restored by exposing DgcA-null slugs to wild-type secretion products or to c-di-GMP. Moreover, c-di-GMP, but not cyclic di-(3':5')-adenosine monophosphate, induced stalk gene expression in dilute cell monolayers. Apart from identifying the long-elusive stalk-inducing morphogen, our work also identifies a role for c-di-GMP in eukaryotes.	[Chen, Zhi-hui; Schaap, Pauline] Univ Dundee, Coll Life Sci, Dundee DD1 5EH, Scotland	University of Dundee	Schaap, P (corresponding author), Univ Dundee, Coll Life Sci, Dundee DD1 5EH, Scotland.	p.schaap@dundee.ac.uk	Schaap, Pauline/M-5355-2019	Schaap, Pauline/0000-0003-4500-2555	Wellcome Trust [090276]; BBSRC [BB/G020426]; Biotechnology and Biological Sciences Research Council [BB/G020426/1, BB/E016308/1] Funding Source: researchfish; BBSRC [BB/G020426/1, BB/E016308/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank R. R. Kay for alerting us to the presence of a putative diguanylate cyclase in the D. discoideum genome. U. Jenal is gratefully acknowledged for advice and an EAL-PDE construct in an early phase of the project. We are grateful to the late H. MacWilliams for plasmids PspA-ile-gal, EcmA-ile-gal and PstO-ile-gal, and to C.Thompson for dmta<SUP>-</SUP> cells. We thank W. Chen and D. Lamont for mass spectrometry and C. Sugden for guidance with qRT-PCR. We are grateful to H. Urushihara and the A. subglobosum genome project (http://acytodb.biol.tsukuba.ac.jp/cgi-bin/index.cgi?org=as) for the A. subglobosum DgcA sequence. This research was supported by Wellcome Trust Project grant 090276 and BBSRC grant BB/G020426.	Blanton RL, 2000, P NATL ACAD SCI USA, V97, P2391, DOI 10.1073/pnas.040565697; BROOKMAN JJ, 1982, DEV BIOL, V91, P191, DOI 10.1016/0012-1606(82)90022-7; CECCARELLI A, 1991, CELL, V65, P983, DOI 10.1016/0092-8674(91)90550-I; Ceccarelli A, 2000, DIFFERENTIATION, V66, P189, DOI 10.1046/j.1432-0436.2000.660405.x; Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101; DINGERMANN T, 1989, GENE, V85, P353, DOI 10.1016/0378-1119(89)90428-9; EARLY AE, 1988, MOL CELL BIOL, V8, P3458, DOI 10.1128/MCB.8.8.3458; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; HARWOOD AJ, 1990, NUCLEIC ACIDS RES, V18, P4292, DOI 10.1093/nar/18.14.4292; Heidel AJ, 2011, GENOME RES, V21, P1882, DOI 10.1101/gr.121137.111; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; Meima ME, 2002, MOL BIOL CELL, V13, P3870, DOI 10.1091/mbc.E02-05-0285; MORRIS HR, 1987, NATURE, V328, P811, DOI 10.1038/328811a0; Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504; RAPER KENNETH B., 1952, BULL TORREY BOT CLUB, V79, P25, DOI 10.2307/2482103; RICHARDSON DL, 1992, GENE DEV, V6, P1058, DOI 10.1101/gad.6.6.1058; ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0; Saito T, 2008, DEV BIOL, V317, P444, DOI 10.1016/j.ydbio.2008.02.036; SCHAAP P, 1993, J BIOL CHEM, V268, P6323; Schaap P, 2007, BIOESSAYS, V29, P635, DOI 10.1002/bies.20599; Schaap P, 2006, SCIENCE, V314, P661, DOI 10.1126/science.1130670; Shadwick LL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006754; Thompson CRL, 2000, MOL CELL, V6, P1509, DOI 10.1016/S1097-2765(00)00147-7; WANG M, 1988, DEVELOPMENT, V103, P611; Williams JG, 2006, EMBO REP, V7, P694, DOI 10.1038/sj.embor.7400714; WILLIAMS JG, 1987, CELL, V49, P185, DOI 10.1016/0092-8674(87)90559-9	27	76	80	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2012	488	7413					680	683		10.1038/nature11313	http://dx.doi.org/10.1038/nature11313			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996NC	22864416	Green Accepted			2022-12-28	WOS:000308095100061
J	Brooks, DWC; Botter, T; Schreppler, S; Purdy, TP; Brahms, N; Stamper-Kurn, DM				Brooks, Daniel W. C.; Botter, Thierry; Schreppler, Sydney; Purdy, Thomas P.; Brahms, Nathan; Stamper-Kurn, Dan M.			Non-classical light generated by quantum-noise-driven cavity optomechanics	NATURE			English	Article							INDUCED TRANSPARENCY; RADIATION-PRESSURE; GROUND-STATE; REDUCTION	Optomechanical systems(1), in which light drives and is affected by the motion of a massive object, will comprise a new framework for nonlinear quantum optics, with applications ranging from the storage(2-4) and transduction(5,6) of quantum information to enhanced detection sensitivity in gravitational wave detectors(7,8). However, quantum optical effects in optomechanical systems have remained obscure, because their detection requires the object's motion to be dominated by vacuum fluctuations in the optical radiation pressure; so far, direct observations have been stymied by technical and thermal noise. Here we report an implementation of cavity optomechanics(9,10) using ultracold atoms in which the collective atomic motion is dominantly driven by quantum fluctuations in radiation pressure. The back-action of this motion onto the cavity light field produces ponderomotive squeezing(11,12). We detect this quantum phenomenon by measuring sub-shot-noise optical squeezing. Furthermore, the system acts as a low-power, high-gain, nonlinear parametric amplifier for optical fluctuations, demonstrating a gain of 20 dB with a pump corresponding to an average of only seven intracavity photons. These findings may pave the way for low-power quantum optical devices, surpassing quantum limits on position and force sensing(13,14), and the control and measurement of motion in quantum gases.	[Brooks, Daniel W. C.; Botter, Thierry; Schreppler, Sydney; Purdy, Thomas P.; Brahms, Nathan; Stamper-Kurn, Dan M.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Stamper-Kurn, Dan M.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Brooks, DWC (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	dwb@berkeley.edu	Stamper-Kurn, Dan/B-5442-2015	Stamper-Kurn, Dan/0000-0002-4845-5835	AFSOR; NSF; FQRNT	AFSOR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NSF(National Science Foundation (NSF)); FQRNT(FQRNT)	We acknowledge C. McLeod for assistance with the manuscript. This work was supported by the AFSOR and NSF. T.B. acknowledges support from the FQRNT.	Abbott BP, 2009, NATURE, V460, P990, DOI 10.1038/nature08278; Botter T, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.013812; BRAGINSKY VB, 1967, SOV PHYS JETP-USSR, V25, P653; Brahms N, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.133601; Brennecke F, 2008, SCIENCE, V322, P235, DOI 10.1126/science.1163218; CAVES CM, 1981, PHYS REV D, V23, P1693, DOI 10.1103/PhysRevD.23.1693; CAVES CM, 1980, PHYS REV LETT, V45, P75, DOI 10.1103/PhysRevLett.45.75; Chan J, 2011, NATURE, V478, P89, DOI 10.1038/nature10461; Clerk AA, 2010, REV MOD PHYS, V82, P1155, DOI 10.1103/RevModPhys.82.1155; Corbitt T, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.023801; FABRE C, 1994, PHYS REV A, V49, P1337, DOI 10.1103/PhysRevA.49.1337; Gupta S, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.213601; Kimble HJ, 2002, PHYS REV D, V65, DOI 10.1103/PhysRevD.65.022002; Kippenberg TJ, 2008, SCIENCE, V321, P1172, DOI 10.1126/science.1156032; MANCINI S, 1994, PHYS REV A, V49, P4055, DOI 10.1103/PhysRevA.49.4055; Marino F, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.073601; Murch KW, 2008, NAT PHYS, V4, P561, DOI 10.1038/nphys965; Nunnenkamp A, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.063602; Purdy TP, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.133602; Rabl P, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.063601; Regal CA, 2011, J PHYS CONF SER, V264, DOI 10.1088/1742-6596/264/1/012025; Safavi-Naeini AH, 2011, NATURE, V472, P69, DOI 10.1038/nature09933; Safavi-Naeini AH, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/1/013017; Teufel JD, 2011, NATURE, V475, P359, DOI 10.1038/nature10261; Teufel JD, 2011, NATURE, V471, P204, DOI 10.1038/nature09898; Verlot P, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.133602; Weis S, 2010, SCIENCE, V330, P1520, DOI 10.1126/science.1195596	27	260	261	4	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 23	2012	488	7412					476	480		10.1038/nature11325	http://dx.doi.org/10.1038/nature11325			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992FS	22895194				2022-12-28	WOS:000307761600029
J	Wedzicha, JA; Vestbo, J				Wedzicha, Jadwiga A.; Vestbo, Jorgen			Can patients with COPD self-manage?	LANCET			English	Editorial Material							OBSTRUCTIVE PULMONARY-DISEASE; EXACERBATIONS; IMPACT; CARE		[Wedzicha, Jadwiga A.] UCL, Ctr Resp Med, London NW3 2PF, England; [Vestbo, Jorgen] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Vestbo, Jorgen] Univ So Denmark, Odense, Denmark	University of London; University College London; University of Manchester; University of Southern Denmark	Wedzicha, JA (corresponding author), UCL, Ctr Resp Med, Royal Free Campus, London NW3 2PF, England.	w.wedzicha@ucl.ac.uk	Vestbo, Jorgen/Y-2912-2019	Vestbo, Jorgen/0000-0001-6355-6362				Aaron SD, 2012, THORAX, V67, P238, DOI 10.1136/thoraxjnl-2011-200768; Bischoff EWMA, 2011, THORAX, V66, P26, DOI 10.1136/thx.2009.127621; Bourbeau J, 2003, ARCH INTERN MED, V163, P585, DOI 10.1001/archinte.163.5.585; Bucknall CE, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1060; Fan VS, 2012, ANN INTERN MED, V156, P673, DOI 10.7326/0003-4819-156-10-201205150-00003; Jeppesen E, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003573.pub2; Patel ARC, 2012, CHEST, V141, P851, DOI 10.1378/chest.11-0853; Price LC, 2006, THORAX, V61, P837, DOI 10.1136/thx.2005.049940; Rice KL, 2010, AM J RESP CRIT CARE, V182, P890, DOI 10.1164/rccm.200910-1579OC; Wedzicha JA, 2007, LANCET, V370, P786, DOI 10.1016/S0140-6736(07)61382-8; Wilkinson TMA, 2004, AM J RESP CRIT CARE, V169, P1298, DOI 10.1164/rccm.200310-1443OC	11	13	13	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 18	2012	380	9842					624	625		10.1016/S0140-6736(12)61339-7	http://dx.doi.org/10.1016/S0140-6736(12)61339-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	991SE	22901870				2022-12-28	WOS:000307721000005
J	Codelia, VA; Irvine, KD				Codelia, Veronica A.; Irvine, Kenneth D.			Hippo Signaling Goes Long Range	CELL			English	Editorial Material							F-ACTIN; PATHWAY; PROTEIN; GROWTH; CANCER	The Hippo-YAP pathway regulates organ size by modulating cell proliferation and apoptosis. Yu et al. now reveal that G-protein-coupled receptors act upstream of the transcriptional coactivators YAP/TAZ. This study reinforces the connection between the actin cytoskeleton and Hippo pathway activity and identifies a class of secreted extracellular regulators of YAP/TAZ activity.	[Irvine, Kenneth D.] Rutgers State Univ, Howard Hughes Med Inst, Waksman Inst, Piscataway, NJ 08854 USA; Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA	Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Irvine, KD (corresponding author), Rutgers State Univ, Howard Hughes Med Inst, Waksman Inst, Piscataway, NJ 08854 USA.	irvine@waksman.rutgers.edu						Densham RM, 2009, MOL CELL BIOL, V29, P6380, DOI 10.1128/MCB.00116-09; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Fernandez BG, 2011, DEVELOPMENT, V138, P2337, DOI 10.1242/dev.063545; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Sansores-Garcia L, 2011, EMBO J, V30, P2325, DOI 10.1038/emboj.2011.157; Staley BK, 2012, DEV DYNAM, V241, P3, DOI 10.1002/dvdy.22723; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111	10	21	22	2	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 17	2012	150	4					669	670		10.1016/j.cell.2012.07.020	http://dx.doi.org/10.1016/j.cell.2012.07.020			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	995IT	22901800	Bronze			2022-12-28	WOS:000308002300002
J	Hulsmann, BB; Labokha, AA; Gorlich, D				Huelsmann, Bastian B.; Labokha, Aksana A.; Goerlich, Dirk			The Permeability of Reconstituted Nuclear Pores Provides Direct Evidence for the Selective Phase Model	CELL			English	Article							REPEAT REGIONS; IMPORTIN-BETA; NUCLEOPORIN NUP98; STRUCTURAL BASIS; DNA-REPLICATION; SINGLE-MOLECULE; XENOPUS EGGS; COMPLEX; TRANSPORT; PROTEIN	Nuclear pore complexes (NPCs) maintain a permeability barrier between the nucleus and the cytoplasm through FG-repeat-containing nucleoporins (Nups). We previously proposed a "selective phase model" in which the FG repeats interact with one another to form a sieve-like barrier that can be locally disrupted by the binding of nuclear transport receptors (NTRs), but not by inert macromolecules, allowing selective passage of NTRs and associated cargo. Here, we provide direct evidence for this model in a physiological context. By using NPCs reconstituted from Xenopus laevis egg extracts, we show that Nup98 is essential for maintaining the permeability barrier. Specifically, the multivalent cohesion between FG repeats is required, including cohesive FG repeats close to the anchorage point to the NPC scaffold. Our data exclude alternative models that are based solely on an interaction between the FG repeats and NTRs and indicate that the barrier is formed by a sieve-like FG hydrogel.	[Huelsmann, Bastian B.; Labokha, Aksana A.; Goerlich, Dirk] Max Planck Inst Biophys Chem, Abt Zellulare Logist, D-37077 Gottingen, Germany	Max Planck Society	Gorlich, D (corresponding author), Max Planck Inst Biophys Chem, Abt Zellulare Logist, Fassberg 11, D-37077 Gottingen, Germany.	goerlich@mpibpc.mpg.de	Görlich, Dirk/B-8296-2017	Görlich, Dirk/0000-0002-4343-5210				Ader C, 2010, P NATL ACAD SCI USA, V107, P6281, DOI 10.1073/pnas.0910163107; Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; Bayliss R, 1999, J MOL BIOL, V293, P579, DOI 10.1006/jmbi.1999.3166; Belgareh N, 2001, J CELL BIOL, V154, P1147, DOI 10.1083/jcb.200101081; BLOW JJ, 1986, CELL, V47, P577, DOI 10.1016/0092-8674(86)90622-7; Brohawn SG, 2009, STRUCTURE, V17, P1156, DOI 10.1016/j.str.2009.07.014; Clarkson WD, 1996, J MOL BIOL, V263, P517, DOI 10.1006/jmbi.1996.0594; CORDES VC, 1995, EUR J CELL BIOL, V68, P240; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; FINLAY DR, 1991, J CELL BIOL, V114, P169, DOI 10.1083/jcb.114.1.169; FINLAY DR, 1990, CELL, V60, P17, DOI 10.1016/0092-8674(90)90712-N; FORBES DJ, 1983, CELL, V34, P13, DOI 10.1016/0092-8674(83)90132-0; Fornerod M, 1997, EMBO J, V16, P807, DOI 10.1093/emboj/16.4.807; Frey S, 2007, CELL, V130, P512, DOI 10.1016/j.cell.2007.06.024; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Gorlich D, 2003, EMBO J, V22, P1088, DOI 10.1093/emboj/cdg113; Gorlich D, 1996, EMBO J, V15, P1810, DOI 10.1002/j.1460-2075.1996.tb00530.x; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Griffis ER, 2003, MOL BIOL CELL, V14, P600, DOI 10.1091/mbc.E02-09-0582; GROTE M, 1995, J CELL SCI, V108, P2963; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Hetzer M, 2000, MOL CELL, V5, P1013, DOI 10.1016/S1097-2765(00)80266-X; Hetzer MW, 2009, DEV CELL, V17, P606, DOI 10.1016/j.devcel.2009.10.007; Hodel AE, 2002, MOL CELL, V10, P347, DOI 10.1016/S1097-2765(02)00589-0; Hu TH, 1996, J CELL BIOL, V134, P589, DOI 10.1083/jcb.134.3.589; HURT EC, 1988, EMBO J, V7, P4323, DOI 10.1002/j.1460-2075.1988.tb03331.x; Iovine MK, 1995, J CELL BIOL, V131, P1699, DOI 10.1083/jcb.131.6.1699; Isgro TA, 2005, STRUCTURE, V13, P1869, DOI 10.1016/j.str.2005.09.007; Krull S, 2004, MOL BIOL CELL, V15, P4261, DOI 10.1091/mbc.E04-03-0165; Kubitscheck U, 2005, J CELL BIOL, V168, P233, DOI 10.1083/jcb.200411005; Kustanovich T, 2004, BIOPHYS J, V86, P2008, DOI 10.1016/S0006-3495(04)74262-9; Laurell E, 2011, CELL, V144, P539, DOI 10.1016/j.cell.2011.01.012; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Lim RYH, 2007, SCIENCE, V318, P640, DOI 10.1126/science.1145980; LOHKA MJ, 1983, SCIENCE, V220, P719, DOI 10.1126/science.6601299; Lowe AR, 2010, NATURE, V467, P600, DOI 10.1038/nature09285; Lu ZH, 1997, J CELL SCI, V110, P2745; Lubas WA, 2000, J BIOL CHEM, V275, P10983, DOI 10.1074/jbc.275.15.10983; MACAULAY C, 1995, J BIOL CHEM, V270, P254, DOI 10.1074/jbc.270.1.254; Milles S, 2011, BIOPHYS J, V101, P1710, DOI 10.1016/j.bpj.2011.08.025; Mohr D, 2009, EMBO J, V28, P2541, DOI 10.1038/emboj.2009.200; Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308; Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044; Peters R, 2005, TRAFFIC, V6, P421, DOI 10.1111/j.1600-0854.2005.00287.x; POWERS MA, 1995, J CELL BIOL, V128, P721, DOI 10.1083/jcb.128.5.721; RADU A, 1995, CELL, V81, P215, DOI 10.1016/0092-8674(95)90331-3; Rao FV, 2006, EMBO J, V25, P1569, DOI 10.1038/sj.emboj.7601026; REXACH M, 1995, CELL, V83, P683, DOI 10.1016/0092-8674(95)90181-7; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Rout MP, 2003, TRENDS CELL BIOL, V13, P622, DOI 10.1016/j.tcb.2003.10.007; Schrader N, 2008, MOL CELL, V29, P46, DOI 10.1016/j.molcel.2007.10.022; Stavru F, 2006, J CELL BIOL, V173, P509, DOI 10.1083/jcb.200601001; Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097; Terry LJ, 2009, EUKARYOT CELL, V8, P1814, DOI 10.1128/EC.00225-09; Tu LC, 2011, BBA-MOL CELL RES, V1813, P1607, DOI 10.1016/j.bbamcr.2010.12.011; Vasu S, 2001, J CELL BIOL, V155, P339, DOI 10.1083/jcb.200108007; Walde S, 2010, TRENDS CELL BIOL, V20, P461, DOI 10.1016/j.tcb.2010.05.001; WATSON ML, 1954, BIOCHIM BIOPHYS ACTA, V15, P475, DOI 10.1016/0006-3002(54)90004-9; Weis K, 2007, CELL, V130, P405, DOI 10.1016/j.cell.2007.07.029; WENTE SR, 1992, J CELL BIOL, V119, P705, DOI 10.1083/jcb.119.4.705; Yamada J, 2010, MOL CELL PROTEOMICS, V9, P2205, DOI 10.1074/mcp.M000035-MCP201; Yang WD, 2004, P NATL ACAD SCI USA, V101, P12887, DOI 10.1073/pnas.0403675101; Zhou HX, 2001, J PHYS CHEM B, V105, P6763, DOI 10.1021/jp011355n	64	191	192	1	74	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 17	2012	150	4					738	751		10.1016/j.cell.2012.07.019	http://dx.doi.org/10.1016/j.cell.2012.07.019			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	995IT	22901806	Bronze			2022-12-28	WOS:000308002300009
J	Neves, FS; Lin, K				Neves, Fabricio Souza; Lin, Katia			Bilateral Foot Drop in Polyarteritis Nodosa	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Neves, Fabricio Souza] Hosp Governador Celso Ramos, Florianopolis, SC, Brazil; [Lin, Katia] Univ Hosp, Florianoplis, SC, Brazil		Neves, FS (corresponding author), Hosp Governador Celso Ramos, Florianopolis, SC, Brazil.		Lin, Katia/G-4891-2012	Lin, Katia/0000-0002-5401-7524					0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 16	2012	367	7					E9	E9		10.1056/NEJMicm1101876	http://dx.doi.org/10.1056/NEJMicm1101876			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988NB	22894599				2022-12-28	WOS:000307496600010
J	O'Neill, D				O'Neill, Desmond			To Live (and Die) as an Original	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Trinity Coll Dublin, Ctr Ageing Neurosci & Humanities, Dublin, Ireland	Trinity College Dublin	O'Neill, D (corresponding author), Trinity Coll Dublin, Ctr Ageing Neurosci & Humanities, Dublin, Ireland.	doneill@tcd.ie	O'Neill, Desmond/D-1486-2013	O'Neill, Desmond/0000-0002-5542-9897				Baltes PB, 1990, SUCCESSFUL AGING PER; Ellis G, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6553; Katsushika H, 1988, HOKUSAI 100 VIEWS MT; O'Neill D, 2009, BMJ-BRIT MED J, V339, pb4215; O'Neill D, 2011, LANCET, V377, P1828, DOI 10.1016/S0140-6736(11)60612-0	5	3	3	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2012	308	7					679	680		10.1001/jama.2012.9200	http://dx.doi.org/10.1001/jama.2012.9200			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988NC	22893164				2022-12-28	WOS:000307496700022
J	Dresser, R				Dresser, Rebecca			Aligning Regulations and Ethics in Human Research	SCIENCE			English	Editorial Material							RESEARCH PARTICIPANTS; CONSENT; TRIALS		[Dresser, Rebecca] Washington Univ, Sch Law, St Louis, MO 63130 USA; [Dresser, Rebecca] Washington Univ, Sch Med, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL)	Dresser, R (corresponding author), Washington Univ, Sch Law, St Louis, MO 63130 USA.	dresser@wulaw.wustl.edu			NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR000448] Funding Source: Medline; NCRR NIH HHS [UL1 RR024992] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		[Anonymous], 1979, ETH PRINC GUID PROT; [Anonymous], 2011, MOR SCI PROT PART HU, P56; Appelbaum P., 2008, OXFORD TXB CLIN RES; Brody B A, 2001, IRB, V23, P1, DOI 10.2307/3564045; Department of Health and Human Services, 2011, FED REG, V76, P44512; Dresser R., 2012, MALIGNANT MED ETHICI; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; Federman D., 2002, RESPONSIBLE RES SYST; Flory J, 2004, JAMA-J AM MED ASSOC, V292, P1593, DOI 10.1001/jama.292.13.1593; Flory J., 2008, OXFORD TXB CLIN RES; London AJ, 2012, SCIENCE, V336, P544, DOI 10.1126/science.1216086; London AJ, 2010, SCIENCE, V328, P829, DOI 10.1126/science.1189369; Moseley JB, 2002, NEW ENGL J MED, V347, P81, DOI 10.1056/NEJMoa013259; National Bioethics Advisory Commission, 2001, ETH POL ISS RES INV, P123; Pike ER, 2012, AM J LAW MED, V38, P7, DOI 10.1177/009885881203800101; Stunkel Leanne, 2010, IRB, V32, P1; Wendler D, 2004, ARCH INTERN MED, V164, P2201, DOI 10.1001/archinte.164.20.2201	17	9	9	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2012	337	6094					527	528		10.1126/science.1218323	http://dx.doi.org/10.1126/science.1218323			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	982PU	22859472	Green Accepted			2022-12-28	WOS:000307058700024
J	Pendry, JB; Aubry, A; Smith, DR; Maier, SA				Pendry, J. B.; Aubry, A.; Smith, D. R.; Maier, S. A.			Transformation Optics and Subwavelength Control of Light	SCIENCE			English	Review							ENHANCED RAMAN-SCATTERING; CYLINDER PAIRS; NANOPARTICLES; RESONANCES; PLASMONICS; REFRACTION; DIMERS	Our intuitive understanding of light has its foundation in the ray approximation and is intimately connected with our vision. As far as our eyes are concerned, light behaves like a stream of particles. We look inside the wavelength and study the properties of plasmonic structures with dimensions of just a few nanometers, where at a tenth or even a hundredth of the wavelength of visible light the ray picture fails. We review the concept of transformation optics that manipulates electric and magnetic field lines, rather than rays; can provide an equally intuitive understanding of subwavelength phenomena; and at the same time can be an exact description at the level of Maxwell's equations.	[Pendry, J. B.; Maier, S. A.] Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Dept Phys, London SW7 2AZ, England; [Aubry, A.] ParisTech, Inst Langevin, Ecole Super Phys & Chim Ind Ville Paris, CNRS,UMR 7587, F-75005 Paris, France; [Smith, D. R.] Duke Univ, Ctr Metamat & Integrated Plasmon, Durham, NC 27708 USA; [Smith, D. R.] Duke Univ, Dept Elect & Comp Engn, Durham, NC 27708 USA	Imperial College London; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Sorbonne Universite; Universite Paris Cite; Duke University; Duke University	Pendry, JB (corresponding author), Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Dept Phys, Prince Consort Rd, London SW7 2AZ, England.	j.pendry@imperial.ac.uk	Smith, David R/E-4710-2012; Maier, Stefan/V-2883-2019	Maier, Stefan/0000-0001-9704-7902; Aubry, Alexandre/0000-0003-3326-3336; Pendry, John/0000-0001-5145-5441	U.S. Army Research Office [W911NF-09-1-0539]; European Community project PHOME [213390]; Leverhulme Trust; Engineering and Physical Sciences Research Council; Engineering and Physical Sciences Research Council [EP/H000917/1, EP/D063329/1, EP/H000917/2] Funding Source: researchfish; EPSRC [EP/D063329/1, EP/H000917/1, EP/H000917/2] Funding Source: UKRI	U.S. Army Research Office; European Community project PHOME; Leverhulme Trust(Leverhulme Trust); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	D.R.S. and J.B.P. were partially supported by the U.S. Army Research Office (grant no. W911NF-09-1-0539); A. A. by the European Community project PHOME (Contract No. 213390); J.B.P. and S. A. M. by the Leverhulme Trust; and S. A. M. by the Engineering and Physical Sciences Research Council.	Aizpurua J, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.035404; Aubry A, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.233901; Aubry A, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.205109; Aubry A, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.125430; Aubry A, 2010, NANO LETT, V10, P2574, DOI 10.1021/nl101235d; Chen HY, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/11/113001; Fernandez-Dominguez AI, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.106802; Fernandez-Dominguez AI, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.266807; FLEISCHMANN M, 1974, CHEM PHYS LETT, V26, P163, DOI 10.1016/0009-2614(74)85388-1; de Abajo FJG, 2008, J PHYS CHEM C, V112, P17983, DOI 10.1021/jp807345h; GarciaVidal FJ, 1996, PHYS REV LETT, V77, P1163, DOI 10.1103/PhysRevLett.77.1163; Ginis V, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.113102; Hill RT, 2010, NANO LETT, V10, P4150, DOI 10.1021/nl102443p; Huidobro PA, 2010, NANO LETT, V10, P1985, DOI 10.1021/nl100800c; Kottmann JP, 2001, OPT EXPRESS, V8, P655, DOI 10.1364/OE.8.000655; Kundtz NB, 2011, P IEEE, V99, P1622, DOI 10.1109/JPROC.2010.2089664; Lei DY, 2011, ACS NANO, V5, P597, DOI 10.1021/nn102819p; Lei DY, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/9/093030; Leonhardt U., 2009, PROG OPTICS, V53, P70; Leonhardt U, 2006, SCIENCE, V312, P1777, DOI 10.1126/science.1126493; Liu YM, 2010, NANO LETT, V10, P1991, DOI 10.1021/nl1008019; Luo Y, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.023901; Luo Y, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.155422; MCPHEDRAN RC, 1980, APPL PHYS, V23, P223, DOI 10.1007/BF00914904; MCPHEDRAN RC, 1981, APPL PHYS, V24, P311, DOI 10.1007/BF00899728; MCPHEDRAN RC, 1987, P ROY SOC LOND A MAT, V411, P313, DOI 10.1098/rspa.1987.0069; Pendry JB, 2006, SCIENCE, V312, P1780, DOI 10.1126/science.1125907; Pendry JB, 2003, OPT EXPRESS, V11, P755, DOI 10.1364/OE.11.000755; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; Prodan E, 2003, SCIENCE, V302, P419, DOI 10.1126/science.1089171; Romero I, 2006, OPT EXPRESS, V14, P9988, DOI 10.1364/OE.14.009988; Schuller JA, 2010, NAT MATER, V9, P193, DOI [10.1038/NMAT2630, 10.1038/nmat2630]; Schurig D, 2006, OPT EXPRESS, V14, P9794, DOI 10.1364/OE.14.009794; Stockman MI, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.137404; Su KH, 2003, NANO LETT, V3, P1087, DOI 10.1021/nl034197f; Sweatlock LA, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.235408; Talley CE, 2005, NANO LETT, V5, P1569, DOI 10.1021/nl050928v; Ward AJ, 1996, J MOD OPTIC, V43, P773, DOI 10.1080/09500349608232782	38	279	283	10	360	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 3	2012	337	6094					549	552		10.1126/science.1220600	http://dx.doi.org/10.1126/science.1220600			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982PU	22859483				2022-12-28	WOS:000307058700035
J	Bennell, KL; Hunter, DJ; Hinman, RS				Bennell, Kim L.; Hunter, David J.; Hinman, Rana S.			Management of osteoarthritis of the knee	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PAIN; RECOMMENDATIONS; ADULTS; METAANALYSIS; GUIDELINES; EXERCISE; EFFICACY; OBESE; HIP		[Bennell, Kim L.; Hinman, Rana S.] Univ Melbourne, Ctr Hlth Exercise & Sports Med, Dept Physiotherapy, Fac Med Dent & Hlth Sci, Melbourne, Vic 3010, Australia; [Hunter, David J.] Univ Sydney, No Clin Sch, Royal N Shore Hosp, Sydney Med Sch, Sydney, NSW 2006, Australia	University of Melbourne; Royal North Shore Hospital; University of Sydney	Bennell, KL (corresponding author), Univ Melbourne, Ctr Hlth Exercise & Sports Med, Dept Physiotherapy, Fac Med Dent & Hlth Sci, Melbourne, Vic 3010, Australia.	k.bennell@unimelb.edu.au	Hunter, David J/A-4622-2010; Bennell, Kim/C-7022-2014	Hunter, David J/0000-0003-3197-752X; Hinman, Rana/0000-0001-6368-9456; Bennell, Kim/0000-0003-4982-5639	DonJoy for an osteoarthritis brace; ASICS for an osteoarthritis shoe	DonJoy for an osteoarthritis brace; ASICS for an osteoarthritis shoe	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work; DJH receives royalties from DonJoy for an osteoarthritis brace; KLB and RSH will receive royalties from ASICS for an osteoarthritis shoe; no other relationships or activities that could appear to have influenced the submitted work.	American Academy of Orthopaedic Surgeons, 2008, GUID TREATM OST KNEE; Bellamy N, 2009, COCHRANE DB SYST REV, V2; Bennell KL, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2912; Brand C., 2009, GUIDELINE NONSURGICA; Brosseau L, 2011, PHYS THER, V91, P843, DOI 10.2522/ptj.20100104; Chappell AS, 2011, PAIN PRACT, V11, P33, DOI 10.1111/j.1533-2500.2010.00401.x; Christensen R, 2007, ANN RHEUM DIS, V66, P433, DOI 10.1136/ard.2006.065904; Conaghan PG, 2008, BRIT MED J, V336, P502, DOI 10.1136/bmj.39490.608009.AD; Dixon KE, 2007, HEALTH PSYCHOL, V26, P241, DOI 10.1037/0278-6133.26.3.241; Fransen M, 2009, J RHEUMATOL, V36, P1109, DOI 10.3899/jrheum.090058; Hochberg MC, 2010, OSTEOARTHR CARTILAGE, V18, pS28, DOI 10.1016/j.joca.2010.02.016; Hochberg MC, 2012, ARTHRIT CARE RES, V64, P465, DOI 10.1002/acr.21596; Jansen MJ, 2011, J PHYSIOTHER, V57, P11, DOI 10.1016/S1836-9553(11)70002-9; Jordan Joanne L, 2010, Cochrane Database Syst Rev, pCD005956, DOI 10.1002/14651858.CD005956.pub2; Kirkley A, 1999, J BONE JOINT SURG AM, V81A, P539, DOI 10.2106/00004623-199904000-00012; Kirkley A, 2008, NEW ENGL J MED, V359, P1097, DOI 10.1056/NEJMoa0708333; Lane NE, 2010, NEW ENGL J MED, V363, P1521, DOI 10.1056/NEJMoa0901510; Little CV, 2009, COCHRANE DB SYST REV, V4; Manheimer E., 2010, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD001977.PUB2.THIS; Navarro-Sarabia F, 2011, ANN RHEUM DIS, V70, P1957, DOI 10.1136/ard.2011.152017; Rutjes AW, 2012, ANN INTERN MED; Spahn G, 2011, KNEE SURG SPORTS TRA; Zhang W, 2008, OSTEOARTHR CARTILAGE, V16, P137, DOI 10.1016/j.joca.2007.12.013; Zhang W, 2010, OSTEOARTHR CARTILAGE, V18, P476, DOI 10.1016/j.joca.2010.01.013; Zhang W, 2010, ANN RHEUM DIS, V69, P483, DOI 10.1136/ard.2009.113100	25	112	113	1	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 30	2012	345								e4934	10.1136/bmj.e4934	http://dx.doi.org/10.1136/bmj.e4934			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	985XA	22846469	Green Submitted			2022-12-28	WOS:000307302600003
J	McCall, B				McCall, Becky			Profile: MLW optimises community engagement in research	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 28	2012	380	9839					328	328		10.1016/S0140-6736(12)61237-9	http://dx.doi.org/10.1016/S0140-6736(12)61237-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	979TN	22852140				2022-12-28	WOS:000306842800015
J	Fazel, S; Singh, JP; Doll, H; Grann, M				Fazel, Seena; Singh, Jay P.; Doll, Helen; Grann, Martin			Use of risk assessment instruments to predict violence and antisocial behaviour in 73 samples involving 24 827 people: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ADULT OFFENDERS; DIAGNOSTIC-TEST; SCHIZOPHRENIA; PSYCHOPATHY; DISORDERS; HOMICIDE; ACCURACY	Objective To investigate the predictive validity of tools commonly used to assess the risk of violence, sexual, and criminal behaviour. Design Systematic review and tabular meta-analysis of replication studies following PRISMA guidelines. Data sources PsycINFO, Embase, Medline, and United States Criminal Justice Reference Service Abstracts. Review methods We included replication studies from 1 January 1995 to 1 January 2011 if they provided contingency data for the offending outcome that the tools were designed to predict. We calculated the diagnostic odds ratio, sensitivity, specificity, area under the curve, positive predictive value, negative predictive value, the number needed to detain to prevent one offence, as well as a novel performance indicator-the number safely discharged. We investigated potential sources of heterogeneity using metaregression and subgroup analyses. Results Risk assessments were conducted on 73 samples comprising 24 847 participants from 13 countries, of whom 5879 (23.7%) offended over an average of 49.6 months. When used to predict violent offending, risk assessment tools produced low to moderate positive predictive values (median 41%, interquartile range 27-60%) and higher negative predictive values (91%, 81-95%), and a corresponding median number needed to detain of 2 (2-4) and number safely discharged of 10 (4-18). Instruments designed to predict violent offending performed better than those aimed at predicting sexual or general crime. Conclusions Although risk assessment tools are widely used in clinical and criminal justice settings, their predictive accuracy varies depending on how they are used. They seem to identify low risk individuals with high levels of accuracy, but their use as sole determinants of detention, sentencing, and release is not supported by the current evidence. Further research is needed to examine their contribution to treatment and management.	[Fazel, Seena] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England; [Singh, Jay P.] Univ S Florida, Dept Mental Hlth Law & Policy, Tampa, FL USA; [Doll, Helen] Univ E Anglia, Dept Populat Hlth & Primary Care, Norwich NR4 7TJ, Norfolk, England; [Grann, Martin] Karolinska Inst, Ctr Violence Prevent, Stockholm, Sweden	University of Oxford; State University System of Florida; University of South Florida; University of East Anglia; Karolinska Institutet	Fazel, S (corresponding author), Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England.	seena.fazel@psych.ox.ac.uk	Fazel, Seena/B-5307-2008	Fazel, Seena/0000-0002-5383-5365	Wellcome Trust	Wellcome Trust(Wellcome Trust)	SF is funded by the Wellcome Trust.	AEgisdottir S, 2006, COUNS PSYCHOL, V34, P341, DOI 10.1177/0011000005285875; American Psychiatric Association, 2004, PRACT GUID TREATM PA; Andrews DA., 1995, LSI R LEVEL SERVICE; [Anonymous], 2010, LANCET, V375, P348, DOI 10.1016/S0140-6736(10)60148-1; Archer RP, 2006, J PERS ASSESS, V87, P84, DOI 10.1207/s15327752jpa8701_07; Blair PR, 2008, CLIN PSYCHOL-SCI PR, V15, P346, DOI 10.1111/j.1468-2850.2008.00147.x; Boer D.P., 1997, MANUAL SEXUAL VIOLEN; Bonta J, 2002, CRIM JUSTICE BEHAV, V29, P355, DOI 10.1177/0093854802029004002; Borum R., 2002, MANUAL STRUCTURED AS; Borum R, 2003, MANUAL STRUCTURED AS; Brundtland GH, 2002, JAMA-J AM MED ASSOC, V288, P1580, DOI 10.1001/jama.288.13.1580; Buchanan A, 2001, LANCET, V358, P1955, DOI 10.1016/S0140-6736(01)06962-8; Campbell MA, 2009, CRIM JUSTICE BEHAV, V36, P567, DOI 10.1177/0093854809333610; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Cooney MT, 2009, J AM COLL CARDIOL, V54, P1209, DOI 10.1016/j.jacc.2009.07.020; Crichton JHM, 2011, J FORENSIC PSYCHI PS, V22, P761, DOI 10.1080/14789949.2011.617832; Davies S, 2004, BRIT MED J, V329, P684, DOI 10.1136/bmj.329.7467.684-c; Deeks J, 2001, SYSTEMATIC REV HLTH, P313, DOI [DOI 10.1002/9780470693926.CH15, DOI 10.1002/9780470693926.CH16]; Doren Dennis M., 2002, EVALUATING SEX OFFEN; Eaves, 1995, MANUAL SPOUSAL ASSAU; Eichler K, 2007, AM HEART J, V153, P722, DOI 10.1016/j.ahj.2007.02.027; Fazel S, 2010, ARCH GEN PSYCHIAT, V67, P931, DOI 10.1001/archgenpsychiatry.2010.97; Fazel S, 2009, JAMA-J AM MED ASSOC, V301, P2016, DOI 10.1001/jama.2009.675; Fleminger S, 1997, BRIT J PSYCHIAT, V171, P287, DOI 10.1192/bjp.171.3.287a; Geddes J, 1999, BRIT MED J, V318, P1225; Gilligan DG, 2004, BMJ             0617; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Gu Y, 2009, PSYCHIAT CLIN NEUROS, V63, P592, DOI 10.1111/j.1440-1819.2009.01999.x; Hanson R.K., 2004, PREDICTORS SEXUAL RE; Hanson R.K., 1999, STATIC 99 IMPROVING; Hanson RK, 2009, PSYCHOL ASSESSMENT, V21, P1, DOI 10.1037/a0014421; Harcourt BernardE., 2007, PREDICTION PROFILING; Hare R. D., 2003, HARE PSYCHOPATHY CHE, V2nd; Harris A, 2003, STATIC 99 CODING RUL; Harrison K, 2010, J SOC WELF FAM LAW, V32, P423, DOI 10.1080/09649069.2010.539915; HART SD, 1988, J CONSULT CLIN PSYCH, V56, P227, DOI 10.1037/0022-006X.56.2.227; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2008, INT J EPIDEMIOL, V37, P1158, DOI 10.1093/ije/dyn204; Higgins N, 2005, PSYCHIATR BULL, V29, P131, DOI 10.1192/pb.29.4.131; Janus ES, 2004, LANCET, V364, P50, DOI 10.1016/S0140-6736(04)17641-1; Jovanovic AA, 2009, VOJNOSANIT PREGL, V66, P13, DOI 10.2298/VSP0901013J; Kemshall H, 2001, RISK ASSESSMENT MANA; Khiroya R, 2009, PSYCHIATR BULL, V33, P129, DOI 10.1192/pb.bp.108.019810; Kropp P. R., 1999, SPOUSAL ASSAULT RISK; Kropp P. R., 1994, MANUAL SPOUSAL ASSAU; Krug EG, 2002, LANCET, V360, P1083, DOI 10.1016/S0140-6736(02)11133-0; Lally SJ, 2003, PROF PSYCHOL-RES PR, V34, P491, DOI 10.1037/0735-7028.34.5.491; Large MM, 2011, HARVARD REV PSYCHIAT, V19, P25, DOI 10.3109/10673229.2011.549770; Leistico AMR, 2008, LAW HUMAN BEHAV, V32, P28, DOI 10.1007/s10979-007-9096-6; Macaskill P, 2010, COCHRANE HDB SYSTEMA; Maden A, 2003, PSYCHIAT B, V27, P201, DOI DOI 10.1192/PB.27.6.201; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; MOSES LE, 1993, STAT MED, V12, P1293, DOI 10.1002/sim.4780121203; MOSSMAN D, 1994, J CONSULT CLIN PSYCH, V62, P783, DOI 10.1037/0022-006X.62.4.783; Mullen P. E., 2006, ADV PSYCHIAT TREATME, V12, P239, DOI DOI 10.1192/APT.12.4.239; National Institute for Health and Clinical Excellence, 2010, ANT PERS DIS TREATM; National Institute for Health and Clinical Excellence, 2009, COR INT TREATM MAN S; Pescosolido BA, 2010, AM J PSYCHIAT, V167, P1321, DOI 10.1176/appi.ajp.2010.09121743; Quinsey V. L., 2006, VIOLENT OFFENDERS AP, V2nd, DOI 10.1037/11367-000; Quinsey Vernon L., 1998, VIOLENT OFFENDERS AP; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Rosenthal Robert, 1994, HDB RES SYNTHESIS, V621, P231; Ruscio J, 2008, PSYCHOL METHODS, V13, P19, DOI 10.1037/1082-989X.13.1.19; Rutter CM, 2001, STAT MED, V20, P2865, DOI 10.1002/sim.942; Simon J, 2005, ANNU REV LAW SOC SCI, V1, P397, DOI 10.1146/annurev.lawsocsci.1.041604.120006; Singh JP, 2011, SCHIZOPHRENIA BULL, V37, P899, DOI 10.1093/schbul/sbr093; Singh JP, 2011, CLIN PSYCHOL REV, V31, P499, DOI 10.1016/j.cpr.2010.11.009; Singh JP, 2010, CRIM JUSTICE BEHAV, V37, P965, DOI 10.1177/0093854810374274; StataCorp, 2007, STAT STAT SOFTW REL; Szmukler G, 2001, BRIT J PSYCHIAT, V178, P84, DOI 10.1192/bjp.178.1.84; Szmukler G., 2003, PSYCHIATRIC B, V27, P205, DOI [DOI 10.1192/PB.27.6.205, 10.1192/pb.27.6.205, DOI 10.1017/S0955603600002257]; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Tyrer P, 2010, MED SCI LAW, V50, P95, DOI 10.1258/msl.2010.010001; Van Hauwaert SM, 2018, EUR J POLIT RES, V57, P68, DOI 10.1111/1475-6765.12216; Viljoen JL, 2010, ASSESSMENT, V17, P377, DOI 10.1177/1073191109359587; Wallace C, 1998, BRIT J PSYCHIAT, V172, P477, DOI 10.1192/bjp.172.6.477; Webster C.D., 1997, HCR 20 ASSESSING RIS; Webster CD., 1995, HCR 20 SCHEME ASSESS; Yang M, 2010, PSYCHOL BULL, V136, P740, DOI 10.1037/a0020473	80	268	271	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 24	2012	345								e4692	10.1136/bmj.e4692	http://dx.doi.org/10.1136/bmj.e4692			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	981UQ	22833604	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000306996900003
J	Yue, D; Ho, J; Al-Hadithy, N				Yue, Dominic; Ho, Jasmine; Al-Hadithy, Nawfal			A case of sudden ankle pain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ACHILLES-TENDON RUPTURES; SIMMONDS-THOMPSON TEST; NONOPERATIVE TREATMENT; ULTRASOUND; DISORDERS		[Yue, Dominic] Royal Free Hosp, London NW3 2QG, England; [Ho, Jasmine; Al-Hadithy, Nawfal] Lister Hosp, Stevenage SG1 4AB, Herts, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Lister Hospital	Yue, D (corresponding author), Royal Free Hosp, Pond St, London NW3 2QG, England.	domyue@doctors.org.uk						ARNER O, 1959, Acta Chir Scand, V116, P484; Calleja M, 2010, SEMIN MUSCULOSKEL R, V14, P307, DOI 10.1055/s-0030-1254520; CARDEN DG, 1987, J BONE JOINT SURG BR, V69, P416, DOI 10.1302/0301-620X.69B3.3294839; CETTI R, 1993, AM J SPORT MED, V21, P791, DOI 10.1177/036354659302100606; CHRISTENSEN I, 1953, ACTA CHIR SCAND, V106, P50; Costa ML, 2003, INJURY, V34, P874, DOI 10.1016/S0020-1383(02)00205-X; Davies MS, 2009, FOOT ANKLE CLIN, V14, P685, DOI 10.1016/j.fcl.2009.07.006; Douglas J, 2009, CAN J SURG, V52, pE40; Doyle HE, 2010, JAAPA-J AM ACAD PHYS, V23, P54; Doyle Heidi E, 2010, JAAPA, V23, P18; Elias DA, 2011, ULTRASOUND, V19, P70, DOI 10.1258/ult.2011.011013; HAINES JF, 1983, ANN RHEUM DIS, V42, P652, DOI 10.1136/ard.42.6.652; HANLON D P, 1992, Journal of Emergency Medicine, V10, P559, DOI 10.1016/0736-4679(92)90136-H; Hess Gregory William, 2010, Foot Ankle Spec, V3, P29, DOI 10.1177/1938640009355191; Kayser R, 2005, BRIT J SPORT MED, V39, P838, DOI 10.1136/bjsm.2005.018416; Khan KM, 2003, BRIT J SPORT MED, V37, P149, DOI 10.1136/bjsm.37.2.149; Khan RJK, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003674.pub4; LAGERGREN C, 1959, Acta Chir Scand, V116, P491; LEA RB, 1968, CLIN ORTHOP RELAT R, P115; Leppilahti J, 1998, SPORTS MED, V25, P79, DOI 10.2165/00007256-199825020-00002; Lo IKY, 1997, CLIN J SPORT MED, V7, P207, DOI 10.1097/00042752-199707000-00010; Maffulli N, 1998, Bull Hosp Jt Dis, V57, P152; Mahler F, 1992, Br J Sports Med, V26, P7; MAHONEY PG, 1981, ANN RHEUM DIS, V40, P416, DOI 10.1136/ard.40.4.416; Mortensen NHM, 1999, J BONE JOINT SURG AM, V81A, P983, DOI 10.2106/00004623-199907000-00011; NISTOR L, 1981, J BONE JOINT SURG AM, V63, P394, DOI 10.2106/00004623-198163030-00012; Paavola Mika, 2002, Foot Ankle Clin, V7, P501, DOI 10.1016/S1083-7515(02)00056-6; Schepsis AA, 2002, AM J SPORT MED, V30, P287, DOI 10.1177/03635465020300022501; SCOTT BW, 1992, J BONE JOINT SURG BR, V74, P314, DOI 10.1302/0301-620X.74B2.1544978; SIMMONDS F A, 1957, Practitioner, V179, P56; Simoneau GG, 1996, ARCH PHYS MED REHAB, V77, P453, DOI 10.1016/S0003-9993(96)90033-7; So V, 1997, Australas Chiropr Osteopathy, V6, P58; Syha R, 2007, BRIT J SPORT MED, V41, P897, DOI 10.1136/bjsm.2007.037812; THOMPSON T C, 1962, Acta Orthop Scand, V32, P461, DOI 10.3109/17453676208989608; Twaddle BC, 2007, AM J SPORT MED, V35, P2033, DOI 10.1177/0363546507307503; Wong J, 2002, AM J SPORT MED, V30, P565, DOI 10.1177/03635465020300041701	36	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 24	2012	345								e4420	10.1136/bmj.e4420	http://dx.doi.org/10.1136/bmj.e4420			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	981UQ	22833580				2022-12-28	WOS:000306996900002
J	Deardorff, MA; Bando, M; Nakato, R; Watrin, E; Itoh, T; Minamino, M; Saitoh, K; Komata, M; Katou, Y; Clark, D; Cole, KE; De Baere, E; Decroos, C; Di Donato, N; Ernst, S; Francey, LJ; Gyftodimou, Y; Hirashima, K; Hullings, M; Ishikawa, Y; Jaulin, C; Kaur, M; Kiyono, T; Lombardi, PM; Magnaghi-Jaulin, L; Mortier, GR; Nozaki, N; Petersen, MB; Seimiya, H; Siu, VM; Suzuki, Y; Takagaki, K; Wilde, JJ; Willems, PJ; Prigent, C; Gillessen-Kaesbach, G; Christianson, DW; Kaiser, FJ; Jackson, LG; Hirota, T; Krantz, ID; Shirahige, K				Deardorff, Matthew A.; Bando, Masashige; Nakato, Ryuichiro; Watrin, Erwan; Itoh, Takehiko; Minamino, Masashi; Saitoh, Katsuya; Komata, Makiko; Katou, Yuki; Clark, Dinah; Cole, Kathryn E.; De Baere, Elfride; Decroos, Christophe; Di Donato, Nataliya; Ernst, Sarah; Francey, Lauren J.; Gyftodimou, Yolanda; Hirashima, Kyotaro; Hullings, Melanie; Ishikawa, Yuuichi; Jaulin, Christian; Kaur, Maninder; Kiyono, Tohru; Lombardi, Patrick M.; Magnaghi-Jaulin, Laura; Mortier, Geert R.; Nozaki, Naohito; Petersen, Michael B.; Seimiya, Hiroyuki; Siu, Victoria M.; Suzuki, Yutaka; Takagaki, Kentaro; Wilde, Jonathan J.; Willems, Patrick J.; Prigent, Claude; Gillessen-Kaesbach, Gabriele; Christianson, David W.; Kaiser, Frank J.; Jackson, Laird G.; Hirota, Toru; Krantz, Ian D.; Shirahige, Katsuhiko			HDAC8 mutations in Cornelia de Lange syndrome affect the cohesin acetylation cycle	NATURE			English	Article							SISTER-CHROMATID COHESION; X-CHROMOSOME-INACTIVATION; S-PHASE; HUMAN GENOME; NIPPED-B; RNA-SEQ; BINDING; COMPLEX; PROTEINS; NIPBL	Cornelia de Lange syndrome (CdLS) is a dominantly inherited congenital malformation disorder, caused by mutations in the cohesin-loading protein NIPBL1,2 for nearly 60% of individuals with classical CdLS3-5, and by mutations in the core cohesin components SMC1A (similar to 5%) and SMC3 (<1%) for a smaller fraction of probands(6,7). In humans, the multisubunit complex cohesin is made up of SMC1, SMC3, RAD21 and a STAG protein. These form a ring structure that is proposed to encircle sister chromatids to mediate sister chromatid cohesion(8) and also has key roles in gene regulation(9). SMC3 is acetylated during S-phase to establish cohesiveness of chromatin-loaded cohesin(10-13), and in yeast, the class I histone deacetylase Hos1 deacetylates SMC3 during anaphase(14-16). Here we identify HDAC8 as the vertebrate SMC3 deacetylase, as well as loss-of-function HDAC8 mutations in six CdLS probands. Loss of HDAC8 activity results in increased SMC3 acetylation and inefficient dissolution of the 'used' cohesin complex released from chromatin in both prophase and anaphase. SMC3 with retained acetylation is loaded onto chromatin, and chromatin immunoprecipitation sequencing analysis demonstrates decreased occupancy of cohesin localization sites that results in a consistent pattern of altered transcription seen in CdLS cell lines with either NIPBL or HDAC8 mutations.	[Deardorff, Matthew A.; Clark, Dinah; Ernst, Sarah; Francey, Lauren J.; Hullings, Melanie; Kaur, Maninder; Wilde, Jonathan J.; Jackson, Laird G.; Krantz, Ian D.] Childrens Hosp Philadelphia, Div Human Genet & Mol Biol, Philadelphia, PA 19104 USA; [Deardorff, Matthew A.; Krantz, Ian D.] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Bando, Masashige; Nakato, Ryuichiro; Minamino, Masashi; Saitoh, Katsuya; Komata, Makiko; Katou, Yuki; Shirahige, Katsuhiko] Univ Tokyo, Inst Mol & Cellular Biosci, Res Ctr Epigenet Dis, Tokyo 1130032, Japan; [Watrin, Erwan; Jaulin, Christian; Magnaghi-Jaulin, Laura; Prigent, Claude] Fac Med, Ctr Natl Rech Sci CNRS, Res Inst Genet & Dev IGDR, F-35043 Rennes, France; [Itoh, Takehiko] Tokyo Inst Technol, Sch & Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 2268503, Japan; [Cole, Kathryn E.; Decroos, Christophe; Lombardi, Patrick M.; Christianson, David W.] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [De Baere, Elfride] Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium; [Di Donato, Nataliya] Tech Univ Dresden, Inst Klin Genet, D-01307 Dresden, Germany; [Gyftodimou, Yolanda; Petersen, Michael B.] Inst Child Hlth, Dept Genet, Athens 11527, Greece; [Hirashima, Kyotaro; Seimiya, Hiroyuki] Japanese Fdn Canc Res, Div Mol Biotherapy, Tokyo 1358550, Japan; [Ishikawa, Yuuichi] Japanese Fdn Canc Res, Dept Pathol, Tokyo 1358550, Japan; [Kiyono, Tohru] Natl Canc Ctr, Res Inst, Div Virol, Tokyo 1040045, Japan; [Mortier, Geert R.] Univ Antwerp Hosp, Dept Med Genet, B-2650 Antwerp, Belgium; [Mortier, Geert R.] Univ Antwerp, B-2650 Antwerp, Belgium; [Nozaki, Naohito] Tokyo Inst Technol, Biofrontier Res Ctr, Yokohama, Kanagawa 2268503, Japan; [Petersen, Michael B.] Aarhus Univ Hosp, Aalborg Hosp, Dept Clin Genet, DK-9100 Aalborg, Denmark; [Siu, Victoria M.] Univ Western Ontario, London, ON N6A 5W9, Canada; [Suzuki, Yutaka; Hirota, Toru] Univ Tokyo, Grad Sch Frontier Sci, Tokyo 2778561, Japan; [Willems, Patrick J.] GENDIA, B-2020 Antwerp, Belgium; [Gillessen-Kaesbach, Gabriele; Kaiser, Frank J.] Med Univ Lubeck, Inst Humangenet Lubeck, D-23538 Lubeck, Germany; [Jackson, Laird G.] Drexel Univ, Sch Med, Dept Obstet & Gynecol, Philadelphia, PA 19102 USA; [Shirahige, Katsuhiko] JST, CREST, Chiyoda Ku, Tokyo 1020076, Japan	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Tokyo; Centre National de la Recherche Scientifique (CNRS); Tokyo Institute of Technology; University of Pennsylvania; Ghent University; Ghent University Hospital; Technische Universitat Dresden; Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research; National Cancer Center - Japan; University of Antwerp; University of Antwerp; Tokyo Institute of Technology; Aalborg University; Aalborg University Hospital; Aarhus University; Western University (University of Western Ontario); University of Tokyo; University of Lubeck; Drexel University; Japan Science & Technology Agency (JST)	Deardorff, MA (corresponding author), Childrens Hosp Philadelphia, Div Human Genet & Mol Biol, Philadelphia, PA 19104 USA.	deardorff@email.chop.edu; ian2@mail.med.upenn.edu; kshirahi@iam.u-tokyo.ac.jp	Jaulin, Christian/L-9126-2018; De Baere, Elfride/E-7405-2017; Nakato, Ryuichiro/AAV-6405-2020; Mortier, Geert/D-2542-2012; Di Donato, Nataliya/G-2357-2019; Petersen, Michael Bjørn B/D-1483-2017; Itoh, Takehiko/E-8873-2014	De Baere, Elfride/0000-0002-5609-6895; Nakato, Ryuichiro/0000-0003-3019-5817; Mortier, Geert/0000-0001-9871-4578; Di Donato, Nataliya/0000-0001-9439-4677; Petersen, Michael Bjørn B/0000-0003-0316-8207; Itoh, Takehiko/0000-0002-6113-557X; Shirahige, Katsuhiko/0000-0002-7862-1144; Francey, Lauren J/0000-0002-9700-2277; watrin, erwan/0000-0002-4582-6493; Takagaki, Kentaro/0000-0001-8085-6201; Seimiya, Hiroyuki/0000-0003-3314-9736; Wilde, Jonathan/0000-0002-0800-8854	US and International Cornelia de Lange Syndrome Foundations; National Institutes of Health [K08HD055488, GM49758, P01 HD052860]; US CdLS Foundation; Children's Hospital of Philadelphia; University of Lubeck (Schwerpunktprogramm, Medizinische Genetik: Von seltenen Varianten zur Krankheitsentstehung); Research Program of Innovative Cell Biology by Innovative Technology; MEXT; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD052860] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD055488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049758] Funding Source: NIH RePORTER	US and International Cornelia de Lange Syndrome Foundations; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US CdLS Foundation; Children's Hospital of Philadelphia; University of Lubeck (Schwerpunktprogramm, Medizinische Genetik: Von seltenen Varianten zur Krankheitsentstehung); Research Program of Innovative Cell Biology by Innovative Technology; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to the individuals and families with Cornelia de Lange syndrome who participated in this study, as well as to the referring physicians and colleagues who have contributed samples and clinical information. We thank Riken Omics Science Center, K. Nakagawa, S. Watanabe, M. Albrecht and J. Eckhold for technical support. We thank J.-M. Peters for the sororin and RAD21 antibodies. We thank F. Beckouet and K. Nasmyth for sharing unpublished results. We are indebted to the continued support of the US and International Cornelia de Lange Syndrome Foundations. This work was supported by National Institutes of Health grants K08HD055488 (NICHD, M. A. D.), GM49758 (D. W. C.) and P01 HD052860 (NICHD; I. D. K.), research grants from the US CdLS Foundation, institutional funds from the Children's Hospital of Philadelphia, Intramural funding from the University of Lubeck (Schwerpunktprogramm, Medizinische Genetik: Von seltenen Varianten zur Krankheitsentstehung; F. J. K., G.G.-K.), Research Program of Innovative Cell Biology by Innovative Technology, Grant-in-Aid for Scientific Research (S) and for innovative science from MEXT (K.Sh.).	ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Amos-Landgraf JM, 2006, AM J HUM GENET, V79, P493, DOI 10.1086/507565; [Anonymous], 2012, PYMOL MOL GRAPH SYST; Beckouet F, 2010, MOL CELL, V39, P689, DOI 10.1016/j.molcel.2010.08.008; Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; Borges V, 2010, MOL CELL, V39, P677, DOI 10.1016/j.molcel.2010.08.009; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Deardorff MA, 2007, AM J HUM GENET, V80, P485, DOI 10.1086/511888; Dorsett D, 2011, CURR OPIN GENET DEV, V21, P199, DOI 10.1016/j.gde.2011.01.018; Dowling DP, 2008, BIOCHEMISTRY-US, V47, P13554, DOI 10.1021/bi801610c; Eddy S R, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P114; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; Gantt SL, 2006, BIOCHEMISTRY-US, V45, P6170, DOI 10.1021/bi060212u; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gillespie PJ, 2004, CURR BIOL, V14, P1598, DOI 10.1016/j.cub.2004.07.053; Gillis LA, 2004, AM J HUM GENET, V75, P610, DOI 10.1086/424698; Gimenez-Abian JF, 2004, CURR BIOL, V14, P1187, DOI 10.1016/j.cub.2004.06.052; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; Heidinger-Pauli JM, 2009, MOL CELL, V34, P311, DOI 10.1016/j.molcel.2009.04.008; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Krantz ID, 2004, NAT GENET, V36, P631, DOI 10.1038/ng1364; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liu JL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000119; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Musio A, 2006, NAT GENET, V38, P528, DOI 10.1038/ng1779; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Nishiyama T, 2010, CELL, V143, P737, DOI 10.1016/j.cell.2010.10.031; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Takahashi TS, 2004, NAT CELL BIOL, V6, P991, DOI 10.1038/ncb1177; Tonkin ET, 2004, NAT GENET, V36, P636, DOI 10.1038/ng1363; Unal E, 2008, SCIENCE, V321, P566, DOI 10.1126/science.1157880; Vannini A, 2007, EMBO REP, V8, P879, DOI 10.1038/sj.embor.7401047; Wang XL, 2007, NAT GENET, V39, P836, DOI 10.1038/ng2057; Wang YL, 2000, TRENDS BIOCHEM SCI, V25, P300, DOI 10.1016/S0968-0004(00)01561-9; Watrin E, 2006, CURR BIOL, V16, P863, DOI 10.1016/j.cub.2006.03.049; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Xiong B, 2010, CURR BIOL, V20, P1660, DOI 10.1016/j.cub.2010.08.019; Zhang B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005232; Zhang JL, 2008, MOL CELL, V31, P143, DOI 10.1016/j.molcel.2008.06.006	44	381	395	2	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2012	489	7415					313	+		10.1038/nature11316	http://dx.doi.org/10.1038/nature11316			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003UC	22885700	Green Accepted			2022-12-28	WOS:000308635900046
J	Plechanovova, A; Jaffray, EG; Tatham, MH; Naismith, JH; Hay, RT				Plechanovova, Anna; Jaffray, Ellis G.; Tatham, Michael H.; Naismith, James H.; Hay, Ronald T.			Structure of a RING E3 ligase and ubiquitin-loaded E2 primed for catalysis	NATURE			English	Article							DNA-DAMAGE; COMPLEX; RNF4; DEGRADATION; INSIGHTS; UBIQUITYLATION; DETERMINANTS; MECHANISM; PATHWAY; BINDING	Ubiquitin modification is mediated by a large family of specificity determining ubiquitin E3 ligases. To facilitate ubiquitin transfer, RING E3 ligases bind both substrate and a ubiquitin E2 conjugating enzyme linked to ubiquitin via a thioester bond, but the mechanism of transfer has remained elusive. Here we report the crystal structure of the dimeric RING domain of rat RNF4 in complex with E2 (UbcH5A) linked by an isopeptide bond to ubiquitin. While the E2 contacts a single protomer of the RING, ubiquitin is folded back onto the E2 by contacts from both RING protomers. The carboxy-terminal tail of ubiquitin is locked into an active site groove on the E2 by an intricate network of interactions, resulting in changes at the E2 active site. This arrangement is primed for catalysis as it can deprotonate the incoming substrate lysine residue and stabilize the consequent tetrahedral transition-state intermediate.	[Plechanovova, Anna; Jaffray, Ellis G.; Tatham, Michael H.; Hay, Ronald T.] Univ Dundee, Coll Life Sci, Wellcome Trust Ctr Gene Regulat & Express, Dundee DD1 5EH, Scotland; [Naismith, James H.] Univ St Andrews, St Andrews KY16 9ST, Fife, Scotland	University of Dundee; University of St Andrews	Hay, RT (corresponding author), Univ Dundee, Coll Life Sci, Wellcome Trust Ctr Gene Regulat & Express, Dundee DD1 5EH, Scotland.	r.t.hay@dundee.ac.uk	Naismith, James Henderson/AAB-8614-2020; Naismith, James Henderson/H-3408-2012; Tatham, Michael H/E-9622-2010; Hay, Ronald/S-3233-2019	Naismith, James Henderson/0000-0001-6744-5061; Naismith, James Henderson/0000-0001-6744-5061; Tatham, Michael H/0000-0001-6986-1691; Hay, Ronald/0000-0001-7113-9024	Wellcome Trust; Cancer Research UK; Scottish Funding Council [SULSA]; Cancer Research UK [13067] Funding Source: researchfish; Wellcome Trust [098391/Z/12/Z] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); Scottish Funding Council; Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank M. Alphey and E. Branigan for assistance with data collection. His-UBE1 was a gift from the Division of Signal Transduction Therapy, University of Dundee. CHIP was a gift from A. Knebel and P. Cohen. A. P. was funded by the Wellcome Trust. This work was supported by a grant to R. T. H. from Cancer Research UK. Structural biology was supported by Scottish Funding Council (ref SULSA) and Wellcome Trust (program grant JHN).	Bentley ML, 2011, EMBO J, V30, P3285, DOI 10.1038/emboj.2011.243; Bosanac I, 2011, J MOL BIOL, V408, P420, DOI 10.1016/j.jmb.2011.03.011; Bosanac I, 2010, MOL CELL, V40, P548, DOI 10.1016/j.molcel.2010.10.009; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; Budhidarmo R, 2012, TRENDS BIOCHEM SCI, V37, P58, DOI 10.1016/j.tibs.2011.11.001; Calabrese MF, 2011, NAT STRUCT MOL BIOL, V18, P947, DOI 10.1038/nsmb.2086; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Galanty Y, 2012, GENE DEV, V26, P1179, DOI 10.1101/gad.188284.112; Gareau JR, 2012, J BIOL CHEM, V287, P4740, DOI 10.1074/jbc.M111.321141; Hamilton KS, 2001, STRUCTURE, V9, P897, DOI 10.1016/S0969-2126(01)00657-8; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Kravtsova-Ivantsiv Y, 2012, J CELL SCI, V125, P539, DOI 10.1242/jcs.093567; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Lebedev AA, 2012, ACTA CRYSTALLOGR D, V68, P431, DOI 10.1107/S090744491200251X; Liew CW, 2010, BIOCHEM J, V431, P23, DOI 10.1042/BJ20100957; Luo KT, 2012, EMBO J, V31, P3008, DOI 10.1038/emboj.2012.158; Mace PD, 2008, J BIOL CHEM, V283, P31633, DOI 10.1074/jbc.M804753200; Martin SF, 2007, ANAL BIOCHEM, V363, P83, DOI 10.1016/j.ab.2006.12.018; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nielsen ML, 2008, NAT METHODS, V5, P459, DOI 10.1038/nmeth0608-459; Plechanovova A, 2011, NAT STRUCT MOL BIOL, V18, P1052, DOI 10.1038/nsmb.2108; Pruneda JN, 2011, BIOCHEMISTRY-US, V50, P1624, DOI 10.1021/bi101913m; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Saha A, 2011, MOL CELL, V42, P75, DOI 10.1016/j.molcel.2011.03.016; Sakata E, 2010, STRUCTURE, V18, P138, DOI 10.1016/j.str.2009.11.007; Schreiber A, 2011, NATURE, V470, P227, DOI 10.1038/nature09756; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu PY, 2003, EMBO J, V22, P5241, DOI 10.1093/emboj/cdg501; Yin YL, 2012, GENE DEV, V26, P1196, DOI 10.1101/gad.189274.112; Yunus AA, 2006, NAT STRUCT MOL BIOL, V13, P491, DOI 10.1038/nsmb1104; Yunus AA, 2009, MOL CELL, V35, P669, DOI 10.1016/j.molcel.2009.07.013; Zhang L, 2011, GENE DEV, V25, P1262, DOI 10.1101/gad.2056211; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023	41	354	358	4	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2012	489	7414					115	U135		10.1038/nature11376	http://dx.doi.org/10.1038/nature11376			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999WW	22842904	Green Accepted			2022-12-28	WOS:000308347000045
J	Fischer, A; du Bois, R				Fischer, Aryeh; du Bois, Roland			Interstitial lung disease in connective tissue disorders	LANCET			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; COLLAGEN VASCULAR-DISEASE; PLACEBO-CONTROLLED TRIAL; SURFACTANT PROTEIN-D; SYSTEMIC-SCLEROSIS; RHEUMATOID-ARTHRITIS; MYCOPHENOLATE-MOFETIL; HISTOPATHOLOGIC SUBSETS; PROGNOSTIC-SIGNIFICANCE; BRONCHOALVEOLAR LAVAGE	Some of the most pressing challenges associated with interstitial lung disease (ILD) are how best to define, diagnose, and treat connective tissue disease-associated ILD (CTD-ILD)-disorders with potentially substantial morbidity and mortality. In this focused review, we address aspects of prognosis for CTD-ILD and what indices might predict outcome, together with lessons that can be learnt from clinical trials of systemic sclerosis-associated ILD and idiopathic pulmonary fibrosis and how these lessons might be applied to future studies of CTD-ILD.	[du Bois, Roland] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; [Fischer, Aryeh] Natl Jewish Hlth, Div Rheumatol & Interstitial Lung Dis Program, Denver, CO USA	Imperial College London; National Jewish Health	du Bois, R (corresponding author), Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England.	ron@du-bois.co.uk						AGUSTI C, 1992, THORAX, V47, P1035, DOI 10.1136/thx.47.12.1035; Antoniou KM, 2009, EUR RESPIR J, V33, P882, DOI 10.1183/09031936.00152607; Azuma A, 2005, AM J RESP CRIT CARE, V171, P1040, DOI 10.1164/rccm.200404-571OC; Bjoraker JA, 1998, AM J RESP CRIT CARE, V157, P199, DOI 10.1164/ajrccm.157.1.9704130; Bonella P, 2011, SARCOIDOSIS VASC DIF, V28, P27; Bouros D, 2002, AM J RESP CRIT CARE, V165, P1581, DOI 10.1164/rccm.2106012; Corte TJ, 2012, EUR RESPIR J, V39, P661, DOI 10.1183/09031936.00174910; Cottin V, 2006, EUR RESPIR J, V28, P893, DOI 10.1183/09031936.00101506; Daniil ZD, 1999, AM J RESP CRIT CARE, V160, P899, DOI 10.1164/ajrccm.160.3.9903021; Dheda K, 2004, CLIN RHEUMATOL, V23, P306, DOI 10.1007/s10067-004-0906-7; Douglas WW, 2001, AM J RESP CRIT CARE, V164, P1182, DOI 10.1164/ajrccm.164.7.2103110; Doyle TJ, 2012, AM J RESP CRIT CARE, V185, P1147, DOI 10.1164/rccm.201108-1420PP; du Bois RM, 2012, AM J RESP CRIT CARE, V186, P712, DOI 10.1164/rccm.201206-1010PP; du Bois RM, 2011, AM J RESP CRIT CARE, V184, P1382, DOI 10.1164/rccm.201105-0840OC; du Bois RM, 2011, AM J RESP CRIT CARE, V184, P459, DOI 10.1164/rccm.201011-1790OC; Fischer A, 2008, CHEST, V134, P601, DOI 10.1378/chest.08-0053; Fischer A, 2006, J RHEUMATOL, V33, P1600; Fischer A, 2012, RESP MED, V106, P1040, DOI 10.1016/j.rmed.2012.03.006; Fischer A, 2010, CHEST, V138, P251, DOI 10.1378/chest.10-0194; Fischer A, 2009, JCR-J CLIN RHEUMATOL, V15, P95, DOI 10.1097/RHU.0b013e31819b715d; Flaherty KR, 2003, AM J RESP CRIT CARE, V167, P1410, DOI 10.1164/rccm.200204-373OC; Fujita J, 2005, RESP MED, V99, P234, DOI 10.1016/j.rmed.2004.07.001; Gerbino AJ, 2008, CHEST, V133, P455, DOI 10.1378/chest.06-2861; Gizinski AM, 2009, CLIN RHEUMATOL, V28, P611, DOI 10.1007/s10067-009-1128-9; Goh NSL, 2008, AM J RESP CRIT CARE, V177, P1248, DOI 10.1164/rccm.200706-877OC; Goh NSL, 2007, ARTHRITIS RHEUM-US, V56, P2005, DOI 10.1002/art.22696; Hant FN, 2009, J RHEUMATOL, V36, P773, DOI 10.3899/jrheum.080633; Hoyles RK, 2006, ARTHRITIS RHEUM-US, V54, P3962, DOI 10.1002/art.22204; Khanna D, 2010, CLIN EXP RHEUMATOL, V28, pS55; Khanna D, 2012, ARTHRITIS RHEUM, V63, P3078; Kim DS, 2002, SARCOIDOSIS VASC DIF, V19, P121; Kim EJ, 2010, EUR RESPIR J, V35, P1322, DOI 10.1183/09031936.00092309; Kim EJ, 2009, CHEST, V136, P1397, DOI 10.1378/chest.09-0444; Kinder BW, 2007, AM J RESP CRIT CARE, V176, P691, DOI 10.1164/rccm.200702-220OC; Kowal-Bielecka O, 2010, SEMIN ARTHRITIS RHEU, V40, P73, DOI 10.1016/j.semarthrit.2008.10.009; Lee HK, 2005, CHEST, V127, P2019, DOI 10.1378/chest.127.6.2019; Liossis SNC, 2006, RHEUMATOLOGY, V45, P1005, DOI 10.1093/rheumatology/kei211; Lynch DA, 2005, RADIOLOGY, V236, P10, DOI 10.1148/radiol.2361031674; Lynch DA, 2007, CHEST, V131, P643, DOI 10.1378/chest.06-2955; Martinez FJ, 2006, NEW ENGL J MED, V354, P2707, DOI 10.1056/NEJMe068095; Mittoo S, 2009, RESP MED, V103, P1152, DOI 10.1016/j.rmed.2009.02.009; Mosca M, 1998, LUPUS, V7, P95, DOI 10.1191/096120398678919787; Mosca M, 2002, J RHEUMATOL, V29, P2345; Mosca M, 1999, CLIN EXP RHEUMATOL, V17, P615; Mosca M, 2007, BEST PRACT RES CL RH, V21, P1011, DOI 10.1016/j.berh.2007.09.004; Nagai S, 1998, EUR RESPIR J, V12, P1010, DOI 10.1183/09031936.98.12051010; Nathan SD, 2011, EUR RESPIR J, V38, P1002, DOI 10.1183/09031936.00068611; Nicholson AC, 2000, AM J RESP CRIT CARE, V162, P2213, DOI 10.1164/ajrccm.162.6.2003049; Noble PW, 2011, LANCET, V377, P1760, DOI 10.1016/S0140-6736(11)60405-4; Oddis CV, 1999, LANCET, V353, P1762, DOI 10.1016/S0140-6736(99)01927-3; Papiris SA, 1997, RESPIRATION, V64, P81, DOI 10.1159/000196648; Park JH, 2007, AM J RESP CRIT CARE, V175, P705, DOI 10.1164/rccm.200607-912OC; Raghu G, 2012, AM J RESP CRIT CARE, V185, P1044, DOI 10.1164/rccm.201201-0006PP; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Riha RL, 2002, EUR RESPIR J, V19, P1114, DOI 10.1183/09031936.02.00244002; SILVER RM, 1990, AM J MED, V88, P470, DOI 10.1016/0002-9343(90)90425-D; SILVER RM, 1993, J RHEUMATOL, V20, P838; Song JW, 2009, CHEST, V136, P23, DOI 10.1378/chest.08-2572; Spagnolo P, 2010, COCHRANE DB SYST REV, V9; STEEN VD, 1994, ARTHRITIS RHEUM-US, V37, P1290, DOI 10.1002/art.1780370904; STEEN VD, 1994, ARTHRITIS RHEUM, V37, P1283, DOI 10.1002/art.1780370903; Strange C, 2004, CLIN CHEST MED, V25, P549, DOI 10.1016/j.ccm.2004.05.009; Strange C, 2008, AM J RESP CRIT CARE, V177, P91, DOI 10.1164/rccm.200705-655OC; Swigris JJ, 2006, CHEST, V130, P30, DOI 10.1016/S0012-3692(15)50949-5; Taniguchi H, 2010, EUR RESPIR J, V35, P821, DOI 10.1183/09031936.00005209; Tashkin DP, 2006, NEW ENGL J MED, V354, P2655, DOI 10.1056/NEJMoa055120; Tashkin DP, 2007, AM J RESP CRIT CARE, V176, P1026, DOI 10.1164/rccm.200702-326OC; Travis W.D., 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Tzelepis GE, 2008, EUR RESPIR J, V31, P11, DOI 10.1183/09031936.00060107; Vij R, 2011, CHEST, V140, P1292, DOI 10.1378/chest.10-2662; WELLS AU, 1994, AM J RESP CRIT CARE, V149, P1583, DOI 10.1164/ajrccm.149.6.8004317; White B, 2000, ANN INTERN MED, V132, P947, DOI 10.7326/0003-4819-132-12-200006200-00004; Yanaba K, 2004, J RHEUMATOL, V31, P1112	73	242	260	3	50	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 18	2012	380	9842					689	698		10.1016/S0140-6736(12)61079-4	http://dx.doi.org/10.1016/S0140-6736(12)61079-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	991SE	22901890				2022-12-28	WOS:000307721000034
J	[Anonymous]				[Anonymous]			Respiratory medicine-challenging times, hope for the future	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 18	2012	380	9842					621	621						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	991SE	22901866	Bronze			2022-12-28	WOS:000307721000001
J	Nijhawan, D; Zack, TI; Ren, Y; Strickland, MR; Lamothe, R; Schumacher, SE; Tsherniak, A; Besche, HC; Rosenbluh, J; Shehata, S; Cowley, GS; Weir, BA; Goldberg, AL; Mesirov, JP; Root, DE; Bhatia, SN; Beroukhim, R; Hahn, WC				Nijhawan, Deepak; Zack, Travis I.; Ren, Yin; Strickland, Matthew R.; Lamothe, Rebecca; Schumacher, Steven E.; Tsherniak, Aviad; Besche, Henrike C.; Rosenbluh, Joseph; Shehata, Shyemaa; Cowley, Glenn S.; Weir, Barbara A.; Goldberg, Alfred L.; Mesirov, Jill P.; Root, David E.; Bhatia, Sangeeta N.; Beroukhim, Rameen; Hahn, William C.			Cancer Vulnerabilities Unveiled by Genomic Loss	CELL			English	Article							COPY-NUMBER ALTERATION; OVARIAN-CANCER; PROTEASOMAL ATPASES; ONCOGENE ADDICTION; DRUG-SENSITIVITY; LUNG-CANCER; CELLS; GENE; IDENTIFICATION; THERAPY	Due to genome instability, most cancers exhibit loss of regions containing tumor suppressor genes and collateral loss of other genes. To identify cancer-specific vulnerabilities that are the result of copy number losses, we performed integrated analyses of genome-wide copy number and RNAi profiles and identified 56 genes for which gene suppression specifically inhibited the proliferation of cells harboring partial copy number loss of that gene. These CYCLOPS (copy number alterations yielding cancer liabilities owing to partial loss) genes are enriched for spliceosome, proteasome, and ribosome components. One CYCLOPS gene, PSMC2, encodes an essential member of the 19S proteasome. Normal cells express excess PSMC2, which resides in a complex with PSMC1, PSMD2, and PSMD5 and acts as a reservoir protecting cells from PSMC2 suppression. Cells harboring partial PSMC2 copy number loss lack this complex and die after PSMC2 suppression. These observations define a distinct class of cancer-specific liabilities resulting from genome instability.	[Nijhawan, Deepak; Zack, Travis I.; Strickland, Matthew R.; Lamothe, Rebecca; Schumacher, Steven E.; Rosenbluh, Joseph; Shehata, Shyemaa; Beroukhim, Rameen; Hahn, William C.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Nijhawan, Deepak; Zack, Travis I.; Strickland, Matthew R.; Lamothe, Rebecca; Schumacher, Steven E.; Rosenbluh, Joseph; Shehata, Shyemaa; Beroukhim, Rameen; Hahn, William C.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Nijhawan, Deepak; Zack, Travis I.; Schumacher, Steven E.; Tsherniak, Aviad; Rosenbluh, Joseph; Cowley, Glenn S.; Weir, Barbara A.; Mesirov, Jill P.; Root, David E.; Bhatia, Sangeeta N.; Beroukhim, Rameen; Hahn, William C.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Zack, Travis I.] Harvard Univ, Biophys Program, Boston, MA 02115 USA; [Besche, Henrike C.; Goldberg, Alfred L.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Ren, Yin; Bhatia, Sangeeta N.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Bhatia, Sangeeta N.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Nijhawan, Deepak; Rosenbluh, Joseph; Bhatia, Sangeeta N.; Beroukhim, Rameen; Hahn, William C.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Bhatia, Sangeeta N.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute	Beroukhim, R (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA.	rameen_beroukhim@dfci.harvard.edu; william_hahn@dfci.harvard.edu	Schumacher, Steven/E-9821-2013; Ren, Yin/ABD-7707-2021; Mesirov, Jill/AGF-7626-2022; qiao, zhixin/I-3408-2012	Schumacher, Steven/0000-0002-6819-5647; Ren, Yin/0000-0002-7901-2439; Tsherniak, Aviad/0000-0002-3797-1877; Rosenbluh, Joseph/0000-0001-9815-8049; Besche, Henrike/0000-0002-9841-9218	NIH/NCI [RC2 CA148268, U54 CA143798, K08 CA122833, T32 GM008313, RO1 GM051923-17, U54 CA112962]; H.L. Snyder Medical Foundation; V Foundation; Conquer Cancer Foundation Young Investigator Award; Sass Foundation Fellowship; Marie D. & Pierre Casimir-Lambert Fund; NATIONAL CANCER INSTITUTE [K08CA122833, R01CA109467, U54CA151884, P01CA050661, RC2CA148268, U54CA143798, U54CA112962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051923, T32GM008313, T32GM007753] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); H.L. Snyder Medical Foundation; V Foundation; Conquer Cancer Foundation Young Investigator Award; Sass Foundation Fellowship; Marie D. & Pierre Casimir-Lambert Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank Leslie Gaffney and Lauren Solomon for support in generating illustrations and graphics and Jesse Boehm, Scott Carter, George Demartino, and members of the Goldberg and Hahn lab for helpful discussion. This work was supported in part by NIH/NCI grants RC2 CA148268 (W. C. H.), U54 CA143798, K08 CA122833 (R. B.), T32 GM008313 (T.I.Z.), RO1 GM051923-17 (A. L. G and H. C. B.), and U54 CA112962 (A. T., J.P.M., W. C. H.), the H.L. Snyder Medical Foundation (W. C. H.), the V Foundation (R. B.), a Conquer Cancer Foundation Young Investigator Award (D.N.), Sass Foundation Fellowship (D.N.), and the Marie D. & Pierre Casimir-Lambert Fund. S.N.B. is a Howard Hughes Investigator. W. C. H. and R. B. are consultants for Novartis Pharmaceuticals.	Aghajanian C, 2002, CLIN CANCER RES, V8, P2505; Ashworth A, 2011, CELL, V145, P30, DOI 10.1016/j.cell.2011.03.020; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Brose MS, 2002, CANCER RES, V62, P6997; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Elsasser S, 2005, METHOD ENZYMOL, V398, P353, DOI 10.1016/S0076-6879(05)98029-4; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; FREI E, 1993, LANCET, V342, P662, DOI 10.1016/0140-6736(93)91764-D; Funakoshi M, 2009, CELL, V137, P887, DOI 10.1016/j.cell.2009.04.061; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Kaneko T, 2009, CELL, V137, P914, DOI 10.1016/j.cell.2009.05.008; Kisselev AF, 2005, METHOD ENZYMOL, V398, P364, DOI 10.1016/S0076-6879(05)98030-0; Liu JS, 2004, CANCER RES, V64, P1655, DOI 10.1158/0008-5472.CAN-03-3380; Marcotte R, 2012, CANCER DISCOV, V2, P172, DOI 10.1158/2159-8290.CD-11-0224; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Park S, 2009, NATURE, V459, P866, DOI 10.1038/nature08065; Ren Y, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003778; Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445; Roelofs J, 2009, NATURE, V459, P861, DOI 10.1038/nature08063; Saeki Y, 2009, CELL, V137, P900, DOI 10.1016/j.cell.2009.05.005; Sawyers CL, 2005, COLD SH Q B, V70, P479, DOI 10.1101/sqb.2005.70.034; Smith DM, 2011, CELL, V144, P526, DOI 10.1016/j.cell.2011.02.005; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Solimini NL, 2007, CELL, V130, P986, DOI 10.1016/j.cell.2007.09.007; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Thompson D, 2009, J BIOL CHEM, V284, P24891, DOI 10.1074/jbc.M109.023218; Weinstein IB, 2006, NAT CLIN PRACT ONCOL, V3, P448, DOI 10.1038/ncponc0558; Zhang R, 2009, NUCLEIC ACIDS RES, V37, pD455, DOI 10.1093/nar/gkn858	35	162	167	1	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 17	2012	150	4					842	854		10.1016/j.cell.2012.07.023	http://dx.doi.org/10.1016/j.cell.2012.07.023			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	995IT	22901813	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000308002300017
J	Wang, TA; Yu, YV; Govindaiah, G; Ye, XY; Artinian, L; Coleman, TP; Sweedler, JV; Cox, CL; Gillette, MU				Wang, Tongfei A.; Yu, Yanxun V.; Govindaiah, Gubbi; Ye, Xiaoying; Artinian, Liana; Coleman, Todd P.; Sweedler, Jonathan V.; Cox, Charles L.; Gillette, Martha U.			Circadian Rhythm of Redox State Regulates Excitability in Suprachiasmatic Nucleus Neurons	SCIENCE			English	Article							CLOCK; TRANSCRIPTION; METABOLISM; COMPONENT; NPAS2	Daily rhythms of mammalian physiology, metabolism, and behavior parallel the day-night cycle. They are orchestrated by a central circadian clock in the brain, the suprachiasmatic nucleus (SCN). Transcription of clock genes is sensitive to metabolic changes in reduction and oxidation (redox); however, circadian cycles in protein oxidation have been reported in anucleate cells, where no transcription occurs. We investigated whether the SCN also expresses redox cycles and how such metabolic oscillations might affect neuronal physiology. We detected self-sustained circadian rhythms of SCN redox state that required the molecular clockwork. The redox oscillation could determine the excitability of SCN neurons through nontranscriptional modulation of multiple potassium (K+) channels. Thus, dynamic regulation of SCN excitability appears to be closely tied to metabolism that engages the clockwork machinery.	[Wang, Tongfei A.; Govindaiah, Gubbi; Artinian, Liana; Sweedler, Jonathan V.; Cox, Charles L.; Gillette, Martha U.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Yu, Yanxun V.; Sweedler, Jonathan V.; Cox, Charles L.; Gillette, Martha U.] Univ Illinois, Neurosci Program, Urbana, IL 61801 USA; [Govindaiah, Gubbi; Ye, Xiaoying; Sweedler, Jonathan V.; Cox, Charles L.; Gillette, Martha U.] Univ Illinois, Beckman Inst, Urbana, IL 61801 USA; [Ye, Xiaoying; Sweedler, Jonathan V.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Coleman, Todd P.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Gillette, Martha U.] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California San Diego; University of Illinois System; University of Illinois Urbana-Champaign	Gillette, MU (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA.	mgillett@illinois.edu	Wang, Tongfei/C-1394-2015; Sweedler, Jonathan V/A-9405-2009	Sweedler, Jonathan V/0000-0003-3107-9922; Coleman, Todd/0000-0002-2144-2495; Wang, Tongfei/0000-0002-6306-7371; Cox, Charles/0000-0002-1179-7014	National Heart, Lung, and Blood Institute [RO1HL092571 Z ARRA, RO1HL086870]; National Eye Institute [EY014024]; National Institute on Drug Abuse [P30DA018310]; National Science Foundation [CHE 11-11705, CCF09-39370]; NATIONAL EYE INSTITUTE [R01EY014024, R56EY014024] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092571, R01HL086870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018310] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Science Foundation(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank S.-H. Tyan for insightful discussions at the inception of this work; G. Robinson, R. Gillette, and J. M. Mitchell for critical feedback; J. M. Ding and G. F. Buchanan for data support; K. E. Weis and J. M. Arnold for technical support; S. C. Liu for data analysis consultation; and M. C. Holtz for manuscript preparation. Research was supported by the National Heart, Lung, and Blood Institute (RO1HL092571 Z ARRA, RO1HL086870) to M.U.G., the National Eye Institute (EY014024) to C.L.C., the National Institute on Drug Abuse (P30DA018310) to J.V.S., and the National Science Foundation (CHE 11-11705 to J.V.S. and CCF09-39370 to T.P.C.). Content is solely the responsibility of the authors and does not necessarily represent the official views of NIH or NSF.	Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Belle MDC, 2009, SCIENCE, V326, P281, DOI 10.1126/science.1169657; Brown TM, 2007, PROG NEUROBIOL, V82, P229, DOI 10.1016/j.pneurobio.2007.05.002; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; de Jeu M, 2002, J NEUROPHYSIOL, V88, P869, DOI 10.1152/jn.2002.88.2.869; Dioum EM, 2002, SCIENCE, V298, P2385, DOI 10.1126/science.1078456; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Golombek DA, 2010, PHYSIOL REV, V90, P1063, DOI 10.1152/physrev.00009.2009; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Harrisingh MC, 2007, J NEUROSCI, V27, P12489, DOI 10.1523/JNEUROSCI.3680-07.2007; Huang SH, 2002, BIOPHYS J, V82, P2811, DOI 10.1016/S0006-3495(02)75621-X; Itri JN, 2010, J NEUROPHYSIOL, V103, P632, DOI 10.1152/jn.00670.2009; Itri JN, 2005, NAT NEUROSCI, V8, P650, DOI 10.1038/nn1448; Kim WS, 2002, ANAL CHEM, V74, P5614, DOI 10.1021/ac025917q; Ko CH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000513; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; O'Neill JS, 2008, SCIENCE, V320, P949, DOI 10.1126/science.1152506; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; O'Neill JS, 2011, NATURE, V469, P554, DOI 10.1038/nature09654; PROSSER RA, 1991, BRAIN RES, V568, P185, DOI 10.1016/0006-8993(91)91396-I; Rice ME, 2000, TRENDS NEUROSCI, V23, P209, DOI 10.1016/S0166-2236(99)01543-X; Robles MS, 2010, SCIENCE, V327, P463, DOI 10.1126/science.1180067; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Sullivan DM, 2002, METHOD ENZYMOL, V353, P101; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750	27	139	145	4	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	2012	337	6096					839	842		10.1126/science.1222826	http://dx.doi.org/10.1126/science.1222826			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	989BQ	22859819	Green Accepted			2022-12-28	WOS:000307535600042
J	Heijnsdijk, EAM; Wever, EM; Auvinen, A; Hugosson, J; Ciatto, S; Nelen, V; Kwiatkowski, M; Villers, A; Paez, A; Moss, SM; Zappa, M; Tammela, TLJ; Makinen, T; Carlsson, S; Korfage, IJ; Essink-Bot, ML; Otto, SJ; Draisma, G; Bangma, CH; Roobol, MJ; Schroder, FH; de Koning, HJ				Heijnsdijk, Eveline A. M.; Wever, Elisabeth M.; Auvinen, Anssi; Hugosson, Jonas; Ciatto, Stefano; Nelen, Vera; Kwiatkowski, Maciej; Villers, Arnauld; Paez, Alvaro; Moss, Sue M.; Zappa, Marco; Tammela, Teuvo L. J.; Makinen, Tuukka; Carlsson, Sigrid; Korfage, Ida J.; Essink-Bot, Marie-Louise; Otto, Suzie J.; Draisma, Gerrit; Bangma, Chris H.; Roobol, Monique J.; Schroder, Fritz H.; de Koning, Harry J.			Quality-of-Life Effects of Prostate-Specific Antigen Screening	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COMBINED ANDROGEN BLOCKADE; ACTIVE SURVEILLANCE; COST-EFFECTIVENESS; RADICAL PROSTATECTOMY; CANCER SURVIVORS; RANDOMIZED-TRIAL; LEAD TIME; FOLLOW-UP; OUTCOMES; HEALTH	Background After 11 years of follow-up, the European Randomized Study of Screening for Prostate Cancer (ERSPC) reported a 29% reduction in prostate-cancer mortality among men who underwent screening for prostate-specific antigen (PSA) levels. However, the extent to which harms to quality of life resulting from overdiagnosis and treatment counterbalance this benefit is uncertain. Methods On the basis of ERSPC follow-up data, we used Microsimulation Screening Analysis (MISCAN) to predict the number of prostate cancers, treatments, deaths, and quality-adjusted life-years (QALYs) gained after the introduction of PSA screening. Various screening strategies, efficacies, and quality-of-life assumptions were modeled. Results Per 1000 men of all ages who were followed for their entire life span, we predicted that annual screening of men between the ages of 55 and 69 years would result in nine fewer deaths from prostate cancer (28% reduction), 14 fewer men receiving palliative therapy (35% reduction), and a total of 73 life-years gained (average, 8.4 years per prostate-cancer death avoided). The number of QALYs that were gained was 56 (range, -21 to 97), a reduction of 23% from unadjusted life-years gained. To prevent one prostate-cancer death, 98 men would need to be screened and 5 cancers would need to be detected. Screening of all men between the ages of 55 and 74 would result in more life-years gained (82) but the same number of QALYs (56). Conclusions The benefit of PSA screening was diminished by loss of QALYs owing to postdiagnosis long-term effects. Longer follow-up data from both the ERSPC and quality-of-life analyses are essential before universal recommendations regarding screening can be made. (Funded by the Netherlands Organization for Health Research and Development and others.)	[Heijnsdijk, Eveline A. M.; Wever, Elisabeth M.; Korfage, Ida J.; Otto, Suzie J.; Draisma, Gerrit; de Koning, Harry J.] Erasmus MC, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands; [Bangma, Chris H.; Roobol, Monique J.; Schroder, Fritz H.] Erasmus MC, Dept Urol, NL-3000 CA Rotterdam, Netherlands; [Essink-Bot, Marie-Louise] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, NL-1105 AZ Amsterdam, Netherlands; [Auvinen, Anssi] Univ Tampere, Tampere Sch Hlth Sci, FIN-33101 Tampere, Finland; [Tammela, Teuvo L. J.] Univ Tampere, Dept Urol, Tampere Univ Hosp, FIN-33101 Tampere, Finland; [Makinen, Tuukka] Seinajoki Cent Hosp, Dept Surg, Seinajoki, Finland; [Auvinen, Anssi] Int Agcy Res Canc, F-69372 Lyon, France; [Villers, Arnauld] Ctr Hosp Reg & Univ Lille, Dept Urol, F-59037 Lille, France; [Hugosson, Jonas] Sahlgrens Univ Hosp, Dept Urol, Gothenburg, Sweden; Inst Canc Prevent, Dept Diagnost Med Imaging, Florence, Italy; [Zappa, Marco] Inst Canc Prevent, Epidemiol Unit, Florence, Italy; [Nelen, Vera] Prov Inst Hyg, Antwerp, Belgium; [Kwiatkowski, Maciej] Kantonsspital Aarau, Dept Urol, Aarau, Switzerland; [Paez, Alvaro] Hosp Fuenlabrada, Dept Urol, Madrid, Spain; [Moss, Sue M.] Queen Mary Univ London, Ctr Canc Prevent, London, England; Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam; Tampere University; Tampere University; Tampere University Hospital; Seinajoki Central Hospital; World Health Organization; International Agency for Research on Cancer (IARC); Universite de Lille - ISITE; CHU Lille; Sahlgrenska University Hospital; Kantonsspital Aarau AG (KSA); Hospital Universitario Fuenlabrada; University of London; Queen Mary University London; Memorial Sloan Kettering Cancer Center	Heijnsdijk, EAM (corresponding author), Erasmus MC, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands.	e.heijnsdijk@erasmusmc.nl	Auvinen, Anssi/AAD-9311-2020; Auvinen, Anssi/AAL-2111-2020; zappa, marco/AAB-3294-2019; Arnauld, VILLERS A/K-6629-2016; PAEZ, ALVARO/G-5458-2012; de+Koning, Harry/AAF-9062-2019	Auvinen, Anssi/0000-0003-1125-4818; zappa, marco/0000-0002-6606-9786; Arnauld, VILLERS A/0000-0002-6298-7758; de+Koning, Harry/0000-0003-4682-3646; Essink-Bot, Marie-Louise/0000-0002-4650-5886; Carlsson, Sigrid/0000-0003-3553-5710	Netherlands Organization for Health Research and Development, Europe against Cancer; fifth and sixth framework program of the European Union; agencies or health authorities in the participating countries; Beckman Coulter; Abbott Pharmaceuticals; GlaxoSmithKline; Astellas Pharma; Amgen; Pfizer; Orion Pharma; Abbott; 365/ArboNed; Ferring; Societe International d'Urologie; European Association of Urology; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Netherlands Organization for Health Research and Development, Europe against Cancer; fifth and sixth framework program of the European Union; agencies or health authorities in the participating countries; Beckman Coulter; Abbott Pharmaceuticals(Abbott Laboratories); GlaxoSmithKline(GlaxoSmithKline); Astellas Pharma(Astellas Pharmaceuticals); Amgen(Amgen); Pfizer(Pfizer); Orion Pharma; Abbott(Abbott Laboratories); 365/ArboNed; Ferring(Ferring Pharmaceuticals); Societe International d'Urologie; European Association of Urology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by grants from the Netherlands Organization for Health Research and Development, Europe against Cancer, and the fifth and sixth framework program of the European Union; by grants from agencies or health authorities in the participating countries; and by unconditional grants from Beckman Coulter.; Dr. Heijnsdijk reports receiving consulting fees from Beckman Coulter; Dr. Hugosson, receiving lecture fees from Abbott Pharmaceuticals and GlaxoSmithKline; Dr. Kwiatkowski, receiving consulting fees from GlaxoSmithKline; Dr. Villers, serving as a board member of GlaxoSmithKline and receiving travel support from Ferring; Dr. Tammela, receiving consulting fees from Astellas Pharma, GlaxoSmithKline, Amgen, Pfizer, and Orion Pharma, lecture fees from Abbott, GlaxoSmithKline, and Amgen, and travel support from Amgen; Dr. Essink-Bot, receiving lecture fees from 365/ArboNed; Dr. Draisma, receiving consulting fees from Beckman Coulter; Dr. Schorder, serving as a board member for European Urology, receiving consulting fees from GlaxoSmithKline and Ferring, and receiving lecture fees and travel support from GlaxoSmithKline, Ferring, Societe International d'Urologie, and the European Association of Urology; and Dr. de Koning, receiving consulting fees from Beckman Coulter. No other potential conflict of interest relevant to this article was reported.	Albertsen PC, 2005, JAMA-J AM MED ASSOC, V293, P2095, DOI 10.1001/jama.293.17.2095; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; [Anonymous], FDSF; [Anonymous], EUR STAND POP; Auvinen A, 2009, CANCER EPIDEM BIOMAR, V18, P2000, DOI 10.1158/1055-9965.EPI-09-0146; Bennett CL, 1996, CANCER-AM CANCER SOC, V77, P1854; Bill-Axelson A, 2008, J NATL CANCER I, V100, P1144, DOI 10.1093/jnci/djn255; Boorjian SA, 2011, CANCER-AM CANCER SOC, V117, P2883, DOI 10.1002/cncr.25900; Calvert NW, 2003, BRIT J CANCER, V88, P31, DOI 10.1038/sj.bjc.6600630; Carlsson S, 2011, EUR J CANCER, V47, P545, DOI 10.1016/j.ejca.2010.10.016; Chen RC, 2009, J CLIN ONCOL, V27, P3916, DOI 10.1200/JCO.2008.18.6486; Cooperberg MR, 2011, CANCER-AM CANCER SOC, V117, P2825, DOI 10.1002/cncr.25914; Cooperberg MR, 2011, J CLIN ONCOL, V29, P3669, DOI 10.1200/JCO.2011.34.9738; Crawford ED, 2008, EUR UROL, V54, P262, DOI 10.1016/j.eururo.2008.05.032; Damber JE, 2008, LANCET, V371, P1710, DOI 10.1016/S0140-6736(08)60729-1; DEHAES JCJM, 1991, INT J CANCER, V49, P538, DOI 10.1002/ijc.2910490411; Draisma G, 2003, J NATL CANCER I, V95, P868, DOI 10.1093/jnci/95.12.868; Draisma G, 2009, JNCI-J NATL CANCER I, V101, P374, DOI 10.1093/jnci/djp001; Essink-Bot ML, 1998, J NATL CANCER I, V90, P925, DOI 10.1093/jnci/90.12.925; Hayes JH, 2011, JAMA-J AM MED ASSOC, V305, P1862, DOI 10.1001/jama.2011.587; Hugosson J, 2000, BJU INT, V85, P1078, DOI 10.1046/j.1464-410x.2000.00679.x; Hugosson J, 2010, LANCET ONCOL, V11, P725, DOI 10.1016/S1470-2045(10)70146-7; Ilic D, 2007, CANCER CAUSE CONTROL, V18, P279, DOI 10.1007/s10552-006-0087-6; Institute for Clinical Research and Health Policy Studies, COST EFF AN REG; Johansson E, 2011, LANCET ONCOL, V12, P891, DOI 10.1016/S1470-2045(11)70162-0; Klotz L, 2010, J CLIN ONCOL, V28, P126, DOI 10.1200/JCO.2009.24.2180; Konski A, 2006, CANCER, V106, P51, DOI 10.1002/cncr.21575; Konski A, 2005, INT J RADIAT ONCOL, V63, P788, DOI 10.1016/j.ijrobp.2005.03.010; Korfage IJ, 2006, SOC SCI MED, V63, P911, DOI 10.1016/j.socscimed.2006.01.027; Korfage IJ, 2005, INT J CANCER, V116, P291, DOI 10.1002/ijc.21043; Korfage IJ, 2006, EUR J CANCER, V42, P165, DOI 10.1016/j.ejca.2005.10.011; Madalinska JB, 2001, J CLIN ONCOL, V19, P1619, DOI 10.1200/JCO.2001.19.6.1619; Moeremans K, 2004, VALUE HEALTH, V7, P472, DOI 10.1111/j.1524-4733.2004.74010.x; Mols F, 2009, INT J RADIAT ONCOL, V73, P30, DOI 10.1016/j.ijrobp.2008.04.004; Penson DF, 2005, J UROLOGY, V174, P547, DOI 10.1097/01.ju.0000165569.48372.4c; Potosky AL, 2004, J NATL CANCER I, V96, P1358, DOI 10.1093/jnci/djh259; Ramsey S, 2005, UROLOGY, V66, P835, DOI 10.1016/j.urology.2005.04.028; Roobol MJ, 2010, EUR UROL, V57, P79, DOI 10.1016/j.eururo.2009.08.025; Roobol MJ, 2009, EUR UROL, V56, P584, DOI 10.1016/j.eururo.2009.07.018; Sanda MG, 2008, NEW ENGL J MED, V358, P1250, DOI 10.1056/NEJMoa074311; Schroder FH, 2003, BJU INT, V92, P1, DOI 10.1111/j.1464-410X.2003.04389.x; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Smith DP, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4817; Stattin P, 2008, J UROLOGY, V180, P2423, DOI 10.1016/j.juro.2008.08.044; Stewart ST, 2005, MED CARE, V43, P347, DOI 10.1097/01.mlr.0000156862.33341.45; Steyerberg EW, 2007, J UROLOGY, V177, P107, DOI 10.1016/j.juro.2006.08.068; Telesca D, 2008, BIOMETRICS, V64, P10, DOI 10.1111/j.1541-0420.2007.00825.x; Thong MSY, 2010, BJU INT, V105, P652, DOI 10.1111/j.1464-410X.2009.08815.x; van den Bergh RCN, 2007, EUR UROL, V52, P1560, DOI 10.1016/j.eururo.2007.05.011; van den Bergh RCN, 2009, EUR UROL, V55, P1, DOI 10.1016/j.eururo.2008.09.007; Wolters T, 2010, INT J CANCER, V126, P2387, DOI 10.1002/ijc.24870; Zappa M, 1998, ANN ONCOL, V9, P1297, DOI 10.1023/A:1008492013196; Zeliadt SB, 2005, AM J MED, V118, P850, DOI 10.1016/j.amjmed.2005.03.001	54	299	312	3	48	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 16	2012	367	7					595	605		10.1056/NEJMoa1201637	http://dx.doi.org/10.1056/NEJMoa1201637			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988NB	22894572	Green Accepted			2022-12-28	WOS:000307496600003
J	Trillsch, F; Aberle, J; Regier, M; Choschzick, M; Mahner, S				Trillsch, Fabian; Aberle, Jens; Regier, Marc; Choschzick, Matthias; Mahner, Sven			Lost in effusion	LANCET			English	Editorial Material							MANAGEMENT; TUMORS		[Trillsch, Fabian; Mahner, Sven] Univ Med Ctr Hamburg Eppendorf, Dept Gynaecol & Gynaecol Oncol, D-20246 Hamburg, Germany; [Aberle, Jens] Univ Med Ctr Hamburg Eppendorf, Interdisciplinary Obes Ctr, Dept Endocrinol & Diabetol, D-20246 Hamburg, Germany; [Regier, Marc] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Radiol, D-20246 Hamburg, Germany; [Choschzick, Matthias] Univ Med Ctr Hamburg Eppendorf, Inst Pathol, D-20246 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Mahner, S (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Gynaecol & Gynaecol Oncol, Martinistr 52, D-20246 Hamburg, Germany.	s.mahner@uke.uni-hamburg.de	Mahner, Sven/F-3560-2014; Trillsch, Fabian/AFO-4235-2022; Regier, Marc/W-5427-2019	Trillsch, Fabian/0000-0002-1860-4350				Cadron I, 2007, J CLIN ONCOL, V25, P2928, DOI 10.1200/JCO.2007.10.8076; Kazanov L, 1998, AM J EMERG MED, V16, P404, DOI 10.1016/S0735-6757(98)90141-3; Meigs JV., 1937, AM J OBSTET GYNECOL, V33, P249, DOI [DOI 10.1016/S0002-9378(37)80015-0], 10.1016/S0002-9378(37)80015-0]; Sangoi AR, 2008, AM J SURG PATHOL, V32, P261, DOI 10.1097/PAS.0b013e318141fc7a; Trillsch F, 2010, EXPERT REV ANTICANC, V10, P1115, DOI 10.1586/ERA.10.90	5	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 11	2012	380	9841					620	620		10.1016/S0140-6736(12)60323-7	http://dx.doi.org/10.1016/S0140-6736(12)60323-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988SQ	22883511				2022-12-28	WOS:000307511400035
J	Fairn, GD; Grinstein, S				Fairn, Gregory D.; Grinstein, Sergio			Precursor or Charge Supplier?	SCIENCE			English	Editorial Material							II PHOSPHATIDYLINOSITOL 4-KINASE; PROTEIN; PHOSPHOINOSITIDES		[Fairn, Gregory D.; Grinstein, Sergio] St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Grinstein, Sergio] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Fairn, GD (corresponding author), St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada.	sergio.grinstein@sickkids.ca		Fairn, Greg/0000-0001-6508-168X				D'Angelo G, 2008, J CELL SCI, V121, P1955, DOI 10.1242/jcs.023630; de Saint-Jean M, 2011, J CELL BIOL, V195, P965, DOI 10.1083/jcb.201104062; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Fairn GD, 2011, J CELL BIOL, V194, P257, DOI 10.1083/jcb.201012028; Hammond GRV, 2012, SCIENCE, V337, P727, DOI 10.1126/science.1222483; KAUFFMANNZEH A, 1995, SCIENCE, V268, P1188, DOI 10.1126/science.7761838; Kim YJ, 2011, DEV CELL, V21, P813, DOI 10.1016/j.devcel.2011.09.005; Nishikawa K, 1998, J BIOL CHEM, V273, P23126, DOI 10.1074/jbc.273.36.23126; van den Bogaart G, 2011, NATURE, V479, P552, DOI 10.1038/nature10545; Waugh MG, 2003, BIOCHEM J, V373, P57, DOI 10.1042/BJ20030089; Wong K, 1997, J BIOL CHEM, V272, P13236, DOI 10.1074/jbc.272.20.13236	11	11	11	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2012	337	6095					653	654		10.1126/science.1227096	http://dx.doi.org/10.1126/science.1227096			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986PE	22879491				2022-12-28	WOS:000307354500028
J	Lowenthal, J; Hull, SC; Pearson, SD				Lowenthal, Justin; Hull, Sara Chandros; Pearson, Steven D.			The Ethics of Early Evidence - Preparing for a Possible Breakthrough in Alzheimer's Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lowenthal, Justin; Hull, Sara Chandros; Pearson, Steven D.] NIH, Dept Bioeth, Ctr Clin, Bethesda, MD 20892 USA; [Hull, Sara Chandros] NHGRI, NIH, Off Clin Director, Bethesda, MD 20892 USA; [Pearson, Steven D.] Massachusetts Gen Hosp, Inst Clin & Econ Review, Inst Technol Assessment, Boston, MA 02114 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Harvard University; Massachusetts General Hospital	Lowenthal, J (corresponding author), NIH, Dept Bioeth, Ctr Clin, Bldg 10, Bethesda, MD 20892 USA.		Lowenthal, Justin/H-3728-2013	Lowenthal, Justin/0000-0001-5909-0520	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIDHG200347] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 HG999999] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Dresser R, 2009, J LAW MED ETHICS, V37, P476, DOI 10.1111/j.1748-720X.2009.00408.x; Food and Drug Administration, 2011, TARGR BEX CAPS 75 MG; Frost J, 2011, J MED INTERNET RES, V13, P129, DOI 10.2196/jmir.1643; Wang SS, 2012, WALL STREET J, pA3	5	16	28	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 9	2012	367	6					488	490		10.1056/NEJMp1203104	http://dx.doi.org/10.1056/NEJMp1203104			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	986AE	22873528	Green Accepted			2022-12-28	WOS:000307310800002
J	Kit, BK; Carroll, MD; Lacher, DA; Sorlie, PD; DeJesus, JM; Ogden, CL				Kit, Brian K.; Carroll, Margaret D.; Lacher, David A.; Sorlie, Paul D.; DeJesus, Janet M.; Ogden, Cynthia L.			Trends in Serum Lipids Among US Youths Aged 6 to 19 Years, 1988-2010	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; CARDIOVASCULAR RISK-FACTORS; UNITED-STATES; CHILDREN; ADOLESCENTS; CHILDHOOD; PREVALENCE; ADULTHOOD; HYPERCHOLESTEROLEMIA; ATHEROSCLEROSIS	Context For more than 20 years, primary prevention of coronary heart disease has included strategies intended to improve overall serum lipid concentrations among youths. Objective To examine trends in lipid concentrations among youths from 19881994 through 2007-2010. Design, Setting, and Participants Cross-sectional analysis of serum lipid concentrations among 16 116 youths aged 6 to 19 years who participated in the nationally representative National Health and Nutrition Examination Survey during 3 time periods: 1988-1994, 1999-2002, and 2007-2010. Main Outcome Measures Among all youths, mean serum total cholesterol (TC), non-high-density lipoprotein cholesterol (non-HDL-C), high-density lipoprotein cholesterol (HDL-C); and among adolescents only, low-density lipoprotein cholesterol (LDL-C) and geometric mean triglyceride levels. Trends in adverse lipid concentrations are reported for TC levels of 200 mg/dL and greater, non-HDL-C levels of 145 mg/dL and greater, HDL-C levels of less than 40 mg/dL, LDL-C levels of 130 mg/dL and greater, and triglyceride levels of 130 mg/dL and greater. Results Among youths aged 6 to 19 years between 1988-1994 and 2007-2010, there was a decrease in mean TC (from 165 mg/dL [95% CI, 164-167] to 160 mg/dL [95% CI, 158-161]; P<.001) and a decrease in the prevalence of elevated TC (from 11.3% [95% CI, 9.8%-12.7%] to 8.1% [95% CI, 6.7%-9.5%]; P=.002). Mean HDL-C significantly increased between 1988-1994 and 2007-2010, but the prevalence of low HDL-C did not change. Mean non-HDL-C and prevalence of elevated non-HDL-C both significantly decreased over the study period. In 2007-2010, 22% (95% CI, 20.3%-23.6%) of youths had either a low HDL-C level or high non-HDL-C, which was lower than the 27.2% (95% CI, 24.6%-29.7%) in 1988-1994 (P=.001). Among adolescents (aged 12-19 years) between 1988-1994 and 2007-2010, there was a decrease in mean LDL-C (from 95 mg/dL [95% CI, 92-98] to 90 mg/dL [95% CI, 88-91]; P=.003) and a decrease in geometric mean triglycerides (from 82 mg/dL [95% CI, 78-86] to 73 mg/dL [95% CI, 70-76]; P<.001). Prevalence of elevated LDL-C and triglycerides between 1988-1994 and 2007-2010 also significantly decreased. Conclusions Between 1988-1994 and 2007-2010, a favorable trend in serum lipid concentrations was observed among youths in the United States but almost 1 in 10 had elevated TC in 2007-2010. JAMA. 2012;308(6):591-600	[Kit, Brian K.; Carroll, Margaret D.; Lacher, David A.; Ogden, Cynthia L.] Ctr Dis Control & Prevent, Div Hlth & Nutr Examinat Surveys, Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA; [Kit, Brian K.] US PHS, Rockville, MD USA; [Sorlie, Paul D.] NHLBI, Div Cardiovasc Sci, NIH, Bethesda, MD 20892 USA; [DeJesus, Janet M.] NHLBI, Div Applicat Res Discoveries, NIH, Bethesda, MD 20892 USA	Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS); United States Public Health Service; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Kit, BK (corresponding author), Ctr Dis Control & Prevent, Div Hlth & Nutr Examinat Surveys, Natl Ctr Hlth Stat, 3311 Toledo Rd,MS PO8,Room 4419, Hyattsville, MD 20782 USA.	bkit@cdc.gov			National Heart, Lung, and Blood Institute, National Institutes of Health [Y1-HC-8039]	National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The laboratory analysis of the lipids described in this paper was funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, Intra-agency Agreement number Y1-HC-8039.	ALLAIN CC, 1974, CLIN CHEM, V20, P470; [Anonymous], 1995, JAMA, V273, P1429; [Anonymous], 1991, ARCH INTERN MED, V151, P1071, DOI 10.1001/archinte.151.6.1071; [Anonymous], 1994, Vital Health Stat 1, P1; [Anonymous], 1992, Pediatrics, V89, P525; [Anonymous], 2011, PEDIATRICS S5, V128, pS213, DOI [10.1542/peds.2009-2107C, DOI 10.1542/PEDS.2009-2107C]; BACHORIK PS, 1984, CLIN CHEM, V30, P839; BERENSON GS, 1981, AM J EPIDEMIOL, V113, P157, DOI 10.1093/oxfordjournals.aje.a113080; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Carroll MD, 2005, JAMA-J AM MED ASSOC, V294, P1773, DOI 10.1001/jama.294.14.1773; Centers for Disease Control and Prevention Division of Adolescent and School Health, 1991, TRENDS PREV TOB US N; Centers for Disease Control and Prevention/National Center for Health Statistics, NHANES 2009 2010 PUB; Centers for Disease Control and Prevention/National Center for Health Statistics, 2010, LAB PROC MAN HIGH DE; Centers for Disease Control and Prevention/National Center for Health Statistics, 2010, LAB PROC MAN TRIGL; Centers for Disease Control and Prevention/National Center for Health Statistics, NHANES 1999 2010; Centers for Disease Control and Prevention/National Center for Health Statistics/Division of Health and Nutrition Surveys, 2010, LAB PROC MAN TOT CHO; Daniels SR, 2008, PEDIATRICS, V122, P198, DOI 10.1542/peds.2008-1349; DONAHUE RP, 1985, AM J EPIDEMIOL, V122, P458, DOI 10.1093/oxfordjournals.aje.a114127; FELDMAN J, 1991, PEDIATRICS, V88, P259; Ford ES, 2009, CIRCULATION, V119, P1108, DOI 10.1161/CIRCULATIONAHA.108.816769; Ford ES, 2004, PEDIATRICS, V114, P1534, DOI 10.1542/peds.2004-0674; Freedman DS, 2012, PEDIATRICS, V130, pE159, DOI 10.1542/peds.2011-3302; Freedman DS, 1999, PEDIATRICS, V103, P1175, DOI 10.1542/peds.103.6.1175; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Friedman LA, 2006, PEDIATRICS, V118, P165, DOI 10.1542/peds.2005-2968; Frontini MG, 2008, PEDIATRICS, V121, P924, DOI 10.1542/peds.2007-1472; Guo, 2002, VITAL HLTH STAT, V11, DOI DOI 10.1016/J.BBRC.2015.06.114; Hickman TB, 1998, PREV MED, V27, P879, DOI 10.1006/pmed.1998.0376; Klish WJ, 1998, PEDIATRICS, V101, P141; LAUER RM, 1990, JAMA-J AM MED ASSOC, V264, P3034, DOI 10.1001/jama.264.23.3034; Li SX, 2003, JAMA-J AM MED ASSOC, V290, P2271, DOI 10.1001/jama.290.17.2271; MCGILL HC, 1990, JAMA-J AM MED ASSOC, V264, P3018; National Center for Health Statistics, NHANES RESP RAT CPS; National Center for Health Statistics, 2010, HLTH US 2010; Neufeld EJ, 1997, CIRCULATION, V96, P1403, DOI 10.1161/01.CIR.96.5.1403; Ogden CL, 2002, JAMA-J AM MED ASSOC, V288, P1728, DOI 10.1001/jama.288.14.1728; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Raitakari OT, 2003, JAMA-J AM MED ASSOC, V290, P2277, DOI 10.1001/jama.290.17.2277; Reedy J, 2010, J AM DIET ASSOC, V110, P1477, DOI 10.1016/j.jada.2010.07.010; Research Triangle Institute, SUDAAN LANG MAN REL; Schober S. E., 2008, Morbidity and Mortality Weekly Report, V57, P744; Sofianou A, 2011, J AM DIET ASSOC, V111, P1563, DOI 10.1016/j.jada.2011.07.005; SUGIUCHI H, 1995, CLIN CHEM, V41, P717; The Centers for Disease Control and Prevention /Lipid Standardization Program, 2012, LAB QUAL ASS STAND P; THORLAND WG, 1981, MED SCI SPORT EXER, V13, P316; US Department of Agriculture and US Department of Health and Human Services, 2010, DIET GUID AM 2010; US Dept of Agriculture Agriculture Research Service, PERC EN PROT CARB FA; Vesper HW, 2012, JAMA-J AM MED ASSOC, V307, P562, DOI 10.1001/jama.2012.112; Wahlefeld A.W., 1974, METHODS ENZYMATIC AN, P1604; WEBBER LS, 1991, AM J EPIDEMIOL, V133, P884, DOI 10.1093/oxfordjournals.aje.a115968; Welsh JA, 2011, CIRCULATION, V123, P249, DOI 10.1161/CIRCULATIONAHA.110.972166; Wiegman A, 2004, JAMA-J AM MED ASSOC, V292, P331, DOI 10.1001/jama.292.3.331; Winer BJ., 1970, STAT PRINCIPLES EXPT, V2nd; Wolters K.M., 1990, VARIANCE ESTIMATION	54	92	95	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2012	308	6					591	600		10.1001/jama.2012.9136	http://dx.doi.org/10.1001/jama.2012.9136			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	984YA	22871871	Bronze			2022-12-28	WOS:000307228400026
J	Kellosalo, J; Kajander, T; Kogan, K; Pokharel, K; Goldman, A				Kellosalo, Juho; Kajander, Tommi; Kogan, Konstantin; Pokharel, Kisun; Goldman, Adrian			The Structure and Catalytic Cycle of a Sodium-Pumping Pyrophosphatase	SCIENCE			English	Article							H+-PYROPHOSPHATASE; SUBSTRATE; K+	Membrane-integral pyrophosphatases (M-PPases) are crucial for the survival of plants, bacteria, and protozoan parasites. They couple pyrophosphate hydrolysis or synthesis to Na+ or H+ pumping. The 2.6-angstrom structure of Thermotoga maritima M-PPase in the resting state reveals a previously unknown solution for ion pumping. The hydrolytic center, 20 angstroms above the membrane, is coupled to the gate formed by the conserved Asp(243), Glu(246), and Lys(707) by an unusual "coupling funnel" of six a helices. Comparison with our 4.0-angstrom resolution structure of the product complex suggests that helix 12 slides down upon substrate binding to open the gate by a simple binding-change mechanism. Below the gate, four helices form the exit channel. Superimposing helices 3 to 6, 9 to 12, and 13 to 16 suggests that M-PPases arose through gene triplication.	[Kellosalo, Juho; Kajander, Tommi; Kogan, Konstantin; Pokharel, Kisun; Goldman, Adrian] Univ Helsinki, Inst Biotechnol, Struct Biol & Biophys Program, FIN-00014 Helsinki, Finland; [Kellosalo, Juho] Grad Sch Informat & Struct Biol, Helsinki, Finland; [Pokharel, Kisun] Univ Turku, Dept Biochem & Food Chem, FIN-20014 Turku, Finland	University of Helsinki; University of Turku	Goldman, A (corresponding author), Univ Helsinki, Inst Biotechnol, Struct Biol & Biophys Program, POB 65, FIN-00014 Helsinki, Finland.	adrian.goldman@helsinki.fi	Pokharel, Kisun/D-4628-2011	Pokharel, Kisun/0000-0002-4924-946X; Goldman, Adrian/0000-0001-8032-9700; Kogan, Konstantin/0000-0003-3270-9391; Kajander, Tommi/0000-0002-5094-227X	European Union Seventh Framework Program EDICT; Sigrid Juselius Foundation; Academy of Finland; Biocenter Finland; National Graduate School of Informational and Structural Biology	European Union Seventh Framework Program EDICT; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Biocenter Finland; National Graduate School of Informational and Structural Biology	We thank D. Bansfield, K. Rosti, and R. Honkanen for technical assistance; S. Maki and the Biocenter Finland crystallization unit; A. Serrano (University of Seville) for the generous gift of plasmid pRS1024; I. Braakman (Utrecht University) for the generous gift of S. cerevisae BJ1991; and R. Kolodziejczyk, M. Wikstrom (University of Helsinki), E. Oksanen (European Spallation Source), and R. Lahti (University of Turku) for fruitful discussions. This work was supported by the European Union Seventh Framework Program EDICT (A.G.), the Sigrid Juselius Foundation (A.G.), the Academy of Finland (A.G. and T.K.), Biocenter Finland (K.K.), and the National Graduate School of Informational and Structural Biology (J.K.). We thank the beamline scientists at ID14-4, ID29, ID23-1 at the European Synchrotron Radiation Facility and at beamline 911-3, Max-Lab. Coordinates and structure factors for the resting state (TmPPase:Ca:Mg) and product complex (TmPPase:Pi<INF>2</INF>:Mg<INF>4</INF>) structures have been deposited in the Protein Data Bank with codes 4AV3 and 4AV6, respectively. The authors declare no competing financial interests.	AGMON N, 1995, CHEM PHYS LETT, V244, P456, DOI 10.1016/0009-2614(95)00905-J; Baltscheffsky M, 1999, FEBS LETT, V457, P525, DOI 10.1016/S0014-5793(99)00914-X; BAYKOV AA, 1994, FEBS LETT, V350, P323, DOI 10.1016/0014-5793(94)00800-0; BAYKOV AA, 1993, EUR J BIOCHEM, V217, P755, DOI 10.1111/j.1432-1033.1993.tb18303.x; Belogurov GA, 2002, J BIOL CHEM, V277, P49651, DOI 10.1074/jbc.M210341200; Hedlund J, 2006, FEBS J, V273, P5183, DOI 10.1111/j.1742-4658.2006.05514.x; Heikinheimo P, 1996, STRUCTURE, V4, P1491, DOI 10.1016/S0969-2126(96)00155-4; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Kellosalo J, 2011, PROTEIN EXPRES PURIF, V79, P25, DOI 10.1016/j.pep.2011.05.020; Lanyi JK, 2006, BBA-BIOENERGETICS, V1757, P1012, DOI 10.1016/j.bbabio.2005.11.003; Lemercier G, 2002, J BIOL CHEM, V277, P37369, DOI 10.1074/jbc.M204744200; Lin SM, 2012, NATURE, V484, P399, DOI 10.1038/nature10963; Luoto HH, 2011, J BIOL CHEM, V286, P21633, DOI 10.1074/jbc.M111.244483; Maeshima M, 2000, BBA-BIOMEMBRANES, V1465, P37, DOI 10.1016/S0005-2736(00)00130-9; Malinen AM, 2007, BIOCHEMISTRY-US, V46, P8872, DOI 10.1021/bi700564b; Malinen AM, 2008, BIOCHEMISTRY-US, V47, P13447, DOI 10.1021/bi801803b; Mimura H, 2004, J BIOL CHEM, V279, P35106, DOI 10.1074/jbc.M406264200; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Stock D, 2000, CURR OPIN STRUC BIOL, V10, P672, DOI 10.1016/S0959-440X(00)00147-0	20	100	102	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 27	2012	337	6093					473	476		10.1126/science.1222505	http://dx.doi.org/10.1126/science.1222505			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979FS	22837527				2022-12-28	WOS:000306802300045
J	Lu, YJ; Kim, J; Chen, HY; Wu, CH; Dabidian, N; Sanders, CE; Wang, CY; Lu, MY; Li, BH; Qiu, XG; Chang, WH; Chen, LJ; Shvets, G; Shih, CK; Gwo, S				Lu, Yu-Jung; Kim, Jisun; Chen, Hung-Ying; Wu, Chihhui; Dabidian, Nima; Sanders, Charlotte E.; Wang, Chun-Yuan; Lu, Ming-Yen; Li, Bo-Hong; Qiu, Xianggang; Chang, Wen-Hao; Chen, Lih-Juann; Shvets, Gennady; Shih, Chih-Kang; Gwo, Shangjr			Plasmonic Nanolaser Using Epitaxially Grown Silver Film	SCIENCE			English	Article							LASERS	A nanolaser is a key component for on-chip optical communications and computing systems. Here, we report on the low-threshold, continuous-wave operation of a subdiffraction nanolaser based on surface plasmon amplification by stimulated emission of radiation. The plasmonic nanocavity is formed between an atomically smooth epitaxial silver film and a single optically pumped nanorod consisting of an epitaxial gallium nitride shell and an indium gallium nitride core acting as gain medium. The atomic smoothness of the metallic film is crucial for reducing the modal volume and plasmonic losses. Bimodal lasing with similar pumping thresholds was experimentally observed, and polarization properties of the two modes were used to unambiguously identify them with theoretically predicted modes. The all-epitaxial approach opens a scalable platform for low-loss, active nanoplasmonics.	[Lu, Yu-Jung; Chen, Hung-Ying; Wang, Chun-Yuan; Gwo, Shangjr] Natl Tsing Hua Univ, Dept Phys, Hsinchu 30013, Taiwan; [Kim, Jisun; Wu, Chihhui; Dabidian, Nima; Sanders, Charlotte E.; Shvets, Gennady; Shih, Chih-Kang] Univ Texas, Dept Phys, Austin, TX 78712 USA; [Lu, Ming-Yen; Chen, Lih-Juann] Natl Tsing Hua Univ, Dept Mat Sci & Engn, Hsinchu 30013, Taiwan; [Li, Bo-Hong; Qiu, Xianggang] Chinese Acad Sci, Beijing Natl Lab Condensed Matter Phys, Beijing 100190, Peoples R China; [Li, Bo-Hong; Qiu, Xianggang] Chinese Acad Sci, Inst Phys, Beijing 100190, Peoples R China; [Chang, Wen-Hao] Natl Chiao Tung Univ, Dept Electrophys, Hsinchu 30010, Taiwan	National Tsing Hua University; University of Texas System; University of Texas Austin; National Tsing Hua University; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Physics, CAS; National Yang Ming Chiao Tung University	Gwo, S (corresponding author), Natl Tsing Hua Univ, Dept Phys, Hsinchu 30013, Taiwan.	shih@physics.utexas.edu; gwo@phys.nthu.edu.tw	Plekhanov, Alexander I/C-5971-2014; Chang, Wen-Hao/C-4906-2013; Gwo, Shangjr/D-6236-2019; Chen, Hung-Ying/D-2611-2009; Gwo, Shangjr/A-9946-2008; Li, Bo-Hong/B-2816-2008; Sanders, Charlotte E./R-2357-2017; Kim, Jisun/A-8774-2014; Sanders, Charlotte/AAH-7828-2021; Lu, Yu-Jung/H-3608-2017; Gwo, S./W-3047-2019	Plekhanov, Alexander I/0000-0002-4073-0636; Chang, Wen-Hao/0000-0003-4880-6006; Gwo, Shangjr/0000-0002-3013-0477; Li, Bo-Hong/0000-0002-5368-8537; Sanders, Charlotte E./0000-0003-0776-4671; Kim, Jisun/0000-0002-5810-1512; Sanders, Charlotte/0000-0003-0776-4671; Lu, Yu-Jung/0000-0002-3932-653X; Gwo, S./0000-0002-3013-0477; Lu, Ming-Yen/0000-0003-1788-1425	National Science Council in Taiwan [NSC-100-2120-M-007-001, NSC-98-2112-M-007-014-MY3, NSC-98-2221-E-007-104-MY3]; United States; NSF [DMR-0906025, CMMI-0928664, DGE-0549417]; Office of Naval Research [N00014-10-1-0929]; Air Force Office of Scientific Research [FA9550-08-1-0394]; Welch Foundation [F-1672]; MOST of China [2009CB929102, 2012CB921302]; Division Of Materials Research [0906025] Funding Source: National Science Foundation	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan); United States; NSF(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Welch Foundation(The Welch Foundation); MOST of China(Ministry of Science and Technology, China); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We acknowledge support from the National Science Council in Taiwan (NSC-100-2120-M-007-001, NSC-98-2112-M-007-014-MY3, and NSC-98-2221-E-007-104-MY3) and, in the United States, the NSF (DMR-0906025, CMMI-0928664, and DGE-0549417), the Office of Naval Research (N00014-10-1-0929), the Air Force Office of Scientific Research (FA9550-08-1-0394), the Welch Foundation (F-1672), and the MOST of China (2009CB929102, 2012CB921302).	Altug H, 2006, NAT PHYS, V2, P484, DOI 10.1038/nphys343; Barnes WL, 2003, NATURE, V424, P824, DOI 10.1038/nature01937; Bergman DJ, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.027402; Gramotnev DK, 2010, NAT PHOTONICS, V4, P83, DOI 10.1038/nphoton.2009.282; Hill MT, 2007, NAT PHOTONICS, V1, P589, DOI 10.1038/nphoton.2007.171; Hill MT, 2010, J OPT SOC AM B, V27, pB36, DOI 10.1364/JOSAB.27.000B36; Huang JS, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1143; Jackson J. D., 1999, CLASSICAL ELECTRODYN; Lu YJ, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3597211; Ma RM, 2011, NAT MATER, V10, P110, DOI 10.1038/nmat2919; Maier SA, 2005, J APPL PHYS, V98, DOI 10.1063/1.1951057; Nagpal P, 2009, SCIENCE, V325, P594, DOI 10.1126/science.1174655; Nezhad MP, 2010, NAT PHOTONICS, V4, P395, DOI 10.1038/NPHOTON.2010.88; Noda S, 2006, SCIENCE, V314, P260, DOI 10.1126/science.1131322; Noginov MA, 2009, NATURE, V460, P1110, DOI 10.1038/nature08318; Oulton RF, 2008, NAT PHOTONICS, V2, P496, DOI 10.1038/nphoton.2008.131; Oulton RF, 2009, NATURE, V461, P629, DOI 10.1038/nature08364; Painter O, 1999, SCIENCE, V284, P1819, DOI 10.1126/science.284.5421.1819; Schuller JA, 2010, NAT MATER, V9, P193, DOI [10.1038/NMAT2630, 10.1038/nmat2630]; Shaklee K. L., 1973, Journal of Luminescence, V7, P284, DOI 10.1016/0022-2313(73)90072-0; Smith AR, 1996, SCIENCE, V273, P226, DOI 10.1126/science.273.5272.226; Stockman MI, 2010, J OPTICS-UK, V12, DOI 10.1088/2040-8978/12/2/024004; Strauf S, 2011, LASER PHOTONICS REV, V5, P607, DOI 10.1002/lpor.201000039; Tandaechanurat A, 2011, NAT PHOTONICS, V5, P91, DOI [10.1038/nphoton.2010.286, 10.1038/NPHOTON.2010.286]; Vahala KJ, 2003, NATURE, V424, P839, DOI 10.1038/nature01939; West PR, 2010, LASER PHOTONICS REV, V4, P795, DOI 10.1002/lpor.200900055; Wu CY, 2011, NANO LETT, V11, P4256, DOI 10.1021/nl2022477; Yu H., 2001, PHYS REV LETT, V88	28	598	606	21	670	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2012	337	6093					450	453		10.1126/science.1223504	http://dx.doi.org/10.1126/science.1223504			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979FS	22837524				2022-12-28	WOS:000306802300038
J	Ma, KF; Lin, YY; Lee, SJ; Mori, J; Brodsky, EE				Ma, Kuo-Fong; Lin, Yen-Yu; Lee, Shiann-Jong; Mori, Jim; Brodsky, Emily E.			Isotropic Events Observed with a Borehole Array in the Chelungpu Fault Zone, Taiwan	SCIENCE			English	Article							1999 CHI-CHI; PHYSICAL-PROPERTIES; EARTHQUAKE; PERMEABILITY; LUBRICATION; POROSITY; RUPTURE	Shear failure is the dominant mode of earthquake-causing rock failure along faults. High fluid pressure can also potentially induce rock failure by opening cavities and cracks, but an active example of this process has not been directly observed in a fault zone. Using borehole array data collected along the low-stress Chelungpu fault zone, Taiwan, we observed several small seismic events (I-type events) in a fluid-rich permeable zone directly below the impermeable slip zone of the 1999 moment magnitude 7.6 Chi-Chi earthquake. Modeling of the events suggests an isotropic, nonshear source mechanism likely associated with natural hydraulic fractures. These seismic events may be associated with the formation of veins and other fluid features often observed in rocks surrounding fault zones and may be similar to artificially induced hydraulic fracturing.	[Ma, Kuo-Fong; Lin, Yen-Yu] Natl Cent Univ, Dept Earth Sci, Jhongli, Taiwan; [Ma, Kuo-Fong; Lin, Yen-Yu] Natl Cent Univ, Inst Geophys, Jhongli, Taiwan; [Ma, Kuo-Fong; Lee, Shiann-Jong] Acad Sinica, Inst Earth Sci, Taipei, Taiwan; [Mori, Jim] Kyoto Univ, Disaster Prevent Res Inst, Kyoto 6068501, Japan; [Brodsky, Emily E.] Univ Calif Santa Cruz, Dept Earth Sci, Santa Cruz, CA 95060 USA	National Central University; National Central University; Academia Sinica - Taiwan; Kyoto University; University of California System; University of California Santa Cruz	Ma, KF (corresponding author), Natl Cent Univ, Dept Earth Sci, Jhongli, Taiwan.	fong@ncu.edu.tw	Brodsky, Emily/B-9139-2014; Ma, Kuo-Fong/H-1445-2012; Lee, S. J./N-3334-2013	Ma, Kuo-Fong/0000-0002-4500-8079; Lee, Shiann-Jong/0000-0002-3111-9675; Brodsky, Emily/0000-0002-6855-6860	National Science Council of Taiwan [NSC 100-2119-M-008 -031]; Ministry of Education at National Central University [100G901-26]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education at National Central University	We thank C. Y. Wang for operational support for the TCDP site. This study benefited from discussions with H. Kanamori, M. Campillo, and T.-R. Alex Song. The TCDP BHS data are available to the public at the Data Center of the Taiwan Earthquake Research Center (TECDC) (http://tecws.earth.sinica.edu.tw/TCDP). This project is supported by National Science Council of Taiwan, NSC 100-2119-M-008 -031, and Ministry of Education 100G901-26 at National Central University.	Ben-Zion Y, 2009, GEOPHYS J INT, V178, P1351, DOI 10.1111/j.1365-246X.2009.04285.x; Bohnhoff M, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2010JB000848; Cappa F, 2005, INT J ROCK MECH MIN, V42, P287, DOI 10.1016/j.ijrmms.2004.11.006; Cappa F, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028980; Carena S, 2002, GEOLOGY, V30, P935, DOI 10.1130/0091-7613(2002)030<0935:ADOTIB>2.0.CO;2; Chan YC, 2005, TERRA NOVA, V17, P493, DOI 10.1111/j.1365-3121.2005.00636.x; Chen C.-Y., 2010, THESIS NATL TAIWAN U; Chen YG, 2001, B SEISMOL SOC AM, V91, P977, DOI 10.1785/0120000721; Davies RJ, 2012, MAR PETROL GEOL, V37, P1, DOI 10.1016/j.marpetgeo.2012.04.001; Doan ML, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026889; Dong JJ, 2010, INT J ROCK MECH MIN, V47, P1141, DOI 10.1016/j.ijrmms.2010.06.019; Hsu YJ, 2007, GEOPHYS J INT, V169, P367, DOI 10.1111/j.1365-246X.2006.03310.x; Hung JH, 2009, TECTONOPHYSICS, V466, P307, DOI 10.1016/j.tecto.2007.11.014; Julian BR, 1996, B SEISMOL SOC AM, V86, P972; Lee SJ, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004615; Lin ATS, 2007, TERR ATMOS OCEAN SCI, V18, P223, DOI 10.3319/TAO.2007.18.2.223(TCDP); Lin YY, 2012, GEOPHYS J INT, V190, P665, DOI 10.1111/j.1365-246X.2012.05513.x; Ma KF, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL015380; Ma KF, 2006, NATURE, V444, P473, DOI 10.1038/nature05253; MCGARR A, 1992, GEOPHYS RES LETT, V19, P1579, DOI 10.1029/92GL01581; Montgomery C.T., 2010, J PET TECHNOL, V62, P26, DOI [10.2118/1210-0026-JPT, DOI 10.2118/1210-0026-JPT]; Oye V, 2003, COMPUT GEOSCI-UK, V29, P851, DOI 10.1016/S0098-3004(03)00088-8; Sibson R. H., 2004, AAPG BULL, V82, P1; SIBSON RH, 1992, TECTONOPHYSICS, V211, P283, DOI 10.1016/0040-1951(92)90065-E; Tanaka H, 2002, TERR ATMOS OCEAN SCI, V13, P227, DOI 10.3319/TAO.2002.13.3.227(CCE); Tanikawa W, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2008GC002269; Wang JH, 2010, TERR ATMOS OCEAN SCI, V21, P655, DOI 10.3319/TAO.2009.09.01.01(T); Wang JH, 2009, J ASIAN EARTH SCI, V36, P135, DOI 10.1016/j.jseaes.2009.01.010; Wu HY, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028050; Yeh EC, 2007, TERR ATMOS OCEAN SCI, V18, P327, DOI 10.3319/TAO.2007.18.2.327(TCDP)	30	20	24	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 27	2012	337	6093					459	463		10.1126/science.1222119	http://dx.doi.org/10.1126/science.1222119			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979FS	22837526				2022-12-28	WOS:000306802300041
J	Jones, DS				Jones, David S.			Olympic Medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Jones, David S.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02115 USA; [Jones, David S.] Harvard Univ, Dept Hist Sci, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University	Jones, DS (corresponding author), Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02115 USA.							Green GB, 1998, JAMA-J AM MED ASSOC, V279, P1485, DOI 10.1001/jama.279.18.1485; RYAN AJ, 1968, J AMER MED ASSOC, V205, P715, DOI 10.1001/jama.205.11.715; Sandel Michael J., 2007, CASE PERFECTION ETHI	3	3	3	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 26	2012	367	4					289	292		10.1056/NEJMp1207775	http://dx.doi.org/10.1056/NEJMp1207775			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	978KD	22830459	Green Submitted			2022-12-28	WOS:000306738300001
J	Boyd, IL				Boyd, Ian L.			The Art of Ecological Modeling	SCIENCE			English	Editorial Material							MARINE ECOSYSTEMS; REGIME SHIFTS; TIPPING POINT; COMPLEX; STABILITY; SYSTEMS		Univ St Andrews, Scottish Oceans Inst, St Andrews KY16 8LB, Fife, Scotland	University of St Andrews	Boyd, IL (corresponding author), Univ St Andrews, Scottish Oceans Inst, St Andrews KY16 8LB, Fife, Scotland.	ilb@st-andrews.ac.uk						Allesina S, 2012, NATURE, V483, P205, DOI 10.1038/nature10832; Carpenter SR, 2011, SCIENCE, V332, P1079, DOI 10.1126/science.1203672; Christensen V, 2009, ECOL MODEL, V220, P1984, DOI 10.1016/j.ecolmodel.2009.04.041; Cury PM, 2011, SCIENCE, V334, P1703, DOI 10.1126/science.1212928; Dai L, 2012, SCIENCE, V336, P1175, DOI 10.1126/science.1219805; Hastings A, 2010, ECOL LETT, V13, P464, DOI 10.1111/j.1461-0248.2010.01439.x; Hilborn R, 2012, NAT RESOUR MODEL, V25, P122, DOI 10.1111/j.1939-7445.2011.00100.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Levin SA, 1998, ECOSYSTEMS, V1, P431, DOI 10.1007/s100219900037; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; Maslin M, 2012, NATURE, V486, P183, DOI 10.1038/486183a; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; Mougi A, 2012, SCIENCE, V337, P349, DOI 10.1126/science.1220529; PRESTON FW, 1962, ECOLOGY, V43, P185, DOI 10.2307/1931976; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Shelton AO, 2011, P NATL ACAD SCI USA, V108, P7075, DOI 10.1073/pnas.1100334108; Smith ADM, 2011, SCIENCE, V333, P1147, DOI 10.1126/science.1209395; Sugihara G, 2011, P NATL ACAD SCI USA, V108, pE1224, DOI 10.1073/pnas.1112033108; Veraart AJ, 2012, NATURE, V481, P357, DOI 10.1038/nature10723; Zarnetske PL, 2012, SCIENCE, V336, P1516, DOI 10.1126/science.1222732	20	22	23	0	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2012	337	6092					306	307		10.1126/science.1225049	http://dx.doi.org/10.1126/science.1225049			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975WQ	22822140				2022-12-28	WOS:000306542600040
J	Hurtgen, MT				Hurtgen, Matthew T.			The Marine Sulfur Cycle, Revisited	SCIENCE			English	Editorial Material							SEAWATER CHEMISTRY; SULFATE		Northwestern Univ, Evanston, IL 60208 USA	Northwestern University	Hurtgen, MT (corresponding author), Northwestern Univ, Evanston, IL 60208 USA.	matt@earth.northwestern.edu	Hurtgen, Matthew/R-4977-2016	Hurtgen, Matthew/0000-0003-1564-7192	Directorate For Geosciences [0955969] Funding Source: National Science Foundation	Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		Arthur M. A., 2000, ENCY VOLCANOES; Canfield DE, 2001, GEOCHIM COSMOCHIM AC, V65, P1117, DOI 10.1016/S0016-7037(00)00584-6; Halevy I, 2012, SCIENCE, V337, P331, DOI 10.1126/science.1220224; Kampschulte A, 2004, CHEM GEOL, V204, P255, DOI 10.1016/j.chemgeo.2003.11.013; Lowenstein TK, 2003, GEOLOGY, V31, P857, DOI 10.1130/G19728R.1; Paytan A, 2004, SCIENCE, V304, P1663, DOI 10.1126/science.1095258; Wortmann UG, 2012, SCIENCE, V337, P334, DOI 10.1126/science.1220656	7	15	20	9	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2012	337	6092					305	306		10.1126/science.1225461	http://dx.doi.org/10.1126/science.1225461			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975WQ	22822139				2022-12-28	WOS:000306542600039
J	Dey, A; Seshasayee, D; Noubade, R; French, DM; Liu, JF; Chaurushiya, MS; Kirkpatrick, DS; Pham, VC; Lill, JR; Bakalarski, CE; Wu, JS; Phu, L; Katavolos, P; LaFave, LM; Abdel-Wahab, O; Modrusan, Z; Seshagiri, S; Dong, K; Lin, ZH; Balazs, M; Suriben, R; Newton, K; Hymowitz, S; Garcia-Manero, G; Martin, F; Levine, RL; Dixit, VM				Dey, Anwesha; Seshasayee, Dhaya; Noubade, Rajkumar; French, Dorothy M.; Liu, Jinfeng; Chaurushiya, Mira S.; Kirkpatrick, Donald S.; Pham, Victoria C.; Lill, Jennie R.; Bakalarski, Corey E.; Wu, Jiansheng; Phu, Lilian; Katavolos, Paula; LaFave, Lindsay M.; Abdel-Wahab, Omar; Modrusan, Zora; Seshagiri, Somasekar; Dong, Ken; Lin, Zhonghua; Balazs, Mercedesz; Suriben, Rowena; Newton, Kim; Hymowitz, Sarah; Garcia-Manero, Guillermo; Martin, Flavius; Levine, Ross L.; Dixit, Vishva M.			Loss of the Tumor Suppressor BAP1 Causes Myeloid Transformation	SCIENCE			English	Article							MYELODYSPLASTIC SYNDROMES; UBIQUITIN HYDROLASE; GENE-EXPRESSION; MUTATIONS; MOUSE; PREDISPOSE; LEUKEMIA; ASXL1	De-ubiquitinating enzyme BAP1 is mutated in a hereditary cancer syndrome with increased risk of mesothelioma and uveal melanoma. Somatic BAP1 mutations occur in various malignancies. We show that mouse Bap1 gene deletion is lethal during embryogenesis, but systemic or hematopoietic-restricted deletion in adults recapitulates features of human myelodysplastic syndrome (MDS). Knockin mice expressing BAP1 with a 3xFlag tag revealed that BAP1 interacts with host cell factor-1 (HCF-1), O-linked N-acetylglucosamine transferase (OGT), and the polycomb group proteins ASXL1 and ASXL2 in vivo. OGT and HCF-1 levels were decreased by Bap1 deletion, indicating a critical role for BAP1 in stabilizing these epigenetic regulators. Human ASXL1 is mutated frequently in chronic myelomonocytic leukemia (CMML) so an ASXL/BAP1 complex may suppress CMML. A BAP1 catalytic mutation found in a MDS patient implies that BAP1 loss of function has similar consequences in mice and humans.	[Dey, Anwesha; Chaurushiya, Mira S.; Suriben, Rowena; Newton, Kim; Dixit, Vishva M.] Genentech Inc, Dept Physiol Chem, San Francisco, CA 94080 USA; [Seshasayee, Dhaya; Noubade, Rajkumar; Martin, Flavius] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [French, Dorothy M.] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Liu, Jinfeng; Bakalarski, Corey E.] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Kirkpatrick, Donald S.; Pham, Victoria C.; Lill, Jennie R.; Wu, Jiansheng; Phu, Lilian] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Katavolos, Paula] Genentech Inc, Dept Safety Assessment, San Francisco, CA 94080 USA; [LaFave, Lindsay M.; Abdel-Wahab, Omar; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [LaFave, Lindsay M.; Abdel-Wahab, Omar; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Leukemia Serv, New York, NY 10065 USA; [Modrusan, Zora; Seshagiri, Somasekar] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Dong, Ken; Hymowitz, Sarah] Genentech Inc, Dept Biol Struct, San Francisco, CA 94080 USA; [Lin, Zhonghua; Balazs, Mercedesz] Genentech Inc, Dept Translat Immunol, San Francisco, CA 94080 USA; [Garcia-Manero, Guillermo] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; University of Texas System; UTMD Anderson Cancer Center	Dixit, VM (corresponding author), Genentech Inc, Dept Physiol Chem, 1 DNA Way, San Francisco, CA 94080 USA.	dixit@gene.com	Ferris, Laura/I-7689-2012; levine, ross/AAE-7658-2019; dixit, vishva m/A-4496-2012; Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	dixit, vishva m/0000-0001-6983-0326; Wu, Jian/0000-0001-9933-7364; Seshagiri, Somasekar/0000-0003-4272-6443; Katavolos, Paula/0000-0001-7923-5328; Abdel-Wahab, Omar/0000-0002-3907-6171; Liu, Jinfeng/0000-0002-0343-8222; Wu, Jian/0000-0002-3394-1507; Bakalarski, Corey/0000-0003-1085-7828; Kirkpatrick, Donald/0000-0003-3091-2804	NATIONAL CANCER INSTITUTE [P30CA008748, R01CA173636] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA173636, P30 CA008748] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abdel-Rahman MH, 2011, J MED GENET, V48, P856, DOI 10.1136/jmedgenet-2011-100156; Abdel-Wahab O, 2011, LEUKEMIA, V25, P1200, DOI 10.1038/leu.2011.58; Beachy SH, 2010, HEMATOL ONCOL CLIN N, V24, P361, DOI 10.1016/j.hoc.2010.02.002; Capotosti F, 2011, CELL, V144, P376, DOI 10.1016/j.cell.2010.12.030; Corey SJ, 2007, NAT REV CANCER, V7, P118, DOI 10.1038/nrc2047; Daou S, 2011, P NATL ACAD SCI USA, V108, P2747, DOI 10.1073/pnas.1013822108; Gelsi-Boyer V, 2009, BRIT J HAEMATOL, V145, P788, DOI 10.1111/j.1365-2141.2009.07697.x; Graubert TA, 2012, NAT GENET, V44, P53, DOI 10.1038/ng.1031; Guo GW, 2012, NAT GENET, V44, P17, DOI 10.1038/ng.1014; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Jensen DE, 1999, CANCER LETT, V143, pS13, DOI 10.1016/S0304-3835(99)90004-6; Jensen DE, 1998, ONCOGENE, V16, P1097, DOI 10.1038/sj.onc.1201861; Klinakis A, 2011, NATURE, V473, P230, DOI 10.1038/nature09999; Kobayashi N, 2007, GENE, V396, P236, DOI 10.1016/j.gene.2007.02.032; Kristie TM, 2010, BBA-GENE REGUL MECH, V1799, P257, DOI 10.1016/j.bbagrm.2009.08.003; Kruger M, 2008, CELL, V134, P353, DOI 10.1016/j.cell.2008.05.033; Machida YJ, 2009, J BIOL CHEM, V284, P34179, DOI 10.1074/jbc.M109.046755; Misaghi S, 2009, MOL CELL BIOL, V29, P2181, DOI 10.1128/MCB.01517-08; Pellagatti A, 2004, BRIT J HAEMATOL, V125, P576, DOI 10.1111/j.1365-2141.2004.04958.x; Scheuermann JC, 2010, NATURE, V465, P243, DOI 10.1038/nature08966; Seibler J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng012; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Testa JR, 2011, NAT GENET, V43, P1022, DOI 10.1038/ng.912; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Wiesner T, 2011, NAT GENET, V43, P1018, DOI 10.1038/ng.910	25	290	293	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2012	337	6101					1541	1546		10.1126/science.1221711	http://dx.doi.org/10.1126/science.1221711			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007UC	22878500	Green Accepted			2022-12-28	WOS:000308912900052
J	Rothballer, A; Kutay, U				Rothballer, Andrea; Kutay, Ulrike			SnapShot: The Nuclear Envelope I	CELL			English	Editorial Material							FUNCTIONAL ARCHITECTURE; PORE COMPLEX; PROTEINS; DISEASE		[Rothballer, Andrea; Kutay, Ulrike] ETH, Inst Biochem, CH-8093 Zurich, Switzerland	ETH Zurich	Rothballer, A (corresponding author), ETH, Inst Biochem, CH-8093 Zurich, Switzerland.							Brachner A, 2011, BIOCHEM SOC T, V39, P1735, DOI 10.1042/BST20110724; Burke B, 2006, ANNU REV GENOM HUM G, V7, P369, DOI 10.1146/annurev.genom.7.080505.115732; Grossman E, 2012, ANNU REV BIOPHYS, V41, P557, DOI [10.1146/annurev-biophys-050511-102328, 10.1146/annurev-biophys-850511-102328]; Maimon T, 2012, STRUCTURE, V20, P998, DOI 10.1016/j.str.2012.03.025; Mellad JA, 2011, CURR OPIN CELL BIOL, V23, P47, DOI 10.1016/j.ceb.2010.11.006; Schirmer EC, 2003, SCIENCE, V301, P1380, DOI 10.1126/science.1088176; Shimi T, 2012, CURR OPIN CELL BIOL, V24, P71, DOI 10.1016/j.ceb.2011.11.007; Sosa BA, 2012, CELL, V149, P1035, DOI 10.1016/j.cell.2012.03.046; Starr DA, 2010, ANNU REV CELL DEV BI, V26, P421, DOI 10.1146/annurev-cellbio-100109-104037; Terry LJ, 2009, EUKARYOT CELL, V8, P1814, DOI 10.1128/EC.00225-09	10	6	6	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 17	2012	150	4					868	U226	868.e1	10.1016/j.cell.2012.07.024	http://dx.doi.org/10.1016/j.cell.2012.07.024			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	995IT	22901815	Bronze			2022-12-28	WOS:000308002300020
J	D'Amico, AV; Smith, MR				D'Amico, Anthony V.; Smith, Matthew R.			Screening for Prostate Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RADICAL PROSTATECTOMY; FOLLOW-UP; MORTALITY		[D'Amico, Anthony V.] Brigham & Womens Hosp, Boston, MA 02115 USA; [D'Amico, Anthony V.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Smith, Matthew R.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital	D'Amico, AV (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.				NATIONAL CANCER INSTITUTE [K24CA121990] Funding Source: NIH RePORTER; NCI NIH HHS [K24 CA121990] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Andriole GL, 2012, J NATL CANCER I, V104, P125, DOI 10.1093/jnci/djr500; Autier P, 2012, NEW ENGL J MED, V366, P2230, DOI 10.1056/NEJMc1204298; Bill-Axelson A, 2011, NEW ENGL J MED, V364, P1708, DOI 10.1056/NEJMoa1011967; Catalona WJ, 2012, ANN INTERN MED, V157, P137, DOI 10.7326/0003-4819-157-2-201207170-00463; Heijnsdijk EAM, 2012, NEW ENGL J MED, V367, P595, DOI 10.1056/NEJMoa1201637; Hugosson J, 2010, LANCET ONCOL, V11, P725, DOI 10.1016/S1470-2045(10)70146-7; IVERSEN P, 1995, SCAND J UROL NEPHROL, P65; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135; Wilt TJ, 2012, NEW ENGL J MED, V367, P203, DOI 10.1056/NEJMoa1113162	10	5	5	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 16	2012	367	7								10.1056/NEJMclde1209426	http://dx.doi.org/10.1056/NEJMclde1209426			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988NB	22894598	Green Accepted			2022-12-28	WOS:000307496600013
J	Huang, YH; Huang, FC				Huang, Yi-Hsun; Huang, Fu-Chin			Ocular Trauma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							IN-SITU KERATOMILEUSIS; COMPLICATIONS; MANAGEMENT; LASIK		[Huang, Yi-Hsun; Huang, Fu-Chin] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Ophthalmol, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital	Huang, FC (corresponding author), Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Ophthalmol, 138 Sheng Li Rd, Tainan 70101, Taiwan.	huangfc@mail.ncku.edu.tw						American Academy of Ophthalmology, 2009, EYE HLTH STAT GLANC; Clare G, 2011, OPHTHALMOLOGY, V118, P1760, DOI 10.1016/j.ophtha.2011.01.053; Gimbel HV, 1998, OPHTHALMOLOGY, V105, P1839, DOI 10.1016/S0161-6420(98)91026-0; Holt DG, 2012, J CATARACT REFR SURG, V38, P357, DOI 10.1016/j.jcrs.2011.10.024; Lin RT, 1999, AM J OPHTHALMOL, V127, P129, DOI 10.1016/S0002-9394(98)00320-1; McLeod SD, 2002, ARCH OPHTHALMOL-CHIC, V120, P1213; Philipp WE, 2003, J CATARACT REFR SURG, V29, P808, DOI 10.1016/S0886-3350(02)01611-5; Stulting RD, 1999, OPHTHALMOLOGY, V106, P13, DOI 10.1016/S0161-6420(99)90000-3	8	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2012	308	7					710	711		10.1001/jama.2012.9348	http://dx.doi.org/10.1001/jama.2012.9348			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988NC	22893168				2022-12-28	WOS:000307496700026
J	Ridker, PM; Pradhan, A; MacFadyen, JG; Libby, P; Glynn, RJ				Ridker, Paul M.; Pradhan, Aruna; MacFadyen, Jean G.; Libby, Peter; Glynn, Robert J.			Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial	LANCET			English	Article							C-REACTIVE PROTEIN; METABOLIC SYNDROME; RANDOMIZED-TRIAL; ROSUVASTATIN; METAANALYSIS; CHOLESTEROL; MELLITUS; DISEASE; WOMEN	Background In view of evidence that statin therapy increases risk of diabetes, the balance of benefit and risk of these drugs in primary prevention has become controversial. We undertook an analysis of participants from the JUPITER trial to address the balance of vascular benefits and diabetes hazard of statin use. Methods In the randomised, double-blind JUPITER trial, 17 603 men and women without previous cardiovascular disease or diabetes were randomly assigned to rosuvastatin 20 mg or placebo and followed up for up to 5 years for the primary endpoint (myocardial infarction, stroke, admission to hospital for unstable angina, arterial revascularisation, or cardiovascular death) and the protocol-prespecified secondary endpoints of venous thromboembolism, all-cause mortality, and incident physician-reported diabetes. In this analysis, participants were stratified on the basis of having none or at least one of four major risk factors for developing diabetes: metabolic syndrome, impaired fasting glucose, body-mass index 30 kg/m(2) or higher, or glycated haemoglobin A(1c) greater than 6%. The trial is registered at ClinicalTrials.gov, NCT00239681. Findings Trial participants with one or more major diabetes risk factor (n=11 508) were at higher risk of developing diabetes than were those without a major risk factor (n=6095). In individuals with one or more risk factors, statin allocation was associated with a 39% reduction in the primary endpoint (hazard ratio [HR] 0.61, 95% CI 0.47-0.79, p=0.0001), a 36% reduction in venous thromboembolism (0.64, 0.39-1.06, p=0.08), a 17% reduction in total mortality (0.83, 0.64-1.07, p=0.15), and a 28% increase in diabetes (1.28, 1.07-1.54, p=0.01). Thus, for those with diabetes risk factors, a total of 134 vascular events or deaths were avoided for every 54 new cases of diabetes diagnosed. For trial participants with no major diabetes risk factors, statin allocation was associated with a 52% reduction in the primary endpoint (HR 0.48, 95% CI 0.33-0.68, p=0.0001), a 53% reduction in venous thromboembolism (0.47, 0.21-1.03, p=0.05), a 22% reduction in total mortality (0.78, 0.59-1.03, p=0.08), and no increase in diabetes (0.99, 0.45-2.21, p=0.99). For such individuals, a total of 86 vascular events or deaths were avoided with no new cases of diabetes diagnosed. In analysis limited to the 486 participants who developed diabetes during follow-up (270 on rosuvastatin vs 216 on placebo; HR 1.25, 95% CI 1.05-1.49, p=0.01), the point estimate of cardiovascular risk reduction associated with statin therapy (HR 0.63, 95% CI 0.25-1.60) was consistent with that for the trial as a whole (0.56, 0.46-0.69). By comparison with placebo, statins accelerated the average time to diagnosis of diabetes by 5.4 weeks (84.3 [SD 47.8] weeks on rosuvastatin vs 89.7 [50.4] weeks on placebo). Interpretation In the JUPITER primary prevention trial, the cardiovascular and mortality benefits of statin therapy exceed the diabetes hazard, including in participants at high risk of developing diabetes.	[Ridker, Paul M.; Pradhan, Aruna; MacFadyen, Jean G.; Glynn, Robert J.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Boston, MA 02215 USA; [Ridker, Paul M.; Libby, Peter] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc Med,Dept Med, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Ridker, PM (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Boston, MA 02215 USA.	pridker@partners.org	Libby, Peter/AAY-6404-2021	Libby, Peter/0000-0002-1502-502X; Venkatasubramanian, Siddharth/0000-0002-5860-0768	AstraZeneca; Novartis; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103742] Funding Source: NIH RePORTER	AstraZeneca(AstraZeneca); Novartis(Novartis); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The JUPITER trial was an investigator-initiated project funded by AstraZeneca. PMR is the principal investigator of the trial and received grant support from AstraZeneca for its conduct. He has served as a consultant to Merck, ISIS, Vascular Biogenics, Boerhinger, Abbott, and Genzyme; receives additional research grant support from Novartis; and is listed as a co-inventor on patents held by the Brigham and Women's Hospital related to inflammatory biomarkers in cardiovascular disease and diabetes that have been licensed to Siemens and AstraZeneca. RJG is the independent academic trial statistician for JUPITER and has received grant support from AstraZeneca for its conduct. PL is an unpaid consultant or involved in clinical trials for AstraZeneca, GlaxoSmithKline, Merck, Novartis, Pfizer, ProNova, and Sigma-Tau and is a member of the scientific advisory boards for Athera Biotechnolgies, Carolus Therapeutics, Interleukin Genetics, and BIND Biosciences. AP and JGM declare that they have no conflicts of interest.	Glynn RJ, 2010, ANN INTERN MED, V152, P488, DOI 10.7326/0003-4819-152-8-201004200-00005; Glynn RJ, 2009, NEW ENGL J MED, V360, P1851, DOI 10.1056/NEJMoa0900241; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Preiss D, 2011, JAMA-J AM MED ASSOC, V305, P2556, DOI 10.1001/jama.2011.860; Rajpathak SN, 2009, DIABETES CARE, V32, P1924, DOI 10.2337/dc09-0738; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2005, JAMA-J AM MED ASSOC, V294, P326, DOI 10.1001/jama.294.3.326; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; US Food and Drug Administration, FDA DRUG SAF COMM IM; Waters DD, 2011, J AM COLL CARDIOL, V57, P1535, DOI 10.1016/j.jacc.2010.10.047; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528	12	552	581	2	60	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 11	2012	380	9841					565	571		10.1016/S0140-6736(12)61190-8	http://dx.doi.org/10.1016/S0140-6736(12)61190-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988SQ	22883507	Green Accepted			2022-12-28	WOS:000307511400029
J	Berenyi, A; Belluscio, M; Mao, D; Buzsaki, G				Berenyi, Antal; Belluscio, Mariano; Mao, Dun; Buzsaki, Gyoergy			Closed-Loop Control of Epilepsy by Transcranial Electrical Stimulation	SCIENCE			English	Article							DEEP BRAIN-STIMULATION; SLEEP; SPINDLES; MEMORY; SPIKE; RATS	Many neurological and psychiatric diseases are associated with clinically detectable, altered brain dynamics. The aberrant brain activity, in principle, can be restored through electrical stimulation. In epilepsies, abnormal patterns emerge intermittently, and therefore, a closed-loop feedback brain control that leaves other aspects of brain functions unaffected is desirable. Here, we demonstrate that seizure-triggered, feedback transcranial electrical stimulation (TES) can dramatically reduce spike-and-wave episodes in a rodent model of generalized epilepsy. Closed-loop TES can be an effective clinical tool to reduce pathological brain patterns in drug-resistant patients.	[Berenyi, Antal; Belluscio, Mariano; Mao, Dun; Buzsaki, Gyoergy] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA; [Berenyi, Antal; Buzsaki, Gyoergy] NYU, Sch Med, Inst Neurosci, New York, NY 10016 USA; [Berenyi, Antal] Univ Szeged, Dept Physiol, H-6720 Szeged, Hungary	Rutgers State University Newark; Rutgers State University New Brunswick; New York University; Szeged University	Buzsaki, G (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA.	gyorgy.buzsaki@nyumc.org	Berényi, Antal/A-9174-2013; Mao, Dun/AAK-2653-2021	Berényi, Antal/0000-0003-0084-8530; Mao, Dun/0000-0001-5523-657X; Buzsaki, Gyorgy/0000-0002-3100-4800	NIH [NS34994, MH54671, NS074015]; Human Frontier Science Program; J. D. McDonnell Foundation; European Community [254780]; Rosztoczy Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074015, R01NS034994] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); J. D. McDonnell Foundation; European Community(European Commission); Rosztoczy Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants NS34994, MH54671, and NS074015; the Human Frontier Science Program; and the J. D. McDonnell Foundation. A. B. was supported by a Marie Curie FP7-PEOPLE-2009-IOF grant within the 7th European Community Framework Programme (no. 254780) and by the Rosztoczy Foundation.	Engel J, 2003, EPILEPSIA, V44, P741, DOI 10.1046/j.1528-1157.2003.48202.x; Fisher R, 2010, EPILEPSIA, V51, P899, DOI 10.1111/j.1528-1167.2010.02536.x; Fisher RS, 2012, ANN NEUROL, V71, P157, DOI 10.1002/ana.22621; Frohlich F, 2010, NEURON, V67, P129, DOI 10.1016/j.neuron.2010.06.005; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Hammond C, 2007, TRENDS NEUROSCI, V30, P357, DOI 10.1016/j.tins.2007.05.004; Hatsopoulos NG, 2009, ANNU REV NEUROSCI, V32, P249, DOI 10.1146/annurev.neuro.051508.135241; Hughes JR, 2009, EPILEPSY BEHAV, V15, P404, DOI 10.1016/j.yebeh.2009.06.007; Jackson A, 2011, IEEE T NEUR SYS REH, V19, P534, DOI 10.1109/TNSRE.2011.2158586; Joundi RA, 2012, CURR BIOL, V22, P403, DOI 10.1016/j.cub.2012.01.024; Kandel A, 1997, J NEUROSCI, V17, P6783; KOSTOPOULOS G, 1981, EXP NEUROL, V73, P55, DOI 10.1016/0014-4886(81)90045-5; Makeyev O., 2011, C P IEEE ENG MED BIO, V2011, P7560; MARESCAUX C, 1992, J NEURAL TRANSM-GEN, P37; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Morrell MJ, 2011, NEUROLOGY, V77, P1295, DOI 10.1212/WNL.0b013e3182302056; Motamedi GK, 2002, EPILEPSIA, V43, P836, DOI 10.1046/j.1528-1157.2002.24901.x; Najib U, 2011, NEUROSURG CLIN N AM, V22, P233, DOI 10.1016/j.nec.2011.01.002; Nitsche MA, 2009, NEUROTHERAPEUTICS, V6, P244, DOI 10.1016/j.nurt.2009.01.003; Ozen S, 2010, J NEUROSCI, V30, P11476, DOI 10.1523/JNEUROSCI.5252-09.2010; Perlmutter JS, 2006, ANNU REV NEUROSCI, V29, P229, DOI 10.1146/annurev.neuro.29.051605.112824; Rosin B, 2011, NEURON, V72, P370, DOI 10.1016/j.neuron.2011.08.023; Rotenberg A, 2009, CLIN NEUROPHYSIOL, V120, P1417, DOI 10.1016/j.clinph.2009.05.004; SCHIFF SJ, 1994, NATURE, V370, P615, DOI 10.1038/370615a0; Steriade M, 2005, TRENDS NEUROSCI, V28, P317, DOI 10.1016/j.tins.2005.03.007; Varga ET, 2011, EPILEPSY RES, V97, P142, DOI 10.1016/j.eplepsyres.2011.07.016	27	296	309	2	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2012	337	6095					735	737		10.1126/science.1223154	http://dx.doi.org/10.1126/science.1223154			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986PE	22879515	Green Accepted			2022-12-28	WOS:000307354500055
J	Farrauto, RJ				Farrauto, Robert J.			Low-Temperature Oxidation of Methane	SCIENCE			English	Editorial Material									Columbia Univ, Dept Earth & Environm Engn, New York, NY 10027 USA	Columbia University	Farrauto, RJ (corresponding author), Columbia Univ, Dept Earth & Environm Engn, New York, NY 10027 USA.	rf2182@columbia.edu						CALVERT JG, 1993, SCIENCE, V261, P37, DOI 10.1126/science.261.5117.37; Cargnello M, 2012, SCIENCE, V337, P713, DOI [10.1126/science.1222887, 10.1126/science.1223488]; Farrauto R. J., 1992, APPL CATAL, V81, P277; Farrauto R. J., [Process conditions for operation of the ignition catalyst for natural gas combustion, U.S. Patent], Patent No. [4, 893, 465, 4893465]; Heck R.M., 2009, CATALYTIC AIR POLLUT; Hightower J., 1974, 67 M AM I CHEM ENG 2; Pfefferle W. C., U.S. Patent, Patent No. [3, 928, 961, 3928961]	7	128	130	9	195	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2012	337	6095					659	660		10.1126/science.1226310	http://dx.doi.org/10.1126/science.1226310			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986PE	22879495				2022-12-28	WOS:000307354500032
J	Roehr, B				Roehr, Bob			The slow and unknown route to a cure for AIDS	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HIV					BobRoehr@aol.com						Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Deeks SG, 2012, NAT REV IMMUNOL, V12, P607, DOI 10.1038/nri3262; Deeks SG, 2012, NATURE, V487, P293, DOI 10.1038/487293a; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Roehr B., 2012, BRIT MED J, V345, pe4859; Roehr B., 2009, SCI AM; Roehr B, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4950; Roehr B, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d1373	8	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 10	2012	345								e5265	10.1136/bmj.e5265	http://dx.doi.org/10.1136/bmj.e5265			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988NG	22885397				2022-12-28	WOS:000307497100006
J	Tuck, CO; Perez, E; Horvath, IT; Sheldon, RA; Poliakoff, M				Tuck, Christopher O.; Perez, Eduardo; Horvath, Istvan T.; Sheldon, Roger A.; Poliakoff, Martyn			Valorization of Biomass: Deriving More Value from Waste	SCIENCE			English	Review							GAMMA-VALEROLACTONE; AEROBIC OXIDATION; CHEMICALS; ACID; CONVERSION; ETHANOL; LIQUID	Most of the carbon-based compounds currently manufactured by the chemical industry are derived from petroleum. The rising cost and dwindling supply of oil have been focusing attention on possible routes to making chemicals, fuels, and solvents from biomass instead. In this context, many recent studies have assessed the relative merits of applying different dedicated crops to chemical production. Here, we highlight the opportunities for diverting existing residual biomass-the by-products of present agricultural and food-processing streams-to this end.	[Horvath, Istvan T.] City Univ Hong Kong, Kowloon, Hong Kong, Peoples R China; [Tuck, Christopher O.; Perez, Eduardo; Poliakoff, Martyn] Univ Nottingham, Nottingham NG7 2RD, England; [Sheldon, Roger A.] Delft Univ Technol, Delft, Netherlands	City University of Hong Kong; University of Nottingham; Delft University of Technology	Horvath, IT (corresponding author), City Univ Hong Kong, Tat Chee Ave, Kowloon, Hong Kong, Peoples R China.	istvan.t.horvath@cityu.edu.hk; r.a.sheldon@tudelft.nl; pczmp@nottingham.ac.uk	Horvath, Istvan T/M-8428-2013; Horvath, Istvan T/A-6825-2010; Sheldon, Roger Arthur/ADM-3421-2022; Espinosa, Eduardo/F-5054-2016; Poliakoff, Martyn/B-9155-2016; Tuck, Christopher/F-6251-2012	Horvath, Istvan T/0000-0002-6324-186X; Espinosa, Eduardo/0000-0002-5195-1557; Poliakoff, Martyn/0000-0002-8704-5636; Tuck, Christopher/0000-0003-0146-3851; Phouam, Suchira/0000-0001-7870-0849; Perez Velilla, Eduardo/0000-0002-9476-5906	EPSRC [DT/E005586/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [DT/E005586/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Anastas P. T., 1998, GREEN CHEM THEORY PR; [Anonymous], 2011, VOLKSKRANT      1221; Bals BD, 2012, BIORESOURCE TECHNOL, V106, P161, DOI 10.1016/j.biortech.2011.12.024; Bjorsvik HR, 1999, ORG PROCESS RES DEV, V3, P330, DOI 10.1021/op9900028; Botha T, 2006, ENERG POLICY, V34, P2654, DOI 10.1016/j.enpol.2004.12.017; Bozell JJ, 2010, GREEN CHEM, V12, P539, DOI 10.1039/b922014c; Carole TM, 2004, APPL BIOCHEM BIOTECH, V113, P871, DOI 10.1385/ABAB:115:1-3:0871; Carrier M, 2011, BIOMASS BIOENERG, V35, P298, DOI 10.1016/j.biombioe.2010.08.067; Casanova O, 2009, CHEMSUSCHEM, V2, P1138, DOI 10.1002/cssc.200900137; DALEV PG, 1994, BIORESOURCE TECHNOL, V48, P265, DOI 10.1016/0960-8524(94)90156-2; Demirbas A, 2011, ENERG CONVERS MANAGE, V52, P1280, DOI 10.1016/j.enconman.2010.09.025; Frost J. W., 2005, Patent No. [WO 2005/123669 A1, 2005123669]; Gallezot P, 2012, CHEM SOC REV, V41, P1538, DOI 10.1039/c1cs15147a; Gildberg A, 2001, PROCESS BIOCHEM, V36, P809, DOI 10.1016/S0032-9592(00)00278-8; Guo QH, 2011, IEEE I SYMP SUST SYS; Horvath I. T., 2006, 10 ANN GREN CHEM ENG; Horvath IT, 2008, GREEN CHEM, V10, P238, DOI 10.1039/b712863k; Keeney D, 2009, ENVIRON SCI TECHNOL, V43, P8, DOI 10.1021/es8016182; Kind S, 2011, APPL MICROBIOL BIOT, V91, P1287, DOI 10.1007/s00253-011-3457-2; Konst PM, 2010, ADV SYNTH CATAL, V352, P1493, DOI 10.1002/adsc.201000034; Lammens TM, 2011, ENVIRON SCI TECHNOL, V45, P8521, DOI 10.1021/es201869e; Lammens TM, 2009, GREEN CHEM, V11, P1562, DOI 10.1039/b913741f; Lane J., 2012, BIOFUELS DIGEST; Matson TD, 2011, J AM CHEM SOC, V133, P14090, DOI 10.1021/ja205436c; Mccoy M, 2012, CHEM ENG NEWS, V90, P15; Mehdi H, 2008, TOP CATAL, V48, P49, DOI 10.1007/s11244-008-9047-6; Montane D, 2002, BIOMASS BIOENERG, V22, P295, DOI 10.1016/S0961-9534(02)00007-7; Mooibroek H, 2007, APPL MICROBIOL BIOT, V77, P257, DOI 10.1007/s00253-007-1178-3; Morschbacker A, 2009, POLYM REV, V49, P79, DOI 10.1080/15583720902834791; Partenheimer W., 2009, HDB GREEN CHEM GREEN, V1, P375; Phillips AL, 2008, AM SCI, V96, P109, DOI 10.1511/2008.70.109; Pukin AV, 2010, J MOL CATAL B-ENZYM, V65, P58, DOI 10.1016/j.molcatb.2009.12.006; Reisch MS, 2012, CHEM ENG NEWS, V90, P22; Roman-Leshkov Y, 2007, NATURE, V447, P982, DOI 10.1038/nature05923; Rosatella AA, 2011, GREEN CHEM, V13, P754, DOI 10.1039/c0gc00401d; Royal Society and Royal Academy of Engineering, 2012, SHALE GAS EXTRACTION; Sanders J, 2007, MACROMOL BIOSCI, V7, P105, DOI 10.1002/mabi.200600223; Scott E, 2007, APPL MICROBIOL BIOT, V75, P751, DOI 10.1007/s00253-007-0932-x; Sergeev AG, 2011, SCIENCE, V332, P439, DOI 10.1126/science.1200437; Shackley S, 2012, ENERG POLICY, V42, P49, DOI 10.1016/j.enpol.2011.11.026; Sheldon R. A., 2001, FINE CHEM HETEROGENE, P611; Sheldon RA, 2007, ADV SYNTH CATAL, V349, P1289, DOI 10.1002/adsc.200700082; Sheldon RA, 2011, CATAL TODAY, V167, P3, DOI 10.1016/j.cattod.2010.10.100; Taarning E, 2008, CHEMSUSCHEM, V1, P75, DOI 10.1002/cssc.200700033; Tullo AH, 2012, CHEM ENG NEWS, V90, P29; Turley A., 2012, CHEM WORLD, V9, P16; van Haveren J, 2008, BIOFUEL BIOPROD BIOR, V2, P41, DOI 10.1002/bbb.43; Vink ETH, 2003, POLYM DEGRAD STABIL, V80, P403, DOI 10.1016/S0141-3910(02)00372-5; Zakzeski J, 2010, CHEM REV, V110, P3552, DOI 10.1021/cr900354u; Zhang ML, 2007, BIOMASS BIOENERG, V31, P250, DOI 10.1016/j.biombioe.2006.08.004	50	1382	1413	79	1197	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2012	337	6095					695	699		10.1126/science.1218930	http://dx.doi.org/10.1126/science.1218930			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986PE	22879509				2022-12-28	WOS:000307354500044
J	Leakey, MG; Spoor, F; Dean, MC; Feibel, CS; Anton, SC; Kiarie, C; Leakey, LN				Leakey, Meave G.; Spoor, Fred; Dean, M. Christopher; Feibel, Craig S.; Anton, Susan C.; Kiarie, Christopher; Leakey, Louise N.			New fossils from Koobi Fora in northern Kenya confirm taxonomic diversity in early Homo	NATURE			English	Article							OLDUVAI-GORGE; TURKANA-BASIN; PLIOPLEISTOCENE HOMINID; EAST RUDOLF; HABILIS; ETHIOPIA; EVOLUTION; TANZANIA; REGION; MA	Since its discovery in 1972 (ref. 1), the cranium KNM-ER 1470 has been at the centre of the debate over the number of species of early Homo present in the early Pleistocene epoch(2) of eastern Africa. KNM-ER 1470 stands out among other specimens attributed to early Homo because of its larger size, and its flat and subnasally orthognathic face with anteriorly placed maxillary zygomatic roots(3). This singular morphology and the incomplete preservation of the fossil have led to different views as to whether KNM-ER 1470 can be accommodated within a single species of early Homo that is highly variable because of sexual, geographical and temporal factors(4-9), or whether it provides evidence of species diversity marked by differences in cranial size and facial or masticatory adaptation(3,10-20). Here we report on three newly discovered fossils, aged between 1.78 and 1.95 million years (Myr) old, that clarify the anatomy and taxonomic status of KNM-ER 1470. KNM-ER 62000, a well-preserved face of a late juvenile hominin, closely resembles KNM-ER 1470 but is notably smaller. It preserves previously unknown morphology, including moderately sized, mesiodistally long postcanine teeth. The nearly complete mandible KNM-ER 60000 and mandibular fragment KNM-ER 62003 have a dental arcade that is short anteroposteriorly and flat across the front, with small incisors; these features are consistent with the arcade morphology of KNM-ER 1470 and KNM-ER 62000. The new fossils confirm the presence of two contemporary species of early Homo, in addition to Homo erectus, in the early Pleistocene of eastern Africa.	[Leakey, Meave G.; Kiarie, Christopher; Leakey, Louise N.] Turkana Basin Inst, Nairobi 00502, Kenya; [Leakey, Meave G.; Leakey, Louise N.] SUNY Stony Brook, Dept Anthropol, Stony Brook, NY 11794 USA; [Spoor, Fred] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, D-04103 Leipzig, Germany; [Spoor, Fred; Dean, M. Christopher] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [Feibel, Craig S.] Rutgers State Univ, Dept Earth & Planetary Sci, Piscataway, NJ 08854 USA; [Feibel, Craig S.] Rutgers State Univ, Dept Anthropol, Piscataway, NJ 08854 USA; [Anton, Susan C.] NYU, Dept Anthropol, New York, NY 10003 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Max Planck Society; University of London; University College London; Rutgers State University New Brunswick; Rutgers State University New Brunswick; New York University	Leakey, MG (corresponding author), Turkana Basin Inst, POB 24926, Nairobi 00502, Kenya.	meaveleakey@gmail.com; f.spoor@eva.mpg.de		Leakey, Louise/0000-0003-3420-6341	Turkana Basin Institute; National Geographic Society; Leakey Foundation; Max Planck Society	Turkana Basin Institute; National Geographic Society(National Geographic Society); Leakey Foundation; Max Planck Society(Max Planck Society)	We thank the Governments of Kenya and Tanzania for permission to carry out this research, the Kenya Wildlife Service for permission to work in the Sibiloi National Park, the National Museums of Kenya and the National Museum of Tanzania for access to specimens in their care, and the Turkana Basin Institute for support. The National Geographic Society, the Leakey Foundation and the Max Planck Society funded fieldwork or laboratory studies. Many people helped us with this research, including N. Adamali, R. Blumenschine, C. Boesch, F. Brown, P. Gunz, J. J. Hublin, W. Kimbel, K. Kupczik, R. Leakey, C. Lepre, D. Lieberman, P. Msemwa, R. Odoyo, R. Quinn, P. Rightmire, L. Schroeder, U. Schwarz, M. Skinner, H. Temming, A. Winzer and B. Wood. Curatorial assistance was given by A. Kweka, F. Manthi, E. Mbua, M. Muungu and J. Thiringi. KNM-ER60000 was discovered by C. Nyete, KNM-ER62000 by D. Elgite and KNM-ER 62003 by R. Moru. We particularly thank the Koobi Fora Research Project field crew: A. Aike, S. Aila, D. Elgite, M. Kirinya, D. Gidole, O. Kyalo, A. Longaye, A. Lawri, E. Linga, J. Lonyericho, S. Lomeiku, D. Muema, A. Moru, R. Moru, S. Muge, C. Nyete, L. Nzuve, H. Sale and A. Sharamo whose fieldwork led to the discovery of these specimens, and camp managers J. Mutuku and T. Ngundo. H. Churcher, J. Coreth, A. Hammond, J. LaCarrubba, F. Kirera, C. Lepre, M. Noback, R. Quinn, M. Skinner, I. Wallace and S. Wright participated in one or more of the 2007, 2008 or 2009 field expeditions when these specimens were discovered. We are grateful to F. and J. Pinto, W. Philips, M. Hettwer, P. Sylvester, H. Buchi, N. Seligman, E. von Simpson, J. Doerr and B. and J. Chelberg for their financial support of this fieldwork.	Blumenschine RJ, 2003, SCIENCE, V299, P1217, DOI 10.1126/science.1075374; Braun DR, 2010, P NATL ACAD SCI USA, V107, P10002, DOI 10.1073/pnas.1002181107; BROCK A, 1974, NATURE, V247, P344, DOI 10.1038/247344a0; BROMAGE TG, 1995, J HUM EVOL, V28, P71, DOI 10.1006/jhev.1995.1007; BROWN FH, 1986, J GEOL SOC LONDON, V143, P297, DOI 10.1144/gsjgs.143.2.0297; Clarke R. J., 2012, J HUM EVOL; Dean M. Christopher, 2009, P101, DOI 10.1007/978-1-4020-9980-9_10; Gibbard PL, 2010, J QUATERNARY SCI, V25, P96, DOI 10.1002/jqs.1338; Groves C., 1989, THEORY HUMAN PRIMATE; Howell F.C., 1978, P154; JOHANSON DC, 1987, NATURE, V327, P205, DOI 10.1038/327205a0; Joordens JCA, 2011, EARTH PLANET SC LETT, V307, P1, DOI 10.1016/j.epsl.2011.05.005; Kimbel WH, 1997, AM J PHYS ANTHROPOL, V103, P235, DOI 10.1002/(SICI)1096-8644(199706)103:2<235::AID-AJPA8>3.3.CO;2-V; KRAMER A, 1995, J HUM EVOL, V29, P443, DOI 10.1006/jhev.1995.1068; LEAKEY REF, 1974, NATURE, V248, P653, DOI 10.1038/248653a0; LEAKEY REF, 1973, NATURE, V242, P447, DOI 10.1038/242447a0; LIEBERMAN DE, 1988, J HUM EVOL, V17, P503, DOI 10.1016/0047-2484(88)90039-5; LOURENS L, 2004, GEOLOGIC TIME SCALE, P409, DOI DOI 10.1017/CBO9780511536045.022; McDougall I, 2006, J GEOL SOC LONDON, V163, P205, DOI 10.1144/0016-764904-166; McDougall I, 2012, J GEOL SOC LONDON, V169, P213, DOI 10.1144/0016-76492010-188; Miller JMA, 2000, AM J PHYS ANTHROPOL, V112, P103, DOI 10.1002/(SICI)1096-8644(200005)112:1<103::AID-AJPA10>3.0.CO;2-6; RIGHTMIRE GP, 1993, AM J PHYS ANTHROPOL, V90, P1, DOI 10.1002/ajpa.1330900102; Stringer C.B., 1986, P266; Suwa G, 1996, AM J PHYS ANTHROPOL, V101, P247, DOI 10.1002/(SICI)1096-8644(199610)101:2<247::AID-AJPA9>3.0.CO;2-Z; Suwa G, 2007, ANTHROPOL SCI, V115, P133, DOI 10.1537/ase.061203; Tobias P. V., 1991, GODUVAI GORGE, V4; WOOD B, 1992, NATURE, V355, P783, DOI 10.1038/355783a0; Wood B., 1985, P206; Wood B, 1999, J HUM EVOL, V36, P115, DOI 10.1006/jhev.1998.0246; Wood B., 1991, HOMINID CRANIAL REMA, V4	30	116	121	0	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2012	488	7410					201	204		10.1038/nature11322	http://dx.doi.org/10.1038/nature11322			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	985LE	22874966				2022-12-28	WOS:000307267000031
J	Mauldin, RL; Berndt, T; Sipila, M; Paasonen, P; Petaja, T; Kim, S; Kurten, T; Stratmann, F; Kerminen, VM; Kulmala, M				Mauldin, R. L., III; Berndt, T.; Sipilae, M.; Paasonen, P.; Petaja, T.; Kim, S.; Kurten, T.; Stratmann, F.; Kerminen, V-M; Kulmala, M.			A new atmospherically relevant oxidant of sulphur dioxide	NATURE			English	Article							OH MEASUREMENTS; FOREST; OXIDATION; OZONE; ACID; SO2; MECHANISM; SYSTEM; CH2OO; AIR	Atmospheric oxidation is a key phenomenon that connects atmospheric chemistry with globally challenging environmental issues, such as climate change(1), stratospheric ozone loss(2), acidification of soils and water(3), and health effects of air quality(4). Ozone, the hydroxyl radical and the nitrate radical are generally considered to be the dominant oxidants that initiate the removal of trace gases, including pollutants, from the atmosphere. Here we present atmospheric observations from a boreal forest region in Finland, supported by laboratory experiments and theoretical considerations, that allow us to identify another compound, probably a stabilized Criegee intermediate (a carbonyl oxide with two free-radical sites) or its derivative, which has a significant capacity to oxidize sulphur dioxide and potentially other trace gases. This compound probably enhances the reactivity of the atmosphere, particularly with regard to the production of sulphuric acid, and consequently atmospheric aerosol formation. Our findings suggest that this new atmospherically relevant oxidation route is important relative to oxidation by the hydroxyl radical, at least at moderate concentrations of that radical. We also find that the oxidation chemistry of this compound seems to be tightly linked to the presence of alkenes of biogenic origin.	[Mauldin, R. L., III; Sipilae, M.; Paasonen, P.; Petaja, T.; Kurten, T.; Kerminen, V-M; Kulmala, M.] Univ Helsinki, Dept Phys, FI-00014 Helsinki, Finland; [Mauldin, R. L., III; Kim, S.] Natl Ctr Atmospher Res, Boulder, CO 80307 USA; [Mauldin, R. L., III] Univ Colorado Boulder, Dept Atmospher & Ocean Sci, Boulder, CO 80309 USA; [Berndt, T.; Sipilae, M.; Stratmann, F.] Leibniz Inst Tropospher Res, D-04318 Leipzig, Germany; [Sipilae, M.] Helsinki Inst Phys, FI-00014 Helsinki, Finland; [Kurten, T.] Univ Helsinki, Dept Chem, FI-00014 Helsinki, Finland	University of Helsinki; National Center Atmospheric Research (NCAR) - USA; University of Colorado System; University of Colorado Boulder; Leibniz Institut fur Tropospharenforschung (TROPOS); Helsinki Institute of Physics; University of Helsinki	Mauldin, RL (corresponding author), Univ Helsinki, Dept Phys, FI-00014 Helsinki, Finland.	roy.mauldin@helsinki.fi	Kerminen, Veli-Matti/M-9026-2014; Petäjä, Tuukka/A-8009-2008; Kulmala, Markku T/I-7671-2016; Paasonen, Pauli/M-2972-2013; Kim, Saewung/E-4089-2012; Sipilä, Mikko/G-3024-2010; Kurtén, Theo C/G-2120-2012	Petäjä, Tuukka/0000-0002-1881-9044; Kulmala, Markku T/0000-0003-3464-7825; Paasonen, Pauli/0000-0002-4625-9590; Kim, Saewung/0000-0003-4847-3272; Sipilä, Mikko/0000-0002-8594-7003; Kurtén, Theo C/0000-0002-6416-4931	European Commission Sixth Framework programme project EUCAARI [036833-2]; Academy of Finland [251427, 139656, 141135]; European Research Council (ATMNUCLE); Kone Foundation; Vaisala Foundation; Maj and Tor Nessling Foundation [2010212]; Otto Malm Foundation; US National Science Foundation	European Commission Sixth Framework programme project EUCAARI; Academy of Finland(Academy of Finland); European Research Council (ATMNUCLE)(European Research Council (ERC)); Kone Foundation; Vaisala Foundation; Maj and Tor Nessling Foundation; Otto Malm Foundation; US National Science Foundation(National Science Foundation (NSF))	We thank K. Pielok and A. Rohmer for technical assistance. This work was partially funded by the European Commission Sixth Framework programme project EUCAARI, contract no. 036833-2 (EUCAARI), the Academy of Finland (251427, 139656, Finnish centre of excellence 141135), the European Research Council (ATMNUCLE), the Kone Foundation, the Vaisala Foundation, the Maj and Tor Nessling Foundation (2010212), the Otto Malm Foundation and the US National Science Foundation.	Arneth A, 2010, NAT GEOSCI, V3, P525, DOI [10.1038/NGEO905, 10.1038/ngeo905]; Arneth A, 2009, SCIENCE, V326, P672, DOI 10.1126/science.1181568; Berndt T, 2010, ATMOS CHEM PHYS, V10, P7101, DOI 10.5194/acp-10-7101-2010; COCKS AT, 1986, ATMOS ENVIRON, V20, P2359, DOI 10.1016/0004-6981(86)90066-1; COX RA, 1971, NATURE, V230, P321, DOI 10.1038/230321a0; Demore W., 1997, JPL PUBLICATION, V97-4; Di Carlo P, 2004, SCIENCE, V304, P722, DOI 10.1126/science.1094392; Drozd GT, 2011, J PHYS CHEM A, V115, P161, DOI 10.1021/jp108773d; EISELE FL, 1991, J GEOPHYS RES-ATMOS, V96, P9295, DOI 10.1029/91JD00198; Fenger J, 2009, ATMOS ENVIRON, V43, P13, DOI 10.1016/j.atmosenv.2008.09.061; Hakola H, 2003, ATMOS ENVIRON, V37, P1623, DOI 10.1016/S1352-2310(03)00014-1; Hari P, 2005, BOREAL ENVIRON RES, V10, P315; HATAKEYAMA S, 1986, J PHYS CHEM-US, V90, P4131, DOI 10.1021/j100408a059; Heald CL, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009092; Hofzumahaus A, 2009, SCIENCE, V324, P1702, DOI 10.1126/science.1164566; Jiang L, 2010, J PHYS CHEM A, V114, P12452, DOI 10.1021/jp107783z; Johnson D, 2001, J PHYS CHEM A, V105, P2933, DOI 10.1021/jp003975e; Kurten T, 2011, J PHYS CHEM A, V115, P8669, DOI 10.1021/jp203907d; Kurten T, 2010, PHYS CHEM CHEM PHYS, V12, P12833, DOI 10.1039/c0cp00383b; Lappalainen HK, 2009, ATMOS CHEM PHYS, V9, P5447, DOI 10.5194/acp-9-5447-2009; Lelieveld J, 2008, NATURE, V452, P737, DOI 10.1038/nature06870; Liao H, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010984; LIKENS GE, 1972, ENVIRONMENT, V14, P33, DOI 10.1080/00139157.1972.9933001; Lou S, 2010, ATMOS CHEM PHYS, V10, P11243, DOI 10.5194/acp-10-11243-2010; Mauldin RL, 1998, J GEOPHYS RES-ATMOS, V103, P16713, DOI 10.1029/98JD00882; Montzka SA, 2011, SCIENCE, V331, P67, DOI 10.1126/science.1197640; Petaja T, 2009, ATMOS CHEM PHYS, V9, P7435, DOI 10.5194/acp-9-7435-2009; Rowland FS, 2006, PHILOS T R SOC B, V361, P769, DOI 10.1098/rstb.2005.1783; Sipila M, 2010, SCIENCE, V327, P1243, DOI 10.1126/science.1180315; Spracklen DV, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL033038; Su H, 2011, SCIENCE, V333, P1616, DOI 10.1126/science.1207687; Tanner DJ, 1997, J GEOPHYS RES-ATMOS, V102, P6415, DOI 10.1029/96JD03919; Welz O, 2012, SCIENCE, V335, P204, DOI 10.1126/science.1213229; XIE ZD, 1992, J PHYS CHEM-US, V96, P1543, DOI 10.1021/j100183a011	34	342	344	24	623	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 9	2012	488	7410					193	196		10.1038/nature11278	http://dx.doi.org/10.1038/nature11278			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985LE	22874964	Green Published			2022-12-28	WOS:000307267000029
J	Yin, J; Ren, JG; Lu, H; Cao, Y; Yong, HL; Wu, YP; Liu, C; Liao, SK; Zhou, F; Jiang, Y; Cai, XD; Xu, P; Pan, GS; Jia, JJ; Huang, YM; Yin, H; Wang, JY; Chen, YA; Peng, CZ; Pan, JW				Yin, Juan; Ren, Ji-Gang; Lu, He; Cao, Yuan; Yong, Hai-Lin; Wu, Yu-Ping; Liu, Chang; Liao, Sheng-Kai; Zhou, Fei; Jiang, Yan; Cai, Xin-Dong; Xu, Ping; Pan, Ge-Sheng; Jia, Jian-Jun; Huang, Yong-Mei; Yin, Hao; Wang, Jian-Yu; Chen, Yu-Ao; Peng, Cheng-Zhi; Pan, Jian-Wei			Quantum teleportation and entanglement distribution over 100-kilometre free-space channels	NATURE			English	Article							HIGH-FIDELITY TRANSMISSION; QUBITS; STATE	Transferring an unknown quantum state over arbitrary distances is essential for large-scale quantum communication and distributed quantum networks. It can be achieved with the help of long-distance quantum teleportation(1,2) and entanglement distribution. The latter is also important for fundamental tests of the laws of quantum mechanics(3,4). Although quantum teleportation(5,6) and entanglement distribution(7-9) over moderate distances have been realized using optical fibre links, the huge photon loss and decoherence in fibres necessitate the use of quantum repeaters(10) for larger distances. However, the practical realization of quantum repeaters remains experimentally challenging(11). Free-space channels, first used for quantum key distribution(12,13), offer a more promising approach because photon loss and decoherence are almost negligible in the atmosphere. Furthermore, by using satellites, ultra-long-distance quantum communication and tests of quantum foundations could be achieved on a global scale. Previous experiments have achieved free-space distribution of entangled photon pairs over distances of 600 metres (ref. 14) and 13 kilometres (ref. 15), and transfer of triggered single photons over a 144-kilometre one-link free-space channel(16). Most recently, following a modified scheme(17), free-space quantum teleportation over 16 kilometres was demonstrated(18) with a single pair of entangled photons. Here we report quantum teleportation of independent qubits over a 97-kilometre one-link free-space channel with multi-photon entanglement. An average fidelity of 80.4 +/- 0.9 per cent is achieved for six distinct states. Furthermore, we demonstrate entanglement distribution over a two-link channel, in which the entangled photons are separated by 101.8 kilometres. Violation of the Clauser-Horne-Shimony-Holt inequality(4) is observed without the locality loophole. Besides being of fundamental interest, our results represent an important step towards a global quantum network. Moreover, the high-frequency and high-accuracy acquiring, pointing and tracking technique developed in our experiment can be directly used for future satellite-based quantum communication and large-scale tests of quantum foundations.	[Yin, Juan; Ren, Ji-Gang; Lu, He; Cao, Yuan; Yong, Hai-Lin; Wu, Yu-Ping; Liu, Chang; Liao, Sheng-Kai; Zhou, Fei; Jiang, Yan; Cai, Xin-Dong; Xu, Ping; Pan, Ge-Sheng; Yin, Hao; Chen, Yu-Ao; Peng, Cheng-Zhi; Pan, Jian-Wei] Univ Sci & Technol China, Natl Lab Phys Sci Microscale, Shanghai Branch, Shanghai 201315, Peoples R China; [Yin, Juan; Ren, Ji-Gang; Lu, He; Cao, Yuan; Yong, Hai-Lin; Wu, Yu-Ping; Liu, Chang; Liao, Sheng-Kai; Zhou, Fei; Jiang, Yan; Cai, Xin-Dong; Xu, Ping; Pan, Ge-Sheng; Yin, Hao; Chen, Yu-Ao; Peng, Cheng-Zhi; Pan, Jian-Wei] Univ Sci & Technol China, Dept Modern Phys, Shanghai 201315, Peoples R China; [Jia, Jian-Jun; Wang, Jian-Yu] Chinese Acad Sci, Shanghai Inst Tech Phys, Shanghai 200083, Peoples R China; [Huang, Yong-Mei] Chinese Acad Sci, Inst Opt & Elect, Chengdu 610209, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Shanghai Institute of Technical Physics, CAS; Chinese Academy of Sciences; Institute of Optics & Electronics, CAS	Chen, YA (corresponding author), Univ Sci & Technol China, Natl Lab Phys Sci Microscale, Shanghai Branch, Shanghai 201315, Peoples R China.	yuaochen@ustc.edu.cn; pcz@ustc.edu.cn; pan@ustc.edu.cn	yin, juan/AAG-3315-2021; Pan, Jian-Wei/A-2332-2010; Chen, Yu-Ao/B-2057-2013; liao, shengkai/L-7149-2019; Yong, Hai-Lin/AAD-3818-2019; cao, yuan/GRR-9461-2022; Cai, Xin-Dong/J-9496-2013	Pan, Jian-Wei/0000-0002-6100-5142; Chen, Yu-Ao/0000-0002-2309-2281; Yong, Hai-Lin/0000-0002-9074-5617; 	Chinese Academy of Sciences; National Natural Science Foundation of China; National Fundamental Research Program [2011CB921300]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Fundamental Research Program	We are grateful to the staff of the Qinghai Lake National Natural Reserve Utilization Administration Bureau, especially Y.-B. He and Z. Xing, for their support during the experiment. We thank B. Zhao and Y.-J. Deng for discussions, and T. Li for proofreading the manuscript before submission. This work was supported by Chinese Academy of Sciences, National Natural Science Foundation of China and the National Fundamental Research Program (under grant no. 2011CB921300).	Aspelmeyer M, 2003, SCIENCE, V301, P621, DOI 10.1126/science.1085593; Bell JS., 1964, PHYS, V1, P195, DOI [10.1103/PhysicsPhysiqueFizika.1.195, 10.1103/Physics-PhysiqueFizika.1.195, DOI 10.1103/PHYSICSPHYSIQUEFIZIKA.1.195]; BENNETT CH, 1993, PHYS REV LETT, V70, P1895, DOI 10.1103/PhysRevLett.70.1895; Boschi D, 1998, PHYS REV LETT, V80, P1121, DOI 10.1103/PhysRevLett.80.1121; Bouwmeester D, 1997, NATURE, V390, P575, DOI 10.1038/37539; Briegel HJ, 1998, PHYS REV LETT, V81, P5932, DOI 10.1103/PhysRevLett.81.5932; Dynes JF, 2009, OPT EXPRESS, V17, P11440, DOI 10.1364/OE.17.011440; Fedrizzi A, 2009, NAT PHYS, V5, P389, DOI 10.1038/NPHYS1255; Hubel H, 2007, OPT EXPRESS, V15, P7853, DOI 10.1364/OE.15.007853; Hughes RJ, 2002, NEW J PHYS, V4, DOI 10.1088/1367-2630/4/1/343; Jin XM, 2010, NAT PHOTONICS, V4, P376, DOI 10.1038/NPHOTON.2010.87; Kim YH, 2003, PHYS REV A, V67, DOI [10.1103/PhysRevA.67.010301, 10.1103/PhysRevA.67.040301]; Kurtsiefer C, 2002, NATURE, V419, P450, DOI 10.1038/419450a; KWIAT PG, 1995, PHYS REV LETT, V75, P4337, DOI 10.1103/PhysRevLett.75.4337; Peng CZ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.150501; POPESCU S, 1994, PHYS REV LETT, V72, P797, DOI 10.1103/PhysRevLett.72.797; Strohbehn J. W., 1978, LASER BEAN PROPAGATI; Ursin R, 2004, NATURE, V430, P849, DOI 10.1038/430849a; Yao XC, 2012, NAT PHOTONICS, V6, P225, DOI 10.1038/nphoton.2011.354; Yuan ZS, 2008, NATURE, V454, P1098, DOI 10.1038/nature07241; Zhang Q, 2008, OPT EXPRESS, V16, P5776, DOI 10.1364/OE.16.005776	23	314	345	17	282	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 9	2012	488	7410					185	188		10.1038/nature11332	http://dx.doi.org/10.1038/nature11332			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985LE	22874963	Green Submitted			2022-12-28	WOS:000307267000027
J	Zhong, FL; Batista, LFZ; Freund, A; Pech, MF; Venteicher, AS; Artandi, SE				Zhong, Franklin L.; Batista, Luis F. Z.; Freund, Adam; Pech, Matthew F.; Venteicher, Andrew S.; Artandi, Steven E.			TPP1 OB-Fold Domain Controls Telomere Maintenance by Recruiting Telomerase to Chromosome Ends	CELL			English	Article							CAJAL BODIES; REVERSE-TRANSCRIPTASE; CATALYTIC SUBUNIT; LENGTH REGULATOR; POT1; RNA; PROTECTION; LOCALIZATION; MUTATIONS; TRF1	Telomere synthesis in cancer cells and stem cells involves trafficking of telomerase to Cajal bodies, and telomerase is thought to be recruited to telomeres through interactions with telomere-binding proteins. Here, we show that the OB-fold domain of the telomere-binding protein TPP1 recruits telomerase to telomeres through an association with the telomerase reverse transcriptase TERT. When tethered away from telomeres and other telomere-binding proteins, the TPP1 OB-fold domain is sufficient to recruit telomerase to a heterologous chromatin locus. Expression of a minimal TPP1 OB-fold inhibits telomere maintenance by blocking access of telomerase to its cognate binding site at telomeres. We identify amino acids required for the TPP1-telomerase interaction, including specific loop residues within the TPP1 OB-fold domain and individual residues within TERT, some of which are mutated in a subset of pulmonary fibrosis patients. These data define a potential interface for telomerase-TPP1 interaction required for telomere maintenance and implicate defective telomerase recruitment in telomerase-related disease.	[Zhong, Franklin L.; Batista, Luis F. Z.; Freund, Adam; Pech, Matthew F.; Venteicher, Andrew S.; Artandi, Steven E.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Zhong, Franklin L.; Freund, Adam; Pech, Matthew F.; Artandi, Steven E.] Stanford Univ, Canc Biol Program, Sch Med, Stanford, CA 94305 USA; [Venteicher, Andrew S.] Stanford Univ, Biophys Program, Sch Med, Stanford, CA 94305 USA; [Artandi, Steven E.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Artandi, SE (corresponding author), Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA.	sartandi@stanford.edu	Venteicher, Andrew/AAN-5666-2021	Venteicher, Andrew/0000-0003-0643-0493; Zhong, Franklin/0000-0002-0516-6021; Batista, Luis/0000-0002-7538-3240	Agency for Science, Technology, and Research (A*STAR), Singapore; California Institute of Regenerative Medicine; NIH [5T32 CA09302, AG033747, CA125453, CA111691]; NSF; Leukemia and Lymphoma Society; Glenn Foundation for Medical Research; NATIONAL CANCER INSTITUTE [R01CA125453, T32CA009302, R01CA111691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG033747, R01AG033747] Funding Source: NIH RePORTER	Agency for Science, Technology, and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR)); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Glenn Foundation for Medical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Amy Li for technical assistance and members of the Artandi lab for helpful discussion. F.L.Z. was supported by a fellowship from the Agency for Science, Technology, and Research (A*STAR), Singapore. L.F.Z.B. was supported by a fellowship from the California Institute of Regenerative Medicine. A. F. was supported by NIH 5T32 CA09302. M. F. P. is the recipient of an NSF graduate research fellowship. This work was supported by NIH grants AG033747, CA125453, and CA111691, by a SCOR grant from the Leukemia and Lymphoma Society, and by the Glenn Foundation for Medical Research.	Abreu E, 2010, MOL CELL BIOL, V30, P2971, DOI 10.1128/MCB.00240-10; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Armbruster BN, 2003, MOL CELL BIOL, V23, P3237, DOI 10.1128/MCB.23.9.3237-3246.2003; Artandi SE, 2010, CARCINOGENESIS, V31, P9, DOI 10.1093/carcin/bgp268; Banik SSR, 2002, MOL CELL BIOL, V22, P6234, DOI 10.1128/MCB.22.17.6234-6246.2002; Batista LFZ, 2011, NATURE, V474, P399, DOI 10.1038/nature10084; Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373; Cech TR, 2004, CELL, V116, P273, DOI 10.1016/S0092-8674(04)00038-8; Chan A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000236; Collins K, 2008, MECH AGEING DEV, V129, P91, DOI 10.1016/j.mad.2007.10.008; Cristofari G, 2006, EMBO J, V25, P565, DOI 10.1038/sj.emboj.7600952; Cristofari G, 2007, MOL CELL, V27, P882, DOI 10.1016/j.molcel.2007.07.020; Darzacq X, 2006, J CELL BIOL, V173, P207, DOI 10.1083/jcb.200601105; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Egan ED, 2012, MOL CELL BIOL, V32, P2428, DOI 10.1128/MCB.00286-12; Gall JG, 2000, ANNU REV CELL DEV BI, V16, P273, DOI 10.1146/annurev.cellbio.16.1.273; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Houghtaling BR, 2004, CURR BIOL, V14, P1621, DOI 10.1016/j.cub.2004.08.052; Jady BE, 2004, J CELL BIOL, V164, P647, DOI 10.1083/jcb.200310138; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Kelleher C, 2005, MOL CELL BIOL, V25, P808, DOI 10.1128/MCB.25.2.808-818.2005; Kibe T, 2010, MOL CELL BIOL, V30, P1059, DOI 10.1128/MCB.01498-09; Latrick CM, 2010, EMBO J, V29, P924, DOI 10.1038/emboj.2009.409; Lee J, 2008, NAT STRUCT MOL BIOL, V15, P990, DOI 10.1038/nsmb.1472; Lei M, 2004, NAT STRUCT MOL BIOL, V11, P1223, DOI 10.1038/nsmb867; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; O'Sullivan RJ, 2010, NAT REV MOL CELL BIO, V11, P171, DOI 10.1038/nrm2848; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pennock E, 2001, CELL, V104, P387, DOI 10.1016/S0092-8674(01)00226-4; Podlevsky JD, 2012, MUTAT RES-FUND MOL M, V730, P3, DOI 10.1016/j.mrfmmm.2011.11.002; Rai R, 2011, NAT STRUCT MOL BIOL, V18, P1400, DOI 10.1038/nsmb.2172; Savage SA, 2008, MECH AGEING DEV, V129, P35, DOI 10.1016/j.mad.2007.11.002; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; Stern JL, 2012, MOL CELL BIOL, V32, P2384, DOI 10.1128/MCB.00379-12; Taggart AKP, 2002, SCIENCE, V297, P1023, DOI 10.1126/science.1074968; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Takai KK, 2011, MOL CELL, V44, P647, DOI 10.1016/j.molcel.2011.08.043; Tejera AM, 2010, DEV CELL, V18, P775, DOI [10.1016/j.devcel.2010.03.011, 10.1016/j.devce1.2010.03.011]; Tomlinson RL, 2008, MOL BIOL CELL, V19, P3793, DOI 10.1091/mbc.E08-02-0184; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; Tsang AR, 2012, AGING CELL, V11, P482, DOI 10.1111/j.1474-9726.2012.00810.x; Tycowski KT, 2009, MOL CELL, V34, P47, DOI 10.1016/j.molcel.2009.02.020; Venteicher AS, 2009, SCIENCE, V323, P644, DOI 10.1126/science.1165357; Verdun RE, 2007, NATURE, V447, P924, DOI 10.1038/nature05976; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Xin HW, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-232; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; Ye JZS, 2004, GENE DEV, V18, P1649, DOI 10.1101/gad.1215404; Ye JZS, 2004, NAT GENET, V36, P618, DOI 10.1038/ng1360; Yu EY, 2008, NAT STRUCT MOL BIOL, V15, P985, DOI 10.1038/nsmb.1471; Zappulla DC, 2006, COLD SPRING HARB SYM, V71, P217, DOI 10.1101/sqb.2006.71.011; Zaug AJ, 2010, GENE DEV, V24, P613, DOI 10.1101/gad.1881810; Zhong F, 2011, GENE DEV, V25, P11, DOI 10.1101/gad.2006411; Zhu YS, 2004, MOL BIOL CELL, V15, P81, DOI 10.1091/mbc.E03-07-0525	57	204	209	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 3	2012	150	3					481	494		10.1016/j.cell.2012.07.012	http://dx.doi.org/10.1016/j.cell.2012.07.012			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	985WO	22863003	Bronze, Green Accepted			2022-12-28	WOS:000307301400009
J	Liniker, E; Al-Jilaihawi, S; Propper, D; Slater, S; Pacey, S				Liniker, E.; Al-Jilaihawi, S.; Propper, D.; Slater, S.; Pacey, S.			CASE REPORT A 46 year old man with carcinoma of unknown primary site	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Liniker, E.; Pacey, S.] Addenbrookes Hosp, Dept Oncol, Cambridge CB2 0QQ, England; [Al-Jilaihawi, S.; Propper, D.; Slater, S.] Queen Mary Univ London, Barts Canc Inst, London, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; Queen Mary University London	Pacey, S (corresponding author), Addenbrookes Hosp, Dept Oncol, Cambridge CB2 0QQ, England.	simonpacey@medschl.cam.ac.uk		Pacey, Simon Christopher/0000-0002-3303-7577				Cancer Research UK, TRIAL CHEM CANC UNK; de Bresser J, 2010, EJSO-EUR J SURG ONC, V36, P114, DOI 10.1016/j.ejso.2009.09.007; Hess KR, 1999, CLIN CANCER RES, V5, P3403; Massard C, 2011, NAT REV CLIN ONCOL, V8, P701, DOI 10.1038/nrclinonc.2011.158; National Institute for Health and Clinical Excellence, 2010, CG104 NAT I HLTH CLI; Pavlidis N, 2010, ANN ONCOL, V21, pv228, DOI 10.1093/annonc/mdq193; Pavlidis N, 2009, CRIT REV ONCOL HEMAT, V69, P271, DOI 10.1016/j.critrevonc.2008.09.005; Shaw PHS, 2007, CLIN ONCOL-UK, V19, P87, DOI 10.1016/j.clon.2006.09.009	8	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 2	2012	345								e5144	10.1136/bmj.e5144	http://dx.doi.org/10.1136/bmj.e5144			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	985XE	22859798				2022-12-28	WOS:000307303000002
J	Davies, P				Davies, Peter			Should patients be able to control their own records?	BRITISH MEDICAL JOURNAL			English	Editorial Material												petergdavies@ntlworld.com						Department of Health, 2012, POW INF PUTT ALL US; Walker J, 2011, ANN INTERN MED, V155, P811, DOI 10.7326/0003-4819-155-12-201112200-00003; Whitfield L, 2012, EHEALTH INSIDER 0522	3	17	17	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUL 30	2012	345								e4905	10.1136/bmj.e4905	http://dx.doi.org/10.1136/bmj.e4905			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	985XA	22846414				2022-12-28	WOS:000307302600001
J	Nattrass, N				Nattrass, Nicoli			How bad ideas gain social traction	LANCET			English	Editorial Material									Univ Cape Town, Ctr Social Sci Res, AIDS & Soc Res Unit, ZA-7701 Rondebosch, South Africa	University of Cape Town	Nattrass, N (corresponding author), Univ Cape Town, Ctr Social Sci Res, AIDS & Soc Res Unit, ZA-7701 Rondebosch, South Africa.	nicoli.nattrass@gmail.com		Nattrass, Nicoli/0000-0002-8422-5631					0	3	3	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 28	2012	380	9839					332	333		10.1016/S0140-6736(12)61238-0	http://dx.doi.org/10.1016/S0140-6736(12)61238-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	979TN	22852141				2022-12-28	WOS:000306842800017
J	Eloubeidi, MA; El Majzoub, NW				Eloubeidi, Mohamad A.; El Majzoub, Nadim Walid			Duodenal Dieulafoy's Lesion	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Eloubeidi, Mohamad A.; El Majzoub, Nadim Walid] Amer Univ Beirut, Beirut, Lebanon	American University of Beirut	Eloubeidi, MA (corresponding author), Amer Univ Beirut, Beirut, Lebanon.	me75@aub.edu.lb		El Majzoub, Nadim/0000-0002-6803-478X					0	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 26	2012	367	4					E6	E6		10.1056/NEJMicm1014025	http://dx.doi.org/10.1056/NEJMicm1014025			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	978KD	22830483				2022-12-28	WOS:000306738300011
J	Jacak, BV; Muller, B				Jacak, Barbara V.; Mueller, Berndt			The Exploration of Hot Nuclear Matter	SCIENCE			English	Review							QUARK-GLUON PLASMA; ELLIPTIC FLOW; COLLISIONS; PERSPECTIVE; SPS	When nuclear matter is heated beyond 2 trillion degrees, it becomes a strongly coupled plasma of quarks and gluons. Experiments using highly energetic collisions between heavy nuclei have revealed that this new state of matter is a nearly ideal, highly opaque liquid. A description based on string theory and black holes in five dimensions has made the quark-gluon plasma an archetypical strongly coupled quantum system. Open questions about the structure and theory of the quark-gluon plasma are under active investigation. Many of the insights are also relevant to ultracold fermionic atoms and strongly correlated condensed matter.	[Mueller, Berndt] Duke Univ, Dept Phys, Durham, NC 27708 USA; [Mueller, Berndt] Duke Univ, Ctr Theoret & Math Sci, Durham, NC 27708 USA; [Jacak, Barbara V.] SUNY Stony Brook, Dept Phys & Astron, Stony Brook, NY 11794 USA	Duke University; Duke University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Muller, B (corresponding author), Duke Univ, Dept Phys, Durham, NC 27708 USA.	mueller@phy.duke.edu			U.S. Department of Energy	U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported by grants from the U.S. Department of Energy.	Aad G, 2011, PHYS LETT B, V697, P294, DOI 10.1016/j.physletb.2011.02.006; Abelev B., ARXIV12021383HEPEX; Abelev BI, 2010, PHYS REV C, V81, DOI 10.1103/PhysRevC.81.024911; Ackermann KH, 2001, PHYS REV LETT, V86, P402, DOI 10.1103/PhysRevLett.86.402; Adams J, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.172302; Adams J, 2005, NUCL PHYS A, V757, P102, DOI 10.1016/j.nuclphysa.2005.03.085; Adare A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.172301; Adare A, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.252301; Adare A, 2011, PHYS REV C, V84, DOI 10.1103/PhysRevC.84.054912; Adare A, 2010, PHYS REV C, V81, DOI 10.1103/PhysRevC.81.034911; Adare A, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.232301; Adcox K, 2002, PHYS REV LETT, V88, DOI [10.1103/PhysRevLett.88.242301, 10.1103/PhysRevLett.88.022301]; Adcox K, 2005, NUCL PHYS A, V757, P184, DOI 10.1016/j.nuclphysa.2005.03.086; Adler C, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.082302; Afanasiev S., ARXIV12055759NUCLEX; Aharony O, 2000, PHYS REP, V323, P183, DOI 10.1016/S0370-1573(99)00083-6; Alessandro B, 2005, EUR PHYS J C, V39, P335, DOI 10.1140/epjc/s2004-02107-9; Alver B, 2010, PHYS REV C, V81, DOI 10.1103/PhysRevC.81.054905; Alver B, 2008, PHYS REV C, V77, DOI 10.1103/PhysRevC.77.014906; Arsene I, 2005, NUCL PHYS A, V757, P1, DOI 10.1016/j.nuclphysa.2005.02.130; Asakawa M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.012001; Back BB, 2005, NUCL PHYS A, V757, P28, DOI 10.1016/j.nuclphysa.2005.03.084; Borsanyi S, 2010, J HIGH ENERGY PHYS, DOI 10.1007/JHEP11(2010)077; Cao C, 2011, SCIENCE, V331, P58, DOI 10.1126/science.1195219; Chan C. L., ARXIVPHYSICS0410042P; Chatrchyan S, 2012, J HIGH ENERGY PHYS, DOI 10.1007/JHEP05(2012)063; Chatrchyan S, 2011, PHYS REV C, V84, DOI 10.1103/PhysRevC.84.024906; Chesler PM, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.021601; DANIELEWICZ P, 1985, PHYS REV D, V31, P53, DOI 10.1103/PhysRevD.31.53; Datta S, 2004, PHYS REV D, V69, DOI 10.1103/PhysRevD.69.094507; Datta S, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.114505; Ding H.-T., 2010, P SCI LAT2010, V2010, P180; GROSS DJ, 1973, PHYS REV LETT, V30, P1343, DOI 10.1103/PhysRevLett.30.1343; Hartnoll S, 2008, SCIENCE, V322, P1639, DOI 10.1126/science.1166668; Kats Y, 2009, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2009/01/044; Kinast J, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.150402; Kolb EW, 1988, EARLY UNIVERSE; Kolb PF, 2001, PHYS LETT B, V500, P232, DOI 10.1016/S0370-2693(01)00079-X; Kovtun PK, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.111601; Luzum M, 2011, J PHYS G NUCL PARTIC, V38, DOI 10.1088/0954-3899/38/12/124026; Maldacena J., 1999, International Journal of Theoretical Physics, V38, P1113, DOI 10.1023/A:1026654312961; McLerran L, 2005, NUCL PHYS A, V752, p355C, DOI 10.1016/j.nuclphysa.2005.02.145; Muller B, 2006, ANNU REV NUCL PART S, V56, P93, DOI 10.1146/annurev.nucl.56.080805.140556; Muller B., ARXIV12023233HEPEX; O'Hara KM, 2002, SCIENCE, V298, P2179, DOI 10.1126/science.1079107; Panero M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.232001; Petersen H, 2008, PHYS REV C, V78, DOI 10.1103/PhysRevC.78.044901; Petreczky P, 2009, NUCL PHYS A, V830, p11C, DOI 10.1016/j.nuclphysa.2009.10.086; POLITZER HD, 1973, PHYS REV LETT, V30, P1346, DOI 10.1103/PhysRevLett.30.1346; Sachdev S, 2012, ANNU REV CONDEN MA P, V3, P9, DOI 10.1146/annurev-conmatphys-020911-125141; Sarmah D, 2006, PHYS SCRIPTA, V74, P288, DOI 10.1088/0031-8949/74/2/025; Schenke B, 2012, PHYS REV C, V85, DOI 10.1103/PhysRevC.85.024901; Song HC, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.192301; Song HC, 2011, PHYS REV C, V83, DOI 10.1103/PhysRevC.83.054912; Teaney D, 2001, PHYS REV LETT, V86, P4783, DOI 10.1103/PhysRevLett.86.4783	56	95	96	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2012	337	6092					310	314		10.1126/science.1215901	http://dx.doi.org/10.1126/science.1215901			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975WQ	22822143				2022-12-28	WOS:000306542600043
J	Bays, PM; Husain, M				Bays, Paul M.; Husain, Masud			Response to Comment on "Dynamic Shifts of Limited Working Memory Resources in Human Vision"	SCIENCE			English	Editorial Material							SHORT-TERM-MEMORY; CAPACITY; NUMBER		[Bays, Paul M.; Husain, Masud] UCL, Inst Cognit Neurosci, London WC1N 3AR, England; [Bays, Paul M.; Husain, Masud] UCL, Inst Neurol, London WC1N 3BG, England	University of London; University College London; University of London; University College London	Bays, PM (corresponding author), UCL, Inst Cognit Neurosci, 17 Queen Sq, London WC1N 3AR, England.	p.bays@ion.ucl.ac.uk	Husain, Masud/C-2074-2008; Bays, Paul/B-3999-2009	Husain, Masud/0000-0002-6850-9255; Bays, Paul/0000-0003-4684-4893	Wellcome Trust [061140] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Alvarez GA, 2004, PSYCHOL SCI, V15, P106, DOI 10.1111/j.0963-7214.2004.01502006.x; Awh E, 2007, PSYCHOL SCI, V18, P622, DOI 10.1111/j.1467-9280.2007.01949.x; Bays PM, 2008, SCIENCE, V321, P851, DOI 10.1126/science.1158023; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Cowan N, 2009, SCIENCE, V323, DOI 10.1126/science.1166478; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; PASHLER H, 1988, PERCEPT PSYCHOPHYS, V44, P369, DOI 10.3758/BF03210419; Pouget A, 2000, NAT REV NEUROSCI, V1, P125, DOI 10.1038/35039062; Rouder JN, 2008, P NATL ACAD SCI USA, V105, P5975, DOI 10.1073/pnas.0711295105; Wilken P, 2004, J VISION, V4, P1120, DOI 10.1167/4.12.11; Zhang WW, 2008, NATURE, V453, P233, DOI 10.1038/nature06860; Zucchini W, 2000, J MATH PSYCHOL, V44, P41, DOI 10.1006/jmps.1999.1276	12	23	24	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2009	323	5916								10.1126/science.1166794	http://dx.doi.org/10.1126/science.1166794			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	406KW	22822271	Green Accepted			2022-12-28	WOS:000263295400019
J	Wood, LV				Wood, Lauren V.			Why I Voted "No" to Truvada PrEP	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							POPULATION PHARMACOKINETICS; HIV-INFECTION; TENOFOVIR		NCI, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Wood, LV (corresponding author), NCI, Bldg 10,Room 6B04,10 Ctr Dr,MSC 1578, Bethesda, MD 20892 USA.	woodl@mail.nih.gov						Baeten JM, 2012, NEW ENGL J MED; Centers for Disease Control and Prevention, 2012, HIV US GLANC; Gagnieu MC, 2008, J CLIN PHARMACOL, V48, P1282, DOI 10.1177/0091270008322908; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Jullien V, 2005, ANTIMICROB AGENTS CH, V49, P3361, DOI 10.1128/AAC.49.8.3361-3366.2005; Scherzer R, 2012, AIDS, V26, P867, DOI 10.1097/QAD.0b013e328351f68f; Thigpen MC, 2012, N ENGL J MED; U.S. Food and Drug Administration, SLID MAY 10 2012 ANT; U.S. Food and Drug Administration, BRIEF INF MAY 10 201; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614	10	9	9	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 2	2012	157	7					519	521		10.7326/0003-4819-157-7-201210020-00511	http://dx.doi.org/10.7326/0003-4819-157-7-201210020-00511			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	016MQ	22821402				2022-12-28	WOS:000309523200007
J	Laurance, WF; Useche, DC; Rendeiro, J; Kalka, M; Bradshaw, CJA; Sloan, SP; Laurance, SG; Campbell, M; Abernethy, K; Alvarez, P; Arroyo-Rodriguez, V; Ashton, P; Benitez-Malvido, J; Blom, A; Bobo, KS; Cannon, CH; Cao, M; Carroll, R; Chapman, C; Coates, R; Cords, M; Danielsen, F; De Dijn, B; Dinerstein, E; Donnelly, MA; Edwards, D; Edwards, F; Farwig, N; Fashing, P; Forget, PM; Foster, M; Gale, G; Harris, D; Harrison, R; Hart, J; Karpanty, S; Kress, WJ; Krishnaswamy, J; Logsdon, W; Lovett, J; Magnusson, W; Maisels, F; Marshall, AR; McClearn, D; Mudappa, D; Nielsen, MR; Pearson, R; Pitman, N; van der Ploeg, J; Plumptre, A; Poulsen, J; Quesada, M; Rainey, H; Robinson, D; Roetgers, C; Rovero, F; Scatena, F; Schulze, C; Sheil, D; Struhsaker, T; Terborgh, J; Thomas, D; Timm, R; Urbina-Cardona, JN; Vasudevan, K; Wright, SJ; Arias-G, JC; Arroyo, L; Ashton, M; Auzel, P; Babaasa, D; Babweteera, F; Baker, P; Banki, O; Bass, M; Bila-Isia, I; Blake, S; Brockelman, W; Brokaw, N; Bruhl, CA; Bunyavejchewin, S; Chao, JT; Chave, J; Chellam, R; Clark, CJ; Clavijo, J; Congdon, R; Corlett, R; Dattaraja, HS; Dave, C; Davies, G; Beisiegel, BD; da Silva, RD; Di Fiore, A; Diesmos, A; Dirzo, R; Doran-Sheehy, D; Eaton, M; Emmons, L; Estrada, A; Ewango, C; Fedigan, L; Feer, F; Fruth, B; Willis, JG; Goodale, U; Goodman, S; Guix, JC; Guthiga, P; Haber, W; Hamer, K; Herbinger, I; Hill, J; Huang, ZL; Sun, IF; Ickes, K; Itoh, A; Ivanauskas, N; Jackes, B; Janovec, J; Janzen, D; Jiangming, M; Jin, C; Jones, T; Justiniano, H; Kalko, E; Kasangaki, A; Killeen, T; King, HB; Klop, E; Knott, C; Kone, I; Kudavidanage, E; Ribeiro, JLD; Lattke, J; Laval, R; Lawton, R; Leal, M; Leighton, M; Lentino, M; Leonel, C; Lindsell, J; Ling-Ling, L; Linsenmair, KE; Losos, E; Lugo, A; Lwanga, J; Mack, AL; Martins, M; McGraw, WS; McNab, R; Montag, L; Thompson, JM; Nabe-Nielsen, J; Nakagawa, M; Nepal, S; Norconk, M; Novotny, V; O'Donnell, S; Opiang, M; Ouboter, P; Parker, K; Parthasarathy, N; Pisciotta, K; Prawiradilaga, D; Pringle, C; Rajathurai, S; Reichard, U; Reinartz, G; Renton, K; Reynolds, G; Reynolds, V; Riley, E; Rodel, MO; Rothman, J; Round, P; Sakai, S; Sanaiotti, T; Savini, T; Schaab, G; Seidensticker, J; Siaka, A; Silman, MR; Smith, TB; de Almeida, SS; Sodhi, N; Stanford, C; Stewart, K; Stokes, E; Stoner, KE; Sukumar, R; Surbeck, M; Tobler, M; Tscharntke, T; Turkalo, A; Umapathy, G; van Weerd, M; Rivera, JV; Venkataraman, M; Venn, L; Verea, C; de Castilho, CV; Waltert, M; Wang, B; Watts, D; Weber, W; West, P; Whitacre, D; Whitney, K; Wilkie, D; Williams, S; Wright, DD; Wright, P; Xiankai, L; Yonzon, P; Zamzani, F				Laurance, William F.; Useche, D. Carolina; Rendeiro, Julio; Kalka, Margareta; Bradshaw, Corey J. A.; Sloan, Sean P.; Laurance, Susan G.; Campbell, Mason; Abernethy, Kate; Alvarez, Patricia; Arroyo-Rodriguez, Victor; Ashton, Peter; Benitez-Malvido, Julieta; Blom, Allard; Bobo, Kadiri S.; Cannon, Charles H.; Cao, Min; Carroll, Richard; Chapman, Colin; Coates, Rosamond; Cords, Marina; Danielsen, Finn; De Dijn, Bart; Dinerstein, Eric; Donnelly, Maureen A.; Edwards, David; Edwards, Felicity; Farwig, Nina; Fashing, Peter; Forget, Pierre-Michel; Foster, Mercedes; Gale, George; Harris, David; Harrison, Rhett; Hart, John; Karpanty, Sarah; Kress, W. John; Krishnaswamy, Jagdish; Logsdon, Willis; Lovett, Jon; Magnusson, William; Maisels, Fiona; Marshall, Andrew R.; McClearn, Deedra; Mudappa, Divya; Nielsen, Martin R.; Pearson, Richard; Pitman, Nigel; van der Ploeg, Jan; Plumptre, Andrew; Poulsen, John; Quesada, Mauricio; Rainey, Hugo; Robinson, Douglas; Roetgers, Christiane; Rovero, Francesco; Scatena, Frederick; Schulze, Christian; Sheil, Douglas; Struhsaker, Thomas; Terborgh, John; Thomas, Duncan; Timm, Robert; Urbina-Cardona, J. Nicolas; Vasudevan, Karthikeyan; Wright, S. Joseph; Arias-G, Juan Carlos; Arroyo, Luzmila; Ashton, Mark; Auzel, Philippe; Babaasa, Dennis; Babweteera, Fred; Baker, Patrick; Banki, Olaf; Bass, Margot; Bila-Isia, Inogwabini; Blake, Stephen; Brockelman, Warren; Brokaw, Nicholas; Bruehl, Carsten A.; Bunyavejchewin, Sarayudh; Chao, Jung-Tai; Chave, Jerome; Chellam, Ravi; Clark, Connie J.; Clavijo, Jose; Congdon, Robert; Corlett, Richard; Dattaraja, H. S.; Dave, Chittaranjan; Davies, Glyn; Beisiegel, Beatriz de Mello; da Silva, Rosa de Nazarepaes; Di Fiore, Anthony; Diesmos, Arvin; Dirzo, Rodolfo; Doran-Sheehy, Diane; Eaton, Mitchell; Emmons, Louise; Estrada, Alejandro; Ewango, Corneille; Fedigan, Linda; Feer, Francois; Fruth, Barbara; Willis, Jacalyn Giacalone; Goodale, Uromi; Goodman, Steven; Guix, Juan C.; Guthiga, Paul; Haber, William; Hamer, Keith; Herbinger, Ilka; Hill, Jane; Huang, Zhongliang; Sun, I. Fang; Ickes, Kalan; Itoh, Akira; Ivanauskas, Natalia; Jackes, Betsy; Janovec, John; Janzen, Daniel; Jiangming, Mo; Jin, Chen; Jones, Trevor; Justiniano, Hermes; Kalko, Elisabeth; Kasangaki, Aventino; Killeen, Timothy; King, Hen-biau; Klop, Erik; Knott, Cheryl; Kone, Inza; Kudavidanage, Enoka; Ribeiro, Jose Lahoz da Silva; Lattke, John; Laval, Richard; Lawton, Robert; Leal, Miguel; Leighton, Mark; Lentino, Miguel; Leonel, Cristiane; Lindsell, Jeremy; Ling-Ling, Lee; Linsenmair, K. Eduard; Losos, Elizabeth; Lugo, Ariel; Lwanga, Jeremiah; Mack, Andrew L.; Martins, Marlucia; McGraw, W. Scott; McNab, Roan; Montag, Luciano; Thompson, Jo Myers; Nabe-Nielsen, Jacob; Nakagawa, Michiko; Nepal, Sanjay; Norconk, Marilyn; Novotny, Vojtech; O'Donnell, Sean; Opiang, Muse; Ouboter, Paul; Parker, Kenneth; Parthasarathy, N.; Pisciotta, Katia; Prawiradilaga, Dewi; Pringle, Catherine; Rajathurai, Subaraj; Reichard, Ulrich; Reinartz, Gay; Renton, Katherine; Reynolds, Glen; Reynolds, Vernon; Riley, Erin; Roedel, Mark-Oliver; Rothman, Jessica; Round, Philip; Sakai, Shoko; Sanaiotti, Tania; Savini, Tommaso; Schaab, Gertrud; Seidensticker, John; Siaka, Alhaji; Silman, Miles R.; Smith, Thomas B.; de Almeida, Samuel Soares; Sodhi, Navjot; Stanford, Craig; Stewart, Kristine; Stokes, Emma; Stoner, Kathryn E.; Sukumar, Raman; Surbeck, Martin; Tobler, Mathias; Tscharntke, Teja; Turkalo, Andrea; Umapathy, Govindaswamy; van Weerd, Merlijn; Rivera, Jorge Vega; Venkataraman, Meena; Venn, Linda; Verea, Carlos; de Castilho, Carolina Volkmer; Waltert, Matthias; Wang, Benjamin; Watts, David; Weber, William; West, Paige; Whitacre, David; Whitney, Ken; Wilkie, David; Williams, Stephen; Wright, Debra D.; Wright, Patricia; Xiankai, Lu; Yonzon, Pralad; Zamzani, Franky			Averting biodiversity collapse in tropical forest protected areas	NATURE			English	Article							EXTINCTION; DEFORESTATION	The rapid disruption of tropical forests probably imperils global biodiversity more than any other contemporary phenomenon(1-3). With deforestation advancing quickly, protected areas are increasingly becoming final refuges for threatened species and natural ecosystem processes. However, many protected areas in the tropics are themselves vulnerable to human encroachment and other environmental stresses(4-9). As pressures mount, it is vital to know whether existing reserves can sustain their biodiversity. A critical constraint in addressing this question has been that data describing a broad array of biodiversity groups have been unavailable for a sufficiently large and representative sample of reserves. Here we present a uniquely comprehensive data set on changes over the past 20 to 30 years in 31 functional groups of species and 21 potential drivers of environmental change, for 60 protected areas stratified across the world's major tropical regions. Our analysis reveals great variation in reserve 'health': about half of all reserves have been effective or performed passably, but the rest are experiencing an erosion of biodiversity that is often alarmingly widespread taxonomically and functionally. Habitat disruption, hunting and forest-product exploitation were the strongest predictors of declining reserve health. Crucially, environmental changes immediately outside reserves seemed nearly as important as those inside in determining their ecological fate, with changes inside reserves strongly mirroring those occurring around them. These findings suggest that tropical protected areas are often intimately linked ecologically to their surrounding habitats, and that a failure to stem broad-scale loss and degradation of such habitats could sharply increase the likelihood of serious biodiversity declines.	[Laurance, William F.; Sloan, Sean P.; Laurance, Susan G.; Campbell, Mason; Edwards, David; Edwards, Felicity; Logsdon, Willis; Roetgers, Christiane] James Cook Univ, Ctr Trop Environm & Sustainabil Sci TESS, Cairns, Qld 4878, Australia; [Laurance, William F.; Sloan, Sean P.; Laurance, Susan G.; Campbell, Mason; Edwards, David; Edwards, Felicity; Logsdon, Willis; Roetgers, Christiane] James Cook Univ, Sch Marine & Trop Biol, Cairns, Qld 4878, Australia; [Laurance, William F.; Useche, D. Carolina; Rendeiro, Julio; Kalka, Margareta; Wright, S. Joseph] Smithsonian Trop Res Inst, Balboa, Ancon, Panama; [Bradshaw, Corey J. A.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA 5005, Australia; [Abernethy, Kate; Maisels, Fiona] Univ Stirling, Stirling FK9 4LA, Scotland; [Alvarez, Patricia; Pitman, Nigel; Struhsaker, Thomas; Terborgh, John; Clark, Connie J.] Duke Univ, Durham, NC 27705 USA; [Arroyo-Rodriguez, Victor; Benitez-Malvido, Julieta; Quesada, Mauricio] UNAM, Morelia, Michoacan, Mexico; [Ashton, Peter] Royal Bot Gardens, Richmond TW9 3AB, Surrey, England; [Blom, Allard; Carroll, Richard; Dinerstein, Eric; Itoh, Akira] World Wildlife Fund WWF, Washington, DC 20037 USA; [Bobo, Kadiri S.] Univ Dschang, Dschang, Cameroon; [Cannon, Charles H.; Cao, Min; Harrison, Rhett; Jin, Chen] Xishuangbanna Trop Bot Garden, Yunnan 666303, Peoples R China; [Chapman, Colin; Auzel, Philippe] McGill Univ, Montreal, PQ H3A 2T7, Canada; [Coates, Rosamond; Estrada, Alejandro] Univ Nacl Autonoma Mexico, Estn Biol Trop Los Tuxtlas, Veracruz 95701, Mexico; [Cords, Marina; West, Paige] Columbia Univ, New York, NY 10027 USA; [Danielsen, Finn] Nord Fdn Dev & Ecol, DK-1159 Copenhagen, Denmark; [De Dijn, Bart] Bart De Dijn Environm Consultancy, Paramaribo, Suriname; [Donnelly, Maureen A.] Florida Int Univ, Miami, FL 33199 USA; [Farwig, Nina] Univ Marburg, D-35043 Marburg, Germany; [Fashing, Peter] Calif State Univ Fullerton, Fullerton, CA 92834 USA; [Forget, Pierre-Michel; Feer, Francois] Museum Natl Hist Nat, F-91800 Brunoy, France; [Foster, Mercedes] US Geol Survey, Smithsonian Inst, Washington, DC 20013 USA; [Gale, George; Savini, Tommaso] King Mongkuts Univ Technol Thonburi, Bangkok 10150, Thailand; [Harris, David] Royal Bot Garden, Edinburgh EH3 5LR, Midlothian, Scotland; [Hart, John] Tshuapa Lomami Lualaba Project, Kinshasa, DEM REP CONGO; [Karpanty, Sarah] Virginia Tech Univ, Blacksburg, VA 24061 USA; [Kress, W. John; Emmons, Louise] Natl Museum Nat Hist, Smithsonian Inst, Washington, DC 20013 USA; [Krishnaswamy, Jagdish] Ashoka Trust Res Ecol & Environm ATREE, Bangalore 560064, Karnataka, India; [Lovett, Jon] Univ Twente, NL-7500 AE Enschede, Netherlands; [Magnusson, William; Sanaiotti, Tania] INPA, BR-69011970 Manaus, Amazonas, Brazil; [Maisels, Fiona; Rainey, Hugo; Blake, Stephen; Stokes, Emma; Weber, William; Wilkie, David] Wildlife Conservat Soc, Bronx, NY 10460 USA; [Marshall, Andrew R.; Hill, Jane] Univ York, York YO10 5DD, N Yorkshire, England; [McClearn, Deedra] La Selva Biol Stn, San Pedro, Costa Rica; [Mudappa, Divya] Nat Conservat Fdn, Mysore 570002, Karnataka, India; [Nielsen, Martin R.] Univ Copenhagen, Copenhagen, Denmark; [Pearson, Richard; Congdon, Robert; Jackes, Betsy; Williams, Stephen] James Cook Univ, Townsville, Qld 4811, Australia; [van der Ploeg, Jan; van Weerd, Merlijn] Leiden Univ, Leiden, Netherlands; [Plumptre, Andrew] Wildlife Conservat Soc, Kampala, Uganda; [Poulsen, John] Woods Hole Res Ctr, Falmouth, MA 02540 USA; [Robinson, Douglas; Thomas, Duncan] Oregon State Univ, Corvallis, OR 97331 USA; [Rovero, Francesco] Museo Sci, I-38122 Trento, Italy; [Scatena, Frederick; Janzen, Daniel] Univ Penn, Philadelphia, PA 19104 USA; [Schulze, Christian] Univ Vienna, A-1030 Vienna, Austria; [Sheil, Douglas] Bwindi Impenetrable Natl Pk, Kabale, Uganda; [Timm, Robert] Univ Kansas, Lawrence, KS 66045 USA; [Urbina-Cardona, J. Nicolas] Pontificia Univ Javeriana, Bogota, Colombia; [Vasudevan, Karthikeyan] Wildlife Inst India, Dehra Dun, India; [Arias-G, Juan Carlos] Unidad Parques Nacl Nat Colombia, Bogota, Colombia; [Arroyo, Luzmila] Museo Hist Nat Noel Kempff, Santa Cruz, Bolivia; [Ashton, Mark; Watts, David] Yale Univ, New Haven, CT 06511 USA; [Babaasa, Dennis] Inst Trop Forest Conservat, Kabale, Uganda; [Babweteera, Fred] Budongo Conservat Field Stn, Masindi, Uganda; [Baker, Patrick] Monash Univ, Melbourne, Vic 3800, Australia; [Banki, Olaf] Univ Utrecht, Utrecht, Netherlands; [Bass, Margot] Finding Species, Takoma Pk, MD 20912 USA; [Bila-Isia, Inogwabini] Univ Kent, Canterbury CT2 7NZ, Kent, England; [Brockelman, Warren] Mahidol Univ Salaya, Nakhon Pathom 73170, Thailand; [Brokaw, Nicholas] Univ Puerto Rico, San Juan, PR 00936 USA; [Bruehl, Carsten A.] Univ Koblenz Landau, D-76829 Landau, Germany; [Bunyavejchewin, Sarayudh] Dept Natl Pk, Bangkok 10900, Thailand; [Chao, Jung-Tai] Taiwan Forestry Res Inst, Taipei 10066, Taiwan; [Chave, Jerome] Univ Toulouse 3, F-31062 Toulouse, France; [Chellam, Ravi] Wildlife Conservat Soc, Bangalore 560070, Karnataka, India; [Clavijo, Jose] Cent Univ Venezuela, Aragua, Venezuela; [Corlett, Richard; Kudavidanage, Enoka; Sodhi, Navjot] Natl Univ Singapore, Singapore 117543, Singapore; [Dattaraja, H. S.] Indian Inst Sci, Bangalore 560012, Karnataka, India; [Dave, Chittaranjan] World Wide Fund Nat WWF, New Delhi 110003, India; [Davies, Glyn] World Wide Fund Nat WWF, Surrey GU7 1XR, England; [Beisiegel, Beatriz de Mello] Inst Chico Mendes Conservacao Biodiversidade, BR-12952011 Sao Paulo, Brazil; [da Silva, Rosa de Nazarepaes] Conselho Reg Engn Arquitetura & Agron Para, Belem, Para, Brazil; [Di Fiore, Anthony] Univ Texas Austin, Austin, TX 78712 USA; [Diesmos, Arvin] Natl Museum Philippines, Manila, Philippines; [Dirzo, Rodolfo] Stanford Univ, Stanford, CA 94305 USA; [Eaton, Mitchell] SUNY Stony Brook, Stony Brook, NY 11794 USA; [Eaton, Mitchell] Univ Colorado, Boulder, CO 80309 USA; [Ewango, Corneille] Wildlife Conservat Soc, Kinshasa, DEM REP CONGO; [Fedigan, Linda] Univ Calgary, Calgary, AB T2N 1N4, Canada; [Fruth, Barbara; Surbeck, Martin] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany; [Willis, Jacalyn Giacalone] Montclair State Univ, Montclair, NJ 07043 USA; [Goodale, Uromi] Univ Calif San Diego, San Diego, CA 92093 USA; [Goodman, Steven] Field Museum Nat Hist, Chicago, IL 60605 USA; [Guix, Juan C.] Univ Barcelona, E-08028 Barcelona, Spain; [Guthiga, Paul] Kenya Inst Publ Policy Res & Anal, Nairobi, Kenya; [Haber, William; Sun, I. Fang] Missouri Bot Garden, St Louis, MO 63166 USA; [Hamer, Keith] Univ Leeds, Leeds LS2 9JT, W Yorkshire, England; [Herbinger, Ilka] Wild Chimpanzee Fdn, Abidjan 23, Cote Ivoire; [Huang, Zhongliang] Dinghushan Biosphere Reserve, Zhaoqing, Peoples R China; Tunghai Univ, Taichung 407, Taiwan; [Ickes, Kalan] Clemson Univ, Clemson, SC 29634 USA; [Itoh, Akira] Osaka City Univ, Osaka 5588585, Japan; [Ivanauskas, Natalia] Inst Florestal, BR-02377000 Sao Paulo, Brazil; [Janovec, John; Tobler, Mathias] Bot Res Inst Texas, Ft Worth, TX 76107 USA; [Jiangming, Mo; Xiankai, Lu] S China Bot Garden, Guangzhou 510650, Guangdong, Peoples R China; [Jones, Trevor] Anglia Ruskin Univ, Cambridge CB1 1PT, England; [Justiniano, Hermes] Fdn Conservac Bosque, Chiquitano, Bolivia; [Kalko, Elisabeth] Univ Ulm, D-89069 Ulm, Germany; [Kasangaki, Aventino] Mbarara Univ Sci & Technol, Mbarara, Uganda; [Killeen, Timothy] Conservat Int, Arlington, VA 22202 USA; [King, Hen-biau] Soc Subtrop Ecol, Taipei, Taiwan; [Klop, Erik] Royal Haskoning Water & Ecol Grp, Groningen, Netherlands; [Knott, Cheryl] Boston Univ, Boston, MA 02215 USA; [Kone, Inza] Ctr Suisse Rech Sci Cote Ivoire, Abidjan, Cote Ivoire; [Ribeiro, Jose Lahoz da Silva] Univ Estadual Londrina, Londrina, Parana, Brazil; [Lattke, John] Cent Univ Venezuela, Caracas, Venezuela; [Laval, Richard] Bat Jungle, Monteverde, Costa Rica; [Lawton, Robert] Univ Alabama, Huntsville, AL 35899 USA; [Lentino, Miguel] Colecc Ornitol Phelps, Caracas, Venezuela; [Leonel, Cristiane] Parque Estadual Horto Florestal, BR-02377000 Sao Paulo, Brazil; [Lindsell, Jeremy] Royal Soc Protect Birds, Sandy SG19 2DL, Beds, England; [Ling-Ling, Lee] Natl Taiwan Univ, Taipei 10764, Taiwan; [Linsenmair, K. Eduard] Univ Wurzburg, D-97074 Wurzburg, Germany; [Losos, Elizabeth] Org Trop Studies, Durham, NC 27705 USA; [Lugo, Ariel] USDA Int Inst Trop Forestry, Rio Piedras, PR 00926 USA; [Lwanga, Jeremiah] Makerere Univ, Kampala, Uganda; [Mack, Andrew L.; Wright, Debra D.] Green Capac Inc, New Florence, PA 15944 USA; [Martins, Marlucia] Museu Paraense Emilio Goeldi, BR-66040170 Belem, Para, Brazil; [McGraw, W. Scott] Ohio State Univ, Columbus, OH 43210 USA; [McNab, Roan] Wildlife Conservat Soc, Flores, Guatemala; [Montag, Luciano] Fed Univ Para, BR-66040170 Belem, Para, Brazil; [Thompson, Jo Myers] Lukuru Wildlife Res Fdn, Kinshasa, DEM REP CONGO; [Nabe-Nielsen, Jacob] Aarhus Univ, DK-4000 Roskilde, Denmark; [Nepal, Sanjay] Univ Waterloo, Waterloo, ON N2L 3G1, Canada; [Nakagawa, Michiko] Nagoya Univ, Nagoya, Aichi 4648601, Japan; [Novotny, Vojtech] Acad Sci Czech Republ, Inst Entomol, CR-37005 Ceske Budejovice, Czech Republic; [O'Donnell, Sean] Univ Washington, Seattle, WA 98195 USA; [Opiang, Muse] PNG Inst Biol Res, Goroka, Papua N Guinea; [Ouboter, Paul] Univ Suriname, Paramaribo, Suriname; [Parthasarathy, N.] Pondicherry Univ, Pondicherry 605014, India; [Pisciotta, Katia] Fundacao Florestal, BR-02377000 Sao Paulo, Brazil; [Prawiradilaga, Dewi] Res Ctr Biol, Cibinong 16911, Indonesia; [Pringle, Catherine] Univ Georgia, Athens, GA 30602 USA; [Rajathurai, Subaraj] Strix Wildlife Consultancy, Singapore, Singapore; [Reichard, Ulrich] So Illinois Univ, Carbondale, IL 62901 USA; [Reinartz, Gay] Zool Soc Milwaukee, Milwaukee, WI 53226 USA; [Renton, Katherine; Rivera, Jorge Vega] Univ Nacl Autonoma Mexico, Estn Biol Chamela, Jalisco 48980, Mexico; [Reynolds, Glen] Danum Valley Field Ctr, Sabah, Malaysia; [Reynolds, Vernon] Univ Oxford, Oxford BN26 5UX, England; [Riley, Erin] San Diego State Univ, San Diego, CA 92182 USA; [Roedel, Mark-Oliver] Museum Naturkunde, Berlin, Germany; [Rothman, Jessica] CUNY, New York, NY 10065 USA; [Round, Philip] Mahidol Univ, Bangkok 10400, Thailand; [Sakai, Shoko] Res Inst Human & Nat, Kyoto, Japan; [Schaab, Gertrud] Karlsruhe Univ Appl Sci, Karlsruhe, Germany; [Seidensticker, John] Natl Zool Pk, Washington, DC 20013 USA; [Siaka, Alhaji] Gola Forest Programme, Kenema, Sierra Leone; [Silman, Miles R.] Wake Forest Univ, Winston Salem, NC 27106 USA; [Smith, Thomas B.; Wang, Benjamin] Univ Calif Los Angeles, Los Angeles, CA 90095 USA; [Stanford, Craig] Univ So Calif, Los Angeles, CA 90089 USA; [Stewart, Kristine] Inst Appl Ethnobotany, Pompano Beach, FL 33069 USA; [Sukumar, Raman] Indian Inst Sci, Bangalore 560012, Karnataka, India; [Stoner, Kathryn E.] Texas A&M Univ, Kingsville, TX 78363 USA; [Tscharntke, Teja; Waltert, Matthias] Univ Gottingen, Gottingen, Germany; [Turkalo, Andrea] Wildlife Conservat Soc, Bangui, Cent Afr Republ; [Umapathy, Govindaswamy] Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India; [Venn, Linda] Paluma Environm Educ Ctr, Paluma, Qld 4816, Australia; [Verea, Carlos] Cent Univ Venezuela, Maracay, Venezuela; [de Castilho, Carolina Volkmer] Embrapa Roraima, Boa Vista, Roraima, Brazil; [Whitacre, David] Treasure Valley Math & Sci Ctr, Boise, ID 83714 USA; [Whitney, Ken] Rice Univ, Houston, TX 77005 USA; [Wright, Patricia] SUNY Stony Brook, Stony Brook, NY 11794 USA; [Yonzon, Pralad] Resources Himalaya Fdn, Kathmandu, Nepal	James Cook University; James Cook University; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Adelaide; University of Stirling; Duke University; Universidad Nacional Autonoma de Mexico; Royal Botanic Gardens, Kew; World Wildlife Fund; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; McGill University; Universidad Nacional Autonoma de Mexico; Columbia University; State University System of Florida; Florida International University; Philipps University Marburg; California State University System; California State University Fullerton; Museum National d'Histoire Naturelle (MNHN); Smithsonian Institution; United States Department of the Interior; United States Geological Survey; King Mongkuts University of Technology Thonburi; Virginia Polytechnic Institute & State University; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Twente; Institute Nacional de Pesquisas da Amazonia; Wildlife Conservation Society; University of York - UK; University of Copenhagen; James Cook University; Leiden University; Leiden University - Excl LUMC; Woods Hole Research Center; Oregon State University; University of Pennsylvania; University of Vienna; University of Kansas; Pontificia Universidad Javeriana; Wildlife Institute of India; Yale University; Monash University; Utrecht University; University of Kent; Mahidol University; University of Puerto Rico; University of Koblenz & Landau; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Central Venezuela; National University of Singapore; Indian Institute of Science (IISC) - Bangalore; University of Texas System; University of Texas Austin; National Museum of the Philippines; Stanford University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Colorado System; University of Colorado Boulder; University of Calgary; Max Planck Society; Montclair State University; University of California System; University of California San Diego; Field Museum of Natural History (Chicago); University of Barcelona; Missouri Botanical Gardens; University of Leeds; Tunghai University; Clemson University; Osaka Metropolitan University; Chinese Academy of Sciences; South China Botanical Garden, CAS; Anglia Ruskin University; Ulm University; Mbarara University of Science & Technology; Conservation International; Boston University; Universidade Estadual de Londrina; University of Central Venezuela; University of Alabama System; University of Alabama Huntsville; Royal Society for Protection of Birds; National Taiwan University; University of Wurzburg; United States Department of Agriculture (USDA); Makerere University; Museu Paraense Emilio Goeldi; University System of Ohio; Ohio State University; Universidade Federal do Para; Aarhus University; University of Waterloo; Nagoya University; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of Washington; University of Washington Seattle; Anton de Kom Universiteit van Suriname; Pondicherry University; University System of Georgia; University of Georgia; Southern Illinois University System; Southern Illinois University; Universidad Nacional Autonoma de Mexico; University of Oxford; California State University System; San Diego State University; Leibniz Institut fur Evolutions und Biodiversitatsforschung; City University of New York (CUNY) System; Mahidol University; Research Institute for Humanity & Nature (RIHN); Karlsruhe University of Applied Sciences; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Wake Forest University; University of California System; University of California Los Angeles; University of Southern California; Indian Institute of Science (IISC) - Bangalore; Texas A&M University System; Texas A&M University Kingsville; University of Gottingen; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); University of Central Venezuela; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Rice University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Laurance, WF (corresponding author), James Cook Univ, Ctr Trop Environm & Sustainabil Sci TESS, Cairns, Qld 4878, Australia.	bill.laurance@jcu.edu.au	Ivanauskas, Natalia/S-4951-2019; Sloan, Sean/A-8630-2012; Pearson, Richard/GQH-2760-2022; Bruhl, Carsten A/F-3385-2012; Raman, Sukumar/C-9809-2013; Chapman, Colin/S-1911-2019; Doran-Sheehy, Diane/GXV-9571-2022; Diesmos, Arvin C./AGG-8542-2022; Nabe-Nielsen, Jacob/A-5891-2010; de Assis Montag, Luciano Fogaça/I-1485-2012; Ribeiro, Jose Eduardo L. S./A-8574-2013; Arroyo-Rodríguez, Víctor/C-9255-2009; Maisels, Fiona/E-7382-2015; Rovero, Francesco/AAI-3157-2020; Laurance, William F/B-2709-2012; Waltert, Matthias/E-9134-2010; Pitman, Nigel C A/A-7681-2008; Hill, Jane K./AAJ-3374-2021; Cannon, Charles H/D-7186-2012; Sheil, Douglas/A-3867-2015; Forget, Pierre-Michel/B-4355-2009; van Weerd, Merlijn/K-6790-2013; de Castilho, Carolina Volkmer/I-6618-2019; Cannon, Charles/AAE-7715-2019; Bradshaw, Corey J.A./A-1311-2008; Williams, Stephen E/A-7250-2008; Bunyavejchewin, Sarayudh/P-1529-2017; Montag, Luciano/AER-1730-2022; Laurance, Susan/G-6021-2011; Kudavidanage, Enoka P./AAM-1316-2021; Nielsen, Martin Reinhardt/E-1173-2015; Campbell, Mason/G-4651-2017; Whitney, Kenneth D/B-2971-2011; Wright, Stuart Joseph/M-3311-2013; Kasangaki, Aventino/ABB-3243-2021; Tobler, Mathias/AFN-0051-2022; Rainey, Hugo/I-6047-2012; Sheil, Douglas/N-3291-2019; Dave, Chittaranjan/GPX-0631-2022; Stoner, Kathryn E/E-1510-2015; Linsenmair, Karl Eduard/Q-2268-2018; Plumptre, Andrew J./X-3145-2019; Novotny, Vojtech/G-9434-2014; Corlett, Richard T./S-2899-2019; Tscharntke, Teja/N-5123-2014; B., John E. Lattke/K-2934-2015; Schulze, Christian/AGJ-7744-2022; Ivanauskas, Natalia/C-2224-2012; Pringle, Catherine M/I-1841-2012; Babweteera, Fred/AAC-3046-2022; van der Ploeg, Jan/AAD-5179-2019; Sakai, Shoko/AFN-1913-2022; Poulsen, John/O-5332-2019; Urbina-Cardona, J. Nicolas/B-5447-2008; Edwards, David/AAC-5091-2019; Lu, Xiankai/M-2127-2014	Ivanauskas, Natalia/0000-0001-6643-8476; Sloan, Sean/0000-0002-7834-0203; Chapman, Colin/0000-0002-8827-8140; Nabe-Nielsen, Jacob/0000-0002-0716-9525; de Assis Montag, Luciano Fogaça/0000-0001-9370-6747; Ribeiro, Jose Eduardo L. S./0000-0002-2389-5631; Arroyo-Rodríguez, Víctor/0000-0002-0858-0324; Maisels, Fiona/0000-0002-0778-0615; Rovero, Francesco/0000-0001-6688-1494; Laurance, William F/0000-0003-4430-9408; Waltert, Matthias/0000-0001-7053-0291; Pitman, Nigel C A/0000-0002-9211-2880; Hill, Jane K./0000-0003-1871-7715; Cannon, Charles H/0000-0003-1901-0420; Sheil, Douglas/0000-0002-1166-6591; Forget, Pierre-Michel/0000-0002-9252-974X; van Weerd, Merlijn/0000-0002-7173-3725; de Castilho, Carolina Volkmer/0000-0002-1064-2758; Cannon, Charles/0000-0003-1901-0420; Bradshaw, Corey J.A./0000-0002-5328-7741; Williams, Stephen E/0000-0002-2510-7408; Bunyavejchewin, Sarayudh/0000-0002-1976-5041; Laurance, Susan/0000-0002-2831-2933; Nielsen, Martin Reinhardt/0000-0002-8941-6031; Campbell, Mason/0000-0001-6803-271X; Whitney, Kenneth D/0000-0002-2523-5469; Wright, Stuart Joseph/0000-0003-4260-5676; Kasangaki, Aventino/0000-0002-9762-4666; Stoner, Kathryn E/0000-0002-9964-1697; Linsenmair, Karl Eduard/0000-0002-2132-8721; Plumptre, Andrew J./0000-0002-9333-4047; Novotny, Vojtech/0000-0001-7918-8023; Corlett, Richard T./0000-0002-2508-9465; B., John E. Lattke/0000-0002-6793-3003; Schulze, Christian/0000-0001-9442-7141; Ivanauskas, Natalia/0000-0001-6643-8476; van der Ploeg, Jan/0000-0001-7099-4002; Sakai, Shoko/0000-0002-4267-8405; Poulsen, John/0000-0002-1532-9808; Urbina-Cardona, J. Nicolas/0000-0002-4174-8467; Edwards, David/0000-0001-8562-3853; Krishnaswamy, Jagdish/0000-0001-7985-0005; Vasudevan, Karthikeyan/0000-0003-2316-3382; Bruhl, Carsten A./0000-0003-1332-535X; Quesada, Mauricio/0000-0002-7776-9286; Eaton, Mitchell/0000-0001-7324-6333; Verea, Carlos/0000-0002-1720-649X; Harrison, Rhett/0000-0001-9055-3546; Goodale, Uromi/0000-0003-3111-8899; Danielsen, Finn/0000-0003-0229-2847; Timm, Robert/0000-0001-6203-3316; Pearson, Richard/0000-0001-6047-031X; Harris, David/0000-0002-6801-2484; Karpanty, Sarah/0000-0003-3831-8914; Reichard, Ulrich H./0000-0002-5564-3922; Lindsell, Jeremy/0000-0003-2088-8927; Inogwabini, Bila-Isia/0000-0002-6897-2477; Baker, Patrick/0000-0002-6560-7124; Banki, Olaf/0000-0001-6197-9951; Kone, Inza/0000-0002-2940-2439; Abernethy, Katharine/0000-0002-0393-9342; Edwards, Felicity/0000-0003-1742-2763; Dave, Chittaranjan/0000-0002-2006-383X; Mack, Andrew L./0000-0001-8823-9101; Coates, Rosamond/0000-0003-0074-1565; Umapathy, Govindhaswamy/0000-0003-4086-7445; Tobler, Mathias/0000-0002-8587-0560	James Cook University; Smithsonian Tropical Research Institute; Australian Laureate Fellowship; NSF [RCN-0741956]; Direct For Social, Behav & Economic Scie [1028471] Funding Source: National Science Foundation; Division Of Integrative Organismal Systems [1209072] Funding Source: National Science Foundation	James Cook University; Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute); Australian Laureate Fellowship; NSF(National Science Foundation (NSF)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The study was supported by James Cook University, the Smithsonian Tropical Research Institute, an Australian Laureate Fellowship (to W. F. L.) and NSF grant RCN-0741956. We thank A. Bruner, R. A. Butler, G. R. Clements, R. Condit, C. N. Cook, S. Goosem, J. Geldmann, L. Joppa, S. L. Pimm and O. Venter for comments.	Adeney JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005014; Asner GP, 2005, SCIENCE, V310, P480, DOI 10.1126/science.1118051; Bradshaw CJA, 2009, FRONT ECOL ENVIRON, V7, P79, DOI 10.1890/070193; Brooks TM, 1999, CONSERV BIOL, V13, P1140, DOI 10.1046/j.1523-1739.1999.98341.x; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Chan KMA, 2008, P NATL ACAD SCI USA, V105, P19342, DOI 10.1073/pnas.0810522105; Curran LM, 2004, SCIENCE, V303, P1000, DOI 10.1126/science.1091714; DeFries R, 2005, ECOL APPL, V15, P19, DOI 10.1890/03-5258; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Hansen AJ, 2007, ECOL APPL, V17, P974, DOI 10.1890/05-1098; Jenkins CN, 2009, BIOL CONSERV, V142, P2166, DOI 10.1016/j.biocon.2009.04.016; Joppa LN, 2008, P NATL ACAD SCI USA, V105, P6673, DOI 10.1073/pnas.0802471105; Laurance WF, 1997, SCIENCE, V278, P1117, DOI 10.1126/science.278.5340.1117; Laurance WF, 2011, BIOL CONSERV, V144, P56, DOI 10.1016/j.biocon.2010.09.021; Lovejoy TE, 2006, TRENDS ECOL EVOL, V21, P329, DOI 10.1016/j.tree.2006.04.005; Maiorano L, 2008, P ROY SOC B-BIOL SCI, V275, P1297, DOI 10.1098/rspb.2007.1756; Peres CA, 2005, CONSERV BIOL, V19, P728, DOI 10.1111/j.1523-1739.2005.00691.x; Peres CA, 2006, TRENDS ECOL EVOL, V21, P227, DOI 10.1016/j.tree.2006.03.007; Pimm SL, 2000, NATURE, V403, P843, DOI 10.1038/35002708; Porter-Bolland L, 2012, FOREST ECOL MANAG, V268, P6, DOI 10.1016/j.foreco.2011.05.034; Possingham HP, 2006, PRINCIPLES CONSERVAT, P516; Scherl L.M., 2004, OPPORTUNITIES LIMITA; Sekercioglu CH, 2008, CONSERV BIOL, V22, P140, DOI 10.1111/j.1523-1739.2007.00852.x; Shoo LP, 2011, GLOBAL CHANGE BIOL, V17, P186, DOI 10.1111/j.1365-2486.2010.02218.x; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Wells M, 2004, AMBIO, V33, P513, DOI 10.1639/0044-7447(2004)033[0513:IPAMWL]2.0.CO;2; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126; Wright SJ, 2007, ECOL APPL, V17, P1259, DOI 10.1890/06-1330.1	30	694	730	36	1218	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2012	489	7415					290	+		10.1038/nature11318	http://dx.doi.org/10.1038/nature11318			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003UC	22832582	Green Accepted, Green Published			2022-12-28	WOS:000308635900041
J	Sarov, M; Murray, JI; Schanze, K; Pozniakovski, A; Niu, W; Angermann, K; Hasse, S; Rupprecht, M; Vinis, E; Tinney, M; Preston, E; Zinke, A; Enst, S; Teichgraber, T; Janette, J; Reis, K; Janosch, S; Schloissnig, S; Ejsmont, RK; Slightam, C; Xu, X; Kim, SK; Reinke, V; Stewart, AF; Snyder, M; Waterston, RH; Hyman, AA				Sarov, Mihail; Murray, John I.; Schanze, Kristin; Pozniakovski, Andrei; Niu, Wei; Angermann, Karolin; Hasse, Susanne; Rupprecht, Michaela; Vinis, Elisabeth; Tinney, Matthew; Preston, Elicia; Zinke, Andrea; Enst, Susanne; Teichgraber, Tina; Janette, Judith; Reis, Kadri; Janosch, Stephan; Schloissnig, Siegfried; Ejsmont, Radoslaw K.; Slightam, Cindie; Xu, Xiao; Kim, Stuart K.; Reinke, Valerie; Stewart, A. Francis; Snyder, Michael; Waterston, Robert H.; Hyman, Anthony A.			A Genome-Scale Resource for In Vivo Tag-Based Protein Function Exploration in C. elegans	CELL			English	Article							CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; SYSTEMATIC ANALYSIS; POSTGENOMIC ERA; GLOBAL ANALYSIS; HIGH-THROUGHPUT; COMPLEXES; YEAST; FATE; RECOMBINATION	Understanding the in vivo dynamics of protein localization and their physical interactions is important for many problems in biology. To enable systematic protein function interrogation in a multicellular context, we built a genome-scale transgenic platform for in vivo expression of fluorescent-and affinity-tagged proteins in Caenorhabditis elegans under endogenous cis regulatory control. The platform combines computer-assisted transgene design, massively parallel DNA engineering, and next-generation sequencing to generate a resource of 14,637 genomic DNA transgenes, which covers 73% of the proteome. The multipurpose tag used allows any protein of interest to be localized in vivo or affinity purified using standard tag-based assays. We illustrate the utility of the resource by systematic chromatin immunopurification and automated 4D imaging, which produced detailed DNA binding and cell/tissue distribution maps for key transcription factor proteins.	[Sarov, Mihail; Schanze, Kristin; Angermann, Karolin; Hasse, Susanne; Rupprecht, Michaela; Vinis, Elisabeth; Tinney, Matthew; Reis, Kadri; Janosch, Stephan; Schloissnig, Siegfried] Max Planck Inst Mol Cell Biol & Genet, Transgene Unit, D-01307 Dresden, Germany; [Murray, John I.; Preston, Elicia; Waterston, Robert H.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Niu, Wei; Janette, Judith; Reinke, Valerie] Yale Univ, Dept Genet, New Haven, CT 06520 USA; [Slightam, Cindie; Xu, Xiao; Kim, Stuart K.] Stanford Univ, Med Ctr, Dept Dev Biol, Stanford, CA 94305 USA; [Snyder, Michael] Stanford Univ, Med Ctr, Dept Genet, Stanford, CA 94305 USA; [Stewart, A. Francis] Tech Univ Dresden, Dept Genom, D-01307 Dresden, Germany	Max Planck Society; University of Washington; University of Washington Seattle; Yale University; Stanford University; Stanford University; Technische Universitat Dresden	Sarov, M (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Transgene Unit, D-01307 Dresden, Germany.	sarov@mpi-cbg.de	Hyman, Anthony A/B-3917-2017; Hyman, Tony/F-1923-2011; Stewart, A. Francis/E-7789-2010	Hyman, Anthony A/0000-0003-3664-154X; Snyder, Michael/0000-0003-0784-7987; Ejsmont, Radoslaw/0000-0001-7176-7848; Reis, Kadri/0000-0002-2144-5856; Janosch, Stephan/0000-0002-2401-6862; Schloissnig, Siegfried/0000-0003-4574-8330	Max Planck Society Initiative "BAC TransgeneOmics"; NIH initiative "modENCODE"; NIH; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004263, U54HG007002, U01HG004267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072675] Funding Source: NIH RePORTER	Max Planck Society Initiative "BAC TransgeneOmics"; NIH initiative "modENCODE"; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The TransgeneOme project was partially funded by the Max Planck Society Initiative "BAC TransgeneOmics." The NIH initiative "modENCODE" funded grants to M.Sn. and R. H. W. J.I.M. was a fellow of the Jane Coffin Childs Memorial Fund for Medical Research and received funding from the NIH. A. F. S. is a shareholder of Gene Bridges GmbH, which holds the exclusive commercial rights to the Red/ET recombineering methodologies. M. Sa. holds the distribution rights for the transgenic constructs collection. M.Sn. is a member of the scientific advisory board of Personalis and Genapsys and is a consultant for Illumina.	Bao ZR, 2006, P NATL ACAD SCI USA, V103, P2707, DOI 10.1073/pnas.0511111103; Bates EA, 2006, J NEUROSCI, V26, P2830, DOI 10.1523/JNEUROSCI.3344-05.2006; BOWERMAN B, 1992, CELL, V68, P1061, DOI 10.1016/0092-8674(92)90078-Q; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CHEESEMAN IM, 2005, SCI STKE; CHEN LS, 1994, DEVELOPMENT, V120, P1631; Ciotta G, 2011, METHODS, V53, P113, DOI 10.1016/j.ymeth.2010.09.003; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Cowing D, 1996, NATURE, V382, P353, DOI 10.1038/382353a0; de Souza N, 2012, NAT METHODS, V9, P27, DOI 10.1038/nmeth.1848; Dolphin CT, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl352; Dunn RK, 2007, MOL CELL, V28, P708, DOI 10.1016/j.molcel.2007.11.022; Ejsmont RK, 2009, NAT METHODS, V6, P435, DOI [10.1038/NMETH.1334, 10.1038/nmeth.1334]; Ejsmont RK, 2011, METHODS MOL BIOL, V772, P445, DOI 10.1007/978-1-61779-228-1_26; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Fukushige T, 2005, DEVELOPMENT, V132, P1795, DOI 10.1242/dev.01774; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Greenwald I, 1998, GENE DEV, V12, P1751, DOI 10.1101/gad.12.12.1751; Hallam S, 2000, DEVELOPMENT, V127, P4239; Hillier LW, 2005, GENOME RES, V15, P1651, DOI 10.1101/gr.3729105; Hofemeister H, 2011, METHODS, V53, P437, DOI 10.1016/j.ymeth.2010.12.026; Huang JY, 2010, BBA-PROTEINS PROTEOM, V1804, P1645, DOI 10.1016/j.bbapap.2009.12.021; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Hunter CP, 1996, CELL, V87, P217, DOI 10.1016/S0092-8674(00)81340-9; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Janke DL, 1997, GENOME RES, V7, P974, DOI 10.1101/gr.7.10.974; Kelly WG, 1998, DEVELOPMENT, V125, P2451; KRAUSE M, 1990, CELL, V63, P907, DOI 10.1016/0092-8674(90)90494-Y; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Long FH, 2009, NAT METHODS, V6, P667, DOI [10.1038/NMETH.1366, 10.1038/nmeth.1366]; Murray JI, 2008, NAT METHODS, V5, P703, DOI 10.1038/nmeth.1228; Murray JI, 2012, GENOME RES, V22, P1282, DOI 10.1101/gr.131920.111; Muyrers JPP, 1999, NUCLEIC ACIDS RES, V27, P1555, DOI 10.1093/nar/27.6.1555; Nedelkova M, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr668; Niu W, 2011, GENOME RES, V21, P245, DOI 10.1101/gr.114587.110; Nov D, 2007, CURR OPIN BIOTECH, V18, P411, DOI 10.1016/j.copbio.2007.07.013; Petersen SC, 2011, J NEUROSCI, V31, P15362, DOI 10.1523/JNEUROSCI.3181-11.2011; Polanowska J, 2004, BIOTECHNIQUES, V36, P778, DOI 10.2144/04365BM05; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Pothof J, 2003, GENE DEV, V17, P443, DOI 10.1101/gad.1060703; Praitis V, 2001, GENETICS, V157, P1217; Priess James R, 2005, WormBook, P1; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Ristevski S, 2005, MOL BIOTECHNOL, V29, P153, DOI 10.1385/MB:29:2:153; Robert V, 2007, EMBO J, V26, P170, DOI 10.1038/sj.emboj.7601463; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Saarikangas J, 2009, CURR BIOL, V19, P95, DOI 10.1016/j.cub.2008.12.029; Saghatelian A, 2005, NAT CHEM BIOL, V1, P130, DOI 10.1038/nchembio0805-130; Sarov M, 2005, TRENDS BIOTECHNOL, V23, P446, DOI 10.1016/j.tibtech.2005.06.007; Sarov M, 2006, NAT METHODS, V3, P839, DOI 10.1038/nmeth933; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; STRUHL G, 1993, CELL, V74, P331, DOI 10.1016/0092-8674(93)90424-O; Tursun B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004625; Voutev R, 2009, FEBS LETT, V583, P456, DOI 10.1016/j.febslet.2008.12.046; Wilm T, 1999, GENE, V229, P31, DOI 10.1016/S0378-1119(99)00043-8; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417; Zhong M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000848	62	165	168	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 17	2012	150	4					855	866		10.1016/j.cell.2012.08.001	http://dx.doi.org/10.1016/j.cell.2012.08.001			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	995IT	22901814	Green Accepted, Bronze			2022-12-28	WOS:000308002300018
J	Guterres, A; Spiegel, P				Guterres, Antonio; Spiegel, Paul			The State of the World's Refugees Adapting Health Responses to Urban Environments	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Spiegel, Paul] Off United Nations High Commissioner Refugees, CH-1202 Geneva, Switzerland; [Guterres, Antonio] United Nations High Commissioner Refugees, Geneva, Switzerland		Spiegel, P (corresponding author), Off United Nations High Commissioner Refugees, 94 Rue Montbrillant, CH-1202 Geneva, Switzerland.	spiegel@unhcr.org	Spiegel, Paul/AAL-3238-2021	Spiegel, Paul/0000-0002-6158-6661				[Anonymous], MAL DISPL EXP UNHCR; [Anonymous], UNHCRS PRINC GUID RE; [Anonymous], GUID NOT HLTH INS SC; Leaning Jennifer, 2011, Confl Health, V5, P6, DOI 10.1186/1752-1505-5-6; Mateen FJ, 2012, B WORLD HEALTH ORGAN, V90, P444, DOI 10.2471/BLT.11.097048; Mowafi H, 2008, JAMA-J AM MED ASSOC, V299, P1713, DOI 10.1001/jama.299.14.1713; Spiegel PB, 2010, LANCET, V375, P341, DOI 10.1016/S0140-6736(09)61873-0; UN General Assembly, POL DECL HIGH LEV M; United Nations High Commissioner for Refugees, UNHCR GLOB TRENDS 20	9	40	40	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2012	308	7					673	674		10.1001/2012.jama.10161	http://dx.doi.org/10.1001/2012.jama.10161			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988NC	22893161				2022-12-28	WOS:000307496700019
J	Ford, JA; Elders, A; Shyangdan, D; Royle, P; Waugh, N				Ford, John A.; Elders, Andrew; Shyangdan, Deepson; Royle, Pamela; Waugh, Norman			The relative clinical effectiveness of ranibizumab and bevacizumab in diabetic macular oedema: an indirect comparison in a systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ENDOTHELIAL GROWTH-FACTOR; INTRAVITREAL BEVACIZUMAB; ANTI-VEGF; LASER PHOTOCOAGULATION; RANDOMIZED-TRIAL; CATARACT-SURGERY; RETINOPATHY; TRIAMCINOLONE; INJECTION; SAFETY	Objective To indirectly compare the effectiveness of ranibizumab and bevacizumab in the treatment of diabetic macular oedema. Design Systematic review and indirect comparison. Data sources Medline (1996-September 2011), Embase (1996-September 2011), and the Cochrane Central Register of Controlled Trials (Issue 4, 2011). Selection criteria for studies Randomised trials evaluating ranibizumab or bevacizumab in diabetic macular oedema with a common comparator and sufficient methodological similarity to be included within an indirect comparison were eligible for inclusion. Main outcome measures The primary outcome was the proportion of patients with an improvement in best corrected visual acuity of more than two lines on the Early Treatment Diabetic Retinopathy Study (ETDRS) scale. Secondary outcomes included mean changes in best corrected visual acuity and in central macular thickness, and adverse events. Best corrected visual acuity was converted to logMAR units, a linear scale of visual acuity with positive values representing increasing visual loss. Indirect comparisons were done using Bayesian methods to estimate relative treatment effects of bevacizumab and ranibizumab. Results Five randomised controlled trials with follow-up of 6-12 months and a common comparator (multiple laser treatment) were sufficiently similar to be included in the indirect comparison. Generally studies were small, resulting in wide credible intervals. The proportions of patients with an improvement in best corrected visual acuity of >2 lines were 21/77 participants (27%) for bevacizumab and 60/152 participants (39%) for ranibizumab (odds ratio 0.95 (95% credible interval 0.23 to 4.32)). The wide credible intervals cannot exclude a greater improvement, or worse outcome, for either drug. The mean change in best corrected visual acuity non-significantly favoured bevacizumab (treatment effect -0.08 logMAR units (-0.19 to 0.04)). The difference in mean change in central macular thickness was not statistically significant between ranibizumab and bevacizumab (treatment effect -6.9 mu m (-88.5 to 65.4)). Conclusions Results suggest no difference in effectiveness between bevacizumab and ranibizumab, but the wide credible intervals cannot exclude the possibility that either drug might be superior. Sufficiently powered, direct head to head trials are needed.	[Ford, John A.; Elders, Andrew] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen AB25 2ZD, Scotland; [Shyangdan, Deepson; Royle, Pamela; Waugh, Norman] Warwick Med Sch, Div Hlth Sci, Coventry, W Midlands, England	University of Aberdeen; University of Warwick	Ford, JA (corresponding author), Univ Aberdeen, Hlth Serv Res Unit, Hlth Serv Bldg, Aberdeen AB25 2ZD, Scotland.	john.ford@uea.ac.uk	Elders, Andrew/N-4195-2015	Elders, Andrew/0000-0003-4172-4702; Ford, John/0000-0001-8033-7081	Chief Scientist Office [HSRU1] Funding Source: researchfish	Chief Scientist Office		Abu El-Asrar AM, 2009, CURR OPIN OPHTHALMOL, V20, P532, DOI 10.1097/ICU.0b013e328330b533; Ahmadieh H, 2008, GRAEF ARCH CLIN EXP, V246, P483, DOI 10.1007/s00417-007-0688-0; Arevalo JF, 2007, OPHTHALMOLOGY, V114, P743, DOI 10.1016/j.ophtha.2006.12.028; Biswas P, 2011, INDIAN J OPHTHALMOL, V59, P191, DOI 10.4103/0301-4738.81023; Boscia F, 2010, DRUGS, V70, P2171, DOI 10.2165/11538130-000000000-00000; Caldwelll RB, 2003, DIABETES-METAB RES, V19, P442, DOI 10.1002/dmrr.415; Campbell RJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4203; Chakravarthy U, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.04.015; Cheema RA, 2009, J CATARACT REFR SURG, V35, P18, DOI 10.1016/j.jcrs.2008.09.019; Ciulla TA, 2009, CURR OPIN OPHTHALMOL, V20, P166, DOI 10.1097/ICU.0b013e328329d173; Cummins E, 2011, ERG COMMETS NOVARTIS; Dias S, 2011, 2 NICE DSU; Elman MJ, 2011, OPHTHALMOLOGY, V118, P609, DOI 10.1016/j.ophtha.2010.12.033; Elman MJ, 2010, OPHTHALMOLOGY, V117, P1064, DOI 10.1016/j.ophtha.2010.02.031; Faghihi H, 2008, EUR J OPHTHALMOL, V18, P941, DOI 10.1177/112067210801800614; Fard MA, 2011, EUR J OPHTHALMOL, V21, P276, DOI 10.5301/EJO.2010.1405; Fung AE, 2006, BRIT J OPHTHALMOL, V90, P1344, DOI 10.1136/bjo.2006.099598; General Medical Council, 2006, GOOD MED PRACT; Glenny AM, 2005, HEALTH TECHNOL ASSES, V9, P1; Googe J, 2011, RETINA-J RET VIT DIS, V31, P1009, DOI 10.1097/IAE.0b013e318217d739; Goyal S, 2011, GRAEF ARCH CLIN EXP, V249, P15, DOI 10.1007/s00417-010-1452-4; Guthoff R, 2011, KLIN MONATSBL AUGENH, V228, P468, DOI 10.1055/s-0029-1245487; Hernández-da Mota S.E., 2008, Arch Soc Esp Oftalmol, V83, P293; Hurwitz H, 2006, SEMIN ONCOL, V33, pS26, DOI 10.1053/j.seminoncol.2006.08.001; Kamba T, 2007, BRIT J CANCER, V96, P1788, DOI 10.1038/sj.bjc.6603813; Karim R, 2010, CLIN OPHTHALMOL, V4, P493; Kubicka-Trzaska Agnieszka, 2010, Klin Oczna, V112, P333; Ladas ID, 2009, RETINA-J RET VIT DIS, V29, P313, DOI 10.1097/IAE.0b013e31819a5f98; Lam DSC, 2009, RETINA-J RET VIT DIS, V29, P292, DOI 10.1097/IAE.0b013e31819a2d61; Lanzagorta-Aresti A, 2009, RETINA-J RET VIT DIS, V29, P530, DOI 10.1097/IAE.0b013e31819c6302; Lanzetta P, 2010, INVEST OPHTH VIS SCI, V51; LEE CM, 1991, OPHTHALMOLOGY, V98, P1594; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Massin P, 2010, DIABETES CARE, V33, P2399, DOI 10.2337/dc10-0493; McCartney M, 2001, BMJ-BRIT MED J, V201, pd6778; Medical University of Vienna, 2007, BEV VERS RAN DIAB RE; Meyer CH, 2007, OPHTHALMOLOGICA, V221, P118, DOI 10.1159/000098257; Michaelides M, 2010, RETINA-J RET VIT DIS, V30, P781, DOI 10.1097/IAE.0b013e3181d2f145; Michaelides M, 2010, OPHTHALMOLOGY, V117, P1078, DOI 10.1016/j.ophtha.2010.03.045; Mitchell P, 2011, OPHTHALMOLOGY, V118, P615, DOI 10.1016/j.ophtha.2011.01.031; Mohamed Q, 2007, JAMA-J AM MED ASSOC, V298, P902, DOI 10.1001/jama.298.8.902; National Institute for Health and Clinical Excellence, 2011, MAC OED DIAB RAN APP; National Institute for Health and Clinical Excellence, 2008, RAN PEG TREATM AG RE; National Institute for Health and Clinical Excellence, 2011, RAN TREATM DIAB MAC; Nguyen QD, 2009, OPHTHALMOLOGY, V116, P2175, DOI 10.1016/j.ophtha.2009.04.023; Nguyen QD, 2006, AM J OPHTHALMOL, V142, P961, DOI 10.1016/j.ajo.2006.06.068; Ozkiris A, 2010, DOC OPHTHALMOL, V120, P243, DOI 10.1007/s10633-010-9219-0; Paccola L, 2008, BRIT J OPHTHALMOL, V92, P76, DOI 10.1136/bjo.2007.129122; Parravano M, 2009, COCHRANE DB SYST REV, V4; Parravano M, 2009, RETINA-J RET VIT DIS, V29, P329, DOI 10.1097/IAE.0b013e31819093e6; PATZ A, 1985, ARCH OPHTHALMOL-CHIC, V103, P1796, DOI 10.1001/archopht.1985.01050120030015; Quan DN, 2010, OPHTHALMOLOGY, V117, P2146, DOI 10.1016/j.ophtha.2010.08.016; Raftery J, 2007, BRIT J OPHTHALMOL, V91, P1244, DOI 10.1136/bjo.2007.116616; Schwartz SG, 2009, EXPERT REV OPHTHALMO, V4, P163, DOI 10.1586/EOP.09.5; Schwartz SG, 2009, EXPERT OPIN PHARMACO, V10, P1123, DOI [10.1517/14656560902910092 , 10.1517/14656560902910092]; Scott IU, 2008, RETINA-J RET VIT DIS, V28, P36, DOI 10.1097/IAE.0b013e31815e9385; Scott IU, 2007, OPHTHALMOLOGY, V114, P1860, DOI 10.1016/j.ophtha.2007.05.062; Seo Jeong Won, 2009, Korean J Ophthalmol, V23, P17, DOI 10.3341/kjo.2009.23.1.17; Sheth S, 2011, CLIN EXP OPHTHALMOL, V39, P673, DOI 10.1111/j.1442-9071.2011.02504.x; Simo R, 2008, DIABETOLOGIA, V51, P1574, DOI 10.1007/s00125-008-0989-9; Soheilian M, 2007, RETINA-J RET VIT DIS, V27, P1187, DOI 10.1097/IAE.0b013e31815ec261; Soheilian M, 2011, RETINA-J RET VIT DIS, V31, P1564, DOI 10.1097/IAE.0b013e31820bde7d; Soheilian M, 2009, OPHTHALMOLOGY, V116, P1142, DOI 10.1016/j.ophtha.2009.01.011; Solaiman KAM, 2010, RETINA-J RET VIT DIS, V30, P1638, DOI 10.1097/IAE.0b013e3181e1ed07; Song Fujian, 2011, BMJ, V343, pd4909, DOI 10.1136/bmj.d4909; Song FJ, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1147; Takamura Y, 2009, OPHTHALMOLOGY, V116, P1151, DOI 10.1016/j.ophtha.2009.01.014; Waisbourd M, 2011, ACTA OPHTHALMOL, V89, P203, DOI 10.1111/j.1755-3768.2010.02010.x; Wang YS, 2011, CHINESE MED J-PEKING, V124, P352, DOI 10.3760/cma.j.issn.0366-6999.2011.03.006; Williams R, 2004, EYE, V18, P963, DOI 10.1038/sj.eye.6701476; Yilmaz T, 2011, ACTA OPHTHALMOL, V89, P709, DOI 10.1111/j.1755-3768.2010.01918.x	74	51	52	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 13	2012	345								e5182	10.1136/bmj.e5182	http://dx.doi.org/10.1136/bmj.e5182			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992BK	22890029	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000307750100009
J	Spence, D				Spence, Des			Unhappy pills	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SEROTONIN REUPTAKE INHIBITORS; DEPRESSION; SEVERITY					destwo@yahoo.co.uk						Arroll B, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007954; Borland S, 2012, DAILY MAIL; Deshauer D, 2008, CAN MED ASSOC J, V178, P1293, DOI 10.1503/cmaj.071068; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Geddes JR, 2003, LANCET, V361, P653, DOI 10.1016/S0140-6736(03)12599-8; Haddad PM., 2007, ADV PSYCHIAT TREATME, V13, P447, DOI [10.1192/apt.bp.105.001966, DOI 10.1192/APT.BP.105.001966]; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; NHS Health and Social Care Information Centre, 2012, PRESCR DISP COMM ENG; *NHS HLTH SOC CAR, 2006, PRESCR COST AN ENGL; Reid IC., 2011, BMJ; Reid S, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1468	11	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 10	2012	345								e5409	10.1136/bmj.e5409	http://dx.doi.org/10.1136/bmj.e5409			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988NG	22885400				2022-12-28	WOS:000307497100004
J	Fraser, CD; Jaquiss, RDB; Rosenthal, DN; Humpl, T; Canter, CE; Blackstone, EH; Naftel, DC; Ichord, RN; Bomgaars, L; Tweddell, JS; Massicotte, MP; Turrentine, MW; Cohen, GA; Devaney, EJ; Pearce, FB; Carberry, KE; Kroslowitz, R; Almond, CS				Fraser, Charles D., Jr.; Jaquiss, Robert D. B.; Rosenthal, David N.; Humpl, Tilman; Canter, Charles E.; Blackstone, Eugene H.; Naftel, David C.; Ichord, Rebecca N.; Bomgaars, Lisa; Tweddell, James S.; Massicotte, M. Patricia; Turrentine, Mark W.; Cohen, Gordon A.; Devaney, Eric J.; Pearce, F. Bennett; Carberry, Kathleen E.; Kroslowitz, Robert; Almond, Christopher S.		Berlin Heart Study Investigators	Prospective Trial of a Pediatric Ventricular Assist Device	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEART-TRANSPLANTATION; CHILDREN; OUTCOMES; DISEASE; STROKE	BACKGROUND Options for mechanical circulatory support as a bridge to heart transplantation in children with severe heart failure are limited. METHODS We conducted a prospective, single-group trial of a ventricular assist device designed specifically for children as a bridge to heart transplantation. Patients 16 years of age or younger were divided into two cohorts according to body-surface area (cohort 1, <0.7 m(2); cohort 2, 0.7 to <1.5 m(2)), with 24 patients in each group. Survival in the two cohorts receiving mechanical support (with data censored at the time of transplantation or weaning from the device owing to recovery) was compared with survival in two propensity-score-matched historical control groups (one for each cohort) undergoing extracorporeal membrane oxygenation (ECMO). RESULTS For participants in cohort 1, the median survival time had not been reached at 174 days, whereas in the matched ECMO group, the median survival was 13 days (P<0.001 by the log-rank test). For participants in cohort 2 and the matched ECMO group, the median survival was 144 days and 10 days, respectively (P<0.001 by the log-rank test). Serious adverse events in cohort 1 and cohort 2 included major bleeding (in 42% and 50% of patients, respectively), infection (in 63% and 50%), and stroke (in 29% and 29%). CONCLUSIONS Our trial showed that survival rates were significantly higher with the ventricular assist device than with ECMO. Serious adverse events, including infection, stroke, and bleeding, occurred in a majority of study participants. (Funded by Berlin Heart and the Food and Drug Administration Office of Orphan Product Development; ClinicalTrials.gov number, NCT00583661.)	[Fraser, Charles D., Jr.; Bomgaars, Lisa] Texas Childrens Hosp, Baylor Coll Med, Houston, TX 77030 USA; [Kroslowitz, Robert] Berlin Heart, The Woodlands, TX USA; [Jaquiss, Robert D. B.] Duke Univ, Sch Med, Duke Childrens Hosp, Durham, NC USA; [Jaquiss, Robert D. B.] Duke Univ, Sch Med, Ctr Hlth, Durham, NC USA; [Rosenthal, David N.] Stanford Univ, Sch Med, Lucile Packard Childrens Hosp, Stanford, CA 94305 USA; [Humpl, Tilman] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Massicotte, M. Patricia] Univ Alberta, Sch Med, Stollery Childrens Hosp, Edmonton, AB, Canada; [Canter, Charles E.] Washington Univ, St Louis Childrens Hosp, Sch Med, St Louis, MO 63110 USA; [Blackstone, Eugene H.] Case Western Reserve Univ, Cleveland Clin Lerner Coll Med, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Blackstone, Eugene H.] Case Western Reserve Univ, Cleveland Clin Lerner Coll Med, Inst Heart & Vasc, Cleveland, OH 44106 USA; [Naftel, David C.] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA; [Ichord, Rebecca N.] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Tweddell, James S.] Med Coll Wisconsin, Childrens Hosp Wisconsin, Milwaukee, WI 53226 USA; [Turrentine, Mark W.] Indiana Univ Sch Med, Riley Hosp Children, Indianapolis, IN USA; [Cohen, Gordon A.] Univ Washington, Sch Med, Seattle Childrens Hosp, Seattle, WA USA; [Devaney, Eric J.] Univ Michigan Hlth Syst, CS Mott Childrens Hosp, Ann Arbor, MI USA; [Almond, Christopher S.] Harvard Univ, Sch Med, Childrens Hosp Boston, Boston, MA USA	Baylor College of Medicine; Duke University; Duke University; Lucile Packard Children's Hospital (LPCH); Stanford University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Stollery Children's Hospital; University of Alberta; St. Louis Children's Hospital; Washington University (WUSTL); Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; University of Alabama System; University of Alabama Birmingham; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Children's Hospital of Wisconsin; Medical College of Wisconsin; Indiana University System; Indiana University Bloomington; James Whitcomb Riley Hospital Children; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; Harvard University; Boston Children's Hospital; Harvard Medical School	Fraser, CD (corresponding author), Texas Childrens Hosp, Baylor Coll Med, 6621 Fannin St,WT 19345H, Houston, TX 77030 USA.	cdfraser@texaschildrens.org		Rosenthal, David/0000-0002-6342-2759	Berlin Heart; Food and Drug Administration Office of Orphan Product Development [1R01FD003557]; FOOD AND DRUG ADMINISTRATION [R01FD003557] Funding Source: NIH RePORTER	Berlin Heart; Food and Drug Administration Office of Orphan Product Development; FOOD AND DRUG ADMINISTRATION(United States Department of Health & Human Services)	Supported by Berlin Heart and by a grant (1R01FD003557) from the Food and Drug Administration Office of Orphan Product Development.	Almond CS, 2011, AM HEART J, V162, P425, DOI 10.1016/j.ahj.2011.05.026; Almond CSD, 2009, CIRCULATION, V119, P717, DOI 10.1161/CIRCULATIONAHA.108.815712; [Anonymous], 2009, REP US ORG PROC TRAN; Aurora P, 2010, J HEART LUNG TRANSPL, V29, P1129, DOI 10.1016/j.healun.2010.08.008; deVeber GA, 2000, J CHILD NEUROL, V15, P316, DOI 10.1177/088307380001500508; Frazier OH, 2001, J THORAC CARDIOV SUR, V122, P1186, DOI 10.1067/mtc.2001.118274; Jeewa A, 2010, ARTIF ORGANS, V34, P1087, DOI 10.1111/j.1525-1594.2009.00969.x; Kirklin JK, 2008, J HEART LUNG TRANSPL, V27, P1065, DOI 10.1016/j.healun.2008.07.021; Lloyd-Jones, 2011, CIRCULATION, V124, pE425, DOI 10.1161/CIR.0b013e3182365a58; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Mah D, 2009, J HEART LUNG TRANSPL, V28, P1292, DOI 10.1016/j.healun.2009.06.013; Miller LW, 2007, NEW ENGL J MED, V357, P885, DOI 10.1056/NEJMoa067758; Reinhartz O, 2001, J HEART LUNG TRANSPL, V20, P439, DOI 10.1016/S1053-2498(00)00236-9; Rosenthal DN, 2000, J HEART LUNG TRANSPL, V19, P751, DOI 10.1016/S1053-2498(00)00135-2; Rossano JW, 2010, CIRCULATION, V122; Slaughter MS, 2007, J THORAC CARDIOV SUR, V133, P1573, DOI 10.1016/j.jtcvs.2006.11.050; Stiller B, 2005, EUR J CARDIO-THORAC, V28, P234, DOI 10.1016/j.ejcts.2005.04.023; Towbin JA, 2006, JAMA-J AM MED ASSOC, V296, P1867, DOI 10.1001/jama.296.15.1867	18	338	342	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 9	2012	367	6					532	541		10.1056/NEJMoa1014164	http://dx.doi.org/10.1056/NEJMoa1014164			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	986AE	22873533				2022-12-28	WOS:000307310800007
J	Braeckman, T; Van Herck, K; Meyer, N; Pircon, JY; Soriano-Gabarro, M; Heylen, E; Zeller, M; Azou, M; Capiau, H; De Koster, J; Maernoudt, AS; Raes, M; Verdonck, L; Verghote, M; Vergison, A; Matthijnssens, J; Van Ranst, M; Van Damme, P				Braeckman, Tessa; Van Herck, Koen; Meyer, Nadia; Pircon, Jean-Yves; Soriano-Gabarro, Montse; Heylen, Elisabeth; Zeller, Mark; Azou, Myriam; Capiau, Heidi; De Koster, Jan; Maernoudt, Anne-Sophie; Raes, Marc; Verdonck, Lutgard; Verghote, Marc; Vergison, Anne; Matthijnssens, Jelle; Van Ranst, Marc; Van Damme, Pierre		RotaBel Study Grp	Effectiveness of rotavirus vaccination in prevention of hospital admissions for rotavirus gastroenteritis among young children in Belgium: case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DIARRHEA-ASSOCIATED HOSPITALIZATIONS; 1ST 2 YEARS; DOUBLE-BLIND; DISEASE; EFFICACY; BURDEN; REDUCTION; INFANTS; SAFETY; VACCINES	Objective To evaluate the effectiveness of rotavirus vaccination among young children in Belgium. Design Prospective case-control study. Setting Random sample of 39 Belgian hospitals, February 2008 to June 2010. Participants 215 children admitted to hospital with rotavirus gastroenteritis confirmed by polymerase chain reaction and 276 age and hospital matched controls. All children were of an eligible age to have received rotavirus vaccination (that is, born after 1 October 2006 and aged >= 14 weeks). Main outcome measure Vaccination status of children admitted to hospital with rotavirus gastroenteritis and matched controls. Results 99 children (48%) admitted with rotavirus gastroenteritis and 244 (91%) controls had received at least one dose of any rotavirus vaccine (P<0.001). The monovalent rotavirus vaccine accounted for 92% (n=594) of all rotavirus vaccine doses. With hospital admission as the outcome, the unadjusted effectiveness of two doses of the monovalent rotavirus vaccine was 90% (95% confidence interval 81% to 95%) overall, 91% (75% to 97%) in children aged 3-11 months, and 90% (76% to 96%) in those aged >= 12 months. The G2P[4] genotype accounted for 52% of cases confirmed by polymerase chain reaction with eligible matched controls. Vaccine effectiveness was 85% (64% to 94%) against G2P[4] and 95% (78% to 99%) against G1P[8]. In 25% of cases confirmed by polymerase chain reaction with eligible matched controls, there was reported co-infection with adenovirus, astrovirus and/or norovirus. Vaccine effectiveness against co-infected cases was 86% (52% to 96%). Effectiveness of at least one dose of any rotavirus vaccine (intention to vaccinate analysis) was 91% (82% to 95%). Conclusions Rotavirus vaccination is effective for the prevention of admission to hospital for rotavirus gastroenteritis among young children in Belgium, despite the high prevalence of G2P[4] and viral co-infection.	[Braeckman, Tessa; Van Damme, Pierre] Univ Antwerp, Vaccine & Infect Dis Inst, Ctr Evaluat Vaccinat, B-2020 Antwerp, Belgium; Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium; [Meyer, Nadia; Pircon, Jean-Yves] GlaxoSmithKline Biol, Wavre, Belgium; [Soriano-Gabarro, Montse] Bayer Healthcare Pharmaceut, Berlin, Germany; [Heylen, Elisabeth; Zeller, Mark; Matthijnssens, Jelle; Van Ranst, Marc] Katholieke Univ Leuven, Louvain, Belgium; [Azou, Myriam] AZ Damiaan, Dept Paediat, Oostende, Belgium; [Capiau, Heidi] AZ St Lucas, Dept Paediat, Ghent, Belgium; [De Koster, Jan] ZOL, Dept Paediat, Genk, Belgium; [Maernoudt, Anne-Sophie] Clin St Pierre, Dept Paediat, Ottignies, Belgium; [Raes, Marc] Jessa Hosp, Dept Paediat, Hasselt, Belgium; [Verdonck, Lutgard] AZ Alma, Dept Paediat, Eeklo, Belgium; [Van Herck, Koen; Verghote, Marc] CHR Namur, Dept Paediat, Namur, Belgium; [Vergison, Anne] Univ Hosp Children, Infect Dis Unit, Brussels, Belgium	University of Antwerp; Ghent University; GlaxoSmithKline; Bayer AG; Bayer Healthcare Pharmaceuticals; KU Leuven; East Limburg Hospital	Van Damme, P (corresponding author), Univ Antwerp, Vaccine & Infect Dis Inst, Ctr Evaluat Vaccinat, B-2020 Antwerp, Belgium.	pierre.vandamme@ua.ac.be	Matthijnssens, Jelle/A-6770-2015; van damme, pierre/I-4846-2013; Van Herck, Koen/G-5223-2013; Matthijnssens, Jelle/O-7069-2019; Heylen, Elisabeth/AAR-5254-2020; Van Ranst, Marc/P-7522-2017; Braeckman, Tessa/AAD-2998-2020; Matthijnssens, Jelle/B-8634-2016; Van Herck, Koen/L-2549-2019	Van Herck, Koen/0000-0003-0717-2406; Matthijnssens, Jelle/0000-0003-1188-9733; Heylen, Elisabeth/0000-0003-4359-7225; Van Ranst, Marc/0000-0002-1674-4157; Matthijnssens, Jelle/0000-0003-1188-9733; Van Herck, Koen/0000-0003-0717-2406; Braeckman, Tessa/0000-0003-2458-383X; van damme, pierre/0000-0002-8642-1249	GlaxoSmithKline Biologicals	GlaxoSmithKline Biologicals(GlaxoSmithKline)	This study was funded by GlaxoSmithKline Biologicals, which helped with study design, data collection, and analysis. GlaxoSmithKline Biologicals also funded Jennifer Coward (independent medical writer, Bollington, UK) to help with writing the paper.	[Anonymous], 2009, Wkly Epidemiol Rec, V84, P533; Bilcke J, 2007, 54C KCE; Bilcke J, 2008, EUR J PEDIATR, V167, P1409, DOI 10.1007/s00431-008-0684-3; Bilcke J, 2009, MED DECIS MAKING, V29, P33, DOI 10.1177/0272989X08324955; Boom JA, 2010, PEDIATRICS, V125, pE199, DOI 10.1542/peds.2009-1021; Boonen M, 2009, VLAAMS INFECTIEZIEKT, V68, P9; Braeckman T, 2011, PEDIATR INFECT DIS J, V30, pS21, DOI 10.1097/INF.0b013e3181fefc51; Buttery JP, 2011, PEDIATR INFECT DIS J, V30, pS25, DOI 10.1097/INF.0b013e3181fefdee; Chan J, 2011, VACCINE, V29, P1242, DOI 10.1016/j.vaccine.2010.11.087; Correia JB, 2010, J INFECT DIS, V201, P363, DOI 10.1086/649843; Cortese Margaret M., 2009, Morbidity and Mortality Weekly Report, V58, P1; de Palma O, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2825; Desai SN, 2010, VACCINE, V28, P7501, DOI 10.1016/j.vaccine.2010.09.013; Diez-Domingo J, 2011, EUR J PEDIATR, V170, P213, DOI 10.1007/s00431-010-1289-1; Field EJ, 2010, PEDIATRICS, V126, pE506, DOI 10.1542/peds.2010-0443; Forster J, 2009, PEDIATRICS, V123, pe393, DOI 10.1542/peds.2008-2088; Giaquinto C, 2010, SCAND J INFECT DIS, V42, P142, DOI 10.3109/00365540903380495; Glass RI, 2006, ADV EXP MED BIOL, V582, P45; Hanquet G, 2011, VACCINE, V29, P4698, DOI 10.1016/j.vaccine.2011.04.098; Hoppenbrouwers K, 2009, VACCINATION COVERAGE; Justino MCA, 2011, PEDIATR INFECT DIS J, V30, P396, DOI 10.1097/INF.0b013e3182055cc2; Linhares AC, 2008, LANCET, V371, P1181, DOI 10.1016/S0140-6736(08)60524-3; Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797; Molto Y, 2011, PEDIATR INFECT DIS J, V30, pS16, DOI 10.1097/INF.0b013e3181fefc68; Parashar UD, 2003, EMERG INFECT DIS, V9, P565, DOI 10.3201/eid0905.020562; Patel M, 2009, J INFECT DIS, V200, pS39, DOI 10.1086/605035; Patel M, 2009, JAMA-J AM MED ASSOC, V301, P2243, DOI 10.1001/jama.2009.756; Paulke-Korinek M, 2010, PEDIATR INFECT DIS J, V29, P319, DOI 10.1097/INF.0b013e3181c18434; Phua KB, 2009, VACCINE, V27, P5936, DOI 10.1016/j.vaccine.2009.07.098; Plenge-Bonig A, 2010, EUR J PEDIATR, V169, P1471, DOI 10.1007/s00431-010-1245-0; Quintanar-Solares M, 2011, PEDIATR INFECT DIS J, V30, pS11, DOI 10.1097/INF.0b013e3181fefb32; Raes M, 2011, PEDIATR INFECT DIS J, V30, pE120, DOI 10.1097/INF.0b013e318214b811; Richardson V, 2010, NEW ENGL J MED, V362, P299, DOI 10.1056/NEJMoa0905211; Rimoldi SG, 2011, ARCH VIROL, V156, P1583, DOI 10.1007/s00705-011-1037-5; Robert E, 2010, ENQUETE COUVERTURE V; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; RUUSKA T, 1990, SCAND J INFECT DIS, V22, P259, DOI 10.3109/00365549009027046; Snelling TL, 2011, CLIN INFECT DIS, V52, P191, DOI 10.1093/cid/ciq101; Soriano-Gabarro M, 2006, PEDIATR INFECT DIS J, V25, pS7, DOI 10.1097/01.inf.0000197622.98559.01; Tate JE, 2011, PEDIATR INFECT DIS J, V30, pS30, DOI 10.1097/INF.0b013e3181ffe3eb; Tate JE, 2009, PEDIATRICS, V124, P465, DOI 10.1542/peds.2008-3528; Todd S, 2010, J INFECT DIS, V202, pS34, DOI 10.1086/653555; Tran A, 2010, J CLIN MICROBIOL, V48, P1943, DOI 10.1128/JCM.02181-09; Van Damme P, 2007, J INFECT DIS, V195, pS4, DOI 10.1086/516714; Vesikari T, 2007, LANCET, V370, P1757, DOI 10.1016/S0140-6736(07)61744-9; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; Vesikari T, 2009, VACCINE, V28, P345, DOI 10.1016/j.vaccine.2009.10.041; World Health Organization, 2008, GEN PROT MON IMP ROT; Yen C, 2011, PEDIATRICS, V127, pE9, DOI 10.1542/peds.2010-1393; Yen C, 2011, PEDIATR INFECT DIS J, V30, pS6, DOI 10.1097/INF.0b013e3181fefa05; Zeller M, 2010, VACCINE, V28, P7507, DOI 10.1016/j.vaccine.2010.09.004	51	103	104	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 8	2012	345								e4752	10.1136/bmj.e4752	http://dx.doi.org/10.1136/bmj.e4752			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988ND	22875947	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000307496800001
J	Layden, J; Michaels, J; Bermingham, S; Higgins, B				Layden, Jennifer; Michaels, Jonathan; Bermingham, Sarah; Higgins, Bernard		Guideline Dev Grp	Diagnosis and management of lower limb peripheral arterial disease: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Michaels, Jonathan] Univ Sheffield, Sheffield S10 2TN, S Yorkshire, England; [Layden, Jennifer; Bermingham, Sarah; Higgins, Bernard] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England	University of Sheffield; Royal College of Physicians	Michaels, J (corresponding author), Univ Sheffield, Sheffield S10 2TN, S Yorkshire, England.	j.michaels@sheffield.ac.uk						[Anonymous], 2008, GUID PROM CREAT PHYS; [Anonymous], 2008, INT GUID WORKPL HLTH; Cayir A., 2018, INTERNAL MED REV, V4, DOI [10.18103/imr.v4i12.776, DOI 10.18103/IMR.V4I12.776]; Leng GC, 1996, INT J EPIDEMIOL, V25, P1172, DOI 10.1093/ije/25.6.1172; *NAT I HLTH CLIN E, 2007, EZ TREATM PRIM HET F; National Institute for Health and Clinical Excellence, 2008, SMOK CESS SERV PRIM; National Institute for Health and Clinical Excellence, 2008, CARD RISK ASS MOD BL; National Institute for Health and Clinical Excellence, 2010, CLOP MOD REL DIP PRE; National Institute for Health and Clinical Excellence, 2011, HYPERT CLIN MAN PRI; National Institute for Health and Clinical Excellence, 2006, BRIEF INT REF SMOK C; National Institute for Health and Clinical Excellence, 2009, GUID MAN; National Institute for Health and Clinical Excellence, 2007, VAR SMOK CESS TECHN; National Institute for Health and Clinical Excellence, 2008, SOC VAL JUDG PRINC D, V2nd; National Institute for Health and Clinical Excellence, 2008, GUID PREV UPT SMOK C; National Institute for Health and Clinical Excellence, 2011, PREV TYP 2 DIAB POP; National Institute for Health and Clinical Excellence, 2012, LOW LIMB PER ART DIS; National Institute for Health and Clinical Excellence, 2003, CLIN EFF COST EFF PA; National Institute for Health and Clinical Excellence, 2006, STAT PREV CARD EV PA; National Institute for Health and Clinical Excellence, 2011, DIAB FOOT INP MAN PE; National Institute for Health and Clinical Excellence, 2008, TYP 2 DIAB MAN TYP 2; National Institute for Health & Clinical Excellence, 2006, 4 COMM US METH INCR; National Institute for HealthandClinical Excellence, 2006, OB PREV ID ASS MAN O; The Vascular Society of Great Britain and Ireland: the provision of services for patients with vascular disease, 2012, VAS SOC GREAT BRIT I	23	94	95	0	17	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 8	2012	345								e4947	10.1136/bmj.e4947	http://dx.doi.org/10.1136/bmj.e4947			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988ND	22875949				2022-12-28	WOS:000307496800006
J	Rutjes, AWS; Juni, P; da Costa, BR; Trelle, S; Nuesch, E; Reichenbach, S				Rutjes, Anne W. S.; Jueni, Peter; da Costa, Bruno R.; Trelle, Sven; Nueesch, Eveline; Reichenbach, Stephan			Viscosupplementation for Osteoarthritis of the Knee A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							INTRAARTICULAR HYALURONIC-ACID; CONTROLLED CLINICAL-TRIAL; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; G-F 20; DOUBLE-BLIND; SODIUM HYALURONATE; HYLAN G-F-20; FUNNEL PLOTS; ARTHROSCOPIC DEBRIDEMENT; MULTICENTER TRIAL	Background: Viscosupplementation, the intra-articular injection of hyaluronic acid, is widely used for symptomatic knee osteoarthritis. Purpose: To assess the benefits and risks of viscosupplementation for adults with symptomatic knee osteoarthritis. Data Sources: MEDLINE (1966 to January 2012), EMBASE (1980 to January 2012), the Cochrane Central Register of Controlled Trials (1970 to January 2012), and other sources. Study Selection: Randomized trials in any language that compared viscosupplementation with sham or nonintervention control in adults with knee osteoarthritis. Data Extraction: Primary outcomes were pain intensity and flare-ups. Secondary outcomes included function and serious adverse events. Reviewers used duplicate abstractions, assessed study quality, pooled data by using a random-effects model, examined funnel plots, and explored heterogeneity by using meta-regression. Data Synthesis: Eighty-nine trials involving 12 667 adults met inclusion criteria. Sixty-eight had a sham control, 40 had a follow-up duration greater than 3 months, and 22 used cross-linked forms of hyaluronic acid. Overall, 71 trials (9617 patients) showed that viscosupplementation moderately reduced pain (effect size, -0.37 [95% CI, -0.46 to -0.28]). There was important between-trial heterogeneity and an asymmetrical funnel plot: Trial size, blinded outcome assessment, and publication status were associated with effect size. Five unpublished trials (1149 patients) showed an effect size of -0.03 (CI, -0.14 to 0.09). Eighteen large trials with blinded outcome assessment (5094 patients) showed a clinically irrelevant effect size of -0.11 (CI, -0.18 to -0.04). Six trials (811 patients) showed that viscosupplementation increased, although not statistically significantly, the risk for flare-ups (relative risk, 1.51 [CI, 0.84 to 2.72]). Fourteen trials (3667 patients) showed that viscosupplementation increased the risk for serious adverse events (relative risk, 1.41 [CI, 1.02 to 1.97]). Limitations: Trial quality was generally low. Safety data were often not reported. Conclusion: In patients with knee osteoarthritis, viscosupplementation is associated with a small and clinically irrelevant benefit and an increased risk for serious adverse events.	Univ Bern, Inst Social & Prevent Med, Clin Trials Unit Bern, Univ Hosp Bern, CH-3012 Bern, Switzerland; Univ G dAnnunzio, Ctr Aging Sci CeSI, Chieti, Italy; London Sch Hyg & Trop Med, London WC1, England	University of Bern; University Hospital of Bern; G d'Annunzio University of Chieti-Pescara; University of London; London School of Hygiene & Tropical Medicine	Juni, P (corresponding author), Univ Bern, Inst Social & Prevent Med, Finkenhubelweg 11, CH-3012 Bern, Switzerland.	juni@ispm.unibe.ch	Juni, Peter/Q-8700-2016; Hunter, David J/A-4622-2010; Trelle, Sven/D-3760-2009; Rutjes, Anne/L-8750-2017; Bannuru, Raveendhara/G-2601-2011	Juni, Peter/0000-0002-5985-0670; Hunter, David J/0000-0003-3197-752X; Trelle, Sven/0000-0002-8162-8910; Rutjes, Anne/0000-0001-9782-779X; Bannuru, Raveendhara/0000-0002-8069-5783; Reichenbach, Stephan/0000-0001-8098-6567; R. da Costa, Bruno/0000-0002-1786-6332	Arco Foundation; Swiss National Science Foundation	Arco Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study is funded by a grant from the Arco Foundation. Dr. Rutjes and Mr. da Costa are supported by the Arco Foundation, and Drs. Juni and Reichenbach are supported by the Swiss National Science Foundation and Arco Foundation.	Adams ME, 1995, OSTEOARTHR CARTILAGE, V3, P213, DOI 10.1016/S1063-4584(05)80013-5; Altman R, 1996, OSTEOARTHR CARTILAGE, V4, P217, DOI 10.1016/S1063-4584(05)80101-3; Altman RD, 2004, OSTEOARTHR CARTILAGE, V12, P642, DOI 10.1016/j.joca.2004.04.010; Altman RD, 1998, J RHEUMATOL, V25, P2203; Altman RD, 2009, SEMIN ARTHRITIS RHEU, V39, P1, DOI 10.1016/j.semarthrit.2009.04.001; Angst F, 2001, ARTHRIT RHEUM-ARTHR, V45, P384, DOI 10.1002/1529-0131(200108)45:4<384::AID-ART352>3.0.CO;2-0; Angst F, 2002, J RHEUMATOL, V29, P131; Anika Therapeutics, 2001, CONF OBT REP; Anika Therapeutics, 2000, CONF OBT REP; Ardic F, 2001, ANN RHEUMATIC DIS S1, V60, P232; Arrich J, 2005, CAN MED ASSOC J, V172, DOI 10.1503/cmaj.1041203; Atay T, 2008, ACTA ORTHOP TRAUMATO, V42, P228, DOI 10.3944/AOTT.2008.228; BALAZS EA, 1993, J RHEUMATOL, V20, P3; Baltzer AWA, 2009, OSTEOARTHR CARTILAGE, V17, P152, DOI 10.1016/j.joca.2008.06.014; Bannuru RR, 2011, OSTEOARTHR CARTILAGE, V19, P611, DOI 10.1016/j.joca.2010.09.014; Baraf HS, 2009, OSTEOARTHR CARTILAGE, V17, pS174; Bayramoglu M, 2003, CLIN RHEUMATOL, V22, P118, DOI 10.1007/s10067-002-0691-0; Bellamy N, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005321.pub2; BLANCO FJ, 2008, OPEN ARTHRITIS J, V1, P1; BRAGANTINI A, 1987, CLIN TRIALS J, V24, P333; Brandt KD, 2000, ARTHRITIS RHEUM-US, V43, P1192, DOI 10.1002/1529-0131(200006)43:6<1192::AID-ANR2>3.0.CO;2-L; Brandt KD, 2001, CLIN ORTHOP RELAT R, P130; Bunyaratavej Narong, 2001, Journal of the Medical Association of Thailand, V84, pS576; Butun B, 2002, RHEUMATISM, V17, P31; Campbell J, 2007, OSTEOARTHR CARTILAGE, V15, P1424, DOI 10.1016/j.joca.2007.01.022; Caracuel MA, 2001, ANN RHEUMATIC DIS S1, V60, P236; Carrabba M., 1995, European Journal of Rheumatology and Inflammation, V15, P25; Chevalier X, 2010, ANN RHEUM DIS, V69, P113, DOI 10.1136/ard.2008.094623; Cogalgil S, 2002, EUR LEAG RHEUM 3 ANN; COHEN MA, 1994, ARTHRITIS RHEUM, V37, pR31; Corrado E. M., 1995, European Journal of Rheumatology and Inflammation, V15, P47; Creamer P, 1994, Osteoarthritis Cartilage, V2, P133, DOI 10.1016/S1063-4584(05)80063-9; Cubukcu D, 2005, CLIN RHEUMATOL, V24, P336, DOI 10.1007/s10067-004-1043-z; Day R, 2004, J RHEUMATOL, V31, P775; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dickson DJ, 2001, J CLIN RES, V4, P41; Diracoglu D, 2009, J BACK MUSCULOSKELET, V22, P1, DOI 10.3233/BMR-2009-0207; DIXON ASJ, 1988, CURR MED RES OPIN, V11, P205, DOI 10.1185/03007998809114237; Dougados M, 1993, Osteoarthritis Cartilage, V1, P97, DOI 10.1016/S1063-4584(05)80024-X; Eberle E, 1999, OSTEOARTHR CARTILAGE, V7, P502, DOI 10.1053/joca.1999.0246; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Formiguera Sala S, 1995, EUR J RHEUMATOL INFL, V15, P33; Genzyme Biomaterials, 2005, CONF OBT REP; Ghirardini M, 1990, REUMATISMO, V42, P132; Graf von der Schulenburg JM, 1997, RHEUMATOL EUR S2, V26, P191; GRECOMORO G, 1987, PHARMATHERAPEUTICA, V5, P137; Groppa L, 2004, EFFICACY COMBINED CH; Groppa LG, 2001, ANN RHEUMATIC DIS S1, V60, P230; Guler M, 1996, 10 NAT RHEUM C PAM D; HENDERSON EB, 1994, ANN RHEUM DIS, V53, P529, DOI 10.1136/ard.53.8.529; Heybeli N, 2008, ACTA ORTHOP TRAUMATO, V42, P221, DOI 10.3944/AOTT.2008.221; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hizmetli S, 2002, 3 ANN EUR C RHEUM ST; Huang MH, 2005, ARTHRIT RHEUM-ARTHR, V53, P812, DOI 10.1002/art.21590; Huang TL, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-221; Huskisson EC, 1999, RHEUMATOLOGY, V38, P602, DOI 10.1093/rheumatology/38.7.602; Isdale AH, 1993, BR J RHEUMATOL S1, V32, P61; Jorgensen A, 2010, ANN RHEUM DIS, V69, P1097, DOI 10.1136/ard.2009.118042; Jubb RW, 2003, INT J CLIN PRACT, V57, P467; Juni P, 2006, BEST PRACT RES CL RH, V20, P721, DOI 10.1016/j.berh.2006.05.002; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Kahan A, 2003, JOINT BONE SPINE, V70, P276, DOI 10.1016/S1297-319X(03)00043-5; Kalay S, 1997, THESIS MINISTRY HLTH; Karlsson J, 2002, RHEUMATOLOGY, V41, P1240, DOI 10.1093/rheumatology/41.11.1240; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kosuwon W, 2010, ANN RHEUM DIS     S3, V69, P267; Kotevoglu N, 2006, RHEUMATOL INT, V26, P325, DOI 10.1007/s00296-005-0611-0; Kul-Panza E, 2010, MINERVA MED, V101, P63; Listrat V, 1997, OSTEOARTHR CARTILAGE, V5, P153, DOI 10.1016/S1063-4584(97)80010-6; Lo GH, 2003, JAMA-J AM MED ASSOC, V290, P3115, DOI 10.1001/jama.290.23.3115; Lohmander LS, 1996, ANN RHEUM DIS, V55, P424, DOI 10.1136/ard.55.7.424; Lundsgaard C, 2008, SCAND J RHEUMATOL, V37, P142, DOI 10.1080/03009740701813103; Medina JM, 2006, J FAM PRACTICE, V55, P669; Miltner O, 2002, OSTEOARTHR CARTILAGE, V10, P680, DOI 10.1053/joca.2002.0815; Modawal A, 2005, J FAM PRACTICE, V54, P758; MORELAND LW, 1993, ARTHRITIS RHEUM, V36, pS165; Moreno SG, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2981; Murray CJL, 1996, GLOBAL BURDEN DIS IN, V1; Navarro-Sarabia F, 2011, ANN RHEUM DIS, V70, P1957, DOI 10.1136/ard.2011.152017; Neustadt D, 2005, J RHEUMATOL, V32, P1928; Nuesch E, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3515; Nuesch E, 2009, ARTHRIT RHEUM-ARTHR, V61, P1633, DOI 10.1002/art.24894; Nuesch E, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3244; Nuesch E, 2009, INT J EPIDEMIOL, V38, P298, DOI 10.1093/ije/dyn265; Palmer TM, 2008, STATA J, V8, P242, DOI 10.1177/1536867X0800800206; Pavelka K, 2010, OSTEOARTHR CARTILAGE, V18, pS144, DOI 10.1016/S1063-4584(10)60353-6; Payne MW, 2000, ARCH PHYS MED REHAB, V81, P598, DOI 10.1016/S0003-9993(00)90041-8; Pedersen PB, 1993, OSTEOARTHR CARTILAGE, V1, P70; Pelletier JP, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6328; Peters JL, 2008, J CLIN EPIDEMIOL, V61, P991, DOI 10.1016/j.jclinepi.2007.11.010; Petrella RJ, 2006, J RHEUMATOL, V33, P951; Petrella RJ, 2002, ARCH INTERN MED, V162, P292, DOI 10.1001/archinte.162.3.292; Petrella RJ, 2009, ANN RHEUM DIS     S3, V68, P479; Petrella RJ, 2008, CLIN RHEUMATOL, V27, P975, DOI 10.1007/s10067-007-0834-4; PEYRON JG, 1974, PATHOL BIOL, V22, P731; Pham T, 2004, ANN RHEUM DIS, V63, P1611, DOI 10.1136/ard.2003.019703; Pham T, 2004, OSTEOARTHR CARTILAGE, V12, P389, DOI 10.1016/j.joca.2004.02.001; Puhl W, 1993, Osteoarthritis Cartilage, V1, P233, DOI 10.1016/S1063-4584(05)80329-2; Raynauld JP, 2002, OSTEOARTHR CARTILAGE, V10, P506, DOI 10.1053/joca.2002.0798; Reichenbach S, 2007, ARTHRIT RHEUM-ARTHR, V57, P1410, DOI 10.1002/art.23103; Reichenbach S, 2007, ANN INTERN MED, V146, P580, DOI 10.7326/0003-4819-146-8-200704170-00009; Renklitepe N, 2000, ANN RHEUM DIS S, V59, P142; Royston P, 2004, STAT MED, V23, P2509, DOI 10.1002/sim.1815; RUSSELL IJ, 1992, ARTHRITIS RHEUM, V35, pS132; Rutjes AWS, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002823.pub2, 10.1002/14651858.CD007321.pub2]; Ruyssen-Witrand A, 2011, J CLIN EPIDEMIOL, V64, P463, DOI 10.1016/j.jclinepi.2010.06.008; Salaffi F, 2004, EUR J PAIN, V8, P283, DOI 10.1016/j.ejpain.2003.09.004; Sanofi-Aventis, TREAD 20 TRIAL HYALG; Saravanan V, 2002, RHEUMATOLOGY, V41, P121; SCALE D, 1994, CURR THER RES CLIN E, V55, P220, DOI 10.1016/S0011-393X(05)80166-3; Schneider U, 1997, Z ORTHOP GRENZGEB, V135, P341, DOI 10.1055/s-2008-1039399; Seikagaku Corporation, 2001, SUMM SAF EFF DAT SOD; Sezgin M, 2005, RHEUMATOL INT, V25, P264, DOI 10.1007/s00296-003-0428-7; Shang AJ, 2005, LANCET, V366, P726, DOI 10.1016/S0140-6736(05)67177-2; Shichikawa K, 1983, Ryumachi, V23, P280; Shichikawa K, 1983, JPN J CLIN PHARM THE, V14, P545; SMALLEY WE, 1995, AM J EPIDEMIOL, V141, P539, DOI 10.1093/oxfordjournals.aje.a117469; Spiegelhalter DJ, 2004, BAYESIAN APPROACHES, DOI DOI 10.1002/0470092602; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8; Tamir E, 2001, CLIN EXP RHEUMATOL, V19, P265; Tetik S, 2003, PAIN CLINIC, V15, P459, DOI 10.1163/156856903770196863; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; Trelle S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7086; Tsai CL, 2003, OSTEOARTHR CARTILAGE, V11, P119; Wandel S, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4675; Wang CT, 2004, J BONE JOINT SURG AM, V86A, P538, DOI 10.2106/00004623-200403000-00012; WEISS C, 1981, SEMIN ARTHRITIS RHEU, V11, P143, DOI 10.1016/0049-0172(81)90081-0; Wobig M, 1998, CLIN THER, V20, P410, DOI 10.1016/S0149-2918(98)80052-0; Wu HB, 2004, ZHONGGUO LINCHUANG K, V8, P5491; Wu J J, 1997, Zhonghua Yi Xue Za Zhi (Taipei), V59, P99	131	376	400	4	75	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 7	2012	157	3					180	+		10.7326/0003-4819-157-3-201208070-00473	http://dx.doi.org/10.7326/0003-4819-157-3-201208070-00473			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992PB	22868835				2022-12-28	WOS:000307789900005
J	Cocucci, E; Aguet, F; Boulant, S; Kirchhausen, T				Cocucci, Emanuele; Aguet, Francois; Boulant, Steeve; Kirchhausen, Tom			The First Five Seconds in the Life of a Clathrin-Coated Pit	CELL			English	Article							MEDIATED ENDOCYTOSIS; LIVING CELLS; DYNAMICS; ADAPTER; RECRUITMENT; ACTIN; MEMBRANE; PROTEINS; RECEPTOR; CARGO	Coated pits assemble by growth of a clathrin lattice, which is linked by adaptors to the underlying membrane. How does this process start? We used live-cell TIRF imaging with single-molecule EGFP sensitivity and high temporal resolution to detect arrival of the clathrin triskelions and AP2 adaptors that initiate coat assembly. Unbiased object identification and trajectory tracking, together with a statistical model, yield the arrival times and numbers of individual proteins, as well as experimentally confirmed estimates of the extent of substitution of endogenous by expressed, fluorescently tagged proteins. Pits initiate by coordinated arrival of clathrin and AP2, which is usually detected as two sequential steps, each of one triskelion with two adaptors. PI-4,5-P-2 is essential for initiation. The accessory proteins FCHo1/2 are not; instead, they are required for sustained growth. This objective picture of coated pit initiation also shows that methods outlined here will be broadly useful for studies of dynamic assemblies in living cells.	[Cocucci, Emanuele; Aguet, Francois; Boulant, Steeve; Kirchhausen, Tom] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Cocucci, Emanuele; Boulant, Steeve; Kirchhausen, Tom] Boston Childrens Hosp, Immune Dis Inst, Boston, MA 02115 USA; [Cocucci, Emanuele; Boulant, Steeve; Kirchhausen, Tom] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM)	Kirchhausen, T (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	kirchhausen@crystal.harvard.edu	Boulant, Steeve/W-3754-2019	Boulant, Steeve/0000-0001-8614-4993; Cocucci, Emanuele/0000-0002-0088-9845	NIH [GM-075252, GM-073165, U54 AI057159]; GlaxoSmithKline; Swiss National Science Foundation; Harvard Digestive Disease Consortium Feasibility Award; New England Regional Center of Excellence in Biodefense and Emerging Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073165, R01GM075252] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GlaxoSmithKline(GlaxoSmithKline); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Harvard Digestive Disease Consortium Feasibility Award; New England Regional Center of Excellence in Biodefense and Emerging Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM-075252 (T. K.), a GlaxoSmithKline Fellowship (E. C.), a Swiss National Science Foundation fellowship (F. A.) and partial support from NIH grant GM-073165 (to G. Danuser, Harvard Medical School) (F. A.), and a Harvard Digestive Disease Consortium Feasibility Award (S. B.). We thank E. Marino (supported by NIH grant U54 AI057159, New England Regional Center of Excellence in Biodefense and Emerging Infectious Diseases) for maintaining the imaging resources, G. Findlay for qtPCR determinations, Janet Iwasa for the graphical abstract, and S. C. Harrison for editorial assistance. We gratefully acknowledge G. Danuser, K. Jaqaman, S. C. Harrison, and members of the Kirchhausen lab for thought-provoking discussions. E. C. and T. K. designed experiments; E. C. and S. B. performed experiments; E. C. and F. A. designed and implemented the computational methods; and E. C. and F. A. analyzed data. E. C., F. A., and T. K. discussed the results and contributed to the final manuscript.	Antonescu CN, 2011, MOL BIOL CELL, V22, P2588, DOI 10.1091/mbc.E11-04-0362; Bocking T, 2011, NAT STRUCT MOL BIOL, V18, P295, DOI 10.1038/nsmb.1985; Boucrot E, 2006, EXP CELL RES, V312, P4036, DOI 10.1016/j.yexcr.2006.09.025; Boucrot E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010597; Boulant S, 2011, NAT CELL BIOL, V13, P1124, DOI 10.1038/ncb2307; Cureton DK, 2012, J VIROL, V86, P5330, DOI 10.1128/JVI.07194-11; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; Gaidarov I, 1999, NAT CELL BIOL, V1, P1, DOI 10.1038/8971; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Gottfried I, 2009, CELL MOL LIFE SCI, V66, P2897, DOI 10.1007/s00018-009-0077-4; Harrison SC, 2010, NATURE, V466, P1048, DOI 10.1038/4661048a; Henne WM, 2010, SCIENCE, V328, P1281, DOI 10.1126/science.1188462; Hinrichsen L, 2006, P NATL ACAD SCI USA, V103, P8715, DOI 10.1073/pnas.0600312103; Howarth M, 2008, NAT PROTOC, V3, P534, DOI 10.1038/nprot.2008.20; Howarth M, 2008, NAT METHODS, V5, P397, DOI 10.1038/NMETH.1206; Jaqaman K, 2006, NAT REV MOL CELL BIO, V7, P813, DOI 10.1038/nrm2030; Kirchhausen T, 2009, TRENDS CELL BIOL, V19, P596, DOI 10.1016/j.tcb.2009.09.002; Lee DW, 2006, J CELL SCI, V119, P3502, DOI 10.1242/jcs.03092; Loerke D, 2011, TRAFFIC, V12, P815, DOI 10.1111/j.1600-0854.2011.01197.x; Loerke D, 2009, PLOS BIOL, V7, P628, DOI 10.1371/journal.pbio.1000057; Massol RH, 2006, P NATL ACAD SCI USA, V103, P10265, DOI 10.1073/pnas.0603369103; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Mettlen M, 2010, J CELL BIOL, V188, P919, DOI 10.1083/jcb.200908078; Miller SE, 2011, CELL, V147, P1118, DOI 10.1016/j.cell.2011.10.038; Nunez D, 2011, TRAFFIC, V12, P1868, DOI 10.1111/j.1600-0854.2011.01273.x; Rapoport I, 1997, EMBO J, V16, P2240, DOI 10.1093/emboj/16.9.2240; Reider A, 2009, EMBO J, V28, P3103, DOI 10.1038/emboj.2009.248; Saffarian S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000191; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Smith DA, 1998, PHILOS T R SOC B, V353, P1969, DOI 10.1098/rstb.1998.0348; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Tebar F, 1996, J BIOL CHEM, V271, P28727, DOI 10.1074/jbc.271.46.28727; Toshima JY, 2006, P NATL ACAD SCI USA, V103, P5793, DOI 10.1073/pnas.0601042103; Traub LM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000192; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Yu A, 2007, DEV CELL, V12, P129, DOI 10.1016/j.devcel.2006.10.015; Zoncu R, 2007, P NATL ACAD SCI USA, V104, P3793, DOI 10.1073/pnas.0611733104	41	237	238	1	73	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 3	2012	150	3					495	507		10.1016/j.cell.2012.05.047	http://dx.doi.org/10.1016/j.cell.2012.05.047			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	985WO	22863004	Green Accepted, Bronze			2022-12-28	WOS:000307301400010
J	Peyronel, T; Firstenberg, O; Liang, QY; Hofferberth, S; Gorshkov, AV; Pohl, T; Lukin, MD; Vuletic, V				Peyronel, Thibault; Firstenberg, Ofer; Liang, Qi-Yu; Hofferberth, Sebastian; Gorshkov, Alexey V.; Pohl, Thomas; Lukin, Mikhail D.; Vuletic, Vladan			Quantum nonlinear optics with single photons enabled by strongly interacting atoms	NATURE			English	Article							ELECTROMAGNETICALLY INDUCED TRANSPARENCY; RYDBERG BLOCKADE; GAS	The realization of strong nonlinear interactions between individual light quanta (photons) is a long-standing goal in optical science and engineering(1,2), being of both fundamental and technological significance. In conventional optical materials, the nonlinearity at light powers corresponding to single photons is negligibly weak. Here we demonstrate a medium that is nonlinear at the level of individual quanta, exhibiting strong absorption of photon pairs while remaining transparent to single photons. The quantum nonlinearity is obtained by coherently coupling slowly propagating photons(3-5) to strongly interacting atomic Rydberg states(6-12) in a cold, dense atomic gas(13,14). Our approach paves the way for quantum-byquantum control of light fields, including single-photon switching(15), all-optical deterministic quantum logic(16) and the realization of strongly correlated many-body states of light(17).	[Firstenberg, Ofer; Hofferberth, Sebastian; Lukin, Mikhail D.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Peyronel, Thibault; Firstenberg, Ofer; Liang, Qi-Yu; Hofferberth, Sebastian; Vuletic, Vladan] MIT, Dept Phys, Cambridge, MA 02139 USA; [Peyronel, Thibault; Firstenberg, Ofer; Liang, Qi-Yu; Hofferberth, Sebastian; Vuletic, Vladan] MIT, Elect Res Lab, Cambridge, MA 02139 USA; [Gorshkov, Alexey V.] CALTECH, Inst Quantum Informat & Matter, Pasadena, CA 91125 USA; [Pohl, Thomas] Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany	Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); California Institute of Technology; Max Planck Society	Lukin, MD (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	lukin@fas.harvard.edu; vuletic@mit.edu	Firstenberg, Ofer/A-6381-2015; Liang, Qiyu/D-9523-2012; Hofferberth, Sebastian/G-7076-2019; Gorshkov, Alexey V/A-9848-2008; Vuletic, Vladan/M-8736-2019; Pohl, Thomas/B-5133-2013	Firstenberg, Ofer/0000-0001-8905-9954; Hofferberth, Sebastian/0000-0003-0309-9715; Gorshkov, Alexey V/0000-0003-0509-3421; Pohl, Thomas/0000-0002-4093-3644	NSF; CUA; AFOSR Quantum Memories MURI; Lee A. DuBridge Foundation; IQIM; NSF Physics Frontiers Center; Gordon and Betty Moore Foundation	NSF(National Science Foundation (NSF)); CUA; AFOSR Quantum Memories MURI; Lee A. DuBridge Foundation; IQIM; NSF Physics Frontiers Center(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	We acknowledge technical support from A. Mazurenko. This work was supported in part by NSF, CUA and the AFOSR Quantum Memories MURI. A. V. G. acknowledges funding from the Lee A. DuBridge Foundation and the IQIM, an NSF Physics Frontiers Center with support from the Gordon and Betty Moore Foundation.	Bajcsy M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.203902; Birnbaum KM, 2005, NATURE, V436, P87, DOI 10.1038/nature03804; Chang DE, 2008, NAT PHYS, V4, P884, DOI 10.1038/nphys1074; Dudin YO, 2012, SCIENCE, V336, P887, DOI 10.1126/science.1217901; Fleischhauer M, 2005, REV MOD PHYS, V77, P633, DOI 10.1103/RevModPhys.77.633; Fleischhauer M, 2000, PHYS REV LETT, V84, P5094, DOI 10.1103/PhysRevLett.84.5094; Fushman I, 2008, SCIENCE, V320, P769, DOI 10.1126/science.1154643; Gaetan A, 2009, NAT PHYS, V5, P115, DOI 10.1038/NPHYS1183; Gorshkov AV, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.133602; Han Y, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.052311; Hau LV, 1999, NATURE, V397, P594, DOI 10.1038/17561; Heidemann R, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.033601; Johnson TA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.113003; Liebisch TC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.253002; Lukin MD, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.037901; Moller D, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.170504; Muller M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.170502; Petrosyan D, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.213601; Pritchard JD, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.193603; Pritchard JD, 2013, ANN REV COLD ATOMS, V1, P301; Reinhard A, 2012, NAT PHOTONICS, V6, P93, DOI [10.1038/nphoton.2011.321, 10.1038/NPHOTON.2011.321]; Saffman M, 2010, REV MOD PHYS, V82, P2313, DOI 10.1103/RevModPhys.82.2313; Schuster I, 2008, NAT PHYS, V4, P382, DOI 10.1038/nphys940; Sevincli S, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.153001; Shahmoon E, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.033806; Singer K, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.163001; Tanji-Suzuki H, 2011, SCIENCE, V333, P1266, DOI 10.1126/science.1208066; Tong D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.063001; Urban E, 2009, NAT PHYS, V5, P110, DOI 10.1038/NPHYS1178; Venkataraman V, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.193902; Yamamoto Y., 1999, MESOSCOPIC QUANTUM O	31	565	569	12	241	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2012	488	7409					57	60		10.1038/nature11361	http://dx.doi.org/10.1038/nature11361			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ZE	22832584	Green Submitted			2022-12-28	WOS:000307010700031
J	Pross, J; Contreras, L; Bijl, PK; Greenwood, DR; Bohaty, SM; Schouten, S; Bendle, JA; Rohl, U; Tauxe, L; Raine, JI; Huck, CE; van de Flierdt, T; Jamieson, SSR; Stickley, CE; van de Schootbrugge, B; Escutia, C; Brinkhuis, H; Dotti, CE; Klaus, A; Fehr, A; Williams, T; Bendle, JAP; Carr, SA; Dunbar, RB; Gonzalez, JJ; Hayden, TG; Iwai, M; Jimenez-Espejo, FJ; Katsuki, K; Kong, GS; Mckay, RM; Nakai, M; Olney, MP; Passchier, S; Pekar, SF; Pross, J; Riesselman, CR; Rohl, U; Sakai, T; Shrivastava, PK; Stickley, CE; Sugisaki, S; Tauxe, L; Tuo, S; Van De Flierdt, T; Welsh, K; Yamane, M				Pross, Joerg; Contreras, Lineth; Bijl, Peter K.; Greenwood, David R.; Bohaty, Steven M.; Schouten, Stefan; Bendle, James A.; Roehl, Ursula; Tauxe, Lisa; Raine, J. Ian; Huck, Claire E.; van de Flierdt, Tina; Jamieson, Stewart S. R.; Stickley, Catherine E.; van de Schootbrugge, Bas; Escutia, Carlota; Brinkhuis, Henk; Dotti, Carlota Escutia; Klaus, Adam; Fehr, Annick; Williams, Trevor; Bendle, James A. P.; Carr, Stephanie A.; Dunbar, Robert B.; Gonzalez, Jhon J.; Hayden, Travis G.; Iwai, Masao; Jimenez-Espejo, Francisco J.; Katsuki, Kota; Kong, Gee Soo; McKay, Robert M.; Nakai, Mutsumi; Olney, Matthew P.; Passchier, Sandra; Pekar, Stephen F.; Pross, Jorg; Riesselman, Christina R.; Rohl, Ursula; Sakai, Toyosaburo; Shrivastava, Prakash K.; Stickley, Catherine E.; Sugisaki, Saiko; Tauxe, Lisa; Tuo, Shouting; van de Flierdt, Tina; Welsh, Kevin; Yamane, Masako		Integrated Ocean Drilling Program	Persistent near-tropical warmth on the Antarctic continent during the early Eocene epoch	NATURE			English	Article							TERRESTRIAL PALEOCLIMATE; POLAR FORESTS; RECONSTRUCTIONS; SENSITIVITY; CLIMATES	The warmest global climates of the past 65 million years occurred during the early Eocene epoch (about 55 to 48 million years ago), when the Equator-to-pole temperature gradients weremuch smaller than today(1,2) and atmospheric carbon dioxide levels were in excess of one thousand parts per million by volume(3,4). Recently the early Eocene has received considerable interest because it may provide insight into the response of Earth's climate and biosphere to the high atmospheric carbon dioxide levels that are expected in the near future(5) as a consequence of unabated anthropogenic carbon emissions(4,6). Climatic conditions of the early Eocene 'greenhouse world', however, are poorly constrained in critical regions, particularly Antarctica. Here we present a well-dated record of early Eocene climate on Antarctica from an ocean sediment core recovered off the Wilkes Land coast of East Antarctica. The information from biotic climate proxies (pollen and spores) and independent organic geochemical climate proxies (indices based on branched tetraether lipids) yields quantitative, seasonal temperature reconstructions for the early Eocene greenhouse world on Antarctica. We show that the climate in lowland settings along the Wilkes Land coast (at a palaeolatitude of about 70 degrees south) supported the growth of highly diverse, near-tropical forests characterized by mesothermal to megathermal floral elements including palms and Bombacoideae. Notably, winters were extremely mild (warmer than 10 degrees C) and essentially frost-free despite polar darkness, which provides a critical new constraint for the validation of climate models and for understanding the response of high-latitude terrestrial ecosystems to increased carbon dioxide forcing.	[Pross, Joerg; Contreras, Lineth; van de Schootbrugge, Bas] Goethe Univ Frankfurt, Inst Geosci, Paleoenvironm Dynam Grp, Altenhoferallee 1, D-60438 Frankfurt, Germany; [Pross, Joerg] Biodivers & Climate Res Ctr, D-60325 Frankfurt, Germany; [Bijl, Peter K.; Brinkhuis, Henk] Univ Utrecht, Inst Environm Biol, Lab Palaeobot & Palynol, NL-3584 CD Utrecht, Netherlands; [Greenwood, David R.] Brandon Univ, Dept Biol, Brandon, MB R7A 6A9, Canada; [Bohaty, Steven M.] Univ Southampton, Natl Oceanog Ctr Southampton, Southampton SO14 3ZH, Hants, England; [Schouten, Stefan] NIOZ Royal Netherlands Inst Sea Res, Dept Marine Organ Biogeochem, NL-1790 AB Den Burg, Texel, Netherlands; [Bendle, James A.] Univ Glasgow, Sch Geog & Earth Sci, Glasgow Mol Organ Geochem Lab, Glasgow G12 8QQ, Lanark, Scotland; [Roehl, Ursula] Univ Bremen, MARUM Ctr Marine Environm Sci, D-28359 Bremen, Germany; [Tauxe, Lisa] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Raine, J. Ian] GNS Sci, Dept Paleontol, Lower Hutt 6009, New Zealand; [Huck, Claire E.; van de Flierdt, Tina] Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London SW7 2AZ, England; [Jamieson, Stewart S. R.] Univ Durham, Sci Labs, Dept Geog, Durham DH1 3LE, England; [Stickley, Catherine E.] Univ Tromso, Dept Geol, N-9037 Tromso, Norway; [Escutia, Carlota] Inst Andaluz Ciencias Tierra, Granada 18100, Spain; [Dotti, Carlota Escutia; Gonzalez, Jhon J.] CSIC Univ Granada, Inst Andaluz Ciencias Tierra, Campus Fuentenueva S N, Granada 18002, Spain; [Klaus, Adam] Texas A&M Univ, Integrated Ocean Drilling Program, United States Implementing Org, 1000 Discovery Dr, College Stn, TX 77845 USA; [Fehr, Annick] Rhein Westfal TH Aachen, Inst Appl Geophys & Geothermal Energy, Mathieustrass 6, D-52074 Aachen, Germany; [Williams, Trevor] Lamont Doherty Earth Observ Columbia Univ, Borehole Res Grp, POB 1000,61 Route 9W, Palisades, NY 10964 USA; [Bendle, James A. P.] Univ Glasgow, Geog & Earth Sci, Glasgow G128QQ, Lanark, Scotland; [Carr, Stephanie A.] Colorado Sch Mines, Dept Chem & Geochem, 1500 Illinois St, Golden, CO 80401 USA; [Dunbar, Robert B.; Riesselman, Christina R.] Stanford Univ, Dept Environm Earth Syst Sci, 325 Braun Hall,Bldg 320, Stanford, CA 94305 USA; [Hayden, Travis G.] Western Michigan Univ, Dept Geol, 1187 Rood Hall,1903 W Michigan Ave, Kalamazoo, MI 49008 USA; [Iwai, Masao] Kochi Univ, Dept Nat Sci, 2-5-1 Akebono cho, Kochi 7808520, Japan; [Jimenez-Espejo, Francisco J.] Japan Agcy Marine Earth Sci & Technol, Inst Res Earth Evolut, Natsushima Cho 2-15, Yokosuka, Kanagawa 2370061, Japan; [Katsuki, Kota] Kochi Univ, Marine Ctr Adv Core Res, B200 Monobe, Nankoku, Kochi 7838502, Japan; [Kong, Gee Soo] Korea Inst Geosci & Mineral Resources, Petr & Marine Res Div, 30 Gajeong Dong, Daejeon 305350, South Korea; [McKay, Robert M.] Victoria Univ Wellington, Antarctic Res Ctr, POB 600, Wellington 6140, New Zealand; [Nakai, Mutsumi] Daito Bunka Univ, Dept Educ, Itabashi Ku, 1-9-1 Takashima Daira, Tokyo 1758571, Japan; [Olney, Matthew P.] Univ S Florida, Dept Geol, 4202 E Fowler Ave, Tampa, FL 33620 USA; [Passchier, Sandra] Montclair State Univ, Earth & Environm Studies, 252 Mallory Hall,1 Normal Ave, Montclair, NJ 07043 USA; [Pekar, Stephen F.] Queens Coll, Sch Earth & Environm Sci, 65-30 Kissena Blvd, Flushing, NY 11367 USA; [Pross, Jorg] Goethe Univ Frankfurt, Inst Geosciences, Paleoenvironmental Dynam Grp, Altenhoferallee 1, D-60438 Frankfurt, Germany; [Pross, Jorg] Biodivers & Climate Res Ctr, Senckenberganlage 25, D-60325 Frankfurt, Germany; [Rohl, Ursula] Univ Bremen, MARUM, Ctr Marine Environm Sci, Leobener Strasse, D-28359 Bremen, Germany; [Sakai, Toyosaburo] Utsunomiya Univ, Dept Geol, 350 Mine Machi, Utsunomiya, Tochigi 3218505, Japan; [Shrivastava, Prakash K.] Geol Survey India, Antarct Div, NH5P, NIT, Faridabad 121001, Harlyana, India; [Stickley, Catherine E.] Univ Tromso, Dept Geol, N-9037 Tromso, Norway; [Sugisaki, Saiko] Grad Univ Adv Study, Dept Polar Sci, 10-3 Midori Cho, Tachikawa, Tokyo 1908518, Japan; [Tauxe, Lisa] Univ Calif, Scripps Inst Oceanog, San Diego, CA 92093 USA; [Tuo, Shouting] Tongji Univ, Sch Ocean & Earth Sci, 1239 Spring Rd, Shanghai 200092, Peoples R China; [van de Flierdt, Tina] Imperial Coll London, Dept Earth Sci & Engn, London SW7 2AZ, England; [Welsh, Kevin] Univ Queensland, Sch Earth Sci, St Lucia, Qld 4072, Australia; [Yamane, Masako] Univ Tokyo, Earth & Planetary Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan; [Jimenez-Espejo, Francisco J.] CSIC Univ Granada, Inst Andaluz Ciencias Tierra, Armilla, Granada 18100, Spain; [Riesselman, Christina R.] Eastern Geol & Paleoclimate Sci Ctr, Natl Ctr, US Geol Survey, Reston, VA 20192 USA; [Sugisaki, Saiko] Japan Agcy Marine Earth Sci & Technol, Frontier Bldg 4F,2-15 Natsushima Cho, Yokosuka, Kanagawa 2370061, Japan	Goethe University Frankfurt; Utrecht University; Brandon University; NERC National Oceanography Centre; University of Southampton; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); University of Glasgow; University of Bremen; University of California System; University of California San Diego; Scripps Institution of Oceanography; GNS Science - New Zealand; Imperial College London; Durham University; UiT The Arctic University of Tromso; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Andaluz de Ciencias de la Tierra (IACT); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Andaluz de Ciencias de la Tierra (IACT); University of Granada; Texas A&M University System; Texas A&M University College Station; RWTH Aachen University; University of Glasgow; Colorado School of Mines; Stanford University; Western Michigan University; Kochi University; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Kochi University; Korea Institute of Geoscience & Mineral Resources (KIGAM); Victoria University Wellington; State University System of Florida; University of South Florida; Montclair State University; City University of New York (CUNY) System; Queens College NY (CUNY); Goethe University Frankfurt; University of Bremen; Utsunomiya University; Geological Survey India; UiT The Arctic University of Tromso; University of California System; University of California San Diego; Scripps Institution of Oceanography; Tongji University; Imperial College London; University of Queensland; University of Tokyo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Andaluz de Ciencias de la Tierra (IACT); University of Granada; United States Department of the Interior; United States Geological Survey; Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Pross, J (corresponding author), Goethe Univ Frankfurt, Inst Geosci, Paleoenvironm Dynam Grp, Altenhoferallee 1, D-60438 Frankfurt, Germany.	joerg.pross@em.uni-frankfurt.de	McKay, Robert/N-2449-2015; Escutia, Carlota/B-8614-2015; Greenwood, David R./C-2758-2008; Jimenez-Espejo, Francisco J/F-4486-2016; Passchier, Sandra/AAQ-2243-2021; Passchier, Sandra/B-1993-2008; Raine, James I/D-5124-2009; Welsh, Kevin/A-9808-2012; Jamieson, Stewart S.R./B-8330-2013; Röhl, Ursula/G-5986-2011; Jimenez-Espejo, Francisco J./AAR-2318-2020; Flores, Jose-Abel/D-4218-2009	McKay, Robert/0000-0002-5602-6985; Escutia, Carlota/0000-0002-4932-8619; Greenwood, David R./0000-0002-8569-9695; Jimenez-Espejo, Francisco J/0000-0002-0335-8580; Passchier, Sandra/0000-0001-7204-7025; Passchier, Sandra/0000-0001-7204-7025; Raine, James I/0000-0001-5294-2102; Welsh, Kevin/0000-0002-4834-4190; Jamieson, Stewart S.R./0000-0002-9036-2317; Röhl, Ursula/0000-0001-9469-7053; Brinkhuis, Henk/0000-0003-0253-6610; Iwai, Masao/0000-0001-7489-1262; Yamane, Masako/0000-0002-5063-0719; Bendle, James/0000-0002-6826-8658; Bijl, Peter/0000-0002-1710-4012; Dunbar, Robert/0000-0002-9728-5609; Flores, Jose-Abel/0000-0003-1909-293X; Riesselman, Christina/0000-0002-2436-4306	US National Science Foundation; German Research Foundation [PR 651/10, RO 1113/6]; Biodiversity and Climate Research Center of the Hessian Initiative for Scientific and Economic Excellence; Netherlands Organisation for Scientific Research; Natural Sciences and Engineering Research Council of Canada [DG 311934]; Natural Environment Research Council [Ne/J019801/1, Ne/I00646X/1, Ne/I006257/1]; US National Science Foundation [OCE 1058858]; New Zealand Ministry of Science and Innovation; Directorate For Geosciences [1129101] Funding Source: National Science Foundation; Natural Environment Research Council [NE/I00646X/1, NE/H014616/1, NE/J019801/1, NE/I006257/1, NE/H025162/1, NE/I00646X/2, NE/H020098/1, NE/H014144/1] Funding Source: researchfish; NERC [NE/H025162/1, NE/I00646X/1, NE/H014144/1, NE/H020098/1, NE/I006257/1, NE/I00646X/2, NE/H014616/1, NE/J019801/1] Funding Source: UKRI	US National Science Foundation(National Science Foundation (NSF)); German Research Foundation(German Research Foundation (DFG)); Biodiversity and Climate Research Center of the Hessian Initiative for Scientific and Economic Excellence; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); US National Science Foundation(National Science Foundation (NSF)); New Zealand Ministry of Science and Innovation; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research used samples and data provided by the Integrated Ocean Drilling Program (IODP). The IODP is sponsored by the US National Science Foundation and participating countries under the management of Joint Oceanographic Institutions, Inc. Financial support for this research was provided by the German Research Foundation, to J.P. (grant PR 651/10) and U. R. (grant RO 1113/6); the Biodiversity and Climate Research Center of the Hessian Initiative for Scientific and Economic Excellence, to J.P.; the Netherlands Organisation for Scientific Research, to H. B. and S. S. (VICI grant); the Natural Sciences and Engineering Research Council of Canada, to D. R. G. (grant DG 311934); the Natural Environment Research Council, to S. M. B. (grant Ne/J019801/1), J.A.B. (grant Ne/I00646X/1) and T.v.d.F. (grant Ne/I006257/1); the US National Science Foundation, to L. T. (grant OCE 1058858); and the New Zealand Ministry of Science and Innovation, to J.I.R.. We thank J. Francis, S. Gollner and M. Huber for discussions, and B. Coles, E. Hopmans, K. Kreissig, A. Mets, J. Ossebaar, B. Schminke, J. Treehorn and N. Welters for technical support.	Abbot DS, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032286; Abbot DS, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036703; Anderson JB, 2011, P NATL ACAD SCI USA, V108, P11356, DOI 10.1073/pnas.1014885108; Beerling DJ, 2011, NAT GEOSCI, V4, P418, DOI 10.1038/ngeo1186; Beerling DJ, 2002, ANN BOT-LONDON, V89, P329, DOI 10.1093/aob/mcf045; Bijl PK, 2009, NATURE, V461, P776, DOI 10.1038/nature08399; Bush MB, 1998, GLOBAL ECOL BIOGEOGR, V7, P379, DOI 10.2307/2997685; DeLucia EH, 1999, SCIENCE, V284, P1177, DOI 10.1126/science.284.5417.1177; Escutia C., 2011, P IODP, V318; Francis JE, 1996, TERRA ANTARCTICA, V3, P135; Greenwood DR, 2005, CAN J EARTH SCI, V42, P167, DOI 10.1139/E04-100; GREENWOOD DR, 1995, GEOLOGY, V23, P1044, DOI 10.1130/0091-7613(1995)023<1044:ECCALT>2.3.CO;2; Hay WW, 1999, GEOL S AM S, P1; Huber M, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001014; Huber M, 2011, CLIM PAST, V7, P603, DOI 10.5194/cp-7-603-2011; Kershaw A.P., 1988, VEGETATION HIST, P237; LARCHER W, 1981, Principes, V25, P143; Lear CH, 2000, SCIENCE, V287, P269, DOI 10.1126/science.287.5451.269; Meinshausen M, 2011, CLIMATIC CHANGE, V109, P213, DOI 10.1007/s10584-011-0156-z; Mosbrugger V, 1997, PALAEOGEOGR PALAEOCL, V134, P61, DOI 10.1016/S0031-0182(96)00154-X; Poole I, 2005, PALAEOGEOGR PALAEOCL, V222, P95, DOI 10.1016/j.palaeo.2005.03.011; READ J, 1992, PALAEOGEOGR PALAEOCL, V99, P271, DOI 10.1016/0031-0182(92)90019-2; Royer DL, 2002, GEOLOGY, V30, P963, DOI 10.1130/0091-7613(2002)030<0963:HCITFS>2.0.CO;2; Shellito CJ, 2003, PALAEOGEOGR PALAEOCL, V193, P113, DOI 10.1016/S0031-0182(02)00718-6; Thomas DJ, 2003, EARTH PLANET SC LETT, V209, P309, DOI 10.1016/S0012-821X(03)00096-7; Tjoelker MG, 2001, GLOBAL CHANGE BIOL, V7, P223, DOI 10.1046/j.1365-2486.2001.00397.x; Truswell EM, 2009, AUST SYST BOT, V22, P57, DOI 10.1071/SB08046; Wilson DS, 2012, PALAEOGEOGR PALAEOCL, V335, P24, DOI 10.1016/j.palaeo.2011.05.028; Yapp CJ, 2004, GEOCHIM COSMOCHIM AC, V68, P935, DOI 10.1016/j.gca.2003.09.002; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588	30	202	204	3	145	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 2	2012	488	7409					73	77		10.1038/nature11300	http://dx.doi.org/10.1038/nature11300			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ZE	22859204				2022-12-28	WOS:000307010700035
J	Venado, A; Prebil, S				Venado, Aida; Prebil, Sarah			Unexpected Swallowing of a Knife	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Venado, Aida; Prebil, Sarah] Emory Univ, Sch Med, Atlanta, GA 30322 USA	Emory University	Venado, A (corresponding author), Emory Univ, Sch Med, Atlanta, GA 30322 USA.								0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 2	2012	367	5					451	451		10.1056/NEJMicm1008826	http://dx.doi.org/10.1056/NEJMicm1008826			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	981VZ	22853016				2022-12-28	WOS:000307001900010
J	Woloshin, S; Schwartz, LM				Woloshin, Steven; Schwartz, Lisa M.			NOT SO STORIES How a charity oversells mammography	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BREAST-CANCER		[Woloshin, Steven; Schwartz, Lisa M.] Dept Vet Affairs Med Ctr, VA Outcomes Grp, White River Jct, VT 05009 USA; [Woloshin, Steven; Schwartz, Lisa M.] Dartmouth Inst Hlth Policy & Clin Practice, Ctr Med & Media, Lebanon, NH USA	VA Outcomes Group; Dartmouth College	Woloshin, S (corresponding author), Dept Vet Affairs Med Ctr, VA Outcomes Grp, White River Jct, VT 05009 USA.	Lisa.Schwartz@dartmouth.edu						Elmore G, 1998, NEW ENGL J MED, V338, P1089, DOI 10.1056/NEJM199804163381601; Esserman L, 2009, JAMA-J AM MED ASSOC, V302, P1685, DOI 10.1001/jama.2009.1498; Gotzsche PC, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub2; Hofvind S, 2008, JNCI-J NATL CANCER I, V100, P1082, DOI 10.1093/jnci/djn224; Kolata G, 2011, NY TIMES        0330, pA21; Nelson HD, SCREENING BREAST CAN; NHS Cancer Screening Programmes, 2011, BREAST CANC SCREEN I; Singer N, 2011, NY TIMES        0330; Susan G Komen for the Cure, AB US; Susan G Komen For the Cure, 2011, SG KOM CUR WORLDS LA; US Department of Health and Human Services, HEALTHF GOV NAT HLTH; Wegwarth O, 2012, ANN INTERN MED, V156, P340, DOI 10.7326/0003-4819-156-5-201203060-00005; Welch HG, 2007, ARCH INTERN MED, V167, P2289, DOI 10.1001/archinte.167.21.2289; Welch HG, 2000, JAMA-J AM MED ASSOC, V283, P2975, DOI 10.1001/jama.283.22.2975; Zackrisson S, 2006, BRIT MED J, V332, P689, DOI 10.1136/bmj.38764.572569.7C	15	38	39	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 2	2012	345								e5132	10.1136/bmj.e5132	http://dx.doi.org/10.1136/bmj.e5132			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	985XE	22859787				2022-12-28	WOS:000307303000001
J	Hirschtick, RE				Hirschtick, Robert E.			John Lennon's Elbow	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Hirschtick, RE (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA.	rober@northwestern.edu						Hirschtick R., SLOPPY AND PASTE; Oxentenko AS, 2010, ARCH INTERN MED, V170, P377, DOI 10.1001/archinternmed.2009.534	2	28	28	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2012	308	5					463	464		10.1001/jama.2012.8331	http://dx.doi.org/10.1001/jama.2012.8331			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	981DQ	22851112				2022-12-28	WOS:000306947400023
J	Zeljkovic, I; Xu, ZJ; Wen, JS; Gu, GD; Markiewicz, RS; Hoffman, JE				Zeljkovic, Ilija; Xu, Zhijun; Wen, Jinsheng; Gu, Genda; Markiewicz, Robert S.; Hoffman, Jennifer E.			Imaging the Impact of Single Oxygen Atoms on Superconducting Bi2+ySr2-yCaCu2O8+x	SCIENCE			English	Article							QUASI-PARTICLE INTERFERENCE; BI2SR2CACU2O8+DELTA; TEMPERATURE; INHOMOGENEITY; EXCITATIONS; PSEUDOGAP; MECHANISM; SCALE; GAP; TC	High-temperature cuprate superconductors display unexpected nanoscale inhomogeneity in essential properties such as pseudogap energy, Fermi surface, and even superconducting critical temperature. Theoretical explanations for this inhomogeneity have ranged from chemical disorder to spontaneous electronic phase separation. We extend the energy range of scanning tunneling spectroscopy on Bi2+ySr2-yCaCu2O8+x, allowing a complete mapping of two types of interstitial oxygen dopants and vacancies at the apical oxygen site. We show that the nanoscale spatial variations in the pseudogap states are correlated with disorder in these dopant concentrations, particularly that of apical oxygen vacancies.	[Zeljkovic, Ilija; Hoffman, Jennifer E.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Xu, Zhijun; Wen, Jinsheng; Gu, Genda] Brookhaven Natl Lab, Condensed Matter Phys & Mat Sci Dept, Upton, NY 11973 USA; [Markiewicz, Robert S.] Northeastern Univ, Dept Phys, Boston, MA 02115 USA	Harvard University; United States Department of Energy (DOE); Brookhaven National Laboratory; Northeastern University	Hoffman, JE (corresponding author), Harvard Univ, Dept Phys, 17 Oxford St, Cambridge, MA 02138 USA.	jhoffman@physics.harvard.edu	Wen, Jinsheng/F-4209-2010; xu, zhijun/A-3264-2013; Zeljkovic, Ilija/N-9439-2013; Hoffman, Jennifer E/H-4334-2011	Wen, Jinsheng/0000-0001-5864-1466; xu, zhijun/0000-0001-7486-2015; Hoffman, Jennifer E/0000-0003-2752-5379; Zeljkovic, Ilija/0000-0001-9966-2140; XU, ZHIJUN/0000-0002-4960-3801	NSF CAREER [DMR-0847433]; AFOSR PECASE [FA9550-06-1-0531]; U.S. Department of Energy (DOE) [DE-AC02-98CH10886]; DOE [DE-FG02-07ER46352]; Direct For Mathematical & Physical Scien [0847433] Funding Source: National Science Foundation	NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); AFOSR PECASE; U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); DOE(United States Department of Energy (DOE)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank A. Bansil, I. Bozovic, S. Davis, E. Hudson, P. Hirschfeld, A. Kapitulnik, D.-H. Lee, and J. Nieminen for useful discussions. J. E. H. acknowledges support from the NSF CAREER grant DMR-0847433 and AFOSR PECASE grant FA9550-06-1-0531. G. D. G. acknowledges support from the U.S. Department of Energy (DOE) under contract DE-AC02-98CH10886. R. S. M. acknowledges support from the DOE under contract DE-FG02-07ER46352.	BEDNORZ JG, 1986, Z PHYS B CON MAT, V64, P189, DOI 10.1007/BF01303701; Berg E, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.094509; Boyer MC, 2007, NAT PHYS, V3, P802, DOI 10.1038/nphys725; Chen W, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/3/033004; Dagotto E, 2005, SCIENCE, V309, P257, DOI 10.1126/science.1107559; Emery VJ, 1997, PHYS REV B, V56, P6120, DOI 10.1103/PhysRevB.56.6120; Gomes KK, 2007, NATURE, V447, P569, DOI 10.1038/nature05881; Goren L, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.094508; Hanaguri T, 2007, NAT PHYS, V3, P865, DOI 10.1038/nphys753; Hoffman JE, 2002, SCIENCE, V295, P466, DOI 10.1126/science.1066974; Hoffman JE, 2002, SCIENCE, V297, P1148, DOI 10.1126/science.1072640; Hufner S, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/6/062501; Kinoda G, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.020502; Kinoda G, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.224509; Kohsaka Y, 2008, NATURE, V454, P1072, DOI 10.1038/nature07243; Kondo T, 2009, NATURE, V457, P296, DOI 10.1038/nature07644; Lang KM, 2002, NATURE, V415, P412, DOI 10.1038/415412a; Martin I, 2001, PHYSICA C, V357, P46, DOI 10.1016/S0921-4534(01)00192-7; McElroy K, 2005, SCIENCE, V309, P1048, DOI 10.1126/science.1113095; McElroy K, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.197005; MITZI DB, 1990, PHYS REV B, V41, P6564, DOI 10.1103/PhysRevB.41.6564; Nunner TS, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.177003; OHTA Y, 1991, PHYS REV B, V43, P2968, DOI 10.1103/PhysRevB.43.2968; Pan SH, 2001, NATURE, V413, P282, DOI 10.1038/35095012; Parker CV, 2010, NATURE, V468, P677, DOI 10.1038/nature09597; Pavarini E, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.047003; PRESLAND MR, 1991, PHYSICA C, V176, P95, DOI 10.1016/0921-4534(91)90700-9; Pushp A, 2009, SCIENCE, V324, P1689, DOI 10.1126/science.1174338; Wise WD, 2009, NAT PHYS, V5, P213, DOI 10.1038/NPHYS1197; ZECH D, 1994, NATURE, V371, P681, DOI 10.1038/371681a0; Zhou S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.076401	32	70	70	5	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2012	337	6092					320	323		10.1126/science.1218648	http://dx.doi.org/10.1126/science.1218648			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975WQ	22822144				2022-12-28	WOS:000306542600045
J	Anderson, JG; Wilmouth, DM; Smith, JB; Sayres, DS				Anderson, James G.; Wilmouth, David M.; Smith, Jessica B.; Sayres, David S.			UV Dosage Levels in Summer: Increased Risk of Ozone Loss from Convectively Injected Water Vapor	SCIENCE			English	Article							IN-SITU MEASUREMENTS; ANTARCTIC OZONE; LOWER STRATOSPHERE; DEPLETION; RADICALS; CHLORINE; VORTEX; OH; REDUCTIONS; EVOLUTION	The observed presence of water vapor convectively injected deep into the stratosphere over the United States can fundamentally change the catalytic chlorine/bromine free-radical chemistry of the lower stratosphere by shifting total available inorganic chlorine into the catalytically active free-radical form, ClO. This chemical shift markedly affects total ozone loss rates and makes the catalytic system extraordinarily sensitive to convective injection into the mid-latitude lower stratosphere in summer. Were the intensity and frequency of convective injection to increase as a result of climate forcing by the continued addition of CO2 and CH4 to the atmosphere, increased risk of ozone loss and associated increases in ultraviolet dosage would follow.	[Anderson, James G.] Harvard Univ, Dept Chem & Chem Biol, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Anderson, JG (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA.	anderson@huarp.harvard.edu		Smith, Jessica/0000-0003-2070-1894	NASA	NASA(National Aeronautics & Space Administration (NASA))	We acknowledge those who have been central to the design of the flight instruments associated with these observations: J. Demusz, N. Allen, C. Tuozzolo, M. Greenberg, M. Rivero, T. Hanisco, J. Paul, L. Moyer, F. Keutsch, and M. Witinski. This research was supported by the NASA Upper Atmosphere Research Program under the technical oversight of K. Jucks.	ANDERSON JG, 1989, J GEOPHYS RES-ATMOS, V94, P11465, DOI 10.1029/JD094iD09p11465; ANDERSON JG, 1991, SCIENCE, V251, P39, DOI 10.1126/science.251.4989.39; ANDERSON JG, 1993, GEOPHYS RES LETT, V20, P2499, DOI 10.1029/93GL03118; COHEN RC, 1994, GEOPHYS RES LETT, V21, P2539, DOI 10.1029/94GL01713; Crutzen PJ, 2006, CLIMATIC CHANGE, V77, P211, DOI 10.1007/s10584-006-9101-y; Dessler AE, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2007JD008609; Dessler AE, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD012075; Dessler AE, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD005209; Diepgen TL, 2002, BRIT J DERMATOL, V146, P1, DOI 10.1046/j.1365-2133.146.s61.2.x; Drdla K., 2010, ATMOS CHEM PHYS DISC, V10, P28687, DOI DOI 10.5194/ACPD-10-28687-2010; Drdla K., 2005, EOS T AGU, V86, pA31D; FARMAN JC, 1985, NATURE, V315, P207, DOI 10.1038/315207a0; Hanisco TF, 2001, J PHYS CHEM A, V105, P1543, DOI 10.1021/jp002334g; Hanisco TF, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL027899; HOFMANN DJ, 1987, NATURE, V326, P59, DOI 10.1038/326059a0; Keim ER, 1996, GEOPHYS RES LETT, V23, P3223, DOI 10.1029/96GL02593; Keith DW, 2010, NATURE, V463, P426, DOI 10.1038/463426a; Keith DW, 2000, J GEOPHYS RES-ATMOS, V105, P15167, DOI 10.1029/2000JD900130; Kirk-Davidoff DB, 1999, NATURE, V402, P399, DOI 10.1038/46521; Lanzendorf EJ, 2001, J PHYS CHEM A, V105, P1535, DOI 10.1021/jp002384l; Liu CT, 2008, J APPL METEOROL CLIM, V47, P2712, DOI 10.1175/2008JAMC1890.1; Manney GL, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002634; Manney GL, 2011, NATURE, V478, P469, DOI 10.1038/nature10556; MCELROY MB, 1986, NATURE, V321, P759, DOI 10.1038/321759a0; MOLINA LT, 1987, J PHYS CHEM-US, V91, P433, DOI 10.1021/j100286a035; Moyer EJ, 1996, GEOPHYS RES LETT, V23, P2385, DOI 10.1029/96GL01489; NEWMAN P, 1991, GEOPHYS RES LETT, V18, P661, DOI 10.1029/91GL00546; Newman P. A., 2007, SCI ASSESSMENT OZONE; Newman PA, 1997, GEOPHYS RES LETT, V24, P2689, DOI 10.1029/97GL52831; Newman PA, 2001, GEOPHYS RES LETT, V28, P959, DOI 10.1029/2000GL011972; NEWMAN PA, 2003, SCI ASSESSMENT OZONE, pCH3; Peter T., 2012, STRATOSPHERIC OZONE, P4, DOI DOI 10.1039/9781849733182-00214; POLLOCK W, 1980, J GEOPHYS RES-OCEANS, V85, P5555, DOI 10.1029/JC085iC10p05555; Salawitch RJ, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021504; Sander S. P., 2011, JPL PUB, V10-6, P1; Sayres DS, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013100; Shi Q, 2001, J GEOPHYS RES-ATMOS, V106, P24259, DOI 10.1029/2000JD000181; Sloan LC, 1998, GEOPHYS RES LETT, V25, P3517, DOI 10.1029/98GL02492; Smith J., 2012, THESIS HARVARD U; Solomon S, 1999, REV GEOPHYS, V37, P275, DOI 10.1029/1999RG900008; SOLOMON S, 1986, NATURE, V321, P755, DOI 10.1038/321755a0; STIMPFLE RM, 1994, GEOPHYS RES LETT, V21, P2543, DOI 10.1029/94GL02373; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; Thornton BF, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007640; Trapp RJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036203; Van Klooster SL, 2009, J CLIMATE, V22, P3317, DOI 10.1175/2009JCLI2697.1; Weinstock MA, 1995, ENVIRON HEALTH PERSP, V103, P251, DOI 10.2307/3432320; WENNBERG PO, 1994, SCIENCE, V266, P398, DOI 10.1126/science.266.5184.398; Wilmouth DM, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006951	49	142	146	4	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2012	337	6096					835	839		10.1126/science.1222978	http://dx.doi.org/10.1126/science.1222978			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	989BQ	22837384				2022-12-28	WOS:000307535600041
J	Chu, S; Majumdar, A				Chu, Steven; Majumdar, Arun			Opportunities and challenges for a sustainable energy future	NATURE			English	Review							FUEL-CELL; LIFE-CYCLE; TECHNOLOGIES; SYSTEMS	Access to clean, affordable and reliable energy has been a cornerstone of the world's increasing prosperity and economic growth since the beginning of the industrial revolution. Our use of energy in the twenty-first century must also be sustainable. Solar and water-based energy generation, and engineering of microbes to produce biofuels are a few examples of the alternatives. This Perspective puts these opportunities into a larger context by relating them to a number of aspects in the transportation and electricity generation sectors. It also provides a snapshot of the current energy landscape and discusses several research and development opportunities and pathways that could lead to a prosperous, sustainable and secure energy future for the world.	[Chu, Steven; Majumdar, Arun] US DOE, Washington, DC 20585 USA	United States Department of Energy (DOE)	Chu, S (corresponding author), US DOE, 1000 Independence Ave SW, Washington, DC 20585 USA.	the.secretary@hq.doe.gov; 4majumdar.pubs@gmail.com	Molina, Carolina/E-3898-2015	Molina, Carolina/0000-0001-6659-994X; Majumdar, Arunava/0000-0003-4226-9705				Abbas HF, 2010, INT J HYDROGEN ENERG, V35, P1160, DOI 10.1016/j.ijhydene.2009.11.036; Advanced Research Projects Agency-Energy, 2010, ARPA E EFF POW CONV; Advanced Research Projects Agency-Energy, 2010, GRID SCAL REN EN STO; America's Energy Future Panel, 2009, LIQ TRANSP FUELS; American Physical Society,, 2011, DIR AIR CAPT CO2 CHE; Angel R., 2011, US Patent Application, Patent No. 20120125400; [Anonymous], 2012, MAN RISKS EXTR EV DI; [Anonymous], 2012, SOL UNV ULTR HIGH PE; [Anonymous], 2012, US SOL MARK INS REP; Bader SD, 2006, REV MOD PHYS, V78, P1, DOI 10.1103/RevModPhys.78.1; Baziliana M., 2012, RECONSIDERING EC PHO; Bloomberg New Energy Finance, 2012, LEV COST EN UPD Q3 2; Bolinger M, 2012, ENERG POLICY, V42, P628, DOI 10.1016/j.enpol.2011.12.036; BP, 2021, BPS STAT REV WORLD E; Chan CC, 2007, P IEEE, V95, P704, DOI 10.1109/JPROC.2007.892489; Chu S., 2010, WALL STREET J   0323; Committee on America's Energy Future National Academy of Sciences National Academy of Engineering and National Research Council, 2009, AM EN FUT TECHN TRAN; Conrado R. J., 2012, ELECTROFUELS NEW PAR; Cuddy M.R., 1997, ANAL FUEL EC BENEFIT; David E, 2005, J MATER PROCESS TECH, V162, P169, DOI 10.1016/j.jmatprotec.2005.02.027; Debe MK, 2012, NATURE, V486, P43, DOI 10.1038/nature11115; Deutch John M, 2009, UPDATE MIT 2003 FUTU; Energy Information Administration, 2010, ANN EN REV 2010; Environmental Protection Agency, 2010, REN FUEL STAND PROGR; Galen Barbose G., 2011, TRACKING SUN HIST SU; Garland JW, 2011, J APPL PHYS, V109, DOI 10.1063/1.3582902; Georgianna DR, 2012, NATURE, V488, P329, DOI 10.1038/nature11479; Gibbs J., 2012, FUNDAMENTALS MAT ENE, P426; Graetzel M, 2012, NATURE, V488, P304, DOI 10.1038/nature11476; Gur I, 2012, SCIENCE, V335, P1454, DOI 10.1126/science.1218761; Hand M.M., 2012, NAT RENEW ENERGY LAB, V4; Holmberg K, 2012, TRIBOL INT, V47, P221, DOI 10.1016/j.triboint.2011.11.022; Inderwildi O., 2012, ENERGY TRANSP ENV, DOI DOI 10.1007/978-1-4471-2717-8_19; International Energy Agency, 2010, TECHN ROADM NUCL EN; International Energy Agency, 2011, WORLD EN OUTL 2011, P180; International Energy Agency, 2011, WORLD EN OUTL 2011, P546; International Energy Agency, 2011, WORLD EN OUTL 2011, p[179, 186]; Ji NA, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3560051; KOMURO M, 1990, J APPL PHYS, V67, P5126, DOI 10.1063/1.344689; Krupnick A.J, 2011, WILL NATURAL GAS VEH; Lee R, 2011, SCIENCE, V333, P569, DOI 10.1126/science.1208859; Lukic SM, 2008, IEEE T IND ELECTRON, V55, P2258, DOI 10.1109/TIE.2008.918390; Manley DK, 2008, PHYS TODAY, V61, P47, DOI 10.1063/1.3027991; Maugeri L., 2012, OIL NEXT REVOLUTION; Mavrokefalos A, 2012, NANO LETT, V12, P2792, DOI 10.1021/nl2045777; McCone A., 2012, ELECT VEHICLE BATTER; Miller OD, 2012, IEEE J PHOTOVOLT, V2, P303, DOI 10.1109/JPHOTOV.2012.2198434; Munich Re, 2012, TOP GEO; Murray LJ, 2009, CHEM SOC REV, V38, P1294, DOI 10.1039/b802256a; NACS, 2011, KEY FACTS FIG; National Research Council, 2008, MINERALS CRITICAL MI; Nuclear Energy Institute, 2012, COSTS FUEL OP WAST D; Nuclear Energy Institute, 2012, COST NEW GEN CAP PER; Paster MD, 2011, INT J HYDROGEN ENERG, V36, P14534, DOI 10.1016/j.ijhydene.2011.07.056; Peralta-Yahya PP, 2012, NATURE, V488, P320, DOI 10.1038/nature11478; Powers WF, 2000, ADV MATER PROCESS, V157, P38; Pruess K, 2006, GEOTHERMICS, V35, P351, DOI 10.1016/j.geothermics.2006.08.002; Rao R. A., 2011, 37 IEEE PHOT SPEC C, P1504; Ruhl C., 2012, EN 2011 DISR CONT BP; Sachs E. M., 2012, US Patent Application, Patent No. 20120067273; Schafer A, 2006, ENERGY, V31, P2064, DOI 10.1016/j.energy.2005.09.011; Scrosati B, 2010, J POWER SOURCES, V195, P2419, DOI 10.1016/j.jpowsour.2009.11.048; Spendelow JS, 2011, FUEL CELLS, V11, P775, DOI 10.1002/fuce.201000189; Stoddard N., 2008, P 18 NREL WORKSH CRY, P7; Stratton RW, 2011, ENVIRON SCI TECHNOL, V45, P4637, DOI 10.1021/es102597f; Swanson R. M., 2012, DOE SUNSHOT GRAND CH; Swanson RM, 2005, IEEE PHOT SPEC CONF, P889, DOI 10.1109/PVSC.2005.1488274; Turner NJ, 2009, NAT CHEM BIOL, V5, P568, DOI 10.1038/nchembio.203; U. S. Department of Energy, 2010, CRIT MAT STRAT; United Nations Environment Programme, 2009, SUST PROD US RES ASS; US Department of Energy, 2011, QUADR TECHN REV REP, VII; US Department of Energy, CONS ADV SIM LWRS PR; US Department of Energy, 2012, SUNSHOT IN; US Department of Energy, 2012, SMALL MOD REACT FACT; US Department of Energy, 2012, SUNSHOT VIS STUD; US Department of Energy, 2011, REP 1 QUAD TECHN REV; US Energy Information Administration, 2011, ANN EN OUTL 2011 LEV; Wiser R, 2012, RECENT DEV LEVELIZED; Worldwach Institute, 2007, BIOF TRANSP; Yang JH, 2006, MRS BULL, V31, P224, DOI 10.1557/mrs2006.49; Yang J, 2010, CHEM SOC REV, V39, P656, DOI 10.1039/b802882f; Zhu XG, 2008, CURR OPIN BIOTECH, V19, P153, DOI 10.1016/j.copbio.2008.02.004	82	6168	6304	424	5049	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2012	488	7411					294	303		10.1038/nature11475	http://dx.doi.org/10.1038/nature11475			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OS	22895334				2022-12-28	WOS:000307501000028
J	Stalmans, P; Benz, MS; Gandorfer, A; Kampik, A; Girach, A; Pakola, S; Haller, JA				Stalmans, Peter; Benz, Matthew S.; Gandorfer, Arnd; Kampik, Anselm; Girach, Aniz; Pakola, Stephen; Haller, Julia A.		MIVI-TRUST Study Grp	Enzymatic Vitreolysis with Ocriplasmin for Vitreomacular Traction and Macular Holes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POSTERIOR VITREOUS DETACHMENT; OPTICAL COHERENCE TOMOGRAPHY; VITREORETINAL INTERFACE; PHARMACOLOGICAL VITREOLYSIS; CATARACT-SURGERY; MICROPLASMIN; ADHESION; DEGENERATION; VITRECTOMY; INJECTION	BACKGROUND Vitreomacular adhesion can lead to pathologic traction and macular hole. The standard treatment for severe, symptomatic vitreomacular adhesion is vitrectomy. Ocriplasmin is a recombinant protease with activity against fibronectin and laminin, components of the vitreoretinal interface. METHODS We conducted two multicenter, randomized, double-blind, phase 3 clinical trials to compare a single intravitreal injection of ocriplasmin (125 mu g) with a placebo injection in patients with symptomatic vitreomacular adhesion. The primary end point was resolution of vitreomacular adhesion at day 28. Secondary end points were total posterior vitreous detachment and nonsurgical closure of a macular hole at 28 days, avoidance of vitrectomy, and change in best-corrected visual acuity. RESULTS Overall, 652 eyes were treated: 464 with ocriplasmin and 188 with placebo. Vitreomacular adhesion resolved in 26.5% of ocriplasmin-injected eyes and in 10.1% of placebo-injected eyes (P < 0.001). Total posterior vitreous detachment was more prevalent among the eyes treated with ocriplasmin than among those injected with placebo (13.4% vs. 3.7%, P < 0.001). Nonsurgical closure of macular holes was achieved in 40.6% of ocriplasmin-injected eyes, as compared with 10.6% of placebo-injected eyes (P < 0.001). The best-corrected visual acuity was more likely to improve by a gain of at least three lines on the eye chart with ocriplasmin than with placebo. Ocular adverse events (e.g., vitreous floaters, photopsia, or injection-related eye pain - all self-reported - or conjunctival hemorrhage) occurred in 68.4% of ocriplasmin-injected eyes and in 53.5% of placebo-injected eyes (P < 0.001), and the incidence of serious ocular adverse events was similar in the two groups (P = 0.26). CONCLUSIONS Intravitreal injection of the vitreolytic agent ocriplasmin resolved vitreomacular traction and closed macular holes in significantly more patients than did injection of placebo and was associated with a higher incidence of ocular adverse events, which were mainly transient. (Funded by ThromboGenics; ClinicalTrials.gov numbers, NCT00781859 and NCT00798317.)	[Haller, Julia A.] Wills Eye Inst, Philadelphia, PA 19107 USA; [Stalmans, Peter] Univ Ziekenhuizen Leuven, Dept Ophthalmol, Louvain, Belgium; [Benz, Matthew S.] Retina Consultants Houston, Houston, TX USA; [Gandorfer, Arnd; Kampik, Anselm] Klinikum Univ Munich, Dept Ophthalmol, Munich, Germany; [Gandorfer, Arnd] Med Versorgungszentrum, Memmingen, Germany; [Girach, Aniz; Pakola, Stephen] Thrombogenics, Heverlee, Belgium	Jefferson University; KU Leuven; University Hospital Leuven; University of Munich	Haller, JA (corresponding author), Wills Eye Inst, 840 Walnut St,Suite 1510, Philadelphia, PA 19107 USA.	jhaller@willseye.org	Huang, Jinhai/ABH-4519-2020; Heimann, Heinrich/AAP-8747-2020; Marticorena, Joaquín/AGZ-4368-2022	Heimann, Heinrich/0000-0002-3298-4644; Gaudric, Alain/0000-0002-2486-4722; Ciulla, Thomas/0000-0001-5557-6777	ThromboGenics, Belgium	ThromboGenics, Belgium	Supported by ThromboGenics, Belgium.	Age-Related Eye Disease Study Research Group, 2001, AM J OPHTHALMOL, V131, P167, DOI [10.1016/s0002-9394(00)00732-7, DOI 10.1016/S0002-9394(00)00732-7]; Benz MS, 2010, OPHTHALMOLOGY, V117, P791, DOI 10.1016/j.ophtha.2009.11.005; Bishop PN, 2000, PROG RETIN EYE RES, V19, P323, DOI 10.1016/S1350-9462(99)00016-6; de Smet MD, 2009, OPHTHALMOLOGY, V116, P1349, DOI 10.1016/j.ophtha.2009.03.051; de Smet MD, 2009, INVEST OPHTH VIS SCI, V50, P814, DOI 10.1167/iovs.08-2185; DiBernardo C., 1998, OPHTHALMIC ULTRASOUN; Ehlies F, 2006, RETINAL IMAGING, P81; FOOS RY, 1982, OPHTHALMOLOGY, V89, P1502; Gandorfer A, 2004, INVEST OPHTH VIS SCI, V45, P641, DOI 10.1167/iovs.03-0930; Gandorfer A, 2009, DEV OPHTHALMOL, V44, P26, DOI 10.1159/000223942; Gass JDM., 1997, DIAGNOSIS TREATMENT, V4th edition; Hikichi T, 1997, OPHTHALMOLOGY, V104, P473, DOI 10.1016/S0161-6420(97)30289-9; Ivastinovic D, 2012, AM J OPHTHALMOL, V153, P705, DOI 10.1016/j.ajo.2011.09.009; Johnson MW, 2010, AM J OPHTHALMOL, V149; Krebs I, 2007, AM J OPHTHALMOL, V144, P741, DOI 10.1016/j.ajo.2007.07.024; Le Goff MM, 2008, EYE, V22, P1214, DOI 10.1038/eye.2008.21; Mangione C., 2000, NATL EYE I 25 ITEM V; Mangione CM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1050, DOI 10.1001/archopht.119.7.1050; Mirshahi A, 2009, J CATARACT REFR SURG, V35, P987, DOI 10.1016/j.jcrs.2009.02.016; Mojana F, 2008, AM J OPHTHALMOL, V146, P218, DOI 10.1016/j.ajo.2008.04.027; Orr P, 2011, INVEST OPHTH VIS SCI, V52, P3354, DOI 10.1167/iovs.10-5645; Ponsioen TL, 2010, PROG RETIN EYE RES, V29, P580, DOI 10.1016/j.preteyeres.2010.07.001; Rheaume MA, 2010, SEMIN OPHTHALMOL, V25, P295, DOI 10.3109/08820538.2010.518865; Rouvas A, 2008, EUR J OPHTHALMOL, V18, P301, DOI 10.1177/112067210801800223; Sebag J, 2004, GRAEF ARCH CLIN EXP, V242, P690, DOI 10.1007/s00417-004-0980-1; SEBAG J, 1991, ARCH OPHTHALMOL-CHIC, V109, P966, DOI 10.1001/archopht.1991.01080070078039; Sebag J, 2009, RETINA-J RET VIT DIS, V29, P871, DOI 10.1097/IAE.0b013e3181ac7b3c; Sheard RM, 2003, J CATARACT REFR SURG, V29, P930, DOI 10.1016/S0886-3350(02)01837-0; Sivaprasad S, 2008, RETINA-J RET VIT DIS, V28, P1435, DOI 10.1097/IAE.0b013e31817f2dae; Stalmans P, 2010, RETINA-J RET VIT DIS, V30, P1122, DOI 10.1097/IAE.0b013e3181e0970a; VERSTRAETEN TC, 1993, ARCH OPHTHALMOL-CHIC, V111, P849, DOI 10.1001/archopht.1993.01090060139038	31	399	416	1	48	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 16	2012	367	7					606	615		10.1056/NEJMoa1110823	http://dx.doi.org/10.1056/NEJMoa1110823			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988NB	22894573	Green Published			2022-12-28	WOS:000307496600004
J	Chu, JH; Kuo, HH; Analytis, JG; Fisher, IR				Chu, Jiun-Haw; Kuo, Hsueh-Hui; Analytis, James G.; Fisher, Ian R.			Divergent Nematic Susceptibility in an Iron Arsenide Superconductor	SCIENCE			English	Article							ELECTRONIC NEMATICITY; STATE; TEMPERATURE	Within the Landau paradigm of continuous phase transitions, ordered states of matter are characterized by a broken symmetry. Although the broken symmetry is usually evident, determining the driving force behind the phase transition can be complicated by coupling between distinct order parameters. We show how measurement of the divergent nematic susceptibility of the iron pnictide superconductor Ba(Fe1-xCox)(2)As-2 distinguishes an electronic nematic phase transition from a simple ferroelastic distortion. These measurements also indicate an electronic nematic quantum phase transition near the composition with optimal superconducting transition temperature.	[Chu, Jiun-Haw; Kuo, Hsueh-Hui; Analytis, James G.; Fisher, Ian R.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Chu, Jiun-Haw; Kuo, Hsueh-Hui; Analytis, James G.; Fisher, Ian R.] Stanford Univ, Geballe Lab Adv Mat, Stanford, CA 94305 USA; [Chu, Jiun-Haw; Kuo, Hsueh-Hui; Analytis, James G.; Fisher, Ian R.] SLAC Natl Accelerator Lab, Stanford Inst Mat & Energy Sci, Menlo Pk, CA 94025 USA	Stanford University; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Chu, JH (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	jhchu@berkeley.edu; irfisher@stanford.edu	analytis, james/ABE-6100-2020; Chu, Jiun-Haw/B-1613-2012	analytis, james/0000-0002-7657-7688; Chu, Jiun-Haw/0000-0001-6222-1210; Fisher, Ian/0000-0002-1278-7862	U.S. Department of Energy, Office of Basic Energy Sciences [DE-AC02-76SF00515]	U.S. Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE))	The authors thank A. Cano, C.-C. Chen, P. Coleman, R. M. Fernandes, S. A. Kivelson, A. Mackenzie, I. Paul, and Q. Si for helpful discussions. This work is supported by the U.S. Department of Energy, Office of Basic Energy Sciences, under contract no. DE-AC02-76SF00515.	Ando Y, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.137005; Borzi RA, 2007, SCIENCE, V315, P214, DOI 10.1126/science.1134796; Cano A, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.020408; Chen CC, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.100504; Chu JH, 2010, SCIENCE, V329, P824, DOI 10.1126/science.1190482; Daou R, 2010, NATURE, V463, P519, DOI 10.1038/nature08716; Fernandes RM, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.157003; Fernandes RM, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.217002; Fisher IR, 2011, REP PROG PHYS, V74, DOI 10.1088/0034-4885/74/12/124506; Fradkin E, 2010, ANNU REV CONDEN MA P, V1, P153, DOI 10.1146/annurev-conmatphys-070909-103925; Hinkov V, 2008, SCIENCE, V319, P597, DOI 10.1126/science.1152309; Kasahara S, 2012, NATURE, V486, P382, DOI 10.1038/nature11178; Lawler MJ, 2010, NATURE, V466, P347, DOI 10.1038/nature09169; Lilly MP, 1999, PHYS REV LETT, V82, P394, DOI 10.1103/PhysRevLett.82.394; Lv WC, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.174512; Shayegan M, 2003, APPL PHYS LETT, V83, P5235, DOI 10.1063/1.1635963; Stingl C, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.026404; Tanatar MA, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.184508; Yoshizawa M, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.024604	20	398	402	12	185	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2012	337	6095					710	712		10.1126/science.1221713	http://dx.doi.org/10.1126/science.1221713			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986PE	22879513	Green Submitted			2022-12-28	WOS:000307354500048
J	Alves, M; Canoui, E; Deforges, L; Garderet, L; Guidet, B; Offenstadt, G; Maury, E				Alves, Mikael; Canoui, Etienne; Deforges, Lionel; Garderet, Laurent; Guidet, Bertrand; Offenstadt, Georges; Maury, Eric			An unexpected trismus	LANCET			English	Editorial Material							TETANUS		[Alves, Mikael; Canoui, Etienne; Guidet, Bertrand; Offenstadt, Georges; Maury, Eric] Hosp St Antoine, Med Intens Care Unit, F-75571 Paris, France; [Garderet, Laurent] Hosp St Antoine, Dept Haematol, F-75571 Paris, France; [Guidet, Bertrand; Offenstadt, Georges; Maury, Eric] Hosp St Antoine, INSERM, UMR S707, F-75571 Paris, France; [Deforges, Lionel] Hosp Henri Mondor, Dept Bacteriol, Creteil, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Alves, M (corresponding author), Hosp St Antoine, Med Intens Care Unit, 184 Rue Fauborg St Antoine, F-75571 Paris, France.	mikael.alves@sat.aphp.fr						Cooke MW, 2009, EMERG MED J, V26, P845, DOI 10.1136/emj.2008.070268; McQuillan GM, 2002, ANN INTERN MED, V136, P660, DOI 10.7326/0003-4819-136-9-200205070-00008; Pescovitz MD, 2011, J ALLERGY CLIN IMMUN, V128, P1295, DOI 10.1016/j.jaci.2011.08.008; Van Damme P, 2011, VACCINE, V29, P5932, DOI 10.1016/j.vaccine.2011.06.049; van Tilburg CM, 2006, LEUKEMIA, V20, P1717, DOI 10.1038/sj.leu.2404326	5	6	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 4	2012	380	9840					536	536		10.1016/S0140-6736(12)60524-8	http://dx.doi.org/10.1016/S0140-6736(12)60524-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	983GY	22863054				2022-12-28	WOS:000307109000034
J	Wen, Q; Goldenson, B; Silver, SJ; Schenone, M; Dancik, V; Huang, Z; Wang, LZ; Lewis, TA; An, WF; Li, XY; Bray, MA; Thiollier, C; Diebold, L; Gilles, L; Vokes, MS; Moore, CB; Bliss-Moreau, M; VerPlank, L; Tolliday, NJ; Mishra, R; Vemula, S; Shi, JJ; Wei, L; Kapur, R; Lopez, CK; Gerby, B; Ballerini, P; Pflumio, F; Gilliland, DG; Goldberg, L; Birger, Y; Izraeli, S; Gamis, AS; Smith, FO; Woods, WG; Taub, J; Scherer, CA; Bradner, JE; Goh, BC; Mercher, T; Carpenter, AE; Gould, RJ; Clemons, PA; Carr, SA; Root, DE; Schreiber, SL; Stern, AM; Crispino, JD				Wen, Qiang; Goldenson, Benjamin; Silver, Serena J.; Schenone, Monica; Dancik, Vlado; Huang, Zan; Wang, Ling-Zhi; Lewis, Timothy A.; An, W. Frank; Li, Xiaoyu; Bray, Mark-Anthony; Thiollier, Clarisse; Diebold, Lauren; Gilles, Laure; Vokes, Martha S.; Moore, Christopher B.; Bliss-Moreau, Meghan; VerPlank, Lynn; Tolliday, Nicola J.; Mishra, Rama; Vemula, Sasidhar; Shi, Jianjian; Wei, Lei; Kapur, Reuben; Lopez, Cecile K.; Gerby, Bastien; Ballerini, Paola; Pflumio, Francoise; Gilliland, D. Gary; Goldberg, Liat; Birger, Yehudit; Izraeli, Shai; Gamis, Alan S.; Smith, Franklin O.; Woods, William G.; Taub, Jeffrey; Scherer, Christina A.; Bradner, James E.; Goh, Boon-Cher; Mercher, Thomas; Carpenter, Anne E.; Gould, Robert J.; Clemons, Paul A.; Carr, Steven A.; Root, David E.; Schreiber, Stuart L.; Stern, Andrew M.; Crispino, John D.			Identification of Regulators of Polyploidization Presents Therapeutic Targets for Treatment of AMKL	CELL			English	Article							ACUTE MEGAKARYOBLASTIC LEUKEMIA; ACUTE MEGAKARYOCYTIC LEUKEMIA; AURORA-A KINASE; INHIBITOR MLN8237; DOWN-SYNDROME; CELL-CYCLE; B KINASE; PHOSPHORYLATION; MEGAKARYOPOIESIS; VALIDATION	The mechanism by which cells decide to skip mitosis to become polyploid is largely undefined. Here we used a high-content image-based screen to identify small-molecule probes that induce polyploidization of megakaryocytic leukemia cells and serve as perturbagens to help understand this process. Our study implicates five networks of kinases that regulate the switch to polyploidy. Moreover, we find that dimethylfasudil (diMF, H-1152P) selectively increased polyploidization, mature cell-surface marker expression, and apoptosis of malignant megakaryocytes. An integrated target identification approach employing proteomic and shRNA screening revealed that a major target of diMF is Aurora kinase A (AURKA). We further find that MLN8237 (Alisertib), a selective inhibitor of AURKA, induced polyploidization and expression of mature megakaryocyte markers in acute megakaryocytic leukemia (AMKL) blasts and displayed potent anti-AMKL activity in vivo. Our findings provide a rationale to support clinical trials of MLN8237 and other inducers of polyploidization and differentiation in AMKL.	[Silver, Serena J.; Schenone, Monica; Dancik, Vlado; Lewis, Timothy A.; An, W. Frank; Li, Xiaoyu; Bray, Mark-Anthony; Vokes, Martha S.; Moore, Christopher B.; Bliss-Moreau, Meghan; VerPlank, Lynn; Tolliday, Nicola J.; Scherer, Christina A.; Bradner, James E.; Carpenter, Anne E.; Gould, Robert J.; Clemons, Paul A.; Carr, Steven A.; Root, David E.; Schreiber, Stuart L.; Stern, Andrew M.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Wen, Qiang; Goldenson, Benjamin; Huang, Zan; Diebold, Lauren; Gilles, Laure; Crispino, John D.] Northwestern Univ, Div Hematol Oncol, Chicago, IL 60611 USA; [Wang, Ling-Zhi; Goh, Boon-Cher] Natl Univ Singapore, Canc Sci Inst, Singapore 117599, Singapore; [Thiollier, Clarisse; Lopez, Cecile K.; Mercher, Thomas] Inst Gustave Roussy, INSERM, U985, F-94805 Villejuif, France; [Mishra, Rama] CMIDD, Evanston, IL USA; [Mishra, Rama] Northwestern Univ, Chicago, IL 60208 USA; [Vemula, Sasidhar; Shi, Jianjian; Wei, Lei; Kapur, Reuben] Indiana Univ, Dept Pediat, Indianapolis, IN 46202 USA; [Gerby, Bastien; Pflumio, Francoise] INSERM, CEA, Inst Radiobiol Cellulaire & Mol, EA 92265,UMR967, Fontenay Aux Roses, France; [Ballerini, Paola] Hop Trousseau, AP HP, F-75571 Paris, France; [Gilliland, D. Gary] Merck Sharp & Dohme Ltd, West Point, PA 19446 USA; [Goldberg, Liat; Birger, Yehudit; Izraeli, Shai] Tel Aviv Univ, Sheba Med Ctr, IL-52621 Ramat Gan, Israel; [Gamis, Alan S.] Childrens Mercy Hosp & Clin, Kansas City, MO 64108 USA; [Smith, Franklin O.] Univ Cincinnati, Inst Canc, Cincinnati, OH 45229 USA; [Woods, William G.] Childrens Healthcare Atlanta, Aflac Canc Ctr, Atlanta, GA 30322 USA; [Woods, William G.] Emory Univ, Atlanta, GA 30322 USA; [Taub, Jeffrey] Childrens Hosp Michigan, Detroit, MI 48201 USA; [Bradner, James E.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Northwestern University; National University of Singapore; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; Northwestern University; Indiana University System; Indiana University-Purdue University Indianapolis; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Merck & Company; Chaim Sheba Medical Center; Tel Aviv University; Children's Mercy Hospital; University System of Ohio; University of Cincinnati; Children's Healthcare of Atlanta (CHOA); Emory University; Children's Hospital of Michigan; Harvard University; Dana-Farber Cancer Institute	Stern, AM (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.	astern@broadinstitute.org; j-crispino@northwestern.edu	Mercher, Thomas/J-2446-2014; Carpenter, Anne/C-4982-2008; Carr, Steven A./AAH-8366-2019; Gerby, Bastien/D-8623-2017; Bray, Mark/C-5973-2008; Pflumio, Francoise/E-2074-2017; Wang, Lingzhi/AAF-1851-2020	Mercher, Thomas/0000-0003-1552-087X; Carpenter, Anne/0000-0003-1555-8261; Gerby, Bastien/0000-0002-2657-4200; Bray, Mark/0000-0002-9748-3592; Wang, Lingzhi/0000-0001-5585-5426; Lopez, Cecile/0000-0003-4473-6311; Crispino, John/0000-0002-8182-8306; Huang, Zan/0000-0001-5623-6950; Pflumio, Francoise/0000-0001-8995-596X; Goldenson, Benjamin/0000-0001-6724-7858; Lewis, Timothy/0000-0001-9748-9575; Stern, Andrew/0000-0002-8437-2957; Gilles, Laure/0000-0001-6567-256X	Samuel Waxman Cancer Research Foundation; US Israel Binational Science Foundation; Leukemia and Lymphoma Society Translational Research Program; Children with Leukaemia UK; Israel Science Foundation; European Hematology Association; Leukemia Research Foundation; NIH [CA101774, HL077177, HL075816, HL081111, GM089652, U54 HG005032, RL1-CA133834, RL1-GM084437, RL1-HG004671, UL1-DE019585]; Foundation Gustave Roussy; Jose Carreras Leukemia Foundation- European Hematology Association; CEA-EA; Ligue Nationale Contre le Cancer; Association Laurette Fugain; Societe Francaise d'Hematologie; Foundation pour la Recherche Medicale; National Cancer Institute (NCI) [U10 CA98543]; NCI's Initiative for Chemical Genetics [N01-CO-12400]; NATIONAL CANCER INSTITUTE [R01CA101774, RL1CA133834, U10CA098543] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081111, R01HL075816, R56HL075816, R01HL077177, P01HL085098] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RL1HG004671, U54HG005032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [UL1DE019585] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089652, RL1GM084437] Funding Source: NIH RePORTER	Samuel Waxman Cancer Research Foundation; US Israel Binational Science Foundation(US-Israel Binational Science Foundation); Leukemia and Lymphoma Society Translational Research Program(Leukemia and Lymphoma Society); Children with Leukaemia UK; Israel Science Foundation(Israel Science Foundation); European Hematology Association; Leukemia Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Gustave Roussy; Jose Carreras Leukemia Foundation- European Hematology Association; CEA-EA; Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Association Laurette Fugain; Societe Francaise d'Hematologie; Foundation pour la Recherche Medicale(Fondation pour la Recherche Medicale); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI's Initiative for Chemical Genetics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Sandeep Gurbuxani, Alex Minella, and Lou Dore for critical reading of the manuscript and Bang Wong for valuable advice on figures of the manuscript. This research was funded by grants from the Samuel Waxman Cancer Research Foundation (J.D.C. and S. I.), the US Israel Binational Science Foundation (to S. I. and J.D.C.), the Leukemia and Lymphoma Society Translational Research Program (J.D.C.), the Children with Leukaemia UK (S. I.), the Israel Science Foundation (S. I.), European Hematology Association (Y.B.), and the Leukemia Research Foundation (Y.B.) and by NIH grants CA101774 (J.D.C.), HL077177 (R. K.), HL075816 (R. K.), and HL081111 (R. K.). Other support included an NIH grant to A. E. C. supporting CellProfiler (GM089652), an NIH grant supporting screening informatics (U54 HG005032), NIH Genomics Based Drug Discovery U54 grants Discovery Pipeline RL1-CA133834, and Driving Medical Projects RL1-GM084437, administratively linked to NIH grants RL1-HG004671 and UL1-DE019585 (A. E. C., P. A. C., V. D., C. B. M., A. M. S., C. A. S., and M. S.). Y.B. is a European Hematology Association Fellow. In vivo treatment of human AMKL samples was supported by Foundation Gustave Roussy and Jose Carreras Leukemia Foundation- European Hematology Association (T. M.), CEA-EA, Ligue Nationale Contre le Cancer (F. P.), Association Laurette Fugain (F. P.), Societe Francaise d'Hematologie (B. G., F. P.), and Foundation pour la Recherche Medicale (C. T.). The authors would also like to thank Jason Berman, Soheil Meshinchi, Todd Alonzo, and Sommer Castro and the Children's Oncology Group (COG) for their assistance with DS-AMKL specimens. Research with DS-AMKL samples was supported by the Chair's Grant U10 CA98543 (to COG) from the National Cancer Institute (NCI). The project has also been funded in part with Federal funds from the NCI's Initiative for Chemical Genetics under Contract N01-CO-12400. The content of this publication is solely the responsibility of the authors and does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. A part of this work was performed by the Northwestern University ChemCore at the Center for Molecular Innovation and Drug Discovery (CMIDD), which is funded by the Chicago Biomedical Consortium with support from The Searle Funds at The Chicago Community Trust. D. G. G. is an employee and shareholder of Merck and Co., Inc. R.J.G. is an employee, shareholder, and board member of Epizyme, Inc. and a member of the SAB of the Michael J. Fox Foundation.	Bluteau D, 2009, J THROMB HAEMOST, V7, P227, DOI 10.1111/j.1538-7836.2009.03398.x; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cowley DO, 2009, MOL CELL BIOL, V29, P1059, DOI 10.1128/MCB.01062-08; D'Alise AM, 2008, MOL CANCER THER, V7, P1140, DOI 10.1158/1535-7163.MCT-07-2051; Ding J, 2011, MOL REPROD DEV, V78, P80, DOI 10.1002/mrd.21272; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Gorgun G, 2010, BLOOD, V115, P5202, DOI 10.1182/blood-2009-12-259523; Hitchcock IS, 2008, BLOOD, V111, P596, DOI 10.1182/blood-2007-05-089680; Ikenoya M, 2002, J NEUROCHEM, V81, P9, DOI 10.1046/j.1471-4159.2002.00801.x; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Lannutti BJ, 2006, ONCOGENE, V25, P3316, DOI 10.1038/sj.onc.1209351; Lannutti BJ, 2005, BLOOD, V105, P3875, DOI 10.1182/blood-2004-10-3934; Li Z, 2005, NAT GENET, V37, P613, DOI 10.1038/ng1566; Lok W, 2010, ANTI-CANCER DRUG, V21, P339, DOI 10.1097/CAD.0b013e3283350dd1; Lordier L, 2010, BLOOD, V116, P2345, DOI 10.1182/blood-2010-01-265785; Ma ZG, 2001, NAT GENET, V28, P220, DOI 10.1038/90054; Mali RS, 2011, CANCER CELL, V20, P357, DOI 10.1016/j.ccr.2011.07.016; Malinge S, 2009, BLOOD, V113, P2619, DOI 10.1182/blood-2008-11-163501; Manfredi MG, 2011, CLIN CANCER RES, V17, P7614, DOI 10.1158/1078-0432.CCR-11-1536; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Margolin AA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007454; Maris JM, 2010, PEDIATR BLOOD CANCER, V55, P26, DOI 10.1002/pbc.22430; Mercher T, 2001, P NATL ACAD SCI USA, V98, P5776, DOI 10.1073/pnas.101001498; Mercher T, 2009, J CLIN INVEST, V119, P852, DOI 10.1172/JCI35901; Mortlock AA, 2007, J MED CHEM, V50, P2213, DOI 10.1021/jm061335f; Muntean AG, 2007, BLOOD, V109, P5199, DOI 10.1182/blood-2006-11-059378; Ong SE, 2009, P NATL ACAD SCI USA, V106, P4617, DOI 10.1073/pnas.0900191106; Pradines JR, 2005, J COMPUT BIOL, V12, P113, DOI 10.1089/cmb.2005.12.113; SATO T, 1989, BRIT J HAEMATOL, V72, P184, DOI 10.1111/j.1365-2141.1989.tb07681.x; Sloane DA, 2010, ACS CHEM BIOL, V5, P563, DOI 10.1021/cb100053q; Stachura DL, 2006, BLOOD, V107, P87, DOI 10.1182/blood-2005-07-2740; Tallman MS, 2000, BLOOD, V96, P2405; Terstappen GC, 2007, NAT REV DRUG DISCOV, V6, P891, DOI 10.1038/nrd2410; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; Vemula S, 2010, BLOOD, V115, P1785, DOI 10.1182/blood-2009-08-237222; Wechsler J, 2002, NAT GENET, V32, P148, DOI 10.1038/ng955; Wen Q, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411002043; Wen Q, 2009, BLOOD, V114, P153, DOI 10.1182/blood-2008-11-190801; Wilkinson RW, 2007, CLIN CANCER RES, V13, P3682, DOI 10.1158/1078-0432.CCR-06-2979; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	41	111	117	1	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 3	2012	150	3					575	589		10.1016/j.cell.2012.06.032	http://dx.doi.org/10.1016/j.cell.2012.06.032			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	985WO	22863010	Green Submitted, Bronze, Green Accepted			2022-12-28	WOS:000307301400016
J	Ballantyne, AP; Alden, CB; Miller, JB; Tans, PP; White, JWC				Ballantyne, A. P.; Alden, C. B.; Miller, J. B.; Tans, P. P.; White, J. W. C.			Increase in observed net carbon dioxide uptake by land and oceans during the past 50 years	NATURE			English	Article							CO2; TRENDS; SINK	One of the greatest sources of uncertainty for future climate predictions is the response of the global carbon cycle to climate change(1). Although approximately one-half of total CO2 emissions is at present taken up by combined land and ocean carbon reservoirs(2), models predict a decline in future carbon uptake by these reservoirs, resulting in a positive carbon-climate feedback(3). Several recent studies suggest that rates of carbon uptake by the land(4-6) and ocean(7-10) have remained constant or declined in recent decades. Other work, however, has called into question the reported decline(11-13). Here we use global-scale atmospheric CO2 measurements, CO2 emission inventories and their full range of uncertainties to calculate changes in global CO2 sources and sinks during the past 50 years. Our mass balance analysis shows that net global carbon uptake has increased significantly by about 0.05 billion tonnes of carbon per year and that global carbon uptake doubled, from 2.4 +/- 0.8 to 5.0 +/- 0.9 billion tonnes per year, between 1960 and 2010. Therefore, it is very unlikely that both land and ocean carbon sinks have decreased on a global scale. Since 1959, approximately 350 billion tonnes of carbon have been emitted by humans to the atmosphere, of which about 55 per cent has moved into the land and oceans. Thus, identifying the mechanisms and locations responsible for increasing global carbon uptake remains a critical challenge in constraining the modern global carbon budget and predicting future carbon-climate interactions.	[Ballantyne, A. P.; White, J. W. C.] Univ Colorado, Dept Geol, Boulder, CO 80309 USA; [Alden, C. B.; White, J. W. C.] Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA; [Miller, J. B.] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Miller, J. B.; Tans, P. P.] Natl Oceanog & Atmospher Adm, Earth Syst Res Lab, Boulder, CO 80305 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; National Oceanic Atmospheric Admin (NOAA) - USA	Ballantyne, AP (corresponding author), Univ Montana, Dept Ecosyst & Conservat Sci, Missoula, MT 59812 USA.	apballantyne@gmail.com	Miller, John B./AAE-7714-2019; Tans, Pieter/AAG-8273-2019; Alden, Caroline B/P-4328-2018; White, James W.C./A-7845-2009	Miller, John B./0000-0001-8630-1610; Tans, Pieter/0000-0002-9883-0787; Alden, Caroline B/0000-0002-5249-7800; White, James W.C./0000-0001-6041-4684	US National Research Council; US National Science Foundation	US National Research Council; US National Science Foundation(National Science Foundation (NSF))	A.P.B. was supported by the US National Research Council and the US National Science Foundation. This manuscript benefitted from comments from J. Neff, N. Lovenduski and G. Marland. We also thank K. Masarie for performing the bootstrap calculations on the atmospheric CO<INF>2</INF> sampling network. This work would not have been possible without the careful measurements made by scientists at NOAA ESRL and volunteer sample collectors throughout the world.	Andrews AE, 2001, J GEOPHYS RES-ATMOS, V106, P10257, DOI 10.1029/2000JD900703; Boden T.A., 2010, GLOBAL REGIONAL NATL; BP, 2011, STAT REV WORLD EN; Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104; Carter A., 1989, GEOPHYS MONOGR SER, V55, P165, DOI DOI 10.1029/GM055P0165; European Commission, 2009, EUR EDGAR OV; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Friedlingstein P, 2010, NAT GEOSCI, V3, P811, DOI 10.1038/ngeo1022; Gloor M, 2010, ATMOS CHEM PHYS, V10, P7739, DOI 10.5194/acp-10-7739-2010; GRIFFITH DWT, 1982, TELLUS, V34, P385; Houghton RA, 2003, TELLUS B, V55, P378, DOI 10.1034/j.1600-0889.2003.01450.x; Knorr W, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040613; Le Quere C, 2007, SCIENCE, V316, P1735, DOI 10.1126/science.1136188; Le Quere C, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003599; Le Quere C, 2009, NAT GEOSCI, V2, P831, DOI 10.1038/ngeo689; Marland G, 2009, J IND ECOL, V13, P4, DOI 10.1111/j.1530-9290.2009.00108.x; MASARIE KA, 1995, J GEOPHYS RES-ATMOS, V100, P11593, DOI 10.1029/95JD00859; McKinley GA, 2011, NAT GEOSCI, V4, P606, DOI 10.1038/ngeo1193; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Piao SL, 2008, NATURE, V451, P49, DOI 10.1038/nature06444; Sarmiento JL, 2010, BIOGEOSCIENCES, V7, P2351, DOI 10.5194/bg-7-2351-2010; Schimel DS, 2001, NATURE, V414, P169, DOI 10.1038/35102500; Schuster U, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003941; Stocker B., 2011, BIOGEOSCIENCES, V7, P921; Yang X, 2010, BIOGEOSCIENCES, V7, P3041, DOI 10.5194/bg-7-3041-2010; Zhao MS, 2010, SCIENCE, V329, P940, DOI [10.1126/science.1192666, 10.1126/science.1189590]	27	410	428	31	519	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 2	2012	488	7409					70	+		10.1038/nature11299	http://dx.doi.org/10.1038/nature11299			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ZE	22859203				2022-12-28	WOS:000307010700034
J	Williams, JB; Peterson, ED; Brennan, JM; Sedrakyan, A; Tavris, D; Alexander, JH; Lopes, RD; Dokholyan, RS; Zhao, Y; O'Brien, SM; Michler, RE; Thourani, VH; Edwards, FH; Duggirala, H; Gross, T; Marinac-Dabic, D; Smith, PK				Williams, Judson B.; Peterson, Eric D.; Brennan, J. Matthew; Sedrakyan, Art; Tavris, Dale; Alexander, John H.; Lopes, Renato D.; Dokholyan, Rachel S.; Zhao, Yue; O'Brien, Sean M.; Michler, Robert E.; Thourani, Vinod H.; Edwards, Fred H.; Duggirala, Hesha; Gross, Thomas; Marinac-Dabic, Danica; Smith, Peter K.			Association Between Endoscopic vs Open Vein-Graft Harvesting and Mortality, Wound Complications, and Cardiovascular Events in Patients Undergoing CABG Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROSPECTIVE RANDOMIZED-TRIAL; ARTERY-BYPASS-SURGERY; PROPORTIONAL HAZARDS MODEL; SAPHENOUS-VEIN; PROPENSITY-SCORE; SOCIETY; DISCRETE; MEDICARE; SURVIVAL; DATABASE	Context The safety and durability of endoscopic vein graft harvest in coronary artery bypass graft (CABG) surgery has recently been called into question. Objective To compare the long-term outcomes of endoscopic vs open vein-graft harvesting for Medicare patients undergoing CABG surgery in the United States. Design, Setting, and Patients An observational study of 235 394 Medicare patients undergoing isolated CABG surgery between 2003 and 2008 at 934 surgical centers participating in the Society of Thoracic Surgeons (STS) national database. The STS records were linked to Medicare files to allow longitudinal assessment (median 3-year follow-up) through December 31, 2008. Main Outcome Measures All-cause mortality. Secondary outcome measures included wound complications and the composite of death, myocardial infarction, and revascularization. Results Based on Medicare Part B coding, 52% of patients received endoscopic vein-graft harvesting during CABG surgery. After propensity score adjustment for clinical characteristics, there were no significant differences between long-term mortality rates (13.2% [12 429 events] vs 13.4% [13 096 events]) and the composite of death, myocardial infarction, and revascularization (19.5% [18 419 events] vs 19.7% [19 232 events]). Time-to-event analysis for those patients receiving endoscopic vs open vein-graft harvesting revealed adjusted hazard ratios [HRs] of 1.00 (95% CI, 0.97-1.04) for mortality and 1.00 (95% CI, 0.98-1.05) for the composite outcome. Endoscopic vein-graft harvesting was associated with lower harvest site wound complications relative to open vein-graft harvesting (3.0% [3654/122 899 events] vs 3.6% [4047/112 495 events]; adjusted HR, 0.83; 95% CI, 0.77-0.89; P < .001). Conclusion Among patients undergoing CABG surgery, the use of endoscopic vein-graft harvesting compared with open vein-graft harvesting was not associated with increased mortality.	[Williams, Judson B.; Smith, Peter K.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Williams, Judson B.; Peterson, Eric D.; Brennan, J. Matthew; Alexander, John H.; Lopes, Renato D.; Dokholyan, Rachel S.; Zhao, Yue; O'Brien, Sean M.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA; [Peterson, Eric D.; Brennan, J. Matthew; Alexander, John H.; Lopes, Renato D.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Sedrakyan, Art] Weill Cornell Med Coll, New York, NY USA; [Tavris, Dale; Duggirala, Hesha; Marinac-Dabic, Danica] US FDA, Silver Spring, MD USA; [Michler, Robert E.] Albert Einstein Coll Med, Montefiore Med Ctr, Dept Cardiovasc & Thorac Surg, New York, NY USA; [Thourani, Vinod H.] Emory Univ, Sch Med, Joseph B Whitehead Dept Surg, Atlanta, GA 30322 USA; [Edwards, Fred H.] Univ Florida, Shands Hosp, Jacksonville, FL USA	Duke University; Duke University; Duke University; Cornell University; US Food & Drug Administration (FDA); Montefiore Medical Center; Yeshiva University; Emory University; State University System of Florida; University of Florida	Smith, PK (corresponding author), Duke Univ, Med Ctr, Dept Surg, Box 3442, Durham, NC 27710 USA.	smith058@mc.duke.edu	Peterson, Eric David/ABF-5033-2021; Alexander, John/GVS-7271-2022; O'Brien, Sean/H-6268-2013; thourani, vinod/AAP-5968-2020	Alexander, John/0000-0002-1444-2462; Marinac-Dabic, Danica/0000-0002-1824-0104; Douglas, Pamela/0000-0001-9876-4049	US Food and Drug Administration through Society of Thoracic Surgeons; National Institutes of Health [T32-HL069749]; National Heart, Lung, and Blood Institute [U01-HL088953]; Eli Lilly; Janssen Pharmaceuticals; Society of Thoracic Surgeons; AstraZeneca; Boehringer-Ingelheim; Daiichi Sankyo; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL088953, T32HL069749] Funding Source: NIH RePORTER	US Food and Drug Administration through Society of Thoracic Surgeons; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Eli Lilly(Eli Lilly); Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Society of Thoracic Surgeons; AstraZeneca(AstraZeneca); Boehringer-Ingelheim(Boehringer Ingelheim); Daiichi Sankyo(Daiichi Sankyo Company Limited); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Peterson reported receiving grants from Eli Lilly, Janssen Pharmaceuticals, and Society of Thoracic Surgeons. Dr Alexander reported being a co-investigator for the Duke Core Clinical Center in the National Institutes of Health CT Surgery Network and being on the Veterans Affairs Cooperative Studies Program Protocol Review Committee. Dr Lopes reported being a consultant for and board membership of Boehringer-Ingelheim and Bristol-Myers Squibb, and receiving grants from AstraZeneca, Boehringer-Ingelheim, and Daiichi Sankyo. Dr Thourani reported receiving honoraria for lectures and being on the advisory board of Maquet Medical. Dr Smith reported receiving honoraria from Society of Thoracic Surgeons. No other authors reported any financial disclosures.; This study was funded by the US Food and Drug Administration through a contract with the Society of Thoracic Surgeons. Dr Williams is supported in part by training grant T32-HL069749 from the National Institutes of Health and is a Cardiothoracic Surgical Trials Network Scholar supported by grant U01-HL088953 from the National Heart, Lung, and Blood Institute, which also supports Drs Smith, Alexander, Thourani, and Michler as investigators of the Cardiothoracic Surgical Trials Network.	Alexander JH, 2005, JAMA-J AM MED ASSOC, V294, P2446; Allen KB, 2003, HEART SURG FORUM, V6, pE143; Allen KB, 1998, ANN THORAC SURG, V66, P26, DOI 10.1016/S0003-4975(98)00392-0; Allen K, 2005, INNOVATIONS, V1, P51, DOI 10.1097/01.gim.0000196315.32179.82; Andreasen JJ, 2008, EUR J CARDIO-THORAC, V34, P384, DOI 10.1016/j.ejcts.2008.04.028; Austin PC, 2008, STAT MED, V27, P2037, DOI 10.1002/sim.3150; Barnard JB, 2011, HEART, V97, P327, DOI 10.1136/hrt.2010.209668; Breslow NE, 1972, J R STAT SOC A STAT, P216; Cole SR, 2004, COMPUT METH PROG BIO, V75, P45, DOI 10.1016/j.cmpb.2003.10.004; Connolly MW, 2009, NEW ENGL J MED, V361, P1907; Cook RC, 2004, J THORAC CARDIOV SUR, V127, P65, DOI 10.1016/S0022-5223(03)01024-9; Curtis LH, 2007, MED CARE, V45, pS103, DOI 10.1097/MLR.0b013e31806518ac; Dacey LJ, 2011, CIRCULATION, V123, P147, DOI 10.1161/CIRCULATIONAHA.110.960765; Hammill BG, 2009, AM HEART J, V157, P995, DOI 10.1016/j.ahj.2009.04.002; Jacobs JP, 2010, ANN THORAC SURG, V90, P1150, DOI 10.1016/j.athoracsur.2010.05.042; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kiaii B, 2002, J THORAC CARDIOV SUR, V123, P204, DOI 10.1067/mtc.2002.118682; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; Lopes RD, 2009, NEW ENGL J MED, V361, P235, DOI 10.1056/NEJMoa0900708; Lumsden A B, 1996, Cardiovasc Surg, V4, P771, DOI 10.1016/S0967-2109(96)00055-5; Lumsden AB, 1995, ENDOSCOPIC PLASTIC S, P535; Markar SR, 2010, INTERACT CARDIOV TH, V10, P266, DOI 10.1510/icvts.2009.222430; NICE, 2010, END SAPH VEIN HARV C; O'Brien SM, 2009, ANN THORAC SURG, V88, pS23, DOI 10.1016/j.athoracsur.2009.05.056; Ouzounian M, 2010, ANN THORAC SURG, V89, P403, DOI 10.1016/j.athoracsur.2009.09.061; Patel NN, 2009, NAT REV CARDIOL, V6, P738, DOI 10.1038/nrcardio.2009.190; Puskas JD, 1999, ANN THORAC SURG, V68, P1509, DOI 10.1016/S0003-4975(99)00952-2; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rousou LJ, 2009, ANN THORAC SURG, V87, P62, DOI 10.1016/j.athoracsur.2008.08.049; Schurr UP, 2002, THORAC CARDIOV SURG, V50, P160, DOI 10.1055/s-2002-32412; Shahian DM, 2009, ANN THORAC SURG, V88, pS2, DOI 10.1016/j.athoracsur.2009.05.053; Shroyer AL, 2009, NEW ENGL J MED, V361, P1827, DOI 10.1056/NEJMoa0902905; Wang SH, 2005, ANN THORAC SURG, V79, P2018, DOI 10.1016/j.athoracsur.2004.12.024; Welke KF, 2004, ANN THORAC SURG, V77, P1137, DOI 10.1016/j.athoracsur.2003.07.030; Yun KL, 2005, J THORAC CARDIOV SUR, V129, P496, DOI 10.1016/j.jtcvs.2004.08.054; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zenati MA, 2011, J THORAC CARDIOV SUR, V141, P338, DOI 10.1016/j.jtcvs.2010.10.004; Zucker DM, 2008, STAT MED, V27, P1911, DOI 10.1002/sim.3159	39	70	80	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2012	308	5					475	484		10.1001/jama.2012.8363	http://dx.doi.org/10.1001/jama.2012.8363			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	981DQ	22851114	Green Accepted			2022-12-28	WOS:000306947400025
J	Jarrell, TA; Wang, Y; Bloniarz, AE; Brittin, CA; Xu, M; Thomson, JN; Albertson, DG; Hall, DH; Emmons, SW				Jarrell, Travis A.; Wang, Yi; Bloniarz, Adam E.; Brittin, Christopher A.; Xu, Meng; Thomson, J. Nichol; Albertson, Donna G.; Hall, David H.; Emmons, Scott W.			The Connectome of a Decision-Making Neural Network	SCIENCE			English	Article							MALE MATING-BEHAVIOR; CAENORHABDITIS-ELEGANS MALE; C-ELEGANS; ULTRASTRUCTURAL ANALYSIS; SENSORY REGULATION; MODEL; NEURONS; GENERATION; DYNAMICS; MALES	In order to understand the nervous system, it is necessary to know the synaptic connections between the neurons, yet to date, only the wiring diagram of the adult hermaphrodite of the nematode Caenorhabditis elegans has been determined. Here, we present the wiring diagram of the posterior nervous system of the C. elegans adult male, reconstructed from serial electron micrograph sections. This region of the male nervous system contains the sexually dimorphic circuits for mating. The synaptic connections, both chemical and gap junctional, form a neural network with four striking features: multiple, parallel, short synaptic pathways directly connecting sensory neurons to end organs; recurrent and reciprocal connectivity among sensory neurons; modular substructure; and interneurons acting in feedforward loops. These features help to explain how the network robustly and rapidly selects and executes the steps of a behavioral program on the basis of the inputs from multiple sensory neurons.	[Jarrell, Travis A.; Wang, Yi; Bloniarz, Adam E.; Brittin, Christopher A.; Xu, Meng; Emmons, Scott W.] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Thomson, J. Nichol; Albertson, Donna G.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Hall, David H.; Emmons, Scott W.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; MRC Laboratory Molecular Biology; Yeshiva University; Albert Einstein College of Medicine	Emmons, SW (corresponding author), Albert Einstein Coll Med, Dept Genet, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	scott.emmons@einstein.yu.edu			MRC; U.S. NIH [R21MH63223, OD 010943]; G. Harold and Leila Y. Mathers Charitable Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH063223] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD010943] Funding Source: NIH RePORTER	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G. Harold and Leila Y. Mathers Charitable Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	H. Eckholdt played a key role in the early stages of this project. Contributions were also made by Z. Martirosyan, A. Singh, T. Stephney, and M. Zhang. C. Crocker made the figures. We thank J. White for encouragement and interest; A. Bergman, M. Chklovskii, D. Faber, A. Massimi, and S. Seung for helpful discussions; N. Baker, H. Buelow, D. Faber, R. Garcia, Z. Kaprielian, R. Lints, D. Portman, J. Sze, and J. Vijg for comments on the manuscript; and J. White and J. Hodgkin for their help in transferring archival transmission EM data from the U.K. Medical Research Council (MRC)-Laboratory of Molecular Biology to the Hall lab at Einstein for long-term curation and study. This work was supported by MRC, the U.S. NIH (R21MH63223 to S.W.E. and OD 010943 to D.H.H.), and by the G. Harold and Leila Y. Mathers Charitable Foundation.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Barr MM, 1999, NATURE, V401, P386, DOI 10.1038/43916; BARR MM, 2006, WORMBOOK; Barrios A, 2008, CURR BIOL, V18, P1865, DOI 10.1016/j.cub.2008.10.050; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; BRENNER S, 1974, GENETICS, V77, P71; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; de Bono M, 2005, ANNU REV NEUROSCI, V28, P451, DOI 10.1146/annurev.neuro.27.070203.144259; de Bono M, 2007, COLD SPRING HARB MON, V49, P437; Garcia LR, 2007, GENETICS, V175, P1761, DOI 10.1534/genetics.106.068304; Garcia LR, 2001, CELL, V107, P777, DOI 10.1016/S0092-8674(01)00600-6; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; Haykin S., 2009, NEURAL NETWORKS LEAR; Hertz JA, 2018, INTRO THEORY NEURAL; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Jezek K, 2011, NATURE, V478, P246, DOI 10.1038/nature10439; Kleemann GA, 2007, ANIM BEHAV, V74, P1339, DOI 10.1016/j.anbehav.2007.02.031; KLEINFELD D, 1986, P NATL ACAD SCI USA, V83, P9469, DOI 10.1073/pnas.83.24.9469; KLEINFELD D, 1988, BIOPHYS J, V54, P1039, DOI 10.1016/S0006-3495(88)83041-8; Koo PK, 2011, J NEUROSCI, V31, P7497, DOI 10.1523/JNEUROSCI.6153-10.2011; Leicht EA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118703; Lichtman JW, 2008, CURR OPIN NEUROBIOL, V18, P346, DOI 10.1016/j.conb.2008.08.010; Lipton J, 2004, J NEUROSCI, V24, P7427, DOI 10.1523/JNEUROSCI.1746-04.2004; Liu K., 1995, THESIS CALTECH; LIU KS, 1995, NEURON, V14, P79, DOI 10.1016/0896-6273(95)90242-2; Liu YS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001326; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Mishchenko Y, 2010, NEURON, V67, P1009, DOI 10.1016/j.neuron.2010.08.014; Nagarajan N, 2008, CURR BIOL, V18, pR756, DOI 10.1016/j.cub.2008.06.043; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Niessing J, 2010, NATURE, V465, P47, DOI 10.1038/nature08961; ROSENBLATT F, 1958, PSYCHOL REV, V65, P386, DOI 10.1037/h0042519; Schikorski T, 1997, J NEUROSCI, V17, P5858; Seung HS, 2009, NEURON, V62, P17, DOI 10.1016/j.neuron.2009.03.020; Seung S., 2012, CONNECTOME BRAINS WI; Simon JM, 2002, P NATL ACAD SCI USA, V99, P1598, DOI 10.1073/pnas.032225799; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; SULSTON JE, 1980, DEV BIOL, V78, P542, DOI 10.1016/0012-1606(80)90352-8; Varshney LR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001066; Wang XJ, 2008, NEURON, V60, P215, DOI 10.1016/j.neuron.2008.09.034; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; White JQ, 2007, CURR BIOL, V17, P1847, DOI 10.1016/j.cub.2007.09.011; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Whittaker AJ, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-33; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905	45	272	274	4	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2012	337	6093					437	444		10.1126/science.1221762	http://dx.doi.org/10.1126/science.1221762			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979FS	22837521				2022-12-28	WOS:000306802300035
J	Delamothe, T				Delamothe, Tony			Monkey business: reflections on testosterone	BRITISH MEDICAL JOURNAL			English	Editorial Material												tdelamothe@bmj.com						Badenoch A W, 1986, Br Med J (Clin Res Ed), V293, P1005; Benatar David, 2012, 2 SEXISM DISCRIMINAT; Coates J., 2012, HOUR DOG WOLF RISK T; Coates JM, 2008, P NATL ACAD SCI USA, V105, P6167, DOI 10.1073/pnas.0704025105; Norrish M, 2009, DAILY TELEGRAPH; VINES G, 1993, RAGING HORMONES DO T; Wallace W, 2012, FINANCIAL TIMES; Wu FCW, 2010, NEW ENGL J MED, V363, P123, DOI 10.1056/NEJMoa0911101	8	6	6	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUL 23	2012	345								e4967	10.1136/bmj.e4967	http://dx.doi.org/10.1136/bmj.e4967			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	981UP	22826580				2022-12-28	WOS:000306996800012
